PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dalziel, SR; Crowther, CA; Harding, JE				Dalziel, Stuart R.; Crowther, Caroline A.; Harding, Jane E.			Antenatal corticosteroids 40 years on: we can do better	LANCET			English	Editorial Material							SYSTEMATIC ANALYSIS; CONTROLLED-TRIAL; PRETERM BIRTH; TIME TRENDS; COUNTRIES; RISK		[Dalziel, Stuart R.] Starship Childrens Hosp, Auckland 1142, New Zealand; [Dalziel, Stuart R.; Crowther, Caroline A.; Harding, Jane E.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	Starship Children's Hospital; University of Auckland	Dalziel, SR (corresponding author), Starship Childrens Hosp, Auckland 1142, New Zealand.	sdalziel@adhb.govt.nz	Harding, Jane E/J-5853-2015	Harding, Jane E/0000-0003-2697-1422				Althabe F, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-22; [Anonymous], 1994, NIH Consens Statement, V12, P1; Azad K, 2014, LANCET GLOB HEALTH, V2, pE191, DOI 10.1016/S2214-109X(14)70020-8; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Dalziel SR, 2005, LANCET, V365, P1856, DOI 10.1016/S0140-6736(05)66617-2; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S5; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; United Nations, MILL DEV GOAL 4 RED; Vogel JP, 2014, LANCET; Wellcome Trust, 2021, US	12	4	4	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1829	1831		10.1016/S0140-6736(14)60722-4	http://dx.doi.org/10.1016/S0140-6736(14)60722-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7LA	25128272				2022-12-28	WOS:000345116800008
J	Wilensky, GR; Berwick, DM				Wilensky, Gail R.; Berwick, Donald M.			Reforming the Financing and Governance of GME	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wilensky, Gail R.] Project HOPE, Bethesda, MD 20814 USA; [Berwick, Donald M.] Inst Healthcare Improvement, Cambridge, MA USA	Institute for Healthcare Improvement	Wilensky, GR (corresponding author), Project HOPE, Bethesda, MD 20814 USA.							[Anonymous], 2011, ENS EFF PHYS WORKF U; [Anonymous], 2010, ENS EFF PHYS WORKF A; Berwick DM, 2008, HEALTH AFFAIR, V27, P759, DOI 10.1377/hlthaff.27.3.759; Eden J., 2014, GRADUATE MED ED MEET	4	19	19	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					792	793		10.1056/NEJMp1406174	http://dx.doi.org/10.1056/NEJMp1406174			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZN	25075619				2022-12-28	WOS:000340819800003
J	Kobayashi, I; Kobayashi-Sun, J; Kim, AD; Pouget, C; Fujita, N; Suda, T; Traver, D				Kobayashi, Isao; Kobayashi-Sun, Jingjing; Kim, Albert D.; Pouget, Claire; Fujita, Naonobu; Suda, Toshio; Traver, David			Jam1a-Jam2a interactions regulate haematopoietic stem cell fate through Notch signalling	NATURE			English	Article							AORTIC ENDOTHELIUM; JAM-B; ZEBRAFISH; GENE; EXPRESSION; MAINTENANCE; SPADETAIL; RECEPTOR	Notch signalling plays a key role in the generation of haematopoietic stem cells (HSCs) during vertebrate development(1-3) and requires intimate contact between signal-emitting and signal-receiving cells, although little is known regarding when, where and how these intercellular events occur. We previously reported that the somitic Notch ligands, Dlc and Dld, are essential for HSC specification(4). It has remained unclear, however, how these somitic requirements are connected to the later emergence of HSCs from the dorsal aorta. Here we show in zebrafish that Notch signalling establishes HSC fate as their shared vascular precursors migrate across the ventral face of the somite and that junctional adhesion molecules (JAMs) mediate this required Notch signal transduction. HSC precursors express jam1a (also known as f11r) and migrate axially across the ventral somite, where Jam2a and the Notch ligands Dlc and Dld are expressed. Despite no alteration in the expression of Notch ligand or receptor genes, loss of function of jam1a led to loss of Notch signalling and loss of HSCs. Enforced activation of Notch in shared vascular precursors rescued HSCs in jam1a or jam2a deficient embryos. Together, these results indicate that Jam1a-Jam2a interactions facilitate the transduction of requisite Notch signals from the somite to the precursors of HSCs, and that these events occur well before formation of the dorsal aorta.	[Kobayashi, Isao; Kobayashi-Sun, Jingjing; Kim, Albert D.; Pouget, Claire; Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Fujita, Naonobu; Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab, Dept Cell Differentiat,Shinjuku Ku, Tokyo 1608582, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; Keio University	Traver, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	dtraver@ucsd.edu	Pouget, Claire/M-9761-2016; Suda, Toshio/H-6761-2013; Fujita, Naonobu/A-1218-2010	Pouget, Claire/0000-0003-4598-6291; Suda, Toshio/0000-0001-7540-1771; Fujita, Naonobu/0000-0003-1914-8438	JSPS; California Institute of Regenerative Medicine; National Institutes of Health [R01-DK074482]; American Heart Association; Grants-in-Aid for Scientific Research [26221309] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074482] Funding Source: NIH RePORTER	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank G. Wright for providing the jam2a<SUP>hu3319</SUP> line, A. Shimizu for help in generating transgenic lines, M. Osato for providing the I-SceI-pBSII SK+ vector, M. Distel for providing phldb1:Gal4-mCherry animals, and W. Clements, Y. Lee and E. Butko provided critical evaluation of the manuscript. This work was supported in part by a JSPS Research fellowship for Young Scientists and a JSPS Postdoctoral fellowship for Research Abroad (I.K.), by a New Investigator Award from the California Institute of Regenerative Medicine, R01-DK074482 from the National Institutes of Health, and an Innovative Science Award from the American Heart Association (D.T.).	Ahimou F, 2004, J CELL BIOL, V167, P1217, DOI 10.1083/jcb.200407100; Arcangeli ML, 2011, BLOOD, V118, P4609, DOI 10.1182/blood-2010-12-323972; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; FurutaniSeiki M, 1996, DEVELOPMENT, V123, P229; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kobayashi I, 2008, BLOOD, V111, P1131, DOI 10.1182/blood-2007-08-104299; Kobayashi I, 2010, BLOOD, V115, pE1, DOI 10.1182/blood-2009-07-232322; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Parsons MJ, 2009, MECH DEVELOP, V126, P898, DOI 10.1016/j.mod.2009.07.002; Powell GT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040810; Powell GT, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001216; Qian F, 2007, PLOS BIOL, V5, P1110, DOI 10.1371/journal.pbio.0050132; Sakaguchi T, 2006, MOL CELL BIOL, V26, P6557, DOI 10.1128/MCB.00729-06; Sugano Y, 2008, BLOOD, V111, P1167, DOI 10.1182/blood-2007-03-081554; THISSE C, 1993, DEVELOPMENT, V119, P1203; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wilkinson RN, 2012, BLOOD, V120, P477, DOI 10.1182/blood-2011-10-383729; Yoon MJ, 2008, MOL CELL BIOL, V28, P4794, DOI 10.1128/MCB.00436-08; Zygmunt T, 2011, DEV CELL, V21, P301, DOI 10.1016/j.devcel.2011.06.033	32	85	91	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					319	+		10.1038/nature13623	http://dx.doi.org/10.1038/nature13623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119047	Green Accepted			2022-12-28	WOS:000340508200037
J	Hart, LE				Hart, Lawrence E.			Methotrexate reduced pain and improved function in symptomatic knee osteoarthritis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Hamilton, ON, Canada	McMaster University	Hart, LE (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Wenham CYJ, 2013, RHEUMATOLOGY, V52, P888, DOI 10.1093/rheumatology/kes386	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC6	10.7326/0003-4819-161-4-201408190-02006	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133385				2022-12-28	WOS:000342347300005
J	Westphal, AJ; Stroud, RM; Bechtel, HA; Brenker, FE; Butterworth, AL; Flynn, GJ; Frank, DR; Gainsforth, Z; Hillier, JK; Postberg, F; Simionovici, AS; Sterken, VJ; Nittler, LR; Allen, C; Anderson, D; Ansari, A; Bajt, S; Bastien, RK; Bassim, N; Bridges, J; Brownlee, DE; Burchell, M; Burghammer, M; Changela, H; Cloetens, P; Davis, AM; Doll, R; Floss, C; Gruen, E; Heck, PR; Hoppe, P; Hudson, B; Huth, J; Kearsley, A; King, AJ; Lai, B; Leitner, J; Lemelle, L; Leonard, A; Leroux, H; Lettieri, R; Marchant, W; Ogliore, R; Ong, WJ; Price, MC; Sandford, SA; Tresseras, JAS; Schmitz, S; Schoonjans, T; Schreiber, K; Silversmit, G; Sole, VA; Srama, R; Stadermann, F; Stephan, T; Stodolna, J; Sutton, S; Trieloff, M; Tsou, P; Tyliszczak, T; Vekemans, B; Vincze, L; Von Korff, J; Wordsworth, N; Zevin, D; Zolensky, ME				Westphal, Andrew J.; Stroud, Rhonda M.; Bechtel, Hans A.; Brenker, Frank E.; Butterworth, Anna L.; Flynn, George J.; Frank, David R.; Gainsforth, Zack; Hillier, Jon K.; Postberg, Frank; Simionovici, Alexandre S.; Sterken, Veerle J.; Nittler, Larry R.; Allen, Carlton; Anderson, David; Ansari, Asna; Bajt, Sasa; Bastien, Ron K.; Bassim, Nabil; Bridges, John; Brownlee, Donald E.; Burchell, Mark; Burghammer, Manfred; Changela, Hitesh; Cloetens, Peter; Davis, Andrew M.; Doll, Ryan; Floss, Christine; Gruen, Eberhard; Heck, Philipp R.; Hoppe, Peter; Hudson, Bruce; Huth, Joachim; Kearsley, Anton; King, Ashley J.; Lai, Barry; Leitner, Jan; Lemelle, Laurence; Leonard, Ariel; Leroux, Hugues; Lettieri, Robert; Marchant, William; Ogliore, Ryan; Ong, Wei Jia; Price, Mark C.; Sandford, Scott A.; Tresseras, Juan-Angel Sans; Schmitz, Sylvia; Schoonjans, Tom; Schreiber, Kate; Silversmit, Geert; Sole, Vicente A.; Srama, Ralf; Stadermann, Frank; Stephan, Thomas; Stodolna, Julien; Sutton, Stephen; Trieloff, Mario; Tsou, Peter; Tyliszczak, Tolek; Vekemans, Bart; Vincze, Laszlo; Von Korff, Joshua; Wordsworth, Naomi; Zevin, Daniel; Zolensky, Michael E.		30714 Stardust Home Dusters	Evidence for interstellar origin of seven dust particles collected by the Stardust spacecraft	SCIENCE			English	Article							COMET 81P/WILD 2; INTERPLANETARY DUST; SIZE DISTRIBUTION; GRAINS; IMPACTS; AEROGEL; EVENTS; WILD-2; RETURN; WIND	Seven particles captured by the Stardust Interstellar Dust Collector and returned to Earth for laboratory analysis have features consistent with an origin in the contemporary interstellar dust stream. More than 50 spacecraft debris particles were also identified. The interstellar dust candidates are readily distinguished from debris impacts on the basis of elemental composition and/or impact trajectory. The seven candidate interstellar particles are diverse in elemental composition, crystal structure, and size. The presence of crystalline grains and multiple iron-bearing phases, including sulfide, in some particles indicates that individual interstellar particles diverge from any one representative model of interstellar dust inferred from astronomical observations and theory.	[Westphal, Andrew J.; Butterworth, Anna L.; Gainsforth, Zack; Anderson, David; Lettieri, Robert; Marchant, William; Stodolna, Julien; Von Korff, Joshua; Zevin, Daniel] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Stroud, Rhonda M.; Bassim, Nabil] Naval Res Lab, Mat Sci & Technol Div, Washington, DC USA; [Bechtel, Hans A.; Tyliszczak, Tolek] Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA USA; [Brenker, Frank E.; Schmitz, Sylvia] Goethe Univ Frankfurt, Geosci Inst, D-60054 Frankfurt, Germany; [Flynn, George J.] SUNY Coll Plattsburgh, Plattsburgh, NY 12901 USA; [Frank, David R.; Bastien, Ron K.] NASA Johnson Space Ctr JSC, Jacobs Technol ESCG, Houston, TX USA; [Hillier, Jon K.; Postberg, Frank; Trieloff, Mario] Heidelberg Univ, Inst Geowissensch, D-69115 Heidelberg, Germany; [Simionovici, Alexandre S.] Observ Sci Univers Grenoble, Inst Sci Terre, Grenoble, France; [Sterken, Veerle J.] Univ Stuttgart, Inst Raumfahrtsyst IRS, D-70174 Stuttgart, Germany; [Sterken, Veerle J.] TU Braunschweig, IGEP, Braunschweig, Germany; [Sterken, Veerle J.; Gruen, Eberhard] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Sterken, Veerle J.; Heck, Philipp R.] Int Space Sci Inst, Bern, Switzerland; [Nittler, Larry R.] Carnegie Inst Sci, Washington, DC USA; [Allen, Carlton; Zolensky, Michael E.] NASA JSC, Houston, TX USA; [Ansari, Asna] Field Museum Nat Hist, Chicago, IL 60605 USA; [Bajt, Sasa] DESY, Hamburg, Germany; [Bridges, John] Univ Leicester, Space Res Ctr, Leicester, Leics, England; [Brownlee, Donald E.] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Burchell, Mark; Price, Mark C.] Univ Kent, Canterbury, Kent, England; [Burghammer, Manfred; Schoonjans, Tom; Silversmit, Geert; Vekemans, Bart; Vincze, Laszlo] Univ Ghent, B-9000 Ghent, Belgium; [Changela, Hitesh] Univ New Mexico, Albuquerque, NM 87131 USA; [Cloetens, Peter; Tresseras, Juan-Angel Sans; Sole, Vicente A.] ESRF, Grenoble, France; [Davis, Andrew M.; King, Ashley J.; Stephan, Thomas] Univ Chicago, Chicago, IL 60637 USA; [Doll, Ryan; Floss, Christine; Leonard, Ariel; Ong, Wei Jia; Schreiber, Kate; Stadermann, Frank] Washington Univ, St Louis, MO USA; [Hoppe, Peter; Huth, Joachim; Leitner, Jan] Max Planck Inst Chem, D-55128 Mainz, Germany; [Kearsley, Anton] Nat Hist Museum, London SW7 5BD, England; [Lai, Barry; Sutton, Stephen] Argonne Natl Lab, Adv Photon Source, Lemont, IL USA; [Lemelle, Laurence] Ecole Normale Super Lyon, F-69364 Lyon, France; [Leroux, Hugues] Univ Lille 1, F-59655 Villeneuve Dascq, France; [Ogliore, Ryan] Univ Hawaii Manoa, Honolulu, HI 96822 USA; [Sandford, Scott A.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Srama, Ralf] Univ Stuttgart, IRS, D-70174 Stuttgart, Germany; [Tsou, Peter] CALTECH, Jet Prop Lab, Pasadena, CA USA; [Wordsworth, Naomi] Wexbury, Stoke Poges, Bucks, England	University of California System; University of California Berkeley; United States Department of Defense; United States Navy; Naval Research Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Goethe University Frankfurt; State University of New York (SUNY) System; SUNY Plattsburgh; National Aeronautics & Space Administration (NASA); Ruprecht Karls University Heidelberg; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; University of Stuttgart; Braunschweig University of Technology; Max Planck Society; Carnegie Institution for Science; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Field Museum of Natural History (Chicago); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Leicester; University of Washington; University of Washington Seattle; University of Kent; Ghent University; University of New Mexico; European Synchrotron Radiation Facility (ESRF); University of Chicago; Washington University (WUSTL); Max Planck Society; Natural History Museum London; United States Department of Energy (DOE); Argonne National Laboratory; Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Lille - ISITE; Universite de Lille; University of Hawaii System; University of Hawaii Manoa; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Stuttgart; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Westphal, AJ (corresponding author), Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.	westphal@ssl.berkeley.edu	Heck, Philipp R/AAU-1433-2021; Stephan, Thomas/C-1023-2008; Postberg, Frank/AAE-6295-2019; Bajt, Sasa/G-2228-2010; Anderson, David/ABC-6011-2021; Stroud, Rhonda/GQZ-0151-2022; Simionovici, Alexandre S/E-5867-2018; Tresserras, Juan Angel Sans/T-8693-2019; Leitner, Jan/A-7391-2015; Vincze, Laszlo/AAP-3914-2020; Hoppe, Peter/B-3032-2015; Stroud, Rhonda M./C-5503-2008; Stroud, Rhonda M/S-4584-2018; Whittaker, Anna C./A-3577-2013; Sans, Juan Angel/J-9362-2014; Cloetens, Peter/AAJ-6131-2020; Leroux, Hugues/S-4570-2017; Bajt, Sasa/O-4695-2019; xi, yang/D-5413-2017; Sterken, Veerle/F-3371-2013	Heck, Philipp R/0000-0002-6319-2594; Stephan, Thomas/0000-0001-6377-8731; Postberg, Frank/0000-0002-5862-4276; Stroud, Rhonda/0000-0001-5242-8015; Simionovici, Alexandre S/0000-0001-5349-6482; Leitner, Jan/0000-0003-3655-6273; Hoppe, Peter/0000-0003-3681-050X; Stroud, Rhonda M./0000-0001-5242-8015; Stroud, Rhonda M/0000-0001-5242-8015; Whittaker, Anna C./0000-0002-5461-0598; Sans, Juan Angel/0000-0001-9047-3992; Cloetens, Peter/0000-0002-4129-9091; Leroux, Hugues/0000-0002-8806-8434; Bajt, Sasa/0000-0002-7163-7602; Zolensky, Michael/0000-0002-3181-1303; Butterworth, Anna/0000-0002-6439-1472; Schoonjans, Tom/0000-0002-3919-3546; xi, yang/0000-0002-2779-7895; Sterken, Veerle/0000-0003-0843-7912; King, Ashley/0000-0001-6113-5417; Sole, Vicente Armando/0000-0003-1107-9730; Burchell, Mark/0000-0002-2680-8943; Silversmit, Geert/0000-0003-1104-1839; Brenker, Frank Erich/0000-0002-9735-8206; Frank, David/0000-0002-3246-4841	NASA [NNX09AC36G, NNX09AC63G, NNH11AQ61I, NNX11AC21G, NNX11AE15G]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) [DE-AC02-05CH11231]; U.S. DOE, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; U.S. DOE [DE-AC02-06CH11357]; Klaus Tschira foundation; Tawani Foundation; Science and Technology Facilities Council (UK); German Science Foundation (DFG) [SPP1385]; Funds for Scientific Research (FWO), Flanders, Belgium [G.0395.11, G.0257.12N, G.0C12.13]; STFC [ST/K001000/1, ST/K000888/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/K001000/1, ST/K000888/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); U.S. DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. DOE(United States Department of Energy (DOE)); Klaus Tschira foundation; Tawani Foundation; Science and Technology Facilities Council (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); German Science Foundation (DFG)(German Research Foundation (DFG)); Funds for Scientific Research (FWO), Flanders, Belgium; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We are deeply grateful to the Stardust@home dusters (list at http://stardustathome.ssl.berkeley.edu/sciencedusters), whose tremendous efforts were critically important to the success of this project. The ISPE consortium gratefully acknowledges the NASA Discovery Program for Stardust, the fourth NASA Discovery mission. NASA grants supported the following authors: NNX09AC36G-A.J.W., A. L. B., Z.G., R. L., D.Z., W. M., and J.V.K.; NNX09AC63G-C.F., R. D., A. L., W.J.O., K. S., and F.J.S.; NNH11AQ61I-R.M.S., H. C. G., and N.D.B.; NNX11AC21G-A.M.D., A.J.K., and T. S.; NNX11AE15G-G.J.F. The Advanced Light Source and the National Center for Electron Microscopy are supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy (DOE) under contract no. DE-AC02-05CH11231. Use of the National Synchrotron Light Source, Brookhaven National Laboratory, was supported by the U.S. DOE, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-98CH10886. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U. S. DOE Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under contract no. DE-AC02-06CH11357. M. T. and F. P. acknowledge support by Klaus Tschira foundation. A. A. and P. R. H. were supported by the Tawani Foundation. M.J.B. and M. C. P. are supported by Science and Technology Facilities Council (UK). F. E. B., J.K.H., P. H., J.L., F. P., S. S., R. S., and M. T. were supported by funding of the German Science Foundation (DFG) within SPP1385: the first ten million years of the solar system-a planetary materials approach. The ESRF ID13 measurements were performed in the framework of ESRF LTP EC337, with financial support by the Funds for Scientific Research (FWO), Flanders, Belgium (contract nr. G.0395.11, G.0257.12N and Big Science program G.0C12.13). G. Silversmit was postdoctoral fellow of the FWO during the ISPE investigations. Data presented in this paper are described in the supplementary materials and in references (9-20).	Bechtel HA, 2014, METEORIT PLANET SCI, V49, P1548, DOI 10.1111/maps.12125; BRADLEY JP, 1994, SCIENCE, V265, P925, DOI 10.1126/science.265.5174.925; Brenker FE, 2014, METEORIT PLANET SCI, V49, P1594, DOI 10.1111/maps.12206; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Burchell MJ, 2012, METEORIT PLANET SCI, V47, P671, DOI 10.1111/j.1945-5100.2011.01294.x; Butterworth AL, 2014, METEORIT PLANET SCI, V49, P1562, DOI 10.1111/maps.12220; Dikarev V, 2001, ESA SPEC PUBL, V495, P609; Draine BT, 2009, SPACE SCI REV, V143, P333, DOI 10.1007/s11214-008-9411-7; Draine BT, 2003, ANNU REV ASTRON ASTR, V41, P241, DOI 10.1146/annurev.astro.41.011802.094840; Flynn GJ, 2014, METEORIT PLANET SCI, V49, P1626, DOI 10.1111/maps.12144; Frank DR, 2014, METEORIT PLANET SCI, V49, P1522, DOI 10.1111/maps.12147; Frisch PC, 2013, SCIENCE, V341, P1080, DOI 10.1126/science.1239925; Frisch PC, 2013, EARTH PLANETS SPACE, V65, P175, DOI 10.5047/eps.2012.05.001; Gainsforth Z, 2014, METEORIT PLANET SCI, V49, P1645, DOI 10.1111/maps.12148; GEHRELS N, 1986, ASTROPHYS J, V303, P336, DOI 10.1086/164079; GRUN E, 1993, NATURE, V362, P428, DOI 10.1038/362428a0; Jenkins EB, 2009, ASTROPHYS J, V700, P1299, DOI 10.1088/0004-637X/700/2/1299; Jones AP, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201014440; Kearsley AT, 2008, METEORIT PLANET SCI, V43, P41, DOI 10.1111/j.1945-5100.2008.tb00609.x; Keller LP, 2011, GEOCHIM COSMOCHIM AC, V75, P5336, DOI 10.1016/j.gca.2011.06.040; Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; Kemper F, 2005, ASTROPHYS J, V633, P534, DOI 10.1086/447764; Kimura H, 2003, ASTROPHYS J, V583, P314, DOI 10.1086/345102; Kruger H, 2010, PLANET SPACE SCI, V58, P951, DOI 10.1016/j.pss.2009.11.002; Kruger H, 2009, SPACE SCI REV, V143, P347, DOI 10.1007/s11214-008-9431-3; Lallement R, 2014, ASTRON ASTROPHYS, V565, DOI 10.1051/0004-6361/201323216; Landgraf M, 1999, PLANET SPACE SCI, V47, P1029, DOI 10.1016/S0032-0633(99)00031-8; Landgraf M, 2000, J GEOPHYS RES-SPACE, V105, P10343, DOI 10.1029/1999JA900359; Messenger S, 2005, SCIENCE, V309, P737, DOI 10.1126/science.1109602; Min M, 2008, ASTRON ASTROPHYS, V489, P135, DOI 10.1051/0004-6361:200809534; Molster FJ, 2003, LECT NOTES PHYS, V609, P121; Postberg F, 2014, METEORIT PLANET SCI, V49, P1666, DOI 10.1111/maps.12173; Price MC, 2010, METEORIT PLANET SCI, V45, P1409, DOI 10.1111/j.1945-5100.2010.01104.x; Price MC, 2012, METEORIT PLANET SCI, V47, P684, DOI 10.1111/j.1945-5100.2011.01300.x; Sandford SA, 2010, METEORIT PLANET SCI, V45, P406, DOI 10.1111/j.1945-5100.2010.01031.x; Simionovici AS, 2014, METEORIT PLANET SCI, V49, P1612, DOI 10.1111/maps.12208; Sterken VJ, 2014, METEORIT PLANET SCI, V49, P1680, DOI 10.1111/maps.12219; Stroud RM, 2014, METEORIT PLANET SCI, V49, P1698, DOI 10.1111/maps.12136; Tsou P, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002109; Vollmer C, 2007, ASTROPHYS J, V666, pL49, DOI 10.1086/521623; Westphal AJ, 2004, METEORIT PLANET SCI, V39, P1375, DOI 10.1111/j.1945-5100.2004.tb00952.x; Westphal AJ, 2014, METEORIT PLANET SCI, V49, P1720, DOI 10.1111/maps.12221; Westphal AJ, 2014, METEORIT PLANET SCI, V49, P1509, DOI 10.1111/maps.12168	43	124	124	2	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					786	791		10.1126/science.1252496	http://dx.doi.org/10.1126/science.1252496			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124433	Green Submitted			2022-12-28	WOS:000340593100038
J	Li, XD; Liang, YQ; LeBlanc, M; Benner, C; Zheng, Y				Li, Xudong; Liang, Yuqiong; LeBlanc, Mathias; Benner, Chris; Zheng, Ye			Function of a Foxp3 cis-Element in Protecting Regulatory T Cell Identity	CELL			English	Article							TRANSCRIPTION FACTOR FOXP3; DNA METHYLATION; GENE-EXPRESSION; IN-VIVO; INTRACHROMOSOMAL INTERACTIONS; REG CELLS; DIFFERENTIATION; INFLAMMATION; BETA; ACTIVATION	The homeostasis of multicellular organisms requires terminally differentiated cells to preserve their lineage specificity. However, it is unclear whether mechanisms exist to actively protect cell identity in response to environmental cues that confer functional plasticity. Regulatory T (Treg) cells, specified by the transcription factor Foxp3, are indispensable for immune system homeostasis. Here, we report that conserved noncoding sequence 2 (CNS2), a CpG-rich Foxp3 intronic cis-element specifically demethylated in mature Tregs, helps maintain immune homeostasis and limit autoimmune disease development by protecting Treg identity in response to signals that shape mature Treg functions and drive their initial differentiation. In activated Tregs, CNS2 helps protect Foxp3 expression from destabilizing cytokine conditions by sensing TCR/NFAT activation, which facilitates the interaction between CNS2 and Foxp3 promoter. Thus, epigenetically marked cis-elements can protect cell identity by sensing key environmental cues central to both cell identity formation and functional plasticity without interfering with initial cell differentiation.	[Li, Xudong; Liang, Yuqiong; LeBlanc, Mathias; Zheng, Ye] Salk Inst Biol Studies, Nomis Fdn Labs Immunobiol & Microbial Pathogenesi, La Jolla, CA 92037 USA; [Benner, Chris] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute; Salk Institute	Zheng, Y (corresponding author), Salk Inst Biol Studies, Nomis Fdn Labs Immunobiol & Microbial Pathogenesi, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	yzheng@salk.edu	Zheng, Ye/G-4866-2015; Li, Xudong/A-9065-2017	Zheng, Ye/0000-0001-5012-4309; Benner, Christopher/0000-0002-4618-0719	Nomis Foundation; Rita Allen Foundation; Emerald Foundation; Hearst Foundation; National Multiple Sclerosis Society; National Institute of Health [AI099295, AI107027]; National Cancer Institute [CA014195]; James B. Pendleton Charitable Trust; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107027, R56AI099295] Funding Source: NIH RePORTER	Nomis Foundation; Rita Allen Foundation; Emerald Foundation; Hearst Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); James B. Pendleton Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank Y. Zhang, C. Gordon, and C. Zhou for mouse colony management; M. Ku and S. Heinz for assistance in RNA-seq experiments; L.-F.Lu, S.Z. Josefowicz, and C.S. Hsieh for critical comments on the manuscript; and A.Y. Rudensky for providing critical reagents and helpful discussion. X.L. was supported by a postdoc fellowship from the Nomis Foundation. Y.Z. was supported by the Nomis Foundation, the Rita Allen Foundation, the Emerald Foundation, the Hearst Foundation, the National Multiple Sclerosis Society, and National Institute of Health (AI099295, AI107027). This work was also supported by National Cancer Institute funded Salk Institute Cancer Center core facilities (CA014195) and the James B. Pendleton Charitable Trust.	Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Tsytsykova AV, 2007, P NATL ACAD SCI USA, V104, P16850, DOI 10.1073/pnas.0708210104; Walker LSK, 2003, J EXP MED, V198, P249, DOI 10.1084/jem.20030315; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Weiss JM, 2012, J EXP MED, V209, P1723, DOI 10.1084/jem.20120914; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yadav M, 2012, J EXP MED, V209, P1713, DOI 10.1084/jem.20120822; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	53	172	176	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					734	748		10.1016/j.cell.2014.07.030	http://dx.doi.org/10.1016/j.cell.2014.07.030			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126782	Green Accepted, Bronze			2022-12-28	WOS:000340944700007
J	Lamborg, CH; Hammerschmidt, CR; Bowman, KL; Swarr, GJ; Munson, KM; Ohnemus, DC; Lam, PJ; Heimburger, LE; Rijkenberg, MJA; Saito, MA				Lamborg, Carl H.; Hammerschmidt, Chad R.; Bowman, Katlin L.; Swarr, Gretchen J.; Munson, Kathleen M.; Ohnemus, Daniel C.; Lam, Phoebe J.; Heimbuerger, Lars-Eric; Rijkenberg, Micha J. A.; Saito, Mak A.			A global ocean inventory of anthropogenic mercury based on water column measurements	NATURE			English	Article							2-STAGE GOLD AMALGAMATION; SEAWATER; MODEL	Mercury is a toxic, bioaccumulating trace metal whose emissions to the environment have increased significantly as a result of anthropogenic activities such as mining and fossil fuel combustion(1,2). Several recent models have estimated that these emissions have increased the oceanic mercury inventory by 36-1,313 million moles since the 1500s(2-9). Such predictions have remained largely untested owing to a lack of appropriate historical data and natural archives. Here we report oceanographic measurements of total dissolved mercury and related parameters from several recent expeditions to the Atlantic, Pacific, Southern and Arctic oceans. We find that deep North Atlantic waters and most intermediate waters are anomalously enriched in mercury relative to the deep waters of the South Atlantic, Southern and Pacific oceans, probably as a result of the incorporation of anthropogenic mercury. We estimate the total amount of anthropogenic mercury present in the global ocean to be 290 +/- 680 million moles, with almost two-thirds residing in water shallower than a thousand metres. Our findings suggest that anthropogenic perturbations to the global mercury cycle have led to an approximately 150 per cent increase in the amount of mercury in thermocline waters and have tripled the mercury content of surface waters compared to pre-anthropogenic conditions. This information may aid our understanding of the processes and the depths at which inorganic mercury species are converted into toxic methyl mercury and subsequently bioaccumulated in marine food webs.	[Lamborg, Carl H.; Swarr, Gretchen J.; Munson, Kathleen M.; Ohnemus, Daniel C.; Lam, Phoebe J.; Saito, Mak A.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; [Hammerschmidt, Chad R.; Bowman, Katlin L.] Wright State Univ, Dept Earth & Environm Sci, Dayton, OH 45435 USA; [Heimbuerger, Lars-Eric] Univ Toulouse 3, IRD, CNRS, Observ Midi Pyrenees,Lab Geosci Environm, F-31400 Toulouse, France; [Rijkenberg, Micha J. A.] Royal Netherlands Inst Sea Res, Dept Biol Oceanog, NL-1790 AB Den Burg, Netherlands	Woods Hole Oceanographic Institution; University System of Ohio; Wright State University Dayton; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Lamborg, CH (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.	clamborg@whoi.edu	Ohnemus, Daniel C/X-7728-2018; Hammerschmidt, Chad/M-3139-2014; Heimbürger-Boavida, Lars-Eric/AAF-6856-2021; Saito, Mak/ADT-4986-2022; Lam, Phoebe/GQQ-7325-2022	Ohnemus, Daniel C/0000-0001-6362-4134; Heimbürger-Boavida, Lars-Eric/0000-0003-0632-5183; Adamczyk, Katlin/0000-0003-3324-0062; Lam, Phoebe J./0000-0001-6609-698X; Lamborg, Carl/0000-0003-4379-3904; Munson, Kathleen/0000-0001-7158-9607	NSF [OCE-0825108, OCE-0825157, OCE-0927274, OCE-0928191, OCE-1031271, OCE-1132480, OCE-1132515];  [ERC-2010-StG_20091028]; Directorate For Geosciences [1233261, 1232760] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the captains and crews of all cruises, as well as: P. Morton, J. Fitzsimmons, R. Shelley, A. Aguilar-Islas, R. Bundy, P. Morris, S. Owens, K. Wang, S. Rigaud and S. Pike for sample collection during the North Atlantic GEOTRACES cruise; L. Groot, D. Weiss, P. Laan, J. de Jong, R. Middag, L. Pena, A. Hartman, J. M. Godoy, L. Gerringa, M. Boye and J. Derot for sample collection during the South Atlantic GEOTRACES cruise; T. Goepfert, E. Bertrand and D. Moran for sampling during the Metalloenzyme cruise; and M. Rutgers van der Loeff and B. Galfond for providing samples from the 2011 Polarstern cruise ARK-XXVI/3-TransArc to the central Arctic Ocean. We are also grateful to D. Cossa and E. Sunderland for providing digital versions of their Southern Ocean and P16 data. We also thank H. Amos, L. Jaegle, B. Jonsson, R. Mason, E. Sunderland and Y. Zhang for discussions and D. Cossa for comments. This work was supported by NSF grant numbers OCE-0825108, OCE-0825157, OCE-0927274, OCE-0928191, OCE-1031271, OCE-1132480 and OCE-1132515. We thank co-Principal Investigators R. Mason and G. Gill. L.-E.H. thanks J. E Sonke for funding Arctic Ocean observations via research grant ERC-2010-StG_20091028 to JES.	Amos HM, 2013, GLOBAL BIOGEOCHEM CY, V27, P410, DOI 10.1002/gbc.20040; ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; [Anonymous], [No title captured]; Bowman K. L., DEEP SEA RE IN PRESS; Cossa D, 2011, GEOCHIM COSMOCHIM AC, V75, P4037, DOI 10.1016/j.gca.2011.05.001; Cutter GA, 2012, LIMNOL OCEANOGR-METH, V10, P425, DOI 10.4319/lom.2012.10.425; EGGIMANN DW, 1976, ANAL CHEM, V48, P886, DOI 10.1021/ac60370a005; FITZGERALD WF, 1979, ANAL CHEM, V51, P1714, DOI 10.1021/ac50047a030; GILL GA, 1987, MAR CHEM, V20, P227, DOI 10.1016/0304-4203(87)90074-0; Gruber N, 1996, GLOBAL BIOGEOCHEM CY, V10, P809, DOI 10.1029/96GB01608; Hammerschmidt CR, 2006, ARCH ENVIRON CON TOX, V51, P416, DOI 10.1007/s00244-005-0265-7; Hammerschmidt CR, 2012, MAR CHEM, V132, P77, DOI 10.1016/j.marchem.2012.02.005; Jaegle L., 2013, 11 INT C MERC GLOB P; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Khatiwala S, 2013, BIOGEOSCIENCES, V10, P2169, DOI 10.5194/bg-10-2169-2013; Lamborg CH, 2008, DEEP-SEA RES PT II, V55, P1540, DOI 10.1016/j.dsr2.2008.04.011; Lamborg CH, 2012, LIMNOL OCEANOGR-METH, V10, P90, DOI 10.4319/lom.2012.10.90; Lamborg CH, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001847; Lamborg CH, 2002, GEOCHIM COSMOCHIM AC, V66, P1105, DOI 10.1016/S0016-7037(01)00841-9; Le Quere C, 2012, EARTH SYST SCI DATA, V5, P1107, DOI [10.5194/ESSDD-5-1107-2012, DOI 10.5194/ESSDD-5-1107-2012]; Mason RP, 2012, ENVIRON RES, V119, P101, DOI 10.1016/j.envres.2012.03.013; Mason RP, 1998, MAR CHEM, V61, P37, DOI 10.1016/S0304-4203(98)00006-1; MASON RP, 1994, GEOCHIM COSMOCHIM AC, V58, P3191, DOI 10.1016/0016-7037(94)90046-9; Morel F.M.M., 2003, TREATISE GEOCHEMISTR, P113, DOI [10.1016/B0-08-043751-6/06108-9, DOI 10.1016/B0-08-043751-6/06108-9]; Pacyna EG, 2010, ATMOS ENVIRON, V44, P2487, DOI 10.1016/j.atmosenv.2009.06.009; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Selin NE, 2014, ENVIRON TOXICOL CHEM, V33, P1202, DOI 10.1002/etc.2374; Selin NE, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003040; Soerensen AL, 2010, ENVIRON SCI TECHNOL, V44, P8574, DOI 10.1021/es102032g; Streets DG, 2011, ENVIRON SCI TECHNOL, V45, P10485, DOI 10.1021/es202765m; Streets DG, 2009, ENVIRON SCI TECHNOL, V43, P2983, DOI 10.1021/es802474j; Strode S, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003728; Sunderland EM, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003425; Sunderland EM, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002876; TALLEY LD, 1995, J PHYS OCEANOGR, V25, P475, DOI 10.1175/1520-0485(1995)025<0475:NPIWIT>2.0.CO;2; Volk T., 1985, GEOPHYS MONOGR SER, V32, P99, DOI DOI 10.1029/GM032P0099; WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9	37	325	329	25	435	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					65	+		10.1038/nature13563	http://dx.doi.org/10.1038/nature13563			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25100482				2022-12-28	WOS:000339908000032
J	Ongen, H; Andersen, CL; Bramsen, JB; Oster, B; Rasmussen, MH; Ferreira, PG; Sandoval, J; Vidal, E; Whiffin, N; Planchon, A; Padioleau, I; Bielser, D; Romano, L; Tomlinson, I; Houlston, RS; Esteller, M; Orntoft, TF; Dermitzakis, ET				Ongen, Halit; Andersen, Claus L.; Bramsen, Jesper B.; Oster, Bodil; Rasmussen, Mads H.; Ferreira, Pedro G.; Sandoval, Juan; Vidal, Enrique; Whiffin, Nicola; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Tomlinson, Ian; Houlston, Richard S.; Esteller, Manel; Orntoft, Torben F.; Dermitzakis, Emmanouil T.			Putative cis-regulatory drivers in colorectal cancer	NATURE			English	Article							MUTATIONS; HETEROZYGOSITY; IDENTIFICATION; MICRORNA; GENE	The cis-regulatory effects responsible for cancer development have not been as extensively studied as the perturbations of the protein coding genome in tumorigenesis(1,2). To better characterize colorectal cancer (CRC) development we conducted an RNA-sequencing experiment of 103 matched tumour and normal colon mucosa samples from Danish CRC patients, 90 of which were germline-genotyped. By investigating allele-specific expression (ASE) we show that the germline genotypes remain important determinants of allelic gene expression in tumours. Using the changes in ASE in matched pairs of samples we discover 71 genes with excess of somaticc is-regulatory effects in CRC, suggesting a cancer driver role. We correlate genotypes and gene expression to identify expression quantitative trait loci (eQTLs) and find 1,693 and 948 eQTLs in normal samples and tumours, respectively. We estimate that 36% of the tumour eQTLs are exclusive to CRC and show that this specificity is partially driven by increased expression of specific transcription factors and changes in methylation patterns. We show that tumour-specific eQTLs are more enriched for low CRC genome-wide association study (GWAS) P values than shared eQTLs, which suggests that some of the GWAS variants are tumour specific regulatory variants. Importantly, tumour-specific eQTL genes also accumulate more somatic mutations when compared to the shared eQTL genes, raising the possibility that they constitute germline-derived cancer regulatory drivers. Collectively the integration of genome and the transcriptome reveals a substantial number of putative somatic and germline cis-regulatory cancer changes that may have a role in tumorigenesis.	[Ongen, Halit; Ferreira, Pedro G.; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Ongen, Halit; Ferreira, Pedro G.; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Dermitzakis, Emmanouil T.] Univ Geneva, Inst Genet & Genom Geneva IGE3, CH-1211 Geneva, Switzerland; [Ongen, Halit; Ferreira, Pedro G.; Planchon, Alexandra; Padioleau, Ismael; Bielser, Deborah; Romano, Luciana; Dermitzakis, Emmanouil T.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Andersen, Claus L.; Bramsen, Jesper B.; Oster, Bodil; Rasmussen, Mads H.; Orntoft, Torben F.] Aarhus Univ Hosp, Dept Mol Med, DK-8000 Aarhus, Denmark; [Sandoval, Juan; Vidal, Enrique] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program PEBC, Barcelona 08908, Catalonia, Spain; [Whiffin, Nicola; Houlston, Richard S.] Inst Canc Res, Div Genet & Epidemiol, Sutton SM2 5NG, Surrey, England; [Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Nuffield Dept Clin Med, Oxford OX3 7BN, England; [Tomlinson, Ian] Wellcome Trust Ctr Human Genet, Oxford NIHR Comprehens Biomed Res Ctr, Oxford OX3 7BN, England; [Esteller, Manel] Univ Barcelona, Sch Med, Dept Physiol Sci 2, E-08007 Barcelona, Spain; [Esteller, Manel] ICREA, Barcelona 08010, Spain	University of Geneva; University of Geneva; Swiss Institute of Bioinformatics; Aarhus University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of London; Institute of Cancer Research - UK; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Barcelona; ICREA	Ongen, H (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	halit.ongen@unige.ch; emmanouil.dermitzakis@unige.ch	W, Nicola/AAG-3227-2020; Vidal, Enrique/J-7118-2015; Vidal, Enrique/A-9455-2014; Padioleau, Ismaël/AAE-8927-2019; Ferreira, Pedro G/J-6379-2013; Esteller, Manel/L-5956-2014; Ferreira, Pedro/HDO-1346-2022; Andersen, Claus L/C-1477-2017; Vidal, Enrique/R-5593-2019; sandoval, juan/M-4593-2015; Andersen, Claus Lindbjerg/A-9217-2012	W, Nicola/0000-0003-1554-6594; Vidal, Enrique/0000-0002-4217-1807; Vidal, Enrique/0000-0002-4217-1807; Padioleau, Ismaël/0000-0003-4935-3248; Ferreira, Pedro G/0000-0003-3838-8664; Esteller, Manel/0000-0003-4490-6093; Vidal, Enrique/0000-0002-4217-1807; sandoval, juan/0000-0002-5100-973X; Houlston, Richard/0000-0002-5268-0242; Rasmussen, Mads Heilskov/0000-0001-5723-6303; Ongen, Halit/0000-0002-4197-5790; Andersen, Claus Lindbjerg/0000-0002-7406-2103	European Commission SYSCOL FP7 [UE7-SYSCOL-258236]; European Research Council [ERC 260927]; Louis Jeantet Foundation; Swiss National Science Foundation [130326, 130342]; NIH-NIMH [MH090941]; Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Council for Independent Research (Medical Sciences); Danish Council for Strategic Research; Danish Cancer Society; Cellex Foundation; Botin Foundation; Fundacion Olga Torres; Health Department of the Catalan Government (Generalitat de Catalunya); Science Department of the Catalan Government (Generalitat de Catalunya); Cancer Research UK [C1298/A8362]; Oxford Comprehensive Biomedical Research Centre;  [090532/Z/09/Z]; ICREA Funding Source: Custom; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090941] Funding Source: NIH RePORTER; Cancer Research UK [15116] Funding Source: researchfish	European Commission SYSCOL FP7; European Research Council(European Research Council (ERC)European Commission); Louis Jeantet Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH-NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Danish National Advanced Technology Foundation; John and Birthe Meyer Foundation; Danish Council for Independent Research (Medical Sciences)(Det Frie Forskningsrad (DFF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Cancer Society(Danish Cancer Society); Cellex Foundation(Foundation CELLEX); Botin Foundation; Fundacion Olga Torres; Health Department of the Catalan Government (Generalitat de Catalunya)(Generalitat de Catalunya); Science Department of the Catalan Government (Generalitat de Catalunya); Cancer Research UK(Cancer Research UK); Oxford Comprehensive Biomedical Research Centre; ; ICREA(ICREA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Cancer Research UK(Cancer Research UK)	This study was designed under the SYSCOL project and samples were collected with informed consent in accordance with local law. This research is supported by grants from European Commission SYSCOL FP7 (UE7-SYSCOL-258236), European Research Council (ERC 260927), Louis Jeantet Foundation, Swiss National Science Foundation (130326, 130342), the NIH-NIMH (MH090941), the Danish National Advanced Technology Foundation, the John and Birthe Meyer Foundation, the Danish Council for Independent Research (Medical Sciences), the Danish Council for Strategic Research, the Danish Cancer Society, The Cellex Foundation, the Botin Foundation, the Fundacion Olga Torres, and the Health and Science Departments of the Catalan Government (Generalitat de Catalunya). The Danish Cancer Biobank is acknowledged for biological material. We thank S. Moran, D. Garcia and C. Arribas for their technical support. This study was also funded by Cancer Research UK and The Oxford Comprehensive Biomedical Research Centre (I.P.T.). Core infrastructure support to the Wellcome Trust Centre for Human Genetics, Oxford, was provided by grant (090532/Z/09/Z). Cancer Research UK provided funding individually to R.S.H. (C1298/A8362-Bobby Moore Fund for Cancer Research UK). This study made use of genotyping data from the 1958 Birth Cohort and NBS samples, kindly made available by the Wellcome Trust Case Control Consortium 2. The computations were performed at the Vital-IT (http://www.vital-it.ch) Center for high-performance computing of the SIB Swiss Institute of Bioinformatics.	Aerts S, 2013, NATURE, V499, P35, DOI 10.1038/499035a; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Dalla-Torre CA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-237; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; EMI M, 1992, CANCER RES, V52, P5368; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lappalainen T, 2011, AM J HUM GENET, V89, P459, DOI 10.1016/j.ajhg.2011.08.004; Ma C, 2008, GENE DEV, V22, P308, DOI 10.1101/gad.1632008; Matsuzaki K, 2005, CLIN CANCER RES, V11, P8564, DOI 10.1158/1078-0432.CCR-05-0859; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; Sun DF, 2013, J BIOL CHEM, V288, P9508, DOI 10.1074/jbc.M112.367763; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Thorsen K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002998; Yan J, 2013, CELL, V154, P801, DOI 10.1016/j.cell.2013.07.034	20	105	106	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					87	90		10.1038/nature13602	http://dx.doi.org/10.1038/nature13602			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25079323				2022-12-28	WOS:000339908000037
J	Qaseem, A; Dallas, P; Owens, DK; Starkey, M; Holty, JEC; Shekelle, P				Qaseem, Amir; Dallas, Paul; Owens, Douglas K.; Starkey, Melissa; Holty, Jon-Erik C.; Shekelle, Paul		Amer Coll Phys	Diagnosis of Obstructive Sleep Apnea in Adults: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							POSITIVE AIRWAY PRESSURE; HOME RESPIRATORY POLYGRAPHY; PORTABLE MONITORING DEVICE; COMMERCIAL VEHICLE DRIVERS; BERLIN QUESTIONNAIRE; HYPOPNEA SYNDROME; HEART HEALTH; APNOEA/HYPOPNOEA SYNDROME; SCREENING TOOL; STOP-BANG	Description: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the diagnosis of obstructive sleep apnea in adults. Methods: This guideline is based on published literature on this topic that was identified by using MEDLINE (1966 through May 2013), the Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews. Searches were limited to English-language publications. The clinical outcomes evaluated for this guideline included all-cause mortality, cardiovascular mortality, nonfatal cardiovascular disease, stroke, hypertension, type 2 diabetes, postsurgical outcomes, and quality of life. Sensitivities, specificities, and likelihood ratios were also assessed as outcomes of diagnostic tests. This guideline grades the evidence and recommendations by using ACP's clinical practice guidelines grading system. Recommendation 1: ACP recommends a sleep study for patients with unexplained daytime sleepiness. (Grade: weak recommendation, low-quality evidence) Recommendation 2: ACP recommends polysomnography for diagnostic testing in patients suspected of obstructive sleep apnea. ACP recommends portable sleep monitors in patients without serious comorbidities as an alternative to polysomnography when polysomnography is not available for diagnostic testing. (Grade: weak recommendation, moderate-quality evidence)	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Virginia Tech, Caril Sch Med, Roanoke, VA USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Stanford Univ, Stanford, CA 94305 USA; West Los Angeles Vet Affairs Med Ctr, Los Angeles, CA USA	American College of Physicians; Virginia Polytechnic Institute & State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Starkey, Melissa/0000-0002-5818-0265; Chou, Roger/0000-0001-9889-8610	ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Abraham William T, 2006, Congest Heart Fail, V12, P241, DOI 10.1111/j.1527-5299.2006.05693.x; Agatsuma T, 2009, RESPIROLOGY, V14, P1143, DOI 10.1111/j.1440-1843.2009.01627.x; Nigro CA, 2013, SLEEP BREATH, V17, P259, DOI 10.1007/s11325-012-0684-4; Nigro CA, 2011, SLEEP BREATH, V15, P679, DOI 10.1007/s11325-010-0421-9; Nigro CA, 2009, SLEEP BREATH, V13, P127, DOI 10.1007/s11325-008-0217-3; Albuquerque FN, 2012, CHEST, V141, P967, DOI 10.1378/chest.11-0975; Alvarez D, 2010, IEEE ENG MED BIO, P847, DOI 10.1109/IEMBS.2010.5626861; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Amir O, 2010, J CLIN SLEEP MED, V6, P59; ANCOLIISRAEL S, 1991, SLEEP, V14, P486, DOI 10.1093/sleep/14.6.486; AncoliIsrael S, 1997, J MED ENG TECHNOL, V21, P10, DOI 10.3109/03091909709030297; [Anonymous], [No title captured]; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Asha'ari ZA, 2012, LARYNGOSCOPE, V122, P2337, DOI 10.1002/lary.23379; Ayappa I, 2008, J CLIN SLEEP MED, V4, P26; Babu AR, 2005, ARCH INTERN MED, V165, P447, DOI 10.1001/archinte.165.4.447; BaHammam A, 2011, MED SCI MONITOR, V17, pMT13, DOI 10.12659/MSM.881379; Ballester E, 2000, EUR RESPIR J, V16, P123, DOI 10.1034/j.1399-3003.2000.16a22.x; Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020; Bixler EO, 1998, AM J RESP CRIT CARE, V157, P144, DOI 10.1164/ajrccm.157.1.9706079; Bixler EO, 2001, AM J RESP CRIT CARE, V163, P608, DOI 10.1164/ajrccm.163.3.9911064; Botros N, 2009, AM J MED, V122, P1122, DOI 10.1016/j.amjmed.2009.04.026; Calleja JM, 2002, EUR RESPIR J, V20, P1505, DOI 10.1183/09031936.02.00297402; Caples SM, 2005, ANN INTERN MED, V142, P187, DOI 10.7326/0003-4819-142-3-200502010-00010; Carrasco O, 1996, EUR RESPIR J, V9, P125, DOI 10.1183/09031936.96.09010125; Centers for Medicare and Medicaid Services, 2008, NAT COV DET NCD CONT; Chai-Coetzer CL, 2011, THORAX, V66, P213, DOI 10.1136/thx.2010.152801; Chami HA, 2011, CIRCULATION, V123, P1280, DOI 10.1161/CIRCULATIONAHA.110.974022; Cheliout-Heraut F, 2011, NEUROPHYSIOL CLIN, V41, P191, DOI 10.1016/j.neucli.2011.09.001; Chen H, 2009, SLEEP BREATH, V13, P213, DOI 10.1007/s11325-008-0232-4; Chesson AL, 1997, SLEEP, V20, P406; Chouchou F, 2011, SLEEP, V34, P1051, DOI 10.5665/SLEEP.1160; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Chung F, 2008, ANESTHESIOLOGY, V108, P812, DOI 10.1097/ALN.0b013e31816d83e4; Chung F, 2008, ANESTHESIOLOGY, V108, P822, DOI 10.1097/ALN.0b013e31816d91b5; Chung SA, 2008, ANESTH ANALG, V107, P1543, DOI 10.1213/ane.0b013e318187c83a; Claman D, 2001, OTOLARYNG HEAD NECK, V125, P227, DOI 10.1067/mhn.2001.118126; Clark AL, 2009, J LARYNGOL OTOL, V123, P746, DOI 10.1017/S0022215109004794; Collop NA, 2007, J CLIN SLEEP MED, V3, P737; CROCKER BD, 1990, AM REV RESPIR DIS, V142, P14, DOI 10.1164/ajrccm/142.1.14; Danzi-Soares ND, 2012, CORONARY ARTERY DIS, V23, P31, DOI 10.1097/MCA.0b013e32834df5d0; de Almeida FR, 2006, SLEEP BREATH, V10, P62, DOI 10.1007/s11325-005-0042-x; Dingli K, 2003, EUR RESPIR J, V21, P253, DOI 10.1183/09031936.03.00298103; Drager LF, 2010, AM J CARDIOL, V105, P1135, DOI 10.1016/j.amjcard.2009.12.017; Driver HS, 2011, CAN RESPIR J, V18, P137, DOI 10.1155/2011/760958; Duran J, 2001, AM J RESP CRIT CARE, V163, P685, DOI 10.1164/ajrccm.163.3.2005065; EMSELLEM HA, 1990, SOUTHERN MED J, V83, P748, DOI 10.1097/00007611-199007000-00006; Enciso R, 2011, SLEEP BREATH, V15, P83, DOI 10.1007/s11325-010-0328-5; Ensrud KE, 2012, SLEEP MED, V13, P1217, DOI 10.1016/j.sleep.2012.04.010; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Erman MK, 2007, J CLIN SLEEP MED, V3, P387; Facco FL, 2012, J CLIN SLEEP MED, V8, P389, DOI 10.5664/jcsm.2030; Farney RJ, 2011, J CLIN SLEEP MED, V7, P459, DOI 10.5664/JCSM.1306; Feng J, 2012, SLEEP BREATH, V16, P31, DOI 10.1007/s11325-011-0481-5; Ferre A, 2012, J CLIN SLEEP MED, V8, P163, DOI 10.5664/jcsm.1770; Ficker JH, 2001, RESPIRATION, V68, P307, DOI 10.1159/000050515; Fietze I, 2002, RESPIRATION, V69, P235, DOI 10.1159/000063626; Finkel KJ, 2009, SLEEP MED, V10, P753, DOI 10.1016/j.sleep.2008.08.007; Fung MM, 2011, HYPERTENSION, V58, P596, DOI 10.1161/HYPERTENSIONAHA.111.174409; Gagnadoux F, 2002, CHEST, V121, P753, DOI 10.1378/chest.121.3.753; Garcia-Diaz E, 2007, CHEST, V131, P725, DOI 10.1378/chest.06-1604; Gasa M, 2011, EUR RESPIR J, V38, P1089, DOI 10.1183/09031936.00198810; Geiger-Brown J, 2013, SLEEP BREATH, V17, P381, DOI 10.1007/s11325-012-0705-3; Gjevre JA, 2011, CAN RESPIR J, V18, P271, DOI 10.1155/2011/408091; Gjevre JA, 2012, MUSCULOSKELET CARE, V10, P187, DOI 10.1002/msc.1016; Goodrich S, 2009, SLEEP MED, V10, P118, DOI 10.1016/j.sleep.2007.11.003; Gruber A, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-22; Gupta RM, 2001, MAYO CLIN PROC, V76, P897, DOI 10.4065/76.9.897; Gurubhagavatula I, 2004, AM J RESP CRIT CARE, V170, P371, DOI 10.1164/rccm.200307-968OC; Gurubhagavatula I, 2001, AM J RESP CRIT CARE, V164, P1904, DOI 10.1164/ajrccm.164.10.2103039; Hallowell PT, 2007, SURGERY, V142, P608, DOI 10.1016/j.surg.2007.08.002; Hedner J, 2011, J CLIN SLEEP MED, V7, P302, DOI 10.5664/JCSM.1078; Heneghan C, 2008, SLEEP, V31, P1432; Heneghan C, 2008, J CLIN SLEEP MED, V4, P223; Howard ME, 2004, AM J RESP CRIT CARE, V170, P1014, DOI 10.1164/rccm.200312-1782oc; Hrubos-Strom H, 2011, J SLEEP RES, V20, P162, DOI 10.1111/j.1365-2869.2010.00861.x; Iber C, 2004, SLEEP, V27, P536, DOI 10.1093/sleep/27.3.536; Jauhar S, 2012, BRIT DENT J, V212, DOI 10.1038/sj.bdj.2012.2; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; KAPUNIAI LE, 1988, SLEEP, V11, P430, DOI 10.1093/sleep/11.5.430; Khoo SM, 2011, SLEEP BREATH, V15, P431, DOI 10.1007/s11325-010-0354-3; Kim GH, 2012, ANAESTHESIA, V67, P755, DOI 10.1111/j.1365-2044.2012.07115.x; Knutson KL, 2012, SLEEP MED, V13, P484, DOI 10.1016/j.sleep.2011.11.009; Kolotkin RL, 2011, SURG OBES RELAT DIS, V7, P605, DOI 10.1016/j.soard.2011.04.226; Kopitovic I, 2011, SLEEP BREATH, V15, P775, DOI 10.1007/s11325-010-0435-3; Koyama RG, 2012, SLEEP MED, V13, P1028, DOI 10.1016/j.sleep.2012.06.017; Kuniyoshi FHS, 2011, CHEST, V140, P1192, DOI 10.1378/chest.10-2625; Kushida CA, 1997, ANN INTERN MED, V127, P581, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00001; Laporta R, 2012, CLIN RES CARDIOL, V101, P737, DOI 10.1007/s00392-012-0453-1; Lavie P, 2005, EUR RESPIR J, V25, P514, DOI 10.1183/09031936.05.00051504; LAVIE P, 1995, SLEEP, V18, P149, DOI 10.1093/sleep/18.3.149; Lloberes P, 1996, THORAX, V51, P1043, DOI 10.1136/thx.51.10.1043; MAN GCW, 1995, CHEST, V108, P388, DOI 10.1378/chest.108.2.388; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Marrone O, 2001, Monaldi Arch Chest Dis, V56, P486; Martinez D, 2012, SLEEP BREATH, V16, P89, DOI 10.1007/s11325-010-0460-2; Martinez D, 2011, SLEEP BREATH, V15, P763, DOI 10.1007/s11325-010-0434-4; Martinez-Garcia MA, 2013, JAMA-J AM MED ASSOC, V310, P2407, DOI 10.1001/jama.2013.281250; Masa JF, 2011, THORAX, V66, P567, DOI 10.1136/thx.2010.152272; MITLER MM, 1982, ELECTROEN CLIN NEURO, V53, P658, DOI 10.1016/0013-4694(82)90142-0; Morales CR, 2012, SLEEP, V35, P1491, DOI 10.5665/sleep.2196; Morrell MJ, 2012, EUR RESPIR J, V40, P386, DOI 10.1183/09031936.00177411; Mykytyn IJ, 1999, CHEST, V115, P114, DOI 10.1378/chest.115.1.114; Nakano H, 2008, EUR RESPIR J, V32, P1060, DOI 10.1183/09031936.00130907; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Ng SSS, 2009, INTERN MED J, V39, P757, DOI 10.1111/j.1445-5994.2008.01827.x; Ng SSS, 2010, RESPIROLOGY, V15, P336, DOI 10.1111/j.1440-1843.2009.01697.x; Nicholl DDM, 2012, J CLIN SLEEP MED, V8, P381, DOI 10.5664/jcsm.2028; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; Nigro CA, 2010, MEDICINA-BUENOS AIRE, V70, P53; O'Brien LM, 2012, J CLIN SLEEP MED, V8, P287, DOI 10.5664/jcsm.1916; O'Connor GT, 2009, AM J RESP CRIT CARE, V179, P1159, DOI 10.1164/rccm.200712-1809OC; Oliveira MG, 2012, SLEEP MED, V13, P1033, DOI 10.1016/j.sleep.2012.06.011; Onder NS, 2012, LARYNGOSCOPE, V122, P1409, DOI 10.1002/lary.23233; Onen SH, 2008, J AM GERIATR SOC, V56, P1920, DOI 10.1111/j.1532-5415.2008.01862.x; Ong TH, 2010, SLEEP BREATH, V14, P371, DOI 10.1007/s11325-010-0350-7; ORR WC, 1994, CHEST, V105, P160, DOI 10.1378/chest.105.1.160; Pang KP, 2007, OTOLARYNG HEAD NECK, V137, P665, DOI 10.1016/j.otohns.2007.03.015; Parra O, 1997, EUR RESPIR J, V10, P1720, DOI 10.1183/09031936.97.10081720; Patt BT, 2010, J CLIN SLEEP MED, V6, P541; Pepin JL, 2009, SLEEP MED, V10, P651, DOI 10.1016/j.sleep.2008.07.002; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Planes C, 2010, SLEEP BREATH, V14, P25, DOI 10.1007/s11325-009-0275-1; Portier F, 2000, AM J RESP CRIT CARE, V162, P814, DOI 10.1164/ajrccm.162.3.9908002; Punjabi Naresh M, 2008, Proc Am Thorac Soc, V5, P136, DOI 10.1513/pats.200709-155MG; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Qaseem A, 2013, ANN INTERN MED, V159, P471, DOI 10.7326/00030003-4819-159-7-201310010-00704; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Quintana-Gallego E, 2004, EUR RESPIR J, V24, P443, DOI 10.1183/09031936.04.00140603; Ragette R, 2010, SLEEP BREATH, V14, P109, DOI 10.1007/s11325-009-0290-2; Ravesloot MJL, 2012, EUR ARCH OTO-RHINO-L, V269, P1865, DOI 10.1007/s00405-012-1948-0; Reda M, 2001, OTOLARYNG HEAD NECK, V125, P324, DOI 10.1067/mhn.2001.118076; REDLINE S, 1991, CHEST, V100, P1281, DOI 10.1378/chest.100.5.1281; Reichert JA, 2003, SLEEP MED, V4, P213, DOI 10.1016/S1389-9457(02)00234-4; Reichmuth KJ, 2005, AM J RESP CRIT CARE, V172, P1590, DOI 10.1164/rccm.200504-637OC; Robinson GV, 2006, EUR RESPIR J, V27, P1229, DOI 10.1183/09031936.06.00062805; Rodrigues MM, 2010, BRAZ J OTORHINOLAR, V76, P557, DOI 10.1590/S1808-86942010000500004; Rodsutti J, 2004, SLEEP, V27, P694, DOI 10.1093/sleep/27.4.694; Rowley JA, 2000, SLEEP, V23, P929, DOI 10.1093/sleep/23.7.929; RTI International, 2004, EFF PORT MON DEV DIA; Santos-Silva R, 2009, SLEEP, V32, P629, DOI 10.1093/sleep/32.5.629; Sareli AE, 2011, OBES SURG, V21, P316, DOI 10.1007/s11695-009-9928-1; Schafer H, 1997, RESPIRATION, V64, P194; Senchak AJ, 2012, MIL MED, V177, P1196, DOI 10.7205/MILMED-D-12-00116; Sforza E, 2011, SLEEP MED, V12, P142, DOI 10.1016/j.sleep.2010.09.004; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Sharkey KM, 2013, SLEEP BREATH, V17, P267, DOI 10.1007/s11325-012-0685-3; Sharma SK, 2006, INDIAN J MED RES, V124, P281; Sharwood LN, 2012, SLEEP, V35, P469, DOI 10.5665/sleep.1726; Silva GE, 2011, J CLIN SLEEP MED, V7, P468, DOI 10.5664/JCSM.1308; Silva GE, 2009, SLEEP, V32, P1049, DOI 10.1093/sleep/32.8.1049; Singh M, 2013, BRIT J ANAESTH, V110, P629, DOI 10.1093/bja/aes465; Smith LA, 2007, J SLEEP RES, V16, P428, DOI 10.1111/j.1365-2869.2007.00612.x; Su CT, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/212498; Su S, 2004, OTOLARYNG HEAD NECK, V131, P844, DOI 10.1016/j.otohns.2004.07.014; Subramanian S, 2011, SLEEP BREATH, V15, P819, DOI 10.1007/s11325-010-0443-3; Sun LM, 2011, SLEEP BREATH, V15, P317, DOI 10.1007/s11325-010-0384-x; Szyszko A, 2009, EUROPACE, V11, P94, DOI 10.1093/europace/eun285; Tanaka S, 2010, J OCCUP HEALTH, V52, P99, DOI 10.1539/joh.L8175; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Thurtell MJ, 2011, J NEURO-OPHTHALMOL, V31, P316, DOI 10.1097/WNO.0b013e31821a4d54; To KW, 2009, RESPIROLOGY, V14, P270, DOI 10.1111/j.1440-1843.2008.01439.x; de Oliveira ACT, 2009, CHEST, V135, P330, DOI 10.1378/chest.08-1859; Tufts-New England Medical Center EPC, 2007, HOM DIAGN OBSTR SLEE; Vana KD, 2013, RES NURS HEALTH, V36, P84, DOI 10.1002/nur.21512; Vaz AP, 2011, REV PORT PNEUMOL, V17, P59; Verse T, 2000, CHEST, V117, P1613, DOI 10.1378/chest.117.6.1613; Victor LD, 1999, AM FAM PHYSICIAN, V60, P2279; Watkins MR, 2009, J OCCUP ENVIRON MED, V51, P1145, DOI 10.1097/JOM.0b013e3181b68d52; WHITE DP, 1995, SLEEP, V18, P115, DOI 10.1093/sleep/18.2.115; WHITE JES, 1994, CLIN OTOLARYNGOL, V19, P218, DOI 10.1111/j.1365-2273.1994.tb01218.x; Whittle AT, 1997, THORAX, V52, P1068, DOI 10.1136/thx.52.12.1068; Wong KKH, 2008, BEHAV RES METHODS, V40, P360, DOI 10.3758/BRM.40.1.360; Yadollahi A, 2010, MED BIOL ENG COMPUT, V48, P1087, DOI 10.1007/s11517-010-0674-2; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Yagi H, 2009, AURIS NASUS LARYNX, V36, P176, DOI 10.1016/j.anl.2008.06.001; Yang GG, 2011, J FORMOS MED ASSOC, V110, P642, DOI 10.1016/j.jfma.2011.08.006; Yin M, 2006, OTOLARYNG HEAD NECK, V134, P204, DOI 10.1016/j.otohns.2005.10.019; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 2002, ARCH INTERN MED, V162, P893, DOI 10.1001/archinte.162.8.893; Young T, 2008, SLEEP, V31, P1071; Zerah-Lancner F, 2000, AM J RESP CRIT CARE, V162, P2208, DOI 10.1164/ajrccm.162.6.2002002; Zucconi M, 1996, EUR RESPIR J, V9, P1251, DOI 10.1183/09031936.96.09061251	186	185	199	1	33	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3					210	U169		10.7326/M12-3187	http://dx.doi.org/10.7326/M12-3187			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3KH	25089864				2022-12-28	WOS:000340486000007
J	Sedgwick, P				Sedgwick, Philip			Understanding why "absence of evidence is not evidence of absence"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIAL		Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Sedgwick P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4287; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5420; Sedgwick P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1041; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4285; Walsh JM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5605	7	5	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2014	349								g4751	10.1136/bmj.g4751	http://dx.doi.org/10.1136/bmj.g4751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5OF	25085689				2022-12-28	WOS:000339909000001
J	Wen, ZX; Nguyen, HN; Guo, ZY; Lalli, MA; Wang, XY; Su, YJ; Kim, NS; Yoon, KJ; Shin, J; Zhang, C; Makri, G; Nauen, D; Yu, HM; Guzman, E; Chiang, CH; Yoritomo, N; Kaibuchi, K; Zou, JZ; Christian, KM; Cheng, LZ; Ross, CA; Margolis, RL; Chen, G; Kosik, KS; Song, HJ; Ming, GL				Wen, Zhexing; Ha Nam Nguyen; Guo, Ziyuan; Lalli, Matthew A.; Wang, Xinyuan; Su, Yijing; Kim, Nam-Shik; Yoon, Ki-Jun; Shin, Jaehoon; Zhang, Ce; Makri, Georgia; Nauen, David; Yu, Huimei; Guzman, Elmer; Chiang, Cheng-Hsuan; Yoritomo, Nadine; Kaibuchi, Kozo; Zou, Jizhong; Christian, Kimberly M.; Cheng, Linzhao; Ross, Christopher A.; Margolis, Russell L.; Chen, Gong; Kosik, Kenneth S.; Song, Hongjun; Ming, Guo-li			Synaptic dysregulation in a human iPS cell model of mental disorders	NATURE			English	Article							DE-NOVO MUTATIONS; STEM-CELLS; SCHIZOPHRENIA; GENE; DISEASE; QUANTIFICATION; INTEGRATION; PROTEINS	Dysregulated neurodevelopment with altered structural and functional connectivity is believed to underlie many neuropsychiatric disorders(1), and 'a disease of synapses' is the major hypothesis for the biological basis of schizophrenia(2). Although this hypothesis has gained indirect support from human post-mortem brain analyses' and genetic studies(5-10), little is known about the pathophysiology of synapses in patient neurons and how susceptibility genes for mental disorders could lead to synaptic deficits in humans. Genetics of most psychiatric disorders are extremely complex due to multiple susceptibility variants with low penetrance and variable phenotypes(11). Rare, multiply affected, large families in which a single genetic locus is probably responsible for conferring susceptibility have proven invaluable for the study of complex disorders. Here we generated induced pluripotent stem (iPS) cells from four members of a family in which a frameshift mutation of disrupted in schizophrenia! (DISCI) co-segregated with major psychiatric disorders' and we further produced different isogenic iPS cell lines via gene editing. We showed that mutant DISCI causes synaptic vesicle release deficits in iPS-cell-derived forebrain neurons. Mutant DISCI depletes wild-type DISCI protein and, furthermore, dysregulates expression of many genes related to synapses and psychiatric disorders in human forebrain neurons. Our study reveals that a psychiatric disorder relevant mutation causes synapse deficits and transcriptional dysregulation in human neurons and our findings provide new insight into the molecular and synaptic etiopathology of psychiatric disorders.	[Wen, Zhexing; Ha Nam Nguyen; Wang, Xinyuan; Su, Yijing; Kim, Nam-Shik; Yoon, Ki-Jun; Shin, Jaehoon; Zhang, Ce; Makri, Georgia; Nauen, David; Yu, Huimei; Chiang, Cheng-Hsuan; Zou, Jizhong; Christian, Kimberly M.; Cheng, Linzhao; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA; [Wen, Zhexing; Su, Yijing; Kim, Nam-Shik; Yoon, Ki-Jun; Zhang, Ce; Makri, Georgia; Yu, Huimei; Chiang, Cheng-Hsuan; Christian, Kimberly M.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Ha Nam Nguyen; Shin, Jaehoon; Ross, Christopher A.; Margolis, Russell L.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Guo, Ziyuan; Chen, Gong] Penn State Univ, Huck Inst Life Sci, Dept Biol, University Pk, PA 16802 USA; [Lalli, Matthew A.; Guzman, Elmer; Kosik, Kenneth S.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Dept Mol Cellular & Dev Biol, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Wang, Xinyuan] Fudan Univ, Sch Basic Med Sci, Shanghai 200032, Peoples R China; [Nauen, David] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Chiang, Cheng-Hsuan; Ross, Christopher A.; Margolis, Russell L.; Song, Hongjun; Ming, Guo-li] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Yoritomo, Nadine; Ross, Christopher A.; Margolis, Russell L.] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Kaibuchi, Kozo] Nagoya Univ, Grad Sch Med, Showa Ku, Dept Cell Pharmacol, Nagoya, Aichi 4668550, Japan; [Zou, Jizhong; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of California System; University of California Santa Barbara; Fudan University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Nagoya University; Johns Hopkins University	Ming, GL (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21205 USA.	gming1@jhmi.edu	Yoon, Ki-Jun/S-8170-2018; Kaibuchi, Kozo/M-4887-2014; Wen, Zhexing/L-1228-2018; Chiang, Jason/N-2766-2018; wang, xinyuan/HHM-2418-2022	Kaibuchi, Kozo/0000-0003-0714-1992; Wen, Zhexing/0000-0002-1518-3845; Chiang, Jason/0000-0003-3623-8996; Lalli, Matthew/0000-0003-0419-1206; Zou, Jizhong/0000-0003-1021-0549; nauen, david/0000-0002-2652-9944; Yoon, Ki-Jun/0000-0003-2985-2541; Wang, Xinyuan/0000-0002-3107-8359; Ming, Guo-li/0000-0002-2517-6075; Chen JNU, Gong/0000-0002-1857-3670; Guo, Ziyuan/0000-0002-2263-0797	NIH [MH087874, N5047344, NS048271, AG045656, MH102978]; IMHRO; SFARI; NARSAD; MSCRF; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES021957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH105128, R21MH092740, R33MH087874, F31MH102978, R01MH083911, R21MH087874] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047344, R37NS047344, R56NS047344, R01NS048271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024984, R01AG045656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IMHRO; SFARI; NARSAD(NARSAD); MSCRF; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of Ming and Song laboratories for discussion, and Q. Hussaini, Y. Cai and L. Liu for technical support. This work was supported by grants from the NIH (MH087874, N5047344), IMHRO, SFARI, NARSAD, and MSCRF to H.S.; from MSCRF, NARSAD and the NIH (NS048271) to G.-I.M.; from Dr. Miriam and Sheldon G. Adelson Medical Research Foundation to G.-I.M. and K.S.K.; from the NIH (AG045656) to CC.: from MSCRF and NARSAD to K.M.C.; by postdoctoral fellowships from MSCRF to Z.W.,Y.S., N.S.K., and G.M.; and by a predoctoral fellowship from the NIH (MH102978) to H.N.N.	Barbosa AC, 2008, P NATL ACAD SCI USA, V105, P9391, DOI 10.1073/pnas.0802679105; Brennand K, 2014, MOL PSYCHIAT; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Camargo LM, 2007, MOL PSYCHIATR, V12, P74, DOI 10.1038/sj.mp.4001880; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Chiang CH, 2011, MOL PSYCHIATR, V16, P358, DOI 10.1038/mp.2011.13; Christian Kimberly M, 2012, Front Biol (Beijing), V7, P179, DOI 10.1007/s11515-012-1216-0; Custer KL, 2006, J NEUROSCI, V26, P1303, DOI 10.1523/JNEUROSCI.2699-05.2006; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; HACKETT JT, 1990, J NEUROPHYSIOL, V63, P701, DOI 10.1152/jn.1990.63.4.701; Ho SY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-230; Honer WG, 2004, INT REV NEUROBIOL, V59, P175; Johnson RD, 2008, ACTA BIOCHIM POL, V55, P619; Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17; Kenny EM, 2014, MOL PSYCHIATR, V19, P872, DOI 10.1038/mp.2013.127; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leliveld SR, 2008, J NEUROSCI, V28, P3839, DOI 10.1523/JNEUROSCI.5389-07.2008; Lips ES, 2012, MOL PSYCHIATR, V17, P996, DOI 10.1038/mp.2011.117; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Malhotra D, 2011, NEURON, V72, P951, DOI 10.1016/j.neuron.2011.11.007; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Sachs NA, 2005, MOL PSYCHIATR, V10, P758, DOI 10.1038/sj.mp.4001667; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Thomson Pippa A, 2013, Front Biol (Beijing), V8, P1; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Wright R, 2014, JAMA PSYCHIAT, V71, P334, DOI 10.1001/jamapsychiatry.2013.4239; Yu DX, 2014, STEM CELL REP, V2, P295, DOI 10.1016/j.stemcr.2014.01.009	40	337	348	7	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					414	+		10.1038/nature13716	http://dx.doi.org/10.1038/nature13716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25132547	Green Accepted			2022-12-28	WOS:000345770600046
J	Xue, ZH; Ye, QH; Anson, SR; Yang, JC; Xiao, G; Kowbel, D; Glass, NL; Crosthwaite, SK; Liu, Y				Xue, Zhihong; Ye, Qiaohong; Anson, Simon R.; Yang, Jichen; Xiao, Guanghua; Kowbel, David; Glass, N. Louise; Crosthwaite, Susan K.; Liu, Yi			Transcriptional interference by antisense RNA is required for circadian clock function	NATURE			English	Article							NEUROSPORA-CRASSA; POLYMERASE-II; TEMPERATURE COMPENSATION; WHITE COLLAR-1; LIGHT; FREQUENCY; GENE; FRQ; INACTIVATION; METHYLATION	Eukaryotic circadian oscillators consist of negative feedback loops that generate endogenous rhythmicities(1). Natural antisense RNAs are found in a wide range of eukaryotic organisms(2-5). Nevertheless, the physiological importance and mode of action of most antisense RNAs are not clear(6-9). frequency (frq) encodes a component of the Neurospora core circadian negative feedback loop, which was thought to generate sustained rhythmicity(10). Transcription of qrf, the long non-coding frq antisense RNA, is induced by light, and its level oscillates in antiphase to frq sense RNA(3). Here we show that qrf transcription is regulated by both light-dependent and light-independent mechanisms. Light-dependent qrf transcription represses frq expression and regulates clock resetting. Light-independent qrf expression, on the other hand, is required for circadian rhythmicity. frq transcription also inhibits qrf expression and drives the antiphasic rhythm of qrf transcripts. The mutual inhibition of frq and qrf transcription thus forms a double negative feedback loop that is interlocked with the core feedback loop. Genetic and mathematical modelling analyses indicate that such an arrangement is required for robust and sustained circadian rhythmicity. Moreover, our results suggest that antisense transcription inhibits sense expression by mediating chromatin modifications and premature termination of transcription. Taken together, our results establish antisense transcription as an essential feature in a circadian system and shed light on the importance and mechanism of antisense action.	[Xue, Zhihong; Ye, Qiaohong; Liu, Yi] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Anson, Simon R.; Crosthwaite, Susan K.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Yang, Jichen; Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Kowbel, David; Glass, N. Louise] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Manchester; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley	Liu, Y (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Yi.Liu@UTsouthwestern.edu	Glass, N. Louise/ABA-7303-2021; yang, jichen/HDL-9203-2022	Xue, Zhihong/0000-0003-3568-2964	National Institutes of Health [GM068496, GM062591, GM081597]; Welch Foundation [I-1560]; Cancer Prevention Research Institute of Texas [RP101496]; Biotechnology and Biological Sciences Research Council [BBS/S/C2005/13012]; Biotechnology and Biological Sciences Research Council [BBS/B/11710] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084283, R01GM062591, R01GM068496, R24GM081597, R35GM118118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Cancer Prevention Research Institute of Texas; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Cha, Y. Dang and H. Yuan for technical assistance, and B. Li for critical comments. Supported by grants from the National Institutes of Health to Y. L. (GM068496, GM062591) and N.L.G. (GM081597), the Welch Foundation (I-1560) to Y. L., the Cancer Prevention Research Institute of Texas (RP101496) to Z. X., and the Biotechnology and Biological Sciences Research Council (BBS/S/C2005/13012) to S. R. A. and S.K.C.	Adhvaryu KK, 2005, EUKARYOT CELL, V4, P1455, DOI 10.1128/EC.4.8.1455-1464.2005; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; Bardiya N, 2007, FUNGAL GENET BIOL, V44, P307, DOI 10.1016/j.fgb.2006.12.011; BARLOW JJ, 1963, BIOCHEM BIOPH RES CO, V13, P61, DOI 10.1016/0006-291X(63)90163-3; Belden WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002166; BellPedersen D, 1996, MOL CELL BIOL, V16, P513; Berretta J, 2009, EMBO REP, V10, P973, DOI 10.1038/embor.2009.181; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Chang SS, 2012, ANNU REV MICROBIOL, V66, P305, DOI 10.1146/annurev-micro-092611-150138; Choudhary S, 2007, MOL CELL BIOL, V27, P3995, DOI 10.1128/MCB.00186-07; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Dang YK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003761; Deuve JL, 2011, ANNU REV CELL DEV BI, V27, P611, DOI 10.1146/annurev-cellbio-092910-154020; DHARMANANDA S, 1980, THESIS U CALIFORNIA; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Ermentrout B., 2007, SCHOLARPEDIA, DOI [DOI 10.4249/SCH0LARPEDIA.1399, 10.4249/scholarpedia.1399]; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; GEAR CW, 1971, IEEE T CIRCUITS SYST, VCT18, P89, DOI 10.1109/TCT.1971.1083221; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; Guo JH, 2009, CELL, V138, P1236, DOI 10.1016/j.cell.2009.06.043; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hobson DJ, 2012, MOL CELL, V48, P365, DOI 10.1016/j.molcel.2012.08.027; Hong CI, 2008, BIOPHYS J, V94, P1221, DOI 10.1529/biophysj.107.115154; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Kramer C, 2003, NATURE, V421, P948, DOI 10.1038/nature01427; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Liu Y, 1997, CELL, V89, P477, DOI 10.1016/S0092-8674(00)80228-7; Menet JS, 2012, ELIFE, V1, DOI 10.7554/eLife.00011; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Ogawa Y, 2008, SCIENCE, V320, P1336, DOI 10.1126/science.1157676; Pall M. L., 1993, FUNGAL GENET NEWSL, V40, P57; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Ruoff P, 2005, P NATL ACAD SCI USA, V102, P17681, DOI 10.1073/pnas.0505137102; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Sauman I, 1996, NEURON, V17, P889, DOI 10.1016/S0896-6273(00)80220-2; Smith KM, 2010, EUKARYOT CELL, V9, P1549, DOI 10.1128/EC.00154-10; Vollmers C, 2012, CELL METAB, V16, P833, DOI 10.1016/j.cmet.2012.11.004; Yoon OK, 2010, RNA, V16, P1256, DOI 10.1261/rna.2038810; Yu YH, 2007, P NATL ACAD SCI USA, V104, P2809, DOI 10.1073/pnas.0611005104; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710; Zhou ZP, 2013, P NATL ACAD SCI USA, V110, pE4867, DOI 10.1073/pnas.1315133110	44	69	69	1	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					650	+		10.1038/nature13671	http://dx.doi.org/10.1038/nature13671			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25132551	Green Accepted, Green Submitted			2022-12-28	WOS:000343801500054
J	Goodman, JL				Goodman, Jesse L.			Studying "Secret Serums" - Toward Safe, Effective Ebola Treatments	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTECTION; VIRUS; MARBURG		[Goodman, Jesse L.] Georgetown Univ, Dept Med, Div Infect Dis, Washington, DC 20007 USA; [Goodman, Jesse L.] Georgetown Univ, Ctr Med Prod Access Safety & Stewardship, Washington, DC USA; [Goodman, Jesse L.] Vet Affairs Med Ctr, Div Infect Dis, Dept Med, Washington, DC 20422 USA	Georgetown University; Georgetown University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Goodman, JL (corresponding author), Georgetown Univ, Dept Med, Div Infect Dis, Washington, DC 20007 USA.							Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Iversen PL, 2012, VIRUSES-BASEL, V4, P2806, DOI 10.3390/v4112806; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Pettitt J, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006608; Uebelhoer LS, 2014, ANTIVIR RES, V106, P86, DOI 10.1016/j.antiviral.2014.03.018; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027	6	49	55	0	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1086	1089		10.1056/NEJMp1409817	http://dx.doi.org/10.1056/NEJMp1409817			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9PI	25140857				2022-12-28	WOS:000341687300003
J	Herzfeld, DJ; Vaswani, PA; Marko, MK; Shadmehr, R				Herzfeld, David J.; Vaswani, Pavan A.; Marko, Mollie K.; Shadmehr, Reza			A memory of errors in sensorimotor learning	SCIENCE			English	Article							MOTOR ADAPTATION; TASK VARIATION; SAVINGS; MODELS; MOVEMENT; STIMULI; SYSTEMS; MONKEY	The current view of motor learning suggests that when we revisit a task, the brain recalls the motor commands it previously learned. In this view, motor memory is a memory of motor commands, acquired through trial-and-error and reinforcement. Here we show that the brain controls how much it is willing to learn from the current error through a principled mechanism that depends on the history of past errors. This suggests that the brain stores a previously unknown form of memory, a memory of errors. A mathematical formulation of this idea provides insights into a host of puzzling experimental data, including savings and meta-learning, demonstrating that when we are better at a motor task, it is partly because the brain recognizes the errors it experienced before.	[Herzfeld, David J.; Marko, Mollie K.; Shadmehr, Reza] Johns Hopkins Univ, Sch Med, Lab Computat Motor Control, Dept Biomed Engn, Baltimore, MD 21205 USA; [Vaswani, Pavan A.] Johns Hopkins Univ, Sch Med, Lab Computat Motor Control, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Herzfeld, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Lab Computat Motor Control, Dept Biomed Engn, Baltimore, MD 21205 USA.	dherzfe1@jhmi.edu	Vaswani, Pavan/ABA-4737-2020	Vaswani, Pavan/0000-0002-1826-6275	NIH grants [T32EB003383, T32GM007057, R01NS078311, 1F31NS079121]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB003383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007057, T32GM007309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078311, F31NS090860, F31NS079121] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants T32EB003383, T32GM007057, R01NS078311, and 1F31NS079121. We thank J. Krakauer, J.-J. Orban de Xivry, and A. A. Ahmed for comments. D.J.H., P.A.V., M.K.M., and R.S. conceived and designed the experiments. D.J.H. performed the experiments, analyzed the data, and performed the simulations. R.S. and D.J.H. wrote the paper. The data reported in this paper and in the supplementary materials are available from the corresponding author.	Braun DA, 2009, CURR BIOL, V19, P352, DOI 10.1016/j.cub.2009.01.036; Castro LNG, 2014, CURR BIOL, V24, P1050, DOI 10.1016/j.cub.2014.03.049; Cheng S, 2006, NEURAL COMPUT, V18, P760, DOI 10.1162/089976606775774651; Donchin O, 2003, J NEUROSCI, V23, P9032; Fine MS, 2006, J NEUROPHYSIOL, V96, P710, DOI 10.1152/jn.00215.2006; Herzfeld DJ, 2014, NEUROIMAGE, V98, P147, DOI 10.1016/j.neuroimage.2014.04.076; Huang VS, 2011, NEURON, V70, P787, DOI 10.1016/j.neuron.2011.04.012; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Kojima Y, 2004, J NEUROSCI, V24, P7531, DOI 10.1523/JNEUROSCI.1741-04.2004; Kording KP, 2007, NAT NEUROSCI, V10, P779, DOI 10.1038/nn1901; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Malone LA, 2011, J NEUROSCI, V31, P15136, DOI 10.1523/JNEUROSCI.1367-11.2011; Marko MK, 2012, J NEUROPHYSIOL, V108, P1752, DOI 10.1152/jn.00177.2012; Mawase F, 2014, J NEUROPHYSIOL, V111, P1444, DOI 10.1152/jn.00734.2013; Patton JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0046466; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Rescorla R. A., 1972, CLASSICAL CONDITIONI; Riedmiller M., 1993, IEEE INT C NEUR NETW, V1, P586, DOI DOI 10.1109/ICNN.1993.298623; Robinson FR, 2003, J NEUROPHYSIOL, V90, P1235, DOI 10.1152/jn.00656.2002; Sarwary AME, 2013, J NEUROPHYSIOL, V110, P1269, DOI 10.1152/jn.00914.2012; Scheidt RA, 2001, J NEUROPHYSIOL, V86, P971, DOI 10.1152/jn.2001.86.2.971; Smith M, 2004, ADV COMPUTATIONAL MO, P3; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Soetedjo R, 2009, J NEUROSCI, V29, P15213, DOI 10.1523/JNEUROSCI.4296-09.2009; Thoroughman KA, 2000, NATURE, V407, P742, DOI 10.1038/35037588; Trent Michael C, 2013, Front Comput Neurosci, V7, P118, DOI 10.3389/fncom.2013.00118; Turnham EJA, 2012, J NEUROPHYSIOL, V107, P1111, DOI 10.1152/jn.00635.2011; van Beers RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049373; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Zarahn E, 2008, J NEUROPHYSIOL, V100, P2537, DOI 10.1152/jn.90529.2008	32	170	172	2	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1349	1353		10.1126/science.1253138	http://dx.doi.org/10.1126/science.1253138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25123484	Green Accepted			2022-12-28	WOS:000341483800066
J	Wallace, EA; Schumann, JH; Weinberger, SE				Wallace, Erik A.; Schumann, John H.; Weinberger, Steven E.			Hospital Relationships With Direct-to-Consumer Screening Companies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wallace, Erik A.] Univ Colorado, Sch Med, Colorado Springs, CO 80918 USA; [Schumann, John H.] Univ Oklahoma, Sch Community Med, Tulsa, OK USA; [Weinberger, Steven E.] Amer Coll Physicians, Philadelphia, PA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado at Colorado Springs; University of Oklahoma System; University of Oklahoma - Tulsa; American College of Physicians	Wallace, EA (corresponding author), Univ Colorado, Sch Med, 4863 N Nevada Ave, Colorado Springs, CO 80918 USA.	erik.wallace@ucdenver.edu						HealthFair, 2014, HEALTHFAIR RESPONSE; O'Gara PT., 2014, REACTION TO PUBLIC C; Public Citizen, 2014, HEALTHFAIR CARDIOVAS; Wallace EA, 2012, ANN INTERN MED, V157, P747, DOI 10.7326/0003-4819-157-10-201211200-00536	4	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					891	892		10.1001/jama.2014.9500	http://dx.doi.org/10.1001/jama.2014.9500			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25110878				2022-12-28	WOS:000341668600014
J	Halper-Stromberg, A; Lu, CL; Klein, F; Horwitz, JA; Bournazos, S; Nogueira, L; Eisenreich, TR; Liu, C; Gazumyan, A; Schaefer, U; Furze, RC; Seaman, MS; Prinjha, R; Tarakhovsky, A; Ravetch, JV; Nussenzweig, MC				Halper-Stromberg, Ariel; Lu, Ching-Lan; Klein, Florian; Horwitz, Joshua A.; Bournazos, Stylianos; Nogueira, Lilian; Eisenreich, Thomas R.; Liu, Cassie; Gazumyan, Anna; Schaefer, Uwe; Furze, Rebecca C.; Seaman, Michael S.; Prinjha, Rab; Tarakhovsky, Alexander; Ravetch, Jeffrey V.; Nussenzweig, Michel C.			Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice	CELL			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; INFECTED RHESUS-MONKEYS; TO-CELL SPREAD; IMMUNE-RESPONSES; SYNERGISTIC ACTIVATION; MONOCLONAL-ANTIBODIES; IN-VIVO; MACAQUES; VIREMIA; CYTOTOXICITY	Latent reservoirs of HIV-1-infected cells are refractory to antiretroviral therapies (ART) and remain the major barrier to curing HIV-1. Because latently infected cells are long-lived, immunologically invisible, and may undergo homeostatic proliferation, a "shock and kill" approach has been proposed to eradicate this reservoir by combining ART with inducers of viral transcription. However, all attempts to alter the HIV-1 reservoir in vivo have failed to date. Using humanized mice, we show that broadly neutralizing antibodies (bNAbs) can interfere with establishment of a silent reservoir by Fc-FcR-mediated mechanisms. In established infection, bNAbs or bNAbs plus single inducers are ineffective in preventing viral rebound. However, bNAbs plus a combination of inducers that act by independent mechanisms synergize to decrease the reservoir as measured by viral rebound. Thus, combinations of inducers and bNAbs constitute a therapeutic strategy that impacts the establishment and maintenance of the HIV-1 reservoir in humanized mice.	[Halper-Stromberg, Ariel; Lu, Ching-Lan; Klein, Florian; Horwitz, Joshua A.; Nogueira, Lilian; Eisenreich, Thomas R.; Liu, Cassie; Gazumyan, Anna; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Lu, Ching-Lan] Weill Cornell Med Coll, New York, NY 10065 USA; [Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA; [Schaefer, Uwe; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10065 USA; [Furze, Rebecca C.; Prinjha, Rab] GlaxoSmithKline, Med Res Ctr, Immuno Inflammat Therapy Area, Stevenage SG1 2NY, Herts, England; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Rockefeller University; Cornell University; Rockefeller University; Rockefeller University; GlaxoSmithKline; Harvard University; Beth Israel Deaconess Medical Center	Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10065 USA.	nussen@rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Ravetch, Jeffrey/Z-1596-2019; Bournazos, Stylianos/ABH-1578-2021	Ravetch, Jeffrey/0000-0003-2024-9041; Liu, Cassie/0000-0003-3907-9409	National Institutes of Health (NIH) Medical Scientist Training Program [T32GM07739]; Bill and Melinda Gates Foundation with Comprehensive Antibody Vaccine Immune Monitoring Consortium [1032144]; Collaboration for AIDS Vaccine Discovery Grant [OPP1033115]; National Center for Advancing Translational Sciences (NCATS) [8 UL1 TR000043]; National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [AI100663-02]; National Institute Of Allergy and Infectious Diseases of the NIH [AI100148-02, AI081677-05]; American Heart Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100148, P01AI081677, T32AI070084, UM1AI100663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation with Comprehensive Antibody Vaccine Immune Monitoring Consortium; Collaboration for AIDS Vaccine Discovery Grant; National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; National Institute Of Allergy and Infectious Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Roberto Speck and Renier Myburgh for help manufacturing ART feed; CellDex Therapeutics for providing 3BNC117; and all members of the Nussenzweig Laboratory for helpful discussion and advice. This work was supported by the National Institutes of Health (NIH) Medical Scientist Training Program grant T32GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program (A.H.-S.); Bill and Melinda Gates Foundation with Comprehensive Antibody Vaccine Immune Monitoring Consortium Grant 1032144 (M.S.S.); and Collaboration for AIDS Vaccine Discovery Grant OPP1033115 (M.C.N. and J.V.R.). This work was also supported, in part, by grant # 8 UL1 TR000043 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery AI100663-02 (M.C.N.), and National Institute Of Allergy and Infectious Diseases of the NIH Grants AI100148-02 and AI081677-05 (M.C.N. and J.V.R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. S.B. receives fellowship support from the American Heart Association. M.C.N. is a Howard Hughes Medical Institute Investigator. R.P. and R.F. are employees of GlaxoSmithKline (GSK).	Abela IA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002634; Agosto LM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003982; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Archin NM, 2014, J INFECT DIS; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Bonsignori M, 2012, J VIROL, V86, P11521, DOI 10.1128/JVI.01023-12; Brehm MA, 2014, J IMMUNOL METHODS, DOI 10.1016j.jim.02.011; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chung AW, 2011, P NATL ACAD SCI USA, V108, P7505, DOI 10.1073/pnas.1016048108; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Dar RD, 2014, SCIENCE, V344, P1392, DOI 10.1126/science.1250220; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Dhodapkar KM, 2005, P NATL ACAD SCI USA, V102, P2910, DOI 10.1073/pnas.0500014102; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dybul M, 2002, J INFECT DIS, V185, P61, DOI 10.1086/338123; Eriksson S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003174; Ferrantelli F, 2007, VIROLOGY, V358, P69, DOI 10.1016/j.virol.2006.07.056; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Forthal D, 2013, CURR OPIN HIV AIDS, V8, P393, DOI 10.1097/COH.0b013e328363d486; Gandhi RT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000321; Hatziioannou T, 2012, NAT REV MICROBIOL, V10, P852, DOI 10.1038/nrmicro2911; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Horton HM, 2010, BLOOD, V116, P3004, DOI 10.1182/blood-2010-01-265280; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Krejsgaard T, 2010, EXP DERMATOL, V19, P1096, DOI 10.1111/j.1600-0625.2010.01138.x; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kwon ED, 1997, P NATL ACAD SCI USA, V94, P8099, DOI 10.1073/pnas.94.15.8099; Lafeuillade A, 2001, J ACQ IMMUN DEF SYND, V26, P44, DOI 10.1097/00126334-200101010-00006; Landovitz RJ, 2009, NEW ENGL J MED, V361, P1768, DOI 10.1056/NEJMcp0904189; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Malbec M, 2013, J EXP MED, V210, P2813, DOI 10.1084/jem.20131244; Marsden MD, 2012, J VIROL, V86, P339, DOI 10.1128/JVI.06366-11; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nischang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038853; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Pietzsch J, 2012, P NATL ACAD SCI USA, V109, P15859, DOI 10.1073/pnas.1213409109; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Quivy V, 2002, J VIROL, V76, P11091, DOI 10.1128/JVI.76.21.11091-11103.2002; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Schiffner T, 2013, VACCINE, V31, P5789, DOI 10.1016/j.vaccine.2013.10.020; Shan L, 2012, IMMUNITY, V36, P491, DOI 10.1016/j.immuni.2012.01.014; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Siliciano JD, 2013, CURR OPIN HIV AIDS, V8, P318, DOI 10.1097/COH.0b013e328361eaca; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sun Y, 2011, J VIROL, V85, P6906, DOI 10.1128/JVI.00326-11; TSAI CC, 1995, SCIENCE, V270, P1197, DOI 10.1126/science.270.5239.1197; Tsai CC, 1998, J VIROL, V72, P4265, DOI 10.1128/JVI.72.5.4265-4273.1998; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291	66	274	279	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					989	999		10.1016/j.cell.2014.07.043	http://dx.doi.org/10.1016/j.cell.2014.07.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25131989	Bronze, Green Accepted			2022-12-28	WOS:000340945000006
J	Kranzusch, PJ; Lee, ASY; Wilson, SC; Solovykh, MS; Vance, RE; Berger, JM; Doudna, JA				Kranzusch, Philip J.; Lee, Amy S. Y.; Wilson, Stephen C.; Solovykh, Mikhail S.; Vance, Russell E.; Berger, James M.; Doudna, Jennifer A.			Structure-Guided Reprogramming of Human cGAS Dinucleotide Linkage Specificity	CELL			English	Article							CYCLIC GMP-AMP; DNA SENSOR; 2ND-MESSENGER; REVEALS; SYNTHASE; ROLES; MODEL	Cyclic dinucleotides (CDNs) play central roles in bacterial pathogenesis and innate immunity. The mammalian enzyme cGAS synthesizes a unique cyclic dinucleotide (cGAMP) containing a 2'-5' phosphodiester linkage essential for optimal immune stimulation, but the molecular basis for linkage specificity is unknown. Here, we show that the Vibrio cholerae pathogenicity factor DncV is a prokaryotic cGAS-like enzyme whose activity provides a mechanistic rationale for the unique ability of cGAS to produce 2'-5' cGAMP. Three high-resolution crystal structures show that DncV and human cGAS generate CDNs in sequential reactions that proceed in opposing directions. We explain 2' and 3' linkage specificity and test this model by reprogramming the human cGAS active site to produce 3'-5' cGAMP, leading to selective stimulation of alternative STING adaptor alleles in cells. These results demonstrate mechanistic homology between bacterial signaling and mammalian innate immunity and explain how active site configuration controls linkage chemistry for pathway-specific signaling.	[Kranzusch, Philip J.; Lee, Amy S. Y.; Solovykh, Mikhail S.; Vance, Russell E.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Lee, Amy S. Y.; Doudna, Jennifer A.] Univ Calif Berkeley, Ctr RNA Syst Biol, Berkeley, CA 94720 USA; [Berger, James M.] Johns Hopkins Univ, Sch Med, Dept Biophys, Baltimore, MD 21205 USA; [Kranzusch, Philip J.; Vance, Russell E.; Doudna, Jennifer A.] Univ Calif Berkeley, HHMI, Berkeley, CA 94720 USA; [Wilson, Stephen C.; Doudna, Jennifer A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Doudna, Jennifer A.] Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Johns Hopkins University; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Berger, JM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys, Baltimore, MD 21205 USA.	jmberger@jhmi.edu; doudna@berkeley.edu			HHMI; G. Harold and Leila Y. Mathers Foundation; National Cancer Institutes [CA077373]; National Institutes of Health [AI063302, AI080749, AI103817]; NIGMS Center for RNA Systems Biology; Life Sciences Research Foundation; American Cancer Society [PF-14-108-01-RMC]; NATIONAL CANCER INSTITUTE [R01CA077373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI063302, R01AI080749, R21AI103817] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); G. Harold and Leila Y. Mathers Foundation; National Cancer Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS Center for RNA Systems Biology; Life Sciences Research Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	X-ray data were collected at Beamline 8.3.1 of the Lawrence Berkeley National Lab Advanced Light Source (ALS) and Beamlines 11.1 and 12.2 of the Stanford Synchrotron Radiation Lightsource (SSRL). The authors are grateful to J. Holton and G. Meigs (ALS); T. Doukov, S. Russi, and A. Gonzalez (SSRL) for technical assistance with data collection and processing; R. Nichiporuk (QB3 Mass Spectrometry Facility) for assistance with product determination; J. Cate, Y. Bai, S. Floor, R. Wilson, and members of the Doudna and Berger labs for helpful comments and discussion. This work was funded by HHMI (R.E.V. and J.A.D.); the G. Harold and Leila Y. Mathers Foundation (J.M.B.); National Cancer Institutes Grant CA077373 (J.M.B.); National Institutes of Health Grants AI063302, AI080749, and AI103817 (R.E.V.); and the NIGMS Center for RNA Systems Biology (A.S.Y.L. and J.A.D.). P.J.K. is supported as an HHMI Fellow of the Life Sciences Research Foundation, and A.S.Y.L. is supported as an American Cancer Society Postdoctoral Fellow (PF-14-108-01-RMC). R.E.V. and J.A.D. are HHMI Investigators.	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Danilchanka O, 2013, CELL, V154, P962, DOI 10.1016/j.cell.2013.08.014; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Inn KS, 2011, MOL CELL, V41, P354, DOI 10.1016/j.molcel.2010.12.029; Jin L, 2011, GENES IMMUN, V12, P263, DOI 10.1038/gene.2010.75; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kato K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076983; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Kranzusch PJ, 2011, P NATL ACAD SCI USA, V108, P19743, DOI 10.1073/pnas.1112742108; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Rahmeh AA, 2009, J VIROL, V83, P11043, DOI 10.1128/JVI.01426-09; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P1863, DOI 10.1107/S0907444999010033; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	33	73	85	3	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 28	2014	158	5					1011	1021		10.1016/j.cell.2014.07.028	http://dx.doi.org/10.1016/j.cell.2014.07.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RI	25131990	Bronze, Green Accepted			2022-12-28	WOS:000340945000008
J	Rozitis, B; MacLennan, E; Emery, JP				Rozitis, Ben; MacLennan, Eric; Emery, Joshua P.			Cohesive forces prevent the rotational breakup of rubble-pile asteroid (29075) 1950 DA	NATURE			English	Article							THERMAL INFRARED OBSERVATIONS; SOLAR-SYSTEM; 101955 BENNU; YARKOVSKY; SURFACES; REGOLITH; HAYABUSA; ITOKAWA; IMPACT; ORBIT	Space missions(1) and ground-based observations(2) have shown that some asteroids are loose collections of rubble rather than solid bodies. The physical behaviour of such 'rubble-pile' asteroids has been traditionally described using only gravitational and frictional forces within a granular material(3). Cohesive forces in the form of small van der Waals forces between constituent grains have recently been predicted to be important for small rubble piles (ten kilometres across or less), and could potentially explain fast rotation rates in the small-asteroid population(4-6). The strongest evidence so far has come from an analysis of the rotational breakup of the main-belt comet P/2013 R3 (ref. 7), although that was indirect and poorly constrained by observations. Here we report that the kilometre-sized asteroid (29075) 1950 DA(ref. 8) is a rubble pile that is rotating faster than is allowed by gravity and friction. We find that cohesive forces are required to prevent surface mass shedding and structural failure, and that the strengths of the forces are comparable to, though somewhat less than, the forces found between the grains of lunar regolith.	[Rozitis, Ben; MacLennan, Eric; Emery, Joshua P.] Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Rozitis, B (corresponding author), Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA.	brozitis@utk.edu		MacLennan, Eric/0000-0002-9870-123X	Planetary Science Division of NASA; NASA [NNM10AA11C, NNX12AP32G]; STFC [ST/L000776/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L000776/1] Funding Source: researchfish	Planetary Science Division of NASA; NASA(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This publication uses data products from NEOWISE, a project of the Jet Propulsion Laboratory/California Institute of Technology, funded by the Planetary Science Division of NASA. We made use of the NASA/IPAC Infrared Science Archive, which is operated by the Jet Propulsion Laboratory/California Institute of Technology under a contract with NASA. This work was supported by NASA contract NNM10AA11C (Principal Investigator D. S. Lauretta) through the New Frontiers programme, and by NASA contract NNX12AP32G (Principal Investigator J. P. Emery) through the Near-Earth Object Observing programme.	AHRENS TJ, 1992, NATURE, V360, P429, DOI 10.1038/360429a0; Bottke WF, 2006, ANNU REV EARTH PL SC, V34, P157, DOI 10.1146/annurev.earth.34.031405.125154; Busch MW, 2007, ICARUS, V190, P608, DOI 10.1016/j.icarus.2007.03.032; Chesley SR, 2014, ICARUS, V235, P5, DOI 10.1016/j.icarus.2014.02.020; Delbo M, 2014, NATURE, V508, P233, DOI 10.1038/nature13153; Emery JP, 2014, ICARUS, V234, P17, DOI 10.1016/j.icarus.2014.02.005; Farnocchia D, 2014, ICARUS, V229, P321, DOI 10.1016/j.icarus.2013.09.022; Farnocchia D, 2013, ICARUS, V224, P1, DOI 10.1016/j.icarus.2013.02.004; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Hirabayashi M, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/1/L12; Holsapple KA, 2007, ICARUS, V187, P500, DOI 10.1016/j.icarus.2006.08.012; Jenniskens P, 2009, NATURE, V458, P485, DOI 10.1038/nature07920; Mainzer A, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/156; Michikami T, 2008, EARTH PLANETS SPACE, V60, P13, DOI 10.1186/BF03352757; Mitchell J. K., 1974, SPACE SCI LAB SERIES, V15, P72; Muller TG, 2005, ASTRON ASTROPHYS, V443, P347, DOI 10.1051/0004-6361:20053862; Murdoch N, 2013, MON NOT R ASTRON SOC, V433, P506, DOI 10.1093/mnras/stt742; Nugent C. R., 2013, THESIS U CALIFORNIA; Pravec P, 2000, ICARUS, V148, P12, DOI 10.1006/icar.2000.6482; Rivkin AS, 2005, ICARUS, V175, P175, DOI 10.1016/j.icarus.2004.11.005; Rozitis B, 2013, ASTRON ASTROPHYS, V555, DOI 10.1051/0004-6361/201321659; Rozitis B, 2012, MON NOT R ASTRON SOC, V423, P367, DOI 10.1111/j.1365-2966.2012.20882.x; Rozitis B, 2011, MON NOT R ASTRON SOC, V415, P2042, DOI 10.1111/j.1365-2966.2011.18718.x; Sanchez P, 2014, METEORIT PLANET SCI, V49, P788, DOI 10.1111/maps.12293; Scheeres DJ, 2010, ICARUS, V210, P968, DOI 10.1016/j.icarus.2010.07.009; Sierks H, 2011, SCIENCE, V334, P487, DOI 10.1126/science.1207325; Walsh KJ, 2012, ICARUS, V220, P514, DOI 10.1016/j.icarus.2012.04.029; Werner R. A., 1996, Celestial Mechanics and Dynamical Astronomy, V65, P313, DOI 10.1007/BF00053511; Wesselink A.J., 1948, B ASTRON I NETH, V10, P351; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868	30	120	121	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					174	+		10.1038/nature13632	http://dx.doi.org/10.1038/nature13632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25119234	Green Accepted			2022-12-28	WOS:000340200700027
J	Howard, S				Howard, Sally			Rape in war: how a US law prevents aid for safe abortions The US "Helms Amendment" threatens all foreign aid	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE					sal@sallyhoward.net						Baldwin H., 2000, 303 USAID CTR DEV ED; Casey SE, 2011, AM J PUBLIC HEALTH, V101, P1054, DOI 10.2105/AJPH.2010.300045; Corbett MR, 2003, INT FAM PLAN PERSPEC, V29, P106, DOI 10.2307/3181075; Department for International Development, 2011, SAF UNS AB UKS POL P; European Commission, 2014, COMM COMM EUR CIT IN; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Guttmacher Institute, 2012, FACTS IND AB WORLDW; HRW, 2005, NO PROT RAP SEX VIOL; Human Rights Watch, 2013, RAP VICT CRIM EC; Ipas, 2011, GLOB DAY ACT GEND BA; Scholz SJ, 2006, INTERVENTION TERRORI; Steiner Birthe, 2009, Confl Health, V3, P3, DOI 10.1186/1752-1505-3-3; Taylor J, 2012, IMPLEMENTING ABORTIO; The Norwegian Agency for Development Cooperation, 2014, SAF AB REP	14	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2014	349								g5073	10.1136/bmj.g5073	http://dx.doi.org/10.1136/bmj.g5073			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RV	25122184				2022-12-28	WOS:000340507100007
J	Gagnon, MG; Lin, JZ; Bulkley, D; Steitz, TA				Gagnon, Matthieu G.; Lin, Jinzhong; Bulkley, David; Steitz, Thomas A.			Crystal structure of elongation factor 4 bound to a clockwise ratcheted ribosome	SCIENCE			English	Article							TRANSFER-RNA; ESCHERICHIA-COLI; HYBRID STATE; LEPA; RESISTANCE; GTPASES; SITE	Elongation factor 4 (EF4/LepA) is a highly conserved guanosine triphosphatase translation factor. It was shown to promote back-translocation of tRNAs on posttranslocational ribosome complexes and to compete with elongation factor G for interaction with pretranslocational ribosomes, inhibiting the elongation phase of protein synthesis. Here, we report a crystal structure of EF4-guanosine diphosphate bound to the Thermus thermophilus ribosome with a P-site tRNA at 2.9 angstroms resolution. The C-terminal domain of EF4 reaches into the peptidyl transferase center and interacts with the acceptor stem of the peptidyl-tRNA in the P site. The ribosome is in an unusual state of ratcheting with the 30S subunit rotated clockwise relative to the 50S subunit, resulting in a remodeled decoding center. The structure is consistent with EF4 functioning either as a back-translocase or a ribosome sequester.	[Gagnon, Matthieu G.; Lin, Jinzhong; Bulkley, David; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gagnon, Matthieu G.; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Bulkley, David; Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu	Lin, Jinzhong/I-9131-2016	Lin, Jinzhong/0000-0001-5666-8526; Gagnon, Matthieu/0000-0003-4516-604X; Bulkley, David/0000-0002-2535-904X	NIH [GM022778]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank P. Moore, S. Seetharaman, I. Lomakin, and Y. Polikanov for valuable discussions and critical reading of the manuscript along with G. Blaha for help in designing and generating the mutant T. thermophilus strain. We thank A. Dahlberg and S. Gregory for providing the thermostable kanamycin gene and advice with genetic manipulations of T. thermophilus. We thank R. Grodzicki for preparing the Phe-tRNA<SUP>Phe</SUP>. We also thank the staffs of the Advanced Photon Source beamline 24-ID and the National Synchrotron Light Source beamlines X25 and X29 for help during data collection and the Center for Structural Biology facility at Yale University for computational support. This work was supported by NIH grant GM022778 (to T.A.S.). Coordinates and structure factors have been deposited in the Protein Data Bank with accession codes 4QJS and 4QJT.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; Clementi N, 2010, RNA BIOL, V7, P521, DOI 10.4161/rna.7.5.12467; Colca JR, 2003, J BIOL CHEM, V278, P21972, DOI 10.1074/jbc.M302109200; Connell SR, 2008, NAT STRUCT MOL BIOL, V15, P910, DOI 10.1038/nsmb.1469; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Evans RN, 2008, P NATL ACAD SCI USA, V105, P4673, DOI 10.1073/pnas.0801308105; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Liu HQ, 2011, P NATL ACAD SCI USA, V108, P16223, DOI 10.1073/pnas.1103820108; Liu HQ, 2010, J MOL BIOL, V396, P1043, DOI 10.1016/j.jmb.2009.12.043; Maguire BA, 2005, MOL CELL, V20, P427, DOI 10.1016/j.molcel.2005.09.009; MARCH PE, 1985, J BIOL CHEM, V260, P7206; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pech M, 2011, P NATL ACAD SCI USA, V108, P3199, DOI 10.1073/pnas.1012994108; Pulk A, 2013, SCIENCE, V340, P1544, DOI 10.1126/science.1235970; Qin Y, 2006, CELL, V127, P721, DOI 10.1016/j.cell.2006.09.037; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Selmer M, 2012, ACTA CRYSTALLOGR D, V68, P578, DOI 10.1107/S0907444912006348; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; Tourigny DS, 2013, SCIENCE, V340, P1542, DOI 10.1126/science.1235490; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yamamoto H, 2014, NAT REV MICROBIOL, V12, P89, DOI 10.1038/nrmicro3176; Yoshizawa S, 2009, BBA-GEN SUBJECTS, V1790, P1404, DOI 10.1016/j.bbagen.2009.03.010; Youngman EM, 2004, CELL, V117, P589, DOI 10.1016/S0092-8674(04)00411-8; Zhang DJ, 2013, BIOCHEM J, V452, P173, DOI 10.1042/BJ20121792; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275; Zhou J, 2013, SCIENCE, V340, P1543, DOI 10.1126/science.1236086; Zhou J, 2012, RNA, V18, P230, DOI 10.1261/rna.031187.111	32	31	33	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					684	687		10.1126/science.1253525	http://dx.doi.org/10.1126/science.1253525			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104389	Green Accepted			2022-12-28	WOS:000339962800042
J	Kristensen, SR; Meacock, R; Turner, AJ; Boaden, R; McDonald, R; Roland, M; Sutton, M				Kristensen, Soren Rud; Meacock, Rachel; Turner, Alex J.; Boaden, Ruth; McDonald, Ruth; Roland, Martin; Sutton, Matthew			Long-Term Effect of Hospital Pay for Performance on Mortality in England	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-CARE; HEALTH-CARE; FOR-PERFORMANCE; INCENTIVES; PROVIDERS; OUTCOMES	BACKGROUND A pay-for-performance program based on the Hospital Quality Incentive Demonstration was introduced in all hospitals in the northwest region of England in 2008 and was associated with a short-term (18-month) reduction in mortality. We analyzed the long-term effects of this program, called Advancing Quality. METHODS We analyzed 30-day in-hospital mortality among 1,825,518 hospital admissions for eight conditions, three of which were covered by the financial-incentive program. The hospitals studied included the 24 hospitals in the northwest region that were participating in the program and 137 elsewhere in England that were not participating. We used difference-in-differences regression analysis to compare risk-adjusted mortality for an 18-month period before the program was introduced with subsequent mortality in the short term (the first 18 months of the program) and the longer term (the next 24 months). RESULTS Throughout the short-term and the long-term periods, the performance of hospitals in the incentive program continued to improve and mortality for the three conditions covered by the program continued to fall. However, the reduction in mortality among patients with these conditions was greater in the control hospitals (those not participating in the program) than in the hospitals that were participating in the program (by 0.7 percentage points; 95% confidence interval [CI], 0.3 to 1.2). By the end of the 42-month follow-up period, the reduced mortality in the participating hospitals was no longer significant (-0.1 percentage points; 95% CI, -0.6 to 0.3). From the short term to the longer term, the mortality for conditions not covered by the program fell more in the participating hospitals than in the control hospitals (by 1.2 percentage points; 95% CI, 0.4 to 2.0), raising the possibility of a positive spillover effect on care for conditions not covered by the program. CONCLUSIONS Short-term relative reductions in mortality for conditions linked to financial incentives in hospitals participating in a pay-for-performance program in England were not maintained.	[Kristensen, Soren Rud; Meacock, Rachel; Turner, Alex J.; Sutton, Matthew] Univ Manchester, Manchester Ctr Hlth Econ, Inst Populat Hlth, Manchester, Lancs, England; [Boaden, Ruth] Univ Manchester, Manchester Business Sch, Manchester M13 9PL, Lancs, England; [McDonald, Ruth] Univ Warwick, Warwick Business Sch, Warwick, England; [Roland, Martin] Univ Cambridge, Cambridge Ctr Hlth Serv Res, Cambridge, England	University of Manchester; University of Manchester; University of Warwick; University of Cambridge	Kristensen, SR (corresponding author), Manchester Ctr Hlth Econ, Rm 1-304,Jean McFarlane Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.	soren.kristensen@manchester.ac.uk	Boaden, Ruth/L-3443-2016	Boaden, Ruth/0000-0003-1927-6405; McDonald, Ruth/0000-0002-3488-4209; Kristensen, Soren Rud/0000-0002-6608-7132; Turner, Alex J./0000-0003-4139-941X; Sutton, Matt/0000-0002-6635-2127; Meacock, Rachel/0000-0001-8933-5058; Roland, Martin/0000-0002-8533-3060	NIHR; Danish Council for Independent Research, Social Sciences; National Institute for Health Research [08/1809/250] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); Danish Council for Independent Research, Social Sciences(Det Frie Forskningsrad (DFF)); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by the NIHR and the Danish Council for Independent Research, Social Sciences.	Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Eijkenaar F, 2013, HEALTH POLICY, V110, P115, DOI 10.1016/j.healthpol.2013.01.008; Eijkenaar F, 2012, MED CARE RES REV, V69, P251, DOI 10.1177/1077558711432891; Glickman SW, 2007, JAMA-J AM MED ASSOC, V297, P2373, DOI 10.1001/jama.297.21.2373; Grossbart SR, 2006, MED CARE RES REV, V63, p29S, DOI 10.1177/1077558705283643; Jha AK, 2012, NEW ENGL J MED, V366, P1606, DOI 10.1056/NEJMsa1112351; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Mehrotra A, 2009, AM J MED QUAL, V24, P19, DOI 10.1177/1062860608326634; Mullen KJ, 2010, RAND J ECON, V41, P64, DOI 10.1111/j.1756-2171.2009.00090.x; Paris V., 2010, HLTH SYSTEMS I CHARA, P50; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rosenthal MB, 2006, MED CARE RES REV, V63, P135, DOI 10.1177/1077558705285291; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; Sutton M, 2012, NEW ENGL J MED, V367, P1821, DOI 10.1056/NEJMsa1114951; Sutton M, 2010, HEALTH ECON, V19, P1, DOI 10.1002/hec.1440	16	65	65	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					540	548		10.1056/NEJMoa1400962	http://dx.doi.org/10.1056/NEJMoa1400962			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM5LE	25099578	Green Published			2022-12-28	WOS:000339899100008
J	Wirth, CD; Blum, MR; da Costa, BR; Baumgartner, C; Collet, TH; Medici, M; Peeters, RP; Aujesky, D; Bauer, DC; Rodondi, N				Wirth, Christina D.; Blum, Manuel R.; da Costa, Bruno R.; Baumgartner, Christine; Collet, Tinh-Hai; Medici, Marco; Peeters, Robin P.; Aujesky, Drahomir; Bauer, Douglas C.; Rodondi, Nicolas			Subclinical Thyroid Dysfunction and the Risk for Fractures A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							BONE-MINERAL DENSITY; CORONARY-HEART-DISEASE; NON-VERTEBRAL FRACTURES; L-THYROXINE TREATMENT; LONG-TERM THYROXINE; BODY-MASS INDEX; FOLLOW-UP; HIP FRACTURE; SERUM TSH; OSTEOPOROTIC FRACTURE	Background: Data on the association between subclinical thyroid dysfunction and fractures conflict. Purpose: To assess the risk for hip and nonspine fractures associated with subclinical thyroid dysfunction among prospective cohorts. Data Sources: Search of MEDLINE and EMBASE (1946 to 16 March 2014) and reference lists of retrieved articles without language restriction. Study Selection: Two physicians screened and identified prospective cohorts that measured thyroid function and followed participants to assess fracture outcomes. Data Extraction: One reviewer extracted data using a standardized protocol, and another verified data. Both reviewers independently assessed methodological quality of the studies. Data Synthesis: The 7 population-based cohorts of heterogeneous quality included 50 245 participants with 1966 hip and 3281 nonspine fractures. In random-effects models that included the 5 higher-quality studies, the pooled adjusted hazard ratios (HRs) of participants with subclinical hyperthyroidism versus euthyrodism were 1.38 (95% CI, 0.92 to 2.07) for hip fractures and 1.20 (CI, 0.83 to 1.72) for nonspine fractures without statistical heterogeneity (P = 0.82 and 0.52, respectively; I-2 = 0%). Pooled estimates for the 7 cohorts were 1.26 (CI, 0.96 to 1.65) for hip fractures and 1.16 (CI, 0.95 to 1.42) for nonspine fractures. When thyroxine recipients were excluded, the HRs for participants with subclinical hyperthyroidism were 2.16 (CI, 0.87 to 5.37) for hip fractures and 1.43 (CI, 0.73 to 2.78) for nonspine fractures. For participants with subclinical hypothyroidism, HRs from higher-quality studies were 1.12 (CI, 0.83 to 1.51) for hip fractures and 1.04 (CI, 0.76 to 1.42) for nonspine fractures (P for heterogeneity = 0.69 and 0.88, respectively; I-2 = 0%). Limitations: Selective reporting cannot be excluded. Adjustment for potential common confounders varied and was not adequately done across all studies. Conclusion: Subclinical hyperthyroidism might be associated with an increased risk for hip and nonspine fractures, but additional large, high-quality studies are needed.	Univ Bern, Bern, Switzerland; Univ Lausanne Hosp, Lausanne, Switzerland; Erasmus MC, Rotterdam, Netherlands; Univ Calif San Francisco, San Francisco, CA 94143 USA	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Erasmus University Rotterdam; Erasmus MC; University of California System; University of California San Francisco	Rodondi, N (corresponding author), Univ Hosp Bern, Inselspital, Dept Gen Internal Med, CH-3010 Bern, Switzerland.	Nicolas.Rodondi@insel.ch	Medici, Marco/U-2777-2018; Collet, Tinh-Hai/I-4462-2019; Peeters, Robin/P-3603-2014; Blum, Manuel/AAG-7479-2019	Collet, Tinh-Hai/0000-0002-3243-1222; Blum, Manuel/0000-0003-4638-775X; Peeters, Robin/0000-0001-7732-9371; Rodondi, Nicolas/0000-0001-9083-6896; Baumgartner, Christine/0000-0003-2296-9632; Schmidt-Wirth, Christina Doris/0000-0003-2604-6253; R. da Costa, Bruno/0000-0002-1786-6332	Swiss National Science Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR051895] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Primary Funding Source: Swiss National Science Foundation.	Acotto CG, 2004, J CLIN DENSITOM, V7, P201, DOI 10.1385/JCD:7:2:201; Ahmed LA, 2006, OSTEOPOROSIS INT, V17, P426, DOI 10.1007/s00198-005-0003-z; Ahmed LA, 2006, OSTEOPOROSIS INT, V17, P46, DOI 10.1007/s00198-005-1892-6; Aloumanis K, 2009, EUR J CLIN INVEST, V39, P3; Appetecchia M, 2005, HORM RES, V64, P293, DOI 10.1159/000089489; Asvold BO, 2007, ARCH INTERN MED, V167, P1428, DOI 10.1001/archinte.167.13.1428; Bach-Mortensen P, 2006, CALCIFIED TISSUE INT, V79, P1, DOI 10.1007/s00223-005-0260-z; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Baldini M, 1996, RIV ITALIANA BIOL ME, V16, P85; Barrett JA, 1999, J CLIN EPIDEMIOL, V52, P243, DOI 10.1016/S0895-4356(98)00167-X; Barrett-Connor E, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1069; Bauer DC, 1997, J CLIN ENDOCR METAB, V82, P2931, DOI 10.1210/jc.82.9.2931; Bauer DC, 2001, ANN INTERN MED, V134, P561, DOI 10.7326/0003-4819-134-7-200104030-00009; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Berlin JA, 2002, STAT MED, V21, P371, DOI 10.1002/sim.1023; Biondi B, 2005, EUR J ENDOCRINOL, V152, P1, DOI 10.1530/eje.1.01809; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; BMJ Evidence Centre, 2012, STUD DES SEARCH FILT; BRABANT G, 1987, J CLIN ENDOCR METAB, V65, P83, DOI 10.1210/jcem-65-1-83; Brennan MD, 2006, THYROID, V16, P375, DOI 10.1089/thy.2006.16.375; Buscemi S, 2007, J ENDOCRINOL INVEST, V30, P230, DOI 10.1007/BF03347430; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Cappola AR, 2006, JAMA-J AM MED ASSOC, V295, P1033, DOI 10.1001/jama.295.9.1033; Ceresini G, 2004, MENOPAUSE, V11, P176, DOI 10.1097/01.GME.0000094169.64352.3B; Chen Z, 2004, MENOPAUSE, V11, P264, DOI 10.1097/01.GME.0000094210.15096.FD; Chirico V, 2013, HORM RES PAEDIAT, V80, P318; Collet TH, 2012, ARCH INTERN MED, V172, P799, DOI 10.1001/archinternmed.2012.402; COMPSTON JE, 1993, CLIN ENDOCRINOL, V39, P519, DOI 10.1111/j.1365-2265.1993.tb02402.x; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Das G, 2012, CLIN ENDOCRINOL, V77, P146, DOI 10.1111/j.1365-2265.2012.04345.x; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; DIAMOND T, 1994, ANN INTERN MED, V120, P8, DOI 10.7326/0003-4819-120-1-199401010-00002; Diez JJ, 2004, J CLIN ENDOCR METAB, V89, P4890, DOI 10.1210/jc.2003-032061; Drake MT, 2012, J CLIN ENDOCR METAB, V97, P1861, DOI 10.1210/jc.2011-3058; Egger M, 1997, BMJ-BRIT MED J, V315, P1371, DOI 10.1136/bmj.315.7119.1371; Egger M., 2001, SYSTEMATIC REV HLTH; Faber J, 1998, CLIN ENDOCRINOL, V48, P285; FABER J, 1994, EUR J ENDOCRINOL, V130, P350, DOI 10.1530/eje.0.1300350; Faber J, CLIN ENDOCRINOL OXF; Finigan J, 2008, J BONE MINER RES, V23, P75, DOI 10.1359/JBMR.070814; Flynn RW, 2010, J CLIN ENDOCR METAB, V95, P186, DOI 10.1210/jc.2009-1625; Flynn RWV, 2011, PHARMACOEPIDEM DR S, V20, pS29; Fowler PBS, 1996, J ROY COLL PHYS LOND, V30, P527; FUJIYAMA K, 1995, THYROID, V5, P13, DOI 10.1089/thy.1995.5.13; Garin MC, 2012, ENDOCRINE REV, V33; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; Grimnes G, 2008, THYROID, V18, P1147, DOI 10.1089/thy.2008.0158; Gyulai L, 1997, BIOL PSYCHIAT, V41, P503, DOI 10.1016/S0006-3223(96)00472-6; Hallengren B, 1999, J INTERN MED, V246, P139, DOI 10.1046/j.1365-2796.1999.00497.x; Helfand M, 2004, ANN INTERN MED, V140, P128, DOI 10.7326/0003-4819-140-2-200401200-00015; Herrick B, 2008, AM FAM PHYSICIAN, V77, P953; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoeg A, 2012, J CLIN ENDOCR METAB, V97, P4061, DOI 10.1210/jc.2012-2121; Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; HUI SL, 1989, ANN INTERN MED, V111, P355, DOI 10.7326/0003-4819-111-5-355; Hulley SB, 2007, DESIGNING CLIN RES; Huopio J, 2005, OSTEOPOROSIS INT, V16, P1404, DOI 10.1007/s00198-005-1851-2; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI 10.1007/s00198-004-1640-3; Kanis JA, 2004, J BONE MINER RES, V19, P893, DOI 10.1359/JBMR.040134; Kanis JA, 2002, J BONE MINER RES, V17, P1237, DOI 10.1359/jbmr.2002.17.7.1237; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Knudsen N, 1998, J INTERN MED, V243, P149; Ko Young-Jin, 2014, J Prev Med Public Health, V47, P36, DOI 10.3961/jpmph.2014.47.1.36; La Vignera S, 2008, Minerva Ginecol, V60, P475; Lee JS, 2010, ARCH INTERN MED, V170, P1876, DOI 10.1001/archinternmed.2010.424; Lee JS, 2010, CTS-CLIN TRANSL SCI, V3, pS11; Leese G, 2010, END ABSTR, V21; LEESE GP, 1992, CLIN ENDOCRINOL, V37, P500, DOI 10.1111/j.1365-2265.1992.tb01480.x; Legroux-Gerot I, 2012, OSTEOPOROSIS INT, V23, P2855, DOI 10.1007/s00198-012-1919-8; Limanova Z, 1990, Cas Lek Cesk, V129, P625; Lin HC, 2010, J THROMB HAEMOST, V8, P2176, DOI 10.1111/j.1538-7836.2010.03993.x; LINDE J, 1979, ACTA ENDOCRINOL-COP, V91, P437, DOI 10.1530/acta.0.0910437; Lindstedt G, INCREASED RISK BONE; MARCOCCI C, 1994, J CLIN ENDOCR METAB, V78, P818, DOI 10.1210/jc.78.4.818; Meier C, 2004, OSTEOPOROSIS INT, V15, P209, DOI 10.1007/s00198-003-1527-8; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Morrison A, 2013, CLINICOECONOMIC OUTC, V5, P9, DOI 10.2147/CEOR.S38721; MUDDE AH, 1994, CLIN ENDOCRINOL, V41, P421, DOI 10.1111/j.1365-2265.1994.tb02571.x; Murphy E, 2010, J CLIN ENDOCR METAB, V95, P3173, DOI 10.1210/jc.2009-2630; Nguyen TT, 1997, J BONE MINER RES, V12, P1092, DOI 10.1359/jbmr.1997.12.7.1092; Obermayer-Pietsch B, 2000, MATURITAS, V35, P159, DOI 10.1016/S0378-5122(00)00114-6; Ochs N, 2008, ANN INTERN MED, V148, P832, DOI 10.7326/0003-4819-148-11-200806030-00225; PARLE JV, 1991, CLIN ENDOCRINOL, V34, P77; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Ricken R, 2012, J AFFECT DISORDERS, V136, pE89, DOI 10.1016/j.jad.2011.06.011; Rochon PA, 2011, BMJ-BRIT MED J, V342, pd2238; Rodondi N, 2006, AM J MED, V119, P541, DOI 10.1016/j.amjmed.2005.09.028; Rodondi N, 2013, J CLIN ENDOCR METAB, V98, P2267, DOI 10.1210/jc.2013-1875; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; STALL GM, 1990, ANN INTERN MED, V113, P265, DOI 10.7326/0003-4819-113-4-265; Stamato F J, 2000, Rev Assoc Med Bras (1992), V46, P177; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228; Svare A, 2013, EUR J ENDOCRINOL, V169, P845, DOI 10.1530/EJE-13-0546; Taylor PN, 2013, J CLIN ENDOCR METAB, V98, P3562, DOI 10.1210/jc.2013-1315; Toft AD, 2001, NEW ENGL J MED, V345, P512, DOI 10.1056/NEJMcp010145; TUNBRIDGE WMG, 1977, CLIN ENDOCRINOL, V7, P481, DOI 10.1111/j.1365-2265.1977.tb01340.x; Uzzan B, 1996, J CLIN ENDOCR METAB, V81, P4278, DOI 10.1210/jc.81.12.4278; van der Deure WM, 2008, CLIN ENDOCRINOL, V68, P175, DOI 10.1111/j.1365-2265.2007.03016.x; Vestergaard P, 2005, CALCIFIED TISSUE INT, V77, P139, DOI 10.1007/s00223-005-0068-x; Vestergaard P, 2003, THYROID, V13, P585, DOI 10.1089/105072503322238854; Vestergaard P, 2002, THYROID, V12, P411, DOI 10.1089/105072502760043503; Waring AC, 2013, J BONE MINER RES, V28, P472, DOI 10.1002/jbmr.1774; Waung JA, 2012, TRENDS ENDOCRIN MET, V23, P155, DOI 10.1016/j.tem.2011.11.002	110	46	50	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3					189	U145		10.7326/M14-0125	http://dx.doi.org/10.7326/M14-0125			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3KH	25089863	Green Published, Green Accepted			2022-12-28	WOS:000340486000004
J	Zuniga, A; Zeller, R				Zuniga, Aimee; Zeller, Rolf			In Turing's hands-the making of digits	SCIENCE			English	Editorial Material							BIOLOGICAL PATTERN-FORMATION; LIMB BUD		[Zuniga, Aimee; Zeller, Rolf] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland	University of Basel	Zuniga, A (corresponding author), Univ Basel, Dept Biomed, Mattenstr 28, CH-4058 Basel, Switzerland.	aimee.zuniga@unibas.ch; rolf.zeller@unibas.ch	Zuniga, Aimée/AAG-7335-2020; Zeller, Rolf/C-2610-2013; Zuniga, Aimée/Q-2692-2018	Zuniga, Aimée/0000-0002-9953-3637; Zeller, Rolf/0000-0002-3186-7403; Zuniga, Aimée/0000-0002-9953-3637				Benazet JD, 2012, DEVELOPMENT, V139, P4250, DOI 10.1242/dev.084822; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; NEWMAN SA, 1979, SCIENCE, V205, P662, DOI 10.1126/science.462174; Raspopovic J, 2014, SCIENCE, V345, P566, DOI 10.1126/science.1252960; Sheth R, 2012, SCIENCE, V338, P1476, DOI 10.1126/science.1226804; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	12	4	4	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					516	517		10.1126/science.1257501	http://dx.doi.org/10.1126/science.1257501			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082687				2022-12-28	WOS:000339651300025
J	Barbui, C; Purgato, M				Barbui, Corrado; Purgato, Marianna			Decisions on WHO's essential medicines need more scrutiny	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIPSYCHOTIC-DRUGS; SCHIZOPHRENIA; LIST		[Barbui, Corrado; Purgato, Marianna] Univ Verona, WHO Collaborating Ctr Res & Training Mental Hlth, Dept Publ Hlth & Community Med, Sect Psychiat,Policlini GB Rossi, I-37134 Verona, Italy	University of Verona	Barbui, C (corresponding author), Univ Verona, WHO Collaborating Ctr Res & Training Mental Hlth, Dept Publ Hlth & Community Med, Sect Psychiat,Policlini GB Rossi, Piazzale Scuro 10, I-37134 Verona, Italy.	corrado.barbui@univr.it						Barbui C, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001530; Barbui C, 2013, LANCET, V382, P1234, DOI 10.1016/S0140-6736(13)60255-X; Barbui C, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000322; Chirac P, 2001, LANCET, V357, P1134, DOI 10.1016/S0140-6736(00)04291-4; Hill S, 2007, LANCET, V369, P1842, DOI 10.1016/S0140-6736(07)60676-X; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Leucht S, 2013, LANCET, V382, P951, DOI 10.1016/S0140-6736(13)60733-3; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Purgato M, 2012, EPIDEMIOL PSYCH SCI, V21, P343, DOI 10.1017/S204579601200039X; WHO, WHO MED STRAT REV PR	10	10	10	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2014	349								g4798	10.1136/bmj.g4798	http://dx.doi.org/10.1136/bmj.g4798			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NW	25081250				2022-12-28	WOS:000339907800002
J	Cordova, JC; Olivares, AO; Shin, Y; Stinson, BM; Calmat, S; Schmitz, KR; Aubin-Tam, ME; Baker, TA; Lang, MJ; Sauer, RT				Cordova, Juan Carlos; Olivares, Adrian O.; Shin, Yongdae; Stinson, Benjamin M.; Calmat, Stephane; Schmitz, Karl R.; Aubin-Tam, Marie-Eve; Baker, Tania A.; Lang, Matthew J.; Sauer, Robert T.			Stochastic but Highly Coordinated Protein Unfolding and Translocation by the ClpXP Proteolytic Machine	CELL			English	Article							ATP-FUELED MACHINES; DEGRADATION MACHINE; PORE LOOPS; PLUS; DENATURATION; SPECIFICITY; STABILITY; DYNAMICS	ClpXP and other AAA+ proteases recognize, mechanically unfold, and translocate target proteins into a chamber for proteolysis. It is not known whether these remarkable molecular machines operate by a stochastic or sequential mechanism or how power strokes relate to the ATP-hydrolysis cycle. Single-molecule optical trapping allows ClpXP unfolding to be directly visualized and reveals translocation steps of similar to 1-4 nm in length, but how these activities relate to solution degradation and the physical properties of substrate proteins remains unclear. By studying single-molecule degradation using different multidomain substrates and ClpXP variants, we answer many of these questions and provide evidence for stochastic unfolding and translocation. We also present a mechanochemical model that accounts for single-molecule, biochemical, and structural results for our observation of enzymatic memory in translocation stepping, for the kinetics of translocation steps of different sizes, and for probabilistic but highly coordinated subunit activity within the ClpX ring.	[Cordova, Juan Carlos; Lang, Matthew J.] Vanderbilt Univ, Dept Chem & Biomol Engn, Nashville, TN 37235 USA; [Olivares, Adrian O.; Stinson, Benjamin M.; Calmat, Stephane; Schmitz, Karl R.; Baker, Tania A.; Sauer, Robert T.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Shin, Yongdae] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Calmat, Stephane; Baker, Tania A.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Aubin-Tam, Marie-Eve] Delft Univ Technol, Kavli Inst Nanosci, Dept Bionanosci, NL-2628 CJ Delft, Netherlands; [Lang, Matthew J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37235 USA	Vanderbilt University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Delft University of Technology; Vanderbilt University	Lang, MJ (corresponding author), Vanderbilt Univ, Dept Chem & Biomol Engn, 221 Kirkland Hall, Nashville, TN 37235 USA.	matt.lang@vanderbilt.edu; bobsauer@mit.edu	Aubin-Tam, Marie-Eve/J-3337-2013	Aubin-Tam, Marie-Eve/0000-0001-9995-2623; /0000-0002-1081-285X; Shin, Yongdae/0000-0003-3441-1986; Schmitz, Karl/0000-0003-1411-7624; Sauer, Robert/0000-0002-1719-5399	NSF [0643745, MCB-1330792]; NIH [GM-101988]; Singapore-MIT Alliance for Re-search and Technology (SMART) program; HHMI; US Department of Education [P200A090323]; Samsung Foundation of Culture; Poitras predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101988] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT Alliance for Re-search and Technology (SMART) program(Singapore-MIT Alliance for Research & Technology Centre (SMART)); HHMI(Howard Hughes Medical Institute); US Department of Education(US Department of Education); Samsung Foundation of Culture(Samsung); Poitras predoctoral fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NSF (Career Award 0643745; MCB-1330792), the NIH (GM-101988), the Singapore-MIT Alliance for Research and Technology (SMART) program, and HHMI. J.C.C. was supported by a GAANN fellowship from the US Department of Education under grant no. P200A090323. Y.S. was supported by a Samsung Scholarship from the Samsung Foundation of Culture. B.M.S. was supported by a Poitras predoctoral fellowship. T.A.B. is an employee of HHMI. We thank Jacob Kerssemakers for the MATLAB implementation of his step-finding algorithm.	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Barkow SR, 2009, CHEM BIOL, V16, P605, DOI 10.1016/j.chembiol.2009.05.007; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Little MA, 2011, BIOPHYS J, V101, P477, DOI 10.1016/j.bpj.2011.05.070; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Nager AR, 2011, J MOL BIOL, V413, P4, DOI 10.1016/j.jmb.2011.07.041; Popa I, 2013, J AM CHEM SOC, V135, P12762, DOI 10.1021/ja4056382; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Shin Y, 2009, P NATL ACAD SCI USA, V106, P19340, DOI 10.1073/pnas.0910484106; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5	29	90	91	0	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					647	658		10.1016/j.cell.2014.05.043	http://dx.doi.org/10.1016/j.cell.2014.05.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083874	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000340944300016
J	Joseph, AE				Joseph, Anton E.			PERSONAL VIEW I certified deaths after judicial executions - and I believe capital punishment should be abolished	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Joseph, Anton E.] St George Hosp, London SW17 0QT, England; [Joseph, Anton E.] Croydon Univ Hosp, Croydon CR7 7YE, England	St Georges University London; Croydon University Hospital		aeajoseph@gmail.com						Davies E, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3061; Dyer O, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3064; Dyer O, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2670	3	0	0	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2014	348								g3312	10.1136/bmj.g3312	http://dx.doi.org/10.1136/bmj.g3312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5FQ	25134142				2022-12-28	WOS:000336154300024
J	Battegay, M; Elzi, L				Battegay, Manuel; Elzi, Luigia			Does HIV antiretroviral therapy still need its backbone?	LANCET			English	Editorial Material							REVERSE-TRANSCRIPTASE INHIBITORS; SPARING REGIMEN; PLUS RALTEGRAVIR; NAIVE ADULTS; OPEN-LABEL; NUCLEOSIDE; INFECTION		[Battegay, Manuel] Univ Basel Hosp, Dept Med, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Clin Res, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Battegay, M (corresponding author), Univ Basel Hosp, Dept Med, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland.	manuel.battegay@usb.ch						[Anonymous], 2014, EACS TREATM GUID VER; Cahn P, 2014, LANCET INFECT DIS, V14, P572, DOI 10.1016/S1473-3099(14)70736-4; Kozal MJ, 2012, HIV CLIN TRIALS, V13, P119, DOI 10.1310/hct1303-119; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Mills A, 2013, JAIDS-J ACQ IMM DEF, V62, P164, DOI 10.1097/QAI.0b013e31827b51b5; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; Raffi F, 2014, LANCET; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Reynes J, 2011, HIV CLIN TRIALS, V12, P255, DOI 10.1310/hct1205-255; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Yombi JC, 2014, AIDS, V28, P621, DOI 10.1097/QAD.0000000000000103	14	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1908	1910		10.1016/S0140-6736(14)61226-5	http://dx.doi.org/10.1016/S0140-6736(14)61226-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25103175				2022-12-28	WOS:000345450100009
J	Lawitz, E; Sulkowski, MS; Ghalib, R; Rodriguez-Torres, M; Younossi, ZM; Corregidor, A; DeJesus, E; Pearlman, B; Rabinovitz, M; Gitlin, N; Lim, JK; Pockros, PJ; Scott, JD; Fevery, B; Lambrecht, T; Ouwerkerk-Mahadevan, S; Callewaert, K; Symonds, WT; Picchio, G; Lindsay, KL; Beumont, M; Jacobson, IM				Lawitz, Eric; Sulkowski, Mark S.; Ghalib, Reem; Rodriguez-Torres, Maribel; Younossi, Zobair M.; Corregidor, Ana; DeJesus, Edwin; Pearlman, Brian; Rabinovitz, Mordechai; Gitlin, Norman; Lim, Joseph K.; Pockros, Paul J.; Scott, John D.; Fevery, Bart; Lambrecht, Tom; Ouwerkerk-Mahadevan, Sivi; Callewaert, Katleen; Symonds, William T.; Picchio, Gaston; Lindsay, Karen L.; Beumont, Maria; Jacobson, Ira M.			Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study	LANCET			English	Article							HCV INFECTION; PHASE-3 TRIAL; DOUBLE-BLIND; ALPHA 2A; PEGINTERFERON; BOCEPREVIR; TELAPREVIR; SVR	Background Interferon-free regimens are needed to treat hepatitis C virus (HCV) infections. We investigated the efficacy of combined simeprevir and sofosbuvir. Methods We enrolled patients with chronic HCV genotype 1 infections who had previously not responded to pegylated interferon (peginterferon) and ribavirin or were treatment naive. Patients were randomly assigned in a 2: 1: 2: 1 ratio to receive 150 mg simeprevir and 400 mg sofosbuvir daily for 24 weeks with (group 1) or without (group 2) ribavirin or for 12 weeks with (group 3) or without (group 4) ribavirin, in two cohorts: previous non-responders with METAVIR scores F0-F2 (cohort 1) and previous non-responders and treatment-naive patients with METAVIR scores F3-F4 (cohort 2). The primary endpoint was sustained virological response 12 weeks after stopping treatment (SVR12). Analysis was done by intention to treat. Safety data from cohorts 1 and 2 were pooled for analysis. This study is registered with ClinicalTrials. gov, number NCT01466790. Findings 168 patients were enrolled and randomised, and 167 started treatment (n=80 in cohort 1 and n=87 in cohort 2). SVR12 was achieved in 154 (92%) patients (n=72 [90%, 95% CI 81-96] in cohort 1 and n=82 [94%, 87-98] in cohort 2). The most common adverse events in the pooled groups were fatigue (n=52 [31%]), headache (n=33 [20%]), and nausea (n=26 [16%]). Grade 4 adverse events were seen in one (2%) of 54 patients in each of groups 1 and 3 and in three (10%) of 31 patients in group 2, whereas grade 3-4 events were reported in less than 5% of all patients, except increased blood amylase concentration. Serious adverse events were seen in four (2%) patients, all in groups 1 and 2. Four (2%) patients discontinued all study treatment because of adverse events, three before week 12. Interpretation Combined simeprevir and sofosbuvir was efficacious and well tolerated.	[Lawitz, Eric] Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, San Antonio, TX 78215 USA; [Sulkowski, Mark S.] Johns Hopkins Univ Sch Med, Baltimore, MD USA; [Ghalib, Reem] Texas Clin Res Inst, Arlington, TX USA; [Rodriguez-Torres, Maribel] Fdn Invest, San Juan, PR USA; [Younossi, Zobair M.] Inova Fairfax Hosp, Dept Med, Falls Church, VA USA; [Corregidor, Ana] Borland Groover Clin, Jacksonville, FL USA; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Pearlman, Brian] Atlanta Med Ctr, Atlanta, GA USA; [Rabinovitz, Mordechai] Univ Pittsburgh Med Ctr, Pittsburgh, PA USA; [Gitlin, Norman] Atlanta Gastroenterol Assoc, Atlanta, GA USA; [Lim, Joseph K.] Yale Liver Ctr, New Haven, CT USA; [Lim, Joseph K.] Yale Univ Sch Med, New Haven, CT USA; [Pockros, Paul J.] Scripps Clin, La Jolla, CA 92037 USA; [Scott, John D.] Harborview Med Ctr, Seattle, WA USA; [Fevery, Bart; Ouwerkerk-Mahadevan, Sivi; Callewaert, Katleen; Beumont, Maria] Janssen Res & Dev, Beerse, Belgium; [Lambrecht, Tom] Novellas Healthcare, Zellik, Belgium; [Symonds, William T.] Gilead Sci Inc, Foster City, CA 94404 USA; [Picchio, Gaston; Lindsay, Karen L.] Janssen Res & Dev, Titusville, NJ USA; [Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY USA	University of Texas System; University of Texas Health San Antonio; Johns Hopkins University; Inova Fairfax Hospital; Orlando Immunology Center; WellStar Atlanta Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University; Yale University; Scripps Research Institute; Harborview Medical Center; Johnson & Johnson; Janssen Pharmaceuticals; Gilead Sciences; Johnson & Johnson; Janssen Pharmaceuticals; Cornell University	Lawitz, E (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Texas Liver Inst, 607 Camden St, San Antonio, TX 78215 USA.	lawitz@txliver.com			Janssen	Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Janssen.	American Association for the Study of Liver Diseases and Infectious Diseases Society of America, REC TEST MAN TREAT H; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; European Association for the Study of the Liver, EASL REC TREATM HEP; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Jacobson IM, 2014, LANCET, V384, P403, DOI 10.1016/S0140-6736(14)60494-3; Jacobson IM, 2013, HEPATOLOGY, V58, p1379A; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lenz O, 2014, J HEPATOL, V60, pS139, DOI 10.1016/S0168-8278(14)60383-4; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; MedDRA, MED DICT REG ACT; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Products Janssen, OL TM SIM FULL PRESC; Reddy KR, 2014, PHASE 3 RANDOMISED D; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; WHO, 2003, WHO HDB REP RES CANC, P132; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	21	611	632	0	37	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1756	1765		10.1016/S0140-6736(14)61036-9	http://dx.doi.org/10.1016/S0140-6736(14)61036-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KX	25078309				2022-12-28	WOS:000345116400026
J	Wang, XT; Ota, N; Manzanillo, P; Kates, L; Zavala-Solorio, J; Eidenschenk, C; Zhang, J; Lesch, J; Lee, WP; Ross, J; Diehl, L; van Bruggen, N; Kolumam, G; Ouyang, WJ				Wang, Xiaoting; Ota, Naruhisa; Manzanillo, Paolo; Kates, Lance; Zavala-Solorio, Jose; Eidenschenk, Celine; Zhang, Juan; Lesch, Justin; Lee, Wyne P.; Ross, Jed; Diehl, Lauri; van Bruggen, Nicholas; Kolumam, Ganesh; Ouyang, Wenjun			Interleukin-22 alleviates metabolic disorders and restores mucosal immunity in diabetes	NATURE			English	Article							INDUCED INSULIN-RESISTANCE; FOOD-INTAKE; CITROBACTER-RODENTIUM; GUT MICROBIOME; PPAR-GAMMA; OBESITY; LEPTIN; CELLS; INFLAMMATION; MICE	The connection between an altered gut microbiota and metabolic disorders such as obesity, diabetes, and cardiovascular disease is well established(1,2). Defects in preserving the integrity of the mucosal barriers can result in systemic endotoxaemia that contributes to chronic low-grade inflammation, which further promotes the development ofmetabolic syndrome(3-5). Interleukin (IL)-22 exerts essential roles in eliciting antimicrobial immunity and maintaining mucosal barrier integrity within the intestine(6,7). Here we investigate the connection between IL-22 and metabolic disorders. We find that the induction of IL-22 from innate lymphoid cells and CD4(+) T cells is impaired in obese mice under various immune challenges, especially in the colon during infection with Citrobacter rodentium. While innate lymphoid cell populations are largely intact in obese mice, the upregulation of IL-23, a cytokine upstream of IL-22, is compromised during the infection. Consequently, these mice are susceptible to C. rodentium infection, and both exogenous IL-22 and IL-23 are able to restore the mucosal host defence. Importantly, we further unveil unexpected functions of IL-22 in regulating metabolism. Mice deficient in IL-22 receptor and fed with high-fat diet are prone to developing metabolic disorders. Strikingly, administration of exogenous IL-22 in genetically obese leptin-receptor-deficient (db/db) mice and mice fed with high-fat diet reverses many of the metabolic symptoms, including hyperglycaemia and insulin resistance. IL-22 shows diverse metabolic benefits, as it improves insulin sensitivity, preserves gut mucosal barrier and endocrine functions, decreases endotoxaemia and chronic inflammation, and regulates lipid metabolism in liver and adipose tissues. In summary, we identify the IL-22 pathway as a novel target for therapeutic intervention in metabolic diseases.	[Wang, Xiaoting; Ota, Naruhisa; Manzanillo, Paolo; Eidenschenk, Celine; Zhang, Juan; Lesch, Justin; Lee, Wyne P.; Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Kates, Lance; Zavala-Solorio, Jose; Ross, Jed; van Bruggen, Nicholas; Kolumam, Ganesh] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA; [Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Ouyang, WJ (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	kolumam@gene.com; ouyang@gene.com	Ouyang, Wenjun/ABA-8763-2020	Ouyang, Wenjun/0000-0002-1811-5864				Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guo X, 2011, MUCOSAL IMMUNOL, V4, P294, DOI 10.1038/mi.2010.76; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ortiz AA, 2007, J PHARMACOL EXP THER, V323, P692, DOI 10.1124/jpet.107.125211; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sham HP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003539; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Van Maele L, 2010, J IMMUNOL, V185, P1177, DOI 10.4049/jimmunol.1000115; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Yang L, 2010, J HEPATOL, V53, P339, DOI 10.1016/j.jhep.2010.03.004; Yu YY, 2013, J IMMUNOL, V190, P3054, DOI 10.4049/jimmunol.1203275; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zhang XM, 2011, DIABETES, V60, P486, DOI 10.2337/db10-0650; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	37	284	307	6	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					237	+		10.1038/nature13564	http://dx.doi.org/10.1038/nature13564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119041				2022-12-28	WOS:000342663100044
J	Mulepati, S; Heroux, A; Bailey, S				Mulepati, Sabin; Heroux, Annie; Bailey, Scott			Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target	SCIENCE			English	Article							IN-VITRO RECONSTITUTION; IMMUNE-SYSTEM; THERMUS-THERMOPHILUS; INTERFERENCE COMPLEX; ANTIVIRAL DEFENSE; CAS SYSTEMS; DNA TARGET; CASCADE; PROTEIN; PROKARYOTES	In prokaryotes, RNA derived from type I and type III CRISPR loci direct large ribonucleoprotein complexes to destroy invading bacteriophage and plasmids. In Escherichia coli, this 405-kilodalton complex is called Cascade. We report the crystal structure of Cascade bound to a single-stranded DNA (ssDNA) target at a resolution of 3.03 angstroms. The structure reveals that the CRISPR RNA and target strands do not form a double helix but instead adopt an underwound ribbon-like structure. This noncanonical structure is facilitated by rotation of every sixth nucleotide out of the RNA-DNA hybrid and is stabilized by the highly interlocked organization of protein subunits. These studies provide insight into both the assembly and the activity of this complex and suggest a mechanism to enforce fidelity of target binding.	[Mulepati, Sabin; Bailey, Scott] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Heroux, Annie] Brookhaven Natl Lab, Photon Sci Directorate, Upton, NY 11973 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; United States Department of Energy (DOE); Brookhaven National Laboratory	Bailey, S (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	scott.bailey@jhu.edu	Bailey, Scott/N-7248-2019		NIH [GM097330, P41GM103473, P41GM103393]; Office of Biological and Environmental Research of U.S. Department of Energy (DOE); Office of Basic Energy Sciences of U.S. Department of Energy (DOE); National Center for Research Resources [P41RR012408]; DOE Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR012408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P41GM103473, R01GM097330] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Biological and Environmental Research of U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Office of Basic Energy Sciences of U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. McMacken, B. Learn, J. Berger, D. Leahy, and J. Kavran for helpful discussions; J. Bosch for providing the tungsten clusters used in the soaking experiments; I. Mathews for help with data collection; and J. Kavran for critical reading of the manuscript. Supported by NIH grant GM097330 (S.B). Data for this study were measured at beamline X25 of the National Synchrotron Light Source (NSLS) and at beamlines 7-1, 11-1, and 12-2 of the Stanford Synchrotron Radiation Lightsource (SSRL). Funding for X25 comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the U.S. Department of Energy (DOE) and from National Center for Research Resources grant P41RR012408 and NIH grant P41GM103473. Use of the SSRL is supported by the DOE Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by NIH grant P41GM103393. The atomic coordinates and structure factors have been deposited into the Protein Data Bank with the accession code 4QYZ.	Agari Y, 2008, PROTEINS, V73, P1063, DOI 10.1002/prot.22224; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Heidrich N, 2013, MOL CELL, V52, P4, DOI 10.1016/j.molcel.2013.09.023; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Hrle A, 2013, RNA BIOL, V10, P1670, DOI 10.4161/rna.26500; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Koo Y, 2013, J MOL BIOL, V425, P3799, DOI 10.1016/j.jmb.2013.02.032; Kowalczykowski SC, 2008, NATURE, V453, P463, DOI 10.1038/453463a; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Mulepati S, 2012, J BIOL CHEM, V287, P22445, DOI 10.1074/jbc.C112.379503; Nam KH, 2012, FEBS LETT, V586, P3956, DOI 10.1016/j.febslet.2012.09.041; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Savir Y, 2010, MOL CELL, V40, P388, DOI 10.1016/j.molcel.2010.10.020; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Szczelkun MD, 2014, P NATL ACAD SCI USA, V111, P9798, DOI 10.1073/pnas.1402597111; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013	38	157	164	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1479	1484		10.1126/science.1256996	http://dx.doi.org/10.1126/science.1256996			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25123481	Green Accepted			2022-12-28	WOS:000341752900035
J	Fauci, AS				Fauci, Anthony S.			Ebola - Underscoring the Global Disparities in Health Care Resources	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.							[Anonymous], CHRON EB HEM FEV OUT; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Feldmann H, 2014, NEW ENGL J MED, V371, P1375, DOI 10.1056/NEJMp1405314; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8	5	114	122	1	71	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2014	371	12					1084	1086		10.1056/NEJMp1409494	http://dx.doi.org/10.1056/NEJMp1409494			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9PI	25119491				2022-12-28	WOS:000341687300002
J	Yelshanskaya, MV; Li, MF; Sobolevsky, AI				Yelshanskaya, Maria V.; Li, Minfen; Sobolevsky, Alexander I.			Structure of an agonist-bound ionotropic glutamate receptor	SCIENCE			English	Article							LIGAND-BINDING DOMAIN; AMPA RECEPTOR; KAINATE RECEPTORS; CRYSTAL-STRUCTURE; DESENSITIZATION; ACTIVATION; MECHANISMS; IMPACT; DYNAMICS; SUBUNITS	Ionotropic glutamate receptors (iGluRs) mediate most excitatory neurotransmission in the central nervous system and function by opening their ion channel in response to binding of agonist glutamate. Here, we report a structure of a homotetrameric rat GluA2 receptor in complex with partial agonist (S)-5-nitrowillardiine. Comparison of this structure with the closed-state structure in complex with competitive antagonist ZK 200775 suggests conformational changes that occur during iGluR gating. Guided by the structures, we engineered disulfide cross-links to probe domain interactions that are important for iGluR gating events. The combination of structural information, kinetic modeling, and biochemical and electrophysiological experiments provides insight into the mechanism of iGluR gating.	[Yelshanskaya, Maria V.; Li, Minfen; Sobolevsky, Alexander I.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	Columbia University	Sobolevsky, AI (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 650 West 168th St, New York, NY 10032 USA.	as4005@columbia.edu			National Institute of General Medical Sciences, NIH [P41 GM103403]; DOE Office of Science [DE-AC02-06CH11357]; NIH [NS083660]; Klingenstein Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, P41GM111244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083660] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Klingenstein Foundation(Klingenstein Philanthropies); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the personnel at beamlines X4A, X4C, X25, and X29 of the National Synchrotron Light Source and at beamlines 24-ID-C and 24-ID-E of the Advanced Photon Source. 24-ID-C and 24-ID-E are the Northeastern Collaborative Access Team beamlines, which are supported by a grant from the National Institute of General Medical Sciences (P41 GM103403) from the NIH. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. We thank L. Wollmuth and R. Kazi for help in setting up electrophysiological experiments and K. Saotome for comments on the manuscript. This work was supported by the NIH (NS083660) and the Klingenstein Foundation (A. I. S.). Coordinates and structure factors have been deposited in the Protein Data Bank with accession numbers 4U4F for GluA2<INF>NOW</INF> and 4U4G for GluA2<INF>ZK</INF>.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahmed AH, 2013, J BIOL CHEM, V288, P27658, DOI 10.1074/jbc.M113.495564; Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Black MD, 2005, PSYCHOPHARMACOLOGY, V179, P154, DOI 10.1007/s00213-004-2065-6; Bowie D, 2008, CNS NEUROL DISORD-DR, V7, P129, DOI 10.2174/187152708784083821; Carbone AL, 2012, NEURON, V74, P845, DOI 10.1016/j.neuron.2012.04.020; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fenwick MK, 2010, J BIOL CHEM, V285, P12334, DOI 10.1074/jbc.M109.086371; HOLLMANN M, 1989, NATURE, V342, P643, DOI 10.1038/342643a0; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; MacLean DM, 2011, J NEUROSCI, V31, P2136, DOI 10.1523/JNEUROSCI.4314-10.2011; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Midgett CR, 2012, FRONT MOL NEUROSCI, V4, DOI [10.3389/fnmol.2011.00056, 10.3389/fnmo1.2011.00056]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; PATNEAU DK, 1992, J NEUROSCI, V12, P595; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Poon K, 2011, MOL PHARMACOL, V80, P49, DOI 10.1124/mol.111.071688; Poon K, 2010, BIOPHYS J, V99, P1437, DOI 10.1016/j.bpj.2010.06.058; Postila PA, 2011, J CHEM INF MODEL, V51, P1037, DOI 10.1021/ci2000055; Ramaswamy S, 2012, J BIOL CHEM, V287, P43557, DOI 10.1074/jbc.M112.371815; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Yao YN, 2013, STRUCTURE, V21, P1788, DOI 10.1016/j.str.2013.07.011; Zhang W, 2008, J NEUROSCI, V28, P932, DOI 10.1523/JNEUROSCI.3309-07.2008	50	85	86	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1070	1074		10.1126/science.1256508	http://dx.doi.org/10.1126/science.1256508			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25103407	Green Accepted			2022-12-28	WOS:000340870900045
J	Lader, E				Lader, Ellis			In noncardiac surgery, perioperative aspirin did not reduce death or MI at 30 d but increased major bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									NYU, Sch Med, Kingston, NY 12401 USA	New York University	Lader, E (corresponding author), NYU, Sch Med, Kingston, NY 12401 USA.							Chopra V, 2012, ARCH SURG-CHICAGO, V147, P181, DOI 10.1001/archsurg.2011.897; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC5	10.7326/0003-4819-161-4-201408190-02005	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133384				2022-12-28	WOS:000342347300004
J	Lu, JT; Campeau, PM; Lee, BH				Lu, James T.; Campeau, Philippe M.; Lee, Brendan H.			Genotype-Phenotype Correlation - Promiscuity in the Era of Next-Generation Sequencing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[Lu, James T.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lu, James T.] Baylor Coll Med, Dept Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Lee, Brendan H.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lee, Brendan H.] Howard Hughes Med Inst, Houston, TX 77030 USA; [Campeau, Philippe M.] Univ Montreal, Hop St Justine, Dept Pediat, Med Genet Serv, Montreal, PQ H3T 1C5, Canada	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Universite de Montreal	Lu, JT (corresponding author), Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA.		Campeau, Philippe/J-8614-2015	Campeau, Philippe/0000-0001-9713-7107				Davis EE, 2012, CURR OPIN GENET DEV, V22, P290, DOI 10.1016/j.gde.2012.04.006; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Shi Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002084; Yang YP, 2013, NEW ENGL J MED, V369, P1502, DOI 10.1056/NEJMoa1306555; Zuk O, 2014, P NATL ACAD SCI USA, V111, pE455, DOI 10.1073/pnas.1322563111	5	62	63	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					593	596		10.1056/NEJMp1400788	http://dx.doi.org/10.1056/NEJMp1400788			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZL	25119605	Green Published			2022-12-28	WOS:000340819600004
J	O'Donnell, M; Mente, A; Rangarajan, S; McQueen, MJ; Wang, XY; Liu, LS; Yan, H; Lee, SF; Mony, P; Devanath, A; Rosengren, A; Lopez-Jaramillo, P; Diaz, R; Avezum, A; Lanas, F; Yusoff, K; Iqbal, R; Ilow, R; Mohammadifard, N; Gulec, S; Yusufali, AH; Kruger, L; Yusuf, R; Chifamba, J; Kabali, C; Dagenais, G; Lear, SA; Teo, K; Yusuf, S				O'Donnell, Martin; Mente, Andrew; Rangarajan, Sumathy; McQueen, Matthew J.; Wang, Xingyu; Liu, Lisheng; Yan, Hou; Lee, Shun Fu; Mony, Prem; Devanath, Anitha; Rosengren, Annika; Lopez-Jaramillo, Patricio; Diaz, Rafael; Avezum, Alvaro; Lanas, Fernando; Yusoff, Khalid; Iqbal, Romaina; Ilow, Rafal; Mohammadifard, Noushin; Gulec, Sadi; Yusufali, Afzal Hussein; Kruger, Lanthe; Yusuf, Rita; Chifamba, Jephat; Kabali, Conrad; Dagenais, Gilles; Lear, Scott A.; Teo, Koon; Yusuf, Salim		PURE Investigators	Urinary Sodium and Potassium Excretion, Mortality, and Cardiovascular Events	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-INCOME COUNTRIES; DISEASE; SALT; HYPERTENSION; REDUCTION; MIDDLE; RISK; PREVALENCE; OUTCOMES; WORLD	BACKGROUND The optimal range of sodium intake for cardiovascular health is controversial. METHODS We obtained morning fasting urine samples from 101,945 persons in 17 countries and estimated 24-hour sodium and potassium excretion (used as a surrogate for intake). We examined the association between estimated urinary sodium and potassium excretion and the composite outcome of death and major cardiovascular events. RESULTS The mean estimated sodium and potassium excretion was 4.93 g per day and 2.12 g per day, respectively. With a mean follow-up of 3.7 years, the composite outcome occurred in 3317 participants (3.3%). As compared with an estimated sodium excretion of 4.00 to 5.99 g per day (reference range), a higher estimated sodium excretion (>= 7.00 g per day) was associated with an increased risk of the composite outcome (odds ratio, 1.15; 95% confidence interval [CI], 1.02 to 1.30), as well as increased risks of death and major cardiovascular events considered separately. The association between a high estimated sodium excretion and the composite outcome was strongest among participants with hypertension (P = 0.02 for interaction), with an increased risk at an estimated sodium excretion of 6.00 g or more per day. As compared with the reference range, an estimated sodium excretion that was below 3.00 g per day was also associated with an increased risk of the composite outcome (odds ratio, 1.27; 95% CI, 1.12 to 1.44). As compared with an estimated potassium excretion that was less than 1.50 g per day, higher potassium excretion was associated with a reduced risk of the composite outcome. CONCLUSIONS In this study in which sodium intake was estimated on the basis of measured urinary excretion, an estimated sodium intake between 3 g per day and 6 g per day was associated with a lower risk of death and cardiovascular events than was either a higher or lower estimated level of intake. As compared with an estimated potassium excretion that was less than 1.50 g per day, higher potassium excretion was associated with a lower risk of death and cardiovascular events.	[O'Donnell, Martin; Mente, Andrew; Rangarajan, Sumathy; McQueen, Matthew J.; Lee, Shun Fu; Kabali, Conrad; Teo, Koon; Yusuf, Salim] McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Dagenais, Gilles] Univ Laval, Heart & Lung Inst, Quebec City, PQ, Canada; [Lear, Scott A.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Lear, Scott A.] Providence Hlth Care, Div Cardiol, Burnaby, BC, Canada; [O'Donnell, Martin] Natl Univ Ireland, Galway Univ Hosp, Clin Res Facil, Hlth Res Board, Galway, Ireland; [Wang, Xingyu] Beijing Hypertens League Inst, Beijing, Peoples R China; [Liu, Lisheng] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Cardiovasc Inst, Beijing 100730, Peoples R China; [Liu, Lisheng] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Yan, Hou] Bridge Community Hlth Serv Ctr Xinghualing Dist, Taiyuan Xinghualing Dist Baling, Taiyuan, Shanxi, Peoples R China; [Mony, Prem; Devanath, Anitha] St Johns Res Inst, Div Epidemiol & Populat Hlth, Bangalore, Karnataka, India; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Lopez-Jaramillo, Patricio] Univ Santander, Santander Med Sch, Fdn Oftalmol, Floridablanca Santander, Colombia; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Santa Fe, Argentina; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [Yusoff, Khalid] Univ Teknol MARA, Fac Med, Selangor, Malaysia; [Yusoff, Khalid] UCSI Univ, Kuala Lumpur, Malaysia; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci & Med, Karachi, Pakistan; [Ilow, Rafal] Wroclaw Med Univ, Dept Food Sci & Dietet, Wroclaw, Poland; [Mohammadifard, Noushin] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Gulec, Sadi] Ankara Univ, Fac Med, Dept Cardiol, TR-06100 Ankara, Turkey; [Yusufali, Afzal Hussein] Hatta Hosp, Dubai Hlth Author, Dubai, U Arab Emirates; [Kruger, Lanthe] North West Univ, Fac Hlth Sci, Potchefstroom, South Africa; [Yusuf, Rita] Independent Univ, Sch Life Sci, Dhaka, Bangladesh; [Yusuf, Rita] Independent Univ, Ctr Hlth Populat & Dev, Dhaka, Bangladesh; [Chifamba, Jephat] Univ Zimbabwe, Dept Psychol, Coll Hlth Sci, Harare, Zimbabwe	McMaster University; Population Health Research Institute; Laval University; Quebec Heart & Lung Institute; Simon Fraser University; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Chinese Hypertension League; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; St. John's National Academy of Health Sciences; St. John's Research Institute; University of Gothenburg; Universidad Industrial de Santander; Instituto Dante Pazzanese de Cardiologia; Universidad de La Frontera; Universiti Teknologi MARA; UCSI University; Aga Khan University; Wroclaw Medical University; Isfahan University Medical Science; Ankara University; North West University - South Africa; Independent University Bangladesh (IUB); Independent University Bangladesh (IUB); University of Zimbabwe	O'Donnell, M (corresponding author), McMaster Univ, David Braley Cardiac Vasc & Stroke Res Inst, Populat Hlth Res Inst, 2nd Fl,Rm C2-104,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	odonnm@mcmaster.ca	O'Donnell, Martin/ABE-7459-2020; Chifamba, Jephat/AHE-4535-2022; Kelishadi, Roya/E-6154-2012; Mony, Prem K./GRF-4752-2022; Mohammadifard, Noushin/M-2244-2018; Igumbor, Ehimario U/B-2652-2012; Kabali, Conrad/AAX-7718-2021; Yusoff, Khalid/I-7029-2019; Lanas, Fernando/AAE-8842-2022; Kabali, Conrad/AAW-6681-2021; Kruger, Iolanthe M/G-8698-2015; Avezum, Alvaro AA/K-6137-2016; Avezum, Alvaro/AAP-7687-2020; Gomez-Arbelaez, Diego/K-1883-2013	O'Donnell, Martin/0000-0002-7347-7761; Chifamba, Jephat/0000-0001-8166-1182; Kelishadi, Roya/0000-0001-7455-1495; Mony, Prem K./0000-0002-1399-0520; Mohammadifard, Noushin/0000-0003-1776-1060; Igumbor, Ehimario U/0000-0002-6313-6031; Yusoff, Khalid/0000-0001-5669-5188; Kabali, Conrad/0000-0002-0553-0305; Kruger, Iolanthe M/0000-0002-8636-7174; Avezum, Alvaro AA/0000-0002-3073-6890; Gulec, Sadi/0000-0002-2685-2522; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Camacho, Paul Anthony/0000-0002-6233-9582; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Yusuf, Salim/0000-0003-4776-5601; Teo, Koon/0000-0002-3731-0956; Jerling, Johann/0000-0003-2600-3536; Yusufali, Afzalhussein/0000-0003-3378-2646; Lanas, Fernando/0000-0003-3595-9759; Rosengren, Annika/0000-0002-5409-6605; Iqbal, Romaina/0000-0002-5364-4366; Yusuf, Rita/0000-0002-0151-9571	Population Health Research Institute	Population Health Research Institute	Funded by the Population Health Research Institute and others.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Brown IJ, 2009, INT J EPIDEMIOL, V38, P791, DOI 10.1093/ije/dyp139; BRUNNER HR, 1972, NEW ENGL J MED, V286, P441, DOI 10.1056/NEJM197203022860901; Chang HY, 2006, AM J CLIN NUTR, V83, P1289, DOI 10.1093/ajcn/83.6.1289; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Cobb LK, 2014, CIRCULATION, V129, P1173, DOI 10.1161/CIR.0000000000000015; Cook NR, 2014, CIRCULATION, V129, P981, DOI 10.1161/CIRCULATIONAHA.113.006032; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Corsi DJ, 2013, AM HEART J, V166, P636, DOI 10.1016/j.ahj.2013.04.019; Coxson PG, 2013, HYPERTENSION, V61, P564, DOI 10.1161/HYPERTENSIONAHA.111.201293; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; Ekinci EI, 2011, DIABETES CARE, V34, P703, DOI 10.2337/dc10-1723; Graudal N, 2014, AM J HYPERTENS; Graudal NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub3; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Heaney RP, 2013, AM J HYPERTENS, V26, P1194, DOI 10.1093/ajh/hpt130; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Joosten MM, 2014, CIRCULATION, V129, P1121, DOI 10.1161/CIRCULATIONAHA.113.004290; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606; Lewington S, 2008, LANCET, V372, P292; McGorrian C, 2011, EUR HEART J, V32, P581, DOI 10.1093/eurheartj/ehq448; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; Mente A, 2009, J NUTR, V139, P743, DOI 10.3945/jn.108.098319; O'Donnell MJ, 2013, EUR HEART J, V34, P1034, DOI 10.1093/eurheartj/ehs409; O'Donnell MJ, 2011, JAMA-J AM MED ASSOC, V306, P2229, DOI 10.1001/jama.2011.1729; Pfister R, 2014, EUR J HEART FAIL; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Stolarz-Skrzypek K, 2011, JAMA-J AM MED ASSOC, V305, P1777, DOI 10.1001/jama.2011.574; Strom BL, 2013, JAMA-J AM MED ASSOC, V310, P31, DOI 10.1001/jama.2013.7687; Teo K, 2013, JAMA-J AM MED ASSOC, V309, P1613, DOI 10.1001/jama.2013.3519; Thomas MC, 2011, DIABETES CARE, V34, P861, DOI 10.2337/dc10-1722; WHO, 2012, GUID SOD INT AD CHIL; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	40	593	601	0	117	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					612	623		10.1056/NEJMoa1311889	http://dx.doi.org/10.1056/NEJMoa1311889			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZL	25119607	Green Published			2022-12-28	WOS:000340819600007
J	Schroers, J				Schroers, Jan			CONDENSED-MATTER PHYSICS Glasses made from pure metals	NATURE			English	Editorial Material							LIQUID	The experimental realization of amorphous pure metals sets the stage for studies of the fundamental processes of glass formation, and suggests that amorphous structures are the most ubiquitous forms of condensed matter.	Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06511 USA	Yale University	Schroers, J (corresponding author), Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06511 USA.	jan.schroers@yale.edu						ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Bhat MH, 2007, NATURE, V448, P787, DOI 10.1038/nature06044; GREER AL, 1993, NATURE, V366, P303, DOI 10.1038/366303a0; Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; Kumar G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2546; Schroers J, 2013, PHYS TODAY, V66, P32, DOI 10.1063/PT.3.1885; TURNBULL D, 1969, CONTEMP PHYS, V10, P473, DOI 10.1080/00107516908204405; Volkert CA, 2008, J APPL PHYS, V103, DOI 10.1063/1.2884584; Zhong L, 2014, NATURE, V512, P177, DOI 10.1038/nature13617	10	27	27	0	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					142	143		10.1038/nature13653	http://dx.doi.org/10.1038/nature13653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25119231	Bronze			2022-12-28	WOS:000340200700018
J	Zhang, SY; Xu, M; Kamigaki, T; Do, JPH; Chang, WC; Jenvay, S; Miyamichi, K; Luo, LQ; Dan, Y				Zhang, Siyu; Xu, Min; Kamigaki, Tsukasa; Johnny Phong Hoang Do; Chang, Wei-Cheng; Jenvay, Sean; Miyamichi, Kazunari; Luo, Liqun; Dan, Yang			Long-range and local circuits for top-down modulation of visual cortex processing	SCIENCE			English	Article							FRONTAL EYE FIELD; FEATURE-BASED ATTENTION; AREA V4; SPATIAL ATTENTION; CORTICAL AREAS; INTERNEURONS; ORGANIZATION; MECHANISMS; NEURONS; SIGNALS	Top-down modulation of sensory processing allows the animal to select inputs most relevant to current tasks. We found that the cingulate (Cg) region of the mouse frontal cortex powerfully influences sensory processing in the primary visual cortex (V1) through long-range projections that activate local gamma-aminobutyric acid-ergic (GABAergic) circuits. Optogenetic activation of Cg neurons enhanced V1 neuron responses and improved visual discrimination. Focal activation of Cg axons in V1 caused a response increase at the activation site but a decrease at nearby locations (center-surround modulation). Whereas somatostatin-positive GABAergic interneurons contributed preferentially to surround suppression, vasoactive intestinal peptide-positive interneurons were crucial for center facilitation. Long-range corticocortical projections thus act through local microcircuits to exert spatially specific top-downmodulation of sensory processing.	[Zhang, Siyu; Xu, Min; Kamigaki, Tsukasa; Johnny Phong Hoang Do; Chang, Wei-Cheng; Jenvay, Sean; Dan, Yang] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst,Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Miyamichi, Kazunari; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; Stanford University	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst,Howard Hughes Med Inst, Berkeley, CA 94720 USA.	ydan@berkeley.edu	Miyamichi, Kazunari/AAO-3705-2021; Xu, Min/AGD-5135-2022	Xu, Min/0000-0002-6936-7543; Luo, Liqun/0000-0001-5467-9264; Zhang, Siyu/0000-0003-1745-2532; Dan, Yang/0000-0002-3818-877X; Zhang, Siyu/0000-0001-7298-1475; Kamigaki, Tsukasa/0000-0002-5184-708X	NIH [R01 EY018861]; NSF [22250400-42533]; Uehara Memorial Foundation; Human Frontier Science Program; NATIONAL EYE INSTITUTE [R01EY018861] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Human Frontier Science Program(Human Frontier Science Program); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank L. Pinto and Y. Zhu for help with data analysis; S. H. Lee and M. Zhao for technical assistance; Standford Neuroscience Gene Vector and Virus Core for AAV-DJ supply; K. Deisseroth, E. Callaway, B. Lim, and B. C. Weissbourd for virus and constructs; and R. Desimone, L. Wang, and M. A. Segraves for helpful discussions. This work was supported by NIH grant R01 EY018861, NSF grant 22250400-42533, a Uehara Memorial Foundation fellowship, and the Human Frontier Science Program. All primary histological, electrophysiological, and behavioral data are archived in the Department of Molecular and Cell Biology, University of California, Berkeley.	Adesnik H, 2012, NATURE, V490, P226, DOI 10.1038/nature11526; Ardid S, 2007, J NEUROSCI, V27, P8486, DOI 10.1523/JNEUROSCI.1145-07.2007; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Bonin V, 2011, J NEUROSCI, V31, P18506, DOI 10.1523/JNEUROSCI.2974-11.2011; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chen Y, 2008, NAT NEUROSCI, V11, P974, DOI 10.1038/nn.2147; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Ekstrom LB, 2008, SCIENCE, V321, P414, DOI 10.1126/science.1153276; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Fu Y, 2014, CELL, V156, P1139, DOI 10.1016/j.cell.2014.01.050; Gregoriou GG, 2009, SCIENCE, V324, P1207, DOI 10.1126/science.1171402; Jiang XL, 2013, NAT NEUROSCI, V16, P210, DOI 10.1038/nn.3305; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Lee S, 2013, NAT NEUROSCI, V16, P1662, DOI 10.1038/nn.3544; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mitchell JF, 2007, NEURON, V55, P131, DOI 10.1016/j.neuron.2007.06.018; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Mysore SP, 2013, NAT NEUROSCI, V16, P473, DOI 10.1038/nn.3352; Noudoost B, 2011, NATURE, V474, P372, DOI 10.1038/nature09995; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Pi HJ, 2013, NATURE, V503, P521, DOI 10.1038/nature12676; Purushothaman G, 2012, NAT NEUROSCI, V15, P905, DOI 10.1038/nn.3106; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Sundberg KA, 2009, NEURON, V61, P952, DOI 10.1016/j.neuron.2009.02.023; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Xu XM, 2010, J COMP NEUROL, V518, P389, DOI 10.1002/cne.22229; Zhou HH, 2011, NEURON, V70, P1205, DOI 10.1016/j.neuron.2011.04.032	40	419	422	8	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					660	665		10.1126/science.1254126	http://dx.doi.org/10.1126/science.1254126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104383	Green Accepted			2022-12-28	WOS:000339962800036
J	Thosani, N; Wolf, DS				Thosani, Nirav; Wolf, David S.			Barium Concretion Causing Obstipation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Thosani, Nirav] Stanford Univ, Stanford, CA 94305 USA; [Wolf, David S.] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA	Stanford University; University of Texas System; University of Texas Health Science Center Houston	Thosani, N (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	ncthosani@gmail.com							0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					560	560	e8	10.1056/NEJMicm1313574	http://dx.doi.org/10.1056/NEJMicm1313574			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25099601				2022-12-28	WOS:000339899100011
J	Roy-Byrne, P; Bumgardner, K; Krupski, A; Dunn, C; Ries, R; Donovan, D; West, II; Maynard, C; Atkins, DC; Graves, MC; Joesch, JM; Zarkin, GA				Roy-Byrne, Peter; Bumgardner, Kristin; Krupski, Antoinette; Dunn, Chris; Ries, Richard; Donovan, Dennis; West, Imara I.; Maynard, Charles; Atkins, David C.; Graves, Meredith C.; Joesch, Jutta M.; Zarkin, Gary A.			Brief Intervention for Problem Drug Use in Safety-Net Primary Care Settings A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUBSTANCE-ABUSE; ALCOHOL MISUSE; SCREENING-TEST; EFFICACY; RELIABILITY; ADDICTION; VALIDITY; IMPACT	IMPORTANCE Although brief intervention is effective for reducing problem alcohol use, few data exist on its effectiveness for reducing problem drug use, a common issue in disadvantaged populations seeking care in safety-net medical settings (hospitals and community health clinics serving low-income patients with limited or no insurance). OBJECTIVE To determine whether brief intervention improves drug use outcomes compared with enhanced care as usual. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial with blinded assessments at baseline and at 3, 6, 9, and 12 months conducted in 7 safety-net primary care clinics in Washington State. Of 1621 eligible patients reporting any problem drug use in the past 90 days, 868 consented and were randomized between April 2009 and September 2012. Follow-up participation was more than 87% at all points. INTERVENTIONS Participants received a single brief intervention using motivational interviewing, a handout and list of substance abuse resources, and an attempted 10-minute telephone booster within 2 weeks (n = 435) or enhanced care as usual, which included a handout and list of substance abuse resources (n = 433). MAIN OUTCOMES AND MEASURES The primary outcomes were self-reported days of problem drug use in the past 30 days and Addiction Severity Index-Lite (ASI) Drug Use composite score. Secondary outcomes were admission to substance abuse treatment; ASI composite scores for medical, psychiatric, social, and legal domains; emergency department and inpatient hospital admissions, arrests, mortality, and human immunodeficiency virus risk behavior. RESULTS Mean days used of the most common problem drug at baseline were 14.40 (SD, 11.29) (brief intervention) and 13.25 (SD, 10.69) (enhanced care as usual); at 3 months postintervention, means were 11.87 (SD, 12.13) (brief intervention) and 9.84 (SD, 10.64) (enhanced care as usual) and not significantly different (difference in differences, beta = 0.89 [95% CI, -0.49 to 2.26]). Mean ASI Drug Use composite score at baseline was 0.11 (SD, 0.10) (brief intervention) and 0.11 (SD, 0.10) (enhanced care as usual) and at 3 months was 0.10 (SD, 0.09) (brief intervention) and 0.09 (SD, 0.09) (enhanced care as usual) and not significantly different (difference in differences, beta = 0.008 [95% CI, -0.006 to 0.021]). During the 12 months following intervention, no significant treatment differences were found for either variable. No significant differences were found for secondary outcomes. CONCLUSIONS AND RELEVANCE A one-time brief intervention with attempted telephone booster had no effect on drug use in patients seen in safety-net primary care settings. This finding suggests a need for caution in promoting widespread adoption of this intervention for drug use in primary care.	[Roy-Byrne, Peter; Bumgardner, Kristin; Krupski, Antoinette; Dunn, Chris; Ries, Richard; Donovan, Dennis; West, Imara I.; Atkins, David C.; Graves, Meredith C.; Joesch, Jutta M.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98104 USA; [Maynard, Charles] Univ Washington, Sch Publ Hlth, Dept Hlth Serv, Seattle, WA 98104 USA; [Joesch, Jutta M.] King Cty Off Performance Strategy & Budget, Seattle, WA USA; [Zarkin, Gary A.] RTI Int, Res Triangle Pk, NC USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Research Triangle Institute	Roy-Byrne, P (corresponding author), Univ Washington, Sch Med, POB 359911,325 Ninth Ave, Seattle, WA 98104 USA.	roybyrne@uw.edu	Roy-Byrne, Peter/AAV-2991-2020; Maynard, Charles/N-3906-2015; roy-byrne, peter/AAC-9130-2019	Maynard, Charles/0000-0002-1644-7814; Donovan, Dennis/0000-0003-2237-4292; Zarkin, Gary/0000-0003-3331-0788; Atkins, David/0000-0002-5781-9880	National Institute on Drug Abuse [R01 DA026014]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA026014] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by National Institute on Drug Abuse grant R01 DA026014 ( Dr Roy-Byrne).	ALTERMAN AI, 1993, J NERV MENT DIS, V181, P576, DOI 10.1097/00005053-199309000-00009; ASHENFELTER O, 1985, REV ECON STAT, V67, P648, DOI 10.2307/1924810; Babor Thomas F, 2007, Subst Abus, V28, P7, DOI 10.1300/J465v28n03_03; Baer JS, 2004, DRUG ALCOHOL DEPEN, V73, P99, DOI 10.1016/j.drugalcdep.2003.10.001; Bernstein J, 2005, DRUG ALCOHOL DEPEN, V77, P49, DOI 10.1016/j.drugalcdep.2004.07.006; Bertholet N, 2005, ARCH INTERN MED, V165, P986, DOI 10.1001/archinte.165.9.986; Cacciola JS, 2007, DRUG ALCOHOL DEPEN, V87, P297, DOI 10.1016/j.drugalcdep.2006.09.002; Carroll KM, 2003, PSYCHIAT SERV, V54, P333, DOI 10.1176/appi.ps.54.3.333; Chan YF, 2013, PSYCHIAT SERV, V64, P88, DOI 10.1176/appi.ps.201200082; Compton WM, 2007, ARCH GEN PSYCHIAT, V64, P566, DOI 10.1001/archpsyc.64.5.566; D'Onofrio G, 2012, ANN EMERG MED, V60, P181, DOI 10.1016/j.annemergmed.2012.02.006; DARKE S, 1991, AIDS, V5, P181, DOI 10.1097/00002030-199102000-00008; Doig GS, 2005, J CRIT CARE, V20, P187, DOI 10.1016/j.jcrc.2005.04.005; Fleming MF, 1997, JAMA-J AM MED ASSOC, V277, P1039, DOI 10.1001/jama.277.13.1039; HALL SM, 1990, J CONSULT CLIN PSYCH, V58, P175, DOI 10.1037/0022-006X.58.2.175; Hardin J, 2013, GENERALIZED ESTIMATI; Humeniuk R, 2012, ADDICTION, V107, P957, DOI 10.1111/j.1360-0443.2011.03740.x; Kaner EFS, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004148.pub4; Kronick R, 2000, HEALTH CARE FINANC R, V21, P29; Krupski A, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-24; Krupski A, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-27; Krupski A, 2010, DRUG ALCOHOL DEPEN, V110, P126, DOI 10.1016/j.drugalcdep.2010.02.018; Kypri Kypros, 2007, Subst Abus, V28, P31, DOI 10.1300/J465v28n03_04; Littlejohn C, 2006, ALCOHOL ALCOHOLISM, V41, P540, DOI 10.1093/alcalc/agl053; Moyers T.B., 2010, REVISED GLOBAL SCALE; Moyers TB, 2005, J SUBST ABUSE TREAT, V28, P19, DOI 10.1016/j.jsat.2004.11.001; Neighbors C, 2010, J CONSULT CLIN PSYCH, V78, P898, DOI 10.1037/a0020766; Otto C, 2009, DRUG ALCOHOL DEPEN, V105, P221, DOI 10.1016/j.drugalcdep.2009.07.010; Roche AM, 2004, DRUG ALCOHOL REV, V23, P11, DOI 10.1080/09595230410001645510; Saitz R, 2010, J ADDICT MED, V4, P123, DOI 10.1097/ADM.0b013e3181db6b67; Saitz Richard, 2007, Subst Abus, V28, P1, DOI 10.1300/J465v28n03_01; Smith PC, 2010, ARCH INTERN MED, V170, P1155, DOI 10.1001/archinternmed.2010.140; Solberg LI, 2008, AM J PREV MED, V34, P143, DOI 10.1016/j.amepre.2007.09.035; Substance Abuse and Mental Health Services Administration (SAMHSA), 2014, SCREENING BRIEF INTE; Sullivan LE, 2011, AM J ADDICTION, V20, P343, DOI 10.1111/j.1521-0391.2011.00143.x; Team R.C.R., 2013, LANG ENV STAT COMP; Touloumis A, 2013, BIOMETRICS, V69, P633, DOI 10.1111/biom.12054; Wickizer TM, 2000, MILBANK Q, V78, P585, DOI 10.1111/1468-0009.00186; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002; Zahradnik A, 2009, ADDICTION, V104, P109, DOI 10.1111/j.1360-0443.2008.02421.x	40	165	165	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					492	501		10.1001/jama.2014.7860	http://dx.doi.org/10.1001/jama.2014.7860			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM4FL	25096689	Green Accepted, Bronze			2022-12-28	WOS:000339808600018
J	Rhon, DI; Boyles, RB; Cleland, JA				Rhon, Daniel I.; Boyles, Robert B.; Cleland, Joshua A.			One-Year Outcome of Subacromial Corticosteroid Injection Compared With Manual Physical Therapy for the Management of the Unilateral Shoulder Impingement Syndrome	ANNALS OF INTERNAL MEDICINE			English	Article							FEAR-AVOIDANCE BELIEFS; QUALITY-OF-LIFE; PATIENT CHARACTERISTICS; MANIPULATIVE THERAPY; MULTIPLE IMPUTATION; GENERAL-PRACTICE; MEDICAL-CARE; DOUBLE-BLIND; PAIN; PHYSIOTHERAPY	Background: Corticosteroid injections (CSIs) and physical therapy are used to treat patients with the shoulder impingement syndrome (SIS) but have never been directly compared. Objective: To compare the effectiveness of 2 common nonsurgical treatments for SIS. Design: Randomized, single-blind, comparative-effectiveness, parallel-group trial. (ClinicalTrials.gov: NCT01190891) Setting: Military hospital-based outpatient clinic in the United States. Patients: 104 patients aged 18 to 65 years with unilateral SIS between June 2010 and March 2012. Intervention: Random assignment into 2 groups: 40-mg triamcinolone acetonide subacromial CSI versus 6 sessions of manual physical therapy. Measurements: The primary outcome was change in Shoulder Pain and Disability Index scores at 1 year. Secondary outcomes included the Global Rating of Change scores, the Numeric Pain Rating Scale scores, and 1-year health care use. Results: Both groups demonstrated approximately 50% improvement in Shoulder Pain and Disability Index scores maintained through 1 year; however, the mean difference between groups was not significant (1.5% [95% CI, -6.3% to 9.4%]). Both groups showed improvements in Global Rating of Change scale and pain rating scores, but between-group differences in scores for the Global Rating of Change scale (0 [CI, -2 to 1]) and pain rating (0.4 [CI, -0.5 to 1.2]) were not significant. During the 1-year follow-up, patients receiving CSI had more SIS-related visits to their primary care provider (60% vs. 37%) and required additional steroid injections (38% vs. 20%), and 19% needed physical therapy. Transient pain from the CSI was the only adverse event reported. Limitation: The study occurred at 1 center with patients referred to physical therapy. Conclusion: Both groups experienced significant improvement. The manual physical therapy group used less 1-year SIS-related health care resources than the CSI group.	Madigan Army Med, Tacoma, WA USA; Univ Puget Sound, Tacoma, WA 98416 USA; Franklin Pierce Univ, Manchester, NH USA	Madigan Army Medical Center	Rhon, DI (corresponding author), Brooke Army Med Ctr, Ctr Intrepid, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA.		Rhon, Daniel/C-9542-2011	Rhon, Daniel/0000-0002-4320-990X	Cardon Rehabilitation Products through the American Academy of Orthopaedic Manual Physical Therapists	Cardon Rehabilitation Products through the American Academy of Orthopaedic Manual Physical Therapists	Primary Funding Source: Cardon Rehabilitation Products through the American Academy of Orthopaedic Manual Physical Therapists.	ADEBAJO AO, 1990, J RHEUMATOL, V17, P1207; Akgun K, 2004, CLIN RHEUMATOL, V23, P496, DOI 10.1007/s10067-004-0930-7; Alvarez CM, 2005, AM J SPORT MED, V33, P255, DOI 10.1177/0363546504267345; [Anonymous], 2010, LANCET, V375, P1225, DOI 10.1016/S0140-6736(10)60523-5; [Anonymous], 1998, OBES RES, p51S; Arroll B, 2005, BRIT J GEN PRACT, V55, P224; Bang MD, 2000, J ORTHOP SPORT PHYS, V30, P126, DOI 10.2519/jospt.2000.30.3.126; Bergman GJD, 2004, ANN INTERN MED, V141, P432, DOI 10.7326/0003-4819-141-6-200409210-00008; Bisset L, 2006, BMJ-BRIT MED J, V333, P939, DOI 10.1136/bmj.38961.584653.AE; Bot SDM, 2005, SPINE, V30, pE459, DOI 10.1097/01.brs.0000174279.44855.02; Boyles RE, 2009, MANUAL THER, V14, P375, DOI 10.1016/j.math.2008.05.005; Buchbinder R, 2003, COCHRANE DATABASE SY; Calis M, 2000, ANN RHEUM DIS, V59, P44, DOI 10.1136/ard.59.1.44; Cho CH, 2013, J SHOULDER ELB SURG, V22, P222, DOI 10.1016/j.jse.2012.04.001; Conroy DE, 1998, J ORTHOP SPORT PHYS, V28, P3, DOI 10.2519/jospt.1998.28.1.3; Coombes BK, 2013, JAMA-J AM MED ASSOC, V309, P461, DOI 10.1001/jama.2013.129; Coombes BK, 2010, LANCET, V376, P1751, DOI 10.1016/S0140-6736(10)61160-9; Fritz JM, 2001, PHYS THER, V81, P776, DOI 10.1093/ptj/81.2.776; Galgano RC, 2005, ANN INTERN MED, V142, P226, DOI 10.7326/0003-4819-142-3-200502010-00021; Gaujoux-Viala C, 2009, ANN RHEUM DIS, V68, P1843, DOI 10.1136/ard.2008.099572; Gebremariam L, 2013, BR J SPORTS MED; Gialanella B, 2011, PAIN MED, V12, P1559, DOI 10.1111/j.1526-4637.2011.01238.x; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Greving K, 2012, SCAND J RHEUMATOL, V41, P150, DOI 10.3109/03009742.2011.605390; Gruson KI, 2008, J SHOULDER ELB SURG, V17, p118S, DOI 10.1016/j.jse.2007.07.009; Hanchard NCA, 2013, COCHRANE DB SYST REV, V4; Hay EM, 2003, ANN RHEUM DIS, V62, P394, DOI 10.1136/ard.62.5.394; Helliwell PS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3037; Ho CYC, 2009, MANUAL THER, V14, P463, DOI 10.1016/j.math.2009.03.008; Huisstede BMA, 2007, OCCUP ENVIRON MED, V64, P313, DOI 10.1136/oem.2005.023861; JAESCHKE R, 1989, CONTROL CLIN TRIALS, V10, P407, DOI 10.1016/0197-2456(89)90005-6; James M, 2005, RHEUMATOLOGY, V44, P1447, DOI 10.1093/rheumatology/kei043; JENSEN MP, 1993, PAIN, V55, P195, DOI 10.1016/0304-3959(93)90148-I; JENSEN MP, 1994, PAIN, V58, P387, DOI 10.1016/0304-3959(94)90133-3; Johansson K, 2011, FAM PRACT, V28, P355, DOI 10.1093/fampra/cmq119; JUNIPER EF, 1994, J CLIN EPIDEMIOL, V47, P81, DOI 10.1016/0895-4356(94)90036-1; Kachingwe AF, 2008, J MAN MANIP THER, V16, P238, DOI 10.1179/106698108790818314; Knapik JJ, 2001, MIL MED, V166, P641; Knapik JJ, 2002, MIL MED, V167, P593; Koester MC, 2007, J AM ACAD ORTHOP SUR, V15, P3, DOI 10.5435/00124635-200701000-00002; Kromer TO, 2009, J REHABIL MED, V41, P870, DOI 10.2340/16501977-0453; Laslett LL, 2007, CLIN EXP RHEUMATOL, V25, P422; LETHEM J, 1983, BEHAV RES THER, V21, P401, DOI 10.1016/0005-7967(83)90009-8; Lewis JS, 2012, J PHYSIOTHER, V58, P127, DOI 10.1016/S1836-9553(12)70093-0; Lozman P R, 1995, J South Orthop Assoc, V4, P177; Mall NA, 2013, AM J SPORT MED, V41, P2684, DOI 10.1177/0363546513485359; Michener LA, 2011, J SPORT REHABIL, V20, P115, DOI 10.1123/jsr.20.1.115; MILGROM C, 1995, J BONE JOINT SURG BR, V77B, P296, DOI 10.1302/0301-620X.77B2.7706351; Mintken PE, 2010, ARCH PHYS MED REHAB, V91, P1128, DOI 10.1016/j.apmr.2010.04.009; Penning LIF, 2012, J BONE JOINT SURG BR, V94B, P1246, DOI 10.1302/0301-620X.94B9.28750; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Ramirez J, 2013, MOD RHEUMATOL; Rechardt M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-165; Reuter RM, 2008, SKELETAL RADIOL, V37, P737, DOI 10.1007/s00256-008-0516-6; Rhon DI, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000137; Rigsby R, 2010, J ATHL TRAINING, V45, P404, DOI 10.4085/1062-6050-45.4.404; Roach K E, 1991, Arthritis Care Res, V4, P143, DOI 10.1002/art.1790040403; Roy JS, 2009, ARTHRIT RHEUM-ARTHR, V61, P623, DOI 10.1002/art.24396; Senbursa G, 2007, KNEE SURG SPORT TR A, V15, P915, DOI 10.1007/s00167-007-0288-x; SHER JS, 1995, J BONE JOINT SURG AM, V77A, P10, DOI 10.2106/00004623-199501000-00002; Sindhu BS, 2012, PHYS THER, V92, P992, DOI 10.2522/ptj.20110309; Spielmann AL, 1999, RADIOLOGY, V213, P705, DOI 10.1148/radiology.213.3.r99dc09705; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Tallia AF, 2003, AM FAM PHYSICIAN, V67, P1271; Tashjian RZ, 2011, J AM ACAD ORTHOP SUR, V19, P380, DOI 10.5435/00124635-201106000-00008; Tekeoglu I, 2013, EUR REV MED PHARMACO, V17, P370; van der Sande R, 2013, ARCH PHYS MED REHAB, V94, P961, DOI 10.1016/j.apmr.2012.11.041; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; Walch G, 1998, J BONE JOINT SURG BR, V80B, P624, DOI 10.1302/0301-620X.80B4.8651; WILLIAMS JW, 1995, J RHEUMATOL, V22, P727; Winters JC, 1997, BRIT MED J, V314, P1320, DOI 10.1136/bmj.314.7090.1320; Wofford JL, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-4; Yu Chung-Ming, 2006, Chang Gung Med J, V29, P474; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	74	54	56	1	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3					161	U108		10.7326/M13-2199	http://dx.doi.org/10.7326/M13-2199			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3KH	25089860				2022-12-28	WOS:000340486000001
J	Millard, C; Brhlikova, P; Pollock, AM				Millard, Colin; Brhlikova, Petra; Pollock, Allyson M.			Commentary: Evidence versus influence in the WHO procedure for approving essential medicines: misoprostol for maternal health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTPARTUM HEMORRHAGE		[Millard, Colin; Brhlikova, Petra; Pollock, Allyson M.] Univ London, Global Hlth Policy & Innovat Unit, London, England	University of London	Millard, C (corresponding author), Univ London, Global Hlth Policy & Innovat Unit, London, England.	colin.millard@qmul.ac.uk		Brhlikova, Petra/0000-0003-2085-0304; pollock, allyson/0000-0002-7388-3110				Chu CS, 2012, J ROY SOC MED, V105, P336, DOI 10.1258/jrsm.2012.120044; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Gynuity Health Projects, MIS POSTP HEM MOV RE; Hofmeyr GJ, 2013, COCHRANE DB SYST REV, V7; Hoj L, 2005, BMJ-BRIT MED J, V331, P723, DOI 10.1136/bmj.331.7519.723; Laing R, 2003, LANCET, V361, P1723, DOI 10.1016/S0140-6736(03)13375-2; Mobeen N, 2011, BJOG-INT J OBSTET GY, V118, P353, DOI 10.1111/j.1471-0528.2010.02807.x; Pollock AM, 2013, BJOG, V120, P287; Starrs A, 2012, INT J GYNECOL OBSTET, V116, P1, DOI 10.1016/j.ijgo.2011.10.005; Tuncalp O, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000494.pub4; Venture Strategies Innovations, 2009, REACH WOM THEY AR; Venture Strategies Innovations, 2011, CONN WOM CAR; Walraven G, 2005, BJOG-INT J OBSTET GY, V112, P1277, DOI 10.1111/j.1471-0528.2005.00711.x; WHO, 2012, SEL US ESS MED REP W; WHO Expert Committee on the Selection and Use of Essential Medicines, 2009, SEL US ESS MED REP W; World Health Organization, ESS MED SEL	16	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2014	349								g4823	10.1136/bmj.g4823	http://dx.doi.org/10.1136/bmj.g4823			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NW	25081251				2022-12-28	WOS:000339907800003
J	Lunt, D				Lunt, Dan			PALAEOCLIMATE SCIENCE Causes and effects of Antarctic ice	NATURE			English	Editorial Material									Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England	University of Bristol	Lunt, D (corresponding author), Univ Bristol, Sch Geog Sci, Bristol BS8 1SS, Avon, England.	d.j.lunt@bristol.ac.uk	Lunt, Daniel J/G-9451-2011	Lunt, Daniel J/0000-0003-3585-6928	Natural Environment Research Council [NE/I006281/1] Funding Source: researchfish; NERC [NE/I006281/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Cornford SL, 2013, J COMPUT PHYS, V232, P529, DOI 10.1016/j.jcp.2012.08.037; Cramer BS, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001683; Francis JE, 2009, DEV EARTH ENV SCI, V8, P309, DOI 10.1016/S1571-9197(08)00008-6; Goldner A, 2014, NATURE, V511, P574, DOI 10.1038/nature13597; Knorr G, 2014, NAT GEOSCI, V7, P376, DOI [10.1038/NGEO2119, 10.1038/ngeo2119]; Lear CH, 2008, GEOLOGY, V36, P251, DOI 10.1130/G24584A.1; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Pagani M, 2011, SCIENCE, V334, P1261, DOI 10.1126/science.1203909; Pearson PN, 2009, NATURE, V461, P1110, DOI 10.1038/nature08447; Sijp WP, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002143	10	0	0	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					536	537		10.1038/511536a	http://dx.doi.org/10.1038/511536a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079547				2022-12-28	WOS:000339566300019
J	Thomas, W				Thomas, W.			PICTURE QUIZ A student with macrocytic anaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEGALOBLASTIC-ANEMIA		Norfolk & Norwich Univ Hosp, Dept Haematol, Norwich NR4 7UY, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Thomas, W (corresponding author), Norfolk & Norwich Univ Hosp, Dept Haematol, Norwich NR4 7UY, Norfolk, England.	whcthomas@gmail.com						Aslinia F, 2006, CLIN MED RES, V4, P236, DOI 10.3121/cmr.4.3.236; Bain BJ., 2003, BLOOD CELLS PRACTICA; Carmel R, 2012, NEW ENGL J MED, V367, P385, DOI 10.1056/NEJMc1204070; Devalia V, 2006, BMJ-BRIT MED J, V333, P385, DOI 10.1136/bmj.333.7564.385; Hoffbrand V., 2011, POSTGRADUATE HAEMATO; Kavimandan A, 2014, INDIAN J GASTROENTER, V33, P114, DOI 10.1007/s12664-013-0366-6; LAWSON DH, 1976, SCAND J HAEMATOL, V17, P347; Shea B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000951.pub2; Stabler SP, 2013, NEW ENGL J MED, V368, P149, DOI [10.1056/NEJMc1304350, 10.1056/NEJMcp1113996]	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2014	348								g3099	10.1136/bmj.g3099	http://dx.doi.org/10.1136/bmj.g3099			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5GP	25134104	Green Published			2022-12-28	WOS:000336156800001
J	Postma, DS; Bush, A; van den Berge, M				Postma, Dirkje S.; Bush, Andrew; van den Berge, Maarten			Risk factors and early origins of chronic obstructive pulmonary disease	LANCET			English	Review							ENVIRONMENTAL TOBACCO-SMOKE; CHRONIC RESPIRATORY SYMPTOMS; REDUCED LUNG-FUNCTION; SCHOOL-AGE-CHILDREN; LONG-TERM EXPOSURE; IN-UTERO EXPOSURE; 1ST 6 YEARS; CHILDHOOD ASTHMA; MATERNAL SMOKING; PASSIVE SMOKING	Chronic obstructive pulmonary disease is mainly a smoking-related disorder and affects millions of people worldwide, with a large effect on individual patients and society as a whole. Although the disease becomes clinically apparent around the age of 40-50 years, its origins can begin very early in life. Different risk factors in very early life-ie, in utero and during early childhood-drive the development of clinically apparent chronic obstructive pulmonary disease in later life. In discussions of which risk factors drive chronic obstructive pulmonary disease, it is important to realise that the disease is very heterogeneous and at present is largely diagnosed by lung function only. In this Review, we will discuss the evidence for risk factors for the various phenotypes of chronic obstructive pulmonary disease during different stages of life.	[Postma, Dirkje S.; van den Berge, Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, NL-9700 RB Groningen, Netherlands; [Postma, Dirkje S.; van den Berge, Maarten] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma, NL-9700 RB Groningen, Netherlands; [Postma, Dirkje S.; van den Berge, Maarten] Univ Groningen, Univ Med Ctr Groningen, COPD, NL-9700 RB Groningen, Netherlands; [Bush, Andrew] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England	University of Groningen; University of Groningen; University of Groningen; Imperial College London	Postma, DS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Box 30-001,Hanzepl 1, NL-9700 RB Groningen, Netherlands.	d.s.postma@umcg.nl			Royal Dutch Academy of Arts and Sciences; Imperial College London (London, UK); NIHR Respiratory Disease Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust (London, UK); Medical Research Council [G1000758B, G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10192] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre] Funding Source: researchfish	Royal Dutch Academy of Arts and Sciences; Imperial College London (London, UK); NIHR Respiratory Disease Biomedical Research Unit at Royal Brompton and Harefield NHS Foundation Trust (London, UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	DSP and MvdB were supported by the Royal Dutch Academy of Arts and Sciences. AB was supported by the NIHR Respiratory Disease Biomedical Research Unit at the Royal Brompton and Harefield NHS Foundation Trust (London, UK) and Imperial College London (London, UK).	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Andersen ZJ, 2011, AM J RESP CRIT CARE, V183, P455, DOI 10.1164/rccm.201006-0937OC; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Ballarin A, 2012, AM J RESP CRIT CARE, V186, P233, DOI 10.1164/rccm.201112-2142OC; Baraldi E, 2005, AM J RESP CRIT CARE, V171, P68, DOI 10.1164/rccm.200403-298Oc; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; BARKER DJP, 1986, LANCET, V1, P1077; Berndt A, 2012, EMBO MOL MED, V4, P1144, DOI 10.1002/emmm.201100627; Beyer D, 2009, EUR J MED RES, V14, P27, DOI 10.1186/2047-783X-14-S4-27; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2012, AM J RESP CRIT CARE, V185, P1183, DOI 10.1164/rccm.201110-1922OC; Bolton CE, 2012, THORAX, V67, P1110, DOI 10.1136/thoraxjnl-2012-202637; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Buczynski BW, 2013, AM J PHYSIOL-LUNG C, V305, pL282, DOI 10.1152/ajplung.00112.2013; Burgel PR, 2012, EUR RESPIR J, V40, P4, DOI 10.1183/09031936.00022412; Burgel PR, 2009, CHEST, V135, P975, DOI 10.1378/chest.08-2062; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Carlsen KCL, 1997, EUR RESPIR J, V10, P1774, DOI 10.1183/09031936.97.10081774; Carraro S, 2010, PEDIATR PULM, V45, P1240, DOI 10.1002/ppul.21317; Casanova C, 2011, AM J RESP CRIT CARE, V184, P1015, DOI 10.1164/rccm.201105-0831OC; CHAN KN, 1989, ARCH DIS CHILD, V64, P1284, DOI 10.1136/adc.64.9.1284; Contoli M, 2010, J ALLERGY CLIN IMMUN, V125, P830, DOI 10.1016/j.jaci.2010.01.003; Copenhaver CC, 2004, AM J RESP CRIT CARE, V170, P175, DOI 10.1164/rccm.200312-1647OC; Covar RA, 2004, AM J RESP CRIT CARE, V170, P234, DOI 10.1164/rccm.200308-1174OC; de Jong K, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-83; Devereux G, 2002, CLIN EXP ALLERGY, V32, P43, DOI 10.1046/j.0022-0477.2001.01267.x; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Doruk S, 2011, CLIN CHEM LAB MED, V49, P2007, DOI 10.1515/CCLM.2011.698; Edwards CA, 2003, CHEST, V124, P18, DOI 10.1378/chest.124.1.18; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Eisner Mark D, 2005, Environ Health, V4, P7, DOI 10.1186/1476-069X-4-7; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Eisner MD, 2002, ENVIRON HEALTH PERSP, V110, P765, DOI 10.1289/ehp.02110765; Elliot J, 1998, AM J RESP CRIT CARE, V158, P802, DOI 10.1164/ajrccm.158.3.9709055; Filippone M, 2012, EUR RESPIR J, V40, P1253, DOI 10.1183/09031936.00185511; FINKELSTEIN R, 1995, AM J RESP CRIT CARE, V152, P267, DOI 10.1164/ajrccm.152.1.7599834; Fu XW, 2011, AM J RESP CELL MOL, V44, P222, DOI 10.1165/rcmb.2010-0109OC; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Gilliland FD, 2002, AM J RESP CRIT CARE, V166, P457, DOI 10.1164/rccm.2112064; GOLD, GLOB STRAT DIAGN MAN; Gosman MME, 2007, THORAX, V62, P242, DOI 10.1136/thx.2006.060988; Grol MH, 1999, AM J RESP CRIT CARE, V160, P1830, DOI 10.1164/ajrccm.160.6.9812100; Guerra S, 2013, THORAX, V68, P1021, DOI 10.1136/thoraxjnl-2013-203538; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Han MLK, 2011, RADIOLOGY, V261, P274, DOI 10.1148/radiol.11110173; Hardaker KM, 2013, RESP PHYSIOL NEUROBI, V189, P106, DOI 10.1016/j.resp.2013.07.009; Hersh CP, 2011, AM J RESP CRIT CARE, V183, P1482, DOI 10.1164/rccm.201010-1751OC; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hofhuis W, 2002, AM J RESP CRIT CARE, V166, P1539, DOI 10.1164/rccm.2202046; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Hyde DM, 2007, AM J PHYSIOL-LUNG C, V293, pL570, DOI 10.1152/ajplung.00467.2006; Iles R, 1997, ARCH DIS CHILD-FETAL, V76, pF113, DOI 10.1136/fn.76.2.F113; Jackson DJ, 2008, AM J RESP CRIT CARE, V178, P667, DOI 10.1164/rccm.200802-309OC; Janson C, 2001, LANCET, V358, P2103, DOI 10.1016/S0140-6736(01)07214-2; Jones PW, 2001, THORAX, V56, P880, DOI 10.1136/thorax.56.11.880; Kabesch M, 2004, THORAX, V59, P569, DOI 10.1136/thx.2003.016667; Kho AT, 2010, AM J RESP CRIT CARE, V181, P54, DOI 10.1164/rccm.200907-1063OC; Kim V, 2011, CHEST, V140, P626, DOI 10.1378/chest.10-2948; Kim WJ, 2013, RESPIROLOGY, V18, P1202, DOI 10.1111/resp.12139; Kotecha SJ, 2012, THORAX, V67, P54, DOI 10.1136/thoraxjnl-2011-200329; Kulkarni N, 2006, NEW ENGL J MED, V355, P21, DOI 10.1056/NEJMoa052972; Latzin P, 2009, EUR RESPIR J, V33, P594, DOI 10.1183/09031936.00084008; LEUENBERGER P, 1994, AM J RESP CRIT CARE, V150, P1222, DOI 10.1164/ajrccm.150.5.7952544; Li YF, 2005, CHEST, V127, P1232, DOI 10.1378/chest.127.4.1232; Mannino DM, 2011, LANCET, V378, P964, DOI 10.1016/S0140-6736(11)61188-4; Marcon A, 2014, J ALLERGY CLIN IMMUN, V133, P104, DOI 10.1016/j.jaci.2013.03.040; Martinez CH, 2012, THORAX, V67, P399, DOI 10.1136/thoraxjnl-2011-201185; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Miravitlles M, 2000, RESPIRATION, V67, P495, DOI 10.1159/000067462; de Oca MM, 2012, EUR RESPIR J, V40, P28, DOI 10.1183/09031936.00141611; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Narang I, 2008, AM J RESP CRIT CARE, V178, P74, DOI 10.1164/rccm.200705-701OC; Narayanan M, 2013, AM J RESP CRIT CARE, V187, P1104, DOI 10.1164/rccm.201210-1850OC; Narayanan M, 2012, AM J RESP CRIT CARE, V185, P186, DOI 10.1164/rccm.201107-1348OC; Nembrini C, 2011, THORAX, V66, P755, DOI 10.1136/thx.2010.152512; Noakes PS, 2006, EUR RESPIR J, V28, P721, DOI 10.1183/09031936.06.00050206; Oswald H, 1997, PEDIATR PULM, V23, P14, DOI 10.1002/(SICI)1099-0496(199701)23:1<14::AID-PPUL2>3.0.CO;2-P; Palmer LJ, 2001, AM J RESP CRIT CARE, V163, P37, DOI 10.1164/ajrccm.163.1.2005013; Penn AL, 2007, ENVIRON HEALTH PERSP, V115, P548, DOI 10.1289/ehp.9780; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Postma DS, 2012, THORAX, V67, P88, DOI 10.1136/thoraxjnl-2011-200758; POSTMA DS, 1991, AM REV RESPIR DIS, V143, P1458, DOI 10.1164/ajrccm/143.6.1458; Postma DS, 1998, AM J RESP CRIT CARE, V158, pS187, DOI 10.1164/ajrccm.158.supplement_2.13tac170; Quanjer PH, 2011, EUR RESPIR J, V37, P658, DOI 10.1183/09031936.00110010; Quanjer PH, 2010, EUR RESPIR J, V36, P1391, DOI 10.1183/09031936.00164109; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Quanjer PH, 2012, EUR RESPIR J, V40, P190, DOI 10.1183/09031936.00161011; Reijmerink NE, 2009, ALLERGY, V64, P898, DOI 10.1111/j.1398-9995.2009.01939.x; Rojas-Martinez R, 2007, AM J RESP CRIT CARE, V176, P377, DOI 10.1164/rccm.200510-1678OC; Rusconi F, 2007, AM J RESP CRIT CARE, V175, P16, DOI 10.1164/rccm.200512-1978OC; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Sekhon HS, 2002, AM J RESP CELL MOL, V26, P31, DOI 10.1165/ajrcmb.26.1.4170; Simoni M, 2007, RESP MED, V101, P531, DOI 10.1016/j.rmed.2006.06.021; Sont JK, 1996, THORAX, V51, P496, DOI 10.1136/thx.51.5.496; Stanojevic S, 2008, AM J RESP CRIT CARE, V177, P253, DOI 10.1164/rccm.200708-1248OC; Stern DA, 2007, LANCET, V370, P758, DOI 10.1016/S0140-6736(07)61379-8; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Stick SM, 1996, LANCET, V348, P1060, DOI 10.1016/S0140-6736(96)04446-7; Svanes C, 2010, THORAX, V65, P14, DOI 10.1136/thx.2008.112136; Swanney MP, 2008, THORAX, V63, P1046, DOI 10.1136/thx.2008.098483; Tashkin DP, 1996, AM J RESP CRIT CARE, V153, P1802, DOI 10.1164/ajrccm.153.6.8665038; TASHKIN DP, 1992, AM REV RESPIR DIS, V145, P301, DOI 10.1164/ajrccm/145.2_Pt_1.301; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Tran H, 2010, EUR RESP J S54, V36, p1016s; Turner S, 2008, THORAX, V63, P234, DOI 10.1136/thx.2006.064642; Turner SW, 2002, ARCH DIS CHILD, V87, P417, DOI 10.1136/adc.87.5.417; Van den Berge M, 2001, AM J RESP CRIT CARE, V164, P1127, DOI 10.1164/ajrccm.164.7.2102135; van den Berge M, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-44; van den Berge M, 2012, EUR RESPIR J, V40, P1098, DOI 10.1183/09031936.00169711; van Diemen CC, 2005, AM J RESP CRIT CARE, V172, P329, DOI 10.1164/rccm.200411-1486OC; Van dn Berge M, 2001, AM J RESP CRIT CARE, V163, P1546, DOI 10.1164/ajrccm.163.7.2010145; van Durme YMTA, 2010, EUR RESPIR J, V36, P89, DOI 10.1183/09031936.00129509; Vestbo J, 1996, AM J RESP CRIT CARE, V153, P1530, DOI 10.1164/ajrccm.153.5.8630597; Vestbo J, 2011, NEW ENGL J MED, V365, P1184, DOI 10.1056/NEJMoa1105482; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424; Watson L, 2004, RESP MED, V98, P1207, DOI 10.1016/j.rmed.2004.05.004; Wilson NM, 2004, PEDIATR PULM, V38, P75, DOI 10.1002/ppul.20049; Wise RA, 2006, AM J MED, V119, pS4, DOI 10.1016/j.amjmed.2006.08.002; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wongtrakool C, 2012, AM J RESP CELL MOL, V46, P695, DOI 10.1165/rcmb.2011-0028OC; Xu XP, 1997, LANCET, V350, P1431, DOI 10.1016/S0140-6736(97)10041-1; Yin P, 2007, LANCET, V370, P751, DOI 10.1016/S0140-6736(07)61378-6; Zhou JJ, 2013, AM J RESP CRIT CARE, V188, P941, DOI 10.1164/rccm.201302-0263OC	128	310	325	18	109	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 7	2015	385	9971					899	909		10.1016/S0140-6736(14)60446-3	http://dx.doi.org/10.1016/S0140-6736(14)60446-3			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC6CB	25123778				2022-12-28	WOS:000350451100038
J	Vogel, JP; Souza, JP; Gulmezoglu, AM; Mori, R; Lumbiganon, P; Qureshi, Z; Carroli, G; Laopaiboon, M; Fawole, B; Ganchimeg, T; Zhang, J; Torloni, MR; Bohren, M; Temmerman, M				Vogel, Joshua P.; Souza, Joao Paulo; Guelmezoglu, A. Metin; Mori, Rintaro; Lumbiganon, Pisake; Qureshi, Zahida; Carroli, Guillermo; Laopaiboon, Malinee; Fawole, Bukola; Ganchimeg, Togoobaatar; Zhang, Jun; Torloni, Maria Regina; Bohren, Meghan; Temmerman, Marleen		WHO Multicountry Survey Maternal	Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health	LANCET			English	Article							RESPIRATORY-DISTRESS	Background Despite the global burden of morbidity and mortality associated with preterm birth, little evidence is available for use of antenatal corticosteroids and tocolytic drugs in preterm births in low-income and middle-income countries. We analysed data from the WHO Multicountry Survey on Maternal and Newborn Health (WHOMCS) to assess coverage for these interventions in preterm deliveries. Methods WHOMCS is a facility-based, cross-sectional survey database of birth outcomes in 359 facilities in 29 countries, with data collected prospectively from May 1, 2010, to Dec 31, 2011. For this analysis, we included deliveries after 22 weeks' gestation and we excluded births that occurred outside a facility or quicker than 3 h after arrival. We calculated use of antenatal corticosteroids in women who gave birth between 26 and 34 weeks' gestation, when antenatal corticosteroids are known to be most beneficial. We also calculated use in women at 22-25 weeks' and 34-36 weeks' gestation. We assessed tocolytic drug use, with and without antenatal corticosteroids, in spontaneous, uncomplicated preterm deliveries at 26-34 weeks' gestation. Findings Of 303 842 recorded deliveries after 22 weeks' gestation, 17 705 (6%) were preterm. 3900 (52%) of 7547 women who gave birth at 26-34 weeks' gestation, 94 (19%) of 497 women who gave birth at 22-25 weeks' gestation, and 2276 (24%) of 9661 women who gave birth at 35-36 weeks' gestation received antenatal corticosteroids. Rates of antenatal corticosteroid use varied between countries (median 54%, range 16-91%; IQR 30-68%). Of 4677 women who were potentially eligible for tocolysis drugs, 1276 (27%) were treated with bed rest or hydration and 2248 (48%) received no treatment. beta-agonists alone (n=346, 7%) were the most frequently used tocolytic drug. Only 848 (18%) of potentially eligible women received both a tocolytic drug and antenatal corticosteroids. Interpretation Use of interventions was generally poor, despite evidence for their benefit for newborn babies. A substantial proportion of antenatal corticosteroid use occurred at gestational ages at which benefit is controversial, and use of less effective or potentially harmful tocolytic drugs was common. Implementation research and contextualised health policies are needed to improve drug availability and increase compliance with best obstetric practice.	[Vogel, Joshua P.] Univ Western Australia, Fac Med Dent & Hlth Sci, Sch Populat Hlth, Crawley, WA, Australia; [Vogel, Joshua P.; Souza, Joao Paulo; Guelmezoglu, A. Metin; Bohren, Meghan; Temmerman, Marleen] WHO, Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, CH-1211 Geneva, Switzerland; [Souza, Joao Paulo] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Social Med, BR-14049 Ribeirao Preto, Brazil; [Mori, Rintaro; Ganchimeg, Togoobaatar] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Lumbiganon, Pisake] Khon Kaen Univ, Fac Med, Dept Obstet & Gynecol, Khon Kaen, Thailand; [Laopaiboon, Malinee] Khon Kaen Univ, Fac Publ Hlth, Dept Biostat & Demog, Khon Kaen, Thailand; [Qureshi, Zahida] Univ Nairobi, Coll Hlth Sci, Sch Med, Dept Obstet & Gynaecol, Nairobi, Kenya; [Carroli, Guillermo] Ctr Rosarino Estudios Perinatales, Rosario, Argentina; [Fawole, Bukola] Univ Ibadan, Ibadan, Nigeria; [Zhang, Jun] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Shanghai 200030, Peoples R China; [Torloni, Maria Regina] Univ Fed Sao Paulo, Dept Obstet, Sao Paulo, Brazil; [Torloni, Maria Regina] Brazilian Cochrane Ctr, Sao Paulo, Brazil; [Bohren, Meghan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA	University of Western Australia; The World Bank; United Nations Population Fund; World Health Organization; Universidade de Sao Paulo; National Center for Child Health & Development - Japan; Khon Kaen University; Khon Kaen University; University of Nairobi; University of Ibadan; Shanghai Jiao Tong University; Universidade Federal de Sao Paulo (UNIFESP); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Vogel, JP (corresponding author), WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.	vogeljo@who.int	Vogel, Joshua/K-7649-2019; Lumbiganon, Pisake/E-8634-2010; Souza, João Paulo/G-1982-2010	Vogel, Joshua/0000-0002-3214-7096; Lumbiganon, Pisake/0000-0001-9372-0071; Souza, João Paulo/0000-0002-2288-4244; Mori, Rintaro/0000-0001-7656-6156; Bohren, Meghan/0000-0002-4179-4682	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); WHO; USAID; Ministry of Health, Labour and Welfare of Japan; Gynuity Health Projects	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); WHO(World Health Organization); USAID(United States Agency for International Development (USAID)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Gynuity Health Projects	UNDP-UNFPA-UNICEF-WHO-World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP); WHO; USAID; Ministry of Health, Labour and Welfare of Japan; Gynuity Health Projects.	Aleman A, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-4; Riganti AA, 2010, INT J GYNECOL OBSTET, V108, P52, DOI 10.1016/j.ijgo.2009.08.022; Anotayanonth S, 2004, COCHRANE DB SYST REV, V4; Colomar Mercedes, 2004, Ginecol Obstet Mex, V72, P455; Crowther CA, 2006, COCHRANE DB SYST REV, V4; Forteza C, 2002, PAEDIAT RES, V77, P313; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Hayes E, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.052; Howson CP., 2012, BORN TOO SOON GLOBAL; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; King JF, 2007, COCHRANE DB SYST REV, V1; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Mori R, 2011, J PEDIATR-US, V159, P110, DOI 10.1016/j.jpeds.2010.12.039; Mwansa-Kambafwile J, 2010, INT J EPIDEMIOL, V39, P122, DOI 10.1093/ije/dyq029; Papatsonis D, 2005, COCHRANE DB SYST REV, V3; Pattanittum P, 2007, BMC PREGNANCY CHILDB, V8, P47; Requejo J, 2012, COUNTDOWN 2015 BUILD; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Silva L K, 1999, Cad Saude Publica, V15, P817, DOI 10.1590/S0102-311X1999000400016; Sosa C, 2003, COCHRANE DB SYST REV, V1; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286; Stan CM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003096.pub2; Stutchfield P, 2005, BMJ-BRIT MED J, V331, P662, DOI 10.1136/bmj.38547.416493.06; Vallejo Valdivieso N, 2002, MED GUAYAQUIL, V8, P36; World Health Organization, 2012, OPTIMIZEMNH WHO REC; World Health Organization, 2011, WHO MOD LISTS ESS ME	29	69	70	1	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1869	1877		10.1016/S0140-6736(14)60580-8	http://dx.doi.org/10.1016/S0140-6736(14)60580-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7LA	25128271	Green Published			2022-12-28	WOS:000345116800027
J	Podolsky, SH				Podolsky, Scott H.			Serotherapy for Ebola: Back to the Future	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Podolsky, Scott H.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Podolsky, SH (corresponding author), Harvard Univ, Sch Med, Dept Global Hlth & Social Med, 641 Huntington Ave, Boston, MA 02115 USA.	scott_podolsky@hms.harvard.edu						Brandt A, 1987, NO MAGIC BULLET SOCI, P191; Bud Robert, 2007, PENICILLIN TRIUMPH T; Dowling HF, 1935, MED ANN DIST COLUMBI, V4, P66; Ehrlich P., 1960, COLLECTED PAPERS P E, VIII, P53; Garrett L., 1994, COMING PLAGUE NEWLY; Gupta S, 2014, EXPT DRUG LIKELY SAV; Osmundsen John A., 1966, LOOK, P140; Podolsky SH, 2010, J HIST MED ALL SCI, V65, P327, DOI 10.1093/jhmas/jrq003; Podolsky SH, 2006, PNEUMONIA ANTIBIOTIC; Whorton James C., 1980, HIST ANTIBIOTICS, P125	10	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					742	743		10.7326/M14-1810	http://dx.doi.org/10.7326/M14-1810			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25110967				2022-12-28	WOS:000347245600032
J	Meyerson, JR; Kumar, J; Chittori, S; Rao, P; Pierson, J; Bartesaghi, A; Mayer, ML; Subramaniam, S				Meyerson, Joel R.; Kumar, Janesh; Chittori, Sagar; Rao, Prashant; Pierson, Jason; Bartesaghi, Alberto; Mayer, Mark L.; Subramaniam, Sriram			Structural mechanism of glutamate receptor activation and desensitization	NATURE			English	Article							LIGAND-BINDING DOMAIN; ION-CHANNEL; CRYSTAL-STRUCTURES; AMPA; GLUR2; VISUALIZATION; RESOLUTION; BEHAVIOR; LIPIDS; TILT	Ionotropic glutamate receptors are ligand-gated ion channels that mediate excitatory synaptic transmission in the vertebrate brain. To gain a better understanding of how structural changes gate ion flux across the membrane, we trapped rat AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) and kainate receptor subtypes in their major functional states and analysed the resulting structures using cryo-electron microscopy. We show that transition to the active state involves a 'corkscrew' motion of the receptor assembly, driven by closure of the ligand-binding domain. Desensitization is accompanied by disruption of the amino-terminal domain tetramer in AMPA, but not kainate, receptors with a two-fold to four-fold symmetry transition in the ligand-binding domains in both subtypes. The 7.6 angstrom structure of a desensitized kainate receptor shows how these changes accommodate channel closing. These findings integrate previous physiological, biochemical and structural analyses of glutamate receptors and provide a molecular explanation for key steps in receptor gating.	[Meyerson, Joel R.; Rao, Prashant; Bartesaghi, Alberto; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kumar, Janesh; Chittori, Sagar; Mayer, Mark L.] NICHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Pierson, Jason] FEI Co, Hillsboro, OR 97124 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Thermo Fisher Scientific; FEI Company	Subramaniam, S (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	mayerm@mail.nih.gov; ss1@nih.gov	Mayer, Mark/AAE-7356-2019; Kumar, Janesh/AAG-3002-2019; Chittori, Sagar/B-9412-2009	Mayer, Mark/0000-0003-4378-8451; Kumar, Janesh/0000-0003-0767-3788; Chittori, Sagar/0000-0003-1417-6552; Subramaniam, Sriram/0000-0003-4231-4115	NCI; NICHD, NIH; IATAP program at NIH; NIH-FEI Living Lab for Structural Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010824, ZIABC010278] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); IATAP program at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-FEI Living Lab for Structural Biology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the intramural programs of the NCI, and NICHD, NIH, the IATAP program at NIH and the NIH-FEI Living Lab for Structural Biology. We thank D. Bleakman, Eli Lilly and Company for the gift of LY451646, Y. J. Eun for discussions on preparation of cryo-EM samples, X. Wu for discussions on fitting crystallographic coordinates to cryo-EM maps, D. Bliss for assistance with preparing schematic illustrations, L. Earl, M. J. Borgnia and J. L. S. Milne for discussions, and S. Fellini, S. Chacko and their colleagues for continued support with use of the Biowulf cluster for computing at NIH.	Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Alushin GM, 2011, NEUROPHARMACOLOGY, V60, P126, DOI 10.1016/j.neuropharm.2010.06.002; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Barrera NP, 2013, TRENDS CELL BIOL, V23, P1, DOI 10.1016/j.tcb.2012.08.007; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Carbone AL, 2012, NEURON, V74, P845, DOI 10.1016/j.neuron.2012.04.020; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Chaudhry C, 2009, EMBO J, V28, P1518, DOI 10.1038/emboj.2009.86; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Dong H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1362; Furukawa H, 2012, J PHYSIOL-LONDON, V590, P63, DOI 10.1113/jphysiol.2011.213850; Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200; Hald H, 2009, J MOL BIOL, V391, P906, DOI 10.1016/j.jmb.2009.07.002; Henderson R, 2011, J MOL BIOL, V413, P1028, DOI 10.1016/j.jmb.2011.09.008; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Jiang QX, 2012, CURR OPIN STRUC BIOL, V22, P529, DOI 10.1016/j.sbi.2012.03.009; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kumar J, 2011, NEURON, V71, P319, DOI 10.1016/j.neuron.2011.05.038; Landes CF, 2011, NAT CHEM BIOL, V7, P168, DOI 10.1038/NCHEMBIO.523; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Liao MF, 2014, CURR OPIN STRUC BIOL, V27, P1, DOI 10.1016/j.sbi.2014.02.005; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Miu P, 2001, NEUROPHARMACOLOGY, V40, P976, DOI 10.1016/S0028-3908(01)00027-2; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Nayeem N, 2009, MOL PHARMACOL, V76, P534, DOI 10.1124/mol.109.056598; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plested AJR, 2007, NEURON, V53, P829, DOI 10.1016/j.neuron.2007.02.025; Plested AJR, 2009, J NEUROSCI, V29, P11912, DOI 10.1523/JNEUROSCI.2971-09.2009; Prieto ML, 2010, J NEUROSCI, V30, P4449, DOI 10.1523/JNEUROSCI.5613-09.2010; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky A. I., 2013, J PHYSL LOND; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Turski L, 1998, P NATL ACAD SCI USA, V95, P10960, DOI 10.1073/pnas.95.18.10960; WL D, 2002, PYMOL MOL GRAPHICS S; Zhao HY, 2012, J GEN PHYSIOL, V139, P371, DOI 10.1085/jgp.201210770	53	164	165	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					328	+		10.1038/nature13603	http://dx.doi.org/10.1038/nature13603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25119039	Green Accepted			2022-12-28	WOS:000342988600043
J	Diehl, R; Siegert, T; Hillebrandt, W; Grebenev, SA; Greiner, J; Krause, M; Kromer, M; Maeda, K; Ropke, F; Taubenberger, S				Diehl, Roland; Siegert, Thomas; Hillebrandt, Wolfgang; Grebenev, Sergei A.; Greiner, Jochen; Krause, Martin; Kromer, Markus; Maeda, Keiichi; Roepke, Friedrich; Taubenberger, Stefan			Early Ni-56 decay gamma rays from SN2014J suggest an unusual explosion	SCIENCE			English	Article							SUB-CHANDRASEKHAR SUPERNOVAE; IA SUPERNOVAE; WHITE-DWARFS; SN 2011FE; PROGENITOR; STAR; DETONATIONS; OBSERVABLES; SPECTRA; MODELS	Type Ia supernovae result from binary systems that include a carbon-oxygen white dwarf, and these thermonuclear explosions typically produce 0.5 solar mass of radioactive Ni-56. The Ni-56 is commonly believed to be buried deeply in the expanding supernova cloud. In SN2014J, we detected the lines at 158 and 812 kiloelectron volts from Ni-56 decay (time similar to 8.8 days) earlier than the expected several-week time scale, only similar to 20 days after the explosion and with flux levels corresponding to roughly 10% of the total expected amount of Ni-56. Some mechanism must break the spherical symmetry of the supernova and at the same time create a major amount of Ni-56 at the outskirts. A plausible explanation is that a belt of helium from the companion star is accreted by the white dwarf, where this material explodes and then triggers the supernova event.	[Diehl, Roland; Siegert, Thomas; Greiner, Jochen; Krause, Martin] Max Planck Inst Extraterr Phys, Giessenbachstr 1, D-85741 Garching, Germany; [Hillebrandt, Wolfgang; Taubenberger, Stefan] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Grebenev, Sergei A.] Russian Acad Sci, Space Res Inst, Moscow 117997, Russia; [Kromer, Markus] Stockholm Univ, AlbaNova, Oskar Klein Ctr, SE-10691 Stockholm, Sweden; [Kromer, Markus] Stockholm Univ, AlbaNova, Dept Astron, SE-10691 Stockholm, Sweden; [Maeda, Keiichi] Kyoto Univ, Dept Astron, Sakyo Ku, Kyoto 6068502, Japan; [Maeda, Keiichi] Univ Tokyo, Kavli Inst WPI, Kashiwa, Chiba 2778583, Japan; [Roepke, Friedrich] Univ Wurzburg, Inst Theoret Phys & Astrophys, D-97074 Wurzburg, Germany	Max Planck Society; Max Planck Society; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Oskar Klein Centre; Stockholm University; Stockholm University; Kyoto University; University of Tokyo; University of Wurzburg	Diehl, R (corresponding author), Max Planck Inst Extraterr Phys, Giessenbachstr 1, D-85741 Garching, Germany.	rod@mpe.mpg.de	Diehl, Roland/K-4496-2016; Grebenev, Sergei/L-4134-2019; Krause, Martin/AAT-7574-2021	Diehl, Roland/0000-0002-8337-9022; Grebenev, Sergei/0000-0002-5501-4253; Krause, Martin/0000-0002-9610-5629; Maeda, Keiichi/0000-0003-2611-7269; Siegert, Thomas/0000-0002-0552-3535	Deutsche Forschungsgemeinschaft (DFG) cluster of excellence "Origin and Structure of the Universe" and from DFG Transregio [33]; Russian Academy of Sciences [RAS P-21]; DFG [RO3676/1-1]; ARCHES prize of the German Ministry for Education and Research; Japan Society for the Promotion of Science [23740141, 26800100]; WPI, at the Ministry of Education, Culture, Sports. Science Technology	Deutsche Forschungsgemeinschaft (DFG) cluster of excellence "Origin and Structure of the Universe" and from DFG Transregio(German Research Foundation (DFG)); Russian Academy of Sciences(Russian Academy of Sciences); DFG(German Research Foundation (DFG)); ARCHES prize of the German Ministry for Education and Research; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); WPI, at the Ministry of Education, Culture, Sports. Science Technology	This research was supported by the Deutsche Forschungsgemeinschaft (DFG) cluster of excellence "Origin and Structure of the Universe" and from DFG Transregio Project No. 33 "Dark Universe." S. A. G. acknowledges support from the Russian Academy of Sciences, program RAS P-21. F. K. R. was supported by the DFG (Emmy Noether Programm RO3676/1-1) and the ARCHES prize of the German Ministry for Education and Research. The work by K. M. is partly supported by a Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (grant no. 23740141 and 26800100) and WPI, at the Ministry of Education, Culture, Sports. Science & Technology. We are grateful to E. Kuulkers for handling the observations and to X. Zhang for preparing our SPI data for the INTEGRAL SN2014J campaign. The INTEGRAL/SPI project has been completed under the responsibility and leadership of CNES Toulouse. We are grateful to the agencies and institutions of ASI, CEA, CNES, DLR, ESA, INTA, NASA, and OSTC for support of this ESA space science mission. INTEGRAL's data archive (http://www.isdc.unige.ch/integral/archive#DataRelease) is at the INTEGRAL Science Data Center in Versoix, Switzerland, and includes the SN2014J data used in this paper.	Bloom JS, 2012, ASTROPHYS J LETT, V744, DOI 10.1088/2041-8205/744/2/L17; Bours MCP, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220692; Cao Y., 2014, ASTRONOMERS TELEGRAM; Dalcanton JJ, 2009, ASTROPHYS J SUPPL S, V183, P67, DOI 10.1088/0067-0049/183/1/67; Diehl R, 2003, ASTRON ASTROPHYS, V411, pL117, DOI 10.1051/0004-6361:20031365; Fink M, 2007, ASTRON ASTROPHYS, V476, P1133, DOI 10.1051/0004-6361:20078438; Fink M, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913892; Fossey J., 2014, CENTRAL BUREAU ELECT; Goobar A, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/1/L12; Goobar A, 2011, ANNU REV NUCL PART S, V61, P251, DOI 10.1146/annurev-nucl-102010-130434; Greiner J., 1996, LECT NOTE PHYS, V472, P299; Guillochon J, 2010, ASTROPHYS J LETT, V709, pL64, DOI 10.1088/2041-8205/709/1/L64; Hillebrandt W, 2013, FRONT PHYS-BEIJING, V8, P116, DOI 10.1007/s11467-013-0303-2; Hillebrandt W, 2000, ANNU REV ASTRON ASTR, V38, P191, DOI 10.1146/annurev.astro.38.1.191; Hoflich P, 2006, NUCL PHYS A, V777, P579, DOI 10.1016/j.nuclphysa.2004.12.038; Isern J, 2013, ASTRON ASTROPHYS, V552, DOI 10.1051/0004-6361/201220303; Kerzendorf WE, 2009, ASTROPHYS J, V701, P1665, DOI 10.1088/0004-637X/701/2/1665; KIPPENHAHN R, 1978, ASTRON ASTROPHYS, V63, P265; Kromer M, 2010, ASTROPHYS J, V719, P1067, DOI 10.1088/0004-637X/719/2/1067; Kuulkers E., 2014, ASTRONOMERS TELEGRAM; LAW WY, 1983, ASTRON ASTROPHYS, V123, P33; Li WD, 2011, NATURE, V480, P348, DOI 10.1038/nature10646; Maeda K, 2012, ASTROPHYS J, V760, DOI 10.1088/0004-637X/760/1/54; Moll R., 2013, AM ASTR SOC ABSTR, V221, P22; Nielsen M. T. B., 2014, UPPER LIMITS LUMINOS; Nugent P, 1997, ASTROPHYS J, V485, P812, DOI 10.1086/304459; Nugent PE, 2011, NATURE, V480, P344, DOI 10.1038/nature10644; Pakmor R, 2012, ASTROPHYS J LETT, V747, DOI 10.1088/2041-8205/747/1/L10; Piro AL, 2004, ASTROPHYS J, V603, P252, DOI 10.1086/381431; Ropke FK, 2012, ASTROPHYS J LETT, V750, DOI 10.1088/2041-8205/750/1/L19; Roques JP, 2003, ASTRON ASTROPHYS, V411, pL91, DOI 10.1051/0004-6361:20031501; Rosswog S, 2009, ASTROPHYS J LETT, V705, pL128, DOI 10.1088/0004-637X/705/2/L128; Ruiter AJ, 2014, MON NOT R ASTRON SOC, V440, pL101, DOI 10.1093/mnrasl/slu030; Ruiz-Lapuente P, 2004, NATURE, V431, P1069, DOI 10.1038/nature03006; Schaefer BE, 2012, NATURE, V481, P164, DOI 10.1038/nature10692; Shappee BJ, 2013, ASTROPHYS J LETT, V762, DOI 10.1088/2041-8205/762/1/L5; Siegert T., 2013, THESIS; Sim SA, 2008, MON NOT R ASTRON SOC, V385, P1681, DOI 10.1111/j.1365-2966.2008.12600.x; Sokoloski JL, 2013, ASTROPHYS J LETT, V770, DOI 10.1088/2041-8205/770/2/L33; Summa A, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201220972; The LS, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/141; Vedrenne G, 2003, ASTRON ASTROPHYS, V411, pL63, DOI 10.1051/0004-6361:20031482; Winkler C, 2003, ASTRON ASTROPHYS, V411, pL1, DOI 10.1051/0004-6361:20031288; Zheng WK, 2014, ASTROPHYS J LETT, V783, DOI 10.1088/2041-8205/783/1/L24	44	82	82	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1162	1165		10.1126/science.1254738	http://dx.doi.org/10.1126/science.1254738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25081484	Green Submitted, Green Published			2022-12-28	WOS:000341179800042
J	Schurr, B; Asch, G; Hainzl, S; Bedford, J; Hoechner, A; Palo, M; Wang, RJ; Moreno, M; Bartsch, M; Zhang, Y; Oncken, O; Tilmann, F; Dahm, T; Victor, P; Barrientos, S; Vilotte, JP				Schurr, Bernd; Asch, Guenter; Hainzl, Sebastian; Bedford, Jonathan; Hoechner, Andreas; Palo, Mauro; Wang, Rongjiang; Moreno, Marcos; Bartsch, Mitja; Zhang, Yong; Oncken, Onno; Tilmann, Frederik; Dahm, Torsten; Victor, Pia; Barrientos, Sergio; Vilotte, Jean-Pierre			Gradual unlocking of plate boundary controlled initiation of the 2014 Iquique earthquake	NATURE			English	Article							SHORT-TERM; CHILE; RUPTURE; MODELS; FAULT; DEFORMATION; PHASE; ZONE; HYPOCENTER; MAGNITUDE	On 1 April 2014, Northern Chile was struck by a magnitude 8.1 earthquake following a protracted series of foreshocks. The Integrated Plate Boundary Observatory Chile monitored the entire sequence of events, providing unprecedented resolution of the build-up to the main event and its rupture evolution. Here we show that the Iquique earthquake broke a central fraction of the so-called northern Chile seismic gap, the last major segment of the South American plate boundary that had not ruptured in the past century(1,2). Since July 2013 three seismic clusters, each lasting a few weeks, hit this part of the plate boundary with earthquakes of increasing peak magnitudes. Starting with the second cluster, geodetic observations show surface displacements that can be associated with slip on the plate interface. These seismic clusters and their slip transients occupied a part of the plate interface that was transitional between a fully locked and a creeping portion. Leading up to this earthquake, the b value of the foreshocks gradually decreased during the years before the earthquake, reversing its trend a few days before the Iquique earthquake. The mainshock finally nucleated at the northern end of the foreshock area, which skirted a locked patch, and ruptured mainly downdip towards higher locking. Peak slip was attained immediately downdip of the foreshock region and at the margin of the locked patch. We conclude that gradual weakening of the central part of the seismic gap accentuated by the foreshock activity in a zone of intermediate seismic coupling was instrumental in causing final failure, distinguishing the Iquique earthquake from most great earthquakes. Finally, only one-third of the gap was broken and the remaining locked segments nowpose a significant, increased seismic hazard with the potential to host an earthquake with a magnitude of > 8.5.	[Schurr, Bernd; Asch, Guenter; Hainzl, Sebastian; Bedford, Jonathan; Hoechner, Andreas; Palo, Mauro; Wang, Rongjiang; Moreno, Marcos; Bartsch, Mitja; Oncken, Onno; Tilmann, Frederik; Dahm, Torsten; Victor, Pia] German Res Ctr Geosci, GFZ Helmholtz Ctr Potsdam, D-14473 Potsdam, Germany; [Zhang, Yong] Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China; [Barrientos, Sergio] Univ Chile, Ctr Sismol Natl, Fac Ciencias Fis & Matemat, Santiago 2002, Chile; [Vilotte, Jean-Pierre] Inst Phys Globe Paris, F-75238 Paris 05, France	Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Peking University; Universidad de Chile; UDICE-French Research Universities; Universite Paris Cite	Schurr, B (corresponding author), German Res Ctr Geosci, GFZ Helmholtz Ctr Potsdam, D-14473 Potsdam, Germany.	schurr@gfz-potsdam.de	Tilmann, Frederik J/E-4293-2012; Palo, Mauro/GON-7381-2022; Moreno, Marcos/M-4632-2013; Zhang, Yong/P-8971-2015; Vilotte, Jean-Pierre/H-1552-2017; Oncken, Onno/AAU-2907-2020	Tilmann, Frederik J/0000-0002-7439-8782; Moreno, Marcos/0000-0002-6023-7283; Vilotte, Jean-Pierre/0000-0002-6085-6498; Oncken, Onno/0000-0002-2894-480X; Palo, Mauro/0000-0001-6974-2334; Hainzl, Sebastian/0000-0002-2875-0933; Dahm, Torsten/0000-0001-6432-7422; Hoechner, Andreas/0000-0002-3494-5200	GFZ; Hannover Re	GFZ; Hannover Re	Data used in this study come from the IPOC initiative (http://www.ipoc-network.org) operated by the GFZ - German Research Centre for Geosciences, Institut de Physique du Globe de Paris, Centro Sismologico National, Universidad de Chile, and Universidad Catolica del Norte, Antofagasta, Chile. We also acknowledge the French-Chilean International Associated Laboratory (LIA) 'Montessus de Ballore' and the USA-Chilean Central Andean Tectonic Observatory Geodetic Array projects for giving access to data of several of their continuous GPS (cGPS) stations in Chile. Part of this work was made possible by the Hazard Assessment and Risk Team (HART) initiative funded by the GFZ and Hannover Re.	Allmendinger RW, 2005, GEOL SOC AM BULL, V117, P89, DOI 10.1130/B25505.1; Bassin C., 2000, EOS T AM GEOPHYS UN, V81, pF897; Bejar-Pizarro M, 2013, NAT GEOSCI, V6, P462, DOI [10.1038/ngeo1802, 10.1038/NGEO1802]; Bilek S. L., 2002, GEOPHYS RES LETT, V29, P1; Boehm J, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025546; Bouchon M, 2013, NAT GEOSCI, V6, P299, DOI [10.1038/ngeo1770, 10.1038/NGEO1770]; Brooks BA, 2011, NAT GEOSCI, V4, P380, DOI [10.1038/ngeo1143, 10.1038/NGEO1143]; Chlieh M, 2004, GEOPHYS J INT, V158, P695, DOI 10.1111/j.1365-246X.2004.02326.x; Chlieh M, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008166; Comte D., 1991, Natural Hazards, V4, P23, DOI 10.1007/BF00126557; Dach R, 2007, BERNESE GPS SOFTWARE; Dach R, 2011, GPS SOLUT, V15, P49, DOI 10.1007/s10291-010-0169-5; DAS S, 1983, J GEOPHYS RES, V88, P4277, DOI 10.1029/JB088iB05p04277; Delouis B, 2009, B SEISMOL SOC AM, V99, P87, DOI 10.1785/0120080192; DORBATH L, 1990, B SEISMOL SOC AM, V80, P551; Habermann R. E., 1981, Earthquake Prediction. An International Review. Symposium on Earthquake Prediction, P29, DOI 10.1029/ME004p0029; Hainzl S, 2013, B SEISMOL SOC AM, V103, P1723, DOI 10.1785/0120120247; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Helmstetter A, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2004JB003286; Helmstetter A, 2006, B SEISMOL SOC AM, V96, P90, DOI 10.1785/0120050067; Holtkamp S, 2014, EARTH PLANET SC LETT, V390, P234, DOI 10.1016/j.epsl.2013.10.033; Husen S, 1999, GEOPHYS J INT, V138, P687, DOI 10.1046/j.1365-246x.1999.00893.x; Ishii M, 2005, NATURE, V435, P933, DOI 10.1038/nature03675; Kagan YY, 2004, B SEISMOL SOC AM, V94, P1207, DOI 10.1785/012003098; Kaneko Y, 2010, NAT GEOSCI, V3, P363, DOI 10.1038/NGEO843; Kato A, 2012, SCIENCE, V335, P705, DOI 10.1126/science.1215141; KENNETT BLN, 1991, GEOPHYS J INT, V105, P429, DOI 10.1111/j.1365-246X.1991.tb06724.x; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; Kruger F, 2005, NATURE, V435, P937, DOI 10.1038/nature03696; Lay T, 2014, GEOPHYS RES LETT, V41, P3818, DOI 10.1002/2014GL060238; Letellier T., 2004, THESIS U TOULOUSE 3; Marsan D, 2013, B SEISMOL SOC AM, V103, P169, DOI 10.1785/0120110304; Marzocchi W, 2003, ANN GEOPHYS-ITALY, V46, P1271; Menke W, 2012, GEOPHYSICAL DATA ANALYSIS: DISCRETE INVERSE THEORY, 3RD EDITION, P1; Metois M, 2013, GEOPHYS J INT, V194, P1283, DOI 10.1093/gji/ggt183; Mignan A, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053946; Nanjo KZ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052997; NEIDELL NS, 1971, GEOPHYSICS, V36, P482, DOI 10.1190/1.1440186; Noda H, 2013, NATURE, V493, P518, DOI 10.1038/nature11703; OGATA Y, 1988, J AM STAT ASSOC, V83, P9, DOI 10.1080/01621459.1988.10478560; Pritchard HD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000597; Roessler D, 2010, NAT HAZARD EARTH SYS, V10, P923, DOI 10.5194/nhess-10-923-2010; Ruegg JC, 1996, GEOPHYS RES LETT, V23, P917, DOI 10.1029/96GL01026; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Schorlemmer D, 2005, NATURE, V437, P539, DOI 10.1038/nature04094; Schurr B, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009030; SHI Y, 1982, B SEISMOL SOC AM, V72, P1677; Sippl C, 2013, J GEOPHYS RES-SOL EA, V118, P1438, DOI 10.1002/jgrb.50128; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; Wang RJ, 2006, COMPUT GEOSCI-UK, V32, P527, DOI 10.1016/j.cageo.2005.08.006; Wang RJ, 1999, B SEISMOL SOC AM, V89, P733; Wdowinski S, 1997, J GEOPHYS RES-SOL EA, V102, P18057, DOI 10.1029/97JB01378; Woessner J, 2005, B SEISMOL SOC AM, V95, P684, DOI 10.1785/0120040007; Yagi Y, 2014, GEOPHYS RES LETT, V41, P4201, DOI 10.1002/2014GL060274; Zhang Y, 2012, GEOPHYS J INT, V191, P1417, DOI 10.1111/j.1365-246X.2012.05694.x	55	210	216	3	73	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					299	+		10.1038/nature13681	http://dx.doi.org/10.1038/nature13681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119049	Green Submitted			2022-12-28	WOS:000340508200032
J	Chiu, HY; Lin, SJ				Chiu, Hsien-Yi; Lin, Sung-Jan			Red Papules on the Tongue of a Patient With Hemiparesis Diagnosis Rendu-Osler-Weber syndrome (hereditary hemorrhagic telangiectasia [HHT]) presenting with a brain abscess	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PULMONARY ARTERIOVENOUS-MALFORMATIONS; BEVACIZUMAB; DISEASE		[Chiu, Hsien-Yi] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Dermatol, Hsinchu, Taiwan; [Chiu, Hsien-Yi; Lin, Sung-Jan] Natl Taiwan Univ Hosp, Dept Dermatol, Taipei 100, Taiwan; [Chiu, Hsien-Yi; Lin, Sung-Jan] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chiu, Hsien-Yi; Lin, Sung-Jan] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Chiu, Hsien-Yi; Lin, Sung-Jan] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Lin, Sung-Jan] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University	Lin, SJ (corresponding author), Natl Taiwan Univ Hosp, Dept Dermatol, 7 Chung Shan South Rd, Taipei 100, Taiwan.	drsjlin@ntu.edu.tw		Chiu, Hsien-Yi/0000-0002-0493-9707; Lin, Sung-Jan/0000-0003-1325-3464				Dupuis-Girod S, 2012, JAMA-J AM MED ASSOC, V307, P948, DOI 10.1001/jama.2012.250; Felton SJ, 2012, JAMA-J AM MED ASSOC, V308, P1685, DOI 10.1001/jama.2012.13656; Finkelstein R, 1996, J INTERN MED, V240, P33, DOI 10.1046/j.1365-2796.1996.471812000.x; Gallitelli M, 2006, RESPIRATION, V73, P553, DOI 10.1159/000087150; Guldmann R, 2012, LARYNGOSCOPE, V122, P953, DOI 10.1002/lary.23230; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Madden JF, 1934, J AMER MED ASSOC, V102, P442, DOI 10.1001/jama.1934.02750060024005; Mathis S, 2012, CLIN NEUROL NEUROSUR, V114, P235, DOI 10.1016/j.clineuro.2011.10.036; Shovlin CL, 2008, THORAX, V63, P259, DOI 10.1136/thx.2007.087452; Tabakow P, 2005, FOLIA NEUROPATHOL, V43, P41	10	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					741	742		10.1001/jama.2014.1658	http://dx.doi.org/10.1001/jama.2014.1658			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25138335				2022-12-28	WOS:000340438700023
J	Geary, C; Rothemund, PWK; Andersen, ES				Geary, Cody; Rothemund, Paul W. K.; Andersen, Ebbe S.			A single-stranded architecture for cotranscriptional folding of RNA nanostructures	SCIENCE			English	Article							DNA NANOSTRUCTURES; COMPLEX; DESIGN; ACID; NANOTECHNOLOGY; ASSEMBLIES; JUNCTIONS; SEQUENCE; SHAPES; FORM	Artificial DNA and RNA structures have been used as scaffolds for a variety of nanoscale devices. In comparison to DNA structures, RNA structures have been limited in size, but they also have advantages: RNA can fold during transcription and thus can be genetically encoded and expressed in cells. We introduce an architecture for designing artificial RNA structures that fold from a single strand, in which arrays of antiparallel RNA helices are precisely organized by RNA tertiary motifs and a new type of crossover pattern. We constructed RNA tiles that assemble into hexagonal lattices and demonstrated that lattices can be made by annealing and/or cotranscriptional folding. Tiles can be scaled up to 660 nucleotides in length, reaching a size comparable to that of large natural ribozymes.	[Geary, Cody; Andersen, Ebbe S.] Aarhus Univ, Ctr DNA Nanotechnol, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark; [Geary, Cody; Andersen, Ebbe S.] Aarhus Univ, Dept Mol Biol & Genet, DK-8000 Aarhus, Denmark; [Rothemund, Paul W. K.] CALTECH, Pasadena, CA 91125 USA	Aarhus University; Aarhus University; California Institute of Technology	Andersen, ES (corresponding author), Aarhus Univ, Ctr DNA Nanotechnol, Interdisciplinary Nanosci Ctr, DK-8000 Aarhus, Denmark.	esa@inano.au.dk	Geary, Cody/L-7685-2019; Andersen, Ebbe S/O-3936-2014	Andersen, Ebbe S/0000-0002-6236-8164; Geary, Cody/0000-0003-2083-4259	Danish Council for Independent Research (Sapere Aude Starting Grant) [DFF-0602-01772]; Danish National Research Foundation funding Centre for DNA Nanotechnology [DNRF81]; U.S. National Science Foundation for Expeditions in Computing [0832824]; Army Research Office [W911NF-11-1-0117]	Danish Council for Independent Research (Sapere Aude Starting Grant); Danish National Research Foundation funding Centre for DNA Nanotechnology; U.S. National Science Foundation for Expeditions in Computing; Army Research Office	The authors thank E. Winfree and M. Dong for use of their AFM facilities. We acknowledge financial support from the Danish Council for Independent Research (Sapere Aude Starting Grant DFF-0602-01772), the Danish National Research Foundation funding Centre for DNA Nanotechnology (grant DNRF81, http://cdna.au.dk/), the U.S. National Science Foundation for Expeditions in Computing funding for the Molecular Programming Project (grant nos. 0832824 and 1317694, http://molecular-programming.org), and Army Research Office award W911NF-11-1-0117. C. G., P. W. K. R., and E. S. A planned experiments and wrote the paper together. C. G. performed all experiments. The authors declare no competing financial interests.	Afonin KA, 2010, NAT NANOTECHNOL, V5, P676, DOI [10.1038/NNANO.2010.160, 10.1038/nnano.2010.160]; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; ARNOTT S, 1973, J MOL BIOL, V81, P107, DOI 10.1016/0022-2836(73)90183-6; Bai XC, 2012, P NATL ACAD SCI USA, V109, P20012, DOI 10.1073/pnas.1215713109; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; DICKERSON RE, 1982, SCIENCE, V216, P475, DOI 10.1126/science.7071593; Ennifar E, 2001, NAT STRUCT BIOL, V8, P1064, DOI 10.1038/nsb727; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Geary C, 2011, NUCLEIC ACIDS RES, V39, P1066, DOI 10.1093/nar/gkq748; Grabow Wade, 2013, F1000Prime Rep, V5, P46, DOI 10.12703/P5-46; Grabow WW, 2014, ACCOUNTS CHEM RES, V47, P1871, DOI 10.1021/ar500076k; Grabow WW, 2011, NANO LETT, V11, P878, DOI 10.1021/nl104271s; Guo PX, 1998, MOL CELL, V2, P149, DOI 10.1016/S1097-2765(00)80124-0; Hamada S, 2009, ANGEW CHEM INT EDIT, V48, P6820, DOI 10.1002/anie.200902662; Heilman-Miller SL, 2003, RNA, V9, P722, DOI 10.1261/rna.5200903; Hochrein LM, 2013, J AM CHEM SOC, V135, P17322, DOI 10.1021/ja404676x; Horiya S, 2003, CHEM BIOL, V10, P645, DOI 10.1016/S1074-5521(03)00146-7; Isambert H, 2009, METHODS, V49, P189, DOI 10.1016/j.ymeth.2009.06.005; Jaeger L, 2000, ANGEW CHEM INT EDIT, V39, P2521, DOI 10.1002/1521-3773(20000717)39:14<2521::AID-ANIE2521>3.0.CO;2-P; Jaeger L, 2006, CURR OPIN STRUC BIOL, V16, P531, DOI 10.1016/j.sbi.2006.07.001; Jossinet F, 2010, BIOINFORMATICS, V26, P2057, DOI 10.1093/bioinformatics/btq321; Kasprzak W, 2011, METHODS, V54, P239, DOI 10.1016/j.ymeth.2010.12.010; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Lee AJ, 1998, STRUCTURE, V6, P993, DOI 10.1016/S0969-2126(98)00101-4; Lee J, 2014, P NATL ACAD SCI USA, V111, P2122, DOI 10.1073/pnas.1313039111; Li Z, 2009, J AM CHEM SOC, V131, P13093, DOI 10.1021/ja903768f; Lin CX, 2008, P NATL ACAD SCI USA, V105, P17626, DOI 10.1073/pnas.0805416105; MOLINARO M, 1995, NUCLEIC ACIDS RES, V23, P3056, DOI 10.1093/nar/23.15.3056; Ohno H, 2011, NAT NANOTECHNOL, V6, P115, DOI 10.1038/nnano.2010.268; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/NNANO.2011.187, 10.1038/nnano.2011.187]; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, J AM CHEM SOC, V126, P16344, DOI 10.1021/ja044319l; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Severcan I, 2010, NAT CHEM, V2, P772, DOI [10.1038/nchem.733, 10.1038/NCHEM.733]; Severcan I, 2009, NANO LETT, V9, P1270, DOI 10.1021/nl900261h; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Sun XP, 2009, J AM CHEM SOC, V131, P13248, DOI 10.1021/ja906475w; Tanaka Y, 1999, NUCLEIC ACIDS RES, V27, P949, DOI 10.1093/nar/27.4.949; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2002, NATURE, V415, P62, DOI 10.1038/415062a; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596	47	207	221	3	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					799	804		10.1126/science.1253920	http://dx.doi.org/10.1126/science.1253920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124436				2022-12-28	WOS:000340593100041
J	Heath, I; Evans, S; Furberg, C; Hippisley-Cox, J; Krumholz, H; Mulrow, C; Wicks, P				Heath, Iona; Evans, Stephen; Furberg, Curt; Hippisley-Cox, Julia; Krumholz, Harlan; Mulrow, Cynthia; Wicks, Paul			Report of the independent panel considering the retraction of two articles in The BMJ	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							BONE MORPHOGENETIC PROTEIN-2; PRIMARY PREVENTION; STATINS; SAFETY; FUSION; RISK		[Heath, Iona] Royal Coll Gen Practitioners, London, England; [Evans, Stephen] London Sch Hyg & Trop Med, London, England; [Furberg, Curt] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Hippisley-Cox, Julia] Univ Nottingham, Nottingham NG7 2RD, England; [Krumholz, Harlan] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Wicks, Paul] Patients Like Me, Cambridge, MA USA	University of London; London School of Hygiene & Tropical Medicine; Wake Forest University; University of Nottingham; Yale University	Heath, I (corresponding author), Royal Coll Gen Practitioners, London, England.		Wicks, Paul/C-6128-2011; Hippisley-Cox, Julia/AAY-2788-2020; , Harlan/AAI-2875-2020	Wicks, Paul/0000-0002-2293-9284; Hippisley-Cox, Julia/0000-0002-2479-7283; Evans, Stephen/0000-0002-1474-2596				Abramson JD, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3329; Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Buettner C, 2008, J GEN INTERN MED, V23, P1182, DOI 10.1007/s11606-008-0636-7; Committee on Publication Ethics, 2009, RETR GUID; Fu RW, 2013, ANN INTERN MED, V158, P890, DOI 10.7326/0003-4819-158-12-201306180-00006; Malhotra A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3332; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Mansi I, 2013, BMJ-BRIT MED J, V173, P1; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; MRC/BHF Heart Protection Study Collaborative Group, 2009, BMC Clin Pharmacol, V9, P6, DOI 10.1186/1472-6904-9-6; Prasad V, 2014, ANN INTERN MED, V160, P867, DOI 10.7326/M13-2974; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Simmonds MC, 2013, ANN INTERN MED, V158, P877, DOI 10.7326/0003-4819-158-12-201306180-00005; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721; Takhar A., 2013, BMJ; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4; Turchin A, 2014, BMJ; Zhang HB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3652; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	23	4	4	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2014	349								g5176	10.1136/bmj.g5176	http://dx.doi.org/10.1136/bmj.g5176			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RZ	25128486	Green Accepted			2022-12-28	WOS:000340507500004
J	Halassa, MM; Chen, Z; Wimmer, RD; Brunetti, PM; Zhao, SL; Zikopoulos, B; Wang, F; Brown, EN; Wilson, MA				Halassa, Michael M.; Chen, Zhe; Wimmer, Ralf D.; Brunetti, Philip M.; Zhao, Shengli; Zikopoulos, Basilis; Wang, Fan; Brown, Emery N.; Wilson, Matthew A.			State-Dependent Architecture of Thalamic Reticular Subnetworks	CELL			English	Article							NEURONS IN-VIVO; NEURAL MECHANISMS; SLEEP SPINDLES; ATTENTION; NUCLEUS; CORTEX; INFORMATION; COGNITION; OSCILLATIONS; DYNAMICS	Behavioral state is known to influence interactions between thalamus and cortex, which are important for sensation, action, and cognition. The thalamic reticular nucleus (TRN) is hypothesized to regulate thalamo-cortical interactions, but the underlying functional architecture of this process and its state dependence are unknown. By combining the first TRN ensemble recording with psychophysics and connectivity-based optogenetic tagging, we found reticular circuits to be composed of distinct subnetworks. While activity of limbic-projecting TRN neurons positively correlates with arousal, sensory-projecting neurons participate in spindles and show elevated synchrony by slow waves during sleep. Sensory-projecting neurons are suppressed by attentional states, demonstrating that their gating of thalamo-cortical interactions is matched to behavioral state. Bidirectional manipulation of attentional performance was achieved through subnetwork-specific optogenetic stimulation. Together, our findings provide evidence for differential inhibition of thalamic nuclei across brain states, where the TRN separately controls external sensory and internal limbic processing facilitating normal cognitive function.	[Halassa, Michael M.; Wimmer, Ralf D.] NYU, Langone Med Ctr, Inst Neurosci, New York, NY 10016 USA; [Halassa, Michael M.; Wimmer, Ralf D.] NYU, Langone Med Ctr, Dept Neurosci & Physiol, New York, NY 10016 USA; [Halassa, Michael M.; Chen, Zhe; Wimmer, Ralf D.] NYU, Langone Med Ctr, Dept Psychiat, New York, NY 10016 USA; [Halassa, Michael M.; Wimmer, Ralf D.; Brunetti, Philip M.; Wilson, Matthew A.] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Zhao, Shengli; Wang, Fan] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Zikopoulos, Basilis] Boston Univ, Dept Hlth Sci, Boston, MA 02215 USA; [Zikopoulos, Basilis] Boston Univ, Program Neurosci, Boston, MA 02215 USA; [Brown, Emery N.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Brown, Emery N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Harvard Mit Div Hlth Sci & Technol, Inst Med Engn & Sci, Cambridge, MA 02139 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Massachusetts Institute of Technology (MIT); Northwell Health; Duke University; Boston University; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Halassa, MM (corresponding author), NYU, Langone Med Ctr, Inst Neurosci, New York, NY 10016 USA.	michael.halassa@nyumc.org	Zikopoulos, Basilis/K-2443-2012	Chen, Zhe (Sage)/0000-0002-6483-6056; Zikopoulos, Vasileios/0000-0002-8834-5104	NIH from the NINDS [K99 NS 078115]; NARSAD Young Investigator Award; NSF-CRCNS [IIS-1307645]; Early Career Award (Mathematical Biosciences Institute); NIMH [R01MH101209, R01MH057414]; NSF [SBE-0354378]; NIH [R01NS077986, DP1MH103908, R01-MH061976]; transformative R01 award [TR01-GM10498]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057414, DP1MH103908, R01MH061976, R01MH101209, R25MH094612] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077986, R00NS078115, K99NS078115] Funding Source: NIH RePORTER	NIH from the NINDS; NARSAD Young Investigator Award(NARSAD); NSF-CRCNS(National Science Foundation (NSF)NSF - Office of the Director (OD)); Early Career Award (Mathematical Biosciences Institute); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); transformative R01 award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Acsady and T. Fellin for helpful comments, as well as all members of the M.A.W. laboratory. M.M.H. is supported by an NIH pathway to independence career award (K99 NS 078115) from the NINDS and a NARSAD Young Investigator Award. Z.C. is supported by an NSF-CRCNS grant (award IIS-1307645) and an Early Career Award (Mathematical Biosciences Institute). B.Z. is supported by grants from NIMH (R01MH101209 and R01MH057414) and NSF (CELEST and SBE-0354378). F.W. is supported by NIH grants (R01NS077986 and DP1MH103908). E.N.B. and M.A.W. are supported by a transformative R01 award (TR01-GM10498). M.A.W. is additionally supported by NIH grant R01-MH061976.	Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Bazhenov M, 2000, J NEUROPHYSIOL, V84, P1076, DOI 10.1152/jn.2000.84.2.1076; Briggs F, 2013, NATURE, V499, P476, DOI 10.1038/nature12276; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Coe BP, 2012, AM J MED GENET C, V160C, P118, DOI 10.1002/ajmg.c.31327; CONTRERAS D, 1993, J PHYSIOL-LONDON, V470, P273, DOI 10.1113/jphysiol.1993.sp019858; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124; Dang-Vu TT, 2010, CURR BIOL, V20, pR626, DOI 10.1016/j.cub.2010.06.032; Deisseroth K, 2013, NEURON, V80, P568, DOI 10.1016/j.neuron.2013.10.032; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Eschenko O, 2006, J NEUROSCI, V26, P12914, DOI 10.1523/JNEUROSCI.3175-06.2006; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Ferrarelli F, 2010, AM J PSYCHIAT, V167, P1339, DOI 10.1176/appi.ajp.2010.09121731; Fitzgerald KD, 2000, BIOL PSYCHIAT, V47, P174, DOI 10.1016/S0006-3223(99)00286-3; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Gardner RJ, 2013, J NEUROSCI, V33, P18469, DOI 10.1523/JNEUROSCI.2197-13.2013; Gonzalez-Burgos G, 2012, SCHIZOPHRENIA BULL, V38, P950, DOI 10.1093/schbul/sbs010; Hahn TTG, 2012, NAT NEUROSCI, V15, P1531, DOI 10.1038/nn.3236; Halassa MM, 2011, NAT NEUROSCI, V14, P1118, DOI 10.1038/nn.2880; Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007; Issa EB, 2011, J NEUROSCI, V31, P2965, DOI 10.1523/JNEUROSCI.4920-10.2011; Jones E G, 1981, Int Rev Physiol, V25, P173; Jones EG, 2002, PROG BRAIN RES, V136, P333; Kahn JB, 2012, LEARN MEMORY, V19, P513, DOI 10.1101/lm.026302.112; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Keshavan MS, 2011, SCHIZOPHR RES, V131, P231, DOI 10.1016/j.schres.2011.05.027; Kimura A, 2012, NEUROSCIENCE, V226, P208, DOI 10.1016/j.neuroscience.2012.09.016; KOCH C, 1993, CURR OPIN NEUROBIOL, V3, P203, DOI 10.1016/0959-4388(93)90211-G; Kubanek J, 2013, NEUROIMAGE, V83, P795, DOI 10.1016/j.neuroimage.2013.06.085; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; Magnin M, 2010, P NATL ACAD SCI USA, V107, P3829, DOI 10.1073/pnas.0909710107; MARKS GA, 1993, BRAIN RES, V623, P241, DOI 10.1016/0006-8993(93)91434-T; Marlinski V, 2012, J NEUROSCI, V32, P15823, DOI 10.1523/JNEUROSCI.0782-12.2012; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Miller EK, 2013, CURR OPIN NEUROBIOL, V23, P216, DOI 10.1016/j.conb.2012.11.011; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008; Preston AR, 2013, CURR BIOL, V23, pR764, DOI 10.1016/j.cub.2013.05.041; Rolls E.T., 2013, CORTEX; Roth JK, 2009, NEUROIMAGE, V48, P601, DOI 10.1016/j.neuroimage.2009.07.002; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Saalmann YB, 2012, SCIENCE, V337, P753, DOI 10.1126/science.1223082; Spreng RN, 2010, NEUROIMAGE, V53, P303, DOI 10.1016/j.neuroimage.2010.06.016; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; STERIADE M, 1986, J NEUROSCI, V6, P68; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Vaingankar V, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00118; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Vyazovskiy VV, 2009, NEURON, V63, P865, DOI 10.1016/j.neuron.2009.08.024; Ward AM, 2014, HUM BRAIN MAPP, V35, P1061, DOI 10.1002/hbm.22234; Weyand TG, 2001, J NEUROPHYSIOL, V85, P1107, DOI 10.1152/jn.2001.85.3.1107; Wimmer RD, 2012, J NEUROSCI, V32, P13917, DOI 10.1523/JNEUROSCI.2313-12.2012; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373; Zikopoulos B, 2012, J NEUROSCI, V32, P5338, DOI 10.1523/JNEUROSCI.4793-11.2012	62	179	182	1	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					808	821		10.1016/j.cell.2014.06.025	http://dx.doi.org/10.1016/j.cell.2014.06.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126786	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000340944700012
J	Hohmann, EL; Ananthakrishnan, AN; Deshpande, V				Hohmann, Elizabeth L.; Ananthakrishnan, Ashwin N.; Deshpande, Vikram			Case 25-2014: A 37-Year-Old Man with Ulcerative Colitis and Bloody Diarrhea	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; FECAL MICROBIOTA TRANSPLANTATION; CLOSTRIDIUM-DIFFICILE INFECTION; CYTOMEGALOVIRUS-INFECTION; PREVALENCE; MANAGEMENT		[Hohmann, Elizabeth L.; Ananthakrishnan, Ashwin N.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Deshpande, Vikram] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hohmann, Elizabeth L.; Ananthakrishnan, Ashwin N.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Deshpande, Vikram] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hohmann, EL (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.				Seres Health; Cubist; AbbVie; Prometheus; Janssen	Seres Health; Cubist; AbbVie(AbbVie); Prometheus; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Dr. Hohmann reports receiving grant support through her institution from Seres Health. Dr. Ananthakrishnan reports receiving fees for serving on advisory boards from Cubist, AbbVie, Prometheus, and Janssen. No other potential conflict of interest relevant to this article was reported.	Ananthakrishnan AN, 2009, GASTROENTEROL CLIN N, V38, P711, DOI 10.1016/j.gtc.2009.07.003; Anderson JL, 2012, ALIMENT PHARM THER, V36, P503, DOI 10.1111/j.1365-2036.2012.05220.x; [Anonymous], 2012, N ENGL J MED, V366, P2040; [Anonymous], 2012, N ENGL J MED, V366, P1039; Cottone M, 2001, AM J GASTROENTEROL, V96, P773, DOI 10.1111/j.1572-0241.2001.03620.x; Domenech E, 2008, INFLAMM BOWEL DIS, V14, P1373, DOI 10.1002/ibd.20498; Dowd JB, 2009, EPIDEMIOL INFECT, V137, P58, DOI 10.1017/S0950268808000551; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Hogenauer C, 2006, NEW ENGL J MED, V355, P2418, DOI 10.1056/NEJMoa054765; Kahn SA, 2013, INFLAMM BOWEL DIS, V19, P1506, DOI 10.1097/MIB.0b013e318281f520; Kambham N, 2004, AM J SURG PATHOL, V28, P365, DOI 10.1097/00000478-200403000-00009; Kandiel A, 2006, AM J GASTROENTEROL, V101, P2857, DOI 10.1111/j.1572-0241.2006.00869.x; Kim YS, 2012, J CLIN GASTROENTEROL, V46, P51, DOI 10.1097/MCG.0b013e3182160c9c; Knights D, 2013, GUT, V62, P1505, DOI 10.1136/gutjnl-2012-303954; Lawlor G, 2010, INFLAMM BOWEL DIS, V16, P1620, DOI 10.1002/ibd.21275; Mccoy MH, 2014, HUM PATHOL, V45, P48, DOI 10.1016/j.humpath.2013.07.040; Papadakis KA, 2001, AM J GASTROENTEROL, V96, P2137, DOI 10.1111/j.1572-0241.2001.03949.x; Pillet S, 2012, DIGEST LIVER DIS, V44, P541, DOI 10.1016/j.dld.2012.03.018; Robinson A, 2013, ALIMENT PHARM THER, V38, P531, DOI 10.1111/apt.12396; Rousseau C, 2012, CLIN INFECT DIS, V55, P1209, DOI 10.1093/cid/cis637; Schwartz M, 2013, AM J GASTROENTEROL, V108, P1367, DOI 10.1038/ajg.2013.164; van Nood E, 2013, NEW ENGL J MED, V368, P2145, DOI 10.1056/NEJMc1303919; Yoshino T, 2007, INFLAMM BOWEL DIS, V13, P1516, DOI 10.1002/ibd.20253	23	45	56	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					668	675		10.1056/NEJMcpc1400842	http://dx.doi.org/10.1056/NEJMcpc1400842			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZL	25119613				2022-12-28	WOS:000340819600013
J	Jones, I; Shakespeare, J				Jones, Ian; Shakespeare, Judy			EASILY MISSED? Postnatal depression	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POSTPARTUM WOMEN		[Jones, Ian] Cardiff Univ, Natl Ctr Mental Hlth, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales; [Shakespeare, Judy] Royal Coll Gen Practitioners, London, England	Cardiff University	Jones, I (corresponding author), Cardiff Univ, Natl Ctr Mental Hlth, MRC Ctr Neuropsychiat Genet & Genom, Cardiff CF10 3AX, S Glam, Wales.	jonesir1@cf.ac.uk	Jones, Ian R/B-4925-2009	Jones, Ian R/0000-0001-5821-5889	Medical Research Council [MR/L010305/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Berle JO, 2011, CURR WOMENS HEALTH R, V7, P28, DOI 10.2174/157340411794474784; Di Florio A, POSTPARTUM DEPRESSIO; Di Florio A, 2013, JAMA PSYCHIAT, V70, P168, DOI 10.1001/jamapsychiatry.2013.279; Jones I, 2009, ADV PSYCHIAT TREAT, V15, P411, DOI [10.1192/apt.bp.107.004333, DOI 10.1192/apt.bp.107.004333]; Jones I, 2010, OXFORD TEXTBOOK OF W; Musters C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a736; National Institute for Health and Care Excellence, 2007, ANTENATAL AND POSTNA; Oates M, 2011, BJOG-INT J OBSTET GY, V118, P132, DOI 10.1111/j.1471-0528.2010.02847.x; Scottish Intercollegiate Guidelines Network (SIGN), 2012, MANAGEMENT OF PERINA; Sharma V, 2008, BIPOLAR DISORD, V10, P742, DOI 10.1111/j.1399-5618.2008.00606.x; Vesga-Lopez O, 2008, ARCH GEN PSYCHIAT, V65, P805, DOI 10.1001/archpsyc.65.7.805; Wisner KL, 2013, JAMA PSYCHIAT, V70, P490, DOI 10.1001/jamapsychiatry.2013.87	12	2	2	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2014	349								g4500	10.1136/bmj.g4500	http://dx.doi.org/10.1136/bmj.g4500			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RX	25125284				2022-12-28	WOS:000340507300002
J	Richardson, SS; Daniels, CR; Gillman, MW; Golden, J; Kukla, R; Kuzawa, C; Rich-Edwards, J				Richardson, Sarah S.; Daniels, Cynthia R.; Gillman, Matthew W.; Golden, Janet; Kukla, Rebecca; Kuzawa, Christopher; Rich-Edwards, Janet			Don't blame the mothers	NATURE			English	Editorial Material							PREGNANCY		Harvard Univ, Cambridge, MA 02138 USA; [Daniels, Cynthia R.] Rutgers State Univ, New Brunswick, NJ 08903 USA; [Gillman, Matthew W.] Harvard Univ, Sch Med, Obes Prevent Program, Boston, MA USA; [Golden, Janet] Rutgers State Univ, Camden, NJ 08102 USA; [Kukla, Rebecca] Georgetown Univ, Washington, DC USA; [Kukla, Rebecca] Northwestern Univ, Evanston, IL USA; [Rich-Edwards, Janet] Harvard Univ, Sch Med, Connors Ctr Womens Hlth & Gender Biol, Boston, MA USA	Harvard University; Rutgers State University New Brunswick; Harvard University; Harvard Medical School; Rutgers State University Camden; Rutgers State University New Brunswick; Georgetown University; Northwestern University; Harvard University; Harvard Medical School	Richardson, SS (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.	srichard@fas.harvard.edu						Barker D, 2013, NATURE, V504, P209, DOI 10.1038/504209a; de Assis S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2058; Frank DA, 2001, JAMA-J AM MED ASSOC, V285, P1613, DOI 10.1001/jama.285.12.1613; KASKUTAS L, 1992, DRUG ALCOHOL DEPEN, V31, P1, DOI 10.1016/0376-8716(92)90002-T; Kesmodel US, 2012, BJOG-INT J OBSTET GY, V119, P1180, DOI 10.1111/j.1471-0528.2012.03393.x; Parboosing R, 2013, JAMA PSYCHIAT, V70, P677, DOI 10.1001/jamapsychiatry.2013.896; PETTITT DJ, 1988, DIABETES, V37, P622, DOI 10.2337/diabetes.37.5.622	7	137	137	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					131	132		10.1038/512131a	http://dx.doi.org/10.1038/512131a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM9KO	25119222	Bronze			2022-12-28	WOS:000340200700009
J	Zhong, L; Wang, JW; Sheng, HW; Zhang, Z; Mao, SX				Zhong, Li; Wang, Jiangwei; Sheng, Hongwei; Zhang, Ze; Mao, Scott X.			Formation of monatomic metallic glasses through ultrafast liquid quenching	NATURE			English	Article							PHASE-CHANGE MATERIALS; AUGMENTED-WAVE METHOD; AMORPHOUS IRON; ELECTRON-DIFFRACTION; MOLECULAR-DYNAMICS; TANTALUM; FILMS; RELAXATION; ADSORPTION; TRANSPORT	It has long been conjectured that any metallic liquid can be vitrified into a glassy state provided that the cooling rate is sufficiently high(1-4). Experimentally, however, vitrification of single-element metallic liquids is notoriously difficult(5). True laboratory demonstration of the formation of monatomic metallic glass has been lacking. Here we report an experimental approach to the vitrification of monatomic metallic liquids by achieving an unprecedentedly high liquid-quenching rate of 10(14)Ks(-1). Under such a high cooling rate, melts of pure refractory body-centred cubic (bcc) metals, such as liquid tantalum and vanadium, are successfully vitrified to form metallic glasses suitable for property interrogations. Combining in situ transmission electron microscopy observation and atoms-to-continuum modelling, we investigated the formation condition and thermal stability of the monatomic metallic glasses as obtained. The availability of monatomic metallic glasses, being the simplest glass formers, offers unique possibilities for studying the structure and property relationships of glasses. Our technique also shows great control over the reversible vitrification-crystallization processes, suggesting its potential in micro-electromechanical applications. The ultrahigh cooling rate, approaching the highest liquid-quenching rate attainable in the experiment, makes it possible to explore the fast kinetics and structural behaviour of supercooled metallic liquids within the nanosecond to picosecond regimes.	[Zhong, Li; Wang, Jiangwei; Mao, Scott X.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15261 USA; [Sheng, Hongwei] George Mason Univ, Sch Phys Astron & Computat Sci, Fairfax, VA 22030 USA; [Sheng, Hongwei] Ctr High Pressure Sci & Technol Adv Res, Shanghai 201203, Peoples R China; [Zhang, Ze] Zhejiang Univ, Dept Mat Sci & Engn, Hangzhou 310027, Zhejiang, Peoples R China; [Zhang, Ze] Zhejiang Univ, State Key Lab Silicon Mat, Hangzhou 310027, Zhejiang, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Mason University; Zhejiang University; Zhejiang University	Mao, SX (corresponding author), Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15261 USA.	hsheng@gmu.edu; sxm2@pitt.edu	Wang, Jiangwei/F-8249-2011; Zhong, Li/I-3714-2014	Wang, Jiangwei/0000-0003-1191-0782; Sheng, Howard/0000-0002-6134-0354; Zhong, Li/0000-0003-1070-280X	National Science Foundation (NSF) through University of Pittsburgh [CMMI 0928517]; US NSF [DMR-0907325]	National Science Foundation (NSF) through University of Pittsburgh; US NSF(National Science Foundation (NSF))	We thank A. J. Coley and Y. Liu for their assistance in designing the electrical circuit for our experiment, and Y. He for performing the liquid-quenching experiment on iridium and rhodium. H.W.S. acknowledges helpful discussions with L. V. Zhigilei. S.X.M. acknowledges National Science Foundation (NSF) grant CMMI 0928517 through the support of the University of Pittsburgh. Work at George Mason University was supported by the US NSF under grant no. DMR-0907325. This work was performed in part at the Center for Integrated Nanotechnologies (CINT), an Office of Science User Facility operated for the US Department of Energy (DOE) Office of Science. The computational work was conducted on the SR10000-K1/52 supercomputing facilities of the Institute for Materials Research, Tohoku University.	Aga RS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.245701; ALLEN PB, 1987, PHYS REV LETT, V59, P1460, DOI 10.1103/PhysRevLett.59.1460; BAUDER U, 1975, SURF SCI, V52, P415, DOI 10.1016/0039-6028(75)90070-9; Bhat MH, 2007, NATURE, V448, P787, DOI 10.1038/nature06044; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Brommer P, 2007, MODEL SIMUL MATER SC, V15, P295, DOI 10.1088/0965-0393/15/3/008; BROUGHTON JQ, 1982, PHYS REV LETT, V49, P1496, DOI 10.1103/PhysRevLett.49.1496; Cheng YQ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.245501; COHEN MH, 1959, J CHEM PHYS, V31, P1164, DOI 10.1063/1.1730566; DAVIES HA, 1973, NATURE-PHYS SCI, V246, P13, DOI 10.1038/physci246013a0; DAW MS, 1984, PHYS REV B, V29, P6443, DOI 10.1103/PhysRevB.29.6443; Ding SY, 2014, NAT MATER, V13, P494, DOI [10.1038/NMAT3939, 10.1038/nmat3939]; DZUGUTOV M, 1992, PHYS REV A, V46, pR2984, DOI 10.1103/PhysRevA.46.R2984; Egerton R.F., 2011, ELECT ENERGY LOSS SP; FUJIME S, 1966, JPN J APPL PHYS, V5, P778, DOI 10.1143/JJAP.5.778; GREER AL, 1995, SCIENCE, V267, P1947, DOI 10.1126/science.267.5206.1947; HAAS TW, 1967, J CHEM PHYS, V46, P3025, DOI 10.1063/1.1841173; HILSCH R, 1960, NONCRYSTALLINE SOLID, P348; Ho C. Y., 1972, J PHYS CHEM REF DATA, V1, P279, DOI DOI 10.1063/1.3253100; HOPKINS BJ, 1971, SURF SCI, V28, P581, DOI 10.1016/0039-6028(71)90065-3; ICHIKAWA T, 1975, PHYS STATUS SOLIDI A, V29, P293, DOI 10.1002/pssa.2210290132; ICHIKAWA T, 1973, PHYS STATUS SOLIDI A, V19, P707, DOI [10.1002/pssa.2210190237, 10.1002/pssb.2220560235]; JOHNSON WL, 1986, PROG MATER SCI, V30, P81, DOI 10.1016/0079-6425(86)90005-8; Johnson WL, 1996, MATER SCI FORUM, V225, P35, DOI 10.4028/www.scientific.net/MSF.225-227.35; Jones RE, 2010, INT J NUMER METH ENG, V83, P940, DOI 10.1002/nme.2857; KIM YW, 1989, ACTA METALL MATER, V37, P247, DOI 10.1016/0001-6160(89)90283-6; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; LEUNG PK, 1974, PHILOS MAG, V30, P185, DOI 10.1080/14786439808206544; Li DY, 2003, APPL PHYS LETT, V83, P3186, DOI 10.1063/1.1619221; LIN CJ, 1982, APPL PHYS LETT, V41, P721, DOI 10.1063/1.93647; Lin Z, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.075133; McCluskey PJ, 2010, J MATER RES, V25, P2086, DOI 10.1557/JMR.2010.0286; POLLARD JH, 1968, J APPL PHYS, V39, P4019, DOI 10.1063/1.1656892; SACHDEV S, 1984, PHYS REV LETT, V53, P1947, DOI 10.1103/PhysRevLett.53.1947; Schelling PK, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.144306; Sheng HW, 2007, NAT MATER, V6, P192, DOI 10.1038/nmat1839; Sheng HW, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134118; Siegrist T, 2011, NAT MATER, V10, P202, DOI [10.1038/nmat2934, 10.1038/NMAT2934]; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; STILLINGER FH, 1984, SCIENCE, V225, P983, DOI 10.1126/science.225.4666.983; SUSLICK KS, 1991, NATURE, V353, P414, DOI 10.1038/353414a0; Tang CG, 2013, NAT MATER, V12, P507, DOI [10.1038/nmat3631, 10.1038/NMAT3631]; Tari A., 2003, SPECIFIC HEAT MATTER, V71; Trudu F, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.105701; TURNBULL D, 1969, CONTEMP PHYS, V10, P473, DOI 10.1080/00107516908204405; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; YAMAMOTO R, 1978, PHYS STATUS SOLIDI A, V45, P305, DOI 10.1002/pssa.2210450136	49	303	310	28	620	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					177	+		10.1038/nature13617	http://dx.doi.org/10.1038/nature13617			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25119235				2022-12-28	WOS:000340200700028
J	Watts, G				Watts, Geoff			Jeannie Isabelle Rosoff obituary	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					488	488		10.1016/S0140-6736(14)61327-1	http://dx.doi.org/10.1016/S0140-6736(14)61327-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9JR	25115004				2022-12-28	WOS:000340198300013
J	Gibson, G				Gibson, Greg			Directions for the drivers	NATURE			English	Editorial Material							GENE-EXPRESSION; IDENTIFICATION; PATTERNS; RISK		Georgia Inst Technol, Sch Biol, Atlanta, GA 30309 USA	University System of Georgia; Georgia Institute of Technology	Gibson, G (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30309 USA.	greg.gibson@biology.gatech.edu						Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Bell JT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r10; Bogaert J, 2014, ANN GASTROENTEROL, V27, P9; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Futreal PA, 2007, CANCER CELL, V12, P493, DOI 10.1016/j.ccr.2007.11.020; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Kim J, 2014, GENOME MED, V6, DOI 10.1186/gm560; Lee RDW, 2013, GENE, V512, P16, DOI 10.1016/j.gene.2012.10.001; Li QY, 2013, CELL, V152, P633, DOI 10.1016/j.cell.2012.12.034; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ongen H, 2014, NATURE, V512, P87, DOI 10.1038/nature13602; Paaby AB, 2014, NAT REV GENET, V15, P247, DOI 10.1038/nrg3688; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Watson IR, 2013, NAT REV GENET, V14, P703, DOI 10.1038/nrg3539; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764	16	5	5	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					31	32		10.1038/nature13649	http://dx.doi.org/10.1038/nature13649			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25079332				2022-12-28	WOS:000339908000021
J	Santos, MA; Faryabi, RB; Ergen, AV; Day, AM; Malhowski, A; Canela, A; Onozawa, M; Lee, JE; Callen, E; Gutierrez-Martinez, P; Chen, HT; Wong, N; Finkel, N; Deshpande, A; Sharrow, S; Rossi, DJ; Ito, K; Ge, K; Aplan, PD; Armstrong, SA; Nussenzweig, A				Santos, Margarida A.; Faryabi, Robert B.; Ergen, Aysegul V.; Day, Amanda M.; Malhowski, Amy; Canela, Andres; Onozawa, Masahiro; Lee, Ji-Eun; Callen, Elsa; Gutierrez-Martinez, Paula; Chen, Hua-Tang; Wong, Nancy; Finkel, Nadia; Deshpande, Aniruddha; Sharrow, Susan; Rossi, Derrick J.; Ito, Keisuke; Ge, Kai; Aplan, Peter D.; Armstrong, Scott A.; Nussenzweig, Andre			DNA-damage-induced differentiation of leukaemic cells as an anti-cancer barrier	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; OXIDATIVE STRESS; RNA-SEQ; MLL; PROGENITORS; BREAKS; RESISTANCE; DISCOVERY; LYMPHOMA; RENEWAL	Self-renewal is the hallmark feature both of normal stem cells and cancer stem cells(1). Since the regenerative capacity of normal haematopoietic stem cells is limited by the accumulation of reactive oxygen species and DNA double-strand breaks(2-4), we speculated that DNA damage might also constrain leukaemic self-renewal and malignant haematopoiesis. Here we show that the histone methyl-transferase MLL4, a suppressor of B-cell lymphoma(5,6), is required for stem-cell activity and an aggressive form of acutemyeloid leukaemia harbouring the MLL-AF9 oncogene. Deletion of MLL4 enhances myelopoiesis and myeloid differentiation of leukaemic blasts, which protects mice from death related to acute myeloid leukaemia. MLL4 exerts its function by regulating transcriptional programs associated with the antioxidant response. Addition of reactive oxygen species scavengers or ectopic expression of FOXO3 protects MLL-/- MLL-AF9 cells from DNA damage and inhibits myeloid maturation. Similar to MLL4 deficiency, loss of ATM or BRCA1 sensitizes transformed cells to differentiation, suggesting that myeloid differentiation is promoted by loss of genome integrity. Indeed, we show that restriction-enzyme-induced double-strand breaks are sufficient to induce differentiation of MLL-AF9 blasts, which requires cyclin-dependent kinase inhibitor p21(Cip1) (Cdkn1a) activity. In summary, we have uncovered an unexpected tumour-promoting role of genome guardians in enforcing the oncogene-induced differentiation blockade in acute myeloid leukaemia.	[Santos, Margarida A.; Faryabi, Robert B.; Ergen, Aysegul V.; Day, Amanda M.; Malhowski, Amy; Canela, Andres; Callen, Elsa; Chen, Hua-Tang; Wong, Nancy; Finkel, Nadia; Nussenzweig, Andre] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Onozawa, Masahiro; Aplan, Peter D.] NCI, Genet Branch, NIH, Bethesda, MD 20892 USA; [Lee, Ji-Eun; Ge, Kai] NIDDKD, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Gutierrez-Martinez, Paula; Rossi, Derrick J.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Gutierrez-Martinez, Paula; Rossi, Derrick J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Deshpande, Aniruddha; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Deshpande, Aniruddha; Armstrong, Scott A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA; [Sharrow, Susan] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Ito, Keisuke] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Dept Cell Biol, Bronx, NY 10461 USA; [Ito, Keisuke] Albert Einstein Coll Med, Dept Med, Albert Einstein Canc Ctr, Bronx, NY 10461 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Nussenzweig, A (corresponding author), NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	Santos, Margarida/GWR-2285-2022; Faryabi, Robert/AAN-5512-2020; Ge, Kai/H-2810-2019; Lee, Ji-Eun/F-7891-2011; Faryabi, Robert B/H-3544-2015; Aplan, Peter D/K-9064-2016	Faryabi, Robert/0000-0002-7931-2175; Ge, Kai/0000-0002-7442-5138; Lee, Ji-Eun/0000-0002-3768-7016; Faryabi, Robert B/0000-0002-7931-2175; 	Leukemia and Lymphoma Society; National Cancer Institute [CA66996, CA140575]; National Institutes of Health; National Cancer Institute; Center for Cancer Research; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [P01CA066996, R01CA140575, P30CA008748, R00CA139009, ZIABC010983, ZICBC009255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098263, R01DK100689, ZIADK075003] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the A. Nussenzweig laboratory, J. Daniel and P. Love for discussions; L. Granger for flow cytometry; M. J. Kruhlak for microscopy; K. Zhao for RNA sequencing; R. Anderson and K. Smith for animal care; K. Naka for the FOXO3 retrovirus; G. Legube for the pBABE-AsiSI-ER plasmid; J. Zuber for pLEPG and pRT3GEPIR plasmids; O. Fernandez-Capetillo for ATRi; and S. John for suggestions. S. A. A. was supported by the Leukemia and Lymphoma Society and National Cancer Institute grants CA66996 and CA140575. This work was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute and the Center for Cancer Research, and an Ellison Medical Foundation Senior Scholar in Aging Award to A.N.	Argast GM, 1998, J MOL BIOL, V280, P345, DOI 10.1006/jmbi.1998.1886; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Cerami EG, 2011, NUCLEIC ACIDS RES, V39, pD685, DOI 10.1093/nar/gkq1039; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kueh HY, 2013, SCIENCE, V341, P670, DOI 10.1126/science.1240831; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee JE, 2013, ELIFE, V2, DOI 10.7554/eLife.01503; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schoppy DW, 2012, J CLIN INVEST, V122, P241, DOI 10.1172/JCI58928; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Somervaille TCP, 2010, INT J HEMATOL, V91, P735, DOI 10.1007/s12185-010-0579-8; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wang JW, 2012, CELL, V148, P1001, DOI 10.1016/j.cell.2012.01.040; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007	40	136	138	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					107	+		10.1038/nature13483	http://dx.doi.org/10.1038/nature13483			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25079327	Green Accepted			2022-12-28	WOS:000342420800045
J	Mccoy, R; Smith, S				Mccoy, Rozalina; Smith, Steven			In diabetes, ACE-Is, but not ARBs, reduce mortality and major CV events compared with placebo or active treatment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Mccoy, Rozalina; Smith, Steven] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Mccoy, R (corresponding author), Mayo Clin, Rochester, MN 55905 USA.		Smith, Steven/HDM-9496-2022					Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC2	10.7326/0003-4819-161-4-201408190-02002	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133381				2022-12-28	WOS:000342347300001
J	Cowie, MR				Cowie, Martin R.			Telemonitoring implants for patients with heart failure	LANCET			English	Editorial Material							DEVICE FOLLOW-UP; MANAGEMENT		Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London SW3 6LY, England	Imperial College London; Royal Brompton Hospital	Cowie, MR (corresponding author), Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, London SW3 6LY, England.	m.cowie@imperial.ac.uk	Cowie, Martin R/AAQ-2818-2020	Cowie, Martin R/0000-0001-7457-2552				Abraham WT, 2011, LANCET, V377, P658, DOI 10.1016/S0140-6736(11)60101-3; Acosta-Lobos A, 2012, FUTUR CARDIOL, V8, P425, DOI [10.2217/FCA.12.7, 10.2217/fca.12.7]; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Desai AS, 2010, NEW ENGL J MED, V363, P2364, DOI 10.1056/NEJMe1011769; Hindricks G, 2014, LANCET, V384, P583, DOI 10.1016/S0140-6736(14)61176-4; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; Koehler F, 2011, CIRCULATION, V123, P1873, DOI 10.1161/CIRCULATIONAHA.111.018473; Morgan JM, EUR J HEART IN PRESS; Pandor A, 2013, HEART, V99, P1717, DOI 10.1136/heartjnl-2013-303811; Saxon LA, 2010, CIRCULATION, V122, P2359, DOI 10.1161/CIRCULATIONAHA.110.960633; van Veldhuisen DJ, 2011, CIRCULATION, V124, P1719, DOI 10.1161/CIRCULATIONAHA.111.043042; Varma N, 2010, CIRCULATION, V122, P325, DOI 10.1161/CIRCULATIONAHA.110.937409	12	2	2	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					560	+		10.1016/S0140-6736(14)61291-5	http://dx.doi.org/10.1016/S0140-6736(14)61291-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN4QR	25131968				2022-12-28	WOS:000340573300005
J	Britt, RD; Oyala, PH				Britt, R. David; Oyala, Paul H.			BIOCHEMISTRY One step closer to O-2	SCIENCE			English	Editorial Material							PHOTOSYSTEM-II; OXYGEN; WATER; MECHANISM; COMPLEX		[Britt, R. David; Oyala, Paul H.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Davis	Britt, RD (corresponding author), Univ Calif Davis, Dept Chem, Davis, CA 95616 USA.	rdbritt@ucdavis.edu	Oyala, Paul/N-1536-2019	Oyala, Paul/0000-0002-8761-4667				Boussac A, 2009, J AM CHEM SOC, V131, P5050, DOI 10.1021/ja900680t; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Cox N, 2013, ACCOUNTS CHEM RES, V46, P1588, DOI 10.1021/ar3003249; Hoganson CW, 1997, SCIENCE, V277, P1953, DOI 10.1126/science.277.5334.1953; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; Limburg J, 1999, J CHEM SOC DALTON, P1353, DOI 10.1039/a807583b; Mukherjee S, 2012, P NATL ACAD SCI USA, V109, P2257, DOI 10.1073/pnas.1115290109; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Taguchi T, 2012, J AM CHEM SOC, V134, P1996, DOI 10.1021/ja210957u; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yano J, 2014, CHEM REV, V114, P4175, DOI 10.1021/cr4004874	12	13	12	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					736	736		10.1126/science.1258008	http://dx.doi.org/10.1126/science.1258008			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124415				2022-12-28	WOS:000340593100017
J	Cox, N; Retegan, M; Neese, F; Pantazis, DA; Boussac, A; Lubitz, W				Cox, Nicholas; Retegan, Marius; Neese, Frank; Pantazis, Dimitrios A.; Boussac, Alain; Lubitz, Wolfgang			Electronic structure of the oxygenevolving complex in photosystem II prior to O-O bond formation	SCIENCE			English	Article							OXYGEN-EVOLVING COMPLEX; SPECTROSCOPIC PROPERTIES; PARAMAGNETIC-RESONANCE; MANGANESE COMPLEX; EPR SPECTROSCOPY; S-2 STATE; WATER; CLUSTER; MECHANISM; OXIDATION	The photosynthetic protein complex photosystem II oxidizes water to molecular oxygen at an embedded tetramanganese-calcium cluster. Resolving the geometric and electronic structure of this cluster in its highest metastable catalytic state (designated S-3) is a prerequisite for understanding the mechanism of O-O bond formation. Here, multifrequency, multidimensional magnetic resonance spectroscopy reveals that all four manganese ions of the catalyst are structurally and electronically similar immediately before the final oxygen evolution step; they all exhibit a 4+ formal oxidation state and octahedral local geometry. Only one structural model derived fromquantum chemicalmodeling is consistentwith allmagnetic resonance data; its formation requires the binding of an additional water molecule. O-O bond formation would then proceed by the coupling of two proximalmanganese-bound oxygens in the transition state of the cofactor.	[Cox, Nicholas; Retegan, Marius; Neese, Frank; Pantazis, Dimitrios A.; Lubitz, Wolfgang] Max Planck Inst Chem Energy Convers, D-45470 Mulheim, Germany; [Boussac, Alain] Commissariat Energie Atom CEA Saclay, CNRS UMR 8221, Inst Biol & Technol Saclay, F-91191 Gif Sur Yvette, France	Max Planck Society; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Cox, N (corresponding author), Max Planck Inst Chem Energy Convers, Stiftstr 34-36, D-45470 Mulheim, Germany.	nicholas.cox@cec.mpg.de; wolfgang.lubitz@cec.mpg.de	Retegan, Marius/I-4184-2016; Neese, Frank/J-4959-2014; Cox, Nicholas/J-8047-2014; Pantazis, Dimitrios/A-2434-2010	Retegan, Marius/0000-0002-1525-1094; Neese, Frank/0000-0003-4691-0547; Cox, Nicholas/0000-0002-7815-6115; Pantazis, Dimitrios/0000-0002-2146-9065	Max-Planck-Gesellschaft; "Bioenergie" program from the CEA; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]	Max-Planck-Gesellschaft(Max Planck Society); "Bioenergie" program from the CEA; French Infrastructure for Integrated Structural Biology (FRISBI)	The authors acknowledge A. Savitsky (Max-Planck-Institut fur Chemische Energiekonversion Mulheim) for his assistance with the EPR measurements and M. Sugiura (Ehime University, Japan) for the gift of the T. elongatus strains. Financial support was provided by the Max-Planck-Gesellschaft, the "Bioenergie" program from the CEA, and by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01.	Ahrling KA, 1997, BIOCHEMISTRY-US, V36, P13148, DOI 10.1021/bi971815w; Boussac A, 1996, BIOCHEMISTRY-US, V35, P6984, DOI 10.1021/bi960636w; Boussac A, 2009, J AM CHEM SOC, V131, P5050, DOI 10.1021/ja900680t; Cox N, 2013, BBA-BIOENERGETICS, V1827, P1020, DOI 10.1016/j.bbabio.2013.01.013; Cox N, 2013, ACCOUNTS CHEM RES, V46, P1588, DOI 10.1021/ar3003249; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; DEXHEIMER SL, 1992, J AM CHEM SOC, V114, P2821, DOI 10.1021/ja00034a010; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; Glockner C, 2013, J BIOL CHEM, V288, P22607, DOI 10.1074/jbc.M113.476622; Haddy A, 2004, BIOPHYS J, V87, P2885, DOI 10.1529/biophysj.104.040238; Haddy A, 2007, PHOTOSYNTH RES, V92, P357, DOI 10.1007/s11120-007-9194-9; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; Haumann M, 2005, BIOCHEMISTRY-US, V44, P1894, DOI 10.1021/bi048697e; Hillier W, 2005, ADV PHOTO RESPIRAT, V22, P567; Horner O, 1998, J AM CHEM SOC, V120, P7924, DOI 10.1021/ja981330a; Klauss A, 2012, P NATL ACAD SCI USA, V109, P16035, DOI 10.1073/pnas.1206266109; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Krewald V, 2013, J AM CHEM SOC, V135, P5726, DOI 10.1021/ja312552f; Kulik LV, 2007, J AM CHEM SOC, V129, P13421, DOI 10.1021/ja071487f; Limburg J, 1999, J CHEM SOC DALTON, P1353, DOI 10.1039/a807583b; Lohmiller T, 2013, APPL MAGN RESON, V44, P691, DOI 10.1007/s00723-012-0437-3; Messinger J, 1997, J AM CHEM SOC, V119, P11349, DOI 10.1021/ja972696a; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; Mukherjee S, 2012, P NATL ACAD SCI USA, V109, P2257, DOI 10.1073/pnas.1115290109; Navarro MP, 2013, P NATL ACAD SCI USA, V110, P15561, DOI 10.1073/pnas.1304334110; Noguchi T, 2008, PHILOS T R SOC B, V363, P1189, DOI 10.1098/rstb.2007.2214; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; Peloquin JM, 2000, J AM CHEM SOC, V122, P10926, DOI 10.1021/ja002104f; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; RANDALL DW, 1995, J AM CHEM SOC, V117, P11780, DOI 10.1021/ja00152a021; Rapatskiy L, 2012, J AM CHEM SOC, V134, P16619, DOI 10.1021/ja3053267; Retegan M, 2014, PHYS CHEM CHEM PHYS, V16, P11901, DOI 10.1039/c4cp00696h; RUTHERFORD AW, 1989, TRENDS BIOCHEM SCI, V14, P227, DOI 10.1016/0968-0004(89)90032-7; Sanakis Y., 2008, PHOTOSYNTHESIS ENERG, P479, DOI [10.1007/978-1-4020-6709-9_108, DOI 10.1007/978-1-4020-6709-9_108]; Schafer KO, 1998, J AM CHEM SOC, V120, P13104, DOI 10.1021/ja9827548; Siegbahn PEM, 2006, CHEM-EUR J, V12, P9217, DOI 10.1002/chem.200600774; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Wiechen M, 2012, CHEM SCI, V3, P2330, DOI 10.1039/c2sc20226c; Yamaguchi K, 2013, INT J QUANTUM CHEM, V113, P453, DOI 10.1002/qua.24280; Yamauchi T, 1997, BIOCHEMISTRY-US, V36, P7520, DOI 10.1021/bi962791g; ZIMMERMANN JL, 1984, BIOCHIM BIOPHYS ACTA, V767, P160, DOI 10.1016/0005-2728(84)90091-4	43	351	353	3	356	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					804	808		10.1126/science.1254910	http://dx.doi.org/10.1126/science.1254910			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124437				2022-12-28	WOS:000340593100042
J	Cahan, P; Li, H; Morris, SA; da Rocha, EL; Daley, GQ; Collins, JJ				Cahan, Patrick; Li, Hu; Morris, Samantha A.; da Rocha, Edroaldo Lummertz; Daley, George Q.; Collins, James J.			CellNet: Network Biology Applied to Stem Cell Engineering	CELL			English	Article							DIRECT CONVERSION; TRANSCRIPTION FACTORS; HUMAN FIBROBLASTS; EXPRESSION; GENERATION; INDUCTION; NEURONS	Somatic cell reprogramming, directed differentiation of pluripotent stem cells, and direct conversions between differentiated cell lineages represent powerful approaches to engineer cells for research and regenerative medicine. We have developed CellNet, a network biology platform that more accurately assesses the fidelity of cellular engineering than existing methodologies and generates hypotheses for improving cell derivations. Analyzing expression data from 56 published reports, we found that cells derived via directed differentiation more closely resemble their in vivo counterparts than products of direct conversion, as reflected by the establishment of target cell-type gene regulatory networks (GRNs). Furthermore, we discovered that directly converted cells fail to adequately silence expression programs of the starting population and that the establishment of unintended GRNs is common to virtually every cellular engineering paradigm. CellNet provides a platform for quantifying how closely engineered cell populations resemble their target cell type and a rational strategy to guide enhanced cellular engineering.	[Cahan, Patrick; Morris, Samantha A.; Daley, George Q.] Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Howard Hughes Med Inst, Div Pediat Hematol & Oncol,Stem Cell Transplantat, Boston, MA 02115 USA; [Cahan, Patrick; Morris, Samantha A.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Cahan, Patrick; Morris, Samantha A.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Cahan, Patrick; Morris, Samantha A.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Hu] Mayo Clin, Coll Med, Ctr Individualized Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [da Rocha, Edroaldo Lummertz; Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA USA; [da Rocha, Edroaldo Lummertz; Collins, James J.] Boston Univ, Ctr Synthet Biol, Boston, MA 02215 USA; [da Rocha, Edroaldo Lummertz] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [da Rocha, Edroaldo Lummertz] Univ Fed Santa Catarina, Grad Program Mat Sci & Engn, BR-88040900 Florianopolis, SC, Brazil	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Mayo Clinic; Boston University; Howard Hughes Medical Institute; Boston University; Harvard University; Universidade Federal de Santa Catarina (UFSC)	Daley, GQ (corresponding author), Boston Childrens Hosp, Manton Ctr Orphan Dis Res, Howard Hughes Med Inst, Div Pediat Hematol & Oncol,Stem Cell Transplantat, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; jcollins@bu.edu		Cahan, Patrick/0000-0003-3652-2540; Lummertz da Rocha, Edroaldo/0000-0003-0537-4223	NIH [R24DK092760]; HHMI; NIH (Progenitor Cell Biology Consortium) [R24DK092760, UO1-HL100001, P50HG005550]; Ellison Medical Foundation; Doris Duke Medical Foundation; Boston Children's Hospital Stem Cell Program; NIDDK [K01DK096013]; NHLBI [T32HL066987, T32HL007623]; Alex's Lemonade Stand Foundation; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; National Council for Scientific and Technological Development; program Science Without Borders (CNPq, Brazil); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL066987, U01HL100001, T32HL007623] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK096013, R24DK092760] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); NIH (Progenitor Cell Biology Consortium)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Doris Duke Medical Foundation(Doris Duke Charitable Foundation (DDCF)); Boston Children's Hospital Stem Cell Program; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Alex's Lemonade Stand Foundation; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); program Science Without Borders (CNPq, Brazil); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	J.J.C. is supported by NIH grant R24DK092760 and the HHMI. G.Q.D. is supported by grants from the NIH (Progenitor Cell Biology Consortium UO1-HL100001, R24DK092760, and P50HG005550), the Ellison Medical Foundation, Doris Duke Medical Foundation, and Boston Children's Hospital Stem Cell Program, and is an affiliate member of the Broad Institute. P.C. is supported by NIDDK (K01DK096013) and received support from NHLBI (T32HL066987 and T32HL007623). S.A.M. is supported by a Young Investigator Award from Alex's Lemonade Stand Foundation. H.L. is supported by Mayo Clinic Center for Individualized Medicine and Mayo Clinic Center for Regenerative Medicine. E.L.d.R. is supported by National Council for Scientific and Technological Development and the program Science Without Borders (CNPq, Brazil).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Arnold P, 2013, GENOME RES, V23, P60, DOI 10.1101/gr.142661.112; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Chowdhury D, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-130; Christoforou N, 2008, J CLIN INVEST, V118, P894, DOI 10.1172/JCI33942; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063577; Correa-Cerro LS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00167; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Efron B, 2007, ANN APPL STAT, V1, P107, DOI 10.1214/07-AOAS101; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Mao T, 2011, P NATL ACAD SCI USA, V108, P15852, DOI 10.1073/pnas.1107394108; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/NMETH.2016, 10.1038/nmeth.2016]; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Mouse ENCODE Consortium, 2012, Genome Biol, V13, P418, DOI 10.1186/gb-2012-13-8-418; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakano H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2569; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nishikawa SI, 2007, NAT REV MOL CELL BIO, V8, P502, DOI 10.1038/nrm2189; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Peng ZF, 2012, J CELL MOL MED, V16, P41, DOI 10.1111/j.1582-4934.2011.01288.x; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rosvall M, 2007, P NATL ACAD SCI USA, V104, P7327, DOI 10.1073/pnas.0611034104; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; STRAIN AJ, 1994, GUT, V35, P433, DOI 10.1136/gut.35.4.433; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Xu HL, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat045; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zheng B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001059; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	45	341	348	3	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					903	915		10.1016/j.cell.2014.07.020	http://dx.doi.org/10.1016/j.cell.2014.07.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126793	Green Accepted, Bronze			2022-12-28	WOS:000340944700019
J	Fox, EJ; Loeb, LA				Fox, Edward J.; Loeb, Lawrence A.			CANCER One cell at a time	NATURE			English	Editorial Material							SINGLE-NUCLEOTIDE; EVOLUTION; MUTATIONS	Single-cell DNA sequencing of two breast-cancer types has shown extensive mutational variation in individual tumours, confirming that generation of genetic diversity may be inherent in how tumours evolve.	[Fox, Edward J.; Loeb, Lawrence A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Loeb, Lawrence A.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fox, EJ (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	eddiefox@uw.edu; laloeb@uw.edu	Fox, Edward/A-4675-2011	Fox, Edward/0000-0002-3740-651X	NCI NIH HHS [R01 CA115802, R01 CA102029, R01 CA160674, P01 CA077852, R33 CA181771] Funding Source: Medline; NIA NIH HHS [R01 AG033061] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA115802, R01CA102029, R33CA181771, P01CA077852, R01CA160674] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033061] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2014, NATURE METH, V11, P1; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; LOEB LA, 1974, CANCER RES, V34, P2311; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tougeron D, 2013, ANN ONCOL, V24, P1267, DOI 10.1093/annonc/mds620; Wang Y, 2014, NATURE, V512, P155, DOI 10.1038/nature13600; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	11	21	23	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					143	144		10.1038/nature13650	http://dx.doi.org/10.1038/nature13650			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25079325	Green Accepted			2022-12-28	WOS:000340200700019
J	Nuotio, I; Hartikainen, JEK; Gronberg, T; Biancari, F; Airaksinen, KEJ				Nuotio, Ilpo; Hartikainen, Juha E. K.; Gronberg, Toni; Biancari, Fausto; Airaksinen, K. E. Juhani			Time to Cardioversion for Acute Atrial Fibrillation and Thromboembolic Complications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Nuotio, Ilpo] Turku Univ Hosp, Div Med, Turku 20521, Finland; [Hartikainen, Juha E. K.] Kuopio Univ Hosp, Ctr Heart, SF-70210 Kuopio, Finland; [Gronberg, Toni; Airaksinen, K. E. Juhani] Turku Univ Hosp, Ctr Heart, Turku 20521, Finland; [Biancari, Fausto] Oulu Univ Hosp, Dept Surg, Oulu, Finland	University of Turku; Kuopio University Hospital; University of Eastern Finland; University of Turku; University of Oulu	Airaksinen, KEJ (corresponding author), Turku Univ Hosp, Ctr Heart, POB 52, Turku 20521, Finland.	juhani.airaksinen@tyks.fi	Biancari, Fausto/A-1039-2008; Airaksinen, Juhani/AAC-7857-2021	Biancari, Fausto/0000-0001-5028-8186; Airaksinen, Juhani/0000-0002-0193-568X				Airaksinen KEJ, 2013, J AM COLL CARDIOL, V62, P1187, DOI 10.1016/j.jacc.2013.04.089; Camm AJ, 2010, EUR HEART J, V31, P2369, DOI [10.1093/eurheartj/ehq278, 10.1093/europace/euq350]; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; You JJ, 2012, CHEST, V141, pE531S, DOI 10.1378/chest.11-2304	4	114	119	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					647	649		10.1001/jama.2014.3824	http://dx.doi.org/10.1001/jama.2014.3824			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117135	Bronze			2022-12-28	WOS:000340136400025
J	Westaby, S				Westaby, Stephen			PERSONAL VIEW Publishing individual surgeons' death rates prompts risk averse behaviour	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARE; IMPROVEMENT; MANAGEMENT; MORTALITY; ENGLAND; FAILURE; RESCUE					swestaby@ahf.org.uk						Ahmed EO, 2014, ANN THORAC SURG, V97, P147, DOI 10.1016/j.athoracsur.2013.07.097; Aiken LH, 2002, JAMA-J AM MED ASSOC, V288, P1987, DOI 10.1001/jama.288.16.1987; Aylin P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2424; Berwick DM, 1996, BRIT MED J, V312, P619, DOI 10.1136/bmj.312.7031.619; Bridgewater B, 2007, HEART, V93, P744, DOI 10.1136/hrt.2006.106393; *BRIST ROY INF INQ, 2001, LEARN BRIST REP PUBL; Dehmer GJ, 2014, J AM COLL CARDIOL, V63, P1239, DOI 10.1016/j.jacc.2013.11.050; Dyer C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3705; ElBardissi AW, 2013, J THORAC CARDIOV SUR, V145, P328, DOI 10.1016/j.jtcvs.2012.09.022; Francis R, 2013, REP MIDSTAFFORDSHIRE; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Goddard AF, 2010, CLIN MED, V10, P330; Hannan EL, 2012, J AM COLL CARDIOL, V59, P2309, DOI 10.1016/j.jacc.2011.12.051; Hickey GL, 2013, EUR J CARDIO-THORAC, V44, P605, DOI 10.1093/ejcts/ezt018; Moffatt-Bruce SD, 2014, J THORAC CARDIOV SUR, V147, P1464, DOI 10.1016/j.jtcvs.2014.01.003; National Advisory Group on the Safety of Patients in England, 2013, PROM LEARN COMM ACT; National Confidential Enquiry into Patient Outcome and Death (NCEPOD), 2010, AG OLD PROBL REV CAR; Reddy HG, 2013, ANN THORAC SURG, V95, P1976, DOI 10.1016/j.athoracsur.2013.03.027; Sergeant PT, 2014, EUR J CARDIO-THORAC, V45, P211, DOI 10.1093/ejcts/ezt484; Shahian DM, 2011, ANN THORAC SURG, V92, pS2, DOI 10.1016/j.athoracsur.2011.06.100; Spiegelhalter D, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5775; West MA, 2002, INT J HUM RESOUR MAN, V13, P1299, DOI 10.1080/09585190210156521; Westaby S, 2014, EUR J CARDI IN PRESS; Westaby S, 2012, HEART, V98, P1117, DOI 10.1136/heartjnl-2011-301365; Williams N, 2013, ANN R COLL SURG ENGL, V95, P250	25	19	19	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2014	349								g5026	10.1136/bmj.g5026	http://dx.doi.org/10.1136/bmj.g5026			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RR	25116038				2022-12-28	WOS:000340506700006
J	Raven, PW				Raven, Peter W.			PERSONAL VIEW If doctors can train part time, why not medical students?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL Fac Med Sci, UCL Med Sch, London WC1E 6BT, England	University of London; University College London	Raven, PW (corresponding author), UCL Fac Med Sci, UCL Med Sch, London WC1E 6BT, England.	p.raven@ucl.ac.uk						*GEN MED COUNC, 2011, CLINICAL PLACEMENTS; General Medical Council (GMC), 2011, GMC POSITION STATEME; Higher Education Statistics Agency, FREE ONLINE STATISTI	3	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2014	349								g4897	10.1136/bmj.g4897	http://dx.doi.org/10.1136/bmj.g4897			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RQ	25113272				2022-12-28	WOS:000340506600001
J	Pinot, M; Vanni, S; Pagnotta, S; Lacas-Gervais, S; Payet, LA; Ferreira, T; Gautier, R; Goud, B; Antonny, B; Barelli, H				Pinot, Mathieu; Vanni, Stefano; Pagnotta, Sophie; Lacas-Gervais, Sandra; Payet, Laurie-Anne; Ferreira, Thierry; Gautier, Romain; Goud, Bruno; Antonny, Bruno; Barelli, Helene			Polyunsaturated phospholipids facilitate membrane deformation and fission by endocytic proteins	SCIENCE			English	Article							FATTY-ACIDS; ALPHA-SYNUCLEIN; LIPID-BILAYERS; DYNAMIN; PACKING; CONSTRICTION; CHOLESTEROL; OMEGA-3	Phospholipids (PLs) with polyunsaturated acyl chains are extremely abundant in a few specialized cellular organelles such as synaptic vesicles and photoreceptor discs, but their effect on membrane properties is poorly understood. Here, we found that polyunsaturated PLs increased the ability of dynamin and endophilin to deform and vesiculate synthetic membranes. When cells incorporated polyunsaturated fatty acids into PLs, the plasma membrane became more amenable to deformation by a pulling force and the rate of endocytosis was accelerated, in particular, under conditions in which cholesterol was limiting. Molecular dynamics simulations and biochemical measurements indicated that polyunsaturated PLs adapted their conformation to membrane curvature. Thus, by reducing the energetic cost of membrane bending and fission, polyunsaturated PLs may help to support rapid endocytosis.	[Pinot, Mathieu; Vanni, Stefano; Gautier, Romain; Antonny, Bruno; Barelli, Helene] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Pinot, Mathieu; Vanni, Stefano; Gautier, Romain; Antonny, Bruno; Barelli, Helene] CNRS, F-06560 Valbonne, France; [Pinot, Mathieu; Goud, Bruno] Inst Curie, UMR 144, F-75248 Paris, France; [Pinot, Mathieu; Goud, Bruno] CNRS, F-75248 Paris, France; [Pagnotta, Sophie; Lacas-Gervais, Sandra] Univ Nice Sophia Antipolis, Ctr Commun Microscopie Appl, F-06000 Nice, France; [Payet, Laurie-Anne; Ferreira, Thierry] Univ Poitiers, Poitiers, France; [Payet, Laurie-Anne; Ferreira, Thierry] CNRS, Poitiers, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Antonny, B (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France.	antonny@ipmc.cnrs.fr	Vanni, Stefano/AAO-3144-2020; Antonny, Bruno/ABH-7434-2020; Pinot, Mathieu/P-8192-2014; Goud, Bruno/GWC-4807-2022; soler, martha maricel m gomez/L-6025-2014; Vanni, Stefano/D-6414-2011	Vanni, Stefano/0000-0003-2146-1140; Antonny, Bruno/0000-0002-9166-8668; soler, martha maricel m gomez/0000-0002-4412-8108; Vanni, Stefano/0000-0003-2146-1140; BARELLI, Helene/0000-0001-6376-863X; Pinot, mathieu/0000-0003-4029-3437; GAUTIER, Romain/0000-0001-6678-132X	CNRS; European Research Council [268888]; Agence Nationale de la Recherche (ANR) [ANR-11-LABX-0028-01]; ANR [ANR09-JCJC-0020-01]; Fondation Pierre Gilles de Gennes; Swiss National Science Foundation [PBELP3_141118]; Inserm	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Research Council(European Research Council (ERC)European Commission); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); Fondation Pierre Gilles de Gennes; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We thank M. de Saint-Jean, C. Thonont, and F. Brau for technical help; A. Lurick for some experiments; J. B. Manneville for training and the microscope setup; J. Bigay, B. Mesmin, and A. Copic for comments on the manuscript; and all members of our laboratories for discussion. This work was supported by the CNRS, the European Research Council (advanced grant 268888), and the Agence Nationale de la Recherche (ANR) (ANR-11-LABX-0028-01). M.P. was supported by the ANR (ANR09-JCJC-0020-01) and the Fondation Pierre Gilles de Gennes. S.V. was supported by the Swiss National Science Foundation (PBELP3_141118). H.B. was supported by Inserm. Additional data described in this work can be found in the supplementary materials. Author contributions: M.P. performed experiments with GUVs; M.P. and H.B. performed mechanical experiments on cells; H.B. designed and performed endocytosis experiments; S.V. and R.G. conducted and analyzed MD simulations; L.-A.P. and T.F. performed phospholipid analysis; S.P., S.L.-G., and B.A. performed electron microscopy; B.A. designed the project, performed biochemical experiments, and wrote the manuscript with the help of B.G., S.V., H.B., and M.P.	Baoukina S, 2012, BIOPHYS J, V102, P1866, DOI 10.1016/j.bpj.2012.03.048; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Bruckner RJ, 2009, BIOPHYS J, V97, P3113, DOI 10.1016/j.bpj.2009.09.025; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Darios F, 2006, NATURE, V440, P813, DOI 10.1038/nature04598; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Gawrisch K, 2003, LIPIDS, V38, P445, DOI 10.1007/s11745-003-1082-0; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; Kubo S, 2005, J BIOL CHEM, V280, P31664, DOI 10.1074/jbc.M504894200; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Marza E, 2008, MOL BIOL CELL, V19, P833, DOI 10.1091/mbc.E07-07-0719; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Mitchell DC, 2001, J BIOL CHEM, V276, P42801, DOI 10.1074/jbc.M105772200; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Rajamoorthi K, 2005, J AM CHEM SOC, V127, P1576, DOI 10.1021/ja046453b; Rawicz W, 2000, BIOPHYS J, V79, P328, DOI 10.1016/S0006-3495(00)76295-3; Risselada HJ, 2009, PHYS CHEM CHEM PHYS, V11, P2056, DOI 10.1039/b818782g; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; TIXIERVIDAL A, 1986, NEUROSCIENCE, V17, P115, DOI 10.1016/0306-4522(86)90230-7; Vamparys L, 2013, BIOPHYS J, V104, P585, DOI 10.1016/j.bpj.2012.11.3836; Vasquez V, 2014, CELL REP, V6, P70, DOI 10.1016/j.celrep.2013.12.012; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; Yang HJ, 2012, J BIOL CHEM, V287, P5290, DOI 10.1074/jbc.M111.316877; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355	30	207	209	6	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					693	697		10.1126/science.1255288	http://dx.doi.org/10.1126/science.1255288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104391				2022-12-28	WOS:000339962800044
J	Rabins, PV; Blass, DM; Cotton, D; Rao, JK; Taichman, D; Williams, S				Rabins, Peter V.; Blass, David M.; Cotton, Deborah; Rao, Jaya K.; Taichman, Darren; Williams, Sankey			Dementia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MILD COGNITIVE IMPAIRMENT; NURSING-HOME PLACEMENT; QUALITY STANDARDS SUBCOMMITTEE; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIALS; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; NEUROPSYCHIATRIC SYMPTOMS; PRACTICE PARAMETER; AMERICAN-ACADEMY											Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bekelman DB, 2005, J PAIN SYMPTOM MANAG, V30, P208, DOI 10.1016/j.jpainsymman.2005.04.003; Beversdorf DQ, 2004, AM J GERIAT PSYCHIAT, V12, P542, DOI 10.1176/appi.ajgp.12.5.542; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Brodaty H, 2012, AM J PSYCHIAT, V169, P946, DOI 10.1176/appi.ajp.2012.11101529; Brodaty H, 2011, LANCET, V378, P375, DOI 10.1016/S0140-6736(11)61031-3; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Camargos EF, 2014, AM J GERIAT PSYCHIAT, V22, P1565, DOI 10.1016/j.jagp.2013.12.174; Chan DC, 2003, J GERONTOL A-BIOL, V58, P548; Daviglus ML, 2011, ARCH NEUROL-CHICAGO, V68, P1185, DOI 10.1001/archneurol.2011.100; DeKosky S. T., 2008, JAMA-J AM MED ASSOC, V19, P2253, DOI DOI 10.1001/JAMA.2008.683; DeKosky ST, 2005, CURR ALZHEIMER RES, V2, P541; Dysken MW, 2014, JAMA-J AM MED ASSOC, V311, P33, DOI 10.1001/jama.2013.282834; Ely EW, JAMA; Emre M, 2004, NEW ENGL J MED, V351, P2509, DOI 10.1056/NEJMoa041470; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Foster NL, 2007, BRAIN, V130, P2616, DOI 10.1093/brain/awm177; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Gill SS, 2007, ANN INTERN MED, V146, P775, DOI 10.7326/0003-4819-146-11-200706050-00006; Haupt M, 2000, INT J GERIATR PSYCH, V15, P1125, DOI 10.1002/1099-1166(200012)15:12<1125::AID-GPS257>3.0.CO;2-F; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Hunt LA, 1997, ARCH NEUROL-CHICAGO, V54, P707, DOI 10.1001/archneur.1997.00550180029008; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Iverson DJ, 2010, NEUROLOGY, V74, P1316, DOI 10.1212/WNL.0b013e3181da3b0f; Johnson KA, 2013, ALZHEIMERS DEMENT, V9, pE1, DOI [10.1016/j.jalz.2013.01.002, 10.1016/j.jalz.2012.10.007, 10.1016/j.jalz.2013.06.001]; Jorm AF, 2004, INT PSYCHOGERIATR, V16, P275, DOI 10.1017/S1041610204000390; Kales HC, 2014, J AM GERIATR SOC, V62, P762, DOI 10.1111/jgs.12730; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; LARSON EB, 1987, ANN INTERN MED, V107, P169, DOI 10.7326/0003-4819-107-2-169; Loy CT, 2014, LANCET, V383, P828, DOI 10.1016/S0140-6736(13)60630-3; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; Massoud F, 2000, J AM GERIATR SOC, V48, P1204, DOI 10.1111/j.1532-5415.2000.tb02591.x; McKeith I, 2000, LANCET, V356, P2031, DOI 10.1016/S0140-6736(00)03399-7; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Mittelman MS, 2006, NEUROLOGY, V67, P1592, DOI 10.1212/01.wnl.0000242727.81172.91; Nasreddine Z., 2014, MONTREAL COGNITIVE; Rabins Peter V, 2011, AJOB Prim Res, V2, P61; Rabins PV, 2006, PRACTICAL DEMENTIA C; Redelmeier DA, 2012, NEW ENGL J MED, V367, P1228, DOI 10.1056/NEJMsa1114310; Roalf DR, 2013, ALZHEIMERS DEMENT, V9, P529, DOI 10.1016/j.jalz.2012.10.001; Saint Louis University School of Medicine, SAINT LOUIS U MENT S; Sano M, 1997, NEW ENGL J MED, V336, P1216, DOI 10.1056/NEJM199704243361704; Schmand B, 2014, J ALZHEIMERS DIS, V40, P409, DOI 10.3233/JAD-131484; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Shumaker SA, 2003, JAMA-J AM MED ASSOC, V289, P2651, DOI 10.1001/jama.289.20.2651; Tariq SH, 2006, AM J GERIAT PSYCHIAT, V14, P900, DOI 10.1097/01.JGP.0000221510.33817.86; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; U.S. Preventive Services Task Force, 2014, SCREEN COGN IMP OLD; Valcour VG, 2000, ARCH INTERN MED, V160, P2964, DOI 10.1001/archinte.160.19.2964; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Zandi PP, 2002, JAMA-J AM MED ASSOC, V288, P2123, DOI 10.1001/jama.288.17.2123; Zubenko GS, 2003, AM J PSYCHIAT, V160, P857, DOI 10.1176/appi.ajp.160.5.857	56	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3							ITC1	10.7326/0003-4819-161-3-201408050-01002	http://dx.doi.org/10.7326/0003-4819-161-3-201408050-01002			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW3RD	25089871				2022-12-28	WOS:000364908500001
J	Nigrin, DJ				Nigrin, Daniel J.			When 'Hacktivists' Target Your Hospital	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Nigrin, Daniel J.] Boston Childrens Hosp, Informat Serv Dept, Boston, MA 02115 USA; [Nigrin, Daniel J.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Nigrin, DJ (corresponding author), Boston Childrens Hosp, Informat Serv Dept, Boston, MA 02115 USA.							[Anonymous], EL MED REC AD MOD EM, DOI [10.1056/NEJMp1407326, DOI 10.1056/NEJMP1407326]	1	12	12	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					393	395		10.1056/NEJMp1407326	http://dx.doi.org/10.1056/NEJMp1407326			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM0SK	25075830				2022-12-28	WOS:000339556900001
J	Tao, T; Xin, KL				Tao, Tao; Xin, Kunlun			A sustainable plan for China's drinking water	NATURE			English	Editorial Material							COUNTRIES		[Tao, Tao; Xin, Kunlun] Tongji Univ, Coll Environm Sci & Engn, Shanghai 200092, Peoples R China; [Tao, Tao; Xin, Kunlun] Tongji Univ, Key Lab Yangtze River Water Environm, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Tao, T (corresponding author), Tongji Univ, Coll Environm Sci & Engn, Shanghai 200092, Peoples R China.	taotao@tongji.edu.cn; xkl@tongji.edu.cn						Clasen TF, 2008, ENVIRON SCI TECHNOL, V42, P4255, DOI 10.1021/es7024802; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Gadgil A, 1998, ANNU REV ENERG ENV, V23, P253, DOI 10.1146/annurev.energy.23.1.253; Ministry of Water Resources of the People's Republic of China, 2012, CHIN WAT RES B 2011; Qiu J., 2009, NATURE; Qiu J, 2011, SCIENCE, V334, P745, DOI 10.1126/science.334.6057.745; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Sobsey MD, 2008, ENVIRON SCI TECHNOL, V42, P4261, DOI 10.1021/es702746n	8	104	113	20	277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					527	528		10.1038/511527a	http://dx.doi.org/10.1038/511527a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079539	Bronze			2022-12-28	WOS:000339566300012
J	Stacy, SR; Suarez-Cuervo, C; Berger, Z; Wilson, LM; Yeh, HC; Bass, EB; Michos, ED				Stacy, Sylvie R.; Suarez-Cuervo, Catalina; Berger, Zackary; Wilson, Lisa M.; Yeh, Hsin-Chieh; Bass, Eric B.; Michos, Erin D.			Role of Troponin in Patients With Chronic Kidney Disease and Suspected Acute Coronary Syndrome A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							CREATINE-KINASE MB; CARDIAC TROPONIN; RENAL-FAILURE; PROGNOSTIC VALUE; CHEST-PAIN; DIAGNOSTIC PERFORMANCE; RISK STRATIFICATION; T LEVELS; ELEVATION; OUTCOMES	Background: Patients with chronic kidney disease (CKD) have high prevalence of elevated serum troponin levels, which makes diagnosis of acute coronary syndrome (ACS) challenging. Purpose: To evaluate the utility of troponin in ACS diagnosis, treatment, and prognosis among patients with CKD. Data Sources: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials through May 2014. Study Selection: Studies examining elevated versus normal troponin levels in terms of their diagnostic performance in detection of ACS, effect on ACS management strategies, and prognostic value for mortality or cardiovascular events after ACS among patients with CKD. Data Extraction: Paired reviewers selected articles for inclusion, extracted data, and graded strength of evidence (SOE). Data Synthesis: Twenty-three studies met inclusion criteria. The sensitivity of troponin T for ACS diagnosis ranged from 71% to 100%, and specificity ranged from 31% to 86% (6 studies; low SOE). The sensitivity and specificity of troponin I ranged from 43% to 94% and from 48% to 100%, respectively (8 studies; low SOE). No studies examined how troponin levels affect management strategies. Twelve studies analyzed prognostic value. Elevated levels of troponin I or troponin T were associated with higher risk for short-term death and cardiac events (low SOE). A similar trend was observed for long-term mortality with troponin I (low SOE), but less evidence was found for long-term cardiac events for troponin I and long-term outcomes for troponin T (insufficient SOE). Patients with advanced CKD tended to have worse prognoses with elevated troponin I levels than those without them (moderate SOE). Limitation: Studies were heterogeneous in design and in ACS definitions and adjudication methods. Conclusion: In patients with CKD and suspected ACS, troponin levels can aid in identifying those with a poor prognosis, but the diagnostic utility is limited by varying estimates of sensitivity and specificity.	Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Michos, ED (corresponding author), Johns Hopkins Univ, Sch Med, Div Cardiol, 600 North Wolfe St,Carnegie 568, Baltimore, MD 21287 USA.	edonnell@jhmi.edu	Berger, Zackary/AAW-5761-2020; Berger, Zackary/I-7032-2013	Michos, Erin/0000-0002-5547-5084; Bass, Eric/0000-0001-9106-527X; Berger, Zackary/0000-0002-5871-0342	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Primary Funding Source: Agency for Healthcare Research and Quality.	Acharji S, 2012, CIRC-CARDIOVASC INTE, V5, P157, DOI 10.1161/CIRCINTERVENTIONS.111.963876; Agency for Healthcare Research and Quality, 2012, AHRQ PUBLICATION; Alcalai R, 2007, ARCH INTERN MED, V167, P276, DOI 10.1001/archinte.167.3.276; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; Anderson JL, 2007, J AM COLL CARDIOL, V50, P652, DOI 10.1016/j.jacc.2007.02.028; Apple FS, 2007, AM J CLIN PATHOL, V127, P598, DOI 10.1309/17220CY5MK5UCQRP; Apple FS, 1999, CLIN CHEM, V45, P199; Aviles RJ, 2002, NEW ENGL J MED, V346, P2047, DOI 10.1056/NEJMoa013456; Bhagavan NV, 1998, J CLIN LAB ANAL, V12, P276, DOI 10.1002/(SICI)1098-2825(1998)12:5<276::AID-JCLA4>3.0.CO;2-4; Bueti J, 2006, NEPHRON CLIN PRACT, V103, pC129, DOI 10.1159/000092909; Cannon CP, 2013, CIRCULATION, V127, P1052, DOI 10.1161/CIR.0b013e3182831a11; Chenevier-Gobeaux C, 2013, AM J CARDIOL, V111, P1701, DOI 10.1016/j.amjcard.2013.02.024; Chew Huck Chin, 2008, Asian Cardiovasc Thorac Ann, V16, P284; Dohi T, 2012, J CARDIOL, V60, P438, DOI 10.1016/j.jjcc.2012.08.007; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Fehr T, 2003, CLIN NEPHROL, V59, P35; Flores LM, 2006, NEFROLOGIA, V26, P107; Flores-Solis LM, 2012, NEFROLOGIA, V32, P809, DOI 10.3265/Nefrologia.pre2012.Jul.10986; Gruberg L, 2002, CATHETER CARDIO INTE, V55, P174, DOI 10.1002/ccd.10081; Haaf P, 2014, EUR HEART J, V35, P365, DOI 10.1093/eurheartj/eht218; Han JH, 2005, AM J EMERG MED, V23, P468, DOI 10.1016/j.ajem.2005.01.006; Ikeda Jun, 2002, Rinsho Byori, V50, P982; Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1763, DOI 10.1016/j.jacc.2006.08.006; Javed U, 2009, AM J CARDIOL, V104, P9, DOI 10.1016/j.amjcard.2009.03.003; Khan IA, 2001, J AM COLL CARDIOL, V38, P991, DOI 10.1016/S0735-1097(01)01513-3; Khan NA, 2005, CIRCULATION, V112, P3088, DOI 10.1161/CIRCULATIONAHA.105.560128; Kontos MC, 2005, AM HEART J, V150, P674, DOI 10.1016/j.ahj.2004.11.008; Kontos MC, 2005, AM HEART J, V150, P666, DOI 10.1016/j.ahj.2004.12.007; Kontos MC, 2008, AM J CARDIOL, V102, P140, DOI 10.1016/j.amjcard.2008.03.023; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Martin GS, 1998, NEPHROL DIAL TRANSPL, V13, P1709, DOI 10.1093/ndt/13.7.1709; McCullough PA, 2002, ACAD EMERG MED, V9, P1389, DOI 10.1111/j.1553-2712.2002.tb01607.x; Metioni C, 2008, CLIN CARDIOL, V31, P125, DOI 10.1002/clc.20210; Michos ED, 2014, AHRQ PUBLICATION; National Institute of Diabetes and Digestive and Kidney Diseases, 2011, US REN DAT SYST 2011; Needham DM, 2004, CAN J CARDIOL, V20, P1212; Newby LK, 2012, J AM COLL CARDIOL, V60, P2427, DOI 10.1016/j.jacc.2012.08.969; Ng SM, 2001, AM J CARDIOL, V87, P994, DOI 10.1016/S0002-9149(01)01436-9; Noeller TP, 2003, AM J EMERG MED, V21, P293, DOI 10.1016/S0735-6757(03)00081-0; Palamalai V, 2013, CLIN BIOCHEM, V46, P1631, DOI 10.1016/j.clinbiochem.2013.06.026; Pfortmueller CA, 2013, AM J CARDIOL, V112, P1968, DOI 10.1016/j.amjcard.2013.08.028; Sukonthasarn Apichard, 2007, Journal of the Medical Association of Thailand, V90, P1749; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Van Lente F, 1999, J AM COLL CARDIOL, V33, P471, DOI 10.1016/S0735-1097(98)00592-0; Wayand D, 2000, CLIN CHEM, V46, P1345; Wu AHB, 2007, CLIN CHEM, V53, P2086, DOI 10.1373/clinchem.2007.095679	46	75	79	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7					502	+		10.7326/M14-0746	http://dx.doi.org/10.7326/M14-0746			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LU	25111593				2022-12-28	WOS:000343896700009
J	Briand, S; Bertherat, E; Cox, P; Formenty, P; Kieny, MP; Myhre, JK; Roth, C; Shindo, N; Dye, C				Briand, Sylvie; Bertherat, Eric; Cox, Paul; Formenty, Pierre; Kieny, Marie-Paule; Myhre, Joel K.; Roth, Cathy; Shindo, Nahoko; Dye, Christopher			The International Ebola Emergency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Briand, Sylvie; Bertherat, Eric; Cox, Paul; Formenty, Pierre; Kieny, Marie-Paule; Myhre, Joel K.; Roth, Cathy; Shindo, Nahoko; Dye, Christopher] World Hlth Org, Geneva, Switzerland	World Health Organization	Briand, S (corresponding author), World Hlth Org, Geneva, Switzerland.		Dye, Christopher/AIC-4659-2022; Kieny, Marie-Paule/Q-1238-2019; Kieny, Marie-Paule/N-3914-2017	Kieny, Marie-Paule/0000-0002-5943-6488; Dye, Christopher/0000-0002-2957-1793	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		ANDERSON R M, 1991; Baize S, NEW ENGL J MED, DOI [10.1065/NEJMoa1404505, DOI 10.1065/NEJMOA1404505]; Chowell G, 2004, J THEOR BIOL, V229, P119, DOI 10.1016/j.jtbi.2004.03.006; Legrand J, 2007, EPIDEMIOL INFECT, V135, P610, DOI 10.1017/S0950268806007217; World Health Organization (WHO), 2014, EB VIR DIS EVD	5	153	162	1	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1180	1183		10.1056/NEJMp1409858	http://dx.doi.org/10.1056/NEJMp1409858			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP4WH	25140855	Bronze			2022-12-28	WOS:000342079700003
J	Parekh, AK; Kronick, R; Tavenner, M				Parekh, Anand K.; Kronick, Richard; Tavenner, Marilyn			Optimizing Health for Persons With Multiple Chronic Conditions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Parekh, Anand K.] US Dept HHS, Off Assistant Secretary Hlth, Washington, DC 20201 USA; [Kronick, Richard] US Dept HHS, Agcy Healthcare Res & Qual, Washington, DC 20201 USA; [Tavenner, Marilyn] US Dept HHS, Ctr Medicare & Medicaid Serv, Washington, DC 20201 USA	Agency for Healthcare Research & Quality; Centers for Medicare & Medicaid Services	Parekh, AK (corresponding author), US Dept HHS, Off Assistant Secretary Hlth, 200 Independence Ave SW, Washington, DC 20201 USA.	anand.parekh@hhs.gov						Blumenthal D, 2012, NEW ENGL J MED, V366, P1953, DOI 10.1056/NEJMp1203427; Lochner KA, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120137; Parekh AK, 2011, PUBLIC HEALTH REP, V126, P460, DOI 10.1177/003335491112600403; Parekh AK, 2010, JAMA-J AM MED ASSOC, V303, P1303, DOI 10.1001/jama.2010.381; Schwenk TL, 2014, JAMA-J AM MED ASSOC, V311, P802, DOI 10.1001/jama.2014.352; Tinetti ME, 2012, JAMA-J AM MED ASSOC, V307, P2493, DOI 10.1001/jama.2012.5265; Ward BW, 2013, PREV CHRONIC DIS, V10, DOI 10.5888/pcd10.120203	7	39	39	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1199	1200		10.1001/jama.2014.10181	http://dx.doi.org/10.1001/jama.2014.10181			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP3QA	25133982				2022-12-28	WOS:000341990600016
J	Alexander, T; Natarajan, P				Alexander, Tal; Natarajan, Priyamvada			Rapid growth of seed black holes in the early universe by supra-exponential accretion	SCIENCE			English	Article							HIGH-REDSHIFT; 1ST GALAXIES; COLD STREAMS; SIMULATIONS; GAS; GRADIENTS; COLLAPSE; CLUSTERS; QUASARS; HALOES	Mass accretion by black holes (BHs) is typically capped at the Eddington rate, when radiation's push balances gravity's pull. However, even exponential growth at the Eddington-limited e-folding time t(E) similar to few x 0.01 billion years is too slow to grow stellar-mass BH seeds into the supermassive luminous quasars that are observed when the universe is 1 billion years old. We propose a dynamical mechanism that can trigger supra-exponential accretion in the early universe, when a BH seed is bound in a star cluster fed by the ubiquitous dense cold gas flows. The high gas opacity traps the accretion radiation, while the low-mass BH's random motions suppress the formation of a slowly draining accretion disk. Supra-exponential growth can thus explain the puzzling emergence of supermassive BHs that power luminous quasars so soon after the Big Bang.	[Alexander, Tal] Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel; [Natarajan, Priyamvada] Yale Univ, Dept Astron, New Haven, CT 06511 USA	Weizmann Institute of Science; Yale University	Alexander, T (corresponding author), Weizmann Inst Sci, Dept Particle Phys & Astrophys, IL-76100 Rehovot, Israel.	tal.alexander@weizmann.ac.il	Natarajan, Priyamvada/AAG-2086-2021		European Research Council Starting Grant [202996]; Deutsch-Israelische Projektkooperation-Bundesministerium fur Bildung und Forschung grant [71-0460-0101]; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [1829/12]; NASA-NSF Theoretical and Computational Astrophysics Networks award [1332858]; NSF grant [PHY11-2591]; Direct For Mathematical & Physical Scien [1333514] Funding Source: National Science Foundation; Division Of Astronomical Sciences [1333360] Funding Source: National Science Foundation	European Research Council Starting Grant(European Research Council (ERC)); Deutsch-Israelische Projektkooperation-Bundesministerium fur Bildung und Forschung grant; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation); NASA-NSF Theoretical and Computational Astrophysics Networks award; NSF grant(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank P. Armitage, B. Bar-Or, M. Begelman, F. Bournaud, M. Colpi, A. Dekel. J.-P. Lasota, C. Reynolds, and N. Sapir for helpful discussions and comments. T. A. acknowledges support by European Research Council Starting Grant no. 202996, Deutsch-Israelische Projektkooperation-Bundesministerium fur Bildung und Forschung grant no. 71-0460-0101, and the I-CORE Program of the Planning and Budgeting Committee and Israel Science Foundation (center no. 1829/12). P. N. acknowledges support from a NASA-NSF Theoretical and Computational Astrophysics Networks award, number 1332858. The authors thank the Kavli Institute for Theoretical Physics, University of California, Santa Barbara, where this work was initiated and supported in part by NSF grant PHY11-2591. T.A. is grateful for the warm hospitality of A. Millan and L. Arkwright of La Posada San Marcos, Alajar, Spain, who hosted the Alajar Workshop where this work was continued.	Agarwal B, 2013, MON NOT R ASTRON SOC, V432, P3438, DOI 10.1093/mnras/stt696; Alvarez MA, 2009, ASTROPHYS J LETT, V701, pL133, DOI 10.1088/0004-637X/701/2/L133; [Anonymous], 2013, ASTROPHYS SPACE SCI, DOI [DOI 10.1007/978-3-642-32362-1_6, DOI 10.1007/978-3-642-32362-1.6]; BEGELMAN MC, 1978, MON NOT R ASTRON SOC, V184, P53, DOI 10.1093/mnras/184.1.53; BEGELMAN MC, 1979, MON NOT R ASTRON SOC, V187, P237, DOI 10.1093/mnras/187.2.237; Begelman MC, 2006, MON NOT R ASTRON SOC, V370, P289, DOI 10.1111/j.1365-2966.2006.10467.x; Binney J., 2008, GALACTIC DYNAMICS; BONDI H, 1952, MON NOT R ASTRON SOC, V112, P195, DOI 10.1093/mnras/112.2.195; Bournaud F, 2011, ASTROPHYS J LETT, V741, DOI 10.1088/2041-8205/741/2/L33; Bromm V, 2003, ASTROPHYS J, V596, P34, DOI 10.1086/377529; Davies MB, 2011, ASTROPHYS J LETT, V740, DOI 10.1088/2041-8205/740/2/L42; Dekel A, 2009, NATURE, V457, P451, DOI 10.1038/nature07648; Devecchi B, 2009, ASTROPHYS J, V694, P302, DOI 10.1088/0004-637X/694/1/302; Dubois Y, 2012, MON NOT R ASTRON SOC, V423, P3616, DOI 10.1111/j.1365-2966.2012.21160.x; Fan XH, 2006, ASTRON J, V131, P1203, DOI 10.1086/500296; Ferrara A, 2013, MON NOT R ASTRON SOC, V434, P2600, DOI 10.1093/mnras/stt1350; Greif TH, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/75; Hopkins PF, 2007, ASTROPHYS J, V662, P110, DOI 10.1086/517512; Hopman C, 2006, ASTROPHYS J, V645, P1152, DOI 10.1086/504400; LIVIO M, 1986, MON NOT R ASTRON SOC, V222, P235, DOI 10.1093/mnras/222.2.235; Lodato G, 2007, MON NOT R ASTRON SOC, V381, P1287, DOI 10.1111/j.1365-2966.2007.12332.x; Lodato G, 2006, MON NOT R ASTRON SOC, V371, P1813, DOI 10.1111/j.1365-2966.2006.10801.x; Mihalas D., 1984, FDN RAD HYDRODYNAMIC; Milosavljevic M, 2009, ASTROPHYS J, V698, P766, DOI 10.1088/0004-637X/698/1/766; Mortlock DJ, 2011, NATURE, V474, P616, DOI 10.1038/nature10159; Natarajan P, 2011, B ASTRON SOC INDIA, V39, P145; Park K, 2012, ASTROPHYS J, V747, DOI 10.1088/0004-637X/747/1/9; Rauch K. P., 1996, New Astronomy, V1, P149, DOI 10.1016/S1384-1076(96)00012-7; Regan JA, 2014, MON NOT R ASTRON SOC, V439, P1160, DOI 10.1093/mnras/stu068; Ruffert M, 1999, ASTRON ASTROPHYS, V346, P861; RUFFERT M, 1995, ASTRON ASTROPHYS, V295, P108; Safranek-Shrader C, 2014, MON NOT R ASTRON SOC, V440, pL76, DOI 10.1093/mnrasl/slu027; SOFFEL MH, 1982, ASTRON ASTROPHYS, V116, P111; Treister E, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/130; Turk MJ, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/2/154; Volonteri M, 2005, ASTROPHYS J, V633, P624, DOI 10.1086/466521; Volonteri M, 2010, ASTRON ASTROPHYS REV, V18, P279, DOI 10.1007/s00159-010-0029-x; Willott CJ, 2003, ASTROPHYS J, V587, pL15, DOI 10.1086/375126; Wise JH, 2008, ASTROPHYS J, V682, P745, DOI 10.1086/588209	41	115	116	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1330	1333		10.1126/science.1251053	http://dx.doi.org/10.1126/science.1251053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25103410	Green Submitted			2022-12-28	WOS:000341483800060
J	Bass, AJ; Thorsson, V; Shmulevich, I; Reynolds, SM; Miller, M; Bernard, B; Hinoue, T; Laird, PW; Curtis, C; Shen, H; Weisenberger, DJ; Schultz, N; Shen, RL; Weinhold, N; Keiser, DP; Bowlby, R; Sipahimalani, P; Cherniack, AD; Getz, G; Liu, YC; Noble, MS; Pedamallu, C; Sougnez, C; Taylor-Weiner, A; Akbani, R; Lee, JS; Liu, WB; Mills, GB; Yang, D; Zhang, W; Pantazi, A; Parfenov, M; Gulley, M; Piazuelo, MB; Schneider, BG; Kim, J; Boussioutas, A; Sheth, M; Demchok, JA; Rabkin, CS; Willis, JE; Ng, S; Garman, K; Beer, DG; Pennathur, A; Raphael, BJ; Wu, HT; Odze, R; Kim, HK; Bowen, J; Leraas, KM; Lichtenberg, TM; Weaver, L; McLellan, M; Wiznerowicz, M; Sakai, R; Getz, G; Sougnez, C; Lawrence, MS; Cibulskis, K; Lichtenstein, L; Fisher, S; Gabriel, SB; Lander, ES; Ding, L; Niu, BF; Ally, A; Balasundaram, M; Birol, I; Bowlby, R; Brooks, D; Butterfield, YSN; Carlsen, R; Chu, A; Chu, J; Chuah, E; Chun, HJE; Clarke, A; Dhalla, N; Guin, R; Holt, RA; Jones, SJM; Kasaian, K; Lee, D; Li, HYA; Lim, E; Ma, Y; Marra, MA; Mayo, M; Moore, RA; Mungall, AJ; Mungall, KL; Nip, KM; Robertson, AG; Schein, JE; Sipahimalani, P; Tam, A; Thiessen, N; Beroukhim, R; Carter, SL; Cherniack, AD; Cho, J; Cibulskis, K; DiCara, D; Frazer, S; Fisher, S; Gabriel, SB; Gehlenborg, N; Heiman, DI; Jung, J; Kim, J; Lander, ES; Lawrence, MS; Lichtenstein, L; Lin, P; Meyerson, M; Ojesina, AI; Pedamallu, CS; Saksena, G; Schumacher, SE; Sougnez, C; Stojanov, P; Tabak, B; Taylor-Weiner, A; Voet, D; Rosenberg, M; Zack, TI; Zhang, HL; Zou, LH; Protopopov, A; Santoso, N; Parfenov, M; Lee, S; Zhang, J; Mahadeshwar, HS; Tang, JB; Ren, XJ; Seth, S; Yang, LX; Xu, AW; Song, XZ; Pantazi, A; Xi, RB; Bristow, CA; Hadjipanayis, A; Seidman, J; Chin, L; Park, PJ; Kucherlapati, R; Akbani, R; Ling, SY; Liu, WB; Rao, A; Weinstein, JN; Kim, SB; Lee, JS; Lu, YL; Mills, G; Hinoue, T; Weisenberger, DJ; Bootwalla, MS; Lai, PH; Shen, H; Triche, T; Van Den Berg, DJ; Baylin, SB; Herman, JG; Getz, G; Chin, L; Liu, YC; Murray, BA; Noble, MS; Askoy, BA; Ciriello, G; Dresdner, G; Gao, JJ; Gross, B; Jacobsen, A; Lee, W; Ramirez, R; Sander, C; Schultz, N; Senbabaoglu, Y; Sinha, R; Sumer, SO; Sun, YC; Weinhold, N; Thorsson, V; Bernard, B; Iype, L; Kramer, RW; Kreisberg, R; Miller, M; Reynolds, SM; Rovira, H; Tasman, N; Shmulevich, I; Ng, S; Haussler, D; Stuart, JM; Akbani, R; Ling, SY; Liu, WB; Rao, A; Weinstein, JN; Verhaak, RGW; Mills, GB; Leiserson, MDM; Raphael, BJ; Wu, HT; Taylor, BS; Black, AD; Bowen, J; Carney, JA; Gastier-Foster, JM; Helsel, C; Leraas, KM; Lichtenberg, TM; McAllister, C; Ramirez, NC; Tabler, TR; Wise, L; Zmuda, E; Penny, R; Crain, D; Gardner, J; Lau, K; Curely, E; Mallery, D; Morris, S; Paulauskis, J; Shelton, T; Shelton, C; Sherman, M; Benz, C; Lee, JH; Fedosenko, K; Manikhas, G; Voronina, O; Belyaev, D; Dolzhansky, O; Rathmell, WK; Brzezinski, J; Ibbs, M; Korski, K; Kycler, W; Lazniak, R; Leporowska, E; Mackiewicz, A; Murawa, D; Murawa, P; Spychala, A; Suchorska, WM; Tatka, H; Teresiak, M; Wiznerowicz, M; Abdel-Misih, R; Bennett, J; Brown, J; Iacocca, M; Rabeno, B; Kwon, SY; Penny, R; Gardner, J; Kemkes, A; Mallery, D; Morris, S; Shelton, T; Shelton, C; Curley, E; Alexopoulou, I; Engel, J; Bartlett, J; Albert, M; Park, DY; Dhir, R; Luketich, J; Landreneau, R; Janjigian, YY; Kelsen, DP; Cho, E; Ladanyi, M; Tang, L; McCall, SJ; Park, YS; Cheong, JH; Ajani, J; Camargo, MC; Alonso, S; Ayala, B; Jensen, MA; Pihl, T; Raman, R; Walton, J; Wan, YH; Demchok, JA; Eley, G; Shaw, KRM; Sheth, M; Tarnuzzer, R; Wang, ZN; Yang, LM; Zenklusen, JC; Davidsen, T; Hutter, CM; Sofia, HJ; Burton, R; Chudamani, S; Liu, J				Bass, Adam J.; Thorsson, Vesteinn; Shmulevich, Ilya; Reynolds, Sheila M.; Miller, Michael; Bernard, Brady; Hinoue, Toshinori; Laird, Peter W.; Curtis, Christina; Shen, Hui; Weisenberger, Daniel J.; Schultz, Nikolaus; Shen, Ronglai; Weinhold, Nils; Keiser, David P.; Bowlby, Reanne; Sipahimalani, Payal; Cherniack, Andrew D.; Getz, Gad; Liu, Yingchun; Noble, Michael S.; Pedamallu, Chandra; Sougnez, Carrie; Taylor-Weiner, Amaro; Akbani, Rehan; Lee, Ju-Seog; Liu, Wenbin; Mills, Gordon B.; Yang, Da; Zhang, Wei; Pantazi, Angeliki; Parfenov, Michael; Gulley, Margaret; Piazuelo, M. Blanca; Schneider, Barbara G.; Kim, Jihun; Boussioutas, Alex; Sheth, Margi; Demchok, John A.; Rabkin, Charles S.; Willis, Joseph E.; Ng, Sam; Garman, Katherine; Beer, David G.; Pennathur, Arjun; Raphael, Benjamin J.; Wu, Hsin-Ta; Odze, Robert; Kim, Hark K.; Bowen, Jay; Leraas, Kristen M.; Lichtenberg, Tara M.; Weaver, Lichtenberg; McLellan, Michael; Wiznerowicz, Maciej; Sakai, Ryo; Getz, Gad; Sougnez, Carrie; Lawrence, Michael S.; Cibulskis, Kristian; Lichtenstein, Lee; Fisher, Sheila; Gabriel, Stacey B.; Lander, Eric S.; Ding, Li; Niu, Beifang; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Bowlby, Reanne; Brooks, Denise; Butterfield, Yaron S. N.; Carlsen, Rebecca; Chu, Andy; Chu, Justin; Chuah, Eric; Chun, Hye-Jung E.; Clarke, Amanda; Dhalla, Noreen; Guin, Ranabir; Holt, Robert A.; Jones, Steven J. M.; Kasaian, Katayoon; Lee, Darlene; Li, Haiyan A.; Lim, Emilia; Ma, Yussanne; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Mungall, Karen L.; Nip, Ka Ming; Robertson, A. Gordon; Schein, Jacqueline E.; Sipahimalani, Payal; Tam, Angela; Thiessen, Nina; Beroukhim, Rameen; Carter, Scott L.; Cherniack, Andrew D.; Cho, Juok; Cibulskis, Kristian; DiCara, Daniel; Frazer, Scott; Fisher, Sheila; Gabriel, Stacey B.; Gehlenborg, Nils; Heiman, David I.; Jung, Joonil; Kim, Jaegil; Lander, Eric S.; Lawrence, Michael S.; Lichtenstein, Lee; Lin, Pei; Meyerson, Matthew; Ojesina, Akinyemi I.; Pedamallu, Chandra Sekhar; Saksena, Gordon; Schumacher, Steven E.; Sougnez, Carrie; Stojanov, Petar; Tabak, Barbara; Taylor-Weiner, Amaro; Voet, Doug; Rosenberg, Mara; Zack, Travis I.; Zhang, Hailei; Zou, Lihua; Protopopov, Alexei; Santoso, Netty; Parfenov, Michael; Lee, Semin; Zhang, Jianhua; Mahadeshwar, Harshad S.; Tang, Jiabin; Ren, Xiaojia; Seth, Sahil; Yang, Lixing; Xu, Andrew W.; Song, Xingzhi; Pantazi, Angeliki; Xi, Ruibin; Bristow, Christopher A.; Hadjipanayis, Angela; Seidman, Jonathan; Chin, Lynda; Park, Peter J.; Kucherlapati, Raju; Akbani, Rehan; Ling, Shiyun; Liu, Wenbin; Rao, Arvind; Weinstein, John N.; Kim, Sang-Bae; Lee, Ju-Seog; Lu, Yiling; Mills, Gordon; Hinoue, Toshinori; Weisenberger, Daniel J.; Bootwalla, Moiz S.; Lai, Phillip H.; Shen, Hui; Triche, Timothy, Jr.; Van Den Berg, David J.; Baylin, Stephen B.; Herman, James G.; Getz, Gad; Chin, Lynda; Liu, Yingchun; Murray, Bradley A.; Noble, Michael S.; Askoy, B. Arman; Ciriello, Giovanni; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Lee, William; Ramirez, Ricardo; Sander, Chris; Schultz, Nikolaus; Senbabaoglu, Yasin; Sinha, Rileen; Sumer, S. Onur; Sun, Yichao; Weinhold, Nils; Thorsson, Vesteinn; Bernard, Brady; Iype, Lisa; Kramer, Roger W.; Kreisberg, Richard; Miller, Michael; Reynolds, Sheila M.; Rovira, Hector; Tasman, Natalie; Shmulevich, Ilya; Ng, Sam; Haussler, David; Stuart, Josh M.; Akbani, Rehan; Ling, Shiyun; Liu, Wenbin; Rao, Arvind; Weinstein, John N.; Verhaak, Roeland G. W.; Mills, Gordon B.; Leiserson, Mark D. M.; Raphael, Benjamin J.; Wu, Hsin-Ta; Taylor, Barry S.; Black, Aaron D.; Bowen, Jay; Carney, Julie Ann; Gastier-Foster, Julie M.; Helsel, Carmen; Leraas, Kristen M.; Lichtenberg, Tara M.; McAllister, Cynthia; Ramirez, Nilsa C.; Tabler, Teresa R.; Wise, Lisa; Zmuda, Erik; Penny, Robert; Crain, Daniel; Gardner, Johanna; Lau, Kevin; Curely, Erin; Mallery, David; Morris, Scott; Paulauskis, Joseph; Shelton, Troy; Shelton, Candace; Sherman, Mark; Benz, Christopher; Lee, Jae-Hyuk; Fedosenko, Konstantin; Manikhas, Georgy; Voronina, Olga; Belyaev, Dmitry; Dolzhansky, Oleg; Rathmell, W. Kimryn; Brzezinski, Jakub; Ibbs, Matthew; Korski, Konstanty; Kycler, Witold; Lazniak, Radoslaw; Leporowska, Ewa; Mackiewicz, Andrzej; Murawa, Dawid; Murawa, Pawel; Spychala, Arkadiusz; Suchorska, Wiktoria M.; Tatka, Honorata; Teresiak, Marek; Wiznerowicz, Maciej; Abdel-Misih, Raafat; Bennett, Joseph; Brown, Jennifer; Iacocca, Mary; Rabeno, Brenda; Kwon, Sun-Young; Penny, Robert; Gardner, Johanna; Kemkes, Ariane; Mallery, David; Morris, Scott; Shelton, Troy; Shelton, Candace; Curley, Erin; Alexopoulou, Iakovina; Engel, Jay; Bartlett, John; Albert, Monique; Park, Do-Youn; Dhir, Rajiv; Luketich, James; Landreneau, Rodney; Janjigian, Yelena Y.; Kelsen, David P.; Cho, Eunjung; Ladanyi, Marc; Tang, Laura; McCall, Shannon J.; Park, Young S.; Cheong, Jae-Ho; Ajani, Jaffer; Camargo, M. Constanza; Alonso, Shelley; Ayala, Brenda; Jensen, Mark A.; Pihl, Todd; Raman, Rohini; Walton, Jessica; Wan, Yunhu; Demchok, John A.; Eley, Greg; Shaw, Kenna R. Mills; Sheth, Margi; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Zenklusen, Jean Claude; Davidsen, Tanja; Hutter, Carolyn M.; Sofia, Heidi J.; Burton, Robert; Chudamani, Sudha; Liu, Jia		Canc Genome Atlas Res Network	Comprehensive molecular characterization of gastric adenocarcinoma	NATURE			English	Article							SOMATIC MUTATIONS; GENE-EXPRESSION; CELL LYMPHOMAS; EBV-INFECTION; CANCER; EXOME; METHYLATION; SUBTYPES; KINASE; CLASSIFICATION	Gastric cancer is a leading cause of cancer deaths, but analysis of molecular and clinical characteristics has been complicated by histological and aetiological heterogeneity. Here we describe a comprehensive molecular evaluation of 295 primary gastric adenocarcinomas as part of The Cancer Genome Atlas (TCGA) project. We propose a molecular classification dividing gastric cancer into four subtypes: tumours positive for Epstein-Barr virus, which display recurrent PIK3CA mutations, extreme DNA hypermethylation, and amplification of JAK2, CD274 (also known as PD-L1) and PDCD1LG2 (also known as PD-L2); microsatellite unstable tumours, which show elevated mutation rates, including mutations of genes encoding targetable oncogenic signalling proteins; genomically stable tumours, which are enriched for the diffuse histological variant and mutations of RHOA or fusions involving RHO-family GTPase-activating proteins; and tumours with chromosomal instability, which show marked aneuploidy and focal amplification of receptor tyrosine kinases. Identification of these subtypes provides a roalmap for patient stratification and trials of targeted therapies.	[Bass, Adam J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Bass, Adam J.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Thorsson, Vesteinn; Shmulevich, Ilya; Reynolds, Sheila M.; Miller, Michael; Bernard, Brady; Iype, Lisa; Kramer, Roger W.; Kreisberg, Richard; Rovira, Hector; Tasman, Natalie] Inst Syst Biol, Seattle, WA 98109 USA; [Hinoue, Toshinori; Laird, Peter W.; Shen, Hui; Weisenberger, Daniel J.; Bootwalla, Moiz S.; Lai, Phillip H.; Triche, Timothy, Jr.; Van Den Berg, David J.] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90033 USA; [Curtis, Christina] Univ So Calif, Dept Prevent Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Schultz, Nikolaus; Weinhold, Nils; Askoy, B. Arman; Ciriello, Giovanni; Dresdner, Gideon; Gao, Jianjiong; Gross, Benjamin; Jacobsen, Anders; Lee, William; Ramirez, Ricardo; Sander, Chris; Senbabaoglu, Yasin; Sinha, Rileen; Sumer, S. Onur; Sun, Yichao] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Shen, Ronglai] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Keiser, David P.; Janjigian, Yelena Y.; Kelsen, David P.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Bowlby, Reanne; Sipahimalani, Payal; Ally, Adrian; Balasundaram, Miruna; Birol, Inanc; Brooks, Denise; Butterfield, Yaron S. N.; Carlsen, Rebecca; Chu, Andy; Chu, Justin; Chuah, Eric; Chun, Hye-Jung E.; Clarke, Amanda; Dhalla, Noreen; Guin, Ranabir; Holt, Robert A.; Jones, Steven J. M.; Kasaian, Katayoon; Lee, Darlene; Li, Haiyan A.; Lim, Emilia; Ma, Yussanne; Marra, Marco A.; Mayo, Michael; Moore, Richard A.; Mungall, Andrew J.; Mungall, Karen L.; Nip, Ka Ming; Robertson, A. Gordon; Schein, Jacqueline E.; Tam, Angela; Thiessen, Nina] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Cherniack, Andrew D.; Getz, Gad; Liu, Yingchun; Noble, Michael S.; Pedamallu, Chandra; Sougnez, Carrie; Taylor-Weiner, Amaro; Lawrence, Michael S.; Cibulskis, Kristian; Lichtenstein, Lee; Fisher, Sheila; Gabriel, Stacey B.; Lander, Eric S.; Beroukhim, Rameen; Carter, Scott L.; Cho, Juok; DiCara, Daniel; Frazer, Scott; Gehlenborg, Nils; Heiman, David I.; Jung, Joonil; Kim, Jaegil; Lin, Pei; Meyerson, Matthew; Ojesina, Akinyemi I.; Pedamallu, Chandra Sekhar; Saksena, Gordon; Schumacher, Steven E.; Stojanov, Petar; Tabak, Barbara; Voet, Doug; Rosenberg, Mara; Zack, Travis I.; Zhang, Hailei; Zou, Lihua; Murray, Bradley A.] Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Akbani, Rehan; Lee, Ju-Seog; Liu, Wenbin; Ling, Shiyun; Rao, Arvind; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Mills, Gordon B.; Kim, Sang-Bae; Lee, Ju-Seog; Lu, Yiling; Mills, Gordon] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Yang, Da; Zhang, Wei] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Pantazi, Angeliki; Parfenov, Michael; Santoso, Netty; Ren, Xiaojia; Hadjipanayis, Angela; Seidman, Jonathan; Kucherlapati, Raju] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Gulley, Margaret] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Piazuelo, M. Blanca; Schneider, Barbara G.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Kim, Jihun; Park, Young S.] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul 138736, South Korea; [Boussioutas, Alex] Univ Melbourne, Sir Peter MacCallum Canc Dept Oncol, East Melbourne 3002, Australia; [Sheth, Margi; Demchok, John A.; Eley, Greg; Shaw, Kenna R. Mills; Tarnuzzer, Roy; Wang, Zhining; Yang, Liming; Zenklusen, Jean Claude] NCI, Bethesda, MD 20892 USA; [Rabkin, Charles S.; Camargo, M. Constanza] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Willis, Joseph E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Ng, Sam; Haussler, David; Stuart, Josh M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Haussler, David; Stuart, Josh M.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Garman, Katherine] Duke Univ, Dept Med, Div Gastroenterol, Durham, NC 27710 USA; [Beer, David G.] Univ Michigan, Ctr Canc, Dept Thorac Surg, Ann Arbor, MI 48109 USA; [Pennathur, Arjun; Dhir, Rajiv; Luketich, James; Landreneau, Rodney] Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Raphael, Benjamin J.; Wu, Hsin-Ta; Leiserson, Mark D. M.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Wu, Hsin-Ta; Leiserson, Mark D. M.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Odze, Robert] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Kim, Hark K.] Natl Canc Ctr, Goyang 410769, South Korea; [Bowen, Jay; Leraas, Kristen M.; Lichtenberg, Tara M.; Weaver, Lichtenberg; Black, Aaron D.; Carney, Julie Ann; Gastier-Foster, Julie M.; Helsel, Carmen; McAllister, Cynthia; Ramirez, Nilsa C.; Tabler, Teresa R.; Wise, Lisa; Zmuda, Erik] Nationwide Childrens Hosp, Res Inst, Columbus, OH 43205 USA; [McLellan, Michael; Ding, Li; Niu, Beifang] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Wiznerowicz, Maciej; Brzezinski, Jakub; Ibbs, Matthew; Korski, Konstanty; Kycler, Witold; Lazniak, Radoslaw; Leporowska, Ewa; Mackiewicz, Andrzej; Murawa, Dawid; Murawa, Pawel; Spychala, Arkadiusz; Suchorska, Wiktoria M.; Tatka, Honorata; Teresiak, Marek] Greater Poland Canc Ctr, PL-61866 Poznan, Poland; [Sakai, Ryo] Katholieke Univ Leuven, Dept Elect Engn ESAT STADIUS, Leuven, Belgium; [Protopopov, Alexei; Zhang, Jianhua; Mahadeshwar, Harshad S.; Tang, Jiabin; Seth, Sahil; Song, Xingzhi; Bristow, Christopher A.; Chin, Lynda; Verhaak, Roeland G. W.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Dept Genom Med, Houston, TX 77054 USA; [Lee, Semin; Yang, Lixing; Xu, Andrew W.; Xi, Ruibin; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Baylin, Stephen B.; Herman, James G.] Johns Hopkins Univ, Canc Biol Div, Baltimore, MD 21231 USA; [Taylor, Barry S.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Penny, Robert; Crain, Daniel; Gardner, Johanna; Lau, Kevin; Curely, Erin; Mallery, David; Morris, Scott; Paulauskis, Joseph; Shelton, Troy; Shelton, Candace; Sherman, Mark; Kemkes, Ariane] Int Genom Consortium, Phoenix, AZ 85004 USA; [Benz, Christopher] Buck Inst Res Aging, Novato, CA 94945 USA; [Lee, Jae-Hyuk] Chonnam Natl Univ, Sch Med, Kwangju 501746, South Korea; [Fedosenko, Konstantin; Manikhas, Georgy] City Clin Oncol Dispensary, St Petersburg 198255, Russia; [Voronina, Olga; Belyaev, Dmitry; Dolzhansky, Oleg] Cureline Inc, San Francisco, CA 94080 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Abdel-Misih, Raafat; Bennett, Joseph; Brown, Jennifer; Iacocca, Mary; Rabeno, Brenda] Christiana Care Hlth Syst, Helen Graham Canc Ctr & Res Inst, Newark, DE 19713 USA; [Kwon, Sun-Young] Keimyung Univ, Sch Med, Taegu 700712, South Korea; [Alexopoulou, Iakovina] St Josephs Healthcare Hamilton, Ontario Tumour Bank, Hamilton, ON L8N 3Z5, Canada; [Engel, Jay] Kingston Gen Hosp, Ontario Tumour Bank, Kingston, ON K7L 5H6, Canada; [Bartlett, John; Albert, Monique] Ontario Inst Canc Res, Ontario Tumour Bank, Toronto, ON M5G 0A3, Canada; [Park, Do-Youn] Pusan Natl Univ Hosp, Pusan 602739, South Korea; [Cho, Eunjung; Ladanyi, Marc; Tang, Laura] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [McCall, Shannon J.] Duke Univ, Dept Pathol, Durham, NC 27710 USA; [Cheong, Jae-Ho] Yonsei Univ, Coll Med, Dept Surg, Seoul 120752, South Korea; [Ajani, Jaffer] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Alonso, Shelley; Ayala, Brenda; Jensen, Mark A.; Pihl, Todd; Raman, Rohini; Walton, Jessica; Wan, Yunhu] SRA Int, Fairfax, VA 22033 USA; [Davidsen, Tanja] NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD 20850 USA; [Hutter, Carolyn M.; Sofia, Heidi J.] NHGRI, Bethesda, MD 20892 USA; [Burton, Robert; Chudamani, Sudha; Liu, Jia] SAIC Frederick Inc, Frederick, MD 21702 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Institute for Systems Biology (ISB); University of Southern California; University of Southern California; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; British Columbia Cancer Agency; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; Vanderbilt University; University of Ulsan; Asan Medical Center; Peter Maccallum Cancer Center; University of Melbourne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Case Western Reserve University; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; Duke University; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; Brown University; Harvard University; Brigham & Women's Hospital; National Cancer Center - Korea (NCC); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Washington University (WUSTL); Wielkopolskie Centrum Onkologii; KU Leuven; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Harvard Medical School; Johns Hopkins University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; International Genomics Consortium; Buck Institute for Research on Aging; Chonnam National University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; Keimyung University; McMaster University; Queens University - Canada; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Pusan National University; Pusan National University Hospital; Memorial Sloan Kettering Cancer Center; Duke University; Yonsei University; Yonsei University Health System; University of Texas System; UTMD Anderson Cancer Center; SRA International; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Science Applications International Corporation (SAIC); SAIC-Frederick	Bass, AJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	adam_bass@dfci.harvard.edu	Pedamallu, Chandra Sekhar/AAV-6745-2020; Lee, Ju-Seog/X-1786-2018; Ladanyi, Marc/AAG-8585-2019; Jones, Steven J/C-3621-2009; luketich, james/AAY-6230-2020; Skanderup, Anders Jacobsen/K-1081-2013; Weisenberger, Daniel/AAA-8314-2020; Holt, Robert A/C-3303-2009; Camargo, M. Constanza/R-9891-2016; Mungall, Andrew J./U-7067-2018; liu, ying/GXF-4294-2022; Akbani, Rehan/AAG-1490-2019; Marra, Marco A/B-5987-2008; Verhaak, Roel/ABE-7058-2020; LIU, YING/GZL-7252-2022; Laird, Peter W/G-8683-2012; Lee, Semin/S-2629-2016; Kucherlapati, Raju/ABC-8807-2021; Schein, Jacquie E/G-3674-2015; Van Den Berg, David J/G-8598-2017; Stojanov, Petar/GQI-4462-2022; Cherniack, Andrew/AAC-5310-2019; Cherniack, Andrew D./AAY-8132-2020; Schultz, Nikolaus/ABE-6347-2020; Shen, Hui/AAO-4387-2020; Birol, Inanc/G-5440-2011; Pedamallu, Chandra Sekhar/AAV-6723-2020; Ling, Shiyun/P-2242-2014; Lawrence, Michael/AAC-8202-2020; Suchorska, Wiktoria/CAG-0479-2022; Seth, Sahil/I-5809-2019; Cibulskis, Kristian/AAC-7380-2019; Ibbs, Matthew/AAU-1511-2021; Gao, JianJiong/B-5673-2016; Senbabaoglu, Yasin/I-4922-2013	Lee, Ju-Seog/0000-0002-5666-9753; Jones, Steven J/0000-0003-3394-2208; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Weisenberger, Daniel/0000-0001-8303-2603; Holt, Robert A/0000-0002-7259-1247; Camargo, M. Constanza/0000-0002-1065-2198; Mungall, Andrew J./0000-0002-0905-2742; Marra, Marco A/0000-0001-7146-7175; Laird, Peter W/0000-0001-9117-3641; Lee, Semin/0000-0002-9015-6046; Van Den Berg, David J/0000-0002-5404-5218; Stojanov, Petar/0000-0001-7815-776X; Cherniack, Andrew D./0000-0003-0470-0111; Birol, Inanc/0000-0003-0950-7839; Seth, Sahil/0000-0003-4579-3959; Ibbs, Matthew/0000-0003-2510-3447; Gao, JianJiong/0000-0002-5739-1781; Bootwalla, Moiz/0000-0001-6158-7114; Shen, Hui/0000-0001-9767-4084; Ciriello, Giovanni/0000-0003-2021-8683; Ojesina, Akinyemi/0000-0003-0755-3639; Weinstein, John/0000-0001-9401-6908; Sinha, Rileen/0000-0001-5497-5055; Cibulskis, Kristian/0000-0003-1343-1582; Schultz, Nikolaus/0000-0002-0131-4904; Bowen, Jay/0000-0001-6861-9043; Xi, Ruibin/0000-0001-7545-7361; Schneider, Barbara/0000-0003-4421-1355; Park, Peter/0000-0001-9378-960X; Tarnuzzer, Roy/0000-0002-3725-4173; Meyerson, Matthew/0000-0002-9133-8108; MCLELLAN, MICHAEL/0000-0002-2703-8784; Suchorska, Wiktoria/0000-0003-4742-2465; Yang, Da/0000-0002-8336-9457; McCall, Shannon/0000-0003-3957-061X; Gehlenborg, Nils/0000-0003-0327-8297; Triche, Tim/0000-0001-5665-946X; Jensen, Mark/0000-0001-5215-101X; Rosenberg, Mara/0000-0001-6400-3161; Curtis, Christina/0000-0003-0166-3802; Heiman, David/0000-0001-7895-4259; Stuart, Joshua/0000-0002-2171-565X; Ajani, Jaffer A/0000-0001-9946-0629; Boussioutas, Alex/0000-0002-8109-6897; Cheong, Jae-Ho/0000-0002-1703-1781; Senbabaoglu, Yasin/0000-0003-0958-958X	Intramural Research Program; United States National Institutes of Health [5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273, P30CA16672]; Div Of Information & Intelligent Systems [1016648] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U24CA143867, K08CA134931, U24CA143835, P01CA028842, R01CA180006, U24CA126543, K99CA166729, U24CA143843, U24CA143883, U24CA143858, U24CA143882, P30CA006973, U24CA143866, U24CA143799, U24CA144025, U24CA143845, U24CA143840, U24CA180951, P30CA016672, U24CA143848, P50CA098258] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273, R01HG005690, U54HG003079, U54HG003067] Funding Source: NIH RePORTER	Intramural Research Program; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Information & Intelligent Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful to all the patients and families who contributed to this study and to C. Gunter and J. Weinstein for scientific editing, to M. Sheth for administrative support and to L. Omberg for support with the Sage Bionetworks Synapse platform. This work was supported by the Intramural Research Program and the following grants from the United States National Institutes of Health: 5U24CA143799, 5U24CA143835, 5U24CA143840, 5U24CA143843, 5U24CA143845, 5U24CA143848, 5U24CA143858, 5U24CA143866, 5U24CA143867, 5U24CA143882, 5U24CA143883, 5U24CA144025, U54HG003067, U54HG003079, U54HG003273 and P30CA16672.	Aznar S, 2001, MOL BIOL CELL, V12, P3282, DOI 10.1091/mbc.12.10.3282; Bernal M, 2012, CANCER IMMUNOL IMMUN, V61, P1359, DOI 10.1007/s00262-012-1321-6; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Boussioutas A, 2003, CANCER RES, V63, P2569; Chen BJ, 2013, CLIN CANCER RES, V19, P3462, DOI 10.1158/1078-0432.CCR-13-0855; Doherty GJ, 2011, MOL BIOL CELL, V22, P4380, DOI 10.1091/mbc.E10-12-0936; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Ferlay J., 2013, IARC CANCERBASE, V11; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Geddert H, 2010, ANAL CELL PATHOL, V33, P143, DOI [10.1155/2010/453764, 10.3233/ACP-CLO-2010-0540]; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Greulich H, 2012, P NATL ACAD SCI USA, V109, P14476, DOI 10.1073/pnas.1203201109; Grossmann V, 2011, BLOOD, V118, P6153, DOI 10.1182/blood-2011-07-365320; International Agency for Research on Cancer, 2010, WHO CLASSIFICATION T; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Keller G, 1996, INT J CANCER, V68, P571; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038892; Lei ZD, 2013, GASTROENTEROLOGY, V145, P554, DOI 10.1053/j.gastro.2013.05.010; Matsusaka K, 2011, CANCER RES, V71, P7187, DOI 10.1158/0008-5472.CAN-11-1349; Murphy G, 2009, GASTROENTEROLOGY, V137, P824, DOI 10.1053/j.gastro.2009.05.001; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Palomero T, 2014, NAT GENET, V46, P166, DOI 10.1038/ng.2873; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sakata-Yanagimoto M, 2014, NAT GENET, V46, P171, DOI 10.1038/ng.2872; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Strong MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003341; Sukawa Y, 2012, WORLD J GASTROENTERO, V18, P6577, DOI 10.3748/wjg.v18.i45.6577; Tan IB, 2011, GASTROENTEROLOGY, V141, P476, DOI 10.1053/j.gastro.2011.04.042; Thumkeo D, 2013, EUR J CELL BIOL, V92, P303, DOI 10.1016/j.ejcb.2013.09.002; Toyota M, 1999, CANCER RES, V59, P5438; Tureci O, 2011, GENE, V481, P83, DOI 10.1016/j.gene.2011.04.007; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang K, 2011, NAT GENET, V43, P1219, DOI 10.1038/ng.982; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	40	3529	3681	38	423	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2014	513	7517					202	209		10.1038/nature13480	http://dx.doi.org/10.1038/nature13480			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO5DP	25079317	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000341362800044
J	Furuta, KM; Yadav, SR; Lehesranta, S; Belevich, I; Miyashima, S; Heo, JO; Vaten, A; Lindgren, O; De Rybel, B; Van Isterdael, G; Somervuo, P; Lichtenberger, R; Rocha, R; Thitamadee, S; Tahtiharju, S; Auvinen, P; Beeckman, T; Jokitalo, E; Helariutta, Y				Furuta, Kaori Miyashima; Yadav, Shri Ram; Lehesranta, Satu; Belevich, Ilya; Miyashima, Shunsuke; Heo, Jung-ok; Vaten, Anne; Lindgren, Ove; De Rybel, Bert; Van Isterdael, Gert; Somervuo, Panu; Lichtenberger, Raffael; Rocha, Raquel; Thitamadee, Siripong; Tahtiharju, Sari; Auvinen, Petri; Beeckman, Tom; Jokitalo, Eija; Helariutta, Yka			Arabidopsis NAC45/86 direct sieve element morphogenesis culminating in enucleation	SCIENCE			English	Article							PHLOEM; CELL; DIFFERENTIATION; PROTEIN	Photoassimilates such as sugars are transported through phloem sieve element cells in plants. Adapted for effective transport, sieve elements develop as enucleated living cells. We used electron microscope imaging and three-dimensional reconstruction to follow sieve element morphogenesis in Arabidopsis. We show that sieve element differentiation involves enucleation, in which the nuclear contents are released and degraded in the cytoplasm at the same time as other organelles are rearranged and the cytosol is degraded. These cellular reorganizations are orchestrated by the genetically redundant NAC domain-containing transcription factors, NAC45 and NAC86 (NAC45/86). Among the NAC45/86 targets, we identified a family of genes required for enucleation that encode proteins with nuclease domains. Thus, sieve elements differentiate through a specialized autolysis mechanism.	[Furuta, Kaori Miyashima; Yadav, Shri Ram; Lehesranta, Satu; Belevich, Ilya; Miyashima, Shunsuke; Heo, Jung-ok; Vaten, Anne; Lindgren, Ove; Somervuo, Panu; Lichtenberger, Raffael; Rocha, Raquel; Thitamadee, Siripong; Tahtiharju, Sari; Auvinen, Petri; Jokitalo, Eija; Helariutta, Yka] Univ Helsinki, Inst Biotechnol, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland; [De Rybel, Bert; Van Isterdael, Gert; Beeckman, Tom] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [De Rybel, Bert; Van Isterdael, Gert; Beeckman, Tom] VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Helariutta, Yka] Cardiff Univ, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Helariutta, Yka] Univ Cambridge, Sainsbury Lab, Cambridge CB2 1LR, England	University of Helsinki; Ghent University; Flanders Institute for Biotechnology (VIB); Cardiff University; University of Cambridge	Helariutta, Y (corresponding author), Univ Helsinki, Inst Biotechnol, Dept Biol & Environm Sci, FIN-00014 Helsinki, Finland.	eija.jokitalo@helsinki.fi; yrjo.helariutta@slcu.cam.ac.uk	Auvinen, Petri/D-5044-2009; Beeckman, Tom/ABI-1703-2020; Jokitalo, Eija/C-8375-2009; Helariutta, Yrjo/AAE-8149-2020; Miyashima, Shunsuke/AAV-1196-2021; Beeckman, Tom/ABA-1164-2020; Auvinen, Petri/AAP-8117-2021	Auvinen, Petri/0000-0002-3947-4778; Beeckman, Tom/0000-0001-8656-2060; Jokitalo, Eija/0000-0002-4159-6934; Helariutta, Yrjo/0000-0002-7287-8459; Van Isterdael, Gert/0000-0001-6626-1316; Vaten, Anne/0000-0003-1788-5127; Belevich, Ilya/0000-0003-2190-4909; Miyashima, Shunsuke/0000-0001-8267-3978; De Rybel, Bert/0000-0002-9551-042X	Japanese Society for the Promotion of Science; Research Foundation-Flanders [FWO - GO20011N]; Belgian Federal Science Policy Office; Academy of Finland; Biocenter Finland; University of Helsinki; Academy of Finland Centre of Excellence programme; European Research Council; Tekes (the Finnish Funding Agency for Technology and Innovation); Gatsby Foundation	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Foundation-Flanders(FWO); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Academy of Finland(Academy of Finland); Biocenter Finland; University of Helsinki; Academy of Finland Centre of Excellence programme(Academy of Finland); European Research Council(European Research Council (ERC)European Commission); Tekes (the Finnish Funding Agency for Technology and Innovation)(Finnish Funding Agency for Technology & Innovation (TEKES)); Gatsby Foundation	We thank K. Kainulainen, M. Herpola, M. Lindman, A. Salminen, and I. Sevilem for technical assistance; R. Siligato, A. Mahonen, the University of Ghent, the Arabidopsis Biological Resource Center, and the Nottingham Arabidopsis Stock Centre for published materials; A. Mahonen, E.-L. Eskelinen, A. Suomalainen-Wartiovaara, and P. Runeberg-Roos for discussions; and P. Benfey, K. Nakajima, and S. El-Showk for their critical comments. The serial block-face electron microscopy was supported by Biocenter Finland. S. M. was financially supported by the Japanese Society for the Promotion of Science. Work in the lab of T. B. was partly financed by grants of the Research Foundation-Flanders (project FWO - GO20011N) and the Interuniversity Attraction Poles Programme from the Belgian Federal Science Policy Office. Work in the E. J. laboratory is funded by the Academy of Finland, Biocenter Finland, and the University of Helsinki. Financial support for the lab of Y. H. was provided by the Academy of Finland Centre of Excellence programme, the University of Helsinki, the European Research Council Advanced Investigator Grant Symdev, Tekes (the Finnish Funding Agency for Technology and Innovation), and the Gatsby Foundation. The supplementary materials contain additional data.	BESSIS M, 1952, Rev Hematol, V7, P407; Bonke M, 2003, NATURE, V426, P181, DOI 10.1038/nature02100; Busse JS, 1999, INT J PLANT SCI, V160, P241, DOI 10.1086/314117; CRONSHAW J, 1968, J CELL BIOL, V38, P292, DOI 10.1083/jcb.38.2.292; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; ELEFTHERIOU EP, 1982, PROTOPLASMA, V113, P221, DOI 10.1007/BF01280911; ESAU K, 1950, BOT REV, V16, P67, DOI 10.1007/BF02919553; ESAU K, 1972, ANN BOT-LONDON, V36, P703, DOI 10.1093/oxfordjournals.aob.a084626; Imlau A, 1999, PLANT CELL, V11, P309, DOI 10.1105/tpc.11.3.309; Liu ML, 2012, EUKARYOT CELL, V11, P494, DOI 10.1128/EC.05296-11; Lucas WJ, 2013, J INTEGR PLANT BIOL, V55, P294, DOI 10.1111/jipb.12041; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mijaljica D, 2013, J CELL SCI, V126, P4325, DOI 10.1242/jcs.133090; Sjolund RD, 1997, PLANT CELL, V9, P1137, DOI 10.1105/tpc.9.7.1137; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; van Doorn WG, 2011, CELL DEATH DIFFER, V18, P1241, DOI 10.1038/cdd.2011.36; Wang LK, 2008, PROTOPLASMA, V234, P87, DOI 10.1007/s00709-008-0023-6; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Wu H, 2003, ACTA BOT SIN, V45, P322	19	124	145	3	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					933	937		10.1126/science.1253736	http://dx.doi.org/10.1126/science.1253736			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25081480				2022-12-28	WOS:000340524700047
J	Murakami, H; Keeney, S				Murakami, Hajime; Keeney, Scott			Temporospatial Coordination of Meiotic DNA Replication and Recombination via DDK Recruitment to Replisomes	CELL			English	Article							SISTER-CHROMATID COHESION; DOUBLE-STRAND BREAKS; S-PHASE; CDC7-DBF4 KINASE; CDC7 KINASE; INITIATION; MRC1; PHOSPHORYLATION; PROTEINS; MEIOSIS	It has been long appreciated that, during meiosis, DNA replication is coordinated with the subsequent formation of the double-strand breaks (DSBs) that initiate recombination, but a mechanistic understanding of this process was elusive. We now show that, in yeast, the replisome-associated components Tof1 and Csm3 physically associate with the Dbf4-dependent Cdc7 kinase (DDK) and recruit it to the replisome, where it phosphorylates the DSB-promoting factor Mer2 in the wake of the replication fork, synchronizing replication with an early prerequisite for DSB formation. Recruiting regulatory kinases to replisomes may be a general mechanism to ensure spatial and temporal coordination of replication with other chromosomal processes.	[Murakami, Hajime; Keeney, Scott] Mem Sloan Kettering Canc Ctr, Mol Biol Program, New York, NY 10065 USA; [Keeney, Scott] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Keeney, S (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10065 USA.	s-keeney@ski.mskcc.org	Murakami, Hajime/AAX-9411-2021; Keeney, Scott/GVR-8515-2022	Keeney, Scott/0000-0002-1283-6417; Murakami, Hajime/0000-0002-7022-6887	NIH [R01 GM058673]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058673] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Agnes Viale (Memorial Sloan Kettering Cancer Center [MSKCC] Genomics Core Laboratory) for DNA sequencing, Nicholas Socci (MSKCC Bioinformatics Core) for mapping sequence reads and advice on data analysis; Nicolas Nocetti, Adolfo Cuesta, Hyejin Choi and Zhicheng Qiu for experimental assistance; Bruce Stillman for anti-Orc6 antibody; Michael Lichten and Valerie Borde for strains and plasmids; Franz Klein and Hannah Blitzblau for sharing unpublished data; Dirk Remus and members of the S.K. laboratory, especially Corentin Claeys Bouuaert, Sarah Kim, Isabel Lam, Neeman Mohibullah, Megan van Overbeek, and Xuan Zhu, for discussion and comments on the manuscript; Andrea Farina and Satoko Murakami for experimental support to H.M. This work was supported by NIH grant R01 GM058673.	Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Baker SP, 2010, NAT CELL BIOL, V12, P294, DOI 10.1038/ncb2030; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Blitzblau HG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002643; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Cha RS, 2000, GENE DEV, V14, P493; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Hochwagen A, 2006, CURR BIOL, V16, pR217, DOI 10.1016/j.cub.2006.03.009; Hochwagen A, 2005, CELL, V122, P861, DOI 10.1016/j.cell.2005.07.010; HOLLINGSWORTH RE, 1993, CHROMOSOMA, V102, P415, DOI 10.1007/BF00360406; Katis VL, 2010, DEV CELL, V18, P397, DOI 10.1016/j.devcel.2010.01.014; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Kugou K, 2009, MOL BIOL CELL, V20, P3064, DOI 10.1091/mbc.E08-12-1223; Labib K, 2007, TRENDS CELL BIOL, V17, P271, DOI 10.1016/j.tcb.2007.04.002; LeClere AR, 2013, FUNGAL GENET BIOL, V50, P33, DOI 10.1016/j.fgb.2012.10.007; Matos J, 2008, CELL, V135, P662, DOI 10.1016/j.cell.2008.10.026; Matsumoto S, 2005, J BIOL CHEM, V280, P42536, DOI 10.1074/jbc.M510575200; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; Miyoshi T, 2012, MOL CELL, V47, P722, DOI 10.1016/j.molcel.2012.06.023; Murakami H, 2003, NUCLEIC ACIDS RES, V31, P4085, DOI 10.1093/nar/gkg441; Murakami H, 2001, NAT GENET, V28, P290, DOI 10.1038/90142; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Murakami H, 2009, METHODS MOL BIOL, V557, P117, DOI 10.1007/978-1-59745-527-5_9; NEWLON CS, 1993, COLD SPRING HARB SYM, V58, P415, DOI 10.1101/SQB.1993.058.01.048; Ogino K, 2006, J BIOL CHEM, V281, P1338, DOI 10.1074/jbc.M505767200; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Panizza S, 2011, CELL, V146, P372, DOI 10.1016/j.cell.2011.07.003; Sasanuma H, 2008, GENE DEV, V22, P398, DOI 10.1101/gad.1626608; SCHILD D, 1978, CHROMOSOMA, V70, P109, DOI 10.1007/BF00292220; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Smith DJ, 2012, NATURE, V483, P434, DOI 10.1038/nature10895; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Thacker D, 2014, NATURE, V510, P241, DOI 10.1038/nature13120; Tonami Y, 2005, P NATL ACAD SCI USA, V102, P5797, DOI 10.1073/pnas.0407236102; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Wan LH, 2006, GENETICS, V174, P1767, DOI 10.1534/genetics.106.064303; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Weinreich M, 2001, P NATL ACAD SCI USA, V98, P11211, DOI 10.1073/pnas.201387198; Wu PYJ, 2014, MOL CELL, V53, P655, DOI 10.1016/j.molcel.2014.01.022; Xu H, 2004, MOL CELL BIOL, V24, P7082, DOI 10.1128/MCB.24.16.7082-7090.2004; Yabuki N, 2002, GENES CELLS, V7, P781, DOI 10.1046/j.1365-2443.2002.00559.x	45	76	76	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					861	873		10.1016/j.cell.2014.06.028	http://dx.doi.org/10.1016/j.cell.2014.06.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126790	Bronze, Green Accepted			2022-12-28	WOS:000340944700016
J	Ball, P				Ball, Philip			Artistic alchemy	NATURE			English	Editorial Material												p.ball@btinternet.com							0	0	0	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					26	27		10.1038/512026a	http://dx.doi.org/10.1038/512026a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM5NX	25100468	Bronze			2022-12-28	WOS:000339908000013
J	Proclemer, A; Arenal, A; Lunati, M; Ferrer, JBM; Hersi, A; Manotta, L; Gasparini, M				Proclemer, Alessandro; Arenal, Angel; Lunati, Maurizio; Martnez Ferrer, Jose Bautista; Hersi, Ahmad; Manotta, Laura; Gasparini, Maurizio			Association of Long vs Standard Detection Intervals for Implantable Cardioverter-Defibrillators With Hospitalizations and Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HEART-FAILURE; TRIAL; ICD		[Proclemer, Alessandro] Azienda Osped Univ S Maria Misericordia, Udine, Italy; [Arenal, Angel] Hosp Gen Univ Gregorio Maranon, Madrid, Spain; [Lunati, Maurizio] Azienda Osped Niguarda Ca Granda, Milan, Italy; [Martnez Ferrer, Jose Bautista] Hosp Txagorritxu C Jose Achotegui, Vitoria, Spain; [Hersi, Ahmad] King Saud Univ, Coll Med, Riyadh 11461, Saudi Arabia; [Manotta, Laura] Medtron Clin Res Inst, Sesto San Giovanni, Italy; [Gasparini, Maurizio] Humanitas Res Hosp, Rozzano, Italy	Hospital Santa Maria della Misericordia; General University Gregorio Maranon Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; King Saud University; IRCCS Humanitas Research Hospital	Gasparini, M (corresponding author), IRRCCS, Humanitas Res Hosp, Electrophysiol & Pacing Unit, Via Manzoni 56, I-20089 Rozzano, Italy.	maurizio.gasparini@humanitas.it	Gasparini, Maurizio/GZL-4963-2022; Hersi, Ahmad/ABC-9266-2020	Gasparini, Maurizio/0000-0002-1365-7357; Arenal Maiz, Angel/0000-0001-6636-5473				Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Gasparini M, 2013, JAMA-J AM MED ASSOC, V309, P1903, DOI 10.1001/jama.2013.4598; Gasparini M, 2009, EUR HEART J, V30, P2758, DOI 10.1093/eurheartj/ehp247; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; Schwab JO, 2009, J CARDIOVASC ELECTR, V20, P663, DOI 10.1111/j.1540-8167.2008.01415.x	5	6	6	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					555	557		10.1001/jama.2014.4783	http://dx.doi.org/10.1001/jama.2014.4783			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	25096697				2022-12-28	WOS:000339808600026
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Courage is treating patients with Ebola	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2014, BBC NEWS AFRICA 0730; [Anonymous], 2014, FRONT PAGE AFRI 0703; Black B., 2014, MED SANS FRONTI 0707; Fofana U., 2014, REUTERS AFRICA  0723; HARDEN B, 2001, NY TIMES MAGAZINE; WHO, 2014, EB VIR DIS W AFR UPD; Withnall Adam, 2014, INDEPENDENT	7	3	3	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2014	349								g4987	10.1136/bmj.g4987	http://dx.doi.org/10.1136/bmj.g4987			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MO	25092659	Green Published, Bronze			2022-12-28	WOS:000340205900001
J	Arimbasseri, AG; Kassavetis, GA; Maraia, RJ				Arimbasseri, Aneeshkumar G.; Kassavetis, George A.; Maraia, Richard J.			Comment on "Mechanism of eukaryotic RNA polymerase III transcription termination"	SCIENCE			English	Editorial Material							SACCHAROMYCES-CEREVISIAE	Nielsen et al. (Reports, 28 June 2013, p. 1577) characterized their RNA polymerase III (Pol III) preparation and concluded that it requires an RNA hairpin/duplex structure for terminating transcription. We could not corroborate their findings using bona fide Pol III from two laboratory sources. We show that Pol III efficiently terminates transcription in the absence of a hairpin/duplex in vitro and in vivo.	[Arimbasseri, Aneeshkumar G.; Maraia, Richard J.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Intramural Res Program, NIH, Bethesda, MD 20847 USA; [Kassavetis, George A.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92103 USA; [Maraia, Richard J.] US PHS, Commissioned Corps, Washington, DC 20201 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Diego; United States Public Health Service	Maraia, RJ (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Intramural Res Program, NIH, Bethesda, MD 20847 USA.	maraiar@mail.nih.gov	Maraia, Richard/ABC-1442-2020	Maraia, Richard/0000-0002-5209-0066; Arimbasseri, Gopalakrishnan Aneeshkumar/0000-0001-5266-2688	Intramural NIH HHS [ZIA HD000412-25, ZIA HD000412-26, Z99 HD999999] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000412] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Arimbasseri AG, 2013, TRANSCRIPTION, V4; Arimbasseri AG, 2013, MOL CELL BIOL, V33, P1571, DOI 10.1128/MCB.01733-12; BOGENHAGEN DF, 1981, CELL, V24, P261, DOI 10.1016/0092-8674(81)90522-5; Cherkasova V, 2012, MOL BIOL CELL, V23, P480, DOI 10.1091/mbc.E11-08-0732; ENGELKE DR, 1985, J BIOL CHEM, V260, P1271; Feldman JL, 2007, PLOS BIOL, V5, P1284, DOI [10.1371/journal.pbio.0050149, 10.1371/journal.pbio.0050286]; Hamada M, 2000, J BIOL CHEM, V275, P29076, DOI 10.1074/jbc.M003980200; Huang Y, 2005, MOL CELL BIOL, V25, P621, DOI 10.1128/MCB.25.2.621-636.2005; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; Maraia RJ, 2011, WIRES RNA, V2, P362, DOI 10.1002/wrna.64; MATSUZAKI H, 1994, J MOL BIOL, V235, P1173, DOI 10.1006/jmbi.1994.1072; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; WANG X, 1994, J BIOL CHEM, V269, P4993; Yen MC, 2013, CANCER GENE THER, V20, P351, DOI 10.1038/cgt.2013.27; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	15	16	16	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196								10.1126/science.1253783	http://dx.doi.org/10.1126/science.1253783			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082694	Green Accepted			2022-12-28	WOS:000339651300034
J	Fields, HL				Fields, Howard L.			More pain; less gain	SCIENCE			English	Editorial Material							NEURONS; ANTICIPATION; DOPAMINE; REWARD		[Fields, Howard L.] Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA; [Fields, Howard L.] Univ Calif San Francisco, Sch Med, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Fields, HL (corresponding author), Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94143 USA.	howard.fields@ucsf.edu	Fields, Howard/ABG-9073-2020					[Anonymous], 2013, WALL MELZACKS TXB PA; Balcita-Pedicino JJ, 2011, J COMP NEUROL, V519, P1143, DOI 10.1002/cne.22561; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Brischoux F, 2009, P NATL ACAD SCI USA, V106, P4894, DOI 10.1073/pnas.0811507106; Bromberg-Martin ES, 2010, NEURON, V68, P815, DOI 10.1016/j.neuron.2010.11.022; DAHLSTRO.A, 1964, ACTA PHYSIOL SCAND, V62, P485, DOI 10.1111/j.1748-1716.1964.tb10446.x; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Koob GF, 2006, NEUR ADD; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Lammel S, 2012, NATURE, V491, P212, DOI 10.1038/nature11527; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Schwartz N, 2014, SCIENCE, V345, P535, DOI 10.1126/science.1253994; Tripathi A, 2010, J COMP NEUROL, V518, P4649, DOI 10.1002/cne.22484	15	11	11	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					513	514		10.1126/science.1258477	http://dx.doi.org/10.1126/science.1258477			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082685				2022-12-28	WOS:000339651300023
J	Pfaff, W; Hensen, BJ; Bernien, H; van Dam, SB; Blok, MS; Taminiau, TH; Tiggelman, MJ; Schouten, RN; Markham, M; Twitchen, DJ; Hanson, R				Pfaff, W.; Hensen, B. J.; Bernien, H.; van Dam, S. B.; Blok, M. S.; Taminiau, T. H.; Tiggelman, M. J.; Schouten, R. N.; Markham, M.; Twitchen, D. J.; Hanson, R.			Unconditional quantum teleportation between distant solid-state quantum bits	SCIENCE			English	Article							SPIN; QUBITS; INFORMATION; REGISTER; DIAMOND	Realizing robust quantum information transfer between long-lived qubit registers is a key challenge for quantum information science and technology. Here we demonstrate unconditional teleportation of arbitrary quantum states between diamond spin qubits separated by 3 meters. We prepare the teleporter through photon-mediated heralded entanglement between two distant electron spins and subsequently encode the source qubit in a single nuclear spin. By realizing a fully deterministic Bell-state measurement combined with real-time feed-forward, quantum teleportation is achieved upon each attempt with an average state fidelity exceeding the classical limit. These results establish diamond spin qubits as a prime candidate for the realization of quantum networks for quantum communication and network-based quantum computing.	[Pfaff, W.; Hensen, B. J.; Bernien, H.; van Dam, S. B.; Blok, M. S.; Taminiau, T. H.; Tiggelman, M. J.; Schouten, R. N.; Hanson, R.] Delft Univ Technol, Kavli Inst Nanosci Delft, NL-2600 GA Delft, Netherlands; [Markham, M.; Twitchen, D. J.] Element Six Ltd, Ascot SL5 8BP, Berks, England	Delft University of Technology; Element Six	Hanson, R (corresponding author), Delft Univ Technol, Kavli Inst Nanosci Delft, POB 5046, NL-2600 GA Delft, Netherlands.	r.hanson@tudelft.nl	Hanson, Ronald/B-9555-2008; Taminiau, Tim Hugo H/A-8094-2008; Bernien, Hannes/AAM-5598-2020; Bernien, Hannes/E-6197-2012; Pfaff, Wolfgang/G-9152-2012; Blok, Machiel/GNP-0018-2022	Taminiau, Tim Hugo H/0000-0002-2355-727X; Bernien, Hannes/0000-0002-1950-7368; Blok, Machiel/0000-0001-9736-4158; Markham, Matthew/0000-0001-8898-5884	Dutch Organization for Fundamental Research on Matter (FOM); Defense Advanced Research Projects Agency QuASAR program; European Union DIAMANT; European Union S3NANO; European Research Council	Dutch Organization for Fundamental Research on Matter (FOM)(FOM (The Netherlands)); Defense Advanced Research Projects Agency QuASAR program(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Union DIAMANT; European Union S3NANO; European Research Council(European Research Council (ERC)European Commission)	We thank L. Childress, L. DiCarlo, M. Hatridge, J. J. L. Morton, A. Reiserer, L. M. K. Vandersypen, and P. Walther for valuable discussions. We acknowledge support from the Dutch Organization for Fundamental Research on Matter (FOM), the Defense Advanced Research Projects Agency QuASAR program, the European Union DIAMANT and S3NANO programs, a Marie Curie Intra-European Fellowship, and the European Research Council through a Starting Grant.	Awschalom DD, 2013, SCIENCE, V339, P1174, DOI 10.1126/science.1231364; Barrett SD, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.060310; Barz S, 2012, SCIENCE, V335, P303, DOI 10.1126/science.1214707; BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Blok MS, 2014, NAT PHYS, V10, P189, DOI [10.1038/nphys2881, 10.1038/NPHYS2881]; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Briegel HJ, 1998, PHYS REV LETT, V81, P5932, DOI 10.1103/PhysRevLett.81.5932; Brunner N, 2014, REV MOD PHYS, V86, DOI 10.1103/RevModPhys.86.419; Childress L, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.070504; de Lange G, 2010, SCIENCE, V330, P60, DOI 10.1126/science.1192739; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Jiang L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073001; Kimble HJ, 2008, NATURE, V453, P1023, DOI 10.1038/nature07127; Kolkowitz S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.137601; Krauter H, 2013, NAT PHYS, V9, P400, DOI 10.1038/nphys2631; Loncar M, 2013, MRS BULL, V38, P144, DOI 10.1557/mrs.2013.19; MASSAR S, 1995, PHYS REV LETT, V74, P1259, DOI 10.1103/PhysRevLett.74.1259; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; Monroe C, 2013, SCIENCE, V339, P1164, DOI 10.1126/science.1231298; Neumann P, 2010, SCIENCE, V329, P542, DOI 10.1126/science.1189075; Nickerson NH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2773; Nolleke C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140403; Olmschenk S, 2009, SCIENCE, V323, P486, DOI 10.1126/science.1167209; Robledo L, 2011, NATURE, V477, P574, DOI 10.1038/nature10401; Ryan CA, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.200402; Siyushev P, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.167402; Takeda S, 2013, NATURE, V500, P315, DOI 10.1038/nature12366; Taminiau TH, 2014, NAT NANOTECHNOL, V9, P171, DOI [10.1038/NNANO.2014.2, 10.1038/nnano.2014.2]; Taminiau TH, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.137602; van der Sar T, 2012, NATURE, V484, P82, DOI 10.1038/nature10900; WOOTTERS WK, 1982, NATURE, V299, P802, DOI 10.1038/299802a0; Zhao N, 2012, NAT NANOTECHNOL, V7, P657, DOI [10.1038/nnano.2012.152, 10.1038/NNANO.2012.152]	38	338	344	9	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					532	535		10.1126/science.1253512	http://dx.doi.org/10.1126/science.1253512			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082696	Green Submitted			2022-12-28	WOS:000339651300038
J	Saunders, DL; Vanachayangkul, P; Lon, C				Saunders, David L.; Vanachayangkul, Pattaraporn; Lon, Chanthap		US Army Mil Malaria Res Program; Ctr Parasitology Entomology; Royal Cambodian Armed Forces	Dihydroartemisinin-Piperaquine Failure in Cambodia	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							FALCIPARUM-MALARIA; PLASMODIUM-FALCIPARUM; EFFICACY		[Saunders, David L.; Vanachayangkul, Pattaraporn] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Lon, Chanthap] Armed Forces Res Inst Med Sci, Phnom Penh, Cambodia	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Saunders, DL (corresponding author), Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand.	david.saunders@afrims.org						Gosi P, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-403; Janssens B, 2007, TROP MED INT HEALTH, V12, P251, DOI [10.1111/j.1365-3165.2006.01786.x, 10.1111/j.1365-3156.2006.01786.x]; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; Lon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093138; Zwang J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006358	5	165	168	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					484	485		10.1056/NEJMc1403007	http://dx.doi.org/10.1056/NEJMc1403007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0SK	25075853				2022-12-28	WOS:000339556900027
J	Toro, J; Reyes, S				Toro, Jaime; Reyes, Saul			Tongue Fasciculations in Amyotrophic Lateral Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Toro, Jaime; Reyes, Saul] Hosp Univ Fdn Santa Fe Bogota, Bogota, Colombia		Toro, J (corresponding author), Hosp Univ Fdn Santa Fe Bogota, Bogota, Colombia.	jtoro@uniandes.edu.co		Reyes, Saul/0000-0002-3230-3263					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5							e7	10.1056/NEJMicm1309849	http://dx.doi.org/10.1056/NEJMicm1309849			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0SK	25075854				2022-12-28	WOS:000339556900012
J	Mehrabadi, A; Liu, SL; Bartholomew, S; Hutcheon, JA; Magee, LA; Kramer, MS; Liston, RM; Joseph, KS				Mehrabadi, Azar; Liu, Shiliang; Bartholomew, Sharon; Hutcheon, Jennifer A.; Magee, Laura A.; Kramer, Michael S.; Liston, Robert M.; Joseph, K. S.		Canadian Perinatal Surveillance	Hypertensive disorders of pregnancy and the recent increase in obstetric acute renal failure in Canada: population based retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEVERE MATERNAL MORBIDITY; ACUTE KIDNEY INJURY; ATONIC POSTPARTUM HEMORRHAGE; TEMPORAL TRENDS; RISK; PREECLAMPSIA; ADMISSION; OUTCOMES; RATES	Objective To examine whether changes in postpartum haemorrhage, hypertensive disorders of pregnancy, or other risk factors explain the increase in obstetric acute renal failure in Canada. Design Retrospective cohort study. Setting Canada (excluding the province of Quebec). Participants All hospital deliveries from 2003 to 2010 (n=2 193 425). Main outcome measures Obstetric acute renal failure identified by ICD-10 diagnostic codes. Methods Information on all hospital deliveries in Canada (excluding Quebec) between 2003 and 2010 (n=2 193 425) was obtained from the Canadian Institute for Health Information. Temporal trends in obstetric acute renal failure were assessed among women with and without postpartum haemorrhage, hypertensive disorders of pregnancy, or other risk factors. Logistic regression was used to determine if changes in risk factors explained the temporal increase in obstetric acute renal failure. Results Rates of obstetric acute renal failure rose from 1.66 to 2.68 per 10 000 deliveries between 2003-04 and 2009-10 (61% increase, 95% confidence interval 24% to 110%). Adjustment for postpartum haemorrhage, hypertensive disorders, and other factors did not attenuate the increase. The temporal increase in acute renal failure was restricted to deliveries with hypertensive disorders (adjusted increase 95%, 95% confidence interval 38% to 176%), and was especially pronounced among women with gestational hypertension with significant proteinuria (adjusted increase 171%, 71% to 329%). No significant increase occurred among women without hypertensive disorders (adjusted increase 12%, -28 to 72%). Conclusions The increase in obstetric acute renal failure in Canada between 2003 and 2010 was restricted to women with hypertensive disorders and was especially pronounced among women with pre-eclampsia. Further study is required to determine the cause of the increase among women with pre-eclampsia.	[Mehrabadi, Azar; Hutcheon, Jennifer A.; Magee, Laura A.; Liston, Robert M.; Joseph, K. S.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Mehrabadi, Azar; Hutcheon, Jennifer A.; Magee, Laura A.; Liston, Robert M.; Joseph, K. S.] Childrens & Womens Hlth Ctr British Columbia, Vancouver, BC, Canada; [Mehrabadi, Azar; Hutcheon, Jennifer A.; Magee, Laura A.; Joseph, K. S.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Liu, Shiliang; Bartholomew, Sharon] Publ Hlth Agcy Canada, Maternal & Infant Hlth Sect, Ottawa, ON, Canada; [Magee, Laura A.] Univ British Columbia, Fac Med, Div Gen Internal Med, Vancouver, BC, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	University of British Columbia; BC Women's Hospital & Health Centre; University of British Columbia; Public Health Agency of Canada; University of British Columbia; McGill University; McGill University	Mehrabadi, A (corresponding author), Womens Hosp British Columbia, Vancouver, BC V6H 3N1, Canada.	azar@alumni.ubc.ca		Hutcheon, Jennifer/0000-0002-6618-6018; Joseph, K.S./0000-0003-2317-5607	Canadian Institutes of Health Research (CIHR) [MAH-115445]; CIHR; Michael Smith Foundation for Health Research; British Columbia's Women's Hospital and Health Centre; Child and Family Research Institute; CIHR chair in maternal, fetal, and infant health services research [APR-126338]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); British Columbia's Women's Hospital and Health Centre; Child and Family Research Institute; CIHR chair in maternal, fetal, and infant health services research(Canadian Institutes of Health Research (CIHR))	This work is supported by a Canadian Institutes of Health Research (CIHR) team grant in severe maternal morbidity (MAH-115445). JAH is the recipient of a CIHR new investigator award and a scholar award from the Michael Smith Foundation for Health Research. LAM receives salary support from British Columbia's Women's Hospital and Health Centre. KSJ is supported by an investigator award from the Child and Family Research Institute and a CIHR chair in maternal, fetal, and infant health services research (APR-126338). The funding sources had no role in the design, analysis, interpretation of the results, or the writing of the manuscript.	Abuelo JG, 2007, NEW ENGL J MED, V357, P797, DOI 10.1056/NEJMra064398; Acharya A, 2013, ADV CHRONIC KIDNEY D, V20, P215, DOI 10.1053/j.ackd.2013.02.002; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Blomberg M, 2011, OBSTET GYNECOL, V118, P561, DOI 10.1097/AOG.0b013e31822a6c59; Callaghan WM, 2012, OBSTET GYNECOL, V120, P1029, DOI [10.1097/AOG.0b013e31826d60c5, http://10.1097/AOG.0b013e31826d60c5]; Callaghan WM, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.011; Choudhury D, 2006, NAT CLIN PRACT NEPHR, V2, P80, DOI 10.1038/ncpneph0076; Dormuth CR, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f880; Drakeley AJ, 2002, AM J OBSTET GYNECOL, V186, P253, DOI 10.1067/mob.2002.120279; Ford JB, 2007, INT J GYNECOL OBSTET, V98, P237, DOI 10.1016/j.ijgo.2007.03.011; Gammill Hilary S, 2005, Crit Care Med, V33, pS372, DOI 10.1097/01.CCM.0000183155.46886.C6; Gandhi S, 2013, JAMA-J AM MED ASSOC, V310, P2544, DOI 10.1001/jama.2013.282426; Gurrieri C, 2012, ARCH GYNECOL OBSTET, V286, P567, DOI 10.1007/s00404-012-2323-5; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Howe CJ, 2011, EPIDEMIOLOGY, V22, P874, DOI 10.1097/EDE.0b013e31823029dd; Hwang YJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001821; Joseph KS, 2007, BJOG-INT J OBSTET GY, V114, P751, DOI 10.1111/j.1471-0528.2007.01316.x; Joseph KS, 2010, J OBSTET GYNAECOL CA, V32, P837, DOI 10.1016/S1701-2163(16)34655-2; Joseph KS, 2009, CHRONIC DIS CAN, V29, P96; Knight M, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-55; Koren G, 2006, LANCET, V368, P704, DOI 10.1016/S0140-6736(06)69255-6; KRANE NK, 1988, ARCH INTERN MED, V148, P2347, DOI 10.1001/archinte.148.11.2347; Lapi F, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8525; Lewis G, 2004, 6 REPORT CONFIDENTIA; Liu SL, 2010, J OBSTET GYNAECOL CA, V32, P847, DOI 10.1016/S1701-2163(16)34656-4; Lutomski JE, 2012, BJOG-INT J OBSTET GY, V119, P306, DOI 10.1111/j.1471-0528.2011.03198.x; Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1; Mehrabadi A, 2013, BJOG-INT J OBSTET GY, V120, P853, DOI 10.1111/1471-0528.12149; Mehrabadi A, 2014, J OBSTET GYNAECOL CA, V36, P21, DOI 10.1016/S1701-2163(15)30680-0; Nzerue CM, 1998, J NATL MED ASSOC, V90, P486; Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101; Rossen J, 2011, OBSTET GYNECOL SURV, V66, P18; Royal College of Obstetricians and Gynaelcologists, 2006, GUIDELINE; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P777, DOI 10.1016/0002-9378(90)91009-2; So L, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-161; STEWART GK, 1971, OBSTET GYNECOL, V37, P510; Thadhani R, 1996, NEW ENGL J MED, V334, P1448, DOI 10.1056/NEJM199605303342207; Thornton CE, 2011, HYPERTENS PREGNANCY, V30, P169, DOI 10.3109/10641950902972140; Tuffnell DJ, 2005, BJOG-INT J OBSTET GY, V112, P875, DOI 10.1111/j.1471-0528.2005.00565.x; TURNEY JH, 1989, BRIT J OBSTET GYNAEC, V96, P679, DOI 10.1111/j.1471-0528.1989.tb03282.x; Vikse BE, 2013, LANCET, V382, P104, DOI 10.1016/S0140-6736(13)60741-2; von Dadelszen P, 2010, OBSTET GYNECOL, V116, P659, DOI 10.1097/AOG.0b013e3181eb669d; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073	43	63	68	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 30	2014	349								g4731	10.1136/bmj.g4731	http://dx.doi.org/10.1136/bmj.g4731			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NP	25077825	hybrid, Green Published			2022-12-28	WOS:000339907000002
J	Doshi, P				Doshi, Peter			DRUGS FOR NEGLECTED DISEASES US incentive scheme for neglected diseases: a good idea gone wrong?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												pdoshi@bmj.com						Bryceson ADM, 2006, T ROY SOC TROP MED H, V100, pS1, DOI 10.1016/j.trstmh.2006.02.016; Ridley DB, 2010, LANCET, V376, P922, DOI 10.1016/S0140-6736(10)60669-1; Ridley DB, 2006, HEALTH AFFAIR, V25, P313, DOI 10.1377/hlthaff.25.2.313; TDR, 2014, BANGL BEATS DEADL SC; TDR, 2007, VISC LEISHM EL DRAFT	5	8	9	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 21	2014	349								g4665	10.1136/bmj.g4665	http://dx.doi.org/10.1136/bmj.g4665			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VM	25099712				2022-12-28	WOS:000339565600004
J	Haynes, R; Harden, P; Judge, P; Blackwell, L; Emberson, J; Landray, MJ; Baigent, C; Friend, PJ				Haynes, Richard; Harden, Paul; Judge, Parminder; Blackwell, Lisa; Emberson, Jonathan; Landray, Martin J.; Baigent, Colin; Friend, Peter J.			Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial	LANCET			English	Article							REQUIRING PROLONGED OBSERVATION; ANTIBODY-MEDIATED REJECTION; RENAL-TRANSPLANTATION; CLINICAL-TRIAL; RECIPIENTS; SURVIVAL; PATIENT; DESIGN; TIME	Background Calcineurin inhibitors (CNIs) reduce short-term kidney transplant failure, but might contribute to transplant failure in the long-term. The role of alemtuzumab (a potent lymphocyte-depleting antibody) as an induction treatment followed by an early reduction in CNI and mycophenolate exposure and steroid avoidance, after kidney transplantation is uncertain. We aimed to assess the efficacy and safety of alemtuzumab-based induction treatment compared with basiliximab-based induction treatment in patients receiving kidney transplants. Methods For this randomised trial, we enrolled patients aged 18 years and older who were scheduled to receive a kidney transplant in the next 24 h from 18 transplant centres in the UK. Using minimised randomisation, we randomly assigned patients (1: 1; minimised for age, sex, and immunological risk) to either alemtuzumab-based induction treatment (ie, alemtuzumab followed by low-dose tacrolimus and mycophenolate without steroids) or basiliximab-based induction treatment (basiliximab followed by standard-dose tacrolimus, mycophenolate, and prednisolone). Participants were reviewed at discharge from hospital and at 1, 3, 6, 9, and 12 months after transplantation. The primary outcome was biopsy-proven acute rejection at 6 months, analysed by intention to treat. The study is registered at ClinicalTrials. gov, number NCT01120028, and isrctn.org, number ISRCTN88894088. Findings Between Oct 4, 2010, and Jan 21, 2013, we randomly assigned 852 participants to treatment: 426 to alemtuzumab-based treatment and 426 to basiliximab-based treatment. Overall, individuals allocated to alemtuzumab-based treatment had a 58% proportional reduction in biopsy-proven acute rejection compared with those allocated to basiliximab-based treatment (31 [7%] patients in the alemtuzumab group vs 68 [16%] patients in the basiliximab group; hazard ratio (HR) 0.42, 95% CI 0.28-0.64; log-rank p<0.0001). We detected no between-group difference in treatment effect on transplant failure during the first 6 months (16 [4%] patients vs 13 [3%] patients; HR 1.23, 0.59-2.55; p= 0.58) or serious infection (135 [32%] patients vs 136 [32%] patients; HR 1.02, 0.80-1.29; p= 0.88). During the first 6 months after transplantation, 11 (3%) patients given alemtuzumab-based treatment and six (1%) patients given basiliximab-based treatment died (HR 1.79, 95% CI 0.66-4.83; p= 0.25). Interpretation Compared with standard basiliximab-based treatment, alemtuzumab-based induction therapy followed by reduced CNI and mycophenolate exposure and steroid avoidance reduced the risk of biopsy-proven acute rejection in a broad range of patients receiving a kidney transplant. Long-term follow-up of this trial will assess whether these effects translate into differences in long-term transplant function and survival.	[Friend, Peter J.] Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Study 3C, Oxford OX3 7LF, England	University of Oxford	Friend, PJ (corresponding author), Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Study 3C, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.	ccc@ctsu.ox.ac.uk	Friend, Peter/AAH-6512-2019; Asderakis, Argiris/L-1891-2019	Asderakis, Argiris/0000-0001-6859-2020; Emberson, Jonathan/0000-0001-7792-9422; Landray, Martin/0000-0001-6646-827X; Clancy, Marc/0000-0002-1709-9743; Sharif, Adnan/0000-0002-7586-9136; Watson, Christopher/0000-0002-0590-4901	UK National Health Service Blood and Transplant Research and Development Programme; Pfizer; Novartis UK; Medical Research Council [MC_EX_G0801669, MC_U137686861] Funding Source: researchfish	UK National Health Service Blood and Transplant Research and Development Programme; Pfizer(Pfizer); Novartis UK(Novartis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK National Health Service Blood and Transplant Research and Development Programme, Pfizer, and Novartis UK.	COX DR, 1972, J R STAT SOC B, V34, P187; Ekberg H, 2008, TRANSPLANTATION, V86, P761, DOI 10.1097/TP.0b013e3181856f39; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; HALE G, 1983, BLOOD, V62, P873; Hanaway MJ, 2011, NEW ENGL J MED, V364, P1909, DOI 10.1056/NEJMoa1009546; Haynes R, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-7; Johnson RJ, 2010, TRANSPLANTATION, V89, P387, DOI 10.1097/TP.0b013e3181c9029d; KDIGO Transplant Work Group, 2009, AM J TRANSPLANT, V9, P1, DOI [10.1038/kisup.2012.74, DOI 10.1111/J.1600-6143.2008.02525.X]; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1289, DOI 10.1111/j.1600-6143.2004.00515.x; Morgan RD, 2012, TRANSPLANTATION, V93, P1179, DOI 10.1097/TP.0b013e318257ad41; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Opelz G, 2008, TRANSPLANTATION, V85, P661, DOI 10.1097/TP.0b013e3181661695; Pascual J, 2008, AM J TRANSPLANT, V8, P237; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shabir S, 2014, AM J KIDNEY DIS, V63, P643, DOI 10.1053/j.ajkd.2013.10.059; STILLER CR, 1983, NEW ENGL J MED, V309, P809; Theodoropoulos N, 2013, AM J TRANSPLANT, V13, P197, DOI 10.1111/j.1600-6143.2012.04314.x; Todeschini M, 2013, J IMMUNOL, V191, P2818, DOI 10.4049/jimmunol.1203261; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Wyld M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001307	23	94	94	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1684	1690		10.1016/S0140-6736(14)61095-3	http://dx.doi.org/10.1016/S0140-6736(14)61095-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KU	25078310				2022-12-28	WOS:000345116200030
J	Michos, ED; Wilson, LM; Yeh, HC; Berger, Z; Suarez-Cuervo, C; Stacy, SR; Bass, EB				Michos, Erin D.; Wilson, Lisa M.; Yeh, Hsin-Chieh; Berger, Zackary; Suarez-Cuervo, Catalina; Stacy, Sylvie R.; Bass, Eric B.			Prognostic Value of Cardiac Troponin in Patients With Chronic Kidney Disease Without Suspected Acute Coronary Syndrome A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							STAGE RENAL-DISEASE; LEFT-VENTRICULAR MASS; C-REACTIVE PROTEIN; CHRONIC-HEMODIALYSIS PATIENTS; PERITONEAL-DIALYSIS PATIENTS; T PREDICTS MORTALITY; CARDIOVASCULAR EVENTS; ASYMPTOMATIC PATIENTS; NATRIURETIC PEPTIDE; NT-PROBNP	Background: Clinicians face uncertainty about the prognostic value of troponin testing in patients with chronic kidney disease (CKD) without suspected acute coronary syndrome (ACS). Purpose: To systematically review the literature on troponin testing in patients with CKD without ACS. Data Sources: MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials through May 2014. Study Selection: Studies examining elevated versus normal troponin levels in patients with CKD without ACS. Data Extraction: Paired reviewers selected articles for inclusion, extracted data, and graded strength of evidence (SOE). Meta-analyses were conducted when studies had sufficient homogeneity of key variables. Data Synthesis: Ninety-eight studies met inclusion criteria. Elevated troponin levels were associated with all-cause and cardiovascular mortality among patients receiving dialysis (moderate SOE). Pooled hazard ratios (HRs) for all-cause mortality from studies that adjusted for age and coronary artery disease or a risk equivalent were 3.0 (95% CI, 2.4 to 4.3) for troponin T and 2.7 (CI, 1.9 to 4.6) for troponin I. The pooled adjusted HRs for cardiovascular mortality were 3.3 (CI, 1.8 to 5.4) for troponin T and 4.2 (CI, 2.0 to 9.2) for troponin I. Findings were similar for patients with CKD who were not receiving dialysis, but there were fewer studies. No study tested treatment strategies by troponin cut points. Limitation: Studies were heterogeneous regarding assays, troponin cut points, covariate adjustment, and follow-up. Conclusion: In patients with CKD without suspected ACS, elevated troponin levels were associated with worse prognosis. Future studies should focus on whether this biomarker is more appropriate than clinical models for reclassifying risk of patients with CKD and whether such classification can help guide treatment in those at highest risk for death.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Michos, ED (corresponding author), Johns Hopkins Univ, Sch Med, Div Cardiol, 600 North Wolfe St, Baltimore, MD 21287 USA.	edonnell@jhmi.edu	Berger, Zackary/AAW-5761-2020; Berger, Zackary/I-7032-2013	Bass, Eric/0000-0001-9106-527X; Michos, Erin/0000-0002-5547-5084; Berger, Zackary/0000-0002-5871-0342	Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Primary Funding Source: Agency for Healthcare Research and Quality.	Abaci A, 2004, CLIN CARDIOL, V27, P704, DOI 10.1002/clc.4960271211; Abbas NA, 2005, CLIN CHEM, V51, P2059, DOI 10.1373/clinchem.2005.055665; Alam A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-247; Apple FS, 2004, CLIN CHEM, V50, P2279, DOI 10.1373/clinchem.2004.035741; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Apple FS, 1997, AM J KIDNEY DIS, V29, P399, DOI 10.1016/S0272-6386(97)90201-8; Artunc F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047610; Assa S, 2013, CLIN RES CARDIOL, V102, P439, DOI 10.1007/s00392-013-0551-8; Bagheri N, 2009, SAUDI J KIDNEY DIS T, V20, P789; Bayes-Genis A, 2013, J CARD FAIL, V19, P768, DOI 10.1016/j.cardfail.2013.09.005; Beciani M, 2003, NEPHROL DIAL TRANSPL, V18, P942, DOI 10.1093/ndt/gfg057; Berkman ND, 2012, AHRQ PUBLICATION, V10(11)-EHC063-EF; Boulier A, 2004, NEPHROL DIAL TRANSPL, V19, P2313, DOI 10.1093/ndt/gfh365; Bozbas H, 2004, CLIN CARDIOL, V27, P559, DOI 10.1002/clc.4960271007; Brunet P, 2008, INT J CARDIOL, V129, P205, DOI 10.1016/j.ijcard.2007.07.004; Choy JB, 2003, CAN J CARDIOL, V19, P907; Chrysochou C, 2009, KIDNEY BLOOD PRESS R, V32, P373, DOI 10.1159/000254337; Claes K, 2010, TRANSPLANTATION, V89, P341, DOI 10.1097/TP.0b013e3181bc405e; Codognotto M, 2010, J NEPHROL, V23, P465; Connolly GM, 2008, NEPHROL DIAL TRANSPL, V23, P1019, DOI 10.1093/ndt/gfm738; Conway B, 2005, NEPHROL DIAL TRANSPL, V20, P2759, DOI 10.1093/ndt/gfi125; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Deegan PB, 2001, KIDNEY INT, V60, P2399, DOI 10.1046/j.1523-1755.2001.00076.x; deFilippi C, 2003, JAMA-J AM MED ASSOC, V290, P353, DOI 10.1001/jama.290.3.353; deFilippi C, 2012, CLIN CHEM, V58, P1342, DOI 10.1373/clinchem.2012.185322; Dierkes J, 2000, CIRCULATION, V102, P1964, DOI 10.1161/01.CIR.102.16.1964; Diris JHC, 2004, CIRCULATION, V109, P23, DOI 10.1161/01.CIR.0000109483.45211.8F; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Duman D, 2005, NEPHROL DIAL TRANSPL, V20, P962, DOI 10.1093/ndt/gfh741; Ellis K, 2001, SOUTHERN MED J, V94, P993; Farkouh ME, 2003, AM J MED, V114, P224, DOI 10.1016/S0002-9343(02)01482-1; Farshid A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-280; Feringa HHH, 2006, AM J CARDIOL, V98, P1515, DOI 10.1016/j.amjcard.2006.06.054; Fernandez-Reyes MJ, 2004, J NEPHROL, V17, P721; Gaiki MR, 2012, INT UROL NEPHROL, V44, P1841, DOI 10.1007/s11255-012-0128-x; Geerse DA, 2013, CLIN CHEM LAB MED, V51, P1321, DOI 10.1515/cclm-2012-0305; Goicoechea M, 2005, KIDNEY INT, V67, pS35, DOI 10.1111/j.1523-1755.2005.09308.x; Goicoechea M, 2004, AM J KIDNEY DIS, V43, P846, DOI 10.1053/j.ajkd.2003.12.048; Hallen J, 2011, SCAND J UROL NEPHROL, V45, P151, DOI 10.3109/00365599.2010.529819; Han SH, 2009, AM J NEPHROL, V29, P129, DOI 10.1159/000151634; Hardy RJ, 1996, STAT MED, V15, P619, DOI 10.1002/(SICI)1097-0258(19960330)15:6<619::AID-SIM188>3.0.CO;2-A; Hasegawa M, 2013, HEART VESSELS, V28, P473, DOI 10.1007/s00380-012-0273-2; Hassan HC, 2014, CLIN CHEM, V60, P389, DOI 10.1373/clinchem.2013.207142; Havekes B, 2006, AM J KIDNEY DIS, V47, P823, DOI 10.1053/j.ajkd.2006.01.019; Heeschen C, 2000, CLIN BIOCHEM, V33, P359, DOI 10.1016/S0009-9120(00)00144-2; Helleskov Madsen Lene, 2008, Acute Card Care, V10, P173, DOI 10.1080/17482940802100279; Hickman PE, 2009, INTERN MED J, V39, P812, DOI 10.1111/j.1445-5994.2009.01846.x; Hickson LJ, 2008, AM J TRANSPLANT, V8, P2352, DOI 10.1111/j.1600-6143.2008.02395.x; Hickson LTJ, 2009, AM J TRANSPLANT, V9, P1354, DOI 10.1111/j.1600-6143.2009.02636.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hocher B, 2004, CIRCULATION, V109, P2266, DOI 10.1161/01.CIR.0000128598.72920.B5; Hocher B, 2003, J AM SOC NEPHROL, V14, P2329, DOI 10.1097/01.ASN.0000081662.64171.9B; Hocher B, 2008, KIDNEY BLOOD PRESS R, V31, P360, DOI 10.1159/000173718; Hojs R, 2005, ARCH MED RES, V36, P367, DOI 10.1016/j.arcmed.2005.03.024; Holden RM, 2012, HEMODIAL INT, V16, P53, DOI 10.1111/j.1542-4758.2011.00630.x; Hung SY, 2004, BLOOD PURIFICAT, V22, P338, DOI 10.1159/000079188; Hussein Magdi, 2004, Hemodial Int, V8, P332, DOI 10.1111/j.1492-7535.2004.80406.x; Ie EHY, 2004, NEPHRON CLIN PRACT, V98, pC87, DOI 10.1159/000080679; Iliou MC, 2003, AM J KIDNEY DIS, V42, P513, DOI 10.1016/S0272-6386(03)00746-7; Ilva T, 2008, EUR J HEART FAIL, V10, P772, DOI 10.1016/j.ejheart.2008.06.009; Ishii J, 2001, CLIN CHIM ACTA, V312, P69, DOI 10.1016/S0009-8981(01)00592-7; Jaffe AS, 2006, J AM COLL CARDIOL, V48, P1763, DOI 10.1016/j.jacc.2006.08.006; Kalaji FR, 2012, SAUDI J KIDNEY DIS T, V23, P939, DOI 10.4103/1319-2442.100868; Kang EW, 2009, NEPHROL DIAL TRANSPL, V24, P1568, DOI 10.1093/ndt/gfn730; Kanwar M, 2006, AM J CARDIOL, V98, P1283, DOI 10.1016/j.amjcard.2006.05.064; Katerinis I, 2008, RENAL FAILURE, V30, P357, DOI 10.1080/08860220801947355; Kertai MD, 2004, EUR J VASC ENDOVASC, V28, P59, DOI 10.1016/j.ejvs.2004.02.026; Khan IA, 2001, J AM COLL CARDIOL, V38, P991, DOI 10.1016/S0735-1097(01)01513-3; Khan NA, 2005, CIRCULATION, V112, P3088, DOI 10.1161/CIRCULATIONAHA.105.560128; Kostrubiec M, 2010, J THROMB HAEMOST, V8, P651, DOI 10.1111/j.1538-7836.2010.03762.x; Lamb EJ, 2007, AM J KIDNEY DIS, V49, P507, DOI 10.1053/j.ajkd.2007.01.015; Lang K, 2001, CLIN NEPHROL, V56, P44; Le Goff C, 2008, IMMUNO-ANAL BIOL SPE, V23, P11, DOI 10.1016/j.immbio.2008.01.003; Levin A, 2014, NEPHROL DIAL TRANSPL, V29, P1037, DOI 10.1093/ndt/gft479; Lowbeer C, 2003, J INTERN MED, V253, P153, DOI 10.1046/j.1365-2796.2003.01069.x; Lowbeer C, 2002, NEPHROL DIAL TRANSPL, V17, P2178, DOI 10.1093/ndt/17.12.2178; Mallamaci F, 2002, AM J KIDNEY DIS, V40, P68, DOI 10.1053/ajkd.2002.33914; Martin GS, 1998, NEPHROL DIAL TRANSPL, V13, P1709, DOI 10.1093/ndt/13.7.1709; McGill D, 2010, CLIN CHIM ACTA, V411, P936, DOI 10.1016/j.cca.2010.03.004; McMurray JJV, 2011, AM HEART J, V162, P748, DOI 10.1016/j.ahj.2011.07.016; Mockel M, 1999, NEPHROL DIAL TRANSPL, V14, P1489, DOI 10.1093/ndt/14.6.1489; Morton AR, 1998, ASAIO J, V44, pM433, DOI 10.1097/00002480-199809000-00021; Musso P, 1999, CLIN BIOCHEM, V32, P125, DOI 10.1016/S0009-9120(98)00089-7; National Institute of Diabetes and Digestive and Kidney Diseases, 2011, US REN DAT SYST 2011; Newby LK, 2012, J AM COLL CARDIOL, V60, P2427, DOI 10.1016/j.jacc.2012.08.969; Ooi DS, 1999, CLIN BIOCHEM, V32, P647, DOI 10.1016/S0009-9120(99)00064-8; Ooi DS, 2001, CLIN CHEM, V47, P412; Orea-Tejeda A, 2010, CARDIOL J, V17, P42; Peetz D, 2003, MED KLIN, V98, P188, DOI 10.1007/s00063-003-1243-3; Petrovic D, 2009, J ARTIF ORGANS, V12, P258, DOI 10.1007/s10047-009-0472-5; Porter G A, 2000, Clin Lab, V46, P469; Porter GA, 1998, EUR HEART J, V19, pN34; Quiroga B, 2013, NEFROLOGIA, V33, P539, DOI 10.3265/Nefrologia.pre2013.May.11895; Roberts MA, 2004, CLIN NEPHROL, V61, P40; Roberts MA, 2009, ANN CLIN BIOCHEM, V46, P291, DOI 10.1258/acb.2009.008213; Roche, 2004, TRADE NEWS      0524; Roppolo LP, 1999, J AM COLL CARDIOL, V34, P448, DOI 10.1016/S0735-1097(99)00207-7; Sahinarslan A, 2008, TURK KARDIYOL DERN A, V36, P382; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Satyan S, 2007, AM J KIDNEY DIS, V50, P1009, DOI 10.1053/j.ajkd.2007.08.017; Scheven L, 2012, EUR HEART J, V33, P2272, DOI 10.1093/eurheartj/ehs163; Scott B, 2003, NEPHROL DIAL TRANSPL, V18, P737, DOI 10.1093/ndt/gfg020; Sharma R, 2006, HEART, V92, P804, DOI 10.1136/hrt.2005.069666; Sharma R, 2006, AM J KIDNEY DIS, V47, P493, DOI 10.1053/j.ajkd.2005.11.026; Sharma R, 2005, Eur J Echocardiogr, V6, P327, DOI 10.1016/j.euje.2005.04.011; Shroff GR, 2012, AM J NEPHROL, V35, P175, DOI 10.1159/000335679; Sommerer C, 2007, EUR J CLIN INVEST, V37, P350, DOI 10.1111/j.1365-2362.2007.01785.x; Stolear JC, 1999, NEPHROL DIAL TRANSPL, V14, P1961, DOI 10.1093/ndt/14.8.1961; Svensson M, 2009, CLIN NEPHROL, V71, P380; Trape J, 2008, SCAND J CLIN LAB INV, V68, P415, DOI 10.1080/00365510701813088; Troyanov S, 2005, HEART, V91, P1227, DOI 10.1136/hrt.2004.051219; Vestergaard P, 2003, BMJ-BRIT MED J, V327, P530, DOI 10.1136/bmj.327.7414.530; Vichairuangthum Kitigon, 2006, Journal of the Medical Association of Thailand, V89, P714; Wang AYM, 2006, KIDNEY INT, V70, P444, DOI 10.1038/sj.ki.5001605; Wang AYM, 2008, J AM SOC NEPHROL, V19, P1643, DOI 10.1681/ASN.2008010012; Wang AYM, 2007, CLIN CHEM, V53, P882, DOI 10.1373/clinchem.2006.078378; Wang AYM, 2010, HYPERTENSION, V56, P210, DOI 10.1161/HYPERTENSIONAHA.110.151167; Wayand D, 2000, CLIN CHEM, V46, P1345; Wolley M, 2013, CLIN KIDNEY J, V6, P402, DOI 10.1093/ckj/sfs122; Wood GNI, 2003, NEPHROL DIAL TRANSPL, V18, P1610, DOI 10.1093/ndt/gfg198; Yakupoglu U, 2002, TRANSPLANT P, V34, P2033, DOI 10.1016/S0041-1345(02)02841-5	121	84	86	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 7	2014	161	7					491	+		10.7326/M14-0743	http://dx.doi.org/10.7326/M14-0743			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LU	25111499				2022-12-28	WOS:000343896700008
J	Bassett, LC; Heremans, FJ; Christle, DJ; Yale, CG; Burkard, G; Buckley, BB; Awschalom, DD				Bassett, Lee C.; Heremans, F. Joseph; Christle, David J.; Yale, Christopher G.; Burkard, Guido; Buckley, Bob B.; Awschalom, David D.			Ultrafast optical control of orbital and spin dynamics in a solid-state defect	SCIENCE			English	Article							QUANTUM; ENTANGLEMENT; DIAMOND; SILICON; QUBITS	The interplay of light and magnetism allowed light to be used as a probe of magnetic materials. Now the focus has shifted to use polarized light to alter or manipulate magnetism. Here, we demonstrate optical control of ferromagnetic materials ranging from magnetic thin films to multilayers and even granular films being explored for ultra-high-density magnetic recording. Our finding shows that optical control of magnetic materials is a much more general phenomenon than previously assumed and may have a major impact on data memory and storage industries through the integration of optical control of ferromagnetic bits.	[Bassett, Lee C.; Heremans, F. Joseph; Christle, David J.; Yale, Christopher G.; Buckley, Bob B.; Awschalom, David D.] Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA; [Heremans, F. Joseph; Christle, David J.; Yale, Christopher G.; Awschalom, David D.] Univ Chicago, Inst Mol Engn, Chicago, IL 60637 USA; [Burkard, Guido] Univ Konstanz, Dept Phys, D-78457 Constance, Germany	University of California System; University of California Santa Barbara; University of Chicago; University of Konstanz	Awschalom, DD (corresponding author), Univ Calif Santa Barbara, Ctr Spintron & Quantum Computat, Santa Barbara, CA 93106 USA.	awsch@uchicago.edu	Burkard, Guido/A-6949-2008; Bassett, Lee/AAD-6466-2019; Christle, David/K-5021-2017	Burkard, Guido/0000-0001-9053-2200; Bassett, Lee/0000-0001-8729-1530; Christle, David/0000-0001-9338-3335; Yale, Christopher/0000-0002-8968-8870	Air Force Office of Scientific Research; NSF [DMR-1306300]; German Research Foundation [SFB 767]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); NSF(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG))	We thank K. Ohno for help with sample characterization and A. Falk for thoughtful comments. We gratefully acknowledge support from the Air Force Office of Scientific Research, the NSF DMR-1306300, and the German Research Foundation (SFB 767). All data described in this Report are presented in the supplementary materials.	Aslam N, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/1/013064; Awschalom DD, 2013, SCIENCE, V339, P1174, DOI 10.1126/science.1231364; Bassett LC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.266403; Batalov A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195506; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Buckley BB, 2010, SCIENCE, V330, P1212, DOI 10.1126/science.1196436; Doherty MW, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025019; Faraon A, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/2/025010; Fu KMC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.256404; Fuchs GD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.157602; Garcia-Ripoll JJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157901; Gilchrist A, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.062310; Hirayama T, 2002, OPT LETT, V27, P860, DOI 10.1364/OL.27.000860; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Koehl WF, 2011, NATURE, V479, P84, DOI 10.1038/nature10562; Lenef A, 1996, PHYS REV B, V53, P13427, DOI 10.1103/PhysRevB.53.13427; Madsen MJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.040505; Marseglia L, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3573870; Maurer PC, 2012, SCIENCE, V336, P1283, DOI 10.1126/science.1220513; Maze JR, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/2/025025; Pla JJ, 2012, NATURE, V489, P541, DOI 10.1038/nature11449; Robledo L, 2011, NATURE, V477, P574, DOI 10.1038/nature10401; Romero G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.120501; Saeedi K, 2013, SCIENCE, V342, P830, DOI 10.1126/science.1239584; Tamarat P, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/045004; Togan E, 2010, NATURE, V466, P730, DOI 10.1038/nature09256; Toyli DM, 2010, NANO LETT, V10, P3168, DOI 10.1021/nl102066q; Yale CG, 2013, P NATL ACAD SCI USA, V110, P7595, DOI 10.1073/pnas.1305920110	30	60	62	1	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2014	345	6202					1333	1337		10.1126/science.1255541	http://dx.doi.org/10.1126/science.1255541			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO6TG	25123482				2022-12-28	WOS:000341483800061
J	Annas, GJ				Annas, George J.			Medical Marijuana, Physicians, and State Law	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.							Annas GJ, 1997, NEW ENGL J MED, V337, P435, DOI 10.1056/NEJM199708073370621; [Anonymous], 2014, NY TIMES; Cole JM, 2013, GUIDANCE REGARDING M; Kassirer JP, 1997, NEW ENGL J MED, V336, P366, DOI 10.1056/NEJM199701303360509	4	19	20	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2014	371	11					983	985		10.1056/NEJMp1408965	http://dx.doi.org/10.1056/NEJMp1408965			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5KD	25099473				2022-12-28	WOS:000341382800002
J	Dulac, C; O'Connell, LA; Wu, Z				Dulac, Catherine; O'Connell, Lauren A.; Wu, Zheng			Neural control of maternal and paternal behaviors	SCIENCE			English	Review							MEDIAL PREOPTIC AREA; PARENTAL BEHAVIOR; MICROTUS-PENNSYLVANICUS; REPRODUCTIVE-BEHAVIOR; MALE-MICE; FEMALE; INFANTICIDE; CARE; NEURONS; SYSTEM	Parental care, including feeding and protection of young, is essential for the survival as well as mental and physical well-being of the offspring. A large variety of parental behaviors has been described across species and sexes, raising fascinating questions about how animals identify the young and how brain circuits drive and modulate parental displays in males and females. Recent studies have begun to uncover a striking antagonistic interplay between brain systems underlying parental care and infant-directed aggression in both males and females, as well as a large range of intrinsic and environmentally driven neural modulation and plasticity. Improved understanding of the neural control of parental interactions in animals should provide novel insights into the complex issue of human parental care in both health and disease.	[Dulac, Catherine; Wu, Zheng] Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA; [O'Connell, Lauren A.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Ctr Brain Sci, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu		Dulac, Catherine/0000-0001-5024-5418; O'Connell, Lauren/0000-0002-2706-4077	Howard Hughes Medical Institute; National Institute on Deafness and Other Communication Disorders; William F. Milton Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013087, R01DC009019] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); William F. Milton Fund; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank A. E. Autry and A. Bendesky for comments on the manuscript, and R. Hellmiss for assistance with figure artwork. Supported by the Howard Hughes Medical Institute (C. D., Z.W.), the National Institute on Deafness and Other Communication Disorders (C. D., Z.W.), and the William F. Milton Fund (L.A.O.). We apologize to colleagues whose work we could not cite because of space constraints.	ALLIN JT, 1972, ANIM BEHAV, V20, P175, DOI 10.1016/S0003-3472(72)80189-1; Angelier F, 2009, PHYSIOL BIOCHEM ZOOL, V82, P590, DOI 10.1086/603634; Beach F. A., 1956, Behaviour, V10, P104, DOI 10.1163/156853956X00129; BROWN RE, 1993, BEHAV PROCESS, V30, P1, DOI 10.1016/0376-6357(93)90009-G; Bruckner GH, 1933, Z PSYCHOL PHYSIOL SI, V128, P1; Chokchaloemwong D, 2013, HORM BEHAV, V64, P53, DOI 10.1016/j.yhbeh.2013.04.010; Cohen L, 2011, NEURON, V72, P357, DOI 10.1016/j.neuron.2011.08.019; Dalgetty L, 2010, BIOL LETTERS, V6, P293, DOI 10.1098/rsbl.2009.0934; DEMSKI LS, 1971, J COMP NEUROL, V143, P1, DOI 10.1002/cne.901430102; EHRET G, 1986, ANIM BEHAV, V34, P821, DOI 10.1016/S0003-3472(86)80067-7; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; ELWOOD RW, 1994, BEHAV PROCESS, V33, P15, DOI 10.1016/0376-6357(94)90057-4; ELWOOD RW, 1985, J COMP PSYCHOL, V99, P457, DOI 10.1037/0735-7036.99.4.457; ELWOOD RW, 1984, ANIM BEHAV, V32, P293, DOI 10.1016/S0003-3472(84)80350-4; Fleming AS, 1997, HORM BEHAV, V32, P85, DOI 10.1006/hbeh.1997.1407; FLEMING AS, 1993, DEV PSYCHOBIOL, V26, P115, DOI 10.1002/dev.420260204; Gettler LT, 2011, P NATL ACAD SCI USA, V108, P16194, DOI 10.1073/pnas.1105403108; HANSEN S, 1991, BEHAV NEUROSCI, V105, P588, DOI 10.1037/0735-7044.105.4.588; HANSEN S, 1991, PHARMACOL BIOCHEM BE, V39, P71, DOI 10.1016/0091-3057(91)90399-M; HAUSER H, 1985, HORM BEHAV, V19, P454, DOI 10.1016/0018-506X(85)90041-8; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Insel TR, 2001, NAT REV NEUROSCI, V2, P129, DOI 10.1038/35053579; KENDRICK KM, 1992, SCIENCE, V256, P833, DOI 10.1126/science.1589766; KETTERSON ED, 1994, ANNU REV ECOL SYST, V25, P601, DOI 10.1146/annurev.es.25.110194.003125; KEVERNE EB, 1983, SCIENCE, V219, P81, DOI 10.1126/science.6849123; KIRKPATRICK B, 1994, BRAIN RES, V658, P112, DOI 10.1016/S0006-8993(09)90016-6; Kokko H, 2012, EVOLUTION OF PARENTAL CARE, P101; Kopel H, 2012, J NEUROSCI, V32, P7519, DOI 10.1523/JNEUROSCI.6354-11.2012; LABOV JB, 1980, BEHAV ECOL SOCIOBIOL, V6, P297, DOI 10.1007/BF00292772; Lee A, 2000, BEHAV BRAIN RES, V108, P213, DOI 10.1016/s0166-4328(98)00109-0; Lerch-Haner JK, 2008, NAT NEUROSCI, V11, P1001, DOI 10.1038/nn.2176; Levy F, 2004, HORM BEHAV, V46, P284, DOI 10.1016/j.yhbeh.2004.02.005; LEVY F, 1983, PHYSIOL BEHAV, V31, P687, DOI 10.1016/S0031-9384(83)80004-3; Levy F, 2009, BEHAV BRAIN RES, V200, P336, DOI 10.1016/j.bbr.2008.12.017; Liu HX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2336; Liu RC, 2006, EUR J NEUROSCI, V23, P3087, DOI 10.1111/j.1460-9568.2006.04840.x; Liu RC, 2007, PLOS BIOL, V5, P1426, DOI 10.1371/journal.pbio.0050173; Lonstein JS, 1999, PHYSIOL BEHAV, V66, P33, DOI 10.1016/S0031-9384(98)00270-4; Lucas BK, 1998, ENDOCRINOLOGY, V139, P4102, DOI 10.1210/en.139.10.4102; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; Macbeth AH, 2010, BEHAV NEUROSCI, V124, P677, DOI 10.1037/a0020799; MALCOLM JR, 1985, AM ZOOL, V25, P853; MCCARTHY MM, 1985, PHYSIOL BEHAV, V35, P843, DOI 10.1016/0031-9384(85)90248-3; MCGUIRE B, 1988, J MAMMAL, V69, P332, DOI 10.2307/1381383; MENDOZA SP, 1986, ANIM BEHAV, V34, P1336, DOI 10.1016/S0003-3472(86)80205-6; MENNELLA JA, 1988, PHYSIOL BEHAV, V42, P19, DOI 10.1016/0031-9384(88)90254-5; MENNELLA JA, 1988, PHYSIOL BEHAV, V42, P303, DOI 10.1016/0031-9384(88)90087-X; MIHOK S, 1979, CAN J ZOOL, V57, P1520, DOI 10.1139/z79-200; MOFFAT SD, 1993, PHYSIOL BEHAV, V53, P805, DOI 10.1016/0031-9384(93)90192-I; MOLTZ H, 1970, PHYSIOL BEHAV, V5, P1373, DOI 10.1016/0031-9384(70)90122-8; Motta SC, 2009, P NATL ACAD SCI USA, V106, P4870, DOI 10.1073/pnas.0900939106; Nishimori K, 1996, P NATL ACAD SCI USA, V93, P11699, DOI 10.1073/pnas.93.21.11699; Numan M, 1997, J NEUROENDOCRINOL, V9, P369, DOI 10.1046/j.1365-2826.1997.t01-1-00597.x; NUMAN M, 1993, HORM BEHAV, V27, P56, DOI 10.1006/hbeh.1993.1005; Numan M., 2003, HORM BR BEHAV; Numan M, 2007, DEV PSYCHOBIOL, V49, P12, DOI 10.1002/dev.20198; Numan M, 2009, BEHAV NEUROSCI, V123, P740, DOI 10.1037/a0016204; Numan M, 2009, FRONT NEUROENDOCRIN, V30, P46, DOI 10.1016/j.yfrne.2008.10.002; O'Connell LA, 2012, HORM BEHAV, V61, P725, DOI 10.1016/j.yhbeh.2012.03.009; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; Olazabal DE, 2013, NEUROSCI BIOBEHAV R, V37, P1875, DOI 10.1016/j.neubiorev.2013.04.004; OLIVERAS D, 1986, ANIM BEHAV, V34, P519, DOI 10.1016/S0003-3472(86)80120-8; Parker KJ, 2001, HORM BEHAV, V39, P285, DOI 10.1006/hbeh.2001.1655; PERRIGO G, 1989, PHYSIOL BEHAV, V46, P121, DOI 10.1016/0031-9384(89)90244-8; PORTER RH, 1991, SMELL TASTE HLTH DIS, P429; PRIESTNALL R, 1978, DEV PSYCHOBIOL, V11, P23, DOI 10.1002/dev.420110107; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; Rich ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098839; Rilling JK, 2014, SCIENCE, V345, P771, DOI 10.1126/science.1252723; ROSENBLATT JS, 1967, SCIENCE, V156, P1512, DOI 10.1126/science.156.3781.1512; Rosenfeld CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075725; Rothschild G, 2013, J NEUROSCI, V33, P12851, DOI 10.1523/JNEUROSCI.4656-12.2013; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; SAAL FSV, 1985, PHYSIOL BEHAV, V34, P7, DOI 10.1016/0031-9384(85)90069-1; Schneider JS, 2003, P NATL ACAD SCI USA, V100, P2951, DOI 10.1073/pnas.0130100100; Schulte LM, 2011, ANIM BEHAV, V81, P1147, DOI 10.1016/j.anbehav.2011.02.019; Sheehan T, 2001, NEUROSCIENCE, V106, P341, DOI 10.1016/S0306-4522(01)00286-X; SIMERLY RB, 1984, J COMP NEUROL, V225, P151, DOI 10.1002/cne.902250202; SMOTHERMAN WP, 1974, BEHAV BIOL, V12, P55, DOI 10.1016/S0091-6773(74)91026-8; SOROKER V, 1988, ANIM BEHAV, V36, P1275, DOI 10.1016/S0003-3472(88)80196-9; Summers K, 1999, HERPETOLOGICA, V55, P254; SVARE B, 1981, PHYSIOL BEHAV, V27, P921, DOI 10.1016/0031-9384(81)90062-7; Tachikawa KS, 2013, J NEUROSCI, V33, P5120, DOI 10.1523/JNEUROSCI.2364-12.2013; Tacon P, 2000, GEN COMP ENDOCR, V117, P54, DOI 10.1006/gcen.1999.7388; TERKEL J, 1968, J COMP PHYSIOL PSYCH, V65, P479, DOI 10.1037/h0025817; Thomas SA, 1997, CELL, V91, P583, DOI 10.1016/S0092-8674(00)80446-8; Tinbergen N, 1951, STUDY INSTINCT; TOWNSEND DS, 1987, HORM BEHAV, V21, P93, DOI 10.1016/0018-506X(87)90034-1; van Iersel JJA., 1953, BEHAVIOUR, V3, P1; WAMBOLDT MZ, 1988, DEV PSYCHOBIOL, V21, P187, DOI 10.1002/dev.420210207; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WERREN JH, 1980, J THEOR BIOL, V82, P619, DOI 10.1016/0022-5193(80)90182-4; WEYGOLDT P, 1987, Z ZOOL SYST EVOL, V25, P51; Wisner KL, 2013, JAMA PSYCHIAT, V70, P490, DOI 10.1001/jamapsychiatry.2013.87; Wu Z, 2014, NATURE, V509, P325, DOI 10.1038/nature13307	95	222	226	5	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					765	770		10.1126/science.1253291	http://dx.doi.org/10.1126/science.1253291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124430	Green Submitted, Green Accepted			2022-12-28	WOS:000340593100034
J	Bartek, J; Hodny, Z				Bartek, Jiri; Hodny, Zdenek			AGEING Old blood stem cells feel the stress	NATURE			English	Editorial Material							DAMAGE; REPAIR	Ageing is accompanied by deterioration in the haematopoietic stem cells that are responsible for regenerating the blood system. Cellular stress in the aged stem cells could be a cause of this decline.	[Bartek, Jiri; Hodny, Zdenek] Inst Mol Genet ASCR, Vvi, Prague 14220, Czech Republic; [Bartek, Jiri] Danish Canc Soc, Res Ctr, Genome Integr Unit, DK-2100 Copenhagen, Denmark	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Danish Cancer Society	Bartek, J (corresponding author), Inst Mol Genet ASCR, Vvi, Prague 14220, Czech Republic.	jb@cancer.dk; hodny@img.cas						Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Geiger H, 2014, CURR OPIN IMMUNOL, V29, P86, DOI 10.1016/j.coi.2014.05.002; Golomb L, 2014, FEBS LETT, V588, P2571, DOI 10.1016/j.febslet.2014.04.014; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	10	5	5	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					140	141		10.1038/nature13652	http://dx.doi.org/10.1038/nature13652			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25079313				2022-12-28	WOS:000340200700017
J	Hollingsworth, JM; Wilt, TJ				Hollingsworth, John M.; Wilt, Timothy J.			Lower urinary tract symptoms in men	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BENIGN PROSTATIC HYPERPLASIA; FLOPPY-IRIS SYNDROME; COMMUNITY-BASED POPULATION; TRANSURETHRAL RESECTION; SAW PALMETTO; DOUBLE-BLIND; COMBINATION THERAPY; BOTULINUM-TOXIN; LASER-ABLATION; ALPHA(1)-ADRENERGIC RECEPTOR	Benign prostatic hyperplasia (BPH) is a highly prevalent and costly condition that affects older men worldwide. Many affected men develop lower urinary tract symptoms, which can have a negative impact on their quality of life. In the past, transurethral resection of the prostate (TURP) was the mainstay of treatment. However, several efficacious drug treatments have been developed, which have transformed BPH from an acute surgical entity to a chronic medical condition. Specifically, multiple clinical trials have shown that a adrenoceptor antagonists can significantly ameliorate lower urinary tract symptoms. Moreover, 5a reductase inhibitors, alone or combined with an a adrenoceptor antagonist, can reverse the natural course of BPH, reducing the risk of urinary retention and the need for surgical intervention. Newer medical regimens including the use of antimuscarinic agents or phosphodiesterase type 5 inhibitors, have shown promise in men with predominantly storage symptoms and concomitant erectile dysfunction, respectively. For men who do not adequately respond to conservative measures or pharmacotherapy, minimally invasive surgical techniques (such as transurethral needle ablation, microwave thermotherapy, and prostatic urethral lift) may be of benefit, although they lack the durability of TURP. A variety of laser procedures have also been introduced, whose improved hemostatic properties abrogate many of the complications associated with traditional surgery.	[Hollingsworth, John M.] Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI USA; [Hollingsworth, John M.] Univ Michigan, Sch Med, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI USA; [Wilt, Timothy J.] Minneapolis VA Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; [Wilt, Timothy J.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities	Wilt, TJ (corresponding author), Minneapolis VA Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA.	tim.wilt@va.gov			Agency for Healthcare Research and Quality [1K08HS020927-01A1]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS020927] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funding from the Agency for Healthcare Research and Quality (1K08HS020927-01A1 to JMH).	Abrams P, 1999, Rev Urol, V1, P65; American Urological Association Guideline, 2010, MAN BEN PROST HYP BP; Andersson KE, 2011, NEUROUROL URODYNAM, V30, P292, DOI 10.1002/nau.20999; Andriole GL, 2010, NEW ENGL J MED, V362, P1192, DOI 10.1056/NEJMoa0908127; ANSON K, 1995, UROLOGY, V46, P305, DOI 10.1016/S0090-4295(99)80211-8; Bales GT, 1999, UROLOGY, V54, P86, DOI 10.1016/S0090-4295(99)00028-X; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Barry MJ, 2011, JAMA-J AM MED ASSOC, V306, P1344, DOI 10.1001/jama.2011.1364; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BARRY MJ, 1995, J UROLOGY, V154, P1770, DOI 10.1016/S0022-5347(01)66780-6; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Belal M, 2006, J UROLOGY, V176, P22, DOI 10.1016/S0022-5347(06)00569-6; Bent S, 2006, NEW ENGL J MED, V354, P557, DOI 10.1056/NEJMoa053085; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Biester K, 2012, BJU INT, V109, P722, DOI 10.1111/j.1464-410X.2011.10512.x; BOSCH JLHR, 1995, UROLOGY, V46, P34; Bouza Carmen, 2006, BMC Urol, V6, P14, DOI 10.1186/1471-2490-6-14; Cabot A T, 1896, Ann Surg, V24, P265, DOI 10.1097/00000658-189607000-00036; CAINE M, 1978, BRIT J UROL, V50, P551, DOI 10.1111/j.1464-410X.1978.tb06210.x; CAINE M, 1975, BRIT J UROL, V47, P193, DOI 10.1111/j.1464-410X.1975.tb03947.x; Cantrell MA, 2008, ANN PHARMACOTHER, V42, P558, DOI 10.1345/aph.1K679; Chang DF, 2008, J CATARACT REFR SURG, V34, P1201, DOI 10.1016/j.jcrs.2008.04.014; Chang DF, 2005, J CATARACT REFR SURG, V31, P664, DOI 10.1016/j.jcrs.2005.02.027; Chang R T M, 2012, Practitioner, V256, P13; Chang RT, 2012, PRACTITIONER, V256, P12; Chapple CR, 2011, EUR UROL, V59, P342, DOI 10.1016/j.eururo.2010.10.046; Chapple CR, 2006, EUR UROL, V49, P651, DOI 10.1016/j.eururo.2006.02.018; Chuang Yao-Chi, 2006, BMC Urol, V6, P12; CHUTE CG, 1993, J UROLOGY, V150, P85, DOI 10.1016/S0022-5347(17)35405-8; COFFEY DS, 1990, UROL CLIN N AM, V17, P461; COHEN P, 1994, HORM METAB RES, V26, P81, DOI 10.1055/s-2007-1000777; COWLES RS, 1995, UROLOGY, V46, P155, DOI 10.1016/S0090-4295(99)80185-X; Coyne KS, 2009, BJU INT, V104, P352, DOI 10.1111/j.1464-410X.2009.08427.x; Dahle SE, 2002, J UROLOGY, V168, P599, DOI 10.1016/S0022-5347(05)64687-3; Doggweiler R, 1998, PROSTATE, V37, P44; European Association of Urology, 2011, GUID TREATM NONN MAL; FABIAN KM, 1980, UROLOGE A, V19, P236; Fenter Thomas C, 2008, Am J Manag Care, V14, pS154; Fibbi B, 2010, J SEX MED, V7, P59, DOI 10.1111/j.1743-6109.2009.01511.x; Filson CP, 2013, J UROLOGY, V190, P2153, DOI 10.1016/j.juro.2013.05.058; FORRAY C, 1994, MOL PHARMACOL, V45, P703; Fried NM, 2005, J ENDOUROL, V19, P25, DOI 10.1089/end.2005.19.25; Fullhase C, 2013, EUR UROL, V64, P228, DOI 10.1016/j.eururo.2013.01.018; Gacci M, 2012, EUR UROL, V61, P994, DOI 10.1016/j.eururo.2012.02.033; Gharaee-Kermani M, 2013, CURR UROL REP, V14, P628, DOI 10.1007/s11934-013-0368-z; GILLATT D, 1995, BRIT J UROL, V75, P341, DOI 10.1111/j.1464-410X.1995.tb07346.x; Gilling PJ, 1996, J ENDOUROL, V10, P459, DOI 10.1089/end.1996.10.459; GIOVANNUCCI E, 1994, AM J EPIDEMIOL, V140, P989, DOI 10.1093/oxfordjournals.aje.a117206; GIRMAN CJ, 1993, J UROLOGY, V150, P887, DOI 10.1016/S0022-5347(17)35640-9; GUAZZONI G, 1994, UROLOGY, V44, P364, DOI 10.1016/S0090-4295(94)80094-4; Hammarsten J, 2001, EUR UROL, V39, P151, DOI 10.1159/000052430; Hawary A, 2009, J ENDOUROL, V23, P2013, DOI 10.1089/end.2009.0129; HAYLEN BT, 1989, BRIT J UROL, V64, P30, DOI 10.1111/j.1464-410X.1989.tb05518.x; Hoffman RM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004135.pub3; Hollingsworth JM, 2009, J UROLOGY, V182, P2410, DOI 10.1016/j.juro.2009.07.029; ISAACS JT, 1989, PROSTATE, P33; Issa SA, 2008, CLIN OPHTHALMOL, V2, P735; Jepsen JV, 1998, UROLOGY, V51, P23, DOI 10.1016/S0090-4295(98)00052-1; Jibrin I, 2006, SOUTH MED J, V99, P611, DOI 10.1097/01.smj.0000215642.76198.44; Kaplan SA, 2006, J UROLOGY, V175, P217, DOI 10.1016/S0022-5347(05)00041-8; Kaplan SA, 2006, JAMA-J AM MED ASSOC, V296, P2319, DOI 10.1001/jama.296.19.2319; Karsenty G, 2008, EUR UROL, V53, P275, DOI 10.1016/j.eururo.2007.10.013; Kirby RS, 2003, UROLOGY, V61, P119, DOI 10.1016/S0090-4295(02)02114-3; Lapi F, 2010, BRIT J CLIN PHARMACO, V69, P558, DOI 10.1111/j.1365-2125.2010.03618.x; Lepor H, 1996, NEW ENGL J MED, V335, P533, DOI 10.1056/NEJM199608223350801; Lepor H, 1998, UROLOGY, V51, P892, DOI 10.1016/S0090-4295(98)00126-5; LEPOR H, 1984, J UROLOGY, V132, P1226, DOI 10.1016/S0022-5347(17)50110-X; Lepor Herbert, 2008, Rev Urol, V10, P85; Lourenco T, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1662; Lucia MS, 2007, JNCI-J NATL CANCER I, V99, P1375, DOI 10.1093/jnci/djm117; Ma JJ, 2012, J UROLOGY, V188, P1375, DOI 10.1016/j.juro.2012.06.007; MacDonald R, 2004, BJU INT, V94, P1263, DOI 10.1111/j.1464-410X.2004.05154.x; MacDonald R, 2012, BJU INT, V109, P1756, DOI 10.1111/j.1464-410X.2012.11172.x; Mackey MJ, 1998, BRIT J UROL, V81, P518; Malek RS, 2000, J UROLOGY, V163, P1730, DOI 10.1016/S0022-5347(05)67530-1; Marberger M, 2013, EUR UROL, V63, P496, DOI 10.1016/j.eururo.2012.10.005; Maria G, 2003, UROLOGY, V62, P259, DOI 10.1016/S0090-4295(03)00477-1; Maserejian NN, 2013, AM J EPIDEMIOL, V177, P1399, DOI 10.1093/aje/kws411; McConnell JD, 1998, NEW ENGL J MED, V338, P557, DOI 10.1056/NEJM199802263380901; McConnell JD, 2003, NEW ENGL J MED, V349, P2387, DOI 10.1056/NEJMoa030656; Meigs JB, 2001, J CLIN EPIDEMIOL, V54, P935, DOI 10.1016/S0895-4356(01)00351-1; Moyad MA, 2008, AM J MED, V121, pS34, DOI 10.1016/j.amjmed.2008.05.025; Narayan P, 1998, J UROLOGY, V160, P1701, DOI 10.1016/S0022-5347(01)62386-3; National Insitute for Health and Care Excellence, 2014, INS PROST UR LIFT IM; Nickel JC, 2011, BJU INT, V108, P388, DOI 10.1111/j.1464-410X.2011.10195.x; Nitti Victor W, 2005, Rev Urol, V7 Suppl 6, pS14; Oeconomou A, 2008, EUR UROL, V54, P765, DOI 10.1016/j.eururo.2008.06.016; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; Omar MI, 2014, BJU INT, V113, P24, DOI 10.1111/bju.12281; Parsons JK, 2006, J CLIN ENDOCR METAB, V91, P2562, DOI 10.1210/jc.2005-2799; Parsons JK, 2009, BJU INT, V104, P63, DOI 10.1111/j.1464-410X.2008.08317.x; Patel AK, 2006, EUR UROL, V50, P684, DOI 10.1016/j.eururo.2006.07.022; Porru D, 1999, NEUROUROL URODYNAM, V18, P647; Reich O, 2008, J UROLOGY, V180, P246, DOI 10.1016/j.juro.2008.03.058; Roehrborn CG, 2003, BJU INT, V92, P257, DOI 10.1046/j.1464-410X.2003.04309.x; Roehrborn CG, 2002, UROLOGY, V60, P434, DOI 10.1016/S0090-4295(02)01905-2; Roehrborn CG, 2010, EUR UROL, V57, P123, DOI 10.1016/j.eururo.2009.09.035; Rosen RC, 2005, EUR UROL, V47, P824, DOI 10.1016/j.eururo.2004.12.013; Sakata K, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-29; SCHROEDER FH, 1986, EUR UROL, V12, P318; SCHULMAN CC, 1993, EUR UROL, V24, P415; Seim A, 2005, BJU INT, V96, P88, DOI 10.1111/j.1464-410X.2005.05573.x; SHAPIRO E, 1986, J UROLOGY, V135, P1038, DOI 10.1016/S0022-5347(17)45971-4; SHAPIRO E, 1990, UROL CLIN N AM, V17, P487; Soda T, 2010, J UROLOGY, V184, P1000, DOI 10.1016/j.juro.2010.05.038; Strope SA, 2011, UROLOGY, V78, P3, DOI 10.1016/j.urology.2010.12.087; T Brown C, 2007, BRIT MED J, V334, P25, DOI 10.1136/bmj.39010.551319.AE; Teng JF, 2013, BJU INT, V111, P312, DOI 10.1111/j.1464-410X.2012.11395.x; Thompson IM, 2003, NEW ENGL J MED, V349, P215, DOI 10.1056/NEJMoa030660; Vallancien G, 2003, J UROLOGY, V169, P2257, DOI 10.1097/01.ju.0000067940.76090.73; Van Moorselaar RJA, 2005, BJU INT, V95, P603, DOI 10.1111/j.1464-410X.2005.05347.x; Warren K, 2014, CURR OPIN UROL, V24, P3, DOI 10.1097/MOU.0000000000000020; Wei JT, 2008, J UROLOGY, V179, pS75, DOI 10.1016/j.juro.2008.03.141; Wichi RB, 2009, CLINICS, V64, P253, DOI 10.1590/S1807-59322009000300017; Wilt TJ, 2002, BJU INT, V89, P214, DOI 10.1046/j.1464-4096.2001.02537.x-i1; Wilt TJ, 2002, J UROLOGY, V167, P177, DOI 10.1016/S0022-5347(05)65407-9; Wilt TJ, 1998, JAMA-J AM MED ASSOC, V280, P1604, DOI 10.1001/jama.280.18.1604; Woo HH, 2011, BJU INT, V108, P82, DOI 10.1111/j.1464-410X.2011.10342.x; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Xia SJ, 2008, EUR UROL, V53, P382, DOI 10.1016/j.eururo.2007.05.019; Yu XH, 2008, J UROLOGY, V180, P241, DOI 10.1016/j.juro.2008.03.039	121	43	45	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2014	349								g4474	10.1136/bmj.g4474	http://dx.doi.org/10.1136/bmj.g4474			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RX	25125424	Green Published			2022-12-28	WOS:000340507300001
J	Schuster, MA; Chung, PJ				Schuster, Mark A.; Chung, Paul J.			Time Off to Care for a Sick Child - Why Family-Leave Policies Matter	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PARENTS		[Schuster, Mark A.] Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA 02115 USA; [Schuster, Mark A.] Harvard Univ, Sch Med, Boston, MA USA; [Schuster, Mark A.; Chung, Paul J.] RAND Corp, Santa Monica, CA USA; [Chung, Paul J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Chung, Paul J.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; RAND Corporation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Schuster, MA (corresponding author), Boston Childrens Hosp, Dept Med, Div Gen Pediat, Boston, MA 02115 USA.							Schuster MA, 2008, JAMA-J AM MED ASSOC, V300, P1047, DOI 10.1001/jama.300.9.1047; Schuster MA, 2011, FUTURE CHILD, V21, P91; Schuster MA, 2009, AM J PUBLIC HEALTH, V99, P698, DOI 10.2105/AJPH.2008.138313; Smith T.W., 2010, PAID SICK DAYS ATTIT	4	9	9	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					493	495		10.1056/NEJMp1404860	http://dx.doi.org/10.1056/NEJMp1404860			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM5LE	25099574				2022-12-28	WOS:000339899100003
J	Zylka, MJ; Philpot, BD; King, IF				Zylka, Mark J.; Philpot, Ben D.; King, Ian F.			Bias towards large genes in autism Reply	NATURE			English	Letter							TRANSCRIPTION		[Zylka, Mark J.; Philpot, Ben D.; King, Ian F.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [Zylka, Mark J.; Philpot, Ben D.] Univ N Carolina, Carolina Inst Dev Disabil, Chapel Hill, NC 27599 USA; [Zylka, Mark J.; Philpot, Ben D.] Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zylka, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.	zylka@med.unc.edu	Shifman, Sagiv/D-8749-2017	Shifman, Sagiv/0000-0003-4071-5361; King, Ian/0000-0003-3405-9767	NIEHS NIH HHS [DP1 ES024088] Funding Source: Medline; NIMH NIH HHS [R01 MH093372] Funding Source: Medline; NINDS NIH HHS [P30 NS045892] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [DP1ES024088] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Shohat S, 2014, NATURE, V512, pE1, DOI 10.1038/nature13583; Solier S, 2013, CANCER RES, V73, P4830, DOI 10.1158/0008-5472.CAN-12-3504; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; Vaags AK, 2012, AM J HUM GENET, V90, P133, DOI 10.1016/j.ajhg.2011.11.025; van Daalen E, 2011, NEUROGENETICS, V12, P315, DOI 10.1007/s10048-011-0297-2; Veloso A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078190	8	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					E2	E2		10.1038/nature13584	http://dx.doi.org/10.1038/nature13584			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25100485	Green Accepted, Bronze			2022-12-28	WOS:000339908000002
J	Watts, G				Watts, Geoff			Michaela Diamant Obituary	LANCET			English	Biographical-Item																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					396	396		10.1016/S0140-6736(14)61264-2	http://dx.doi.org/10.1016/S0140-6736(14)61264-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9IV	25093224				2022-12-28	WOS:000340195800014
J	Goldner, A; Herold, N; Huber, M				Goldner, A.; Herold, N.; Huber, M.			Antarctic glaciation caused ocean circulation changes at the Eocene-Oligocene transition	NATURE			English	Article							CIRCUMPOLAR CURRENT; DRAKE PASSAGE; ONSET; PARAMETERIZATION; SENSITIVITY; GREENHOUSE; INITIATION; IMPACTS; GATEWAY; MODEL	Two main hypotheses compete to explain global cooling and the abrupt growth of the Antarctic ice sheet across the Eocene-Oligocene transition about 34 million years ago: thermal isolation of Antarctica due to southern ocean gateway opening(1-4), and declining atmospheric CO2 (refs 5, 6). Increases in ocean thermal stratification and circulation in proxies across the Eocene-Oligocene transition have been interpreted as a unique signature of gateway opening(2,4),but at present both mechanisms remain possible. Here, using a coupled ocean-atmosphere model, we show that the rise of Antarctic glaciation, rather than altered palaeogeography, is best able to explain the observed oceanographic changes. We find that growth of the Antarctic ice sheet caused enhanced northward transport of Antarctic intermediate water and invigorated the formation of Antarctic bottom water, fundamentally reorganizing ocean circulation. Conversely, gateway openings had much less impact on ocean thermal stratification and circulation. Our results support available evidence that CO2 draw down not gateway opening-caused Antarctic ice sheet growth, and further show that these feedbacks in turn altered ocean circulation. The precise timing and rate of glaciation, and thus its impacts on ocean circulation, reflect the balance between potentially positive feedbacks (increases in sea ice extent and enhanced primary productivity) and negative feedbacks (stronger southward heat transport and localized high-latitude warming). The Antarctic ice sheet had a complex, dynamic role in ocean circulation and heat fluxes during its initiation, and these processes are likely to operate in the future.	[Goldner, A.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Goldner, A.] Amer Geophys Union, Washington, DC 20009 USA; [Herold, N.; Huber, M.] Univ New Hampshire, Dept Earth Sci, Durham, NH 03824 USA; [Huber, M.] Univ New Hampshire, Earth Syst Res Ctr, Inst Earth Ocean & Space Sci, Durham, NH 03824 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire	Goldner, A (corresponding author), Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA.	aarongoldner@gmail.com; matthew.huber@unh.edu	Huber, Matthew/A-7677-2008	Huber, Matthew/0000-0002-2771-9977	Graduate Assistance in Areas of National Need (GAANN) fellowship through the Computational Sciences and Engineering Program at Purdue University; National Science Foundation (NSF) [OCE 0902882, EAR 1049921]; National Center for Atmospheric Research; NSF; Division Of Earth Sciences [1445404] Funding Source: National Science Foundation; EPSCoR [1101245] Funding Source: National Science Foundation	Graduate Assistance in Areas of National Need (GAANN) fellowship through the Computational Sciences and Engineering Program at Purdue University; National Science Foundation (NSF)(National Science Foundation (NSF)); National Center for Atmospheric Research; NSF(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	A.G. was funded by a Graduate Assistance in Areas of National Need (GAANN) fellowship through the Computational Sciences and Engineering Program at Purdue University. M.H. and N.H. were supported by National Science Foundation (NSF) P2C2 grants OCE 0902882 and EAR 1049921. Computing was performed on Rosen Center for Advanced Computing resources on the Hansen and Coates cluster at Purdue University. Proxy records were compiled from refs 2, 4, and specific records and references are described in extended data. The CESM model is supported and developed by the National Center for Atmospheric Research, which is supported by the NSF.	Ali JR, 2010, NATURE, V463, P653, DOI 10.1038/nature08706; Bijl PK, 2013, P NATL ACAD SCI USA, V110, P9645, DOI 10.1073/pnas.1220872110; Bitz CM, 2012, J CLIMATE, V25, P3053, DOI 10.1175/JCLI-D-11-00290.1; Bohaty SM, 2012, EARTH PLANET SC LETT, V317, P251, DOI 10.1016/j.epsl.2011.11.037; Broecker WS, 1989, PALEOCEANOGRAPHY, V4, P207, DOI 10.1029/PA004i002p00207; Coxall HK, 2005, NATURE, V433, P53, DOI 10.1038/nature03135; Cramer BS, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001683; Dalziel IWD, 2014, GEOLOGY, V42, P367, DOI 10.1130/focus042014.1; Danabasoglu G, 2008, J CLIMATE, V21, P1192, DOI 10.1175/2007JCLI1508.1; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeConto R, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001350; Eldrett JS, 2009, NATURE, V459, P969, DOI 10.1038/nature08069; Ferrari R, 2009, ANNU REV FLUID MECH, V41, P253, DOI 10.1146/annurev.fluid.40.111406.102139; Foster GL, 2013, P NATL ACAD SCI USA, V110, P1209, DOI 10.1073/pnas.1216073110; Fox-Kemper B, 2008, J PHYS OCEANOGR, V38, P1145, DOI 10.1175/2007JPO3792.1; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; GENT PR, 1990, J PHYS OCEANOGR, V20, P150, DOI 10.1175/1520-0485(1990)020<0150:IMIOCM>2.0.CO;2; Goldner A, 2013, CLIM PAST, V9, P173, DOI 10.5194/cp-9-173-2013; Heavens NG, 2012, J ADV MODEL EARTH SY, V4, DOI 10.1029/2012MS000166; Hill DJ, 2013, GEOPHYS RES LETT, V40, P5199, DOI 10.1002/grl.50941; Houben AJP, 2013, SCIENCE, V340, P341, DOI 10.1126/science.1223646; Hren MT, 2013, P NATL ACAD SCI USA, V110, P7562, DOI 10.1073/pnas.1210930110; Huber M, 2006, PALAEOGEOGR PALAEOCL, V231, P9, DOI 10.1016/j.palaeo.2005.07.037; Huber M, 2011, CLIM PAST, V7, P603, DOI 10.5194/cp-7-603-2011; Jochum M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005030; Katz ME, 2008, NAT GEOSCI, V1, P329, DOI 10.1038/ngeo179; Katz ME, 2011, SCIENCE, V332, P1076, DOI 10.1126/science.1202122; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Knorr G, 2014, NAT GEOSCI, V7, P376, DOI [10.1038/NGEO2119, 10.1038/ngeo2119]; Large WG, 2006, J CLIMATE, V19, P2325, DOI 10.1175/JCLI3740.1; Large WG, 2001, J PHYS OCEANOGR, V31, P518, DOI 10.1175/1520-0485(2001)031<0518:ECOAGO>2.0.CO;2; Lawrence DM, 2012, J CLIMATE, V25, P2240, DOI 10.1175/JCLI-D-11-00103.1; Lawver LA, 2011, AM GEOPHYS UNION SP, V63, P5, DOI 10.1029/2010SP001017; Lear CH, 2008, GEOLOGY, V36, P251, DOI 10.1130/G24584A.1; Lefebvre V, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002345; Liu ZH, 2009, SCIENCE, V323, P1187, DOI 10.1126/science.1166368; Lyle M, 2007, GEOLOGY, V35, P691, DOI 10.1130/G23806A.1; Miller KG, 2009, GEOL SOC AM SPEC PAP, V452, P169, DOI 10.1130/2009.2452(11); Pagani M, 2011, SCIENCE, V334, P1261, DOI 10.1126/science.1203909; Pearson PN, 2009, NATURE, V461, P1110, DOI 10.1038/nature08447; Pollard D, 2005, GLOBAL PLANET CHANGE, V45, P9, DOI 10.1016/j.gloplacha.2004.09.011; Sijp WP, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2011PA002143; Sijp WP, 2009, J CLIMATE, V22, P6639, DOI 10.1175/2009JCLI3003.1; Toggweiler J. R., 1994, DEEP SEA RES OCEANOG, V42, P477; Wilson DS, 2013, GEOPHYS RES LETT, V40, P4305, DOI 10.1002/grl.50797; Zachos JC, 2005, GLOBAL PLANET CHANGE, V47, P51, DOI 10.1016/j.gloplacha.2005.01.001	46	106	109	5	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					574	+		10.1038/nature13597	http://dx.doi.org/10.1038/nature13597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079555				2022-12-28	WOS:000339566300031
J	Sedgwick, P				Sedgwick, Philip			Ecological studies: advantages and disadvantages	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Pickett KE, 2007, BMJ-BRIT MED J, V335, P1080, DOI 10.1136/bmj.39377.580162.55; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5407; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4483	3	31	33	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 2	2014	348								g2979	10.1136/bmj.g2979	http://dx.doi.org/10.1136/bmj.g2979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5SN	25134102				2022-12-28	WOS:000335478900001
J	Mizielinska, S; Gronke, S; Niccoli, T; Ridler, CE; Clayton, EL; Devoy, A; Moens, T; Norona, FE; Woollacott, IOC; Pietrzyk, J; Cleverley, K; Nicoll, AJ; Pickering-Brown, S; Dols, J; Cabecinha, M; Hendrich, O; Fratta, P; Fisher, EMC; Partridge, L; Isaacs, AM				Mizielinska, Sarah; Groenke, Sebastian; Niccoli, Teresa; Ridler, Charlotte E.; Clayton, Emma L.; Devoy, Anny; Moens, Thomas; Norona, Frances E.; Woollacott, Ione O. C.; Pietrzyk, Julian; Cleverley, Karen; Nicoll, Andrew J.; Pickering-Brown, Stuart; Dols, Jacqueline; Cabecinha, Melissa; Hendrich, Oliver; Fratta, Pietro; Fisher, Elizabeth M. C.; Partridge, Linda; Isaacs, Adrian M.			C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; HEXANUCLEOTIDE REPEAT; FRONTOTEMPORAL DEMENTIA; RNA FOCI; GGGGCC REPEAT; ANTISENSE TRANSCRIPTS; MYOTONIC-DYSTROPHY; ALS; TRANSLATION; FTD	An expanded GGGGCC repeat in C9orf72 is the most common genetic cause of frontotemporal dementia and amyotrophic lateral sclerosis. A fundamental question is whether toxicity is driven by the repeat RNA itself and/or by dipeptide repeat proteins generated by repeat-associated, non-ATG translation. To address this question, we developed in vitro and in vivo models to dissect repeat RNA and dipeptide repeat protein toxicity. Expression of pure repeats, but not stop codon-interrupted "RNA-only" repeats in Drosophila caused adult-onset neurodegeneration. Thus, expanded repeats promoted neurodegeneration through dipeptide repeat proteins. Expression of individual dipeptide repeat proteins with a non-GGGGCC RNA sequence revealed that both poly-(glycine-arginine) and poly-(proline-arginine) proteins caused neurodegeneration. These findings are consistent with a dual toxicity mechanism, whereby both arginine-rich proteins and repeat RNA contribute to C9orf72-mediated neurodegeneration.	[Mizielinska, Sarah; Ridler, Charlotte E.; Clayton, Emma L.; Devoy, Anny; Moens, Thomas; Norona, Frances E.; Woollacott, Ione O. C.; Pietrzyk, Julian; Cleverley, Karen; Nicoll, Andrew J.; Fratta, Pietro; Fisher, Elizabeth M. C.; Isaacs, Adrian M.] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; [Groenke, Sebastian; Niccoli, Teresa; Dols, Jacqueline; Hendrich, Oliver; Partridge, Linda] Max Planck Inst Biol Ageing, D-50931 Cologne, Germany; [Niccoli, Teresa; Moens, Thomas; Cabecinha, Melissa; Partridge, Linda] UCL, Inst Hlth Ageing, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Nicoll, Andrew J.] UCL Inst Neurol, MRC Prion Unit, London WC1N 3BG, England; [Pickering-Brown, Stuart] Univ Manchester, Fac Human & Med Sci, Inst Brain Behav & Mental Hlth, Manchester M13 9PT, Lancs, England; [Fratta, Pietro; Fisher, Elizabeth M. C.] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England	University of London; University College London; Max Planck Society; University of London; University College London; University of London; University College London; University of Manchester; University of London; University College London	Isaacs, AM (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England.	l.partridge@ucl.ac.uk; a.isaacs@prion.ucl.ac.uk	Fratta, Pietro/G-1296-2019; Fisher, Elizabeth MC/C-2168-2008; Pickering-Brown, Stuart/D-4008-2009; Partridge, Linda/E-7342-2015	Fratta, Pietro/0000-0002-8762-8188; Fisher, Elizabeth MC/0000-0003-2850-9936; Pickering-Brown, Stuart/0000-0003-1561-6054; Partridge, Linda/0000-0001-9615-0094; Hendrich, Oliver/0000-0003-1185-520X; Clayton, Emma/0000-0003-0937-2874; Gronke, Sebastian/0000-0002-1539-5346; Woollacott, Ione/0000-0003-1166-6417; Devoy, Anny/0000-0002-1293-0630; Niccoli, Teresa/0000-0001-9337-0411; Norona, Frances/0000-0003-3982-8406; Mizielinska, Sarah/0000-0001-8052-600X; fratta, pietro/0000-0002-7554-1632; Moens, Thomas/0000-0002-4783-6257	Alzheimer's Research UK; Motor Neurone Disease Association; Middlesex Hospital; National Institute for Health Research (NIHR)/University College London Hospitals Biomedical Research Centre; BRT; NIHR Academic Clinical Fellowship; UK Medical Research Council; Wellcome Trust; Max Planck Society; Medical School General Charitable Trust; MRC [MR/J004022/1, MR/K018523/1, G1000287, G0701441, MR/L021056/1] Funding Source: UKRI; Alzheimers Research UK [ARUK-PPG2012A-14, ARUK-PhD2012-29] Funding Source: researchfish; Medical Research Council [G0701441, MR/J004022/1, MR/L021056/1, G1000287, MR/K018523/1] Funding Source: researchfish; National Institute for Health Research [ACF-2012-18-009] Funding Source: researchfish; Motor Neurone Disease Association [Isaacs/Apr13/818-791] Funding Source: researchfish	Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Motor Neurone Disease Association; Middlesex Hospital; National Institute for Health Research (NIHR)/University College London Hospitals Biomedical Research Centre(National Institute for Health Research (NIHR)); BRT; NIHR Academic Clinical Fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Medical School General Charitable Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Motor Neurone Disease Association	We thank J. Wadsworth and N. Alic for helpful discussion. Funding was provided by Alzheimer's Research UK (A. M. I.), the Motor Neurone Disease Association (A. M. I., E. M. C. F., P. F.), the Middlesex Hospital and Medical School General Charitable Trust (A. M. I.), National Institute for Health Research (NIHR)/University College London Hospitals Biomedical Research Centre (P. F.), BRT (T. M.), a NIHR Academic Clinical Fellowship (I.O.C.W.), the UK Medical Research Council (A. M. I., E. M. C. F., P. F.), the Wellcome Trust (L. P.), and the Max Planck Society (L. P.). Clones from the Isaacs lab will be distributed under material transfer agreements for academic use. L. P. dedicates this work to the memory of Noreen Murray.	Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Beck J, 2013, AM J HUM GENET, V92, P345, DOI 10.1016/j.ajhg.2013.01.011; de Haro M, 2006, HUM MOL GENET, V15, P2138, DOI 10.1093/hmg/ddl137; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fratta P, 2013, ACTA NEUROPATHOL, V126, P401, DOI 10.1007/s00401-013-1147-0; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Harms MB, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2013.03.006; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lashley T, 2013, NEURON, V77, P597, DOI 10.1016/j.neuron.2013.02.009; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Lillo P, 2009, J CLIN NEUROSCI, V16, P1131, DOI 10.1016/j.jocn.2009.03.005; Mackenzie IR, 2013, ACTA NEUROPATHOL, V126, P859, DOI 10.1007/s00401-013-1181-y; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n; Mizielinska S, 2013, ACTA NEUROPATHOL, V126, P845, DOI 10.1007/s00401-013-1200-z; Mori K, 2013, ACTA NEUROPATHOL, V126, P881, DOI 10.1007/s00401-013-1189-3; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Orengo JP, 2008, P NATL ACAD SCI USA, V105, P2646, DOI 10.1073/pnas.0708519105; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sakamoto N, 2001, J BIOL CHEM, V276, P27178, DOI 10.1074/jbc.M101852200; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Suzuki N, 2013, NAT NEUROSCI, V16, P1725, DOI 10.1038/nn.3566; van Blitterswijk M, 2013, LANCET NEUROL, V12, P978, DOI 10.1016/S1474-4422(13)70210-2; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	31	443	447	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1192	1194		10.1126/science.1256800	http://dx.doi.org/10.1126/science.1256800			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25103406	Green Accepted, Green Submitted			2022-12-28	WOS:000341179800050
J	Svanstrom, H; Pasternak, B; Hviid, A				Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders			Use of clarithromycin and roxithromycin and risk of cardiac death: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TORSADE-DE-POINTES; QT-INTERVAL PROLONGATION; ORAL ERYTHROMYCIN; AZITHROMYCIN; DRUGS; ANTIBIOTICS; MACROLIDES; REGISTER; PATIENT; SYSTEM	Objective To assess the risk of cardiac death associated with the use of clarithromycin and roxithromycin. Design Cohort study. Setting Denmark, 1997-2011. Participants Danish adults, 40-74 years of age, who received seven day treatment courses with clarithromycin (n= 160 297), roxithromycin (n= 588 988), and penicillin V (n= 4 355 309). Main outcome measures The main outcome was risk of cardiac death associated with clarithromycin and roxithromycin, compared with penicillin V. Subgroup analyses were conducted according to sex, age, risk score, and concomitant use of drugs that inhibit the cytochrome P450 3A enzyme, which metabolises macrolides. Results A total of 285 cardiac deaths were observed. Compared with use of penicillin V (incidence rate 2.5 per 1000 person years), use of clarithromycin was associated with a significantly increased risk of cardiac death (5.3 per 1000 person years; adjusted rate ratio 1.76, 95% confidence interval 1.08 to 2.85) but use of roxithromycin was not (2.5 per 1000 person years; adjusted rate ratio 1.04, 0.72 to 1.51). The association with clarithromycin was most pronounced among women (adjusted rate ratios 2.83 (1.50 to 5.36) in women and 1.09 (0.51 to 2.35) in men). Compared with penicillin V, the adjusted absolute risk difference was 37 (95% confidence interval 4 to 90) cardiac deaths per 1 million courses with clarithromycin and 2 (-14 to 25) cardiac deaths per 1 million courses with roxithromycin. Conclusions This large cohort study found a significantly increased risk of cardiac death associated with clarithromycin. No increased risk was seen with roxithromycin. Given the widespread use of clarithromycin, these findings call for confirmation in independent populations.	[Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark	Statens Serum Institut	Svanstrom, H (corresponding author), Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen S, Denmark.	htr@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127				Brookhart MA, 2013, CIRC-CARDIOVASC QUAL, V6, P604, DOI 10.1161/CIRCOUTCOMES.113.000359; Helweg-Larsen K, 2011, SCAND J PUBLIC HEALT, V39, P26, DOI 10.1177/1403494811399958; Hensey C, 2008, IRISH J MED SCI, V177, P67, DOI 10.1007/s11845-007-0057-3; Huang BH, 2007, PACE, V30, P1579, DOI 10.1111/j.1540-8159.2007.00912.x; Indiana University School of Medicine, 2013, P450 DRUG INT TABL A; Justo D, 2006, EUR J INTERN MED, V17, P254, DOI 10.1016/j.ejim.2005.12.003; Kamochi H, 1999, JPN CIRC J, V63, P421, DOI 10.1253/jcj.63.421; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Katapadi K, 1997, ANGIOLOGY, V48, P821, DOI 10.1177/000331979704800909; Kezerashvili A, 2007, J INTERV CARD ELECTR, V18, P243, DOI 10.1007/s10840-007-9124-y; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Koh TW, 2001, PACE, V24, P1575, DOI 10.1046/j.1460-9592.2001.01575.x; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mosholder AD, 2013, NEW ENGL J MED, V368, P1665, DOI 10.1056/NEJMp1302726; Ohtani H, 2000, ANTIMICROB AGENTS CH, V44, P2630, DOI 10.1128/AAC.44.10.2630-2637.2000; Owens RC, 2004, DRUGS, V64, P1091, DOI 10.2165/00003495-200464100-00005; Owens RC, 2006, CLIN INFECT DIS, V43, P1603, DOI 10.1086/508873; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Piquette RK, 1999, ANN PHARMACOTHER, V33, P22, DOI 10.1345/aph.18107; Promphan W, 2003, PACE, V26, P1424, DOI 10.1046/j.1460-9592.2003.t01-1-00204.x; Ray WA, 2004, NEW ENGL J MED, V351, P1089, DOI 10.1056/NEJMoa040582; Roden DM, 2004, NEW ENGL J MED, V350, P1013, DOI 10.1056/NEJMra032426; Rubinstein E, 2001, INT J ANTIMICROB AG, V18, pS71, DOI 10.1016/S0924-8579(01)00397-1; Shaffer D, 2002, CLIN INFECT DIS, V35, P197, DOI 10.1086/340861; Straus SMJM, 2005, EUR HEART J, V26, P2007, DOI 10.1093/eurheartj/ehi312; Sturmer T, 2005, AM J EPIDEMIOL, V161, P891, DOI 10.1093/aje/kwi106; Svanstrom H, 2013, NEW ENGL J MED, V368, P1704, DOI 10.1056/NEJMoa1300799; Volberg WA, 2002, J PHARMACOL EXP THER, V302, P320, DOI 10.1124/jpet.302.1.320; Yamazaki H, 1998, DRUG METAB DISPOS, V26, P1053; Yap YG, 2003, HEART, V89, P1363, DOI 10.1136/heart.89.11.1363	31	50	53	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2014	349								g4930	10.1136/bmj.g4930	http://dx.doi.org/10.1136/bmj.g4930			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FK	25139799	Green Published, hybrid			2022-12-28	WOS:000340838500002
J	Kaushik, S; Lomi, N; Singh, MP; Pandav, SS; Gupta, A				Kaushik, Sushmita; Lomi, Neiwete; Singh, Mini P.; Pandav, Surinder Singh; Gupta, Amod			Acute retinal necrosis presenting as bilateral acute angle closure	LANCET			English	Editorial Material									[Kaushik, Sushmita; Lomi, Neiwete; Pandav, Surinder Singh; Gupta, Amod] Postgrad Inst Med Educ & Res, Adv Eye Ctr, Chandigarh 160012, India; [Singh, Mini P.] Postgrad Inst Med Educ & Res, Dept Virol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Kaushik, S (corresponding author), Postgrad Inst Med Educ & Res, Adv Eye Ctr, Chandigarh 160012, India.	sushmita_kaushik@yahoo.com	Kaushik, Sushmita/AAE-3806-2019; Gupta, Amod/V-7633-2017	Kaushik, Sushmita/0000-0002-9175-5497; Gupta, Amod/0000-0001-8427-5738				Craig JE, 2004, AM J OPHTHALMOL, V137, P193, DOI 10.1016/S0002-9394(03)00774-8; DUKER JS, 1991, SURV OPHTHALMOL, V35, P327, DOI 10.1016/0039-6257(91)90183-G; Ganatra JB, 2000, AM J OPHTHALMOL, V129, P166, DOI 10.1016/S0002-9394(99)00316-5; Meige P, 1989, Bull Soc Ophtalmol Fr, V89, P449	4	4	4	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					636	636		10.1016/S0140-6736(14)61035-7	http://dx.doi.org/10.1016/S0140-6736(14)61035-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25131983				2022-12-28	WOS:000340573300036
J	Hoegger, MJ; Fischer, AJ; McMenimen, JD; Ostedgaard, LS; Tucker, AJ; Awadalla, MA; Moninger, TO; Michalski, AS; Hoffman, EA; Zabner, J; Stoltz, DA; Welsh, MJ				Hoegger, Mark J.; Fischer, Anthony J.; McMenimen, James D.; Ostedgaard, Lynda S.; Tucker, Alex J.; Awadalla, Maged A.; Moninger, Thomas O.; Michalski, Andrew S.; Hoffman, Eric A.; Zabner, Joseph; Stoltz, David A.; Welsh, Michael J.			Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis	SCIENCE			English	Article							AIRWAY SUBMUCOSAL GLANDS; LIQUID SECRETION; FLUID SECRETION; MUCIN SECRETION; HCO3-TRANSPORT; CFTR; CLEARANCE; BICARBONATE; CELLS; EXPRESSION	Lung disease in people with cystic fibrosis (CF) is initiated by defective host defense that predisposes airways to bacterial infection. Advanced CF is characterized by a deficit in mucociliary transport (MCT), a process that traps and propels bacteria out of the lungs, but whether this deficit occurs first or is secondary to airway remodeling has been unclear. To assess MCT, we tracked movement of radiodense microdisks in airways of newborn piglets with CF. Cholinergic stimulation, which elicits mucus secretion, substantially reduced microdisk movement. Impaired MCT was not due to periciliary liquid depletion; rather, CF submucosal glands secreted mucus strands that remained tethered to gland ducts. Inhibiting anion secretion in non-CF airways replicated CF abnormalities. Thus, impaired MCT is a primary defect in CF, suggesting that submucosal glands and tethered mucus may be targets for early CF treatment.	[Hoegger, Mark J.; Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Fischer, Anthony J.] Univ Iowa, Dept Pediat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [McMenimen, James D.; Ostedgaard, Lynda S.; Tucker, Alex J.; Awadalla, Maged A.; Michalski, Andrew S.; Hoffman, Eric A.; Zabner, Joseph; Stoltz, David A.; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Moninger, Thomas O.] Univ Iowa, Cent Microscopy Res Facil, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Hoffman, Eric A.; Stoltz, David A.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, HHMI, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa	Stoltz, DA (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	david-stoltz@uiowa.edu; michael-welsh@uiowa.edu	Hoegger, Mark/K-7926-2019	Stoltz, David/0000-0003-0893-9015; Ostedgaard, Lynda/0000-0001-7717-3442; Awadalla, Maged/0000-0002-6342-8704; Zabner, Joseph/0000-0002-9606-1339; Hoffman, Eric/0000-0001-8456-9437; Welsh, Michael/0000-0002-1646-6206; Fischer, Anthony J./0000-0002-7179-6400	NIH [HL051670, HL091842, DK054759, DP2 HL117744]; Carver Foundation; Cystic Fibrosis Foundation (CFF); Gilead Sciences Research Scholars Program in Cystic Fibrosis; CFF Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051670, DP2HL117744, P01HL091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carver Foundation; Cystic Fibrosis Foundation (CFF); Gilead Sciences Research Scholars Program in Cystic Fibrosis; CFF Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Abou Alaiwa, R. J. Adam, E. Allard, L. A. Askland, D. C. Bouzek, K. Chaloner, N. D. Gansemer, O. A. Itani, T. A. Mayhew, S. Mobberley, J. H. Morgan, L. R. Reznikov, J. Sieren, M. R. Stroik, P. J. Taft, and T. J. Wallen for valuable assistance and discussions. This work was supported by the NIH (HL051670, HL091842, DK054759), the Carver Foundation, and the Cystic Fibrosis Foundation (CFF). D. A. S. is supported by the Gilead Sciences Research Scholars Program in Cystic Fibrosis and the NIH (DP2 HL117744). A. J. F. is supported by a CFF Fellowship. M. J. W. is an Investigator of the HHMI. The University of Iowa Research Foundation has submitted patent applications for CF pigs and has licensed materials and technologies to Exemplar Genetics. M. J. W. was a cofounder of and holds equity in Exemplar Genetics. E. A. H. is a founder of and holds equity in VIDA Diagnostics, a company commercializing lung image analysis software.	Ballard ST, 2004, J PHYSIOL-LONDON, V556, P1, DOI 10.1113/jphysiol.2003.052779; Ballard ST, 2007, RESP PHYSIOL NEUROBI, V159, P271, DOI 10.1016/j.resp.2007.06.017; Billet A, 2013, J PHYSIOL-LONDON, V591, P5273, DOI 10.1113/jphysiol.2013.261909; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Chen JH, 2010, CELL, V143, P911, DOI 10.1016/j.cell.2010.11.029; Cohen-Cymberknoh M, 2014, CHEST, V145, P738, DOI 10.1378/chest.13-1162; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Griesenbach U, 2011, AM J RESP CELL MOL, V44, P309, DOI 10.1165/rcmb.2009-0265OC; Gustafsson JK, 2012, J EXP MED, V209, P1263, DOI 10.1084/jem.20120562; Hoegger MJ, 2014, P NATL ACAD SCI USA, V111, P2355, DOI 10.1073/pnas.1323633111; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Lee RJ, 2008, J GEN PHYSIOL, V132, P161, DOI 10.1085/jgp.200810017; Lee RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412817; McShane D, 2004, EUR RESPIR J, V24, P95, DOI 10.1183/09031936.04.00097503; Moon S, 1997, AM J PHYSIOL-LUNG C, V273, pL1208, DOI 10.1152/ajplung.1997.273.6.L1208; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Quinton PM, 2010, AM J PHYSIOL-CELL PH, V299, pC1222, DOI 10.1152/ajpcell.00362.2010; REGNIS JA, 1994, AM J RESP CRIT CARE, V150, P66, DOI 10.1164/ajrccm.150.1.8025774; Robinson M, 2002, PEDIATR PULM, V33, P293, DOI 10.1002/ppul.10079; Staudinger BJ, 2014, AM J RESP CRIT CARE, V189, P812, DOI 10.1164/rccm.201312-2142OC; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Trout L, 1998, AM J PHYSIOL-LUNG C, V275, pL1095, DOI 10.1152/ajplung.1998.275.6.L1095; Wanner A, 1996, AM J RESP CRIT CARE, V154, P1868, DOI 10.1164/ajrccm.154.6.8970383; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wine JJ, 2007, AUTON NEUROSCI-BASIC, V133, P35, DOI 10.1016/j.autneu.2007.01.008; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; Wu DXY, 1998, AM J PHYSIOL-LUNG C, V274, pL388, DOI 10.1152/ajplung.1998.274.3.L388	30	271	274	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					818	822		10.1126/science.1255825	http://dx.doi.org/10.1126/science.1255825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124441	Green Accepted			2022-12-28	WOS:000340593100046
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED The fight is on: military metaphors for cancer may harm patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Byrne A, 2002, PATIENT EDUC COUNS, V48, P15, DOI 10.1016/S0738-3991(02)00094-0; Diamond J., 1999, C BECAUSE COWARDS GE; Petticrew M, 2002, BRIT MED J, V325, P1066, DOI 10.1136/bmj.325.7372.1066; Rigby E, 2009, SCIENCE BLOG; Wiggins NM, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4706	5	10	10	1	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2014	349								g5155	10.1136/bmj.g5155	http://dx.doi.org/10.1136/bmj.g5155			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RZ	25128488	Bronze, Green Published			2022-12-28	WOS:000340507500001
J	Claudi, B; Sprote, P; Chirkova, A; Personnic, N; Zankl, J; Schurmann, N; Schmidt, A; Bumann, D				Claudi, Beatrice; Sproete, Petra; Chirkova, Anna; Personnic, Nicolas; Zankl, Janine; Schuermann, Nura; Schmidt, Alexander; Bumann, Dirk			Phenotypic Variation of Salmonella in Host Tissues Delays Eradication by Antimicrobial Chemotherapy	CELL			English	Article							ENTERICA SEROVAR TYPHIMURIUM; BACTERIAL PERSISTENCE; ESCHERICHIA-COLI; FLUORESCENT PROTEIN; GENE-EXPRESSION; GROWTH; MACROPHAGES; METABOLISM; VIRULENCE; OXYGEN	Antibiotic therapy often fails to eliminate a fraction of transiently refractory bacteria, causing relapses and chronic infections. Multiple mechanisms can induce such persisters with high antimicrobial tolerance in vitro, but their in vivo relevance remains unclear. Using a fluorescent growth rate reporter, we detected extensive phenotypic variation of Salmonella in host tissues. This included slow-growing subsets as well as well-nourished fast-growing subsets driving disease progression. Monitoring of Salmonella growth and survival during chemotherapy revealed that antibiotic killing correlated with single-cell division rates. Nondividing Salmonella survived best but were rare, limiting their impact. Instead, most survivors originated from abundant moderately growing, partially tolerant Salmonella. These data demonstrate that host tissues diversify pathogen physiology, with major consequences for disease progression and control.	[Claudi, Beatrice; Sproete, Petra; Chirkova, Anna; Personnic, Nicolas; Schuermann, Nura; Bumann, Dirk] Univ Basel, Focal Area Infect Biol, CH-4056 Basel, Switzerland; [Zankl, Janine] Univ Basel, FACS Core Facil, CH-4056 Basel, Switzerland; [Schmidt, Alexander] Univ Basel, Prote Core Facil Biozentrum, CH-4056 Basel, Switzerland; [Sproete, Petra] BASF SE, D-67056 Ludwigshafen, Germany	University of Basel; University of Basel; University of Basel; BASF	Bumann, D (corresponding author), Univ Basel, Focal Area Infect Biol, CH-4056 Basel, Switzerland.	dirk.bumann@unibas.ch		Personnic, Nicolas/0000-0003-4180-8260	Swiss National Foundation [31003A-121834]; SystemsX.ch ("BattleX"); Marie Curie Intra-European Fellowship [PIEF-GA-2011-301840]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); SystemsX.ch ("BattleX"); Marie Curie Intra-European Fellowship(European Commission)	We thank Sophie Helaine and David Holden for plasmid pFCcGi, Leyla Razik Develioglu and Christoph Hess for various antibiotics, Nela Nikolic and Karl Kochanowski for help with minichemostats, and David Holden and Urs Jenal for helpful discussions. This research was supported by the Swiss National Foundation (31003A-121834), SystemsX.ch ("BattleX"), and a Marie Curie Intra-European Fellowship (PIEF-GA-2011-301840, "BONAFIDE," to A.C.).	ABSHIRE KZ, 1993, J BACTERIOL, V175, P3744, DOI 10.1128/JB.175.12.3744-3748.1993; Aldridge BB, 2012, SCIENCE, V335, P100, DOI 10.1126/science.1216166; Aziz A, 2009, SCIENCE, V326, P867, DOI 10.1126/science.1176056; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barat S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042007; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; BENJAMIN WH, 1990, J IMMUNOL, V144, P3143; Bishop RE, 1998, J MOL BIOL, V280, P583, DOI 10.1006/jmbi.1998.1894; Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533, DOI 10.1152/ajpheart.2001.280.6.H2533; Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x; Burton NA, 2014, CELL HOST MICROBE, V15, P72, DOI 10.1016/j.chom.2013.12.006; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; Cheminay U, 2004, INFECT IMMUN, V72, P468, DOI 10.1128/IAI.72.1.468-477.2004; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; De la Cruz MA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003827; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Dominguez-Bernal G, 2004, MOL MICROBIOL, V53, P1437, DOI 10.1111/j.1365-2958.2004.04213.x; ENG RHK, 1991, ANTIMICROB AGENTS CH, V35, P1824, DOI 10.1128/AAC.35.9.1824; Evans MR, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-58; Fink RC, 2007, J BACTERIOL, V189, P2262, DOI 10.1128/JB.00726-06; Giraudeau C, 2012, NMR BIOMED, V25, P654, DOI 10.1002/nbm.1781; Grant AJ, 2008, PLOS BIOL, V6, P757, DOI 10.1371/journal.pbio.0060074; Grant AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003070; Griffin AJ, 2011, INFECT IMMUN, V79, P1479, DOI 10.1128/IAI.01033-10; Helaine S, 2014, SCIENCE, V343, P204, DOI 10.1126/science.1244705; Helaine S, 2010, P NATL ACAD SCI USA, V107, P3746, DOI 10.1073/pnas.1000041107; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Hooper DC, 2001, CLIN INFECT DIS, V32, pS9, DOI 10.1086/319370; Kaiser P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001793; Kaiser P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003532; Kint CI, 2012, TRENDS MICROBIOL, V20, P577, DOI 10.1016/j.tim.2012.08.009; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Mastroeni P, 2011, INFECT IMMUN, V79, P636, DOI 10.1128/IAI.00954-10; Orman MA, 2013, ANTIMICROB AGENTS CH, V57, P3230, DOI 10.1128/AAC.00243-13; Peterson CN, 2012, GENE DEV, V26, P548, DOI 10.1101/gad.183517.111; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Ramachandran VK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-25; Richardson EJ, 2011, J BACTERIOL, V193, P3162, DOI 10.1128/JB.00394-11; Rollenhagen C, 2006, INFECT IMMUN, V74, P1649, DOI 10.1128/IAI.74.3.1649-1660.2006; Roostalu J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-68; Ryall B, 2012, MICROBIOL MOL BIOL R, V76, P597, DOI 10.1128/MMBR.05028-11; Sanchez-Vargas FM, 2011, TRAVEL MED INFECT DI, V9, P263, DOI 10.1016/j.tmaid.2011.11.001; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Steeb B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003301; Strack RL, 2010, J AM CHEM SOC, V132, P8496, DOI 10.1021/ja1030084; Terskikh A, 2000, SCIENCE, V290, P1585, DOI 10.1126/science.290.5496.1585; Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10; TUOMANEN E, 1986, J GEN MICROBIOL, V132, P1297; VAUPEL P, 1989, CANCER RES, V49, P6449; Verkhusha VV, 2003, BIOCHEMISTRY-US, V42, P7879, DOI 10.1021/bi034555t; You CH, 2013, NATURE, V500, P301, DOI 10.1038/nature12446	56	192	193	2	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					722	733		10.1016/j.cell.2014.06.045	http://dx.doi.org/10.1016/j.cell.2014.06.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126781	Bronze			2022-12-28	WOS:000340944700006
J	Guo, M; Ehrlicher, AJ; Jensen, MH; Renz, M; Moore, JR; Goldman, RD; Lippincott-Schwartz, J; Mackintosh, FC; Weitz, DA				Guo, Ming; Ehrlicher, Allen J.; Jensen, Mikkel H.; Renz, Malte; Moore, Jeffrey R.; Goldman, Robert D.; Lippincott-Schwartz, Jennifer; Mackintosh, Frederick C.; Weitz, David A.			Probing the Stochastic, Motor-Driven Properties of the Cytoplasm Using Force Spectrum Microscopy	CELL			English	Article							BREAST-CANCER CELLS; LIVING CELLS; MOLECULAR MOTORS; CHROMOSOMAL LOCI; DIFFUSION; MECHANICS; DYNAMICS; MICRORHEOLOGY; SPECTROSCOPY; MIGRATION	Molecular motors in cells typically produce highly directed motion; however, the aggregate, incoherent effect of all active processes also creates randomly fluctuating forces, which drive diffusive-like, non-thermal motion. Here, we introduce force-spectrum-microscopy (FSM) to directly quantify random forces within the cytoplasm of cells and thereby probe stochastic motor activity. This technique combines measurements of the random motion of probe particles with independent micromechanical measurements of the cytoplasm to quantify the spectrum of force fluctuations. Using FSM, we show that force fluctuations substantially enhance intracellular movement of small and large components. The fluctuations are three times larger in malignant cells than in their benign counterparts. We further demonstrate that vimentin acts globally to anchor organelles against randomly fluctuating forces in the cytoplasm, with no effect on their magnitude. Thus, FSM has broad applications for understanding the cytoplasm and its intracellular processes in relation to cell physiology in healthy and diseased states.	[Guo, Ming; Ehrlicher, Allen J.; Jensen, Mikkel H.; Weitz, David A.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ehrlicher, Allen J.] Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Jensen, Mikkel H.; Moore, Jeffrey R.] Boston Univ, Dept Phys & Biophys, Boston, MA 02118 USA; [Renz, Malte; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Mackintosh, Frederick C.] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Weitz, David A.] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Harvard University; Beth Israel Deaconess Medical Center; Boston University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Northwestern University; Feinberg School of Medicine; Vrije Universiteit Amsterdam; Harvard University	Weitz, DA (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	weitz@seas.harvard.edu	MacKintosh, Frederick/AAB-9332-2021; MacKintosh, Fred C/A-9450-2008; guo, ming/D-4564-2015; Renz, Malte/L-6186-2019	MacKintosh, Frederick/0000-0002-2607-9541; MacKintosh, Fred C/0000-0002-2607-9541; Renz, Malte/0000-0001-9535-7560; Herholdt Jensen, Mikkel/0000-0002-4821-3318; Ehrlicher, Allen/0000-0003-3030-979X	NIH [PO1GM096971, DK083592, HL86655, HL077280]; Harvard Materials Research Science and Engineering Center [DMR-0820484]; NSF [DMR-1310266]; FOM/NWO; Hannah's Hope Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655, R01HL077280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM096971] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Materials Research Science and Engineering Center(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); FOM/NWO(FOM (The Netherlands)Netherlands Organization for Scientific Research (NWO)); Hannah's Hope Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Rowat, S. Lindstrom, K. Kasza for helpful discussions; we thank F. Deng and A. Pegoraro for comments on the manuscript. This work was supported by the NIH (PO1GM096971), the Harvard Materials Research Science and Engineering Center (DMR-0820484), the NSF (DMR-1310266). A.J.E. was supported by NIH grant DK083592; M.H.J. and J.R.M. were supported by NIH grants HL86655 and HL077280; F.C.M. was supported in part by FOM/NWO. R.D.G. was supported by NIH PO1GM096971 and Hannah's Hope Fund.	Agus DB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01449; Ananthanarayanan V, 2013, CELL, V153, P1526, DOI 10.1016/j.cell.2013.05.020; Baker EL, 2010, BIOPHYS J, V99, P2048, DOI 10.1016/j.bpj.2010.07.051; Brangwynne CP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118104; Brangwynne CP, 2008, J CELL BIOL, V183, P583, DOI 10.1083/jcb.200806149; Bursac P, 2005, NAT MATER, V4, P557, DOI 10.1038/nmat1404; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Doyle AD, 2010, NATURE, V466, P192, DOI 10.1038/466192a; Dufrene YF, 2011, NAT METHODS, V8, P123, DOI 10.1038/nmeth0211-123; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Gundersen GG, 2013, CELL, V152, P1376, DOI 10.1016/j.cell.2013.02.031; Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037; Gupton SL, 2005, J CELL BIOL, V168, P619, DOI 10.1083/jcb.200406063; Hale CM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007054; Hammar P, 2012, SCIENCE, V336, P1595, DOI 10.1126/science.1221648; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hendricks AG, 2012, P NATL ACAD SCI USA, V109, P18447, DOI 10.1073/pnas.1215462109; Hoffman BD, 2006, P NATL ACAD SCI USA, V103, P10259, DOI 10.1073/pnas.0510348103; Holzer RG, 2003, BREAST CANCER RES TR, V77, P65, DOI 10.1023/A:1021175931177; Howard J., 2001, MECH MOTOR PROTEINS; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Koenderink GH, 2009, P NATL ACAD SCI USA, V106, P15192, DOI 10.1073/pnas.0903974106; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kraning-Rush CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032572; Kyoung M, 2008, BIOPHYS J, V95, P5789, DOI 10.1529/biophysj.108.128934; Lau AWC, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.198101; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; MacKintosh FC, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018104; MacKintosh FC, 2012, P NATL ACAD SCI USA, V109, P7138, DOI 10.1073/pnas.1204794109; Mendez MG, 2010, FASEB J, V24, P1838, DOI 10.1096/fj.09-151639; Mizuno D, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.168102; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Parry BR, 2014, CELL, V156, P183, DOI 10.1016/j.cell.2013.11.028; Plodinec M, 2013, BIOPHYS J, V104, p321A, DOI 10.1016/j.bpj.2012.11.1779; Rai AK, 2013, CELL, V152, P172, DOI 10.1016/j.cell.2012.11.044; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Valentine MT, 2004, BIOPHYS J, V86, P4004, DOI 10.1529/biophysj.103.037812; Veigel C, 1998, BIOPHYS J, V75, P1424, DOI 10.1016/S0006-3495(98)74061-5; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Wilhelm C, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.028101; Wu PH, 2012, NAT PROTOC, V7, P155, DOI 10.1038/nprot.2011.436; Yamada S, 2000, BIOPHYS J, V78, P1736, DOI 10.1016/S0006-3495(00)76725-7; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	55	330	332	2	128	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					822	832		10.1016/j.cell.2014.06.051	http://dx.doi.org/10.1016/j.cell.2014.06.051			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126787	Green Accepted, Bronze			2022-12-28	WOS:000340944700013
J	Yang, B; Treweek, JB; Kulkarni, RP; Deverman, BE; Chen, CK; Lubeck, E; Shah, S; Cai, L; Gradinaru, V				Yang, Bin; Treweek, Jennifer B.; Kulkarni, Rajan P.; Deverman, Benjamin E.; Chen, Chun-Kan; Lubeck, Eric; Shah, Sheel; Cai, Long; Gradinaru, Viviana			Single-Cell Phenotyping within Transparent Intact Tissue through Whole-Body Clearing	CELL			English	Article							MESSENGER-RNA DETECTION; NEURONS; VISUALIZATION; VECTORS; CLARITY; ORGANS	Understanding the structure-function relationships at cellular, circuit, and organ-wide scale requires 3D anatomical and phenotypical maps, currently unavailable for many organs across species. At the root of this knowledge gap is the absence of a method that enables whole-organ imaging. Herein, we present techniques for tissue clearing in which whole organs and bodies are rendered macromolecule-permeable and optically transparent, thereby exposing their cellular structure with intact connectivity. We describe PACT (passive clarity technique), a protocol for passive tissue clearing and immunostaining of intact organs; RIMS (refractive index matching solution), a mounting media for imaging thick tissue; and PARS (perfusion-assisted agent release in situ), a method for whole-body clearing and immunolabeling. We show that in rodents PACT, RIMS, and PARS are compatible with endogenous-fluorescence, immunohistochemistry, RNA single-molecule FISH, long-term storage, and microscopy with cellular and subcellular resolution. These methods are applicable for high-resolution, high-content mapping and phenotyping of normal and pathological elements within intact organs and bodies.	[Yang, Bin; Treweek, Jennifer B.; Kulkarni, Rajan P.; Deverman, Benjamin E.; Chen, Chun-Kan; Lubeck, Eric; Shah, Sheel; Gradinaru, Viviana] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Kulkarni, Rajan P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Dermatol, Los Angeles, CA 90095 USA; [Cai, Long] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology	Gradinaru, V (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	viviana@caltech.edu	Treweek, Jennifer/AAL-7647-2021; Treweek, Jennifer/U-8768-2017	Yang, Bin/0000-0002-3878-1530	NIH/NINDS New Innovator [NIH IDP20D017782-01]; NIH [1R01AG047664-01, R01HD075605, 1R01NS085910-01, 1R21MH103824-01]; Startup funds from the President and Provost of California Institute of Technology; Biology and Biological Engineering Division of California Institute of Technology; Beckman Institute of Caltech; Pew Charitable Trust; Sidney Kimmel Foundation; Human Frontiers in Science Program; Mallinckrodt Foundation; Gordon and Betty Moore Foundation; Michael J. Fox Foundation; Caltech-GIST; Caltech Biology Division Training grant [NIH/NRSA 5T32GM07616]; NIH/NIAMS [5T32AR058921]; Colvin Postdoctoral Fellowship; CALTECH Division of BBE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD075605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR058921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042, T32GM007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH103824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085910, DP2NS087949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047664] Funding Source: NIH RePORTER	NIH/NINDS New Innovator; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Startup funds from the President and Provost of California Institute of Technology; Biology and Biological Engineering Division of California Institute of Technology; Beckman Institute of Caltech; Pew Charitable Trust; Sidney Kimmel Foundation; Human Frontiers in Science Program(Human Frontier Science Program); Mallinckrodt Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Michael J. Fox Foundation; Caltech-GIST; Caltech Biology Division Training grant; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Colvin Postdoctoral Fellowship; CALTECH Division of BBE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the entire Gradinaru lab for helpful discussions. We also thank Drs. Dianne Newman and David Anderson for helpful discussions and suggestions. We thank Drs. Amir Arbabi and Andrei Faraon for assistance with SEM imaging. We thank Richard Bennett and Erik Cabral for assistance with tumor procurement. We thank Leica Microsystems for acquiring some of the images presented with a Leica TCS SP8 with Leica HC FLUOTAR L 253/1.00 IMM CORR objective designed for CLARITY imaging. B. D. and V. G. especially wish to acknowledge the contributions of Paul H. Patterson (1943-2014), whose desire to apply tissue clearing to unresolved questions in neuroscience pushed us to further evolve these methods. This work was funded by: the NIH/NINDS New Innovator (NIH IDP20D017782-01); NIH 1R01AG047664-01; Startup funds from the President and Provost of California Institute of Technology and the Biology and Biological Engineering Division of California Institute of Technology; the Beckman Institute of Caltech; the Pew Charitable Trust; the Sidney Kimmel Foundation (to V. G.). And NIH R01HD075605 (to L. C.). V. G. is also supported by: Human Frontiers in Science Program, the Mallinckrodt Foundation, the Gordon and Betty Moore Foundation, the Michael J. Fox Foundation, Caltech-GIST, NIH 1R01NS085910-01, NIH 1R21MH103824-01. C-K. C., S. S., E. L., acknowledge support from the Caltech Biology Division Training grant (NIH/NRSA 5T32GM07616). R. P. K. acknowledges support from NIH/NIAMS (5T32AR058921). J. B. T. acknowledges the Colvin Postdoctoral Fellowship and CALTECH Division of BBE. B.Y. and V. G. have disclosed these methods and findings to the Caltech Office of Technology Transfer (CIT File No.: CIT-6686-P). V. G. is a cofounder of Circuit Therapeutics and holds related IP and stock (less than 5%). At this writing, V. G. receives no research funding, royalties, or consultant fees from any for-profit organization.	Becker Klaus, 2013, Cold Spring Harb Protoc, V2013, P704, DOI 10.1101/pdb.top076539; Becker K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033916; Buxbaum AR, 2014, SCIENCE, V343, P419, DOI 10.1126/science.1242939; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Deisseroth K.A., 2012, U.S. patent, Patent No. [US 2014030192, 2014030192]; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2013, EXP NEUROL, V242, P57, DOI 10.1016/j.expneurol.2012.10.018; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Gage Gregory J, 2012, J Vis Exp, DOI 10.3791/3564; George MS, 2000, BIOL PSYCHIAT, V47, P287, DOI 10.1016/S0006-3223(99)00308-X; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; JONKERS BW, 1984, J NEUROSCI METH, V12, P141, DOI 10.1016/0165-0270(84)90013-X; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Kim SY, 2013, TRENDS COGN SCI, V17, P596, DOI 10.1016/j.tics.2013.10.005; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; LEONG SK, 1990, J NEUROSCI METH, V32, P15, DOI 10.1016/0165-0270(90)90067-P; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Lock M, 2010, HUM GENE THER, V21, P1259, DOI 10.1089/hum.2010.055; Lyubimova A, 2013, NAT PROTOC, V8, P1743, DOI 10.1038/nprot.2013.109; Moy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053753; Pulicherla N, 2011, MOL THER, V19, P1070, DOI 10.1038/mt.2011.22; Spalteholz W., 1914, DURCHSICHTIGMACHEN M; Steinke H, 2001, ANN ANAT, V183, P91, DOI 10.1016/S0940-9602(01)80020-0; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Zhang MD, 2014, P NATL ACAD SCI USA, V111, pE1149, DOI 10.1073/pnas.1402318111	31	595	635	7	213	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					945	958		10.1016/j.cell.2014.07.017	http://dx.doi.org/10.1016/j.cell.2014.07.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25088144	Bronze, Green Accepted			2022-12-28	WOS:000340944700022
J	Naryshkin, NA; Weetall, M; Dakka, A; Narasimhan, J; Zhao, X; Feng, ZH; Ling, KKY; Karp, GM; Qi, HY; Woll, MG; Chen, GM; Zhang, NJ; Gabbeta, V; Vazirani, P; Bhattacharyya, A; Furia, B; Risher, N; Sheedy, J; Kong, R; Ma, JY; Turpoff, A; Lee, CS; Zhang, XY; Moon, YC; Trifillis, P; Welch, EM; Colacino, JM; Babiak, J; Almstead, NG; Peltz, SW; Eng, LA; Chen, KS; Mull, JL; Lynes, MS; Rubin, LL; Fontoura, P; Santarelli, L; Haehnke, D; McCarthy, KD; Schmucki, R; Ebeling, M; Sivaramakrishnan, M; Ko, CP; Paushkin, SV; Ratni, H; Gerlach, I; Ghosh, A; Metzger, F				Naryshkin, Nikolai A.; Weetall, Marla; Dakka, Amal; Narasimhan, Jana; Zhao, Xin; Feng, Zhihua; Ling, Karen K. Y.; Karp, Gary M.; Qi, Hongyan; Woll, Matthew G.; Chen, Guangming; Zhang, Nanjing; Gabbeta, Vijayalakshmi; Vazirani, Priya; Bhattacharyya, Anuradha; Furia, Bansri; Risher, Nicole; Sheedy, Josephine; Kong, Ronald; Ma, Jiyuan; Turpoff, Anthony; Lee, Chang-Sun; Zhang, Xiaoyan; Moon, Young-Choon; Trifillis, Panayiota; Welch, Ellen M.; Colacino, Joseph M.; Babiak, John; Almstead, Neil G.; Peltz, Stuart W.; Eng, Loren A.; Chen, Karen S.; Mull, Jesse L.; Lynes, Maureen S.; Rubin, Lee L.; Fontoura, Paulo; Santarelli, Luca; Haehnke, Daniel; McCarthy, Kathleen D.; Schmucki, Roland; Ebeling, Martin; Sivaramakrishnan, Manaswini; Ko, Chien-Ping; Paushkin, Sergey V.; Ratni, Hasane; Gerlach, Irene; Ghosh, Anirvan; Metzger, Friedrich			SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy	SCIENCE			English	Article							3' ADENYLATION; SURVIVAL; PROTEIN; GENE; EXON; INHIBITORS; POLN	Spinal muscular atrophy (SMA) is a genetic disease caused by mutation or deletion of the survival of motor neuron 1 (SMN1) gene. A paralogous gene in humans, SMN2, produces low, insufficient levels of functional SMN protein due to alternative splicing that truncates the transcript. The decreased levels of SMN protein lead to progressive neuromuscular degeneration and high rates of mortality. Through chemical screening and optimization, we identified orally available small molecules that shift the balance of SMN2 splicing toward the production of full-length SMN2 messenger RNA with high selectivity. Administration of these compounds to D7 mice, a model of severe SMA, led to an increase in SMN protein levels, improvement of motor function, and protection of the neuromuscular circuit. These compounds also extended the life span of the mice. Selective SMN2 splicing modifiers may have therapeutic potential for patients with SMA.	[Naryshkin, Nikolai A.; Weetall, Marla; Dakka, Amal; Narasimhan, Jana; Zhao, Xin; Karp, Gary M.; Qi, Hongyan; Woll, Matthew G.; Chen, Guangming; Zhang, Nanjing; Gabbeta, Vijayalakshmi; Vazirani, Priya; Bhattacharyya, Anuradha; Furia, Bansri; Risher, Nicole; Sheedy, Josephine; Kong, Ronald; Ma, Jiyuan; Turpoff, Anthony; Lee, Chang-Sun; Zhang, Xiaoyan; Moon, Young-Choon; Trifillis, Panayiota; Welch, Ellen M.; Colacino, Joseph M.; Babiak, John; Almstead, Neil G.; Peltz, Stuart W.] PTC Therapeut, South Plainfield, NJ 07080 USA; [Feng, Zhihua; Ling, Karen K. Y.; Ko, Chien-Ping] Univ So Calif, Neurobiol Sect, Dept Biol Sci, Los Angeles, CA 90089 USA; [Eng, Loren A.; Chen, Karen S.; McCarthy, Kathleen D.; Paushkin, Sergey V.] SMA Fdn, New York, NY 10019 USA; [Mull, Jesse L.; Lynes, Maureen S.; Rubin, Lee L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mull, Jesse L.; Lynes, Maureen S.; Rubin, Lee L.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Fontoura, Paulo; Santarelli, Luca; Haehnke, Daniel; Schmucki, Roland; Ebeling, Martin; Sivaramakrishnan, Manaswini; Ratni, Hasane; Gerlach, Irene; Ghosh, Anirvan; Metzger, Friedrich] F Hoffmann La Roche, Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, CH-4070 Basel, Switzerland	University of Southern California; Harvard University; Harvard University; Roche Holding	Metzger, F (corresponding author), F Hoffmann La Roche, Roche Innovat Ctr Basel, Roche Pharmaceut Res & Early Dev, Grenzacherstr 124, CH-4070 Basel, Switzerland.	speltz@ptcbio.com; friedrich.metzger@roche.com	Ko, Chien-Ping/AAN-2314-2020	Ma, Jiyuan/0000-0001-6538-4023; Hahnke, Daniel/0000-0002-7008-6503; Rubin, Lee/0000-0002-8658-841X	SMA Foundation; Harvard Stem Cell Institute	SMA Foundation; Harvard Stem Cell Institute	We thank O. Khwaja, C. Czech, T. Kremer, L. Muller, W. Muster, S. Kirchner, L. Green, E. Pinard, J. Kazenwadel, C. Horn, O. Spleiss, C. Sarry, P. Kueng, F. Knoflach, L. Himmelein, F. Birzele, K. von Herrmann, A. Mollin, J. Hedrick, M. Dumble, I. Huq, P. Martin, D. Mankoff, S. Jung, J. Crona, M. Haley, T. Yang, S. Choi, S. Hwang, M. Dali, W. Lennox, S. Yeh, J. Yang, J. Petruska, J. Breslin, J. Baird, B. Scharf, T. Tripodi, G. Ryan, J. Tivade, J. Du, D. Minn, C. Romfo, and C. Trotta for help and support with this project. This work was supported by grants from the SMA Foundation and the Harvard Stem Cell Institute. F. Hoffmann-La Roche and PTC Therapeutics have filed three patent applications entitled "Compounds for Treating Spinal Muscular Atrophy" (WO2013/101974 A1, WO2013/112788 A1, and WO2013/119916 A2).	Arkblad E, 2009, ACTA PAEDIATR, V98, P865, DOI 10.1111/j.1651-2227.2008.01201.x; Berg MG, 2012, MOL CELL BIOL, V32, P1271, DOI 10.1128/MCB.05788-11; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Burnett BG, 2009, MOL CELL BIOL, V29, P1107, DOI 10.1128/MCB.01262-08; Burroughs AM, 2010, GENOME RES, V20, P1398, DOI 10.1101/gr.106054.110; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Chang JG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018643; Cho SC, 2010, GENE DEV, V24, P438, DOI 10.1101/gad.1884910; Crawford TO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033572; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; Fallini C, 2012, BRAIN RES, V1462, P81, DOI 10.1016/j.brainres.2012.01.044; Feldkotter M, 2002, AM J HUM GENET, V70, P358, DOI 10.1086/338627; Hasegawa M, 2011, ACS CHEM BIOL, V6, P229, DOI 10.1021/cb100248e; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Kai ZS, 2010, NAT STRUCT MOL BIOL, V17, P5, DOI 10.1038/nsmb.1762; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kinjo ER, 2013, EXP NEUROL, V248, P546, DOI 10.1016/j.expneurol.2013.07.022; Kolb SJ, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-6; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Kuhn AN, 2009, RNA, V15, P153, DOI 10.1261/rna.1332609; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lewelt A, 2012, CURR NEUROL NEUROSCI, V12, P42, DOI 10.1007/s11910-011-0240-9; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 2000, HUM MOL GENET, V9, P259, DOI 10.1093/hmg/9.2.259; Mailman MD, 2002, GENET MED, V4, P20, DOI 10.1097/00125817-200201000-00004; Markowitz JA, 2012, PEDIATR NEUROL, V46, P1, DOI 10.1016/j.pediatrneurol.2011.09.001; Moldovan GL, 2010, MOL CELL BIOL, V30, P1088, DOI 10.1128/MCB.01124-09; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Osborne M, 2012, HUM MOL GENET, V21, P4431, DOI 10.1093/hmg/dds285; Passini MA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001777; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; PEARN J, 1980, LANCET, V1, P919; Sahashi K, 2013, EMBO MOL MED, V5, P1586, DOI 10.1002/emmm.201302567; Schrank B, 1997, P NATL ACAD SCI USA, V94, P9920, DOI 10.1073/pnas.94.18.9920; Seo J, 2013, BBA-MOL BASIS DIS, V1832, P2180, DOI 10.1016/j.bbadis.2013.08.005; Singh NN, 2007, NUCLEIC ACIDS RES, V35, P371, DOI 10.1093/nar/gkl1050; Singh NN, 2013, NUCLEIC ACIDS RES, V41, P8144, DOI 10.1093/nar/gkt609; Singh NN, 2011, RNA BIOL, V8, P600, DOI 10.4161/rna.8.4.16224; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Sugarman EA, 2012, EUR J HUM GENET, V20, P27, DOI 10.1038/ejhg.2011.134; Takata K, 2006, J BIOL CHEM, V281, P23445, DOI 10.1074/jbc.M604317200; Wang CH, 2007, J CHILD NEUROL, V22, P1027, DOI 10.1177/0883073807305788; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; Younis I, 2010, MOL CELL BIOL, V30, P1718, DOI 10.1128/MCB.01301-09; Zietlow L, 2009, BIOCHEMISTRY-US, V48, P11817, DOI 10.1021/bi9015346	48	330	355	2	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					688	693		10.1126/science.1250127	http://dx.doi.org/10.1126/science.1250127			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104390				2022-12-28	WOS:000339962800043
J	Harjunmaa, E; Seidel, K; Hakkinen, T; Renvoise, E; Corfe, IJ; Kallonen, A; Zhang, ZQ; Evans, AR; Mikkola, ML; Salazar-Ciudad, I; Klein, OD; Jernvall, J				Harjunmaa, Enni; Seidel, Kerstin; Hakkinen, Teemu; Renvoise, Elodie; Corfe, Ian J.; Kallonen, Aki; Zhang, Zhao-Qun; Evans, Alistair R.; Mikkola, Marja L.; Salazar-Ciudad, Isaac; Klein, Ophir D.; Jernvall, Jukka			Replaying evolutionary transitions from the dental fossil record	NATURE			English	Article							MAMMALIAN TEETH; PATTERNS; ECTODYSPLASIN; MOLECULES; RADIATION; DYNAMICS; GENES; MODEL; TREES	The evolutionary relationships of extinct species are ascertained primarily through the analysis of morphological characters. Character inter-dependencies can have a substantial effect on evolutionary interpretations, but the developmental underpinnings of character inter-dependence remain obscure because experiments frequently do not provide detailed resolution of morphological characters. Here we show experimentally and computationally how gradual modification of development differentially affects characters in the mouse dentition. We found that intermediate phenotypes could be produced by gradually adding ectodysplas in A (EDA) protein in culture to tooth explants carrying a null mutation in the tooth-patterning gene Eda. By identifying development-based character inter-dependencies, we show how to predict morphological patterns of teeth among mammalian species. Finally, in vivo inhibition of sonic hedgehog signalling in Eda null teeth enabled us to reproduce characters deep in the rodent ancestry. Taken together, evolutionarily informative transitions can be experimentally reproduced, thereby providing development-based expectations for character-state transitions used in evolutionary studies.	[Harjunmaa, Enni; Hakkinen, Teemu; Renvoise, Elodie; Corfe, Ian J.; Mikkola, Marja L.; Salazar-Ciudad, Isaac; Jernvall, Jukka] Univ Helsinki, Inst Biotechnol, Dev Biol Program, FIN-00014 Helsinki, Finland; [Seidel, Kerstin; Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, San Francisco, CA 94114 USA; [Seidel, Kerstin; Klein, Ophir D.] Univ Calif San Francisco, Dept Orofacial Sci, San Francisco, CA 94114 USA; [Kallonen, Aki] Univ Helsinki, Dept Phys, Div Mat Phys, FIN-00014 Helsinki, Finland; [Zhang, Zhao-Qun] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Evans, Alistair R.] Monash Univ, Sch Biol Sci, Clayton, Vic 3800, Australia; [Evans, Alistair R.] Museum Victoria, Melbourne, Vic 3001, Australia; [Salazar-Ciudad, Isaac] Univ Autonoma Barcelona, Dept Genet & Microbiol, Genom Bioinformat & Evolut Group, Cerdanyola Del Valles 08193, Spain; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94114 USA; [Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94114 USA	University of Helsinki; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Helsinki; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Monash University; Museum Victoria; Autonomous University of Barcelona; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jernvall, J (corresponding author), Univ Helsinki, Inst Biotechnol, Dev Biol Program, POB 56, FIN-00014 Helsinki, Finland.	ophir.klein@ucsf.edu; jernvall@fastmail.fm	Corfe, Ian/GSN-6109-2022; Salazar-Ciudad, Isaac/R-2238-2018; Evans, Alistair R/D-4239-2011	Evans, Alistair R/0000-0002-4078-4693; Klein, Ophir/0000-0002-6254-7082; Salazar Ciudad, Isaac/0000-0003-1607-0962; Corfe, Ian/0000-0002-1824-755X	Academy of Finland; NIH/NIDCR [R01-DE021420]; NIH [DP2-OD007191]; Australian Research Council; MST [2012CB821904]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021420, K99DE024214] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007191] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); MST; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Fortelius, J. Eronen, I. Thesleff, P. Munne for discussions; S. Alto, M. Makinen, R. Santalahti, R. Savolainen, and M. Christensen for technical assistance; P. Schneider for the Fc-EDA-A1-protein; F. de Sauvage for HhAntag compound; Hou Yemao for tomography; and the Finnish Museum of Natural History (Helsinki, Finland), Museum of Natural History (Stockholm, Sweden), and Museum fur Naturkunde (Berlin, Germany) for specimen loans. This work was supported by the Academy of Finland to J.J., M.M., I.S.-C., R01-DE021420 (NIH/NIDCR) and an NIH Director's New Innovator Award DP2-OD007191 to O.D.K., an Australian Research Council Future Fellowship to A.R.E, and the Major Basic Research Projects (2012CB821904) of MST to Z.-Q.Z. Data are presented in the Supplementary and Extended Data Tables, available in the MorphoBrowser database (http://morphobrowser.biocenter.helsinki.fi/) and from the authors, and models can be accessed at (http://www.biocenter.helsinki.fi/bi/evodevo/toothmaker.html).	Arthur W., 2011, EVOLUTION DEV APPROA; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; BUTLER PM, 1990, BIOL REV, V65, P529, DOI 10.1111/j.1469-185X.1990.tb01237.x; Cho SW, 2011, DEVELOPMENT, V138, P1807, DOI 10.1242/dev.056051; Doyle JJ, 1997, SYST BIOL, V46, P537, DOI 10.2307/2413695; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; Fliniaux I, 2008, DEV BIOL, V320, P60, DOI 10.1016/j.ydbio.2008.04.023; Gaide O, 2003, NAT MED, V9, P614, DOI 10.1038/nm861; Goswami Anjali, 2010, P141; GRUNEBERG H, 1965, J EMBRYOL EXP MORPH, V14, P137; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Harjunmaa E, 2012, NATURE, V483, P324, DOI 10.1038/nature10876; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Kangas AT, 2004, NATURE, V432, P211, DOI 10.1038/nature02927; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Antonanzas RL, 2009, ZOOL J LINN SOC-LOND, V156, P664, DOI 10.1111/j.1096-3642.2008.00494.x; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Mauldin EA, 2009, AM J MED GENET A, V149A, P2045, DOI 10.1002/ajmg.a.32916; Meng Jin, 2001, Journal of Mammalian Evolution, V8, P1, DOI 10.1023/A:1011328616715; Narhi K, 2010, METHODS MOL BIOL, V666, P253, DOI 10.1007/978-1-60761-820-1_16; O'Keefe FR, 2001, SYST BIOL, V50, P657, DOI 10.1080/106351501753328794; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Osborn J.W., 1973, Breviora, VNo. 399, P1; Polly PD, 2008, EVOL BIOL, V35, P83, DOI 10.1007/s11692-008-9020-0; Rice SH, 2008, ANN NY ACAD SCI, V1133, P67, DOI 10.1196/annals.1438.002; Rodrigues HG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3504; Salazar-Ciudad I, 2013, NATURE, V497, P361, DOI 10.1038/nature12142; Salazar-Ciudad I, 2010, NATURE, V464, P583, DOI 10.1038/nature08838; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; VANVALEN L, 1970, DEV BIOL, V23, P456, DOI 10.1016/0012-1606(70)90110-7; Wake D.B., 1989, Geobios Memoire Special (Villeurbanne), P369; Wessels W., 2009, GEOL ULTRAIECTINA, V307; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275	43	75	78	1	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					44	+		10.1038/nature13613	http://dx.doi.org/10.1038/nature13613			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25079326	Green Accepted			2022-12-28	WOS:000339908000027
J	Zink, A; Ring, J				Zink, Alexander; Ring, Johannes			Phototoxic Dermatitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zink, Alexander; Ring, Johannes] Tech Univ Munich, D-80290 Munich, Germany	Technical University of Munich	Zink, A (corresponding author), Tech Univ Munich, D-80290 Munich, Germany.	zink@lrz.tum.de	Zink, Alexander/S-4445-2019; Ring, Johannes/GLN-4341-2022	Zink, Alexander/0000-0001-9313-6588; Ring, Johannes/0000-0001-8236-3152					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					559	559		10.1056/NEJMicm1315566	http://dx.doi.org/10.1056/NEJMicm1315566			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25099580				2022-12-28	WOS:000339899100010
J	Wolfe, SM				Wolfe, Sidney M.			THE WASHINGTON BRIEF Does $760m a year of industry funding affect the FDA's drug approval process?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA		Wolfe, SM (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA.	Swolfe@citizen.org						Food and Drug Administration, CDER NEW DRUG REV 20; Food and Drug Administration, FY 2015 JUST EST APP; Frank C, 2014, HEALTH AFFAIR, V33, P1453, DOI 10.1377/hlthaff.2014.0122; Lurie P, 1998, FDA MED OFFICERS REP; Wolfe SM, 2012, AUST PRESCR, V35, P138	5	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2014	349								g5012	10.1136/bmj.g5012	http://dx.doi.org/10.1136/bmj.g5012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MP	25096994	Green Published, hybrid			2022-12-28	WOS:000340206000025
J	Cox, E; Laessig, K				Cox, Edward; Laessig, Katherine			FDA Approval of Bedaquiline - The Benefit-Risk Balance for Drug-Resistant Tuberculosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cox, Edward; Laessig, Katherine] US FDA, Off Antimicrobial Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Cox, E (corresponding author), US FDA, Off Antimicrobial Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.		Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984				[Anonymous], SIRT BED PROD INS; Avorn J, 2013, JAMA-J AM MED ASSOC, V309, P1349, DOI 10.1001/jama.2013.623; Center for Drug Evaluation and Research, MED OFF REV SIRT BED; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	5	119	128	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					689	691		10.1056/NEJMp1314385	http://dx.doi.org/10.1056/NEJMp1314385			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3SV	25140952	Bronze			2022-12-28	WOS:000340509900001
J	Verdecchia, P; Reboldi, G				Verdecchia, Paolo; Reboldi, Gianpaolo			Risk and decision making in patients with hypertension	LANCET			English	Editorial Material							GUIDELINES; MANAGEMENT		[Verdecchia, Paolo] Hosp Assisi, Dept Med, I-06081 Assisi, Italy; [Reboldi, Gianpaolo] Univ Perugia, Dept Med, I-06100 Perugia, Italy	University of Perugia	Verdecchia, P (corresponding author), Hosp Assisi, Dept Med, I-06081 Assisi, Italy.	verdec@tin.it	Reboldi, Gianpaolo/A-3444-2009	Reboldi, Gianpaolo/0000-0002-9877-0702				Ahmed I, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-3; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Hackam DG, 2013, CAN J CARDIOL, V29, P528, DOI 10.1016/j.cjca.2013.01.005; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Pitt B, 2004, NEW ENGL J MED, V351, P2115, DOI 10.1056/NEJMe048255; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Weber MA, 2014, J CLIN HYPERTENS, V16, P14, DOI 10.1111/jch.12237	12	5	6	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					562	564		10.1016/S0140-6736(14)61334-9	http://dx.doi.org/10.1016/S0140-6736(14)61334-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25131969				2022-12-28	WOS:000340573300006
J	Karzbrun, E; Tayar, AM; Noireaux, V; Bar-Ziv, RH				Karzbrun, Eyal; Tayar, Alexandra M.; Noireaux, Vincent; Bar-Ziv, Roy H.			Programmable on-chip DNA compartments as artificial cells	SCIENCE			English	Article							FREE EXPRESSION; NETWORKS; CIRCUITS; STEP	The assembly of artificial cells capable of executing synthetic DNA programs has been an important goal for basic research and biotechnology. We assembled two-dimensional DNA compartments fabricated in silicon as artificial cells capable of metabolism, programmable protein synthesis, and communication. Metabolism is maintained by continuous diffusion of nutrients and products through a thin capillary, connecting protein synthesis in the DNA compartment with the environment. We programmed protein expression cycles, autoregulated protein levels, and a signaling expression gradient, equivalent to a morphogen, in an array of interconnected compartments at the scale of an embryo. Gene expression in the DNA compartment reveals a rich, dynamic system that is controlled by geometry, offering a means for studying biological networks outside a living cell.	[Karzbrun, Eyal; Tayar, Alexandra M.; Bar-Ziv, Roy H.] Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel; [Noireaux, Vincent] Univ Minnesota, Dept Phys, Minneapolis, MN 55455 USA	Weizmann Institute of Science; University of Minnesota System; University of Minnesota Twin Cities	Bar-Ziv, RH (corresponding author), Weizmann Inst Sci, Dept Mat & Interfaces, IL-76100 Rehovot, Israel.	roy.bar-ziv@weizmann.ac.il		Karzbrun, Eyal/0000-0001-8724-7855; noireaux, vincent/0000-0002-5213-273X; Tayar, alexandra/0000-0002-1418-2058	Israel Science Foundation; Minerva Foundation; U.S.-Israel Binational Science Foundation; NSF [PHY-0750133]; Azrieli Foundation	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); NSF(National Science Foundation (NSF)); Azrieli Foundation	We thank A. Yoffe, S. Garussi, and Y. Barak of the Helen and Martin Kimmel Center for Nanoscale Science for guidance and assistance; I. Kaplan-Ashiri for scanning electron microscopy imaging; J. Hasty, University of California San Diego, for the generous gift of positive-feedback construct; and S. S. Daube and A. Libchaber for helpful discussions. This work was supported by the Israel Science Foundation (R.H.B.-Z.), the Minerva Foundation (R.H.B.-.Z), the U.S.-Israel Binational Science Foundation (R.H.B.-Z. and V.N.), NSF grant PHY-0750133 (V.N.), and the Azrieli Foundation (E.K.).	Bracha D, 2014, ACCOUNTS CHEM RES, V47, P1912, DOI 10.1021/ar5001428; Buxboim A, 2007, SMALL, V3, P500, DOI 10.1002/smll.200600489; Franco E, 2011, P NATL ACAD SCI USA, V108, pE784, DOI 10.1073/pnas.1100060108; Gerber D, 2009, NAT METHODS, V6, P71, DOI [10.1038/NMETH.1289, 10.1038/nmeth.1289]; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heyman Y, 2012, NAT NANOTECHNOL, V7, P374, DOI [10.1038/nnano.2012.65, 10.1038/NNANO.2012.65]; Hockenberry AJ, 2012, CURR OPIN CHEM BIOL, V16, P253, DOI 10.1016/j.cbpa.2012.05.179; Isalan M, 2005, PLOS BIOL, V3, P488, DOI 10.1371/journal.pbio.0030064; Kim J, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100099; Matthies D, 2011, J MOL BIOL, V413, P593, DOI 10.1016/j.jmb.2011.08.055; Muller P, 2013, DEVELOPMENT, V140, P1621, DOI 10.1242/dev.083519; Niederholtmeyer H, 2013, P NATL ACAD SCI USA, V110, P15985, DOI 10.1073/pnas.1311166110; Noireaux V, 2004, P NATL ACAD SCI USA, V101, P17669, DOI 10.1073/pnas.0408236101; Noireaux V, 2003, P NATL ACAD SCI USA, V100, P12672, DOI 10.1073/pnas.2135496100; Shin J, 2012, ACS SYNTH BIOL, V1, P408, DOI 10.1021/sb300049p; Shin J, 2012, ACS SYNTH BIOL, V1, P29, DOI 10.1021/sb200016s; Shin Jonghyeon, 2010, J Biol Eng, V4, P9, DOI 10.1186/1754-1611-4-9; Shin Jonghyeon, 2010, J Biol Eng, V4, P8, DOI 10.1186/1754-1611-4-8; SPIRIN AS, 1988, SCIENCE, V242, P1162, DOI 10.1126/science.3055301; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996	22	173	179	4	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					829	832		10.1126/science.1255550	http://dx.doi.org/10.1126/science.1255550			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124443				2022-12-28	WOS:000340593100049
J	Durr, KL; Chen, L; Stein, RA; De Zorzi, R; Folea, IM; Walz, T; Mchaourab, HS; Gouaux, E				Duerr, Katharina L.; Chen, Lei; Stein, Richard A.; De Zorzi, Rita; Folea, I. Mihaela; Walz, Thomas; Mchaourab, Hassane S.; Gouaux, Eric			Structure and Dynamics of AMPA Receptor GluA2 in Resting, Pre-Open, and Desensitized States	CELL			English	Article							LIGAND-BINDING DOMAIN; X-RAY-STRUCTURE; GLUTAMATE-RECEPTOR; DISTANCE MEASUREMENTS; HIPPOCAMPAL-NEURONS; SYNAPTIC CURRENTS; MOLECULAR-CLONING; TERMINAL DOMAIN; CRYO-EM; ACTIVATION	Ionotropic glutamate receptors (iGluRs) mediate the majority of fast excitatory signaling in the nervous system. Despite the profound importance of iGluRs to neurotransmission, little is known about the structures and dynamics of intact receptors in distinct functional states. Here, we elucidate the structures of the intact GluA2 AMPA receptor in an apo resting/closed state, in an activated/pre-open state bound with partial agonists and a positive allosteric modulator, and in a desensitized/closed state in complex with fluorowilliardiine. To probe the conformational properties of these states, we carried out double electron-electron resonance experiments on cysteine mutants and cryoelectron microscopy studies. We show how agonist binding modulates the conformation of the ligand-binding domain "layer" of the intact receptors and how, upon desensitization, the receptor undergoes large conformational rearrangements of the amino-terminal and ligand-binding domains. We define mechanistic principles by which to understand antagonism, activation, and desensitization in AMPA iGluRs.	[Duerr, Katharina L.; Chen, Lei; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Stein, Richard A.; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [De Zorzi, Rita; Folea, I. Mihaela; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Vanderbilt University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Duerr, Katharina/A-6975-2015	Gouaux, Eric/0000-0002-8549-2360; Walz, Thomas/0000-0003-2606-2835; Duerr, Katharina/0000-0002-3245-4088; DE ZORZI, Rita/0000-0001-7001-7498; Chen, Lei/0000-0002-7619-8311	American Heart Association postdoctoral fellowship [13POST13960004]; Long-Term Fellowship of the European Molecular Biology Organization; institutional National Research Service Award (NRSA); individual NRSA [F32MH100331]; NIH [NCRR 1S10RR028832-01];  [U54-GM087519];  [S10 RR027091]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027091, S10RR028832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077659, U54GM087519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH100331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800, R01NS038631, R37NS038631] Funding Source: NIH RePORTER	American Heart Association postdoctoral fellowship(American Heart Association); Long-Term Fellowship of the European Molecular Biology Organization; institutional National Research Service Award (NRSA); individual NRSA; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Vaskalis for figures, ALS BCSB and APS NE-CAT beamline staff for support, and M. Suga for early work on thermostability mutation screening. We thank P. Penczek for guidance in the use of SPARX and ISAC. L.C. is supported by an American Heart Association postdoctoral fellowship (13POST13960004). K.L.D. was supported by a Long-Term Fellowship of the European Molecular Biology Organization and an institutional National Research Service Award (NRSA) and is currently the recipient of an individual NRSA (F32MH100331). H.S.M. and R.A.S. were supported by grants U54-GM087519 and S10 RR027091. The Orchestra High Performance Compute Cluster at Harvard Medical School is a shared facility partially supported by NIH grant NCRR 1S10RR028832-01. This work was supported by the NIH (E.G.). E.G. and T.W. are investigators with the Howard Hughes Medical Institute.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; BERTOLINO M, 1993, RECEPTOR CHANNEL, V1, P267; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; Christie LA, 2010, P NATL ACAD SCI USA, V107, P9412, DOI 10.1073/pnas.0908206107; Dong H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1362; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez J, 2010, P NATL ACAD SCI USA, V107, P9891, DOI 10.1073/pnas.0911854107; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; ISAACSON JS, 1991, P NATL ACAD SCI USA, V88, P10936, DOI 10.1073/pnas.88.23.10936; Jeschke G, 2002, CHEMPHYSCHEM, V3, P927, DOI 10.1002/1439-7641(20021115)3:11<927::AID-CPHC927>3.0.CO;2-Q; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Kaae BH, 2007, CHEM BIOL, V14, P1294, DOI 10.1016/j.chembiol.2007.10.012; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Levchenko-Lambert Y, 2011, J NEUROSCI, V31, P9359, DOI 10.1523/JNEUROSCI.6761-10.2011; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Moykkynen T, 2014, J BIOL CHEM, V289, P13197, DOI 10.1074/jbc.M113.526301; O'Neill MJ, 2004, CNS NEUROL DISORD-DR, V3, P181, DOI 10.2174/1568007043337508; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Saab AS, 2012, SCIENCE, V337, P749, DOI 10.1126/science.1221140; Schauder DM, 2013, P NATL ACAD SCI USA, V110, P5921, DOI 10.1073/pnas.1217549110; Smith TC, 2000, NAT NEUROSCI, V3, P992, DOI 10.1038/79931; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Whorton MR, 2013, NATURE, V498, P190, DOI 10.1038/nature12241; YAMADA KA, 1992, J PHYSIOL-LONDON, V458, P409, DOI 10.1113/jphysiol.1992.sp019424; YAMADA KA, 1993, J NEUROSCI, V13, P3904; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Yuan P, 2012, NATURE, V481, P94, DOI 10.1038/nature10670	50	154	154	1	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					778	792		10.1016/j.cell.2014.07.023	http://dx.doi.org/10.1016/j.cell.2014.07.023			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25109876	Green Accepted, Bronze			2022-12-28	WOS:000340944700010
J	Galeazzi, M; Chiao, M; Collier, MR; Cravens, T; Koutroumpa, D; Kuntz, KD; Lallement, R; Lepri, ST; McCammon, D; Morgan, K; Porter, FS; Robertson, IP; Snowden, SL; Thomas, NE; Uprety, Y; Ursino, E; Walsh, BM				Galeazzi, M.; Chiao, M.; Collier, M. R.; Cravens, T.; Koutroumpa, D.; Kuntz, K. D.; Lallement, R.; Lepri, S. T.; McCammon, D.; Morgan, K.; Porter, F. S.; Robertson, I. P.; Snowden, S. L.; Thomas, N. E.; Uprety, Y.; Ursino, E.; Walsh, B. M.			The origin of the local 1/4-keV X-ray flux in both charge exchange and a hot bubble	NATURE			English	Article							SOLAR-WIND; BACKGROUND FLUX; EMISSION; GAS; INFERENCES; MODEL	The solar neighbourhood is the closest and most easily studied sample of the Galactic interstellar medium, an understanding of which is essential for models of star formation and galaxy evolution. Observations of an unexpectedly intense diffuse flux of easily absorbed 1/4-kiloelectronvolt X-rays(1,2), coupled with the discovery that interstellar space within about a hundred parsecs of the Sun is almost completely devoid of cool absorbing gas(3), led to a picture of a 'local cavity' filled with X-ray-emitting hot gas, dubbed the local hot bubble(4-6). This model was recently challenged by suggestions that the emission could instead be readily produced within the Solar System by heavy solar-wind ions exchanging electrons with neutral H and He in interplanetary space(7-11), potentially removing the major piece of evidence for the local existence of million-degree gas within the Galactic disk(12-15). Here we report observations showing that the total solar-wind charge-exchange contribution is approximately 40 per cent of the 1/4-keV flux in the Galactic plane. The fact that the measured flux is not dominated by charge exchange supports the notion of a million-degree hot bubble extending about a hundred parsecs from the Sun.	[Galeazzi, M.; Uprety, Y.; Ursino, E.] Univ Miami, Dept Phys, Coral Gables, FL 33124 USA; [Chiao, M.; Collier, M. R.; Porter, F. S.; Snowden, S. L.; Thomas, N. E.; Walsh, B. M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Cravens, T.; Robertson, I. P.] Univ Kansas, Dept Phys & Astron, Lawrence, KS 66045 USA; [Koutroumpa, D.] Univ Paris 06, Sorbonne Univ, Univ Versailles St Quentin, CNRS,INSU,LATMOS IPSL, F-78280 Guyancourt, France; [Kuntz, K. D.] Johns Hopkins Univ, Henry A Rowland Dept Phys & Astron, Baltimore, MD 21218 USA; [Lallement, R.] Univ Paris Diderot, GEPI Observ Paris, CNRS, UMR 8111, F-92190 Meudon, France; [Lepri, S. T.] Univ Michigan, Dept Atmospher Ocean & Space Sci, Ann Arbor, MI 48109 USA; [McCammon, D.; Morgan, K.] Univ Wisconsin, Dept Phys, Madison, WI 53706 USA	University of Miami; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Kansas; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Universite Paris Saclay; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Universite Paris Cite; University of Michigan System; University of Michigan; University of Wisconsin System; University of Wisconsin Madison	Galeazzi, M (corresponding author), Univ Miami, Dept Phys, Coral Gables, FL 33124 USA.	galeazzi@physics.miami.edu	Morgan, Kelsey/J-5053-2016; Lepri, Susan T./I-8611-2012; Collier, Michael/I-4864-2013; Porter, Frederick S/D-3501-2012; McCammon, Dan/AGW-1730-2022; Uprety, Youaraj/C-8104-2015; Walsh, Brian/C-4899-2016	Morgan, Kelsey/0000-0002-6597-1030; Collier, Michael/0000-0001-9658-6605; Porter, Frederick S/0000-0002-6374-1119; McCammon, Dan/0000-0001-5170-4567; Uprety, Youaraj/0000-0001-9101-2063; Walsh, Brian/0000-0001-7426-5413; Koutroumpa, Dimitra/0000-0002-5716-3412	NASA [NNX11AF04G, NNX09AF09G]; French space agency CNES; National Program 'Physique Chimie du Milieu Interstellaire' of the Institut National des Sciences de l'Univers (INSU)	NASA(National Aeronautics & Space Administration (NASA)); French space agency CNES(Centre National D'etudes Spatiales); National Program 'Physique Chimie du Milieu Interstellaire' of the Institut National des Sciences de l'Univers (INSU)	We thank the personnel at NASA's Wallops Flight Facility and the White Sands Military Range for their support of payload development, integration and launch, and the technical personnel at the University of Miami, NASA's Goddard Space Flight Center and the University of Michigan for their support of the instrument's development. This work was supported by NASA award numbers NNX11AF04G and NNX09AF09G. D.K. and R.L. acknowledge financial support for their activity through the programme 'Soleil Heliosphere Magnetosphere' of the French space agency CNES, and the National Program 'Physique Chimie du Milieu Interstellaire' of the Institut National des Sciences de l'Univers (INSU). M.C. and N.E.T. are employed through the Center for Research and Exploration in Space Science and Technology (CRESST) and the University of Maryland, Baltimore County, Baltimore, Maryland, USA.	BOWYER CS, 1968, NATURE, V217, P32, DOI 10.1038/217032a0; Breitschwerdt D., 1998, LECT NOTE PHYS, V506, P121; BUNNER AN, 1969, NATURE, V223, P1222, DOI 10.1038/2231222a0; Burlaga LF, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/146; Cox D. P., 1986, ADV SPACE RES, V6, P97; COX DP, 1982, ASTROPHYS J, V253, P268, DOI 10.1086/159632; Cravens TE, 1997, GEOPHYS RES LETT, V24, P105, DOI 10.1029/96GL03780; Cravens TE, 2000, ASTROPHYS J, V532, pL153, DOI 10.1086/312574; FRISCH PC, 1981, NATURE, V293, P377, DOI 10.1038/293377a0; Frisch PC, 2000, J GEOPHYS RES-SPACE, V105, P10279, DOI 10.1029/1999JA900238; Galeazzi M, 2011, EXP ASTRON, V32, P83, DOI 10.1007/s10686-011-9249-y; JENKINS EB, 1974, ASTROPHYS J, V193, pL121, DOI 10.1086/181647; Koutroumpa D, 2006, ASTRON ASTROPHYS, V460, P289, DOI 10.1051/0004-6361:20065250; Koutroumpa D, 2009, ASTROPHYS J, V696, P1517, DOI 10.1088/0004-637X/696/2/1517; Lallement R, 2004, ASTRON ASTROPHYS, V418, P143, DOI 10.1051/0004-6361:20040059; Lallement R, 2007, SPACE SCI REV, V130, P341, DOI 10.1007/s11214-007-9178-2; Mobius E, 2004, ASTRON ASTROPHYS, V426, P897, DOI 10.1051/0004-6361:20035834; Puspitarini L., 2014, LOCAL ISM 3D DISTRIB; SANDERS WT, 1977, ASTROPHYS J, V217, pL87, DOI 10.1086/182545; Snowden SL, 1990, ASTROPHYS J, V354, P211, DOI 10.1086/168680; Snowden S. L, ASTROPHYS J IN PRESS; SNOWDEN SL, 1995, ASTROPHYS J, V454, P643, DOI 10.1086/176517; Welsh BY, 2009, ASTROPHYS SPACE SCI, V323, P1, DOI 10.1007/s10509-009-0053-3; Welsh BY, 2005, ASTRON ASTROPHYS, V436, P615, DOI 10.1051/0004-6361:20042611	24	51	51	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					171	+		10.1038/nature13525	http://dx.doi.org/10.1038/nature13525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25079321	Green Submitted			2022-12-28	WOS:000340200700026
J	Malpani, A				Malpani, Aniruddha			PERSONAL VIEW Use patient power to tackle medical corruption in India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Hlth Educ Lib People, Bombay 400034, Maharashtra, India		Malpani, A (corresponding author), Hlth Educ Lib People, Bombay 400034, Maharashtra, India.	info@drmalpani.com						[Anonymous], 2010, HINDU; Berger D, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3169; Chattopadhyay Subrata, 2013, Indian J Med Ethics, V10, P153; DeBronkart D, 2013, LET PATIENTS HELP; Sachan D, 2013, LANCET, V382, pE23, DOI 10.1016/S0140-6736(13)62364-8; Yunus M., 2003, BANKER POOR STORY GR	6	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2014	349								g5156	10.1136/bmj.g5156	http://dx.doi.org/10.1136/bmj.g5156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RX	25125438				2022-12-28	WOS:000340507300005
J	Morris, SA; Cahan, P; Li, H; Zhao, AM; Roman, AKS; Shivdasani, RA; Collins, JJ; Daley, GQ				Morris, Samantha A.; Cahan, Patrick; Li, Hu; Zhao, Anna M.; Roman, Adrianna K. San; Shivdasani, Ramesh A.; Collins, James J.; Daley, George Q.			Dissecting Engineered Cell Types and Enhancing Cell Fate Conversion via CellNet	CELL			English	Article							TRANSCRIPTION FACTOR CDX2; DEFINED FACTORS; MOUSE FIBROBLASTS; FUNCTIONAL-NEURONS; STEM-CELLS; IDENTITY; TRANSPLANTATION; REGENERATION; HEPATOCYTES; BINDING	Engineering clinically relevant cells in vitro holds promise for regenerative medicine, but most protocols fail to faithfully recapitulate target cell properties. To address this, we developed CellNet, a network biology platform that determines whether engineered cells are equivalent to their target tissues, diagnoses aberrant gene regulatory networks, and prioritizes candidate transcriptional regulators to enhance engineered conversions. Using CellNet, we improved B cell to macrophage conversion, transcriptionally and functionally, by knocking down predicted B cell regulators. Analyzing conversion of fibroblasts to induced hepatocytes (iHeps), CellNet revealed an unexpected intestinal program regulated by the master regulator Cdx2. We observed long-term functional engraftment of mouse colon by iHeps, thereby establishing their broader potential as endoderm progenitors and demonstrating direct conversion of fibroblasts into intestinal epithelium. Our studies illustrate how CellNet can be employed to improve direct conversion and to uncover unappreciated properties of engineered cells.	[Morris, Samantha A.; Cahan, Patrick; Zhao, Anna M.; Daley, George Q.] Boston Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol,Stem Cell Transplantat, Boston, MA 02115 USA; [Morris, Samantha A.; Cahan, Patrick; Zhao, Anna M.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Morris, Samantha A.; Cahan, Patrick; Zhao, Anna M.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Morris, Samantha A.; Cahan, Patrick; Zhao, Anna M.; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Hu] Mayo Clin, Coll Med, Ctr Individualized Med, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Roman, Adrianna K. San; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Roman, Adrianna K. San; Shivdasani, Ramesh A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Roman, Adrianna K. San; Shivdasani, Ramesh A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Collins, James J.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Mayo Clinic; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Howard Hughes Medical Institute; Harvard University	Daley, GQ (corresponding author), Boston Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Div Pediat Hematol & Oncol,Stem Cell Transplantat, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu		Cahan, Patrick/0000-0003-3652-2540	NIH (Progenitor Cell Biology Consortium) [UO1-HL100001, R24DK092760]; Boston Children's Hospital Stem Cell Program; Alex's Lemonade Stand Foundation; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; NIH [R24DK092760, R01DK082889]; HHMI;  [P50HG005550];  [1K01DK096013];  [2T32HL066987];  [5T32HL007623]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, T32HL066987, T32HL007623] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK092760, R01DK082889, K01DK096013] Funding Source: NIH RePORTER	NIH (Progenitor Cell Biology Consortium); Boston Children's Hospital Stem Cell Program; Alex's Lemonade Stand Foundation; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Center for Regenerative Medicine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); ; ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank members of the Daley laboratory for critical discussion, the Dana Farber Cancer Institute Hematological Neoplasia flow facility for assistance with cell sorting, and Thomas Graf for the C10 and RAW264.7 cells. G.Q.D. is supported by grants from the NIH (Progenitor Cell Biology Consortium UO1-HL100001 and R24DK092760), and the Boston Children's Hospital Stem Cell Program. G.Q.D. is an affiliate member of the Broad Institute, and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. S.A.M. is supported by a Young Investigator Award from Alex's Lemonade Stand Foundation and P50HG005550. P.C is supported by 1K01DK096013, 2T32HL066987, and 5T32HL007623. H.L. is supported by Mayo Clinic Center for Individualized Medicine and Mayo Clinic Center for Regenerative Medicine. J.J.C. is supported by NIH grant R24DK092760 and the HHMI. R.A.S. is supported by NIH grant R01DK082889.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bernardo GM, 2012, BIOSCIENCE REP, V32, P113, DOI 10.1042/BSR20110046; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Di Tullio A, 2011, P NATL ACAD SCI USA, V108, P17016, DOI 10.1073/pnas.1112169108; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Fordham RP, 2013, CELL STEM CELL, V13, P734, DOI 10.1016/j.stem.2013.09.015; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Lins K, 2003, EMBO J, V22, P2188, DOI 10.1093/emboj/cdg199; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Morris SA, 2013, CELL RES, V23, P33, DOI 10.1038/cr.2013.1; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Pereira CF, 2013, CELL STEM CELL, V13, P205, DOI 10.1016/j.stem.2013.05.024; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Sheaffer KL, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008284; Sherwood RI, 2009, DEV DYNAM, V238, P29, DOI 10.1002/dvdy.21810; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; STRAIN AJ, 1994, GUT, V35, P433, DOI 10.1136/gut.35.4.433; Verzi MP, 2013, MOL CELL BIOL, V33, P281, DOI 10.1128/MCB.01185-12; Verzi MP, 2010, DEV CELL, V19, P713, DOI 10.1016/j.devcel.2010.10.006; Vierbuchen T, 2011, NAT BIOTECHNOL, V29, P892, DOI 10.1038/nbt.1946; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Willenbring H, 2011, CELL STEM CELL, V9, P89, DOI 10.1016/j.stem.2011.07.009; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhou QQ, 2012, J CELL MOL MED, V16, P1900, DOI 10.1111/j.1582-4934.2011.01485.x	33	171	173	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					889	902		10.1016/j.cell.2014.07.021	http://dx.doi.org/10.1016/j.cell.2014.07.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126792	Green Accepted, Bronze			2022-12-28	WOS:000340944700018
J	Conrad, ME; Knodell, RG				Conrad, Marcel E.; Knodell, Robert G.			Viral Hepatitis-1975 (Reprinted from vol 233, pg 1277, 1975)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		CONRAD ME, 1975, JAMA-J AM MED ASSOC, V233, P1277	1	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					654	654		10.1001/jama.2013.279664	http://dx.doi.org/10.1001/jama.2013.279664			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117146				2022-12-28	WOS:000340136400035
J	Manning, KD				Manning, Kimberly D.			If These Walls Could Talk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Emory Clin, Sch Med, Atlanta, GA 30322 USA	Emory University	Manning, KD (corresponding author), Emory Clin, Sch Med, Atlanta, GA 30322 USA.	kdmanni@emory.edu							0	0	0	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					599	600		10.1001/jama.2014.6778	http://dx.doi.org/10.1001/jama.2014.6778			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117126				2022-12-28	WOS:000340136400016
J	Smith, MTJ; Rubinstein, JL				Smith, Martin T. J.; Rubinstein, John L.			STRUCTURAL BIOLOGY Beyond blob-ology	SCIENCE			English	Editorial Material							BEAM-INDUCED MOTION; CRYOELECTRON MICROSCOPY; ELECTRON CRYOMICROSCOPY; CRYO-EM		[Smith, Martin T. J.; Rubinstein, John L.] Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada; [Rubinstein, John L.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Rubinstein, John L.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Smith, MTJ (corresponding author), Hosp Sick Children, Res Inst, Mol Struct & Funct Program, Toronto, ON M5G 0A4, Canada.	john.rubinstein@utoronto.ca						Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; DUBOCHET J, 1982, ULTRAMICROSCOPY, V10, P55, DOI 10.1016/0304-3991(82)90187-5; Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872; Henderson R, 2013, P NATL ACAD SCI USA, V110, P18037, DOI 10.1073/pnas.1314449110; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lu PL, 2014, NATURE, V512, P166, DOI 10.1038/nature13567; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Ruskin RS, 2013, J STRUCT BIOL, V184, P385, DOI 10.1016/j.jsb.2013.10.016; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041	14	34	35	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					617	619		10.1126/science.1256358	http://dx.doi.org/10.1126/science.1256358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104368				2022-12-28	WOS:000339962800016
J	O'Gara, PT; Harold, JG; Zoghbi, WA				O'Gara, Patrick T.; Harold, John Gordon; Zoghbi, William A.			Thinking globally to transform cardiovascular care	LANCET			English	Editorial Material									[O'Gara, Patrick T.] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA; [Harold, John Gordon] Cedars Sinai Med Ctr, Div Cardiol, Los Angeles, CA 90048 USA; [Zoghbi, William A.] Houston Methodist Hosp, Dept Cardiol, Houston, TX USA	Harvard University; Brigham & Women's Hospital; Cedars Sinai Medical Center; The Methodist Hospital System; The Methodist Hospital - Houston	O'Gara, PT (corresponding author), Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA.	pogara@partners.org	Harold, John Gordon/AAS-9266-2021	Harold, John Gordon/0000-0001-6475-4002				American College of Cardiology, 2014, 47 ANN NEW YORK CARD; American College of Cardiology Brazilian Society of Cardiology, 2014, 3 ANN CARD S BRAZ MA; American College of Cardiology Foundation, 2014, NAT CARD DAT; American College of Cardiology Foundation, PINNACLE IND HEALTHC; American College of Cardiology Foundation, 2012, CARDIOLOGY, V41, P23; CardioSmart American College of Cardiology, 2014, CARD ESP; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; World Health Organization, 2013, PROP PROGR BUDG 2014; World Health Organization, WHO NCD SURV STRAT; World Health Organization, 2013, GLOB ACT PLAN PREV C	10	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					379	380		10.1016/S0140-6736(14)61141-7	http://dx.doi.org/10.1016/S0140-6736(14)61141-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9IV	25088849				2022-12-28	WOS:000340195800005
J	Gerard, A; Patino-Lopez, G; Beemiller, P; Nambiar, R; Ben-Aissa, K; Liu, Y; Totah, FJ; Tyska, MJ; Shaw, S; Krummel, MF				Gerard, Audrey; Patino-Lopez, Genaro; Beemiller, Peter; Nambiar, Rajalakshmi; Ben-Aissa, Khadija; Liu, Yin; Totah, Fadi J.; Tyska, Matthew J.; Shaw, Stephen; Krummel, Matthew F.			Detection of Rare Antigen-Presenting Cells through T Cell-Intrinsic Meandering Motility, Mediated by Myo1g	CELL			English	Article							MYOSIN-I; MEMBRANE TENSION; PLASMA-MEMBRANE; DENDRITIC CELLS; LYMPH-NODES; LEVY WALKS; MIGRATION; CHEMOKINES; EFFECTOR; CYTOSKELETON	To mount an immune response, T lymphocytes must successfully search for foreign material bound to the surface of antigen-presenting cells. How T cells optimize their chances of encountering and responding to these antigens is unknown. T cell motility in tissues resembles a random or Levy walk and is regulated in part by external factors including chemokines and lymph-node topology, but motility parameters such as speed and propensity to turn may also be cell intrinsic. Here we found that the unconventional myosin 1g (Myo1g) motor generates membrane tension, enforces cell-intrinsic meandering search, and enhances T-DC interactions during lymph-node surveillance. Increased turning and meandering motility, as opposed to ballistic motility, is enhanced by Myo1g. Myo1g acts as a "turning motor'' and generates a form of cellular "flanerie.'' Modeling and antigen challenges show that these intrinsically programmed elements of motility search are critical for the detection of rare cognate antigen-presenting cells.	[Gerard, Audrey; Beemiller, Peter; Totah, Fadi J.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Patino-Lopez, Genaro; Ben-Aissa, Khadija; Liu, Yin; Shaw, Stephen] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Nambiar, Rajalakshmi; Tyska, Matthew J.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37205 USA	University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Vanderbilt University	Krummel, MF (corresponding author), Univ Calif San Francisco, Dept Pathol, 513 Parnassus Ave,HSW512, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu	Patiño López, Genaro/GQI-4414-2022; Patino-Lopez, Genaro/O-3484-2018	Patino-Lopez, Genaro/0000-0002-8716-722X; Beemiller, Peter/0000-0002-2736-3405	NIH [DK075555, AI052116]; American Heart Association; NIH Intramural Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL024136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, R01AI052116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075555] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NIH Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Biological Imaging Development Center personnel for technical assistance with imaging. We thank G. A. Bizarri, F. Bartumeus, G. Altan-Bonnet, D. Barber D. Erle, and S. Dumont for helpful comments and suggestions and the ImmGen consortium for array data. We thank M. B. Headley for critical reading of the manuscript. This work was supported by grants from NIH (DK075555) and American Heart Association to M.J.T., The NIH Intramural Research Program to S. S., and NIH (AI052116) to M. F. K.	Andrew N, 2007, NAT CELL BIOL, V9, P193, DOI 10.1038/ncb1536; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Beauchemin C, 2007, J IMMUNOL, V178, P5505, DOI 10.4049/jimmunol.178.9.5505; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Beltman JB, 2009, J IMMUNOL METHODS, V347, P54, DOI 10.1016/j.jim.2009.05.013; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Bonifaz L, 2002, J EXP MED, V196, P1627, DOI 10.1084/jem.20021598; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; Dang I, 2013, NATURE, V503, P281, DOI 10.1038/nature12611; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Friedl P, 1998, EUR J IMMUNOL, V28, P2331, DOI 10.1002/(SICI)1521-4141(199808)28:08<2331::AID-IMMU2331>3.0.CO;2-C; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; Friedman RS, 2010, J EXP MED, V207, P2733, DOI 10.1084/jem.20091201; Fukui Y, 2002, CELL BIOL INT, V26, P933, DOI 10.1006/cbir.2002.0959; Gerard A, 2013, NAT IMMUNOL, V14, P356, DOI 10.1038/ni.2547; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Graw F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002436; Greenberg MJ, 2013, TRENDS CELL BIOL, V23, P81, DOI 10.1016/j.tcb.2012.10.008; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; JAY PY, 1995, J CELL SCI, V108, P387; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Keren K, 2011, EUR BIOPHYS J BIOPHY, V40, P1013, DOI 10.1007/s00249-011-0741-0; Kim SV, 2008, CELL MOL LIFE SCI, V65, P2128, DOI 10.1007/s00018-008-7435-5; Kim SV, 2006, SCIENCE, V314, P136, DOI 10.1126/science.1131920; Krummel MF, 2000, SCIENCE, V289, P1349, DOI 10.1126/science.289.5483.1349; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Maravillas-Montero JL, 2011, J IMMUNOL, V187, P3053, DOI 10.4049/jimmunol.1004018; McConnell RE, 2010, TRENDS CELL BIOL, V20, P418, DOI 10.1016/j.tcb.2010.04.004; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miramontes O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034317; Mrass P, 2010, SEMIN IMMUNOPATHOL, V32, P257, DOI 10.1007/s00281-010-0212-1; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; OSTER GF, 1987, J CELL SCI, P35; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Patino-Lopez G, 2010, J BIOL CHEM, V285, P8675, DOI 10.1074/jbc.M109.086959; Preston SP, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011910; Reynolds AM, 2009, J THEOR BIOL, V260, P98, DOI 10.1016/j.jtbi.2009.05.033; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Textor J, 2011, P NATL ACAD SCI USA, V108, P12401, DOI 10.1073/pnas.1102288108; Usherwood EJ, 1999, J IMMUNOL, V162, P3350; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Wulfing C, 1997, J EXP MED, V185, P1815, DOI 10.1084/jem.185.10.1815; ZHDANOV VP, 1988, CATAL REV, V30, P501, DOI 10.1080/01614948808071752	53	78	81	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					492	505		10.1016/j.cell.2014.05.044	http://dx.doi.org/10.1016/j.cell.2014.05.044			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083865	Green Accepted, Bronze			2022-12-28	WOS:000340944300005
J	Kumar, A; Mazzanti, M; Mistrik, M; Kosar, M; Beznoussenko, GV; Mironov, AA; Garre, M; Parazzoli, D; Shivashankar, GV; Scita, G; Bartek, J; Foiani, M				Kumar, Amit; Mazzanti, Michele; Mistrik, Martin; Kosar, Martin; Beznoussenko, Galina V.; Mironov, Alexandre A.; Garre, Massimiliano; Parazzoli, Dario; Shivashankar, G. V.; Scita, Giorgio; Bartek, Jiri; Foiani, Marco			ATR Mediates a Checkpoint at the Nuclear Envelope in Response to Mechanical Stress	CELL			English	Article							CELL-CYCLE ARREST; DNA-DAMAGE; EXTRACELLULAR-MATRIX; REPLICATION STRESS; FORK PROGRESSION; POTENT TOOL; ACTIVATION; CHROMATIN; GENOME; STABILITY	ATR controls chromosome integrity and chromatin dynamics. We have previously shown that yeast Mec1/ATR promotes chromatin detachment from the nuclear envelope to counteract aberrant topological transitions during DNA replication. Here, we provide evidence that ATR activity at the nuclear envelope responds to mechanical stress. Human ATR associates with the nuclear envelope during S phase and prophase, and both osmotic stress and mechanical stretching relocalize ATR to nuclear membranes throughout the cell cycle. The ATR-mediated mechanical response occurs within the range of physiological forces, is reversible, and is independent of DNA damage signaling. ATR-defective cells exhibit aberrant chromatin condensation and nuclear envelope breakdown. We propose that mechanical forces derived from chromosome dynamics and torsional stress on nuclear membranes activate ATR to modulate nuclear envelope plasticity and chromatin association to the nuclear envelope, thus enabling cells to cope with the mechanical strain imposed by these molecular processes.	[Kumar, Amit; Beznoussenko, Galina V.; Mironov, Alexandre A.; Garre, Massimiliano; Parazzoli, Dario; Scita, Giorgio; Foiani, Marco] Fdn Ist FIRC Oncol Mol IFOM, I-20139 Milan, Italy; [Mazzanti, Michele; Scita, Giorgio; Foiani, Marco] Univ Milan, I-20122 Milan, Italy; [Mistrik, Martin; Bartek, Jiri] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc 77115, Czech Republic; [Kosar, Martin; Bartek, Jiri] Danish Canc Soc Res Ctr, DK-2100 Copenhagen, Denmark; [Kosar, Martin; Bartek, Jiri] Acad Sci Czech Republ, Inst Mol Genet, Vvi, CR-14220 Prague, Czech Republic; [Shivashankar, G. V.] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore; [Shivashankar, G. V.] Natl Univ Singapore, Dept Biol Sci, Singapore 117411, Singapore	IFOM - FIRC Institute of Molecular Oncology; IRCCS Istituti Fisioterapici Ospitalieri (IFO); University of Milan; Palacky University Olomouc; Danish Cancer Society; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; National University of Singapore; National University of Singapore	Bartek, J (corresponding author), Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Olomouc 77115, Czech Republic.	jb@cancer.dk; marco.foiani@ifom.eu	Foiani, Marco/M-8234-2014; Kosar, Martin/B-7143-2018	Foiani, Marco/0000-0003-4795-834X; Kosar, Martin/0000-0002-9400-2327; Kumar, Amit/0000-0003-1732-440X; Mistrik, Martin/0000-0002-2321-0348; Mazzanti, Michele/0000-0002-1819-3811; Scita, Giorgio/0000-0001-7984-1889; Garre', Massimiliano/0000-0001-9332-0270	European Molecular Biology Organization fellowship; Marie Curie Intra-European fellowship [274093]; Fondazione Umberto Veronesi postdoctoral fellowship; Associazione Italiana per la Ricerca sul Cancro; Association for International Cancer Research; Telethon-Italy; CEN-Italy; Ministero dell'Istruzione Universitaria e della Ricerca; Danish Cancer Society; Lundbeck Foundation; Danish Council for Independent Research; European Commission; Mechanobiology Institute, NUS, Singapore; Novo Nordisk Fonden [NNF12OC0002290] Funding Source: researchfish	European Molecular Biology Organization fellowship(European Molecular Biology Organization (EMBO)); Marie Curie Intra-European fellowship(European Commission); Fondazione Umberto Veronesi postdoctoral fellowship; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Association for International Cancer Research; Telethon-Italy(Fondazione Telethon); CEN-Italy; Ministero dell'Istruzione Universitaria e della Ricerca; Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); European Commission; Mechanobiology Institute, NUS, Singapore(National University of Singapore); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank Nancy Kleckner (Harvard University) for stimulating discussions, Karlene Cimprich (Stanford University), Oscar F. Capetillo (CNIO) for reagents and suggestions, Gururaj Kidiyoor (IFOM) and Radhakrishnan (MBI-NUS) for assistance, the imaging department of CEN and IFOM for support, and Michele Giannattasio, Dana Branzei, and our groups for discussions. A.K. was supported by a long-term European Molecular Biology Organization fellowship, a Marie Curie Intra-European (under grant agreement 274093) fellowship, and a Fondazione Umberto Veronesi postdoctoral fellowship. This work was supported by grants from Associazione Italiana per la Ricercasul Cancro, Association for International Cancer Research, Telethon-Italy, CEN-Italy, Ministero dell'Istruzione Universitaria e della Ricerca, the Danish Cancer Society, the Lundbeck Foundation, the Danish Council for Independent Research, and the European Commission (projects DDResponse, aDDRess, Biomedreg). G.V.S. is funded by the Mechanobiology Institute, NUS, Singapore.	Aguilar PS, 2006, MOL MICROBIOL, V62, P1507, DOI 10.1111/j.1365-2958.2006.05484.x; Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Berchtold D, 2012, NAT CELL BIOL, V14, P542, DOI 10.1038/ncb2480; Bermejo R, 2007, GENE DEV, V21, P1921, DOI 10.1101/gad.432107; Bermejo R, 2012, TRENDS CELL BIOL, V22, P465, DOI 10.1016/j.tcb.2012.05.007; Bermejo R, 2012, MOL CELL, V45, P710, DOI 10.1016/j.molcel.2012.03.001; Bermejo R, 2011, CELL, V146, P233, DOI 10.1016/j.cell.2011.06.033; Blasius M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r78; BOURGEOIS CA, 1979, J ULTRA MOL STRUCT R, V68, P328, DOI 10.1016/S0022-5320(79)90165-5; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; COMINGS DE, 1980, HUM GENET, V53, P131, DOI 10.1007/BF00273484; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Duursma AM, 2013, MOL CELL, V50, P116, DOI 10.1016/j.molcel.2013.03.006; Enserink JM, 2006, J CELL BIOL, V175, P729, DOI 10.1083/jcb.200605080; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; FUJIKAWAYAMAMOTO K, 1989, CELL STRUCT FUNCT, V14, P485, DOI 10.1247/csf.14.485; Gerlitz G, 2010, J CELL SCI, V123, P2207, DOI 10.1242/jcs.058271; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Hashash N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002978; Hu SH, 2005, BIOCHEM BIOPH RES CO, V329, P423, DOI 10.1016/j.bbrc.2005.02.026; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kultz D, 2001, P NATL ACAD SCI USA, V98, P1999, DOI 10.1073/pnas.98.4.1999; Kumar A, 2006, MOL CELL BIOL, V26, P9116, DOI 10.1128/MCB.00783-06; Kumar A, 2011, MOL CELL BIOL, V31, P2122, DOI 10.1128/MCB.01313-10; Kumar A, 2010, P NATL ACAD SCI USA, V107, P7491, DOI 10.1073/pnas.0914242107; Kweon HS, 2004, MOL BIOL CELL, V15, P4710, DOI 10.1091/mbc.E03-12-0881; Mammoto A, 2012, J CELL SCI, V125, P3061, DOI 10.1242/jcs.093005; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Martins RP, 2012, ANNU REV BIOMED ENG, V14, P431, DOI [10.1146/annurev-bioeng-071910-124638, 10.1146/annurev.bioeng-071910-124638]; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mazumder A, 2008, BIOPHYS J, V95, P3028, DOI 10.1529/biophysj.108.132274; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Mironov AA, 2009, J MICROSC-OXFORD, V235, P308, DOI 10.1111/j.1365-2818.2009.03222.x; Mironov AA, 2012, METHOD ENZYMOL, V504, P201, DOI 10.1016/B978-0-12-391857-4.00010-0; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ostlund C, 2006, BIOCHEMISTRY-US, V45, P1374, DOI 10.1021/bi052156n; Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3; Polishchuk RS, 1999, EUR J CELL BIOL, V78, P170, DOI 10.1016/S0171-9335(99)80096-X; Rowat AC, 2006, BIOPHYS J, V91, P4649, DOI 10.1529/biophysj.106.086454; Shivashankar GV, 2011, ANNU REV BIOPHYS, V40, P361, DOI 10.1146/annurev-biophys-042910-155319; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Vigh L, 2007, ANN NY ACAD SCI, V1113, P40, DOI 10.1196/annals.1391.027; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195; Zhang XH, 2007, J CELL SCI, V120, P4134, DOI 10.1242/jcs.015834; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	65	132	133	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					633	646		10.1016/j.cell.2014.05.046	http://dx.doi.org/10.1016/j.cell.2014.05.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083873	Green Published, hybrid			2022-12-28	WOS:000340944300015
J	Satpute-Krishnan, P; Ajinkya, M; Bhat, S; Itakura, E; Hegde, RS; Lippincott-Schwartz, J				Satpute-Krishnan, Prasanna; Ajinkya, Monica; Bhat, Savithri; Itakura, Eisuke; Hegde, Ramanujan S.; Lippincott-Schwartz, Jennifer			ER Stress-Induced Clearance of Misfolded GPI-Anchored Proteins via the Secretory Pathway	CELL			English	Article							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; PRION PROTEIN; PLASMA-MEMBRANE; TRANSCRIPTION FACTOR; CELL; RECEPTOR; TRANSPORT; GOLGI; TRAFFICKING	Proteins destined for the cell surface are first assessed in the endoplasmic reticulum (ER) for proper folding before release into the secretory pathway. This ensures that defective proteins are normally prevented from entering the extracellular environment, where they could be disruptive. Here, we report that, when ER folding capacity is saturated during stress, misfolded glycosylphosphatidylinositol-anchored proteins dissociate from resident ER chaperones, engage export receptors, and quantitatively leave the ER via vesicular transport to the Golgi. Clearance from the ER commences within minutes of acute ER stress, before the transcriptional component of the unfolded protein response is activated. These aberrant proteins then access the cell surface transiently before destruction in lysosomes. Inhibiting this stress-induced pathway by depleting the ER-export receptors leads to aggregation of the ER-retained misfolded protein. Thus, this rapid response alleviates the elevated burden of misfolded proteins in the ER at the onset of ER stress, promoting protein homeostasis in the ER.	[Satpute-Krishnan, Prasanna; Ajinkya, Monica; Bhat, Savithri; Lippincott-Schwartz, Jennifer] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Cell Biol & Metab Program, Bethesda, MD 20892 USA; [Itakura, Eisuke; Hegde, Ramanujan S.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); MRC Laboratory Molecular Biology	Hegde, RS (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.	rhegde@mrc-lmb.cam.ac.uk; lippincj@mail.nih.gov	BHAT, SAVITHRI/AAU-6982-2020; Itakura, Eisuke/AAY-7977-2021; Satpute-Krishnan, Prasanna/ABE-5421-2020	Itakura, Eisuke/0000-0001-7248-9333; BHAT, SAVITHRI/0000-0003-3918-0726; Hegde, Ramanujan/0000-0001-8338-852X	Intramural Research Program of the National Institutes of Health; HHMI summer research grant at Swarthmore College; UK Medical Research Council [MC_UP_A022_1007]; JSPS postdoctoral fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001609] Funding Source: NIH RePORTER; Medical Research Council [MC_UP_A022_1007] Funding Source: researchfish; MRC [MC_UP_A022_1007] Funding Source: UKRI	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI summer research grant at Swarthmore College; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); JSPS postdoctoral fellowship(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Weare grateful to Drs. Prabuddha Sengupta, Schuyler Van Engelenburg, Angelika Rambold, Peter Kim, Dale Hailey, Aarthi Ashok, Carolyn Suzuki, Yihong Ye, Linda Hendershot, Graham Diering, Michael Lizardo, and Chand Khanna for critical discussions, reagents, and assistance. We are grateful to Dr. Ajay Sharma, Nora Tsai, and Rafael Villasmil of the NEI Flow Cytometry Core Facility for invaluable technical support. This work was supported by the Intramural Research Program of the National Institutes of Health (J.L.-S. and P.S.-K.), the HHMI summer research grant at Swarthmore College (M. A.), the UK Medical Research Council (MC_UP_A022_1007 to R.S.H.), and a JSPS postdoctoral fellowship (E. I.).	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Apaja PM, 2010, J CELL BIOL, V191, P553, DOI 10.1083/jcb.201006012; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957; BERGERON JJM, 1994, TRENDS BIOCHEM SCI, V19, P124, DOI 10.1016/0968-0004(94)90205-4; Blum R, 1996, J BIOL CHEM, V271, P17183, DOI 10.1074/jbc.271.29.17183; Boltz KA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-212; BONIFACINO J S, 1991, Current Opinion in Cell Biology, V3, P592, DOI 10.1016/0955-0674(91)90028-W; Bonnon C, 2010, J CELL SCI, V123, P1705, DOI 10.1242/jcs.062950; Brunsing R, 2008, J BIOL CHEM, V283, P17954, DOI 10.1074/jbc.M801395200; Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3; Diehl JA, 2011, GASTROENTEROLOGY, V141, P38, DOI 10.1053/j.gastro.2011.05.018; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; Ferguson M. A. J., 2009, ESSENTIALS GLYCOBIOL; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Grapp M, 2012, BRAIN, V135, P2022, DOI 10.1093/brain/aws122; Gu YP, 2007, J MOL NEUROSCI, V32, P90, DOI 10.1007/s12031-007-0023-6; Hegde RS, 2010, CURR OPIN CELL BIOL, V22, P437, DOI 10.1016/j.ceb.2010.05.005; Hetz CA, 2006, CURR MOL MED, V6, P37, DOI 10.2174/156652406775574578; Ivanova L, 2001, J BIOL CHEM, V276, P42409, DOI 10.1074/jbc.M106928200; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KLAUSNER RD, 1990, ANNU REV CELL BIOL, V6, P403, DOI 10.1146/annurev.cb.06.110190.002155; Kovacs GG, 2002, J NEUROL, V249, P1567, DOI 10.1007/s00415-002-0896-9; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; Ma YJ, 2004, J CHEM NEUROANAT, V28, P51, DOI 10.1016/j.jchemneu.2003.08.007; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Negro A, 2001, MOL CELL NEUROSCI, V17, P521, DOI 10.1006/mcne.2000.0953; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; Nickel W, 1997, P NATL ACAD SCI USA, V94, P11393, DOI 10.1073/pnas.94.21.11393; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Perman JC, 2011, J CLIN INVEST, V121, P2625, DOI 10.1172/JCI43068; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rane NS, 2004, EMBO J, V23, P4550, DOI 10.1038/sj.emboj.7600462; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhao YY, 2013, ELIFE, V2, DOI 10.7554/eLife.00459	49	102	102	0	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					522	533		10.1016/j.cell.2014.06.026	http://dx.doi.org/10.1016/j.cell.2014.06.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083867	Green Published, hybrid			2022-12-28	WOS:000340944300007
J	Xue, W; Chen, SD; Yin, H; Tammela, T; Papagiannakopoulos, T; Joshi, NS; Cai, WX; Yang, GL; Bronson, R; Crowley, DG; Zhang, F; Anderson, DG; Sharp, PA; Jacks, T				Xue, Wen; Chen, Sidi; Yin, Hao; Tammela, Tuomas; Papagiannakopoulos, Thales; Joshi, Nikhil S.; Cai, Wenxin; Yang, Gillian; Bronson, Roderick; Crowley, Denise G.; Zhang, Feng; Anderson, Daniel G.; Sharp, Phillip A.; Jacks, Tyler			CRISPR-mediated direct mutation of cancer genes in the mouse liver	NATURE			English	Article							ONE-STEP GENERATION; P53 RESTORATION; MICE; CAS9; SPECIFICITY	The study of cancer genes in mouse models has traditionally relied on genetically-engineered strains made via transgenesis or gene targeting in embryonic stem cells(1). Here we describe a new method of cancer model generation using the CRISPR/Cas (clustered regularly interspaced short palindromic repeats/CRISPR-associated proteins) system in vivo in wild-type mice. We used hydrodynamic injection to deliver a CRISPR plasmid DNA expressing Cas9 and single guide RNAs (sgRNAs)(2-4) to the liver that directly target the tumour suppressor genes Pten (ref. 5) and p53 (also known as TP53 and Trp53) (ref. 6), alone and in combination. CRISPR-mediated Pten mutation led to elevated Akt phosphorylation and lipid accumulation in hepatocytes, phenocopying the effects of deletion of the gene using Cre-LoxP technology(7,8). Simultaneous targeting of Pten and p53 induced liver tumours that mimicked those caused by Cre-loxP-mediated deletion of Pten and p53. DNA sequencing of liver and tumour tissue revealed insertion or deletion mutations of the tumour suppressor genes, including bi-allelic mutations of both Pten and p53 in tumours. Furthermore, co-injection of Cas9 plasmids harbouring sgRNAs targeting the beta-catenin gene and a single-stranded DNA oligonucleotide donor carrying activating point mutations led to the generation of hepatocytes with nuclear localization of b-catenin. This study demonstrates the feasibility of direct mutation of tumour suppressor genes and oncogenes in the liver using the CRISPR/Cas system, which presents a new avenue for rapid development of liver cancer models and functional genomics.	[Xue, Wen; Chen, Sidi; Yin, Hao; Tammela, Tuomas; Papagiannakopoulos, Thales; Joshi, Nikhil S.; Cai, Wenxin; Yang, Gillian; Crowley, Denise G.; Anderson, Daniel G.; Sharp, Phillip A.; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Bronson, Roderick] Tufts Univ, Boston, MA 02115 USA; [Bronson, Roderick] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Zhang, Feng] MIT, Broad Inst, Cambridge, MA 02142 USA; [Zhang, Feng] Harvard, Cambridge, MA 02142 USA; [Anderson, Daniel G.] MIT, Dept Chem Engn, Cambridge, MA 02142 USA; [Anderson, Daniel G.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Anderson, Daniel G.] MIT, Inst Med Engn & Sci, Cambridge, MA 02142 USA; [Sharp, Phillip A.; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02142 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Tufts University; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA.	tjacks@mit.edu	Macrae, Rhiannon/AAX-1536-2020; CHEN, SIDI/D-8284-2016	CHEN, SIDI/0000-0002-3819-5005; /0000-0003-3675-6961; Joshi, Nikhil/0000-0002-7045-7837; Xue, Wen/0000-0002-9797-8042	National Institutes of Health [2-PO1-CA42063, RO1-EB000244, RO1-CA115527, RO1-CA132091]; Cancer Center Support (core) grant from the National Cancer Institute [P30-CA14051]; NIH [R01-CA133404]; Casimir-Lambert Fund; NIH Centers for Cancer Nanotechnology Excellence [5-U54-CA151884-04]; Harvard-MIT Center of Cancer Nanotechnology Excellence; American Association for Cancer Research; Leukemia Lymphoma Society;  [1K99CA169512]; NATIONAL CANCER INSTITUTE [U54CA151884, R00CA169512, R01CA115527, R01CA132091, R01CA133404, P30CA014051, K99CA169512, P01CA042063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000244, R37EB000244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support (core) grant from the National Cancer Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Casimir-Lambert Fund; NIH Centers for Cancer Nanotechnology Excellence; Harvard-MIT Center of Cancer Nanotechnology Excellence; American Association for Cancer Research; Leukemia Lymphoma Society(Leukemia and Lymphoma Society); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. McFadden, N. Dimitrova, E. Snyder, A. Farago, M. Muzumdar, F. Sanchez-Rivera, J. Doench, L. Cong and S. Levine for discussions and for sharing reagents. We thank the Koch Institute Swanson Biotechnology Center (SBC) for technical support, specifically the Hope Babette Tang (1983) Histology Facility and K. Cormier. This work was supported by grants 2-PO1-CA42063, RO1-EB000244, RO1-CA115527 and RO1-CA132091 from the National Institutes of Health and supported in part by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute. This work was supported, in part, by NIH Grant R01-CA133404 and Casimir-Lambert Fund to P. A. S. H.Y. is supported by 5-U54-CA151884-04 NIH Centers for Cancer Nanotechnology Excellence and the Harvard-MIT Center of Cancer Nanotechnology Excellence. S. C. is a Damon Runyon Fellow (DRG-2117-12). W. X. was supported by fellowships from the American Association for Cancer Research and the Leukemia Lymphoma Society and is currently supported by grant 1K99CA169512. T. J. is a Howard Hughes Medical Institute (HHMI) Investigator, the David H. Koch Professor of Biology, and a Daniel K. Ludwig Scholar.	Chen SD, 2014, GENE DEV, V28, P1054, DOI 10.1101/gad.239681.114; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Horie Y, 2004, J CLIN INVEST, V113, P1774, DOI 10.1172/JCI200420513; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Katz SF, 2012, GASTROENTEROLOGY, V142, P1229, DOI 10.1053/j.gastro.2012.02.009; Li DL, 2013, NAT BIOTECHNOL, V31, P681, DOI 10.1038/nbt.2661; Li W, 2013, NAT BIOTECHNOL, V31, P684, DOI 10.1038/nbt.2652; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malina A, 2013, GENE DEV, V27, P2602, DOI 10.1101/gad.227132.113; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Niu YY, 2014, CELL, V156, P836, DOI 10.1016/j.cell.2014.01.027; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Shen B, 2013, CELL RES, V23, P720, DOI 10.1038/cr.2013.46; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Tward AD, 2007, P NATL ACAD SCI USA, V104, P14771, DOI 10.1073/pnas.0706578104; Van Dyke T, 2002, CELL, V108, P135, DOI 10.1016/S0092-8674(02)00621-9; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Xue W, 2011, CANCER DISCOV, V1, P236, DOI 10.1158/2159-8290.CD-11-0073; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030	33	497	562	19	427	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					380	+		10.1038/nature13589	http://dx.doi.org/10.1038/nature13589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25119044	Green Submitted, Green Accepted			2022-12-28	WOS:000342988600055
J	Bronson, DL; Franco, KS				Bronson, David L.; Franco, Kathleen S.			In uncontrolled type 2 diabetes, CBT improved glycemic control and reduced depression	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bronson, David L.; Franco, Kathleen S.] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Bronson, DL (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.							Nouwen A, 2010, DIABETOLOGIA, V53, P2480, DOI 10.1007/s00125-010-1874-x; Pouwer F, 2013, ENDOCRIN METAB CLIN, V42, P529, DOI 10.1016/j.ecl.2013.05.002; van Bastelaar KMP, 2011, DIABETES CARE, V34, P320, DOI 10.2337/dc10-1248; White CA, 2001, CHRONIC BEHAV THERAP	4	1	1	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC3	10.7326/0003-4819-161-4-201408190-02003	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133382				2022-12-28	WOS:000342347300002
J	Flint, E; Cummins, S; Sacker, A				Flint, Ellen; Cummins, Steven; Sacker, Amanda			Associations between active commuting, body fat, and body mass index: population based, cross sectional study in the United Kingdom	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICAL-ACTIVITY LEVELS; CARDIOVASCULAR RISK-FACTORS; WEIGHT; OBESITY; WORK; TRANSPORT; OVERWEIGHT; WALKING; HEALTH; SCHOOL	Objective To determine if promotion of active modes of travel is an effective strategy for obesity prevention by assessing whether active commuting (walking or cycling for all or part of the journey to work) is independently associated with objectively assessed biological markers of obesity. Design Cross sectional study of data from the wave 2 Health Assessment subsample of Understanding Society, the UK Household Longitudinal Study (UKHLS). The exposure of interest, commuting mode, was self reported and categorised as three categories: private transport, public transport, and active transport. Participants The analytic samples (7534 for body mass index (BMI) analysis, 7424 for percentage body fat analysis) were drawn from the representative subsample of wave 2 respondents of UKHLS who provided health assessment data (n= 15 777). Main outcome measures Body mass index (weight (kg)/height (m)(2)); percentage body fat (measured by electrical impedance). Results Results from multivariate linear regression analyses suggest that, compared with using private transport, commuting by public or active transport modes was significantly and independently predictive of lower BMI for both men and women. In fully adjusted models, men who commuted via public or active modes had BMI scores 1.10 (95% CI 0.53 to 1.67) and 0.97 (0.40 to 1.55) points lower, respectively, than those who used private transport. Women who commuted via public or active modes had BMI scores 0.72 (0.06 to 1.37) and 0.87 (0.36 to 0.87) points lower, respectively, than those using private transport. Results for percentage body fat were similar in terms of magnitude, significance, and direction of effects. Conclusions Men and women who commuted to work by active and public modes of transport had significantly lower BMI and percentage body fat than their counterparts who used private transport. These associations were not attenuated by adjustment for a range of hypothesised confounding factors.	[Flint, Ellen; Cummins, Steven] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1H 9SH, England; [Sacker, Amanda] UCL, Res Dept Epidemiol & Publ Hlth, ESRC Int Ctr Lifecourse Studies Soc & Hlth, London WC1E 6BT, England	University of London; London School of Hygiene & Tropical Medicine; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); University of London; University College London	Flint, E (corresponding author), London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1H 9SH, England.	ellen.flint@lshtm.ac.uk	Cummins, Steven/C-1230-2009	Cummins, Steven/0000-0002-3957-4357; Sacker, Amanda/0000-0001-8796-5398	UK National Institute of Health Research (NIHR); UK Economic and Social Research Council (ESRC) [ES/J019119/1]; ESRC [ES/J019119/1] Funding Source: UKRI; Economic and Social Research Council [ES/J019119/1] Funding Source: researchfish; National Institute for Health Research [SRF-2010-03-05] Funding Source: researchfish	UK National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	SC and EF are supported by a UK National Institute of Health Research (NIHR) Senior Fellowship to SC. AS is supported by the UK Economic and Social Research Council (ESRC) ES/J019119/1. The authors affirm their independence from these funders. The funders played no part in the study design, collection, analysis or interpretation of data, or in the writing of the report, or in the decision to submit the article for publication. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR or the UK Department of Health.	[Anonymous], UNDERSTANDING SOC WO; Audrey S, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-37; Barengo NC, 2006, EUR J CARDIOV PREV R, V13, P51, DOI 10.1097/00149831-200602000-00008; Bassett DR, 2008, J PHYS ACT HEALTH, V5, P795, DOI 10.1123/jpah.5.6.795; Boreham R, 2012, UNDERSTANDING SOC W2; Department of Health, 2011, START ACT STAY ACT R; Department of Health, 2004, LEAST 5 WEEK EV IMP; Faulkner GEJ, 2009, PREV MED, V48, P3, DOI 10.1016/j.ypmed.2008.10.017; Fuller D, 2012, PREV MED, V54, P74, DOI 10.1016/j.ypmed.2011.09.021; Goodman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071790; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gutierrez-Fisac JL, 2002, OBES RES, V10, P270, DOI 10.1038/oby.2002.37; Hagenaars A., 1994, POVERTY STAT LATE 19; HAGLUND BJA, 1987, SCAND J SOC MED, V15, P19, DOI 10.1177/140349488701500104; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; He K, 2004, INT J OBESITY, V28, P1569, DOI 10.1038/sj.ijo.0802795; Hu G, 2002, BRIT J NUTR, V88, P91, DOI 10.1079/BJNBJN2002590; JEFFERY RW, 1991, INT J OBESITY, V15, P689; Laverty AA, 2013, AM J PREV MED, V45, P282, DOI 10.1016/j.amepre.2013.04.012; Lindstrom M, 2008, PREV MED, V46, P22, DOI 10.1016/j.ypmed.2007.07.012; Lynn P., 2011, SAMPLE DESIGN UNDERS; McFall S., 2013, UNDERSTANDING SOC UK; National Institute for Health and Care Excellence, 2012, WALK CYCL LOC MEAS P, V41; Office for National Statistics, 2014, 2011 CENS CYCL WORK; Ogilvie D, 2007, BMJ-BRIT MED J, V334, P1204, DOI 10.1136/bmj.39198.722720.BE; Petticrew M, 2005, PUBLIC HEALTH, V119, P751, DOI 10.1016/j.puhe.2004.11.008; Pucher J, 2010, AM J PUBLIC HEALTH, V100, P1986, DOI 10.2105/AJPH.2009.189324; Rissel C, 2012, INT J ENV RES PUB HE, V9, P2454, DOI 10.3390/ijerph9072454; Saunders LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069912; StataCorp, 2011, STAT STAT SOFTW REL; STENDER M, 1993, INT J EPIDEMIOL, V22, P644, DOI 10.1093/ije/22.4.644; Stephens SK, 2014, PREV MED, V62, P167, DOI 10.1016/j.ypmed.2014.02.008; University of Essex. Institute for Social and Economic Research and National Centre for Social Research, 2012, UND SOC WAV 1 2 2009; University of Essex. National Institute for Social and Economic Research and Centre for Social Research, 2013, UND SOC WAV 2 NURS H; Wanner M, 2012, AM J PREV MED, V42, P493, DOI 10.1016/j.amepre.2012.01.030; Xu HL, 2013, ASIA-PAC J PUBLIC HE, V25, P298, DOI 10.1177/1010539513482965	36	72	74	1	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 19	2014	349								g4887	10.1136/bmj.g4887	http://dx.doi.org/10.1136/bmj.g4887			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN8FK	25139861	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000340838500001
J	Navar-Boggan, AM; Newby, LK				Navar-Boggan, Ann Marie; Newby, L. Kristin			ACC/AHA Pooled Cohort Risk Equations predicted 5-y risk for CV events in adults considered for statin initiation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Navar-Boggan, Ann Marie; Newby, L. Kristin] Duke Univ, Med Ctr, Durham, NC 27708 USA	Duke University	Navar-Boggan, AM (corresponding author), Duke Univ, Med Ctr, Durham, NC 27708 USA.							Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC12	10.7326/0003-4819-161-4-201408190-02012	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133379				2022-12-28	WOS:000342347300011
J	Ridker, PM				Ridker, Paul M.			LDL cholesterol: controversies and future therapeutic directions	LANCET			English	Article							DENSITY-LIPOPROTEIN-CHOLESTEROL; SUBTILISIN/KEXIN TYPE 9; HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA; C-REACTIVE PROTEIN; TRIGLYCERIDE TRANSFER PROTEIN; RESIDUAL VASCULAR RISK; CORONARY-HEART-DISEASE; N-3 FATTY-ACIDS; MONOCLONAL-ANTIBODY; STATIN THERAPY	Lifelong exposure to raised concentrations of LDL cholesterol increases cardiovascular event rates, and the use of statin therapy as an adjunct to diet, exercise, and smoking cessation has proven highly effective in reducing the population burden associated with hyperlipidaemia. Yet, despite consistent biological, genetic, and epidemiological data, and evidence from randomised trials, there is controversy among national guidelines and clinical practice with regard to LDL cholesterol, its measurement, the usefulness of population-based screening, the net benefit-to-risk ratio for different LDL-lowering drugs, the benefit of treatment targets, and whether aggressive lowering of LDL is safe. Several novel therapies have been introduced for the treatment of people with genetic defects that result in loss of function within the LDL receptor, a major determinant of inherited hyperlipidaemias. Moreover, the usefulness of monoclonal antibodies that extend the LDL-receptor lifecycle ( and thus result in substantial lowering of LDL cholesterol below the levels achieved with statins alone) is being assessed in phase 3 trials that will enrol more than 60 000 at-risk patients worldwide. These trials represent an exceptionally rapid translation of genetic observations into clinical practice and will address core questions of how low LDL cholesterol can be safely reduced, whether the mechanism of LDL-cholesterol lowering matters, and whether ever more aggressive lipid-lowering provides a safe, long-term mechanism to prevent atherothrombotic complications.	[Ridker, Paul M.] Harvard Univ, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA.	pridker@partners.org		Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Heart Lung and Blood Institute; American Heart Association; Leducq Foundation; Reynolds Foundation; AstraZeneca; Novartis; Amgen; Pfizer	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); Leducq Foundation(Leducq Foundation); Reynolds Foundation; AstraZeneca(AstraZeneca); Novartis(Novartis); Amgen(Amgen); Pfizer(Pfizer)	PMR has received investigator-initiated research grants from the National Heart Lung and Blood Institute, the American Heart Association, the Leducq Foundation, the Reynolds Foundation, AstraZeneca, Novartis, Amgen, and Pfizer, and served as a consultant to Pfizer, ISIS, Amgen, Vascular Biogenics, and BostonHeart. He is listed as a co-inventor on patents held by the Brigham and Women's Hospital related to the use of inflammatory biomarkers in cardiovascular disease and diabetes that have been licensed to AstraZeneca and Seimens.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Ballantyne CM, 2013, J AM COLL CARDIOL, V62, P1154, DOI 10.1016/j.jacc.2013.05.050; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Bays HE, 2011, J CLIN ENDOCR METAB, V96, P2889, DOI 10.1210/jc.2011-1061; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Boekholdt SM, 2012, JAMA-J AM MED ASSOC, V307, P1302, DOI 10.1001/jama.2012.366; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Braunwald E, 2012, EUR HEART J, V33, P430, DOI 10.1093/eurheartj/ehr310; Bu DX, 2011, CURR OPIN LIPIDOL, V22, P165, DOI 10.1097/MOL.0b013e3283453e41; Cannon CP, 2008, AM HEART J, V156, P826, DOI 10.1016/j.ahj.2008.07.023; Chasman DI, 2012, CIRC-CARDIOVASC GENE, V5, P257, DOI 10.1161/CIRCGENETICS.111.961144; Choi YJ, 2012, ATHEROSCLEROSIS, V220, P470, DOI 10.1016/j.atherosclerosis.2011.10.029; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; Cuchel M, 2007, NEW ENGL J MED, V356, P148, DOI 10.1056/NEJMoa061189; Cuchel M, 2013, LANCET, V381, P40, DOI 10.1016/S0140-6736(12)61731-0; Davidson M, 2013, J LIPID RES, V54, P467, DOI 10.1194/jlr.M032615; Desai NR, 2013, CIRCULATION, V128, P962, DOI 10.1161/CIRCULATIONAHA.113.001969; Di Angelantonio E, 2012, JAMA-J AM MED ASSOC, V307, P2499, DOI 10.1001/jama.2012.6571; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Fitzgerald K, 2014, LANCET, V383, P60, DOI 10.1016/S0140-6736(13)61914-5; Genest J, 2003, J INHERIT METAB DIS, V26, P267, DOI 10.1023/A:1024449603891; Genest J, 2012, LIPOPROTEIN DISORDER, P975; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gutierrez MJ, 2014, ARTERIOSCL THROM VAS, V34, P676, DOI 10.1161/ATVBAHA.113.302677; Hayward RA, 2012, CIRC-CARDIOVASC QUAL, V5, P2, DOI 10.1161/CIRCOUTCOMES.111.964676; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Hsia J, 2011, J AM COLL CARDIOL, V57, P1666, DOI 10.1016/j.jacc.2010.09.082; Ioannidis JPA, 2014, JAMA-J AM MED ASSOC, V311, P463, DOI 10.1001/jama.2013.284657; Jialal I, 2014, AM J CLIN PATHOL, V141, P772, DOI 10.1309/AJCPED9X7RNMYAEQ; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Khera AV, 2014, CIRCULATION, V129, P635, DOI 10.1161/CIRCULATIONAHA.113.004406; Koren MJ, 2012, LANCET, V380, P1995, DOI 10.1016/S0140-6736(12)61771-1; Kromhout D, 2010, NEW ENGL J MED, V363, P2015, DOI 10.1056/NEJMoa1003603; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lund SS, 2011, CLIN CHEM, V57, P298, DOI 10.1373/clinchem.2009.133868; Martin SS, 2013, JAMA-J AM MED ASSOC, V310, P2061, DOI 10.1001/jama.2013.280532; Martin SS, 2013, J AM COLL CARDIOL, V62, P732, DOI 10.1016/j.jacc.2013.01.079; McGowan MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049006; McKenney JM, 2012, J AM COLL CARDIOL, V59, P2344, DOI 10.1016/j.jacc.2012.03.007; McKinney JS, 2012, STROKE, V43, P2149, DOI 10.1161/STROKEAHA.112.655894; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Miller WG, 2010, CLIN CHEM, V56, P977, DOI 10.1373/clinchem.2009.142810; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Mora S, 2014, CIRCULATION, V129, P553, DOI 10.1161/CIRCULATIONAHA.113.005873; Mora S, 2013, CIRCULATION, V128, P1189, DOI 10.1161/CIRCULATIONAHA.113.002671; Mora S, 2009, CLIN CHEM, V55, P888, DOI 10.1373/clinchem.2008.117929; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Nicholls SJ, 2011, NEW ENGL J MED, V365, P2078, DOI 10.1056/NEJMoa1110874; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Norata GD, 2013, EUR HEART J, V34, P1783, DOI 10.1093/eurheartj/eht088; Pencina MJ, 2014, NEW ENGL J MED, V370, P1422, DOI 10.1056/NEJMoa1315665; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Puri R, 2013, CIRCULATION, V128, P2395, DOI 10.1161/CIRCULATIONAHA.113.004243; Raal F, 2012, CIRCULATION, V126, P2408, DOI 10.1161/CIRCULATIONAHA.112.144055; Raal FJ, 2013, LANCET, V381, P7, DOI 10.1016/S0140-6736(12)61845-5; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Rader DJ, 2014, ANNU REV MED, V65, P385, DOI 10.1146/annurev-med-050311-163305; Ray KK, 2014, EUR HEART J, V35, P960, DOI 10.1093/eurheartj/ehu107; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2014, EUR HEART J, V35, P1782, DOI 10.1093/eurheartj/ehu203; Ridker PM, 2013, JAMA-J AM MED ASSOC, V310, P1123, DOI 10.1001/jama.2013.276529; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Robins SJ, 2001, JAMA-J AM MED ASSOC, V285, P1585, DOI 10.1001/jama.285.12.1585; Roncaglioni MC, 2013, NEW ENGL J MED, V368, P1800, DOI 10.1056/NEJMoa1205409; Roth EM, 2012, NEW ENGL J MED, V367, P1891, DOI 10.1056/NEJMoa1201832; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Schaefer EJ, 2011, CLIN CHEM, V57, P1081, DOI 10.1373/clinchem.2010.159483; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Seed M, 2012, JRSM CARDIOVASC DIS, V1, DOI 10.1258/cvd.2012.012011; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Sever PS, 2012, J AM COLL CARDIOL, V62, P717; Sjostrom L, 2012, JAMA-J AM MED ASSOC, V307, P56, DOI 10.1001/jama.2011.1914; Smith RJ, 2013, JAMA INTERN MED, V173, P1491, DOI 10.1001/jamainternmed.2013.6624; Sniderman AD, 2014, J AM COLL CARDIOL, V63, P1935, DOI 10.1016/j.jacc.2014.01.060; Sniderman AD, 2012, ATHEROSCLEROSIS, V225, P444, DOI 10.1016/j.atherosclerosis.2012.08.039; Stein EA, 2013, CIRCULATION, V128, P2113, DOI 10.1161/CIRCULATIONAHA.113.004678; Stein EA, 2012, CIRCULATION, V126, P2283, DOI 10.1161/CIRCULATIONAHA.112.104125; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Stroes E, 2014, J AM COLL CARDIOL, V63, P2541, DOI 10.1016/j.jacc.2014.03.019; Sullivan D, 2012, JAMA-J AM MED ASSOC, V308, P2497, DOI 10.1001/jama.2012.25790; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tawakol A, 2013, J AM COLL CARDIOL, V62, P909, DOI 10.1016/j.jacc.2013.04.066; van der Leeuw J, 2014, EUR HEART J, V35, P837, DOI 10.1093/eurheartj/ehu004; Varbo A, 2013, CIRCULATION, V128, P1298, DOI 10.1161/CIRCULATIONAHA.113.003008; Wald NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018742; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Wong Elaine, 2014, P T, V39, P119; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3	101	157	167	1	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					607	617		10.1016/S0140-6736(14)61009-6	http://dx.doi.org/10.1016/S0140-6736(14)61009-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25131980				2022-12-28	WOS:000340573300033
J	Pikaar, I; Sharma, KR; Hu, SH; Gernjak, W; Keller, J; Yuan, ZG				Pikaar, Ilje; Sharma, Keshab R.; Hu, Shihu; Gernjak, Wolfgang; Keller, Juerg; Yuan, Zhiguo			Reducing sewer corrosion through integrated urban water management	SCIENCE			English	Article							ENHANCED COAGULATION; ORGANIC-MATTER; DRINKING-WATER; REMOVAL; SYSTEMS; IMPACT	Sewer systems are among the most critical infrastructure assets for modern urban societies and provide essential human health protection. Sulfide-induced concrete sewer corrosion costs billions of dollars annually and has been identified as a main cause of global sewer deterioration. We performed a 2-year sampling campaign in South East Queensland (Australia), an extensive industry survey across Australia, and a comprehensive model-based scenario analysis of the various sources of sulfide. Aluminum sulfate addition during drinking water production contributes substantially to the sulfate load in sewage and indirectly serves as the primary source of sulfide. This unintended consequence of urban water management structures could be avoided by switching to sulfate-free coagulants, with no or only marginal additional expenses compared with the large potential savings in sewer corrosion costs.	[Pikaar, Ilje; Sharma, Keshab R.; Hu, Shihu; Gernjak, Wolfgang; Keller, Juerg; Yuan, Zhiguo] Univ Queensland, Adv Water Management Ctr, Brisbane, Qld 4072, Australia	University of Queensland	Yuan, ZG (corresponding author), Univ Queensland, Adv Water Management Ctr, Brisbane, Qld 4072, Australia.	z.yuan@awmc.uq.edu.au	Hu, Shihu/L-6085-2019; Gernjak, Wolfgang/D-3252-2018; Sharma, Keshab/B-1579-2012; Yuan, Zhiguo/C-4980-2013; Yuan, Zhiguo/AAO-1328-2021	Gernjak, Wolfgang/0000-0003-3317-7710; Sharma, Keshab/0000-0002-2366-9044; Yuan, Zhiguo/0000-0002-7566-1482; Hu, Shihu/0000-0002-1858-8872; Keller, Jurg/0000-0001-6796-0936; pikaar, ilje/0000-0002-1820-9983				ASCE, 2011, FAIL ACT IMP CURR IN; AWWA, 2001, DAWN REPL ER REINV D; Brongers M. P. H., 2002, FEDERAL HIGHWAY ADM; Cyna B, 2002, DESALINATION, V147, P69, DOI 10.1016/S0011-9164(02)00578-7; Edwards M, 2004, ENHANCED COAGULATION; Edzwald JK, 1999, WATER SCI TECHNOL, V40, P63, DOI 10.2166/wst.1999.0444; Elimelech M, 2011, SCIENCE, V333, P712, DOI 10.1126/science.1200488; EPA, 1974, EPA PUBL; *EPA, 2003, EPA PUBL; EPA, 2011, EPA600R10078; Fabris R, 2008, WATER RES, V42, P4188, DOI 10.1016/j.watres.2008.06.023; Ganigue R, 2011, WATER RES, V45, P6564, DOI 10.1016/j.watres.2011.09.054; Matilainen A, 2010, ADV COLLOID INTERFAC, V159, P189, DOI 10.1016/j.cis.2010.06.007; PARKER CD, 1945, AUST J EXP BIOL MED, V23, P81, DOI 10.1038/icb.1945.13; Richardson SD, 2007, MUTAT RES-REV MUTAT, V636, P178, DOI 10.1016/j.mrrev.2007.09.001; Sedlak DL, 2011, SCIENCE, V331, P42, DOI 10.1126/science.1196397; Sharma KR, 2008, WATER RES, V42, P2527, DOI 10.1016/j.watres.2008.02.013; SHARMA KR, 2008, WATER, V35, P132; Sharp EL, 2006, SCI TOTAL ENVIRON, V363, P183, DOI 10.1016/j.scitotenv.2005.05.032; US EPA, 1991, US EPA PUBL; Volk C, 2000, WATER RES, V34, P3247, DOI 10.1016/S0043-1354(00)00033-6; Wang DS, 2013, SEP PURIF TECHNOL, V110, P188, DOI 10.1016/j.seppur.2013.03.020; Water Environment Research Foundation, 2007, WERF PUBL; WHO, 2004, CHLORP DRINK WAT BAC; Zhang L, 2008, WATER RES, V42, P1, DOI 10.1016/j.watres.2007.07.013	25	151	158	15	281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					812	814		10.1126/science.1251418	http://dx.doi.org/10.1126/science.1251418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124439				2022-12-28	WOS:000340593100044
J	Dechartres, A; Altman, DG; Trinquart, L; Boutron, I; Ravaud, P				Dechartres, Agnes; Altman, Douglas G.; Trinquart, Ludovic; Boutron, Isabelle; Ravaud, Philippe			Association Between Analytic Strategy and Estimates of Treatment Outcomes in Meta-analyses	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIALS; SYSTEMATIC REVIEWS; EMPIRICAL-EVIDENCE; CLINICAL-TRIALS; HEALTH-CARE; QUALITY; BIAS; PUBLICATION; DISCREPANCIES; IMPACT	IMPORTANCE A persistent dilemma when performingmeta-analyses is whether all available trials should be included in the meta-analysis. OBJECTIVES To compare treatment outcomes estimated by meta-analysis of all trials and several alternative analytic strategies: single most precise trial (ie, trial with the narrowest confidence interval), meta-analysis restricted to the 25% largest trials, limit meta-analysis (a meta-analysis model adjusted for small-study effect), and meta-analysis restricted to trials at low overall risk of bias. DATA SOURCES One hundred sixty-three meta-analyses published between 2008 and 2010 in high-impact-factor journals and between 2011 and 2013 in the Cochrane Database of Systematic Reviews: 92 (705 randomized clinical trials [RCTs]) with subjective outcomes and 71 (535 RCTs) with objective outcomes. DATA SYNTHESIS For each meta-analysis, the difference in treatment outcomes between meta-analysis of all trials and each alternative strategy, expressed as a ratio of odds ratios (ROR), was assessed considering the dependency between strategies. A difference greater than 30% was considered substantial. RORs were combined by random-effects meta-analysis models to obtain an average difference across the sample. An ROR greater than 1 indicates larger treatment outcomes with meta-analysis of all trials. Subjective and objective outcomes were analyzed separately. RESULTS Treatment outcomes were larger in the meta-analysis of all trials than in the single most precise trial (combined ROR, 1.13 [95% CI, 1.07-1.19]) for subjective outcomes and 1.03 (95% CI, 1.01-1.05) for objective outcomes). The difference in treatment outcomes between these strategies was substantial in 47 of 92 (51%) meta-analyses of subjective outcomes (meta-analysis of all trials showing larger outcomes in 40/47) and in 28 of 71 (39%) meta-analyses of objective outcomes (meta-analysis of all trials showing larger outcomes in 21/28). The combined ROR for subjective and objective outcomes was, respectively, 1.08 (95% CI, 1.04-1.13) and 1.03 (95% CI, 1.00-1.06) when comparingmeta-analysis of all trials and meta-analysis of the 25% largest trials, 1.17 (95% CI, 1.11-1.22) and 1.13 (95% CI, 0.82-1.55) when comparingmeta-analysis of all trials and limit meta-analysis, and 0.94 (95% CI, 0.86-1.04) and 1.03 (95% CI, 1.00-1.06) when comparingmeta-analysis of all trials and meta-analysis restricted to trials at low risk of bias. CONCLUSIONS AND RELEVANCE Estimation of treatment outcomes inmeta-analyses differs depending on the strategy used. This instability in findings can result in major alterations in the conclusions derived from the analysis and underlines the need for systematic sensitivity analyses.	[Dechartres, Agnes; Trinquart, Ludovic; Boutron, Isabelle; Ravaud, Philippe] INSERM, U1153, Ctr Epidemiol & Stat, Paris, France; [Dechartres, Agnes; Boutron, Isabelle; Ravaud, Philippe] Hop Hotel Dieu, AP HP, Ctr Epidemiol Clin, F-75004 Paris, France; [Dechartres, Agnes; Boutron, Isabelle; Ravaud, Philippe] Univ Paris 05, Sorbonne Paris Cite, Fac Med, Paris, France; [Altman, Douglas G.] Ctr Stat Med, Oxford, England; [Trinquart, Ludovic; Ravaud, Philippe] Columbia Univ, Sch Publ Hlth, Div Epidemiol, New York, NY USA; [Boutron, Isabelle; Ravaud, Philippe] French Cochrane Ctr, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Oxford; Columbia University	Dechartres, A (corresponding author), Hop Hotel Dieu, Ctr Rech Epidemiol & Stat, Ctr Epidemiol Clin, INSERM,U1153, 1 Pl Parvis, F-75004 Paris, France.	agnes.dechartres@htd.aphp.fr	Trinquart, Ludovic/H-4961-2019; ravaud, philippe/C-1694-2009	Trinquart, Ludovic/0000-0002-3028-4900; Boutron, Isabelle/0000-0002-5263-6241; Ravaud, Philippe/0000-0001-8264-9206	program "Equipe espoir de la Recherche," Fondation pour la Recherche Medicale, Paris, France [DEQ20101221475]; Institut National de la Sante et de la Recherche Medicale; Cancer Research UK [C5529]; Cancer Research UK [16895] Funding Source: researchfish	program "Equipe espoir de la Recherche," Fondation pour la Recherche Medicale, Paris, France; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	Our team is supported by an academic grant from the program "Equipe espoir de la Recherche," Fondation pour la Recherche Medicale, Paris, France (No. DEQ20101221475). Dr Dechartres is funded by the Institut National de la Sante et de la Recherche Medicale. Dr Altman is supported by Cancer Research UK (C5529).	Bent S, 1998, NEW ENGL J MED, V338, P60; BORZAK S, 1995, ANN INTERN MED, V123, P873, DOI 10.7326/0003-4819-123-11-199512010-00010; Cappelleri JC, 1996, JAMA-J AM MED ASSOC, V276, P1332, DOI 10.1001/jama.276.16.1332; Chalmers I, 1995, SYSTEMATIC REVIEWS; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Cuijpers P, 2008, AM J PSYCHIAT, V165, P1272, DOI 10.1176/appi.ajp.2008.07091422; Dechartres A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2304; Dechartres A, 2011, ANN INTERN MED, V155, P39, DOI 10.7326/0003-4819-155-1-201107050-00006; EGGER M, 1995, BRIT MED J, V311, P753, DOI 10.1136/bmj.311.7007.753c; Flather MD, 1997, CONTROL CLIN TRIALS, V18, P568, DOI 10.1016/S0197-2456(97)00024-X; Glasziou PP, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-23; Hartling L, 2013, J CLIN EPIDEMIOL, V66, P973, DOI 10.1016/j.jclinepi.2012.07.005; Hartling L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4012; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hopewell S, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2013-003342, 10.1136/bmjopen-2012-002154]; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 1998, NEW ENGL J MED, V338, P59; Ioannidis JPA, 1998, JAMA-J AM MED ASSOC, V279, P1089, DOI 10.1001/jama.279.14.1089; Johnson BT, 1997, JAMA-J AM MED ASSOC, V277, P377, DOI 10.1001/jama.277.5.377; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Juni P, 1999, JAMA-J AM MED ASSOC, V282, P1054, DOI 10.1001/jama.282.11.1054; Khan S, 1998, NEW ENGL J MED, V338, P60; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Klebanoff MA, 1997, JAMA-J AM MED ASSOC, V277, P376, DOI 10.1001/jama.277.5.376; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; LeLorier J, 1998, JAMA-J AM MED ASSOC, V280, P518, DOI 10.1001/jama.280.6.518; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; Moreno SG, 2012, STAT MED, V31, P1407, DOI 10.1002/sim.4488; Moreno SG, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-2; Moseley AM, 2009, J CLIN EPIDEMIOL, V62, P1021, DOI 10.1016/j.jclinepi.2008.09.018; Moses LE, 2002, STAT MED, V21, P793, DOI 10.1002/sim.1098; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Pereira TV, 2011, J CLIN EPIDEMIOL, V64, P1060, DOI 10.1016/j.jclinepi.2010.12.012; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Piscione F, 2010, HEART, V96, P588, DOI 10.1136/hrt.2009.183277; Rucker G, 2011, BIOMETRICAL J, V53, P351, DOI 10.1002/bimj.201000151; Rucker G, 2011, BIOSTATISTICS, V12, P122, DOI 10.1093/biostatistics/kxq046; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schneider MP, 2010, J AM COLL CARDIOL, V55, P2299, DOI 10.1016/j.jacc.2010.01.043; Schriger DL, 2010, INT J EPIDEMIOL, V39, P421, DOI 10.1093/ije/dyp370; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Shea B, 2002, EVAL HEALTH PROF, V25, P116, DOI 10.1177/0163278702025001008; SLAVIN RE, 1995, J CLIN EPIDEMIOL, V48, P9, DOI 10.1016/0895-4356(94)00097-A; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2001, BMJ-BRIT MED J, V323, P101, DOI 10.1136/bmj.323.7304.101; Sterne JAC, 2002, STAT MED, V21, P1513, DOI 10.1002/sim.1184; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2; VILLAR J, 1995, LANCET, V345, P772, DOI 10.1016/S0140-6736(95)90646-0; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	55	117	118	3	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					623	630		10.1001/jama.2014.8166	http://dx.doi.org/10.1001/jama.2014.8166			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117131				2022-12-28	WOS:000340136400021
J	Nilsson, L				Nilsson, Lina			Ph.D.s, come out of the closet!	SCIENCE			English	Editorial Material									[Nilsson, Lina] Univ Calif Berkeley, Blum Ctr Dev Econ, Berkeley, CA 94720 USA	University of California System; University of California Berkeley									0	1	1	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					706	706		10.1126/science.345.6197.706	http://dx.doi.org/10.1126/science.345.6197.706			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM6GW	25104392				2022-12-28	WOS:000339962800045
J	Luo, ZX				Luo, Zhe-Xi			Tooth structure re-engineered	NATURE			English	Editorial Material							TRIBOSPHENIC MAMMALS; EVOLUTION		Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago	Luo, ZX (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	zxluo@uchicago.edu	Luo, Zhe-XI/AAU-2263-2021					Abzhanov A, 2013, TRENDS GENET, V29, P712, DOI 10.1016/j.tig.2013.09.004; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Charles C, 2009, P NATL ACAD SCI USA, V106, P22364, DOI 10.1073/pnas.0910086106; Cho SW, 2011, DEVELOPMENT, V138, P1807, DOI 10.1242/dev.056051; Crompton AW, 1971, ZOOLOGICAL J LINN S1, P65; Gomes-Rodrigues H., 2013, NATURE COMMUN, V4, P2504; Gould S.J, 1985, ONTOGENY PHYLOGENY; Harjunmaa E, 2014, NATURE, V512, P44, DOI 10.1038/nature13613; KIELAN-JAWOROWSKA Z, 2004, MAMMALS AGE DINOSAUR; Luo ZX, 2007, NATURE, V450, P93, DOI 10.1038/nature06221; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; Meng J., 2007, J MAMM EVOL, V8, P1; Mikkola ML, 2003, CYTOKINE GROWTH F R, V14, P211, DOI 10.1016/S1359-6101(03)00020-0	13	4	5	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					36	37		10.1038/nature13651	http://dx.doi.org/10.1038/nature13651			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25079312				2022-12-28	WOS:000339908000025
J	Cole, TB				Cole, Thomas B.			Fire-Swept, Algoma Franz Johnston	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					466	467		10.1001/jama.2013.279643	http://dx.doi.org/10.1001/jama.2013.279643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	25096675				2022-12-28	WOS:000339808600001
J	Crider, KS; Devine, O; Hao, L; Dowling, NF; Li, S; Molloy, AM; Li, Z; Zhu, JH; Berry, RJ				Crider, Krista S.; Devine, Owen; Hao, Ling; Dowling, Nicole F.; Li, Song; Molloy, Anne M.; Li, Zhu; Zhu, Jianghui; Berry, Robert J.			Population red blood cell folate concentrations for prevention of neural tube defects: bayesian model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLIC-ACID FORTIFICATION; DOUBLE-BLIND TRIAL; UNITED-STATES; CHILDBEARING AGE; HOMOCYSTEINE CONCENTRATIONS; ERYTHROCYTE FOLATE; FOOD FORTIFICATION; SPINA-BIFIDA; WOMEN; SUPPLEMENTATION	Objective To determine an optimal population red blood cell (RBC) folate concentration for the prevention of neural tube birth defects. Design Bayesian model. Setting Data from two population based studies in China. Participants 247 831 participants in a prospective community intervention project in China (1993-95) to prevent neural tube defects with 400 mu g/day folic acid supplementation and 1194 participants in a population based randomized trial (2003-05) to evaluate the effect of folic acid supplementation on blood folate concentration among Chinese women of reproductive age. Intervention Folic acid supplementation (400 mu g/day). Main outcome measures Estimated RBC folate concentration at time of neural tube closure (day 28 of gestation) and risk of neural tube defects. Results Risk of neural tube defects was high at the lowest estimated RBC folate concentrations (for example, 25.4 (95% uncertainty interval 20.8 to 31.2) neural tube defects per 10 000 births at 500 nmol/L) and decreased as estimated RBC folate concentration increased. Risk of neural tube defects was substantially attenuated at estimated RBC folate concentrations above about 1000 nmol/L (for example, 6 neural tube defects per 10 000 births at 1180 (1050 to 1340) nmol/L). The modeled dose-response relation was consistent with the existing literature. In addition, neural tube defect risk estimates developed using the proposed model and population level RBC information were consistent with the prevalence of neural tube defects in the US population before and after food fortification with folic acid. Conclusions A threshold for "optimal" population RBC folate concentration for the prevention of neural tube defects could be defined (for example, approximately 1000 nmol/L). Population based RBC folate concentrations, as a biomarker for risk of neural tube defects, can be used to facilitate evaluation of prevention programs as well as to identify subpopulations at elevated risk for a neural tube defect affected pregnancy due to folate insufficiency.	[Crider, Krista S.; Devine, Owen; Dowling, Nicole F.; Berry, Robert J.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA; [Hao, Ling; Li, Zhu; Zhu, Jianghui] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Hao, Ling] US Ctr Dis Control & Prevent, US Embassy, Beijing, Peoples R China; [Li, Song] Peking Univ, Hosp 3, Beijing 100871, Peoples R China; [Molloy, Anne M.] Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland; [Zhu, Jianghui] China Natl Ctr Food Safety Risk Assessment, Div Risk Assessment, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA; Peking University; Peking University; Trinity College Dublin	Crider, KS (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.	kcrider@cdc.gov		Berry, Robert/0000-0002-7162-5046; Crider, Krista/0000-0001-6997-5955; Molloy, Anne/0000-0002-1688-9049	Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Funding for salaries of CDC employees was provided by the Centers for Disease Control and Prevention. No specific funding was provided for this project. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Adank C, 2003, ANN NUTR METAB, V47, P55, DOI 10.1159/000069278; Agopian AJ, 2013, BIRTH DEFECTS RES A, V97, P42, DOI 10.1002/bdra.23100; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bestwick JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089354; Bradbury KE, 2012, J NUTR, V142, P1633, DOI 10.3945/jn.112.161562; Branum AM, 2013, J NUTR, V143, P486, DOI 10.3945/jn.112.169987; Calonge N, 2009, ANN INTERN MED, V150, P626, DOI 10.7326/0003-4819-150-9-200905050-00009; Chen LT, 2004, NUTR REV, V62, pS40, DOI 10.1301/nr.2004.jun.S40-S43; Cordero A., 2010, Morbidity and Mortality Weekly Report, V59, P980; Cortes F, 2012, AM J MED GENET A, V158A, P1885, DOI 10.1002/ajmg.a.35430; Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671; Cuskelly GJ, 1999, AM J CLIN NUTR, V70, P234; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; Daly S, 1997, LANCET, V350, P1666, DOI 10.1016/S0140-6736(97)07247-4; De Wals P, 2008, BIRTH DEFECTS RES A, V82, P622, DOI 10.1002/bdra.20485; De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103; Finer LB, 2011, CONTRACEPTION, V84, P478, DOI 10.1016/j.contraception.2011.07.013; Green TJ, 2005, ASIA PAC J CLIN NUTR, V14, P173; Hao L, 2003, J NUTR, V133, P3630, DOI 10.1093/jn/133.11.3630; Hao L, 2008, AM J CLIN NUTR, V88, P448, DOI 10.1093/ajcn/88.2.448; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Horn F, 2014, BRATISL MED J, V115, P91, DOI 10.4149/BLL_2014_020; Hursthouse NA, 2011, NUTRIENTS, V3, P49, DOI 10.3390/nu3010049; Lamers Y, 2006, AM J CLIN NUTR, V84, P156, DOI 10.1093/ajcn/84.1.156; Mao RF, 2008, CELL BIOCHEM FUNCT, V26, P352, DOI 10.1002/cbf.1450; McDonnell R, 2014, J PUBLIC HLTH OXF; McMahon DM, 2013, BIRTH DEFECTS RES A, V97, P115, DOI 10.1002/bdra.23113; Milman N, 2006, EUR J HAEMATOL, V76, P200, DOI 10.1111/j.1600-0609.2005.00606.x; Nelson CRM, 2014, CAN J PUBLIC HEALTH, V105, pE40, DOI 10.17269/cjph.105.4155; Norsworthy B, 2004, EUR J CLIN NUTR, V58, P548, DOI 10.1038/sj.ejcn.1601843; OBROIN S, 1992, J CLIN PATHOL, V45, P344, DOI 10.1136/jcp.45.4.344; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pfeiffer CM, 2012, J NUTR, V142, P886, DOI 10.3945/jn.111.156919; Pfeiffer CM, 2011, J NUTR, V141, P1402, DOI 10.3945/jn.111.141515; Sayed AR, 2008, BIRTH DEFECTS RES A, V82, P211, DOI 10.1002/bdra.20442; SCHORAH CJ, 1983, BRIT J NUTR, V49, P203, DOI 10.1079/BJN19830026; Selhub J, 2008, FOOD NUTR BULL, V29, pS67, DOI 10.1177/15648265080292S110; Shibuya KMC, 1998, HLTH DIMENSIONS SEX, P455; Tinker SC, 2010, AM J PREV MED, V38, P534, DOI 10.1016/j.amepre.2010.01.025; Ubeda N, 2011, NUTRITION, V27, P925, DOI 10.1016/j.nut.2010.10.017; WALD N, 1991, LANCET, V338, P131; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Williams LJ, 2002, TERATOLOGY, V66, P33, DOI 10.1002/tera.10060; Yan LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041689; Yang QH, 2010, AM J CLIN NUTR, V91, P64, DOI 10.3945/ajcn.2009.28401; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059570	48	125	128	0	115	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2014	349								g4554	10.1136/bmj.g4554	http://dx.doi.org/10.1136/bmj.g4554			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NG	25073783	Green Published, hybrid			2022-12-28	WOS:000339906000002
J	Hill, MD; Coutts, SB				Hill, Michael D.; Coutts, Shelagh B.			Alteplase in acute ischaemic stroke: the need for speed	LANCET			English	Editorial Material							TISSUE-PLASMINOGEN ACTIVATOR; COMPUTED-TOMOGRAPHY; THROMBOLYSIS		[Hill, Michael D.; Coutts, Shelagh B.] Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada; [Hill, Michael D.; Coutts, Shelagh B.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 2T9, Canada; [Hill, Michael D.] Univ Calgary, Dept Med, Calgary, AB T2N 2T9, Canada; [Hill, Michael D.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 2T9, Canada; [Hill, Michael D.] Univ Calgary, Dept Radiol, Calgary, AB T2N 2T9, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary	Hill, MD (corresponding author), Univ Calgary, Dept Clin Neurosci, Calgary, AB T2N 2T9, Canada.	michael.hill@ucalgary.ca	Hill, Michael D/C-9073-2012	Hill, Michael D/0000-0002-6269-1543	Alberta Innovates [201300690] Funding Source: researchfish	Alberta Innovates		Barber PA, 2005, J NEUROL NEUROSUR PS, V76, P1528, DOI 10.1136/jnnp.2004.059261; Barber PA, 2000, LANCET, V355, P1670, DOI 10.1016/S0140-6736(00)02237-6; Bray BD, 2013, STROKE, V44, P3129, DOI 10.1161/STROKEAHA.113.001981; Canadian Stroke Network, 2011, QUAL STROK CAR CAN; Demchuk AM, 1999, STROKE, V30, P34, DOI 10.1161/01.STR.30.1.34; Emberson J, 2014, LANCET; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Kent DM, 2005, STROKE, V36, P62, DOI 10.1161/01.STR.0000150515.15576.29; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Poppe AY, 2011, INT J STROKE, V6, P278, DOI 10.1111/j.1747-4949.2011.00586.x; Walter S, 2012, LANCET NEUROL, V11, P397, DOI 10.1016/S1474-4422(12)70057-1	11	7	7	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1904	1906		10.1016/S0140-6736(14)60662-0	http://dx.doi.org/10.1016/S0140-6736(14)60662-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25106064	hybrid			2022-12-28	WOS:000345450100007
J	Wolfe, AL; Singh, K; Zhong, Y; Drewe, P; Rajasekhar, VK; Sanghvi, VR; Mavrakis, KJ; Jiang, M; Roderick, JE; Van der Meulen, J; Schatz, JH; Rodrigo, CM; Zhao, CY; Rondou, P; de Stanchina, E; Teruya-Feldstein, J; Kelliher, MA; Speleman, F; Porco, JA; Pelletier, J; Ratsch, G; Wendel, HG				Wolfe, Andrew L.; Singh, Kamini; Zhong, Yi; Drewe, Philipp; Rajasekhar, Vinagolu K.; Sanghvi, Viraj R.; Mavrakis, Konstantinos J.; Jiang, Man; Roderick, Justine E.; Van der Meulen, Joni; Schatz, Jonathan H.; Rodrigo, Christina M.; Zhao, Chunying; Rondou, Pieter; de Stanchina, Elisa; Teruya-Feldstein, Julie; Kelliher, Michelle A.; Speleman, Frank; Porco, John A., Jr.; Pelletier, Jerry; Raetsch, Gunnar; Wendel, Hans-Guido			RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; OF-FUNCTION MUTATIONS; C-MYC; INITIATION; EIF4E; CAP; AKT; TRANSCRIPTION; INHIBITION; MOTIF	The translational control of oncoprotein expression is implicated in many cancers. Here we report an eIF4A RNA helicase-dependent mechanism of translational control that contributes to oncogenesis and underlies the anticancer effects of silvestrol and related compounds. For example, eIF4A promotes T-cell acute lymphoblastic leukaemia development in vivo and is required for leukaemia maintenance. Accordingly, inhibition of eIF4A with silvestrol has powerful therapeutic effects against murine and human leukaemic cells in vitro and in vivo. We use transcriptome-scale ribosome footprinting to identify the hallmarks of eIF4A-dependent transcripts. These include 5' untranslated region (UTR) sequences such as the 12-nucleotide guanine quartet (CGG)(4) motif that can form RNA G-quadruplex structures. Notably, among the most eIF4A-dependent and silvestrol-sensitive transcripts are a number of oncogenes, superenhancer-associated transcription factors, and epigenetic regulators. Hence, the 5' UTRs of select cancer genes harbour a targetable requirement for the eIF4A RNA helicase.	[Wolfe, Andrew L.; Singh, Kamini; Sanghvi, Viraj R.; Mavrakis, Konstantinos J.; Jiang, Man; Van der Meulen, Joni; Schatz, Jonathan H.; Zhao, Chunying; Wendel, Hans-Guido] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Wolfe, Andrew L.] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Zhong, Yi; Drewe, Philipp; Raetsch, Gunnar] Mem Sloan Kettering Canc Ctr, Computat Biol Dept, New York, NY 10065 USA; [Rajasekhar, Vinagolu K.] Mem Sloan Kettering Canc Ctr, Stem Cell Ctr, New York, NY 10065 USA; [Rajasekhar, Vinagolu K.] Mem Sloan Kettering Canc Ctr, Dev Biol Program, New York, NY 10065 USA; [Roderick, Justine E.; Kelliher, Michelle A.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Van der Meulen, Joni; Rondou, Pieter; Speleman, Frank] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Schatz, Jonathan H.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Rodrigo, Christina M.; Porco, John A., Jr.] Boston Univ, Dept Chem, Ctr Chem Methodol & Lib Dev, Boston, MA 02215 USA; [de Stanchina, Elisa] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, New York, NY 10065 USA; [Teruya-Feldstein, Julie] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Pelletier, Jerry] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Pelletier, Jerry] McGill Univ, Dept Oncol, Montreal, PQ H3G 1Y6, Canada; [Pelletier, Jerry] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3G 1Y6, Canada	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; Ghent University; Memorial Sloan Kettering Cancer Center; Boston University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; McGill University; McGill University; McGill University	Wendel, HG (corresponding author), Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.	Ratschg@mskcc.org; wendelh@mskcc.org	speleman, frank/AAR-5184-2020; Van der Meulen, Joni/AFS-1616-2022; Rätsch, Gunnar/O-5914-2017	speleman, frank/0000-0002-6628-8559; Van der Meulen, Joni/0000-0002-1916-2769; Rätsch, Gunnar/0000-0001-5486-8532; van der Meulen, Jan/0000-0002-9451-2335; Wolfe, Andrew/0000-0003-0418-716X; Sanghvi, Viraj/0000-0001-6526-7820; Boss, Philipp/0000-0002-5459-9771; Vinagolu, Rajasekhar/0000-0002-7364-2675; Schatz, Jonathan/0000-0003-1842-228X	National Cancer Institute [R01-CA142798-01]; Leukemia Research Foundation; Experimental Therapeutics Center; American Cancer Society [10284, PF-11-077-01-CDD]; European Union [PITN-GA-2012-316861]; Fund for Scientific Research FWO Flanders [G.0198.08, G.0869.10N]; GOA-UGent [12051203]; Stichting tegen Kanker; Belgian Program of Interuniversity Poles of Attraction; Belgian Foundation Against Cancer; Lymphoma Research Foundation; National Institutes of Health [GM-067041, GM-073855]; Canadian Institutes of Health Research [MOP-10653]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA142798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073855, P50GM067041] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation; Experimental Therapeutics Center; American Cancer Society(American Cancer Society); European Union(European Commission); Fund for Scientific Research FWO Flanders(FWO); GOA-UGent; Stichting tegen Kanker; Belgian Program of Interuniversity Poles of Attraction; Belgian Foundation Against Cancer; Lymphoma Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of A.L.W.'s thesis committee: N. Rosen, A. M. Brown and S. W. Lowe. For reagents and advice we thank J. T. Barata, W. S. Pear, R. Cencic, S. Shuman, J. Cools, A. A. Ferrando, C. S. Fraser, N. J. Lajkiewicz, A. Luz, J. F. Glickman, C. Y. Park, P. Yellen, A. Heguy, K. Huberman and A. Viale. H.-G. W. is a Scholar of the Leukemia and Lymphoma Society. This research was supported by National Cancer Institute R01-CA142798-01 (H.-G. W.), the Leukemia Research Foundation (H.-G. W.), the Experimental Therapeutics Center (H.-G. W.), the American Cancer Society 10284 (H.-G. W.), European Union grant no. PITN-GA-2012-316861 (Y.Z.), the Fund for Scientific Research FWO Flanders (J.V.d.M. and P. R.), grants G.0198.08 and G.0869.10N (F. S.), the GOA-UGent 12051203 (F. S.), Stichting tegen Kanker (F. S.), the Belgian Program of Interuniversity Poles of Attraction (F. S.), the Belgian Foundation Against Cancer (F. S.), the American Cancer Society PF-11-077-01-CDD (C. M. R.), the Lymphoma Research Foundation (J. H. S.), National Institutes of Health grants GM-067041 and GM-073855 (J. A. P.), and the Canadian Institutes of Health Research MOP-10653 (J.P.).	Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Chakraborty P, 2011, DNA REPAIR, V10, P654, DOI 10.1016/j.dnarep.2011.04.013; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Drewe P, 2013, NUCLEIC ACIDS RES, V41, P5189, DOI 10.1093/nar/gkt211; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Galicia-Vazquez G, 2012, RNA, V18, P1373, DOI 10.1261/rna.033209.112; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Huppert JL, 2008, NUCLEIC ACIDS RES, V36, P6260, DOI 10.1093/nar/gkn511; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jean G., 2010, BIOINFORMATICS, V32; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Menten B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-124; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Morris MJ, 2010, J AM CHEM SOC, V132, P17831, DOI 10.1021/ja106287x; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; PENN LJZ, 1990, EMBO J, V9, P1113, DOI 10.1002/j.1460-2075.1990.tb08217.x; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rajasekhar VK, 2003, MOL CELL, V12, P889, DOI 10.1016/S1097-2765(03)00395-2; Rodrigo CM, 2012, J MED CHEM, V55, P558, DOI 10.1021/jm201263k; Rong L, 2008, RNA, V14, P1318, DOI 10.1261/rna.950608; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Sadlish H, 2013, ACS CHEM BIOL, V8, P1519, DOI 10.1021/cb400158t; Schatz JH, 2011, J EXP MED, V208, P1799, DOI 10.1084/jem.20110846; Shahid R, 2010, BIOCHEMISTRY-US, V49, P8300, DOI 10.1021/bi100957h; Shochat C, 2011, J EXP MED, V208, P901, DOI 10.1084/jem.20110580; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Zenatti PP, 2011, NAT GENET, V43, P932, DOI 10.1038/ng.924; Zuurbier L, 2012, HAEMATOL-HEMATOL J, V97, P1405, DOI 10.3324/haematol.2011.059030	56	378	385	3	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					65	+		10.1038/nature13485	http://dx.doi.org/10.1038/nature13485			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25079319	Green Accepted			2022-12-28	WOS:000341174800030
J	Carre, M; Sachs, JP; Purca, S; Schauer, AJ; Braconnot, P; Falcon, RA; Julien, M; Lavallee, D				Carre, Matthieu; Sachs, Julian P.; Purca, Sara; Schauer, Andrew J.; Braconnot, Pascale; Angeles Falcon, Rommel; Julien, Michele; Lavallee, Daniele			Holocene history of ENSO variance and asymmetry in the eastern tropical Pacific	SCIENCE			English	Article							EL-NINO/SOUTHERN-OSCILLATION; SOUTHERN-OSCILLATION; NINO; VARIABILITY; RECORD; CLIMATE; PERU	Understanding the response of the El Nino-Southern Oscillation (ENSO) to global warming requires quantitative data on ENSO under different climate regimes. Here, we present a reconstruction of ENSO in the eastern tropical Pacific spanning the past 10,000 years derived from oxygen isotopes in fossil mollusk shells from Peru. We found that ENSO variance was close to the modern level in the early Holocene and severely damped similar to 4000 to 5000 years ago. In addition, ENSO variability was skewed toward cold events along coastal Peru 6700 to 7500 years ago owing to a shift of warm anomalies toward the Central Pacific. The modern ENSO regime was established similar to 3000 to 4500 years ago. We conclude that ENSO was sensitive to changes in climate boundary conditions during the Holocene, including but not limited to insolation.	[Carre, Matthieu] UM2, CNRS, IRD, Inst Sci Evolut Montpellier,UMR 5554, F-34095 Montpellier, France; [Sachs, Julian P.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Purca, Sara] Inst Mar Peru IMARPE, Callao, Peru; [Schauer, Andrew J.] Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; [Braconnot, Pascale] Univ Versailles St Quentin En Yvelines, CNRS, Inst Pierre Simon Laplace, Lab Sci Climat & Environm,Unite Mixte CEA, F-91191 Gif Sur Yvette, France; [Angeles Falcon, Rommel] Museo Sitio Pachacamac, Minist Cultura, Lima, Peru; [Julien, Michele] Maison Rene Ginouves, UMR 7041, Archeol & Sci Antiquite, F-92023 Nanterre, France; [Lavallee, Daniele] Maison Rene Ginouves, Archeol Amer, UMR 8096, F-92023 Nanterre, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Washington; University of Washington Seattle; Instituto del Mar del Peru; University of Washington; University of Washington Seattle; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Carre, M (corresponding author), UM2, CNRS, IRD, Inst Sci Evolut Montpellier,UMR 5554, Pl Eugene Bataillon, F-34095 Montpellier, France.	matthieu.carre@univ-montp2.fr	Carre, Matthieu/G-6324-2012; Purca, Sara/E-5698-2010	Carre, Matthieu/0000-0001-8178-7316; Purca, Sara/0000-0001-8751-1476; Schauer, Andrew/0000-0002-5941-5396	French Perou-Sud archaeological project; University of Washington-National Oceanic and Atmospheric Administration (NOAA) Joint Institute for the Study of Atmosphere and Ocean; U.S. National Science Foundation under grant NSF [ATM-0811382]; NOAA [NOAANA08OAR4310685]; French National Research Agency under EL PASO grant [10-Blan-608-01]; French Institut National des Sciences de l'Univers	French Perou-Sud archaeological project; University of Washington-National Oceanic and Atmospheric Administration (NOAA) Joint Institute for the Study of Atmosphere and Ocean; U.S. National Science Foundation under grant NSF; NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); French National Research Agency under EL PASO grant(French National Research Agency (ANR)); French Institut National des Sciences de l'Univers	This work was supported by the French Perou-Sud archaeological project (D. L.), by the University of Washington-National Oceanic and Atmospheric Administration (NOAA) Joint Institute for the Study of Atmosphere and Ocean through a postdoctoral fellowship (M. C.), by the U.S. National Science Foundation under grant NSF-ATM-0811382 (J.P.S.), by NOAA under grant NOAANA08OAR4310685 (J.P.S.), by the French National Research Agency under EL PASO grant 10-Blan-608-01 (P. B.), and by the French Institut National des Sciences de l'Univers with accelerator mass spectrometry dating (M. C.). We thank I. Bentaleb and H. Vonhof for their support in the early phase of this work, A. Portal for scanning electron microscopy observations at UM2, and M. Fontugne for his help and for providing the H4 shell sample. We are grateful to N. Mitma Garcia, G. d'Herbes, J. Sadler, and M. Azzoug for technical assistance with sample preparation and to A. Mitma Garcia for his help with fieldwork. The data reported in this paper are tabulated in the supplementary materials.	An SI, 2004, J CLIMATE, V17, P2399, DOI 10.1175/1520-0442(2004)017<2399:NAAOE>2.0.CO;2; Braconnot P, 2012, CLIM DYNAM, V38, P1081, DOI 10.1007/s00382-011-1029-x; Carre M, 2005, PALAEOGEOGR PALAEOCL, V228, P4, DOI 10.1016/j.palaeo.2005.03.045; Carre M, 2012, CLIM PAST, V8, P433, DOI 10.5194/cp-8-433-2012; Carre M, 2012, QUATERN INT, V253, P55, DOI 10.1016/j.quaint.2011.02.004; Carre M, 2013, PALAEOGEOGR PALAEOCL, V371, P45, DOI 10.1016/j.palaeo.2012.12.014; Clement AC, 1999, PALEOCEANOGRAPHY, V14, P441, DOI 10.1029/1999PA900013; Cobb KM, 2013, SCIENCE, V339, P67, DOI 10.1126/science.1228246; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Dewitte B, 2012, DEEP-SEA RES PT II, V77-80, P143, DOI 10.1016/j.dsr2.2012.04.011; Fontugne M, 1999, QUATERNARY RES, V52, P171, DOI 10.1006/qres.1999.2059; Kao HY, 2009, J CLIMATE, V22, P615, DOI 10.1175/2008JCLI2309.1; Keefer DK, 2003, PALAEOGEOGR PALAEOCL, V194, P41, DOI 10.1016/S0031-0182(03)00271-2; Koutavas A, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2012PA002378; Lee T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044007; Luan Y, 2012, CLIM PAST, V8, P1093, DOI 10.5194/cp-8-1093-2012; McGregor HV, 2013, NAT GEOSCI, V6, P949, DOI [10.1038/ngeo1936, 10.1038/NGEO1936]; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Rein B, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001099; Rein B, 2007, QUATERN INT, V161, P56, DOI 10.1016/j.quaint.2006.10.023; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rodbell DT, 2008, QUATERNARY SCI REV, V27, P1612, DOI 10.1016/j.quascirev.2008.06.004; Rodbell DT, 1999, SCIENCE, V283, P516, DOI 10.1126/science.283.5401.516; Sadler J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003595; Sandweiss D.H., 2007, CLIMATE CHANGE CULTU, P25, DOI DOI 10.1016/B978-012088390-5.50007-8; Sandweiss DH, 1998, SCIENCE, V281, P1830, DOI 10.1126/science.281.5384.1830; Santoso A, 2013, NATURE, V504, P126, DOI 10.1038/nature12683; Takahashi K, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047364; Tudhope AW, 2001, SCIENCE, V291, P1511, DOI 10.1126/science.1057969; WELLS LE, 1990, GEOLOGY, V18, P1134, DOI 10.1130/0091-7613(1990)018<1134:HHOTEN>2.3.CO;2; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710; Zheng W, 2008, CLIM DYNAM, V30, P745, DOI 10.1007/s00382-007-0320-3	32	152	154	1	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1045	1048		10.1126/science.1252220	http://dx.doi.org/10.1126/science.1252220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25103408				2022-12-28	WOS:000340870900038
J	Hassaine, G; Deluz, C; Grasso, L; Wyss, R; Tol, MB; Hovius, R; Graff, A; Stahlberg, H; Tomizaki, T; Desmyter, A; Moreau, C; Li, XD; Poitevin, F; Vogel, H; Nury, H				Hassaine, Gherici; Deluz, Cedric; Grasso, Luigino; Wyss, Romain; Tol, Menno B.; Hovius, Ruud; Graff, Alexandra; Stahlberg, Henning; Tomizaki, Takashi; Desmyter, Aline; Moreau, Christophe; Li, Xiao-Dan; Poitevin, Frederic; Vogel, Horst; Nury, Hugues			X-ray structure of the mouse serotonin 5-HT3 receptor	NATURE			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING DOMAIN; SELECTIVITY-FILTER; AGONIST BINDING; PERMEATION; PORE; DETERMINANTS; MECHANISM; CONDUCTANCE	Neurotransmitter-gated ion channels of the Cys-loop receptor family mediate fast neurotransmission throughout the nervous system. The molecular processes of neurotransmitter binding, subsequent opening of the ion channel and ion permeation remain poorly understood. Here we present the X-ray structure of a mammalian Cys-loop receptor, the mouse serotonin 5-HT3 receptor, at 3.5 angstrom resolution. The structure of the proteolysed receptor, made up of two fragments and comprising part of the intracellular domain, was determined in complex with stabilizing nanobodies. The extracellular domain reveals the detailed anatomy of the neurotransmitter binding site capped by a nanobody. The membrane domain delimits an aqueous pore with a 4.6 angstrom constriction. In the intracellular domain, a bundle of five intracellular helices creates a closed vestibule where lateral portals are obstructed by loops. This 5-HT3 receptor structure, revealing part of the intracellular domain, expands the structural basis for understanding the operating mechanism of mammalian Cys-loop receptors.	[Hassaine, Gherici; Deluz, Cedric; Grasso, Luigino; Wyss, Romain; Tol, Menno B.; Hovius, Ruud; Vogel, Horst; Nury, Hugues] Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, CH-1015 Lausanne, Switzerland; [Graff, Alexandra; Stahlberg, Henning] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt, CH-4058 Basel, Switzerland; [Tomizaki, Takashi] Paul Scherrer Inst, Swiss Light Source, CH-5234 Villigen, Switzerland; [Desmyter, Aline] CNRS, UMR 7257, F-13288 Marseille, France; [Desmyter, Aline] Univ Aix Marseille, F-13288 Marseille, France; [Moreau, Christophe; Nury, Hugues] Univ Grenoble Alpes, IBS, F-38000 Grenoble, France; [Moreau, Christophe; Nury, Hugues] CNRS, IBS, F-38000 Grenoble, France; [Moreau, Christophe; Nury, Hugues] CEA, DSV, IBS, F-38000 Grenoble, France; [Li, Xiao-Dan] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Poitevin, Frederic] Inst Pasteur, CNRS, UMR3528, Unite Dynam Struct Macromol, F-75015 Paris, France	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Basel; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Nury, H (corresponding author), Ecole Polytech Fed Lausanne, Lab Phys Chem Polymers & Membranes, CH-1015 Lausanne, Switzerland.	horst.vogel@epfl.ch; hugues.nury@ibs.fr	MOREAU, Christophe/AAC-7912-2020; Hovius, Ruud/B-5647-2009; Poitevin, Frederic/K-1718-2014; MOREAU, Christophe J/D-3736-2009; Vogel, Horst/AAJ-5490-2021; Stahlberg, Henning/H-1868-2011	MOREAU, Christophe/0000-0002-5463-9593; Hovius, Ruud/0000-0001-9258-6587; MOREAU, Christophe J/0000-0002-5463-9593; Stahlberg, Henning/0000-0002-1185-4592; Nury, Hugues/0000-0002-3433-256X; li, xiaodan/0000-0001-8647-7317	Swiss National Science Foundation [31003A-133141]; Ecole Polytechnique Federale de Lausanne; European Community [211800]; Human Frontier Science Program; Agence Nationale de la Recherche (VenomPicoScreen project) [ANR-11-RPIB-022-04]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne; European Community(European Commission); Human Frontier Science Program(Human Frontier Science Program); Agence Nationale de la Recherche (VenomPicoScreen project)(French National Research Agency (ANR))	Research in the laboratory of H. V. was supported by the Swiss National Science Foundation (grant 31003A-133141; SystemsX/CINA program), internal funds of the Ecole Polytechnique Federale de Lausanne, the European Community's Seventh Framework Program FP7/2007-2013 under Grant 211800, the Human Frontier Science Program (postdoc fellowship to H.N.). Additional support was provided by The Agence Nationale de la Recherche (VenomPicoScreen project, grant ANR-11-RPIB-022-04). We thank S. Thurnheer and the expression facility, F. Pojer and the crystallization facility at the EPFL, D. Blot, the HTXLab and the SLS and ESRF beamlines staff. We are particularly appreciative of discussions with H. V. laboratory members and E. Pebay-Peyroula. We thank the company Theranyx for the discovery and production of the functional nanobody used for the structure resolution.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aimon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025529; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; Beene DL, 2002, BIOCHEMISTRY-US, V41, P10262, DOI 10.1021/bi020266d; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; BOUZAT C, 1994, NEURON, V13, P1395, DOI 10.1016/0896-6273(94)90424-3; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Calimet N, 2013, P NATL ACAD SCI USA, V110, pE3987, DOI 10.1073/pnas.1313785110; Carland JE, 2013, J BIOL CHEM, V288, P31592, DOI 10.1074/jbc.M113.503300; Changeux JP, 2013, NAT REV MOL CELL BIO, V14, P819, DOI 10.1038/nrm3695; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Conrath K, 2009, PROTEIN SCI, V18, P619, DOI 10.1002/pro.69; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Corringer PJ, 1999, NEURON, V22, P831, DOI 10.1016/S0896-6273(00)80741-2; Cymes GD, 2012, NAT CHEM BIOL, V8, P975, DOI [10.1038/NCHEMBIO.1092, 10.1038/nchembio.1092]; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; Dang H, 2000, MOL PHARMACOL, V57, P1114; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hassaine G, 2013, BBA-BIOMEMBRANES, V1828, P2544, DOI 10.1016/j.bbamem.2013.05.028; Herget S, 2008, CARBOHYD RES, V343, P2162, DOI 10.1016/j.carres.2008.03.011; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hovius R, 1998, J NEUROCHEM, V70, P824; Hu XQ, 2003, J BIOL CHEM, V278, P46583, DOI 10.1074/jbc.M308974200; Huang S, 2013, BIOCHEM J, V454, P303, DOI 10.1042/BJ20130636; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Kesters D, 2013, EMBO REP, V14, P49, DOI 10.1038/embor.2012.189; Koehl P, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3298862; Kozuska JL, 2014, BRIT J PHARMACOL, V171, P1617, DOI 10.1111/bph.12536; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Li TF, 2012, FASEB J, V26, P3969, DOI 10.1096/fj.11-201384; Livesey MR, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.219618; Lummis SCR, 2012, J BIOL CHEM, V287, P40239, DOI 10.1074/jbc.R112.406496; MARICQ AV, 1991, SCIENCE, V254, P432, DOI 10.1126/science.1718042; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McKinnon NK, 2011, J GEN PHYSIOL, V138, P453, DOI 10.1085/jgp.201110686; Miles TF, 2012, ACS CHEM NEUROSCI, V3, P753, DOI 10.1021/cn3000586; Montes LR, 2007, BIOPHYS J, V93, P3548, DOI 10.1529/biophysj.107.116228; Moroni M, 2011, J BIOL CHEM, V286, P13414, DOI 10.1074/jbc.M110.204610; Mukhtasimova N, 2013, BIOPHYS J, V104, P355, DOI 10.1016/j.bpj.2012.12.013; Muller N, 2005, BIOTECHNOL BIOENG, V89, P400, DOI 10.1002/bit.20358; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Panicker S, 2002, J NEUROSCI, V22, P1629, DOI 10.1523/JNEUROSCI.22-05-01629.2002; Peters JA, 2010, J PHYSIOL-LONDON, V588, P587, DOI 10.1113/jphysiol.2009.183137; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Reeves DC, 2001, J BIOL CHEM, V276, P42035, DOI 10.1074/jbc.M106066200; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Schmauder R, 2011, CHEMBIOCHEM, V12, P2431, DOI 10.1002/cbic.201100302; Schrodinger LLC, 2013, PYMOL MOL GRAPH SYST; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Thompson AJ, 2003, BRIT J PHARMACOL, V140, P359, DOI 10.1038/sj.bjp.0705424; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2012, J MOL BIOL, V422, P617, DOI 10.1016/j.jmb.2012.07.010; Walstab J, 2010, PHARMACOL THERAPEUT, V128, P146, DOI 10.1016/j.pharmthera.2010.07.001; Wang HL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040041; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088; Zuber B, 2013, P NATL ACAD SCI USA, V110, P10622, DOI 10.1073/pnas.1301277110	75	286	288	5	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					276	+		10.1038/nature13552	http://dx.doi.org/10.1038/nature13552			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119048				2022-12-28	WOS:000340508200027
J	Pronovost, P; Jha, AK				Pronovost, Peter; Jha, Ashish K.			Did Hospital Engagement Networks Actually Improve Care?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pronovost, Peter] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD 21287 USA; [Pronovost, Peter] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Pronovost, Peter] Johns Hopkins Univ, Dept Surg, Baltimore, MD USA; [Pronovost, Peter] Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21218 USA; [Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Pronovost, P (corresponding author), Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD 21287 USA.							Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d199; Dixon-Woods M, 2011, MILBANK Q, V89, P167, DOI 10.1111/j.1468-0009.2011.00625.x; Fan E, 2010, JAMA-J AM MED ASSOC, V304, P2279, DOI 10.1001/jama.2010.1692; McKinney Maureen, 2013, Mod Healthc, V43, P9	5	19	19	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					691	693		10.1056/NEJMp1405800	http://dx.doi.org/10.1056/NEJMp1405800			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN3SV	25140953				2022-12-28	WOS:000340509900002
J	Kwan, A; Abraham, RS; Currier, R; Brower, A; Andruszewski, K; Abbott, JK; Baker, M; Ballow, M; Bartoshesky, LE; Bonilla, FA; Brokopp, C; Brooks, E; Caggana, M; Celestin, J; Church, JA; Comeau, AM; Connelly, JA; Cowan, MJ; Cunningham-Rundles, C; Dasu, T; Dave, N; De La Morena, MT; Duffner, U; Fong, CT; Forbes, L; Freedenberg, D; Gelfand, EW; Hale, JE; Hanson, IC; Hay, BN; Hu, D; Infante, A; Johnson, D; Kapoor, N; Kay, DM; Kohn, DB; Lee, R; Lehman, H; Lin, ZL; Lorey, F; Abdel-Mageed, A; Manning, A; McGhee, S; Moore, TB; Naides, SJ; Notarangelo, LD; Orange, JS; Pai, SY; Porteus, M; Rodriguez, R; Romberg, N; Routes, J; Ruehle, M; Rubenstein, A; Saavedra-Matiz, CA; Scott, G; Scott, PM; Secord, E; Seroogy, C; Shearer, WT; Siegel, S; Silvers, SK; Stiehm, ER; Sugerman, RW; Sullivan, JL; Tanksley, S; Tierce, ML; Verbsky, J; Vogel, B; Walker, R; Walkovich, K; Walter, JE; Wasserman, RL; Watson, MS; Weinberg, GA; Weiner, LB; Wood, H; Yates, AB; Puck, JM				Kwan, Antonia; Abraham, Roshini S.; Currier, Robert; Brower, Amy; Andruszewski, Karen; Abbott, Jordan K.; Baker, Mei; Ballow, Mark; Bartoshesky, Louis E.; Bonilla, Francisco A.; Brokopp, Charles; Brooks, Edward; Caggana, Michele; Celestin, Jocelyn; Church, Joseph A.; Comeau, Anne Marie; Connelly, James A.; Cowan, Morton J.; Cunningham-Rundles, Charlotte; Dasu, Trivikram; Dave, Nina; De La Morena, Maria T.; Duffner, Ulrich; Fong, Chin-To; Forbes, Lisa; Freedenberg, Debra; Gelfand, Erwin W.; Hale, Jaime E.; Hanson, I. Celine; Hay, Beverly N.; Hu, Diana; Infante, Anthony; Johnson, Daisy; Kapoor, Neena; Kay, Denise M.; Kohn, Donald B.; Lee, Rachel; Lehman, Heather; Lin, Zhili; Lorey, Fred; Abdel-Mageed, Aly; Manning, Adrienne; McGhee, Sean; Moore, Theodore B.; Naides, Stanley J.; Notarangelo, Luigi D.; Orange, Jordan S.; Pai, Sung-Yun; Porteus, Matthew; Rodriguez, Ray; Romberg, Neil; Routes, John; Ruehle, Mary; Rubenstein, Arye; Saavedra-Matiz, Carlos A.; Scott, Ginger; Scott, Patricia M.; Secord, Elizabeth; Seroogy, Christine; Shearer, William T.; Siegel, Subhadra; Silvers, Stacy K.; Stiehm, E. Richard; Sugerman, Robert W.; Sullivan, John L.; Tanksley, Susan; Tierce, Millard L.; Verbsky, James; Vogel, Beth; Walker, Rosalyn; Walkovich, Kelly; Walter, Jolan E.; Wasserman, Richard L.; Watson, Michael S.; Weinberg, Geoffrey A.; Weiner, Leonard B.; Wood, Heather; Yates, Anne B.; Puck, Jennifer M.			Newborn Screening for Severe Combined Immunodeficiency in 11 Screening Programs in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OMENN SYNDROME; CHILDREN; MUTATIONS; TRANSPLANTATION; IDENTIFICATION; EXPERIENCE; PHENOTYPES; TTC7A; AGE	IMPORTANCE Newborn screening for severe combined immunodeficiency (SCID) using assays to detect T-cell receptor excision circles (TRECs) began in Wisconsin in 2008, and SCID was added to the national recommended uniform panel for newborn screened disorders in 2010. Currently 23 states, the District of Columbia, and the Navajo Nation conduct population-wide newborn screening for SCID. The incidence of SCID is estimated at 1 in 100 000 births. OBJECTIVES To present data from a spectrum of SCID newborn screening programs, establish population-based incidence for SCID and other conditions with T-cell lymphopenia, and document early institution of effective treatments. DESIGN Epidemiological and retrospective observational study. SETTING Representatives in states conducting SCID newborn screening were invited to submit their SCID screening algorithms, test performance data, and deidentified clinical and laboratory information regarding infants screened and cases with nonnormal results. Infants born from the start of each participating program from January 2008 through the most recent evaluable date prior to July 2013 were included. Representatives from 10 states plus the Navajo Area Indian Health Service contributed data from 3 030 083 newborns screened with a TREC test. MAIN OUTCOMES AND MEASURES Infants with SCID and other diagnoses of T-cell lymphopenia were classified. Incidence and, where possible, etiologies were determined. Interventions and survival were tracked. RESULTS Screening detected 52 cases of typical SCID, leaky SCID, and Omenn syndrome, affecting 1 in 58 000 infants (95% CI, 1/46 000-1/80 000). Survival of SCID-affected infants through their diagnosis and immune reconstitution was 87% (45/52), 92% (45/49) for infants who received transplantation, enzyme replacement, and/or gene therapy. Additional interventions for SCID and non-SCID T-cell lymphopenia included immunoglobulin infusions, preventive antibiotics, and avoidance of live vaccines. Variations in definitions and follow-up practices influenced the rates of detection of non-SCID T-cell lymphopenia. CONCLUSIONS AND RELEVANCE Newborn screening in 11 programs in the United States identified SCID in 1 in 58 000 infants, with high survival. The usefulness of detection of non-SCID T-cell lymphopenias by the same screening remains to be determined.	[Kwan, Antonia; Cowan, Morton J.; Puck, Jennifer M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Kwan, Antonia; Cowan, Morton J.; Puck, Jennifer M.] Univ Calif San Francisco, Benioff Childrens Hosp, San Francisco, CA USA; [Abraham, Roshini S.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Currier, Robert; Lorey, Fred] Calif Dept Publ Hlth, Genet Dis Screening Program, Richmond, CA USA; [Brower, Amy; Watson, Michael S.] Amer Coll Med Genet & Genom, Newborn Screening Translat Res Network, Bethesda, MD USA; [Andruszewski, Karen; Wood, Heather] Michigan Dept Community Hlth, Lansing, MI USA; [Abbott, Jordan K.; Gelfand, Erwin W.] Natl Jewish Hlth, Div Allergy & Immunol, Dept Pediat, Denver, CO USA; [Baker, Mei] Wisconsin State Lab Hyg, Newborn Screening Lab, Madison, WI USA; [Baker, Mei] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Ballow, Mark; Lehman, Heather] Women & Childrens Hosp Buffalo, Buffalo, NY USA; [Bartoshesky, Louis E.] Christiana Care Hlth Syst, Dept Pediat, Wilmington, DE USA; [Bonilla, Francisco A.; Notarangelo, Luigi D.; Pai, Sung-Yun] Boston Childrens Hosp, Dept Med, Boston, MA USA; [Bonilla, Francisco A.; Notarangelo, Luigi D.; Pai, Sung-Yun] Harvard Univ, Sch Med, Boston, MA USA; [Brokopp, Charles] Univ Wisconsin, Dept Populat Hlth Sci, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Brooks, Edward; Infante, Anthony] Univ Texas Hlth Sci Ctr San Antonio, Dept Pediat, San Antonio, TX 78229 USA; [Caggana, Michele; Kay, Denise M.; Saavedra-Matiz, Carlos A.; Vogel, Beth] New York State Dept Hlth, Newborn Screening Program, Wadsworth Ctr, Albany, NY 12237 USA; [Celestin, Jocelyn] Albany Med Coll, Div Allergy & Immunol, Albany, NY 12208 USA; [Church, Joseph A.; Kapoor, Neena] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Church, Joseph A.; Kapoor, Neena] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Comeau, Anne Marie; Hale, Jaime E.] Univ Massachusetts, Sch Med, New England Newborn Screening Program, Jamaica Plain, MA USA; [Connelly, James A.; Walkovich, Kelly] Univ Michigan, CS Mott Childrens Hosp, Ann Arbor, MI 48109 USA; [Cunningham-Rundles, Charlotte] Mt Sinai Med Ctr, New York, NY 10029 USA; [Dasu, Trivikram] Med Coll Wisconsin, Clin Immunodiagnost & Res Lab, Milwaukee, WI 53226 USA; [Dave, Nina; Rodriguez, Ray; Walker, Rosalyn; Yates, Anne B.] Univ Mississippi, Med Ctr, Dept Pediat, Jackson, MS USA; [De La Morena, Maria T.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Duffner, Ulrich; Abdel-Mageed, Aly] Helen DeVos Childrens Hosp, Div Blood & Bone Marrow Transplantat, Grand Rapids, MI USA; [Fong, Chin-To; Weinberg, Geoffrey A.] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Forbes, Lisa; Hanson, I. Celine; Orange, Jordan S.; Shearer, William T.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Forbes, Lisa; Hanson, I. Celine; Orange, Jordan S.; Shearer, William T.] Texas Childrens Hosp, Houston, TX 77030 USA; [Freedenberg, Debra; Johnson, Daisy; Scott, Ginger; Tanksley, Susan] Texas Dept State Hlth Serv, Austin, TX USA; [Comeau, Anne Marie; Hay, Beverly N.; Sullivan, John L.] Univ Massachusetts, Sch Med, Dept Pediat, Worcester, MA USA; [Hu, Diana] Tuba City Reg Hlth Care, Tuba City, AZ USA; [Kohn, Donald B.; Moore, Theodore B.; Stiehm, E. Richard] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Lin, Zhili] PerkinElmer Genet, Bridgeville, PA USA; [Manning, Adrienne] Connecticut Dept Publ Hlth Lab, Rocky Hill, CT USA; [McGhee, Sean; Porteus, Matthew] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA; [McGhee, Sean; Porteus, Matthew] Lucille Packard Childrens Hosp, Palo Alto, CA USA; [Naides, Stanley J.] Quest Diagnost Nichols Inst, Dept Immunol, San Juan Capistrano, CA USA; [Romberg, Neil] Yale Univ, Sch Med, Dept Pediat, Div Allergy & Clin Immunol, New Haven, CT 06510 USA; [Routes, John; Verbsky, James] Med Coll Wisconsin, Dept Pediat, Childrens Res Inst, Milwaukee, WI 53226 USA; [Ruehle, Mary; Secord, Elizabeth; Tierce, Millard L.] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Rubenstein, Arye] Montefiore Med Pk, Div Allergy & Immunol, Bronx, NY USA; [Scott, Patricia M.] Delaware Publ Hlth Lab, Newborn Screening Program, Smyrna, DE USA; [Seroogy, Christine] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA; [Siegel, Subhadra] New York Med Coll, Westchester Med Ctr, Valhalla, NY 10595 USA; [Silvers, Stacy K.; Sugerman, Robert W.; Wasserman, Richard L.] Med City Childrens Hosp, Dallas, TX USA; [Walter, Jolan E.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Walter, Jolan E.] Harvard Univ, Sch Med, Boston, MA USA; [Weiner, Leonard B.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Mayo Clinic; California Department of Public Health; MDHHS - Michigan Department of Health & Human Services; National Jewish Health; University of Wisconsin System; University of Wisconsin Madison; Women & Children's Hospital of Buffalo; Christiana Care Health System; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; University of Texas System; University of Texas Health San Antonio; State University of New York (SUNY) System; Wadsworth Center; Albany Medical College; University of Southern California; Children's Hospital Los Angeles; University of Massachusetts System; University of Michigan System; University of Michigan; Icahn School of Medicine at Mount Sinai; Medical College of Wisconsin; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Rochester; Baylor College of Medicine; Baylor College of Medicine; Texas Department of State Health Services; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California Los Angeles; Stanford University; Lucile Packard Children's Hospital (LPCH); Nichols Institute; Yale University; Medical College of Wisconsin; Children's Hospital of Michigan; Montefiore Medical Center; University of Wisconsin System; University of Wisconsin Madison; New York Medical College; Westchester Medical Center; Medical City Dallas Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Puck, JM (corresponding author), Univ Calif San Francisco, Dept Pediat, HSE-301A,513 Parnassus Ave, San Francisco, CA 94143 USA.	puckj@peds.ucsf.edu	Routes, john/AAA-4833-2021; Lehman, Heather/AAZ-4560-2021; Weinberg, Geoffrey A./W-7510-2019; Abbott, Jordan K/P-2509-2016; Pai, Sung-Yun/AAH-7762-2019; Notarangelo, Luigi D/F-9718-2016	Routes, john/0000-0001-8378-3773; Weinberg, Geoffrey A./0000-0002-3900-379X; Abbott, Jordan K/0000-0001-6334-5266; Pai, Sung-Yun/0000-0002-0158-8147; Notarangelo, Luigi D/0000-0002-8335-0262; Kay, Denise/0000-0002-9928-2698; orange, jordan/0000-0001-7117-7725; Shearer, William/0000-0002-2483-2130; Bonagura, Vincent/0000-0002-0681-2099; Romberg, Neil/0000-0002-1881-5318; Hanson, Imelda/0000-0001-9457-0757; Currier, Robert/0000-0001-9168-5604	California: National Institutes of Health (NIH) [HHSN267200603430C]; National Institutes of Health (NIH) through New York [R01 FD003005-01, U01 AI1087628, RO1 AI078248, AI105776]; HCA International Foundation Travelling Scholarship; Jeffrey Modell Foundation; Perkin Elmer Genetics; Colorado: Colorado Department of Public Heath and Environment; Delaware: Centers for Disease Control and Prevention (CDC) [U01 EH000454]; Massachusetts: CDC [UO1 EH000362]; New England Newborn Screening Program funds; Michigan: CDC [U01 EH000936]; Mississippi: Mississippi State Department of Health; Navajo Nation: NIH [RO3HD060311]; New York: NIH [HHSN26720060343OC]; New York State Department of Health; Texas: CDC through New England Newborn Screening Program; Texas: Jeffery Modell Foundation; Children's Hospital of Wisconsin; Wisconsin State Laboratory of Hygiene; CDC [U01 EH000365]; Primary Immunodeficiency Treatment Consortium [U54 A1082973, R13-A1094943]; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH [HHSN27520080001C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD060311] Funding Source: NIH RePORTER; FOOD AND DRUG ADMINISTRATION [R01FD003005] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U24CA076518] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004, UL1TR001079] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000365, U01EH000936, U01EH000362, U01EH000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI086037, R13AI088855, R01AI078248, R13AI066891, R13AI069762, R01AI105776, R18AI048693, K08AI103035, R13AI082823, R13AI100548, R13AI065141, U54AI082973, R13AI094943] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS064808] Funding Source: NIH RePORTER	California: National Institutes of Health (NIH); National Institutes of Health (NIH) through New York(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HCA International Foundation Travelling Scholarship; Jeffrey Modell Foundation; Perkin Elmer Genetics; Colorado: Colorado Department of Public Heath and Environment; Delaware: Centers for Disease Control and Prevention (CDC); Massachusetts: CDC; New England Newborn Screening Program funds; Michigan: CDC; Mississippi: Mississippi State Department of Health; Navajo Nation: NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York: NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health; Texas: CDC through New England Newborn Screening Program; Texas: Jeffery Modell Foundation; Children's Hospital of Wisconsin; Wisconsin State Laboratory of Hygiene; CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Primary Immunodeficiency Treatment Consortium; Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study received support from the following institutions: in California: National Institutes of Health (NIH) (HHSN267200603430C through New York, R01 FD003005-01, U01 AI1087628 [D. B. K.]; RO1 AI078248, AI105776 [J. M.P.]); HCA International Foundation Travelling Scholarship (A. K.); Jeffrey Modell Foundation; and Perkin Elmer Genetics. In Colorado: Colorado Department of Public Heath and Environment. In Connecticut: state appropriation, pursuant to Public Act 11-48, Sections 38 and 39, which mandated the inclusion of testing for severe combined immunodeficiency (SCID) in the Connecticut Newborn Screening Disorders Panel and provided increased agency funding to accomplish this mandate. In Delaware: Centers for Disease Control and Prevention (CDC) (U01 EH000454) and state funding. In Massachusetts: CDC (UO1 EH000362) and New England Newborn Screening Program funds. In Michigan: CDC (U01 EH000936). In Mississippi: Mississippi State Department of Health. In the Navajo Nation: NIH (RO3HD060311 [J. M. P.]) and a gift to Navajo-area delivering hospitals from PerlkinElmer Genetics, Bridgeville, Pennsylvania. In New York: NIH (HHSN26720060343OC), Jeffrey Modell Foundation, and New York State Department of Health. In Texas: CDC grant through New England Newborn Screening Program (pilot phase), Jeffrey Modell Foundation, and the Texas Department of State Health Services. In Wisconsin: Jeffery Modell Foundation, Children's Hospital of Wisconsin, Wisconsin State Laboratory of Hygiene, CDC (U01 EH000365), and Primary Immunodeficiency Treatment Consortium (U54 A1082973 [M. J. C.], R13-A1094943 [M. J. C., L.D.N.]). The Newborn Screening Translational Research Network (NBSTRN) is a contract to the American College of Medical Genetics and Genomics by Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH (HHSN27520080001C).	Al-Herz W, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00162; Andrews LB, 1994, ASSESSING GENETIC RI, P39; Bakare N, 2010, VACCINE, V28, P6609, DOI 10.1016/j.vaccine.2010.07.039; Borte S, 2012, BLOOD, V119, P2552, DOI 10.1182/blood-2011-08-371021; Brown L, 2011, BLOOD, V117, P3243, DOI 10.1182/blood-2010-08-300384; Buckley RH, 2004, ANNU REV IMMUNOL, V22, P625, DOI 10.1146/annurev.immunol.22.012703.104614; Centers for Disease Control and Prevention [CDC], NEWB SCREEN QUAL ASS; Chan A, 2011, CLIN IMMUNOL, V138, P3, DOI 10.1016/j.clim.2010.09.010; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Chen R, 2013, J ALLERGY CLIN IMMUN, V132, P656, DOI 10.1016/j.jaci.2013.06.013; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Dvorak CC, 2013, J CLIN IMMUNOL, V33, P1156, DOI 10.1007/s10875-013-9917-y; FASTH A, 1982, J CLIN IMMUNOL, V2, P86, DOI 10.1007/BF00916891; Fischer A, 2013, GENE, V525, P170, DOI 10.1016/j.gene.2013.03.092; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Gerstel-Thompson JL, 2010, CLIN CHEM, V56, P1466, DOI 10.1373/clinchem.2010.144915; Giampietro PF, 2013, AM J MED GENET A, V161A, P1432, DOI 10.1002/ajmg.a.35885; Haldane JBS, 2004, J GENET, V83, P235, DOI 10.1007/BF02717892; Hale JE, 2010, J ALLERGY CLIN IMMUN, V126, P1073, DOI 10.1016/j.jaci.2010.08.043; Hamilton Brady E., 2014, NATL VITAL STAT REP, V64, P1; Hannon WH, 2014, NBS06A CLSI; Howell RR, 2011, REPORT NEWBORN SCREE; JONES JF, 1991, HUM BIOL, V63, P669; Kuo CY, 2013, J ALLERGY CLIN IMMUN, V131, P1693, DOI 10.1016/j.jaci.2013.01.019; Kwan A, 2013, J ALLERGY CLIN IMMUN, V132, P140, DOI 10.1016/j.jaci.2013.04.024; la Marca G, 2013, J ALLERGY CLIN IMMUN, V131, P1604, DOI 10.1016/j.jaci.2012.08.054; Li LY, 2002, J IMMUNOL, V168, P6323, DOI 10.4049/jimmunol.168.12.6323; Mallott J, 2013, J CLIN IMMUNOL, V33, P540, DOI 10.1007/s10875-012-9846-1; Marquardt G, 2012, GENET MED, V14, P648, DOI 10.1038/gim.2012.2; McHugh DMS, 2011, GENET MED, V13, P230, DOI 10.1097/GIM.0b013e31820d5e67; Morinishi Y, 2009, J PEDIATR-US, V155, P829, DOI 10.1016/j.jpeds.2009.05.026; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Pai SY, 2014, NEW ENGL J MED, V371, P434, DOI 10.1056/NEJMoa1401177; REESER SLT, 1992, AM J MED GENET, V42, P815, DOI 10.1002/ajmg.1320420614; Routes JM, 2009, JAMA-J AM MED ASSOC, V302, P2465, DOI 10.1001/jama.2009.1806; RYSER O, 1988, J CLIN IMMUNOL, V8, P479, DOI 10.1007/BF00916954; Samuels ME, 2013, J MED GENET, V50, P324, DOI 10.1136/jmedgenet-2012-101483; SANTISTEBAN I, 1995, HUM MOL GENET, V4, P2081, DOI 10.1093/hmg/4.11.2081; Savic RM, 2013, BIOL BLOOD MARROW TR, V19, P1608, DOI 10.1016/j.bbmt.2013.08.014; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P961, DOI 10.1016/j.jaci.2013.11.043; Shearer WT, 2014, J ALLERGY CLIN IMMUN, V133, P1092, DOI 10.1016/j.jaci.2013.09.044; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; STEPHAN JL, 1993, J PEDIATR-US, V123, P564, DOI 10.1016/S0022-3476(05)80951-5; Strauss KA, 2008, CLIN IMMUNOL, V128, P31, DOI 10.1016/j.clim.2008.02.016; Verbsky JW, 2012, J CLIN IMMUNOL, V32, P82, DOI 10.1007/s10875-011-9609-4; Villa A, 2008, J ALLERGY CLIN IMMUN, V122, P1082, DOI 10.1016/j.jaci.2008.09.037; Vogel BH, 2014, J CLIN IMMUNOL, V34, P289, DOI 10.1007/s10875-014-0006-7	47	407	419	3	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					729	738		10.1001/jama.2014.9132	http://dx.doi.org/10.1001/jama.2014.9132			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25138334	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000340438700021
J	Rigotti, NA; Regan, S; Levy, DE; Japuntich, S; Chang, YC; Park, ER; Viana, JC; Kelley, JHI; Reyen, M; Singer, DE				Rigotti, Nancy A.; Regan, Susan; Levy, Douglas E.; Japuntich, Sandra; Chang, Yuchiao; Park, Elyse R.; Viana, Joseph C.; Kelley, Jennifer H. I.; Reyen, Michele; Singer, Daniel E.			Sustained Care Intervention and Postdischarge Smoking Cessation Among Hospitalized Adults A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NICOTINE DEPENDENCE; FOLLOW-UP; SMOKERS; OUTCOMES; SYSTEM; HEALTH	IMPORTANCE Health care systems need effective models to manage chronic diseases like tobacco dependence across transitions in care. Hospitalizations provide opportunities for smokers to quit, but research suggests that hospital-delivered interventions are effective only if treatment continues after discharge. OBJECTIVE To determine whether an intervention to sustain tobacco treatment after hospital discharge increases smoking cessation rates compared with standard care. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial compared sustained care (a postdischarge tobacco cessation intervention) with standard care among 397 hospitalized daily smokers (mean age, 53 years; 48% were males; 81% were non-Hispanic whites) who wanted to quit smoking after discharge and received a tobacco dependence intervention in the hospital; 92% of eligible patients and 44% of screened patients enrolled. The study was conducted from August 2010 through November 2012 at Massachusetts General Hospital. INTERVENTIONS Sustained care participants received automated interactive voice response telephone calls and their choice of free smoking cessation medication (any type approved by the US Food and Drug Administration) for up to 90 days. The automated telephone calls promoted cessation, provided medication management, and triaged smokers for additional counseling. Standard care participants received recommendations for postdischarge pharmacotherapy and counseling. MAIN OUTCOMES AND MEASURES The primary outcome was biochemically confirmed past 7-day tobacco abstinence at 6-month follow-up after discharge from the hospital; secondary outcomes included self-reported tobacco abstinence. RESULTS Smokers randomly assigned to sustained care (n = 198) used more counseling and more pharmacotherapy at each follow-up assessment than those assigned to standard care (n = 199). Biochemically validated 7-day tobacco abstinence at 6 months was higher with sustained care (26%) than with standard care (15%) (relative risk [RR], 1.71 [95% CI, 1.14-2.56], P = .009; number needed to treat, 9.4 [95% CI, 5.4-35.5]). Using multiple imputation for missing outcomes, the RR for 7-day tobacco abstinence was 1.55 (95% CI, 1.03-2.21; P = .04). Sustained care also resulted in higher self-reported continuous abstinence rates for 6 months after discharge (27% vs 16% for standard care; RR, 1.70 [95% CI, 1.15-2.51]; P = .007). CONCLUSIONS AND RELEVANCE Among hospitalized adult smokers who wanted to quit smoking, a postdischarge intervention providing automated telephone calls and free medication resulted in higher rates of smoking cessation at 6 months compared with a standard recommendation to use counseling and medication after discharge. These findings, if replicated, suggest an approach to help achieve sustained smoking cessation after a hospital stay.	[Rigotti, Nancy A.; Regan, Susan; Levy, Douglas E.; Japuntich, Sandra; Park, Elyse R.; Viana, Joseph C.; Kelley, Jennifer H. I.; Reyen, Michele] Massachusetts Gen Hosp, Tobacco Res & Treatment Ctr, Boston, MA 02114 USA; [Rigotti, Nancy A.; Regan, Susan; Chang, Yuchiao; Reyen, Michele; Singer, Daniel E.] Massachusetts Gen Hosp, Div Gen Internal Med, Med Serv, Boston, MA 02114 USA; [Rigotti, Nancy A.; Levy, Douglas E.; Park, Elyse R.; Kelley, Jennifer H. I.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Rigotti, Nancy A.; Levy, Douglas E.; Park, Elyse R.; Kelley, Jennifer H. I.] Partners HealthCare, Boston, MA USA; [Rigotti, Nancy A.; Regan, Susan; Levy, Douglas E.; Chang, Yuchiao; Singer, Daniel E.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Japuntich, Sandra] VA Boston Healthcare Syst, Natl Ctr PTSD, Boston, MA USA; [Japuntich, Sandra] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Park, Elyse R.] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Viana, Joseph C.] Univ Calif Los Angeles, Dept Hlth Policy & Management, Los Angeles, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles	Rigotti, NA (corresponding author), Massachusetts Gen Hosp, Tobacco Res & Treatment Ctr, 50 Staniford St, Boston, MA 02114 USA.	nrigotti@partners.org	Levy, Douglas/W-1516-2019	Levy, Douglas/0000-0001-9446-7899	National Institutes of Health/National Heart, Lung, and Blood Institute [RC1 HL099668, K24 HL004440]; National Heart, Lung, and Blood Institute; National Cancer Institute; National Institute on Drug Abuse; National Institutes of Health Office of Behavioral and Social Science Research; US Department of Veterans Affairs Clinical Sciences Research and Development Service [11K2CX000918-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL004440, RC1HL099668] Funding Source: NIH RePORTER	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institutes of Health Office of Behavioral and Social Science Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Veterans Affairs Clinical Sciences Research and Development Service(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants RC1 HL099668 and K24 HL004440 from the National Institutes of Health/National Heart, Lung, and Blood Institute. This study is part of the Consortium of Hospitals Advancing Research on Tobacco initiative, jointly sponsored by the National Heart, Lung, and Blood Institute, the National Cancer Institute, the National Institute on Drug Abuse, and the National Institutes of Health Office of Behavioral and Social Science Research. TelAsk Technologies (Ottawa, Ontario, Canada) developed and provided the interactive voice response services and was compensated for this work by the National Heart, Lung, and Blood Institute grants that funded the project. This work was supported in part by career development award 11K2CX000918-01A1 (Dr Japuntich) from the US Department of Veterans Affairs Clinical Sciences Research and Development Service.	Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Brendryen H, 2008, ADDICTION, V103, P478, DOI 10.1111/j.1360-0443.2007.02119.x; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Carlini BH, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-507; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Fiore MC, 2008, TREATING TOBACCO USE; Fiore MC, 2012, NEW ENGL J MED, V366, P1172, DOI 10.1056/NEJMp1115176; Forster AJ, 2009, J GEN INTERN MED, V24, P520, DOI 10.1007/s11606-009-0910-3; Gourevitch MN, 2014, ACAD MED, V89, P544, DOI 10.1097/ACM.0000000000000171; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hedeker D, 2007, ADDICTION, V102, P1564, DOI 10.1111/j.1360-0443.2007.01946.x; Hughes JR, 2003, NICOTINE TOB RES, V5, P13, DOI 10.1080/1462220031000070552; Japuntich SJ, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-124; Kindig D, 2003, AM J PUBLIC HEALTH, V93, P380, DOI 10.2105/AJPH.93.3.380; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; McDaniel AM, 2005, NICOTINE TOB RES, V7, pS57, DOI 10.1080/14622200500078139; McDonough JE, 2014, JAMA-J AM MED ASSOC, V311, P569, DOI 10.1001/jama.2013.286067; MELCHIOR LA, 1993, EDUC PSYCHOL MEAS, V53, P1117, DOI 10.1177/0013164493053004024; Oake N, 2009, AM J MANAG CARE, V15, P383; Papadakis S, 2013, PREV MED, V56, P390, DOI 10.1016/j.ypmed.2013.02.018; Piette JD, 2000, MED CARE, V38, P218, DOI 10.1097/00005650-200002000-00011; Regan S, 2012, NICOTINE TOB RES, V14, P885, DOI 10.1093/ntr/ntr244; Regan S, 2011, NICOTINE TOB RES, V13, P255, DOI 10.1093/ntr/ntq248; Reid RD, 2007, PATIENT EDUC COUNS, V66, P319, DOI 10.1016/j.pec.2007.01.005; Reid RD, 2010, NICOTINE TOB RES, V12, P11, DOI 10.1093/ntr/ntp165; Rigotti NA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001837.pub3; Rutten LJF, 2011, J CANCER EDUC, V26, P79, DOI 10.1007/s13187-010-0163-1; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; Stead LF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008286.pub2; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; US Department of Labor, FAQS AFF CAR ACT IMP	32	93	95	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					719	728		10.1001/jama.2014.9237	http://dx.doi.org/10.1001/jama.2014.9237			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN2TR	25138333	Green Accepted, Bronze			2022-12-28	WOS:000340438700020
J	Shaw, DM				Shaw, David M.			Beyond Conflicts of Interest Disclosing Medical Biases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Basel, Inst Biomed Eth, Basel, Switzerland	University of Basel	Shaw, DM (corresponding author), Univ Basel, Inst Biomed Eth, Basel, Switzerland.	david.shaw@unibas.ch						Greenland S, 2009, J EPIDEMIOL COMMUN H, V63, P593, DOI 10.1136/jech.2008.084913; Shaw D., 2012, MED LAW INT, V12, P11, DOI DOI 10.1177/0968533212438642; Shaw D., 2009, CLIN ETHICS, V4, P181, DOI DOI 10.1258/ce.2009.009029	3	13	14	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					697	698		10.1001/jama.2014.8035	http://dx.doi.org/10.1001/jama.2014.8035			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25138329				2022-12-28	WOS:000340438700015
J	Kim, G; LeBlanc, ML; Wafula, EK; Depamphilis, CW; Westwood, JH				Kim, Gunjune; LeBlanc, Megan L.; Wafula, Eric K.; dePamphilis, Claude W.; Westwood, James H.			Genomic-scale exchange of mRNA between a parasitic plant and its hosts	SCIENCE			English	Article							LONG-DISTANCE TRANSPORT; GENE-TRANSFER; PHLOEM; MOBILE; TRAFFICKING; TRANSCRIPTS; DODDER; QUANTIFICATION; TRANSLOCATION; TRANSMISSION	Movement of RNAs between cells of a single plant is well documented, but cross-species RNA transfer is largely unexplored. Cuscuta pentagona (dodder) is a parasitic plant that forms symplastic connections with its hosts and takes up host messenger RNAs (mRNAs). We sequenced transcriptomes of Cuscuta growing on Arabidopsis and tomato hosts to characterize mRNA transfer between species and found that mRNAs move in high numbers and in a bidirectional manner. The mobile transcripts represented thousands of different genes, and nearly half the expressed transcriptome of Arabidopsis was identified in Cuscuta. These findings demonstrate that parasitic plants can exchange large proportions of their transcriptomes with hosts, providing potential mechanisms for RNA-based interactions between species and horizontal gene transfer.	[Kim, Gunjune; LeBlanc, Megan L.; Westwood, James H.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Wafula, Eric K.; dePamphilis, Claude W.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Wafula, Eric K.; dePamphilis, Claude W.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Virginia Polytechnic Institute & State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Westwood, JH (corresponding author), Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.	westwood@vt.edu	dePamphilis, Claude W/P-6652-2016	Westwood, James/0000-0001-5127-7294	National Center for Biotechnology Information BioProject [PRJNA257158]; NSF [IOS-0843372]; NSF Plant Genome Research Program [DBI-0701748, IOS-1238057]; U.S. Department of Agriculture Hatch Project [135997]; Direct For Biological Sciences [0843372] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1238057] Funding Source: National Science Foundation	National Center for Biotechnology Information BioProject; NSF(National Science Foundation (NSF)); NSF Plant Genome Research Program(National Science Foundation (NSF)NSF - Office of the Director (OD)); U.S. Department of Agriculture Hatch Project; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Data are archived at National Center for Biotechnology Information BioProject ID PRJNA257158. This research was supported by NSF award IOS-0843372 to J.H.W. and NSF Plant Genome Research Program awards DBI-0701748 and IOS-1238057 to J.H.W. and C. W. D., with additional support to J.H.W. from the U.S. Department of Agriculture Hatch Project no. 135997. This work was facilitated by resources provided by the iPlant Collaborative. We are grateful to T. Lanini for supplying C. pentagona seeds. Additional data are in supplementary materials.	Alakonya A, 2012, PLANT CELL, V24, P3153, DOI 10.1105/tpc.112.099994; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Banerjee AK, 2009, PLANT PHYSIOL, V151, P1831, DOI 10.1104/pp.109.144428; Birschwilks M, 2006, J EXP BOT, V57, P911, DOI 10.1093/jxb/erj076; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; David-Schwartz R, 2008, NEW PHYTOL, V179, P1133, DOI 10.1111/j.1469-8137.2008.02540.x; Dawson Jean H., 1994, Reviews of Weed Science, V6, P265; Deeken R, 2008, PLANT J, V55, P746, DOI 10.1111/j.1365-313X.2008.03555.x; Doering-Saad C, 2006, J EXP BOT, V57, P3183, DOI 10.1093/jxb/erl082; Dorst H. J. M. van, 1974, Netherlands Journal of Plant Pathology, V80, P85, DOI 10.1007/BF01980613; Goldwasser Y, 2001, WEED SCI, V49, P520, DOI 10.1614/0043-1745(2001)049[0520:TOTVTL]2.0.CO;2; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Hannapel DJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00257; Hannapel DJ, 2010, J INTEGR PLANT BIOL, V52, P40, DOI 10.1111/j.1744-7909.2010.00911.x; Haupt S, 2001, J EXP BOT, V52, P173, DOI 10.1093/jexbot/52.354.173; Haywood V, 2005, PLANT J, V42, P49, DOI 10.1111/j.1365-313X.2005.02351.x; HOSFORD RM, 1967, BOT REV, V33, P387, DOI 10.1007/BF02858742; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Jiang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081389; Kaminska M, 1999, ACTA PHYSIOL PLANT, V21, P21, DOI 10.1007/s11738-999-0023-y; Kim M, 2001, SCIENCE, V293, P287, DOI 10.1126/science.1059805; LeBlanc M, 2013, NEW PHYTOL, V200, P1225, DOI 10.1111/nph.12439; Li CY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00073; Lucas WJ, 2013, J INTEGR PLANT BIOL, V55, P294, DOI 10.1111/jipb.12041; Molnar A, 2010, SCIENCE, V328, P872, DOI 10.1126/science.1187959; Mower JP, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-150; Mower JP, 2004, NATURE, V432, P165, DOI 10.1038/432165b; Notaguchi M, 2012, J INTEGR PLANT BIOL, V54, P760, DOI 10.1111/j.1744-7909.2012.01155.x; Roney JK, 2007, PLANT PHYSIOL, V143, P1037, DOI 10.1104/pp.106.088369; Ruiz-Medrano R, 1999, DEVELOPMENT, V126, P4405; Sarkies P, 2013, SCIENCE, V341, P467, DOI 10.1126/science.1243175; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turnbull CGN, 2013, NEW PHYTOL, V198, P33, DOI 10.1111/nph.12167; Vaughn KC, 2003, PROTOPLASMA, V220, P189, DOI 10.1007/s00709-002-0038-3; Vaughn KC, 2006, INT J PLANT SCI, V167, P1099, DOI 10.1086/507872; Westwood JH, 2009, PEST MANAG SCI, V65, P533, DOI 10.1002/ps.1727; Yoshida S, 2010, SCIENCE, V328, P1128, DOI 10.1126/science.1187145; Zhang DL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-19; Zhang YT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-48	39	172	185	14	257	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					808	811		10.1126/science.1253122	http://dx.doi.org/10.1126/science.1253122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124438				2022-12-28	WOS:000340593100043
J	Zuryn, S; Ahier, A; Portoso, M; White, ER; Morin, MC; Margueron, R; Jarriault, S				Zuryn, Steven; Ahier, Arnaud; Portoso, Manuela; White, Esther Redhouse; Morin, Marie-Charlotte; Margueron, Raphael; Jarriault, Sophie			Sequential histone-modifying activities determine the robustness of transdifferentiation	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; CAENORHABDITIS-ELEGANS; COMPLEX; JMJD3; REGENERATION; EXPRESSION; GENES; NANOG; UTX	Natural interconversions between distinct somatic cell types have been reported in species as diverse as jellyfish and mice. The efficiency and reproducibility of some reprogramming events represent unexploited avenues in which to probe mechanisms that ensure robust cell conversion. We report that a conserved H3K27me3/me2 demethylase, JMJD-3.1, and the H3K4 methyltransferase Set1 complex cooperate to ensure invariant transdifferentiation (Td) of postmitotic Caenorhabditis elegans hindgut cells into motor neurons. At single-cell resolution, robust conversion requires stepwise histone-modifying activities, functionally partitioned into discrete phases of Td through nuclear degradation of JMJD-3.1 and phase-specific interactions with transcription factors that have conserved roles in cell plasticity and terminal fate selection. Our results draw parallels between epigenetic mechanisms underlying robust Td in nature and efficient cell reprogramming in vitro.	[Zuryn, Steven; Ahier, Arnaud; White, Esther Redhouse; Morin, Marie-Charlotte; Jarriault, Sophie] Univ Strasbourg, Dept Dev & Stem Cells, Inst Genet & Biol Mol & Cellulaire, CNRS UMR 7104,INSERM U964, F-67404 Illkirch Cu Strasbourg, France; [Portoso, Manuela; Margueron, Raphael] Inst Curie, INSERM U934, CNRS UMR3215, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm)	Jarriault, S (corresponding author), Univ Strasbourg, Dept Dev & Stem Cells, Inst Genet & Biol Mol & Cellulaire, CNRS UMR 7104,INSERM U964, F-67404 Illkirch Cu Strasbourg, France.	sophie@igbmc.fr	Margueron, Raphael F/B-9996-2015; Zuryn, Steven/C-7967-2018	Margueron, Raphael F/0000-0002-9093-7977; Zuryn, Steven/0000-0002-3551-6790; Ahier, Arnaud/0000-0002-9999-3887	European Research Council-Stg (REPODDID) grant; ATIP-Avenir grant; Fondation pour la Recherche Medicale (FRM) grant; FRM; Fondation ARC pour la recherche sur le cancer; Association Francaise contre les Myopathies (AFM); Fondation Schlumberger pour l'Enseignement et la Recherche (FSER); European Molecular Biology Organization Young Investigator program (EMBO YIP)	European Research Council-Stg (REPODDID) grant; ATIP-Avenir grant; Fondation pour la Recherche Medicale (FRM) grant; FRM(Fondation pour la Recherche Medicale); Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation Schlumberger pour l'Enseignement et la Recherche (FSER); European Molecular Biology Organization Young Investigator program (EMBO YIP)	We are grateful to S. Gasser, R. Klose, M. Labouesse, B. Prud'homme, and R. Schneider for their comments on the manuscript. Work in R.M.'s laboratory is funded by a European Research Council-Stg (REPODDID) grant, an ATIP-Avenir grant, and a Fondation pour la Recherche Medicale (FRM) grant. Work in S.J.'s laboratory is funded by grants from FRM, the Fondation ARC pour la recherche sur le cancer, the Association Francaise contre les Myopathies (AFM), the Fondation Schlumberger pour l'Enseignement et la Recherche (FSER), and the European Molecular Biology Organization Young Investigator program (EMBO YIP). S.Z. is a FRM and ARC postdoctoral fellow, and S.J. is a Centre National de la Recherche Scientifique research director.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jarriault S, 2008, P NATL ACAD SCI USA, V105, P3790, DOI 10.1073/pnas.0712159105; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kagias K, 2012, P NATL ACAD SCI USA, V109, P6596, DOI 10.1073/pnas.1117031109; Karakuzu O, 2009, DEVELOPMENT, V136, P943, DOI 10.1242/dev.029363; Kratsios P, 2012, NAT NEUROSCI, V15, P205, DOI 10.1038/nn.2989; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Richard JP, 2011, DEVELOPMENT, V138, P1483, DOI 10.1242/dev.063115; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Tanaka EM, 2011, DEV CELL, V21, P172, DOI 10.1016/j.devcel.2011.06.016; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Voigt P, 2012, CELL, V151, P181, DOI 10.1016/j.cell.2012.09.002; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006; Zuryn S, 2010, GENETICS, V186, P427, DOI 10.1534/genetics.110.119230	23	45	55	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					826	829		10.1126/science.1255885	http://dx.doi.org/10.1126/science.1255885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124442				2022-12-28	WOS:000340593100048
J	Deng, WL; Rupon, JW; Krivega, I; Breda, L; Motta, I; Jahn, KS; Reik, A; Gregory, PD; Rivella, S; Dean, A; Blobel, GA				Deng, Wulan; Rupon, Jeremy W.; Krivega, Ivan; Breda, Laura; Motta, Irene; Jahn, Kristen S.; Reik, Andreas; Gregory, Philip D.; Rivella, Stefano; Dean, Ann; Blobel, Gerd A.			Reactivation of Developmentally Silenced Globin Genes by Forced Chromatin Looping	CELL			English	Article							FETAL-HEMOGLOBIN EXPRESSION; LOCUS-CONTROL REGION; SICKLE-CELL-DISEASE; GAMMA-GLOBIN; ORDER; ORGANIZATION; HYDROXYUREA; PROTEINS; REQUIRES; GATA-1	Distal enhancers commonly contact target promoters via chromatin looping. In erythroid cells, the locus control region (LCR) contacts beta-type globin genes in a developmental stage-specific manner to stimulate transcription. Previously, we induced LCR-promoter looping by tethering the self-association domain (SA) of Ldb1 to the beta-globin promoter via artificial zinc fingers. Here, we show that targeting the SA to a developmentally silenced embryonic globin gene in adult murine erythroblasts triggers its transcriptional reactivation. This activity depends on the LCR, consistent with an LCR-promoter looping mechanism. Strikingly, targeting the SA to the fetal gamma-globin promoter in primary adult human erythroblasts increases gamma-globin promoter-LCR contacts, stimulating transcription to approximately 85% of total beta-globin synthesis, with a reciprocal reduction in adult beta-globin expression. Our findings demonstrate that forced chromatin looping can override a stringent developmental gene expression program and suggest a novel approach to control the balance of globin gene transcription for therapeutic applications.	[Deng, Wulan; Rupon, Jeremy W.; Jahn, Kristen S.; Blobel, Gerd A.] Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA; [Deng, Wulan] Howard Hughes Med Inst, Transcript Imaging Consortium, Ashburn, VA 20147 USA; [Krivega, Ivan; Dean, Ann] NIDDK, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA; [Breda, Laura; Motta, Irene; Rivella, Stefano] Weill Cornell Med Coll, Dept Pediat, Div Hematol Oncol, New York, NY 10021 USA; [Reik, Andreas; Gregory, Philip D.] Sangamo BioSci, Richmond, CA 94804 USA; [Rivella, Stefano] Weill Cornell Med Coll, Dept Cell & Biol Dev, Div Hematol Oncol, New York, NY 10021 USA; [Blobel, Gerd A.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Cornell University; Sangamo Therapeutics, Inc.; Cornell University; University of Pennsylvania; Pennsylvania Medicine	Blobel, GA (corresponding author), Childrens Hosp Philadelphia, Div Hematol, Philadelphia, PA 19104 USA.	blobel@email.chop.edu	Krivega, Ivan/G-9247-2015; Motta, Irene/AAC-3087-2019; Deng, Wulan/ABX-6870-2022; Breda, Laura/T-3997-2017	Krivega, Ivan/0000-0002-3473-4198; Rivella, Stefano/0000-0002-0938-6558; Motta, Irene/0000-0001-5701-599X; Gregory, Philip/0000-0001-9249-2468; Breda, Laura/0000-0003-2133-4432	NIH [5R37DK058044, 1RO1HL119479, NHLBI-5R01HL102449, DK015508]; American Heart Association postdoctoral fellowship [13POST16950014]; NIDDK; Associazione Veneta per la Lotta alla Talassemia (AVLT, IT); European Community [FP7-HEALTH-2012-INNOVATION]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119479, R01HL102449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015508, R01DK058044, R37DK058044, ZIADK075033] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Associazione Veneta per la Lotta alla Talassemia (AVLT, IT); European Community(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Andrew Wilber for the GG1 constructs. We are grateful to Hongxin Wang for technical assistance, Jongjoo Lee for help with mouse experiments, and members of the laboratory for valuable discussions. This work was supported by NIH grants (5R37DK058044 and 1RO1HL119479) (to G.A.B.). J.W.R. was supported by an American Heart Association postdoctoral fellowship (13POST16950014). A.D. and I.K. were supported by the intramural program of the NIDDK, NIH (DK015508). Additional support was provided by the Associazione Veneta per la Lotta alla Talassemia (AVLT, IT) (to L.B.), by an NIH grant (NHLBI-5R01HL102449) (to S.R.), and by a European Community grant (FP7-HEALTH-2012-INNOVATION) (to L.B. and S.R.). A.R. and P.D.G. are employees of Sangamo Biosciences Inc.	ADAMS CC, 1995, MOL CELL BIOL, V15, P1405; Atweh G, 2010, HEMATOL ONCOL CLIN N, V24, P1131, DOI 10.1016/j.hoc.2010.08.001; Bartsevich VV, 2003, STEM CELLS, V21, P632, DOI 10.1634/stemcells.21-6-632; Bauchwitz R, 2000, HUM MOL GENET, V9, P561, DOI 10.1093/hmg/9.4.561; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; Bradner JE, 2010, P NATL ACAD SCI USA, V107, P12617, DOI 10.1073/pnas.1006774107; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; ENVER T, 1990, NATURE, V344, P309, DOI 10.1038/344309a0; FIBACH E, 1993, BLOOD, V81, P1630; Graslund T, 2005, J BIOL CHEM, V280, P3707, DOI 10.1074/jbc.M406809200; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; HANSCOMBE O, 1991, GENE DEV, V5, P1387, DOI 10.1101/gad.5.8.1387; Hardison RC, 2013, SCIENCE, V342, P206, DOI 10.1126/science.1245813; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Kiefer CM, 2011, BLOOD, V118, P6200, DOI 10.1182/blood-2011-06-363101; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; OU CN, 1993, CLIN CHEM, V39, P820; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Palstra RJ, 2008, ADV GENET, V61, P107, DOI 10.1016/S0065-2660(07)00004-1; Perez-Pinera P, 2013, NAT METHODS, V10, P973, DOI [10.1038/NMETH.2600, 10.1038/nmeth.2600]; PETERSON KR, 1993, MOL CELL BIOL, V13, P4836, DOI 10.1128/MCB.13.8.4836; Platt OS, 2008, NEW ENGL J MED, V358, P1362, DOI 10.1056/NEJMct0708272; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Pop R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000484; Pope SH, 2000, EUR J HAEMATOL, V64, P292, DOI 10.1034/j.1600-0609.2000.90032.x; Sankaran VG, 2010, BRIT J HAEMATOL, V149, P181, DOI 10.1111/j.1365-2141.2010.08105.x; Sankaran VG, 2009, NATURE, V460, P1093, DOI 10.1038/nature08243; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Smith RD, 2000, BLOOD, V95, P863, DOI 10.1182/blood.V95.3.863.003k12_863_869; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Sun N, 2012, MOL BIOSYST, V8, P1255, DOI 10.1039/c2mb05461b; Tanimoto K, 1999, NATURE, V398, P344, DOI 10.1038/18698; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Tripic T, 2009, BLOOD, V113, P2191, DOI 10.1182/blood-2008-07-169417; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Weatherall DJ, 2001, NAT REV GENET, V2, P245, DOI 10.1038/35066048; Weiss MJ, 1997, MOL CELL BIOL, V17, P1642, DOI 10.1128/MCB.17.3.1642; Welch JJ, 2004, BLOOD, V104, P3136, DOI 10.1182/blood-2004-04-1603; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Wilber A, 2010, BLOOD, V115, P3033, DOI 10.1182/blood-2009-08-240556; Xu J, 2013, P NATL ACAD SCI USA, V110, P6518, DOI 10.1073/pnas.1303976110; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310	47	273	286	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					849	860		10.1016/j.cell.2014.05.050	http://dx.doi.org/10.1016/j.cell.2014.05.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126789	Green Accepted, Bronze			2022-12-28	WOS:000340944700015
J	Feng, YQ; Arvey, A; Chinen, T; Van der Veeken, JD; Gasteiger, G; Rudensky, AY				Feng, Yongqiang; Arvey, Aaron; Chinen, Takatoshi; van der Veeken, Joris; Gasteiger, Georg; Rudensky, Alexander Y.			Control of the Inheritance of Regulatory T Cell Identity by a cis Element in the Foxp3 Locus	CELL			English	Article							IN-VIVO; EXPRESSION; INDUCTION; GENE; DIFFERENTIATION; PLASTICITY; LINEAGE; DEMETHYLATION; STIMULATION; ACTIVATION	In multicellular organisms, specialized functions are delegated to distinct cell types whose identity and functional integrity are maintained upon challenge. However, little is known about the mechanisms enabling lineage inheritance and their biological implications. Regulatory T (Treg) cells, which express the transcription factor Foxp3, suppress fatal auto-immunity throughout the lifespan of animals. Here, we show that a dedicated Foxp3 intronic element CNS2 maintains Treg cell lineage identity by acting as a sensor of the essential Treg cell growth factor IL-2 and its downstream target STAT5. CNS2 sustains Foxp3 expression during division of mature Treg cells when IL-2 is limiting and counteracts proinflammatory cytokine signaling that leads to the loss of Foxp3. CNS2-mediated stable inheritance of Foxp3 expression is critical for adequate suppression of diverse types of chronic inflammation by Treg cells and prevents their differentiation into inflammatory effector cells. The described mechanism may represent a general principle of the inheritance of differentiated cell states.	[Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Program Immunol, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.	rudenska@mskcc.org	Feng, Yongqiang/N-2731-2018; Feng, Yongqiang/AAR-7719-2021	Feng, Yongqiang/0000-0002-2320-5063; Feng, Yongqiang/0000-0002-2320-5063; Arvey, Aaron/0000-0002-8789-0290; Gasteiger, Georg/0000-0001-6986-127X	Cancer Center Support Grant [CCSG P30 CA008748]; Postdoctoral Fellowship of the Cancer Research Institute; NIH [AI034206]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034206, R37AI034206, R29AI034206] Funding Source: NIH RePORTER	Cancer Center Support Grant; Postdoctoral Fellowship of the Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank MSKCC Genomics and Bioinformatics Core facilities for RNA sequencing and Flow Cytometry Core facility for assistance with cell sorting. We thank W. Hu for assistance with the analysis of bisulfite sequencing data and P. DeRoos, S. Hemmers, Q. Li, G. Loeb, and S. Dikiy for technical assistance. MSKCC core facilities are supported by Cancer Center Support Grant CCSG P30 CA008748. Y.F. was supported by a Postdoctoral Fellowship of the Cancer Research Institute. This study was supported by NIH grant AI034206 and the Howard Hughes Medical Institute (A.Y.R.).	Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Bettini ML, 2012, IMMUNITY, V36, P717, DOI 10.1016/j.immuni.2012.03.020; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Gottesfeld JM, 1997, TRENDS BIOCHEM SCI, V22, P197, DOI 10.1016/S0968-0004(97)01045-1; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Komatsu N, 2014, NAT MED, V20, P62, DOI 10.1038/nm.3432; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Miyao T, 2012, IMMUNITY, V36, P262, DOI 10.1016/j.immuni.2011.12.012; Mullen AC, 2001, CURR BIOL, V11, P1695, DOI 10.1016/S0960-9822(01)00533-4; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Pachner AR, 2011, CURR OPIN NEUROL, V24, P291, DOI 10.1097/WCO.0b013e328346c226; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Punkosdy GA, 2011, P NATL ACAD SCI USA, V108, P3677, DOI 10.1073/pnas.1100213108; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Sekiya T, 2013, NAT IMMUNOL, V14, P230, DOI 10.1038/ni.2520; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Toker A, 2013, J IMMUNOL, V190, P3180, DOI 10.4049/jimmunol.1203473; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zhang Q, 2005, P NATL ACAD SCI USA, V102, P6948, DOI 10.1073/pnas.0501959102; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	39	258	270	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					749	763		10.1016/j.cell.2014.07.031	http://dx.doi.org/10.1016/j.cell.2014.07.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126783	Green Accepted, Bronze			2022-12-28	WOS:000340944700008
J	Felton, S; Tolley, M; Demaine, E; Rus, D; Wood, R				Felton, S.; Tolley, M.; Demaine, E.; Rus, D.; Wood, R.			A method for building self-folding machines	SCIENCE			English	Article							DESIGN	Origami can turn a sheet of paper into complex three-dimensional shapes, and similar folding techniques can produce structures and mechanisms. To demonstrate the application of these techniques to the fabrication of machines, we developed a crawling robot that folds itself. The robot starts as a flat sheet with embedded electronics, and transforms autonomously into a functional machine. To accomplish this, we developed shape-memory composites that fold themselves along embedded hinges. We used these composites to recreate fundamental folded patterns, derived from computational origami, that can be extrapolated to a wide range of geometries and mechanisms. This origami-inspired robot can fold itself in 4 minutes and walk away without human intervention, demonstrating the potential both for complex self-folding machines and autonomous, self-controlled assembly.	[Felton, S.; Tolley, M.; Wood, R.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Felton, S.; Tolley, M.; Wood, R.] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Demaine, E.; Rus, D.] MIT, Cambridge, MA 02139 USA; [Demaine, E.; Rus, D.] MIT, Artificial Intelligence Lab, Cambridge, MA 02139 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Felton, S (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	sam@seas.harvard.edu			NSF [CCF-1138967, EFRI-1240383]; Wyss Institute for Biologically Inspired Research; Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship [32 CFR 168a]	NSF(National Science Foundation (NSF)); Wyss Institute for Biologically Inspired Research; Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	Supported by NSF grants CCF-1138967 and EFRI-1240383, the Wyss Institute for Biologically Inspired Research, and the Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship, 32 CFR 168a. Special thanks to D. Vogt for his expertise with 3D printing. Any opinions, findings, conclusions, or recommendations expressed in this material are those of the authors and do not necessarily reflect those of the funding organizations. Data are presented in the supplementary materials.	Abbott T, 2008, THESIS MIT; An B., 2014, IEEE INT C ROB AUT H; Birkmeyer P., 2009, IEEE INT C INT ROB S; Coros S, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2461953; Demaine ED, 2000, COMP GEOM-THEOR APPL, V16, P3, DOI 10.1016/S0925-7721(99)00056-5; Felton S. M., 2013, IEEE INT C ROB AUT K; Felton SM, 2013, SOFT MATTER, V9, P7688, DOI 10.1039/c3sm51003d; FRANKS NR, 1992, ANIM BEHAV, V44, P357, DOI 10.1016/0003-3472(92)90041-7; Greenberg HC, 2011, MECH SCI, V2, P217, DOI 10.5194/ms-2-217-2011; Guan JJ, 2005, J PHYS CHEM B, V109, P23134, DOI 10.1021/jp054341g; Hawkes E, 2010, P NATL ACAD SCI USA, V107, P12441, DOI 10.1073/pnas.0914069107; HOWELL LL, 1994, J MECH DESIGN, V116, P280, DOI 10.1115/1.2919359; Kapovich M, 2002, TOPOLOGY, V41, P1051, DOI 10.1016/S0040-9383(01)00034-9; Liu Y, 2012, SOFT MATTER, V8, P1764, DOI 10.1039/c1sm06564e; Mejia- Ariza J., 2006, ADA453559 VIRG POL I; Miura K, 1985, I SPACE ASTRONAUT SC, V618, P1; Monnard PA, 2002, ANAT RECORD, V268, P196, DOI 10.1002/ar.10154; Moon F. C., 1993, NONLINEAR DYNAM; Okuzaki H., 2008, Journal of Physics: Conference Series, V127, DOI 10.1088/1742-6596/127/1/012001; Onal CD, 2011, IEEE INT CONF ROBOT; Pfeifer R, 2007, SCIENCE, V318, P1088, DOI 10.1126/science.1145803; Schenk M, 2011, ORIGAMI(5): FIFTH INTERNATIONAL MEETING OF ORIGAMI SCIENCE, MATHEMATICS, AND EDUCATION, P291; Shin B., 2014, IEEE INT C ROB AUT K; Song G, 2004, IEEE T ROBOTIC AUTOM, V20, P60, DOI 10.1109/TRA.2003.820926; Soo A. S., 2006, ADA444670 ARM SOLD B; Sreetharan PS, 2012, J MICROMECH MICROENG, V22, DOI 10.1088/0960-1317/22/5/055027; Tachi T, 2009, ORIGAMI4 4 INT C ORI, V4, P175; Tachi T., ORIGAMIZER; Tachi T, 2010, IEEE T VIS COMPUT GR, V16, P298, DOI 10.1109/TVCG.2009.67; Tolley M.T., 2013, IEEE INT C INT ROB S; Trease BP, 2005, J MECH DESIGN, V127, P788, DOI 10.1115/1.1900149; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Yi YW, 1999, J MICROELECTROMECH S, V8, P10, DOI 10.1109/84.749397	33	663	682	58	708	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					644	646		10.1126/science.1252610	http://dx.doi.org/10.1126/science.1252610			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104380				2022-12-28	WOS:000339962800031
J	Graciani, J; Mudiyanselage, K; Xu, F; Baber, AE; Evans, J; Senanayake, SD; Stacchiola, DJ; Liu, P; Hrbek, J; Sanz, JF; Rodriguez, JA				Graciani, Jesus; Mudiyanselage, Kumudu; Xu, Fang; Baber, Ashleigh E.; Evans, Jaime; Senanayake, Sanjaya D.; Stacchiola, Dario J.; Liu, Ping; Hrbek, Jan; Fernandez Sanz, Javier; Rodriguez, Jose A.			Highly active copper-ceria and copper-ceria-titania catalysts for methanol synthesis from CO2	SCIENCE			English	Article							GAS SHIFT REACTION; MIXED-METAL OXIDE; NANOMETER LEVEL; IN-SITU; WATER; HYDROGENATION; SURFACES; CU; NANOPARTICLES; SPECTROSCOPY	The transformation of CO2 into alcohols or other hydrocarbon compounds is challenging because of the difficulties associated with the chemical activation of CO2 by heterogeneous catalysts. Pure metals and bimetallic systems used for this task usually have low catalytic activity. Here we present experimental and theoretical evidence for a completely different type of site for CO2 activation: a copper-ceria interface that is highly efficient for the synthesis of methanol. The combination of metal and oxide sites in the copper-ceria interface affords complementary chemical properties that lead to special reaction pathways for the CO2 -> CH3OH conversion.	[Graciani, Jesus; Fernandez Sanz, Javier] Univ Seville, Dept Phys Chem, E-41012 Seville, Spain; [Mudiyanselage, Kumudu; Xu, Fang; Baber, Ashleigh E.; Senanayake, Sanjaya D.; Stacchiola, Dario J.; Liu, Ping; Hrbek, Jan; Rodriguez, Jose A.] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; [Evans, Jaime] Cent Univ Venezuela, Fac Ciencias, Caracas 10201, Venezuela	University of Sevilla; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Central Venezuela	Rodriguez, JA (corresponding author), Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA.	rodrigez@bnl.gov	Senanayake, Sanjaya D/D-4769-2009; Sanz, Javier Fdez./E-1368-2012; Stacchiola, Dario J/B-1918-2009; Mudiyanselage, Kumudu/B-2277-2013	Senanayake, Sanjaya D/0000-0003-3991-4232; Sanz, Javier Fdez./0000-0003-2064-7007; Stacchiola, Dario J/0000-0001-5494-3205; Mudiyanselage, Kumudu/0000-0002-3539-632X; Xu, Fang/0000-0002-8166-0275	U.S. Department of Energy, Chemical Sciences Division [DE-AC02-98CH10886]; Instituto de Tecnologia Venezolana para el Petroleo; Ministerio de Economia y Competitividad (Spain) [MAT2012-31526, CSD2008-0023]; European Regional Development Fund; U.S. Department of Energy [DE-AC02-05CH11231]	U.S. Department of Energy, Chemical Sciences Division(United States Department of Energy (DOE)); Instituto de Tecnologia Venezolana para el Petroleo; Ministerio de Economia y Competitividad (Spain); European Regional Development Fund(European Commission); U.S. Department of Energy(United States Department of Energy (DOE))	The research carried out at Brookhaven National Laboratory was supported by the U.S. Department of Energy, Chemical Sciences Division (DE-AC02-98CH10886). J.E. is grateful to the Instituto de Tecnologia Venezolana para el Petroleo for support of the work carried out at the Universidad Central de Venezuela. The work performed at the University of Seville was funded by the Ministerio de Economia y Competitividad (Spain, grants MAT2012-31526 and CSD2008-0023) and European Regional Development Fund. Computational resources were provided by the Barcelona Supercomputing Center/Centro Nacional de Supercomputacion (Spain). The AP-XPS spectra were acquired at the Advanced Light Source (beamline 9.3.2), which is supported by the U.S. Department of Energy under contract no. DE-AC02-05CH11231.	Ansari MB, 2011, GREEN CHEM, V13, P1416, DOI 10.1039/c0gc00951b; Aresta, 2010, CARBON DIOXIDE CHEM; Baber AE, 2013, J AM CHEM SOC, V135, P16781, DOI 10.1021/ja408506y; Behrens M, 2012, SCIENCE, V336, P893, DOI [10.1126/science.12198331, 10.1126/science.1219831]; CHINCHEN GC, 1987, APPL CATAL, V30, P333, DOI 10.1016/S0166-9834(00)84123-8; Deng XY, 2008, LANGMUIR, V24, P9474, DOI 10.1021/la8011052; Gordon WO, 2009, PHYS CHEM CHEM PHYS, V11, P11171, DOI 10.1039/b913310k; Graciani J, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3337918; Green IX, 2011, SCIENCE, V333, P736, DOI 10.1126/science.1207272; LI C, 1989, J CHEM SOC FARAD T 1, V85, P929, DOI 10.1039/f19898500929; Mudiyanselage K, 2013, ANGEW CHEM INT EDIT, V52, P5101, DOI 10.1002/anie.201210077; Olah G. A, 2011, OIL GAS METHANOL EC; Park JB, 2010, J AM CHEM SOC, V132, P356, DOI 10.1021/ja9087677; Park JB, 2009, P NATL ACAD SCI USA, V106, P4975, DOI 10.1073/pnas.0812604106; Preti D, 2011, ANGEW CHEM INT EDIT, V50, P12551, DOI 10.1002/anie.201105481; RASMUSSEN PB, 1994, SURF SCI, V318, P267, DOI 10.1016/0039-6028(94)90101-5; Rodriguez JA, 2009, ANGEW CHEM INT EDIT, V48, P8047, DOI 10.1002/anie.200903918; Seiferth O, 1999, SURF SCI, V421, P176, DOI 10.1016/S0039-6028(98)00857-7; Senanayake SD, 2013, ACCOUNTS CHEM RES, V46, P1702, DOI 10.1021/ar300231p; Spencer MS, 1999, TOP CATAL, V8, P259, DOI 10.1023/A:1019181715731; Studt F, 2014, NAT CHEM, V6, P320, DOI [10.1038/NCHEM.1873, 10.1038/nchem.1873]; Vidal AB, 2012, J PHYS CHEM LETT, V3, P2275, DOI 10.1021/jz300989e; Yang Y, 2013, J CATAL, V298, P10, DOI 10.1016/j.jcat.2012.10.028; Yang YX, 2012, J PHYS CHEM C, V116, P248, DOI 10.1021/jp208448c; Yang YX, 2010, PHYS CHEM CHEM PHYS, V12, P9909, DOI 10.1039/c001484b; Yoshihara J, 1996, J CATAL, V161, P776, DOI 10.1006/jcat.1996.0240; Zhao YF, 2011, J CATAL, V281, P199, DOI 10.1016/j.jcat.2011.04.012	27	901	911	96	1752	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					546	550		10.1126/science.1253057	http://dx.doi.org/10.1126/science.1253057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082699				2022-12-28	WOS:000339651300041
J	Joseph-Williams, N; Edwards, A; Elwyn, G				Joseph-Williams, Natalie; Edwards, Adrian; Elwyn, Glyn			Power imbalance prevents shared decision making	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICIANS; INTERVENTION; FACILITATORS; QUESTIONS; DIFFICULT; BARRIERS; ASK		[Joseph-Williams, Natalie; Edwards, Adrian] Cardiff Univ, Sch Med, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [Elwyn, Glyn] Dartmouth Coll, Dartmouth Ctr Healthcare Delivery Sci, Hanover, NH 03755 USA; [Elwyn, Glyn] Dartmouth Coll, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH 03755 USA	Cardiff University; Dartmouth College; Dartmouth College	Joseph-Williams, N (corresponding author), Cardiff Univ, Sch Med, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales.	josephnj1@cf.ac.uk	Elwyn, G./L-4292-2015; Elwyn, Glyn/B-4798-2009	Elwyn, Glyn/0000-0002-0917-6286				Advancing Quality Alliance, 2013, YOUR HLTH YOUR DEC E; Aronson L, 2013, NEW ENGL J MED, V369, P796, DOI 10.1056/NEJMp1303057; Belkora J, 2006, PATIENT EDUC COUNS, V64, P350, DOI 10.1016/j.pec.2006.03.017; Brown RF, 2004, HEALTH EXPECT, V7, P303, DOI 10.1111/j.1369-7625.2004.00294.x; Butow P, 2004, J CLIN ONCOL, V22, P4401, DOI 10.1200/JCO.2004.66.155; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Edwards A, 2001, Health Expect, V4, P151, DOI 10.1046/j.1369-6513.2001.00116.x; Elwyn G, 2012, J GEN INTERN MED, V27, P1361, DOI 10.1007/s11606-012-2077-6; Francis R., 2013, REP MIDST NHS FDN TR; Frosch DL, 2012, HEALTH AFFAIR, V31, P1030, DOI 10.1377/hlthaff.2011.0576; Granger K., 2012, OTHER SIDE; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; Health Foundation, 2013, MAGIC PROGR EV; Health Foundation, 2013, IMPL SHAR DEC MAK CL; Joseph-Williams N, 2014, PATIENT EDUC COUNS, V94, P291, DOI 10.1016/j.pec.2013.10.031; Judson TJ, 2013, JAMA-J AM MED ASSOC, V309, P2325, DOI 10.1001/jama.2013.5797; Kinnersley P, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004565.pub2; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; Lloyd A, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-102; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; ROST KM, 1991, DIABETES CARE, V14, P881, DOI 10.2337/diacare.14.10.881; Sepucha Karen R, 2003, Oncol Nurs Forum, V30, P99, DOI 10.1188/03.ONF.99-106; Shepherd HL, 2011, PATIENT EDUC COUNS, V84, P379, DOI 10.1016/j.pec.2011.07.022; Stacey D, 2012, MED DECIS MAKING, V32, pE22, DOI 10.1177/0272989X12443311; Tomlinson J, 2014, BETTER NHS EXPLORING	26	108	109	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2014	348								g3178	10.1136/bmj.g3178	http://dx.doi.org/10.1136/bmj.g3178			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH5FQ	25134115				2022-12-28	WOS:000336154300011
J	Bhaskaran, K; Douglas, I; Forbes, H; dos-Santos-Silva, I; Leon, DA; Smeeth, L				Bhaskaran, Krishnan; Douglas, Ian; Forbes, Harriet; dos-Santos-Silva, Isabel; Leon, David A.; Smeeth, Liam			Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults	LANCET			English	Article							HORMONE REPLACEMENT THERAPY; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; FOLLOW-UP; OBESITY; VALIDITY; HEIGHT; SIZE; METAANALYSIS; OVERWEIGHT	Background High body-mass index (BMI) predisposes to several site-specific cancers, but a large-scale systematic and detailed characterisation of patterns of risk across all common cancers adjusted for potential confounders has not previously been undertaken. We aimed to investigate the links between BMI and the most common site-specifi c cancers. Methods With primary care data from individuals in the Clinical Practice Research Datalink with BMI data, we fitted Cox models to investigate associations between BMI and 22 of the most common cancers, adjusting for potential confounders. We fitted linear then non-linear (spline) models; investigated effect modification by sex, menopausal status, smoking, and age; and calculated population effects. Findings 5.24 million individuals were included; 166 955 developed cancers of interest. BMI was associated with 17 of 22 cancers, but effects varied substantially by site. Each 5 kg/m(2) increase in BMI was roughly linearly associated with cancers of the uterus (hazard ratio [HR] 1.62, 99% CI 1.56-1. 69; p < 0.0001), gallbladder (1.31, 1.12-1.52; p < 0.0001), kidney (1.25, 1.17-1.33; p < 0.0001), cervix (1.10, 1.03-1 17; p = 0.00035), thyroid (1.09, 1.00-1.19; p = 0.0088), and leukaemia (1.09, 1.05-1.13; p = 0.0001). BMI was positively associated with liver (1.19, 1.12-1 27), colon (1.10, 1.07-1.13), ovarian (1.09, 1.04-1.14), and postmenopausal breast cancers (1.05, 1.03-1.07) overall (all p < 0.0001), but these effects varied by underlying BMI or individual-level characteristics. We estimated inverse associations with prostate and premenopausal breast cancer risk, both overall (prostate 0.98, 0.95-1.00; premenopausal breast cancer 0.89, 0.86-0.92) and in never-smokers (prostate 0.96, 0.93-0.99; premenopausal breast cancer 0.89, 0.85-0.94). By contrast, for lung and oral cavity cancer, we observed no association in never smokers (lung 0.99, 0.93-1.05; oral cavity 1.07, 0.91-1.26): inverse associations overall were driven by current smokers and ex-smokers, probably because of residual confounding by smoking amount. Assuming causality, 41% of uterine and 10% or more of gallbladder, kidney, liver, and colon cancers could be attributable to excess weight. We estimated that a 1 kg/m(2) population-wide increase in BMI would result in 3790 additional annual UK patients developing one of the ten cancers positively associated with BMI. Interpretation BMI is associated with cancer risk, with substantial population-level eff ects. The heterogeneity in the eff ects suggests that different mechanisms are associated with different cancer sites and different patient subgroups. Funding National Institute for Health Research, Wellcome Trust, and Medical Research Council. Copyright (C) Bhaskaran et al. Open Access article distributed under the terms of CC BY.	[Bhaskaran, Krishnan; Douglas, Ian; Forbes, Harriet; dos-Santos-Silva, Isabel; Leon, David A.; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Smeeth, Liam] Farr Inst Hlth Informat Res, London, England	University of London; London School of Hygiene & Tropical Medicine	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	Leon, David A/G-2195-2010; Smeeth, Liam/X-5862-2018	Leon, David A/0000-0001-9747-1762; Forbes, Harriet/0000-0001-6888-2212; Smeeth, Liam/0000-0002-9168-6022; Bhaskaran, Krishnan/0000-0001-5364-8757; dos Santos Silva, Isabel/0000-0002-6596-8798	National Institute for Health Research; Wellcome Trust; Medical Research Council; MRC methodology research fellowship; Medical Research Council [G0802403, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [PDF-2011-04-007, NF-SI-0510-10090] Funding Source: researchfish; MRC [G0802403] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC methodology research fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	National Institute for Health Research, Wellcome Trust, and Medical Research Council.; This report is independent research arising from a postdoctoral fellowship (for KB) supported by the National Institute for Health Research. LS is supported by a Wellcome Trust senior research fellowship in clinical science. ID is supported by an MRC methodology research fellowship. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Beral V, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001200; Bhaskaran K, REPRESENTATIVENESS O; Boggon R, 2013, PHARMACOEPIDEM DR S, V22, P168, DOI 10.1002/pds.3374; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Campbell PT, 2010, JNCI-J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011; Cancer Research UK, 2012, CANC INC COMM CANC; Crosbie EJ, 2010, CANCER EPIDEM BIOMAR, V19, P3119, DOI 10.1158/1055-9965.EPI-10-0832; Discacciati A, 2012, ANN ONCOL, V23, P1665, DOI 10.1093/annonc/mdr603; Dregan A, 2012, CANCER EPIDEMIOL, V36, P425, DOI 10.1016/j.canep.2012.05.013; Engeland A, 2003, JNCI-J NATL CANCER I, V95, P1244, DOI 10.1093/jnci/djg010; Engeland A, 2006, BRIT J CANCER, V95, P366, DOI 10.1038/sj.bjc.6603249; Glymour M.M., 2008, MODERN EPIDEMIOLOGY, P183; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Her Majesty's Government Department for Communities and Local Government, 2011, IND MULT DEPR; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Hoffmeister M, 2013, CANCER EPIDEM BIOMAR, V22, P2303, DOI 10.1158/1055-9965.EPI-13-0239; Hughes LAE, 2012, INT J EPIDEMIOL, V41, P1060, DOI 10.1093/ije/dys055; Hughes LAE, 2011, AM J EPIDEMIOL, V174, P1127, DOI 10.1093/aje/kwr247; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lewis JD, 2004, PHARMACOEPIDEM DR S, V13, P437, DOI 10.1002/pds.902; NHS Information Centre, HLTH SURV ENGL 2010; Parkinson J, 2007, PHARMACOVIGILANCE, P341, DOI DOI 10.1002/9780470059210.CH27; Pylypchuk RD, 2009, AM J EPIDEMIOL, V170, P297, DOI 10.1093/aje/kwp123; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan Andrew G., 2008, Archives of Physiology and Biochemistry, V114, P71, DOI [10.1080/13813450801954303, 10.1080/13813450801954303 ]; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ritte R, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3186; Robsahm TE, 2013, EUR J CANCER PREV, V22, P492, DOI 10.1097/CEJ.0b013e328360f434; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831; Smith L, 2012, JNCI-J NATL CANCER I, V104, P778, DOI 10.1093/jnci/djs179; Song YM, 2008, J CLIN ONCOL, V26, P3395, DOI 10.1200/JCO.2007.15.7867; Spencer EA, 2002, PUBLIC HEALTH NUTR, V5, P561, DOI 10.1079/PHN2001322; Ulmer H, 2012, GYNECOL ONCOL, V125, P330, DOI 10.1016/j.ygyno.2012.01.052; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; WHO, WORLD HLTH STAT 2011; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	39	908	951	11	152	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					755	765		10.1016/S0140-6736(14)60892-8	http://dx.doi.org/10.1016/S0140-6736(14)60892-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5DD	25129328	Green Published, Green Accepted			2022-12-28	WOS:000341361500036
J	Zhang, X; Lohmann, G; Knorr, G; Purcell, C				Zhang, Xu; Lohmann, Gerrit; Knorr, Gregor; Purcell, Conor			Abrupt glacial climate shifts controlled by ice sheet changes	NATURE			English	Article							MILLENNIAL-SCALE CHANGES; NORTH-ATLANTIC; DANSGAARD-OESCHGER; THERMOHALINE CIRCULATION; OCEAN CIRCULATION; LATE PLEISTOCENE; MIS 3; ATMOSPHERIC CIRCULATION; HEINRICH EVENTS; RAPID CHANGES	During glacial periods of the Late Pleistocene, an abundance of proxy data demonstrates the existence of large and repeated millennial-scale warming episodes, known as Dansgaard-Oeschger (DO) events(1). This ubiquitous feature of rapid glacial climate change can be extended back as far as 800,000 years before present (BP) in the ice core record(2), and has drawn broad attention within the science and policy-making communities alike(3). Many studies have been dedicated to investigating the underlying causes of these changes, but no coherent mechanism has yet been identified(3-15). Here we show, by using a comprehensive fully coupled model(16), that gradual changes in the height of the Northern Hemisphere ice sheets (NHISs) canalter the coupled atmosphere ocean system and cause rapid glacial climate shifts closely resembling DO events. The simulated global climate responses-including abrupt warming in the North Atlantic, a northward shift of the tropical rain-belts, and Southern Hemisphere cooling related to the bipolar seesa ware generally consistent with empirical evidence(1,3,17). As a result of the coexistence of two glacial ocean circulation states at intermediate heights of the ice sheets, minor changes in the height of the NHISs and the amount of atmospheric CO2 can trigger the rapid climate transitions via a local positive atmosphere-ocean-sea-ice feedback in the North Atlantic. Our results, although based on a single model, thus provide a coherent concept for understanding the recorded millennial scale variability and abrupt climate changes in the coupled atmosphere ocean system, as well as their linkages to the volume of the intermediate ice sheets during glacials.	[Zhang, Xu; Lohmann, Gerrit; Knorr, Gregor; Purcell, Conor] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27570 Bremerhaven, Germany; [Lohmann, Gerrit] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Knorr, Gregor; Purcell, Conor] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen; Cardiff University	Zhang, X (corresponding author), Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, Bussestr 24, D-27570 Bremerhaven, Germany.	xu.zhang@awi.de	Lohmann, Gerrit/M-7453-2016; Zhang, Xu/AFX-8847-2022	Lohmann, Gerrit/0000-0003-2089-733X; Zhang, Xu/0000-0003-1833-9689; Knorr, Gregor/0000-0002-8317-5046	Polar Regions and Coasts in the Changing Earth System (PACES) programme of the AWI; 'Helmholtz Climate Initiative REKLIM' (Regional Climate Change), a joint research project of the Helmholtz Association of German research centres (HGF)	Polar Regions and Coasts in the Changing Earth System (PACES) programme of the AWI; 'Helmholtz Climate Initiative REKLIM' (Regional Climate Change), a joint research project of the Helmholtz Association of German research centres (HGF)	We thank the colleagues in the Paleoclimate Dynamics group at the Alfred Wegener Institute Helmholtz Centre for Polar and Marine Research (AWI) in Bremerhaven for useful discussions, and I. Hall for comments on a previous draft of the manuscript. G. K. acknowledges helpful discussion with S. Barker. We thank the AWI colleagues who provide technical support on graphics and keep the AWI supercomputer running. This study is promoted by Helmholtz funding through the Polar Regions and Coasts in the Changing Earth System (PACES) programme of the AWI. Funding by 'Helmholtz Climate Initiative REKLIM' (Regional Climate Change), a joint research project of the Helmholtz Association of German research centres (HGF), is gratefully acknowledged (G.K.).	Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; Arz HW, 2007, QUATERNARY SCI REV, V26, P312, DOI 10.1016/j.quascirev.2006.07.016; Arzel O, 2010, J CLIMATE, V23, P2233, DOI 10.1175/2009JCLI3227.1; Asmerom Y, 2010, NAT GEOSCI, V3, P114, DOI 10.1038/NGEO754; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Baker PA, 2001, NATURE, V409, P698, DOI 10.1038/35055524; Banderas R, 2012, CLIM PAST, V8, P1011, DOI 10.5194/cp-8-1011-2012; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Barker S, 2007, P NATL ACAD SCI USA, V104, P17278, DOI 10.1073/pnas.0708494104; Barker S, 2011, SCIENCE, V334, P347, DOI 10.1126/science.1203580; Bethke I, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002258; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; Broecker WS, 2000, EARTH-SCI REV, V51, P137, DOI 10.1016/S0012-8252(00)00019-2; Brovkin V, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037543; Burns SJ, 2003, SCIENCE, V301, P1365, DOI 10.1126/science.1086227; Cacho I, 1999, PALEOCEANOGRAPHY, V14, P698, DOI 10.1029/1999PA900044; Caniupan M, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002049; Clark PU, 2002, NATURE, V415, P863, DOI 10.1038/415863a; Cruz FW, 2006, EARTH PLANET SC LETT, V248, P495, DOI 10.1016/j.epsl.2006.06.019; Cruz FW, 2005, NATURE, V434, P63, DOI 10.1038/nature03365; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Dima M, 2009, CLIM DYNAM, V32, P301, DOI 10.1007/s00382-008-0471-x; Dokken TM, 2013, PALEOCEANOGRAPHY, V28, P491, DOI 10.1002/palo.20042; Elliot M, 2002, QUATERNARY SCI REV, V21, P1153, DOI 10.1016/S0277-3791(01)00137-8; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Gildor H, 2003, PHILOS T R SOC A, V361, P1935, DOI 10.1098/rsta.2003.1244; Giorgetta M.E.M., 2003, REPORTMAX PLANCK INS, DOI DOI 10.17617/2.995269; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; Grimm EC, 2006, QUATERNARY SCI REV, V25, P2197, DOI 10.1016/j.quascirev.2006.04.008; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Harada N, 2006, GLOBAL PLANET CHANGE, V53, P29, DOI 10.1016/j.gloplacha.2006.01.010; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Hendy IL, 2000, PALEOCEANOGRAPHY, V15, P30, DOI 10.1029/1999PA000413; HIBLER WD, 1979, J PHYS OCEANOGR, V9, P815, DOI 10.1175/1520-0485(1979)009<0815:ADTSIM>2.0.CO;2; Hodell DA, 2008, QUATERNARY SCI REV, V27, P1152, DOI 10.1016/j.quascirev.2008.02.008; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Jennerjahn TC, 2004, SCIENCE, V306, P2236, DOI 10.1126/science.1102490; Jonkers L, 2010, QUATERNARY SCI REV, V29, P1791, DOI 10.1016/j.quascirev.2010.03.014; Jungclaus JH, 2010, CLIM PAST, V6, P723, DOI 10.5194/cp-6-723-2010; Kandiano ES, 2004, PALAEOGEOGR PALAEOCL, V204, P145, DOI 10.1016/S0031-0182(03)00728-4; Kanner LC, 2012, SCIENCE, V335, P570, DOI 10.1126/science.1213397; Kiefer T, 2001, PALEOCEANOGRAPHY, V16, P179, DOI 10.1029/2000PA000545; Kim JH, 2012, EARTH PLANET SC LETT, V339, P95, DOI 10.1016/j.epsl.2012.05.018; Kissel C, 1999, EARTH PLANET SC LETT, V171, P489, DOI 10.1016/S0012-821X(99)00162-4; Knorr G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048873; Knorr G, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001604; Knorr G, 2014, NAT GEOSCI, V7, P376, DOI [10.1038/NGEO2119, 10.1038/ngeo2119]; Kwasniok F, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066104; Lamy F, 2004, SCIENCE, V304, P1959, DOI 10.1126/science.1097863; Li C, 2010, J CLIMATE, V23, P5457, DOI 10.1175/2010JCLI3409.1; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; MACAYEAL DR, 1993, PALEOCEANOGRAPHY, V8, P775, DOI 10.1029/93PA02200; Marsland SJ, 2003, OCEAN MODEL, V5, P91, DOI 10.1016/S1463-5003(02)00015-X; Martrat B, 2007, SCIENCE, V317, P502, DOI 10.1126/science.1139994; Masson-Delmotte V, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P383; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; Menviel L, 2011, QUATERNARY SCI REV, V30, P1155, DOI 10.1016/j.quascirev.2011.02.005; Muller UC, 2011, QUATERNARY SCI REV, V30, P273, DOI 10.1016/j.quascirev.2010.11.016; Naafs BDA, 2013, PALEOCEANOGRAPHY, V28, DOI 10.1029/2012PA002354; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Peck VL, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2008PA001631; Peck VL, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001321; Petersen SV, 2013, PALEOCEANOGRAPHY, V28, DOI 10.1029/2012PA002364; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Rahmstorf S, 2002, NATURE, V419, P207, DOI 10.1038/nature01090; Rasmussen TL, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001453; Rasmussen TL, 2004, PALAEOGEOGR PALAEOCL, V210, P101, DOI 10.1016/j.palaeo.2004.04.005; Rasmussen TL, 2003, MAR MICROPALEONTOL, V47, P143, DOI 10.1016/S0377-8398(02)00115-9; Rasmussen TL, 2002, MAR GEOL, V188, P165, DOI 10.1016/S0025-3227(02)00280-3; Rasmussen TL, 1996, GEOLOGY, V24, P937, DOI 10.1130/0091-7613(1996)024<0937:CCITFS>2.3.CO;2; Roberts WHG, 2014, EARTH PLANET SC LETT, V386, P1, DOI 10.1016/j.epsl.2013.10.020; Roche D, 2004, NATURE, V432, P379, DOI 10.1038/nature03059; Sachs JP, 1999, SCIENCE, V286, P756, DOI 10.1126/science.286.5440.756; Schmittner A, 2002, SCIENCE, V295, P1489, DOI 10.1126/science.1066174; Schmittner A, 2008, NATURE, V456, P373, DOI 10.1038/nature07531; Schulz H, 1998, NATURE, V393, P54, DOI 10.1038/31750; Schulz M, 1999, GEOPHYS RES LETT, V26, P3385, DOI 10.1029/1999GL006069; Siddall M, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000226; Simon MH, 2013, EARTH PLANET SC LETT, V383, P101, DOI 10.1016/j.epsl.2013.09.035; Stepanek C, 2012, GEOSCI MODEL DEV, V5, P1221, DOI 10.5194/gmd-5-1221-2012; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Stouffer RJ, 2006, J CLIMATE, V19, P1365, DOI 10.1175/JCLI3689.1; Turney CSM, 2004, NATURE, V428, P306, DOI 10.1038/nature02386; Van Meerbeeck CJ, 2011, QUATERNARY SCI REV, V30, P3618, DOI 10.1016/j.quascirev.2011.08.002; Voelker AHL, 2002, QUATERNARY SCI REV, V21, P1185, DOI 10.1016/S0277-3791(01)00139-1; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang XF, 2006, QUATERNARY SCI REV, V25, P3391, DOI 10.1016/j.quascirev.2006.02.009; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wei W, 2012, J CLIMATE, V25, P6989, DOI 10.1175/JCLI-D-11-00667.1; Wei W, 2012, J PHYS OCEANOGR, V42, P785, DOI 10.1175/JPO-D-11-038.1; Wunsch C, 2006, QUATERNARY RES, V65, P191, DOI 10.1016/j.yqres.2005.10.006; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220; Zahn R, 1997, PALEOCEANOGRAPHY, V12, P696, DOI 10.1029/97PA00581; Zhang R, 2005, J CLIMATE, V18, P1853, DOI 10.1175/JCLI3460.1; Zhang X, 2013, CLIM PAST, V9, P2319, DOI 10.5194/cp-9-2319-2013; Ziegler M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2897	99	153	161	4	172	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					290	+		10.1038/nature13592	http://dx.doi.org/10.1038/nature13592			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119027				2022-12-28	WOS:000340508200030
J	Sundstrom, J; Arima, H; Woodward, M; Jackson, R; Karmali, K; Lloyd-Jones, D; Baigent, C; Emberson, J; Rahimi, K; MacMahon, S; Patel, A; Perkovic, V; Turnbull, F; Neal, B				Sundstrom, Johan; Arima, Hisatomi; Woodward, Mark; Jackson, Rod; Karmali, Kunal; Lloyd-Jones, Donald; Baigent, Colin; Emberson, Jonathan; Rahimi, Kazem; MacMahon, Stephen; Patel, Anushka; Perkovic, Vlado; Turnbull, Fiona; Neal, Bruce		Blood Pressure Lowering Treatment	Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data	LANCET			English	Article							PLACEBO-CONTROLLED TRIAL; DISEASE PREVENTION; EUROPEAN GUIDELINES; COST-EFFECTIVENESS; CLINICAL-PRACTICE; OLDER PATIENTS; DOUBLE-BLIND; NEW-ZEALAND; HYPERTENSION; BENEFIT	Background We aimed to investigate whether the benefits of blood pressure-lowering drugs are proportional to baseline cardiovascular risk, to establish whether absolute risk could be used to inform treatment decisions for blood pressure-lowering therapy, as is recommended for lipid-lowering therapy. Methods This meta-analysis included individual participant data from trials that randomly assigned patients to either blood pressure-lowering drugs or placebo, or to more intensive or less intensive blood pressure-lowering regimens. The primary outcome was total major cardiovascular events, consisting of stroke, heart attack, heart failure, or cardiovascular death. Participants were separated into four categories of baseline 5-year major cardiovascular risk using a risk prediction equation developed from the placebo groups of the included trials (<11%, 11-15%, 15-21%, >21%). Findings 11 trials and 26 randomised groups met the inclusion criteria, and included 67 475 individuals, of whom 51 917 had available data for the calculation of the risk equations. 4167 (8%) had a cardiovascular event during a median of 4.0 years (IQR 3.4-4.4) of follow-up. The mean estimated baseline levels of 5-year cardiovascular risk for each of the four risk groups were 6 0% (SD 2.0), 12.1% (1.5), 17.7% (1.7), and 26.8% (5.4). In each consecutive higher risk group, blood pressure-lowering treatment reduced the risk of cardiovascular events relatively by 18% (95% CI 7-27), 15% (4-25), 13% (2-22), and 15% (5-24), respectively (p=0.30 for trend). However, in absolute terms, treating 1000 patients in each group with blood pressure-lowering treatment for 5 years would prevent 14 (95% CI 8-21), 20 (8-31), 24 (8-40), and 38 (16-61) cardiovascular events, respectively (p=0.04 for trend). Interpretation Lowering blood pressure provides similar relative protection at all levels of baseline cardiovascular risk, but progressively greater absolute risk reductions as baseline risk increases. These results support the use of predicted baseline cardiovascular disease risk equations to inform blood pressure-lowering treatment decisions.	[Sundstrom, Johan] Uppsala Univ, SE-75185 Uppsala, Sweden; [Sundstrom, Johan] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Arima, Hisatomi; Woodward, Mark; Rahimi, Kazem; MacMahon, Stephen; Patel, Anushka; Perkovic, Vlado; Turnbull, Fiona; Neal, Bruce] George Inst Global Hlth, Sydney, NSW, Australia; [Woodward, Mark; Baigent, Colin; Emberson, Jonathan] Univ Oxford, Oxford, England; [Jackson, Rod] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand; [Karmali, Kunal] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Lloyd-Jones, Donald] Feinberg Sch Med, Chicago, IL USA; [Neal, Bruce] Imperial Coll London, London, England	Uppsala University; George Institute for Global Health; University of Sydney; George Institute for Global Health; University of Sydney; University of Oxford; University of Auckland; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Imperial College London	Sundstrom, J (corresponding author), Uppsala Univ, Univ Uppsala Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden.	johan.sundstrom@medsci.uu.se	Sundström, Johan/A-6286-2009; Woodward, Mark/D-8492-2015; Staessen, Jan A/A-1065-2011; Rahimi, Kazem/Q-1279-2015; Asselbergs, Folkert W./ABD-6752-2021; Perkovic, Vlado/AAY-1933-2021; Sundstrom, Johan/R-2139-2019; Rahimi, Kazem/AAA-4250-2022; de Zeeuw, Dick/E-9080-2014; Woodward, Mark/L-6817-2017; Remuzzi, Giuseppe/V-9766-2017	Sundström, Johan/0000-0003-2247-8454; Staessen, Jan A/0000-0002-3026-1637; Rahimi, Kazem/0000-0002-4807-4610; Asselbergs, Folkert W./0000-0002-1692-8669; Sundstrom, Johan/0000-0003-2247-8454; de Zeeuw, Dick/0000-0003-3434-7777; Rodgers, Anthony/0000-0003-1282-1896; Ohkubo, Takayoshi/0000-0002-3283-8196; Pepine, Carl/0000-0002-6011-681X; Neal, Bruce/0000-0002-0490-7465; Lloyd-Jones, Donald/0000-0003-0847-6110; Anderson, Craig/0000-0002-7248-4863; Remuzzi, Giuseppe/0000-0002-6194-3446; MacMahon, Stephen/0000-0003-2064-7699; van Gilst, Wiek/0000-0003-2968-8585; Patel, Anushka/0000-0003-3825-4092	Swedish Heart-Lung Foundation [20041151]; Swedish Research Council [2007-5942, 2010-1078]; Kjell och Marta Beijers Stiftelse; Nystroms Amerikastipendium; Bergholmska fonden; Heart Foundation of Australia; National Health and Medical Research Council of Australia (NHMRC); ARC; Medical Research Council, UK; NHMRC; Australian Research Council (ARC); National Institute for Health Research [CDF-2013-06-012] Funding Source: researchfish	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Kjell och Marta Beijers Stiftelse; Nystroms Amerikastipendium; Bergholmska fonden; Heart Foundation of Australia(National Heart Foundation of Australia); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); National Institute for Health Research(National Institute for Health Research (NIHR))	JS was funded by the Swedish Heart-Lung Foundation (grant 20041151) and the Swedish Research Council (grants 2007-5942 and 2010-1078). JS also received grants from Kjell och Marta Beijers Stiftelse, Nystroms Amerikastipendium, and Bergholmska fonden. VP has received grants from Heart Foundation of Australia. BN is supported by an Australian Research Council (ARC) Future Fellowship and a National Health and Medical Research Council of Australia (NHMRC) Senior Research Fellowship. HA is supported by an ARC Fellowship. CB is supported by the Medical Research Council, UK. MW, VP, FT, SM, and BN received grants from NHMRC. The researchers were independent of the funders, which had no role in the study.	Agodoa L, 2007, J HYPERTENS, V25, P951; Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Black HR, 1997, ARCH INTERN MED, V157, P2413; Califf RM, 1997, AM HEART J, V133, P630, DOI 10.1016/S0002-8703(97)70164-9; Cobiac LJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-398; Cooper A, 2008, BRIT MED J, V336, P1246, DOI 10.1136/bmj.39554.624086.AD; De Backer G, 2003, EUR HEART J, V24, P1601, DOI 10.1016/S0195-668X(03)00347-6; Dorresteijn JAN, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5888; Eddy DM, 2011, ANN INTERN MED, V154, P627, DOI 10.7326/0003-4819-154-9-201105030-00008; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Fox KM, 2003, LANCET, V362, P782; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; Germano G, 2012, EUR HEART J, V33, P137; Gerstein HC, 2000, LANCET, V355, P253; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hackam DG, 2013, CAN J CARDIOL, V29, P528, DOI 10.1016/j.cjca.2013.01.005; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Jackson R, 2005, LANCET, V365, P434, DOI 10.1016/S0140-6736(05)17833-7; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; Jackson R, 2000, BMJ-BRIT MED J, V320, P709, DOI 10.1136/bmj.320.7236.709; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kent DM, 2002, AM J MED, V113, P104, DOI 10.1016/S0002-9343(02)01160-9; Krause T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4891; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACMAHON S, 1993, CLIN EXP HYPERTENS, V15, P967, DOI 10.3109/10641969309037085; MacMahon S, 2001, LANCET, V358, P1033, DOI 10.1016/S0140-6736(01)06178-5; MacMahon S, 2000, J AM COLL CARDIOL, V36, P438, DOI 10.1016/S0735-1097(00)00736-1; Marre M, 2004, BRIT MED J, V328, P495, DOI 10.1136/bmj.37970.629537.0D; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Montgomery AA, 2003, J HYPERTENS, V21, P1753, DOI 10.1097/00004872-200309000-00026; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Pitt B, 2000, CIRCULATION, V102, P1503, DOI 10.1161/01.CIR.102.13.1503; Reboldi G, 2014, HYPERTENSION, V63, P475, DOI 10.1161/HYPERTENSIONAHA.113.02089; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Teo KK, 2000, CIRCULATION, V102, P1748; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Tonkin Andrew, 2005, Heart Lung Circ, V14, P275; Turnbull F, 2003, LANCET, V362, P1527; WHO Int Soc Hyperten Blood Press Lower, 1998, J HYPERTENS, V16, P127	47	410	419	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					591	598						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25131978				2022-12-28	WOS:000340573300031
J	Purnell, BA				Purnell, Beverly A.			A legacy that transcends genes	SCIENCE			English	Editorial Material																			0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					742	743		10.1126/science.345.6198.742	http://dx.doi.org/10.1126/science.345.6198.742			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124422	Bronze			2022-12-28	WOS:000340593100026
J	Holme, O; Loberg, M; Kalager, M; Bretthauer, M; Hernan, MA; Aas, E; Eide, TJ; Skovlund, E; Schneede, J; Tveit, KM; Hoff, G				Holme, Oyvind; Loberg, Magnus; Kalager, Mette; Bretthauer, Michael; Hernan, Miguel A.; Aas, Eline; Eide, Tor J.; Skovlund, Eva; Schneede, Jorn; Tveit, Kjell Magne; Hoff, Geir			Effect of Flexible Sigmoidoscopy Screening on Colorectal Cancer Incidence and Mortality A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL-OCCULT-BLOOD; ONCE-ONLY SIGMOIDOSCOPY; BASE-LINE FINDINGS; ASYMPTOMATIC ADULTS; COLONIC NEOPLASIA; RISK; SURVEILLANCE; COLONOSCOPY; POPULATION; PREVALENCE	IMPORTANCE Colorectal cancer is a major health burden. Screening is recommended in many countries. OBJECTIVE To estimate the effectiveness of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality in a population-based trial. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial of 100 210 individuals aged 50 to 64 years, identified from the population of Oslo city and Telemark County, Norway. Screening was performed in 1999-2000 (55-64-year age group) and in 2001 (50-54-year age group), with follow-up ending December 31, 2011. Of those selected, 1415 were excluded due to prior colorectal cancer, emigration, or death, and 3 could not be traced in the population registry. INTERVENTIONS Participants randomized to the screening group were invited to undergo screening. Within the screening group, participants were randomized 1: 1 to receive once-only flexible sigmoidoscopy or combination of once-only flexible sigmoidoscopy and fecal occult blood testing (FOBT). Participants with positive screening test results (cancer, adenoma, polyp >= 10 mm, or positive FOBT) were offered colonoscopy. The control group received no intervention. MAIN OUTCOMES AND MEASURES Colorectal cancer incidence and mortality. RESULTS A total of 98 792 participants were included in the intention-to-screen analyses, of whom 78 220 comprised the control group and 20 572 comprised the screening group (10 283 randomized to receive a flexible sigmoidoscopy and 10 289 to receive flexible sigmoidoscopy and FOBT). Adherence with screening was 63%. After a median of 10.9 years, 71 participants died of colorectal cancer in the screening group vs 330 in the control group (31.4 vs 43.1 deaths per 100 000 person-years; absolute rate difference, 11.7 [95% CI, 3.0-20.4]; hazard ratio [HR], 0.73 [95% CI, 0.56-0.94]). Colorectal cancer was diagnosed in 253 participants in the screening group vs 1086 in the control group (112.6 vs 141.0 cases per 100 000 person-years; absolute rate difference, 28.4 [95% CI, 12.1-44.7]; HR, 0.80 [95% CI, 0.70-0.92]). Colorectal cancer incidence was reduced in both the 50-to 54-year age group (HR, 0.68; 95% CI, 0.49-0.94) and the 55-to 64-year age group (HR, 0.83; 95% CI, 0.71-0.96). There was no difference between the flexible sigmoidoscopy only vs the flexible sigmoidoscopy and FOBT screening groups. CONCLUSIONS AND RELEVANCE In Norway, once-only flexible sigmoidoscopy screening or flexible sigmoidoscopy and FOBT reduced colorectal cancer incidence and mortality on a population level compared with no screening. Screening was effective both in the 50-to 54-year and the 55-to 64-year age groups.	[Holme, Oyvind; Bretthauer, Michael] Sorlandet Hosp Kristiansand, Dept Med, N-4604 Kristiansand, Norway; [Holme, Oyvind; Loberg, Magnus; Kalager, Mette; Bretthauer, Michael; Aas, Eline; Hoff, Geir] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Holme, Oyvind; Loberg, Magnus; Kalager, Mette; Bretthauer, Michael; Hernan, Miguel A.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Holme, Oyvind; Loberg, Magnus; Kalager, Mette; Bretthauer, Michael; Hernan, Miguel A.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Holme, Oyvind; Loberg, Magnus; Kalager, Mette; Bretthauer, Michael; Hernan, Miguel A.] Harvard Mit Div Hlth Sci & Technol, Boston, MA USA; [Loberg, Magnus; Bretthauer, Michael] Oslo Univ Hosp, Dept Transplantat Med, Oslo, Norway; [Kalager, Mette; Hoff, Geir] Telemark Hosp Skien, Skien, Norway; [Eide, Tor J.] Univ Oslo, Oslo, Norway; [Eide, Tor J.] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Skovlund, Eva] Univ Oslo, Sch Pharm, N-0316 Oslo, Norway; [Schneede, Jorn] Umea Univ, Dept Pharmacol & Clin Neurosci, Clin Pharmacol Unit, Umea, Sweden; [Tveit, Kjell Magne] Oslo Univ Hosp, Dept Oncol, Oslo, Norway; [Hoff, Geir] Canc Registry Norway, Oslo, Norway	University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; University of Oslo; Telemark Hospital Trust; University of Oslo; University of Oslo; University of Oslo; Umea University; University of Oslo; University of Oslo	Holme, O (corresponding author), Sorlandet Hosp Kristiansand, Postboks 416, N-4604 Kristiansand, Norway.	oyvind.holme@sshf.no	Løberg, Magnus/F-1152-2016	Løberg, Magnus/0000-0003-2231-1304; Hernan, Miguel/0000-0003-1619-8456	Norwegian government; Norwegian Cancer Society; Research Council of Norway; South-East Regional Health Authority of Norway; Fulbright Foundation; Sorlandet Hospital Kristiansand; National Institutes of Health [PO1 CA134294]; NATIONAL CANCER INSTITUTE [P01CA134294] Funding Source: NIH RePORTER	Norwegian government; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); South-East Regional Health Authority of Norway; Fulbright Foundation; Sorlandet Hospital Kristiansand; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The NORCCAP trial was funded by research grants from the Norwegian government and the Norwegian Cancer Society. Work with the present article was funded by research grants from the Norwegian Cancer Society, the Research Council of Norway, The South-East Regional Health Authority of Norway, The Fulbright Foundation, Sorlandet Hospital Kristiansand, and the National Institutes of Health grant PO1 CA134294.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Bretthauer N, 2002, SCAND J GASTROENTERO, V37, P568, DOI 10.1080/00365520252903125; Cancer Registry of Norway, GASTRONET RESULTATER; Ederer F, 1999, J CLIN EPIDEMIOL, V52, P447, DOI 10.1016/S0895-4356(99)00016-5; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Forsberg AM, 2012, SCAND J GASTROENTERO, V47, P184, DOI 10.3109/00365521.2011.647062; Gondal G, 2003, SCAND J GASTROENTERO, V38, P635, DOI 10.1080/00365520310003002; Gondal G, 2003, GUT, V52, P398, DOI 10.1136/gut.52.3.398; Hoff G, 1996, SCAND J GASTROENTERO, V31, P834, DOI 10.3109/00365529609051989; Hoff G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1846; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Lansdorp-Vogelaar I, 2011, EPIDEMIOL REV, V33, P88, DOI 10.1093/epirev/mxr004; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; Lash RH, 2010, J CLIN PATHOL, V63, P681, DOI 10.1136/jcp.2010.075507; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2001, NEW ENGL J MED, V345, P555, DOI 10.1056/NEJMoa010328; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; Rate Inflation, UNITED KINGDOM CONSU; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Segnan N, 2002, J NATL CANCER I, V94, P1763; Segnan N, 2011, J NATL CANCER I, V103, P1310, DOI 10.1093/jnci/djr284; Tappenden P, 2004, REPORT TO THE ENGLIS; Toh S, 2008, INT J BIOSTAT, V4, P1117; West NJ, 2009, INT J COLORECTAL DIS, V24, P731, DOI 10.1007/s00384-009-0690-6; Zavoral M, 2009, WORLD J GASTROENTERO, V15, P5907, DOI 10.3748/wjg.15.5907	32	266	273	1	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					606	615		10.1001/jama.2014.8266	http://dx.doi.org/10.1001/jama.2014.8266			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117129	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000340136400019
J	Laviano, A				Laviano, Alessandro			Young Blood	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ERYTHROPOIESIS		Univ Roma La Sapienza, Dept Clin Med, I-00185 Rome, Italy	Sapienza University Rome	Laviano, A (corresponding author), Univ Roma La Sapienza, Dept Clin Med, Piazzale Aldo Moro 5, I-00185 Rome, Italy.							Dussiot M, 2014, NAT MED, V20, P398, DOI 10.1038/nm.3468; Katsimpardi L, 2014, SCIENCE, V344, P630, DOI 10.1126/science.1251141; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Sinha M, 2014, SCIENCE, V344, P649, DOI 10.1126/science.1251152; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Villeda SA, 2014, NAT MED, V20, P659, DOI 10.1038/nm.3569	6	21	24	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					573	575		10.1056/NEJMcibr1407158	http://dx.doi.org/10.1056/NEJMcibr1407158			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25099584				2022-12-28	WOS:000339899100016
J	Tubio, JMC; Li, YL; Ju, YS; Martincorena, I; Cooke, SL; Tojo, M; Gundem, G; Pipinikas, CP; Zamora, J; Raine, K; Menzies, A; Roman-Garcia, P; Fullam, A; Gerstung, M; Shlien, A; Tarpey, PS; Papaemmanuil, E; Knappskog, S; Van Loo, P; Ramakrishna, M; Davies, HR; Marshall, J; Wedge, DC; Teague, J; Butler, AP; Nik-Zainal, S; Alexandrov, L; Behjati, S; Yates, LR; Bolli, N; Mudie, L; Hardy, C; Martin, S; McLaren, S; O'Meara, S; Anderson, E; Maddison, M; Gamble, S; Foster, C; Warren, AY; Whitaker, H; Brewer, D; Eeles, R; Cooper, C; Neal, D; Lynch, AG; Visakorpi, T; Isaacs, WB; van't Veer, L; Caldas, C; Desmedt, C; Sotiriou, C; Aparicio, S; Foekens, JA; Eyfjord, JE; Lakhani, SR; Thomas, G; Myklebost, O; Span, PN; Borresen-Dale, AL; Richardson, AL; Van de Vijver, M; Vincent-Salomon, A; Van den Eynden, GG; Flanagan, AM; Futreal, PA; Janes, SM; Bova, GS; Stratton, MR; McDermott, U; Campbell, PJ				Tubio, Jose M. C.; Li, Yilong; Ju, Young Seok; Martincorena, Inigo; Cooke, Susanna L.; Tojo, Marta; Gundem, Gunes; Pipinikas, Christodoulos P.; Zamora, Jorge; Raine, Keiran; Menzies, Andrew; Roman-Garcia, Pablo; Fullam, Anthony; Gerstung, Moritz; Shlien, Adam; Tarpey, Patrick S.; Papaemmanuil, Elli; Knappskog, Stian; Van Loo, Peter; Ramakrishna, Manasa; Davies, Helen R.; Marshall, John; Wedge, David C.; Teague, Jonw.; Butler, Adam P.; Nik-Zainal, Serena; Alexandrov, Ludmil; Behjati, Sam; Yates, Lucy R.; Bolli, Niccolo; Mudie, Laura; Hardy, Claire; Martin, Sancha; McLaren, Stuart; O'Meara, Sarah; Anderson, Elizabeth; Maddison, Mark; Gamble, Stephen; Foster, Christopher; Warren, Anne Y.; Whitaker, Hayley; Brewer, Daniel; Eeles, Rosalind; Cooper, Colin; Neal, David; Lynch, Andy G.; Visakorpi, Tapio; Isaacs, William B.; van't Veer, Laura; Caldas, Carlos; Desmedt, Christine; Sotiriou, Christos; Aparicio, Sam; Foekens, John A.; Eyfjord, Jorunn Erla; Lakhani, Sunil R.; Thomas, Gilles; Myklebost, Ola; Span, Paul N.; Borresen-Dale, Anne-Lise; Richardson, Andrea L.; Van de Vijver, Marc; Vincent-Salomon, Anne; Van den Eynden, Gert G.; Flanagan, Adrienne M.; Futreal, P. Andrew; Janes, Sam M.; Bova, G. Steven; Stratton, Michael R.; McDermott, Ultan; Campbell, Peter J.		ICGC Breast Canc Grp; ICGC Bone Canc Grp; ICGC Prostate Canc Grp	Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes	SCIENCE			English	Article							SOMATIC RETROTRANSPOSITION; HUMAN BRAIN; MUTATIONS; EVOLUTION; ELEMENTS; CARCINOMAS; LANDSCAPE; SEQUENCE; OVARIAN; CELLS	Long interspersed nuclear element-1 (L1) retrotransposons are mobile repetitive elements that are abundant in the human genome. L1 elements propagate through RNA intermediates. In the germ line, neighboring, nonrepetitive sequences are occasionally mobilized by the L1 machinery, a process called 3' transduction. Because 3' transductions are potentially mutagenic, we explored the extent to which they occur somatically during tumorigenesis. Studying cancer genomes from 244 patients, we found that tumors from 53% of the patients had somatic retrotranspositions, of which 24% were 3' transductions. Fingerprinting of donor L1s revealed that a handful of source L1 elements in a tumor can spawn from tens to hundreds of 3' transductions, which can themselves seed further retrotranspositions. The activity of individual L1 elements fluctuated during tumor evolution and correlated with L1 promoter hypomethylation. The 3' transductions disseminated genes, exons, and regulatory elements to new locations, most often to heterochromatic regions of the genome.	[Tubio, Jose M. C.; Li, Yilong; Ju, Young Seok; Martincorena, Inigo; Cooke, Susanna L.; Gundem, Gunes; Zamora, Jorge; Raine, Keiran; Menzies, Andrew; Roman-Garcia, Pablo; Fullam, Anthony; Gerstung, Moritz; Shlien, Adam; Tarpey, Patrick S.; Papaemmanuil, Elli; Knappskog, Stian; Van Loo, Peter; Ramakrishna, Manasa; Davies, Helen R.; Marshall, John; Wedge, David C.; Teague, Jonw.; Butler, Adam P.; Nik-Zainal, Serena; Alexandrov, Ludmil; Behjati, Sam; Yates, Lucy R.; Bolli, Niccolo; Mudie, Laura; Hardy, Claire; Martin, Sancha; McLaren, Stuart; O'Meara, Sarah; Anderson, Elizabeth; Maddison, Mark; Gamble, Stephen; Futreal, P. Andrew; Stratton, Michael R.; McDermott, Ultan; Campbell, Peter J.; ICGC Breast Canc Grp; ICGC Bone Canc Grp] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Tojo, Marta] Univ Santiago de Compostela, Inst Invest Sanitarias, Ctr Res Mol Med & Chron Dis, Dept Physiol,Sch Med, Santiago De Compostela, Spain; [Pipinikas, Christodoulos P.; Janes, Sam M.] UCL, Rayne Inst, Lungs Living Res Ctr, London, England; [Knappskog, Stian] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Knappskog, Stian] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Van Loo, Peter] VIB, Dept Human Genet, Human Genome Lab, Leuven, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Leuven, Belgium; [Brewer, Daniel; Eeles, Rosalind; Cooper, Colin] Inst Canc Res, London SW3 6JB, England; [Whitaker, Hayley; Neal, David; Lynch, Andy G.; Caldas, Carlos; ICGC Prostate Canc Grp] Univ Cambridge, Canc Res UK CRUK Cambridge Inst, Cambridge, England; [Foster, Christopher] Univ Liverpool, London, England; [Foster, Christopher] HCA Pathol Labs, London, England; [Nik-Zainal, Serena; Warren, Anne Y.; Campbell, Peter J.] Cambridge Univ Hosp Natl Hlth Serv NHS Fdn Trust, Cambridge, England; [Brewer, Daniel; Cooper, Colin] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Visakorpi, Tapio; Bova, G. Steven] Univ Tampere, Inst Biosci & Med Technol BioMediTech, FIN-33101 Tampere, Finland; [Visakorpi, Tapio; Bova, G. Steven] Tampere Univ Hosp, Tampere, Finland; [Isaacs, William B.] Johns Hopkins Univ, Baltimore, MD USA; [van't Veer, Laura] Netherlands Canc Inst, Amsterdam, Netherlands; [Desmedt, Christine; Sotiriou, Christos] Univ Libre Bruxelles, Inst Jules Bordet, Breast Canc Translat Res Lab, Brussels, Belgium; [Aparicio, Sam] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Foekens, John A.] Erasmus Univ, Med Ctr, Erasmus Med Ctr, Dept Med Oncol,Canc Inst, Rotterdam, Netherlands; [Eyfjord, Jorunn Erla] Univ Iceland, Canc Res Lab, Reykjavik, Iceland; [Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Pathol Queensland, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Thomas, Gilles] Univ Lyon 1, Inst Natl Canc INCa Synergie, F-69365 Lyon, France; [Myklebost, Ola; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Inst Canc Res, Oslo, Norway; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, NL-6525 ED Nijmegen, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, NL-6525 ED Nijmegen, Netherlands; [Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Van de Vijver, Marc] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Vincent-Salomon, Anne] Inst Bergonie, F-33076 Bordeaux, France; [Vincent-Salomon, Anne] Inst Curie, Dept Tumor Biol, F-75248 Paris 05, France; [Van den Eynden, Gert G.] GZA Hosp, Translat Canc Res Unit, Antwerp, Belgium; [Van den Eynden, Gert G.] GZA Hosp, Dept Pathol, Antwerp, Belgium; [Flanagan, Adrienne M.] Royal Natl Orthopaed Hosp, Stanmore, Middx, England; [Flanagan, Adrienne M.] UCL, UCL Canc Inst, London, England; [Futreal, P. Andrew] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Bolli, Niccolo; Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge, England	Wellcome Trust Sanger Institute; Universidade de Santiago de Compostela; University of London; King's College London; University College London; University of Bergen; University of Bergen; Haukeland University Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Liverpool; University of East Anglia; Tampere University; Tampere University; Tampere University Hospital; Johns Hopkins University; Netherlands Cancer Institute; Institut Jules Bordet; Universite Libre de Bruxelles; British Columbia Cancer Agency; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Iceland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Oslo; Radboud University Nijmegen; Radboud University Nijmegen; Harvard University; Dana-Farber Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; UNICANCER; Institut Bergonie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; University of Texas System; UTMD Anderson Cancer Center; University of Cambridge	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Hinxton, Cambs, England.	pc8@sanger.ac.uk	Bolli, Niccolo/D-4057-2011; Sweep, C.G.J./H-8096-2014; Desmedt, Christine/P-7438-2017; Alexandrov, Ludmil/AAS-1454-2021; Caldas, Carlos/U-7250-2019; Ehinger, Anna/I-8516-2014; Simpson, Peter/F-1225-2010; Stunnenberg, Hendrik G./D-6875-2012; Wedge, David/AAC-4977-2021; Ju, Young Seok/E-1324-2012; Brewer, Daniel S/D-6201-2018; Myklebost, Ola/E-9335-2010; Tubio, Jose/AAG-7345-2019; Span, Paul/G-4710-2012; Lakhani, Sunil R/I-1970-2018; Tubio, Jose M.C./H-5076-2015; Roman-Garcia, Pablo/D-7368-2016; Nik-Zainal, Serena/ABD-4437-2020; Gamble, Stephen/D-1417-2011	Bolli, Niccolo/0000-0002-1018-5139; Sweep, C.G.J./0000-0003-1103-3070; Desmedt, Christine/0000-0002-5223-5579; Alexandrov, Ludmil/0000-0003-3596-4515; Caldas, Carlos/0000-0003-3547-1489; Ehinger, Anna/0000-0001-9225-7396; Simpson, Peter/0000-0002-4816-8289; Stunnenberg, Hendrik G./0000-0002-0066-1576; Ju, Young Seok/0000-0002-5514-4189; Brewer, Daniel S/0000-0003-4753-9794; Myklebost, Ola/0000-0002-2866-3223; Tubio, Jose/0000-0003-3540-2459; Span, Paul/0000-0002-1930-6638; Lakhani, Sunil R/0000-0003-4067-2760; Tubio, Jose M.C./0000-0003-3540-2459; Martin, Sancha/0000-0001-6213-5259; Roman-Garcia, Pablo/0000-0003-1904-5674; McDermott, Ultan/0000-0001-9032-4700; Knappskog, Stian/0000-0002-4153-1655; Fullam, Anthony/0000-0002-0884-8124; Van Loo, Peter/0000-0003-0292-1949; Raine, Keiran/0000-0002-5634-1539; chin, suet-feung/0000-0001-5697-1082; Mithen, Richard/0000-0001-7307-4324; Visakorpi, Tapio/0000-0002-5004-0364; Wedge, David/0000-0002-7572-3196; Gerstung, Moritz/0000-0001-6709-963X; Nik-Zainal, Serena/0000-0001-5054-1727; Flanagan, Adrienne/0000-0002-2832-1303; Massie, Charlie/0000-0003-2314-4843; Berney, Daniel/0000-0001-5474-8696; Gamble, Stephen/0000-0002-0867-3723; Bova, George/0000-0003-1639-3104; Dudderidge, Tim/0000-0001-6373-3613; Martincorena, Inigo/0000-0003-1122-4416; Aparicio, Samuel/0000-0002-0487-9599; van de Vijver, Marc/0000-0002-0385-4787; Janes, Sam/0000-0002-6634-5939; Eeles, Rosalind/0000-0002-3698-6241	Marie Curie Fellowship [328264]; Wellcome Trust [WT100183MA]; Chordoma Foundation; Skeletal Cancer Action Trust; European Molecular Biology Organization [LTF 1203-2012, 1287-2012]; CRUK Clinician Scientist fellowship; National Institute for Health Research; University College London Hospitals Biomedical Research Centre; Cancer Research UK University College London Experimental Cancer Centre; Brussels Region-Impulse Programme Life Sciences; European Union (BASIS); Wellcome Trust; CRUK [C5047/A14835]; Dallaglio Foundation; Bob Champion Trust; Orchid Cancer appeal; RoseTrees Trust; North West Cancer Research Fund, Big C; Grand Charity of Freemasons; Research Foundation Flanders (FWO); 14M Genomics Limited; BBSRC [BBS/E/F/00044431, BBS/E/F/00042686] Funding Source: UKRI; MRC [G0900871] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044431, BBS/E/F/00042686] Funding Source: researchfish; Cancer Research UK [15007, 16942, 17528, 14835, 19556] Funding Source: researchfish; Medical Research Council [G0900871] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish; Rosetrees Trust [M35-F1-CD1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	Marie Curie Fellowship(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Chordoma Foundation; Skeletal Cancer Action Trust; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); CRUK Clinician Scientist fellowship; National Institute for Health Research(National Institute for Health Research (NIHR)); University College London Hospitals Biomedical Research Centre(General Electric); Cancer Research UK University College London Experimental Cancer Centre; Brussels Region-Impulse Programme Life Sciences; European Union (BASIS); Wellcome Trust(Wellcome TrustEuropean Commission); CRUK(Cancer Research UK); Dallaglio Foundation; Bob Champion Trust; Orchid Cancer appeal; RoseTrees Trust(Rosetrees Trust); North West Cancer Research Fund, Big C; Grand Charity of Freemasons; Research Foundation Flanders (FWO)(FWO); 14M Genomics Limited; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Rosetrees Trust(Rosetrees Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.M.C.T. is supported by a Marie Curie Fellowship FP7-PEOPLE-2012-IEF (project number 328264) and thanks H. Kazazian and S. Solyom for providing with L1Hs specific oligonucleotide primer sequences. We thank the TCGA project team and their specimen donors for providing sequencing data. This work was supported by the Wellcome Trust, the Chordoma Foundation, and the Skeletal Cancer Action Trust. Y.S.J. and I. M. are supported by European Molecular Biology Organization long-term fellowships (LTF 1203-2012 and 1287-2012). P.J.C. and S.M.J. are Wellcome Trust Senior Clinical Fellows. P. V. L. is a postdoctoral researcher of the Research Foundation Flanders (FWO). S.N.-Z. is funded by a Wellcome Trust Intermediate Clinical Research Fellowship (WT100183MA). U. M. is supported by a CRUK Clinician Scientist fellowship. Support was provided to A. M. F. by the National Institute for Health Research, the University College London Hospitals Biomedical Research Centre, and the Cancer Research UK University College London Experimental Cancer Centre. C. D. is supported by a grant from the Brussels Region-Impulse Programme Life Sciences. Samples from Addenbrooke's Hospital were collected with support from the NIHR Cambridge Biomedical Resource Centre. The ICGC Breast Cancer Consortium was supported by a grant from the European Union (BASIS) and the Wellcome Trust. The ICGC Prostate UK Cancer Consortium is funded by CRUK grant C5047/A14835, by the Dallaglio Foundation, and the Wellcome Trust. We also acknowledge support from the Bob Champion Trust, the Orchid Cancer appeal, the RoseTrees Trust, the North West Cancer Research Fund, Big C, the Grand Charity of Freemasons, and the Research Foundation Flanders (FWO). We acknowledge the Biomedical Research Centre at the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust. We thank the NIHR, Hutchison Whampoa Limited, Human Research Tissue Bank (Addenbrookes Hospital), CRUK Cambridge Research Institute Histopathology, In-situ Hybridisation Core Facility, Genomics Core Facility Cambridge, and Cambridge University Hospitals Media Studio. P.J.C. holds equity in, and is a paid consultant for, 14M Genomics Limited.	Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cooke SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4644; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ejima Y, 2003, HUM MOL GENET, V12, P1321, DOI 10.1093/hmg/ddg138; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Ewing AD, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r22; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hur K, 2014, GUT, V63, P635, DOI 10.1136/gutjnl-2012-304219; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Macfarlane CM, 2013, HUM MUTAT, V34, P974, DOI 10.1002/humu.22327; McBride DJ, 2012, J PATHOL, V227, P446, DOI 10.1002/path.4042; Menendez L, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-12; MIKI Y, 1992, CANCER RES, V52, P643; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Szak ST, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r30; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	36	240	244	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					531	531	1251343	10.1126/science.1251343	http://dx.doi.org/10.1126/science.1251343			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082706	Green Accepted			2022-12-28	WOS:000339651300037
J	Olsen, MF; Abdissa, A; Kaestel, P; Tesfaye, M; Yilma, D; Girma, T; Wells, JCK; Ritz, C; Molgaard, C; Michaelsen, KF; Zerfu, D; Brage, S; Andersen, AB; Friis, H				Olsen, Mette F.; Abdissa, Alemseged; Kaestel, Pernille; Tesfaye, Markos; Yilma, Daniel; Girma, Tsinuel; Wells, Jonathan C. K.; Ritz, Christian; Molgaard, Christian; Michaelsen, Kim F.; Zerfu, Dilnesaw; Brage, Soren; Andersen, Ase B.; Friis, Henrik			Effects of nutritional supplementation for HIV patients starting antiretroviral treatment: randomised controlled trial in Ethiopia	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; PLASMA GLUTATHIONE LEVELS; BODY CELL MASS; WEIGHT-LOSS; WHEY PROTEINS; RESISTANCE EXERCISE; PHYSICAL-ACTIVITY; INFECTED PATIENTS; MUSCLE STRENGTH; DOUBLE-BLIND	Objectives To determine the effects of lipid based nutritional supplements with either whey or soy protein in patients with HIV during the first three months of antiretroviral treatment (ART) and to explore effects of timing by comparing supplementation at the start of ART and after three months delay. Design Randomised controlled trial. Setting Three public ART facilities in Jimma, Oromia region, Ethiopia. Participants Adults with HIV eligible for ART with body mass index (BMI) >16. Intervention Daily supplementation with 200 g (4600 kJ) of supplement containing whey or soy during either the first three or the subsequent three months of ART. Outcome measures Primary: lean body mass assessed with deuterium dilution, grip strength measured with dynamometers, and physical activity measured with accelerometer and heart rate monitors. Secondary: viral load and CD4 counts. Auxiliary: weight and CD3 and CD8 counts. Results Of 318 patients enrolled, 210 (66%) were women, mean age was 33 (SD 9), and mean BMI was 19.5 (SD 2.4). At three months, participants receiving the supplements containing whey or soy had increased their lean body mass by 0.85 kg (95% confidence interval 0.16 kg to 1.53 kg) and 0.97 kg (0.29 kg to 1.64 kg), respectively, more than controls. This was accompanied by an increased gain of grip strength of 0.68 kg (-0.11 kg to 1.46 kg) for the whey supplement group and 0.93 kg (0.16 kg to 1.70 kg) for the soy supplement group. There were no effects on physical activity. Total weight gain increased by 2.05 kg (1.12 kg to 2.99 kg) and 2.06 kg (1.14 kg to 2.97 kg) for the whey and soy groups, respectively. In addition, in the whey supplement group overall CD3 counts improved by 150 cells/mu L (24 to 275 cells/mu L), of which 112 cells/mu L (15 to 209 cells/mu L) were CD8 and 25 cells/mu L (-2 to 53 cells/mu L) were CD4. Effects of the soy containing supplement on immune recovery were not significant. The effects of the two supplements, however, were not significantly different in direct comparison. Exploratory analysis showed that relatively more lean body mass was gained by patients with undetectable viral load at three months. Patients receiving delayed supplementation had higher weight gain but lower gains in functional outcomes. Conclusions Lipid based nutritional supplements improved gain of weight, lean body mass, and grip strength in patients with HIV starting ART. Supplements containing whey were associated with improved immune recovery.	[Olsen, Mette F.; Kaestel, Pernille; Ritz, Christian; Molgaard, Christian; Michaelsen, Kim F.; Friis, Henrik] Univ Copenhagen, Dept Nutr Exercise & Sports, DK-1958 Frederiksberg C, Denmark; [Abdissa, Alemseged] Jimma Univ, Dept Lab Sci & Pathol, Jimma, Ethiopia; [Tesfaye, Markos] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Psychiat, Jimma, Ethiopia; [Yilma, Daniel] Jimma Univ Specialized Hosp, Dept Internal Med, Jimma, Ethiopia; [Girma, Tsinuel] Jimma Univ Specialized Hosp, Dept Paediat & Child Hlth, Jimma, Ethiopia; [Wells, Jonathan C. K.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England; [Zerfu, Dilnesaw] Ethiopian Hlth & Nutr Res Inst, Addis Ababa, Ethiopia; [Brage, Soren] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Andersen, Ase B.] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark	University of Copenhagen; Jimma University; Jimma University; University of London; University College London; Ethiopian Health & Nutrition Research Institute; University of Cambridge; University of Southern Denmark; Odense University Hospital	Olsen, MF (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Rolighedsvej 30, DK-1958 Frederiksberg C, Denmark.	mette.frahm.olsen@gmail.com	Brage, Soren/C-6415-2013; Wells, Jonathan/A-4604-2009; Olsen, Mette F/S-6119-2016; Mølgaard, Christian/D-2052-2014; Tesfaye, Markos/H-9297-2019; Friis, Henrik/N-2047-2014; Friis, Henrik/P-2891-2019; Yilma, Daniel/AAJ-2072-2021; Ritz, Christian/P-6159-2014	Brage, Soren/0000-0002-1265-7355; Wells, Jonathan/0000-0003-0411-8025; Olsen, Mette F/0000-0002-5742-6403; Mølgaard, Christian/0000-0002-5311-9457; Friis, Henrik/0000-0002-2848-2940; Friis, Henrik/0000-0002-2848-2940; Yilma, Daniel/0000-0001-6058-2696; Abdissa, Alemseged/0000-0003-3798-5037; Tesfaye, Markos/0000-0002-3351-701X; Michaelsen, Kim F/0000-0003-0449-0839; Ritz, Christian/0000-0002-5095-0624; Abdissa, Alemseged/0000-0001-6871-1958; Kaestel, Pernille/0000-0003-2769-4666	US Dairy Export Council; International Atomic Energy Agency (IAEA); Ministry of Foreign Affairs of Denmark (DANIDA); MRC [MC_U106179473, MC_UU_12015/3] Funding Source: UKRI; Medical Research Council [MC_UU_12015/3, MC_U106179473] Funding Source: researchfish	US Dairy Export Council; International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Ministry of Foreign Affairs of Denmark (DANIDA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by US Dairy Export Council, International Atomic Energy Agency (IAEA), and Ministry of Foreign Affairs of Denmark (DANIDA). Nutriset developed the supplements and partially covered transportation expenses. The funders had no role in study design, data collection, and analysis, the decision to publish or preparation of the manuscript	Agin D, 2001, AIDS, V15, P2431, DOI 10.1097/00002030-200112070-00011; Agin D, 2000, ANN NY ACAD SCI, V904, P607, DOI 10.1111/j.1749-6632.2000.tb06523.x; Anema A, 2012, PUBLIC HEALTH NUTR, V15, P938, DOI 10.1017/S136898001100125X; [Anonymous], 2008, GUID MAN OPP INF ANT; BOUNOUS G, 1993, CLIN INVEST MED, V16, P204; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Christensen DL, 2012, AM J HUM BIOL, V24, P723, DOI 10.1002/ajhb.22303; Desquilbet L, 2007, J GERONTOL A-BIOL, V62, P1279, DOI 10.1093/gerona/62.11.1279; Ethiopian Health and Nutrition Research Institute (EHNRI), 1998, FOOD COMPOSITION TAB; Ethiopian Nutrition Institute, 1980, ETH TRAD REC; Fao/Who, 2001, HUM VIT MIN REQ; Federal Ministry of Health, 2011, NAT GUID NUTR CAR SU; Gillespie S. R., 2006, AIDS POVERTY HUNGER; Grobler L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004536.pub3; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Heimburger DC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010687; Hoppe C, 2008, J NUTR, V138, p145S, DOI 10.1093/jn/138.1.145S; IAEA human health series, 2010, INTR BOD COMP ASS US; Koethe JR, 2010, AM J CLIN NUTR, V91, p1138S, DOI 10.3945/ajcn.2010.28608D; Koethe JR, 2010, JAIDS-J ACQ IMM DEF, V53, P507, DOI 10.1097/QAI.0b013e3181b32baf; KOTLER DP, 1990, JPEN-PARENTER ENTER, V14, P454, DOI 10.1177/0148607190014005454; KOTLER DP, 1989, AM J CLIN NUTR, V50, P444, DOI 10.1093/ajcn/50.3.444; Kusko RL, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-10; Lamb MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038443; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lugassy DM, 2010, EMERG MED CLIN N AM, V28, P409, DOI 10.1016/j.emc.2010.01.011; Madec Y, 2009, AIDS, V23, P853, DOI 10.1097/QAD.0b013e32832913ee; Malvy D, 2001, J AM COLL NUTR, V20, P609, DOI 10.1080/07315724.2001.10719065; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Melchior JC, 1999, NUTRITION, V15, P865, DOI 10.1016/S0899-9007(99)00210-5; Micke P, 2001, EUR J CLIN INVEST, V31, P171, DOI 10.1046/j.1365-2362.2001.00781.x; Micke P, 2002, EUR J NUTR, V41, P12, DOI 10.1007/s003940200001; Ndekha MJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1867; Olsen MF, 2013, PATIENT PREFER ADHER, V7, P481, DOI 10.2147/PPA.S44413; OTT M, 1995, J ACQ IMMUN DEF SYND, V9, P20; Paton NIJ, 1997, J ACQ IMMUN DEF SYND, V14, P119, DOI 10.1097/00042560-199702010-00004; Raso V, 2013, JAIDS-J ACQ IMM DEF, V63, pE30, DOI 10.1097/QAI.0b013e31828c42bb; Sadler K, 2012, MEASURING IMPACT COS, P29; Sattler FR, 2008, AM J CLIN NUTR, V88, P1313, DOI 10.3945/ajcn.2006.23583; Schwenk A, 2000, AM J CLIN NUTR, V72, P496; Shabert JK, 1996, MED HYPOTHESES, V46, P252, DOI 10.1016/S0306-9877(96)90251-0; Shabert JK, 1999, NUTRITION, V15, P860, DOI 10.1016/S0899-9007(99)00213-0; Sudfeld CR, 2013, AM J CLIN NUTR, V97, P1278, DOI 10.3945/ajcn.112.053728; SUTTMANN U, 1995, J ACQ IMMUN DEF SYND, V8, P239, DOI 10.1097/00042560-199503010-00004; Tang AM, 2005, JAIDS-J ACQ IMM DEF, V40, P70, DOI 10.1097/01.qai.0000159627.54149.2e; Wanke C, 2002, AIDS PATIENT CARE ST, V16, P375, DOI 10.1089/10872910260196404; WELBOURNE TC, 1995, AM J CLIN NUTR, V61, P1058, DOI 10.1093/ajcn/61.5.1058	49	42	43	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2014	348								g3187	10.1136/bmj.g3187	http://dx.doi.org/10.1136/bmj.g3187			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5GP	25134117	Green Published, hybrid			2022-12-28	WOS:000336156800003
J	Pawlotsky, JM				Pawlotsky, Jean-Michel			Hepatitis E screening for blood donations: an urgent need?	LANCET			English	Editorial Material							E VIRUS-INFECTION; AGENTS		[Pawlotsky, Jean-Michel] Univ Paris Est, Natl Reference Ctr Viral Hepatitis B C & D, Dept Virol, Hop Henri Mondor, F-94010 Creteil, France; [Pawlotsky, Jean-Michel] Hop Henri Mondor, INSERM, U955, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Pawlotsky, JM (corresponding author), Univ Paris Est, Natl Reference Ctr Viral Hepatitis B C & D, Dept Virol, Hop Henri Mondor, F-94010 Creteil, France.	jean-michel.pawlotsky@hmn.aphp.fr	Pawlotsky, Jean-Michel/R-8159-2018	Pawlotsky, Jean-Michel/0000-0003-0745-7559				Coilly A, 2013, TRANSPLANTATION, V96, pE4, DOI 10.1097/TP.0b013e318296c9f7; Coste J, 2005, VOX SANG, V88, P289, DOI 10.1111/j.1423-0410.2005.00636_1.x; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Feray C, 2014, LANCET, V383, P218, DOI 10.1016/S0140-6736(14)60072-6; Hewitt EP, 2014, LANCET; Hogema BM, 2014, TRANSFUSION, V54, P3092, DOI 10.1111/trf.12733; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2014, CLIN MICROBIOL REV, V27, P116, DOI 10.1128/CMR.00057-13; Kamar N, 2011, GASTROENTEROLOGY, V140, P1481, DOI 10.1053/j.gastro.2011.02.050; Khuroo MS, 2004, J GASTROEN HEPATOL, V19, P778, DOI 10.1111/j.1440-1746.2004.03437.x; Ollier L, 2009, ANN INTERN MED, V150, P430, DOI 10.7326/0003-4819-150-6-200903170-00026; Peron JM, 2007, J VIRAL HEPATITIS, V14, P298, DOI 10.1111/j.1365-2893.2007.00858.x; Stramer SL, 2000, CURR OPIN HEMATOL, V7, P387, DOI 10.1097/00062752-200011000-00011; Vollmer T, 2012, J CLIN MICROBIOL, V50, P2708, DOI 10.1128/JCM.01119-12	14	38	38	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1729	1730		10.1016/S0140-6736(14)61187-9	http://dx.doi.org/10.1016/S0140-6736(14)61187-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KX	25078305	hybrid			2022-12-28	WOS:000345116400008
J	Wang, KT; Sitsel, O; Meloni, G; Autzen, HE; Andersson, M; Klymchuk, T; Nielsen, AM; Rees, DC; Nissen, P; Gourdon, P				Wang, Kaituo; Sitsel, Oleg; Meloni, Gabriele; Autzen, Henriette Elisabeth; Andersson, Magnus; Klymchuk, Tetyana; Nielsen, Anna Marie; Rees, Douglas C.; Nissen, Poul; Gourdon, Pontus			Structure and mechanism of Zn2+-transporting P-type ATPases	NATURE			English	Article							MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; TRANSMEMBRANE TRANSPORT; CU+ CHAPERONES; METAL-BINDING; CALCIUM-PUMP; ZINC; COORDINATION; SITES; ZNTA	Zinc is an essential micronutrient for all living organisms. It is required for signalling and proper functioning of a range of proteins involved in, for example, DNA binding and enzymatic catalysis(1). In prokaryotes and photosynthetic eukaryotes, Zn2+-transporting P-type ATPases of class IB (ZntA) are crucial for cellular redistribution and detoxification of Zn2+ and related elements(2,3). Here we present crystal structures representing the phosphoenzyme ground state (E2P) and a dephosphorylation intermediate (E2.P-i) of ZntA from Shigella sonnei, determined at 3.2 angstrom and 2.7 angstrom resolution, respectively. The structures reveal a similar fold to Cu+-ATPases, with an amphipathic helix at the membrane interface. A conserved electronegative funnel connects this region to the intramembranous high-affinity ion-binding site and may promote specific uptake of cellular Zn2+ ions by the transporter. The E2P structure displays a wide extracellular release pathway reaching the invariant residues at the high-affinity site, including C392, C394 and D714. The pathway closes in the E2.P-i state, in which D714 interacts with the conserved residue K693, which possibly stimulates Zn2+ release as a built-in counter ion, as has been proposed for H+-ATPases. Indeed, transport studies in liposomes provide experimental support for ZntA activity without counter transport. These findings suggest a mechanistic link between P-IB-type Zn2+-ATPases and P-III-type H+-ATPases and at the same time show structural features of the extracellular release pathway that resemble P-II-type ATPases such as the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase(4,5) (SERCA) and Na+, K+-ATPase(6). These findings considerably increase our understanding of zinc transport in cells and represent new possibilities for biotechnology and biomedicine.	[Wang, Kaituo; Sitsel, Oleg; Meloni, Gabriele; Autzen, Henriette Elisabeth; Klymchuk, Tetyana; Nielsen, Anna Marie; Nissen, Poul; Gourdon, Pontus] Aarhus Univ, Dept Mol Biol & Genet, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPkin, DK-8000 Aarhus C, Denmark; [Andersson, Magnus] KTH Royal Inst Technol, Dept Theoret Phys, Swedish E Sci Res Ctr, Sci Life Lab, SE-17121 Solna, Sweden; [Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	Aarhus University; Danmarks Grundforskningsfond; Royal Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Gourdon, P (corresponding author), Univ Copenhagen, Dept Biomed Sci, Blegdamsvej 3B, DK-2200 Copenhagen, Denmark.	pontus@sund.ku.dk	Gourdon, Pontus/E-1076-2014; wang, kaituo/G-9249-2016; Gourdon, Pontus/HCI-8898-2022; Autzen, Henriette Elisabeth/AAI-1084-2019	Gourdon, Pontus/0000-0002-8631-3539; wang, kaituo/0000-0002-5922-7109; Autzen, Henriette Elisabeth/0000-0003-3691-5010; Andersson, Magnus/0000-0002-3364-6647; Meloni, Gabriele/0000-0003-4976-1401; Nissen, Poul/0000-0003-0948-6628	Graduate School of Science and Technology at Aarhus University; Marie Curie International Outgoing Fellowship (European Commission) [252961]; Marie Curie Career Integration Grant [FP7-MC-CIG-618558]; European Research Council [250322 Biomemos]; Lundbeck Foundation; Swedish Research Council [K2013-99X-22251-01-5]; Danscatt program of the Danish Council of Independent Research; BioStruct-X [860]; Lundbeck Foundation [R139-2012-12689] Funding Source: researchfish; Novo Nordisk Fonden [NNF12OC0002082] Funding Source: researchfish	Graduate School of Science and Technology at Aarhus University; Marie Curie International Outgoing Fellowship (European Commission); Marie Curie Career Integration Grant; European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Swedish Research Council(Swedish Research CouncilEuropean Commission); Danscatt program of the Danish Council of Independent Research; BioStruct-X; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	We thank J. L Karlsen for support with crystallographic computing. O.S. and H.E.A. are supported by the Graduate School of Science and Technology at Aarhus University. G.M. is supported by a Marie Curie International Outgoing Fellowship (European Commission, grant no. 252961). M.A. was supported by a Marie Curie Career Integration Grant (FP7-MC-CIG-618558). P.N. was supported by an advanced research grant from the European Research Council (250322 Biomemos), and P.G. was supported, in the later stage, by the Lundbeck Foundation and the Swedish Research Council (K2013-99X-22251-01-5). We are grateful for assistance with crystal screening from Maxlab, beam lines 911-2/3, and with data collection from the Swiss Light Source, beam line X06SA. Access to synchrotron sources was supported by the Danscatt program of the Danish Council of Independent Research and by BioStruct-X contract 860.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Andersson M, 2014, NAT STRUCT MOL BIOL, V21, P43, DOI 10.1038/nsmb.2721; Andreini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026325; Arguello JM, 2011, BIOCHEMISTRY-US, V50, P9940, DOI 10.1021/bi201418k; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Banci L, 2002, J MOL BIOL, V323, P883, DOI 10.1016/S0022-2836(02)01007-0; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Clausen JD, 2010, J BIOL CHEM, V285, P20780, DOI 10.1074/jbc.M110.116459; Counago RM, 2014, NAT CHEM BIOL, V10, P35, DOI [10.1038/NCHEMBIO.1382, 10.1038/nchembio.1382]; Damjanovic A, 2009, PROTEINS, V76, P1007, DOI 10.1002/prot.22439; DOMINGO JL, 1994, J TOXICOL ENV HEALTH, V42, P123, DOI 10.1080/15287399409531868; Dutta SJ, 2007, BIOCHEMISTRY-US, V46, P3692, DOI 10.1021/bi0616394; Ekberg K, 2013, J BIOL CHEM, V288, P9610, DOI 10.1074/jbc.M112.417345; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Faxen K, 2011, J BIOL CHEM, V286, P1609, DOI 10.1074/jbc.M110.176784; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gonzalez-Guerrero M, 2008, P NATL ACAD SCI USA, V105, P5992, DOI 10.1073/pnas.0711446105; Gourdon P, 2011, NATURE, V475, P59, DOI 10.1038/nature10191; Gourdon P, 2011, CRYST GROWTH DES, V11, P2098, DOI 10.1021/cg101360d; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Laursen M, 2013, P NATL ACAD SCI USA, V110, P10958, DOI 10.1073/pnas.1222308110; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mattle D, 2013, J MOL BIOL, V425, P2299, DOI 10.1016/j.jmb.2013.03.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Okkeri J, 2006, BBA-BIOENERGETICS, V1757, P1485, DOI 10.1016/j.bbabio.2006.06.008; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Padilla-Benavides T, 2013, J BIOL CHEM, V288, P69, DOI 10.1074/jbc.M112.420810; Patel K, 2007, BBA-PROTEINS PROTEOM, V1774, P1247, DOI 10.1016/j.bbapap.2007.07.010; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POST RL, 1972, J BIOL CHEM, V247, P6530; Raimunda D, 2012, BBA-BIOMEMBRANES, V1818, P1374, DOI 10.1016/j.bbamem.2012.02.020; Schrodinger LLC, 2010, PYMOL MOL GRAPH SYST; Sharma R, 2000, J BIOL CHEM, V275, P3873, DOI 10.1074/jbc.275.6.3873; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Toyoshima C, 2007, P NATL ACAD SCI USA, V104, P19831, DOI 10.1073/pnas.0709978104; Toyoshima C, 2013, NATURE, V495, P260, DOI 10.1038/nature11899; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Winther AML, 2013, NATURE, V495, P265, DOI 10.1038/nature11900; Wu CC, 2006, J BIOL CHEM, V281, P29533, DOI 10.1074/jbc.M604658200; Yang W, 2003, P NATL ACAD SCI USA, V100, P874, DOI 10.1073/pnas.0337432100; Zhitnitsky D, 2014, MOL MICROBIOL, V91, P777, DOI 10.1111/mmi.12495	54	81	83	2	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					518	+		10.1038/nature13618	http://dx.doi.org/10.1038/nature13618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25132545	Green Accepted			2022-12-28	WOS:000343775900046
J	De Raedt, T; Beert, E; Pasmant, E; Luscan, A; Brems, H; Ortonne, N; Helin, K; Hornick, JL; Mautner, V; Kehrer-Sawatzki, H; Clapp, W; Bradner, J; Vidaud, M; Upadhyaya, M; Legius, E; Cichowski, K				De Raedt, Thomas; Beert, Eline; Pasmant, Eric; Luscan, Armelle; Brems, Hilde; Ortonne, Nicolas; Helin, Kristian; Hornick, Jason L.; Mautner, Victor; Kehrer-Sawatzki, Hildegard; Clapp, Wade; Bradner, James; Vidaud, Michel; Upadhyaya, Meena; Legius, Eric; Cichowski, Karen			PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies	NATURE			English	Article							BET BROMODOMAIN INHIBITION; NF1 MICRODELETION PATIENTS; NEUROFIBROMATOSIS TYPE-1; CANCER; TUMORS; GENE; SUPPRESSOR; MUTATIONS; MICE; EZH2	The polycomb repressive complex 2 (PRC2) exerts oncogenic effects in many tumour types(1). However, loss-of-function mutations in PRC2 components occur in a subset of haematopoietic malignancies, suggesting that this complex plays a dichotomous and poorly understood role in cancer(2,3). Here we provide genomic, cellular, and mouse modelling data demonstrating that the polycomb group gene SUZ12 functions as tumour suppressor in PNS tumours, high-grade gliomas and melanomas by cooperating with mutations in NF1. NF1 encodes a Ras GTPase-activating protein (RasGAP) and its loss drives cancer by activating Ras(4). We show that SUZ12 loss potentiates the effects of NF1 mutations by amplifying Ras-driven transcription through effects on chromatin. Importantly, however, SUZ12 inactivation also triggers an epigenetic switch that sensitizes these cancers to bromodomain inhibitors. Collectively, these studies not only reveal an unexpected connection between the PRC2 complex, NF1 and Ras, but also identify a promising epigenetic-based therapeutic strategy that may be exploited for a variety of cancers.	[De Raedt, Thomas; Cichowski, Karen] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [De Raedt, Thomas; Bradner, James; Cichowski, Karen] Harvard Univ, Sch Med, Boston, MA 02115 USA; [De Raedt, Thomas; Cichowski, Karen] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA 02115 USA; [Beert, Eline; Brems, Hilde; Legius, Eric] Katholieke Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Pasmant, Eric; Luscan, Armelle; Ortonne, Nicolas; Vidaud, Michel] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, INSERM UMR S745, F-75006 Paris, France; [Pasmant, Eric; Luscan, Armelle; Ortonne, Nicolas; Vidaud, Michel] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, EA7331, F-75006 Paris, France; [Pasmant, Eric; Luscan, Armelle; Ortonne, Nicolas; Vidaud, Michel] Hop Cochin, AP HP, Serv Biochim & Genet Mol, F-75014 Paris, France; [Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen, Denmark; [Helin, Kristian] Univ Copenhagen, Danish Stem Cell Ctr Danstem, DK-2200 Copenhagen, Denmark; [Hornick, Jason L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Mautner, Victor] Univ Med Ctr, Dept Maxillofacial Surg, D-20246 Hamburg, Germany; [Kehrer-Sawatzki, Hildegard] Univ Ulm, Inst Human Genet, D-89081 Ulm, Germany; [Clapp, Wade] Indiana Univ Sch Med, Dept Pediat, Herman Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Bradner, James] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Upadhyaya, Meena] Cardiff Univ, Inst Med Genet, Cardiff CF14 4XN, S Glam, Wales; [Legius, Eric] Univ Hosp Leuven, Ctr Human Genet, B-3000 Leuven, Belgium	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; KU Leuven; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Copenhagen; University of Copenhagen; University of Copenhagen; Harvard University; Brigham & Women's Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; Indiana University System; Indiana University Bloomington; Harvard University; Dana-Farber Cancer Institute; Cardiff University; KU Leuven; University Hospital Leuven	Cichowski, K (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.	Eric.Legius@uzleuven.be; kcichowski@rics.bwh.harvard.edu	Brems, Hilde/AAN-4075-2020; De Raedt, Thomas/AAC-3172-2021; Helin, Kristian/K-2526-2019; Pasmant, Eric/O-7249-2017; Vidaud, Michel/O-7346-2017; Luscan, Armelle/O-8081-2017; Helin, Kristian/HDM-8306-2022	Pasmant, Eric/0000-0002-1881-8762; Helin, Kristian/0000-0003-1975-6097; De Raedt, Thomas/0000-0002-7492-851X; Hornick, Jason/0000-0001-6475-8345	US Department of Defense [W81XWH-11-1-0138]; Ludwig Center at DF/HCC and the Children's Tumor Foundation; Children's Tumor Foundation; FWO-Flanders [G.0784.10N]; Emmanuel Vanderschueren Fellowship from the Vlaamse Liga tegen Kanker	US Department of Defense(United States Department of Defense); Ludwig Center at DF/HCC and the Children's Tumor Foundation; Children's Tumor Foundation; FWO-Flanders(FWO); Emmanuel Vanderschueren Fellowship from the Vlaamse Liga tegen Kanker	This work was supported by the following organizations: The US Department of Defense (W81XWH-11-1-0138), the Ludwig Center at DF/HCC and the Children's Tumor Foundation (K.C.); T.D. was a recipient of the Young Investigator Award of the Children's Tumor Foundation; FWO-Flanders G.0784.10N (E.L.). E.B. was a recipient of an Emmanuel Vanderschueren Fellowship from the Vlaamse Liga tegen Kanker. Association Neurofibromatoses et Recklinghausen, Ligue Francaise Contre les Neurofibromatoses, Association pour la Recherche sur le Cancer, Comite de Paris de la Ligue Contre le Cancer, the French Clinical Research program (PHRC 2002, P. Wolkenstein) and INSERM (Nf1GeneModif project) (M.V. and E.P.). We thank the Platform of Biological Resources, Assistance Publique Hopitaux de Paris, Hopital Henri Mondor, Creteil, France, for providing tissue samples.	Beert E, 2011, GENE CHROMOSOME CANC, V50, P1021, DOI 10.1002/gcc.20921; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Chang T, 2013, J CLIN INVEST, V123, P335, DOI 10.1172/JCI63193; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; De Raedt T, 2004, GENOMICS, V84, P346, DOI 10.1016/j.ygeno.2004.03.006; De Raedt T, 2003, AM J HUM GENET, V72, P1288, DOI 10.1086/374821; De Raedt T, 2011, CANCER CELL, V20, P400, DOI 10.1016/j.ccr.2011.08.014; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Johannessen CM, 2008, CURR BIOL, V18, P56, DOI 10.1016/j.cub.2007.11.066; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; LEGIUS E, 1994, GENE CHROMOSOME CANC, V10, P250, DOI 10.1002/gcc.2870100405; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Maertens Ophelia, 2014, Advances in Biological Regulation, V55, P1, DOI 10.1016/j.jbior.2014.04.002; Mautner VF, 2010, J MED GENET, V47, P623, DOI 10.1136/jmg.2009.075937; McGillicuddy LT, 2009, CANCER CELL, V16, P44, DOI 10.1016/j.ccr.2009.05.009; McLaughlin SK, 2013, CANCER CELL, V24, P365, DOI 10.1016/j.ccr.2013.08.004; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Widemann BC, 2009, CURR ONCOL REP, V11, P322, DOI 10.1007/s11912-009-0045-z; Xu J, 2013, CANCER DISCOV, V3, P993, DOI 10.1158/2159-8290.CD-13-0096; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	33	299	301	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					247	+		10.1038/nature13561	http://dx.doi.org/10.1038/nature13561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119042				2022-12-28	WOS:000342663100046
J	Pan, L; Wang, S; Lu, TL; Weng, CJ; Song, XQ; Park, JK; Sun, J; Yang, ZH; Yu, JJ; Tang, H; McKearin, DM; Chamovitz, DA; Ni, JQ; Xie, T				Pan, Lei; Wang, Su; Lu, Tinglin; Weng, Changjiang; Song, Xiaoqing; Park, Joseph K.; Sun, Jin; Yang, Zhi-Hao; Yu, Junjing; Tang, Hong; McKearin, Dennis M.; Chamovitz, Daniel A.; Ni, Jianquan; Xie, Ting			Protein competition switches the function of COP9 from self-renewal to differentiation	NATURE			English	Article							GERMLINE STEM-CELLS; BAG-OF-MARBLES; DROSOPHILA OVARY; SIGNALOSOME; MELANOGASTER; MAINTENANCE; DIVISION; NICHE; TRANSCRIPTION; DEGRADATION	The balance between stem cell self-renewal and differentiation is controlled by intrinsic factors and niche signals(1,2). In the Drosophila melanogaster ovary, some intrinsic factors promote germline stem cell (GSC) self-renewal, whereas others stimulate differentiation(3). However, it remains poorly understood how the balance between self-renewal and differentiation is controlled. Here we use D. mel-anogaster ovarian GSCs to demonstrate that the differentiation factor Bam controls the functional switch of the COP9 complex from self-renewal to differentiation via protein competition. The COP9 complex is composed of eight Csn subunits, Csn1-8, and removes Nedd8 modifications from target proteins(4,5). Genetic results indicated that the COP9 complex is required intrinsically for GSC self-renewal, whereas other Csn proteins, with the exception of Csn4, were also required for GSC progeny differentiation. Bam-mediated Csn4 sequestration from the COP9 complex via protein competition inactivated the self-renewing function of COP9 and allowed other Csn proteins to promote GSC differentiation. Therefore, this study reveals a protein-competition-based mechanism for controlling the balance between stem cell self-renewal and differentiation. Because numerous self-renewal factors are ubiquitously expressed throughout the stem cell lineage in various systems, protein competition may function as an important mechanism for controlling the self-renewal-to-differentiation switch.	[Pan, Lei; Wang, Su; Weng, Changjiang; Song, Xiaoqing; Yu, Junjing; Xie, Ting] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Pan, Lei; Yu, Junjing; Tang, Hong] Chinese Acad Sci, Key Lab Infect & Immun, Inst Biophys, Beijing 100101, Peoples R China; [Wang, Su; Xie, Ting] Univ Kansas, Sch Med, Dept Cell Biol & Anat, Kansas City, KS 66160 USA; [Lu, Tinglin; Sun, Jin; Yang, Zhi-Hao; Ni, Jianquan] Tsinghua Univ, Sch Med, Ctr Life Sci, Beijing 100084, Peoples R China; [Park, Joseph K.; McKearin, Dennis M.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Park, Joseph K.; McKearin, Dennis M.] Univ Texas SW Med Ctr Dallas, Grad Sch Biomed Sci, Dallas, TX 75390 USA; [Park, Joseph K.; McKearin, Dennis M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Chamovitz, Daniel A.] Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel	Stowers Institute for Medical Research; Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Kansas; University of Kansas Medical Center; Tsinghua University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; Tel Aviv University	Xie, T (corresponding author), Stowers Inst Med Res, 1000 East 50th St, Kansas City, MO 64110 USA.	tgx@stowers.org	weng, changjiang/HHR-8479-2022; Chamovitz, Daniel/S-5021-2019	Chamovitz, Daniel/0000-0002-2815-2909; Pan, Lei/0000-0002-0500-8904; Park, Joseph/0000-0003-1699-3951	Stowers Institute for Medical Research; National Institutes of Health [GM64428]; National Natural Science Foundation of China [31370909]; Ministry of Science and Technology of China [2012CB518900]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064428] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Y. Yamashita, the Developmental Studies Hybridoma Bank and the Bloomington Drosophila Stock Center for reagents, Xie laboratory members for discussions, and D. Chao and R. Krumlauf for critical comments on the manuscript. This work was supported by the Stowers Institute for Medical Research (T.X.), the National Institutes of Health (GM64428, T.X.), the National Natural Science Foundation of China (31370909, L.P.) and the Ministry of Science and Technology of China (2012CB518900, L.P.).	Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Djagaeva I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007577; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li Y, 2009, P NATL ACAD SCI USA, V106, P9304, DOI 10.1073/pnas.0901452106; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; LIN HF, 1994, DEVELOPMENT, V120, P947; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Oron E, 2002, DEVELOPMENT, V129, P4399; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Shen R, 2009, P NATL ACAD SCI USA, V106, P11623, DOI 10.1073/pnas.0903325106; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xie T, 2013, WIRES DEV BIOL, V2, P261, DOI 10.1002/wdev.60; Yu JJ, 2010, J BIOL CHEM, V285, P8454, DOI 10.1074/jbc.M109.075036	28	35	35	4	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					233	+		10.1038/nature13562	http://dx.doi.org/10.1038/nature13562			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119050				2022-12-28	WOS:000342663100043
J	Han, P; Li, W; Lin, CH; Yang, J; Shang, C; Nurnberg, ST; Jin, KK; Xu, WH; Lin, CY; Lin, CJ; Xiong, YQ; Chien, HC; Zhou, B; Ashley, E; Bernstein, D; Chen, PS; Chen, HSV; Quertermous, T; Chang, CP				Han, Pei; Li, Wei; Lin, Chiou-Hong; Yang, Jin; Shang, Ching; Nurnberg, Sylvia T.; Jin, Kevin Kai; Xu, Weihong; Lin, Chieh-Yu; Lin, Chien-Jung; Xiong, Yiqin; Chien, Huan-Chieh; Zhou, Bin; Ashley, Euan; Bernstein, Daniel; Chen, Peng-Sheng; Chen, Huei-Sheng Vincent; Quertermous, Thomas; Chang, Ching-Pin			A long noncoding RNA protects the heart from pathological hypertrophy	NATURE			English	Article							CARDIAC-HYPERTROPHY; STRUCTURAL BASIS; IN-VIVO; CHROMATIN; TRANSCRIPTION; GROWTH; DOMAIN; GENE; MORPHOGENESIS; RECOGNITION	The role of long noncoding RNA(lncRNA) in adult hearts is unknown; also unclear is how lncRNA modulates nucleosome remodelling. An estimated 70% of mouse genes undergo antisense transcription(1), including myosin heavy chain 7 (Myh7), which encodes molecular motor proteins for heart contraction(2). Here we identify a cluster of lncRNA transcripts from Myh7 loci and demonstrate a new lncRNA-chromatin mechanism for heart failure. In mice, these transcripts, which we named myosin heavy-chain-associated RNA transcripts (Myheart, orMhrt), are cardiac-specific and abundant in adult hearts. Pathological stress activates the Brg1-Hdac-Parp chromatin repressor complex(3) to inhib-it Mhrt transcription in the heart. Such stress-induced Mhrt repression is essential for cardiomyopathy to develop: restoring Mhrt to the prestress level protects the heart from hypertrophy and failure. Mhrt antagonizes the function of Brg1, a chromatin-remodelling factor that is activated by stress to trigger aberrant gene expression and cardiac myopathy(3). Mhrt prevents Brg1 from recognizing its genomic DNA targets, thus inhibiting chromatin targeting and gene regulation by Brg1. It does so by binding to the helicase domain of Brg1, a domain that is crucial for tethering Brg1 to chromatinized DNA targets. Brg1 helicase has dual nucleic-acid-binding specificities: it is capable of binding lncRNA(Mhrt) and chromatinized-but not naked-DNA. This dual-binding feature of helicase enables a competitive inhibition mechanism by which Mhrt sequesters Brg1 from its genomic DNA targets to prevent chromatin remodelling. A Mhrt-Brg1 feedback circuit is thus crucial for heart function. Human MHRT also originates from MYH7 loci and is repressed in various types of myopathic hearts, suggesting a conserved lncRNA mechanism in human cardiomyopathy. Our studies identify a cardioprotective lncRNA, define a new targeting mechanism for ATP-dependent chromatin-remodelling factors, and establish a new paradigm for lncRNA chromatin interaction.	[Han, Pei; Li, Wei; Yang, Jin; Chen, Peng-Sheng; Chang, Ching-Pin] Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Han, Pei; Li, Wei; Yang, Jin; Chen, Peng-Sheng; Chang, Ching-Pin] Indiana Univ, Sch Med, Div Cardiol, Dept Med, Indianapolis, IN 46202 USA; [Han, Pei; Li, Wei; Lin, Chiou-Hong; Shang, Ching; Nurnberg, Sylvia T.; Jin, Kevin Kai; Lin, Chieh-Yu; Lin, Chien-Jung; Xiong, Yiqin; Chien, Huan-Chieh; Ashley, Euan; Quertermous, Thomas] Stanford Univ, Sch Med, Cardiovasc Inst, Div Cardiovasc Med, Stanford, CA 94305 USA; [Xu, Weihong] Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; [Zhou, Bin] Yeshiva Univ Albert Einstein Coll Med, Dept Genet Pediat & Med Cardiol, Bronx, NY 10461 USA; [Bernstein, Daniel] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Chen, Huei-Sheng Vincent] Sanford Burnham Med Res Inst, Del E Webb Neurosci Aging & Stem Cell Res Ctr, La Jolla, CA 92037 USA; [Chang, Ching-Pin] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Chang, Ching-Pin] Indiana Univ, Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Stanford University; Stanford University; Yeshiva University; Albert Einstein College of Medicine; Stanford University; Sanford Burnham Prebys Medical Discovery Institute; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Chang, CP (corresponding author), Indiana Univ, Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA.	changcp@iu.edu	Xu, Weihong/C-4175-2012; Xiong, Yiqin/H-1710-2012; Lin, Chiou-Hong/L-1749-2015	Xu, Weihong/0000-0002-3988-3571; Quertermous, Thomas/0000-0002-7645-9067; Nurnberg, Sylvia/0000-0002-0869-484X; Bernstein, Daniel/0000-0001-7761-5853	American Heart Association (AHA) [12EIA8960018]; National Institutes of Health (NIH) [HL118087, HL121197]; March of Dimes Foundation [6-FY11-260]; California Institute of Regenerative Medicine (CIRM) [RN2-00909]; Oak Foundation; Baxter Foundation; Stanford Heart Center Research Program; Indiana University (IU) School of Medicine-IU Health Strategic Research Initiative; IU Physician-Scientist Initiative; AHA; Lucile Packard Children's Foundation; NIH [HL109512, HL105194, HL78931, HL71140, HL116997, HL111770]; CIRM [RB2-01512, RB4-06276]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111770, R01HL118087, R01HL071140, R56HL071140, R01HL109512, R01HL116997, P01HL078931, R01HL121197, R01HL105194] Funding Source: NIH RePORTER	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Oak Foundation; Baxter Foundation; Stanford Heart Center Research Program; Indiana University (IU) School of Medicine-IU Health Strategic Research Initiative; IU Physician-Scientist Initiative; AHA(American Heart Association); Lucile Packard Children's Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank C.-H. Chen for assisting with echocardiography; L. Chen, A. Kuo and G. Crabtree for transgene injection and northern blot; M. Ecarkt and E. Zuo for ribosome analysis. C.-P. C. was supported by the American Heart Association (AHA; Established Investigator Award 12EIA8960018), National Institutes of Health (NIH; HL118087, HL121197), March of Dimes Foundation (#6-FY11-260), California Institute of Regenerative Medicine (CIRM; RN2-00909), Oak Foundation, Baxter Foundation, Stanford Heart Center Research Program, Indiana University (IU) School of Medicine-IU Health Strategic Research Initiative, and the IU Physician-Scientist Initiative, endowed by Lilly Endowment. W. L. and Y.X. were supported by the Oak Foundation; Y.X. by the AHA and Lucile Packard Children's Foundation; C. S. by an NIH fellowship; T. Q. by NIH (HL109512); H.-S.V.C. by CIRM (RB2-01512, RB4-06276) and NIH (HL105194); P.-S.C. by NIH (HL78931, HL71140); B.Z. by NIH (HL116997, HL111770).	Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Fu Xue-Mei, 2005, Sichuan Da Xue Xue Bao Yi Xue Ban, V36, P641; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haddad F, 2003, J BIOL CHEM, V278, P37132, DOI 10.1074/jbc.M305911200; Hahn MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018844; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Hauk G, 2010, MOL CELL, V39, P711, DOI 10.1016/j.molcel.2010.08.012; Hesselberth JR, 2009, NAT METHODS, V6, P283, DOI [10.1038/NMETH.1313, 10.1038/nmeth.1313]; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kuhnert F, 2010, SCIENCE, V330, P985, DOI 10.1126/science.1196554; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; LOMPRE AM, 1979, NATURE, V282, P105, DOI 10.1038/282105a0; Lopez BA, 2013, CARDIOVASC RES, V99, P111, DOI 10.1093/cvr/cvt100; Mallam AL, 2012, NATURE, V490, P121, DOI 10.1038/nature11402; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1266, DOI 10.1038/nsmb.2435; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Schultz JEJ, 2002, J CLIN INVEST, V109, P787, DOI 10.1172/JCI200214190; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; Szabo G, 2002, CIRC RES, V90, P100, DOI 10.1161/hh0102.102657; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van der Vlag J, 2000, J BIOL CHEM, V275, P697, DOI 10.1074/jbc.275.1.697; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wei KV, 2008, J MOL MED, V86, P161, DOI 10.1007/s00109-007-0261-7; Wu BR, 2010, GENESIS, V48, P63, DOI 10.1002/dvg.20573; Xiong YQ, 2013, DEV CELL, V25, P169, DOI 10.1016/j.devcel.2013.03.015; Yang J, 2008, MOL CELL BIOCHEM, V310, P215, DOI 10.1007/s11010-007-9683-3; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	51	513	550	4	193	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					102	+		10.1038/nature13596	http://dx.doi.org/10.1038/nature13596			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25119045	Green Accepted, Green Submitted			2022-12-28	WOS:000342420800044
J	Frieden, TR; Damon, I; Bell, BP; Kenyon, T; Nichol, S				Frieden, Thomas R.; Damon, Inger; Bell, Beth P.; Kenyon, Thomas; Nichol, Stuart			Ebola 2014-New Challenges, New Global Response and Responsibility	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Frieden, Thomas R.; Damon, Inger; Bell, Beth P.; Kenyon, Thomas; Nichol, Stuart] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.			Frieden, Thomas/0000-0002-4759-2256				[Anonymous], 2014, INT GUID EB INF AIRL; Bausch DG, 2007, J INFECT DIS, V196, pS136, DOI 10.1086/520542; Centers for Disease Control and Prevention, 2014, INF PREV CONTR REC H; Centers for Disease Control and Prevention, 2014, OUTBR CHRON EB HEM F; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8	5	157	165	0	80	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1177	1180		10.1056/NEJMp1409903	http://dx.doi.org/10.1056/NEJMp1409903			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP4WH	25140858				2022-12-28	WOS:000342079700002
J	Pasham, DR; Strohmayer, TE; Mushotzky, RF				Pasham, Dheeraj R.; Strohmayer, Tod E.; Mushotzky, Richard F.			A 400-solar-mass black hole in the galaxy M82	NATURE			English	Article							QUASI-PERIODIC OSCILLATIONS; X-RAY SOURCE; MICROQUASAR GRO J1655-40; XTE J1550-564; RXTE OBSERVATIONS; TIMING EXPLORER; DOMINANT STATE; MASS; X-1; DISCOVERY	M82 X-1, the brightest X-ray source in the galaxy M82, has been thought to be an intermediate-mass black hole (100 to 10,000 solar masses) because of its extremely high luminosity and variability characteristics(1-6), although some models suggest that its mass may be only about 20 solar masses(3,7). The previous mass estimates were based on scaling relations that use low-frequency characteristic time-scales which have large intrinsic uncertainties(8,9). For stellar-mass black holes, we know that the high-frequency quasi-periodic oscillations (100-450 hertz) in the X-ray emission that occur in a 3: 2 frequency ratio are stable and scale in frequency inversely with black hole mass with a reasonably small dispersion(10-15). The discovery of such stable oscillations thus potentially offers an alternative and less ambiguous means of mass determination for intermediate-mass black holes, but has hitherto not been realized. Here we report stable, twin-peak (3: 2 frequency ratio) X-ray quasi-periodic oscillations from M82 X-1 at frequencies of 3.32+/-0.06 hertz and 5.07+/-0.06 hertz. Assuming that we can extrapolate the inverse-mass scaling that holds for stellar-mass black holes, we estimate the black hole mass of M82 X-1 to be 428+/-105 solar masses. In addition, we can estimate the mass using the relativistic precession model, from which we get a value of 415+/-63 solar masses.	[Pasham, Dheeraj R.; Mushotzky, Richard F.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Pasham, Dheeraj R.; Strohmayer, Tod E.] NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; [Pasham, Dheeraj R.; Strohmayer, Tod E.] NASA, Goddard Space Flight Ctr, Joint Space Sci Inst, Greenbelt, MD 20771 USA	University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Pasham, DR (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	dheeraj@astro.umd.edu	Mushotzky, Richard/AAW-9465-2021	Mushotzky, Richard/0000-0002-7962-5446				Abramowicz M. A., 2003, INTERPRETING BLACK H; Abramowicz MA, 2004, ASTROPHYS J, V609, pL63, DOI 10.1086/422810; Beer ME, 2002, MON NOT R ASTRON SOC, V331, P351, DOI 10.1046/j.1365-8711.2002.05189.x; Belloni TM, 2012, MON NOT R ASTRON SOC, V426, P1701, DOI 10.1111/j.1365-2966.2012.21634.x; Caballero-Garcia MD, 2013, MON NOT R ASTRON SOC, V436, P3262, DOI 10.1093/mnras/stt1807; Casella P, 2008, MON NOT R ASTRON SOC, V387, P1707, DOI 10.1111/j.1365-2966.2008.13372.x; Casella P, 2005, ASTROPHYS J, V629, P403, DOI 10.1086/431174; Chiang YK, 2011, MON NOT R ASTRON SOC, V414, P1329, DOI 10.1111/j.1365-2966.2011.18466.x; D'Ai A., 2014, ASTRON TELEGR, V5858; Dewangan GC, 2006, ASTROPHYS J, V637, pL21, DOI 10.1086/499235; Feng H, 2010, ASTROPHYS J LETT, V712, pL169, DOI 10.1088/2041-8205/712/2/L169; Feng H, 2010, ASTROPHYS J LETT, V710, pL137, DOI 10.1088/2041-8205/710/2/L137; Giles AB, 1996, ASTROPHYS J, V469, pL25, DOI 10.1086/310262; Jahoda K, 1999, NUCL PHYS B-PROC SUP, V69, P210, DOI 10.1016/S0920-5632(98)00210-2; Jin J, 2010, ASTROPHYS J, V716, P181, DOI 10.1088/0004-637X/716/1/181; Kaaret P, 2007, ASTROPHYS J, V669, P106, DOI 10.1086/521598; Kommers JM, 1997, ASTROPHYS J, V482, pL53, DOI 10.1086/310669; Laycock S, 2005, ASTROPHYS J SUPPL S, V161, P96, DOI 10.1086/432884; LEAHY DA, 1983, ASTROPHYS J, V266, P160, DOI 10.1086/160766; Linares M., 2014, ASTRON TELEGR, V5883; Matsumoto H, 2001, ASTROPHYS J, V547, pL25, DOI 10.1086/318878; McClintock J. E., 2006, COMPACT STELLAR XRAY, P157, DOI DOI 10.2277/0521826594; Middleton MJ, 2011, MON NOT R ASTRON SOC, V411, P644, DOI 10.1111/j.1365-2966.2010.17712.x; Negoro H., 2014, ASTRON TELEGR, V5790; Okajima T, 2006, ASTROPHYS J, V652, pL105, DOI 10.1086/510153; Orosz JA, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/75; Pasham DR, 2013, ASTROPHYS J LETT, V774, DOI 10.1088/2041-8205/774/2/L16; Pasham DR, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/101; Patruno A, 2006, MON NOT R ASTRON SOC, V370, pL6, DOI 10.1111/j.1745-3933.2006.00176.x; Pintore F., 2014, ASTRON TELEGR, V5901; Remillard RA, 2002, ASTROPHYS J, V580, P1030, DOI 10.1086/343791; Rodriguez J, 2004, ASTROPHYS J, V612, P1018, DOI 10.1086/422672; Sazonov SY, 1997, ASTRON LETT+, V23, P286; Steeghs D, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/185; Strohmayer TE, 2001, ASTROPHYS J, V554, pL169, DOI 10.1086/321720; van der Klis M, 1989, P NATO ADV STUDY I T, P27; Voss R, 2011, MON NOT R ASTRON SOC, V418, pL124, DOI 10.1111/j.1745-3933.2011.01157.x; Wilson-Hodge C., 2014, ASTRON TELEGR, V5810; Wood KS, 2000, ASTROPHYS J, V544, pL45, DOI 10.1086/317287; Younes G., 2014, ASTRON TELEGR, V5845; Zhou XL, 2010, ASTROPHYS J, V710, P16, DOI 10.1088/0004-637X/710/1/16; Zwart SFP, 2004, NATURE, V428, P724, DOI 10.1038/nature02448	48	132	134	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					74	+		10.1038/nature13710	http://dx.doi.org/10.1038/nature13710			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25132552	Green Published, Green Submitted			2022-12-28	WOS:000341174800032
J	Delaney, S; Gardella, C; Saracino, M; Magaret, A; Wald, A				Delaney, Shani; Gardella, Carolyn; Saracino, Misty; Magaret, Amalia; Wald, Anna			Seroprevalence of Herpes Simplex Virus Type 1 and 2 Among Pregnant Women, 1989-2010	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							STATES		[Delaney, Shani; Gardella, Carolyn] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Saracino, Misty; Magaret, Amalia] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wald, Anna] Univ Washington, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Delaney, S (corresponding author), Univ Washington, Dept Obstet & Gynecol, 1959 NE Pacific St, Seattle, WA 98195 USA.	delaneys@u.washington.edu		Delaney, Shani/0000-0001-8017-5043	NIAID NIH HHS [K24 AI071113, AI-030731, P01 AI030731] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731, K24AI071113] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ashley RL, 1988, J CLIN MICROBIOL, V26, P622; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; Fanfair RN, 2013, SEX TRANSM DIS, V40, P860, DOI 10.1097/OLQ.0000000000000043; Kropp RY, 2006, PEDIATRICS, V117, P1955, DOI 10.1542/peds.2005-1778; Morris SR, 2008, SEX TRANSM DIS, V35, P14, DOI 10.1097/OLQ.0b013e3180f62bc7	6	22	23	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					746	748		10.1001/jama.2014.4359	http://dx.doi.org/10.1001/jama.2014.4359			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25138337	Bronze, Green Accepted			2022-12-28	WOS:000340438700025
J	Reiling, J				Reiling, Jennifer			Hasty Generalizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					753	753		10.1001/jama.2013.279678	http://dx.doi.org/10.1001/jama.2013.279678			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25138346				2022-12-28	WOS:000340438700033
J	Van Spall, HGC				Van Spall, Harriette G. C.			Natriuretic peptide-guided therapy reduces mortality more than clinically guided therapy in heart failure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	McMaster University; Population Health Research Institute	Van Spall, HGC (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.			Van Spall, Harriette Gillian Christine/0000-0002-8370-4569				Packer M, 1999, CIRCULATION, V100, P2312, DOI 10.1161/01.CIR.100.23.2312	1	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC10	10.7326/0003-4819-161-4-201408190-02010	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133377				2022-12-28	WOS:000342347300009
J	Hindricks, G; Taborsky, M; Glikson, M; Heinrich, U; Schumacher, B; Katz, A; Brachmann, J; Lewalter, T; Goette, A; Block, M; Kautzner, J; Sack, S; Husser, D; Piorkowski, C; Sogaard, P				Hindricks, Gerhard; Taborsky, Milos; Glikson, Michael; Heinrich, Ullus; Schumacher, Burghard; Katz, Amos; Brachmann, Johannes; Lewalter, Thorsten; Goette, Andreas; Block, Michael; Kautzner, Josef; Sack, Stefan; Husser, Daniela; Piorkowski, Christopher; Sogaard, Peter		IN-TIME Study Grp	Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial	LANCET			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERTER-DEFIBRILLATOR SHOCKS; DEVICE FOLLOW-UP; ATRIAL-FIBRILLATION; MANAGEMENT; INAPPROPRIATE; SURVIVAL; ASSOCIATION; PREDICTORS; MORTALITY	Background An increasing number of patients with heart failure receive implantable cardioverter-defibrillators (ICDs) or cardiac resynchronisation defibrillators (CRT-Ds) with telemonitoring function. Early detection of worsening heart failure, or upstream factors predisposing to worsening heart failure, by implant-based telemonitoring might enable pre-emptive intervention and improve outcomes, but the evidence is weak. We investigated this possibility in IN-TIME, a clinical trial. Methods We did this randomised, controlled trial at 36 tertiary clinical centres and hospitals in Australia, Europe, and Israel. We enrolled patients with chronic heart failure, NYHA class II-III symptoms, ejection fraction of no more than 35%, optimal drug treatment, no permanent atrial fibrillation, and a recent dual-chamber ICD or CRT-D implantation. After a 1 month run-in phase, patients were randomly assigned (1: 1) to either automatic, daily, implant-based, multiparameter telemonitoring in addition to standard care or standard care without telemonitoring. Investigators were not masked to treatment allocation. Patients were masked to allocation unless they were contacted because of telemonitoring findings. Follow-up was 1 year. The primary outcome measure was a composite clinical score combining all-cause death, overnight hospital admission for heart failure, change in NYHA class, and change in patient global self-assessment, for the intention-to-treat population. The trial is registered with ClinicalTrials.gov, number NCT00538356. Findings We enrolled 716 patients, of whom 664 were randomly assigned (333 to telemonitoring, 331 to control). Mean age was 65.5 years and mean ejection fraction was 26%. 285 (43%) of patients had NYHA functional class II and 378 (57%) had NYHA class III. Most patients received CRT-Ds (390; 58.7%). At 1 year, 63 (18.9%) of 333 patients in the telemonitoring group versus 90 (27.2%) of 331 in the control group (p=0.013) had worsened composite score (odds ratio 0.63, 95% CI 0.43-0.90). Ten versus 27 patients died during follow-up. Interpretation Automatic, daily, implant-based, multiparameter telemonitoring can significantly improve clinical outcomes for patients with heart failure. Such telemonitoring is feasible and should be used in clinical practice.	[Hindricks, Gerhard; Husser, Daniela; Piorkowski, Christopher] Herzzentrum Leipzig, Leipzig, Germany; [Taborsky, Milos] Fac Med & Dent, Dept Internal Med Cardiol 1, Olomouc, Czech Republic; [Glikson, Michael] Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; [Heinrich, Ullus] Praxis Dr Heinrich, Nordhausen, Germany; [Schumacher, Burghard] Herz & Gefassklinikum GmbH Bad Neustadt, Bad Neustadt an der Saale, Germany; [Katz, Amos] Barzilai Govt Hosp, Ashqelon, Israel; [Brachmann, Johannes] Klinikum Coburg GmbH, Coburg, Germany; [Lewalter, Thorsten] Isar Herzzentrum, Munich, Germany; [Goette, Andreas] St Vincenz Krankenhaus GmbH, Paderborn, Germany; [Block, Michael] Klin Augustinum, Munich, Germany; [Kautzner, Josef] Inst Clin & Expt Med, Prague, Czech Republic; [Sack, Stefan] Klinikum Schwabing, Munich, Germany; [Sogaard, Peter] Aalborg Univ Hosp, Ctr Heart, Aalborg, Denmark; [Sogaard, Peter] Aalborg Univ Hosp, Inst Clin, Aalborg, Denmark	Heart Center Leipzig GMBH; Chaim Sheba Medical Center; Ben Gurion University; Barzilai Medical Center; Klinikum Coburg; Institute for Clinical & Experimental Medicine (IKEM); Munchen Klinik; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital	Hindricks, G (corresponding author), Heart Ctr Leipzig, Struempellstr 39, D-04289 Leipzig, Germany.	gerhard.hindricks@medizin.uni-leipzig.de	Brachmann, Johannes/AAD-1499-2021; Piorkowski, Christopher/G-2026-2016	Katz, Amos/0000-0003-0422-934X	Biotronik SE Co. KG	Biotronik SE Co. KG	Biotronik SE & Co. KG.	Arya A, 2008, EUR J HEART FAIL, V10, P1143, DOI 10.1016/j.ejheart.2008.08.004; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Burri H, 2009, EUROPACE, V11, P701, DOI 10.1093/europace/eup110; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Chung ES, 2008, CIRCULATION, V117, P2608, DOI 10.1161/CIRCULATIONAHA.107.743120; Crossley GH, 2011, J AM COLL CARDIOL, V57, P1181, DOI 10.1016/j.jacc.2010.12.012; Daubert JP, 2008, J AM COLL CARDIOL, V51, P1357, DOI 10.1016/j.jacc.2007.09.073; Daubert JC, 2004, EUROPACE, V5, pS1, DOI 10.1016/j.eupc.2004.07.002; Gasparini M, 2008, EUR HEART J, V29, P1644, DOI 10.1093/eurheartj/ehn133; Guedon-Moreau L, 2014, J CARDIOVASC ELECTR, V25, P763, DOI 10.1111/jce.12405; Hasan A, 2011, EUR HEART J, V32, P1457, DOI 10.1093/eurheartj/ehr005; Hayes DL, 2011, HEART RHYTHM, V8, P1469, DOI 10.1016/j.hrthm.2011.04.015; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Inglis SC, 2011, EUR J HEART FAIL, V13, P1028, DOI 10.1093/eurjhf/hfr039; Koehler F, 2011, CIRCULATION, V123, P1873, DOI 10.1161/CIRCULATIONAHA.111.018473; Koneru JN, 2011, CIRC-ARRHYTHMIA ELEC, V4, P778, DOI 10.1161/CIRCEP.110.961243; Landolina M, 2012, CIRCULATION, V125, P2985, DOI 10.1161/CIRCULATIONAHA.111.088971; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; Martin DO, 2012, J CARDIOVASC ELECTR, V23, P1317, DOI 10.1111/j.1540-8167.2012.02402.x; Moss AJ, 2004, CIRCULATION, V110, P3760, DOI 10.1161/01.CIR.0000150390.04704.B7; Packer M, 2001, J CARD FAIL, V7, P176, DOI 10.1054/jcaf.2001.25652; Poole JE, 2008, NEW ENGL J MED, V359, P1009, DOI 10.1056/NEJMoa071098; Sack S, 2011, EUR J HEART FAIL, V13, P1019, DOI 10.1093/eurjhf/hfr089; Saxon LA, 2006, CIRCULATION, V114, P2766, DOI 10.1161/CIRCULATIONAHA.106.642892; Saxon LA, 2010, CIRCULATION, V122, P2359, DOI 10.1161/CIRCULATIONAHA.110.960633; Spencker S, 2009, EUROPACE, V11, P483, DOI 10.1093/europace/eun350; van Veldhuisen DJ, 2011, CIRCULATION, V124, P1719, DOI 10.1161/CIRCULATIONAHA.111.043042; Varma N, 2011, HEART FAIL CLIN, V7, P215, DOI 10.1016/j.hfc.2010.12.005; Varma N, 2010, CIRCULATION, V122, P325, DOI 10.1161/CIRCULATIONAHA.110.937409; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Yancy CW, 2013, CIRCULATION, V128, P1810, DOI 10.1161/CIR.0b013e31829e8807	31	396	400	1	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					583	590		10.1016/S0140-6736(14)61176-4	http://dx.doi.org/10.1016/S0140-6736(14)61176-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25131977				2022-12-28	WOS:000340573300030
J	Nordestgaard, BG; Varbo, A				Nordestgaard, Borge G.; Varbo, Anette			Triglycerides and cardiovascular disease	LANCET			English	Article							ISCHEMIC-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; OF-FUNCTION MUTATIONS; GENETICALLY HYPERLIPIDEMIC RABBITS; EUROPEAN-ATHEROSCLEROSIS-SOCIETY; CORONARY-ARTERY-DISEASE; HIGH-RISK PATIENTS; NONFASTING TRIGLYCERIDES; REMNANT CHOLESTEROL; HDL CHOLESTEROL	After the introduction of statins, clinical emphasis first focussed on LDL cholesterol-lowering, then on the potential for raising HDL cholesterol, with less focus on lowering triglycerides. However, the understanding from genetic studies and negative results from randomised trials that low HDL cholesterol might not cause cardiovascular disease as originally thought has now generated renewed interest in raised concentrations of triglycerides. This renewed interest has also been driven by epidemiological and genetic evidence supporting raised triglycerides, remnant cholesterol, or triglyceride-rich lipoproteins as an additional cause of cardiovascular disease and all-cause mortality. Triglycerides can be measured in the non-fasting or fasting states, with concentrations of 2-10 mmol/L conferring increased risk of cardiovascular disease, and concentrations greater than 10 mmol/L conferring increased risk of acute pancreatitis and possibly cardiovascular disease. Although randomised trials showing cardiovascular benefit of triglyceride reduction are scarce, new triglyceride-lowering drugs are being developed, and large-scale trials have been initiated that will hopefully provide conclusive evidence as to whether lowering triglycerides reduces the risk of cardiovascular disease.	[Nordestgaard, Borge G.; Varbo, Anette] Copenhagen Univ Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; [Nordestgaard, Borge G.; Varbo, Anette] Copenhagen Univ Hosp, Copenhagen Gen Populat Study, Herlev Hosp, DK-2730 Herlev, Denmark; [Varbo, Anette] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen	Nordestgaard, BG (corresponding author), Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark.	Boerge.Nordestgaard@regionh.dk	Nordestgaard, Borge Gronne/ABF-1310-2020	Nordestgaard, Borge/0000-0002-1954-7220				Agerholm-Larsen B, 2000, CIRCULATION, V101, P1907, DOI 10.1161/01.CIR.101.16.1907; Andersen RV, 2003, J AM COLL CARDIOL, V41, P1972, DOI 10.1016/S0735-1097(03)00407-8; [Anonymous], 1984, ARTERIOSCLEROSIS, V4, pA443; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Benn M, 2010, J AM COLL CARDIOL, V55, P2833, DOI 10.1016/j.jacc.2010.02.044; Berglund L, 2012, J CLIN ENDOCR METAB, V97, P2969, DOI 10.1210/jc.2011-3213; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Boren J, 2014, CLIN CHIM ACTA, V431, P131, DOI 10.1016/j.cca.2014.01.015; BRUNZELL JD, 2001, METABOLIC MOL BASES, P2789; CARLSON LA, 1988, ACTA MED SCAND, V223, P405; Chapman MJ, 2011, EUR HEART J, V32, P1345, DOI 10.1093/eurheartj/ehr112; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; ENDO A, 1992, J LIPID RES, V33, P1569; Freiberg JJ, 2008, JAMA-J AM MED ASSOC, V300, P2142, DOI 10.1001/jama.2008.621; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Goldberg IJ, 2011, ARTERIOSCL THROM VAS, V31, P1716, DOI 10.1161/ATVBAHA.111.226100; Goldstein JL, 2001, METABOLIC MOL BASES, V8th, P2863; Gotoda T, 2012, J ATHEROSCLER THROMB, V19, P1; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; Haynes R, 2013, EUR HEART J, V34, P1279, DOI 10.1093/eurheartj/eht055; Hegele RA, 2013, LANCET DIABETES ENDO; Hokanson J E, 1996, J Cardiovasc Risk, V3, P213, DOI 10.1097/00043798-199604000-00014; Johannsen TH, 2012, J AM COLL CARDIOL, V60, P2041, DOI 10.1016/j.jacc.2012.07.045; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Jorgensen AB, 2013, EUR HEART J, V34, P1826, DOI 10.1093/eurheartj/ehs431; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Kolovou GD, 2011, CURR VASC PHARMACOL, V9, P258; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Langsted A, 2011, CLIN CHEM, V57, P482, DOI 10.1373/clinchem.2010.157164; LEWIS B, 1987, EUR HEART J, V8, P77; LEWIS B, 1988, EUR HEART J, V9, P571; MANNINEN V, 1988, JAMA-J AM MED ASSOC, V260, P641, DOI 10.1001/jama.260.5.641; Martin SS, 2013, JAMA-J AM MED ASSOC, V310, P2061, DOI 10.1001/jama.2013.280532; Mihas C, 2011, CURR VASC PHARMACOL, V9, P271, DOI 10.2174/157016111795495530; Miller M, 2011, CIRCULATION, V123, P2292, DOI 10.1161/CIR.0b013e3182160726; Mora S, 2009, CLIN CHEM, V55, P888, DOI 10.1373/clinchem.2008.117929; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; NORDESTGAARD BG, 1992, ARTERIOSCLER THROMB, V12, P6, DOI 10.1161/01.ATV.12.1.6; NORDESTGAARD BG, 1988, J LIPID RES, V29, P1491; NORDESTGAARD BG, 1995, ARTERIOSCL THROM VAS, V15, P534, DOI 10.1161/01.ATV.15.4.534; NORDESTGAARD BG, 1988, ARTERIOSCLEROSIS, V8, P421, DOI 10.1161/01.ATV.8.4.421; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Nordestgaard Borge G, 2009, Ugeskr Laeger, V171, P1093; Nordestgaard G, 2009, CURR DRUG TARGETS, V10, P328, DOI 10.2174/138945009787846434; PEDERSEN TR, 1994, LANCET, V344, P1383; Perk J, 2012, EUR HEART J, V33, P1635, DOI 10.1093/eurheartj/ehs092; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Proctor SD, 2002, CURR OPIN LIPIDOL, V13, P461, DOI 10.1097/00041433-200210000-00001; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Rubins HB, 1999, NEW ENGL J MED, V341, P410, DOI 10.1056/NEJM199908053410604; Rutledge JC, 2000, CIRC RES, V86, P768, DOI 10.1161/01.RES.86.7.768; Saraswathi V, 2006, J LIPID RES, V47, P1406, DOI 10.1194/jlr.M600159-JLR200; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4; Schlesinger Z, 2000, CIRCULATION, V102, P21, DOI 10.1161/01.CIR.102.1.21; Schwartz GG, 2012, NEW ENGL J MED, V367; Scott R, 2009, DIABETES CARE, V32, P493, DOI 10.2337/dc08-1543; SHAIKH M, 1991, ARTERIOSCLER THROMB, V11, P569, DOI 10.1161/01.ATV.11.3.569; Sidhu D, 2012, ARCH INTERN MED, V172, P1707, DOI 10.1001/archinternmed.2012.3708; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Steinberg D, 1997, CIRCULATION, V95, P1062; Stone NJ, 2014, J AM COLL CARDIOL, V63, P2889, DOI 10.1016/j.jacc.2013.11.002; Tanno K, 2010, CLIN CHIM ACTA, V411, P1774, DOI 10.1016/j.cca.2010.07.034; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomsen M, 2014, CLIN CHEM, V60, P737, DOI 10.1373/clinchem.2013.219881; Varbo A, 2014, PHARMACOL THERAPEUT, V141, P358, DOI 10.1016/j.pharmthera.2013.11.008; Varbo A, 2013, CIRCULATION, V128, P1298, DOI 10.1161/CIRCULATIONAHA.113.003008; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Watts GF, 2013, NAT REV CARDIOL, V10, P648, DOI 10.1038/nrcardio.2013.140; Wittrup HH, 1999, CIRCULATION, V99, P2901, DOI 10.1161/01.CIR.99.22.2901; ZILVERSMIT DB, 1979, CIRCULATION, V60, P473, DOI 10.1161/01.CIR.60.3.473	79	747	774	8	129	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					626	635		10.1016/S0140-6736(14)61177-6	http://dx.doi.org/10.1016/S0140-6736(14)61177-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25131982				2022-12-28	WOS:000340573300035
J	Niaura, RS; Glynn, TJ; Abrams, DB				Niaura, Raymond S.; Glynn, Thomas J.; Abrams, David B.			Youth Experimentation With e-Cigarettes Another Interpretation of the Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								JAMAPEDIATRICS Electronic Cigarettes and Conventional Cigarette Use Among US Adolescents: A Cross-sectional Study Lauren M. Dutra, ScD; Stanton A. Glantz, PhD IMPORTANCE Electronic cigarette (e-cigarette) use is increasing rapidly among adolescents, and e-cigarettes are currently unregulated. OBJECTIVE To examine e-cigarette use and conventional cigarette smoking. DESIGN, SETTING, AND PARTICIPANTS Cross-sectional analyses of survey data from a representative sample of US middle and high school students in 2011 (n = 17 353) and 2012 (n = 22 529) who completed the 2011 and 2012 National Youth Tobacco Survey. EXPOSURES Ever and current e-cigarette use. MAIN OUTCOMES AND MEASURES Experimentation with, ever, and current smoking, and smoking abstinence. RESULTS Among cigarette experimenters (> 1 puff), ever e-cigarette use was associated with higher odds of ever smoking cigarettes (>= 100 cigarettes; odds ratio [OR] = 6.31; 95% CI, 5.39-7.39) and current cigarette smoking (OR = 5.96; 95% CI, 5.67-6.27). Current e-cigarette use was positively associated with ever smoking cigarettes (OR = 7.42; 95% CI, 5.63-9.79) and current cigarette smoking (OR = 7.88; 95% CI, 6.01-10.32). In 2011, current cigarette smokers who had ever used e-cigarettes were more likely to intend to quit smoking within the next year (OR = 1.53; 95% CI, 1.03-2.28). Among experimenters with conventional cigarettes, ever use of e-cigarettes was associated with lower 30-day (OR = 0.24; 95% CI, 0.21-0.28), 6-month (OR = 0.24; 95% CI, 0.21-0.28), and 1-year (OR = 0.25; 95% CI, 0.21-0.30) abstinence from cigarettes. Current e-cigarette use was also associated with lower 30-day (OR = 0.11; 95% CI, 0.08-0.15), 6-month (OR = 0.11; 95% CI, 0.08-0.15), and 1-year (OR = 0.12; 95% CI, 0.07-0.18) abstinence. Among ever smokers of cigarettes (>= 100 cigarettes), ever e-cigarette use was negatively associated with 30-day (OR = 0.61; 95% CI, 0.42-0.89), 6-month (OR = 0.53; 95% CI, 0.33-0.83), and 1-year (OR = 0.32; 95% CI, 0.18-0.56) abstinence from conventional cigarettes. Current e-cigarette use was also negatively associated with 30-day (OR = 0.35; 95% CI, 0.18-0.69), 6-month (OR = 0.30; 95% CI, 0.13-0.68), and 1-year (OR = 0.34; 95% CI, 0.13-0.87) abstinence. CONCLUSIONS AND RELEVANCE Use of e-cigaretteswas associated with higher odds of ever or current cigarette smoking, higher odds of established smoking, higher odds of planning to quit smoking among current smokers, and, among experimenters, lower odds of abstinence from conventional cigarettes. Use of e-cigarettes does not discourage, and may encourage, conventional cigarette use among US adolescents.	[Niaura, Raymond S.; Abrams, David B.] Legacy, Schroeder Inst Tobacco Res & Policy Studies, Washington, DC USA; [Niaura, Raymond S.; Abrams, David B.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Niaura, Raymond S.; Abrams, David B.] Lombardi Comprehens Canc Ctr, Canc Prevent & Control Program, Washington, DC USA; [Niaura, Raymond S.; Abrams, David B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Glynn, Thomas J.] Amer Canc Soc, Washington, DC USA	Georgetown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; American Cancer Society	Abrams, DB (corresponding author), Legacy Fdn, Schroeder Inst, 1724 Massachusetts Ave NW, Washington, DC 20036 USA.	dabrams@legacyforhealth.org	Abrams, David B/AAY-7699-2020; Niaura, Raymond/AAE-7319-2019	Abrams, David B/0000-0002-0868-4350; Niaura, Raymond/0000-0002-0856-3540				[Anonymous], POPULATION ASSESSMEN; Centers for Disease Control and Prevention, NATIONAL YOUTH TOBAC; Cervellati F, 2014, TOXICOL IN VITRO, V28, P999, DOI 10.1016/j.tiv.2014.04.012; Dutra LM, 2014, JAMA PEDIATR, V168, P684, DOI 10.1001/jamapediatrics.2013.5488; Fix BV, 2014, ADDICT BEHAV, V39, P768, DOI 10.1016/j.addbeh.2013.12.015; US Department of Health and Human Services, 2014, THE HEALTH CONSEQUEN	6	37	38	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					641	642		10.1001/jama.2014.6894	http://dx.doi.org/10.1001/jama.2014.6894			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117133				2022-12-28	WOS:000340136400023
J	Oberg, AS; Hernandez-Diaz, S; Frisell, T; Greene, MF; Almqvist, C; Bateman, BT				Oberg, Anna Sara; Hernandez-Diaz, Sonia; Frisell, Thomas; Greene, Michael F.; Almqvist, Catarina; Bateman, Brian T.			Genetic contribution to postpartum haemorrhage in Swedish population: cohort study of 466 686 births	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FAMILIAL AGGREGATION; RISK-FACTORS; FETAL; EPIDEMIOLOGY; PREECLAMPSIA; SAMPLE	Objective To investigate the familial clustering of postpartum haemorrhage in the Swedish population, and to quantify the relative contributions of genetic and environmental effects. Design Register based cohort study. Setting Swedish population (multi-generation and medical birth registers). Main outcome measure Postpartum haemorrhage, defined as >1000 mL estimated blood loss. Participants The first two live births to individuals in Sweden in 1997-2009 contributed to clusters representing intact couples (n=366 350 births), mothers with separate partners (n=53 292), fathers with separate partners (n=47 054), sister pairs (n=97 228), brother pairs (n=91 168), and mixed sibling pairs (n=177 944). Methods Familial clustering was quantified through cluster specific tetrachoric correlation coefficients, and the influence of potential sharing of known risk factors was evaluated with alternating logistic regression. Relative contributions of genetic and environmental effects to the variation in liability for postpartum haemorrhage were quantified with generalised linear mixed models. Results The overall prevalence of postpartum haemorrhage after vaginal deliveries in our sample was 4.6%. Among vaginal deliveries, 18% (95% confidence interval 9% to 26%) of the variation in postpartum haemorrhage liability was attributed to maternal genetic factors, 10% (1% to 19%) to unique maternal environment, and 11% (0% to 26%) to fetal genetic effects. Adjustment for known risk factors only partially explained estimates of familial clustering, suggesting that the observed shared genetic and environmental effects operate in part through pathways independent of known risk factors. There were similar patterns of familial clustering for both of the main subtypes examined (atony and retained placenta), though strongest for haemorrhage after retained placenta. Conclusions There is a maternal genetic predisposition to postpartum haemorrhage, but more than half of the total variation in liability is attributable to factors that are not shared in families.	[Oberg, Anna Sara; Hernandez-Diaz, Sonia] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Oberg, Anna Sara; Almqvist, Catarina] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Frisell, Thomas] Karolinska Univ Hosp, Dept Med, Clin Epidemiol Unit, S-17176 Stockholm, Sweden; [Greene, Michael F.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Obstet & Gynecol, Boston, MA 02114 USA; [Almqvist, Catarina] Karolinska Univ Hosp, Lung & Allergy Unit, Astrid Lindgren Childrens Hosp, S-17176 Stockholm, Sweden; [Bateman, Brian T.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Bateman, Brian T.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Bateman, Brian T.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Bateman, Brian T.] Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Karolinska Institutet; Karolinska University Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Oberg, AS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	oberg@hsph.harvard.edu	Frisell, Thomas/E-2772-2017; Oberg, Anna Sara/AAH-1078-2021	Frisell, Thomas/0000-0002-5735-9626; Oberg, Anna Sara/0000-0001-6638-1895	Swedish Research Council [2012-340, 2011-3060]; Swedish Initiative for Research on microdata in the Social and Medical Science (SIMSAM) framework [340-2013-5867]; strategic research program in epidemiology at Karolinska Institutet; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [K08HD075831]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Initiative for Research on microdata in the Social and Medical Science (SIMSAM) framework; strategic research program in epidemiology at Karolinska Institutet; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the Swedish Research Council's international postdoc grant 2012-340 (ASO), research grant 2011-3060 (CA), and through the Swedish Initiative for Research on microdata in the Social and Medical Science (SIMSAM) framework grant 340-2013-5867 (ASO, CA), the strategic research program in epidemiology at Karolinska Institutet (CA), as well as by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award No K08HD075831 (BTB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrams ET, 2011, AM ANTHROPOL, V113, P417, DOI 10.1111/j.1548-1433.2011.01351.x; Al Kadri HMF, 2011, ARCH GYNECOL OBSTET, V283, P1207, DOI 10.1007/s00404-010-1522-1; Bateman BT, 2010, ANESTH ANALG, V110, P1368, DOI 10.1213/ANE.0b013e3181d74898; Berg CJ, 2010, OBSTET GYNECOL, V116, P1302, DOI 10.1097/AOG.0b013e3181fdfb11; Blomberg M, 2011, OBSTET GYNECOL, V118, P561, DOI 10.1097/AOG.0b013e31822a6c59; Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257; COMBS CA, 1991, OBSTET GYNECOL, V77, P69; Ford JB, 2007, MED J AUSTRALIA, V187, P391, DOI 10.5694/j.1326-5377.2007.tb01308.x; Ford JB, 2013, AUST NZ J OBSTET GYN, V53, P90, DOI 10.1111/ajo.12019; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kominiarek MA, 2007, SEMIN PERINATOL, V31, P159, DOI 10.1053/j.semperi.2007.03.001; Lie RT, 1998, BRIT MED J, V316, P1343, DOI 10.1136/bmj.316.7141.1343; Magann EF, 2005, SOUTH MED J, V98, P419, DOI 10.1097/01.SMJ.0000152760.34443.86; McLintock C, 2011, J THROMB HAEMOST, V9, P1441, DOI 10.1111/j.1538-7836.2011.04398.x; Multi-generation register, 2010, MULT REG 2009 DESCR, P1; National Board of Health and Welfare, 2011, PREGN DEL NEWB INF S; Oberg AS, 2013, AM J EPIDEMIOL, V177, P531, DOI 10.1093/aje/kws244; Oberg AS, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.872; Oyelese Y, 2010, CLIN OBSTET GYNECOL, V53, P147, DOI 10.1097/GRF.0b013e3181cc406d; Pawitan Y, 2004, STAT MED, V23, P449, DOI 10.1002/sim.1603; Qureshi N, 2012, ANN INTERN MED, V156, P253, DOI 10.7326/0003-4819-156-4-201202210-00002; Rubinstein WS, 2011, GENET MED, V13, P956, DOI 10.1097/GIM.0b013e3182241d88; Sheiner E, 2005, J MATERN-FETAL NEO M, V18, P149, DOI 10.1080/14767050500170088; Sivertsen A, 2008, BRIT MED J, V336, P432, DOI 10.1136/bmj.39458.563611.AE; Suarez BK, 2005, GENETIC LIABILITY MO; Svensson AC, 2006, AM J OBSTET GYNECOL, V194, P475, DOI 10.1016/j.ajog.2005.08.019; Svensson AC, 2009, AM J EPIDEMIOL, V170, P1365, DOI 10.1093/aje/kwp328; Swedish medical birth register, 2003, SWED MED BIRTH REG S; Toledo P, 2007, ANESTH ANALG, V105, P1736, DOI 10.1213/01.ane.0000286233.48111.d8; TRIVERS RL, 1974, AM ZOOL, V14, P249; Walfish M, 2009, BR J ANAESTH S1, V103, pi47, DOI [DOI 10.1093/BJA/AEP303, DOI 10.1093/bja/aep303]	32	12	13	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2014	349								g4984	10.1136/bmj.g4984	http://dx.doi.org/10.1136/bmj.g4984			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RV	25121825	Green Published, hybrid			2022-12-28	WOS:000340507100001
J	Watts, G				Watts, Geoff			Ann Starrs: enabling women to fulfil their potential	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					393	393		10.1016/S0140-6736(14)61262-9	http://dx.doi.org/10.1016/S0140-6736(14)61262-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9IV	25088851				2022-12-28	WOS:000340195800013
J	Isbister, GK; Bawaskar, HS				Isbister, Geoffrey K.; Bawaskar, Himmatrao Saluba			Scorpion Envenomation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; ANTIVENOM PLUS PRAZOSIN; CLINICAL-MANIFESTATIONS; STINGS; CHILDREN; EFFICACY; SAFETY		[Isbister, Geoffrey K.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia; [Isbister, Geoffrey K.] Calvary Mater Newcastle, Newcastle, NSW, Australia; [Bawaskar, Himmatrao Saluba] Bawaskar Hosp & Res Ctr, Mahad, Maharashtra, India	University of Newcastle; Calvary Mater Newcastle Hospital	Isbister, GK (corresponding author), Calvary Mater Newcastle, Dept Clin Toxicol & Pharmacol, Edith St, Waratah, NSW 2298, Australia.	geoff.isbister@gmail.com	Isbister, Geoffrey K/G-8052-2015	Isbister, Geoffrey K/0000-0003-1519-7419				Abroug F, 2003, INTENS CARE MED, V29, P2266, DOI 10.1007/s00134-003-1947-0; Abroug F, 1999, LANCET, V354, P906, DOI 10.1016/S0140-6736(98)12083-4; Armstrong EP, 2013, TOXICON, V76, P394, DOI 10.1016/j.toxicon.2013.09.001; Bahloul M, 2004, INTENS CARE MED, V30, P461, DOI 10.1007/s00134-003-2082-7; Bahloul M, 2013, INT J CARDIOL, V162, P86, DOI 10.1016/j.ijcard.2011.10.013; Bahloul M, 2010, AM J TROP MED HYG, V83, P1084, DOI [10.4269/ajtmh.2010.10-0036, 10.4269/ajtmh.2010.10.0036]; Bawaskar Himmatrao Saluba, 2012, J Assoc Physicians India, V60, P46; Bawaskar HS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7136; Benmosbah M, 2013, TOXICON, V73, P56, DOI 10.1016/j.toxicon.2013.05.025; BERG RA, 1991, PEDIATRICS, V87, P930; Bouaziz M, 2008, TOXICON, V52, P918, DOI 10.1016/j.toxicon.2008.09.004; Boyer LV, 2013, TOXICON, V76, P377, DOI 10.1016/j.toxicon.2013.07.014; Boyer L, 2013, TOXICON, V76, P386, DOI 10.1016/j.toxicon.2013.07.017; Boyer LV, 2009, NEW ENGL J MED, V360, P2090, DOI 10.1056/NEJMoa0808455; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Diaz P, 2005, TOXICON, V45, P27, DOI 10.1016/j.toxicon.2004.09.008; FREIREMAIA L, 1994, TOXICON, V32, P1009, DOI 10.1016/0041-0101(94)90382-4; Isbister GK, 2011, LANCET, V378, P2039, DOI 10.1016/S0140-6736(10)62230-1; Isbister GK, 2003, TOXICON, V41, P877, DOI 10.1016/S0041-0101(03)00065-5; Khattabi A, 2011, T ROY SOC TROP MED H, V105, P364, DOI 10.1016/j.trstmh.2011.03.007; Otero R, 2004, T ROY SOC TROP MED H, V98, P742, DOI 10.1016/j.trstmh.2003.12.018; Pandi K, 2014, ARCH DIS CHILD, V99, P575, DOI 10.1136/archdischild-2013-305483; Pipelzadeh MH, 2007, TOXICON, V50, P984, DOI 10.1016/j.toxicon.2007.07.018; POONKING T, 1963, BMJ-BRIT MED J, P374, DOI 10.1136/bmj.1.5327.374; Quintero-Hernandez V, 2013, TOXICON, V76, P328, DOI 10.1016/j.toxicon.2013.07.012	25	126	135	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					457	463		10.1056/NEJMra1401108	http://dx.doi.org/10.1056/NEJMra1401108			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0SK	25075837				2022-12-28	WOS:000339556900010
J	Nouws, J; Shadel, GS				Nouws, Jessica; Shadel, Gerald S.			microManaging Mitochondrial Translation	CELL			English	Editorial Material							MICRORNAS; IMPORT	Regulation of gene expression in mammalian mitochondria by microRNAs is reported by Zhang et al. During muscle cell differentiation, localization of a miRNA is increased within mitochondria, where it interacts with Ago2 to selectively activate translation of mtDNA-encoded mRNAs. The findings represent a new mitochondrial regulatory pathway and a potentially powerful means to purposefully manipulate mtDNA expression.	[Nouws, Jessica; Shadel, Gerald S.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06437 USA; [Shadel, Gerald S.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06437 USA	Yale University; Yale University	Shadel, GS (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06437 USA.	gerald.shadel@yale.edu		Nouws, Jessica/0000-0003-3347-3595				Bandiera S, 2013, FREE RADICAL BIO MED, V64, P12, DOI 10.1016/j.freeradbiomed.2013.06.013; Bestwick ML, 2013, TRENDS BIOCHEM SCI, V38, P283, DOI 10.1016/j.tibs.2013.03.006; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; Pearce S, 2013, MOL CELL NEUROSCI, V55, P1, DOI 10.1016/j.mcn.2012.08.013; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Tarassov I, 2007, CELL CYCLE, V6, P2473, DOI 10.4161/cc.6.20.4783; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Wang G, 2010, CELL, V142, P456, DOI 10.1016/j.cell.2010.06.035; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390	9	9	9	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					477	478		10.1016/j.cell.2014.07.010	http://dx.doi.org/10.1016/j.cell.2014.07.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083863	Bronze			2022-12-28	WOS:000340944300002
J	Schroder, FH; Hugosson, J; Roobol, MJ; Tammela, TLJ; Zappa, M; Nelen, V; Kwiatkowski, M; Lujan, M; Maattanen, L; Lilja, H; Denis, LJ; Recker, F; Paez, A; Bangma, CH; Carlsson, S; Puliti, D; Villers, A; Rebillard, X; Hakama, M; Stenman, UH; Kujala, P; Taari, K; Aus, G; Huber, A; van der Kwast, TH; van Schaik, RHN; de Koning, HJ; Moss, SM; Auvinen, A				Schroder, Fritz H.; Hugosson, Jonas; Roobol, Monique J.; Tammela, Teuvo L. J.; Zappa, Marco; Nelen, Vera; Kwiatkowski, Maciej; Lujan, Marcos; Maattanen, Liisa; Lilja, Hans; Denis, Louis J.; Recker, Franz; Paez, Alvaro; Bangma, Chris H.; Carlsson, Sigrid; Puliti, Donella; Villers, Arnauld; Rebillard, Xavier; Hakama, Matti; Stenman, Ulf-Hakan; Kujala, Paula; Taari, Kimmo; Aus, Gunnar; Huber, Andreas; van der Kwast, Theo H.; van Schaik, Ron H. N.; de Koning, Harry J.; Moss, Sue M.; Auvinen, Anssi		ERSPC Investigators	Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up	LANCET			English	Article							ANTIGEN; TRIAL; RISK; BIOPSY; DEATH	Background The European Randomised study of Screening for Prostate Cancer (ERSPC) has shown significant reductions in prostate cancer mortality after 9 years and 11 years of follow-up, but screening is controversial because of adverse events such as overdiagnosis. We provide updated results of mortality from prostate cancer with follow-up to 2010, with analyses truncated at 9, 11, and 13 years. Methods ERSPC is a multicentre, randomised trial with a predefined centralised database, analysis plan, and core age group (55-69 years), which assesses prostate-specific antigen (PSA) testing in eight European countries. Eligible men aged 50-74 years were identified from population registries and randomly assigned by computer generated random numbers to screening or no intervention (control). Investigators were masked to group allocation. The primary outcome was prostate cancer mortality in the core age group. Analysis was by intention to treat. We did a secondary analysis that corrected for selection bias due to non-participation. Only incidence and no mortality data at 9 years' follow-up are reported for the French centres. This study is registered with Current Controlled Trials, number ISRCTN49127736. Findings With data truncated at 13 years of follow-up, 7408 prostate cancer cases were diagnosed in the intervention group and 6107 cases in the control group. The rate ratio of prostate cancer incidence between the intervention and control groups was 1.91 (95% CI 1.83-1.99) after 9 years (1.64 [1.58-1.69] including France), 1.66 (1.60-1.73) after 11 years, and 1.57 (1.51-1.62) after 13 years. The rate ratio of prostate cancer mortality was 0.85 (0.70-1.03) after 9 years, 0.78 (0.66-0.91) after 11 years, and 0.79 (0.69-0.91) at 13 years. The absolute risk reduction of death from prostate cancer at 13 years was 0.11 per 1000 person-years or 1.28 per 1000 men randomised, which is equivalent to one prostate cancer death averted per 781 (95% CI 490-1929) men invited for screening or one per 27 (17-66) additional prostate cancer detected. After adjustment for non-participation, the rate ratio of prostate cancer mortality in men screened was 0.73 (95% CI 0.61-0.88). Interpretation In this update the ERSPC confirms a substantial reduction in prostate cancer mortality attributable to testing of PSA, with a substantially increased absolute effect at 13 years compared with findings after 9 and 11 years. Despite our findings, further quantification of harms and their reduction are still considered a prerequisite for the introduction of populated-based screening.	[Schroder, Fritz H.; Roobol, Monique J.; Bangma, Chris H.] Erasmus Univ, Med Ctr, Dept Urol, Rotterdam, Netherlands; [Hugosson, Jonas; Carlsson, Sigrid] Univ Gothenburg, Sahlgrenska Acad, Dept Urol, Gothenburg, Sweden; [Tammela, Teuvo L. J.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Tammela, Teuvo L. J.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Zappa, Marco; Puliti, Donella] ISPO, Unit Clin & Descript Epidemiol, Florence, Italy; [Nelen, Vera] Prov Inst Hyg, Antwerp, Belgium; [Kwiatkowski, Maciej; Recker, Franz] Kantonsspital Aarau, Dept Urol, Aarau, Switzerland; [Kwiatkowski, Maciej] Acad Hosp Braunschweig, Dept Urol, Braunschweig, Germany; [Lujan, Marcos] Hosp Infanta Cristina, Dept Urol, Madrid, Spain; [Lujan, Marcos; Paez, Alvaro] Hosp Univ Getafe, Dept Urol, Madrid, Spain; [Lujan, Marcos] Univ Complutense Madrid, Madrid, Spain; [Maattanen, Liisa; Hakama, Matti] Finnish Canc Registry, FIN-00170 Helsinki, Finland; [Lilja, Hans; Carlsson, Sigrid] Mem Sloan Kettering Canc Ctr, Dept Urol Surg, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Lab Med, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Med GU Oncol, New York, NY 10021 USA; [Lilja, Hans] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Lilja, Hans] Lund Univ, Dept Lab Med, Malmo, Sweden; [Lilja, Hans] Univ Tampere, Inst Biomed Technol, FIN-33101 Tampere, Finland; [Denis, Louis J.] Oncol Ctr Antwerp, Antwerp, Belgium; [Paez, Alvaro] Hosp Univ Fuenlabrada, Dept Urol, Madrid, Spain; [Paez, Alvaro] Univ Rey Juan Carlos, Madrid, Spain; [Villers, Arnauld] Univ Lille Nord France, CHU Lille, Dept Urol, Lille, France; [Rebillard, Xavier] Clin BeauSoleil, Serv Urol, Montpellier, France; [Hakama, Matti; Auvinen, Anssi] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Stenman, Ulf-Hakan] Univ Helsinki, Cent Hosp, Lab Div HUSLAB, Dept Clin Chem, Helsinki, Finland; [Kujala, Paula] Dept Pathol, FIMLAB, Tampere, Finland; [Taari, Kimmo] Univ Helsinki, Cent Hosp, Dept Urol, Helsinki, Finland; [Taari, Kimmo] Univ Helsinki, Helsinki, Finland; [Aus, Gunnar] Carlanderska Sjukhuset, Dept Urol, Gothenburg, Sweden; [Huber, Andreas] Kantonsspital Aarau, Ctr Lab Med, Aarau, Switzerland; [van der Kwast, Theo H.] Erasmus Univ, Med Ctr, Dept Pathol, Rotterdam, Netherlands; [van Schaik, Ron H. N.] Erasmus Univ, Med Ctr, Dept Clin Chem, Rotterdam, Netherlands; [de Koning, Harry J.] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Moss, Sue M.] Queen Mary Univ London, Ctr Canc Prevent, London, England	Erasmus University Rotterdam; Erasmus MC; University of Gothenburg; Tampere University; Tampere University Hospital; Tampere University; Kantonsspital Aarau AG (KSA); Hospital Universitario de Getafe; Complutense University of Madrid; Finnish Cancer Registry; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Oxford; Lund University; Tampere University; Hospital Universitario Fuenlabrada; Universidad Rey Juan Carlos; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Beau Soleil Clinic; Universite de Montpellier; Tampere University; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Kantonsspital Aarau AG (KSA); Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of London; Queen Mary University London	Schroder, FH (corresponding author), Erasmus Univ, Med Ctr, Dept Urol, POB 2040, Rotterdam, Netherlands.	secr.schroder@erasmusmc.nl	Zhu, Xiaoye/P-5629-2018; Auvinen, Anssi/AAL-2111-2020; van Schaik, Ron H.N./G-6816-2013; NEELS, Hugo M/B-4721-2017; de+Koning, Harry/AAF-9062-2019; Grosclaude, Pascale/B-6079-2015; zappa, marco/AAB-3294-2019; Auvinen, Anssi/AAD-9311-2020; Rubeca, Tiziana/J-5280-2018; Lilja, Hans/S-9703-2019; Arnauld, VILLERS A/K-6629-2016; Puliti, Donella/K-6578-2016	Zhu, Xiaoye/0000-0001-5705-6660; Auvinen, Anssi/0000-0003-1125-4818; NEELS, Hugo M/0000-0002-9034-168X; de+Koning, Harry/0000-0003-4682-3646; zappa, marco/0000-0002-6606-9786; Rubeca, Tiziana/0000-0002-1870-4722; Lilja, Hans/0000-0001-5871-7846; Arnauld, VILLERS A/0000-0002-6298-7758; Stenman, Ulf-Hakan/0000-0002-2695-3454; Angulo, Javier/0000-0002-1735-8792; Taari, Kimmo/0000-0002-0077-4896; Carlsson, Sigrid/0000-0003-3553-5710; grosclaude, pascale/0000-0002-6755-5970; Holmberg, Erik/0000-0001-5107-4550; Kilpelainen, Tuomas P./0000-0002-7697-0148; Venderbos, Lionne/0000-0002-4269-0623; Rietbergen, John/0000-0002-3840-0873; Stranne, Johan/0000-0002-4295-6524; Puliti, Donella/0000-0002-3820-4442; Van der Kwast, Theodorus/0000-0001-8640-5786; Bokhorst, Leonard Pieter/0000-0003-1154-4794; Grobholz, Rainer/0000-0002-1901-7967	NATIONAL CANCER INSTITUTE [P50CA092629, R01CA160816, P30CA008748] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA160816, P50 CA092629, P30 CA008748, R01 CA160816, P50-CA92629] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALEN O, 1978, ANN STAT, V6, P701, DOI 10.1214/aos/1176344247; Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; Cooperberg MR, 2004, J CLIN ONCOL, V22, P2141, DOI 10.1200/JCO.2004.10.062; Cuzick J, 1997, STAT MED, V16, P1017, DOI 10.1002/(SICI)1097-0258(19970515)16:9<1017::AID-SIM508>3.0.CO;2-V; de Koning HJ, 2002, INT J CANCER, V98, P268, DOI 10.1002/ijc.10188; De Koning HJ, 2003, BJU INT, V92, P71, DOI 10.1111/j.1465-5101.2003.04402.x; De Koning HJ, 2003, BJU INT, V92, P112, DOI 10.1111/j.1464-410X.2003.4410x.x; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; European Randomized Study of Screening for Prostate Cancer, STUD PROT ERSPC; GANN PH, 1995, JAMA-J AM MED ASSOC, V273, P289, DOI 10.1001/jama.273.4.289; Heijnsdijk EAM, 2012, NEW ENGL J MED, V367, P595, DOI 10.1056/NEJMoa1201637; Ilic Dragan, 2014, Recent Results Cancer Res, V202, P65, DOI 10.1007/978-3-642-45195-9_8; Loeb S, 2013, EUR UROL, V64, P876, DOI 10.1016/j.eururo.2013.05.049; Loeb S, 2013, J UROLOGY, V189, P867, DOI 10.1016/j.juro.2012.10.005; Makinen T, 2008, INT J CANCER, V122, P413, DOI 10.1002/ijc.23126; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Popiolek M, 2013, EUR UROL, V63, P428, DOI 10.1016/j.eururo.2012.10.002; Roobol MJ, 2003, BJU INT, V92, P117, DOI 10.1111/j.1464-410X.2003.4698x.x; SCHRODER FH, 1995, CANCER, V76, P129, DOI 10.1002/1097-0142(19950701)76:1<129::AID-CNCR2820760120>3.0.CO;2-1; Schroder FH, 1996, INT J CANCER, V65, P145, DOI 10.1002/(SICI)1097-0215(19960117)65:2&lt;145::AID-IJC4&gt;3.0.CO;2-Z; Schroder Fritz H, 2014, Recent Results Cancer Res, V202, P59, DOI 10.1007/978-3-642-45195-9_7; Schroder FH, 2012, EUR UROL, V62, P745, DOI 10.1016/j.eururo.2012.05.068; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; STENMAN UH, 1994, LANCET, V344, P1594, DOI 10.1016/S0140-6736(94)90405-7; Vickers AJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2023; Wolters T, 2010, INT J CANCER, V126, P2387, DOI 10.1002/ijc.24870; Zappa M, 2014, EUR UROL, V66, P401, DOI 10.1016/j.eururo.2013.12.055	29	943	974	1	96	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2027	2035		10.1016/S0140-6736(14)60525-0	http://dx.doi.org/10.1016/S0140-6736(14)60525-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BD	25108889	Green Accepted			2022-12-28	WOS:000346353600024
J	Ntziachristos, P; Tsirigos, A; Welstead, GG; Trimarchi, T; Bakogianni, S; Xu, LY; Loizou, E; Holmfeldt, L; Strikoudis, A; King, B; Mullenders, J; Becksfort, J; Nedjic, J; Paietta, E; Tallman, MS; Rowe, JM; Tonon, G; Satoh, T; Kruidenier, L; Prinjha, R; Akira, S; Van Vlierberghe, P; Ferrando, AA; Jaenisch, R; Mullighan, CG; Aifantis, I				Ntziachristos, Panagiotis; Tsirigos, Aristotelis; Welstead, G. Grant; Trimarchi, Thomas; Bakogianni, Sofia; Xu, Luyao; Loizou, Evangelia; Holmfeldt, Linda; Strikoudis, Alexandros; King, Bryan; Mullenders, Jasper; Becksfort, Jared; Nedjic, Jelena; Paietta, Elisabeth; Tallman, Martin S.; Rowe, Jacob M.; Tonon, Giovanni; Satoh, Takashi; Kruidenier, Laurens; Prinjha, Rab; Akira, Shizuo; Van Vlierberghe, Pieter; Ferrando, Adolfo A.; Jaenisch, Rudolf; Mullighan, Charles G.; Aifantis, Iannis			Contrasting roles of histone 3 lysine 27 demethylases in acute lymphoblastic leukaemia	NATURE			English	Article							INITIATING CELL-ACTIVITY; ACUTE MYELOID-LEUKEMIA; H3K27 DEMETHYLASE; EXPRESSION PROFILES; JMJD3 CONTRIBUTES; STEM-CELL; UTX; MUTATIONS; ACTIVATION; GENOME	T-cell acute lymphoblastic leukaemia (T-ALL) is a haematological malignancy with a dismal overall prognosis, including a relapse rate of up to 25%, mainly because of the lack of non-cytotoxic targeted therapy options. Drugs that target the function of key epigenetic factors have been approved in the context of haematopoietic disorders(1), and mutations that affect chromatin modulators in a variety of leukaemias have recently been identified(2,3); however, epigenetic drugs are not currently used for T-ALL treatment. Recently, we described that the polycomb repressive complex 2 (PRC2) has a tumour-suppressor role in T-ALL(4). Here we delineated the role of the histone 3 lysine 27 (H3K27) demethylases JMJD3 and UTX in T-ALL. We show that JMJD3 is essential for the initiation and maintenance of T-ALL, as it controls important oncogenic gene targets by modulating H3K27 methylation. By contrast, we found that UTX functions as a tumour suppressor and is frequently genetically inactivated in T-ALL. Moreover, we demonstrated that the small molecule inhibitor GSKJ4 (ref. 5) affects T-ALL growth, by targeting JMJD3 activity. These findings show that two proteins with a similar enzymatic function can have opposing roles in the context of the same disease, paving the way for treating haematopoietic malignancies with a new category of epigenetic inhibitors.	[Ntziachristos, Panagiotis; Tsirigos, Aristotelis; Trimarchi, Thomas; Bakogianni, Sofia; Loizou, Evangelia; Strikoudis, Alexandros; King, Bryan; Mullenders, Jasper; Nedjic, Jelena; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Ntziachristos, Panagiotis; Tsirigos, Aristotelis; Trimarchi, Thomas; Bakogianni, Sofia; Loizou, Evangelia; Strikoudis, Alexandros; King, Bryan; Mullenders, Jasper; Nedjic, Jelena; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Ntziachristos, Panagiotis; Trimarchi, Thomas; Bakogianni, Sofia; Loizou, Evangelia; Strikoudis, Alexandros; King, Bryan; Mullenders, Jasper; Nedjic, Jelena; Aifantis, Iannis] NYU, Sch Med, NYU Canc Inst, New York, NY 10016 USA; [Ntziachristos, Panagiotis; Trimarchi, Thomas; Bakogianni, Sofia; Loizou, Evangelia; Strikoudis, Alexandros; King, Bryan; Mullenders, Jasper; Nedjic, Jelena; Aifantis, Iannis] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA; [Tsirigos, Aristotelis] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Welstead, G. Grant; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Welstead, G. Grant; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA; [Xu, Luyao; Van Vlierberghe, Pieter; Ferrando, Adolfo A.] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Holmfeldt, Linda; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Becksfort, Jared] St Jude Childrens Res Hosp, Dept Computat Biol, Memphis, TN 38105 USA; [Paietta, Elisabeth] Montefiore Med Ctr North, Bronx, NY 10467 USA; [Tallman, Martin S.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Rowe, Jacob M.] Technion Israel Inst Technol, IL-31096 Haifa, Israel; [Rowe, Jacob M.] Shaare Zedek Med Ctr, IL-9103102 Jerusalem, Israel; [Tonon, Giovanni] Ist Sci San Raffaele, IRCCS, Div Mol Oncol, Funct Genom Canc Unit, I-20132 Milan, Italy; [Satoh, Takashi; Akira, Shizuo] Osaka Univ, WPI IFReC, Lab Host Def, Suita, Osaka 5650871, Japan; [Satoh, Takashi; Akira, Shizuo] Osaka Univ, RIMD, Dept Host Def, Suita, Osaka 5650871, Japan; [Kruidenier, Laurens; Prinjha, Rab] GlaxoSmithKline R&D, Med Res Ctr, Immunoinflammat Therapy Area, Epinova DPU, Stevenage SG1 2NY, Herts, England; [Van Vlierberghe, Pieter] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Ferrando, Adolfo A.] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Ferrando, Adolfo A.] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; New York University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Columbia University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Montefiore Medical Center; Memorial Sloan Kettering Cancer Center; Technion Israel Institute of Technology; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Osaka University; Osaka University; GlaxoSmithKline; Ghent University; Ghent University Hospital; Columbia University; Columbia University	Tsirigos, A (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	Aristotelis.Tsirigos@nyumc.org; charles.mullighan@stjude.org	Tonon, Giovanni/J-9804-2018; Mullenders, Jasper/J-2398-2015; Ntziachristos, Panagiotis/CAG-2071-2022; Mullighan, Charles/H-3253-2011; xu, Luyao/F-2381-2015; Akira, Shizuo/C-3134-2009; Van Vlierberghe, Pieter/G-8894-2013	Tonon, Giovanni/0000-0003-2973-5038; Mullenders, Jasper/0000-0003-3737-6901; Mullighan, Charles/0000-0002-1871-1850; Van Vlierberghe, Pieter/0000-0001-9063-7205; Tsirigos, Aristotelis/0000-0002-7512-8477; Holmfeldt, Linda/0000-0003-4140-3423	National Institutes of Health (NIH)/National Cancer Institute (NCI) grant [P30 CA016087-30]; NIH/NCI [5P30CA16087-31, K99CA188293]; NIH [1R01CA133379, 1R01CA105129, 1R01CA149655, 5R01CA173636, 5R01CA169784, 5 T32 CA009161-37, R37-HD04502, R01CA120196]; Damon Runyon Cancer Research Foundation; NYU Cell and Molecular Biology Training Program; Lady Tata Memorial Trust for leukaemia; American Society of Hematology; Research Foundation Flanders; Odysseus type II grant; NCI [U24 CA114737, U10 CA21115]; Stand Up To Cancer Innovative Research Award; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society; Ralph S. French Charitable Foundation Trust; Chemotherapy Foundation; V Foundation for Cancer Research; St. Baldrick's Foundation; ECOG tumour bank; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U10CA180820, R01CA120196, R01CA173636, R01CA149655, R01CA133379, U10CA180827, R01CA105129, U10CA021115, U24CA114737, P30CA016087, R01CA169784, P30CA014051, P30CA021765, T32CA009161, K99CA188293] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute (NCI) grant; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NYU Cell and Molecular Biology Training Program; Lady Tata Memorial Trust for leukaemia; American Society of Hematology; Research Foundation Flanders(FWO); Odysseus type II grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up To Cancer Innovative Research Award; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Ralph S. French Charitable Foundation Trust; Chemotherapy Foundation; V Foundation for Cancer Research; St. Baldrick's Foundation; ECOG tumour bank; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Aifantis laboratory and J. Siegle for discussions throughout the duration of the project; S. Shen for discussions on the analysis of sequencing data; GlaxoSmithKline for the GSKJ4 and GSKJ5 inhibitory compounds; A. Heguy and the NYU Genome Technology Center (supported in part by National Institutes of Health (NIH)/National Cancer Institute (NCI) grant P30 CA016087-30) for assistance with sequencing experiments; the NYU Flow Cytometry facility (supported in part by NIH/NCI grant 5P30CA16087-31) for cell sorting; the NYU Histology Core (5P30CA16087-31) and the NYU mouse facility (NYU Cancer Institute Center Grant 5P30CA16087-31); G. Natoli for providing the anti-JMJ D3 antibody; J. Zhang for help with the analysis of the mutation data; and I. Rigo for technical support. I.A. was supported by the NIH (grants 1R01CA133379, 1R01CA105129, 1R01CA149655, 5R01CA173636 and 5R01CA169784). J.N. was supported by the Damon Runyon Cancer Research Foundation. B.K. was supported by the NYU Cell and Molecular Biology Training Program. P.N. was supported by fellowships from Lady Tata Memorial Trust for leukaemia and the American Society of Hematology and NIH/NCI (K99CA188293). T.T. is supported by the NIH training grant 5 T32 CA009161-37. P.V.V. was supported by the Research Foundation Flanders and an Odysseus type II grant Moreover, this study was supported by an NIH grant (R37-HD04502) to R.J., the ECOG tumour bank, an NIH grant (R01CA120196) to A.A.F.; NCI grants (U24 CA114737 and U10 CA21115) to E.P. and the Stand Up To Cancer Innovative Research Award (A.A.F.). I.A. was also supported by the William Lawrence and Blanche Hughes Foundation, The Leukemia & Lymphoma Society, the Ralph S. French Charitable Foundation Trust, The Chemotherapy Foundation, The V Foundation for Cancer Research and the St. Baldrick's Foundation. I.A. is a Howard Hughes Medical Institute Early Career Scientist. A.T. carried out part of this work while at the Computational Biology Center, IBM Research, Yorktown Heights, New York.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Armstrong F, 2009, BLOOD, V113, P1730, DOI 10.1182/blood-2008-02-138172; Barradas M, 2009, GENE DEV, V23, P1177, DOI 10.1101/gad.511109; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Chen K, 2007, GENOME RES, V17, P659, DOI 10.1101/gr.6151507; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dik WA, 2005, J EXP MED, V201, P1715, DOI 10.1084/jem.20042524; Espinosa L, 2010, CANCER CELL, V18, P268, DOI 10.1016/j.ccr.2010.08.006; Hubner MR, 2010, COLD SH Q B, V75, P43, DOI 10.1101/sqb.2010.75.020; Jankowska AM, 2011, BLOOD, V118, P3932, DOI 10.1182/blood-2010-10-311019; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kruidenier L, 2012, NATURE, V488, P404, DOI 10.1038/nature11262; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Mar BG, 2012, LEUKEMIA, V26, P1881, DOI 10.1038/leu.2012.56; Marks DI, 2009, BLOOD, V114, P5136, DOI 10.1182/blood-2009-08-231217; Mullighan CG, 2011, METHODS MOL BIOL, V730, P235, DOI 10.1007/978-1-61779-074-4_17; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Simon C, 2012, GENE DEV, V26, P651, DOI 10.1101/gad.186411.111; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thieme S, 2013, BLOOD, V121, P2462, DOI 10.1182/blood-2012-08-452003; Torres CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060020; Tsirigos A, 2012, BIOINFORMATICS, V28, P282, DOI 10.1093/bioinformatics/btr646; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Welstead GG, 2012, P NATL ACAD SCI USA, V109, P13004, DOI 10.1073/pnas.1210787109; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Zhang JH, 2005, PLOS COMPUT BIOL, V1, P395, DOI 10.1371/journal.pcbi.0010053; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	47	260	272	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2014	514	7523					513	+		10.1038/nature13605	http://dx.doi.org/10.1038/nature13605			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR7RC	25132549	Green Accepted, Green Submitted			2022-12-28	WOS:000343775900045
J	Thompson, IM; Leach, RJ; Ankerst, DP				Thompson, Ian M., Jr.; Leach, Robin J.; Ankerst, Donna P.			Focusing PSA Testing on Detection of High-Risk Prostate Cancers by Incorporating Patient Preferences Into Decision Making	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PREVENTION TRIAL; MORTALITY		[Thompson, Ian M., Jr.; Leach, Robin J.; Ankerst, Donna P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [Thompson, Ian M., Jr.; Leach, Robin J.; Ankerst, Donna P.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Ankerst, Donna P.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Ankerst, Donna P.] Tech Univ Munich, Dept Math, D-80290 Munich, Germany	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Technical University of Munich	Thompson, IM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, 7979 Wurzbach Ave,Ste U627, San Antonio, TX 78229 USA.	thompsoni@uthscsa.edu		Ankerst, Donna/0000-0003-4229-2462; Leach, Robin/0000-0002-3201-5579	NATIONAL CANCER INSTITUTE [P30CA054174, P01CA108964, U01CA086402] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA054174, P01CA108964, P01 CA108964, U01 CA086402] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Ankerst DP, 2014, UROLOGY, V83, P1362, DOI 10.1016/j.urology.2014.02.035; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Nam RK, 2013, J UROLOGY, V189, pS12, DOI 10.1016/j.juro.2012.11.015; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131	9	22	22	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2014	312	10					995	996		10.1001/jama.2014.9680	http://dx.doi.org/10.1001/jama.2014.9680			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5LF	25090603	Green Accepted			2022-12-28	WOS:000341385600012
J	Grant, JE				Grant, Jon E.			Obsessive-Compulsive Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COGNITIVE-BEHAVIOR THERAPY; LONG-TERM TREATMENT; FOLLOW-UP; METAANALYSIS; CHILDREN; ASSOCIATION; ONSET	A 19-year-old man is brought to his primary physician by his father, who explains that his son washes his hands a hundred times a day, will not touch anything that has been touched by someone else without scrubbing it first, and has a fear of germs that has left him isolated in his bedroom, unable to eat, and wishing he were dead. Although the father reports that his son has always been finicky, this problem started approximately 2 years ago and has gradually become completely disabling. How should this patient be evaluated and treated?	[Grant, Jon E.] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA	University of Chicago	Grant, JE (corresponding author), Univ Chicago, Pritzker Sch Med, Dept Psychiat & Behav Neurosci, 5841 S Maryland Ave,MC 3077, Chicago, IL 60637 USA.	jongrant@uchicago.edu						Abramowitz JS, 2006, CAN J PSYCHIAT, V51, P407, DOI 10.1177/070674370605100702; Ackerman DL, 2002, J CLIN PSYCHOPHARM, V22, P309, DOI 10.1097/00004714-200206000-00012; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Andersson E, 2012, PSYCHOL MED, V42, P2193, DOI 10.1017/S0033291712000244; [Anonymous], 2005, OBS COMP DIS COR INT; Ayuso-Mateos JL., 2006, GLOBAL BURDEN OBSESS; Bandelow B, 2008, WORLD J BIOL PSYCHIA, V9, P248, DOI 10.1080/15622970802465807; BAXTER LR, 1987, ARCH GEN PSYCHIAT, V44, P211; Blanco C, 2006, J CLIN PSYCHIAT, V67, P946, DOI 10.4088/JCP.v67n0611; Bloch MH, 2006, MOL PSYCHIATR, V11, P622, DOI 10.1038/sj.mp.4001823; Chamberlain SR, 2008, SCIENCE, V321, P421, DOI 10.1126/science.1154433; Foa Edna B, 2010, Dialogues Clin Neurosci, V12, P199; Fontenelle LF, 2004, J PSYCHIATR RES, V38, P403, DOI 10.1016/j.jpsychires.2003.12.004; Geller DA, 2006, PSYCHIAT CLIN N AM, V29, P353, DOI 10.1016/j.psc.2006.02.012; Geller DA, 2001, J NERV MENT DIS, V189, P471, DOI 10.1097/00005053-200107000-00009; Ginsburg GS, 2008, J AM ACAD CHILD PSY, V47, P868, DOI 10.1097/CHI.0b013e3181799ebd; Goodman WK, 2012, ANNU REV MED, V63, P511, DOI 10.1146/annurev-med-052209-100401; Grant JE, 2007, PSYCHIAT RES, V152, P21, DOI 10.1016/j.psychres.2006.09.015; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; GREENBERG D, 1994, ISRAEL J PSYCHIAT, V31, P211; Greist JH, 2003, CNS SPECTR, V8, P7, DOI 10.1017/S1092852900006908; Greist JH, 2002, J CLIN PSYCHIAT, V63, P138, DOI 10.4088/JCP.v63n0209; Jacob ML, 2014, COMPR PSYCHIAT, V55, P896, DOI 10.1016/j.comppsych.2013.12.016; Kalra SK, 2009, J CLIN INVEST, V119, P737, DOI 10.1172/JCI37563; KARNO M, 1988, ARCH GEN PSYCHIAT, V45, P1094, DOI 10.1001/archpsyc.1988.01800360042006; Kordon A, 2005, EUR ARCH PSY CLIN N, V255, P48, DOI 10.1007/s00406-004-0533-y; Lovell K, 2006, BMJ-BRIT MED J, V333, P883, DOI 10.1136/bmj.38940.355602.80; Mancebo MC, 2006, J CLIN PSYCHIAT, V67, P1713, DOI 10.4088/JCP.v67n1107; Menzies L, 2007, BRAIN, V130, P3223, DOI 10.1093/brain/awm205; Milad MR, 2012, TRENDS COGN SCI, V16, P43, DOI 10.1016/j.tics.2011.11.003; Narayanaswamy JC, 2012, PSYCHIAT RES, V200, P554, DOI 10.1016/j.psychres.2012.03.037; Piras F, 2013, NEUROSCI BIOBEHAV R, V37, P2856, DOI 10.1016/j.neubiorev.2013.10.008; Ponniah K, 2013, J OBSESS-COMPULS REL, V2, P207, DOI 10.1016/j.jocrd.2013.02.005; RACHMAN S, 1978, BEHAV RES THER, V16, P233, DOI 10.1016/0005-7967(78)90022-0; Ravizza L, 1998, CNS DRUGS, V10, P247, DOI 10.2165/00023210-199810040-00003; Reddy YCJ, 2010, J CLIN PSYCHOPHARM, V30, P267, DOI 10.1097/JCP.0b013e3181dbfb53; Reddy YCJ, 2005, J CLIN PSYCHIAT, V66, P744, DOI 10.4088/JCP.v66n0611; Romanelli RJ, 2014, DEPRESS ANXIETY; Rosa-Alcazar AI, 2008, CLIN PSYCHOL REV, V28, P1310, DOI 10.1016/j.cpr.2008.07.001; Ruscio AM, 2010, MOL PSYCHIATR, V15, P53, DOI 10.1038/mp.2008.94; Saxena S, 2000, PSYCHIAT CLIN N AM, V23, P563, DOI 10.1016/S0193-953X(05)70181-7; Simpson HB, 2013, JAMA PSYCHIAT, V70, P1190, DOI 10.1001/jamapsychiatry.2013.1932; Simpson HB, 2011, J CONSULT CLIN PSYCH, V79, P247, DOI 10.1037/a0022659; Skoog G, 1999, ARCH GEN PSYCHIAT, V56, P121, DOI 10.1001/archpsyc.56.2.121; Soomro GM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001765.pub3; Stewart SE, 2013, MOL PSYCHIATR, V18, P788, DOI 10.1038/mp.2012.85; Stewart SE, 2013, AM J MED GENET B, V162B, P367, DOI 10.1002/ajmg.b.32137; van Grootheest DS, 2005, TWIN RES HUM GENET, V8, P450, DOI 10.1375/183242705774310060; van Oppen P, 2010, J CLIN PSYCHIAT, V71, P1158, DOI 10.4088/JCP.08m04990blu; Wang PS, 2007, AM J PSYCHIAT, V164, P1, DOI 10.1176/appi.ajp.164.1.1	50	51	57	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					646	653		10.1056/NEJMcp1402176	http://dx.doi.org/10.1056/NEJMcp1402176			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZL	25119610				2022-12-28	WOS:000340819600010
J	Clarfield, AM				Clarfield, A. Mark			We are both doctors: an Israeli doctor writes to a Palestinian colleague	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Clarfield, A. Mark] Ben Gurion Univ Negev, Soroka Hosp, Dept Geriatr, IL-84101 Beer Sheva, Israel; [Clarfield, A. Mark] McGill Univ, Montreal, PQ, Canada	Ben Gurion University; Soroka Medical Center; McGill University	Clarfield, AM (corresponding author), Ben Gurion Univ Negev, Soroka Hosp, Dept Geriatr, IL-84101 Beer Sheva, Israel.	markclar@bgu.ac.il							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2014	349								g5023	10.1136/bmj.g5023	http://dx.doi.org/10.1136/bmj.g5023			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RV	25122514				2022-12-28	WOS:000340507100002
J	Arie, S				Arie, Sophie			INFECTIOUS DISEASES Ebola: an opportunity for a clinical trial?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						Arie S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g4123; Baize S., 2014, N ENGL J MED; Chan M., 2014, WHO DIRECTOR GEN ASS; Hotez P. R., 2013, STRENGTHENING MECH P; McGrath M., 2012, COMMERCIAL EBOLA VIR; Torjesen I., 2014, BMJ-BRIT MED J, V349, P4895; United Nations Development Programme, 2014, HUM DEV IND HDI; US Food and Drug Administration, 2014, GUID IND PROD DEV AN; Wellcome Trust, 2014, WE MUST LEARN LESS T; WHO, 2014, EB VIR DIS	10	8	9	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 6	2014	349								g4997	10.1136/bmj.g4997	http://dx.doi.org/10.1136/bmj.g4997			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MQ	25098954	Bronze, Green Published			2022-12-28	WOS:000340206100002
J	D'Silva, KA; Dahm, P; Wong, CL				D'Silva, Karen A.; Dahm, Philipp; Wong, Camilla L.			Does This Man With Lower Urinary Tract Symptoms Have Bladder Outlet Obstruction? The Rational Clinical Examination: A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BENIGN PROSTATIC HYPERPLASIA; PORTABLE ULTRASOUND SCANNER; QUALITY-OF-LIFE; RESIDUAL URINE; DIAGNOSTIC-ACCURACY; VOLUME MEASUREMENT; PRIMARY-CARE; FLOW-RATE; MEN; DEVICE	IMPORTANCE Early, accurate diagnosis of bladder outlet obstruction in men with lower urinary tract symptoms may reduce the need for invasive testing (ie, catheter placement, urodynamics), and prompt early treatment to provide symptomatic relief and avoid complications. OBJECTIVES To systematically review the evidence on (1) the diagnostic accuracy of office-based tests for bladder outlet obstruction in men with lower urinary tract symptoms; and (2) the accuracy of the bladder scan as a measure of urine volume because management decisions rely on measuring postvoid bladder residual volumes. DATA SOURCES AND STUDY SELECTION MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials (1950-March 2014), along with reference lists from retrieved articles were searched to identify studies of diagnostic test accuracy among males with lower urinary tract symptoms due to bladder outlet obstruction. MEDLINE, EMBASE, CINAHL, and the Cochrane Library (1950-March 2014) were searched to identify studies of urine volumes measured with a bladder scanner vs those measured with bladder catheterization. Prospective studies were selected if they compared 1 or more office-based, noninvasive diagnostic test with the reference test or were invasive urodynamic studies, and if urine volumes were measured with a bladder scanner and bladder catheterization. DATA EXTRACTION AND SYNTHESIS For the bladder outlet obstruction objective, 8628 unique citations were identified. Ten studies (1262 patients among 9 unique cohorts) met inclusion criteria. For the bladder scan objective, 2254 unique citations were identified. Twenty studies (n = 1397 patients) met inclusion criteria. MAIN OUTCOMES AND MEASURES The first main outcome and measure was the diagnostic accuracy of individual symptoms and questionnaires compared with the reference standard (urodynamic studies) for the diagnosis of bladder outlet obstruction in males with lower urinary tract symptoms. The second was the correlation between urine volumes measured with a bladder scanner and those measured with bladder catheterization. RESULTS Among males with lower urinary tract symptoms, the likelihood ratios (LRs) of individual symptoms and questionnaires for diagnosing bladder outlet obstruction from the highest quality studies had 95% CIs that included 1.0, suggesting they are not significantly associated with one another. An International Prostate Symptom Score cutoff of 20 or greater increased the likelihood of bladder outlet obstruction (positive LR, 1.5; 95% CI, 1.1-2.0), whereas scores of less than 20 had an LR that included 1.0 in the 95% CI (negative LR, 0.82; 95% CI, 0.67-1.00). We found no data on the accuracy of physical examination findings to predict bladder outlet obstruction. Urine volumes measured by a bladder scanner correlated highly with urine volumes measured by bladder catheterization (summary correlation coefficient, 0.93; 95% CI, 0.91-0.95). CONCLUSIONS AND RELEVANCE In patients with lower urinary tract symptoms, the symptoms alone are not enough to adequately diagnose bladder outlet obstruction. A bladder scan for urine volume should be performed to assess patients with suspected large postvoid residual volumes.	[D'Silva, Karen A.; Wong, Camilla L.] Univ Toronto, Dept Med, Toronto, ON, Canada; [D'Silva, Karen A.; Wong, Camilla L.] St Michaels Hosp, Div Geriatr, Toronto, ON M5B 1W8, Canada; [Dahm, Philipp] Univ Florida, Coll Med, Dept Urol, Gainesville, FL USA; [Dahm, Philipp] Malcom Randall Vet Affairs Med Ctr, Gainesville, FL USA; [Wong, Camilla L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; State University System of Florida; University of Florida; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	D'Silva, KA (corresponding author), St Michaels Hosp, 30 Bond St, Toronto, ON M5B 1W8, Canada.	karen.dsilva@medportal.ca	Wong, Camilla/J-6419-2019; Dahm, Philipp/I-1614-2019	Wong, Camilla/0000-0002-4430-2321; Dahm, Philipp/0000-0003-2819-2553				Abrams P, 2013, J UROLOGY, V189, pS93, DOI 10.1016/j.juro.2012.11.021; Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052; Aganovic D, 2012, BOSNIAN J BASIC MED, V12, P144, DOI 10.17305/bjbms.2012.2459; Aganovic Damir, 2004, Med Arh, V58, P109; Araki Y, 2003, MINIM INVASIV THER, V12, P245, DOI 10.1080/13645700310015554; AUA Practise Guidelines Committee, 2003, J UROLOGY, V170, P530, DOI 10.1097/01.ju.0000078083.38675.79; Barrington JW, 1996, J UROLOGY, V155, P82, DOI 10.1016/S0022-5347(01)66549-2; BARRY MJ, 1995, MED CARE, V33, pAS145; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Borrie M J, 2001, Rehabil Nurs, V26, P187; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cam K, 2003, BJU INT, V91, P186, DOI 10.1046/j.1464-410X.2003.04055.x; Carballido J, 2011, INT J CLIN PRACT, V65, P989, DOI 10.1111/j.1742-1241.2011.02735.x; CARDENAS DD, 1988, ARCH PHYS MED REHAB, V69, P514; Chan H, 1993, J Neurosci Nurs, V25, P309; Chapple CR, 2008, EUR UROL, V54, P563, DOI 10.1016/j.eururo.2008.03.109; Choe JH, 2007, INT UROGYNECOL J, V18, P641, DOI 10.1007/s00192-006-0219-2; COOMBES GM, 1994, J UROLOGY, V152, P2083, DOI 10.1016/S0022-5347(17)32314-5; Ding Y. Y., 1996, Singapore Medical Journal, V37, P365; Ding Y Y, 1997, Geriatr Nephrol Urol, V7, P17, DOI 10.1023/A:1008299528728; Donovan JL, 1997, BRIT J UROL, V80, P712, DOI 10.1046/j.1464-410X.1997.00461.x; Fuse H., 1996, International Urology and Nephrology, V28, P633, DOI 10.1007/BF02552157; HALD T, 1991, SCAND J UROL NEPHROL, P59; Hatala R, 2005, CAN MED ASSOC J, V172, P661, DOI 10.1503/cmaj.1031920; Haynes RB, 2004, BMJ-BRIT MED J, V328, P1040; IRETON RC, 1990, J UROLOGY, V143, P909, DOI 10.1016/S0022-5347(17)40133-9; Madersbacher S, 1997, BRIT J UROL, V80, P72, DOI 10.1046/j.1464-410X.1997.00220.x; Marks LS, 1997, UROLOGY, V50, P341, DOI 10.1016/S0090-4295(97)00293-8; MASSAGLI TL, 1989, J UROLOGY, V142, P969, DOI 10.1016/S0022-5347(17)38955-3; Master VA, 2010, UROLOGY, V75, P148, DOI 10.1016/j.urology.2009.06.060; McVary KT, 2011, J UROLOGY, V185, P1793, DOI 10.1016/j.juro.2011.01.074; Nitti Victor W, 2005, Rev Urol, V7 Suppl 6, pS14; O'Farrell B, 2001, J Neurosci Nurs, V33, P301; Oelke M, 2007, EUR UROL, V52, P827, DOI 10.1016/j.eururo.2006.12.023; Oh-Oka H, 2007, J UROLOGY, V177, P595, DOI 10.1016/j.juro.2006.09.056; OUSLANDER JG, 1994, J AM GERIATR SOC, V42, P1189, DOI 10.1111/j.1532-5415.1994.tb06987.x; REVORD JP, 1993, ARCH PHYS MED REHAB, V74, P457, DOI 10.1016/0003-9993(93)90104-I; Reynard J, 1996, UROLOGY, V47, P491, DOI 10.1016/S0090-4295(99)80483-X; Reynard JM, 1996, BRIT J UROL, V77, P705, DOI 10.1046/j.1464-410X.1996.95615.x; Rhodes PR, 1999, UROLOGY, V53, P1090, DOI 10.1016/S0090-4295(99)00041-2; Schott-Baer F D, 2001, Urol Nurs, V21, P193; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simel DL, 2008, RATIONAL CLIN EXAMIN, P9; Sirls LT, 1996, NEUROUROL URODYNAM, V15, P447, DOI 10.1002/(SICI)1520-6777(1996)15:5<447::AID-NAU2>3.3.CO;2-4; Steele GS, 2000, J UROLOGY, V164, P344, DOI 10.1016/S0022-5347(05)67356-9; Tanguay S, 2009, CUAJ-CAN UROL ASSOC, V3, pS92; Teng Ching-Hwa, 2005, J Nurs Res, V13, P216; Thuroff JW, 2011, EUR UROL, V59, P387, DOI 10.1016/j.eururo.2010.11.021; TOPPER AK, 1993, J MED ENG TECHNOL, V17, P99, DOI 10.3109/03091909309016214; van Venrooij GEPM, 2008, UROLOGY, V71, P469, DOI 10.1016/j.urology.2007.11.033; Wei JT, 2008, J UROLOGY, V179, pS75, DOI 10.1016/j.juro.2008.03.141; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wilczynski NL, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-7; Winters JC, 2012, J UROLOGY, V188, P2464, DOI 10.1016/j.juro.2012.09.081; Wuerstle MC, 2011, ARCH INTERN MED, V171, P1680, DOI 10.1001/archinternmed.2011.475; YALLA SV, 1995, J UROLOGY, V153, P674, DOI 10.1016/S0022-5347(01)67682-1; Yap TL, 2007, EUR UROL, V52, P811, DOI 10.1016/j.eururo.2007.01.013; Yucel S, 2005, NEUROUROL URODYNAM, V24, P358, DOI 10.1002/nau.20147	60	27	31	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					535	542		10.1001/jama.2014.5555	http://dx.doi.org/10.1001/jama.2014.5555			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	25096693				2022-12-28	WOS:000339808600022
J	Mansh, M; Johnson, W; Lai, J				Mansh, Matthew; Johnson, Weilan; Lai, Jennifer			Malar Rash in a Stem Cell Transplant Recipient	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VERSUS-HOST-DISEASE		[Mansh, Matthew; Johnson, Weilan; Lai, Jennifer] Stanford Univ, Dept Dermatol, Sch Med, Stanford, CA 94305 USA; [Lai, Jennifer] Vet Affairs Palo Alto Hlth Care Syst, Dermatol Serv, Palo Alto, CA 94034 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Lai, J (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Dept Dermatol, 3801Miranda Ave,Mail Code 123, Palo Alto, CA 94034 USA.	jennifer.lai3@va.gov						Alousi AM, 2012, J AM ACAD DERMATOL, V66, pe1; Arin MJ, 2006, CLIN EXP DERMATOL, V31, P141, DOI 10.1111/j.1365-2230.2005.01934.x; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Goiriz R, 2008, LUPUS, V17, P591, DOI 10.1177/0961203307087874; Lee SJ, 2006, BONE MARROW TRANSPL, V38, P305, DOI 10.1038/sj.bmt.1705434; Lee SJ, 2005, BLOOD, V105, P4200, DOI 10.1182/blood-2004-10-4023; Marra DE, 2004, J AM ACAD DERMATOL, V51, P543, DOI 10.1016/j.jaad.2004.02.019; Martires KJ, 2011, BLOOD, V118, P4250, DOI 10.1182/blood-2011-04-350249; Patriarca F, 2006, EXP HEMATOL, V34, P389, DOI 10.1016/j.exphem.2005.12.011; Wolff D, 2010, BIOL BLOOD MARROW TR, V16, P1611, DOI 10.1016/j.bbmt.2010.06.015	10	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					547	548		10.1001/jama.2014.1370	http://dx.doi.org/10.1001/jama.2014.1370			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	25096696				2022-12-28	WOS:000339808600025
J	Mendelson, A				Mendelson, Ali			You	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Mendelson, Ali] NYU, Sch Med, Dept Internal Med, New York, NY USA	New York University	Mendelson, A (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	alimendelson@gmail.com	Mendelson, Ali/O-8915-2019						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					487	487		10.1001/jama.2014.7236	http://dx.doi.org/10.1001/jama.2014.7236			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	25096686				2022-12-28	WOS:000339808600015
J	Kabiri, M; Jazwinski, AB; Roberts, MS; Schaefer, AJ; Chhatwal, J				Kabiri, Mina; Jazwinski, Alison B.; Roberts, Mark S.; Schaefer, Andrew J.; Chhatwal, Jagpreet			The Changing Burden of Hepatitis C Virus Infection in the United States: Model-Based Predictions	ANNALS OF INTERNAL MEDICINE			English	Article							SOFOSBUVIR PLUS RIBAVIRIN; TREATMENT-NAIVE PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; LIVER FIBROSIS PROGRESSION; INTERFERON-FREE TREATMENT; HCV GENOTYPE 2; HEPATOCELLULAR-CARCINOMA; PEGINTERFERON ALPHA-2A; COST-EFFECTIVENESS; COMBINATION	Background: Chronic hepatitis C virus (HCV) infection causes a substantial health and economic burden in the United States. With the availability of direct-acting antiviral agents, recently approved therapies and those under development, and 1-time birth-cohort screening, the burden of this disease is expected to decrease. Objective: To predict the effect of new therapies and screening on chronic HCV infection and associated disease outcomes. Design: Individual-level state-transition model. Setting: Existing and anticipated therapies and screening for HCV infection in the United States. Patients: Total HCV-infected population in the United States. Measurements: The number of cases of chronic HCV infection and outcomes of advanced-stage HCV infection. Results: The number of cases of chronic HCV infection decreased from 3.2 million in 2001 to 2.3 million in 2013. One-time birth-cohort screening beginning in 2013 is expected to identify 487 000 cases of HCV infection in the next 10 years. In contrast, 1-time universal screening could identify 933 700 cases. With the availability of highly effective therapies, HCV infection could become a rare disease in the next 22 years. Recently approved therapies for HCV infection and 1-time birth-cohort screening could prevent approximately 124 200 cases of decompensated cirrhosis, 78 800 cases of hepatocellular carcinoma, 126 500 liver-related deaths, and 9900 liver transplantations by 2050. Increasing the treatment capacity would further reduce the burden of HCV disease. Limitation: Institutionalized patients with HCV infection were excluded, and empirical data on the effectiveness of future therapies and on the future annual incidence and treatment capacity of HCV infection are lacking. Conclusion: New therapies for HCV infection and widespread implementation of screening and treatment will play an important role in reducing the burden of HCV disease. More aggressive screening recommendations are needed to identify a large pool of infected patients.	Univ Pittsburgh, Pittsburgh, PA USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; UTMD Anderson Cancer Center	Chhatwal, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Hlth Serv Res, Unit 1444, 1515 Holcombe Blvd, Houston, TX 77030 USA.	JChhatwal@mdanderson.org		Kabiri, Mina/0000-0002-3486-7652	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Primary Funding Source: National Institutes of Health.	American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society, 2014, REC TEST MAN TREAT H; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Aronsohn A, 2012, HEPATOLOGY, V56, P1591, DOI 10.1002/hep.25957; Arora S, 2011, NEW ENGL J MED, V364, P2199, DOI 10.1056/NEJMoa1009370; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Blatt LM, 2000, J VIRAL HEPATITIS, V7, P196; Bourliere M, 2012, LIVER INT, V32, P113, DOI 10.1111/j.1478-3231.2011.02702.x; Bronowicki JP, 2012, J HEPATOL, V56, pS6, DOI 10.1016/S0168-8278(12)60025-7; CDC, 2013, SURV VIR HEP US 2011; Coffin PO, 2012, CLIN INFECT DIS, V54, P1259, DOI 10.1093/cid/cis011; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; Dieterich D, 2012, HEPATOLOGY, V55, P664, DOI 10.1002/hep.25528; Dore GJ, 2013, J HEPATOL, V58, pS570, DOI 10.1016/S0168-8278(13)61417-8; Doyle JS, 2013, BRIT J CLIN PHARMACO, V75, P931, DOI 10.1111/j.1365-2125.2012.04419.x; Drenth JPH, 2013, NEW ENGL J MED, V368, P1931, DOI 10.1056/NEJMe1303818; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Everson GT, 2012, HEPATOLOGY S, V56, pLB3; Falck-Ytter Y, 2002, ANN INTERN MED, V136, P288, DOI 10.7326/0003-4819-136-4-200202190-00008; Feld JJ, 2012, HEPATOLOGY, V56, p231A; Gane EJ, 2012, J HEPATOL, V56, pS555, DOI 10.1016/S0168-8278(12)61423-8; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Gane EJ, 2012, HEPATOLOGY, V56, p306A; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gonzalez Stevan A, 2012, Clin Liver Dis (Hoboken), V1, P2, DOI 10.1002/cld.3; Hagan LM, 2013, LIVER INT, V33, P68, DOI 10.1111/liv.12063; Honeycutt AA, 2007, PUBLIC HEALTH REP, V122, P55, DOI 10.1177/00333549071220S211; Hoofnagle JH, 2014, NEW ENGL J MED, V370, P1552, DOI 10.1056/NEJMe1401508; Jacobson I., 2013, 64 ANN M AM ASS STUD; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2012, HEPATOLOGY, V56, p308A; Jacobson IM, 2012, HEPATOLOGY, V56, p232A; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kanwal F, 2014, CLIN GASTROENTEROL H; Kim WR, 2013, AM J TRANSPLANT, V13, P73, DOI 10.1111/ajt.12021; Kowdley KV, 2012, HEPATOLOGY, V56, P1515; Lang K, 2009, J HEPATOL, V50, P89, DOI 10.1016/j.jhep.2008.07.029; Lawitz E., 2013, 64 ANN M AM ASS STUD; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; McGarry LJ, 2012, HEPATOLOGY, V55, P1344, DOI 10.1002/hep.25510; McGovern BH, 2012, CLIN INFECT DIS, V55, P414, DOI 10.1093/cid/cis378; Moyer VA, 2013, ANN INTERN MED, V159, P349, DOI 10.7326/0003-4819-159-5-201309030-00672; Ngo-Metzger Q, 2013, ANN INTERN MED, V159, P364, DOI 10.7326/0003-4819-159-5-201309030-00675; Nguyen Mindie H, 2005, Clin Gastroenterol Hepatol, V3, pS97, DOI 10.1016/S1542-3565(05)00711-1; Osinusi A, 2012, HEPATOLOGY, V56, P1518; Pawlotsky JM, 2012, HEPATOLOGY, V56, p309A; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Poordad F, 2012, HEPATOLOGY, V56, p233A; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 2001, J HEPATOL, V34, P730, DOI 10.1016/S0168-8278(00)00097-0; Poynard T, 2009, GASTROENTEROLOGY, V136, P1618, DOI 10.1053/j.gastro.2009.01.039; Razavi H, 2013, HEPATOLOGY, V57, P2164, DOI 10.1002/hep.26218; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Rein DB, 2011, DIGEST LIVER DIS, V43, P66, DOI 10.1016/j.dld.2010.05.006; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Ruane PJ, 2013, HEPATOLOGY, V58, p736A; Shiffman ML, 2007, NEW ENGL J MED, V357, P124, DOI 10.1056/NEJMoa066403; Siebert U, 2012, VALUE HEALTH, V15, P812, DOI 10.1016/j.jval.2012.06.014; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Soriano V, 2012, HEPATOLOGY, V56, p234A; U.S. Census Bureau, 2012, 2012 NAT POP PROJ; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Volk ML, 2009, HEPATOLOGY, V50, P1750, DOI 10.1002/hep.23220; Zeuzem S, 2013, HEPATOLOGY, V58, p733A; Zeuzem S, 2012, HEPATOLOGY, V56, p308A; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	72	109	109	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3					170	U120		10.7326/M14-0095	http://dx.doi.org/10.7326/M14-0095			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3KH	25089861	Green Accepted			2022-12-28	WOS:000340486000002
J	Arnold, C				Arnold, Carrie			The stressed-out postdoc	SCIENCE			English	Editorial Material																			0	6	6	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					594	594		10.1126/science.345.6196.594	http://dx.doi.org/10.1126/science.345.6196.594			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM2AU	25082705				2022-12-28	WOS:000339651300050
J	Raspopovic, J; Marcon, L; Russo, L; Sharpe, J				Raspopovic, J.; Marcon, L.; Russo, L.; Sharpe, J.			Digit patterning is controlled by a Bmp-Sox9-Wnt Turing network modulated by morphogen gradients	SCIENCE			English	Article							REACTION-DIFFUSION MODEL; LIMB DEVELOPMENT; VERTEBRATE LIMB; MOUSE LIMB; TRANSCRIPTION FACTOR; GENE-EXPRESSION; EMBRYONIC LIMB; BETA-CATENIN; FACTOR SOX9; CHICK LIMB	During limb development, digits emerge from the undifferentiated mesenchymal tissue that constitutes the limb bud. It has been proposed that this process is controlled by a self-organizing Turing mechanism, whereby diffusible molecules interact to produce a periodic pattern of digital and interdigital fates. However, the identities of the molecules remain unknown. By combining experiments and modeling, we reveal evidence that a Turing network implemented by Bmp, Sox9, and Wnt drives digit specification. We develop a realistic two-dimensional simulation of digit patterning and show that this network, when modulated by morphogen gradients, recapitulates the expression patterns of Sox9 in the wild type and in perturbation experiments. Our systems biology approach reveals how a combination of growth, morphogen gradients, and a self-organizing Turing network can achieve robust and reproducible pattern formation.	[Raspopovic, J.; Marcon, L.; Russo, L.; Sharpe, J.] CRG, Syst Biol Program, Barcelona 08003, Spain; [Raspopovic, J.; Marcon, L.; Russo, L.; Sharpe, J.] Univ Pompeu Fabra, Barcelona 08003, Spain; [Sharpe, J.] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Sharpe, J (corresponding author), CRG, Syst Biol Program, Dr Aiguader 88, Barcelona 08003, Spain.	james.sharpe@crg.eu	Marcon, Luciano/AAK-5535-2020; Sharpe, James/AAB-7948-2019; Marcon, Luciano LM/X-9975-2018; Sharpe, James/L-1150-2014	Marcon, Luciano/0000-0003-0957-9170; Marcon, Luciano LM/0000-0003-0957-9170; Sharpe, James/0000-0002-1434-9743; Raspopovic, Jelena/0000-0003-3233-3806	CRG; ICREA; Fundacao para a Ciencia e Tecnologia; Ministerio de Economia y Competitividad (MINECO) [BFU2010-16428]; Centro de Excelencia Severo Ochoa [SEV-2012-0208]; ICREA Funding Source: Custom	CRG; ICREA(ICREA); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Ministerio de Economia y Competitividad (MINECO); Centro de Excelencia Severo Ochoa; ICREA(ICREA)	The Sox9-EGFP mouse line was kindly provided by H. Akiyama and P. Jay. The mRNA probe for Bmp2 was kindly provided by C. Pujades. We thank R. Zeller for the Smad4 mutant limbs; A. R. Moreno for in situs of Fgf4, 8 and Twist1; and D. Barcena for the help with the micromass cultures. J.S. was supported by CRG and ICREA, L. R. by Ministerio de Economia y Competitividad (MINECO) BFU2010-16428, and Centro de Excelencia Severo Ochoa, SEV-2012-0208, and L. M. by the CRG; J.R. was funded by a Ph.D. Fellowship from the Fundacao para a Ciencia e Tecnologia. Confocal microscopy was done in the CRG Advanced Light Microscopy Unit, and FACS and microarrays in the CRG Core Facilities. The microarray data discussed in this publication are accessible through Gene Expression Omnibus series accession number GSE58158.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Badugu A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00991; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Benazet JD, 2012, DEVELOPMENT, V139, P4250, DOI 10.1242/dev.084822; Bhat R, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-6; Bienz M, 2005, CURR BIOL, V15, pR64, DOI 10.1016/j.cub.2004.12.058; Crampin EJ, 1999, B MATH BIOL, V61, P1093, DOI 10.1006/bulm.1999.0131; Georgiadis V, 2007, DEV DYNAM, V236, P1014, DOI 10.1002/dvdy.21123; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Hentschel HGE, 2004, P ROY SOC B-BIOL SCI, V271, P1713, DOI 10.1098/rspb.2004.2772; Hill TP, 2006, DEVELOPMENT, V133, P1219, DOI 10.1242/dev.02298; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Kulyk WM, 2000, EXP CELL RES, V255, P327, DOI 10.1006/excr.1999.4784; LEONARD CM, 1991, DEV BIOL, V145, P99, DOI 10.1016/0012-1606(91)90216-P; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Marcon L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001071; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Mercader N, 2000, DEVELOPMENT, V127, P3961; Miura T, 2000, DEV DYNAM, V217, P241, DOI 10.1002/(SICI)1097-0177(200003)217:3<241::AID-DVDY2>3.0.CO;2-K; Miura T, 2006, J THEOR BIOL, V240, P562, DOI 10.1016/j.jtbi.2005.10.016; Nakamura Y, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1242; NEWMAN SA, 1979, SCIENCE, V205, P662, DOI 10.1126/science.462174; Pan QH, 2008, J CELL PHYSIOL, V217, P228, DOI 10.1002/jcp.21496; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sheth R, 2012, SCIENCE, V338, P1476, DOI 10.1126/science.1226804; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; Summerhurst K, 2008, GENE EXPR PATTERNS, V8, P331, DOI 10.1016/j.gep.2008.01.007; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; WRIGHT E, 1995, NAT GENET, V9, P15, DOI 10.1038/ng0195-15; Zehentner BK, 1999, J BONE MINER RES, V14, P1734, DOI 10.1359/jbmr.1999.14.10.1734; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; ZWILLING E, 1964, DEV BIOL, V9, P20, DOI 10.1016/0012-1606(64)90012-0	34	276	277	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					566	570		10.1126/science.1252960	http://dx.doi.org/10.1126/science.1252960			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082703				2022-12-28	WOS:000339651300046
J	Adam, D				Adam, David			Cause is not everything in mental illness	NATURE			English	Editorial Material												d.adam@nature.com						2014, NATURE, V511, P393	1	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					509	509		10.1038/511509a	http://dx.doi.org/10.1038/511509a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0VT	25079519	Bronze			2022-12-28	WOS:000339566300003
J	Wang, X; Ouyang, YY; Liu, J; Zhu, MM; Zhao, G; Bao, W; Hu, FB				Wang, Xia; Ouyang, Yingying; Liu, Jun; Zhu, Minmin; Zhao, Gang; Bao, Wei; Hu, Frank B.			Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; MEDITERRANEAN DIET; PUBLICATION BIAS; TREND ESTIMATION; MAGNESIUM INTAKE; US ADULTS; RISK; MEN; WOMEN	Objective To examine and quantify the potential dose-response relation between fruit and vegetable consumption and risk of all cause, cardiovascular, and cancer mortality. Data sources Medline, Embase, and the Cochrane library searched up to 30 August 2013 without language restrictions. Reference lists of retrieved articles. Study selection Prospective cohort studies that reported risk estimates for all cause, cardiovascular, and cancer mortality by levels of fruit and vegetable consumption. Data synthesis Random effects models were used to calculate pooled hazard ratios and 95% confidence intervals and to incorporate variation between studies. The linear and non-linear dose-response relations were evaluated with data from categories of fruit and vegetable consumption in each study. Results Sixteen prospective cohort studies were eligible in this meta-analysis. During follow-up periods ranging from 4.6 to 26 years there were 56 423 deaths (11 512 from cardiovascular disease and 16 817 from cancer) among 833 234 participants. Higher consumption of fruit and vegetables was significantly associated with a lower risk of all cause mortality. Pooled hazard ratios of all cause mortality were 0.95 (95% confidence interval 0.92 to 0.98) for an increment of one serving a day of fruit and vegetables (P=0.001), 0.94 (0.90 to 0.98) for fruit (P=0.002), and 0.95 (0.92 to 0.99) for vegetables (P=0.006). There was a threshold around five servings of fruit and vegetables a day, after which the risk of all cause mortality did not reduce further. A significant inverse association was observed for cardiovascular mortality (hazard ratio for each additional serving a day of fruit and vegetables 0.96, 95% confidence interval 0.92 to 0.99), while higher consumption of fruit and vegetables was not appreciably associated with risk of cancer mortality. Conclusions This meta-analysis provides further evidence that a higher consumption of fruit and vegetables is associated with a lower risk of all cause mortality, particularly cardiovascular mortality.	[Wang, Xia] Shandong Univ, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Jinan 250100, Peoples R China; [Wang, Xia; Ouyang, Yingying; Liu, Jun] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Wuhan 430074, Peoples R China; [Zhu, Minmin] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430074, Peoples R China; [Zhao, Gang] Shandong Univ, Shandong Prov Hosp, Dept Cardiovasc Sci, Jinan 250100, Peoples R China; [Bao, Wei] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Epidemiol Branch, Div Intramural Populat Hlth Res, NIH, Rockville, MD 20852 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Shandong University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Hu, FB (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.	wei.bao@nih.gov; nhbfh@channing.harvard.edu	Zhu, Minmin/E-7943-2011; Bao, Wei/AAG-2431-2019	Bao, Wei/0000-0002-7301-5786	National Natural Science Foundation of China [NSFC 81071081]; Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by National Natural Science Foundation (NSFC 81071081) of China. WB was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. The funders had no role in study design, data collection and analysis, preparation of the manuscript, or decision to publish.	Agudo A, 2007, AM J CLIN NUTR, V85, P1634, DOI 10.1093/ajcn/85.6.1634; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Asplund K, 2002, J INTERN MED, V251, P372, DOI 10.1046/j.1365-2796.2002.00973.x; Bazzano LA, 2002, AM J CLIN NUTR, V76, P93; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bellavia A, 2013, AM J CLIN NUTR, V98, P454, DOI 10.3945/ajcn.112.056119; Benetou V, 2008, CANCER EPIDEM BIOMAR, V17, P387, DOI 10.1158/1055-9965.EPI-07-2665; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Boffetta P, 2010, JNCI-J NATL CANCER I, V102, P529, DOI 10.1093/jnci/djq072; COLDITZ GA, 1985, AM J CLIN NUTR, V41, P32, DOI 10.1093/ajcn/41.1.32; Coory MD, 2010, INT J EPIDEMIOL, V39, P932, DOI 10.1093/ije/dyp157; Crowe FL, 2011, EUR HEART J, V32, P1235, DOI 10.1093/eurheartj/ehq465; Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Genkinger JM, 2004, AM J EPIDEMIOL, V160, P1223, DOI 10.1093/aje/kwh339; George SM, 2009, AM J CLIN NUTR, V89, P347, DOI 10.3945/ajcn.2008.26722; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; He FJ, 2006, LANCET, V367, P320, DOI 10.1016/S0140-6736(06)68069-0; Hedges LV, 2014, STAT METHODS META AN; Hertog MGL, 1996, CANCER EPIDEM BIOMAR, V5, P673; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Holst B, 2008, CURR OPIN BIOTECH, V19, P73, DOI 10.1016/j.copbio.2008.03.003; Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296; Jackson D, 2010, STAT MED, V29, P1282, DOI 10.1002/sim.3602; Jansen MCJF, 2001, INT J CANCER, V92, P913, DOI 10.1002/ijc.1278; John JH, 2002, LANCET, V359, P1969, DOI 10.1016/S0140-6736(02)98858-6; Kaluza J, 2010, AM J EPIDEMIOL, V171, P801, DOI 10.1093/aje/kwp467; Key TIJ, 2003, AM J CLIN NUTR, V78, p533S, DOI 10.1093/ajcn/78.3.533S; Key TJ, 2010, BRIT J CANCER, V104, P6; Key TJ TM, 1996, BMJ-BRIT MED J, V313, P75; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; KUSHI LH, 1985, NEW ENGL J MED, V312, P811, DOI 10.1056/NEJM198503283121302; Leenders M, 2013, AM J EPIDEMIOL, V178, P590, DOI 10.1093/aje/kwt006; LEFER AM, 1990, CIRCULATION, V81, P2013, DOI 10.1161/01.CIR.81.6.2013; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Meyers LD, 2006, DRI DIETARY REFERENC; Nagura J, 2009, BRIT J NUTR, V102, P285, DOI 10.1017/S0007114508143586; Nakamura K, 2008, J NUTR, V138, P1129, DOI 10.1093/jn/138.6.1129; National Academy of Sciences CoDaH National Research Council, 1989, DIET HLTH IMPL RED C; Nicklett EJ, 2012, J AM GERIATR SOC, V60, P862, DOI 10.1111/j.1532-5415.2012.03924.x; Nothlings U, 2008, J NUTR, V138, P775, DOI 10.1093/jn/138.4.775; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265; Orsini N, 2011, STATA J, V11, P1; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Rissanen TH, 2003, J NUTR, V133, P199, DOI 10.1093/jn/133.1.199; Sahyoun NR, 1996, AM J EPIDEMIOL, V144, P501, DOI 10.1093/oxfordjournals.aje.a008957; Sauvaget C, 2003, BRIT J CANCER, V88, P689, DOI 10.1038/sj.bjc.6600775; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Steffen LM, 2003, AM J CLIN NUTR, V78, P383, DOI 10.1093/ajcn/78.3.383; Strandhagen E, 2000, EUR J CLIN NUTR, V54, P337, DOI 10.1038/sj.ejcn.1600959; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Tucker KL, 2005, J NUTR, V135, P556, DOI 10.1093/jn/135.3.556; VERLANGIERI AJ, 1985, MED HYPOTHESES, V16, P7, DOI 10.1016/0306-9877(85)90035-0; Wells GA., 2015, NEWCASTLE OTTAWA SCA; Whiteman D, 1999, PUBLIC HEALTH NUTR, V2, P477, DOI 10.1017/S136898009900066X; WHO, 2003, WHO TECH REP SER, V916, P1; Willett WC, 2010, J NATL CANCER I, V102, P510, DOI 10.1093/jnci/djq098; World Health Organisation, 2012, TOP 10 CAUS DEATH; Yang QH, 2011, ARCH INTERN MED, V171, P1183, DOI 10.1001/archinternmed.2011.257; Zhang W, 2012, ATHEROSCLEROSIS, V221, P587, DOI 10.1016/j.atherosclerosis.2012.01.034; Zhang XL, 2011, AM J CLIN NUTR, V94, P240, DOI 10.3945/ajcn.110.009340; Zino S, 1997, BMJ-BRIT MED J, V314, P1787, DOI 10.1136/bmj.314.7097.1787	67	964	999	6	80	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2014	349								g4490	10.1136/bmj.g4490	http://dx.doi.org/10.1136/bmj.g4490			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NG	25073782	hybrid, Green Published			2022-12-28	WOS:000339906000001
J	Vaclavkova, A; Chimenti, S; Arenberger, P; Hollo, P; Sator, PG; Burcklen, M; Stefani, M; D'Ambrosio, D				Vaclavkova, Andrea; Chimenti, Sergio; Arenberger, Petr; Hollo, Peter; Sator, Paul-Gunther; Burcklen, Michel; Stefani, Mylene; D'Ambrosio, Daniele			Oral ponesimod in patients with chronic plaque psoriasis: a randomised, double-blind, placebo-controlled phase 2 trial	LANCET			English	Article							RECEPTOR MODULATOR; FINGOLIMOD; EFFICACY; MODERATE; FTY720; SAFETY; RISK	Background We assessed the efficacy, safety, and tolerability of ponesimod, an oral, selective, reversible modulator of sphingosine 1-phosphate receptor 1, in patients with moderate to severe chronic plaque psoriasis. Methods Between Sept 22, 2010, and Oct 24, 2012, patients with psoriasis area and severity index (PASI) scores higher than 10 were enrolled into this multicentre double-blind, phase 2 study. They received 20 mg or 40 mg ponesimod or placebo once daily for 16 weeks. Those with at least 50% reduction in PASI score at 16 weeks and who were receiving ponesimod were rerandomised to receive maintenance ponesimod therapy or placebo until week 28. The primary endpoint was reduction in PASI score from baseline of at least 75% (PASI75) at week 16. This study is registered with ClinicalTrials.gov, number NCT01208090. Findings Of 326 patients initially randomised (20 mg ponesimod n=126, 40 mg ponesimod n=133, and placebo n=67) PASI75 was achieved at week 16 in 58 (46.0%), 64 (48.1%), and nine (13.4%), respectively. The treatment effect was significant for the two ponesimod doses (both p < 0.0001). Of 219 patients who entered the maintenance period, PASI75 was achieved by week 28 in 35 (71.4%) of 49 who continued on 20 mg ponesimod and 41 (77.4%) of 53 on 40 mg ponesimod, and in 19 (42.2%) of 45 who swapped from 20 mg to placebo and 19 (40.4%) of 47 from 40 mg to placebo. Ponesimod was associated with dyspnoea, raised liver enzyme concentrations, and dizziness. Interpretation Significant clinical benefit was seen at week 16 that increased with maintenance therapy.	[Vaclavkova, Andrea; Burcklen, Michel; Stefani, Mylene; D'Ambrosio, Daniele] Actelion Pharmaceut Ltd, CH-4123 Allschwil, Switzerland; [Chimenti, Sergio] Univ Roma Tor Vergata, PTV Policlin Tor Vergata, Dept Dermatol, Rome, Italy; [Arenberger, Petr] Charles Univ Prague, Fac Med 3, Dept Dermatol, Prague, Czech Republic; [Hollo, Peter] Semmelweis Univ, Dept Dermatovenerol & Oncodermatol, H-1085 Budapest, Hungary; [Sator, Paul-Gunther] Municipal Hosp Hietzing, Dept Dermatol, Vienna, Austria	Actelion Pharmaceuticals Ltd; University of Rome Tor Vergata; Charles University Prague; Semmelweis University; Hietzing Hospital	D'Ambrosio, D (corresponding author), Actelion Pharmaceut Ltd, Gewerbestr 16, CH-4123 Allschwil, Switzerland.	daniele.dambrosio@actelion.com	Arenberger, Petr/C-7481-2018; Holló, Peter/Q-6505-2018	Arenberger, Petr/0000-0002-4800-5877; 	Actelion Pharmaceuticals	Actelion Pharmaceuticals	Actelion Pharmaceuticals.	Bewley A, 2014, J EUR ACAD DERMATOL, V28, P763, DOI 10.1111/jdv.12174; Bolli MH, 2010, J MED CHEM, V53, P4198, DOI 10.1021/jm100181s; Bremmer S, 2010, J AM ACAD DERMATOL, V63, P1058, DOI 10.1016/j.jaad.2009.09.053; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brossard P, 2014, J CLIN PHARMACOL, V54, P179, DOI 10.1002/jcph.244; Brossard P, 2013, BRIT J CLIN PHARMACO, V76, P888, DOI 10.1111/bcp.12129; Clark L, 2008, J AM ACAD DERMATOL, V58, P443, DOI 10.1016/j.jaad.2007.11.011; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Gatfield J, 2014, CELL SIGNAL, V26, P1576, DOI 10.1016/j.cellsig.2014.03.029; Gelfand JM, 2006, J INVEST DERMATOL, V126, P2194, DOI 10.1038/sj.jid.5700410; Gergely P, 2012, BRIT J PHARMACOL, V167, P1035, DOI 10.1111/j.1476-5381.2012.02061.x; Hick J, 2007, J AM ACAD DERMATOL, V57, P972, DOI 10.1016/j.jaad.2007.08.008; Jain N, 2012, NEUROLOGY, V78, P672, DOI 10.1212/WNL.0b013e318248deea; Johnson-Huang LM, 2012, DIS MODEL MECH, V5, P423, DOI 10.1242/dmm.009092; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Olsson T, 2014, J NEUROL NEUROSUR PS, V85, P1198, DOI 10.1136/jnnp-2013-307282; Papp KA, 2012, BRIT J DERMATOL, V167, P668, DOI 10.1111/j.1365-2133.2012.11168.x; Papp K, 2012, LANCET, V380, P738, DOI 10.1016/S0140-6736(12)60642-4; Pathirana D, 2009, J EUR ACAD DERMATOL, V23, P1, DOI 10.1111/j.1468-3083.2009.03389.x; Paul C, 2012, J EUR ACAD DERMATOL, V26, P1, DOI 10.1111/j.1468-3083.2012.04518.x; Pelletier D, 2012, NEW ENGL J MED, V366, P339, DOI 10.1056/NEJMct1101691; Peters SLM, 2007, CURR OPIN PHARMACOL, V7, P186, DOI 10.1016/j.coph.2006.09.008; Piali L, 2011, J PHARMACOL EXP THER, V337, P547, DOI 10.1124/jpet.110.176487; Pouplard C, 2013, J EUR ACAD DERMATOL, V27, P36, DOI 10.1111/jdv.12165; Pozzilli C, 2013, 29 C EUR COMM RES TR; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Rey M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074285; Roviezzo F, 2007, AM J RESP CELL MOL, V36, P757, DOI 10.1165/rcmb.2006-0383OC; Rustin MHA, 2012, BRIT J DERMATOL, V167, P3, DOI 10.1111/j.1365-2133.2012.11208.x; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Ware JE, 2007, USERS MANUAL SF 36V2	32	91	94	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2036	2045		10.1016/S0140-6736(14)60803-5	http://dx.doi.org/10.1016/S0140-6736(14)60803-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BD	25127208				2022-12-28	WOS:000346353600025
J	Tavora, B; Reynolds, LE; Batista, S; Demircioglu, F; Fernandez, I; Lechertier, T; Lees, DM; Wong, PP; Alexopoulou, A; Elia, G; Clear, A; Ledoux, A; Hunter, J; Perkins, N; Gribben, JG; Hodivala-Dilke, KM				Tavora, Bernardo; Reynolds, Louise E.; Batista, Silvia; Demircioglu, Fevzi; Fernandez, Isabelle; Lechertier, Tanguy; Lees, Delphine M.; Wong, Ping-Pui; Alexopoulou, Annika; Elia, George; Clear, Andrew; Ledoux, Adeline; Hunter, Jill; Perkins, Neil; Gribben, John G.; Hodivala-Dilke, Kairbaan M.			Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy	NATURE			English	Article							FOCAL ADHESION KINASE; NF-KAPPA-B; CANCER-CELLS; RESISTANCE; MICROENVIRONMENT; INFLAMMATION; ACTIVATION; ANGIOGENESIS; METASTASIS; EXPRESSION	Chemoresistance is a serious limitation of cancer treatment(1). Until recently, almost all the work done to study this limitation has been restricted to tumour cells(2). Here we identify a novel molecular mechanism by which endothelial cells regulate chemosensitivity. We establish that specific targeting of focal adhesion kinase (FAK; also known as PTK2) in endothelial cells is sufficient to induce tumour-cell sensitization to DNA-damaging therapies and thus inhibit tumour growth in mice. The clinical relevance of this work is supported by our observations that low blood vessel FAK expression is associated with complete remission in human lymphoma. Our study shows that deletion of FAK in endothelial cells has no apparent effect on blood vessel function per se, but induces increased apoptosis and decreased proliferation within perivascular tumour-cell compartments of doxorubicin-and radiotherapy-treated mice. Mechanistically, we demonstrate that endothelial-cell FAK is required for DNA-damage induced NF-kappa B activation in vivo and in vitro, and the production of cytokines from endothelial cells. Moreover, loss of endothelial-cell FAK reduces DNA-damage-induced cytokine production, thus enhancing chemosensitization of tumour cells to DNA-damaging therapies in vitro and in vivo. Overall, our data identify endothelial-cell FAK as a regulator of tumour chemosensitivity. Furthermore, we anticipate that this proof-of-principle data will be a starting point for the development of new possible strategies to regulate chemosensitization by targeting endothelial-cell FAK specifically.	[Tavora, Bernardo; Reynolds, Louise E.; Batista, Silvia; Demircioglu, Fevzi; Fernandez, Isabelle; Lechertier, Tanguy; Lees, Delphine M.; Wong, Ping-Pui; Alexopoulou, Annika; Hodivala-Dilke, Kairbaan M.] Queen Mary Univ London, CR UK Ctr Excellence, Barts Canc Inst, Adhes & Angiogenesis Lab,Ctr Tumour Biol, London EC1M 6BQ, England; [Elia, George] Queen Mary Univ London, CR UK Ctr Excellence, Barts Canc Inst, London EC1M 6BQ, England; [Clear, Andrew; Gribben, John G.] Queen Mary Univ London, CR UK Ctr Excellence, Barts Canc Inst, Ctr Haematooncol, London EC1M 6BQ, England; [Ledoux, Adeline; Hunter, Jill; Perkins, Neil] Newcastle Univ, Sch Med, Inst Cell & Mol Biosci ICaMB, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; Newcastle University - UK	Hodivala-Dilke, KM (corresponding author), Queen Mary Univ London, CR UK Ctr Excellence, Barts Canc Inst, Adhes & Angiogenesis Lab,Ctr Tumour Biol, London EC1M 6BQ, England.	K.Hodivala-Dilke@qmul.ac.uk		Lees, Delphine M/0000-0002-2119-3978; Lechertier, Tanguy/0000-0002-0202-8424; Ledoux, Adeline/0000-0001-6907-6116; Fernandez, Isabelle/0000-0003-3390-3284; Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Wong, Ping Pui/0000-0003-1592-4823	CR-UK [C9218/A12007, C1443/A9215]; AICR [12-1068]; Medical Research Council [G0901609]; National Cancer Institute [P01 CA95426]; Leukemia Lymphoma Research [11022]; NATIONAL CANCER INSTITUTE [P01CA095426, P01CA081534] Funding Source: NIH RePORTER; Cancer Research UK [12007] Funding Source: researchfish; Medical Research Council [1365527] Funding Source: researchfish; Worldwide Cancer Research [12-1068] Funding Source: researchfish; MRC [G0901609] Funding Source: UKRI	CR-UK(Cancer Research UK); AICR; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Lymphoma Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Worldwide Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank A. Papachristodoulou, J. Holdsworth and B. Williams for their help with immunostaining and animal husbandry. Also M. Hemann for his critical appraisal of the manuscript. The work was funded by CR-UK (C9218/A12007), AICR (12-1068), Medical Research Council (G0901609), National Cancer Institute (P01 CA95426:JGG); Leukemia Lymphoma Research (11022); and CR-UK PhD studentship (C1443/A9215).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; De Vita VT, 2001, CANC PRINCIPLES PRAC; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; Funakoshi-Tago M, 2003, J BIOL CHEM, V278, P29359, DOI 10.1074/jbc.M213115200; Gilbert LA, 2010, CELL, V143, P355, DOI 10.1016/j.cell.2010.09.043; Hagemeister FB, 2002, CANCER CHEMOTH PHARM, V49, pS13, DOI 10.1007/s00280-002-0447-1; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Lim ST, 2012, J CELL BIOL, V197, P907, DOI 10.1083/jcb.201109067; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; May T, 2005, J BIOTECHNOL, V120, P99, DOI 10.1016/j.jbiotec.2005.03.027; McLean GW, 2004, GENE DEV, V18, P2998, DOI 10.1101/gad.316304; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Nakamura J, 2008, BIOCHEM BIOPH RES CO, V374, P699, DOI 10.1016/j.bbrc.2008.07.123; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Reynolds LE, 2006, METH MOLEC MED, V120, P503; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Rottenberg S, 2008, DRUG RESIST UPDATE, V11, P51, DOI 10.1016/j.drup.2007.11.002; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Stokes JB, 2011, MOL CANCER THER, V10, P2135, DOI 10.1158/1535-7163.MCT-11-0261; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Tavora B, 2010, EMBO MOL MED, V2, P516, DOI 10.1002/emmm.201000106; Tseng WP, 2010, J CELL PHYSIOL, V223, P389, DOI 10.1002/jcp.22047; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Zhang HFM, 2006, AM J PHYSIOL-CELL PH, V290, pC1310, DOI 10.1152/ajpcell.00450.2005	30	108	114	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					112	+		10.1038/nature13541	http://dx.doi.org/10.1038/nature13541			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25079333	Green Accepted			2022-12-28	WOS:000342420800046
J	Gostin, LO; Lucey, D; Phelan, A				Gostin, Lawrence O.; Lucey, Daniel; Phelan, Alexandra			The Ebola Epidemic A Global Health Emergency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Phelan, Alexandra] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, Washington, DC 20001 USA; [Lucey, Daniel] Georgetown Univ, Med Ctr, Dept Microbiol & Immunol, Washington, DC 20001 USA	Georgetown University; Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Phelan, Alexandra/0000-0002-3084-9158; Gostin, Lawrence/0000-0001-5286-4044				Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Blinder A., 2014, ATLANTA HOSP ADMITS; Hinshaw D, EBOLA VIRUS INFLICTS; McWhirter C, 2014, GIVING AM DRUG EBOLA; Nossiter A, 2014, NY TIMES, pA1; Williams WCL., 2014, NY TIMES; World Health Organization, 2014, EB VIR DIS GUIN	7	107	114	0	92	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2014	312	11					1095	1096		10.1001/jama.2014.11176	http://dx.doi.org/10.1001/jama.2014.11176			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO8SN	25111044				2022-12-28	WOS:000341624700015
J	Stagg, HR; Zenner, D; Harris, RJ; Munoz, L; Lipman, MC; Abubakar, I				Stagg, Helen R.; Zenner, Dominik; Harris, Ross J.; Munoz, Laura; Lipman, Marc C.; Abubakar, Ibrahim			Treatment of Latent Tuberculosis Infection A Network Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							ISONIAZID PREVENTIVE THERAPY; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; CHEMOPROPHYLAXIS REGIMENS; HIV-INFECTION; PROPHYLAXIS; PYRAZINAMIDE; ADULTS; RIFAMPIN; CHILDREN	Background: Effective treatment of latent tuberculosis infection (LTBI) is an important component of TB elimination programs. Promising new regimens that may be more effective are being introduced. Because few regimens can be directly compared, network meta-analyses, which allow indirect comparisons to be made, strengthen conclusions. Purpose: To determine the most efficacious regimen for preventing active TB with the lowest likelihood of adverse events to inform LTBI treatment policies. Data Sources: PubMed, EMBASE, and Web of Science up to 29 January 2014; clinical trial registries; and conference abstracts. Study Selection: Randomized, controlled trials that evaluated LTBI treatment in humans and recorded at least 1 of 2 prespecified end points (preventing active TB or hepatotoxicity), without language or date restrictions. Data Extraction: Data from eligible studies were independently extracted by 2 investigators according to a standard protocol. Data Synthesis: Of the 1516 articles identified, 53 studies met the inclusion criteria. Data on 15 regimens were available; of 105 possible comparisons, 42 (40%) were compared directly. Compared with placebo, isoniazid for 6 months (odds ratio [OR], 0.64 [95% credible interval {CrI}, 0.48 to 0.83]) or 12 months or longer (OR, 0.52 [CrI, 0.41 to 0.66]), rifampicin for 3 to 4 months (OR, 0.41 [CrI, 0.18 to 0.86]), and rifampicin-isoniazid regimens for 3 to 4 months (OR, 0.52 [CrI, 0.34 to 0.79]) were efficacious within the network. Limitations: The risk of bias was unclear for many studies across various domains. Evidence was sparse for some comparisons, particularly hepatotoxicity. Conclusion: Comparison of different LTBI treatment regimens showed that various therapies containing rifamycins for 3 months or more were efficacious at preventing active TB, potentially more so than isoniazid alone. Regimens containing rifamycins may be effective alternatives to isoniazid monotherapy.	UCL, London WC1E 6JB, England; Publ Hlth England, London NW9 5EQ, England; Royal Free London Natl Hlth Serv Fdn Trust, London NW3 2QG, England; Bellvitge Univ Hosp IDIBELL, Barcelona 08907, Spain	University of London; University College London; Public Health England; University of London; University College London; Royal Free London NHS Foundation Trust; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona	Stagg, HR (corresponding author), UCL, Dept Infect & Populat Hlth, London WC1E 6JB, England.	h.stagg@ucl.ac.uk	Zenner, Dominik/AAF-5134-2019	Zenner, Dominik/0000-0002-9200-6180; Abubakar, Ibrahim/0000-0002-0370-1430; Stagg, Helen/0000-0003-4022-3447; Lipman, Marc/0000-0001-7501-4448	United Kingdom National Institute for Health Research	United Kingdom National Institute for Health Research(National Institute for Health Research (NIHR))	From the United Kingdom National Institute for Health Research (Drs. Abubakar, Stagg, and Lipman).	Ades AE, 2003, STAT MED, V22, P2995, DOI 10.1002/sim.1566; Agarwal S. K., 2004, International Urology and Nephrology, V36, P425, DOI 10.1007/s11255-004-6251-6; Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Alfaro EM, 2000, MED CLIN-BARCELONA, V115, P161; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Ayieko J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-91; BAILEY WC, 1974, ANN INTERN MED, V81, P200, DOI 10.7326/0003-4819-81-2-200; Brooks SP, 1998, ANN STAT, V26, P398; BUSH OB, 1965, AM REV RESPIR DIS, V92, P732; Centers for Disease Control and Prevention, 2013, TREATM LAT TB INF; Chan PC, 2012, INT J TUBERC LUNG D, V16, P633, DOI 10.5588/ijtld.11.0504; Comstock GW, 1999, INT J TUBERC LUNG D, V3, P847; COMSTOCK GW, 1967, AM REV RESPIR DIS, V95, P935; Cooper NJ, 2009, STAT MED, V28, P1861, DOI 10.1002/sim.3594; Cowie RL, 1996, TUBERCLE LUNG DIS, V77, P239, DOI 10.1016/S0962-8479(96)90007-6; Davies G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005159.pub2; DelCastillo H, 1965, B QUEZON I, V7, P277; Dias S., 2011, NICE DSU TECHNICAL S; EGSMOSE T, 1965, B WORLD HEALTH ORGAN, V33, P419; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; Fitzgerald DW, 2001, J ACQ IMMUN DEF SYND, V28, P305; Frigati LJ, 2011, THORAX, V66, P496, DOI 10.1136/thx.2010.156752; GIRLING DJ, 1992, AM REV RESPIR DIS, V145, P36; Gordin F, 2000, JAMA-J AM MED ASSOC, V283, P1445, DOI 10.1001/jama.283.11.1445; Gordin FM, 2004, CLIN INFECT DIS, V39, P561, DOI 10.1086/422724; Gordin FM, 1997, NEW ENGL J MED, V337, P315, DOI 10.1056/NEJM199707313370505; Gupta D. K., 1993, Indian Journal of Tuberculosis, V40, P125; Halsey NA, 1998, LANCET, V351, P786, DOI 10.1016/S0140-6736(97)06532-X; Hawken MP, 1997, AIDS, V11, P875, DOI 10.1097/00002030-199707000-00006; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; HORWITZ O, 1966, B WORLD HEALTH ORGAN, V35, P509; JOHN GT, 1994, TRANSPLANTATION, V57, P1683; Johnson JL, 2001, AIDS, V15, P2137, DOI 10.1097/00002030-200111090-00009; Kunst H, 2010, INT J TUBERC LUNG D, V14, P1374; Leung CC, 2003, CHEST, V124, P2112, DOI 10.1378/chest.124.6.2112; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Lumley T, 2002, STAT MED, V21, P2313, DOI 10.1002/sim.1201; Madhi SA, 2011, NEW ENGL J MED, V365, P21, DOI 10.1056/NEJMoa1011214; Magdorf K, 1994, Pneumologie, V48, P761; Martinez Alfaro E, 1998, Med Clin (Barc), V111, P401; Martinson NA, 2011, NEW ENGL J MED, V365, P11, DOI 10.1056/NEJMoa1005136; Matteelli A, 1999, INT J TUBERC LUNG D, V3, P1043; Menzies D, 2011, INDIAN J MED RES, V133, P257; Mohammed A, 2007, INT J TUBERC LUNG D, V11, P1114; MOUNT FW, 1962, AM REV RESPIR DIS, V85, P821; Mwinga A, 1998, AIDS, V12, P2447, DOI 10.1097/00002030-199818000-00014; Naqvi R, 2010, NEPHROL DIAL TRANSPL, V25, P634, DOI 10.1093/ndt/gfp489; National Cancer Institute, 2010, NCI COMM TERM CRIT A; Geijo MP, 2007, ENFERM INFEC MICR CL, V25, P300, DOI 10.1157/13102264; PAPE JW, 1993, LANCET, V342, P268, DOI 10.1016/0140-6736(93)91817-6; Portilla J, 2003, ENFERM INFEC MICR CL, V21, P293, DOI 10.1157/13048576; Quigley MA, 2001, AIDS, V15, P215, DOI 10.1097/00002030-200101260-00011; Rivero A, 2007, ENFERM INFEC MICR CL, V25, P305, DOI 10.1157/13102265; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; Sanchez F., 2010, Journal of Infection Prevention, V11, P12, DOI 10.1177/1757177409354732; Sanchez F, 2002, ENF EMERG, V4, P62; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Schechter M, 2006, AM J RESP CRIT CARE, V173, P922, DOI 10.1164/rccm.200512-1953OC; Sharma SK, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007545.pub2; Smieja MJ, 2000, COCHRANE DB SYST REV, V1999, DOI DOI 10.1002/14651858.CD001363; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiegelhalter DJ, 2003, STAT MED, V22, P3687, DOI 10.1002/sim.1586; Spyridis NP, 2007, CLIN INFECT DIS, V45, P715, DOI 10.1086/520983; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Swaminathan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047400; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Tortajada C, 2005, INT J TUBERC LUNG D, V9, P276; Trinquart L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-150; Veening G J, 1968, Bull Int Union Tuberc, V41, P169; Vikrant S, 2005, TRANSPL INFECT DIS, V7, P99, DOI 10.1111/j.1399-3062.2005.00103.x; Warkentin J, 2013, MMWR-MORBID MORTAL W, V62, P398; Whalen CC, 1997, NEW ENGL J MED, V337, P801, DOI 10.1056/NEJM199709183371201; WOLDEHANNA S, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000171.PUB2; Xie Qi-Bing, 2009, Sichuan Da Xue Xue Bao Yi Xue Ban, V40, P138; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	75	108	114	1	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2014	161	6					419	U80		10.7326/M14-1019	http://dx.doi.org/10.7326/M14-1019			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9LF	25111745				2022-12-28	WOS:000343894400017
J	Long, CZ; McAnally, JR; Shelton, JM; Mireault, AA; Bassel-Duby, R; Olson, EN				Long, Chengzu; McAnally, John R.; Shelton, John M.; Mireault, Alex A.; Bassel-Duby, Rhonda; Olson, Eric N.			Prevention of muscular dystrophy in mice by CRISPR/Cas9-mediated editing of germline DNA	SCIENCE			English	Article							MODIFIED MESSENGER-RNA; ONE-STEP GENERATION; SATELLITE CELLS; GENE CORRECTION; GENOME; CAS9; EXPRESSION; MOUSE; ENDONUCLEASE; MDX	Duchenne muscular dystrophy (DMD) is an inherited X-linked disease caused by mutations in the gene encoding dystrophin, a protein required for muscle fiber integrity. DMD is characterized by progressive muscle weakness and a shortened life span, and there is no effective treatment. We used clustered regularly interspaced short palindromic repeat/Cas9 (CRISPR/Cas9)-mediated genome editing to correct the dystrophin gene (Dmd) mutation in the germ line of mdx mice, a model for DMD, and then monitored muscle structure and function. Genome editing produced genetically mosaic animals containing 2 to 100% correction of the Dmd gene. The degree of muscle phenotypic rescue in mosaic mice exceeded the efficiency of gene correction, likely reflecting an advantage of the corrected cells and their contribution to regenerating muscle. With the anticipated technological advances that will facilitate genome editing of postnatal somatic cells, this strategy may one day allow correction of disease-causing mutations in the muscle tissue of patients with DMD.	[Long, Chengzu; McAnally, John R.; Mireault, Alex A.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Long, Chengzu; McAnally, John R.; Mireault, Alex A.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Shelton, John M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu			NIH [HL-077439, HL-111665, HL-093039, DK-099653, U01-HL-100401]; Robert A. Welch Foundation [1-0025]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087351] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111665, R01HL077439, U01HL100401, R01HL093039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Z. Wang and B. Nelson for advice and constructive criticism; L. Sutherland, H. Zhou, and J. Ren for discussions and technical help; C. Xing and R. Kittler for analysis of off-target effects; S. Rovinsky and E. Plautz for grip-strength testing; and R. Hammer, J. Ritter, and J. Richardson for advice. We thank G. Church for hCas9 (human codon optimized Cas9) and the gRNA cloning vector plasmids. This work was supported by grants from NIH (HL-077439, HL-111665, HL-093039, DK-099653, and U01-HL-100401) and the Robert A. Welch Foundation (grant 1-0025 to E.N.O.).	BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Duan JZ, 2014, CELL RES, V24, P1009, DOI 10.1038/cr.2014.87; Fairclough RJ, 2013, NAT REV GENET, V14, P373, DOI 10.1038/nrg3460; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Harris TJ, 2010, BIOMATERIALS, V31, P998, DOI 10.1016/j.biomaterials.2009.10.012; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kormann MSD, 2011, NAT BIOTECHNOL, V29, P154, DOI 10.1038/nbt.1733; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kuscu C, 2014, NAT BIOTECHNOL, V32, P677, DOI 10.1038/nbt.2916; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Osborn MJ, 2013, MOL THER, V21, P1151, DOI 10.1038/mt.2013.56; Ousterout DG, 2013, MOL THER, V21, P1718, DOI 10.1038/mt.2013.111; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Peng BW, 2005, BIOCHEM BIOPH RES CO, V338, P1490, DOI 10.1016/j.bbrc.2005.10.111; Pigozzo SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072147; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; WORTON RG, 1988, ANNU REV GENET, V22, P601, DOI 10.1146/annurev.ge.22.120188.003125; Wu XB, 2014, NAT BIOTECHNOL, V32, P670, DOI 10.1038/nbt.2889; Wu YX, 2013, CELL STEM CELL, V13, P659, DOI 10.1016/j.stem.2013.10.016; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Yin H, 2014, NAT BIOTECHNOL, V32, P551, DOI 10.1038/nbt.2884; Zangi L, 2013, NAT BIOTECHNOL, V31, P898, DOI 10.1038/nbt.2682	33	450	505	8	400	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1184	1188		10.1126/science.1254445	http://dx.doi.org/10.1126/science.1254445			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25123483	Green Accepted			2022-12-28	WOS:000341179800048
J	Qin, N; Yang, FL; Li, A; Prifti, E; Chen, YF; Shao, L; Guo, J; Le Chatelier, E; Yao, J; Wu, LJ; Zhou, JW; Ni, SJ; Liu, L; Pons, N; Batto, JM; Kennedy, SP; Leonard, P; Yuan, CH; Ding, WC; Chen, YT; Hu, XJ; Zheng, BW; Qian, GR; Xu, W; Ehrlich, SD; Zheng, SS; Li, LJ				Qin, Nan; Yang, Fengling; Li, Ang; Prifti, Edi; Chen, Yanfei; Shao, Li; Guo, Jing; Le Chatelier, Emmanuelle; Yao, Jian; Wu, Lingjiao; Zhou, Jiawei; Ni, Shujun; Liu, Lin; Pons, Nicolas; Batto, Jean Michel; Kennedy, Sean P.; Leonard, Pierre; Yuan, Chunhui; Ding, Wenchao; Chen, Yuanting; Hu, Xinjun; Zheng, Beiwen; Qian, Guirong; Xu, Wei; Ehrlich, S. Dusko; Zheng, Shusen; Li, Lanjuan			Alterations of the human gut microbiome in liver cirrhosis	NATURE			English	Article							BACTERIAL TRANSLOCATION; INTESTINAL MICROBIOTA; OBESITY; CATALOG; GENOMES; IMPACT; LONG	Liver cirrhosis occurs as a consequence of many chronic liver diseases that are prevalent worldwide. Here we characterize the gut microbiome in liver cirrhosis by comparing 98 patients and 83 healthy control individuals. We build a reference gene set for the cohort containing 2.69 million genes, 36.1% of which are novel. Quantitative metagenomics reveals 75,245 genes that differ in abundance between the patients and healthy individuals (false discovery rate < 0.0001) and can be grouped into 66 clusters representing cognate bacterial species; 28 are enriched in patients and 38 in control individuals. Most (54%) of the patient-enriched, taxonomically assigned species are of buccal origin, suggesting an invasion of the gut from the mouth in liver cirrhosis. Biomarkers specific to liver cirrhosis at gene and function levels are revealed by a comparison with those for type 2 diabetes and inflammatory bowel disease. On the basis of only 15 biomarkers, a highly accurate patient discrimination index is created and validated on an independent cohort. Thus microbiota-targeted biomarkers may be a powerful tool for diagnosis of different diseases.	[Qin, Nan; Yang, Fengling; Li, Ang; Chen, Yanfei; Shao, Li; Guo, Jing; Yao, Jian; Wu, Lingjiao; Zhou, Jiawei; Ni, Shujun; Liu, Lin; Yuan, Chunhui; Ding, Wenchao; Chen, Yuanting; Hu, Xinjun; Zheng, Beiwen; Qian, Guirong; Xu, Wei; Li, Lanjuan] Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Qin, Nan; Shao, Li; Yao, Jian; Zheng, Beiwen; Zheng, Shusen; Li, Lanjuan] Zhejiang Univ, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China; [Prifti, Edi; Le Chatelier, Emmanuelle; Pons, Nicolas; Batto, Jean Michel; Kennedy, Sean P.; Leonard, Pierre; Ehrlich, S. Dusko] INRA, Metagenopolis, F-78350 Jouy En Josas, France; [Ehrlich, S. Dusko] Kings Coll London, Dent Inst Cent Off, Guys Hosp, Ctr Host Microbiome Interact, London SE1 9RT, England; [Zheng, Shusen] Zhejiang Univ, Affiliated Hosp 1, Minist Publ Hlth, Key Lab Combined Multiorgan Transplantat, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Zhejiang University	Li, LJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Coll Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	dusko.ehrlich@jouy.inra.fr; zyzsss@zju.edu.cn; ljli@zju.edu.cn	LE CHATELIER, Emmanuelle/O-1243-2017; Jian, YAO/AAT-4231-2021; Ehrlich, S./Y-2423-2019; Prifti, Edi/F-3967-2019	LE CHATELIER, Emmanuelle/0000-0002-2724-0536; Jian, YAO/0000-0002-3746-1279; Ehrlich, S./0000-0002-7563-4046; Prifti, Edi/0000-0001-8861-1305; Yuan, Chunhui/0000-0002-0922-4209; LI, Lanjuan/0000-0001-6945-0593; Kennedy, Sean/0000-0002-3932-8922	National Program on Key Basic Research Project [2013CB531401]; National Natural Science Foundation of China [81301475, 81330011]; Science Fund for Creative Research Groups of the National Natural Science Foundation of China [81121002]; Technology Group Project for Infectious Disease Control of Zhejiang Province [2009R50041]; Metagenopolis [ANR-11-DPBS-0001]	National Program on Key Basic Research Project(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Group Project for Infectious Disease Control of Zhejiang Province; Metagenopolis	This work was supported by the National Program on Key Basic Research Project (2013CB531401), the National Natural Science Foundation of China (81301475 and 81330011), the Science Fund for Creative Research Groups of the National Natural Science Foundation of China (81121002), the Technology Group Project for Infectious Disease Control of Zhejiang Province (2009R50041) and the Metagenopolis grant ANR-11-DPBS-0001. We thank Q. Cao, K. Su, J. Shao and A. Ghozlane for help with data computation, and H. Zhang, H. Lu, Q. Bao, J. Ge, J. Jiang, Z. Ren and M. Ye for assistance with sample collection. We are thankful to the MetaHIT consortium for generating the gut gene set and the Human Microbiome Project for generating the reference genomes from human gut microbes.	Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Bauer TM, 2002, AM J GASTROENTEROL, V97, P2364; Benten D, 2012, J HEPATOL, V56, P1221, DOI 10.1016/j.jhep.2012.03.003; Cesaro C, 2011, DIGEST LIVER DIS, V43, P431, DOI 10.1016/j.dld.2010.10.015; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; FERENCI P, 1983, LANCET, V2, P811; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Garcia-Tsao G, 2004, BEST PRACT RES CL GA, V18, P353, DOI 10.1016/j.bpg.2003.10.005; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Hwang Jow-Jyh, 2002, Journal of Microbiology Immunology and Infection, V35, P65; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; KRIEGER D, 1995, LANCET, V346, P270, DOI 10.1016/S0140-6736(95)92164-8; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Marchandin H, 2001, EUR J CLIN MICROBIOL, V20, P340, DOI 10.1007/PL00011273; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; MINUK GY, 1985, HEPATO-GASTROENTEROL, V32, P171; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Nielsen H. B., 2014, NATURE BIOTECHNOL; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Nolan JP, 2010, HEPATOLOGY, V52, P1829, DOI 10.1002/hep.23917; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Saarela M, 2000, J BIOTECHNOL, V84, P197, DOI 10.1016/S0168-1656(00)00375-8; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wiest R, 2005, HEPATOLOGY, V41, P422, DOI 10.1002/hep.20632; Wiest R, 2012, GUT, V61, P297, DOI 10.1136/gutjnl-2011-300779; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Xu M, 2012, MICROB ECOL, V63, P304, DOI 10.1007/s00248-011-9925-5; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	55	1149	1250	18	471	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					59	+		10.1038/nature13568	http://dx.doi.org/10.1038/nature13568			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25079328				2022-12-28	WOS:000341174800029
J	Hayes, GP; Herman, MW; Barnhart, WD; Furlong, KP; Riquelme, S; Benz, HM; Bergman, E; Barrientos, S; Earle, PS; Samsonov, S				Hayes, Gavin P.; Herman, Matthew W.; Barnhart, William D.; Furlong, Kevin P.; Riquelme, Sebastian; Benz, Harley M.; Bergman, Eric; Barrientos, Sergio; Earle, Paul S.; Samsonov, Sergey			Continuing megathrust earthquake potential in Chile after the 2014 Iquique earthquake	NATURE			English	Article							INVERSION; DEFORMATION; RESOLUTION; IRAN; GPS	The seismic gap theory(1) identifies regions of elevated hazard based on a lack of recent seismicity in comparison with other portions of a fault. It has successfully explained past earthquakes (see, for example, ref. 2) and is useful for qualitatively describing where large earthquakes might occur. A large earthquake had been expected in the subduction zone adjacent to northern Chile(3-6), which had not ruptured in a megathrust earthquake since a M similar to 8.8 event in 1877. On 1 April 2014 a M8.2 earthquake occurred within this seismic gap. Here we present an assessment of the seismotectonics of the March-April 2014 Iquique sequence, including analyses of earthquake relocations, moment tensors, finite fault models, moment deficit calculations and cumulative Coulomb stress transfer. This ensemble of information allows us to place the sequence within the context of regional seismicity and to identify areas of remaining and/or elevated hazard. Our results constrain the size and spatial extent of rupture, and indicate that this was not the earthquake that had been anticipated. Significant sections of the northern Chile subduction zone have not ruptured in almost 150 years, so it is likely that future megathrust earthquakes will occur to the south and potentially to the north of the 2014 Iquique sequence.	[Hayes, Gavin P.; Barnhart, William D.; Benz, Harley M.; Earle, Paul S.] US Geol Survey, Natl Earthquake Informat Ctr, Golden, CO 80401 USA; [Herman, Matthew W.; Furlong, Kevin P.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Riquelme, Sebastian; Barrientos, Sergio] Univ Chile, Ctr Sismol Nacl, Santiago 8370449, Chile; [Bergman, Eric] Global Seismol Serv, Golden, CO 80401 USA; [Samsonov, Sergey] Nat Resources Canada, Canada Ctr Mapping & Earth Observat, Ottawa, ON K1A 0E4, Canada	United States Department of the Interior; United States Geological Survey; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidad de Chile; Natural Resources Canada; Strategic Policy & Results Sector - Natural Resources Canada; Canada Centre for Mapping & Earth Observation (CCMEO)	Hayes, GP (corresponding author), US Geol Survey, Natl Earthquake Informat Ctr, Golden, CO 80401 USA.	ghayes@usgs.gov	Barnhart, William/L-9446-2015; Herman, Matthew/AAB-5938-2020	Herman, Matthew/0000-0003-4684-9459; Samsonov, Sergey/0000-0002-6798-4847; Riquelme, Sebastian/0000-0002-3953-3504	National Science Foundation [EAR-1153317]; Directorate For Geosciences [1153317] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank R. Briggs for his comments in improving the manuscript. We thank the CSN, and member institutions of the IPOC network for their operation of seismic stations in northern Chile and for the contribution of waveform data and phase picks to this study. This study made use of broadband seismic data from globally distributed seismometers available to the USGS NEIC in real timeor near real time (networks AE, BK, C, CN, CU, DK, G, GE, GT, IC, II, IU, IW and US) and archived in the NEIC Central Waveform Buffer and at the Incorporated Research Institutions for Seismology Data Management Center. RADARSAT-2 data were provided by the Canadian Space Agency and MDA Corporation. Bathymetry data come from GEBCO 2008 (ref. 30). Many of the figures were made with the Generic Mapping Tools software package<SUP>31</SUP>. National Science Foundation grant EAR-1153317 provided support to K. P. F. and M. W. H. for this research. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the US Government.	ARMIJO R, 1990, EARTH PLANET SC LETT, V98, P40, DOI 10.1016/0012-821X(90)90087-E; Barnhart WD, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2010JB007545; Barnhart WD, 2014, GEOPHYS RES LETT, V41, P32, DOI 10.1002/2013GL058096; Bedford J, 2013, EARTH PLANET SC LETT, V383, P26, DOI 10.1016/j.epsl.2013.09.020; Bejar-Pizarro M, 2010, GEOPHYS J INT, V183, P390, DOI 10.1111/j.1365-246X.2010.04748.x; Bejar-Pizarro M, 2013, NAT GEOSCI, V6, P462, DOI [10.1038/ngeo1802, 10.1038/NGEO1802]; Blaser L, 2010, B SEISMOL SOC AM, V100, P2914, DOI 10.1785/0120100111; Brodsky EE, 2014, SCIENCE, V344, P700, DOI 10.1126/science.1255202; Chlieh M, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008166; Comte D., 1991, Natural Hazards, V4, P23, DOI 10.1007/BF00126557; DeMets C, 2010, GEOPHYS J INT, V181, P1, DOI 10.1111/j.1365-246X.2009.04491.x; Duputel Z, 2012, GEOPHYS J INT, V189, P1125, DOI 10.1111/j.1365-246X.2012.05419.x; Ekstrom G, 2005, PHYS EARTH PLANET IN, V148, P327, DOI 10.1016/j.pepi.2004.09.006; Hayes GP, 2014, EARTH PLANET SC LETT, V388, P265, DOI 10.1016/j.epsl.2013.11.010; Hayes GP, 2013, GEOPHYS J INT, V195, P1034, DOI 10.1093/gji/ggt238; Hayes GP, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008524; Hayes GP, 2011, SEISMOL RES LETT, V82, P481, DOI 10.1785/gssrl.82.4.481; Herrmann RB, 2011, B SEISMOL SOC AM, V101, P2609, DOI 10.1785/0120110095; Ji C, 2002, B SEISMOL SOC AM, V92, P1192, DOI 10.1785/0120000916; JORDAN TH, 1981, B SEISMOL SOC AM, V71, P1105; Jordan TH, 2010, SEISMOL RES LETT, V81, P571, DOI 10.1785/gssrl.81.4.571; Kausel E., 1986, B ACAD CHILENA CIENC, V3, P8; Lay T, 2014, GEOPHYS RES LETT, V41, P3818, DOI 10.1002/2014GL060238; Lay T, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006280; Loveless JP, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048561; MCCANN WR, 1979, PURE APPL GEOPHYS, V117, P1082, DOI 10.1007/BF00876211; Metois M, 2013, GEOPHYS J INT, V194, P1283, DOI 10.1093/gji/ggt183; OKADA Y, 1992, B SEISMOL SOC AM, V82, P1018; Podlaha A., 2014, IMPACT FORECASTING A; Sambridge M, 1999, GEOPHYS J INT, V138, P479, DOI 10.1046/j.1365-246X.1999.00876.x; Stein RS, 1997, GEOPHYS J INT, V128, P594, DOI 10.1111/j.1365-246X.1997.tb05321.x; USGS, M8 2 94KM NW IQ CHIL; USGS, ANSS COMPR CAT; Walker RT, 2005, GEOPHYS J INT, V160, P707, DOI 10.1111/j.1365-246X.2005.02516.x; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]; Witze A, 2014, NATURE, V508, P440, DOI 10.1038/508440a	36	134	136	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					295	+		10.1038/nature13677	http://dx.doi.org/10.1038/nature13677			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119028				2022-12-28	WOS:000340508200031
J	Sedgwick, P				Sedgwick, Philip			Randomised controlled trials: inferring significance of treatment effects based on confidence intervals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Ndekha MJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1867; Sedgwick P., 2010, BMJ, V340, pc2673, DOI [10.1136/bmj.c2673, DOI 10.1136/BMJ.C2673]; Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3557; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5420; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4960	5	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2014	349								g5196	10.1136/bmj.g5196	http://dx.doi.org/10.1136/bmj.g5196			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN8FE	25134844				2022-12-28	WOS:000340837900002
J	Lincoff, AM				Lincoff, A. Michael			Heparin monotherapy for percutaneous coronary intervention?	LANCET			English	Editorial Material							GLYCOPROTEIN-IIB/IIIA BLOCKADE; CONTROLLED TRIAL; BIVALIRUDIN; EPTIFIBATIDE; CLOPIDOGREL		Cleveland Clin, Dept Cardiovasc Med, Cleveland Clin Coordinating Ctr Clin Res C5Res, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Lincoff, AM (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Cleveland Clin Coordinating Ctr Clin Res C5Res, Cleveland, OH 44195 USA.	lincofa@ccf.org						[Anonymous], 2000, LANCET, V356, P2037; Cavender MA, 2014, LANCET, V384, P599, DOI 10.1016/S0140-6736(14)61216-2; EPISTENT Investigators, 1998, LANCET, V352, P87; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Palmerini T, 2013, J AM COLL CARDIOL, V62, P1915, DOI 10.1016/j.jacc.2013.08.725; Rao SV, 2008, AM HEART J, V155, P369, DOI 10.1016/j.ahj.2007.10.014; Romagnoli E, 2012, J AM COLL CARDIOL, V60, P2481, DOI 10.1016/j.jacc.2012.06.017; Shahzad A, 2014, LANCET; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	13	2	2	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					564	566		10.1016/S0140-6736(14)61333-7	http://dx.doi.org/10.1016/S0140-6736(14)61333-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25131970				2022-12-28	WOS:000340573300007
J	Duan, X; Krishnaswamy, A; De la Huerta, I; Sanes, JR				Duan, Xin; Krishnaswamy, Arjun; De la Huerta, Irina; Sanes, Joshua R.			Type II Cadherins Guide Assembly of a Direction-Selective Retinal Circuit	CELL			English	Article							N-CADHERIN; DIFFERENTIAL EXPRESSION; CLASSIC CADHERINS; GANGLION-CELLS; BIPOLAR CELLS; IDENTIFICATION; ORGANIZATION; DENDRITES; PROTOCADHERINS; MORPHOGENESIS	Complex retinal circuits process visual information and deliver it to the brain. Few molecular determinants of synaptic specificity in this system are known. Using genetic and optogenetic methods, we identified two types of bipolar interneurons that convey visual input from photoreceptors to a circuit that computes the direction in which objects are moving. We then sought recognition molecules that promote selective connections of these cells with previously characterized components of the circuit. We found that the type II cadherins, cdh8 and cdh9, are each expressed selectively by one of the two bipolar cell types. Using loss- and gain-of-function methods, we showed that they are critical determinants of connectivity in this circuit and that perturbation of their expression leads to distinct defects in visually evoked responses. Our results reveal cellular components of a retinal circuit and demonstrate roles of type II cadherins in synaptic choice and circuit function.	[Duan, Xin; Krishnaswamy, Arjun; De la Huerta, Irina; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Duan, Xin; Krishnaswamy, Arjun; De la Huerta, Irina; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Sanes, JR (corresponding author), Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA.	sanesj@mcb.harvard.edu	De la Huerta, Irina/V-1308-2018		NIH [NS029169, EY022073]; Natural Sciences and Engineering Research Council (NSERC); Banting Fellowship; Howard Hughes Medical Institute-Life Sciences Research Foundation (HHMI-LSRF) Fellowship; NATIONAL EYE INSTITUTE [R01EY022073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029169, R37NS029169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Banting Fellowship; Howard Hughes Medical Institute-Life Sciences Research Foundation (HHMI-LSRF) Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Takeichi for Cdh8<SUP>LacZ</SUP> mice, H. Zeng for Al27 mice; P. Arlotta for 5HT3R-GFP mice; M. Williams for the cdh9 cDNA; M. Yamagata, I-J. Kim, J. Kay, E. Soucy, and J. Greenwood for advice and assistance; J. Johnson (Penn Vector Core) for advice on AAV serotypes; and the Genome Modification Facility (GMF) at Harvard for generating mouse lines. This work was supported by grants from NIH (NS029169 and EY022073 to J.R.S.), a Natural Sciences and Engineering Research Council (NSERC) Fellowship to I.D.l.H., NSERC and Banting Fellowships to A.K., and a Howard Hughes Medical Institute-Life Sciences Research Foundation (HHMI-LSRF) Fellowship to X.D.	Andrasfalvy BK, 2010, P NATL ACAD SCI USA, V107, P11981, DOI 10.1073/pnas.1006620107; Biswas S, 2010, J CELL BIOL, V191, P1029, DOI 10.1083/jcb.201007008; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Chow RL, 2004, P NATL ACAD SCI USA, V101, P1754, DOI 10.1073/pnas.0306520101; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; De la Huerta I, 2012, P NATL ACAD SCI USA, V109, P17663, DOI 10.1073/pnas.1215806109; Elshatory Y, 2007, J COMP NEUROL, V503, P182, DOI 10.1002/cne.21390; Emanuela P, 2009, J COMP NEUROL, V517, P737, DOI 10.1002/cne.22200; Etzrodt J, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-153; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2009, NEUROSCIENCE, V160, P126, DOI 10.1016/j.neuroscience.2009.01.081; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hirano S, 2012, PHYSIOL REV, V92, P597, DOI 10.1152/physrev.00014.2011; Hong YK, 2011, J COMP NEUROL, V519, P1691, DOI 10.1002/cne.22595; Honjo M, 2000, INVEST OPHTH VIS SCI, V41, P546; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Kay JN, 2012, NATURE, V483, P465, DOI 10.1038/nature10877; Kay JN, 2011, NAT NEUROSCI, V14, P965, DOI 10.1038/nn.2859; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kerschensteiner D, 2009, NATURE, V460, P1016, DOI 10.1038/nature08236; Kim DS, 2008, J COMP NEUROL, V507, P1795, DOI 10.1002/cne.21639; Kim IJ, 2010, J NEUROSCI, V30, P1452, DOI 10.1523/JNEUROSCI.4779-09.2010; KITTILA CA, 1995, J NEUROPHYSIOL, V73, P703, DOI 10.1152/jn.1995.73.2.703; Krishna-K K, 2011, NEUROSCIENCE, V175, P37, DOI 10.1016/j.neuroscience.2010.11.056; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Matsuoka RL, 2011, NATURE, V470, P259, DOI 10.1038/nature09675; Morgan JL, 2006, NAT NEUROSCI, V9, P85, DOI 10.1038/nn1615; Morita H, 2010, DEVELOPMENT, V137, P1315, DOI 10.1242/dev.043190; Morrow EM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-2; Nern A, 2008, NEURON, V58, P34, DOI 10.1016/j.neuron.2008.03.022; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Pagnamenta AT, 2011, J MED GENET, V48, P48, DOI 10.1136/jmg.2010.079426; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; Redies C, 1996, DEV BIOL, V180, P413, DOI 10.1006/dbio.1996.0315; Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Schreiner D, 2010, P NATL ACAD SCI USA, V107, P14893, DOI 10.1073/pnas.1004526107; Shimoyama Y, 2000, BIOCHEM J, V349, P159, DOI 10.1042/0264-6021:3490159; Siegert S, 2009, NAT NEUROSCI, V12, P1197, DOI 10.1038/nn.2370; Sun LO, 2013, SCIENCE, V342, P590, DOI 10.1126/science.1241974; Suzuki SC, 2007, J NEUROSCI, V27, P3466, DOI 10.1523/JNEUROSCI.0243-07.2007; Tanabe K, 2006, DEVELOPMENT, V133, P4085, DOI 10.1242/dev.02566; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Trenholm S, 2011, NEURON, V71, P683, DOI 10.1016/j.neuron.2011.06.020; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Wei W, 2011, TRENDS NEUROSCI, V34, P638, DOI 10.1016/j.tins.2011.08.002; Williams ME, 2011, NEURON, V71, P640, DOI 10.1016/j.neuron.2011.06.019; Wohrn JCP, 1998, J COMP NEUROL, V396, P20; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yamagata M, 2006, MOL CELL NEUROSCI, V33, P296, DOI 10.1016/j.mcn.2006.08.001; Yamagata M, 2012, J NEUROSCI, V32, P14402, DOI 10.1523/JNEUROSCI.3193-12.2012; Yonehara K, 2013, NEURON, V79, P1078, DOI 10.1016/j.neuron.2013.08.005	67	132	133	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					793	807		10.1016/j.cell.2014.06.047	http://dx.doi.org/10.1016/j.cell.2014.06.047			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126785	Bronze			2022-12-28	WOS:000340944700011
J	Homem, CCF; Steinmann, V; Burkard, TR; Jais, A; Esterbauer, H; Knoblich, JA				Homem, Catarina C. F.; Steinmann, Victoria; Burkard, Thomas R.; Jais, Alexander; Esterbauer, Harald; Knoblich, Juergen A.			Ecdysone and Mediator Change Energy Metabolism to Terminate Proliferation in Drosophila Neural Stem Cells	CELL			English	Article							REGULATES SELF-RENEWAL; BRAIN-TUMOR; TRANSCRIPTION FACTORS; ASYMMETRIC SEGREGATION; LARVAL NEUROBLASTS; TEMPORAL IDENTITY; FACS PURIFICATION; NERVOUS-SYSTEM; BREAST-CANCER; PROTEIN	Stem cells are highly abundant during early development but become a rare population in most adult organs. The molecular mechanisms causing stem cells to exit proliferation at a specific time are not well understood. Here, we show that changes in energy metabolism induced by the steroid hormone ecdysone and the Mediator initiate an irreversible cascade of events leading to cell-cycle exit in Drosophila neural stem cells. We show that the timely induction of oxidative phosphorylation and the mitochondrial respiratory chain are required in neuroblasts to uncouple the cell cycle from cell growth. This results in a progressive reduction in neuroblast cell size and ultimately in terminal differentiation. Brain tumor mutant neuroblasts fail to undergo this shrinkage process and continue to proliferate until adulthood. Our findings show that cell size control can be modified by systemic hormonal signaling and reveal a unique connection between metabolism and proliferation in stem cells.	[Homem, Catarina C. F.; Steinmann, Victoria; Burkard, Thomas R.; Knoblich, Juergen A.] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Jais, Alexander; Esterbauer, Harald] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Medical University of Vienna	Knoblich, JA (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria.	juergen.knoblich@imba.oeaw.ac.at	Knoblich, Juergen A/C-2974-2015; Jais, Alexander/AAQ-9102-2021	Knoblich, Juergen A/0000-0002-6751-3404; Jais, Alexander/0000-0002-9897-4983; Homem, Catarina/0000-0003-4243-0298; Esterbauer, Harald/0000-0001-7343-7455; Burkard, Thomas/0000-0002-0884-2929	Austrian Academy of Sciences; Austrian Science Fund (FWF) [I_552-B19, Z_153_B09]; European Research Council (ERC); Austrian Science Fund (FWF) [Z 153, I 1281] Funding Source: researchfish	Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council (ERC)(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank T. Lendl, E. Eroglu, C. Jueschke, P. Serrano, J. Steinmann, I. Reichardt, H. Harzer, and M. Lancaster for experimental help and manuscript input. We thank the Vienna Drosophila Resource Center (VDRC), the Bloomington Drosophila Stock Center, G. Schmauss, G. Steng, P. Pasierbek, IMBA's fly-house, and the Campus Science Support Facilities Next Generation Sequencing Unit for technical support. We thank all the members of the J.A.K. laboratory for discussions. We thank J. Treisman, K. Keleman, and C. Doe for fly stocks and reagents. Work in the J.A.K. laboratory is supported by the Austrian Academy of Sciences, the Austrian Science Fund (FWF; grants I_552-B19 and Z_153_B09), and an advanced grant of the European Research Council (ERC).	Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5; Berger C, 2012, CELL REP, V2, P407, DOI 10.1016/j.celrep.2012.07.008; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bhalerao S, 2005, CURR BIOL, V15, P1583, DOI 10.1016/j.cub.2005.07.061; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004; Cai JL, 2002, DEV BIOL, V251, P221, DOI 10.1006/dbio.2002.0828; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Ceron J, 2006, EUR J CELL BIOL, V85, P567, DOI 10.1016/j.ejcb.2006.02.006; Chai PC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001494; Chang KC, 2012, BIOESSAYS, V34, P301, DOI 10.1002/bies.201100090; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Cheng LY, 2011, CELL, V146, P435, DOI 10.1016/j.cell.2011.06.040; Conaway RC, 2013, BBA-GENE REGUL MECH, V1829, P69, DOI 10.1016/j.bbagrm.2012.08.017; COONEY GJ, 1981, BIOCHEM J, V200, P701, DOI 10.1042/bj2000701; Culig Z, 2014, CANCER METAST REV, V33, P413, DOI 10.1007/s10555-013-9474-0; Fernandez-Hernandez I, 2013, CELL REP, V3, P1857, DOI 10.1016/j.celrep.2013.05.034; FRERMAN FE, 1985, P NATL ACAD SCI USA, V82, P4517, DOI 10.1073/pnas.82.13.4517; GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y; GATEFF E, 1978, SCIENCE, V200, P1448, DOI 10.1126/science.96525; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Harzer H, 2013, NAT PROTOC, V8, P1088, DOI 10.1038/nprot.2013.062; HAY BA, 1994, DEVELOPMENT, V120, P2121; HIRATA J, 1995, NATURE, V377, P627, DOI 10.1038/377627a0; Homem CCF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079588; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Iglesias-Bartolome R, 2011, CURR OPIN CELL BIOL, V23, P716, DOI 10.1016/j.ceb.2011.08.002; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Jiang PP, 2010, P NATL ACAD SCI USA, V107, P6765, DOI 10.1073/pnas.1001814107; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kalyani AJ, 1998, BIOCHEM CELL BIOL, V76, P1051, DOI 10.1139/bcb-76-6-1051; Kamoshida Y, 2012, BIOCHEM BIOPH RES CO, V421, P203, DOI 10.1016/j.bbrc.2012.03.135; Kirilly D, 2011, NEURON, V72, P86, DOI 10.1016/j.neuron.2011.08.003; KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0; Kohlmaier A, 2008, CURR OPIN CELL BIOL, V20, P699, DOI 10.1016/j.ceb.2008.10.002; Kozlova T, 2002, DEVELOPMENT, V129, P1739; Kucherenko MM, 2012, EMBO J, V31, P4511, DOI 10.1038/emboj.2012.298; Kugler SJ, 2011, GENETICS, V188, P127, DOI 10.1534/genetics.111.127795; Laporte D, 2011, J CELL BIOL, V192, P949, DOI 10.1083/jcb.201009028; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; LONGO N, 1992, J BIOL CHEM, V267, P12416; Loop T, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-24; Lyne R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r129; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; McKnight SL, 2010, SCIENCE, V330, P1338, DOI 10.1126/science.1199908; Napoli C, 2012, BIOCHIMIE, V94, P579, DOI 10.1016/j.biochi.2011.09.016; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Ou QX, 2013, CURR TOP DEV BIOL, V103, P35, DOI 10.1016/B978-0-12-385979-2.00002-2; PIKE MC, 1993, EPIDEMIOL REV, V15, P17, DOI 10.1093/oxfordjournals.epirev.a036102; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; Siegrist SE, 2010, CURR BIOL, V20, P643, DOI 10.1016/j.cub.2010.01.060; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Sousa-Nunes R, 2010, CURR OPIN NEUROBIOL, V20, P50, DOI 10.1016/j.conb.2009.12.005; Tretter L, 2000, J NEUROSCI, V20, P8972; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; von Trotha JW, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-9; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; ZELHOF AC, 1995, MOL CELL BIOL, V15, P6736; Zhang XT, 2005, MOL CELL, V19, P89, DOI 10.1016/j.molcel.2005.05.015; Zhu SJ, 2006, CELL, V127, P409, DOI 10.1016/j.cell.2006.08.045	76	125	127	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					874	888		10.1016/j.cell.2014.06.024	http://dx.doi.org/10.1016/j.cell.2014.06.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126791	Bronze			2022-12-28	WOS:000340944700017
J	Licht, S; Cui, BC; Wang, BH; Li, FF; Lau, J; Liu, SZ				Licht, Stuart; Cui, Baochen; Wang, Baohui; Li, Fang-Fang; Lau, Jason; Liu, Shuzhi			RETRACTED: AMMONIA SYNTHESIS Ammonia synthesis by N-2 and steam electrolysis in molten hydroxide suspensions of nanoscale Fe2O3 (Retracted article. See vol. 369, pg. 780, 2020)	SCIENCE			English	Article; Retracted Publication							NITRIDE SOLUTIONS; HIGH-TEMPERATURE; NITROGEN; SALTS; WATER; CELL	The Haber-Bosch process to produce ammonia for fertilizer currently relies on carbon-intensive steam reforming of methane as a hydrogen source. We present an electrochemical pathway in which ammonia is produced by electrolysis of air and steam in a molten hydroxide suspension of nano-Fe2O3. At 200 degrees C in an electrolyte with a molar ratio of 0.5 NaOH/0.5 KOH, ammonia is produced at 1.2 volts (V) under 2 milliamperes per centimeter squared (mA cm(-2)) of applied current at coulombic efficiency of 35% (35% of the applied current results in the six-electron conversion of N-2 and water to ammonia, and excess H-2 is cogenerated with the ammonia). At 250 degrees C and 25 bar of steam pressure, the electrolysis voltage necessary for 2 mA cm(-2) current density decreased to 1.0 V.	[Licht, Stuart; Cui, Baochen; Wang, Baohui; Li, Fang-Fang; Lau, Jason; Liu, Shuzhi] George Washington Univ, Dept Chem, Washington, DC 20052 USA	George Washington University	Licht, S (corresponding author), George Washington Univ, Dept Chem, Washington, DC 20052 USA.	slicht@gwu.edu	Li, Fang-Fang/F-3440-2013	Li, Fang-Fang/0000-0001-6850-2857; Wang, Baohui/0000-0003-2547-9954	Office of Naval Research [N00014-13-1-0791]	Office of Naval Research(Office of Naval Research)	Full materials and methods and a section on solar thermal-constrained volume pressurization are presented in the supplementary materials. The authors are grateful for partial support of this research by the Office of Naval Research (award N00014-13-1-0791). A related provisional U.S. patent has been filed.)	Amar IA, 2011, J SOLID STATE ELECTR, V15, P1845, DOI 10.1007/s10008-011-1376-x; Appl M, 2011, ULLMANNS ENCY IND CH, DOI [10.1002/14356007.o02, DOI 10.1002/14356007.O02]; BONOMI A, 1979, J ELECTROCHEM SOC, V126, P248, DOI 10.1149/1.2129013; BONOMI A, 1977, J ELECTROCHEM SOC, V124, P982, DOI 10.1149/1.2133513; Chase MW, 1998, J PHYS CHEM REF DATA, V9, DOI [10.18434/T42S31, DOI 10.18434/T42S31]; FURUYA N, 1990, J ELECTROANAL CHEM, V291, P269, DOI 10.1016/0022-0728(90)87195-P; Ganley JC, 2008, J POWER SOURCES, V178, P44, DOI 10.1016/j.jpowsour.2007.11.093; Ganley JC, 2009, INT J HYDROGEN ENERG, V34, P3604, DOI 10.1016/j.ijhydene.2009.02.083; Glenn Research Center National Aeronautics and Space Administration (NASA), 2006, THERMOBUILD ACCESS T; Hahm T, 1999, SOL ENERGY, V65, P33, DOI 10.1016/S0038-092X(98)00119-4; Hellman A, 2006, J PHYS CHEM B, V110, P17719, DOI 10.1021/jp056982h; Ito Y, 2005, J NUCL MATER, V344, P128, DOI 10.1016/j.jnucmat.2005.04.030; Kordali V, 2000, CHEM COMMUN, P1673, DOI 10.1039/b004885m; Lan R, 2013, RSC ADV, V3, P18016, DOI 10.1039/c3ra43432j; Lan R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01145; Licht S, 2003, CHEM COMMUN, P3006, DOI 10.1039/b309397b; Licht S, 2011, ADV MATER, V23, P5592, DOI 10.1002/adma.201103198; Licht S, 2009, J PHYS CHEM C, V113, P16283, DOI 10.1021/jp9044644; McKone JR, 2014, CHEM SCI, V5, P865, DOI 10.1039/c3sc51711j; Murakami T, 2005, ELECTROCHEM SOLID ST, V8, pD12, DOI 10.1149/1.1870633; Murakami T, 2003, J AM CHEM SOC, V125, P334, DOI 10.1021/ja028891t; Murakami T, 2007, ELECTROCHEM SOLID ST, V10, pE4, DOI 10.1149/1.2437674; Pelton A., 2012, 283 BINARY SALT PHAS; PICKETT CJ, 1985, NATURE, V317, P652, DOI 10.1038/317652a0; Pitz-Paal R, 2007, SOLAR ENERGY CONVERS; Rockstrom J, 2009, NATURE, V461, P472, DOI 10.1038/461472a; Santos DMF, 2013, QUIM NOVA, V36, P1176, DOI 10.1590/S0100-40422013000800017; Serizawa N, 2012, J ELECTROCHEM SOC, V159, pE87, DOI 10.1149/2.099204jes; Skulason E, 2012, PHYS CHEM CHEM PHYS, V14, P1235, DOI 10.1039/c1cp22271f; Smil V., 2004, ENRICHING THE EARTH; Strait R., 2010, NITROGEN SYNGAS, V303, P1; Zeng K, 2010, PROG ENERG COMBUST, V36, P307, DOI 10.1016/j.pecs.2009.11.002; Ziqing W., 2013, J CATAL, V33, P377	34	539	547	9	818	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					637	640		10.1126/science.1254234	http://dx.doi.org/10.1126/science.1254234			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104378				2022-12-28	WOS:000339962800029
J	Binswanger, IA; Carson, EA; Krueger, PM; Mueller, SR; Steiner, JF; Sabol, WJ				Binswanger, Ingrid A.; Carson, E. Ann; Krueger, Patrick M.; Mueller, Shane R.; Steiner, John F.; Sabol, William J.			Prison tobacco control policies and deaths from smoking in United States prisons: population based retrospective analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; RISK; BAN; DISPARITIES; PREVALENCE; RELEASE; WALES	Objective To determine the mortality attributable to smoking and years of potential life lost from smoking among people in prison and whether bans on smoking in prison are associated with reductions in smoking related deaths. Design Analysis of cross sectional survey data with the smoking attributable mortality, morbidity, and economic costs system; population based time series analysis. Setting All state prisons in the United States. Main outcome measures Prevalence of smoking from cross sectional survey of inmates in state correctional facilities. Data on state prison tobacco policies from web based searches of state policies and legislation. Deaths and causes of death in US state prisons from the deaths in custody reporting program of the Bureau of Justice Statistics for 2001-11. Smoking attributable mortality and years of potential life lost was assessed from the smoking attributable mortality, morbidity, and economic costs system of the Centers for Disease Control and Prevention. Multivariate Poisson models quantified the association between bans and smoking related cancer, cardiovascular and pulmonary deaths. Results The most common causes of deaths related to smoking among people in prison were lung cancer, ischemic heart disease, other heart disease, cerebrovascular disease, and chronic airways obstruction. The age adjusted smoking attributable mortality and years of potential life lost rates were 360 and 5149 per 100 000, respectively; these figures are higher than rates in the general US population (248 and 3501, respectively). The number of states with any smoking ban increased from 25 in 2001 to 48 by 2011. In prisons the mortality rate from smoking related causes was lower during years with a ban than during years without a ban (110.4/100 000 v 128.9/100 000). Prisons that implemented smoking bans had a 9% reduction (adjusted incidence rate ratio 0.91, 95% confidence interval 0.88 to 0.95) in smoking related deaths. Bans in place for longer than nine years were associated with reductions in cancer mortality (adjusted incidence rate ratio 0.81, 95% confidence interval 0.74 to 0.90). Conclusions Smoking contributes to substantial mortality in prison, and prison tobacco control policies are associated with reduced mortality. These findings suggest that smoking bans have health benefits for people in prison, despite the limits they impose on individual autonomy and the risks of relapse after release.	[Binswanger, Ingrid A.; Mueller, Shane R.] Univ Colorado, Sch Med, Div Gen Internal Med, Dept Med, Aurora, CO 80045 USA; [Carson, E. Ann; Sabol, William J.] Dept Justice, Bur Justice Stat, Washington, DC 20531 USA; [Krueger, Patrick M.] Univ Colorado, Dept Hlth & Behav Sci, Denver, CO 80217 USA; [Steiner, John F.] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80237 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Denver; Kaiser Permanente	Binswanger, IA (corresponding author), Univ Colorado, Sch Med, Div Gen Internal Med, Dept Med, Mail Stop B180,12631 E 17th Ave, Aurora, CO 80045 USA.	ingrid.binswanger@ucdenver.edu	Binswanger, Ingrid/X-4496-2019	Binswanger, Ingrid/0000-0001-8862-8078; Krueger, Patrick/0000-0003-3689-2488	Bureau of Justice Statistics Visiting Fellows Program, US Department of Justice [2011-BJ-CX-K073]	Bureau of Justice Statistics Visiting Fellows Program, US Department of Justice	This study was supported by the Bureau of Justice Statistics Visiting Fellows Program, US Department of Justice (grant No 2011-BJ-CX-K073). The views and opinions expressed do not necessarily represent the views and opinion of the Bureau of Justice Statistics or the US Department of Justice.	Adhikari B., 2008, Morbidity and Mortality Weekly Report, V57, P1226; American Nonsmokers' Rights Foundation, 2012, 100 SMOK CORR FAC; Awofeso N, 2001, TOB CONTROL, V10, P84; Baker A, 2006, DRUG ALCOHOL REV, V25, P85, DOI 10.1080/09595230500459552; BBC News, 2013, BBC NEWS; Belcher JM, 2006, DRUG ALCOHOL REV, V25, P343, DOI 10.1080/09595230600741198; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Binswanger IA, 2013, ANN INTERN MED, V159, P592, DOI 10.7326/0003-4819-159-9-201311050-00005; Binswanger IA, 2012, J URBAN HEALTH, V89, P98, DOI 10.1007/s11524-011-9614-1; Bondy SJ, 2009, TOB CONTROL, V18, P317, DOI 10.1136/tc.2008.027276; Butler T, 2007, TOB CONTROL, V16, P291, DOI 10.1136/tc.2007.021600; Carson EA, 2012, PRISONERS 2011; Centers for Disease Control and Prevention, 2009, JAMA-J AM MED ASSOC, V302, P2654; Centers for Disease Control and Prevention (CDC), 2011, BEH RISK FACT SURV S; Clarke JG, 2013, JAMA INTERN MED, V173, P789, DOI 10.1001/jamainternmed.2013.197; Cork K, 2012, TOBACCO BARS POLICY; Cropsey K, 2008, AM J PUBLIC HEALTH, V98, P1894, DOI 10.2105/AJPH.2007.128207; Cropsey KL, 2006, NICOTINE TOB RES, V8, P653, DOI 10.1080/14622200600789684; Cropsey KL, 2005, ADDICT BEHAV, V30, P589, DOI 10.1016/j.addbeh.2004.07.003; Dorsett J, 2013, ABC NEWS; Durose Matthew R., 2014, RECIDIVISM PRISONERS; Fry JS, 2013, REGUL TOXICOL PHARM, V67, P13, DOI 10.1016/j.yrtph.2013.06.001; Idaho Department of Corrections, 1996, TOB FREE ENV POL 104; Institute of Medicine, 2009, SEC SMOK EXP CARD EF; Inter-university Consortium for Political and Social Research, 2007, SURV INM STAT FED CO; Khuder SA, 2007, PREV MED, V45, P3, DOI 10.1016/j.ypmed.2007.03.011; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Lincoln Thomas, 2009, J Correct Health Care, V15, P190, DOI 10.1177/1078345809333388; Massoglia M, 2008, LAW SOC REV, V42, P275, DOI 10.1111/j.1540-5893.2008.00342.x; McAnulty JM, 1994, TOB CONTROL, V3, P115; Proescholdbell SK, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.022038; Ritter C, 2012, TOB CONTROL, V21, P488, DOI 10.1136/tc.2011.043356; Singleton N, 2003, INT REV PSYCHIATR, V15, P150, DOI 10.1080/0954026021000046092; State of North Carolina, 2011, N CAR SMOK FREE REST; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; Thomas AR, 2001, TOB CONTROL, V10, P161, DOI 10.1136/tc.10.2.161; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; US Department of Justice Office of Justice Programs Bureau of Justice Statistics, 2012, ICPSR30641 US DEP JU; WHO, 2013, TOB FACT SHEET	40	56	56	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2014	349								g4542	10.1136/bmj.g4542	http://dx.doi.org/10.1136/bmj.g4542			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9MP	25097186	Green Published, hybrid			2022-12-28	WOS:000340206000001
J	Tschaharganeh, DF; Xue, W; Calvisi, DF; Evert, M; Michurina, TV; Dow, LE; Banito, A; Katz, SF; Kastenhuber, ER; Weissmueller, S; Huang, CH; Lechel, A; Andersen, JB; Capper, D; Zender, L; Longerich, T; Enikolopov, G; Lowe, SW				Tschaharganeh, Darjus F.; Xue, Wen; Calvisi, Diego F.; Evert, Matthias; Michurina, Tatyana V.; Dow, Lukas E.; Banito, Ana; Katz, Sarah F.; Kastenhuber, Edward R.; Weissmueller, Susann; Huang, Chun-Hao; Lechel, Andre; Andersen, Jesper B.; Capper, David; Zender, Lars; Longerich, Thomas; Enikolopov, Grigori; Lowe, Scott W.			p53-Dependent Nestin Regulation Links Tumor Suppression to Cellular Plasticity in Liver Cancer	CELL			English	Article							INTERMEDIATE-FILAMENT NESTIN; STEM-CELLS; INTRAHEPATIC CHOLANGIOCARCINOMA; IN-VIVO; P53; EXPRESSION; MICE; GROWTH; DEDIFFERENTIATION; DIFFERENTIATION	The p53 tumor suppressor coordinates a series of antiproliferative responses that restrict the expansion of malignant cells, and as a consequence, p53 is lost or mutated in the majority of human cancers. Here, we show that p53 restricts expression of the stem and progenitor-cell-associated protein nestin in an Sp1/3 transcription-factor-dependent manner and that Nestin is required for tumor initiation in vivo. Moreover, loss of p53 facilitates dedifferentiation of mature hepatocytes into nestin-positive progenitor-like cells, which are poised to differentiate into hepatocellular carcinomas (HCCs) or cholangiocarcinomas (CCs) in response to lineage-specific mutations that target Wnt and Notch signaling, respectively. Many human HCCs and CCs show elevated nestin expression, which correlates with p53 loss of function and is associated with decreased patient survival. Therefore, transcriptional repression of Nestin by p53 restricts cellular plasticity and tumorigenesis in liver cancer.	[Tschaharganeh, Darjus F.; Dow, Lukas E.; Banito, Ana; Kastenhuber, Edward R.; Weissmueller, Susann; Huang, Chun-Hao; Lowe, Scott W.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA; [Xue, Wen; Michurina, Tatyana V.; Weissmueller, Susann; Zender, Lars; Enikolopov, Grigori; Lowe, Scott W.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Calvisi, Diego F.; Evert, Matthias] Univ Med, Inst Pathol, D-17487 Greifswald, Germany; [Katz, Sarah F.; Lechel, Andre] Univ Ulm, Dept Internal Med 1, D-89070 Ulm, Germany; [Andersen, Jesper B.] NCI, Lab Expt Carcinogenesis, CCR, NIH, Bethesda, MD 20892 USA; [Andersen, Jesper B.] Univ Copenhagen, BRIC, DK-2200 Copenhagen, Denmark; [Capper, David; Longerich, Thomas] Univ Heidelberg Hosp, Inst Pathol, D-69120 Heidelberg, Germany; [Capper, David] German Canc Res Ctr, Clin Cooperat Unit Neuropathol, D-69120 Heidelberg, Germany; [Lowe, Scott W.] Howard Hughes Med Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Ulm University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Copenhagen; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Howard Hughes Medical Institute	Lowe, SW (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10065 USA.	lowes@mskcc.org	Lechel, André/AAQ-2041-2021; Banito, Ana/P-6168-2017; Enikolopov, Grigori/P-5731-2019; Capper, David/I-8500-2014	Lechel, André/0000-0003-0221-6959; Enikolopov, Grigori/0000-0001-8178-8917; Xue, Wen/0000-0002-9797-8042; Banito, Ana/0000-0003-2188-0003; Kastenhuber, Edward/0000-0002-1872-212X; Andersen, Jesper B/0000-0003-1760-5244; Capper, David/0000-0003-1945-497X; Dow, Lukas/0000-0001-7048-1418	National Cancer Institute; National Center for Tumor Disease, Heidelberg; German Research Foundation (DFG) [SFB/TRR77]; German Cancer Aid; German Research Foundation (DFG); NATIONAL CANCER INSTITUTE [P01CA087497, P30CA045508, P01CA013106, P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Tumor Disease, Heidelberg(Deutsche KrebshilfeHelmholtz Association); German Research Foundation (DFG)(German Research Foundation (DFG)); German Cancer Aid(Deutsche Krebshilfe); German Research Foundation (DFG)(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all members of the Lowe lab for stimulating discussion and, in particular, Dr. Charles J. Sherr for important suggestions and editing the manuscript. We thank D. Grace, J. Simon, the MSKCC animal facility, and MSKCC molecular cytology core for outstanding technical support. This work was supported by program project grants from the National Cancer Institute (S.W.L.). This study was supported by the National Center for Tumor Disease, Heidelberg, and grants of the German Research Foundation (DFG, SFB/TRR77) and the German Cancer Aid (T.L.). D.F.T. is funded by a postdoctoral fellowship of the German Research Foundation (DFG). S.W.L. is the Geoffrey Beene Chair for Cancer Biology and a Howard Hughes Medical Institute investigator.	Andersen JB, 2012, GASTROENTEROLOGY, V142, P1021, DOI 10.1053/j.gastro.2011.12.005; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Broz DK, 2010, CARCINOGENESIS, V31, P1311, DOI 10.1093/carcin/bgp331; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheng LP, 2004, FEBS LETT, V565, P195, DOI 10.1016/j.febslet.2004.03.097; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Fellous TG, 2009, HEPATOLOGY, V49, P1655, DOI 10.1002/hep.22791; Friedmann-Morvinski D, 2012, SCIENCE, V338, P1080, DOI 10.1126/science.1226929; Gleiberman AS, 2005, DEV DYNAM, V234, P413, DOI 10.1002/dvdy.20536; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Katz SF, 2012, GASTROENTEROLOGY, V142, P1229, DOI 10.1053/j.gastro.2012.02.009; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Krupkova O, 2010, NEOPLASMA, V57, P291, DOI 10.4149/neo_2010_04_291; Li H, 2012, LIVER INT, V32, P38, DOI 10.1111/j.1478-3231.2011.02646.x; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Lu WJ, 2011, INT J CANCER, V128, P343, DOI 10.1002/ijc.25586; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Markert EK, 2011, P NATL ACAD SCI USA, V108, P21276, DOI 10.1073/pnas.1117029108; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mizuno H, 2010, P NATL ACAD SCI USA, V107, P22745, DOI 10.1073/pnas.1017001108; Nault JC, 2011, SEMIN LIVER DIS, V31, P173, DOI 10.1055/s-0031-1276646; Neumann O, 2012, HEPATOLOGY, V56, P1817, DOI 10.1002/hep.25870; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; RUMSBY PC, 1994, MOL CARCINOGEN, V9, P71, DOI 10.1002/mc.2940090204; Saborowski A, 2013, P NATL ACAD SCI USA, V110, P19513, DOI 10.1073/pnas.1311707110; Sahlgren CM, 2006, EMBO J, V25, P4808, DOI 10.1038/sj.emboj.7601366; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; SODDU S, 1994, BLOOD, V83, P2230, DOI 10.1182/blood.V83.8.2230.bloodjournal8382230; Spike Benjamin T, 2011, Genes Cancer, V2, P404, DOI 10.1177/1947601911410224; Sugimoto K, 2011, TRENDS CELL BIOL, V21, P212, DOI 10.1016/j.tcb.2010.12.004; Takakuwa O, 2013, LUNG CANCER, V81, P174, DOI 10.1016/j.lungcan.2013.04.022; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wu DY, 2006, CELL RES, V16, P319, DOI 10.1038/sj.cr.7310040; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yant SR, 2000, NAT GENET, V25, P35, DOI 10.1038/75568; Yun MH, 2013, P NATL ACAD SCI USA, V110, P17392, DOI 10.1073/pnas.1310519110; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang LL, 2000, CANCER RES, V60, P3655; Zhao YY, 2013, ONCOL REP, V30, P1782, DOI 10.3892/or.2013.2627	53	135	139	1	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					579	592		10.1016/j.cell.2014.05.051	http://dx.doi.org/10.1016/j.cell.2014.05.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083869	Green Accepted, Bronze			2022-12-28	WOS:000340944300011
J	Lupascu, A				Lupascu, Adrian			QUANTUM PHYSICS The path most travelled	NATURE			English	Editorial Material									[Lupascu, Adrian] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Lupascu, Adrian] Univ Waterloo, Inst Quantum Comp, Waterloo, ON N2L 3G1, Canada	University of Waterloo; University of Waterloo	Lupascu, A (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada.	adrian.lupascu@uwaterloo.ca						Braginsky V. B., 1995, QUANTUM MEASUREMENT; Chantasri A, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.042110; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Haroche S., 2006, EXPLORING QUANTUM; Korotkov AN, 1999, PHYS REV B, V60, P5737, DOI 10.1103/PhysRevB.60.5737; Murch KW, 2013, NATURE, V502, P211, DOI 10.1038/nature12539; Weber SJ, 2014, NATURE, V511, P570, DOI 10.1038/nature13559; You JQ, 2011, NATURE, V474, P589, DOI 10.1038/nature10122	8	0	0	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					538	539		10.1038/511538a	http://dx.doi.org/10.1038/511538a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079548				2022-12-28	WOS:000339566300021
J	Faehnle, CR; Walleshauser, J; Joshua-Tor, L				Faehnle, Christopher R.; Walleshauser, Jack; Joshua-Tor, Leemor			Mechanism of Dis3l2 substrate recognition in the Lin28-let-7 pathway	NATURE			English	Article							YEAST EXOSOME CORE; PERLMAN SYNDROME; RNA DEGRADATION; MATURATION; ZCCHC11; SUBUNIT; LIN-28; PHENIX; TUT4	The pluripotency factor Lin28 inhibits the biogenesis of the let-7 family of mammalian microRNAs(1-4). Lin28 is highly expressed in embryonic stem cells and has a fundamental role in regulation of development(5), glucose metabolism(6) and tissue regeneration(7). Over-expression of Lin28 is correlated with the onset of numerous cancers(8), whereas let-7, a tumour suppressor, silences several human oncogenes(5). Lin28 binds to precursor let-7 (pre-let-7) hairpins(9), triggering the 39 oligo-uridylation activity of TUT4 and TUT7 (refs 10-12). The oligoU tail added to pre-let-7 serves as a decay signal, as it is rapidly degraded by Dis3l2 (refs 13, 14), a homologue of the catalytic subunit of the RNA exosome. The molecular basis of Lin28-mediated recruitment of TUT4 and TUT7 to pre-let-7 and its subsequent degradation by Dis3l2 is largely unknown. To examine the mechanism of Dis3l2 substrate recognition we determined the structure of mouse Dis3l2 in complex with an oligoU RNA to mimic the uridylated tail of pre-let-7. Three RNA-binding domains form an open funnel on one face of the catalytic domain that allows RNA to navigate a path to the active site different from that of its exosome counterpart. The resulting path reveals an extensive network of uracil-specific interactions spanning the first 12 nucleotides of an oligoU-tailed RNA. We identify three U-specificity zones that explain how Dis3l2 recognizes, binds and processes uridylated pre-let-7 in the final step of the Lin28-let-7 pathway.	[Faehnle, Christopher R.; Walleshauser, Jack; Joshua-Tor, Leemor] WM Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA; [Faehnle, Christopher R.; Walleshauser, Jack; Joshua-Tor, Leemor] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Walleshauser, Jack; Joshua-Tor, Leemor] Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Joshua-Tor, Leemor] Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Joshua-Tor, L (corresponding author), WM Keck Struct Biol Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu		Joshua-Tor, Leemor/0000-0001-8185-8049	Watson School of Biological Sciences; Louis Morin Charitable Trust; Robertson Research Fund of Cold Spring Harbor Laboratory; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, T32GM065094] Funding Source: NIH RePORTER	Watson School of Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Louis Morin Charitable Trust; Robertson Research Fund of Cold Spring Harbor Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. M. Hammell for comments on this manuscript and members of the Joshua-Tor laboratory for comments and suggestions. We thank A. Heroux for help at the National Synchrotron Light Source, which is supported by Department of Energy, Office of Basic Energy Sciences. We also thank the Protein Core Facility at Columbia University. This work was supported by the Watson School of Biological Sciences (to J.W. and L.J.), the Louis Morin Charitable Trust and the Robertson Research Fund of Cold Spring Harbor Laboratory (to L.J.). L.J. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Astuti D, 2012, NAT GENET, V44, P277, DOI 10.1038/ng.1071; Barbas A, 2009, J BIOL CHEM, V284, P20486, DOI 10.1074/jbc.M109.020693; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Chang H, 2014, MOL CELL, V53, P1044, DOI 10.1016/j.molcel.2014.02.007; Choi YS, 2012, RNA, V18, P394, DOI 10.1261/rna.029306.111; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lubas M, 2013, EMBO J, V32, P1855, DOI 10.1038/emboj.2013.135; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445; Reis FP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076504; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Shechner DM, 2011, NAT STRUCT MOL BIOL, V18, P1036, DOI 10.1038/nsmb.2107; Shyh-Chang N, 2013, CELL, V155, P778, DOI 10.1016/j.cell.2013.09.059; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thornton JE, 2012, RNA, V18, P1875, DOI 10.1261/rna.034538.112; Thornton JE, 2012, TRENDS CELL BIOL, V22, P474, DOI 10.1016/j.tcb.2012.06.001; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Urbach A, 2014, GENE DEV, V28, P971, DOI 10.1101/gad.237149.113; Ustianenko D, 2013, RNA, V19, P1632, DOI 10.1261/rna.040055.113; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	43	80	83	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					252	+		10.1038/nature13553	http://dx.doi.org/10.1038/nature13553			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119025	Green Accepted			2022-12-28	WOS:000342663100047
J	Lee, N				Lee, Naomi			The Lancet Technology: August, 2014	LANCET			English	Editorial Material												naomi.lee@lancet.com							0	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					573	573		10.1016/S0140-6736(14)61354-4	http://dx.doi.org/10.1016/S0140-6736(14)61354-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN4QR	25136716	Bronze			2022-12-28	WOS:000340573300012
J	Leontis, NB; Westhof, E				Leontis, Neocles B.; Westhof, Eric			CHEMISTRY Self-assembled RNA nanostructures	SCIENCE			English	Editorial Material							DNA; DESIGN; CREATE; SHAPES		[Leontis, Neocles B.] Bowling Green State Univ, Dept Chem, Bowling Green, OH 43403 USA; [Westhof, Eric] CNRS, Inst Biol Mol & Cellulaire, Architecture & React ARN, F-67084 Strasbourg, France	University System of Ohio; Bowling Green State University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Leontis, NB (corresponding author), Bowling Green State Univ, Dept Chem, Bowling Green, OH 43403 USA.	leontis@bgsu.edu; e.westhof@ibmc-cnrs.unistra.fr	Leontis, Neocles/E-8866-2011	Leontis, Neocles/0000-0003-3521-5119				Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Endo M., 2014, ANGEW CHEM INT ENGL; Geary C, 2014, SCIENCE, V345, P799, DOI 10.1126/science.1253920; Hara T, 2013, CHEM COMMUN, V49, P3833, DOI 10.1039/c3cc38688k; Krishnan Y, 2011, ANGEW CHEM INT EDIT, V50, P3124, DOI 10.1002/anie.200907223; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SEEMAN NC, 1983, BIOPHYS J, V44, P201, DOI 10.1016/S0006-3495(83)84292-1; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yamazaki T, 2014, NANOSCALE, V6, P9122, DOI 10.1039/c4nr01598c; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274	12	10	13	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					732	733		10.1126/science.1257989	http://dx.doi.org/10.1126/science.1257989			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124412				2022-12-28	WOS:000340593100014
J	Griffith, LC				Griffith, Leslie C.			NEUROSCIENCE What females really want	NATURE			English	Editorial Material							DROSOPHILA; RECEPTIVITY	The identification of neural subcircuits used by female fruit flies to make a choice about whether to copulate with a potential mate provides a template for understanding how the brain integrates complex information to reach decisions.	[Griffith, Leslie C.] Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA; [Griffith, Leslie C.] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Griffith, LC (corresponding author), Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA.	griffith@brandeis.edu		Griffith, Leslie/0000-0003-3164-9876	NIGMS NIH HHS [R01 GM054408] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bussell JJ, 2014, CURR BIOL, V24, P1584, DOI 10.1016/j.cub.2014.06.011; Feng K, 2014, NEURON, V83, P135, DOI 10.1016/j.neuron.2014.05.017; Ferveur JF, 2010, CURR OPIN NEUROBIOL, V20, P764, DOI 10.1016/j.conb.2010.09.007; Pavlou HJ, 2013, CURR OPIN NEUROBIOL, V23, P76, DOI 10.1016/j.conb.2012.09.002; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Zhou C, 2014, NEURON, V83, P149, DOI 10.1016/j.neuron.2014.05.038	7	1	1	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					138	139		10.1038/512138a	http://dx.doi.org/10.1038/512138a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25119229				2022-12-28	WOS:000340200700015
J	Smith, JM				Smith, Jeanette M.			The Aqueduct William Sartain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		ACKERMAN GM, 1994, AM ORIENTALISTS, V10, P190; MARTINEZ K, 2000, PHILADELPHIAS CULTUR, V1, P15	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					582	583		10.1001/jama.2013.279657	http://dx.doi.org/10.1001/jama.2013.279657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117114				2022-12-28	WOS:000340136400001
J	Seguna, R; Maw, KZ; Lyall, HD; Bowles, KM				Seguna, Ryan; Maw, Kyaw Z.; Lyall, Hamish D.; Bowles, Kristian M.			"Haemorrhagic disease of the newborn" 89 years later than expected: vitamin K deficiency bleeding	LANCET			English	Editorial Material									[Seguna, Ryan] Norfolk & Norwich Univ Hosp, Dept Med, Norwich, Norfolk, England; [Maw, Kyaw Z.; Lyall, Hamish D.; Bowles, Kristian M.] Norfolk & Norwich Univ Hosp, Dept Haematol, Norwich, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Bowles, KM (corresponding author), Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England.	k.bowles@uea.ac.uk		Bowles, Kristian/0000-0003-1334-4526				Committee statement on nutrition, 1961, AM ACAD PAEDIAT, V28, P501; Dam H, 1935, NATURE, V135, P652, DOI 10.1038/135652b0; Shearer MJ, 2009, BLOOD REV, V23, P49, DOI 10.1016/j.blre.2008.06.001; Townsend CW., 1894, ARCH PEDIAT, V11, P559; Winckel M, 2009, EUR J PEDIATR, V168, P127, DOI 10.1007/s00431-008-0856-1	5	0	1	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					556	556		10.1016/S0140-6736(14)60999-5	http://dx.doi.org/10.1016/S0140-6736(14)60999-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9JR	25110271				2022-12-28	WOS:000340198300034
J	Moda, F; Gambetti, P; Notari, S; Concha-Marambio, L; Catania, M; Park, KW; Maderna, E; Suardi, S; Haik, S; Brandel, JP; Ironside, J; Knight, R; Tagliavini, F; Soto, C				Moda, Fabio; Gambetti, Pierluigi; Notari, Silvio; Concha-Marambio, Luis; Catania, Marcella; Park, Kyung-Won; Maderna, Emanuela; Suardi, Silvia; Haik, Stephane; Brandel, Jean-Philippe; Ironside, James; Knight, Richard; Tagliavini, Fabrizio; Soto, Claudio			Prions in the Urine of Patients with Variant Creutzfeldt- Jakob Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MISFOLDING CYCLIC AMPLIFICATION; BLOOD-TRANSFUSION; INFECTIOUS PRIONS; PROTEIN; TRANSMISSION; EXCRETION; TISSUES; HUMANS; AGENT; VCJD	BACKGROUND Prions, the infectious agents responsible for transmissible spongiform encephalopathies, consist mainly of the misfolded prion protein (PrPSc). The unique mechanism of transmission and the appearance of a variant form of Creutzfeldt-Jakob disease, which has been linked to consumption of prion-contaminated cattle meat, have raised concerns about public health. Evidence suggests that variant Creutzfeldt-Jakob disease prions circulate in body fluids from people in whom the disease is silently incubating. METHODS To investigate whether PrPSc can be detected in the urine of patients with variant Creutzfeldt-Jakob disease, we used the protein misfolding cyclic amplification (PMCA) technique to amplify minute quantities of PrPSc, enabling highly sensitive detection of the protein. We analyzed urine samples from several patients with various transmissible spongiform encephalopathies (variant and sporadic Creutzfeldt-Jakob disease and genetic forms of prion disease), patients with other degenerative or nondegenerative neurologic disorders, and healthy persons. RESULTS PrPSc was detectable only in the urine of patients with variant Creutzfeldt-Jakob disease and had the typical electrophoretic profile associated with this disease. PrPSc was detected in 13 of 14 urine samples obtained from patients with variant Creutzfeldt-Jakob disease and in none of the 224 urine samples obtained from patients with other neurologic diseases and from healthy controls, resulting in an estimated sensitivity of 92.9% (95% confidence interval [CI], 66.1 to 99.8) and a specificity of 100.0% (95% CI, 98.4 to 100.0). The PrPSc concentration in urine calculated by means of quantitative PMCA was estimated at 1x10(-16) g per milliliter, or 3x10(-21) mol per milliliter, which extrapolates to approximately 40 to 100 oligomeric particles of PrPSc per milliliter of urine. CONCLUSIONS Urine samples obtained from patients with variant Creutzfeldt-Jakob disease contained minute quantities of PrPSc.	[Moda, Fabio; Concha-Marambio, Luis; Park, Kyung-Won; Soto, Claudio] Univ Texas Med Sch Houston, Mitchell Ctr Res Alzheimers Dis & Related Brain D, Houston, TX 77030 USA; [Moda, Fabio; Catania, Marcella; Maderna, Emanuela; Suardi, Silvia; Tagliavini, Fabrizio] Fdn Carlo Besta Neurol Inst, Milan, Italy; [Gambetti, Pierluigi; Notari, Silvio] Case Western Reserve Univ, Natl Prion Dis Pathol Surveillance Ctr, Cleveland, OH 44106 USA; [Concha-Marambio, Luis] Univ Los Andes, Fac Med, Santiago, Chile; [Haik, Stephane; Brandel, Jean-Philippe] Univ Paris 06, Grp Hosp Pitie Salpetriere, Assistance Publ Hop Paris,INSERM,U1127, Cellule Natl Reference Malad Creutzfeldt Jakob, Paris, France; [Haik, Stephane; Brandel, Jean-Philippe] CNRS, UMR, Paris, France; [Ironside, James; Knight, Richard] Univ Edinburgh, Western Gen Hosp, Natl CJD Res & Surveillance Unit, Edinburgh, Midlothian, Scotland	University of Texas System; University of Texas Health Science Center Houston; IRCCS Istituto Neurologico Besta; Case Western Reserve University; Universidad de los Andes - Chile; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); University of Edinburgh	Soto, C (corresponding author), Univ Texas Med Sch Houston, 6431 Fannin St, Houston, TX 77030 USA.	claudio.soto@uth.tmc.edu	Catania, Marcella/K-1430-2016; maderna, emanuela/F-1420-2019; Tagliavini, Fabrizio/AAO-7891-2021; Haik, Stephane/M-7247-2018; Moda, Fabio/J-6445-2018; Concha-Marambio, Luis/V-3247-2019	Catania, Marcella/0000-0003-0370-1905; maderna, emanuela/0000-0002-5736-3166; Tagliavini, Fabrizio/0000-0003-1039-7315; Moda, Fabio/0000-0002-2820-9880; Concha-Marambio, Luis/0000-0002-9454-8389; Ironside, James/0000-0001-5869-2108	National Institutes of Health [P01AI077774, R42NS079060, R01NS049173, R01NS078745]; PrioNet Canada; Italian Ministry of Health; Associazione Italiana Encefalopatie da Prioni; Ministero dell'Universita e della Ricerca [RBAP11FRE9]; Charles S. Britton Fund [P01AG14359]; U.K. Department of Health; Scottish Government; Merck Serono; Medical Research Council [G0900580, G0600953] Funding Source: researchfish; MRC [G0600953, G0900580] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173, R01NS078745, R42NS079060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PrioNet Canada; Italian Ministry of Health(Ministry of Health, Italy); Associazione Italiana Encefalopatie da Prioni; Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Charles S. Britton Fund; U.K. Department of Health; Scottish Government; Merck Serono(Merck & Company); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by grants from the National Institutes of Health (P01AI077774, R42NS079060, R01NS049173, and R01NS078745, to Dr. Soto), PrioNet Canada and Merck Serono (to Dr. Soto), the Italian Ministry of Health, Associazione Italiana Encefalopatie da Prioni, and Ministero dell'Universita e della Ricerca (RBAP11FRE9, to Dr. Tagliavini), the Charles S. Britton Fund (P01AG14359, to Dr. Gambetti), and the U.K. Department of Health and the Scottish Government (to Drs. Ironside and Knight).	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; [Anonymous], 2004, NAT REV MICROBIOL, V2, P809; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Brandner S, 2008, PHILOS T R SOC B, V363, P3755, DOI 10.1098/rstb.2008.0091; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Gill ON, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5675; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Gregori L, 2008, EMERG INFECT DIS, V14, P1406, DOI 10.3201/eid1409.080259; Haley NJ, 2011, J VIROL, V85, P6309, DOI 10.1128/JVI.00425-11; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Hill AF, 2003, BRIT MED BULL, V66, P161, DOI 10.1093/bmb/66.1.161; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Morales R, 2012, NAT PROTOC, V7, P1397, DOI 10.1038/nprot.2012.067; Murayama Y, 2007, J GEN VIROL, V88, P2890, DOI 10.1099/vir.0.82786-0; Newman PK, 2014, J NEUROL NEUROSURG P; Notari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008765; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Seeger H, 2005, SCIENCE, V310, P324, DOI 10.1126/science.1118829; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8	34	119	125	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					530	539		10.1056/NEJMoa1404401	http://dx.doi.org/10.1056/NEJMoa1404401			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25099577	Green Published, Green Accepted			2022-12-28	WOS:000339899100007
J	Orru, CD; Bongianni, M; Tonoli, G; Ferrari, S; Hughson, AG; Groveman, BR; Fiorini, M; Pocchiari, M; Monaco, S; Caughey, B; Zanusso, G				Orru, Christina D.; Bongianni, Matilde; Tonoli, Giovanni; Ferrari, Sergio; Hughson, Andrew G.; Groveman, Bradley R.; Fiorini, Michele; Pocchiari, Maurizio; Monaco, Salvatore; Caughey, Byron; Zanusso, Gianluigi			A Test for Creutzfeldt-Jakob Disease Using Nasal Brushings	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUAKING-INDUCED CONVERSION; RECOMBINANT PRION PROTEIN; CHRONIC WASTING DISEASE; CEREBROSPINAL-FLUID; OLFACTORY EPITHELIUM; MAMMALIAN PRIONS; DIAGNOSIS; TRANSMISSION; CRITERIA; SCRAPIE	BACKGROUND Definite diagnosis of sporadic Creutzfeldt-Jakob disease in living patients remains a challenge. A test that detects the specific marker for Creutzfeldt-Jakob disease, the prion protein (PrPCJD), by means of real-time quaking-induced conversion (RT-QuIC) testing of cerebrospinal fluid has a sensitivity of 80 to 90% for the diagnosis of sporadic Creutzfeldt-Jakob disease. We have assessed the accuracy of RT-QuIC analysis of nasal brushings from olfactory epithelium in diagnosing sporadic Creutzfeldt-Jakob disease in living patients. METHODS We collected olfactory epithelium brushings and cerebrospinal fluid samples from patients with and patients without sporadic Creutzfeldt-Jakob disease and tested them using RT-QuIC, an ultrasensitive, multiwell plate-based fluorescence assay involving PrPCJD-seeded polymerization of recombinant PrP into amyloid fibrils. RESULTS The RT-QuIC assays seeded with nasal brushings were positive in 30 of 31 patients with Creutzfeldt-Jakob disease (15 of 15 with definite sporadic Creutzfeldt-Jakob disease, 13 of 14 with probable sporadic Creutzfeldt-Jakob disease, and 2 of 2 with inherited Creutzfeldt-Jakob disease) but were negative in 43 of 43 patients without Creutzfeldt-Jakob disease, indicating a sensitivity of 97% (95% confidence interval [CI], 82 to 100) and specificity of 100% (95% CI, 90 to 100) for the detection of Creutzfeldt-Jakob disease. By comparison, testing of cerebrospinal fluid samples from the same group of patients had a sensitivity of 77% (95% CI, 57 to 89) and a specificity of 100% (95% CI, 90 to 100). Nasal brushings elicited stronger and faster RT-QuIC responses than cerebrospinal fluid (P<0.001 for the between-group comparison of strength of response). Individual brushings contained approximately 105 to 107 prion seeds, at concentrations several logs 10 greater than in cerebrospinal fluid. CONCLUSIONS In this preliminary study, RT-QuIC testing of olfactory epithelium samples obtained from nasal brushings was accurate in diagnosing Creutzfeldt-Jakob disease and indicated substantial prion seeding activity lining the nasal vault.	[Orru, Christina D.; Bongianni, Matilde; Hughson, Andrew G.; Groveman, Bradley R.; Caughey, Byron] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Orru, Christina D.] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Bongianni, Matilde; Ferrari, Sergio; Fiorini, Michele; Monaco, Salvatore; Zanusso, Gianluigi] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy; [Tonoli, Giovanni] Azienda Osped Univ Integrata, Policlin GB Rossi, Clin Otorinolaringoiatr, Verona, Italy; [Pocchiari, Maurizio] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cagliari; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Istituto Superiore di Sanita (ISS)	Caughey, B (corresponding author), NIAID, Rocky Mt Labs, 903 S 4th St, Hamilton, MT 59840 USA.	bcaughey@nih.gov; gianluigi.zanusso@univr.it	Zanusso, Gianluigi/K-2823-2018; Monaco, Salvatore/K-4659-2018; Ferrari, Sergio/AAE-5649-2019; Pocchiari, Maurizio/J-8443-2018	Zanusso, Gianluigi/0000-0001-5199-6264; Monaco, Salvatore/0000-0003-3191-8597; Pocchiari, Maurizio/0000-0002-7269-2486; ferrari, sergio/0000-0003-3855-5135; Fiorini, Michele/0000-0002-5339-8716	National Institute of Allergy and Infectious Diseases (NIAID); Fondazione Cariverona (Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi); Italian Ministry of Health [RF2009-1474758]; Creutzfeldt-Jakob Disease Foundation; Programma Master and Back-Percorsi di rientro [PRR-MAB-A2011-19199]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001086] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fondazione Cariverona (Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi); Italian Ministry of Health(Ministry of Health, Italy); Creutzfeldt-Jakob Disease Foundation; Programma Master and Back-Percorsi di rientro; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIAID), by a grant from Fondazione Cariverona (Disabilita cognitiva e comportamentale nelle demenze e nelle psicosi, to Dr. Monaco), by a grant from the Italian Ministry of Health (RF2009-1474758, to Drs. Zanusso and Pocchiari), by a grant from the Creutzfeldt-Jakob Disease Foundation (to Dr. Orru), by a fellowship from Programma Master and Back-Percorsi di rientro (PRR-MAB-A2011-19199, to Dr. Orru), and by donations to the NIAID Gift Fund from Mary Hilderman Smith, Zoe Smith Jaye, and Jenny Smith Unruh, in memory of Jeffrey Smith.	Atarashi R, 2011, NAT MED, V17, P175, DOI 10.1038/nm.2294; Bessen RA, 2012, J VIROL, V86, P1777, DOI 10.1128/JVI.06626-11; Bessen RA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000837; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Brown P, 2012, EMERG INFECT DIS, V18, P901, DOI 10.3201/eid1806.120116; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Cummings JL, 2013, MED CLIN N AM, V97, P363, DOI 10.1016/j.mcna.2013.01.001; Deleault NR, 2008, P NATL ACAD SCI USA, V105, P12636, DOI 10.1073/pnas.0807173105; Denkers ND, 2013, J VIROL, V87, P1890, DOI 10.1128/JVI.02852-12; Denkers ND, 2010, J GEN VIROL, V91, P1651, DOI 10.1099/vir.0.017335-0; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Haybaeck J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001257; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Jones M, 2011, ACTA NEUROPATHOL, V121, P135, DOI 10.1007/s00401-010-0708-8; Kim JI, 2010, J BIOL CHEM, V285, P14083, DOI 10.1074/jbc.C110.113464; Kincaid AE, 2007, J VIROL, V81, P4482, DOI 10.1128/JVI.02649-06; Kincaid AE, 2012, J VIROL, V86, P12731, DOI 10.1128/JVI.01930-12; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Krasnianski A, 2006, BRAIN, V129, P2288, DOI 10.1093/brain/awl123; Ladogana A, 2005, NEUROLOGY, V64, P1586, DOI 10.1212/01.WNL.0000160117.56690.B2; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; McGuire LI, 2012, ANN NEUROL, V72, P278, DOI 10.1002/ana.23589; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Orru CD, 2012, J CLIN MICROBIOL, V50, P1464, DOI 10.1128/JCM.06099-11; Parchi P, 2012, ACTA NEUROPATHOL, V124, P517, DOI 10.1007/s00401-012-1002-8; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Puoti G, 2012, LANCET NEUROL, V11, P618, DOI 10.1016/S1474-4422(12)70063-7; Respondek G, 2013, MOVEMENT DISORD, V28, P504, DOI 10.1002/mds.25327; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Tabaton M, 2004, ANN NEUROL, V55, P294, DOI 10.1002/ana.20038; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Zanusso G, 2003, NEW ENGL J MED, V348, P711, DOI 10.1056/NEJMoa022043; Zerr I, 2012, BRAIN, V135, P1335, DOI 10.1093/brain/awr029	37	215	225	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					519	529		10.1056/NEJMoa1315200	http://dx.doi.org/10.1056/NEJMoa1315200			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25099576	Green Accepted			2022-12-28	WOS:000339899100006
J	Kagihara, JM; Brahmbhatt, NM; Paladino, J				Kagihara, Jamie M.; Brahmbhatt, Nishal M.; Paladino, Jonathan			A fatal pasteurella empyema	LANCET			English	Editorial Material							MULTOCIDA		[Kagihara, Jamie M.; Brahmbhatt, Nishal M.; Paladino, Jonathan] John A Burns Sch Med, Honolulu, HI 96813 USA		Paladino, J (corresponding author), John A Burns Sch Med, Dept Med, 1356 Lusitana St,Suite 700, Honolulu, HI 96813 USA.	drpaladino@yahoo.com						Breen D, 2000, PATHOLOGY, V32, P152, DOI 10.1080/003130200104448; Grijalva CG, 2011, THORAX, V66, P663, DOI 10.1136/thx.2010.156406; Luh SP, 2005, CHEST, V127, P1427, DOI 10.1378/chest.127.4.1427; Sianhandou T, 2012, PEDIATR INFECT DIS J, V31, P536; WEBER DJ, 1984, MEDICINE, V63, P133, DOI 10.1097/00005792-198405000-00001	5	3	4	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 2	2014	384	9941					468	468		10.1016/S0140-6736(14)60922-3	http://dx.doi.org/10.1016/S0140-6736(14)60922-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9IV	25088857				2022-12-28	WOS:000340195800029
J	Schich, M; Song, CM; Ahn, YY; Mirsky, A; Martino, M; Barabasi, AL; Helbing, D				Schich, Maximilian; Song, Chaoming; Ahn, Yong-Yeol; Mirsky, Alexander; Martino, Mauro; Barabasi, Albert-Laszlo; Helbing, Dirk			A network framework of cultural history	SCIENCE			English	Article								The emergent processes driving cultural history are a product of complex interactions among large numbers of individuals, determined by difficult-to-quantify historical conditions. To characterize these processes, we have reconstructed aggregate intellectual mobility over two millennia through the birth and death locations of more than 150,000 notable individuals. The tools of network and complexity theory were then used to identify characteristic statistical patterns and determine the cultural and historical relevance of deviations. The resulting network of locations provides a macroscopic perspective of cultural history, which helps us to retrace cultural narratives of Europe and North America using large-scale visualization and quantitative dynamical tools and to derive historical trends of cultural centers beyond the scope of specific events or narrow time intervals.	[Schich, Maximilian] Univ Texas Dallas, Sch Arts & Humanities, Richardson, TX 75080 USA; [Schich, Maximilian; Mirsky, Alexander; Helbing, Dirk] ETH, Chair Sociol Particular Modeling & Simulat SOMS, CH-8092 Zurich, Switzerland; [Schich, Maximilian; Martino, Mauro; Barabasi, Albert-Laszlo] Northeastern Univ, Dept Phys Biol & Comp Sci, Ctr Complex Network Res, Boston, MA 02115 USA; [Song, Chaoming] Univ Miami, Dept Phys, Coral Gables, FL 33146 USA; [Ahn, Yong-Yeol] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Barabasi, Albert-Laszlo] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Barabasi, Albert-Laszlo] Cent European Univ, Ctr Network Sci, H-1052 Budapest, Hungary	University of Texas System; University of Texas Dallas; Swiss Federal Institutes of Technology Domain; ETH Zurich; Northeastern University; University of Miami; Indiana University System; Indiana University Bloomington; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Central European University	Schich, M (corresponding author), Univ Texas Dallas, Sch Arts & Humanities, Richardson, TX 75080 USA.	maximilian.schich@utdallas.edu	Ahn, Yong-Yeol/C-6334-2011; Barabasi, Albert-Laszlo/S-6474-2017	Ahn, Yong-Yeol/0000-0002-4352-4301; Barabasi, Albert/0000-0002-4028-3522	German Research Foundation (DFG) [SCHI 1065/2-1]; European Research Council [324247]	German Research Foundation (DFG)(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	We are grateful to Verlag Walther De Gruyter (AKL), The Getty Research Institute (ULAN), and Biering and Brinkmann (WCEN) for making data available to us and for allowing all data needed to replicate the conclusions of the paper to be available as SM. We furthermore thank our collaborators at Barab siLab and ETH SOMS for discussions and comments on the manuscript. The work of M.S. was partially supported by German Research Foundation (DFG) grant (no. SCHI 1065/2-1) and The University of Texas at Dallas Arts and Technology (ATEC) Fellowship no. 1. D. H. is grateful for partial support by the European Research Council Advanced Investigator Grant "Momentum" (grant no. 324247).	Abel GJ, 2014, SCIENCE, V343, P1520, DOI 10.1126/science.1248676; [Anonymous], 2009, GOOGL NGRAM ENGL DAT; Batty M, 2006, NATURE, V444, P592, DOI 10.1038/nature05302; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Beyer A., 2010, ALLGEMEINES KUNSTLER; Beyer A., 1991, ALLGEMEINES KUNSTLER; Bianconi G, 2001, PHYS REV LETT, V86, P5632, DOI 10.1103/PhysRevLett.86.5632; Blumm N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128701; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Carneiro R. L., 2000, MUSE HIST SCI CULTUR; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Freebase.com, 2011, COMM CUR DAT WELL KN; Getty Vocabulary Program, 2010, UN LIST ART NAM; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Heaps Harold Stanley, 1978, INFORM RETRIEVAL COM; KEIDING N, 1990, PHILOS T ROY SOC A, V332, P487, DOI 10.1098/rsta.1990.0128; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Ravenstein E.G., 1885, J ROY STAT SOC, V48, P167, DOI [DOI 10.2307/2979333, 10.2307/2979181, 10.2307/2979333]; Ravenstein E.G., 1885, J STAT SOC LONDON, V48, P167; Ren P., 2011, LIFETIME MOBILITY US; Song CM, 2010, NAT PHYS, V6, P818, DOI 10.1038/NPHYS1760; Spinney L, 2012, NATURE, V488, P24, DOI 10.1038/488024a; Thieme Ulrich, 1907, ALLGEMEINES LEXIKON; Thieme Ulrich, 1907, ALLGEMEINES LEXIKON; Vollmer H., 1980, ALLGEMEINES LEXIKON; Vollmer H., 1962, ALLGEMEINES LEXIKON; Vollmer H., 1953, ALLGEMEINES LEXIKON; White D. R., 2007, GLOBALIZATION EVOLUT, P190; Winckelmann-Gesellschaft Stendal, 2000, CORPUS ANTIKEN DENKM; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	33	85	92	12	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					558	562		10.1126/science.1240064	http://dx.doi.org/10.1126/science.1240064			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AM2AU	25082701				2022-12-28	WOS:000339651300044
J	Brouwer, MC; Tunkel, AR; McKhann, GM; van de Beek, D				Brouwer, Matthijs C.; Tunkel, Allan R.; McKhann, Guy M., II; van de Beek, Diederik			Brain Abscess	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ORGAN TRANSPLANT RECIPIENTS; CENTRAL-NERVOUS-SYSTEM; CYSTIC MASS LESIONS; BACTERIAL-MENINGITIS; CEREBRAL ABSCESSES; MANAGEMENT; TUBERCULOSIS; THERAPY; SURGERY		[Brouwer, Matthijs C.; van de Beek, Diederik] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; [Tunkel, Allan R.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [McKhann, Guy M., II] Columbia Univ, Dept Neurol Surg, Neurol Inst, New York, NY USA	University of Amsterdam; Academic Medical Center Amsterdam; Brown University; Columbia University	van de Beek, D (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, Dept Neurol, POB 22660, NL-1100 DD Amsterdam, Netherlands.	d.vandebeek@amc.uva.nl	van de Beek, Diederik/Y-2713-2019	van de Beek, Diederik/0000-0002-4571-044X; Brouwer, Matthijs/0000-0001-7775-7843				Al Masalma M, 2012, CLIN INFECT DIS, V54, P202, DOI 10.1093/cid/cir797; Al Masalma M, 2009, CLIN INFECT DIS, V48, P1169, DOI 10.1086/597578; [Anonymous], 2000, BR J NEUROSURG, V14, P525; Baddley JW, 2002, CLIN TRANSPLANT, V16, P419, DOI 10.1034/j.1399-0012.2002.02033.x; Barlas O, 1999, SURG NEUROL, V52, P404, DOI 10.1016/S0090-3019(99)00118-4; BRITT RH, 1981, J NEUROSURG, V55, P590, DOI 10.3171/jns.1981.55.4.0590; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; Carpenter J, 2007, EUR J CLIN MICROBIOL, V26, P1, DOI 10.1007/s10096-006-0236-6; Carroll MW, 2013, ANTIMICROB AGENTS CH, V57, P3903, DOI 10.1128/AAC.00753-13; Chuang MJ, 2010, J NEUROL NEUROSUR PS, V81, P913, DOI 10.1136/jnnp.2009.195073; DiGiulio DB, 2009, CLIN INFECT DIS, V48, P1179, DOI 10.1086/597579; Ferreyra MC, 2013, MAYO CLIN PROC, V88, P422, DOI 10.1016/j.mayocp.2013.02.001; Vives CHG, 2009, J NEUROSURG, V111, P306, DOI 10.3171/2008.10.JNS08918; Gutierrez-Cuadra M, 2009, REV ESP QUIM, V22, P201; Hayashi K, 2012, NEUROL MED-CHIR, V52, P165, DOI 10.2176/nmc.52.165; Helweg-Larsen J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-332; Jim KK, 2012, J INFECTION, V64, P236, DOI 10.1016/j.jinf.2011.11.011; Kutlay M, 2008, NEUROSURGERY, V62, P540, DOI [10.1227/01.NEU.0000186012.95462.E5, 10.1227/01.neu.0000316257.21478.5b]; Lai PH, 2007, SURG NEUROL, V68, pS25, DOI 10.1016/j.surneu.2007.07.080; MAMELAK AN, 1995, NEUROSURGERY, V36, P76, DOI 10.1227/00006123-199501000-00010; Martin-Canal G, 2010, INT J ANTIMICROB AG, V35, P301, DOI 10.1016/j.ijantimicag.2009.11.012; Mathis S, 2012, CLIN NEUROL NEUROSUR, V114, P235, DOI 10.1016/j.clineuro.2011.10.036; Nathoo N, 2011, WORLD NEUROSURG, V75, P716, DOI 10.1016/j.wneu.2010.11.043; Nelson CA, 2011, CLIN INFECT DIS, V53, P915, DOI 10.1093/cid/cir508; NICOLOSI A, 1991, NEUROEPIDEMIOLOGY, V10, P122, DOI 10.1159/000110257; Reddy JS, 2006, SURG NEUROL, V66, P246, DOI 10.1016/j.surneu.2006.03.032; ROSENBLUM ML, 1980, J NEUROSURG, V52, P217, DOI 10.3171/jns.1980.52.2.0217; Schwartz S, 2005, BLOOD, V106, P2641, DOI 10.1182/blood-2005-02-0733; Selby R, 1997, ARCH SURG-CHICAGO, V132, P304; SHAW MDM, 1975, J NEUROL NEUROSUR PS, V38, P429, DOI 10.1136/jnnp.38.5.429; Shen H, 2011, BRIT J NEUROSURG, V25, P636, DOI 10.3109/02688697.2010.534201; Skoutelis AT, 2000, EUR J CLIN MICROBIOL, V19, P332, DOI 10.1007/s100960050489; Tan IL, 2012, LANCET NEUROL, V11, P605, DOI 10.1016/S1474-4422(12)70098-4; Thwaites GE, 2013, LANCET NEUROL, V12, P999, DOI 10.1016/S1474-4422(13)70168-6; Tremont-Lukats IW, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004424.pub2; Tunkel AR, 2010, PRINCIPLES PRACTICE, P1265; van de Beek D, 2010, NEW ENGL J MED, V362, P146, DOI 10.1056/NEJMra0804573; Yang KY, 2006, INFECTION, V34, P247, DOI 10.1007/s15010-006-5607-5	38	225	238	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					447	456		10.1056/NEJMra1301635	http://dx.doi.org/10.1056/NEJMra1301635			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0SK	25075836				2022-12-28	WOS:000339556900009
J	Mannstadt, M; Lin, AE; Le, LP				Mannstadt, Michael; Lin, Angela E.; Le, Long P.			Case 24-2014: A 27-Year-Old Man with Severe Osteoporosis and Multiple Bone Fractures	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OSTEOGENESIS IMPERFECTA; TERIPARATIDE TREATMENT; ADULTS		[Mannstadt, Michael] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Lin, Angela E.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Le, Long P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Mannstadt, Michael] Harvard Univ, Sch Med, Endocrine Unit, Boston, MA USA; [Lin, Angela E.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Le, Long P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mannstadt, M (corresponding author), Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA.		Mannstadt, Michael/AAO-1124-2020	Mannstadt, Michael/0000-0003-0867-9778				Adami S, 2003, J BONE MINER RES, V18, P126, DOI 10.1359/jbmr.2003.18.1.126; ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; Byers PH, 2006, GENET MED, V8, P383, DOI 10.1097/01.gim.0000223557.54670.aa; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Gatti D, 2013, CALCIFIED TISSUE INT, V93, P448, DOI 10.1007/s00223-013-9770-2; Harbuz R, 2013, AM J MED GENET A, V161, P2504, DOI 10.1002/ajmg.a.36122; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Krassas GE, 2000, ANN NY ACAD SCI, V900, P409; Manning M, 2010, GENET MED, V12, P742, DOI 10.1097/GIM.0b013e3181f8baad; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Orwoll ES, 2014, J CLIN INVEST, V124, P491, DOI 10.1172/JCI71101; SCHMICKEL RD, 1986, J PEDIATR-US, V109, P231, DOI 10.1016/S0022-3476(86)80377-8; Shapiro JR, 2010, CALCIFIED TISSUE INT, V87, P120, DOI 10.1007/s00223-010-9383-y; van Dijk FS, 2010, GENET MED, V12, P736, DOI 10.1097/GIM.0b013e3181f01617	14	7	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					465	472		10.1056/NEJMcpc1404139	http://dx.doi.org/10.1056/NEJMcpc1404139			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0SK	25075839				2022-12-28	WOS:000339556900013
J	Russell, R; Matouschek, A				Russell, Rick; Matouschek, Andreas			Chance, Destiny, and the Inner Workings of ClpXP	CELL			English	Editorial Material							AAA; TRANSLOCATION; PROTEASES; MACHINE; RING	AAA+ proteases are responsible for protein degradation in all branches of life. Using single-molecule and ensemble assays, Cordova et al. investigate how the bacterial protease ClpXP steps through a substrate's polypeptide chain and construct a quantitative kinetic model that recapitulates the interplay between stochastic and deterministic behaviors of ClpXP.	[Russell, Rick; Matouschek, Andreas] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Russell, Rick; Matouschek, Andreas] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Russell, R (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	rick_russell@cm.utexas.edu; matouschek@austin.utexas.edu	Matouschek, Andreas/L-9379-2013	Matouschek, Andreas/0000-0001-6016-2341	NIGMS NIH HHS [U54 GM105816, R01 GM070456] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070456, U54GM105816] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Nyquist K, 2014, TRENDS BIOCHEM SCI, V39, P53, DOI 10.1016/j.tibs.2013.11.003; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Stinson BM, 2013, CELL, V153, P628, DOI 10.1016/j.cell.2013.03.029	9	2	2	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					479	480		10.1016/j.cell.2014.07.009	http://dx.doi.org/10.1016/j.cell.2014.07.009			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083864	Bronze, Green Accepted			2022-12-28	WOS:000340944300003
J	McCartney, M				McCartney, Margaret			NHS Health Check betrays the ethos of public health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				NHS Choices, WHY SHOULD I HAV NHS; NHS Choices, YOUR NHS HLTH CHECK	2	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2014	349								g4752	10.1136/bmj.g4752	http://dx.doi.org/10.1136/bmj.g4752			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VN	25099727	Green Published, Bronze			2022-12-28	WOS:000339565700012
J	Ryan, C; Menter, A				Ryan, Caitriona; Menter, Alan			Ponesimod-a future oral therapy for psoriasis?	LANCET			English	Editorial Material							S1P(1) RECEPTOR MODULATOR; SEVERE PLAQUE PSORIASIS; MULTIPLE-SCLEROSIS; OPEN-LABEL; TRIAL; PHARMACOKINETICS; FINGOLIMOD; SAFETY		[Menter, Alan] Baylor Univ, Med Ctr, Dept Dermatol, Dallas, TX 75246 USA; Texas A&M Hlth Sci Ctr, Dallas, TX 75246 USA	Baylor University; Baylor University Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Menter, A (corresponding author), Baylor Univ, Med Ctr, Dept Dermatol, Dallas, TX 75246 USA.	amderm@gmail.com		Ryan, Caitriona/0000-0003-1915-546X				Barker J, 2011, BRIT J DERMATOL, V165, P1109, DOI 10.1111/j.1365-2133.2011.10615.x; Brossard P, 2014, J CLIN PHARMACOL, V54, P179, DOI 10.1002/jcph.244; Brossard P, 2013, BRIT J CLIN PHARMACO, V76, P888, DOI 10.1111/bcp.12129; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Laroni A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-65; Liu GW, 2014, J IMMUNOL, V192, P3068, DOI 10.4049/jimmunol.1301193; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Menter A, 2008, J AM ACAD DERMATOL, V58, P826, DOI 10.1016/j.jaad.2008.02.039; Menter A, 2007, J AM ACAD DERMATOL, V56, P31, DOI 10.1016/j.jaad.2006.07.017; Olsson T, 2014, J NEUROL NEUROSUR PS, V85, P1198, DOI 10.1136/jnnp-2013-307282; Papp K, 2014, J AM ACAD DERMATOL, V70, pAB164; Paul C, 2014, J AM ACAD DERMATO S1, V70, pAB164; Reyes M, 2014, EUR J CLIN PHARMACOL, V70, P287, DOI 10.1007/s00228-013-1625-2; Ryan C, 2011, JAMA-J AM MED ASSOC, V306, P864, DOI 10.1001/jama.2011.1211; US Food and Drug Administration, FDA DRUG SAF COMM RE; Vaclavkova A, 2014, LANCET	16	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2006	2008		10.1016/S0140-6736(14)61039-4	http://dx.doi.org/10.1016/S0140-6736(14)61039-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BD	25127207				2022-12-28	WOS:000346353600008
J	Block, JP; Roberto, CA				Block, Jason P.; Roberto, Christina A.			Potential Benefits of Calorie Labeling in Restaurants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHAIN RESTAURANTS		[Block, Jason P.] Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Obes Prevent Program,Dept Populat Med, Boston, MA 02215 USA; [Roberto, Christina A.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Dept Social & Behav Sci, Boston, MA 02215 USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Block, JP (corresponding author), Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Dept Populat Med, 133 Brookline Ave,Sixth Floor, Boston, MA 02215 USA.	jblock1@partners.org			NHLBI NIH HHS [1K23HL111211-01A1, K23 HL111211] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL111211] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Auchincloss AH, 2013, AM J PREV MED, V45, P710, DOI 10.1016/j.amepre.2013.07.014; Bollinger B, 2011, AM ECON J-ECON POLIC, V3, P91, DOI 10.1257/pol.3.1.91; Bruemmer B, 2012, J ACAD NUTR DIET, V112, P1169, DOI 10.1016/j.jand.2012.04.019; Bruni, 2013, NEW YORK TIMES; Clifford Gay, 1977, NEW YORK TIMES; Dumanovsky Tamara, 2011, BMJ, V343, pd4464, DOI 10.1136/bmj.d4464; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Morain S, 2013, HEALTH AFFAIR, V32, P486, DOI 10.1377/hlthaff.2012.0609	8	30	30	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 3	2014	312	9					887	888		10.1001/jama.2014.9239	http://dx.doi.org/10.1001/jama.2014.9239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO9IE	25077460	Green Accepted			2022-12-28	WOS:000341668600012
J	Chen, L; Durr, KL; Gouaux, E				Chen, Lei; Duerr, Katharina L.; Gouaux, Eric			X-ray structures of AMPA receptor-cone snail toxin complexes illuminate activation mechanism	SCIENCE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; LIGAND-BINDING CORE; CONFORMATIONAL-CHANGES; ION-CHANNEL; KAINATE; DESENSITIZATION; CYCLOTHIAZIDE; ARCHITECTURE; MUTATION; NEURONS	AMPA-sensitive glutamate receptors are crucial to the structural and dynamic properties of the brain, to the development and function of the central nervous system, and to the treatment of neurological conditions from depression to cognitive impairment. However, the molecular principles underlying AMPA receptor activation have remained elusive. We determined multiple x-ray crystal structures of the GluA2 AMPA receptor in complex with a Conus striatus cone snail toxin, a positive allosteric modulator, and orthosteric agonists, at 3.8 to 4.1 angstrom resolution. We show how the toxin acts like a straightjacket on the ligand-binding domain (LBD) "gating ring," restraining the domains via both intra-and interdimer cross-links such that agonist-induced closure of the LBD "clamshells" is transduced into an irislike expansion of the gating ring. By structural analysis of activation-enhancing mutants, we show how the expansion of the LBD gating ring results in pulling forces on the M3 helices that, in turn, are coupled to ion channel gating.	[Chen, Lei; Duerr, Katharina L.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Gouaux, Eric/Y-4370-2019; Duerr, Katharina/A-6975-2015	Gouaux, Eric/0000-0002-8549-2360; Chen, Lei/0000-0002-7619-8311; Duerr, Katharina/0000-0002-3245-4088	American Heart Association [13POST13960004]; Long-Term Fellowship of European Molecular Biology Organization; institutional National Research Service Award (NRSA); NRSA [F32MH100331]; NIH; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH100331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038631, R37NS038631] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Long-Term Fellowship of European Molecular Biology Organization; institutional National Research Service Award (NRSA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	All members of the Gouaux laboratory and I. Baconguis are gratefully acknowledged for their support and assistance. We thank L. Vaskalis for assistance with figures, the beam line staff at Advanced Light Source-Berkeley Center for Structural Biology and Stanford Synchrotron Radiation Lightsource 12-2 for their support during data collection, B. Olivera for providing crude Conus striatus venom, D. King and L. David for mass spectrum analysis, and M. Suga for early work on thermostability mutation screening. L. C. is supported by an American Heart Association postdoctoral fellowship (13POST13960004). K. L. D. was supported by a Long-Term Fellowship of the European Molecular Biology Organization and an institutional National Research Service Award (NRSA) and is currently a recipient of an individual NRSA (F32MH100331). This work is supported by the NIH (E. G.), and E. G. is an investigator with the Howard Hughes Medical Institute. The coordinates have been deposited in the PDB with codes 4U5B, 4U5C, 4U5D, 4U5E, and 4U5F for the GluA2 receptor toxin complex and codes 4U5G and 4U5H for the isolated toxin. L. C. contributed to all aspects of the research; K. L. D. contributed to thermostabilization mutation screening and initial characterization of native snail venom by two-electrode voltage clamp. E. G. directed the research. All authors contributed to the preparation of the manuscript.	Ahmed AH, 2011, J BIOL CHEM, V286, P35257, DOI 10.1074/jbc.M111.269001; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kaae BH, 2007, CHEM BIOL, V14, P1294, DOI 10.1016/j.chembiol.2007.10.012; Kazi R, 2014, NAT NEUROSCI, V17, P914, DOI 10.1038/nn.3724; Kumar J, 2013, ANNU REV PHYSIOL, V75, P313, DOI 10.1146/annurev-physiol-030212-183711; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Lau AY, 2013, NEURON, V79, P492, DOI 10.1016/j.neuron.2013.06.003; Lee CH, 2014, NATURE, V511, P191, DOI 10.1038/nature13548; Moore BS, 2013, J BIOL CHEM, V288, P18842, DOI 10.1074/jbc.M113.465187; O'Neill MJ, 2004, CNS NEUROL DISORD-DR, V3, P181, DOI 10.2174/1568007043337508; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; RAMAN IM, 1992, NEURON, V9, P173, DOI 10.1016/0896-6273(92)90232-3; Rogawski MA, 2013, ACTA NEUROL SCAND, V127, P9, DOI 10.1111/ane.12099; Sobolevsky AI, 2004, NEURON, V41, P367, DOI 10.1016/S0896-6273(04)00008-X; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Walker CS, 2009, CURR BIOL, V19, P900, DOI 10.1016/j.cub.2009.05.017; Wollmuth LP, 2000, J NEUROSCI, V20, P5973, DOI 10.1523/JNEUROSCI.20-16-05973.2000; Zuo J, 1997, NATURE, V388, P769, DOI 10.1038/42009	29	87	89	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 29	2014	345	6200					1021	1026		10.1126/science.1258409	http://dx.doi.org/10.1126/science.1258409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8RE	25103405	Green Accepted			2022-12-28	WOS:000340870900031
J	Zipkin, DA; Umscheid, CA; Keating, NL; Allen, E; Aung, K; Beyth, R; Kaatz, S; Mann, DM; Sussman, JB; Korenstein, D; Schardt, C; Nagi, A; Sloane, R; Feldstein, DA				Zipkin, Daniella A.; Umscheid, Craig A.; Keating, Nancy L.; Allen, Elizabeth; Aung, Koko; Beyth, Rebecca; Kaatz, Scott; Mann, Devin M.; Sussman, Jeremy B.; Korenstein, Deborah; Schardt, Connie; Nagi, Avishek; Sloane, Richard; Feldstein, David A.			Evidence-Based Risk Communication A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; BREAST-CANCER RISKS; DECISION-MAKING; PRESENTING RISK; RELATIVE RISK; QUANTITATIVE INFORMATION; FRAMING INFORMATION; INFORMING PATIENTS; DIFFERENT FORMATS; PATIENT RECALL	Background: Effective communication of risks and benefits to patients is critical for shared decision making. Purpose: To review the comparative effectiveness of methods of communicating probabilistic information to patients that maximize their cognitive and behavioral outcomes. Data Sources: PubMed (1966 to March 2014) and CINAHL, EMBASE, and the Cochrane Central Register of Controlled Trials (1966 to December 2011) using several keywords and structured terms. Study Selection: Prospective or cross-sectional studies that recruited patients or healthy volunteers and compared any method of communicating probabilistic information with another method. Data Extraction: Two independent reviewers extracted study characteristics and assessed risk of bias. Data Synthesis: Eighty-four articles, representing 91 unique studies, evaluated various methods of numerical and visual risk display across several risk scenarios and with diverse outcome measures. Studies showed that visual aids (icon arrays and bar graphs) improved patients' understanding and satisfaction. Presentations including absolute risk reductions were better than those including relative risk reductions for maximizing accuracy and seemed less likely than presentations with relative risk reductions to influence decisions to accept therapy. The presentation of numbers needed to treat reduced understanding. Comparative effects of presentations of frequencies (such as 1 in 5) versus event rates (percentages, such as 20%) were inconclusive. Limitation: Most studies were small and highly variable in terms of setting, context, and methods of administering interventions. Conclusion: Visual aids and absolute risk formats can improve patients' understanding of probabilistic information, whereas numbers needed to treat can lessen their understanding. Due to study heterogeneity, the superiority of any single method for conveying probabilistic information is not established, but there are several good options to help clinicians communicate with patients.	[Zipkin, Daniella A.] Duke Univ, Med Ctr, Durham, NC 27710 USA; [Umscheid, Craig A.] Univ Penn, Ctr Evidence Based Practice, Philadelphia, PA 19104 USA; [Keating, Nancy L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Allen, Elizabeth] Portland VA Med Ctr, Portland, OR 97207 USA; [Aung, Koko] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Beyth, Rebecca] North Florida South Georgia Vet Hlth Syst, Geriatric Res Educ & Clin Ctr T2 182, Gainesville, FL 32608 USA; [Kaatz, Scott] Hurley Med Ctr, Flint, MI 48503 USA; [Mann, Devin M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Sussman, Jeremy B.] Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Korenstein, Deborah] Amer Coll Physicians, Philadelphia, PA 19106 USA; [Schardt, Connie] Univ N Carolina, Sch Lib & Informat Sci, Chapel Hill, NC 27599 USA; [Nagi, Avishek] Vet Affairs Med Ctr, Durham, NC 27705 USA; [Sloane, Richard] Duke Univ, Med Ctr, Ctr Study Aging, Durham, NC 27710 USA; [Feldstein, David A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53705 USA	Duke University; University of Pennsylvania; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; Boston University; American College of Physicians; University of North Carolina; University of North Carolina Chapel Hill; US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; University of Wisconsin System; University of Wisconsin Madison	Zipkin, DA (corresponding author), Duke Univ, Med Ctr, Box 2992, Durham, NC 27710 USA.	daniella.zipkin@duke.edu	Keating, Nancy L/I-9968-2019; Sussman, Jeremy/W-3394-2019; Aung, KoKo/I-1236-2019	Keating, Nancy L/0000-0002-8274-4681; Sussman, Jeremy/0000-0002-2158-3618; Mann, Devin/0000-0002-2099-0852; Umscheid, Craig/0000-0003-1853-1013; Aung, KoKo/0000-0002-3152-0610				Ahmed H, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3996; Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006776.pub2; Almashat S, 2008, PATIENT EDUC COUNS, V71, P102, DOI 10.1016/j.pec.2007.11.004; Alston C., 2012, COMMUNICATING PATIEN; Ancker JS, 2006, J AM MED INFORM ASSN, V13, P608, DOI 10.1197/jamia.M2115; Ancker JS, 2011, MED DECIS MAKING, V31, P130, DOI 10.1177/0272989X10364847; [Anonymous], WHAT IS SHAR DEC MAK; Armstrong K, 2002, MED DECIS MAKING, V22, P76, DOI 10.1177/02729890222062946; Astley CM, 2008, HEART LUNG CIRC, V17, P25, DOI 10.1016/j.hlc.2007.04.008; Barilli E, 2010, HEALTH RISK SOC, V12, P546, DOI 10.1080/13698575.2010.515667; Bergus GR, 2002, J GEN INTERN MED, V17, P612, DOI 10.1046/j.1525-1497.2002.11001.x; Berry D, 2004, PATIENT EDUC COUNS, V53, P129, DOI 10.1016/S0738-3991(03)00111-3; Berry DC, 2003, PSYCHOL HEAL MED, V8, P251, DOI [10.1080/1354850031000135704, DOI 10.1080/1354850031000135704]; Berry DC, 2006, PATIENT EDUC COUNS, V63, P89, DOI 10.1016/j.pec.2005.09.003; Carling C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003693; Carling CLL, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000140; Carling CLL, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000134; Cheung YB, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-55; Cochrane Bias Methods Group, ASS RISK BIAS INCL S; Cox DS, 2010, HEALTH PSYCHOL, V29, P29, DOI 10.1037/a0016942; Cuite CL, 2008, MED DECIS MAKING, V28, P377, DOI 10.1177/0272989X08315246; Dolan JG, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-14; Edwards AGK, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001865.pub2; Edwards A, 2006, PATIENT EDUC COUNS, V63, P336, DOI 10.1016/j.pec.2005.12.016; Fagerlin A, 2011, JNCI-J NATL CANCER I, V103, P1436, DOI 10.1093/jnci/djr318; Fortin J M, 2001, BMC Med Inform Decis Mak, V1, P2, DOI 10.1186/1472-6947-1-2; Gaissmaier W, 2012, HEALTH PSYCHOL, V31, P286, DOI 10.1037/a0024850; Galesic M, 2011, PATIENT EDUC COUNS, V82, P30, DOI 10.1016/j.pec.2010.02.008; Garcia-Retamero R, 2013, SOC SCI MED, V83, P27, DOI 10.1016/j.socscimed.2013.01.034; Garcia-Retamero R, 2011, PATIENT EDUC COUNS, V84, P245, DOI 10.1016/j.pec.2010.07.027; Garcia-Retamero R, 2010, J GEN INTERN MED, V25, P1323, DOI 10.1007/s11606-010-1484-9; Garcia-Retamero R, 2010, SOC SCI MED, V70, P1019, DOI 10.1016/j.socscimed.2009.11.031; Garcia-Retamero R, 2009, AM J PUBLIC HEALTH, V99, P2196, DOI 10.2105/AJPH.2009.160234; Ghosh Karthik, 2008, BMC Womens Health, V8, P18, DOI 10.1186/1472-6874-8-18; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Goodyear-Smith F, 2008, ANN FAM MED, V6, P213, DOI 10.1370/afm.795; Green MJ, 2001, AM J MED GENET, V103, P16, DOI 10.1002/ajmg.1500; Griffith JM, 2009, MED DECIS MAKING, V29, P167, DOI 10.1177/0272989X08327492; Grimes DA, 1999, OBSTET GYNECOL, V93, P910, DOI 10.1016/S0029-7844(98)00567-5; Guise JM, 2014, AHRQ PUBLICATION; Guyatt G, 2008, USERS GUIDES MED LIT, P67; Halvorsen PA, 2007, ANN INTERN MED, V146, P848, DOI 10.7326/0003-4819-146-12-200706190-00006; Han PKJ, 2011, MED DECIS MAKING, V31, P354, DOI 10.1177/0272989X10371830; Hawley ST, 2008, PATIENT EDUC COUNS, V73, P448, DOI 10.1016/j.pec.2008.07.023; Hinshaw K, 2007, EUR J OBSTET GYN R B, V133, P40, DOI 10.1016/j.ejogrb.2006.07.036; HOPPER KD, 1994, RADIOLOGY, V192, P67, DOI 10.1148/radiology.192.1.8208968; Hudson B, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588439; Hutton JL, 2000, J ROY STAT SOC A STA, V163, P403, DOI 10.1111/1467-985X.00175; Johnson FR, 2007, J WOMENS HEALTH, V16, P1028, DOI 10.1089/jwh.2006.0218; Keller C, 2009, RISK ANAL, V29, P1255, DOI 10.1111/j.1539-6924.2009.01261.x; Keller C, 2009, MED DECIS MAKING, V29, P483, DOI 10.1177/0272989X09333122; Knapp P, 2004, QUAL SAF HEALTH CARE, V13, P176, DOI 10.1136/qshc.2003.009076; Knapp P, 2009, DRUG SAFETY, V32, P837, DOI 10.2165/11316570-000000000-00000; Lin PJ, 2013, EXPERT REV PHARM OUT, V13, P513, DOI 10.1586/14737167.2013.814948; Lipkus IM, 2001, HEALTH COMMUN, V13, P205, DOI 10.1207/S15327027HC1302_5; Lipkus IM, 2001, CANCER EPIDEM BIOMAR, V10, P895; LLEWELLYNTHOMAS HA, 1995, MED DECIS MAKING, V15, P4, DOI 10.1177/0272989X9501500103; Man-Son-Hing Malcolm, 2002, Health Expect, V5, P246, DOI 10.1046/j.1369-6513.2002.00188.x; Marteau TM, 2000, PRENATAL DIAG, V20, P714, DOI 10.1002/1097-0223(200009)20:9<714::AID-PD906>3.0.CO;2-4; Marteau TM, 2001, BRIT MED J, V322, P526, DOI 10.1136/bmj.322.7285.526; Martin RW, 2012, PATIENT EDUC COUNS, V86, P329, DOI 10.1016/j.pec.2011.06.001; MAZUR DJ, 1993, J AM GERIATR SOC, V41, P223, DOI 10.1111/j.1532-5415.1993.tb06696.x; Mazur DJ, 1996, EUR J SURG, V162, P101; McCaffery KJ, 2012, MED DECIS MAKING, V32, P532, DOI 10.1177/0272989X11424926; Miron-Shatz T, 2009, J HEALTH COMMUN, V14, P439, DOI 10.1080/10810730903032986; Morrison A, 2012, INT J TECHNOL ASSESS, V28, P138, DOI 10.1017/S0266462312000086; Natter HM., 2005, PSYCHOL HEALTH MED, V10, P326, DOI [DOI 10.1080/13548500500093407, 10.1080/13548500500093407]; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; O'Donoghue AC, 2014, PATIENT EDUC COUNS, V95, P271, DOI 10.1016/j.pec.2013.12.010; Peters E, 2011, MED DECIS MAKING, V31, P432, DOI 10.1177/0272989X10391672; Price M, 2007, PATIENT EDUC COUNS, V69, P121, DOI 10.1016/j.pec.2007.08.006; Roshan F, 2010, ATHEROSCLEROSIS, V212, P586, DOI 10.1016/j.atherosclerosis.2010.07.020; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; Severtson DJ, 2009, RISK ANAL, V29, P1549, DOI 10.1111/j.1539-6924.2009.01299.x; Sheridan SL, 2003, J GEN INTERN MED, V18, P884, DOI 10.1046/j.1525-1497.2003.21102.x; Siegrist M, 2008, MED DECIS MAKING, V28, P567, DOI 10.1177/0272989X08315237; Silver B, 2012, NEUROLOGY, V78, P315, DOI 10.1212/WNL.0b013e31824528df; Smith HK, 2012, INJURY, V43, P1534, DOI 10.1016/j.injury.2011.06.419; Sorensen L, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-31; Steiner MJ, 2003, OBSTET GYNECOL, V102, P709, DOI 10.1016/S0029-7844(03)00662-8; Stovring H, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-25; Tait AR, 2012, AM J MED, V125, P1103, DOI 10.1016/j.amjmed.2012.04.040; Tait AR, 2010, ANESTH ANALG, V111, P718, DOI 10.1213/ANE.0b013e3181e8570a; Tait AR, 2010, J HEALTH COMMUN, V15, P487, DOI 10.1080/10810730.2010.492560; Timmermans D, 2004, PATIENT EDUC COUNS, V54, P255, DOI 10.1016/s0738-3991(03)00238-6; Trevena LJ, 2006, J EVAL CLIN PRACT, V12, P13, DOI 10.1111/j.1365-2753.2005.00596.x; Trevena LJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S7; Ubel PA, 2010, PATIENT EDUC COUNS, V80, P158, DOI 10.1016/j.pec.2009.10.021; Visschers VHM, 2009, RISK ANAL, V29, P267, DOI 10.1111/j.1539-6924.2008.01137.x; Waters EA, 2006, J HEALTH COMMUN, V11, P167, DOI 10.1080/10810730500526695; Waters EA, 2007, J EXP PSYCHOL-APPL, V13, P11, DOI 10.1037/1076-898X.13.1.11; Wegwarth O, 2012, ANN INTERN MED, V156, P340, DOI 10.7326/0003-4819-156-5-201203060-00005; Wells G., NEWCASTLE OTTAWA SCA; Whatley S, 2002, BRIT J GEN PRACT, V52, P483; Wolf AMD, 2000, J GEN INTERN MED, V15, P24, DOI 10.1046/j.1525-1497.2000.01079.x; Woloshin S, 2011, ANN INTERN MED, V155, P87, DOI 10.7326/0003-4819-155-2-201107190-00004; Wright AJ, 2009, BRIT J HEALTH PSYCH, V14, P107, DOI 10.1348/135910708X304432; Wright Patricia, 2004, Commun Med, V1, P183, DOI 10.1515/come.2004.1.2.183; Young SD, 2006, CLIN THER, V28, P129, DOI 10.1016/j.clinthera.2006.01.013; Zikmund-Fisher BJ, 2008, PATIENT EDUC COUNS, V73, P209, DOI 10.1016/j.pec.2008.05.010; Zikmund-Fisher BJ, 2008, J HEALTH COMMUN, V13, P107, DOI 10.1080/10810730701854011; Zikmund-Fisher BJ, 2012, J MED INTERNET RES, V14, P148, DOI 10.2196/jmir.2030; Zikmund-Fisher BJ, 2008, CANCER-AM CANCER SOC, V113, P3382, DOI 10.1002/cncr.23959	103	218	220	5	61	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					270	+		10.7326/M14-0295	http://dx.doi.org/10.7326/M14-0295			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP8RU	25133362				2022-12-28	WOS:000342347300017
J	Kastelein, JJP				Kastelein, John J. P.			Dyslipidaemia in perspective	LANCET			English	Editorial Material							CORONARY-HEART-DISEASE; OF-FUNCTION MUTATIONS; TRIGLYCERIDES; CHOLESTEROL; EVENTS; TRIAL; APOC3; RISK		Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Kastelein, JJP (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.j.kastelein@amc.uva.nl	Kastelein, John/AAF-7950-2020					Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Graham MJ, 2013, CIRC RES, V112, P1479, DOI 10.1161/CIRCRESAHA.111.300367; Jorgensen AB, 2014, NEW ENGL J MED, V371, P32, DOI 10.1056/NEJMoa1308027; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Nicholls SJ, 2014, JAMA-J AM MED ASSOC, V311, P252, DOI 10.1001/jama.2013.282836; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; PEDERSEN TR, 1994, LANCET, V344, P1383; Rader DJ, 2014, LANCET, V384, P618, DOI 10.1016/S0140-6736(14)61217-4; Ridker PM, 2014, LANCET, V384, P607, DOI 10.1016/S0140-6736(14)61009-6; The FIELD study investigators, 2005, LANCET, V366, P1849; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; White HD, 2014, NEW ENGL J MED, V370, P1702, DOI 10.1056/NEJMoa1315878	14	2	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					566	568		10.1016/S0140-6736(14)61332-5	http://dx.doi.org/10.1016/S0140-6736(14)61332-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25131971				2022-12-28	WOS:000340573300008
J	Flach, J; Bakker, ST; Mohrin, M; Conroy, PC; Pietras, EM; Reynaud, D; Alvarez, S; Diolaiti, ME; Ugarte, F; Forsberg, EC; Le Beau, MM; Stohr, BA; Mendez, J; Morrison, CG; Passegue, E				Flach, Johanna; Bakker, Sietske T.; Mohrin, Mary; Conroy, Pauline C.; Pietras, Eric M.; Reynaud, Damien; Alvarez, Silvia; Diolaiti, Morgan E.; Ugarte, Fernando; Forsberg, E. Camilla; Le Beau, Michelle M.; Stohr, Bradley A.; Mendez, Juan; Morrison, Ciaran G.; Passegue, Emmanuelle			Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells	NATURE			English	Article							DNA-DAMAGE-RESPONSE; ORIGIN; MAINTENANCE; DEFICIENCY; EXPRESSION; MUTATIONS; PROTEINS; COMPLEX; REPAIR; CYCLE	Haematopoietic stem cells (HSCs) self-renew for life, thereby making them one of the few blood cells that truly age(1,2). Paradoxically, although HSCs numerically expand with age, their functional activity declines over time, resulting in degraded blood production and impaired engraftment following transplantation(2). While many drivers of HSC ageing have been proposed(2-5), the reason why HSC function degrades with age remains unknown. Here we show that cycling old HSCs in mice have heightened levels of replication stress associated with cell cycle defects and chromosome gaps or breaks, which are due to decreased expression of mini-chromosome maintenance (MCM) helicase components and altered dynamics of DNA replication forks. Nonetheless, old HSCs survive replication unless confronted with a strong replication challenge, such as transplantation. Moreover, once old HSCs re-establish quiescence, residual replication stress on ribosomal DNA (rDNA) genes leads to the formation of nucleolar-associated gamma H2AX signals, which persist owing to ineffective H2AX dephosphorylation by mislocalized PP4c phosphatase rather than ongoing DNA damage. Persistent nucleolar gamma H2AX also acts as a histone modification marking the transcriptional silencing of rDNA genes and decreased ribosome biogenesis in quiescent old HSCs. Our results identify replication stress as a potent driver of functional decline in old HSCs, and highlight the MCM DNA helicase as a potential molecular target for rejuvenation therapies.	[Flach, Johanna; Bakker, Sietske T.; Mohrin, Mary; Pietras, Eric M.; Reynaud, Damien; Passegue, Emmanuelle] Univ Calif San Francisco, Dept Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Hem Onc Div, San Francisco, CA 94143 USA; [Flach, Johanna] Ctr Comprehens Canc, Inst Expt Canc Res, D-89081 Ulm, Germany; [Conroy, Pauline C.; Morrison, Ciaran G.] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Alvarez, Silvia; Mendez, Juan] Spanish Natl Canc Res Ctr CNIO, E-28049 Madrid, Spain; [Diolaiti, Morgan E.; Stohr, Bradley A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Ugarte, Fernando; Forsberg, E. Camilla] Univ Calif Santa Cruz, Inst Biol Stem Cells, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Le Beau, Michelle M.] Univ Chicago, Sect Hematol Oncol, Chicago, IL 60637 USA; [Le Beau, Michelle M.] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA	University of California System; University of California San Francisco; Ulm University; Ollscoil na Gaillimhe-University of Galway; Centro Nacional de Investigaciones Oncologicas (CNIO); University of California System; University of California San Francisco; University of California System; University of California Santa Cruz; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago	Passegue, E (corresponding author), Univ Calif San Francisco, Dept Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Hem Onc Div, San Francisco, CA 94143 USA.	PassegueE@stemcell.ucsf.edu	Mendez, Juan/K-8001-2014; Morrison, Ciaran/B-6568-2008; Morrison, Ciaran/AAH-2034-2019	Mendez, Juan/0000-0002-3235-2559; Morrison, Ciaran/0000-0003-2401-7029; Morrison, Ciaran/0000-0003-2401-7029; Passegue, Emmanuelle/0000-0002-3516-297X; Reynaud, Damien/0000-0001-8765-8419; Alvarez Nanez, Silvia/0000-0003-0664-650X; Bakker, Sietske/0000-0003-4962-3594	National Institutes of Health (NIH) [F32 HL106989]; Science Foundation Ireland PI award [10/IN.1/B2972]; CIRM New Faculty Award [RN2-00934, NIH R01 HL092471]; California Institute for Regenerative Medicine (CIRM); NATIONAL CANCER INSTITUTE [R01CA184014] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092471, R01HL115158, F32HL106989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Science Foundation Ireland PI award(Science Foundation Ireland); CIRM New Faculty Award; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Brunet and S. Villeda for providing some old C57BL/6 mice, B. McStay for advice on nucleolar analyses, C. Klijn for assistance with microarray analyses, S. Katzman for the SNP analyses, E. Davis for help with cytogenetic studies, I. Grummt for the rDNA plasmid, M. Kissner and M. Lee for management of our Flow Cytometry Core Facility, and all members of the Passegue laboratory for critical insights and suggestions. S. T. B. and M. M. were supported by a California Institute for Regenerative Medicine (CIRM) training grant and E. M. P. by National Institutes of Health (NIH) F32 HL106989. This work was supported by Science Foundation Ireland PI award 10/IN.1/B2972 to C. G. M. and a CIRM New Faculty Award RN2-00934 and NIH R01 HL092471 to E.P.	Aparicio T, 2009, NUCLEIC ACIDS RES, V37, P2087, DOI 10.1093/nar/gkp065; Beerman I, 2014, CELL STEM CELL, V15, P37, DOI 10.1016/j.stem.2014.04.016; Bersenev A, 2012, AGING CELL, V11, P949, DOI 10.1111/j.1474-9726.2012.00862.x; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Burhans WC, 2007, NUCLEIC ACIDS RES, V35, P7545, DOI 10.1093/nar/gkm1059; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cooley C, 2009, MOL BIOL CELL, V20, P2563, DOI 10.1091/mbc.E08-10-1019; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Fumagalli M, 2012, NAT CELL BIOL, V14, P355, DOI 10.1038/ncb2466; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Narla A, 2011, INT J HEMATOL, V93, P144, DOI 10.1007/s12185-011-0776-0; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Norddahl GL, 2011, CELL STEM CELL, V8, P499, DOI 10.1016/j.stem.2011.03.009; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Pruitt SC, 2007, STEM CELLS, V25, P3121, DOI 10.1634/stemcells.2007-0483; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rube CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017487; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Will B, 2013, NAT IMMUNOL, V14, P437, DOI 10.1038/ni.2572; Zhong Y, 2013, J CELL BIOL, V201, P373, DOI 10.1083/jcb.201208060	36	381	390	0	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					198	+		10.1038/nature13619	http://dx.doi.org/10.1038/nature13619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25079315	Green Published, Green Accepted			2022-12-28	WOS:000340200700033
J	Kim, KP; Scholer, HR				Kim, Kee-Pyo; Schoeler, Hans R.			CellNet-Where Your Cells Are Standing	CELL			English	Editorial Material							DEFINED FACTORS; STEM-CELLS; FIBROBLASTS; MOUSE	The manufacturing of clinically relevant cells is a widely used strategy in regenerative medicine. Cahan et al. develop a network biology platform named CellNet to accurately assess the fidelity of such cells and spot aberrant regulatory networks, and Morris et al. apply this platform to improve cell manufacturing.	[Kim, Kee-Pyo; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany	Max Planck Society	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	, HS/AAB-4434-2019	, HS/0000-0003-2643-5136				Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Davidson EH, 2010, NATURE, V468, P911, DOI 10.1038/nature09645; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; Ma H, 2014, NATURE, V511, P177, DOI 10.1038/nature13551; Morris SA, 2014, CELL, V158, P889, DOI 10.1016/j.cell.2014.07.021; Sekiya S, 2011, NATURE, V475, P390, DOI 10.1038/nature10263; Vallier L, 2014, CELL STEM CELL, V14, P267, DOI 10.1016/j.stem.2014.02.010; Yu B, 2013, CELL STEM CELL, V13, P328, DOI 10.1016/j.stem.2013.06.017	9	5	5	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					699	701		10.1016/j.cell.2014.08.001	http://dx.doi.org/10.1016/j.cell.2014.08.001			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126778	Bronze			2022-12-28	WOS:000340944700003
J	Gialdini, G; Nearing, K; Bhave, PD; Bonuccelli, U; Iadecola, C; Healey, JS; Kamel, H				Gialdini, Gino; Nearing, Katherine; Bhave, Prashant D.; Bonuccelli, Ubaldo; Iadecola, Costantino; Healey, Jeff S.; Kamel, Hooman			Perioperative Atrial Fibrillation and the Long-term Risk of Ischemic Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONCARDIAC SURGERY; PREDICTORS; PREVENTION; PROGNOSIS; MORTALITY; ACCURACY; OUTCOMES	IMPORTANCE Clinically apparent atrial fibrillation increases the risk of ischemic stroke. In contrast, perioperative atrial fibrillation may be viewed as a transient response to physiological stress, and the long-term risk of stroke after perioperative atrial fibrillation is unclear. OBJECTIVE To examine the association between perioperative atrial fibrillation and the long-term risk of stroke. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study using administrative claims data on patients hospitalized for surgery (as defined by surgical diagnosis related group codes), and discharged alive and free of documented cerebrovascular disease or preexisting atrial fibrillation from nonfederal California acute care hospitals between 2007 and 2011. Patients undergoing cardiac vs other types of surgery were analyzed separately. MAIN OUTCOMES AND MEASURES Previously validated diagnosis codes were used to identify ischemic strokes after discharge from the index hospitalization for surgery. The primary predictor variable was atrial fibrillation newly diagnosed during the index hospitalization, as defined by previously validated present-on-admission codes. Patients were censored at postdischarge emergency department encounters or hospitalizations with a recorded diagnosis of atrial fibrillation. RESULTS Of 1 729 360 eligible patients, 24 711 (1.43%; 95% CI, 1.41%-1.45%) had new-onset perioperative atrial fibrillation during the index hospitalization and 13 952 (0.81%; 95% CI, 0.79%-0.82%) experienced a stroke after discharge. In a Cox proportional hazards analysis accounting for potential confounders, perioperative atrial fibrillation was associated with subsequent stroke both after noncardiac and cardiac surgery. [GRAPHICS] The association with stroke was significantly stronger for perioperative atrial fibrillation after noncardiac vs cardiac surgery (P < .001 for interaction). CONCLUSIONS AND RELEVANCE Among patients hospitalized for surgery, perioperative atrial fibrillation was associated with an increased long-term risk of ischemic stroke, especially following noncardiac surgery.	[Gialdini, Gino; Iadecola, Costantino; Kamel, Hooman] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA; [Nearing, Katherine; Iadecola, Costantino; Kamel, Hooman] Weill Cornell Med Coll, Dept Neurol, New York, NY 10065 USA; [Bhave, Prashant D.] Univ Iowa, Div Cardiol, Carver Coll Med, Iowa City, IA USA; [Bonuccelli, Ubaldo] Univ Pisa, Neurol Sect, Dept Clin & Expt Med, Pisa, Italy; [Healey, Jeff S.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada	Cornell University; Cornell University; University of Iowa; University of Pisa; McMaster University; Population Health Research Institute	Kamel, H (corresponding author), Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, Dept Neurol, 407 E 61st St,Fifth Floor, New York, NY 10065 USA.	hok9010@med.cornell.edu	Iadecola, c/ABB-8377-2020; Kamel, Hooman/AGG-9071-2022; Bonuccelli, Ubaldo/K-8681-2016	Bonuccelli, Ubaldo/0000-0001-6218-6312; Iadecola, Costantino/0000-0001-9797-073X	National Institute of Neurological Disorders and Stroke [K23NS082367]; Heart and Stroke Foundation, Ontario Provincial Office [MC7450]; Feil Family Foundation; Michael Goldberg Stroke Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037853, K23NS082367, R01NS034179] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Heart and Stroke Foundation, Ontario Provincial Office(Heart & Stroke Foundation of Ontario); Feil Family Foundation; Michael Goldberg Stroke Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grant K23NS082367 (awarded to Dr Kamel) from the National Institute of Neurological Disorders and Stroke, grant MC7450 (Dr Healey) from the Heart and Stroke Foundation, Ontario Provincial Office, and funding from the Feil Family Foundation (Dr Gialdini) and the Michael Goldberg Stroke Research Fund (Dr Kamel).	Ahlsson A, 2010, EUR J CARDIO-THORAC, V37, P1353, DOI 10.1016/j.ejcts.2009.12.033; Almassi GH, 1997, ANN SURG, V226, P501, DOI 10.1097/00000658-199710000-00011; Bhave PD, 2012, AM HEART J, V164, P918, DOI 10.1016/j.ahj.2012.09.004; Brambatti M, 2014, CIRCULATION, V129, P2094, DOI 10.1161/CIRCULATIONAHA.113.007825; Centers for Medicare & Medicaid Services, FILES FOR FY 2008 FI; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Devereaux PJ, 2011, ANN INTERN MED, V154, P523, DOI 10.7326/0003-4819-154-8-201104190-00003; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein AE, 2005, CHEST, V128, p24S, DOI 10.1378/chest.128.2_suppl.24S; Goldman LE, 2011, HEALTH SERV RES, V46, P1946, DOI 10.1111/j.1475-6773.2011.01300.x; Goldstein LB, 1998, STROKE, V29, P1602, DOI 10.1161/01.STR.29.8.1602; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Hogue CW, 1999, CIRCULATION, V100, P642, DOI 10.1161/01.CIR.100.6.642; Hollenberg SM, 2000, CRIT CARE MED, V28, pN145, DOI 10.1097/00003246-200010001-00006; Horwich P, 2013, J CARDIAC SURG, V28, P8, DOI 10.1111/jocs.12033; Kaw R, 2011, J THORAC CARDIOV SUR, V141, P1305, DOI 10.1016/j.jtcvs.2010.10.040; Lin HJ, 1996, STROKE, V27, P1760, DOI 10.1161/01.STR.27.10.1760; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Maisel WH, 2001, ANN INTERN MED, V135, P1061, DOI 10.7326/0003-4819-135-12-200112180-00010; Mariscalco G, 2008, CIRCULATION, V118, P1612, DOI 10.1161/CIRCULATIONAHA.108.777789; O'Neal WT, 2013, J CARDIAC SURG, V28, P484, DOI 10.1111/jocs.12178; Ommen SR, 1997, NEW ENGL J MED, V336, P1429, DOI 10.1056/NEJM199705153362006; REED GL, 1988, NEW ENGL J MED, V319, P1246, DOI 10.1056/NEJM198811103191903; RUBIN DA, 1987, J THORAC CARDIOV SUR, V94, P331; Saxena A, 2012, AM J CARDIOL, V109, P219, DOI 10.1016/j.amjcard.2011.08.033; Selim M, 2007, NEW ENGL J MED, V356, P706, DOI 10.1056/NEJMra062668; Tanawuttiwat T, 2014, J AM COLL CARDIOL, V63, P1510, DOI 10.1016/j.jacc.2013.11.046; TAYLOR GJ, 1987, AM J CARDIOL, V60, P905, DOI 10.1016/0002-9149(87)91045-9; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Villareal RP, 2004, J AM COLL CARDIOL, V43, P742, DOI 10.1016/j.jacc.2003.11.023; Walkey AJ, 2011, JAMA-J AM MED ASSOC, V306, P2248, DOI 10.1001/jama.2011.1615; Weidinger F, 2014, EUR J CARDIO-THORAC, V45, P318, DOI 10.1093/ejcts/ezt282	32	215	226	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					616	622		10.1001/jama.2014.9143	http://dx.doi.org/10.1001/jama.2014.9143			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117130	Green Accepted, Green Published			2022-12-28	WOS:000340136400020
J	Hallal, PC; Martins, RC; Ramirez, A				Hallal, Pedro C.; Martins, Rafaela C.; Ramirez, Andrea			The Lancet Physical Activity Observatory: promoting physical activity worldwide	LANCET			English	Editorial Material							INACTIVITY		[Hallal, Pedro C.; Martins, Rafaela C.] Univ Fed Pelotas, BR-96020220 Pelotas, RJ, Brazil; [Ramirez, Andrea] Univ Los Andes, Bogota, Colombia	Universidade Federal de Pelotas; Universidad de los Andes (Colombia)	Hallal, PC (corresponding author), Univ Fed Pelotas, BR-96020220 Pelotas, RJ, Brazil.	prchallal@gmail.com	Martins, Rafaela C/E-2819-2014; Hallal, Pedro C/A-3249-2011	Hallal, Pedro C/0000-0003-1470-6461; Ramirez Varela, Andrea/0000-0003-2685-9617; Costa Martins, Rafaela/0000-0003-3538-7228				Bauman AE, 2012, LANCET, V380, P258, DOI 10.1016/S0140-6736(12)60735-1; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Pratt M, 2012, LANCET, V380, P282, DOI 10.1016/S0140-6736(12)60736-3; Rydin Y, 2012, LANCET, V379, P2079, DOI 10.1016/S0140-6736(12)60435-8	7	42	45	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					471	472		10.1016/S0140-6736(14)61321-0	http://dx.doi.org/10.1016/S0140-6736(14)61321-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM9JR	25110267				2022-12-28	WOS:000340198300004
J	Lugaro, M; Heger, A; Osrin, D; Goriely, S; Zuber, K; Karakas, AI; Gibson, BK; Doherty, CL; Lattanzio, JC; Ott, U				Lugaro, Maria; Heger, Alexander; Osrin, Dean; Goriely, Stephane; Zuber, Kai; Karakas, Amanda I.; Gibson, Brad K.; Doherty, Carolyn L.; Lattanzio, John C.; Ott, Ulrich			Stellar origin of the Hf-182 cosmochronometer and the presolar history of solar system matter	SCIENCE			English	Article							GIANT BRANCH STARS; MOLECULAR CLOUDS; LIVED RADIONUCLIDES; R-PROCESSES; NUCLEOSYNTHESIS; SUN; METEORITES; ABUNDANCE; NUCLEAR; PHYSICS	Among the short-lived radioactive nuclei inferred to be present in the early solar system via meteoritic analyses, there are several heavier than iron whose stellar origin has been poorly understood. In particular, the abundances inferred for Hf-182 (half-life = 8.9 million years) and I-129 (half-life = 15.7 million years) are in disagreement with each other if both nuclei are produced by the rapid neutron-capture process. Here, we demonstrate that contrary to previous assumption, the slow neutron-capture process in asymptotic giant branch stars produces Hf-182. This has allowed us to date the last rapid and slow neutron-capture events that contaminated the solar system material at similar to 100 million years and similar to 30 million years, respectively, before the formation of the Sun.	[Lugaro, Maria; Heger, Alexander; Osrin, Dean; Doherty, Carolyn L.; Lattanzio, John C.] Monash Univ, Monash Ctr Astrophys MoCA, Clayton, Vic 3800, Australia; [Heger, Alexander] Univ Notre Dame, JINA, Dept Phys, Notre Dame, IN 46556 USA; [Heger, Alexander] Univ Minnesota, Sch Phys & Astron, Minneapolis, MN 55455 USA; [Goriely, Stephane] Univ Libre Bruxelles, Inst Astron & Astrophys, B-1050 Brussels, Belgium; [Zuber, Kai] Tech Univ Dresden, Inst Kern & Teilchenphys, D-01069 Dresden, Germany; [Karakas, Amanda I.] Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT 2611, Australia; [Karakas, Amanda I.] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Todai Inst Adv Study, Tokyo 1138654, Japan; [Gibson, Brad K.] Univ Cent Lancashire, Jeremiah Horrocks Inst, Preston PR1 2HE, Lancs, England; [Gibson, Brad K.] St Marys Univ, Dept Phys & Astron, Inst Computat Astrophys, Halifax, NS BH3 3C3, Canada; [Ott, Ulrich] Univ West Hungary, Fac Nat Sci, H-9700 Szombathely, Hungary	Monash University; University of Notre Dame; University of Minnesota System; University of Minnesota Twin Cities; Universite Libre de Bruxelles; Technische Universitat Dresden; Australian National University; University of Tokyo; University of Central Lancashire; Saint Marys University - Canada	Lugaro, M (corresponding author), Monash Univ, Monash Ctr Astrophys MoCA, Clayton, Vic 3800, Australia.	maria.lugaro@monash.edu	Goriely, Stephane/AAE-1742-2021; Ott, Ulrich/ABH-2337-2020; Gibson, Brad/M-3592-2015	Gibson, Brad/0000-0003-4446-3130; Lattanzio, John/0000-0003-2952-859X; Karakas, Amanda/0000-0002-3625-6951; Heger, Alexander/0000-0002-3684-1325; Ulrich, Ott/0000-0003-3574-9591	Australian Research Council (ARC) [FT100100305, FT120100363, FT10100475]; ARC [DP0877317, DP1095368, DP120101815]; Fonds National de la Recherche Scientifique, Belgium; STFC [ST/J001341/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/J001341/1] Funding Source: researchfish	Australian Research Council (ARC)(Australian Research Council); ARC(Australian Research Council); Fonds National de la Recherche Scientifique, Belgium(Fonds de la Recherche Scientifique - FNRS); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank M. Asplund for providing us updated early solar system abundances, D. Price and C. Federrath for comments, and M. Pignatari for discussion. The data described in the paper are presented in fig. S2 and table S1. M.L., A.H., and A.I.K. are Australian Research Council (ARC) Future Fellows on projects FT100100305, FT120100363, and FT10100475, respectively. This research was partly supported under ARC's Discovery Projects funding scheme (project nos. DP0877317, DP1095368, and DP120101815). S.G. acknowledges financial support from the Fonds National de la Recherche Scientifique, Belgium. U.O. thanks the Max Planck Institute for Chemistry for use of its IT facilities.	Amelin Y, 2010, EARTH PLANET SC LETT, V300, P343, DOI 10.1016/j.epsl.2010.10.015; Arnould M, 2007, PHYS REP, V450, P97, DOI 10.1016/j.physrep.2007.06.002; Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; Bondarenko V, 2002, NUCL PHYS A, V709, P3, DOI 10.1016/S0375-9474(02)00646-2; Brazzle RH, 1999, GEOCHIM COSMOCHIM AC, V63, P739, DOI 10.1016/S0016-7037(98)00314-7; Brennecka GA, 2010, SCIENCE, V327, P449, DOI 10.1126/science.1180871; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; Burkhardt C, 2008, GEOCHIM COSMOCHIM AC, V72, P6177, DOI 10.1016/j.gca.2008.10.023; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; Frebel A, 2007, ASTROPHYS J, V660, pL117, DOI 10.1086/518122; Heger A, 2010, ASTROPHYS J, V724, P341, DOI 10.1088/0004-637X/724/1/341; Holst JC, 2013, P NATL ACAD SCI USA, V110, P8819, DOI 10.1073/pnas.1300383110; Karakas AI, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/8; Lugaro M, 2014, ASTROPHYS J, V780, DOI 10.1088/0004-637X/780/1/95; Lugaro M, 2012, METEORIT PLANET SCI, V47, P1998, DOI 10.1111/j.1945-5100.2012.01411.x; Meyer B. S., 2005, ASP C SER, V341, P515; Murray N, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/133; Ott U, 2008, NEW ASTRON REV, V52, P396, DOI 10.1016/j.newar.2008.05.001; Rauscher T, 2002, ASTROPHYS J, V576, P323, DOI 10.1086/341728; Schonbachler M, 2008, GEOCHIM COSMOCHIM AC, V72, P5330, DOI 10.1016/j.gca.2008.07.032; TAKAHASHI K, 1987, ATOM DATA NUCL DATA, V36, P375, DOI 10.1016/0092-640X(87)90010-6; Thielemann FK, 2011, PROG PART NUCL PHYS, V66, P346, DOI 10.1016/j.ppnp.2011.01.032; Vasileiadis A, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/1/L8; Wasserburg GJ, 2006, NUCL PHYS A, V777, P5, DOI 10.1016/j.nuclphysa.2005.07.015; WASSERBURG GJ, 1994, ASTROPHYS J, V424, P412, DOI 10.1086/173899; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	33	59	60	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					650	653		10.1126/science.1253338	http://dx.doi.org/10.1126/science.1253338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104382	Green Submitted, Green Accepted			2022-12-28	WOS:000339962800033
J	Sedgwick, P				Sedgwick, Philip			Before and after study designs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Inst Med & Biomed Educ, London, England	University of London	Sedgwick, P (corresponding author), Univ London, Inst Med & Biomed Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Akhtar PC, 2007, BMJ-BRIT MED J, V335, P545, DOI 10.1136/bmj.39311.550197.AE; Sedgwick P, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5741	2	25	25	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 8	2014	349								g5074	10.1136/bmj.g5074	http://dx.doi.org/10.1136/bmj.g5074			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MS	25106742				2022-12-28	WOS:000340206300002
J	Yang, J; Hu, WF; Usvyat, D; Matthews, D; Schutz, M; Chan, GKL				Yang, Jun; Hu, Weifeng; Usvyat, Denis; Matthews, Devin; Schuetz, Martin; Chan, Garnet Kin-Lic			Ab initio determination of the crystalline benzene lattice energy to sub-kilojoule/mole accuracy	SCIENCE			English	Article							BASIS-SETS	Computation of lattice energies to an accuracy sufficient to distinguish polymorphs is a fundamental bottleneck in crystal structure prediction. For the lattice energy of the prototypical benzene crystal, we combined the quantum chemical advances of the last decade to attain sub-kilojoule per mole accuracy, an order-of-magnitude improvement in certainty over prior calculations that necessitates revision of the experimental extrapolation to 0 kelvin. Our computations reveal the nature of binding by improving on previously inaccessible or inaccurate multibody and many-electron contributions and provide revised estimates of the effects of temperature, vibrations, and relaxation. Our demonstration raises prospects for definitive first-principles resolution of competing polymorphs in molecular crystal structure prediction.	[Yang, Jun; Hu, Weifeng; Chan, Garnet Kin-Lic] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Usvyat, Denis; Schuetz, Martin] Univ Regensburg, Inst Phys & Theoret Chem, D-93040 Regensburg, Germany; [Matthews, Devin] Univ Texas Austin, Dept Chem & Biochem, Austin, TX USA	Princeton University; University of Regensburg; University of Texas System; University of Texas Austin	Chan, GKL (corresponding author), Princeton Univ, Dept Chem, Princeton, NJ 08544 USA.	gkchan@princeton.edu	Usvyat, Denis/C-8711-2012; Yang, Jun/Y-9978-2019; Schütz, Martin/C-6096-2008	Usvyat, Denis/0000-0001-6351-9289; Yang, Jun/0000-0001-8701-9297; Schütz, Martin/0000-0002-2688-3214; Matthews, Devin/0000-0003-2795-5483	U.S. Department of Energy [DE-SC0008624, DE-SC0010530, DE-FG02-97ER25308]; NSF [OCI-1265278, CHE-1265277]; Deutsche Forschungsgemeinschaft (DFG) [US-103/1-1, SCHU 1456/12-1]	U.S. Department of Energy(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	We acknowledge many helpful discussions with C. D. Sherrill, G. J. O. Beran, and R. Podeszwa. We especially thank R. Podeszwa for providing the detailed data on dimer and trimer geometries and A. Tkatchenko for providing unpublished ZPE data. Work performed by J.Y., W.H., and G.K.-L.C. was supported by the U.S. Department of Energy under grant no. DE-SC0008624, with secondary support from grant no. DE-SC0010530. The DMRG software package BLOCK used in part of this work was developed with primary funding from NSF grant no. OCI-1265278. BLOCK implements theoretical methods developed under NSF grant no. CHE-1265277. D.M. was supported by the U.S. Department of Energy through a Computational Science Graduate Fellowship, funded by grant no. DE-FG02-97ER25308. D.U. and M.S. acknowledge financial support from the Deutsche Forschungsgemeinschaft (DFG), grants US-103/1-1 and SCHU 1456/12-1.	BACON GE, 1964, PROC R SOC LON SER-A, V279, P98, DOI 10.1098/rspa.1964.0092; Bardwell DA, 2011, ACTA CRYSTALLOGR B, V67, P535, DOI 10.1107/S0108768111042868; BLOCK S, 1970, SCIENCE, V169, P586, DOI 10.1126/science.169.3945.586; Bludsky O, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.092103; Booth GH, 2013, NATURE, V493, P365, DOI 10.1038/nature11770; Bygrave PJ, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4759079; DAVID WIF, 1992, PHYSICA B, V180, P597, DOI 10.1016/0921-4526(92)90406-I; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; HEHRE WJ, 1972, J CHEM PHYS, V56, P2257, DOI 10.1063/1.1677527; Hermann A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.183005; Hirata S, 2005, MOL PHYS, V103, P2255, DOI 10.1080/00268970500083788; Kallay M, 2001, J CHEM PHYS, V115, P2945, DOI 10.1063/1.1383290; Kamiya M, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2828517; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Kong LG, 2012, CHEM REV, V112, P75, DOI 10.1021/cr200204r; MADDOX J, 1988, NATURE, V335, P201, DOI 10.1038/335201a0; Muller C, 2013, J CHEM THEORY COMPUT, V9, P5590, DOI 10.1021/ct400797w; Paulus B, 2006, PHYS REP, V428, P1, DOI 10.1016/j.physrep.2006.01.003; Podeszwa R, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2733648; Podeszwa R, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.115503; Reilly AM, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4812819; Reilly AM, 2013, J PHYS CHEM LETT, V4, P1028, DOI 10.1021/jz400226x; Ringer AL, 2008, CHEM-EUR J, V14, P2542, DOI 10.1002/chem.200701622; Ruzicka K, 2014, J CHEM THERMODYN, V68, P40, DOI 10.1016/j.jct.2013.08.022; Schutz M, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4789415; Schweizer WB, 2006, J CHEM THEORY COMPUT, V2, P288, DOI 10.1021/ct0502357; Sharma S, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3695642; STOLL H, 1992, PHYS REV B, V46, P6700, DOI 10.1103/PhysRevB.46.6700; van Eijck BP, 1998, ACTA CRYSTALLOGR B, V54, P291, DOI 10.1107/S0108768197013384; Roux MV, 2008, J PHYS CHEM REF DATA, V37, P1855, DOI 10.1063/1.2955570; Wen SH, 2012, PHYS CHEM CHEM PHYS, V14, P7578, DOI 10.1039/c2cp23949c; Wen SH, 2011, J CHEM THEORY COMPUT, V7, P3733, DOI 10.1021/ct200541h; Yang J, 2012, J CHEM PHYS, V136, DOI 10.1063/1.3696963	34	191	192	6	130	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					640	643		10.1126/science.1254419	http://dx.doi.org/10.1126/science.1254419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104379				2022-12-28	WOS:000339962800030
J	Abad, CL; Moseley, RH; Crnich, CJ; Saint, S; Safdar, N				Abad, Cybele L.; Moseley, Richard H.; Crnich, Christopher J.; Saint, Sanjay; Safdar, Nasia			A Gut Instinct	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUBERCULOSIS INFECTION; ABDOMINAL-PAIN		[Abad, Cybele L.; Crnich, Christopher J.; Safdar, Nasia] Univ Wisconsin, Sch Med, Dept Med, Madison, WI 53706 USA; [Crnich, Christopher J.; Safdar, Nasia] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA; [Moseley, Richard H.; Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Moseley, Richard H.; Saint, Sanjay] Ann Arbor Healthcare Syst & Hlth Serv Res & Dev C, Dept Vet Affairs, Ann Arbor, MI USA	University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Safdar, N (corresponding author), William S Middleton Mem Vet Adm Med Ctr, 2500 Overlook Terrace, Madison, WI 53705 USA.	ns2@medicine.wisc.edu	Crnich, Christopher/Y-2785-2019; Saint, Sanjay/AAF-5126-2019	Crnich, Christopher/0000-0002-9320-9262	Covance; Doximity; Jvion	Covance; Doximity; Jvion	Dr. Moseley reports providing expert testimony in a case related to chronic hepatitis B virus infection; Dr. Crnich, receiving fees for serving on a data and safety monitoring board from Covance; and Dr. Saint, receiving fees for board membership from Doximity and Jvion. No other potential conflict of interest relevant to this article was reported.	American Thoracic Society, 2003, MMWR Recomm Rep, V52, P1; [Anonymous], 2011, N ENGL J MED, V365, P940; [Anonymous], 2013, N ENGL J MED, V368, P375; [Anonymous], 2011, MMWR MORB MORTAL WKL, V60, P333; *CDCP, 2007, REP TUB US 2006; Guirat A, 2011, CLIN RES HEPATOL GAS, V35, P60, DOI 10.1016/j.gcb.2010.07.023; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Ichikawa T, 2009, CLIN GASTROENTEROL H, V7, pXX, DOI 10.1016/j.cgh.2009.02.015; Jacob JT, 2009, AM J MED, V122, P12, DOI 10.1016/j.amjmed.2008.09.018; MEHTA JB, 1991, CHEST, V99, P1134, DOI 10.1378/chest.99.5.1134; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Peto HM, 2009, CLIN INFECT DIS, V49, P1350, DOI 10.1086/605559	12	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					560	564		10.1056/NEJMcps1202137	http://dx.doi.org/10.1056/NEJMcps1202137			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25099581				2022-12-28	WOS:000339899100012
J	Dharnidharka, VR; Fiorina, P; Harmon, WE				Dharnidharka, Vikas R.; Fiorina, Paolo; Harmon, William E.			Kidney Transplantation in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							PEDIATRIC RENAL-TRANSPLANTATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; COMPLETE STEROID AVOIDANCE; MESENCHYMAL STEM-CELLS; RANDOMIZED-TRIAL; UNITED-STATES; MYCOPHENOLATE-MOFETIL; ORGAN-TRANSPLANTATION; MESSENGER-RNA; RECIPIENTS		[Dharnidharka, Vikas R.] Washington Univ, Div Pediat Nephrol, Sch Med, St Louis, MO 63130 USA; [Dharnidharka, Vikas R.] St Louis Childrens Hosp, St Louis, MO 63110 USA; [Fiorina, Paolo; Harmon, William E.] Boston Childrens Hosp, Div Nephrol, Boston, MA 02115 USA; [Fiorina, Paolo; Harmon, William E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Fiorina, Paolo] Univ Milan, Osped San Raffaele, Ist Ricovero & Cura Carattere Sci, Div Transplant Med, I-20127 Milan, Italy	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Harmon, WE (corresponding author), Boston Childrens Hosp, Div Nephrol, 300 Longwood Ave, Boston, MA 02115 USA.	william.harmon@childrens.harvard.edu	PERUZZI, LICIA/I-1873-2012; Destri, Giovanni Li/E-3275-2016; Fiorina, Paolo/B-4532-2019	Destri, Giovanni Li/0000-0001-6976-8171; Fiorina, Paolo/0000-0002-1093-7724	Astellas Pharma; Alexion Pharmaceuticals; Genzyme; Audio-Digest Foundation; Amgen; Otsuka; Bristol-Myers Squibb	Astellas Pharma(Astellas Pharmaceuticals); Alexion Pharmaceuticals; Genzyme(Sanofi-AventisGenzyme Corporation); Audio-Digest Foundation; Amgen(Amgen); Otsuka(Otsuka Pharmaceutical); Bristol-Myers Squibb(Bristol-Myers Squibb)	Dr. Dharnidharka reports receiving fees for serving on a data and safety monitoring board from Astellas Pharma, fees for serving on an advisory board from Alexion Pharmaceuticals, consulting fees from Genzyme, lecture fees from the Audio-Digest Foundation, honoraria from Bristol-Myers Squibb, and grant support from Amgen and Genzyme; Dr. Fiorina, receiving grant support from Otsuka and holding stock in Sorgente; and Dr. Harmon, receiving grant support from Bristol-Myers Squibb and Genzyme and serving as an unpaid consultant for Genzyme. No other potential conflict of interest relevant to this article was reported.	Al Khasawneh E, 2013, PEDIATR TRANSPLANT, V17, P129, DOI 10.1111/j.1399-3046.2012.01773.x; [Anonymous], CHRONIC KIDNEY DIS D; Bell LE, 2008, AM J TRANSPLANT, V8, P2230, DOI 10.1111/j.1600-6143.2008.02415.x; Brennan DC, 2005, AM J TRANSPLANT, V5, P582, DOI 10.1111/j.1600-6143.2005.00742.x; Brugnoni D, 1996, IMMUNOL LETT, V52, P61; Chaudhuri A, 2013, J AM SOC NEPHROL, V24, P655, DOI 10.1681/ASN.2012070663; CHIBA Y, 1989, J MED VIROL, V28, P133, DOI 10.1002/jmv.1890280304; Cooney GF, 1997, CLIN PHARMACOKINET, V32, P481, DOI 10.2165/00003088-199732060-00004; De Serres SA, 2012, J AM SOC NEPHROL, V23, P174, DOI 10.1681/ASN.2011040360; Dharnidharka VR, 2011, AM J TRANSPLANT, V11, P751, DOI 10.1111/j.1600-6143.2011.03470.x; Dharnidharka VR, 2008, TRANSPLANTATION, V85, P986, DOI 10.1097/TP.0b013e318169bf11; Dharnidharka VR, 2007, CLIN J AM SOC NEPHRO, V2, P100, DOI 10.2215/CJN.01820506; Dharnidharka VR, 2011, PEDIATR NEPHROL, V26, P1763, DOI 10.1007/s00467-010-1716-6; Dharnidharka VR, 2009, TRANSPLANTATION, V87, P1019, DOI 10.1097/TP.0b013e31819cc383; Dharnidharka VR, 2005, AM J TRANSPLANT, V5, P1513, DOI 10.1111/j.1600-6143.2005.00878.x; Dobbels F, 2010, PEDIATR TRANSPLANT, V14, P603, DOI 10.1111/j.1399-3046.2010.01299.x; Filler G, 2008, THER DRUG MONIT, V30, P138, DOI 10.1097/FTD.0b013e31816ba73a; Fine RN, 2010, PEDIATR NEPHROL, V25, P725, DOI 10.1007/s00467-009-1409-1; Fine RN, 2002, KIDNEY INT, V62, P688, DOI 10.1046/j.1523-1755.2002.00489.x; Fiorina P, 2011, ENDOCR REV, V32, P725, DOI 10.1210/er.2011-0008; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Funch DP, 2005, AM J TRANSPLANT, V5, P2894, DOI 10.1111/j.1600-6143.2005.01115.x; Genberg H, 2006, AM J TRANSPLANT, V6, P2418, DOI 10.1111/j.1600-6143.2006.01497.x; Gupta A, 2008, TRANSPLANTATION, V85, P1200, DOI 10.1097/TP.0b013e31816b1c37; Gurkan S, 2010, AM J TRANSPLANT, V10, P2132, DOI 10.1111/j.1600-6143.2010.03210.x; Haas M, 2014, AM J TRANSPLANT, V14, P272, DOI 10.1111/ajt.12590; Hanna-Wakim R, 2009, J INFECT DIS, V200, P1921, DOI 10.1086/648375; Harmon W, 2013, AM J TRANSPLANT, V13, P36; HARMON WE, 1992, TRANSPLANTATION, V54, P232, DOI 10.1097/00007890-199208000-00008; Harmon WE, 2009, PEDIAT NEPHROLOGY, P1867; Hartel C, 2005, CLIN EXP IMMUNOL, V142, P446, DOI 10.1111/j.1365-2249.2005.02928.x; Hassan J, 1996, IMMUNOLOGY, V87, P604, DOI 10.1046/j.1365-2567.1996.476587.x; Hocker B, 2005, PEDIATR TRANSPLANT, V9, P504, DOI 10.1111/j.1399-3046.2005.00335.x; Horslen S, 2007, AM J TRANSPLANT, V7, P1339, DOI 10.1111/j.1600-6143.2007.01780.x; Hsu DT, 2005, PEDIATR TRANSPLANT, V9, P416, DOI 10.1111/j.1399-3046.2005.00352.x; Jyonouchi H, 2010, EUR J PEDIATR, V169, P1233, DOI 10.1007/s00431-010-1210-y; Knechtle SJ, 2009, AM J TRANSPLANT, V9, P1087, DOI 10.1111/j.1600-6143.2009.02581.x; Knechtle SJ, 2004, PEDIATR TRANSPLANT, V8, P106, DOI 10.1046/j.1399-3046.2003.00139.x; Li L, 2012, AM J TRANSPLANT, V12, P2710, DOI 10.1111/j.1600-6143.2012.04253.x; Li L, 2009, AM J TRANSPLANT, V9, P1362, DOI 10.1111/j.1600-6143.2009.02640.x; Mackall CL, 1997, IMMUNOL REV, V160, P91, DOI 10.1111/j.1600-065X.1997.tb01030.x; Marks WH, 2011, TRANSPL P, V43, P1395, DOI 10.1016/j.transproceed.2011.03.036; MCENERY PT, 1992, NEW ENGL J MED, V326, P1727, DOI 10.1056/NEJM199206253262602; McFarland RD, 2000, P NATL ACAD SCI USA, V97, P4215, DOI 10.1073/pnas.070061597; Mitchell ME, 2009, PEDIAT NEPHROLOGY, P1379; Mota C, 2010, ANN TRANSPL, V15, P84; Moudgil A, 2013, TRANSPLANTATION, V95, P319, DOI 10.1097/TP.0b013e3182719203; Murray JE, 2005, J AM COLL SURGEONS, V200, P5, DOI 10.1016/j.jamcollsurg.2004.09.033; Muthukumar T, 2005, NEW ENGL J MED, V353, P2342, DOI 10.1056/NEJMoa051907; Naesens M, 2012, AM J TRANSPLANT, V12, P2730, DOI 10.1111/j.1600-6143.2012.04144.x; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Neu A M, 1998, Pediatr Transplant, V2, P263; North American Pediatric Renal Trials and Collaborative Studies, 2010 ANN TRANSPL REP; Organ Procurement and Transplantation Network, 2010, ALL DEC KIDN; Pape L, 2005, LANCET, V366, P151, DOI 10.1016/S0140-6736(05)66872-9; Pham MX, 2010, NEW ENGL J MED, V362, P1890, DOI 10.1056/NEJMoa0912965; Plotnicki L, 2013, TRANSPL P, V45, P1414, DOI 10.1016/j.transproceed.2013.01.007; Reese PP, 2014, J AM SOC NEPHROL, V25, P827, DOI 10.1681/ASN.2013070684; Riley P, 2010, TRANSPLANTATION, V89, P1299, DOI 10.1097/TP.0b013e3181de5b8c; Rizvi SAH, 2013, AM J TRANSPLANT, V13, P2441, DOI 10.1111/ajt.12356; Rostaing L, 2013, AM J TRANSPLANT, V13, P2875, DOI 10.1111/ajt.12460; Salvatierra Oscar Jr, 2006, Semin Pediatr Surg, V15, P208, DOI 10.1053/j.sempedsurg.2006.03.007; Sarwal MM, 2012, AM J TRANSPLANT, V12, P2719, DOI 10.1111/j.1600-6143.2012.04145.x; Sarwal MM, 2001, TRANSPLANTATION, V72, P13, DOI 10.1097/00007890-200107150-00006; Sarwal MM, 2000, TRANSPLANTATION, V70, P1728, DOI 10.1097/00007890-200012270-00012; Schachter AD, 2006, PEDIATR TRANSPLANT, V10, P914, DOI 10.1111/j.1399-3046.2006.00541.x; Scientific Registry of Transplant Recipients, 2012 ANN DAT REP; Shapiro R, 2010, PEDIATR CLIN N AM, V57, P393, DOI 10.1016/j.pcl.2010.01.016; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Solez K, 2008, AM J TRANSPLANT, V8, P753, DOI 10.1111/j.1600-6143.2008.02159.x; Suthanthiran M, 2013, NEW ENGL J MED, V369, P20, DOI 10.1056/NEJMoa1215555; Tan JM, 2012, JAMA-J AM MED ASSOC, V307, P1169, DOI 10.1001/jama.2012.316; Thomas A, 2007, TRANSPLANTATION, V84, P433, DOI 10.1097/01.tp.0000269616.21698.10; Trompeter R, 2002, PEDIATR NEPHROL, V17, P141, DOI 10.1007/s00467-001-0795-9; Trzonkowski P, 2008, AM J TRANSPLANT, V8, P338, DOI 10.1111/j.1600-6143.2007.02078.x; Wilson CH, 2005, TRANSPLANTATION, V80, P877, DOI 10.1097/01.tp.0000181197.21706.fa; Yu CC, 2013, NEW ENGL J MED, V369, P2416, DOI 10.1056/NEJMoa1304572; Zarkhin V, 2011, TRANSPLANTATION, V91, P1010, DOI 10.1097/TP.0b013e318213df29	79	151	158	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					549	558		10.1056/NEJMra1314376	http://dx.doi.org/10.1056/NEJMra1314376			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25099579	Green Published			2022-12-28	WOS:000339899100009
J	McCully, C; Jha, SW; Foley, RJ; Bildsten, L; Fong, WF; Kirshner, RP; Marion, GH; Riess, AG; Stritzinger, MD				McCully, Curtis; Jha, Saurabh W.; Foley, Ryan J.; Bildsten, Lars; Fong, Wen-fai; Kirshner, Robert P.; Marion, G. H.; Riess, Adam G.; Stritzinger, Maximilian D.			A luminous, blue progenitor system for the type Iax supernova 2012Z	NATURE			English	Article							HUBBLE-SPACE-TELESCOPE; CORE-COLLAPSE SUPERNOVA; SN 2005HK; HELIUM NOVA; STARS; MODELS; 2002CX	Type Iax supernovae are stellar explosions that are spectroscopically similar to some type Ia supernovae at the time of maximum light emission, except with lower ejecta velocities(1,2). They are also distinguished by lower luminosities. At late times, their spectroscopic properties diverge from those of other supernovae(3-6), but their composition (dominated by iron-group and intermediate-mass elements(1,7)) suggests a physical connection to normal type Ia supernovae. Supernovae of type Iax are not rare; they occur at a rate between 5 and 30 per cent of the normal type Ia rate(1). The leading models for type Iax supernovae are thermonuclear explosions of accreting carbon-oxygen white dwarfs that do not completely unbind the star(8-10), implying that they are 'less successful' versions of normal type Ia supernovae, where complete stellar disruption is observed. Here we report the detection of the luminous, blue progenitor system of the type Iax SN 2012Z in deep pre-explosion imaging. The progenitor system's luminosity, colours, environment and similarity to the progenitor of the Galactic helium nova V445 Puppis(11-13) suggest that SN 2012Z was the explosion of a white dwarf accretingmaterial from a helium-star companion. Observations over the next few years, after SN 2012Z has faded, will either confirm this hypothesis or perhaps show that this super-nova was actually the explosive death of a massive star(14,15).	[McCully, Curtis; Jha, Saurabh W.] Rutgers State Univ, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Foley, Ryan J.] Univ Illinois, Dept Astron, Urbana, IL 61801 USA; [Foley, Ryan J.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Bildsten, Lars] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Bildsten, Lars] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Fong, Wen-fai; Kirshner, Robert P.; Marion, G. H.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Marion, G. H.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Riess, Adam G.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Riess, Adam G.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Stritzinger, Maximilian D.] Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus C, Denmark	Rutgers State University New Brunswick; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Texas System; University of Texas Austin; Johns Hopkins University; Space Telescope Science Institute; Aarhus University	Jha, SW (corresponding author), Rutgers State Univ, Dept Phys & Astron, 136 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	saurabh@physics.rutgers.edu	Riess, Adam/ABF-2480-2020	Foley, Ryan/0000-0002-2445-5275; Fong, Wen-fai/0000-0002-7374-935X; McCully, Curtis/0000-0001-5807-7893; stritzinger, maximilian/0000-0002-5571-1833; Jha, Saurabh/0000-0001-8738-6011	NASA/HST [GO-12913.01, GO-12999.01]; National Science Foundation (NSF) CAREER [AST-0847157]; NSF [PHY 11-25915, AST 11-09174]; Danish Agency for Science, Technology, and Innovation; NASA from the Space Telescope Science Institute [GO-12913, GO-12999]; NASA [NAS5-26555]; Direct For Mathematical & Physical Scien [1109174] Funding Source: National Science Foundation; Division Of Astronomical Sciences [0847157] Funding Source: National Science Foundation	NASA/HST(National Aeronautics & Space Administration (NASA)); National Science Foundation (NSF) CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF(National Science Foundation (NSF)); Danish Agency for Science, Technology, and Innovation; NASA from the Space Telescope Science Institute; NASA(National Aeronautics & Space Administration (NASA)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We dedicate this paper to the memory of our friend and colleague Weidong Li, whose work on the Lick Observatory Supernova Search, SN 2002cx-like supernovae, and Hubble Space Telescope observations of supernova progenitors continues to inspire us. We thank the SH<INF>0</INF>ES team for assistance with data from HST programme GO-12880, E. Bertin for the development of the STIFF software to produce colour images, and A. Dolphin for software and guidance in photometry. This research at Rutgers University was supported through NASA/HST grant GO-12913.01 and National Science Foundation (NSF) CAREER award AST-0847157 to S.W.J.; NASA/HST grant GO-12999.01 to R.J.F. supported this work at the University of Illinois. At UC Santa Barbara, this work was supported by NSF grants PHY 11-25915 and AST 11-09174 to L.B. The Danish Agency for Science, Technology, and Innovation supported M.D.S. through a Sapere Aude Level 2 grant. Support for HST programmes GO-12913 and GO-12999 was provided by NASA through a grant from the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy, Inc., under NASA contract NAS5-26555.	ARNETT WD, 1989, ANNU REV ASTRON ASTR, V27, P629, DOI 10.1146/annurev.aa.27.090189.003213; Bertelli G, 2009, ASTRON ASTROPHYS, V508, P355, DOI 10.1051/0004-6361/200912093; Cenko S. B., 2012, CBET, V3014; Fink M, 2014, MON NOT R ASTRON SOC, V438, P1762, DOI 10.1093/mnras/stt2315; Foley RJ, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/57; Foley RJ, 2010, ASTRON J, V140, P1321, DOI 10.1088/0004-6256/140/5/1321; Foley RJ, 2009, ASTRON J, V138, P376, DOI 10.1088/0004-6256/138/2/376; Georgy C, 2013, ASTRON ASTROPHYS, V553, DOI 10.1051/0004-6361/201220558; Gonzaga S., 2012, DRIZZLEPAC HDB; Goranskij V., 2010, PEREM ZVEZDY, V30, P4; Groh JH, 2013, ASTRON ASTROPHYS, V558, DOI 10.1051/0004-6361/201321906; IBEN I, 1991, ASTROPHYS J, V370, P615, DOI 10.1086/169848; Jha S, 2006, ASTRON J, V132, P189, DOI 10.1086/504599; Jordan GC, 2012, ASTROPHYS J LETT, V761, DOI 10.1088/2041-8205/761/2/L23; Kato M, 2008, ASTROPHYS J, V684, P1366, DOI 10.1086/590329; Kelly PL, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/1/3; Kromer M, 2013, MON NOT R ASTRON SOC, V429, P2287, DOI 10.1093/mnras/sts498; Li WD, 2003, PUBL ASTRON SOC PAC, V115, P453, DOI 10.1086/374200; Li WD, 2011, NATURE, V480, P348, DOI 10.1038/nature10646; Liu WM, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/201014180; Lyman JD, 2013, MON NOT R ASTRON SOC, V434, P527, DOI 10.1093/mnras/stt1038; Maoz D, 2008, MON NOT R ASTRON SOC, V388, P421, DOI 10.1111/j.1365-2966.2008.13403.x; McCully C, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/2/134; Moriya T, 2010, ASTROPHYS J, V719, P1445, DOI 10.1088/0004-637X/719/2/1445; Phillips MM, 2007, PUBL ASTRON SOC PAC, V119, P360, DOI 10.1086/518372; Riess AG, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/119; Riess AG, 2009, ASTROPHYS J SUPPL S, V183, P109, DOI 10.1088/0067-0049/183/1/109; Sahu DK, 2008, ASTROPHYS J, V680, P580, DOI 10.1086/587772; Shara MM, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/6/162; Smartt SJ, 2009, ANNU REV ASTRON ASTR, V47, P63, DOI 10.1146/annurev-astro-082708-101737; Stritzinger MD, 2014, ASTRON ASTROPHYS, V561, DOI 10.1051/0004-6361/201322889; Valenti S, 2009, NATURE, V459, P674, DOI 10.1038/nature08023; Woudt PA, 2009, ASTROPHYS J, V706, P738, DOI 10.1088/0004-637X/706/1/738	34	106	106	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					54	+		10.1038/nature13615	http://dx.doi.org/10.1038/nature13615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25100479	Green Submitted			2022-12-28	WOS:000339908000029
J	Shohat, S; Shifman, S				Shohat, Shahar; Shifman, Sagiv			Bias towards large genes in autism	NATURE			English	Letter							DE-NOVO MUTATIONS; SPECTRUM DISORDERS		[Shohat, Shahar; Shifman, Sagiv] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Shohat, S (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	sagiv@vms.huji.ac.il	Shifman, Sagiv/D-8749-2017	Shifman, Sagiv/0000-0003-4071-5361; Shohat, Shahar/0000-0001-6664-3226				Abrahams BS, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-36; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Iossifov I, 2012, NEURON, V74, P285, DOI 10.1016/j.neuron.2012.04.009; King IF, 2013, NATURE, V501, P58, DOI 10.1038/nature12504; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002	9	11	11	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					E1	E2		10.1038/nature13583	http://dx.doi.org/10.1038/nature13583			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25100484				2022-12-28	WOS:000339908000001
J	Lee, MSY; Cau, A; Naish, D; Dyke, GJ				Lee, Michael S. Y.; Cau, Andrea; Naish, Darren; Dyke, Gareth J.			Sustained miniaturization and anatomical innovation in the dinosaurian ancestors of birds	SCIENCE			English	Article							BODY-SIZE; EVOLUTION; ORIGIN; THEROPOD; RATES	Recent discoveries have highlighted the dramatic evolutionary transformation of massive, ground-dwelling theropod dinosaurs into light, volant birds. Here, we apply Bayesian approaches (originally developed for inferring geographic spread and rates of molecular evolution in viruses) in a different context: to infer size changes and rates of anatomical innovation (across up to 1549 skeletal characters) in fossils. These approaches identify two drivers underlying the dinosaur-bird transition. The theropod lineage directly ancestral to birds undergoes sustained miniaturization across 50 million years and at least 12 consecutive branches (internodes) and evolves skeletal adaptations four times faster than other dinosaurs. The distinct, prolonged phase of miniaturization along the bird stem would have facilitated the evolution of many novelties associated with small body size, such as reorientation of body mass, increased aerial ability, and paedomorphic skulls with reduced snouts but enlarged eyes and brains.	[Lee, Michael S. Y.] S Australian Museum, Earth Sci Sect, Adelaide, SA 5000, Australia; [Lee, Michael S. Y.] Univ Adelaide, Sch Earth & Environm Sci, Adelaide, SA 5005, Australia; [Cau, Andrea] Museo Geol & Paleontol Giovanni Capellini, I-40126 Bologna, Italy; [Cau, Andrea] Alma Mater Studiorum Univ Bologna, Dipartimento Sci Biol Geol & Ambientali, I-40126 Bologna, Italy; [Naish, Darren; Dyke, Gareth J.] Univ Southampton, Southampton SO14 3ZH, Hants, England; [Dyke, Gareth J.] Univ Debrecen, MTA DE Lendulet Behav Ecol Res Grp, Dept Evolutionary Zool & Human Biol, H-4032 Debrecen, Hungary	University of Adelaide; University of Bologna; University of Southampton; University of Debrecen	Lee, MSY (corresponding author), S Australian Museum, Earth Sci Sect, North Terrace, Adelaide, SA 5000, Australia.	mike.lee@samuseum.sa.gov.au	Dyke, Gareth/AAJ-9320-2020; Cau, Andrea/ABB-7972-2021; Cau, Andrea/S-8546-2016	Dyke, Gareth/0000-0002-8390-7817; Cau, Andrea/0000-0001-8761-3720; 	Environment Institute (University of Adelaide); Australian Research Council	Environment Institute (University of Adelaide); Australian Research Council(Australian Research Council)	We thank e-research SA for use of high-performance computing facilities, the Environment Institute (University of Adelaide) and Australian Research Council for funding, and the University of Bologna for logistic support. Author contributions. A. C., G.J.D., and D.N. collected phylogenetic and stratigraphic data; M.S.Y.L. analyzed data and assisted with data collection; all authors contributed to interpretation of results; M.S.Y.L. wrote and revised manuscript with input from all other authors. Data files are archived on Dryad Digital Repository (doi:10.5061/dryad.jm6pj).	Allen V, 2013, NATURE, V497, P104, DOI 10.1038/nature12059; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benson RBJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1780; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Choiniere JN, 2010, SCIENCE, V327, P571, DOI 10.1126/science.1182143; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Dececchi TA, 2013, EVOLUTION, V67, P2741, DOI 10.1111/evo.12150; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Dyke G., 2011, LIVING DINOSAURS EVO; Gaudin Timothy J., 2006, P1; Gauthier J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P7; GAUTHIER JA, 1986, MEM CALIF ACAD SCI, V8, P1; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; Heers AM, 2012, TRENDS ECOL EVOL, V27, P296, DOI 10.1016/j.tree.2011.12.003; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Kemp TS, 2007, P ROY SOC B-BIOL SCI, V274, P1667, DOI 10.1098/rspb.2007.0288; Novas Fernando E, 2012, Rev. Mus. Argent. Cienc. Nat., V14, P57; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Pagel M., 2013, BAYESTRAITS SOFTWARE; Puttick MN, 2014, EVOLUTION, V68, P1497, DOI 10.1111/evo.12363; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sookias RB, 2012, P ROY SOC B-BIOL SCI, V279, P2180, DOI 10.1098/rspb.2011.2441; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Zanno LE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2526; Zelenitsky DK, 2012, SCIENCE, V338, P510, DOI 10.1126/science.1225376; Zheng XT, 2013, SCIENCE, V339, P1309, DOI 10.1126/science.1228753	30	162	164	2	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					562	566		10.1126/science.1252243	http://dx.doi.org/10.1126/science.1252243			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082702				2022-12-28	WOS:000339651300045
J	Jensen, ELN; Akeson, R				Jensen, Eric L. N.; Akeson, Rachel			Misaligned protoplanetary disks in a young binary star system	NATURE			English	Article							ON CIRCUMSTELLAR DISK; T-TAURI; PLANETARY ORBITS; ACCRETION DISCS; TRIPLE SYSTEM; MU-M; EVOLUTION; PERTURBATIONS; ALIGNMENT; DYNAMICS	Many extrasolar planets follow orbits that differ from the nearly coplanar and circular orbits found in our Solar System; their orbits may be eccentric(1) or inclined with respect to the host star's equator(2,3), and the population of giant planets orbiting close to their host stars suggests appreciable orbital migration(4). There is at present no consensus on what produces such orbits. Theoretical explanations often invoke interactions with a binary companion star in an orbit that is inclined relative to the planet's orbital plane(4,5). Such mechanisms require significant mutual inclinations between the planetary and binary star orbital planes. The protoplanetary disks in a few young binaries are misaligned(6-12), but often the measurements of these mis-alignments are sensitive only to a small portion of the inner disk, and the three-dimensional misalignment of the bulk of the planet-forming disk mass has hitherto not been determined. Here we report that the protoplanetary disks in the young binary system HK Tauri are misaligned by 60 to 68 degrees, such that one or both of the disks are significantly inclined to the binary orbital plane. Our results demonstrate that the necessary conditions exist for misalignment-driven mechanisms to modify planetary orbits, and that these conditions are present at the time of planet formation, apparently because of the binary formation process.	[Jensen, Eric L. N.] Swarthmore Coll, Dept Phys & Astron, Swarthmore, PA 19081 USA; [Akeson, Rachel] CALTECH, IPAC, NASA, Exoplanet Sci Inst, Pasadena, CA 91125 USA	Swarthmore College; California Institute of Technology; National Aeronautics & Space Administration (NASA)	Jensen, ELN (corresponding author), Swarthmore Coll, Dept Phys & Astron, 500 Coll Ave, Swarthmore, PA 19081 USA.	ejensen1@swarthmore.edu		Jensen, Eric/0000-0002-4625-7333; Akeson, Rachel/0000-0001-9674-1564				Akeson RL, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/62; Albrecht S, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/1/18; Andrews SM, 2013, ASTROPHYS J, V771, DOI 10.1088/0004-637X/771/2/129; Bally J, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/143; Bate MR, 2012, MON NOT R ASTRON SOC, V419, P3115, DOI 10.1111/j.1365-2966.2011.19955.x; Bate MR, 2000, MON NOT R ASTRON SOC, V317, P773, DOI 10.1046/j.1365-8711.2000.03648.x; Batygin K, 2012, NATURE, V491, P418, DOI 10.1038/nature11560; BOHM KH, 1994, ASTROPHYS J, V430, P277, DOI 10.1086/174402; Clarke C. J., 2007, P IAU S S, V2, P337; de Gregorio-Monsalvo I, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201321603; Duchene G, 2005, ASTROPHYS J, V628, P832, DOI 10.1086/431144; Duchene G, 2003, ASTRON ASTROPHYS, V400, P559, DOI 10.1051/0004-6361:20021906; Dullemond C. P., 2012, ASTROPHYSICS SOURCE, V1202, P015; Fabrycky D, 2007, ASTROPHYS J, V669, P1298, DOI 10.1086/521702; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Fragner MM, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200913088; Goodman J, 2010, COMM APP MATH COM SC, V5, P65, DOI 10.2140/camcos.2010.5.65; Guilloteau S, 2013, ASTRON ASTROPHYS, V549, DOI 10.1051/0004-6361/201220298; Hartmann L, 1998, ASTROPHYS J, V495, P385, DOI 10.1086/305277; Heintz W. D., 1978, DOUBLE STARS, V32; Innanen KA, 1997, ASTRON J, V113, P1915, DOI 10.1086/118405; Jensen ELN, 2004, ASTROPHYS J, V600, P789, DOI 10.1086/380089; Jensen ELN, 2003, ASTROPHYS J, V584, P875, DOI 10.1086/345719; Koresko CD, 1998, ASTROPHYS J, V507, pL145, DOI 10.1086/311694; KOZAI Y, 1962, ASTRON J, V67, P591, DOI 10.1086/108790; Larwood JD, 1996, MON NOT R ASTRON SOC, V282, P597, DOI 10.1093/mnras/282.2.597; LIDOV ML, 1962, PLANET SPACE SCI, V9, P719, DOI 10.1016/0032-0633(62)90129-0; Lubow SH, 2000, ASTROPHYS J, V538, P326, DOI 10.1086/309101; MONETI A, 1991, ASTRON ASTROPHYS, V242, P428; Monin JL, 1998, ASTRON ASTROPHYS, V339, P113; Naoz S, 2013, MON NOT R ASTRON SOC, V431, P2155, DOI 10.1093/mnras/stt302; Offner SSR, 2010, ASTROPHYS J, V725, P1485, DOI 10.1088/0004-637X/725/2/1485; Offner SSR, 2009, ASTROPHYS J, V703, P131, DOI 10.1088/0004-637X/703/1/131; PAPALOIZOU JCB, 1995, MON NOT R ASTRON SOC, V274, P987; Ratzka T, 2009, ASTRON ASTROPHYS, V502, P623, DOI 10.1051/0004-6361/200811390; Roccatagliata V, 2011, ASTRON ASTROPHYS, V534, DOI 10.1051/0004-6361/201116805; Rosenfeld KA, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/136; Rosenfeld KA, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/16; Rosenfeld KA, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/119; Simon M, 2000, ASTROPHYS J, V545, P1034, DOI 10.1086/317838; Skemer AJ, 2008, ASTROPHYS J, V676, P1082, DOI 10.1086/527555; Stapelfeldt KR, 1998, ASTROPHYS J, V502, pL65, DOI 10.1086/311479; Torres RM, 2009, ASTROPHYS J, V698, P242, DOI 10.1088/0004-637X/698/1/242; Winn JN, 2010, ASTROPHYS J LETT, V718, pL145, DOI 10.1088/2041-8205/718/2/L145; Wu Y, 2003, ASTROPHYS J, V589, P605, DOI 10.1086/374598	47	85	85	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					567	+		10.1038/nature13521	http://dx.doi.org/10.1038/nature13521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079553	Green Submitted, Green Accepted			2022-12-28	WOS:000339566300029
J	Reik, W; Kelsey, G				Reik, Wolf; Kelsey, Gavin			EPIGENETICS Cellular memory erased in human embryos	NATURE			English	Editorial Material							DNA METHYLATION; PATERNAL GENOME; LANDSCAPE; OOCYTES		[Reik, Wolf; Kelsey, Gavin] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Reik, Wolf; Kelsey, Gavin] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 1TN, England; [Reik, Wolf] Wellcome Trust Sanger Inst, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Wellcome Trust Sanger Institute	Reik, W (corresponding author), Babraham Inst, Epigenet Programme, Babraham Res Campus, Cambridge CB22 3AT, England.		Reik, Wolf/I-6794-2012	Kelsey, Gavin/0000-0002-9762-5634; Reik, Wolf/0000-0003-0216-9881	Medical Research Council [MR/K011332/1] Funding Source: Medline; Wellcome Trust [095645] Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0403, BBS/E/B/0000H334] Funding Source: researchfish; BBSRC [BBS/E/B/0000H334, BBS/E/B/000C0403] Funding Source: UKRI; MRC [MR/K011332/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Proudhon C, 2012, MOL CELL, V47, P909, DOI 10.1016/j.molcel.2012.07.010; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240	15	13	14	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					540	541		10.1038/nature13648	http://dx.doi.org/10.1038/nature13648			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079550				2022-12-28	WOS:000339566300022
J	Mackey, J; Mohamed, S; Gvaramadze, VV; Kotak, R; Langer, N; Meyer, DMA; Moriya, TJ; Neilson, HR				Mackey, Jonathan; Mohamed, Shazrene; Gvaramadze, Vasilii V.; Kotak, Rubina; Langer, Norbert; Meyer, Dominique M-A; Moriya, Takashi J.; Neilson, Hilding R.			Interacting supernovae from photoionization-confined shells around red supergiant stars	NATURE			English	Article							BOW-SHOCK; MASSIVE STARS; CIRCUMSTELLAR INTERACTION; EMISSION; PROGENITORS; EVOLUTION; DISCOVERY; DENSITY; 2006GY; MODELS	Betelgeuse, a nearby red supergiant, is a fast-moving star with a powerful stellar wind that drives a bowshock into its surroundings1-4. This picture has been challenged by the discovery of a dense and almost static shell(5) that is three times closer to the star than the bow shock and has been decelerated by some external force. The two physically distinct structures cannot both be formed by the hydrodynamic interaction of the wind with the interstellar medium. Here we report that a model in which Betelgeuse's wind is photoionized by radiation from external sources can explain the static shell without requiring a new understanding of the bow shock. Pressure from the photoionized wind generates a standing shock in the neutral part of the wind6 and forms an almost static, photoionization-confined shell. Other red supergiants should have much more massive shells than Betelgeuse, because the photoionization-confined shell traps up to 35 per cent of all mass lost during the red supergiant phase, confining this gas close to the star until it explodes. After the supernova explosion, massive shells dramatically affect the supernova light curve, providing a natural explanation for the many supernovae that have signatures of circumstellar interaction.	[Mackey, Jonathan; Langer, Norbert; Meyer, Dominique M-A; Moriya, Takashi J.] Argelander Inst Astron, D-53121 Bonn, Germany; [Mohamed, Shazrene] S African Astron Observ, ZA-7935 Observatory, South Africa; [Gvaramadze, Vasilii V.] Moscow MV Lomonosov State Univ, Sternberg Astron Inst, Moscow 119992, Russia; [Gvaramadze, Vasilii V.] Isaac Newton Inst Chile, Moscow Branch, Moscow 119992, Russia; [Gvaramadze, Vasilii V.] Russian Acad Sci, Space Res Inst, Moscow 117997, Russia; [Kotak, Rubina] Queens Univ Belfast, Sch Math & Phys, Astrophys Res Ctr, Belfast BT7 1NN, Antrim, North Ireland; [Neilson, Hilding R.] E Tennessee State Univ, Dept Phys & Astron, Johnson City, TN 37614 USA	University of Bonn; National Research Foundation - South Africa; South African Astronomical Observatory; Lomonosov Moscow State University; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Queens University Belfast; East Tennessee State University	Mackey, J (corresponding author), Argelander Inst Astron, Hugel 71, D-53121 Bonn, Germany.	jmackey@astro.uni-bonn.de	Langer, Norbert/ABD-7263-2021; Kotak, Rubina/F-3325-2011; Mohamed, Shazrene/AHA-7739-2022; Meyer, Dominique M.-A./AAD-3379-2019	Kotak, Rubina/0000-0001-5455-3653; Meyer, Dominique M.-A./0000-0001-8258-9813; Moriya, Takashi/0000-0003-1169-1954; Neilson, Hilding/0000-0002-7322-7236; Mohamed, Shazrene/0000-0002-1856-9225; Mackey, Jonathan/0000-0002-5449-6131	Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [1573]; National Research Foundation (NRF) of South Africa; Japan Society for the Promotion of Science [26.51]; NSF [AST-0807664]; STFC [ST/L000709/1]; Direct For Mathematical & Physical Scien [0807664] Funding Source: National Science Foundation; Science and Technology Facilities Council [ST/L000709/1] Funding Source: researchfish	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NSF(National Science Foundation (NSF)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	J.M. and S. M. are grateful to P. Kervella, T. Le Bertre and G. Perrin, the organisers of the Betelgeuse Workshop in Paris (November 2012), where the ideas for this work were first developed. J.M. acknowledges funding from a fellowship from the Alexander von Humboldt Foundation and from the Deutsche Forschungsgemeinschaft priority program 1573, 'Physics of the Interstellar Medium'. S. M. acknowledges the receipt of research funding from the National Research Foundation (NRF) of South Africa. T.J.M. is supported by the Japan Society for the Promotion of Science Postdoctoral Fellowships for Research Abroad (26.51). H.R.N. acknowledges funding from a NSF grant (AST-0807664). R. K. acknowledges support from STFC (ST/L000709/1). The authors acknowledge the John von Neumann Institute for Computing for a grant of computing time on the JUROPA supercomputer at Julich Supercomputing Centre.	Asplund M, 2009, ANNU REV ASTRON ASTR, V47, P481, DOI 10.1146/annurev.astro.46.060407.145222; AXFORD WI, 1961, PHILOS TR R SOC S-A, V253, P301, DOI 10.1098/rsta.1961.0002; BROWN AGA, 1995, ASTRON ASTROPHYS, V300, P903; CHEVALIER RA, 1994, ASTROPHYS J, V420, P268, DOI 10.1086/173557; Decin L, 2012, ASTRON ASTROPHYS, V548, DOI 10.1051/0004-6361/201219792; Dougherty SM, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200913505; Fox OD, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/1/2; Gvaramadze VV, 2014, MON NOT R ASTRON SOC, V437, P843, DOI 10.1093/mnras/stt1943; Henney WJ, 2005, ASTROPHYS J, V627, P813, DOI 10.1086/430593; HUMMER DG, 1994, MON NOT R ASTRON SOC, V268, P109, DOI 10.1093/mnras/268.1.109; Kahn F. D., 1954, B ASTRON I NETH, V12, P187; Kotak R, 2009, ASTROPHYS J, V704, P306, DOI 10.1088/0004-637X/704/1/306; Langer N, 2012, ANNU REV ASTRON ASTR, V50, P107, DOI 10.1146/annurev-astro-081811-125534; Le Bertre T, 2012, MON NOT R ASTRON SOC, V422, P3433, DOI 10.1111/j.1365-2966.2012.20853.x; Mackey J, 2012, ASTRON ASTROPHYS, V539, DOI 10.1051/0004-6361/201117984; Mackey J, 2012, ASTROPHYS J LETT, V751, DOI 10.1088/2041-8205/751/1/L10; Mackey J, 2010, MON NOT R ASTRON SOC, V403, P714, DOI 10.1111/j.1365-2966.2009.16181.x; Martins F, 2005, ASTRON ASTROPHYS, V436, P1049, DOI 10.1051/0004-6361:20042386; Matzner CD, 1999, ASTROPHYS J, V510, P379, DOI 10.1086/306571; Meyer DMA, 2014, MON NOT R ASTRON SOC, V439, pL41, DOI 10.1093/mnrasl/slt176; Mihalas D., 1999, FDN RAD HYDRODYNAMIC, p[295, 611]; Mohamed S, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118002; Moriya TJ, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322992; Moriya TJ, 2014, MON NOT R ASTRON SOC, V439, P2917, DOI 10.1093/mnras/stu163; Moriya TJ, 2013, MON NOT R ASTRON SOC, V435, P1520, DOI 10.1093/mnras/stt1392; Moriya TJ, 2013, MON NOT R ASTRON SOC, V428, P1020, DOI 10.1093/mnras/sts075; MORRIS M, 1983, ASTROPHYS J, V267, P179, DOI 10.1086/160856; NoriegaCrespo A, 1997, ASTRON J, V114, P837, DOI 10.1086/118517; Ofek EO, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/2/104; Osterbrock D. E., 2005, ASTROPHYSICS GASEOUS, P19; PARKER EN, 1958, ASTROPHYS J, V128, P664, DOI 10.1086/146579; Quataert E, 2012, MON NOT R ASTRON SOC, V423, pL92, DOI 10.1111/j.1745-3933.2012.01264.x; Ritzerveld J, 2005, ASTRON ASTROPHYS, V439, pL23, DOI 10.1051/0004-6361:200500150; Rybicki G. B., 1979, RAD PROCESSES ASTROP, P8; Smartt SJ, 2009, ANNU REV ASTRON ASTR, V47, P63, DOI 10.1146/annurev-astro-082708-101737; Smith N, 2008, ASTROPHYS J, V686, P485, DOI 10.1086/590141; Smith N, 2007, ASTROPHYS J, V666, P1116, DOI 10.1086/519949; Smith N, 2009, ASTRON J, V137, P3558, DOI 10.1088/0004-6256/137/3/3558; Ueta T, 2008, PUBL ASTRON SOC JPN, V60, pS407, DOI 10.1093/pasj/60.sp2.S407; van Marle AJ, 2006, ASTRON ASTROPHYS, V460, P105, DOI 10.1051/0004-6361:20065709; van Marle AJ, 2014, ASTRON ASTROPHYS, V561, DOI 10.1051/0004-6361/201321968; van Marle AJ, 2010, MON NOT R ASTRON SOC, V407, P2305, DOI 10.1111/j.1365-2966.2010.16851.x; Williams RJR, 2009, MON NOT R ASTRON SOC, V400, P263, DOI 10.1111/j.1365-2966.2009.15447.x; Wright NJ, 2014, MON NOT R ASTRON SOC, V437, pL1, DOI 10.1093/mnrasl/slt127; Yoon SC, 2010, ASTROPHYS J LETT, V717, pL62, DOI 10.1088/2041-8205/717/1/L62; YUSEFZADEH F, 1991, ASTROPHYS J, V371, pL59, DOI 10.1086/186002	46	49	49	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					282	+		10.1038/nature13522	http://dx.doi.org/10.1038/nature13522			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119040	Green Submitted			2022-12-28	WOS:000340508200028
J	Romero, R; Dey, SK; Fisher, SJ				Romero, Roberto; Dey, Sudhansu K.; Fisher, Susan J.			Preterm labor: One syndrome, many causes	SCIENCE			English	Review							MATERNAL ANTIFETAL REJECTION; FETAL DNA; SYSTEMATIC ANALYSIS; INTRAUTERINE INFECTION; EXTRACELLULAR-MATRIX; PREMATURE RUPTURE; IDENTIFY PATIENTS; MEMBRANE RUPTURE; GENE-EXPRESSION; TIME TRENDS	Preterm birth is associated with 5 to 18% of pregnancies and is a leading cause of infant morbidity and mortality. Spontaneous preterm labor, a syndrome caused by multiple pathologic processes, leads to 70% of preterm births. The prevention and the treatment of preterm labor have been long-standing challenges. We summarize the current understanding of the mechanisms of disease implicated in this condition and review advances relevant to intra-amniotic infection, decidual senescence, and breakdown of maternal-fetal tolerance. The success of progestogen treatment to prevent preterm birth in a subset of patients at risk is a cause for optimism. Solving the mystery of preterm labor, which compromises the health of future generations, is a formidable scientific challenge worthy of investment.	[Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Program Perinatal Res & Obstet, Div Intramural Res,NIH, Bethesda, MD USA; [Romero, Roberto] Wayne State Univ, Detroit Med Ctr, Detroit, MI USA; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Dey, Sudhansu K.] Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Perinatal Inst, Cincinnati, OH 45229 USA; [Fisher, Susan J.] Univ Calif San Francisco, Dept Anat, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Fisher, Susan J.] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Detroit Medical Center; Wayne State University; University of Michigan System; University of Michigan; Michigan State University; Cincinnati Children's Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Romero, R (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Program Perinatal Res & Obstet, Div Intramural Res,NIH, Bethesda, MD USA.	romeror@mail.nih.gov	Romero, Roberto/A-5268-2019	Romero, Roberto/0000-0002-4448-5121	Division of Intramural Research of the Eunice Kennedy Shriver NICHD, NIH/Department of Health and Human Services; NIH [HD068524, DA06668]; March of Dimes [21-FY12-127, 22-FY14-470];  [R37 HD076253];  [U54 HD055764]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068524, R37HD076253, U54HD055764, ZIAHD002400, P50HD055764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA006668, R37DA006668] Funding Source: NIH RePORTER	Division of Intramural Research of the Eunice Kennedy Shriver NICHD, NIH/Department of Health and Human Services; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors regret that, because of page limitations, the contributions of many investigators to the study of parturition could not be credited in this article. The authors thank S. Curtis for editing the manuscript. The work of R. R. is supported by the Division of Intramural Research of the Eunice Kennedy Shriver NICHD, NIH/Department of Health and Human Services. Studies from S.K.D.'s lab were supported in part by grants from the NIH (HD068524 and DA06668) and March of Dimes (21-FY12-127 and 22-FY14-470). The work of S. F. is supported by R37 HD076253 and U54 HD055764. We thank M. Gormley for assistance preparing the figures.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001; Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; Bezold KY, 2013, GENOME MED, V5, DOI 10.1186/gm438; Bianchi DW, 2012, NAT MED, V18, P1041, DOI 10.1038/nm.2829; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009; CARROLL SG, 1995, ARCH DIS CHILD-FETAL, V72, pF43, DOI 10.1136/fn.72.1.F43; Cha J, 2013, J CLIN INVEST, V123, P4063, DOI 10.1172/JCI70098; Chaiworapongsa T, 2009, J MATERN-FETAL NEO M, V22, P1122, DOI 10.3109/14767050902994838; Condon JC, 2006, MOL ENDOCRINOL, V20, P764, DOI 10.1210/me.2005-0242; Elovitz MA, 2003, AM J PATHOL, V163, P2103, DOI 10.1016/S0002-9440(10)63567-5; Elovitz MA, 2000, AM J OBSTET GYNECOL, V183, P799, DOI 10.1067/mob.2000.108897; Erlebacher A, 2013, NAT REV IMMUNOL, V13, P23, DOI 10.1038/nri3361; Esplin S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.09.021; *EUN KENN SHRIV NI, 2014, HUM PLAC PROJ PLAC S; Farina A, 2005, AM J OBSTET GYNECOL, V193, P421, DOI 10.1016/j.ajog.2004.12.023; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gomez R, 1998, AM J OBSTET GYNECOL, V179, P194, DOI 10.1016/S0002-9378(98)70272-8; Gravett MG, 2004, JAMA-J AM MED ASSOC, V292, P462, DOI 10.1001/jama.292.4.462; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Han CS, 2011, CLIN PERINATOL, V38, P407, DOI 10.1016/j.clp.2011.06.001; Heng YJJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096901; Hirota Y, 2010, J CLIN INVEST, V120, P803, DOI 10.1172/JCI40051; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Jakobsen TR, 2012, PRENATAL DIAG, V32, P840, DOI 10.1002/pd.3917; Jobe AH, 2010, PEDIATR NEONATOL, V51, P7, DOI 10.1016/S1875-9572(10)60003-4; Kannan S, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003162; Kim CJ, 2010, MODERN PATHOL, V23, P1000, DOI 10.1038/modpathol.2010.73; Kim MJ, 2009, LAB INVEST, V89, P924, DOI 10.1038/labinvest.2009.49; Kim YM, 2003, AM J OBSTET GYNECOL, V189, P1063, DOI 10.1067/S0002-9378(03)00838-X; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Lee J, 2013, AM J REPROD IMMUNOL, V70, P265, DOI 10.1111/aji.12142; Lee J, 2013, AM J REPROD IMMUNOL, V70, P162, DOI 10.1111/aji.12141; Lee J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016806, 10.1371/journal.pone.0020933]; Leung TN, 1998, LANCET, V352, P1904, DOI 10.1016/S0140-6736(05)60395-9; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Macones GA, 2004, AM J OBSTET GYNECOL, V190, P1504, DOI 10.1016/j.ajog.2004.01.001; Madianos PN, 2013, J CLIN PERIODONTOL, V40, pS170, DOI [10.1902/jop.2013.1340015, 10.1111/jcpe.12082]; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; McDonagh S, 2004, J INFECT DIS, V190, P826, DOI 10.1086/422330; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Menon R, 2007, BEST PRACT RES CL OB, V21, P467, DOI 10.1016/j.bpobgyn.2007.01.008; Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511; Moore RM, 2006, PLACENTA, V27, P1037, DOI 10.1016/j.placenta.2006.01.002; Muglia LJ, 2010, NEW ENGL J MED, V362, P529, DOI 10.1056/NEJMra0904308; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; *NAT RES COUNC, 2007, PRETERM BIRTH CAUSES, P400; Petraglia F, 2010, ENDOCR REV, V31, P783, DOI 10.1210/er.2009-0019; Phillippe M, 2014, NEW ENGL J MED, V370, P2534, DOI 10.1056/NEJMcibr1404324; Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661; Renthal NE, 2013, NAT REV ENDOCRINOL, V9, P391, DOI 10.1038/nrendo.2013.96; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4; Romero R, 2013, J PERINAT MED, V41, P27, DOI 10.1515/jpm-2012-0272; Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Scharfe-Nugent A, 2012, J IMMUNOL, V188, P5706, DOI 10.4049/jimmunol.1103454; Shynlova O, 2009, EUR J OBSTET GYN R B, V144, pS2, DOI 10.1016/j.ejogrb.2009.02.044; Strauss JF, 2013, REPROD SCI, V20, P140, DOI 10.1177/1933719111424454; Tan HQ, 2012, J CLIN ENDOCR METAB, V97, pE719, DOI 10.1210/jc.2011-3251; Thaxton JE, 2009, J IMMUNOL, V183, P1144, DOI 10.4049/jimmunol.0900788; Waldorf KA, 2014, REPROD SCI, V21, p96A; Wang H, 2008, HUM MOL GENET, V17, P1087, DOI 10.1093/hmg/ddm381; Wegorzewska M, 2014, J IMMUNOL, V192, P1938, DOI 10.4049/jimmunol.1302403; Whidbey C, 2013, J EXP MED, V210, P1265, DOI 10.1084/jem.20122753	73	1055	1114	8	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					760	765		10.1126/science.1251816	http://dx.doi.org/10.1126/science.1251816			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124429	Green Published, Green Accepted			2022-12-28	WOS:000340593100033
J	Susiarjo, M; Bartolomei, MS				Susiarjo, Martha; Bartolomei, Marisa S.			EPIGENETICS You are what you eat, but what about your DNA?	SCIENCE			English	Editorial Material							IN-UTERO UNDERNUTRITION		[Susiarjo, Martha; Bartolomei, Marisa S.] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Susiarjo, M (corresponding author), Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	bartolom@mail.med.upenn.edu		Bartolomei, Marisa/0000-0001-9410-5222	NIEHS NIH HHS [P30 ES013508] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kaati G, 2002, EUR J HUM GENET, V10, P682, DOI 10.1038/sj.ejhg.5200859; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Martinez D, 2014, CELL METAB, V19, P941, DOI 10.1016/j.cmet.2014.03.026; Park HJ, 2008, J CLIN INVEST, V118, P259, DOI 10.1172/JCI32011; Radford EJ, 2014, SCIENCE, V345, P785, DOI 10.1126/science.1255903; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001	10	9	10	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					733	734		10.1126/science.1258654	http://dx.doi.org/10.1126/science.1258654			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124413				2022-12-28	WOS:000340593100015
J	Wine, JJ				Wine, Jeffrey J.			MEDICINE Letting go of mucus	SCIENCE			English	Editorial Material							SUBMUCOSAL GLANDS; CYSTIC-FIBROSIS; FLUID SECRETION; TRANSPORT; MODEL		Stanford Univ, Dept Psychol, CF Res Lab, Stanford, CA 94305 USA	Stanford University	Wine, JJ (corresponding author), Stanford Univ, Dept Psychol, CF Res Lab, Stanford, CA 94305 USA.	wine@stanford.edu						Ballard ST, 2007, RESP PHYSIOL NEUROBI, V159, P271, DOI 10.1016/j.resp.2007.06.017; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; Hoegger MJ, 2014, SCIENCE, V345, P818, DOI 10.1126/science.1255825; Inglis SK, 1998, AM J PHYSIOL-LUNG C, V274, pL762, DOI 10.1152/ajplung.1998.274.5.L762; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Joo NS, 2002, J BIOL CHEM, V277, P28167, DOI 10.1074/jbc.M202712200; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lee RJ, 2010, AM J PHYSIOL-LUNG C, V298, pL210, DOI 10.1152/ajplung.00342.2009; Quinton PM, 2010, AM J PHYSIOL-CELL PH, V299, pC1222, DOI 10.1152/ajpcell.00362.2010; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Stoltz DA, 2013, J CLIN INVEST, V123, P2685, DOI 10.1172/JCI68867; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015	13	1	1	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					730	731		10.1126/science.1258493	http://dx.doi.org/10.1126/science.1258493			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124411				2022-12-28	WOS:000340593100013
J	Cox, LM; Yamanishi, S; Sohn, J; Alekseyenko, AV; Leung, JM; Cho, I; Kim, SG; Li, H; Gao, Z; Mahana, D; Rodriguez, JGZ; Rogers, AB; Robine, N; Loke, P; Blaser, MJ				Cox, Laura M.; Yamanishi, Shingo; Sohn, Jiho; Alekseyenko, Alexander V.; Leung, Jacqueline M.; Cho, Ilseung; Kim, Sungheon G.; Li, Huilin; Gao, Zhan; Mahana, Douglas; Rodriguez, Jorge G. Zarate; Rogers, Arlin B.; Robine, Nicolas; Loke, P'ng; Blaser, Martin J.			Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences	CELL			English	Article							DIET-INDUCED OBESITY; GUT MICROBIOTA; INDIGENOUS MICROBES; DELIVERY MODE; WEIGHT-GAIN; MICE; ANTIBIOTICS; FAT; ADIPOSITY; CHILDHOOD	Acquisition of the intestinal microbiota begins at birth, and a stable microbial community develops from a succession of key organisms. Disruption of the microbiota during maturation by low-dose antibiotic exposure can alter host metabolism and adiposity. We now show that low-dose penicillin (LDP), delivered from birth, induces metabolic alterations and affects ileal expression of genes involved in immunity. LDP that is limited to early life transiently perturbs the microbiota, which is sufficient to induce sustained effects on body composition, indicating that microbiota interactions in infancy may be critical determinants of long-term host metabolic effects. In addition, LDP enhances the effect of high-fat diet induced obesity. The growth promotion phenotype is transferrable to germ-free hosts by LDP-selected microbiota, showing that the altered microbiota, not antibiotics per se, play a causal role. These studies characterize important variables in early-life microbe-host metabolic interaction and identify several taxa consistently linked with metabolic alterations.	[Cox, Laura M.; Leung, Jacqueline M.; Mahana, Douglas; Loke, P'ng; Blaser, Martin J.] NYU, Langone Med Ctr, Dept Microbiol, New York, NY 10016 USA; [Cox, Laura M.; Yamanishi, Shingo; Sohn, Jiho; Alekseyenko, Alexander V.; Cho, Ilseung; Gao, Zhan; Blaser, Martin J.] NYU, Langone Med Ctr, Dept Med, New York, NY 10016 USA; [Alekseyenko, Alexander V.] NYU, Langone Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Kim, Sungheon G.] NYU, Langone Med Ctr, Dept Radiol, New York, NY 10016 USA; [Li, Huilin] NYU, Langone Med Ctr, Dept Populat Hlth Biostatist, New York, NY 10016 USA; [Li, Huilin] NYU, Langone Med Ctr, Dept Environm Med, New York, NY 10016 USA; [Rogers, Arlin B.] Tufts Univ, Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA; [Rodriguez, Jorge G. Zarate] NYU, Dept Biol, Abu Dhabi, U Arab Emirates; [Robine, Nicolas] New York Genome Ctr, New York, NY 10013 USA; [Blaser, Martin J.] Vet Affairs Med Ctr, New York Harbor Dept, New York, NY 10010 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Tufts University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Blaser, MJ (corresponding author), NYU, Langone Med Ctr, Dept Microbiol, New York, NY 10016 USA.	martin.blaser@nyumc.org	Blaser, Martin/ABF-6878-2021; Loke, Png/X-2278-2019; Zarate, Jorge/GLR-3294-2022; Cox, Laura/ABG-5883-2020	Zarate, Jorge/0000-0002-6790-7729; Cox, Laura/0000-0002-9564-9894; Gao, Zhan/0000-0003-0976-8836; Kim, S. Gene/0000-0002-6288-0678; Alekseyenko, Alexander/0000-0002-5748-2085; Cho, Ilseung/0000-0002-7308-8707; Robine, Nicolas/0000-0001-5698-8183; Sohn, Jiho/0000-0001-6728-136X; Li, Huilin/0000-0002-8288-7068; Leung, Jacqueline/0000-0002-1963-3380	NIH [R01 DK 090989, 1UL1RR029893]; Diane Belfer Program in Human Microbial Ecology; Knapp Family Foundation; Daniel Ziff Foundation; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diane Belfer Program in Human Microbial Ecology; Knapp Family Foundation; Daniel Ziff Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We acknowledge assistance with sequencing from Argonne National Laboratory and NYULMC Genome Technology Center and help from the NYULMC Histology Core and the New York Genome Center. These studies were supported by NIH grants R01 DK 090989 and 1UL1RR029893, the Diane Belfer Program in Human Microbial Ecology, Knapp Family Foundation, and Daniel Ziff Foundation.	Ajslev TA, 2011, INT J OBESITY, V35, P522, DOI 10.1038/ijo.2011.27; Anders S., 2014, HTSEQ PYTHON FRAMEWO; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 1849, P NATL ACAD SCI PHIL; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Antunes LCM, 2011, GUT MICROBES, V2, P105, DOI 10.4161/gmic.2.2.15610; Beijerinck MW., 1901, ARCH NEERLANDAISES S, V6, P212; Blaser MJ, 2006, EMBO REP, V7, P956, DOI 10.1038/sj.embor.7400812; Bluher M, 2010, CURR OPIN LIPIDOL, V21, P38, DOI 10.1097/MOL.0b013e3283346ccc; Blustein J, 2013, INT J OBESITY, V37, P900, DOI 10.1038/ijo.2013.49; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chai G, 2012, PEDIATRICS, V130, P23, DOI 10.1542/peds.2011-2879; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037; Clavenna A, 2011, ARCH DIS CHILD, V96, P590, DOI 10.1136/adc.2010.183541; COATES ME, 1963, BRIT J NUTR, V17, P141, DOI 10.1079/BJN19630015; COLLINS MD, 1985, SYST APPL MICROBIOL, V6, P79, DOI 10.1016/S0723-2020(85)80015-1; Cox LM, 2013, CELL METAB, V17, P883, DOI 10.1016/j.cmet.2013.05.004; Cromwell GL, 2002, ANIM BIOTECHNOL, V13, P7, DOI 10.1081/ABIO-120005767; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; DAVIS CP, 1976, INFECT IMMUN, V13, P180, DOI 10.1128/IAI.13.1.180-188.1976; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; DUBOS R, 1963, J EXP MED, V117, P245, DOI 10.1084/jem.117.2.245; Erturk-Hasdemir D, 2013, CURR OPIN IMMUNOL, V25, P450, DOI 10.1016/j.coi.2013.06.001; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Gaskins HR, 2002, ANIM BIOTECHNOL, V13, P29, DOI 10.1081/ABIO-120005768; Goyal A., 2012, GLOBAL J MED RES, V12, P39; Greetham HL, 2004, ANAEROBE, V10, P301, DOI 10.1016/j.anaerobe.2004.06.004; Grudell April B M, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P52, DOI 10.1097/MED.0b013e3280123119; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Huh SY, 2012, ARCH DIS CHILD, V97, P610, DOI 10.1136/archdischild-2011-301141; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jiang HQ, 2001, INFECT IMMUN, V69, P3611, DOI 10.1128/IAI.69.6.3611-3617.2001; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Karlsson CLJ, 2011, BRIT J NUTR, V106, P887, DOI 10.1017/S0007114511001036; KNITTLE JL, 1968, J CLIN INVEST, V47, P2091, DOI 10.1172/JCI105894; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Million M, 2012, MICROB PATHOGENESIS, V53, P100, DOI 10.1016/j.micpath.2012.05.007; Morrison CD, 2009, BBA-MOL BASIS DIS, V1792, P409, DOI 10.1016/j.bbadis.2008.09.005; Murphy R, 2013, INT J OBES LOND; Pantoja-Feliciano IG, 2013, ISME J, V7, P1112, DOI 10.1038/ismej.2013.15; Pettersson US, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046057; Rasouli N, 2007, DIABETES OBES METAB, V9, P1, DOI 10.1111/j.1463-1326.2006.00590.x; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Reeder SB, 2005, MAGNET RESON MED, V54, P636, DOI 10.1002/mrm.20624; Reeder SB, 2004, MAGNET RESON MED, V51, P35, DOI 10.1002/mrm.10675; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; SCHAEDLER RW, 1965, J EXP MED, V122, P59, DOI 10.1084/jem.122.1.59; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Trasande L, 2013, INT J OBESITY, V37, P16, DOI 10.1038/ijo.2012.132; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; VISEK WJ, 1978, J ANIM SCI, V46, P1447, DOI 10.2527/jas1978.4651447x; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	70	1112	1182	21	318	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					705	721		10.1016/j.cell.2014.05.052	http://dx.doi.org/10.1016/j.cell.2014.05.052			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126780	Green Accepted, Bronze			2022-12-28	WOS:000340944700005
J	Merolla, PA; Arthur, JV; Alvarez-Icaza, R; Cassidy, AS; Sawada, J; Akopyan, F; Jackson, BL; Imam, N; Guo, C; Nakamura, Y; Brezzo, B; Vo, I; Esser, SK; Appuswamy, R; Taba, B; Amir, A; Flickner, MD; Risk, WP; Manohar, R; Modha, DS				Merolla, Paul A.; Arthur, John V.; Alvarez-Icaza, Rodrigo; Cassidy, Andrew S.; Sawada, Jun; Akopyan, Filipp; Jackson, Bryan L.; Imam, Nabil; Guo, Chen; Nakamura, Yutaka; Brezzo, Bernard; Vo, Ivan; Esser, Steven K.; Appuswamy, Rathinakumar; Taba, Brian; Amir, Arnon; Flickner, Myron D.; Risk, William P.; Manohar, Rajit; Modha, Dharmendra S.			A million spiking-neuron integrated circuit with a scalable communication network and interface	SCIENCE			English	Article							ARCHITECTURE	Inspired by the brain's structure, we have developed an efficient, scalable, and flexible non-von Neumann architecture that leverages contemporary silicon technology. To demonstrate, we built a 5.4-billion-transistor chip with 4096 neurosynaptic cores interconnected via an intrachip network that integrates 1 million programmable spiking neurons and 256 million configurable synapses. Chips can be tiled in two dimensions via an interchip communication interface, seamlessly scaling the architecture to a cortexlike sheet of arbitrary size. The architecture is well suited to many applications that use complex neural networks in real time, for example, multiobject detection and classification. With 400-pixel-by-240-pixel video input at 30 frames per second, the chip consumes 63 milliwatts.	[Merolla, Paul A.; Arthur, John V.; Alvarez-Icaza, Rodrigo; Cassidy, Andrew S.; Akopyan, Filipp; Jackson, Bryan L.; Esser, Steven K.; Appuswamy, Rathinakumar; Taba, Brian; Amir, Arnon; Flickner, Myron D.; Risk, William P.; Modha, Dharmendra S.] IBM Res Almaden, San Jose, CA 95120 USA; [Sawada, Jun; Vo, Ivan] IBM Res Austin, Austin, TX 78758 USA; [Imam, Nabil] Cornell Univ, Ithaca, NY 14853 USA; [Guo, Chen] IBM Engn & Technol Serv, San Jose Design Ctr, San Jose, CA 95120 USA; [Nakamura, Yutaka] IBM Res Tokyo, Koto Ku, Tokyo 1358511, Japan; [Brezzo, Bernard] IBM TJ Watson Res Ctr, Yorktown Hts, NY 10598 USA; [Manohar, Rajit] Cornell Tech, New York, NY 10011 USA	International Business Machines (IBM); Cornell University; International Business Machines (IBM); International Business Machines (IBM)	Modha, DS (corresponding author), IBM Res Almaden, 650 Harry Rd, San Jose, CA 95120 USA.	dmodha@us.ibm.com		Alvarez-Icaza, Rodrigo/0000-0002-5737-3719	Defense Advanced Research Projects Agency (DARPA) [HR0011-09-C-0002]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This research was sponsored by Defense Advanced Research Projects Agency (DARPA) under contract no. HR0011-09-C-0002. The views and conclusions contained herein are those of the authors and should not be interpreted as representing the official policies, either expressly or implied, of DARPA or the U.S. Government. U.S. patents 8473439 and 8515885 and U.S. patent applications 13/235,341 and 13/434,733 pertain to aspects of this work. We are grateful to many collaborators: A. Agrawal, A. Andreopoulos, S. Asaad, C. Baks, D. Barch, M Beakes, R. Bellofatto, D. Berg, J. Bong, T. Christensen, A. Cox, P. Datta, D. Friedman, S. Gilson, J. Guan, S. Hall, R. Haring, C. Haymes, J. Ho, S. Iyer, J. Krawiecki, J. Kusnitz, J. Liu, J. B. Kuang, E. McQuinn, R. Mousalli, B. Nathanson, T. Nayak, D. Nguyen, H. Nguyen, T. Nguyen, N. Pass, K. Prasad, M. Ohmacht, C. Ortega-Otero, Z. Saliba, D. L. Satterfield, J.-s. Seo, B. Shaw, K. Shimohashi, K. Shiraishi, A. Shokoubakhsh, R. Singh, T. Takken, F. Tsai, J. Tierno, K. Wecker, S.-y. Wang, and T. Wong. We thank two anonymous reviewers for their thoughtful comments.	[Anonymous], INT JOINT C NEUR NET; [Anonymous], 2013, INT JT C NEURAL NETW, DOI DOI 10.1109/IJCNN.2013.6707077; [Anonymous], THESIS PRINCETON U P; [Anonymous], 1994, SPRINGER INT SERIES; [Anonymous], 2011, DIGITAL NEUROSYNAPTI; [Anonymous], CUST INT CIRC C CICC; [Anonymous], 2013, P 2013 INT JOINT C N, DOI DOI 10.1109/IJCNN.2013.6706927; BACKUS J, 1978, COMMUN ACM, V21, P613, DOI 10.1145/359576.359579; Benjamin B, 2014, P IEEE, V102, P699, DOI 10.1109/JPROC.2014.2313565; Churchland PS, 2017, COMPUT NEUROSCI-MIT; Dally WJ, 2001, DES AUT CON, P684, DOI 10.1109/DAC.2001.935594; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Eliasmith C, 2012, SCIENCE, V338, P1202, DOI 10.1126/science.1225266; Hahnloser RHR, 2000, NATURE, V405, P947, DOI 10.1038/35016072; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Indiveri G, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00073; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Liu SC, 2010, CURR OPIN NEUROBIOL, V20, P288, DOI 10.1016/j.conb.2010.03.007; MAHOWALD M, 1991, NATURE, V354, P515, DOI 10.1038/354515a0; Mead C.A., 1989, ANALOG VLSI NEURAL S; MISHKIN M, 1983, TRENDS NEUROSCI, V6, P414, DOI 10.1016/0166-2236(83)90190-X; Modha DS, 2010, P NATL ACAD SCI USA, V107, P13485, DOI 10.1073/pnas.1008054107; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Ohno T, 2011, NAT MATER, V10, P591, DOI [10.1038/NMAT3054, 10.1038/nmat3054]; Preissl R, 2012, INT CONF HIGH PERFOR; Schemmel Johannes, 2012, 2012 IEEE International Symposium on Circuits and Systems - ISCAS 2012, DOI 10.1109/ISCAS.2012.6272131; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Teifel J, 2004, INT SYMP ASYNCHRON C, P17, DOI 10.1109/ASYNC.2004.1299284; Von Neumann J., 2012, COMPUTER BRAIN; Yu T, 2012, BIOMED CIRC SYST C, P21, DOI 10.1109/BioCAS.2012.6418479	30	2113	2181	81	725	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					668	673		10.1126/science.1254642	http://dx.doi.org/10.1126/science.1254642			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104385				2022-12-28	WOS:000339962800038
J	Vigevani, L; Valcarcel, J				Vigevani, Luisa; Valcarcel, Juan			MOLECULAR BIOLOGY A splicing magic bullet	SCIENCE			English	Editorial Material							MOUSE MODEL		[Vigevani, Luisa; Valcarcel, Juan] Ctr Regulacio Genom, Barcelona 08003, Spain; [Vigevani, Luisa; Valcarcel, Juan] Univ Pompeu Fabra, Barcelona 08003, Spain; [Valcarcel, Juan] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA	Vigevani, L (corresponding author), Ctr Regulacio Genom, Dr Aiguader 88, Barcelona 08003, Spain.	luisa.vigevani@crg.eu; juan.valcarcel@crg.eu	Vigevani, Luisa/K-1995-2015; Valcarcel, Juan/O-9814-2014	Vigevani, Luisa/0000-0002-2590-8141; Valcarcel, Juan/0000-0001-5398-3571	ICREA Funding Source: Custom	ICREA(ICREA)		Bonnal S, 2012, NAT REV DRUG DISCOV, V11, P847, DOI 10.1038/nrd3823; Hua YM, 2011, NATURE, V478, P123, DOI 10.1038/nature10485; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; Kariya S, 2014, J CLIN INVEST, V124, P785, DOI 10.1172/JCI72017; Kolb SJ, 2011, ARCH NEUROL-CHICAGO, V68, P979, DOI 10.1001/archneurol.2011.74; Li D. K., 2014, SEM CELL DEV BIOL; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Monani UR, 2014, FUTUR NEUROL, V9, P49, DOI 10.2217/FNL.13.58; Naryshkin NA, 2014, SCIENCE, V345, P688, DOI 10.1126/science.1250127; Strebhardt K, 2008, NAT REV CANCER, V8, P473, DOI 10.1038/nrc2394; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zheng SX, 2009, CHEM BIOL, V16, P557, DOI 10.1016/j.chembiol.2009.03.009	12	3	3	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					624	625		10.1126/science.1258444	http://dx.doi.org/10.1126/science.1258444			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104373				2022-12-28	WOS:000339962800021
J	Chung, WH; Chang, WC; Lee, YS; Wu, YY; Yang, CH; Ho, HC; Chen, MJ; Lin, JY; Hui, RCY; Ho, JC; Wu, WM; Chen, TJ; Wu, T; Wu, YR; Hsih, MS; Tu, PH; Chang, CN; Hsu, CN; Wu, TL; Choon, SE; Hsu, CK; Chen, DY; Liu, CS; Lin, CY; Kaniwa, N; Saito, Y; Takahashi, Y; Nakamura, R; Azukizawa, H; Shi, YY; Wang, TH; Chuang, SS; Tsai, SF; Chang, CJ; Chang, YS; Hung, SI				Chung, Wen-Hung; Chang, Wan-Chun; Lee, Yun-Shien; Wu, Ying-Ying; Yang, Chih-Hsun; Ho, Hsin-Chun; Chen, Ming-Jing; Lin, Jing-Yi; Hui, Rosaline Chung-Yee; Ho, Ji-Chen; Wu, Wei-Ming; Chen, Ting-Jui; Wu, Tony; Wu, Yih-Ru; Hsih, Mo-Song; Tu, Po-Hsun; Chang, Chen-Nen; Hsu, Chien-Ning; Wu, Tsu-Lan; Choon, Siew-Eng; Hsu, Chao-Kai; Chen, Der-Yuan; Liu, Chin-San; Lin, Ching-Yuang; Kaniwa, Nahoko; Saito, Yoshiro; Takahashi, Yukitoshi; Nakamura, Ryosuke; Azukizawa, Hiroaki; Shi, Yongyong; Wang, Tzu-Hao; Chuang, Shiow-Shuh; Tsai, Shih-Feng; Chang, Chee-Jen; Chang, Yu-Sun; Hung, Shuen-Iu		Taiwan Severe Cutaneous Adverse; Japan Pharmacogenomics Data Sci	Genetic Variants Associated With Phenytoin-Related Severe Cutaneous Adverse Reactions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STEVENS-JOHNSON-SYNDROME; TOXIC EPIDERMAL NECROLYSIS; INDUCED HYPERSENSITIVITY REACTIONS; DRUG-REACTIONS; ANTIEPILEPTIC DRUGS; HAN CHINESE; HLA-B-ASTERISK-1502 ALLELE; RISK-FACTOR; HLA-B; CARBAMAZEPINE	IMPORTANCE The antiepileptic drug phenytoin can cause cutaneous adverse reactions, ranging from maculopapular exanthema to severe cutaneous adverse reactions, which include drug reactions with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, and toxic epidermal necrolysis. The pharmacogenomic basis of phenytoin-related severe cutaneous adverse reactions remains unknown. OBJECTIVE To investigate the genetic factors associated with phenytoin-related severe cutaneous adverse reactions. DESIGN, SETTING, AND PARTICIPANTS Case-control study conducted in 2002-2014 among 105 cases with phenytoin-related severe cutaneous adverse reactions (n=61 Stevens-Johnson syndrome/toxic epidermal necrolysis and n=44 drug reactions with eosinophilia and systemic symptoms), 78 cases with maculopapular exanthema, 130 phenytoin-tolerant control participants, and 3655 population controls from Taiwan, Japan, and Malaysia. A genome-wide association study (GWAS), direct sequencing of the associated loci, and replication analysis were conducted using the samples from Taiwan. The initial GWAS included samples of 60 cases with phenytoin-related severe cutaneous adverse reactions and 412 population controls from Taiwan. The results were validated in (1) 30 cases with severe cutaneous adverse reactions and 130 phenytoin-tolerant controls from Taiwan, (2) 9 patients with Stevens-Johnson syndrome/toxic epidermal necrolysis and 2869 population controls from Japan, and (3) 6 cases and 374 population controls from Malaysia. MAIN OUTCOMES AND MEASURES Specific genetic factors associated with phenytoin-related severe cutaneous adverse reactions. RESULTS The GWAS discovered a cluster of 16 single-nucleotide polymorphisms in CYP2C genes at 10q23.33 that reached genome-wide significance. Direct sequencing of CYP2C identified missense variant rs1057910 (CYP2C9*3) that showed significant association with phenytoin-related severe cutaneous adverse reactions (odds ratio, 12; 95% CI, 6.6-20; P=1.1 x 10-1). The statistically significant association between CYP2C9*3 and phenytoin-related severe cutaneous adverse reactions was observed in additional samples from Taiwan, Japan, and Malaysia. Ameta-analysis using the data from the 3 populations showed an overall odds ratio of 11 (95% CI, 6.2-18; z=8.58; P < .00001) for CYP2C9* 3 association with phenytoin-related severe cutaneous adverse reactions. Delayed clearance of plasma phenytoin was detected in patients with severe cutaneous adverse reactions, especially CYP2C9* 3 carriers, providing a functional link of the associated variants to the disease. CONCLUSIONS AND RELEVANCE This study identified CYP2C variants, including CYP2C9* 3, known to reduce drug clearance, as important genetic factors associated with phenytoin-related severe cutaneous adverse reactions.	[Chung, Wen-Hung; Ho, Hsin-Chun; Lin, Jing-Yi] Chang Gung Mem Hosp, Dept Dermatol, Keelung, Taiwan; [Chung, Wen-Hung; Yang, Chih-Hsun; Chen, Ming-Jing; Hui, Rosaline Chung-Yee] Chang Gung Mem Hosp, Dept Dermatol, Drug Hypersensit Clin & Res Ctr, Linkou, Taiwan; [Chung, Wen-Hung; Yang, Chih-Hsun; Ho, Hsin-Chun; Chen, Ming-Jing; Lin, Jing-Yi; Hui, Rosaline Chung-Yee; Ho, Ji-Chen; Wu, Wei-Ming; Wu, Tony; Wu, Yih-Ru; Hsih, Mo-Song; Tu, Po-Hsun; Chang, Chen-Nen; Hsu, Chien-Ning; Wu, Tsu-Lan; Wang, Tzu-Hao; Chuang, Shiow-Shuh; Chang, Chee-Jen] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Chang, Wan-Chun; Wu, Ying-Ying; Chen, Ting-Jui; Hung, Shuen-Iu] Natl Yang Ming Univ, Inst Pharmacol, Sch Med, Taipei 112, Taiwan; [Lee, Yun-Shien] Ming Chuan Univ, Dept Biotechnol, Taoyuan, Taiwan; [Ho, Hsin-Chun; Wu, Wei-Ming] Chang Gung Mem Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Chen, Ting-Jui] Taipei Med Univ, Wan Fang Hosp, Dept Dermatol, Taipei, Taiwan; [Wu, Tony; Wu, Yih-Ru; Hsih, Mo-Song] Chang Gung Mem Hosp, Dept Neurol, Linkou, Taiwan; [Tu, Po-Hsun; Chang, Chen-Nen] Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan; [Hsu, Chien-Ning] Chang Gung Mem Hosp, Dept Pharm, Kaohsiung, Taiwan; [Wu, Tsu-Lan] Chang Gung Mem Hosp, Dept Lab Med, Linkou, Taiwan; [Choon, Siew-Eng] Hosp Sultanah Aminah Johor Bahru, Dept Dermatol, Johor Baharu, Malaysia; [Hsu, Chao-Kai] Natl Cheng Kung Univ, Coll Med, Dept Dermatol, Tainan 70101, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Rheumatol, Taichung, Taiwan; [Liu, Chin-San] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Lin, Ching-Yuang] China Med Univ, Dept Pediat, Taichung, Taiwan; [Kaniwa, Nahoko; Saito, Yoshiro; Nakamura, Ryosuke] Natl Inst Hlth Sci, Div Med Safety Sci, Tokyo, Japan; [Takahashi, Yukitoshi] Shizuoka Inst Epilepsy & Neurol Disorders, Natl Epilepsy Ctr, Dept Clin Res, Shizuoka, Japan; [Azukizawa, Hiroaki] Osaka Univ, Grad Sch Med, Course Integrated Med, Dept Dermatol, Suita, Osaka, Japan; [Shi, Yongyong] Shanghai Genome Pilot Inst Genom & Human Hlth, Shanghai, Peoples R China; [Wang, Tzu-Hao] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Linkou, Taiwan; [Wang, Tzu-Hao] Chang Gung Mem Hosp, Genom Med Res Core Lab, Linkou, Taiwan; [Chuang, Shiow-Shuh] Chang Gung Mem Hosp, Dept Plast Surg, Linkou, Taiwan; [Chuang, Shiow-Shuh] Chang Gung Mem Hosp, Burn Ctr, Linkou, Taiwan; [Tsai, Shih-Feng] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan, Miaoli, Taiwan; [Chang, Chee-Jen] Chang Gung Mem Hosp, Biostat Ctr Clin Res, Linkou, Taiwan; [Chang, Yu-Sun] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University; Ming Chuan University; Chang Gung Memorial Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Cheng Kung University; Taichung Veterans General Hospital; Changhua Christian Hospital; China Medical University Taiwan; National Institute of Health Sciences - Japan; Osaka University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University	Chung, WH (corresponding author), Chang Gung Mem Hosp, Dept Dermatol, 5 Fusing St, Taoyuan 333, Taiwan.	chung1@cgmh.org.tw; sihung@ym.edu.tw	Chang, Wan-Chun/AAG-3728-2020; Hung, Shuen-Iu/HHS-9012-2022; Shi, Yongyong/GSO-1627-2022; Hung, Shuen-Iu/ABB-2139-2021; Hsu, Chien-Ning/GLS-4014-2022; Tsai, Shih-Feng/E-3997-2010; CHOON, SIEW ENG/AAU-8192-2021	Chang, Wan-Chun/0000-0001-7069-7083; Shi, Yongyong/0000-0003-1710-1505; Hung, Shuen-Iu/0000-0001-6531-5538; Hsu, Chien-Ning/0000-0001-7470-528X; CHOON, SIEW ENG/0000-0002-7796-5746; Chang, Chee Jen/0000-0002-7725-7555; Hsu, Chao-Kai/0000-0003-4365-4533; Chang, Yu-Sun/0000-0002-6457-3890; Takahashi, Yukitoshi/0000-0002-1922-8967	National Science Council, Taiwan [NSC101-2320-B-010-072-MY3, NSC101-2321-B-010-027, NSC101-2628-B-182-001-MY3, NSC101-2321-B-182008, NSC102-2314-B-010-014-MY3]; National Core Facility Program for Biotechnology (Bioinformatics Consortium of Taiwan [NSC100-2319-B-010-002]; Chang Gung Memorial Hospital [OMRPG-2C0011, OMRPG-2C0021, CMRPG-290051-3, CMRPG-3D0351]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Core Facility Program for Biotechnology (Bioinformatics Consortium of Taiwan; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the National Science Council, Taiwan (grants NSC101-2320-B-010-072-MY3, NSC101-2321-B-010-027, NSC101-2628-B-182-001-MY3, NSC101-2321-B-182008, and NSC102-2314-B-010-014-MY3), the National Core Facility Program for Biotechnology (Bioinformatics Consortium of Taiwan; grant NSC100-2319-B-010-002) for statistical assistance, and Chang Gung Memorial Hospital (grants OMRPG-2C0011, OMRPG-2C0021, CMRPG-290051-3, and CMRPG-3D0351).	Arif H, 2007, NEUROLOGY, V68, P1701, DOI 10.1212/01.wnl.0000261917.83337.db; Cheung YK, 2013, EPILEPSIA, V54, P1307, DOI 10.1111/epi.12217; Chung WH, 2008, NAT MED, V14, P1343, DOI 10.1038/nm.1884; Chung WH, 2004, NATURE, V428, P486, DOI 10.1038/428486a; Depondt C, 2011, EUR J NEUROL, V18, P1159, DOI 10.1111/j.1468-1331.2011.03361.x; Fields MC, 2013, JAMA NEUROL, V70, P360, DOI 10.1001/2013.jamaneurol.337; Goldstein JA, 2001, BRIT J CLIN PHARMACO, V52, P349, DOI 10.1046/j.0306-5251.2001.01499.x; HANDE KR, 1984, AM J MED, V76, P47, DOI 10.1016/0002-9343(84)90743-5; Hu FY, 2011, SEIZURE-EUR J EPILEP, V20, P431, DOI 10.1016/j.seizure.2011.01.005; Hung SI, 2010, PHARMACOGENOMICS, V11, P349, DOI 10.2217/PGS.09.162; Hung SL, 2006, PHARMACOGENET GENOM, V16, P297, DOI 10.1097/01.fpc.0000199500.46842.4a; Hung SL, 2005, P NATL ACAD SCI USA, V102, P4134, DOI 10.1073/pnas.0409500102; Kardaun SH, 2007, BRIT J DERMATOL, V156, P609, DOI 10.1111/j.1365-2133.2006.07704.x; Kesavan R, 2010, EUR J CLIN PHARMACOL, V66, P689, DOI 10.1007/s00228-010-0817-2; Knowles SR, 2012, EXPERT OPIN DRUG SAF, V11, P767, DOI 10.1517/14740338.2012.705828; Ko TM, 2011, J ALLERGY CLIN IMMUN, V128, P1266, DOI 10.1016/j.jaci.2011.08.013; Komatsu T, 2000, DRUG METAB DISPOS, V28, P1361; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P2845, DOI 10.1001/jama.2008.890; Lee AY, 2004, EUR J CLIN PHARMACOL, V60, P155, DOI 10.1007/s00228-004-0753-0; Locharernkul C, 2008, EPILEPSIA, V49, P2087, DOI 10.1111/j.1528-1167.2008.01719.x; Mallal S, 2002, LANCET, V359, P727, DOI 10.1016/S0140-6736(02)07873-X; Man CBL, 2007, EPILEPSIA, V48, P1015, DOI 10.1111/j.1528-1167.2007.01022.x; McCormack M, 2012, PHARMACOGENOMICS, V13, P399, DOI [10.2217/PGS.11.165, 10.2217/pgs.11.165]; McCormack M, 2011, NEW ENGL J MED, V364, P1134, DOI 10.1056/NEJMoa1013297; McCorry D, 2004, LANCET NEUROL, V3, P729, DOI 10.1016/S1474-4422(04)00935-4; Mockenhaupt M, 2005, NEUROLOGY, V64, P1134, DOI 10.1212/01.WNL.0000156354.20227.F0; Nakamoto K, 2007, PHARMACOGENET GENOM, V17, P103, DOI 10.1097/FPC.0b013e32801152c2; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Ngow HA, 2009, SINGAP MED J, V50, P490; Niinuma Y, 2014, PHARMACOGENOMICS J, V14, P107, DOI 10.1038/tpj.2013.22; Ozeki T, 2011, HUM MOL GENET, V20, P1034, DOI 10.1093/hmg/ddq537; Sassolas B, 2010, CLIN PHARMACOL THER, V88, P60, DOI 10.1038/clpt.2009.252; Stamp LK, 2012, ARTHRITIS RHEUM-US, V64, P2529, DOI 10.1002/art.34488; Takanashi K, 2000, PHARMACOGENETICS, V10, P95, DOI 10.1097/00008571-200003000-00001; Thorn CF, 2012, PHARMACOGENET GENOM, V22, P466, DOI 10.1097/FPC.0b013e32834aeedb; Tse KP, 2009, AM J HUM GENET, V85, P194, DOI 10.1016/j.ajhg.2009.07.007; Wei CY, 2012, J ALLERGY CLIN IMMUN, V129, P1562, DOI 10.1016/j.jaci.2011.12.990; Xie HG, 2001, ANNU REV PHARMACOL, V41, P815, DOI 10.1146/annurev.pharmtox.41.1.815; Yang CY, 2011, NEUROLOGY, V77, P2025, DOI 10.1212/WNL.0b013e31823b478c; Yun J, 2013, CLIN EXP ALLERGY, V43, P1246, DOI 10.1111/cea.12184	40	185	191	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					525	534		10.1001/jama.2014.7859	http://dx.doi.org/10.1001/jama.2014.7859			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	25096692	Bronze			2022-12-28	WOS:000339808600021
J	Kamerow, D; Graham, R				Kamerow, Douglas; Graham, Robert			YANKEE DOODLING Lessons from a fallen hero	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Graham, Robert] Ctr Policy Studies Primary Care, Washington, DC USA			dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Center for Advancing Health, BE PREP PAT; Gruman J, 2010, AFTERSHOCK WHAT DO D; Gruman J, 2013, YEAR LIVING SICKISHL; Gruman J, 2013, CANC SURVIVORSHIP WH; Gruman J, 2008, BEHAV MATTERS 15 YEA; Gruman J, 2010, PATIENT EDUC COUNS, V78, P350, DOI 10.1016/j.pec.2010.02.002; Richards T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3726; ViewSonic Library, 2021, WHAT IS DELTA E WHY	8	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2014	349								g4992	10.1136/bmj.g4992	http://dx.doi.org/10.1136/bmj.g4992			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MP	25096596				2022-12-28	WOS:000340206000023
J	Morris, S; Hunter, RM; Ramsay, AIG; Boaden, R; McKevitt, C; Perry, C; Pursani, N; Rudd, AG; Schwamm, LH; Turner, SJ; Tyrrell, PJ; Wolfe, CDA; Fulop, NJ				Morris, Stephen; Hunter, Rachael M.; Ramsay, Angus I. G.; Boaden, Ruth; McKevitt, Christopher; Perry, Catherine; Pursani, Nanik; Rudd, Anthony G.; Schwamm, Lee H.; Turner, Simon J.; Tyrrell, Pippa J.; Wolfe, Charles D. A.; Fulop, Naomi J.			Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE ISCHEMIC-STROKE; UNIT CARE; IMPLEMENTATION; PERFORMANCE; ENGLAND; MODELS	Objective To investigate whether centralisation of acute stroke services in two metropolitan areas of England was associated with changes in mortality and length of hospital stay. Design Analysis of difference-in-differences between regions with patient level data from the hospital episode statistics database linked to mortality data supplied by the Office for National Statistics. Setting Acute stroke services in Greater Manchester and London, England. Participants 258 915 patients with stroke living in urban areas and admitted to hospital in January 2008 to March 2012. Interventions "Hub and spoke" model for acute stroke care. In London hyperacute care was provided to all patients with stroke. In Greater Manchester hyperacute care was provided to patients presenting within four hours of developing symptoms of stroke. Main outcome measures Mortality from any cause and at any place at 3, 30, and 90 days after hospital admission; length of hospital stay. Results In London there was a significant decline in risk adjusted mortality at 3, 30, and 90 days after admission. At 90 days the absolute reduction was -1.1% (95% confidence interval -2.1 to -0.1; relative reduction 5%), indicating 168 fewer deaths (95% confidence interval 19 to 316) during the 21 month period after reconfiguration in London. In both areas there was a significant decline in risk adjusted length of hospital stay: -2.0 days in Greater Manchester (95% confidence interval -2.8 to -1.2; 9%) and -1.4 days in London (-2.3 to -0.5; 7%). Reductions in mortality and length of hospital stay were largely seen among patients with ischaemic stroke. Conclusions A centralised model of acute stroke care, in which hyperacute care is provided to all patients with stroke across an entire metropolitan area, can reduce mortality and length of hospital stay.	[Morris, Stephen; Ramsay, Angus I. G.; Turner, Simon J.; Fulop, Naomi J.] UCL, Dept Appl Hlth Res, London WC1E 7HB, England; [Hunter, Rachael M.] UCL, Res Dept Primary Care & Populat Hlth, London NW3 2PF, England; [Boaden, Ruth; Perry, Catherine] Univ Manchester, Manchester Business Sch, Manchester M15 6PB, Lancs, England; [McKevitt, Christopher; Wolfe, Charles D. A.] Kings Coll London, Div Hlth & Social Care Res, Sch Med, London SE1 3QD, England; [Pursani, Nanik] Kings Coll London, Stroke Res Patients & Family Grp, Sch Med, Div Hlth & Social Care Res, London SE1 3QD, England; [Rudd, Anthony G.] Guys & St Thomas NHS Fdn Trust, St Thomas Hosp, London SE1 7EH, England; [Schwamm, Lee H.] Harvard Univ, Sch Med, Dept Neurol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Tyrrell, Pippa J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Salford Royal Hosp NHS Fdn Trust, Stroke & Vasc Ctr, Salford M6 8HD, Lancs, England; [Wolfe, Charles D. A.] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth, Res Comprehens Biomed Res Ctr, London SE1 7EH, England; [Wolfe, Charles D. A.] Kings Coll London, London SE1 3QD, England	University of London; University College London; University of London; University College London; University of Manchester; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Harvard University; Harvard Medical School; Massachusetts General Hospital; Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Morris, S (corresponding author), UCL, Dept Appl Hlth Res, London WC1E 7HB, England.	steve.morris@ucl.ac.uk	mckevitt, christopher/AAN-7271-2021; Hunter, Rachael Maree/H-7846-2019; Boaden, Ruth/L-3443-2016	Hunter, Rachael Maree/0000-0002-7447-8934; Boaden, Ruth/0000-0003-1927-6405; Fulop, Naomi/0000-0001-5306-6140; MCKEVITT, CHRISTOPHER/0000-0002-5290-4613; Morris, Stephen/0000-0002-5828-3563; Perry, Catherine/0000-0002-8496-6923; Schwamm, Lee/0000-0003-0592-9145; Ramsay, Angus/0000-0002-4446-6916; Tyrrell, Pippa/0000-0001-9609-1231	Department of Health [10/1009/09]; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre at King's College London; NIHR Collaboration for Leadership in Applied Health Research and Care Funding scheme; National Institute for Health Research [10/1009/09, NF-SI-0510-10060, RP-PG-0407-10184] Funding Source: researchfish	Department of Health; NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust; NIHR Biomedical Research Centre at King's College London; NIHR Collaboration for Leadership in Applied Health Research and Care Funding scheme; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper presents independent research commissioned by the health services and delivery research programme of the National Institute for Health Research (NIHR), funded by the Department of Health (study reference 10/1009/09). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. CDAW was supported by the NIHR Biomedical Research Centre at Guy's and St Thomas' NHS Foundation Trust and King's College London, and also by the NIHR Collaboration for Leadership in Applied Health Research and Care Funding scheme.	Audebert Heinrich J, 2009, Cerebrovasc Dis, V27 Suppl 4, P15, DOI 10.1159/000213054; Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Bray BD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2827; Cadilhac DA, 2013, STROKE, V44, P2848, DOI 10.1161/STROKEAHA.113.001258; Craig P, 2012, J EPIDEMIOL COMMUNIT; Data.gov.uk, IND MULT DEPR 2004; Demaerschalk BM, 2009, MAYO CLIN PROC, V84, P53, DOI 10.1016/S0025-6196(11)60808-2; Department of Health, 2007, NAT STROK STRAT; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Fosbol EL, 2013, CIRCULATION, V127, P604, DOI 10.1161/CIRCULATIONAHA.112.118463; Fulop N, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-5; Gabbe BJ, 2012, ANN SURG, V255, P1009, DOI 10.1097/SLA.0b013e31824c4b91; Greater Manchester and Cheshire Cardiac and Stroke Network Support Team, 2011, DEV STROK SERV GREAT; Health and Social Care Information Centre, HOS EP STAT; Health and Social Care Information Centre, LINK HES ONS MORT DA; Higashida R, 2013, STROKE, V44, P2961, DOI 10.1161/STR.0b013e3182a6d2b2; Hunter RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070420; Imbens GW, 2008, RECENT DEV ECONOMETR; Intercollegiate Stroke Working Party, 2012, NAT CLIN GUID STROK; Lahr MMH, 2013, J NEUROL, V260, P960, DOI 10.1007/s00415-012-6647-7; Lahr MMH, 2012, STROKE, V43, P1336, DOI 10.1161/STROKEAHA.111.641795; Langhorne P, 2013, STROKE, V44, P3044, DOI 10.1161/STROKEAHA.113.001564; Langhorne P, 2010, J NEUROL NEUROSUR PS, V81, P1301, DOI 10.1136/jnnp.2009.195131; Mackay J, 2004, ATLAS HEART DIS STRO; Mohan KM, 2011, STROKE, V42, P1489, DOI 10.1161/STROKEAHA.110.602615; National Audit Office, 2010, 291 HC NAT AUD OFF C; Office for National Statistics, 2012, 2011 CENS US RES POP; Office for National Statistics, 2001 URB CLASS; Prabhakaran S, 2013, JAMA NEUROL, V70, P1126, DOI 10.1001/jamaneurol.2013.293; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ramelyte M, 2012, STROKE ANN REPORT 20; Royal College of Physicians, 2013, SINAP LAT RES; Sacco S, 2009, STROKE, V40, P394, DOI 10.1161/STROKEAHA.108.523209; Silva GS, 2012, STROKE, V43, P2078, DOI 10.1161/STROKEAHA.111.645861; Slot KB, 2009, ACTA NEUROL SCAND, V120, P270, DOI 10.1111/j.1600-0404.2009.01162.x; Smith Eric E, 2008, Crit Pathw Cardiol, V7, P173, DOI 10.1097/HPC.0b013e318184e2bc; Sudlow C, 2009, BMJ, V338; Sutton M, 2012, NEW ENGL J MED, V367, P1821, DOI 10.1056/NEJMsa1114951; Townsend N, 2012, CORONARY HEART DIS S; Weir NU, 2005, J NEUROL NEUROSUR PS, V76, P863, DOI 10.1136/jnnp.2004.053462; Williams D., 2011, MAJOR RECONFIGURATIO; Woo YL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007945.pub2	42	136	138	4	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2014	349								g4757	10.1136/bmj.g4757	http://dx.doi.org/10.1136/bmj.g4757			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MP	25098169	Green Published, hybrid			2022-12-28	WOS:000340206000004
J	Nair-Gupta, P; Baccarini, A; Tung, N; Seyffer, F; Florey, O; Huang, YJ; Banerjee, M; Overholtzer, M; Roche, PA; Tampe, R; Brown, BD; Amsen, D; Whiteheart, SW; Blander, JM				Nair-Gupta, Priyanka; Baccarini, Alessia; Tung, Navpreet; Seyffer, Fabian; Florey, Oliver; Huang, Yunjie; Banerjee, Meenakshi; Overholtzer, Michael; Roche, Paul A.; Tampe, Robert; Brown, Brian D.; Amsen, Derk; Whiteheart, Sidney W.; Blander, J. Magarian			TLR Signals Induce Phagosomal MHC-I Delivery from the Endosomal Recycling Compartment to Allow Cross-Presentation	CELL			English	Article							DENDRITIC CELLS; ANTIGEN; MATURATION; MEMBRANE; IMMUNITY; SNAP-23; CROSSPRESENTATION; PHOSPHORYLATION; RECOGNITION; ACTIVATION	Adaptation of the endoplasmic reticulum (ER) pathway for MHC class I (MHC-I) presentation in dendritic cells enables cross-presentation of peptides derived from phagocytosed microbes, infected cells, or tumor cells to CD8 T cells. How these peptides intersect with MHC-I molecules remains poorly understood. Here, we show that MHC-I selectively accumulate within phagosomes carrying microbial components, which engage Toll-like receptor (TLR) signaling. Although cross-presentation requires Sec22b-mediated phagosomal recruitment of the peptide loading complex from the ER-Golgi intermediate compartment (ERGIC), this step is independent of TLR signaling and does not deliver MHC-I. Instead, MHC-I are recruited from an endosomal recycling compartment (ERC), which is marked by Rab11a, VAMP3/cellubrevin, and VAMP8/endobrevin and holds large reserves of MHC-I. While Rab11a activity stocks ERC stores with MHC-I, MyD88-dependent TLR signals drive I kappa B-kinase (IKK) 2-mediated phosphorylation of phagosome-associated SNAP23. Phospho-SNAP23 stabilizes SNARE complexes orchestrating ERC-phagosome fusion, enrichment of phagosomes with ERC-derived MHC-I, and subsequent cross-presentation during infection.	[Nair-Gupta, Priyanka; Baccarini, Alessia; Tung, Navpreet; Brown, Brian D.; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA; [Tung, Navpreet; Brown, Brian D.; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA; [Nair-Gupta, Priyanka; Tung, Navpreet; Blander, J. Magarian] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA; [Baccarini, Alessia; Brown, Brian D.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Nair-Gupta, Priyanka; Tung, Navpreet] Icahn Sch Med Mt Sinai, Grad Sch Biol Sci, New York, NY 10029 USA; [Seyffer, Fabian; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, Cluster Excellence Macromol Complexes, D-60438 Frankfurt, Germany; [Florey, Oliver; Overholtzer, Michael] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Huang, Yunjie; Banerjee, Meenakshi; Whiteheart, Sidney W.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Roche, Paul A.] NCI, Expt Cell Biol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Amsen, Derk] Sanquin Res & Landsteiner Lab, Dept Hematopoiesis, NL-1066 CX Amsterdam, Netherlands	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Goethe University Frankfurt; Memorial Sloan Kettering Cancer Center; University of Kentucky; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Amsterdam	Blander, JM (corresponding author), Icahn Sch Med Mt Sinai, Inst Immunol, New York, NY 10029 USA.	julie.blander@mssm.edu	Banerjee, Meenakshi/AAL-6738-2020; Tampé, Robert/H-2953-2015; Huang, Yunjie/AAW-8751-2021	Tampé, Robert/0000-0002-0403-2160; Banerjee, Meenakshi/0000-0002-5139-5861; Florey, Oliver/0000-0002-1075-7424; Huang, Yunjie/0000-0002-2151-9499; Blander, Julie Magarian/0000-0001-9207-1700; Whiteheart, Sidney/0000-0001-5577-0473; Roche, Paul/0000-0002-8949-9172	NIH [5R24 CA095823-04, S10 RR0 9145-01, AI073899, HL56652, HL082193, AI104848, CA154649, DK072201, AI095245]; NSF [DBI-9724504]; German Research Foundation-Membrane Transport and Communication [SFB 807, TA157/7]; Landsteiner Foundation for Blood Research; Dutch Organization for Science; Burroughs Wellcome Fund; American Cancer Society [117254]; NATIONAL CANCER INSTITUTE [R24CA095823, R01CA154649, ZIABC011035] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091893, R01HL056652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073899, R56AI073899, R01AI104848, R01AI095245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK072201] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); German Research Foundation-Membrane Transport and Communication; Landsteiner Foundation for Blood Research; Dutch Organization for Science; Burroughs Wellcome Fund(Burroughs Wellcome Fund); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank E. S. Trombetta, T. Moran, A. Garcia-Sastre, C. Harding, R. Germain, N. Aronin, M. M. DiFiglia, I. Verma, K. Suzuki, and S. Amigorena for reagents. We are grateful to E. Kavalali, B. Trinite, F. Gebhardt, H. Peche, current J.M.B. laboratory members, H. Gupta, M. Blander, and S.J. Blander for technical assistance, discussions, and support. ISMMS-Microscopy Shared Resource Facility was supported by NIH grants 5R24 CA095823-04, S10 RR0 9145-01, and NSF DBI-9724504. This work was supported by NIH grants AI073899 to J.M.B., HL56652 and HL082193 to S. W. W., AI104848 to B. D. B., CA154649 to M.O., German Research Foundation grants SFB 807-Membrane Transport and Communication and TA157/7 to R. T., and grants from the Landsteiner Foundation for Blood Research and The Dutch Organization for Science to D. A. J.M.B. is supported by NIH grants DK072201 and AI095245, the Burroughs Wellcome Fund, and American Cancer Society grant 117254.	Ackerman AL, 2003, J IMMUNOL, V170, P4178, DOI 10.4049/jimmunol.170.8.4178; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Arpaia N, 2011, CURR OPIN VIROL, V1, P447, DOI 10.1016/j.coviro.2011.10.006; Bethani I, 2009, TRAFFIC, V10, P1543, DOI 10.1111/j.1600-0854.2009.00959.x; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; Cebrian I, 2011, CELL, V147, P1355, DOI 10.1016/j.cell.2011.11.021; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Karim ZA, 2013, BLOOD, V121, P4567, DOI 10.1182/blood-2012-11-470468; Lugrin J, 2014, BIOL CHEM, V395, P203, DOI 10.1515/hsz-2013-0241; Mathan TSM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00372; Nair P, 2011, TRAFFIC, V12, P1669, DOI 10.1111/j.1600-0854.2011.01251.x; Nair-Gupta P, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00401; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Sakurai C, 2012, MOL BIOL CELL, V23, P4849, DOI 10.1091/mbc.E12-01-0069; Saraste J, 2007, MOL BIOL CELL, V18, P1430, DOI 10.1091/mbc.E06-10-0933; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Stow JL, 2006, NAT REV IMMUNOL, V6, P919, DOI 10.1038/nri1980; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wagner CS, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00138; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451	34	204	212	2	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					506	521		10.1016/j.cell.2014.04.054	http://dx.doi.org/10.1016/j.cell.2014.04.054			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083866	Bronze, Green Accepted			2022-12-28	WOS:000340944300006
J	White, NJ; Pukrittayakamee, S; Phyo, AP; Rueangweerayut, R; Nosten, F; Jittamala, P; Jeeyapant, A; Jain, JP; Lefevre, G; Li, RB; Magnusson, B; Diagana, TT; Leong, FJ				White, Nicholas J.; Pukrittayakamee, Sasithon; Phyo, Aung Pyae; Rueangweerayut, Ronnatrai; Nosten, Francois; Jittamala, Podjanee; Jeeyapant, Atthanee; Jain, Jay Prakash; Lefevre, Gilbert; Li, Ruobing; Magnusson, Baldur; Diagana, Thierry T.; Leong, F. Joel			Spiroindolone KAE609 for Falciparum and Vivax Malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMODIUM-FALCIPARUM; PARASITE CLEARANCE; POTENT	BACKGROUND KAE609 (cipargamin; formerly NITD609, Novartis Institute for Tropical Diseases) is a new synthetic antimalarial spiroindolone analogue with potent, dose-dependent antimalarial activity against asexual and sexual stages of Plasmodium falciparum. METHODS We conducted a phase 2, open-label study at three centers in Thailand to assess the antimalarial efficacy, safety, and adverse-event profile of KAE609, at a dose of 30 mg per day for 3 days, in two sequential cohorts of adults with uncomplicated P. vivax malaria (10 patients) or P. falciparum malaria (11). The primary end point was the parasite clearance time. RESULTS The median parasite clearance time was 12 hours in each cohort (interquartile range, 8 to 16 hours in patients with P. vivax malaria and 10 to 16 hours in those with P. falciparum malaria). The median half-lives for parasite clearance were 0.95 hours (range, 0.68 to 2.01; interquartile range, 0.85 to 1.14) in the patients with P. vivax malaria and 0.90 hours (range, 0.68 to 1.64; interquartile range, 0.78 to 1.07) in those with P. falciparum malaria. By comparison, only 19 of 5076 patients with P. falciparum malaria (<1%) who were treated with oral artesunate in Southeast Asia had a parasite clearance half-life of less than 1 hour. Adverse events were reported in 14 patients (67%), with nausea being the most common. The adverse events were generally mild and did not lead to any discontinuations of the drug. The mean terminal half-life for the elimination of KAE609 was 20.8 hours (range, 11.3 to 37.6), supporting a once-daily oral dosing regimen. CONCLUSIONS KAE609, at dose of 30 mg daily for 3 days, cleared parasitemia rapidly in adults with uncomplicated P. vivax or P. falciparum malaria. (Funded by Novartis and others; ClinicalTrials.gov number, NCT01524341.)	[White, Nicholas J.; Nosten, Francois; Jeeyapant, Atthanee] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand; [Pukrittayakamee, Sasithon; Jittamala, Podjanee] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok 10400, Thailand; [Phyo, Aung Pyae; Nosten, Francois] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Rueangweerayut, Ronnatrai] Mae Sot Gen Hosp, Mae Sot, Thailand; [White, Nicholas J.; Nosten, Francois] Univ Oxford, Nuffield Dept Med, Ctr Trop Med, Oxford, England; [Jain, Jay Prakash] Novartis Healthcare, Hyderabad, Andhra Pradesh, India; [Lefevre, Gilbert; Magnusson, Baldur] Novartis, Basel, Switzerland; [Li, Ruobing] Novartis Inst Biomed Res, Beijing, Peoples R China; [Diagana, Thierry T.; Leong, F. Joel] Novartis Inst Trop Dis, Singapore, Singapore	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; Novartis; Novartis	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.	nickw@tropmedres.ac	Nosten, Francois/AAC-5509-2019; White, Nick/AAC-6527-2019; Phyo, Aung Pyae/GYU-6181-2022; Phyo, Aung Pyae/K-2413-2019	Nosten, Francois/0000-0002-7951-0745; White, Nick/0000-0002-1897-1978; Phyo, Aung Pyae/0000-0002-0383-9624; Phyo, Aung Pyae/0000-0002-0383-9624	Novartis; Wellcome Trust of Great Britain; Wellcome Trust; Medicines for Malaria Venture	Novartis(Novartis); Wellcome Trust of Great Britain(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); Medicines for Malaria Venture	Supported by Novartis. The studies in Bangkok and the Shoklo Malaria Research Unit were part of the Wellcome Trust-Mahidol University-Oxford Tropical Medicine Research Programme, which is supported by the Wellcome Trust of Great Britain. The Wellcome Trust and Medicines for Malaria Venture provided support to the Novartis Institute for Tropical Diseases drug discovery program and for the early clinical development of KAE609.	Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Pukrittayakamee S, 2000, ANTIMICROB AGENTS CH, V44, P1680, DOI 10.1128/AAC.44.6.1680-1685.2000; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Spillman NJ, 2013, CELL HOST MICROBE, V13, P227, DOI 10.1016/j.chom.2012.12.006; van Pelt-Koops JC, 2012, ANTIMICROB AGENTS CH, V56, P3544, DOI 10.1128/AAC.06377-11; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278; WHITE NJ, 1992, BRIT J CLIN PHARMACO, V34, P1; WHO, 2010, GUID TREATM MAL, V2nd; Yeung BKS, 2010, J MED CHEM, V53, P5155, DOI 10.1021/jm100410f	14	163	165	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					403	410		10.1056/NEJMoa1315860	http://dx.doi.org/10.1056/NEJMoa1315860			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0SK	25075833	Green Accepted			2022-12-28	WOS:000339556900005
J	Gerstein, HC; Miller, ME; Ismail-Beigi, F; Largay, J; McDonald, C; Lochnan, HA; Booth, GL				Gerstein, Hertzel C.; Miller, Michael E.; Ismail-Beigi, Faramarz; Largay, Joe; McDonald, Charlotte; Lochnan, Heather A.; Booth, Gillian L.		ACCORD Study Grp	Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial	LANCET			English	Article							GLUCOSE CONTROL; FOLLOW-UP; MORTALITY; ASSOCIATION; RISK	Background Hyperglycaemia could substantially increase the risk of ischaemic heart disease in patients with type 2 diabetes. We investigated whether intensive lowering of glucose concentrations affects risk. Methods We assessed 10 251 adults aged 40-79 years with established type 2 diabetes, mean glycated haemoglobin A(1c) (HbA(1c)) concentration of 67 mmol/mol (8.3%), and risk factors for ischaemic heart disease enrolled in the ACCORD trial. Participants were assigned to intensive or standard therapy (target HbA(1c) less than 42 or 53-63 mmol/mol [less than 6.0% or 7.0-7.9%], respectively). We assessed fatal or non-fatal myocardial infarction, coronary revascularisation, unstable angina, and new angina during active treatment (mean 3.7 years) plus a further mean 1.2 years. This trial is registered with ClinicalTrials.gov, number NCT00000620. Findings Myocardial infarction was less frequent in the intensive than in the standard therapy group during active treatment (hazard ratio [HR] 0.80, 95% CI 0.67-0.96; p=0.015) and overall (0.84, 0.72-0.97; p=0.02). Findings were similar for combined myocardial infarction, coronary revascularisation, and unstable angina (active treatment HR 0.89, 95% CI 0.79-0.99, overall 0.87 0.79-0.96) and for coronary revascularisation alone (0.84, 0.75-0.94) and unstable angina alone (0.81, 0.67-0.97) during full follow-up. With lowest achieved HbA(1c) concentrations included as a time-dependent covariate, all hazards became non-significant. Interpretation Raised glucose concentration is a modifiable risk factor for ischaemic heart disease in middle-aged people with type 2 diabetes and other cardiovascular risk factors.	[Gerstein, Hertzel C.] McMaster Univ, Dept Med, Hamilton, ON L8S 4K1, Canada; [Gerstein, Hertzel C.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8S 4K1, Canada; [Gerstein, Hertzel C.] Hamilton Hlth Sci, Hamilton, ON, Canada; [Miller, Michael E.] Wake Forest Sch Med, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC USA; [Ismail-Beigi, Faramarz] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz] Cleveland VA Med Ctr, Cleveland, OH USA; [Largay, Joe] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [McDonald, Charlotte] Univ Western Ontario, Schulich Sch Med, St Josephs Hlth Care London, London, ON, Canada; [Lochnan, Heather A.] Univ Ottawa, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Booth, Gillian L.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada	McMaster University; McMaster University; Population Health Research Institute; McMaster University; Wake Forest University; Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; University of North Carolina; University of North Carolina Chapel Hill; Western University (University of Western Ontario); University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Gerstein, HC (corresponding author), McMaster Univ, Dept Med, Room 3V38,1280 Main St West, Hamilton, ON L8S 4K1, Canada.	gerstein@mcmaster.ca	Greiver, Michelle/N-8764-2015; Gerstein, Hertzel/ABB-8781-2020; Gerstein, Hertzel C/B-1235-2013	Greiver, Michelle/0000-0001-8957-0285; Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836; Lochnan, Heather/0000-0002-3820-7897	National Heart, Lung, and Blood Institute; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute on Aging; National Eye Intitute; Centers for Disease Control and Prevention; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095184, N01HC095178, N01HC095181, N01HC095180, N01HC095183, N01HC095179, N01HC095182] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Intitute; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute on Aging, National Eye Intitute, and Centers for Disease Control and Prevention.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc10-S062, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062]; Benn M, 2012, J AM COLL CARDIOL, V59, P2356, DOI 10.1016/j.jacc.2012.02.043; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2011, NEW ENGL J MED, V364, P818, DOI 10.1056/NEJMoa1006524; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Lachin JM, 2010, DIABETES CARE, V33, P2719, DOI 10.2337/dc10-1506; Pop-Busui R, 2010, DIABETES CARE, V33, P1578, DOI 10.2337/dc10-0125; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Riddle MC, 2010, DIABETES CARE, V33, P2722, DOI 10.2337/dc10-1658; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829, DOI 10.1056/NEJMoa1008862; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0	18	116	120	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1936	1941		10.1016/S0140-6736(14)60611-5	http://dx.doi.org/10.1016/S0140-6736(14)60611-5			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25088437	Green Published, Green Accepted			2022-12-28	WOS:000345450100029
J	Raffi, F; Babiker, AG; Richert, L; Molina, JM; George, EC; Antinori, A; Arribas, JR; Grarup, J; Hudson, F; Schwimmer, C; Saillard, J; Wallet, C; Jansson, PO; Allavena, C; Van Leeuwen, R; Delfraissy, JF; Vella, S; Chene, G; Pozniak, A				Raffi, Francois; Babiker, Abdel G.; Richert, Laura; Molina, Jean-Michel; George, Elizabeth C.; Antinori, Andrea; Arribas, Jose R.; Grarup, Jesper; Hudson, Fleur; Schwimmer, Christine; Saillard, Juliette; Wallet, Cedrick; Jansson, Per O.; Allavena, Clotilde; Van Leeuwen, Remko; Delfraissy, Jean-Francois; Vella, Stefano; Chene, Genevieve; Pozniak, Anton		NEAT001 ANRS143 Study Grp	Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial	LANCET			English	Article							ONCE-DAILY DARUNAVIR/RITONAVIR; HIV-1-INFECTED PATIENTS; DOUBLE-BLIND; INITIAL TREATMENT; SPARING REGIMENS; PLUS RALTEGRAVIR; LOPINAVIR/RITONAVIR; EFFICACY; SAFETY; TENOFOVIR/EMTRICITABINE	Background Standard first-line antiretroviral therapy for HIV-1 infection includes two nucleoside or nucleotide reverse transcriptase inhibitors (NtRTIs), but these drugs have limitations. We assessed the 96 week efficacy and safety of an NtRTI-sparing regimen. Methods Between August, 2010, and September, 2011, we enrolled treatment-naive adults into this randomised, open-label, non-inferiority trial in treatment-naive adults in 15 European countries. The composite primary outcome was change to randomised treatment before week 32 because of insufficient virological response, no virological response by week 32, HIV-1 RNA concentration 50 copies per mL or higher at any time after week 32; death from any cause; any new or recurrent AIDS event; or any serious non-AIDS event. Patients were randomised in a 1:1 ratio to receive oral treatment with 400 mg raltegravir twice daily plus 800 mg darunavir and 100 mg ritonavir once daily (NtRTI-sparing regimen) or tenofovir-emtricitabine in a 245 mg and 200 mg fixed-dose combination once daily, plus 800 mg darunavir and 100 mg ritonavir once daily (standard regimen). This trial was registered with ClinicalTrials.gov, number NCT01066962. Findings Of 805 patients enrolled, 401 received the NtRTI-sparing regimen and 404 the standard regimen, with median follow-up of 123 weeks (IQR 112-133). Treatment failure was seen in 77 (19%) in the NtRTI-sparing group and 61 (15%) in the standard group. Kaplan-Meier estimated proportions of treatment failure by week 96 were 17.8% and 13.8%, respectively (difference 4.0%, 95% CI -0.8 to 8.8). The frequency of serious or treatment-modifying adverse events were similar (10.2 vs 8.3 per 100 person-years and 3.9 vs 4.2 per 100 person-years, respectively). Interpretation Our NtRTI-sparing regimen was non-inferior to standard treatment and represents a treatment option for patients with CD4 cell counts higher than 200 cells per mu L.	[Raffi, Francois; Allavena, Clotilde] Univ Nantes, Dept Infect Dis, F-44093 Nantes, France; [Babiker, Abdel G.; George, Elizabeth C.; Hudson, Fleur] UCL, MRC, Clin Trials Unit, London, England; [Richert, Laura; Schwimmer, Christine; Wallet, Cedrick; Chene, Genevieve] Univ Bordeaux, INSERM, Epidemiol Biostat U897, Bordeaux, France; [Molina, Jean-Michel] Hop St Louis, AP HP, Dept Infect Dis, Paris, France; [Molina, Jean-Michel] Univ Paris Diderot, Paris, France; [Antinori, Andrea] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Clin Dept, Rome, Italy; [Arribas, Jose R.] Hosp La Paz, Internal Med Serv, HIV Unit, Madrid, Spain; [Grarup, Jesper; Jansson, Per O.] Univ Copenhagen, Rigshosp, Dept Infect Dis & Rheumatol, DK-2100 Copenhagen, Denmark; [Saillard, Juliette] ANRS, Paris, France; [Van Leeuwen, Remko] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, NL-1105 AZ Amsterdam, Netherlands; [Delfraissy, Jean-Francois] CHU Bicetre, ANRS, Serv Med Interne, Immunol Clin, Paris, France; [Vella, Stefano] Ist Super Sanita, I-00161 Rome, Italy; [Pozniak, Anton] Chelsea & Westminster NHS Fdn Trust, London, England	Nantes Universite; Medical Research Council Clinical Trials Unit; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; IRCCS Lazzaro Spallanzani; Hospital Universitario La Paz; Rigshospitalet; University of Copenhagen; University of Amsterdam; Academic Medical Center Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Istituto Superiore di Sanita (ISS); Imperial College London	Raffi, F (corresponding author), Univ Nantes, Dept Infect Dis, Hotel Dieu, F-44093 Nantes, France.	francois.raffi@wanadoo.fr	Stephan, Christoph/D-1305-2014; Nieuwkerk, Pythia/S-4084-2017; Berenguer, Juan/A-1347-2009; Richert, Laura/T-5801-2019; chene, genevieve/H-8665-2014; Vandekerckhove, Linos/J-6420-2013; VELLA, STEFANO/V-8440-2019; Allavena, Clotilde/AAH-4310-2019; Soriano, Vicente/O-5730-2018; VELLA, STEFANO/ABI-3368-2020; Antinori, Andrea/K-7125-2016; Odermarsky, Michal/I-6951-2013; Portilla, Joaquín/O-7609-2018; George, Elizabeth/V-3381-2017; perno, carlo federico/O-1544-2016; Knobel, Hernando/B-5223-2016; Vella, Stefano/GZM-0519-2022; Arribas, Jose/A-1595-2015; Gisslen, Magnus/D-7454-2015	Stephan, Christoph/0000-0003-3777-9006; Nieuwkerk, Pythia/0000-0002-2616-1414; Berenguer, Juan/0000-0001-8541-8200; chene, genevieve/0000-0002-8368-6460; Vandekerckhove, Linos/0000-0002-8600-1631; VELLA, STEFANO/0000-0003-2347-5984; Soriano, Vicente/0000-0002-4624-5199; Antinori, Andrea/0000-0003-2121-4684; Odermarsky, Michal/0000-0002-0852-5691; Portilla, Joaquín/0000-0002-3676-9511; George, Elizabeth/0000-0002-2928-3580; Knobel, Hernando/0000-0003-3186-6416; PERNO, CARLO FEDERICO/0000-0002-0825-5388; Torok, Mili Estee/0000-0001-9098-8590; Knellwolf, Anne-Laure/0000-0002-5080-5144; Leen, Clifford/0000-0001-8439-7719; Arribas, Jose/0000-0002-7410-9450; Gonzalez-Garcia, Juan/0000-0002-3652-002X; Friis-Moller, Nina/0000-0002-7449-7393; MASSELLA, MAURIZIO/0000-0002-4155-1162; Cabie, Andre/0000-0003-0117-3061; Boyd, Mark/0000-0002-6848-3307; Richert, Laura/0000-0002-7682-2225; Gisslen, Magnus/0000-0002-2357-1020; fox, Julie/0000-0002-0583-8019; Marquez, Manuel/0000-0002-7901-6966	European Union; Inserm-ANRS; Gilead Sciences; Janssen Pharmaceuticals; Merck Laboratories; MRC [MC_UU_12023/16, MC_U122886352] Funding Source: UKRI; Academy of Medical Sciences (AMS) [AMS-CSF4-Torok] Funding Source: researchfish; Medical Research Council [MC_UU_12023/16, MC_U122886352] Funding Source: researchfish	European Union(European Commission); Inserm-ANRS; Gilead Sciences(Gilead Sciences); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck Laboratories(Merck & Company); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	European Union Sixth Framework Programme, Inserm-ANRS, Gilead Sciences, Janssen Pharmaceuticals, Merck Laboratories.	[Anonymous], 2019, IDF DIABETES ATLAS, V9th; [Anonymous], 1997, AIDS CLIN CARE; Brown Todd T, 2013, Top Antivir Med, V21, P115; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; European AIDS Clinical Society, GUID TREATM HIV INF; Flandre P, 2013, AIDS, V27, P653, DOI 10.1097/QAD.0b013e32835b105e; Gunthard HF, 2014, JAMA-J AM MED ASSOC, V312, P410, DOI 10.1001/jama.2014.8722; Hall AM, 2011, AM J KIDNEY DIS, V57, P773, DOI 10.1053/j.ajkd.2011.01.022; Haubrich RH, 2009, AIDS, V23, P1109, DOI 10.1097/QAD.0b013e32832b4377; Jackson A, 2011, JAIDS-J ACQ IMM DEF, V58, P450, DOI 10.1097/QAI.0b013e3182364c67; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Kobayashi M, 2011, ANTIMICROB AGENTS CH, V55, P813, DOI 10.1128/AAC.01209-10; Kozal MJ, 2012, HIV CLIN TRIALS, V13, P119, DOI 10.1310/hct1303-119; Landovitz RJ, 2014, 21 C RETR OPP INF BO; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; McComsey GA, 2010, CLIN INFECT DIS, V51, P937, DOI 10.1086/656412; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Murray JM, 2007, AIDS, V21, P2315, DOI 10.1097/QAD.0b013e3282f12377; Nachega JB, 2014, CLIN INFECT DIS, V58, P1297, DOI 10.1093/cid/ciu046; Orkin C, 2013, HIV MED, V14, P49, DOI 10.1111/j.1468-1293.2012.01060.x; Ortiz R, 2008, AIDS, V22, P1389, DOI 10.1097/QAD.0b013e32830285fb; POCOCK SJ, 1992, BMJ-BRIT MED J, V305, P235, DOI 10.1136/bmj.305.6847.235; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Reynes J, 2013, AIDS RES HUM RETROV, V29, P256, DOI [10.1089/aid.2011.0275, 10.1089/AID.2011.0275]; Reynes J, 2011, HIV CLIN TRIALS, V12, P255, DOI 10.1310/hct1205-255; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Rockstroh JK, 2013, JAIDS-J ACQ IMM DEF, V63, P77, DOI 10.1097/QAI.0b013e31828ace69; Taiwo B, 2011, AIDS, V25, P2113, DOI 10.1097/QAD.0b013e32834bbaa9; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; Wittkop L, 2010, CLIN TRIALS, V7, P19, DOI 10.1177/1740774509356117; Zolopa A, 2013, JAIDS-J ACQ IMM DEF, V63, P96, DOI 10.1097/QAI.0b013e318289545c	33	141	151	0	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1942	1951		10.1016/S0140-6736(14)61170-3	http://dx.doi.org/10.1016/S0140-6736(14)61170-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25103176				2022-12-28	WOS:000345450100030
J	Osborn, J; Thompson, M				Osborn, Justin; Thompson, Matthew			Management of same-day appointments in primary care	LANCET			English	Editorial Material							NURSE TELEPHONE TRIAGE		[Osborn, Justin; Thompson, Matthew] Univ Washington, Dept Family Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Thompson, M (corresponding author), Univ Washington, Dept Family Med, Seattle, WA 98195 USA.	mjt@uw.edu						Balla J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000414; Berry LL, 2013, MAYO CLIN PROC, V88, P184, DOI 10.1016/j.mayocp.2012.10.016; Campbell JL, 2014, LANCET; Flarup L, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-114; Huibers L, 2012, EUR J EMERG MED, V19, P309, DOI 10.1097/MEJ.0b013e32834d3e67; NHS England, 2013, TRANSF URG EM CAR SE; Richards DA, 2002, BRIT MED J, V325, P1214, DOI 10.1136/bmj.325.7374.1214; ROSENBERG K, 2012, AM J NURS, V112, P16; U. S. Department of Health and Human Services-Health Resources and Services Administration, 2013, PROJ SUPPL DEM PRIM; VA Office of Inspector General, 2014, REV PAT WAIT TIM SCH	10	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1828	1829		10.1016/S0140-6736(14)61173-9	http://dx.doi.org/10.1016/S0140-6736(14)61173-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7LA	25098488	hybrid			2022-12-28	WOS:000345116800007
J	Zhao, HT; Sheng, G; Wang, JY; Wang, M; Bunkoczi, G; Gong, WM; Wei, ZY; Wang, YL				Zhao, Hongtu; Sheng, Gang; Wang, Jiuyu; Wang, Min; Bunkoczi, Gabor; Gong, Weimin; Wei, Zhiyi; Wang, Yanli			Crystal structure of the RNA-guided immune surveillance Cascade complex in Escherichia coli	NATURE			English	Article							IN-VITRO RECONSTITUTION; CRISPR-CAS SYSTEMS; TARGET RECOGNITION; ANTIVIRAL DEFENSE; SEED SEQUENCE; DNA; INTERFERENCE; PROKARYOTES; DEGRADATION; CRYSTALLOGRAPHY	Clustered regularly interspaced short palindromic repeats (CRISPR) together with CRISPR-associated (Cas) proteins form the CRISPR/Cas system to defend against foreign nucleic acids of bacterial and archaeal origin(1-9). In the I-E subtype CRISPR/Cas system, eleven subunits from five Cas proteins (CasA(1)B(2)C(6)D(1)E(1)) assemble along a CRISPR RNA (crRNA) to form the Cascade complex(10-13). Here we report on the 3.05 angstrom crystal structure of the 405-kilodalton Escherichia coli Cascade complex that provides molecular details beyond those available from earlier lower-resolution cryo-electron microscopy structures. The bound 61-nucleotide crRNA spans the entire 11-protein subunit-containing complex, where it interacts with all six CasC subunits (named CasC1-6), with its 5 ' and 3 ' terminal repeats anchored by CasD and CasE, respectively. The crRNA spacer region is positioned along a continuous groove on the concave surface generated by the aligned CasC1-6 subunits. The five long beta-hairpins that project from individual CasC2-6 subunits extend across the crRNA, with each beta-hairpin inserting into the gap between the last stacked base and its adjacent splayed counterpart, and positioned within the groove of the preceding CasC subunit. Therefore, instead of continuously stacking, the crRNA spacer region is divided into five equal fragments, with each fragment containing five stacked bases flanked by one flipped-out base. Each of those crRNA spacer fragments interacts with CasC in a similar fashion. Furthermore, our structure explains why the seed sequence, with its outward directed bases, has a critical role in target DNA recognition. Inconclusion, our structure of the Cascade complex provides novel molecular details of protein-protein and protein-RNA alignments and interactions required for generation of a complex mediating RNA-guided immune surveillance.	[Zhao, Hongtu; Sheng, Gang; Wang, Jiuyu; Wang, Min; Gong, Weimin; Wang, Yanli] Chinese Acad Sci, Inst Biophys, Lab RNA Biol, Beijing 100101, Peoples R China; [Zhao, Hongtu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Bunkoczi, Gabor] Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Wei, Zhiyi] South Univ Sci & Technol China, Dept Biol, Shenzhen 518055, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Southern University of Science & Technology	Wang, YL (corresponding author), Chinese Acad Sci, Inst Biophys, Lab RNA Biol, Beijing 100101, Peoples R China.	wei.zy@sustc.edu.cn; ylwang@ibp.ac.cn	Wei, Zhiyi/N-9995-2019; Wei, Zhiyi/C-4315-2014	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Wang, Yanli/0000-0002-5969-1745	Chinese Ministry of Science and Technology [2014CB910102, 2011CBA01105]; Natural Science Foundation of China [31222014, 31170705]; Strategic Priority Research program of the Chinese Academy of Sciences [XDB08010203]; South University of Science and Technology of China; Shenzhen Government	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research program of the Chinese Academy of Sciences(Chinese Academy of Sciences); South University of Science and Technology of China; Shenzhen Government	We thank the staff at beamline BL-17U at Shanghai Synchrotron Radiation Facility (SSRF), and beamlines BL-1A, BL-5A and BL-17A at Photon Factory. The research was funded by Chinese Ministry of Science and Technology (2014CB910102 and 2011CBA01105), the Natural Science Foundation of China (31222014 and 31170705), and the Strategic Priority Research program of the Chinese Academy of Sciences (XDB08010203) to Y.W., and was supported by the Research Startup Fund from South University of Science and Technology of China and Shenzhen Government to Z.W. We thank D. Patel for assistance with manuscript editing, H. Wang, H. Li and F. Sun for experimental assistance, and T. Juelich for critical reading and editing of our manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Hrle A, 2013, RNA BIOL, V10, P1670, DOI 10.4161/rna.26500; Jackson RN, 2014, CURR OPIN STRUC BIOL, V24, P106, DOI 10.1016/j.sbi.2014.01.001; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2013, BIOCHEM SOC T, V41, P1392, DOI 10.1042/BST20130038; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mulepati S, 2013, J BIOL CHEM, V288, P22184, DOI 10.1074/jbc.M113.472233; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sinkunas T, 2013, EMBO J, V32, P385, DOI 10.1038/emboj.2012.352; Sinkunas T, 2011, EMBO J, V30, P1335, DOI 10.1038/emboj.2011.41; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Xiong Y, 2008, ACTA CRYSTALLOGR D, V64, P76, DOI 10.1107/S090744490705398X	39	119	127	5	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2014	515	7525					147	+		10.1038/nature13733	http://dx.doi.org/10.1038/nature13733			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AS3OE	25118175				2022-12-28	WOS:000344187500047
J	Kinsinger, LS; Atkins, D; Provenzale, D; Anderson, C; Petzel, R				Kinsinger, Linda S.; Atkins, David; Provenzale, Dawn; Anderson, Charles; Petzel, Robert			Implementation of a New Screening Recommendation in Health Care: The Veterans Health Administration's Approach to Lung Cancer Screening	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kinsinger, Linda S.; Atkins, David; Provenzale, Dawn; Anderson, Charles; Petzel, Robert] Vet Hlth Adm, Washington, DC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kinsinger, LS (corresponding author), Vet Hlth Adm, Natl Ctr Hlth Promot & Dis Prevent, 3022 Croasdaile Dr,Suite 200, Durham, NC 27705 USA.	Linda.Kinsinger@va.gov						Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Detterbeck FC, 2014, ANN INTERN MED, V160, P363, DOI 10.7326/M13-2904; Detterbeck FC, 2013, CHEST, V143, pE78, DOI 10.1378/chest.12-2350; Donabedian A., 1980, DEFINITION QUALITY A, V1; Goulart BHL, 2013, ONCOLOGIST, V18, P941, DOI 10.1634/theoncologist.2013-0007; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771	6	31	31	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2014	161	8					597	U97		10.7326/M14-1070	http://dx.doi.org/10.7326/M14-1070			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9PL	25111673				2022-12-28	WOS:000343906800022
J	Marshall, JC				Marshall, John C.			Selective digestive decontamination reduces mortality more than chlorhexidine in general ICU patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RESISTANCE		Univ Toronto, St Michaels Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Marshall, JC (corresponding author), Univ Toronto, St Michaels Hosp, Toronto, ON, Canada.							Daneman N, 2013, LANCET INFECT DIS, V13, P328, DOI 10.1016/S1473-3099(12)70322-5; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653	2	0	0	1	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC9	10.7326/0003-4819-161-4-201408190-02009	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133388				2022-12-28	WOS:000342347300008
J	Sarvananthan, S; Punjabi, PP				Sarvananthan, Sajiram; Punjabi, Prakash P.			In atrial fibrillation, dabigatran had similar efficacy to warfarin but caused less bleeding in higher GFR	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANTICOAGULANTS		[Sarvananthan, Sajiram; Punjabi, Prakash P.] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Sarvananthan, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, London, England.		Punjabi, Prakash P/AAG-8724-2019	Punjabi, Prakash P/0000-0002-6587-1603				Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Harel Z, 2014, J AM SOC NEPHROL, V25, P431, DOI 10.1681/ASN.2013040361; Hart RG, 2012, NAT REV NEPHROL, V8, P569, DOI 10.1038/nrneph.2012.160	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC7	10.7326/0003-4819-161-4-201408190-02007	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133386				2022-12-28	WOS:000342347300006
J	Lin, H				Lin, Herbert			INFORMATION TECHNOLOGY Technology's limited role in resolving debates over digital surveillance	SCIENCE			English	Editorial Material									CNR, Comp Sci & Telecommun Board, Washington, DC 20001 USA		Lin, H (corresponding author), CNR, Comp Sci & Telecommun Board, Washington, DC 20001 USA.	hlin@nas.edu						Gentry C, 2010, COMMUN ACM, V53, P97, DOI 10.1145/1666420.1666444; Marimow Ann, 2014, WASHINGTON POST; Nakashima Ellen, 2014, WASHINGTON POST; President's Council of Advisors on Science and Technology, 2014, BIG DAT PRIV TECHN P; Weitzner DJ, 2008, COMMUN ACM, V51, P82, DOI 10.1145/1349026.1349043; Wingfield N., 2014, NY TIMES	6	0	0	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					728	730		10.1126/science.1251485	http://dx.doi.org/10.1126/science.1251485			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN4XM	25124410				2022-12-28	WOS:000340593100012
J	Ghimire, P				Ghimire, Pranita			PERSONAL VIEW Nepal may have enough doctors but they're in the wrong place	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SURGICAL CAPACITY; SIERRA-LEONE; RWANDA		Manmohan Mem Eastern Reg Community Hosp & Res Ctr, Birtamode 00977, Jhapa, Nepal		Ghimire, P (corresponding author), Manmohan Mem Eastern Reg Community Hosp & Res Ctr, Birtamode 00977, Jhapa, Nepal.	pranitaghimire690@gmail.com						Groen RS, 2012, LANCET, V380, P1082, DOI 10.1016/S0140-6736(12)61081-2; Groen RS, 2012, WORLD J SURG, V36, P1970, DOI 10.1007/s00268-012-1591-3; Petroze RT, 2012, BRIT J SURG, V99, P436, DOI 10.1002/bjs.7816; Petroze RT, 2013, SURGERY, V153, P457, DOI 10.1016/j.surg.2012.10.001; Public Health Perspective Nepal, PUBL HLTH PERSP NEP	5	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2014	349								g4913	10.1136/bmj.g4913	http://dx.doi.org/10.1136/bmj.g4913			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RX	25125152				2022-12-28	WOS:000340507300004
J	Wang, Q				Wang, Qiang			China should aim for a total cap on emissions	NATURE			English	Editorial Material									Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS	Wang, Q (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Peoples R China.	qiangwang7@gmail.com	WANG, Qiang/F-4618-2011	WANG, Qiang/0000-0002-8751-8093					0	33	33	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					115	115		10.1038/512115a	http://dx.doi.org/10.1038/512115a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25119205	Bronze			2022-12-28	WOS:000340200700003
J	Zhao, B; Guan, KL				Zhao, Bin; Guan, Kun-Liang			Hippo Pathway Key to Ploidy Checkpoint	CELL			English	Editorial Material							TUMOR-SUPPRESSOR; LATS2	Tetraploid cells generated by abnormal cell division are often arrested during the cell cycle or cleared by apoptosis. Evasion of these defense mechanisms leads to genomic instability and tumorigenesis. In this issue, Ganem et al. report that extra centrosome-induced activation of the Hippo pathway kinase LATS2 is a key mechanism of tetraploidy-induced cell-cycle arrest.	[Zhao, Bin] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhao, Bin] Zhejiang Univ, Innovat Ctr Cell Biol, Hangzhou 310058, Zhejiang, Peoples R China; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Zhejiang University; Zhejiang University; University of California System; University of California San Diego; University of California System; University of California San Diego	Guan, KL (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022		NATIONAL CANCER INSTITUTE [R01CA132809] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY022611] Funding Source: NIH RePORTER; NCI NIH HHS [CA132809] Funding Source: Medline; NEI NIH HHS [EY022611] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aylon Y, 2009, ONCOGENE, V28, P4469, DOI 10.1038/onc.2009.270; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; McPherson JP, 2004, EMBO J, V23, P3677, DOI 10.1038/sj.emboj.7600371; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Tschop K, 2011, GENE DEV, V25, P814, DOI 10.1101/gad.2000211; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112	10	3	3	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					695	696		10.1016/j.cell.2014.07.041	http://dx.doi.org/10.1016/j.cell.2014.07.041			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126776	Bronze			2022-12-28	WOS:000340944700001
J	Abuelaish, I				Abuelaish, Izzeldin			We are both doctors: a Palestinian doctor writes to an Israeli colleague	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada	University of Toronto	Abuelaish, I (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada.	izzeldin.abuelaish@utoronto.ca							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2014	349								g5106	10.1136/bmj.g5106	http://dx.doi.org/10.1136/bmj.g5106			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RV	25121507				2022-12-28	WOS:000340507100011
J	Saitz, R; Palfai, TPA; Cheng, DM; Alford, DP; Bernstein, JA; Lloyd-Travaglini, CA; Meli, SM; Chaisson, CE; Samet, JH				Saitz, Richard; Palfai, Tibor P. A.; Cheng, Debbie M.; Alford, Daniel P.; Bernstein, Judith A.; Lloyd-Travaglini, Christine A.; Meli, Seville M.; Chaisson, Christine E.; Samet, Jeffrey H.			Screening and Brief Intervention for Drug Use in Primary Care The ASPIRE Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY-DEPARTMENT; PREVENTIVE SERVICES; TREATMENT-SEEKING; ALCOHOL MISUSE; ILLICIT DRUG; RISK; VALIDATION; SETTINGS; SEVERITY; VALIDITY	IMPORTANCE The United States has invested substantially in screening and brief intervention for illicit drug use and prescription drug misuse, based in part on evidence of efficacy for unhealthy alcohol use. However, it is not a recommended universal preventive service in primary care because of lack of evidence of efficacy. OBJECTIVE To test the efficacy of 2 brief counseling interventions for unhealthy drug use (any illicit drug use or prescription drug misuse)-a brief negotiated interview (BNI) and an adaptation of motivational interviewing (MOTIV)-compared with no brief intervention. DESIGN, SETTING, AND PARTICIPANTS This 3-group randomized trial took place at an urban hospital-based primary care internal medicine practice; 528 adult primary care patients with drug use (Alcohol, Smoking, and Substance Involvement Screening Test [ASSIST] substance-specific scores of >= 4) were identified by screening between June 2009 and January 2012 in Boston, Massachusetts. INTERVENTIONS Two interventions were tested: the BNI is a 10- to 15-minute structured interview conducted by health educators; the MOTIV is a 30- to 45-minute intervention based on motivational interviewing with a 20- to 30-minute booster conducted by master's-level counselors. All study participants received a written list of substance use disorder treatment and mutual help resources. MAIN OUTCOMES AND MEASURES Primary outcome was number of days of use in the past 30 days of the self-identified main drug as determined by a validated calendar method at 6 months. Secondary outcomes included other self-reported measures of drug use, drug use according to hair testing, ASSIST scores (severity), drug use consequences, unsafe sex, mutual help meeting attendance, and health care utilization. RESULTS At baseline, 63% of participants reported their main drug was marijuana, 19% cocaine, and 17% opioids. At 6 months, 98% completed follow-up. Mean adjusted number of days using the main drug at 6 months was 12 for no brief intervention vs 11 for the BNI group (incidence rate ratio [IRR], 0.97; 95% CI, 0.77-1.22) and 12 for the MOTIV group (IRR, 1.05; 95% CI, 0.84-1.32; P = .81 for both comparisons vs no brief intervention). There were also no significant effects of BNI or MOTIV on any other outcome or in analyses stratified by main drug or drug use severity. CONCLUSIONS AND RELEVANCE Brief intervention did not have efficacy for decreasing unhealthy drug use in primary care patients identified by screening. These results do not support widespread implementation of illicit drug use and prescription drug misuse screening and brief intervention.	[Saitz, Richard; Meli, Seville M.; Samet, Jeffrey H.] Boston Univ, Sch Publ Hlth, Dept Community Hlth Sci, Boston, MA 02118 USA; [Saitz, Richard; Cheng, Debbie M.; Alford, Daniel P.; Samet, Jeffrey H.] Boston Med Ctr, Dept Med, Gen Internal Med Sect, Clin Addict Res & Educ CARE Unit, Boston, MA USA; [Saitz, Richard; Cheng, Debbie M.; Alford, Daniel P.; Samet, Jeffrey H.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Palfai, Tibor P. A.] Boston Univ, Dept Psychol, Boston, MA 02118 USA; [Cheng, Debbie M.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Lloyd-Travaglini, Christine A.; Chaisson, Christine E.] Boston Univ, Sch Publ Hlth, Data Coordinating Ctr, Boston, MA 02118 USA	Boston University; Boston Medical Center; Boston University; Boston University; Boston University; Boston University	Saitz, R (corresponding author), Boston Univ, Sch Publ Hlth, 801 Massachusetts Ave,4th Floor, Boston, MA 02118 USA.	rsaitz@bu.edu		/0000-0002-2535-1427; Samet, Jeffrey/0000-0002-0897-3400	National Institute on Drug Abuse [R01 DA025068]; Center for Substance Abuse Treatment, SAMHSA; SAMHSA [TI018311]; Boston Medical Center to deliver BNI services [INTF2330M04W76112076]; National Center for Research Resources [UL1RR025771]; Center for Substance Abuse Treatment [U79TI018311] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771, M01RR000533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025068] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Center for Substance Abuse Treatment, SAMHSA; SAMHSA; Boston Medical Center to deliver BNI services; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Substance Abuse Treatment(United States Department of Health & Human Services); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The ASPIRE study was funded by an award from the National Institute on Drug Abuse (R01 DA025068), a portion of which was funded by the Center for Substance Abuse Treatment, SAMHSA. BNI counselors, training, and supervision were supported by a contract from the SAMHSA (TI018311) to the Massachusetts Department of Public Health Bureau of Substance Abuse Services, which contracted with Boston Medical Center to deliver BNI services (INTF2330M04W76112076). The study was also supported in part by the National Center for Research Resources (UL1RR025771).	Alterman AI, 2009, J STUD ALCOHOL DRUGS, V70, P304, DOI 10.15288/jsad.2009.70.304; [Anonymous], TECHN ASS PUBL TAP S, V13-4741; [Anonymous], SCREEN BRIEF INT REF; [Anonymous], SCREEN BRIEF INT REF; Beck CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066551; Bernstein E, 1997, ANN EMERG MED, V30, P181, DOI 10.1016/S0196-0644(97)70140-9; Bernstein E, 2009, ACAD EMERG MED, V16, P1174, DOI 10.1111/j.1553-2712.2009.00490.x; Bernstein J, 2005, DRUG ALCOHOL DEPEN, V77, P49, DOI 10.1016/j.drugalcdep.2004.07.006; Bray JW, 2007, J STUD ALCOHOL DRUGS, V68, P248, DOI 10.15288/jsad.2007.68.248; D'Amico E, 2008, J SUBST ABUSE TREAT, V35, P53, DOI 10.1016/j.jsat.2007.08.008; D'Onofrio G, 2008, ANN EMERG MED, V51, P742, DOI 10.1016/j.annemergmed.2007.11.028; D'Onofrio G, 2012, ANN EMERG MED, V60, P181, DOI 10.1016/j.annemergmed.2012.02.006; Daeppen JB, 2007, ADDICTION, V102, P1224, DOI 10.1111/j.1360-0443.2007.01869.x; De Alba I, 2004, AM J ADDICTION, V13, P33, DOI 10.1080/10550490490265307; De Micheli Denise, 2004, Rev. Assoc. Med. Bras., V50, P305, DOI 10.1590/S0104-42302004000300040; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Field CA, 2010, DRUG ALCOHOL DEPEN, V111, P13, DOI 10.1016/j.drugalcdep.2009.11.025; Guth S, 2008, J STUD ALCOHOL DRUGS, V69, P243, DOI 10.15288/jsad.2008.69.243; Hao L, 2007, QUANTILE REGRESSION; Heather N, 2008, DRUG ALCOHOL DEPEN, V98, P235, DOI 10.1016/j.drugalcdep.2008.06.005; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Humeniuk R, 2008, ADDICTION, V103, P1039, DOI 10.1111/j.1360-0443.2007.02114.x; Humeniuk R, 2012, ADDICTION, V107, P957, DOI 10.1111/j.1360-0443.2011.03740.x; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; Kessler R.C., 1998, INT J METHODS PSYCHI, V7, P171, DOI [10.1002/mpr.47, DOI 10.1002/MPR.47]; Kim TW, 2013, J ADDICT MED, V7, P204, DOI 10.1097/ADM.0b013e31828da017; Koenker R., 2005, ECONOMETRIC SOC MONO; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Madras BK, 2009, DRUG ALCOHOL DEPEN, V99, P280, DOI 10.1016/j.drugalcdep.2008.08.003; Mertens JR, 2003, ARCH INTERN MED, V163, P2511, DOI 10.1001/archinte.163.20.2511; Moyer A, 2002, ADDICTION, V97, P279, DOI 10.1046/j.1360-0443.2002.00018.x; Moyers TB, 2005, J SUBST ABUSE TREAT, V28, P19, DOI 10.1016/j.jsat.2004.11.001; National Institute on Alcohol Abuse and Alcoholism, HELP PAT WHO DRINK T, V2005; National Institute on Drug Abuse, SCREEN DRUG US GEN M; NAVALINE HA, 1994, AIDS RES HUM RETROV, V10, pS281; Norman SB, 2006, DEPRESS ANXIETY, V23, P245, DOI 10.1002/da.20182; Saitz R, 2010, J ADDICT MED, V4, P123, DOI 10.1097/ADM.0b013e3181db6b67; Solberg LI, 2008, AM J PREV MED, V34, P143, DOI 10.1016/j.amepre.2007.09.035; Takach M, 2012, HEALTH AFFAIR, V31, P2432, DOI 10.1377/hlthaff.2012.0447; US Preventative Services Task Force, SCREEN ILL DRUG US U; Weisner C, 2001, JAMA-J AM MED ASSOC, V286, P1715, DOI 10.1001/jama.286.14.1715; Westerberg Verner S., 1998, Subst Abus, V19, P179, DOI 10.1023/A:1021429429459; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Woodruff SI, 2014, ADDICT SCI CLIN PRAC, V9, DOI 10.1186/1940-0640-9-8; Zahradnik A, 2009, ADDICTION, V104, P109, DOI 10.1111/j.1360-0443.2008.02421.x	46	224	227	2	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					502	513		10.1001/jama.2014.7862	http://dx.doi.org/10.1001/jama.2014.7862			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM4FL	25096690	Green Accepted			2022-12-28	WOS:000339808600019
J	Hu, H; Gan, J; Jonas, P				Hu, Hua; Gan, Jian; Jonas, Peter			Fast-spiking, parvalbumin(+) GABAergic interneurons: From cellular design to microcircuit function	SCIENCE			English	Review							SYNCHRONIZED GAMMA-OSCILLATIONS; ACTION-POTENTIAL INITIATION; HIPPOCAMPAL GRANULE CELLS; CHANNEL SUBUNIT KV3.1B; GATED K+ CHANNELS; PYRAMIDAL CELLS; DENTATE GYRUS; BASKET CELLS; TRANSMITTER RELEASE; INHIBITORY NEURONS	The success story of fast-spiking, parvalbumin-positive (PV+) GABAergic interneurons (GABA, gamma-aminobutyric acid) in the mammalian central nervous system is noteworthy. In 1995, the properties of these interneurons were completely unknown. Twenty years later, thanks to the massive use of subcellular patch-clamp techniques, simultaneous multiple-cell recording, optogenetics, in vivo measurements, and computational approaches, our knowledge about PV+ interneurons became more extensive than for several types of pyramidal neurons. These findings have implications beyond the "small world" of basic research on GABAergic cells. For example, the results provide a first proof of principle that neuroscientists might be able to close the gaps between the molecular, cellular, network, and behavioral levels, representing one of the main challenges at the present time. Furthermore, the results may form the basis for PV+ interneurons as therapeutic targets for brain disease in the future. However, much needs to be learned about the basic function of these interneurons before clinical neuroscientists will be able to use PV+ interneurons for therapeutic purposes.	[Hu, Hua; Gan, Jian; Jonas, Peter] IST Austria, A-3400 Klosterneuburg, Austria	Institute of Science & Technology - Austria	Jonas, P (corresponding author), IST Austria, Campus 1, A-3400 Klosterneuburg, Austria.	peter.jonas@ist.ac.at		Gan, Jian/0000-0002-0155-6241; Jonas, Peter/0000-0001-5001-4804; Hu, Hua/0000-0001-8187-4735	Fond zur Forderung der Wissenschaftlichen Forschung [P 24909-B24]; European Union (European Research Council) [268548]; Austrian Science Fund (FWF) [P 24909] Funding Source: researchfish	Fond zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); European Union (European Research Council)(European Research Council (ERC)European Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank J. Csicsvari, T. Freund, S. Hippenmeyer, T. Klausberger, J. Lisman, and I. Soltesz for critically reading the manuscript; A. Solymosi for text editing; and all colleagues at IST Austria for generating a stimulating scientific environment. This work was supported by the Fond zur Forderung der Wissenschaftlichen Forschung (grant P 24909-B24 to P.J.) and the European Union (European Research Council Advanced Grant 268548 to P.J.). We apologize for the fact that, owing to space constraints, not all relevant papers could be cited.	Abe Y, 2011, J NEUROSCI, V31, P5699, DOI 10.1523/JNEUROSCI.3477-10.2011; AIKA Y, 1994, EXP BRAIN RES, V99, P267; Aponte Y, 2008, J PHYSIOL-LONDON, V586, P2061, DOI 10.1113/jphysiol.2007.147298; Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; Bartolini G, 2013, NEURON, V79, P849, DOI 10.1016/j.neuron.2013.08.014; Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; Bartos M, 2002, P NATL ACAD SCI USA, V99, P13222, DOI 10.1073/pnas.192233099; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Bezaire MJ, 2013, HIPPOCAMPUS, V23, P751, DOI 10.1002/hipo.22141; Bottoms CA, 2004, PROTEIN SCI, V13, P1724, DOI 10.1110/ps.03571004; Bucurenciu I, 2008, NEURON, V57, P536, DOI 10.1016/j.neuron.2007.12.026; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Buetfering C, 2014, NAT NEUROSCI, V17, P710, DOI 10.1038/nn.3696; BUZSAKI G, 1981, BRAIN RES, V230, P346, DOI 10.1016/0006-8993(81)90413-3; Camire O, 2014, J NEUROSCI, V34, P3864, DOI 10.1523/JNEUROSCI.2253-13.2014; Campanac E, 2013, NEURON, V77, P712, DOI 10.1016/j.neuron.2012.12.020; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; CELIO MR, 1986, SCIENCE, V231, P995, DOI 10.1126/science.3945815; Cheah CS, 2012, P NATL ACAD SCI USA, V109, P14646, DOI 10.1073/pnas.1211591109; Chiovini B, 2014, NEURON, V82, P908, DOI 10.1016/j.neuron.2014.04.004; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Crick F, 1988, WHAT MAD PURSUIT PER, P150; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; de Almeida L, 2009, J NEUROSCI, V29, P7497, DOI 10.1523/JNEUROSCI.6044-08.2009; de Almeida L, 2009, J NEUROSCI, V29, P7504, DOI 10.1523/JNEUROSCI.6048-08.2009; DeFelipe J, 2013, NAT REV NEUROSCI, V14, P202, DOI 10.1038/nrn3444; del Pino I, 2013, NEURON, V79, P1152, DOI 10.1016/j.neuron.2013.07.010; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Du J, 1996, J NEUROSCI, V16, P506; Dutton SB, 2013, NEUROBIOL DIS, V49, P211, DOI 10.1016/j.nbd.2012.08.012; Eggermann E, 2012, NAT NEUROSCI, V15, P20, DOI 10.1038/nn.3002; Eggermann E, 2012, NAT REV NEUROSCI, V13, P7, DOI 10.1038/nrn3125; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Goldberg EM, 2005, J NEUROSCI, V25, P5230, DOI 10.1523/JNEUROSCI.0722-05.2005; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Goldberg JH, 2003, J PHYSIOL-LONDON, V551, P49, DOI 10.1113/jphysiol.2003.042580; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hajos N, 2013, J NEUROSCI, V33, P11677, DOI 10.1523/JNEUROSCI.5729-12.2013; Halasy K, 1993, J Hirnforsch, V34, P299; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hioki H, 2013, J NEUROSCI, V33, P544, DOI 10.1523/JNEUROSCI.2255-12.2013; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Hu H, 2014, NAT NEUROSCI, V17, P686, DOI 10.1038/nn.3678; Hu H, 2010, SCIENCE, V327, P52, DOI 10.1126/science.1177876; Janssen MJ, 2012, J NEUROSCI, V32, P13889, DOI 10.1523/JNEUROSCI.1420-12.2012; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kerr AM, 2008, P NATL ACAD SCI USA, V105, P15581, DOI 10.1073/pnas.0800621105; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Kubota Y, 2011, SCI REP-UK, V1, DOI 10.1038/srep00089; Kuhlman SJ, 2013, NATURE, V501, P543, DOI 10.1038/nature12485; Kvitsiani D, 2013, NATURE, V498, P363, DOI 10.1038/nature12176; Lapray D, 2012, NAT NEUROSCI, V15, P1265, DOI 10.1038/nn.3176; Lee SH, 2014, NEURON, V82, P1129, DOI 10.1016/j.neuron.2014.03.034; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Li KX, 2012, NAT NEUROSCI, V15, P267, DOI 10.1038/nn.3006; Li LY, 2007, J NEUROSCI, V27, P13420, DOI 10.1523/JNEUROSCI.1709-07.2007; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Martina M, 1998, J NEUROSCI, V18, P8111; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Mashimo T, 2010, J NEUROSCI, V30, P5744, DOI 10.1523/JNEUROSCI.3360-09.2010; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Meeks JP, 2007, J NEUROPHYSIOL, V97, P3460, DOI 10.1152/jn.01288.2006; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Norenberg A, 2010, P NATL ACAD SCI USA, V107, P894, DOI 10.1073/pnas.0910716107; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ogiwara I, 2013, HUM MOL GENET, V22, P4784, DOI 10.1093/hmg/ddt331; Okaty BW, 2009, J NEUROSCI, V29, P7040, DOI 10.1523/JNEUROSCI.0105-09.2009; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; PARNAS I, 1979, J PHYSIOL-LONDON, V295, P323, DOI 10.1113/jphysiol.1979.sp012971; Pastoll H, 2013, NEURON, V77, P141, DOI 10.1016/j.neuron.2012.11.032; Pernia-Andrade AJ, 2014, NEURON, V81, P140, DOI 10.1016/j.neuron.2013.09.046; Pfeffer CK, 2013, NAT NEUROSCI, V16, P1068, DOI 10.1038/nn.3446; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Polack PO, 2013, NAT NEUROSCI, V16, P1331, DOI 10.1038/nn.3464; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Rossignol E, 2013, ANN NEUROL, V74, P209, DOI 10.1002/ana.23913; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Rudy B, 2001, TRENDS NEUROSCI, V24, P517, DOI 10.1016/S0166-2236(00)01892-0; Runyan CA, 2010, NEURON, V67, P847, DOI 10.1016/j.neuron.2010.08.006; Schmidt-Hieber C, 2008, J PHYSIOL-LONDON, V586, P1849, DOI 10.1113/jphysiol.2007.150151; Schwaller Beat, 2002, Cerebellum, V1, P241, DOI 10.1080/147342202320883551; SIK A, 1995, J NEUROSCI, V15, P6651; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Sommeijer JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035323; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sparta DR, 2014, J NEUROSCI, V34, P3699, DOI 10.1523/JNEUROSCI.0235-13.2014; Stark E, 2013, NEURON, V80, P1263, DOI 10.1016/j.neuron.2013.09.033; Strueber M., 2011, NEUR M PLANN; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Taniguchi H, 2013, SCIENCE, V339, P70, DOI 10.1126/science.1227622; Thomson AM, 1996, J PHYSIOL-LONDON, V496, P81, DOI 10.1113/jphysiol.1996.sp021667; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Tukker JJ, 2013, J NEUROSCI, V33, P6809, DOI 10.1523/JNEUROSCI.5052-12.2013; Varga C, 2012, P NATL ACAD SCI USA, V109, pE2726, DOI 10.1073/pnas.1210929109; Vervaeke K, 2012, SCIENCE, V335, P1624, DOI 10.1126/science.1215101; WEISER M, 1995, J NEUROSCI, V15, P4298; Wen L, 2010, P NATL ACAD SCI USA, V107, P1211, DOI 10.1073/pnas.0910302107; Westbrook GL., 2013, PRINCIPLES NEURAL SC, P1116; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wilson NR, 2012, NATURE, V488, P343, DOI 10.1038/nature11347; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Xue MS, 2014, NATURE, V511, P596, DOI 10.1038/nature13321; Yazaki-Sugiyama Y, 2009, NATURE, V462, P218, DOI 10.1038/nature08485; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zaitsev AV, 2007, J NEUROPHYSIOL, V97, P3567, DOI 10.1152/jn.01293.2006	134	602	613	14	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					529	+	1255263	10.1126/science.1255263	http://dx.doi.org/10.1126/science.1255263			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082707				2022-12-28	WOS:000339651300036
J	Nielsen, S; Zenkin, N				Nielsen, Soren; Zenkin, Nikolay			Response to Comment on "Mechanism of eukaryotic RNA polymerase III transcription termination"	SCIENCE			English	Editorial Material							TAGETITOXIN	Arimbasseri et al., in their Comment, suggest that to terminate transcription in vivo, RNA polymerase III uses a mechanism other than hairpin-dependent termination and that properties of purified polymerase may depend on preparation procedure. Evidence suggests that our preparation is indeed different from that of other methods. Our new data suggest that, apart from hairpin-dependent termination, one or more "fail-safe" termination mechanisms may exist in the cell.	[Nielsen, Soren; Zenkin, Nikolay] Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England	Newcastle University - UK	Zenkin, N (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Inst Cell & Mol Biosci, Baddiley Clark Bldg,Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	n.zenkin@ncl.ac.uk		Zenkin, Nikolay/0000-0003-2212-9545	BBSRC [BB/L010003/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L010003/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council Funding Source: Medline; European Research Council [202994] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission)		Arimbasseri AG, 2014, SCIENCE, V345, DOI 10.1126/science.1253783; Jeong SW, 1996, J BIOL CHEM, V271, P16104, DOI 10.1074/jbc.271.27.16104; Nielsen S, 2013, TRANSCR-AUSTIN, V4, P209, DOI 10.4161/trns.27062; Nielsen S, 2013, SCIENCE, V340, P1577, DOI 10.1126/science.1237934; STEINBERG TH, 1990, J BIOL CHEM, V265, P499; STEINBERG TH, 1992, J BIOL CHEM, V267, P20204; WHITEHALL SK, 1994, J BIOL CHEM, V269, P2299; Yuzenkova Y, 2013, NUCLEIC ACIDS RES, V41, P9257, DOI 10.1093/nar/gkt708	8	5	5	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196								10.1126/science.1254246	http://dx.doi.org/10.1126/science.1254246			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082695	Green Accepted			2022-12-28	WOS:000339651300035
J	Sedgwick, P				Sedgwick, Philip			STATISTICAL QUESTION What is a crossover trial?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175				Sedgwick P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2674; Svendsen KB, 2004, BMJ-BRIT MED J, V329, P253, DOI 10.1136/bmj.38149.566979.AE	2	11	11	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 9	2014	348								g3191	10.1136/bmj.g3191	http://dx.doi.org/10.1136/bmj.g3191			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH0OT	25134118				2022-12-28	WOS:000335820400004
J	Kass, N				Kass, Nancy			Ebola, Ethics, and Public Health: What Next?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA	Johns Hopkins University	Kass, N (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, 1809 Ashland Ave, Baltimore, MD 21205 USA.	nkass@jhu.edu						[Anonymous], 1871, J BR ARCHAEOL ASSOC, V27, P255; Ezeome ER, 2010, DEV WORLD BIOETH, V10, P1, DOI 10.1111/j.1471-8847.2008.00239.x; Fatima K, 2013, J INFECT DEV COUNTR, V7, P897, DOI 10.3855/jidc.3647; Loria K, 2014, HERES EVERYTHING WE; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; Mapp Biopharmaceutical, 2014, ZMAPP INF SHEET; Page-Shafer K, 2005, LANCET, V366, P1499, DOI 10.1016/S0140-6736(05)67146-2; U.S. Food and Drug Administration, 2013, FIN RUL EXP ACC INV; WHO, 2014, EB VIR DIS; World Health Organization, 2014, WHO CONV ETH REV EXP	10	23	24	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					744	U196		10.7326/M14-1864	http://dx.doi.org/10.7326/M14-1864			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25133473				2022-12-28	WOS:000347245600033
J	Li, J; Hou, B; Tumova, S; Muraki, K; Bruns, A; Ludlow, MJ; Sedo, A; Hyman, AJ; McKeown, L; Young, RS; Yuldasheva, NY; Majeed, Y; Wilson, LA; Rode, B; Bailey, MA; Kim, HR; Fu, ZJ; Carter, DAL; Bilton, J; Imrie, H; Ajuh, P; Dear, TN; Cubbon, RM; Kearney, MT; Prasad, KR; Evans, PC; Ainscough, JFX; Beech, DJ				Li, Jing; Hou, Bing; Tumova, Sarka; Muraki, Katsuhiko; Bruns, Alexander; Ludlow, Melanie J.; Sedo, Alicia; Hyman, Adam J.; McKeown, Lynn; Young, Richard S.; Yuldasheva, Nadira Y.; Majeed, Yasser; Wilson, Lesley A.; Rode, Baptiste; Bailey, Marc A.; Kim, Hyejeong R.; Fu, Zhaojun; Carter, Deborah A. L.; Bilton, Jan; Imrie, Helen; Ajuh, Paul; Dear, T. Neil; Cubbon, Richard M.; Kearney, Mark T.; Prasad, K. Raj; Evans, Paul C.; Ainscough, Justin F. X.; Beech, David J.			Piezol integration of vascular architecture with physiological force	NATURE			English	Article							ACTIVATED CATION CHANNELS; FLUID SHEAR-STRESS; ENDOTHELIAL-CELLS; PROTEOME ANALYSIS; DISTURBED FLOW; CALPAIN; MECHANOTRANSDUCTION; TISSUES; GENE; MICE	The mechanisms by which physical forces regulate endothelial cells to determine the complexities of vascular structure and function are enigmatic(1-5). Studies of sensory neurons have suggested Piezo proteins as subunits of Ca2+-permeable non-selective cationic channels for detection of noxious mechanical impact(6-8). Here we show Piezol (Fam38a) channels as sensors of frictional force (shear stress) and determinants of vascular structure in both development and adult physiology. Global or endothelial-specific disruption of mouse Piezol profoundly disturbed the developing vasculature and was embryonic lethal within days of the heart beating. Haploinsufficiency was not lethal but endothelial abnormality was detected in mature vessels. The importance of Piezol channels as sensors of blood flow was shown by Piezol dependence of shear-stress-evoked ionic current and calcium influx in endothelial cells and the ability of exogenous Piezol to confer sensitivity to shear stress on otherwise resistant cells. Down-stream of this calcium influx there was protease activation and spatial reorganization of endothelial cells to the polarity of the applied force. The data suggest that Piezol channels function as pivotal integrators in vascular biology.	[Li, Jing; Hou, Bing; Tumova, Sarka; Bruns, Alexander; Ludlow, Melanie J.; Sedo, Alicia; Hyman, Adam J.; McKeown, Lynn; Young, Richard S.; Yuldasheva, Nadira Y.; Majeed, Yasser; Wilson, Lesley A.; Rode, Baptiste; Bailey, Marc A.; Fu, Zhaojun; Carter, Deborah A. L.; Bilton, Jan; Imrie, Helen; Dear, T. Neil; Cubbon, Richard M.; Kearney, Mark T.; Ainscough, Justin F. X.; Beech, David J.] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [Li, Jing; Hou, Bing; Tumova, Sarka; Bruns, Alexander; Ludlow, Melanie J.; Sedo, Alicia; Hyman, Adam J.; McKeown, Lynn; Young, Richard S.; Yuldasheva, Nadira Y.; Majeed, Yasser; Wilson, Lesley A.; Rode, Baptiste; Bailey, Marc A.; Fu, Zhaojun; Carter, Deborah A. L.; Bilton, Jan; Imrie, Helen; Dear, T. Neil; Cubbon, Richard M.; Kearney, Mark T.; Ainscough, Justin F. X.; Beech, David J.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds LS2 9JT, W Yorkshire, England; [Muraki, Katsuhiko] Aichi Gakuin Univ, Sch Pharm, Chikusa Ku, Nagoya, Aichi 4648650, Japan; [Prasad, K. Raj] St James Univ Hosp, Dept Hepatobiliary & Transplant Surg, Leeds LS9 7TF, W Yorkshire, England; [Kim, Hyejeong R.; Evans, Paul C.] Univ Sheffield, Sheffield S10 2RX, S Yorkshire, England; [Ajuh, Paul] Dundee Cell Prod Ltd, Dundee DD1 5JJ, Scotland	University of Leeds; University of Leeds; Aichi Gakuin University; Saint James's University Hospital; University of Sheffield	Beech, DJ (corresponding author), Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England.	d.j.beech@leeds.ac.uk	Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Tumova, Sarka/AAD-6353-2019; Majeed, Yasser/ABG-3662-2021; HOU, BING/AAC-5247-2022; McKeown, Lynn/AAC-6037-2020	Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Tumova, Sarka/0000-0003-2044-4998; HOU, BING/0000-0002-8348-3831; McKeown, Lynn/0000-0003-2326-7595; Ludlow, Melanie/0000-0002-0720-5581; Evans, Paul/0000-0001-7975-681X; Hyman, Adam/0000-0003-0874-6678; Bailey, Marc/0000-0001-5038-1970; Ainscough, Justin/0000-0003-0231-433X; Beech, David/0000-0002-7683-9422	Wellcome Trust; Medical Research Council; Leeds Teaching Hospitals Trust Charitable Foundation; British Heart Foundation; University of Leeds; China Scholarship Council; BBSRC PhD Studentship; Cancer Research UK Clinical Fellowship; BBSRC-AstraZeneca PhD Studentship; British Heart Foundation Fellowship; Biotechnology and Biological Sciences Research Council [1360947] Funding Source: researchfish; British Heart Foundation [RG/13/1/30042, FS/12/54/29671, FS/12/80/29821, FS/14/22/30734] Funding Source: researchfish; Medical Research Council [MR/L019051/1, G1002076] Funding Source: researchfish; MRC [G1002076, MR/L019051/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leeds Teaching Hospitals Trust Charitable Foundation; British Heart Foundation(British Heart Foundation); University of Leeds; China Scholarship Council(China Scholarship Council); BBSRC PhD Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK Clinical Fellowship; BBSRC-AstraZeneca PhD Studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation Fellowship(British Heart Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The research was supported by research grants from the Wellcome Trust, the Medical Research Council, the Leeds Teaching Hospitals Trust Charitable Foundation, and the British Heart Foundation. B.H. was supported by a Scholarship from the University of Leeds and the China Scholarship Council. A.J.H. was supported by a BBSRC PhD Studentship. R.S.Y. was supported by a Cancer Research UK Clinical Fellowship. L.A.W. was supported by a BBSRC-AstraZeneca PhD Studentship. M.A.B. was supported by a British Heart Foundation Fellowship.	AbouAlaiwi WA, 2009, CIRC RES, V104, P860, DOI 10.1161/CIRCRESAHA.108.192765; Ando J, 2013, CARDIOVASC RES, V99, P260, DOI 10.1093/cvr/cvt084; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Babaei F, 2013, J PROTEOME RES, V12, P1580, DOI 10.1021/pr3009226; Bae C, 2013, P NATL ACAD SCI USA, V110, pE1162, DOI 10.1073/pnas.1219777110; Bae C, 2011, BIOCHEMISTRY-US, V50, P6295, DOI 10.1021/bi200770q; Balligand JL, 2009, PHYSIOL REV, V89, P481, DOI 10.1152/physrev.00042.2007; Brakemeier S, 2002, CARDIOVASC RES, V53, P209, DOI 10.1016/S0008-6363(01)00476-X; Chiu JJ, 2011, PHYSIOL REV, V91, P327, DOI 10.1152/physrev.00047.2009; Conway Daniel, 2012, F1000 Biol Rep, V4, P1, DOI 10.3410/B4-1; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dolan JM, 2013, ANN BIOMED ENG, V41, P1411, DOI 10.1007/s10439-012-0695-0; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johnson BD, 2011, VASC MED, V16, P365, DOI 10.1177/1358863X11422109; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; LANGILLE BL, 1981, CIRC RES, V48, P481, DOI 10.1161/01.RES.48.4.481; Lebart MC, 2006, FEBS J, V273, P3415, DOI 10.1111/j.1742-4658.2006.05350.x; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Lucitti JL, 2007, DEVELOPMENT, V134, P3317, DOI 10.1242/dev.02883; Mammoto T, 2010, DEVELOPMENT, V137, P1407, DOI 10.1242/dev.024166; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; McHugh BJ, 2010, J CELL SCI, V123, P51, DOI 10.1242/jcs.056424; Miyazaki T, 2007, AM J PHYSIOL-CELL PH, V293, pC1216, DOI 10.1152/ajpcell.00083.2007; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Thingholm TE, 2006, NAT PROTOC, V1, P1929, DOI 10.1038/nprot.2006.185; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Warboys CM, 2014, ARTERIOSCL THROM VAS, V34, P985, DOI 10.1161/ATVBAHA.114.303415; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yamamoto K, 2006, NAT MED, V12, P133, DOI 10.1038/nm1338; Zarychanski R, 2012, BLOOD, V120, P1908, DOI 10.1182/blood-2012-04-422253; Zhuang XD, 2011, BIOCHEM SOC T, V39, P1571, DOI 10.1042/BST20110746	37	517	544	21	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2014	515	7526					279	U308		10.1038/nature13701	http://dx.doi.org/10.1038/nature13701			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AT0MZ	25119035	Green Accepted			2022-12-28	WOS:000344631400053
J	Manns, M; Pol, S; Jacobson, IM; Marcellin, P; Gordon, SC; Peng, CY; Chang, TT; Everson, GT; Heo, J; Gerken, G; Yoffe, B; Towner, WJ; Bourliere, M; Metivier, S; Chu, CJ; Sievert, W; Bronowicki, JP; Thabut, D; Lee, YJ; Kao, JH; McPhee, F; Kopit, J; Mendez, P; Linaberry, M; Hughes, E; Noviello, S				Manns, Michael; Pol, Stanislas; Jacobson, Ira M.; Marcellin, Patrick; Gordon, Stuart C.; Peng, Cheng-Yuan; Chang, Ting-Tsung; Everson, Gregory T.; Heo, Jeong; Gerken, Guido; Yoffe, Boris; Towner, William J.; Bourliere, Marc; Metivier, Sophie; Chu, Chi-Jen; Sievert, William; Bronowicki, Jean-Pierre; Thabut, Dominique; Lee, Youn-Jae; Kao, Jia-Horng; McPhee, Fiona; Kopit, Justin; Mendez, Patricia; Linaberry, Misti; Hughes, Eric; Noviello, Stephanie		HALLMARK-DUAL Study Team	All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study	LANCET			English	Article							PROTEASE INHIBITOR; HCV; SOFOSBUVIR; ABT-450/R-OMBITASVIR; EPIDEMIOLOGY; RETREATMENT; MANAGEMENT; LEDIPASVIR; THERAPIES; DASABUVIR	Background An unmet need exists for interferon-free and ribavirin-free treatments for chronic hepatitis C virus (HCV) infection. In this study, we assessed all-oral therapy with daclatasvir (NS5A replication complex inhibitor) plus asunaprevir (NS3 protease inhibitor) in patients with genotype 1b infection, including those with high unmet needs or cirrhosis, or both. Methods We did this phase 3, multicohort study (HALLMARK-DUAL) at 116 sites in 18 countries between May 11, 2012, and Oct 9, 2013. Patients were adults with chronic HCV genotype 1b infection who were treatment-naive; previous non-responders to peginterferon alfa plus ribavirin; or medically ineligible for, previously intolerant of, or ineligible for and intolerant of peginterferon alfa plus ribavirin. Treatment-naive patients were randomly assigned (2: 1 ratio) by an interactive voice-response system with a computer-generated random allocation sequence (stratified by cirrhosis status) to receive daclatasvir 60 mg once daily plus asunaprevir 100 mg twice daily or placebo for 12 weeks. Patients and investigator sites were masked to treatment assignment and HCV RNA results to the end of week 12. The treatment-naive group assigned to daclatasvir plus asunaprevir continued open-label treatment to the end of week 24; participants assigned to placebo entered another daclatasvir plus asunaprevir study. Non-responders and ineligible, intolerant, or ineligible and intolerant patients received open-label daclatasvir plus asunaprevir for 24 weeks. The primary endpoint was sustained virological response at post-treatment week 12. Efficacy analyses were restricted to patients given daclatasvir plus asunaprevir. This trial is registered with ClinicalTrials.gov, number NCT01581203. Findings This study included 307 treatment-naive patients (205 received daclatasvir plus asunaprevir and 102 received placebo; all randomly assigned patients received the intended treatment), 205 non-responders, and 235 ineligible, intolerant, or ineligible and intolerant patients. Daclatasvir plus asunaprevir provided sustained virological response in 182 (90%, 95% CI 85-94) patients in the treatment-naive cohort, 168 (82%, 77-87) in the non-responder cohort, and 192 (82%, 77-87) in the ineligible, intolerant, or ineligible and intolerant cohort. Serious adverse events occurred in 12 (6%) patients in the treatment-naive group; 11 (5%) non-responders, and 16 (7%) ineligible, intolerant, or ineligible and intolerant patients; adverse events leading to discontinuation (most commonly reversible increases in alanine or aspartate aminotransferase) occurred in six (3%), two (1%), and two (1%) patients, respectively, with no deaths recorded. Grade 3 or 4 laboratory abnormalities were uncommon, with low incidences of aminotransferase increases during the first 12 weeks with daclatasvir plus asunaprevir and placebo in treatment-naive patients (<= 2% each). Interpretation Daclatasvir plus asunaprevir provided high sustained virological response rates in treatment-naive, non-responder, and ineligible, intolerant, or ineligible and intolerant patients, and was well tolerated in patients with HCV genotype 1b infection. These results support the use of daclatasvir plus asunaprevir as an all-oral, interferonfree and ribavirin-free treatment option for patients with HCV genotype 1b infection, including those with cirrhosis.	[Manns, Michael] Hannover Med Sch, D-30625 Hannover, Germany; [Manns, Michael] German Ctr Infect Res DZIF, Hannover, Germany; [Pol, Stanislas] Hop Cochin, F-75674 Paris, France; [Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY USA; [Marcellin, Patrick] Hop Beaujon, Clichy, France; [Gordon, Stuart C.] Henry Ford Hlth Syst, Detroit, MI USA; [Peng, Cheng-Yuan] China Med Univ, Sch Med, Taichung, Taiwan; [Chang, Ting-Tsung] Natl Cheng Kung Univ Hosp, Tainan 70428, Taiwan; [Everson, Gregory T.] Univ Colorado Denver, Aurora, CO USA; [Heo, Jeong] Pusan Natl Univ, Coll Med, Dept Internal Med, Pusan, South Korea; [Heo, Jeong] Pusan Natl Univ, Med Res Inst, Pusan, South Korea; [Gerken, Guido] Univ Duisburg Essen, Essen, Germany; [Yoffe, Boris] Baylor Coll Med, VAMC, Houston, TX 77030 USA; [Towner, William J.] Kaiser Permanente, Los Angeles, CA USA; [Bourliere, Marc] Hop St Joseph, Marseille, France; [Metivier, Sophie] CHU Purpan, Toulouse, France; [Chu, Chi-Jen] Taipei Vet Gen Hosp, Taipei, Taiwan; [Chu, Chi-Jen] Natl Yang Ming Univ, Taipei 112, Taiwan; [Sievert, William] Monash Hlth, Melbourne, Vic, Australia; [Sievert, William] Monash Univ, Melbourne, Vic 3004, Australia; [Bronowicki, Jean-Pierre] Ctr Hosp Univ Nancy, INSERM, Unite 954, Vandoeuvre Les Nancy, France; [Bronowicki, Jean-Pierre] Univ Lorraine, Vandoeuvre Les Nancy, France; [Thabut, Dominique] Hop La Pitie Salpetriere, Paris, France; [Lee, Youn-Jae] Inje Univ, Busan Paik Hosp, Pusan, South Korea; [Kao, Jia-Horng] Natl Taiwan Univ Hosp, Taipei, Taiwan; [McPhee, Fiona; Kopit, Justin] Bristol Myers Squibb Res & Dev, Wallingford, CT USA; [Mendez, Patricia; Linaberry, Misti; Hughes, Eric; Noviello, Stephanie] Bristol Myers Squibb Res & Dev, Princeton, NJ USA	Hannover Medical School; German Center for Infection Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Cornell University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Henry Ford Health System; Henry Ford Hospital; China Medical University Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Pusan National University; Pusan National University; University of Duisburg Essen; Baylor College of Medicine; Kaiser Permanente; CHU de Toulouse; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Monash University; CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Inje University; National Taiwan University; National Taiwan University Hospital; Bristol-Myers Squibb; Bristol-Myers Squibb	Manns, M (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.	manns.michael@mh-hannover.de	Kao, Jia-Horng/AAB-8947-2019	Kao, Jia-Horng/0000-0002-2442-7952	Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	Bristol-Myers Squibb.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Bourliere M, 2012, LIVER INT, V32, P113, DOI 10.1111/j.1478-3231.2011.02702.x; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Cornberg M, 2011, LIVER INT, V31, P30, DOI 10.1111/j.1478-3231.2011.02539.x; Everson GT, 2014, GASTROENTEROLOGY, V146, P420, DOI 10.1053/j.gastro.2013.10.057; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Food and Drug Administration, 2014, SOVALDI SOF PRESCR I; Gao M, 2013, CURR OPIN VIROL, V3, P514, DOI 10.1016/j.coviro.2013.06.014; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Jacobson IM, 2014, LANCET; Janssen Therapeutics, 2014, OLYSIO SIM PRESCR IN; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Manns M, 2014, LANCET; Manns MP, 2013, NAT REV DRUG DISCOV, V12, P595, DOI 10.1038/nrd4050; Manos MM, 2012, J MED VIROL, V84, P1744, DOI 10.1002/jmv.23399; McPhee F, 2012, ANTIMICROB AGENTS CH, V56, P5387, DOI 10.1128/AAC.01186-12; Melia MT, 2011, HEPATOLOGY, V54, P70, DOI 10.1002/hep.24358; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Negro F, 2011, LIVER INT, V31, P1, DOI 10.1111/j.1478-3231.2011.02537.x; Omata M, 2012, HEPATOL INT, V6, P409, DOI 10.1007/s12072-012-9342-y; Pawlotsky JM, 2014, GASTROENTEROLOGY, V146, P1176, DOI 10.1053/j.gastro.2014.03.003; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Suzuki Y, 2013, J HEPATOL, V58, P655, DOI 10.1016/j.jhep.2012.09.037; Zeuzem S, 2014, TOP ANTIVIR MED, V22, P34; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	31	275	302	0	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1597	1605		10.1016/S0140-6736(14)61059-X	http://dx.doi.org/10.1016/S0140-6736(14)61059-X			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AR9NK	25078304				2022-12-28	WOS:000343901700028
J	Ko, SY; Pegu, A; Rudicell, RS; Yang, ZY; Joyce, MG; Chen, XJ; Wang, KY; Bao, S; Kraemer, TD; Rath, T; Zeng, M; Schmidt, SD; Todd, JP; Penzak, SR; Saunders, KO; Nason, MC; Haase, AT; Rao, SS; Blumberg, RS; Mascola, JR; Nabel, GJ				Ko, Sung-Youl; Pegu, Amarendra; Rudicell, Rebecca S.; Yang, Zhi-yong; Joyce, M. Gordon; Chen, Xuejun; Wang, Keyun; Bao, Saran; Kraemer, Thomas D.; Rath, Timo; Zeng, Ming; Schmidt, Stephen D.; Todd, John-Paul; Penzak, Scott R.; Saunders, Kevin O.; Nason, Martha C.; Haase, Ashley T.; Rao, Srinivas S.; Blumberg, Richard S.; Mascola, John R.; Nabel, Gary J.			Enhanced neonatal Fc receptor function improves protection against primate SHIV infection	NATURE			English	Article							NEUTRALIZING ANTIBODIES; HALF-LIFE; HIV-1 VACCINE; HUMAN IGG1; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; IN-VIVO; TRANSPORT; CHALLENGE; IMMUNITY	To protect against human immunodeficiency virus (HIV-1) infection, broadly neutralizing antibodies (bnAbs) must be active at the portals of viral entry in the gastrointestinal or cervicovaginal tracts. The localization and persistence of antibodies at these sites is influenced by the neonatal Fc receptor (FcRn)(1,2), whose role in protecting against infection in vivo has not been defined. Here, we show that a bnAb with enhanced FcRn binding has increased gut mucosal tissue localization, which improves protection against lentiviral infection in non-human primates. A bnAb directed to the CD4-binding site of the HIV-1 envelope (Env) protein (denoted VRC01)(3) was modified by site-directed mutagenesis to increase its binding affinity for FcRn. This enhanced FcRn-binding mutant bnAb, denoted VRC01-LS, displayed increased transcytosis across human FcRn-expressing cellular monolayers in vitro while retaining Fc gamma RIIIa binding and function, including antibody-dependent cell-mediated cytotoxicity (ADCC) activity, at levels similar to VRC01 (the wild type). VRC01-LS had a threefold longer serum half-life than VRC01 in non-human primates and persisted in the rectal mucosa even when it was no longer detectable in the serum. Notably, VRC01-LSmediated protection superior to that afforded by VRC01 against intrarectal infection with simian-human immunodeficiency virus (SHIV). These findings suggest that modification of FcRn binding provides a mechanism not only to increase serum half-life but also to enhance mucosal localization that confers immune protection. Mutations that enhance FcRn function could therefore increase the potency and durability of passive immunization strategies to prevent HIV-1 infection.	[Ko, Sung-Youl; Pegu, Amarendra; Rudicell, Rebecca S.; Yang, Zhi-yong; Joyce, M. Gordon; Chen, Xuejun; Wang, Keyun; Bao, Saran; Schmidt, Stephen D.; Todd, John-Paul; Saunders, Kevin O.; Rao, Srinivas S.; Mascola, John R.; Nabel, Gary J.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Kraemer, Thomas D.; Rath, Timo; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Div Gastroenterol, Dept Med, Boston, MA 02115 USA; [Zeng, Ming; Haase, Ashley T.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA; [Penzak, Scott R.] NIH, Clin Pharmacokinet Lab, Dept Pharm, Bethesda, MD 20814 USA; [Nason, Martha C.] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Brigham & Women's Hospital; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Nabel, GJ (corresponding author), Sanofi, 640 Mem Dr, Cambridge, MA 02139 USA.	jmascola@nih.gov; Gary.Nabel@sanofi.com	Mascola, John/AAI-7193-2021; Schmidt, Stephen/AAC-6967-2019; Schmidt, Stephen/B-5398-2012; Pegu, Amarendra/X-1361-2019	Pegu, Amarendra/0000-0003-3564-6453; Rath, Timo/0000-0002-7728-9338	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Foundation for the National Institutes of Health; Collaboration for AIDS Vaccine Discovery (CAVD) award from the Bill & Melinda Gates Foundation [OPP1039775]; NIH [DK044319, DK051362, DK053056, DK088199]; Harvard Digestive Diseases Center [DK0034854]; German research foundation (DFG) [RA 2040/1-1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005002, ZIAAI005122, ZIAAI005009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK088199, R01DK044319, R01DK053056, R56DK053056, R37DK044319, R01DK051362] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH); Foundation for the National Institutes of Health; Collaboration for AIDS Vaccine Discovery (CAVD) award from the Bill & Melinda Gates Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; German research foundation (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Roederer for advice on the design and statistical analysis of animal studies. This research was supported by the Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), and in part by a grant from the Foundation for the National Institutes of Health with support from the Collaboration for AIDS Vaccine Discovery (CAVD), award OPP1039775, from the Bill & Melinda Gates Foundation. R. S. B. is supported by the NIH (DK044319, DK051362, DK053056 and DK088199) and the Harvard Digestive Diseases Center (DK0034854). T. R. is supported by the German research foundation (DFG; RA 2040/1-1). The findings and conclusions in this report are those of the authors and do not necessarily reflect the views of the funding agencies.	Baker K, 2013, IMMUNITY, V39, P1095, DOI 10.1016/j.immuni.2013.11.003; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Claypool SM, 2002, J BIOL CHEM, V277, P28038, DOI 10.1074/jbc.M202367200; Dall'Acqua WF, 2002, J IMMUNOL, V169, P5171, DOI 10.4049/jimmunol.169.9.5171; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; GASTINEL LN, 1992, P NATL ACAD SCI USA, V89, P638, DOI 10.1073/pnas.89.2.638; Gomez-Roman VR, 2006, J IMMUNOL METHODS, V308, P53, DOI 10.1016/j.jim.2005.09.018; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hinton PR, 2006, J IMMUNOL, V176, P346, DOI 10.4049/jimmunol.176.1.346; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klein K, 2013, J VIROL, V87, P11604, DOI 10.1128/JVI.01361-13; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li ZL, 2011, P NATL ACAD SCI USA, V108, P4388, DOI 10.1073/pnas.1012861108; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; ONORATO IM, 1991, J INFECT DIS, V163, P1, DOI 10.1093/infdis/163.1.1; Pegu A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008992; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shu Y, 2007, VACCINE, V25, P1398, DOI 10.1016/j.vaccine.2006.10.046; SICINSKI P, 1990, GASTROENTEROLOGY, V98, P56, DOI 10.1016/0016-5085(90)91290-M; Smalls-Mantey A, 2012, J VIROL, V86, P8672, DOI 10.1128/JVI.00287-12; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Ward ES, 2009, ADV IMMUNOL, V103, P77, DOI 10.1016/S0065-2776(09)03004-1; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yoshida M, 2004, IMMUNITY, V20, P769, DOI 10.1016/j.immuni.2004.05.007; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zeng M, 2011, J CLIN INVEST, V121, P998, DOI 10.1172/JCI45157	37	228	235	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					642	+		10.1038/nature13612	http://dx.doi.org/10.1038/nature13612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25119033	Green Accepted			2022-12-28	WOS:000343801500052
J	Shi, JJ; Zhao, Y; Wang, YP; Gao, WQ; Ding, JJ; Li, P; Hu, LY; Shao, F				Shi, Jianjin; Zhao, Yue; Wang, Yupeng; Gao, Wenqing; Ding, Jingjin; Li, Peng; Hu, Liyan; Shao, Feng			Inflammatory caspases are innate immune receptors for intracellular LPS	NATURE			English	Article							LIPOPOLYSACCHARIDE RECOGNITION; ACTIVATION; PROTEIN; MECHANISMS; PYROPTOSIS; FLAGELLIN; PROMOTES; BACTERIA; BINDING; TLR4	The murine caspase-11 non-canonical inflammasome responds to various bacterial infections. Caspase-11 activation-induced pyroptosis, in response to cytoplasmic lipopolysaccharide (LPS), is critical for endotoxic shock in mice. The mechanism underlying cytosolic LPS sensing and the responsible pattern recognition receptor are unknown. Here we show that human monocytes, epithelial cells and keratinocytes undergo necrosis upon cytoplasmic delivery of LPS. LPS-induced cytotoxicity was mediated by human caspase-4 that could functionally complement murine caspase-11. Human caspase-4 and the mouse homologue caspase-11 (hereafter referred to as caspase-4/11) and also human caspase-5, directly bound to LPS and lipid A with high specificity and affinity. LPS associated with endogenous caspase-11 in pyroptotic cells. Insect-cell purified caspase-4/11 underwent oligomerization upon LPS binding, resulting in activation of the caspases. Underacylated lipid IVa and lipopolysaccharide from Rhodobacter sphaeroides (LPS-RS) could bind to caspase-4/11 but failed to induce their oligomerization and activation. LPS binding was mediated by the CARD domain of the caspase. Binding-deficient CARD-domain point mutants did not respond to LPS with oligomerization or activation and failed to induce pyroptosis upon LPS electroporation or bacterial infections. The function of caspase-4/5/11 represents a new mode of pattern recognition in immunity and also an unprecedented means of caspase activation.	[Shi, Jianjin; Shao, Feng] Natl Inst Biol Sci, Peking Univ Tsinghua Univ Natl Inst Biol Sci Join, Beijing 102206, Peoples R China; [Shi, Jianjin; Zhao, Yue; Wang, Yupeng; Gao, Wenqing; Ding, Jingjin; Li, Peng; Hu, Liyan; Shao, Feng] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Ding, Jingjin; Shao, Feng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Shao, Feng] Natl Inst Biol Sci, Collaborat Innovat Ctr Canc Med, Beijing 102206, Peoples R China	National Institute of Biological Sciences, Beijing; Tsinghua University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; National Institute of Biological Sciences, Beijing	Shao, F (corresponding author), Natl Inst Biol Sci, Peking Univ Tsinghua Univ Natl Inst Biol Sci Join, Beijing 102206, Peoples R China.	shaofeng@nibs.ac.cn	Zhao, Yue/A-5285-2018	Zhao, Yue/0000-0003-1509-9261; Shi, Jianjin/0000-0001-8048-5180; Ding, Jingjin/0000-0001-9941-7997	International Early Career Scientist grant from the Howard Hughes Medical Institute; Beijing Scholar Program; National Basic Research Program of China 973 Program [2012CB518700]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB08020202]; China National Science Foundation Program for Distinguished Young Scholars [31225002]	International Early Career Scientist grant from the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Beijing Scholar Program; National Basic Research Program of China 973 Program(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); China National Science Foundation Program for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC))	We thank Y. Fujimoto and K. Fukase for providing biotin-conjugated lipid A and lipid IVa and B. Finlay for S. typhimurium Delta sifA strain. We also thank W. Li at Tsinghua University for assistance in SLS and AU analyses and members of the Shao laboratory for discussions and technical assistance. The research was supported in part by an International Early Career Scientist grant from the Howard Hughes Medical Institute and the Beijing Scholar Program to F.S. This work was also supported by the National Basic Research Program of China 973 Program (2012CB518700), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB08020202) and China National Science Foundation Program for Distinguished Young Scholars (31225002) to F.S.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Akhter A, 2012, IMMUNITY, V37, P35, DOI 10.1016/j.immuni.2012.05.001; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Broz P, 2012, NATURE, V490, P288, DOI 10.1038/nature11419; Brumell JH, 2002, INFECT IMMUN, V70, P3264, DOI 10.1128/IAI.70.6.3264-3270.2002; Case CL, 2013, P NATL ACAD SCI USA, V110, P1851, DOI 10.1073/pnas.1211521110; Ferguson AD, 2000, STRUCTURE, V8, P585; Ge JN, 2012, P NATL ACAD SCI USA, V109, P6193, DOI 10.1073/pnas.1117490109; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Gurung P, 2012, J BIOL CHEM, V287, P34474, DOI 10.1074/jbc.M112.401406; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kobayashi T, 2013, CELL HOST MICROBE, V13, P570, DOI 10.1016/j.chom.2013.04.012; Koshiba T, 2007, J BIOL CHEM, V282, P3962, DOI 10.1074/jbc.M609198200; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lin XY, 2000, J BIOL CHEM, V275, P39920, DOI 10.1074/jbc.M007255200; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Meunier E, 2014, NATURE, V509, P366, DOI 10.1038/nature13157; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pilla DM, 2014, P NATL ACAD SCI USA, V111, P6046, DOI 10.1073/pnas.1321700111; Qureshi N, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P687; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Rathinam VAK, 2012, CELL, V150, P606, DOI 10.1016/j.cell.2012.07.007; Raymond AA, 2007, BRIT J DERMATOL, V156, P420, DOI 10.1111/j.1365-2133.2006.07656.x; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Shin HJ, 2007, MOL CELLS, V24, P119; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; Whitfield C, 2014, ANNU REV BIOCHEM, V83, P99, DOI 10.1146/annurev-biochem-060713-035600; Yang JL, 2013, P NATL ACAD SCI USA, V110, P14408, DOI 10.1073/pnas.1306376110; Yoon SI, 2010, P NATL ACAD SCI USA, V107, P10990, DOI 10.1073/pnas.1004153107; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhu YQ, 2010, P NATL ACAD SCI USA, V107, P4699, DOI 10.1073/pnas.0914231107	39	1176	1245	19	558	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					187	+		10.1038/nature13683	http://dx.doi.org/10.1038/nature13683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119034				2022-12-28	WOS:000342663100033
J	Kaukua, N; Shahidi, MK; Konstantinidou, C; Dyachuk, V; Kaucka, M; Furlan, A; An, ZW; Wang, LL; Hultman, I; Ahrlund-Richter, L; Blom, H; Brismar, H; Lopes, NA; Pachnis, V; Suter, U; Clevers, H; Thesleff, I; Sharpe, P; Ernfors, P; Fried, K; Adameyko, I				Kaukua, Nina; Shahidi, Maryam Khatibi; Konstantinidou, Chrysoula; Dyachuk, Vyacheslav; Kaucka, Marketa; Furlan, Alessandro; An, Zhengwen; Wang, Longlong; Hultman, Isabell; Ahrlund-Richter, Larsa; Blom, Hans; Brismar, Hjalmar; Lopes, Natalia Assaife; Pachnis, Vassilis; Suter, Ueli; Clevers, Hans; Thesleff, Irma; Sharpe, Paul; Ernfors, Patrik; Fried, Kaj; Adameyko, Igor			Glial origin of mesenchymal stem cells in a tooth model system	NATURE			English	Article							CRANIAL NEURAL CREST; REGENERATION; HOMEOSTASIS; GENERATION; MICE	Mesenchymal stem cells occupy niches in stromal tissues where they provide sources of cells for specialized mesenchymal derivatives during growth and repair(1). The origins of mesenchymal stem cells have been the subject of considerable discussion, and current consensus holds that perivascular cells form mesenchymal stem cells in most tissues. The continuously growing mouse incisor tooth offers an excellent model to address the origin of mesenchymal stem cells. These stem cells dwell in a niche at the tooth apex where they produce a variety of differentiated derivatives. Cells constituting the tooth are mostly derived from two embryonic sources: neural crest ectomesenchyme and ectodermal epithelium(2). It has been thought for decades that the dental mesenchymal stem cells(3) giving rise to pulp cells and odontoblasts derive from neural crest cells after their migration in the early head and formation of ectomesenchymal tissue(4,5). Here we show that a significant population of mesenchymal stem cells during development, self-renewal and repair of a tooth are derived from peripheral nerve-associated glia. Glial cells generate multipotent mesenchymal stem cells that produce pulp cells and odontoblasts. By combining a clonal colour-coding technique(6) with tracing of peripheral glia, we provide new insights into the dynamics of tooth organogenesis and growth.	[Kaukua, Nina; Fried, Kaj] Karolinska Inst, Dept Neurosci, S-17177 Stockholm, Sweden; [Konstantinidou, Chrysoula; Pachnis, Vassilis] Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England; [Dyachuk, Vyacheslav; Kaucka, Marketa; Adameyko, Igor] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Dyachuk, Vyacheslav] Russian Acad Sci, Far Eastern Branch, AV Zhirmunsky Inst Marine Biol, Vladivostok 690041, Russia; [Furlan, Alessandro; Lopes, Natalia Assaife; Ernfors, Patrik] Karolinska Inst, Dept Med Biochem & Biophys, Mol Neurobiol Unit, S-17177 Stockholm, Sweden; [An, Zhengwen; Wang, Longlong; Sharpe, Paul] Guys Hosp, Inst Dent, Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London SE1 3QD, England; [Hultman, Isabell; Ahrlund-Richter, Larsa] Karolinska Inst, Dept Womens & Childrens Hlth, S-17177 Stockholm, Sweden; [Blom, Hans; Brismar, Hjalmar] Royal Inst Technol, Sci Life Lab, S-17177 Stockholm, Sweden; [Suter, Ueli] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Dept Biol, CH-8093 Zurich, Switzerland; [Clevers, Hans] Koninklijke Nederlandse Akad Wetenschappen KNAW, Hubrecht Inst, NL-3508 AD Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Dept Mol Genet, NL-3508 GA Utrecht, Netherlands; [Clevers, Hans] Univ Helsinki, Dev Biol Program, Inst Biotechnol, FI-00014 Helsinki, Finland	Karolinska Institutet; MRC National Institute for Medical Research; Karolinska Institutet; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Karolinska Institutet; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Karolinska Institutet; Royal Institute of Technology; Swiss Federal Institutes of Technology Domain; ETH Zurich; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Helsinki	Adameyko, I (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	Kaj.Fried@ki.se; Igor.Adameyko@ki.se	Suter, Ueli/A-1624-2010; An, Zhengwen/HGE-7458-2022; Furlan, Alessandro/AAM-4680-2021; Kaucka, Marketa/AAG-2000-2021; Dyachuk, Vyacheslav/U-9115-2019; Brismar, Hjalmar/E-8524-2011	An, Zhengwen/0000-0003-0360-7388; Furlan, Alessandro/0000-0001-5149-6331; Kaucka, Marketa/0000-0002-8781-9769; Dyachuk, Vyacheslav/0000-0001-8100-7367; Brismar, Hjalmar/0000-0003-0578-4003; Pachnis, Vassilis/0000-0001-9733-7686; Sharpe, Paul/0000-0003-2116-9561; Adameyko, Igor/0000-0001-5471-0356	Swedish Research Council; Bertil Hallsten Research Foundation; StratRegen; Wallenberg Foundation; Swiss National Science Foundation; Medical Research Council [G0901599]; Wallenberg Scholar and European Research Council; National Graduate School in Odontological Science; Swedish Dental Association; EMBO Long-Term Fellowship; Stockholm County Council; Developmental Studies Hybridoma Bank; MRC [MC_U117537087, G0901599, MR/K018035/1] Funding Source: UKRI; Medical Research Council [MR/K018035/1, MC_U117537087] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Bertil Hallsten Research Foundation; StratRegen; Wallenberg Foundation(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wallenberg Scholar and European Research Council; National Graduate School in Odontological Science; Swedish Dental Association; EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Stockholm County Council(Stockholm County Council); Developmental Studies Hybridoma Bank; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	P. Kovaleva and O. Rogachevskaya helped with illustrations. This study was supported by the Swedish Research Council (I. A., K. F., P. E.), The Bertil Hallsten Research Foundation (I. A.), StratRegen and the Wallenberg Foundation (CLICK, I. A.), the Swiss National Science Foundation (U.S.), Medical Research Council (G0901599; P. S.), a Wallenberg Scholar and European Research Council advanced grant (P. E.), National Graduate School in Odontological Science (M. K. S.), the Swedish Dental Association(N.K., M. K. S.), an EMBO Long-Term Fellowship(M. K.) and Stockholm County Council (N.K.) and Developmental Studies Hybridoma Bank.	Adameyko I, 2012, DEVELOPMENT, V139, P397, DOI 10.1242/dev.065581; Adameyko I, 2010, CELL MOL LIFE SCI, V67, P3037, DOI 10.1007/s00018-010-0390-y; Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; Caton J, 2009, J ANAT, V214, P502, DOI 10.1111/j.1469-7580.2008.01014.x; Chung IH, 2009, STEM CELLS, V27, P866, DOI 10.1002/stem.2; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Dewachter I, 2002, J NEUROSCI, V22, P3445; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; Hari L, 2012, DEVELOPMENT, V139, P2107, DOI 10.1242/dev.073064; Jinno H, 2010, STEM CELLS, V28, P2027, DOI 10.1002/stem.525; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Koussoulakou DS, 2009, INT J BIOL SCI, V5, P226; Laranjeira C, 2011, J CLIN INVEST, V121, P3412, DOI 10.1172/JCI58200; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Luukko K, 2008, ANN ANAT, V190, P178, DOI 10.1016/j.aanat.2007.10.003; Miletich Isabelle, 2004, Birth Defects Res C Embryo Today, V72, P200, DOI 10.1002/bdrc.20012; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013	18	267	275	4	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					551	+		10.1038/nature13536	http://dx.doi.org/10.1038/nature13536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25079316				2022-12-28	WOS:000342075800041
J	Cole, TB				Cole, Thomas B.			"The Beautyful Ones Are Not Yet Born" Might Not Hold True For Much Longer Njideka Akunyili	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					680	681		10.1001/jama.2013.279671	http://dx.doi.org/10.1001/jama.2013.279671			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25138318				2022-12-28	WOS:000340438700001
J	VanWagner, LB; Green, RM				VanWagner, Lisa B.; Green, Richard M.			Elevated Serum Ferritin	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEREDITARY HEMOCHROMATOSIS; IRON-OVERLOAD		[VanWagner, Lisa B.] Northwestern Univ, Dept Prevent Med, Div Gastroenterol & Hepatol, Feinberg Sch Med, Chicago, IL 60611 USA; [VanWagner, Lisa B.] Northwestern Univ, Dept Med, Div Gastroenterol & Hepatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Green, Richard M.] Northwestern Univ, Dept Med, Div Gastroenterol & Hepatol, Sect Hepatol,Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	VanWagner, LB (corresponding author), Northwestern Univ, Div Gastroenterol & Hepatol & Prevent Med, Dept Med, Feinberg Sch Med, 680 N Lake Shore Dr,Ste 1400,14-079K, Chicago, IL 60611 USA.	lvw@northwestern.edu		VanWagner, Lisa/0000-0002-6264-2573	NHLBI NIH HHS [1F32HL116151-01, F32 HL116151] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL116151] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams PC, 2005, NEW ENGL J MED, V352, P1769, DOI 10.1056/NEJMoa041534; Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Bacon BR, 2011, HEPATOLOGY, V54, P328, DOI 10.1002/hep.24330; Chandrasekharan S, 2010, GENET MED, V12, pS155, DOI 10.1097/GIM.0b013e3181d7acb0; McKinnon EJ, 2013, CLIN GASTROENTEROL H, P30; Moore C, 2013, JCR-J CLIN RHEUMATOL, V19, P324, DOI 10.1097/RHU.0b013e31829ce01f; Pippard MJ, 1997, LANCET, V349, P73, DOI 10.1016/S0140-6736(05)60880-X; Powell LW, 2006, ARCH INTERN MED, V166, P294, DOI 10.1001/archinte.166.3.294; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009	10	6	7	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					743	744		10.1001/jama.2014.302	http://dx.doi.org/10.1001/jama.2014.302			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25138336	Green Accepted			2022-12-28	WOS:000340438700024
J	Wang, Y; Waters, J; Leung, ML; Unruh, A; Roh, W; Shi, XQ; Chen, K; Scheet, P; Vattathil, S; Liang, H; Multani, A; Zhang, H; Zhao, R; Michor, F; Meric-Bernstam, F; Navin, NE				Wang, Yong; Waters, Jill; Leung, Marco L.; Unruh, Anna; Roh, Whijae; Shi, Xiuqing; Chen, Ken; Scheet, Paul; Vattathil, Selina; Liang, Han; Multani, Asha; Zhang, Hong; Zhao, Rui; Michor, Franziska; Meric-Bernstam, Funda; Navin, Nicholas E.			Clonal evolution in breast cancer revealed by single nucleus genome sequencing	NATURE			English	Article							GROWTH-RATE; CARCINOMAS; MUTATIONS; HETEROGENEITY; REARRANGEMENT; HYBRIDIZATION; NUCLEOTIDE; PATTERNS; EXPRESS	Sequencing studies of breast tumour cohorts have identified many prevalent mutations, but provide limited insight into the genomic diversity within tumours. Here we developed a whole-genome and exome single cell sequencing approach called nuc-seq that uses G2/M nuclei to achieve 91% mean coverage breadth. We applied this method to sequence single normal and tumour nuclei from an oestrogen-receptor-positive(ER+) breast cancer and a triple-negative ductal carcinoma. In parallel, we performed single nuclei copy number profiling. Our data show that aneuploid rearrangements occurred early in tumour evolution and remained highly stable as the tumour masses clonally expanded. In contrast, point mutations evolved gradually, generating extensive clonal diversity. Using targeted single-molecule sequencing, many of the diverse mutations were shown to occur at low frequencies (<10%) in the tumour mass. Using mathematical modelling we found that the triple-negative tumour cells had an increased mutation rate (13.3x), whereas the ER+ tumour cells did not. These findings have important implications for the diagnosis, therapeutic treatment and evolution of chemoresistance in breast cancer.	[Wang, Yong; Waters, Jill; Leung, Marco L.; Unruh, Anna; Roh, Whijae; Shi, Xiuqing; Multani, Asha; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Leung, Marco L.; Scheet, Paul; Vattathil, Selina; Navin, Nicholas E.] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Chen, Ken; Liang, Han; Navin, Nicholas E.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Scheet, Paul] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Zhang, Hong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Zhao, Rui; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Zhao, Rui; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA; [Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Texas System; UTMD Anderson Cancer Center	Navin, NE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	nnavin@mdanderson.org	Leung, Marco/AAH-3178-2021; Chen, Ken/AAU-1432-2021	Chen, Ken/0000-0003-4013-5279; Casasent, Anna/0000-0002-7857-179X; Roh, Whijae/0000-0002-7395-9939; Wang, Yong/0000-0001-7183-3737	NIH [R21CA174397-01, TR000371, U24CA143883]; NCI [1RO1CA169244-01, RO1CA172652, CA016672]; T.C. Hsu and the Alice-Reynolds Kleberg Foundation; Center for Genetics Genomics; Susan Komen [SAC10006]; PS-OC [U54CA143798]; Dell Foundation; ALA; NATIONAL CANCER INSTITUTE [R01CA169244, P30CA016672, R21CA174397, U24CA143883, P50CA098258, R01CA172652, U54CA143798] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); T.C. Hsu and the Alice-Reynolds Kleberg Foundation; Center for Genetics Genomics; Susan Komen(Susan G. Komen Breast Cancer Foundation); PS-OC; Dell Foundation; ALA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank L. Ramagli, H. Tang, E. Thompson, K. Khanna, W. Schober and J. Tyler. We are grateful to S. Kennedy and L. Loeb for help with the duplex protocols. We thank M. Edgerton, J. Hicks, M. Wigler and J. Kendall for discussions. We thank R. Krahe and M. Rui for reviewing the manuscript. N.E.N. is a Nadia's Gift Foundation Damon Runyon-Rachleff Innovator (DRR-25-13). This research was supported by grants to N.E.N. from NIH (R21CA174397-01) and NCI (1RO1CA169244-01). N.E.N. was supported by T. C. Hsu and the Alice-Reynolds Kleberg Foundation. N.E.N. and P. S. were supported by the Center for Genetics & Genomics. F.M.-B was supported by an NIH UL1 (TR000371) and Susan Komen (SAC10006). K. C. was supported by the NCI (RO1CA172652). H. L. was supported by the NIH (U24CA143883). F. M. was supported by PS-OC (U54CA143798). K. C. and H. L. were supported by the Dell Foundation. M. L. L. is a CPRIT scholar and is supported by ALA. This work was also supported by an NCI center grant (CA016672). A.U. is a Rosalie B. Hite Fellow.	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Baca SC, 2013, CELL, V153, P666, DOI 10.1016/j.cell.2013.03.021; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dichosa AEK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037387; Drake JW, 1998, GENETICS, V148, P1667; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grubor V, 2009, BLOOD, V113, P1294, DOI 10.1182/blood-2008-05-158865; Hicks J, 2006, GENOME RES, V16, P1465, DOI 10.1101/gr.5460106; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; KUROISHI T, 1990, JPN J CANCER RES, V81, P454, DOI 10.1111/j.1349-7006.1990.tb02591.x; Kytola S, 2000, GENE CHROMOSOME CANC, V28, P308, DOI 10.1002/1098-2264(200007)28:3<308::AID-GCC9>3.0.CO;2-B; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loeb LA, 2011, NAT REV CANCER, V11, P450, DOI 10.1038/nrc3063; Lorenz MO, 1905, J AM STAT ASSOC, V9, P209; Luria SE, 1943, GENETICS, V28, P491; McClintock B, 1941, GENETICS, V26, P234; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Michaelson J., 2003, J WOMENS IMAGING, V5, P11; Nachman MW, 2000, GENETICS, V156, P297; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; PEER PGM, 1993, CANCER, V71, P3547, DOI 10.1002/1097-0142(19930601)71:11<3547::AID-CNCR2820711114>3.0.CO;2-C; Pellman D, 2007, NATURE, V446, P38, DOI 10.1038/446038a; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Torres L, 2007, BREAST CANCER RES TR, V102, P143, DOI 10.1007/s10549-006-9317-6; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	51	673	706	3	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					155	+		10.1038/nature13600	http://dx.doi.org/10.1038/nature13600			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25079324	Green Submitted, Green Accepted			2022-12-28	WOS:000340200700023
J	Hawkes, N				Hawkes, Nigel			The community care chest is running out of cards Will the end of many of the current contracts provide a chance to reinvigorate the sector?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Kings Fund, 2014, COMM SERV THEY CAN T; Kmietowicz Z, 2014, BMJ-BRIT MED J, V348, pg1942; Torjesen I, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4905	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 13	2014	349								g5067	10.1136/bmj.g5067	http://dx.doi.org/10.1136/bmj.g5067			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RV	25122560				2022-12-28	WOS:000340507100006
J	Tan, K; Petrie, KJ; Faasse, K; Bolland, MJ; Grey, A				Tan, Kirin; Petrie, Keith J.; Faasse, Kate; Bolland, Mark J.; Grey, Andrew			Unhelpful information about adverse drug reactions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PLACEBO GROUPS; MEDICATION; TRIALS; THERAPY; EVENTS; HARMS; ALENDRONATE; BENEFITS; WOMEN		[Tan, Kirin; Bolland, Mark J.; Grey, Andrew] Univ Auckland, Dept Med, Auckland, New Zealand; [Petrie, Keith J.; Faasse, Kate] Univ Auckland, Auckland 1, New Zealand	University of Auckland; University of Auckland	Grey, A (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland, New Zealand.	a.grey@auckland.ac.nz	Bolland, Mark J/A-7554-2008	Bolland, Mark J/0000-0003-0465-2674; tan, kirin/0000-0003-3842-6093				Amanzio M, 2009, PAIN, V146, P261, DOI 10.1016/j.pain.2009.07.010; Barron AJ, 2013, INT J CARDIOL, V168, P3572, DOI 10.1016/j.ijcard.2013.05.068; Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622; Berry DC, 2002, LANCET, V359, P853, DOI 10.1016/S0140-6736(02)07923-0; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; Colloca L, 2012, JAMA-J AM MED ASSOC, V307, P567, DOI 10.1001/jama.2012.115; Compston JE, 2006, LANCET, V368, P973, DOI 10.1016/S0140-6736(06)69394-X; de Langen J, 2008, DRUG SAFETY, V31, P515, DOI 10.2165/00002018-200831060-00006; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Faasse K, 2013, POSTGRAD MED J, V89, P540, DOI 10.1136/postgradmedj-2012-131730; Finegold JA, 2014, EUR J PREV CARDIOL, V21, P464, DOI 10.1177/2047487314525531; Fried TR, 2011, ARCH INTERN MED, V171, P923, DOI 10.1001/archinternmed.2011.32; Goh SK, 2007, J BONE JOINT SURG BR, V89B, P349, DOI 10.1302/0301-620X.89B3.18146; Grimes DA, 2011, CONTRACEPTION, V83, P5, DOI 10.1016/j.contraception.2010.06.010; Horne R, 2013, BRIT J HEALTH PSYCH, V18, P18, DOI 10.1111/j.2044-8287.2012.02071.x; Ioannidis JPA, 2009, ARCH INTERN MED, V169, P1737, DOI 10.1001/archinternmed.2009.313; Jin Jing, 2008, Ther Clin Risk Manag, V4, P269; Joy TR, 2014, ANN INTERN MED, V160, P301, DOI 10.7326/M13-1921; Kaptchuk TJ, 2006, BMJ-BRIT MED J, V332, P391, DOI 10.1136/bmj.38726.603310.55; Ko DT, 2002, JAMA-J AM MED ASSOC, V288, P351, DOI 10.1001/jama.288.3.351; Law MR, 2011, ANN PHARMACOTHER, V45, P350, DOI 10.1345/aph.1P572; Mondaini N, 2007, J SEX MED, V4, P1708, DOI 10.1111/j.1743-6109.2007.00563.x; MYERS MG, 1987, CLIN PHARMACOL THER, V42, P250, DOI 10.1038/clpt.1987.142; Papanikolaou PN, 2006, CAN MED ASSOC J, V174, P635, DOI 10.1503/cmaj.050873; Petrie KJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005374; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rief W, 2006, ARCH INTERN MED, V166, P155, DOI 10.1001/archinte.166.2.155; Rief W, 2009, DRUG SAFETY, V32, P1041, DOI 10.2165/11316580-000000000-00000; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Tosteson ANA, 2003, AM J MED, V115, P209, DOI 10.1016/S0002-9343(03)00362-0; Wells RE, 2012, AM J BIOETHICS, V12, P22, DOI 10.1080/15265161.2011.652798; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738; Zorzela L, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7668	33	35	35	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2014	349								g5019	10.1136/bmj.g5019	http://dx.doi.org/10.1136/bmj.g5019			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RR	25115975				2022-12-28	WOS:000340506700005
J	Haines, A; Whitmee, S; Horton, R				Haines, Andy; Whitmee, Sarah; Horton, Richard			Planetary health: a call for papers	LANCET			English	Editorial Material							CO2		[Haines, Andy] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1, England; [Haines, Andy] London Sch Hyg & Trop Med, Dept Populat Hlth, London WC1, England; [Whitmee, Sarah] UCL, Ctr Biodivers & Environm Res, Dept Genet Evolut & Environm, Div Biosci, London WC1E 6BT, England; [Horton, Richard] Lancet, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Whitmee, S (corresponding author), UCL, Ctr Biodivers & Environm Res, Dept Genet Evolut & Environm, Div Biosci, London WC1E 6BT, England.	s.whitmee@ucl.ac.uk		Whitmee, Sarah/0000-0001-9161-868X; Haines, Andy/0000-0002-8053-4605				Dunne JP, 2013, NAT CLIM CHANGE, V3, P563, DOI 10.1038/NCLIMATE1827; Horton R, 2014, LANCET, V384, P218, DOI 10.1016/S0140-6736(14)61178-8; Horton R, 2014, LANCET, V383, P847, DOI 10.1016/S0140-6736(14)60409-8; Knox J, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034032; Myers SS, 2014, NATURE, V510, P139, DOI 10.1038/nature13179; Sanders D, 2006, PLOS MED, V3, P719, DOI 10.1371/journal.pmed.0030186; Taub DR, 2008, GLOBAL CHANGE BIOL, V14, P565, DOI 10.1111/j.1365-2486.2007.01511.x	7	3	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 9	2014	384	9942					479	480		10.1016/S0140-6736(14)61289-7	http://dx.doi.org/10.1016/S0140-6736(14)61289-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9JR	25110268				2022-12-28	WOS:000340198300009
J	Meckenstock, RU; von Netzer, F; Stumpp, C; Lueders, T; Himmelberg, AM; Hertkorn, N; Schmitt-Kopplin, P; Harir, M; Hosein, R; Haque, S; Schulze-Makuch, D				Meckenstock, Rainer U.; von Netzer, Frederick; Stumpp, Christine; Lueders, Tillmann; Himmelberg, Anne M.; Hertkorn, Norbert; Schmitt-Kopplin, Philipp; Harir, Mourad; Hosein, Riad; Haque, Shirin; Schulze-Makuch, Dirk			Water droplets in oil are microhabitats for microbial life	SCIENCE			English	Article							DEEP SUBSURFACE; ANAEROBIC DEGRADATION; BIODEGRADATION	Anaerobic microbial degradation of hydrocarbons, typically occurring at the oil-water transition zone, influences the quality of oil reservoirs. In Pitch Lake, Trinidad and Tobago-the world's largest asphalt lake-we found that microorganisms are metabolically active in minuscule water droplets (1 to 3 microliters) entrapped in oil. Pyrotag sequencing of individual droplet microbiomes revealed complex methanogenic microbial communities actively degrading the oil into a diverse range of metabolites, as shown by nuclear magnetic resonance and Fourier transform ion cyclotron resonance mass spectrometry. High salinity and water-stable isotopes of the droplets indicate a deep subsurface origin. The 13.5% water content and the large surface area of the droplets represent an underestimated potential for biodegradation of oil away from the oil-water transition zone.	[Meckenstock, Rainer U.; von Netzer, Frederick; Stumpp, Christine; Lueders, Tillmann; Himmelberg, Anne M.] Helmholtz Zentrum Munchen, Inst Groundwater Ecol, D-85764 Neuherberg, Germany; [Hertkorn, Norbert; Schmitt-Kopplin, Philipp; Harir, Mourad] Helmholtz Zentrum Munchen, Res Unit Biogeochem, D-85764 Neuherberg, Germany; [Hosein, Riad] Univ W Indies, Fac Sci & Agr, Dept Chem, St Augustine, Trinidad Tobago; [Haque, Shirin] Univ W Indies, Fac Sci & Agr, Dept Phys, St Augustine, Trinidad Tobago; [Schulze-Makuch, Dirk] Washington State Univ, Sch Environm, Pullman, WA 99164 USA; [Schulze-Makuch, Dirk] Tech Univ Berlin, Ctr Astron & Astrophys, D-10623 Berlin, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University West Indies Mona Jamaica; University West Indies Saint Augustine; University West Indies Mona Jamaica; University West Indies Saint Augustine; Washington State University; Technical University of Berlin	Meckenstock, RU (corresponding author), Univ Duisburg Essen, Biofilm Ctr, D-45141 Essen, Germany.	rainer.meckenstock@uni-due.de	Schmitt-Kopplin, Philippe/H-6271-2011; Himmelberg, Anne/A-7237-2015; Lueders, Tillmann/B-1486-2013; Stumpp, Christine/AGG-8290-2022; Hertkorn, Norbert/AAA-5990-2022; Meckenstock, Rainer/K-6894-2012; Stumpp, Christine/K-6934-2012; von Netzer, Frederick/E-1442-2013	Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Himmelberg, Anne/0000-0001-7535-0134; Lueders, Tillmann/0000-0002-9361-5009; Stumpp, Christine/0000-0001-9041-2735; Schulze-Makuch, Dirk/0000-0002-1923-9746	Helmholtz Zentrum Munchen; DFG [SPP1319]	Helmholtz Zentrum Munchen(Helmholtz Association); DFG(German Research Foundation (DFG))	We thank G. Barthel, K. Hormann, and M. Stockl for technical assistance and B. Horsefield for helpful discussions. Funding was provided by Helmholtz Zentrum Munchen and the DFG priority program SPP1319. Pyrotag sequencing data for community analyses are deposited at NCBI BioSample (www.ncbi.nlm.nih.gov/biosample) under accession number SRP036082. Original data from FTICR-MS analyses are provided in the supplementary materials.	Aitken CM, 2004, NATURE, V431, P291, DOI 10.1038/nature02922; An DS, 2013, ENVIRON SCI TECHNOL, V47, P10708, DOI 10.1021/es4020184; Annweiler E, 2002, APPL ENVIRON MICROB, V68, P852, DOI 10.1128/AEM.68.2.852-858.2002; Battani B., 2010, SHALE TECTONICS, V93, P225; Bennett B, 2013, ORG GEOCHEM, V56, P94, DOI 10.1016/j.orggeochem.2012.12.011; Clark I., 1997, ENV ISOTOPES HYDROLO; Eberlein C, 2013, MOL MICROBIOL, V88, P1032, DOI 10.1111/mmi.12238; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; Horita J, 2005, ISOTOPES IN THE WATER CYCLE: PAST, PRESENT AND FUTURE OF A DEVELOPING SCIENCE, P271, DOI 10.1007/1-4020-3023-1_17; Jones DM, 2008, NATURE, V451, P176, DOI 10.1038/nature06484; Kim JS, 2007, APPL ENVIRON MICROB, V73, P4579, DOI 10.1128/AEM.01372-06; Meckenstock RU, 2011, CURR OPIN BIOTECH, V22, P406, DOI 10.1016/j.copbio.2011.02.009; Schatzinger R. A., 1999, RESERVOIR CHARACTERI; Schulze-Makuch D, 2011, ASTROBIOLOGY, V11, P241, DOI 10.1089/ast.2010.0488	15	91	97	3	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					673	676		10.1126/science.1252215	http://dx.doi.org/10.1126/science.1252215			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104386				2022-12-28	WOS:000339962800039
J	Furyk, JS; Meek, R; McKenzie, S				Furyk, Jeremy S.; Meek, Robert; McKenzie, Suzanne			THERAPEUTICS Drug treatment of adults with nausea and vomiting in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EMERGENCY-DEPARTMENT; DOUBLE-BLIND; METOCLOPRAMIDE; ONDANSETRON; PROMETHAZINE; MANAGEMENT; TRIAL	This is one of a series of occasional articles on therapeutics for common or serious conditions, covering new drugs and old drugs with important new indications or concerns. The series advisers are Robin Ferner, honorary professor of clinical pharmacology, University of Birmingham and Birmingham City Hospital, and Albert Ferro, professor of cardiovascular clinical pharmacology, King's College London. To suggest a topic, please email us at practice@bmj.com.	[Furyk, Jeremy S.] Townsville Hosp, Townsville, Qld 4810, Australia; [Furyk, Jeremy S.; Meek, Robert] James Cook Univ, Townsville, Qld 4811, Australia; [Meek, Robert; McKenzie, Suzanne] Monash Hlth, Melbourne, Vic, Australia; [McKenzie, Suzanne] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	James Cook University; University of New South Wales Sydney	Furyk, JS (corresponding author), Townsville Hosp, Angus Smith Dr, Townsville, Qld 4810, Australia.	Jeremy.Furyk@health.qld.gov.au		Furyk, Jeremy/0000-0002-9503-0928				American Gastroenterological Association, 2001, Gastroenterology, V120, P261; Australian Government Department of Health, 2013, PHARM BEN SCHEM; Australian Government Department of Health Therapeutic Goods Administration, 2014, SEARCH RES; Barrett TW, 2011, AM J EMERG MED, V29, P247, DOI 10.1016/j.ajem.2009.09.028; Billio A, 2010, COCHRANE DB SYST REV, V1; Braude D, 2006, AM J EMERG MED, V24, P177, DOI 10.1016/j.ajem.2005.08.017; Braude D, 2008, ACAD EMERG MED, V15, P209, DOI 10.1111/j.1553-2712.2008.00060.x; British National Formulary, 2014, BRIT NATL FORMULARY; Carlisle JB, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004125.pub2; CARPENTER DO, 1990, CAN J PHYSIOL PHARM, V68, P230, DOI 10.1139/y90-036; Chae J, 2011, EMERG MED AUSTRALAS, V23, P554, DOI 10.1111/j.1742-6723.2011.01444.x; Cham Swee, 2004, Emerg Med Australas, V16, P208, DOI 10.1111/j.1742-6723.2004.00588.x; Colman I, 2004, BMJ-BRIT MED J, V329, P1369, DOI 10.1136/bmj.38281.595718.7C; Egerton-Warburton D, 2014, ANN EMERG MED; Ernst AA, 2000, ANN EMERG MED, V36, P89, DOI 10.1067/mem.2000.108652; European Medicines Agency, 2014, CMDH CONF REC RESTR; Fedorowicz Z, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005506.pub5; Friedman BW, 2009, ANN EMERG MED, V53, P379, DOI 10.1016/j.annemergmed.2008.08.003; Fullerton L, 2012, PREHOSP EMERG CARE, V16, P463, DOI 10.3109/10903127.2012.695430; Jarvis S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3606; LaValley J, 2003, ACAD EMERG MED, V10, P461; Mathews A, 2010, COCHRANE DB SYST REV, V9; Mee MJ, 2011, EMERG MED AUSTRALAS, V23, P162, DOI 10.1111/j.1742-6723.2011.01386.x; Meek R, 2009, ACAD EMERG MED, V16, P1304, DOI 10.1111/j.1553-2712.2009.00581.x; NHS Choices, 2013, MED A Z; Pasternak B, 2013, NEW ENGL J MED, V368, P814, DOI 10.1056/NEJMoa1211035; Quigley EMM, 2001, GASTROENTEROLOGY, V120, P263, DOI 10.1053/gast.2001.20516; Salvucci AA, 2011, PREHOSP EMERG CARE, V15, P34, DOI 10.3109/10903127.2010.519822; Spevak C, 2012, PAIN MED, V13, P1072, DOI 10.1111/j.1526-4637.2012.01406.x; Spinks A., 2011, COCHRANE DB SYST REV, V6, P1	30	4	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2014	349								g4714	10.1136/bmj.g4714	http://dx.doi.org/10.1136/bmj.g4714			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MR	25103458				2022-12-28	WOS:000340206200001
J	Justham, S				Justham, Stephen			Portrait of a doomed star	NATURE			English	Editorial Material							IA SUPERNOVA; CIRCUMSTELLAR MATERIAL; PROGENITOR; EXPLOSION		Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China	Chinese Academy of Sciences; National Astronomical Observatory, CAS	Justham, S (corresponding author), Chinese Acad Sci, Natl Astron Observ, Beijing 100012, Peoples R China.	sjustham@nao.cas.cn						Cenko S. B., 2012, CBET, V3014; Dilday B, 2012, SCIENCE, V337, P942, DOI 10.1126/science.1219164; Foley RJ, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/57; Kasliwal MM, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/161; Kasliwal MM, 2010, ASTROPHYS J LETT, V723, pL98, DOI 10.1088/2041-8205/723/1/L98; Li WD, 2003, PUBL ASTRON SOC PAC, V115, P453, DOI 10.1086/374200; McCully C, 2014, NATURE, V512, P54, DOI 10.1038/nature13615; Patat F, 2007, SCIENCE, V317, P924, DOI 10.1126/science.1143005; Perets HB, 2010, NATURE, V465, P322, DOI 10.1038/nature09056; Poznanski D, 2010, SCIENCE, V327, P58, DOI 10.1126/science.1181709; Riess AG, 2009, ASTROPHYS J SUPPL S, V183, P109, DOI 10.1088/0067-0049/183/1/109; Sternberg A, 2011, SCIENCE, V333, P856, DOI 10.1126/science.1203836; Voss R, 2008, NATURE, V451, P802, DOI 10.1038/nature06602	13	0	0	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					34	35		10.1038/512034a	http://dx.doi.org/10.1038/512034a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25100478				2022-12-28	WOS:000339908000023
J	Press, MJ				Press, Matthew J.			Instant Replay - A Quarterback's View of Care Coordination	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Press, Matthew J.] Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10021 USA; [Press, Matthew J.] Weill Cornell Med Coll, Dept Med, New York, NY USA	Cornell University; Cornell University	Press, MJ (corresponding author), Weill Cornell Med Coll, Dept Healthcare Policy & Res, New York, NY 10021 USA.							Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Hinds PJ, 2003, ORGAN SCI, V14, P615, DOI 10.1287/orsc.14.6.615.24872; Press MJ, 2012, AM J MANAG CARE, V18, P778; Stavert RR, 2013, NEW ENGL J MED, V368, P8, DOI 10.1056/NEJMp1210501; 2007, IMPROVING AM HOSP JO	5	44	44	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					489	491		10.1056/NEJMp1406033	http://dx.doi.org/10.1056/NEJMp1406033			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM5LE	25099572				2022-12-28	WOS:000339899100001
J	Crump, C				Crump, Casey			Medical history taking in adults should include questions about preterm birth	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH BEHAVIORS; YOUNG ADULTHOOD; GESTATIONAL-AGE; PREMATURE BIRTH; MORTALITY; DISEASE; WOMEN; MEN		Stanford Univ, Dept Med, Palo Alto, CA 94304 USA	Stanford University	Crump, C (corresponding author), Stanford Univ, Dept Med, Palo Alto, CA 94304 USA.	kccrump@stanford.edu	Crump, Casey/AAO-8802-2021	Crump, Casey/0000-0002-2990-1166				Adegboye ARA, 2008, BJOG-INT J OBSTET GY, V115, P886, DOI 10.1111/j.1471-0528.2008.01717.x; Baraldi E, 2007, NEW ENGL J MED, V357, P1946, DOI 10.1056/NEJMra067279; Bolton CE, 2012, THORAX, V67, P1110, DOI 10.1136/thoraxjnl-2012-202637; Crump C, 2013, EPIDEMIOLOGY, V24, P270, DOI 10.1097/EDE.0b013e318280da0f; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Wilson BJ, 2009, ANN INTERN MED, V151, P878, DOI [10.7326/0000605-200912150-00177, 10.7326/0003-4819-151-12-200912150-00177]	12	28	30	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2014	349								g4860	10.1136/bmj.g4860	http://dx.doi.org/10.1136/bmj.g4860			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5OF	25085466				2022-12-28	WOS:000339909000002
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING The world's deadliest animal	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20036 USA		Kamerow, D (corresponding author), Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20036 USA.	dkamerow@aafp.org		Kamerow, Douglas/0000-0001-7000-9957				Centers for Disease Control and Prevention, DENG US; Centers for Disease Control and Prevention, IMP MAL; Centers for Disease Control and Prevention, CHIK VIR; Centers for Disease Control and Prevention, W NIL VIR; Centers for Disease Control and Prevention, FAQ INS REP US SAF; Gates B, DEADLIEST ANIMAL WOR	6	0	0	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2014	348								g3258	10.1136/bmj.g3258	http://dx.doi.org/10.1136/bmj.g3258			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5GP	25134129				2022-12-28	WOS:000336156800005
J	Chang, LJ; Dowd, KA; Mendoza, FH; Saunders, JG; Sitar, S; Plummer, SH; Yamshchikov, G; Sarwar, UN; Hu, ZH; Enama, ME; Bailer, RT; Koup, RA; Schwartz, RM; Akahata, W; Nabel, GJ; Mascola, JR; Pierson, TC; Graham, BS; Ledgerwood, JE				Chang, Lee-Jah; Dowd, Kimberly A.; Mendoza, Floreliz H.; Saunders, Jamie G.; Sitar, Sandra; Plummer, Sarah H.; Yamshchikov, Galina; Sarwar, Uzma N.; Hu, Zonghui; Enama, Mary E.; Bailer, Robert T.; Koup, Richard A.; Schwartz, Richard M.; Akahata, Wataru; Nabel, Gary J.; Mascola, John R.; Pierson, Theodore C.; Graham, Barney S.; Ledgerwood, Julie E.		VRC 311 Study Team	Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trial	LANCET			English	Article							PROTECTS MICE; INFECTION; EPIDEMIC; DISEASE; IMMUNOGENICITY; CANDIDATES; EMERGENCE	Background Chikungunya virus-a mosquito-borne alphavirus-is endemic in Africa and south and southeast Asia and has recently emerged in the Caribbean. No drugs or vaccines are available for treatment or prevention. We aimed to assess the safety, tolerability, and immunogenicity of a new candidate vaccine. Methods VRC 311 was a phase 1, dose-escalation, open-label clinical trial of a virus-like particle (VLP) chikungunya virus vaccine, VRC-CHKVLP059-00-VP, in healthy adults aged 18-50 years who were enrolled at the National Institutes of Health Clinical Center (Bethesda, MD, USA). Participants were assigned to sequential dose level groups to receive vaccinations at 10 mu g, 20 mu g, or 40 mu g on weeks 0, 4, and 20, with follow-up for 44 weeks after enrolment. The primary endpoints were safety and tolerability of the vaccine. Secondary endpoints were chikungunya virus-specific immune responses assessed by ELISA and neutralising antibody assays. This trial is registered with ClinicalTrials.gov, NCT01489358. Findings 25 participants were enrolled from Dec 12, 2011, to March 22, 2012, into the three dosage groups: 10 mu g (n=5), 20 mu g (n=10), and 40 mu g (n=10). The protocol was completed by all five participants at the 10 mu g dose, all ten participants at the 20 mu g dose, and eight of ten participants at the 40 mu g dose; non-completions were for personal circumstances unrelated to adverse events. 73 vaccinations were administered. All injections were well tolerated, with no serious adverse events reported. Neutralising antibodies were detected in all dose groups after the second vaccination (geometric mean titres of the half maximum inhibitory concentration: 2688 in the 10 mu g group, 1775 in the 20 mu g group, and 7246 in the 40 mu g group), and a significant boost occurred after the third vaccination in all dose groups (10 mu g group p = 0.0197, 20 mu g group p < 0.0001, and 40 mu g group p < 0.0001). 4 weeks after the third vaccination, the geometric mean titres of the half maximum inhibitory concentration were 8745 for the 10 mu g group, 4525 for the 20 mu g group, and 5390 for the 40 mu g group. Interpretation The chikungunya VLP vaccine was immunogenic, safe, and well tolerated. This study represents an important step in vaccine development to combat this rapidly emerging pathogen. Further studies should be done in a larger number of participants and in more diverse populations.	[Chang, Lee-Jah; Mendoza, Floreliz H.; Saunders, Jamie G.; Sitar, Sandra; Plummer, Sarah H.; Yamshchikov, Galina; Sarwar, Uzma N.; Enama, Mary E.; Bailer, Robert T.; Koup, Richard A.; Schwartz, Richard M.; Akahata, Wataru; Nabel, Gary J.; Mascola, John R.; Graham, Barney S.; Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Dowd, Kimberly A.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Hu, Zonghui] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ledgerwood, JE (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ledgerwood@mail.nih.gov	Graham, Barney S./AAC-5898-2019; Mascola, John/AAI-7193-2021	Graham, Barney S./0000-0001-8112-0853; Chang, Lee-Jah/0000-0003-1766-3153; Dowd, Kimberly/0000-0003-3641-6852	Intramural Research Program of the Vaccine Research Center; National Institutes of Health; National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005123, ZIAAI005047, ZIAAI005037, ZIAAI001022, ZIBAI005110] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Intramural Research Program of the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, and National Institutes of Health.	Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; Arankalle VA, 2007, J GEN VIROL, V88, P1967, DOI 10.1099/vir.0.82714-0; Arpino C, 2009, REV MED VIROL, V19, P121, DOI 10.1002/rmv.606; Brandler S, 2013, VACCINE, V31, P3718, DOI 10.1016/j.vaccine.2013.05.086; Cavrini F, 2009, J INFECT DEV COUNTR, V3, P744, DOI 10.3855/jidc.169; CDC, 2014, CHIK AM; Centers for Disease Control and Prevent (CDC), CHIK VIR; Centers for Disease Control and Prevention (CDC), CHIK VIR SYMPT DIAGN; Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289; Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042; Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381; Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006; ECDC, 2014, EP UPD AUT CAS CHIK; Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681; Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13; Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13; HARRISON VR, 1971, J IMMUNOL, V107, P643; Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13; Her Z, 2009, MICROBES INFECT, V11, P1165, DOI 10.1016/j.micinf.2009.09.004; Hoarau JJ, 2010, J IMMUNOL, V184, P5914, DOI 10.4049/jimmunol.0900255; Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]; Kalantri SP, 2006, NATL MED J INDIA, V19, P315; Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12; Kam YW, 2012, J INFECT DIS, V205, P1147, DOI 10.1093/infdis/jis033; Metz SW, 2013, VACCINE, V31, P6092, DOI 10.1016/j.vaccine.2013.09.045; Metz SW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002124; Mohan Alladi, 2010, Indian J Dermatol, V55, P54, DOI 10.4103/0019-5154.60355; Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060; Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012; PAHO, 2014, CHIK; Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312; Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Rajapakse S, 2010, T ROY SOC TROP MED H, V104, P89, DOI 10.1016/j.trstmh.2009.07.031; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Safaeian M, 2013, CANCER PREV RES, V6, P1242, DOI 10.1158/1940-6207.CAPR-13-0203; Soden M, 2000, ARTHRITIS RHEUM, V43, P365, DOI 10.1002/1529-0131(200002)43:2<365::AID-ANR16>3.0.CO;2-E; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062; U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, 2007, GUID IND TOX GRAD SC; Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054; Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/ERV.12.84, 10.1586/erv.12.84]; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; WHO, CHIK	46	158	165	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2046	2052		10.1016/S0140-6736(14)61185-5	http://dx.doi.org/10.1016/S0140-6736(14)61185-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AW6BD	25132507				2022-12-28	WOS:000346353600026
J	Smith, MR; Ortega-Hernandez, J				Smith, Martin R.; Ortega-Hernandez, Javier			Hallucigenia's onychophoran-like claws and the case for Tactopoda	NATURE			English	Article							CAMBRIAN LOBOPODIANS; BURGESS SHALE; TARDIGRADES; PHYLOGENY; INSIGHTS; ORGANIZATION; MUSCULATURE; MORPHOLOGY; MICRORNAS; EVOLUTION	The Palaeozoic form-taxon Lobopodia encompasses a diverse range of soft-bodied 'legged worms' known from exceptional fossil deposits1-. Although lobopodians occupy a deep phylogenetic position within Panarthropoda, a shortage of derived characters obscures their evolutionary relationships with extant phyla (Onychophora, Tardigrada and Euarthropoda)(2,3,5,10-15). Here we describe a complex feature in the terminal claws of the mid-Cambrian lobopodian Hallucigenia sparsa-their construction from a stack of constituent elements-and demonstrate that equivalent elements make up the jaws and claws of extant Onychophora. A cladistic analysis, informed by developmental data on panarthropod head segmentation, indicates that the stacked sclerite components in these two taxa are homologous-resolving hallucigeniid lobopodians as stem-group onychophorans. The results indicate a sister-group relationship between Tardigrada and Euarthropoda, adding palaeontological support to the neurological(16,17) and musculoskeletal(18,19) evidence uniting these disparate clades. These findings elucidate the evolutionary transformations that gave rise to the panarthropod phyla, and expound the lobopodian-like morphology of the ancestral panarthropod.	[Smith, Martin R.; Ortega-Hernandez, Javier] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England	University of Cambridge	Smith, MR (corresponding author), Univ Cambridge, Dept Earth Sci, Downing Site, Cambridge CB2 3EQ, England.	ms609@cam.ac.uk	Smith, Martin Ross/B-8461-2012	Smith, Martin Ross/0000-0001-5660-1727	Research Fellowships at Clare College; Emmanuel College, University of Cambridge, UK; H.B. Whittington Research Grant (Paleontological Society); Willi Hennig Society	Research Fellowships at Clare College; Emmanuel College, University of Cambridge, UK; H.B. Whittington Research Grant (Paleontological Society); Willi Hennig Society	The authors are supported by Research Fellowships at Clare College (M. R. S.) and Emmanuel College (J.O.-H.),University of Cambridge, UK. Thanks to J.-B. Caron and T. Harvey for images, access to material and discussions. D. Erwin, K. Hollis and P. Fenton facilitated access to museum specimens, and S. Whittaker assisted with electron microscopy. E. kanangrensis were collected from the Blue Mountains, New South Wales, with assistance from G. Budd and N. Tait and funding from an H.B. Whittington Research Grant (Paleontological Society). N. Butterfield and R. Janssen provided additional material. Parks Canada provided research and collection permits to Royal Ontario Museum teams led by D. Collins. The software TNT is funded by the Willi Hennig Society.	Bergstrom J, 2001, ZOOL ANZ, V240, P237, DOI 10.1078/0044-5231-00031; Budd GE, 2001, ZOOL ANZ, V240, P265, DOI 10.1078/0044-5231-00034; Budd GE, 2002, NATURE, V417, P271, DOI 10.1038/417271a; Budd GE, 1996, LETHAIA, V29, P1, DOI 10.1111/j.1502-3931.1996.tb01831.x; Campbell LI, 2011, P NATL ACAD SCI USA, V108, P15920, DOI 10.1073/pnas.1105499108; Campiglia S., 1990, PROC 7TH INT CONGR M, P461; Caron JB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1613; Daley AC, 2009, SCIENCE, V323, P1597, DOI 10.1126/science.1169514; Dewel RA, 1999, ZOOL ANZ, V238, P191; DZIK J, 1989, LETHAIA, V22, P169, DOI 10.1111/j.1502-3931.1989.tb01679.x; Engel Michael S., 2013, P269; FARRIS JS, 1969, SYST ZOOL, V18, P374, DOI 10.2307/2412182; Goloboff PA, 1999, CLADISTICS, V15, P415, DOI 10.1111/j.1096-0031.1999.tb00278.x; GOLOBOFF PA, 1993, CLADISTICS, V9, P83, DOI 10.1111/j.1096-0031.1993.tb00209.x; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Harvey THP, 2012, ACTA PALAEONTOL POL, V57, P423, DOI 10.4202/app.2011.0028; HOU XG, 1995, ZOOL J LINN SOC-LOND, V114, P3, DOI 10.1006/zjls.1995.0014; Legg DA, 2011, NATURE, V476, pE2, DOI 10.1038/nature10267; Liu JN, 2011, NATURE, V470, P526, DOI 10.1038/nature09704; Ma XY, 2014, J SYST PALAEONTOL, V12, P445, DOI 10.1080/14772019.2013.770418; Marchioro T, 2013, ZOOL J LINN SOC-LOND, V169, P580, DOI 10.1111/zoj.12079; Mirande JM, 2009, CLADISTICS, V25, P574, DOI 10.1111/j.1096-0031.2009.00262.x; Martin C, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00007; Mayer G, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-230; Mayer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059090; Nixon K., 2003, TNT TREE ANALYSIS US; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Olempska E, 2012, HYDROBIOLOGIA, V688, P139, DOI 10.1007/s10750-011-0659-7; Oliveira ID, 2013, J MORPHOL, V274, P1180, DOI 10.1002/jmor.20171; Ou Q, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2272; Ramskold L, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P107; RAUP DAVID M., 1966, J PALEONTOL, V40, P1178; ROBSON EA, 1964, Q J MICROSC SCI, V105, P281; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Schulze Corinna, 2011, Meiofauna Marina, V19, P195; Steiner M, 2012, B GEOSCI, V87, P107, DOI 10.3140/bull.geosci.1280; Topper TP, 2013, LETHAIA, V46, P490, DOI 10.1111/let.12026; WHITTINGTON HB, 1978, PHILOS T R SOC B, V284, P165, DOI 10.1098/rstb.1978.0061; Wills MA, 1998, ARTHROPOD FOSSILS AND PHYLOGENY, P33	39	89	90	1	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					363	+		10.1038/nature13576	http://dx.doi.org/10.1038/nature13576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25132546	Green Accepted			2022-12-28	WOS:000342988600051
J	O'Malley, J; Wardlaw, T; You, DZ; Hug, L; Anthony, D				O'Malley, Jeffrey; Wardlaw, Tessa; You, Danzhen; Hug, Lucia; Anthony, David			Africa's child demographics and the world's future	LANCET			English	Editorial Material									[O'Malley, Jeffrey; Wardlaw, Tessa; You, Danzhen; Hug, Lucia; Anthony, David] UNICEF, Div Data Res & Policy, New York, NY 10017 USA	UNICEF	O'Malley, J (corresponding author), UNICEF, Div Data Res & Policy, New York, NY 10017 USA.	jomalley@unicef.org						UNICEF, 2015, COMMITTING CHILD SUR; UNICEF, 2014, GEN 2030 AFR; You D, 2012, GENERATION 2025 CRIT	3	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					730	732		10.1016/S0140-6736(14)61331-3	http://dx.doi.org/10.1016/S0140-6736(14)61331-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DD	25129327				2022-12-28	WOS:000341361500013
J	Moura-Alves, P; Fae, K; Houthuys, E; Dorhoi, A; Kreuchwig, A; Furkert, J; Barison, N; Diehl, A; Munder, A; Constant, P; Skrahina, T; Guhlich-Bornhof, U; Klemm, M; Koehler, AB; Bandermann, S; Goosmann, C; Mollenkopf, HJ; Hurwitz, R; Brinkmann, V; Fillatreau, S; Daffe, M; Tummler, B; Kolbe, M; Oschkinat, H; Krause, G; Kaufmann, SHE				Moura-Alves, Pedro; Fae, Kellen; Houthuys, Erica; Dorhoi, Anca; Kreuchwig, Annika; Furkert, Jens; Barison, Nicola; Diehl, Anne; Munder, Antje; Constant, Patricia; Skrahina, Tatsiana; Guhlich-Bornhof, Ute; Klemm, Marion; Koehler, Anne-Britta; Bandermann, Silke; Goosmann, Christian; Mollenkopf, Hans-Joachim; Hurwitz, Robert; Brinkmann, Volker; Fillatreau, Simon; Daffe, Mamadou; Tuemmler, Burkhard; Kolbe, Michael; Oschkinat, Hartmut; Krause, Gerd; Kaufmann, Stefan H. E.			AhR sensing of bacterial pigments regulates antibacterial defence	NATURE			English	Article							ARYL-HYDROCARBON RECEPTOR; LIGAND-BINDING DOMAIN; PSEUDOMONAS-AERUGINOSA; GENE BATTERY; PYOCYANIN; ACTIVATION; EXPRESSION; TOXICITY; DIFFERENTIATION; IDENTIFICATION	The aryl hydrocarbon receptor (AhR) is a highly conserved ligand-dependent transcription factor that senses environmental toxins and endogenous ligands, thereby inducing detoxifying enzymes and modulating immune cell differentiation and responses. We hypothesized that AhR evolved to sense not only environmental pollutants but also microbial insults. We characterized bacterial pigmented virulence factors, namely the phenazines from Pseudomonas aeruginosa and the naphthoquinone phthiocol from Mycobacterium tuberculosis, as ligands of AhR Upon ligand binding, AhR activation leads to virulence factor degradation and regulated cytokine and chemokine production The relevance of AhR to host defence is underlined by heightened susceptibility of AhR-deficient mice to both P. aeruginosa and M. tuberculosis. Thus, we demonstrate that AhR senses distinct bacterial virulence factors and controls antibacterial responses, supporting a previously unidentified role for AhR as an intracellular pattern recognition receptor, and identify bacterial pigments as a new class of pathogen-associated molecular patterns.	[Moura-Alves, Pedro; Fae, Kellen; Houthuys, Erica; Dorhoi, Anca; Skrahina, Tatsiana; Guhlich-Bornhof, Ute; Klemm, Marion; Koehler, Anne-Britta; Bandermann, Silke; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany; [Kreuchwig, Annika; Furkert, Jens; Diehl, Anne; Oschkinat, Hartmut; Krause, Gerd] Leibniz Inst Mol Pharmacol FMP, D-13125 Berlin, Germany; [Barison, Nicola; Kolbe, Michael] Max Planck Inst Infect Biol, D-10117 Berlin, Germany; [Munder, Antje; Tuemmler, Burkhard] Hannover Med Sch, Clin Res Grp, Clin Pediat Pneumol Allergol & Neonatol, D-30625 Hannover, Germany; [Constant, Patricia; Daffe, Mamadou] CNRS, IPBS, F-31077 Toulouse 04, France; [Constant, Patricia; Daffe, Mamadou] Univ Toulouse 3, F-31077 Toulouse 04, France; [Goosmann, Christian; Brinkmann, Volker] Max Planck Inst Infect Biol, Dept Immunol, Microscopy Core Facil, D-10117 Berlin, Germany; [Mollenkopf, Hans-Joachim] Max Planck Inst Infect Biol, Dept Immunol, Microarray Core Facil, D-10117 Berlin, Germany; [Hurwitz, Robert] Max Planck Inst Infect Biol, Prot Purificat Core Facil, D-10117 Berlin, Germany; [Fillatreau, Simon] German Rheumatism Res Ctr Berlin DRFZ, D-10117 Berlin, Germany	Max Planck Society; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Max Planck Society; Hannover Medical School; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Max Planck Society; Max Planck Society; Max Planck Society; Deutsches Rheuma-Forschungszentrum (DRFZ)	Kaufmann, SHE (corresponding author), Max Planck Inst Infect Biol, Dept Immunol, Charitepl 1, D-10117 Berlin, Germany.	kaufmann@mpiib-berlin.mpg.de	Moura-Alves, Pedro/R-7727-2016; Alves, Pedro Moura/AAX-6854-2020; Mollenkopf, Hans-Joachim/AAH-2500-2019; Brinkmann, Volker/A-6015-2009; Kaufmann, Stefan HE/I-5454-2014	Moura-Alves, Pedro/0000-0003-4337-9113; Mollenkopf, Hans-Joachim/0000-0003-1167-4783; Munder, Antje/0000-0002-3198-8336; Diehl, Anne/0000-0001-7295-9972; Kaufmann, Stefan HE/0000-0001-9866-8268; Fillatreau, Simon/0000-0002-7730-9917; Oschkinat, Hartmut/0000-0002-4384-9544	European Union [Health-F3-2009-241745, Health-F4-2008-223451]	European Union(European Commission)	The authors are highly grateful to J. Welch for his contribution in the early stage of research, and for support in AhR ligand screening,A. Zychlinsky and L. E. Dietrich for discussions, H.-G. Hoymann for support in lung function measurements and interpretation of results, U. Klemm for mouse breeding and M. L. Grossman for excellent support in preparing the manuscript. Ahr<SUP>-/-</SUP> mice were provided by B. Stockinger and shRNA constructs by D. Krastev and F. Buchholz. The PA14 WT2 and PA14 Delta phz1/2 were a gift from D. K. Newman and L. E. Dietrich. M. Kolbe acknowledges grant support from the European Union's Seventh Framework Programmes (EU-FP7/2007-2013). S.H.E.K. acknowledges grant support from the European Union's Seventh Framework Programmes (EU-FP7) NEWTBVAC (Health-F3-2009-241745) and PHAGOSYS (Health-F4-2008-223451).	Apetoh L, 2010, NAT IMMUNOL, V11, P854, DOI 10.1038/ni.1912; Barouki Robert, 2012, Drug Metabolism and Drug Interactions, V27, P3, DOI 10.1515/dmdi-2011-0035; Bisson WH, 2009, J MED CHEM, V52, P5635, DOI 10.1021/jm900199u; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; Casado FL, 2010, BLOOD CELL MOL DIS, V44, P199, DOI 10.1016/j.bcmd.2010.01.005; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cheon H, 2007, EXP MOL MED, V39, P524, DOI 10.1038/emm.2007.58; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Denning GM, 2003, AM J PHYSIOL-LUNG C, V285, pL584, DOI 10.1152/ajplung.00086.2003; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Dorhoi A, 2011, IMMUNOL REV, V240, P235, DOI 10.1111/j.1600-065X.2010.00994.x; Echenique P, 2007, MOL PHYS, V105, P3057, DOI 10.1080/00268970701757875; Eisele NA, 2011, J PATHOG, V2011, DOI 10.4061/2011/249802; Fan MQ, 2009, ANAL BIOCHEM, V384, P279, DOI 10.1016/j.ab.2008.10.003; Farmahin R, 2013, TOXICOL SCI, V131, P139, DOI 10.1093/toxsci/kfs259; Fraccalvieri D, 2013, BIOCHEMISTRY-US, V52, P714, DOI 10.1021/bi301457f; Gandhi R, 2010, NAT IMMUNOL, V11, P846, DOI 10.1038/ni.1915; Gardner PR, 1996, ARCH BIOCHEM BIOPHYS, V333, P267, DOI 10.1006/abbi.1996.0390; Goldberg JB, 2000, TRENDS MICROBIOL, V8, P514, DOI 10.1016/S0966-842X(00)01872-2; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Hunter RC, 2012, AM J RESP CELL MOL, V47, P738, DOI 10.1165/rcmb.2012-0088OC; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Jensen Brenda A, 2003, Environ Health, V2, P16, DOI 10.1186/1476-069X-2-16; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kerr J.R., 2000, INFECT DIS REV, V2, P184; Kimura A, 2009, J EXP MED, V206, P2027, DOI 10.1084/jem.20090560; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klockgether J, 2010, J BACTERIOL, V192, P1113, DOI 10.1128/JB.01515-09; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Kursar M, 2007, J IMMUNOL, V178, P2661, DOI 10.4049/jimmunol.178.5.2661; Lai ZW, 1996, CHEM-BIOL INTERACT, V100, P97, DOI 10.1016/0009-2797(96)03691-5; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lau GW, 2004, TRENDS MOL MED, V10, P599, DOI 10.1016/j.molmed.2004.10.002; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Lee YC, 2011, AM J RESP CELL MOL, V45, P270, DOI 10.1165/rcmb.2010-0313OC; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Mavrodi DV, 2006, ANNU REV PHYTOPATHOL, V44, P417, DOI 10.1146/annurev.phyto.44.013106.145710; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Morrissey JP, 2004, PSEUDOMONAS, VOL 3: BIOSYNTHESIS OF MACROMOLECULES AND MOLECULAR METABOLISM, P637; Motto I, 2011, J CHEM INF MODEL, V51, P2868, DOI 10.1021/ci2001617; Muller M, 2011, FREE RADICAL BIO MED, V50, P971, DOI 10.1016/j.freeradbiomed.2011.01.012; Munder A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-148; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; NEBERT DW, 1993, ANN NY ACAD SCI, V685, P624, DOI 10.1111/j.1749-6632.1993.tb35928.x; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; O'Malley YQ, 2004, AM J PHYSIOL-LUNG C, V287, pL94, DOI 10.1152/ajplung.00025.2004; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pandini A, 2007, BIOCHEMISTRY-US, V46, P696, DOI 10.1021/bi061460t; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Rada B, 2013, TRENDS MICROBIOL, V21, P73, DOI 10.1016/j.tim.2012.10.004; Reszka KJ, 2012, AM J PHYSIOL-LUNG C, V302, pL1044, DOI 10.1152/ajplung.00172.2011; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; Schrenk D, 1998, BIOCHEM PHARMACOL, V55, P1155; SCHUSTER MG, 1994, AIDS, V8, P1437, DOI 10.1097/00002030-199410000-00010; Smith KJ, 2011, J PHARMACOL EXP THER, V338, P318, DOI 10.1124/jpet.110.178392; Tijet N, 2006, MOL PHARMACOL, V69, P140, DOI 10.1124/mol.105.018705; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Vogel CFA, 2009, BIOCHEM PHARMACOL, V77, P734, DOI 10.1016/j.bcp.2008.09.036; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; WILSON R, 1987, J CLIN INVEST, V79, P221, DOI 10.1172/JCI112787; WILSON R, 1988, INFECT IMMUN, V56, P2515, DOI 10.1128/IAI.56.9.2515-2517.1988; Wincent E, 2012, P NATL ACAD SCI USA, V109, P4479, DOI 10.1073/pnas.1118467109	67	231	246	6	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					387	U332		10.1038/nature13684	http://dx.doi.org/10.1038/nature13684			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25119038				2022-12-28	WOS:000340840600024
J	Marzeion, B; Cogley, JG; Richter, K; Parkes, D				Marzeion, Ben; Cogley, J. Graham; Richter, Kristin; Parkes, David			Attribution of global glacier mass loss to anthropogenic and natural causes	SCIENCE			English	Article							CLIMATE; BALANCE	The ongoing global glacier retreat is affecting human societies by causing sea-level rise, changing seasonal water availability, and increasing geohazards. Melting glaciers are an icon of anthropogenic climate change. However, glacier response times are typically decades or longer, which implies that the present-day glacier retreat is a mixed response to past and current natural climate variability and current anthropogenic forcing. Here we show that only 25 +/- 35% of the global glacier mass loss during the period from 1851 to 2010 is attributable to anthropogenic causes. Nevertheless, the anthropogenic signal is detectable with high confidence in glacier mass balance observations during 1991 to 2010, and the anthropogenic fraction of global glacier mass loss during that period has increased to 69 +/- 24%.	[Marzeion, Ben; Richter, Kristin; Parkes, David] Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria; [Cogley, J. Graham] Trent Univ, Dept Geog, Peterborough, ON K9J 7B8, Canada	University of Innsbruck; Trent University	Marzeion, B (corresponding author), Univ Innsbruck, Inst Meteorol & Geophys, A-6020 Innsbruck, Austria.	ben.marzeion@uibk.ac.at	Marzeion, Ben/G-6514-2013	Marzeion, Ben/0000-0002-6185-3539; Parkes, David/0000-0002-6339-1681	Austrian Science Fund [PP25362-N26]; Austrian Ministry of Science Bundesministerium fur Wissenschaft und Forschung, UniInfrastrukturprogramm of the Research Platform Scientific Computing at the University of Innsbruck; Austrian Science Fund (FWF) [P 22443] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry of Science Bundesministerium fur Wissenschaft und Forschung, UniInfrastrukturprogramm of the Research Platform Scientific Computing at the University of Innsbruck; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by the Austrian Science Fund (grant PP25362-N26) and supported by the Austrian Ministry of Science Bundesministerium fur Wissenschaft und Forschung as part of the UniInfrastrukturprogramm of the Research Platform Scientific Computing at the University of Innsbruck. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups (listed in the table S1) for producing and making available their model output. For CMIP, the U. S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provided coordinating support and led the development of software infrastructure in partnership with the Global Organization for Earth System Science Portals.	Arendt A., 2012, RANDOLPH GLACIER INV; Cogley JG, 2009, ANN GLACIOL, V50, P96, DOI 10.3189/172756409787769744; Flato G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P741; Gardner AS, 2013, SCIENCE, V340, P852, DOI 10.1126/science.1234532; Giesen RH, 2013, CLIM DYNAM, V41, P3283, DOI 10.1007/s00382-013-1743-7; Gregory JM, 2013, J CLIMATE, V26, P4476, DOI 10.1175/JCLI-D-12-00319.1; Harrison WD, 2001, J GLACIOL, V47, P659, DOI 10.3189/172756501781831837; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Immerzeel WW, 2010, SCIENCE, V328, P1382, DOI 10.1126/science.1183188; JOHANNESSON T, 1989, J GLACIOL, V35, P355, DOI 10.3189/S002214300000928X; Kaser G, 2010, P NATL ACAD SCI USA, V107, P20223, DOI 10.1073/pnas.1008162107; Leclercq PW, 2011, SURV GEOPHYS, V32, P519, DOI 10.1007/s10712-011-9121-7; Marzeion B, 2014, CRYOSPHERE, V8, P59, DOI 10.5194/tc-8-59-2014; Marzeion B, 2012, CRYOSPHERE, V6, P1295, DOI 10.5194/tc-6-1295-2012; Meinshausen M, 2011, CLIMATIC CHANGE, V109, P213, DOI 10.1007/s10584-011-0156-z; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; OERLEMANS J, 1988, J GLACIOL, V34, P333, DOI 10.3189/S0022143000007103; Oerlemans J, 2005, SCIENCE, V308, P675, DOI 10.1126/science.1107046; Pfeffer WT, 2014, J GLACIOL, V60, P537, DOI 10.3189/2014JoG13J176; Radic V, 2014, CLIM DYNAM, V42, P37, DOI 10.1007/s00382-013-1719-7; Reichert BK, 2002, J CLIMATE, V15, P3069, DOI 10.1175/1520-0442(2002)015<3069:RGREIV>2.0.CO;2; Richardson SD, 2000, QUATERN INT, V65-6, P31, DOI 10.1016/S1040-6182(99)00035-X; Roe GH, 2009, J GLACIOL, V55, P839, DOI 10.3189/002214309790152438; Vaughan DG, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P317	26	191	197	13	131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					919	921		10.1126/science.1254702	http://dx.doi.org/10.1126/science.1254702			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25123485				2022-12-28	WOS:000340524700043
J	Donohue, JM				Donohue, Julie M.			The Impact and Evolution of Medicare Part D	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							IMPLEMENTATION; NEEDS		Univ Pittsburgh, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Donohue, JM (corresponding author), Univ Pittsburgh, Dept Hlth Policy & Management, Pittsburgh, PA 15260 USA.			Donohue, Julie/0000-0003-2418-6017				DHHS Office of Inspector General, 2011, HIGH REB BRAND NAM D; Gellad WF, 2013, ANN INTERN MED, V159, P105, DOI 10.7326/0003-4819-159-2-201307160-00664; Madden JM, 2008, JAMA-J AM MED ASSOC, V299, P1922, DOI 10.1001/jama.299.16.1922; McWilliams JM, 2011, JAMA-J AM MED ASSOC, V306, P402, DOI 10.1001/jama.2011.1026; Zhou C, 2012, HEALTH AFFAIR, V31, P2259, DOI 10.1377/hlthaff.2012.0087	5	10	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 21	2014	371	8					693	695		10.1056/NEJMp1402471	http://dx.doi.org/10.1056/NEJMp1402471			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN3SV	25140954				2022-12-28	WOS:000340509900003
J	Nguyen, PD; Hollway, GE; Sonntag, C; Miles, LB; Hall, TE; Berger, S; Fernandez, KJ; Gurevich, DB; Cole, NJ; Alaei, S; Ramialison, M; Sutherland, RL; Polo, JM; Lieschke, GJ; Currie, PD				Phong Dang Nguyen; Hollway, Georgina Elizabeth; Sonntag, Carmen; Miles, Lee Barry; Hall, Thomas Edward; Berger, Silke; Fernandez, Kristine Joy; Gurevich, David Baruch; Cole, Nicholas James; Alaei, Sara; Ramialison, Mirana; Sutherland, Robert Lyndsay; Polo, Jose Maria; Lieschke, Graham John; Currie, Peter David			Haematopoietic stem cell induction by somite-derived endothelial cells controlled by meox1	NATURE			English	Article							TRANSGENIC ZEBRAFISH; AORTIC ENDOTHELIUM; SMOOTH-MUSCLE; PROGENITORS; BLOOD; EXPRESSION; HEDGEHOG; IDENTIFICATION; MESODERM; DATABASE	Haematopoietic stem cells (HSCs) are self-renewing stem cells capable of replenishing all blood lineages. In all vertebrate embryos that have been studied, definitive HSCs are generated initially within the dorsal aorta (DA) of the embryonic vasculature by a series of poorly understood inductive events(1-3). Previous studies have identified that signalling relayed from adjacent somites coordinates HSC induction, but the nature of this signal has remained elusive(4). Here we reveal that somite specification of HSCs occurs via the deployment of a specific endothelial precursor population, which arises within a sub-compartment of the zebrafish somite that we have defined as the endotome. Endothelial cells of the endotomeare specified within the nascent somite by the activity of the homeobox genemeox(1). Specified endotomal cells consequently migrate and colonize the DA, where they induce HSC formation through the deployment of chemokine signalling activated in these cells during endotome formation. Loss of meox(1) activity expands the endotome at the expense of a second somitic cell type, the muscle precursors of the dermomyotomal equivalent in zebrafish, the external cell layer. The resulting increase in endotome-derived cells that migrate to colonize the DA generates a dramatic increase in chemokine-dependent HSC induction. This study reveals the molecular basis for a novel somite lineage restriction mechanism and defines a new paradigm in induction of definitive HSCs.	[Phong Dang Nguyen; Sonntag, Carmen; Miles, Lee Barry; Hall, Thomas Edward; Berger, Silke; Gurevich, David Baruch; Alaei, Sara; Ramialison, Mirana; Polo, Jose Maria; Lieschke, Graham John; Currie, Peter David] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Hollway, Georgina Elizabeth; Fernandez, Kristine Joy; Sutherland, Robert Lyndsay] Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia; [Hollway, Georgina Elizabeth; Fernandez, Kristine Joy; Sutherland, Robert Lyndsay] Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Hollway, Georgina Elizabeth; Sutherland, Robert Lyndsay] Univ New S Wales, Fac Med, St Vincents Clin Sch, Kensington, NSW 2052, Australia; [Cole, Nicholas James] Univ Sydney, Sch Med, Dept Anat, Camperdown, NSW 2006, Australia; [Cole, Nicholas James] Macquarie Univ, Australian Sch Adv Med, MND Res Program, N Ryde, NSW 2109, Australia; [Alaei, Sara] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia; [Currie, Peter David] Monash Univ, EMBL Australia, Clayton, Vic 3800, Australia	Australian Regenerative Medicine Institute; Monash University; Garvan Institute of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; University of Sydney; Macquarie University; Monash University; European Molecular Biology Laboratory (EMBL); Monash University	Currie, PD (corresponding author), Monash Univ, Australian Regenerat Med Inst, Level 1,Bldg 75,Wellington Rd, Clayton, Vic 3800, Australia.	peter.currie@monash.edu	Ramialison, Mirana/AEG-6305-2022; Hollway, Georgina E/E-6764-2010; cole, nicholas/M-7010-2016; Hall, Thomas/J-2125-2014	Cole, Nicholas/0000-0003-1006-2662; Ramialison, Mirana/0000-0001-6315-4777; Alaei, Sara/0000-0003-4897-6339; Hall, Thomas/0000-0002-7718-7614; Currie, Peter/0000-0001-8874-8862; Nguyen, Phong Dang/0000-0003-1889-3276; Gurevich, David/0000-0002-7194-7520; Sonntag, Carmen/0000-0003-2560-1710; Lieschke, Graham/0000-0003-0325-798X; Miles, Lee/0000-0002-2718-1353; Polo, Jose M/0000-0002-2531-778X	National Health and Medical Research Council of Australia (NHMRC); Australian Research Council; Cancer Institute NSW (CINSW); Australian Postgraduate Award; NHMRC; CINSW; RT Hall Foundation; State Government of Victoria; Australian Federal Government	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Cancer Institute NSW (CINSW); Australian Postgraduate Award(Australian Government); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CINSW; RT Hall Foundation; State Government of Victoria; Australian Federal Government(Australian Government)	We thank G. Kardon and B. Hogan for reading and critique of the manuscript. We also thank C.-H. Wang, F. Ellett, V. Nikolova-Krstevski and Fishcore staff for technical assistance. This work was supported by a National Health and Medical Research Council of Australia (NHMRC) grant to P. D. C. and an Australian Research Council grant to P. D. C. and G. E. H.; G. E. H. was supported by a Cancer Institute NSW (CINSW) Career Development Fellowship, R. L. S. by the CINSW and RT Hall Foundation, P.D.N. by an Australian Postgraduate Award, G.J.L. by a NHMRC Senior Research Fellowship and P. D. C. by a NHMRC Principal Research Fellowship. The Australian Regenerative Medicine Institute is supported by funds from the State Government of Victoria and the Australian Federal Government.	Ben-Yair R, 2008, J CELL BIOL, V180, P607, DOI 10.1083/jcb.200707206; Berger J, 2013, GENESIS, V51, P443, DOI 10.1002/dvg.22385; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140; Cerdan C, 2010, INT J DEV BIOL, V54, P955, DOI 10.1387/ijdb.103067cc; Cha YR, 2012, DEV CELL, V22, P824, DOI 10.1016/j.devcel.2012.01.011; Childs S, 2002, DEVELOPMENT, V129, P973; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Curado S, 2008, NAT PROTOC, V3, P948, DOI 10.1038/nprot.2008.58; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106; Esner M, 2006, DEVELOPMENT, V133, P737, DOI 10.1242/dev.02226; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; Hollway GE, 2007, DEV CELL, V12, P207, DOI 10.1016/j.devcel.2007.01.001; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Johnson JLFA, 2012, DEV BIOL, V368, P193, DOI 10.1016/j.ydbio.2012.05.007; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kohli V, 2013, DEV CELL, V25, P196, DOI 10.1016/j.devcel.2013.03.017; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Li Q, 2005, J NEUROSCI, V25, P1711, DOI 10.1523/JNEUROSCI.4393-04.2005; Liao EC, 1998, GENE DEV, V12, P621, DOI 10.1101/gad.12.5.621; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Ma DD, 2011, BLOOD, V118, P289, DOI 10.1182/blood-2010-12-327403; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Neyt C, 2000, NATURE, V408, P82, DOI 10.1038/35040549; NODEN DM, 1989, AM REV RESPIR DIS, V140, P1097, DOI 10.1164/ajrccm/140.4.1097; PARDANAUD L, 1995, ANAT EMBRYOL, V192, P301, DOI 10.1007/BF00710099; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Pisharath H, 2007, MECH DEVELOP, V124, P218, DOI 10.1016/j.mod.2006.11.005; Pouget C, 2006, DEVELOPMENT, V133, P1013, DOI 10.1242/dev.02269; Proulx K, 2010, DEV BIOL, V348, P34, DOI 10.1016/j.ydbio.2010.08.036; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Seo HC, 1998, MECH DEVELOP, V70, P49, DOI 10.1016/S0925-4773(97)00175-5; Shimshek DR, 2002, GENESIS, V32, P19, DOI 10.1002/gene.10023; Stellabotte F, 2007, DEVELOPMENT, V134, P1253, DOI 10.1242/dev.000067; Svetic V, 2007, DEVELOPMENT, V134, P1011, DOI 10.1242/dev.02789; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Villefranc JA, 2007, DEV DYNAM, V236, P3077, DOI 10.1002/dvdy.21354; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE; Whitesell TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090590; Williams C, 2010, DEV BIOL, V341, P196, DOI 10.1016/j.ydbio.2010.02.028; WILTING J, 1995, DEV DYNAM, V202, P165, DOI 10.1002/aja.1002020208; Yabe T, 2012, DEV BIOL, V370, P213, DOI 10.1016/j.ydbio.2012.07.029; Zhang XY, 2007, DEV BIOL, V307, P179, DOI 10.1016/j.ydbio.2007.04.002; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	54	81	84	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					314	+		10.1038/nature13678	http://dx.doi.org/10.1038/nature13678			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119043				2022-12-28	WOS:000340508200036
J	MacKenzie, T; Gifford, AH; Sabadosa, KA; Quinton, HB; Knapp, EA; Goss, CH; Marshall, BC				MacKenzie, Todd; Gifford, Alex H.; Sabadosa, Kathryn A.; Quinton, Hebe B.; Knapp, Emily A.; Goss, Christopher H.; Marshall, Bruce C.			Longevity of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry	ANNALS OF INTERNAL MEDICINE			English	Article							RISK-FACTORS; MORTALITY; ADULTS; CARE; ASSOCIATION; HEALTH; GUIDELINES; DIAGNOSIS; CHILDREN; DISEASE	Background: Advances in treatments for cystic fibrosis (CF) continue to extend survival. An updated estimate of survival is needed for better prognostication and to anticipate evolving adult care needs. Objective: To characterize trends in CF survival between 2000 and 2010 and to project survival for children born and diagnosed with the disease in 2010. Design: Registry-based study. Setting: 110 Cystic Fibrosis Foundation-accredited care centers in the United States. Patients: All patients represented in the Cystic Fibrosis Foundation Patient Registry (CFFPR) between 2000 and 2010. Measurements: Survival was modeled with respect to age, age at diagnosis, gender, race or ethnicity, F508del mutation status, and symptoms at diagnosis. Results: Between 2000 and 2010, the number of patients in the CFFPR increased from 21 000 to 26 000, median age increased from 14.3 to 16.7 years, and adjusted mortality decreased by 1.8% per year (95% CI, 0.5% to 2.7%). Males had a 19% (CI, 13% to 24%) lower adjusted risk for death than females. Median survival of children born and diagnosed with CF in 2010 is projected to be 37 years (CI, 35 to 39 years) for females and 40 years (CI, 39 to 42 years) for males if mortality remains at 2010 levels and more than 50 years if mortality continues to decrease at the rate observed between 2000 and 2010. Limitations: The CFFPR does not include all patients with CF in the United States, and loss to follow-up and missing data were observed. Additional analyses to address these limitations suggest that the survival projections are conservative. Conclusion: Children born and diagnosed with CF in the United States in 2010 are expected to live longer than those born earlier. This has important implications for prognostic discussions and suggests that the health care system should anticipate greater numbers of adults with CF.	[MacKenzie, Todd] Dartmouth Hitchcock Med Ctr, Clin Res Sect, Lebanon, NH 03756 USA; [Gifford, Alex H.; Quinton, Hebe B.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA; [Sabadosa, Kathryn A.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03766 USA; [Knapp, Emily A.; Marshall, Bruce C.] Cyst Fibrosis Fdn, Bethesda, MD 20814 USA; [Goss, Christopher H.] Univ Washington, Seattle, WA 98195 USA	Dartmouth College; Dartmouth College; Dartmouth College; Cystic Fibrosis Foundation; University of Washington; University of Washington Seattle	Sabadosa, KA (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, 30 Lafayette St,Suite 300, Lebanon, NH 03766 USA.	Todd.A.MacKenzie@Dartmouth.edu; Kathryn.A.Sabadosa@Dartmouth.edu		Knapp, Emily/0000-0003-3953-9874; Gifford, Alex/0000-0002-6404-3793; Goss, Christopher/0000-0001-8602-0309	Cystic Fibrosis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001086, KL2TR001088] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Cystic Fibrosis Foundation.	ABBOTT J, 1994, THORAX, V49, P115, DOI 10.1136/thx.49.2.115; Al-Aloul M, 2005, PEDIATR PULM, V39, P15, DOI 10.1002/ppul.20138; ANDERSEN D H, 1958, J Chronic Dis, V7, P58, DOI 10.1016/0021-9681(58)90185-1; Andersson-Segesten K, 1989, Scand J Caring Sci, V3, P35; Barr HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4662; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Cystic Fibrosis Foundation, 2012, CYST FIBR PAT REG; Cystic Fibrosis Foundation, 2012, CYST FIBR; Cystic Fibrosis Foundation, 2010, CYST FIBR PAT REG AN; Dasenbrook EC, 2010, JAMA-J AM MED ASSOC, V303, P2386, DOI 10.1001/jama.2010.791; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; ELBORN JS, 1991, THORAX, V46, P881, DOI 10.1136/thx.46.12.881; Emerson J, 2002, PEDIATR PULM, V34, P91, DOI 10.1002/ppul.10127; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Figueroa V, 2002, AM J CLIN NUTR, V75, P1005, DOI 10.1093/ajcn/75.6.1005; FITZSIMMONS SC, 1993, J PEDIATR-US, V122, P1, DOI 10.1016/S0022-3476(05)83478-X; Flume PA, 2007, AM J RESP CRIT CARE, V176, P957, DOI 10.1164/rccm.200705-664OC; Fogarty AW, 2012, CHEST, V142, P712, DOI 10.1378/chest.11-2124; Gilljam M, 2004, CHEST, V126, P1215, DOI 10.1378/chest.126.4.1215; Godfrey MM, 2014, BMJ QUAL SAF, V23, P23, DOI 10.1136/bmjqs-2014-002804; Hemandez-Jimenez F, 2008, J CYST FIBROS, V7, P343, DOI 10.1016/j.jcf.2008.02.006; Iles N, 2010, HEALTH SOC CARE COMM, V18, P21, DOI 10.1111/j.1365-2524.2009.00871.x; Jackson AD, 2011, THORAX, V66, P674, DOI 10.1136/thoraxjnl-2011-200038; Jackson AD, 2011, J CYST FIBROS, V10, P62, DOI 10.1016/j.jcf.2010.08.021; KLEIN JP, 1990, BIOMETRICS, V46, P795, DOI 10.2307/2532097; Konstan MW, 2007, J PEDIATR-US, V151, P134, DOI 10.1016/j.jpeds.2007.03.006; Kulich M, 2003, J PEDIATR-US, V142, P631, DOI 10.1067/mpd.2003.197; Liou TG, 2001, JAMA-J AM MED ASSOC, V286, P2683, DOI 10.1001/jama.286.21.2683; Marshall BC, 2009, J PEDIATR-US, V155, pS71, DOI 10.1016/j.jpeds.2009.09.004; Mayer-Hamblett N, 2002, AM J RESP CRIT CARE, V166, P1550, DOI 10.1164/rccm.200202-087OC; McKone EF, 2003, LANCET, V361, P1671, DOI 10.1016/S0140-6736(03)13368-5; Modi AC, 2008, CHILD HEALTH CARE, V37, P78, DOI 10.1080/02739610701766925; MOESCHBERGER ML, 1985, BIOMETRICS, V41, P253, DOI 10.2307/2530660; Moran A, 2010, DIABETES CARE, V33, P2697, DOI 10.2337/dc10-1768; Nick JA, 2010, AM J RESP CRIT CARE, V182, P614, DOI 10.1164/rccm.201001-0092OC; O'Connor GT, 2002, PEDIATR PULM, V33, P99, DOI 10.1002/ppul.10042; Okumura MJ, 2014, BMJ QUAL SAF, V23, P64, DOI 10.1136/bmjqs-2013-002364; Quittner AL, 2008, CURR OPIN PULM MED, V14, P582, DOI 10.1097/MCP.0b013e3283121cf1; Quon BS, 2011, AM J RESP CRIT CARE, V184, P1147, DOI 10.1164/rccm.201105-0932OC; Rayas MS, 2014, PEDIAT PULMONOL; Riekert KA, 2007, CHEST, V132, P231, DOI 10.1378/chest.06-2474; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; Sabadosa KA, 2014, BMJ QUAL SAF, V23, P90, DOI 10.1136/bmjqs-2013-002782; Sawicki GS, 2009, J CYST FIBROS, V8, P91, DOI 10.1016/j.jcf.2008.09.007; Scarsi KK, 2010, INT J ANTIMICROB AG, V36, P94, DOI 10.1016/j.ijantimicag.2010.02.018; Schechter MS, 2014, BMJ QUAL SAF, V23, P9, DOI 10.1136/bmjqs-2013-002378; Schluchter MD, 2002, STAT MED, V21, P1271, DOI 10.1002/sim.1104; Schwarzenberg SJ, 2007, DIABETES CARE, V30, P1056, DOI 10.2337/dc06-1576; Stallings VA, 2008, J AM DIET ASSOC, V108, P832, DOI 10.1016/j.jada.2008.02.020; Sueblinvong V, 2007, CLIN CHEST MED, V28, P433, DOI 10.1016/j.ccm.2007.02.009; Therneau TM., 2013, PACKAGE SURVIVAL ANA; Wand M.P., 1994, KERNEL SMOOTHING; Zeitlin PL, 2008, J CLIN INVEST, V118, P3841, DOI 10.1172/JCI37778; Zielenski J, 1995, ANNU REV GENET, V29, P777, DOI 10.1146/annurev.ge.29.120195.004021	54	226	232	1	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					233	+		10.7326/M13-0636	http://dx.doi.org/10.7326/M13-0636			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP8RU	25133359	Green Accepted			2022-12-28	WOS:000342347300013
J	Yacoub, MH; El-Hamamsy, I; Sievers, HH; Carabello, BA; Bonow, RO; Stelzer, P; da Costa, FDA; Schafers, HJ; Skillington, P; Charitos, EI; Luciani, GB; Takkenberg, JJM				Yacoub, Magdi H.; El-Hamamsy, Ismail; Sievers, Hans-Hinrich; Carabello, Blase A.; Bonow, Robert O.; Stelzer, Paul; da Costa, Francisco D. A.; Schaefers, Hans J.; Skillington, Peter; Charitos, Efstratios I.; Luciani, Giovanni Battista; Takkenberg, Johanna J. M.			Under-use of the Ross operation-a lost opportunity	LANCET			English	Editorial Material							AORTIC-VALVE DISEASE; QUALITY-OF-LIFE; REPLACEMENT; HOMOGRAFT; AUTOGRAFT; ROOT		[Yacoub, Magdi H.] Univ London Imperial Coll Sci Technol & Med, Magdi Yacoub Inst, London UB9 6JH, England; [El-Hamamsy, Ismail] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Sievers, Hans-Hinrich; Charitos, Efstratios I.] Univ Hosp Lubeck, Lubeck, Germany; [Bonow, Robert O.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Carabello, Blase A.; Stelzer, Paul] Mt Sinai Hosp, New York, NY 10029 USA; [da Costa, Francisco D. A.] Dept Cardiovasc Surg, Santa Casa De Curitiba, Brazil; [Schaefers, Hans J.] Univ Saarland, Med Ctr, Homburg, Germany; [Skillington, Peter] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Luciani, Giovanni Battista] Univ Verona, I-37100 Verona, Italy; [Takkenberg, Johanna J. M.] Erasmus MC, Dept Cardiothorac Surg, Rotterdam, Netherlands	Imperial College London; Universite de Montreal; University of Lubeck; Northwestern University; Feinberg School of Medicine; Icahn School of Medicine at Mount Sinai; Saarland University; Royal Melbourne Hospital; University of Verona; Erasmus University Rotterdam; Erasmus MC	Yacoub, MH (corresponding author), Univ London Imperial Coll Sci Technol & Med, Magdi Yacoub Inst, London UB9 6JH, England.	m.yacoub@imperial.ac.uk	Charitos, Efstratios/AAG-2005-2020; Takkenberg, Johanna/B-9368-2009; Luciani, Giovanni Battista/AAC-3939-2022	Takkenberg, Johanna/0000-0001-9809-5623; Luciani, Giovanni Battista/0000-0003-0931-018X				Aicher D, 2011, J THORAC CARDIOV SUR, V142, pE19, DOI 10.1016/j.jtcvs.2011.02.006; Carapetis JR, 2005, LANCET, V366, P155, DOI 10.1016/S0140-6736(05)66874-2; Charitos EI, 2012, J THORAC CARDIOV SUR, V144, P813, DOI 10.1016/j.jtcvs.2012.07.005; El-Hamamsy I, 2010, LANCET, V376, P524, DOI 10.1016/S0140-6736(10)60828-8; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Notzold A, 2001, J AM COLL CARDIOL, V37, P1963, DOI 10.1016/S0735-1097(01)01267-0; Sievers HH, 2010, J THORAC CARDIOV SUR, V140, P816, DOI 10.1016/j.jtcvs.2009.11.042; Skillington Peter D, 2013, Glob Cardiol Sci Pract, V2013, P383, DOI 10.5339/gcsp.2013.46; Svensson LG, 2013, ANN THORAC SURG, V95, pS1, DOI 10.1016/j.athoracsur.2013.01.083; Treasure T, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2466; United Nations (UN), WORLD POP PROSP; Yacoub MH, 1999, ANN THORAC SURG, V68, pS37, DOI 10.1016/S0003-4975(99)00745-6; Yacoub N, 2005, NAT CLIN PRACT CARD, V2, P60, DOI 10.1038/ncpcardio0112	13	45	45	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					559	560		10.1016/S0140-6736(14)61090-4	http://dx.doi.org/10.1016/S0140-6736(14)61090-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN4QR	25131967				2022-12-28	WOS:000340573300004
J	Ellerbroek, B				Ellerbroek, Brent			ASTRONOMICAL INSTRUMENTATION Atmospheric blurring has a new enemy	NATURE			English	Editorial Material							ADAPTIVE OPTICS	A fully automated optics system that corrects atmospheric blurring of celestial objects has imaged 715 star systems thought to harbour planets, completing each observation in less time than it takes to read this article.	Thirty Meter Telescope Observ Corp, Instrumentat Dept, Pasadena, CA 90807 USA		Ellerbroek, B (corresponding author), Thirty Meter Telescope Observ Corp, Instrumentat Dept, Pasadena, CA 90807 USA.	brente@caltech.edu						Adams ER, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/2/42; Baranec C, 2014, ASTROPHYS J LETT, V790, DOI 10.1088/2041-8205/790/1/L8; Baranec C, 2013, JOVE-J VIS EXP, DOI 10.3791/50021; Davies R, 2012, ANNU REV ASTRON ASTR, V50, P305, DOI 10.1146/annurev-astro-081811-125447; Fressin F, 2012, NATURE, V482, P195, DOI 10.1038/nature10780; Law NM, 2014, ASTROPHYS J, V791, DOI 10.1088/0004-637X/791/1/35; Lillo-Box J, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219631; Petigura EA, 2013, P NATL ACAD SCI USA, V110, P19273, DOI 10.1073/pnas.1319909110	8	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					144	145		10.1038/512144a	http://dx.doi.org/10.1038/512144a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25119232				2022-12-28	WOS:000340200700020
J	Ganem, NJ; Cornils, H; Chiu, SY; O'Rourke, KP; Arnaud, J; Yimlamai, D; Thery, M; Camargo, FD; Pellman, D				Ganem, Neil J.; Cornils, Hauke; Chiu, Shang-Yi; O'Rourke, Kevin P.; Arnaud, Jonathan; Yimlamai, Dean; Thery, Manuel; Camargo, Fernando D.; Pellman, David			Cytokinesis Failure Triggers Hippo Tumor Suppressor Pathway Activation	CELL			English	Article							CELL-CYCLE PROGRESSION; MAMMALIAN-CELLS; CENTROSOME AMPLIFICATION; CHROMOSOMAL INSTABILITY; CLEAVAGE FAILURE; CANCER; YAP; TETRAPLOIDY; PLOIDY; LIVER	Genetically unstable tetraploid cells can promote tumorigenesis. Recent estimates suggest that similar to 37% of human tumors have undergone a genome-doubling event during their development. This potentially oncogenic effect of tetraploidy is countered by a p53-dependent barrier to proliferation. However, the cellular defects and corresponding signaling pathways that trigger growth suppression in tetraploid cells are not known. Here, we combine RNAi screening and in vitro evolution approaches to demonstrate that cytokinesis failure activates the Hippo tumor suppressor pathway in cultured cells, as well as in naturally occurring tetraploid cells in vivo. Induction of the Hippo pathway is triggered in part by extra centrosomes, which alter small G protein signaling and activate LATS2 kinase. LATS2 in turn stabilizes p53 and inhibits the transcriptional regulators YAP and TAZ. These findings define an important tumor suppression mechanism and uncover adaptive mechanisms potentially available to nascent tumor cells that bypass this inhibitory regulation.	[Ganem, Neil J.; Cornils, Hauke; Chiu, Shang-Yi; O'Rourke, Kevin P.; Pellman, David] Harvard Univ, Sch Med, Childrens Hosp, Dana Farber Canc Inst,Howard Hughes Med Inst,Dept, Boston, MA 02115 USA; [Ganem, Neil J.; Cornils, Hauke; Chiu, Shang-Yi; O'Rourke, Kevin P.; Pellman, David] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Arnaud, Jonathan; Thery, Manuel] CEA UJF INRA CNRS, Inst Rech Technol & Sci Vivant, UMR5168, F-38054 Grenoble, France; [Yimlamai, Dean; Camargo, Fernando D.] Childrens Hosp Boston, Stem Cell Program, Boston, MA 02115 USA; [Thery, Manuel] Univ Paris Diderot, Hop St Louis, AP HP, INSERM,Inst Univ Hematol, F-75010 Paris, France	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Harvard University; Boston Children's Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ganem, NJ (corresponding author), Boston Univ, Sch Med, Ctr Canc, Dept Pharmacol & Expt Therapeut,Div Hematol & Onc, Boston, MA 02118 USA.	nganem@bu.edu; david_pellman@dfci.harvard.edu	Yimlamai, Dean/AAA-6607-2020	Yimlamai, Dean/0000-0002-7936-7168; Ganem, Neil/0000-0003-0269-6585	NIH [1S10RR026582-01, DK099559, GM083299-1]; NCI K99 award [K99CA154531-01]; ERC [31047]; BCH Career Development Award; Manton Center for Orphan Disease Research; NATIONAL CANCER INSTITUTE [K99CA154531, R00CA154531] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK105351, R01DK099559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083299] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI K99 award; ERC(European Research Council (ERC)European Commission); BCH Career Development Award; Manton Center for Orphan Disease Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank S. Jhaveri-Schneider and A. Salic for comments on the manuscript; members of the ICCB screening facility; K. Lunquist for technical assistance; H. Li, K. Ross, and K. Stegmaier for assistance with microarray analysis; R. Beroukhim for assistance with ploidy analysis of the CCLE collection; S. Godinho for reagents; P. Nagaruri Gonchi and D. Williams for discussions; and T. Vignaud, F. Senger, and J.-L. Martiel for advice on traction force microscopy. NIH grant 1S10RR026582-01 to C. Shamu supported the IsoCyte/Velos laser scanning cytometer. N.J.G. is supported by an NCI K99 award (K99CA154531-01) and is a member of the Shamim and Ashraf Dahod Breast Cancer Research Laboratories; H.C. is a fellow of the Leukemia and Lymphoma Society; M.T. is supported by ERC grant 31047; D.Y. is supported by a BCH Career Development Award and is a George Ferry Young Investigator of NASPGHAN; F.D.C. is supported by the Manton Center for Orphan Disease Research and NIH grant DK099559; and D.P. is a HHMI investigator and is supported by NIH grant GM083299-1.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; CARTER SB, 1967, NATURE, V213, P261, DOI 10.1038/213261a0; Davoli T, 2012, CANCER CELL, V21, P765, DOI 10.1016/j.ccr.2012.03.044; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Duncan AW, 2013, SEMIN CELL DEV BIOL, V24, P347, DOI 10.1016/j.semcdb.2013.01.003; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Krzywicka-Racka A, 2011, J CELL BIOL, V194, P199, DOI 10.1083/jcb.201101073; Kuffer C, 2013, CHROMOSOMA, V122, P305, DOI 10.1007/s00412-013-0414-0; Kurinna S, 2013, HEPATOLOGY, V57, P2004, DOI 10.1002/hep.26233; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Nakamura K, 2011, INT J CANCER, V128, P2613, DOI 10.1002/ijc.25606; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Senovilla L, 2012, SCIENCE, V337, P1678, DOI 10.1126/science.1224922; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wong C, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-6; WRIGHT WE, 1972, EXP CELL RES, V74, P187, DOI 10.1016/0014-4827(72)90496-X; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111	38	239	242	3	51	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					833	848		10.1016/j.cell.2014.06.029	http://dx.doi.org/10.1016/j.cell.2014.06.029			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126788	Green Accepted, Bronze			2022-12-28	WOS:000340944700014
J	George, JN; Nester, CM				George, James N.; Nester, Carla M.			Syndromes of Thrombotic Microangiopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							HEMOLYTIC-UREMIC-SYNDROME; VON-WILLEBRAND-FACTOR; INDUCED IMMUNE THROMBOCYTOPENIA; UPSHAW-SCHULMAN SYNDROME; TERM-FOLLOW-UP; ESCHERICHIA-COLI; CLINICAL-FEATURES; SHIGA-TOXIN; ADAMTS13-DEFICIENT MICE; ADAMTS13 DEFICIENCY		[George, James N.] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK 73126 USA; [George, James N.] Univ Oklahoma, Hlth Sci Ctr, Coll Med, Dept Internal Med, Oklahoma City, OK 73126 USA; [Nester, Carla M.] Univ Iowa, Stead Family Dept Pediat, Iowa City, IA USA; [Nester, Carla M.] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Iowa; University of Iowa	George, JN (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Internal Med, POB 26901, Oklahoma City, OK 73126 USA.	james-george@ouhsc.edu		Nester, Carla/0000-0002-0629-7576	Alexion; Celldex	Alexion; Celldex	Dr. George reports receiving fees for serving on advisory boards from Alexion; and Dr. Nester receiving grant support from Celldex and fees for serving on advisory boards from Alexion. No other potential conflict of interest relevant to this article was reported.	AMOROSI EL, 1966, MEDICINE, V45, P139, DOI 10.1097/00005792-196603000-00003; BELL BP, 1994, JAMA-J AM MED ASSOC, V272, P1349, DOI 10.1001/jama.272.17.1349; Bougie DW, 2006, BLOOD, V108, P922, DOI 10.1182/blood-2006-01-009803; Bu FX, 2014, J AM SOC NEPHROL, V25, P55, DOI 10.1681/ASN.2013050453; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Chandler WL, 2002, NEW ENGL J MED, V346, P23, DOI 10.1056/NEJMoa011033; Coppola A, 2000, SEMIN THROMB HEMOST, V26, P243, DOI 10.1055/s-2000-8469; Deford CC, 2013, BLOOD, V122, P2023, DOI 10.1182/blood-2013-04-496752; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Ergonul Z, 2003, PEDIATR NEPHROL, V18, P246, DOI 10.1007/s00467-002-1025-9; FARR MJ, 1975, Q J MED, V44, P161; Froehlich-Zahnd R, 2012, HAEMATOL-HEMATOL J, V97, P297, DOI 10.3324/haematol.2011.051433; FUCHS WE, 1976, JAMA-J AM MED ASSOC, V235, P2126, DOI 10.1001/jama.235.19.2126; Fujimura Y, 2011, J THROMB HAEMOST, V9, P283, DOI 10.1111/j.1538-7836.2011.04341.x; Furlan M, 1999, THROMB HAEMOSTASIS, V81, P8; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Gall ECL, 2014, AM J KIDNEY DIS, V63, P119, DOI 10.1053/j.ajkd.2013.08.031; Gandhi C, 2012, BLOOD, V119, P2385, DOI 10.1182/blood-2011-09-376202; Garg AX, 2003, JAMA-J AM MED ASSOC, V290, P1360, DOI 10.1001/jama.290.10.1360; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; George JN, 2011, BLOOD, V117, P5551; George JN, 2012, J CLIN APHERESIS, V27, P302, DOI 10.1002/jca.21248; GERAGHTY MT, 1992, J PEDIATR-US, V120, P934, DOI 10.1016/S0022-3476(05)81967-5; Glynne P, 1999, AM J KIDNEY DIS, V33, P133, DOI 10.1016/S0272-6386(99)70269-6; GOTTSCHALL JL, 1994, AM J HEMATOL, V47, P283, DOI 10.1002/ajh.2830470407; Hosler GA, 2003, ARCH PATHOL LAB MED, V127, P834; Hovinga JAK, 2010, BLOOD, V115, P1500, DOI 10.1182/blood-2009-09-243790; Huang J, 2010, BLOOD, V116, P3653, DOI 10.1182/blood-2010-02-271957; Hughes AK, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000027873.85792.52; Huynh M, 2005, ANN PHARMACOTHER, V39, P1346, DOI 10.1345/aph.1G067; JAVETT SN, 1962, PEDIATRICS, V29, P209; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; KAPLAN BS, 1975, NEW ENGL J MED, V292, P1090, DOI 10.1056/NEJM197505222922102; KARMALI MA, 1983, LANCET, V1, P619, DOI 10.1016/s0140-6736(83)91795-6; Karpac CA, 2008, BRIT J HAEMATOL, V141, P696, DOI 10.1111/j.1365-2141.2008.07116.x; Kennedy AS, 2009, TRANSFUSION, V49, P1092, DOI 10.1111/j.1537-2995.2009.02101.x; Kojouri K, 2001, ANN INTERN MED, V135, P1047, DOI 10.7326/0003-4819-135-12-200112180-00008; Laszik Z. G., 2007, HEPTINSTALLS PATHOLO, V6th, P699; Legendre CM, 2013, NEW ENGL J MED, V368, P2169, DOI 10.1056/NEJMoa1208981; Lemaire M, 2013, NAT GENET, V45, P531, DOI 10.1038/ng.2590; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Loriat C, PEDIAT NEPH IN PRESS; Lotta LA, 2012, BLOOD, V120, P440, DOI 10.1182/blood-2012-01-403113; Maki DG, 2006, NEW ENGL J MED, V355, P1952, DOI 10.1056/NEJMp068225; Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1; Moake JL, 2002, NEW ENGL J MED, V347, P589, DOI 10.1056/NEJMra020528; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Moatti-Cohen M, 2012, BLOOD, V119, P5888, DOI 10.1182/blood-2012-02-408914; Moschcowitz E., 1924, P NY PATHOL SOC, V24, P21; Motto DG, 2005, J CLIN INVEST, V115, P2752, DOI 10.1172/JCI26007; Naik S, 2013, J PEDIAT HEMATOL ONC, V35, P551, DOI 10.1097/MPH.0b013e3182755c38; Nishimura J, 2014, NEW ENGL J MED, V370, P632, DOI 10.1056/NEJMoa1311084; Noris M, 2010, CLIN J AM SOC NEPHRO, V5, P1844, DOI 10.2215/CJN.02210310; Ozaltin F, 2013, J AM SOC NEPHROL, V24, P377, DOI 10.1681/ASN.2012090903; Pennington H, 2010, LANCET, V376, P1428, DOI 10.1016/S0140-6736(10)60963-4; Quaggin SE, 2013, NAT GENET, V45, P475, DOI 10.1038/ng.2622; RAHAMAN MM, 1975, JOHNS HOPKINS MED J, V136, P65; Reese JA, 2013, PEDIATR BLOOD CANCER, V60, P1676, DOI 10.1002/pbc.24612; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; Robinson LA, 1995, PEDIATR NEPHROL, V9, P700, DOI 10.1007/BF00868715; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Rosales A, 2012, CLIN INFECT DIS, V54, P1413, DOI 10.1093/cid/cis196; RUSSO P, 1992, HUM PATHOL, V23, P504, DOI 10.1016/0046-8177(92)90127-O; Saif MW, 2009, EXPERT OPIN DRUG SAF, V8, P257, DOI 10.1517/14740330902942299; Sartelet H, 2005, AM J TRANSPLANT, V5, P2441, DOI 10.1111/j.1600-6143.2005.01047.x; Stahl AL, 2008, BLOOD, V111, P5307, DOI 10.1182/blood-2007-08-106153; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; THOMPSON RA, 1981, CLIN EXP IMMUNOL, V46, P110; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; WEBB RF, 1980, NEW ZEAL MED J, V91, P14; Wittenberg DF, 1999, S AFR MED J, V89, P750	75	605	634	5	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					654	666		10.1056/NEJMra1312353	http://dx.doi.org/10.1056/NEJMra1312353			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZL	25119611				2022-12-28	WOS:000340819600011
J	Howard, DH				Howard, David H.			Adverse Effects of Prohibiting Narrow Provider Networks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Howard, David H.] Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA; [Howard, David H.] Emory Univ, Dept Econ, Atlanta, GA 30322 USA; [Howard, David H.] Emory Univ, Winship Canc Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Howard, DH (corresponding author), Emory Univ, Dept Hlth Policy & Management, Atlanta, GA 30322 USA.							Bauman N, 2014, HOSP NETWORKS UPDATE; Howard David H, 2008, Forum Health Econ Policy, V11, P2, DOI 10.2202/1558-9544.1088; McGuire TG, 2014, J HEALTH ECON, V35, P47, DOI 10.1016/j.jhealeco.2014.01.009	3	19	19	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					591	593		10.1056/NEJMp1402705	http://dx.doi.org/10.1056/NEJMp1402705			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZL	25119604	Bronze			2022-12-28	WOS:000340819600003
J	Price, SL				Price, Sarah L.			CHEMISTRY Lattice energy, nailed?	SCIENCE			English	Editorial Material							POLYMORPHISM		UCL, Dept Chem, London WC1H 0AJ, England	University of London; University College London	Price, SL (corresponding author), UCL, Dept Chem, 20 Gordon St, London WC1H 0AJ, England.	s.l.price@ucl.ac.uk	Price, Sarah Lois/C-1580-2008	Price, Sarah Lois/0000-0002-1230-7427				Braun DE, 2014, CRYST GROWTH DES, V14, P2056, DOI 10.1021/cg500185h; Bucar DK, 2013, CHEM SCI, V4, P4417, DOI 10.1039/c3sc51419f; Huang Y., 2013, J CHEM PHYS, V138; Klimes J, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4754130; Lee AY, 2011, ANNU REV CHEM BIOMOL, V2, P259, DOI 10.1146/annurev-chembioeng-061010-114224; Newman A, 2013, ORG PROCESS RES DEV, V17, P457, DOI 10.1021/op300241f; Price SL, 2014, CHEM SOC REV, V43, P2098, DOI 10.1039/c3cs60279f; Price SL, 2013, ACTA CRYSTALLOGR B, V69, P313, DOI 10.1107/S2052519213018861; Raiteri P, 2005, ANGEW CHEM INT EDIT, V44, P3769, DOI 10.1002/anie.200462760; Stone A., 2013, THEORY INTERMOLECULA; Sun CQ, 2009, J PHARM SCI-US, V98, P1744, DOI 10.1002/jps.21554; Yang J, 2014, SCIENCE, V345, P640, DOI 10.1126/science.1254419	12	9	9	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					619	620		10.1126/science.1257250	http://dx.doi.org/10.1126/science.1257250			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104369				2022-12-28	WOS:000339962800017
J	Hawkes, N				Hawkes, Nigel			PUBLICATION ETHICS Risks in the balance: the statins row	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						Abramson JD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6123; Boseley S, 2014, GUARDIAN; Hawkes N, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4694; Heath I, 2014, BMJ PAPERS      0802; Huffman MD., 2013, BMJ; Malhotra A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6340; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Wise J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3937; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	9	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2014	349								g5007	10.1136/bmj.g5007	http://dx.doi.org/10.1136/bmj.g5007			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MR	25103564				2022-12-28	WOS:000340206200002
J	Gini, G; Espelage, DL				Gini, Gianluca; Espelage, Dorothy L.			Peer Victimization, Cyberbullying, and Suicide Risk in Children and Adolescents	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								IMPORTANCE Peer victimization is related to an increased chance of suicidal ideation and suicide attempts among children and adolescents. OBJECTIVE To examine the relationship between peer victimization and suicidal ideation or suicide attempts using meta-analysis. DATA SOURCES Ovid MEDLINE, PsycINFO, and Web of Science were searched for articles from 1910 to 2013. The search terms were bully*, teas*, victim*, mobbing, ragging, and harassment in combination with the term suic*. Of the 491 studies identified, 34 reported on the relationship between peer victimization and suicidal ideation, with a total of 284 375 participants. Nine studies reported on the relationship between peer victimization and suicide attempts, with a total of 70 102 participants. STUDY SELECTION Studies were eligible for inclusion if they reported an effect size on the relationship between peer victimization and suicidal ideation or suicide attempt in children or adolescents. DATA EXTRACTION AND SYNTHESIS Two observers independently coded the effect sizes from the articles. Data were pooled using a random effects model. MAIN OUTCOMES AND MEASURES This study focused on suicidal ideation and suicide attempts. Peer victimization was hypothesized to be related to suicidal ideation and suicide attempts. RESULTS Peer victimization was found to be related to both suicidal ideation (odds ratio, 2.23 [95% CI, 2.10-2.37]) and suicide attempts (2.55 [1.95-3.34]) among children and adolescents. Analyses indicated that these results were not attributable to publication bias. Results were not moderated by sex, age, or study quality. Cyberbullying was more strongly related to suicidal ideation compared with traditional bullying. CONCLUSIONS AND RELEVANCE Peer victimization is a risk factor for child and adolescent suicidal ideation and attempts. Schools should use evidence-based practices to reduce bullying.	[Gini, Gianluca] Univ Padua, Dept Dev & Social Psychol, Via Venezia 8, I-35131 Padua, Italy; [Espelage, Dorothy L.] Univ Illinois, Dept Educ Psychol, Urbana, IL 61801 USA	University of Padua; University of Illinois System; University of Illinois Urbana-Champaign	Gini, G (corresponding author), Univ Padua, Dept Dev & Social Psychol, Via Venezia 8, I-35131 Padua, Italy.	gianluca.gini@unipd.it		Gini, Gianluca/0000-0002-8251-7550				Due P, 2005, EUR J PUBLIC HEALTH, V15, P128, DOI 10.1093/eurpub/cki105; Espelage DL, 2013, J ADOLESCENT HEALTH, V53, pS27, DOI 10.1016/j.jadohealth.2012.09.017; Gini G, 2013, PEDIATRICS, V132, P720, DOI 10.1542/peds.2013-0614; Gladden R.M., BULLYING SURVEILLANC; Smith GA, 2009, PEDIATRICS, V124, P393, DOI 10.1542/peds.2009-0943; Ttofi MM, 2011, J AGGRESS CONFL PEAC, V3, P63, DOI 10.1108/17596591111132873; Van Geel M, 2014, JAMA PEDIATR, V168, P435, DOI 10.1001/jamapediatrics.2013.4143	7	91	97	3	108	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					545	+		10.1001/jama.2014.3212	http://dx.doi.org/10.1001/jama.2014.3212			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	25096695				2022-12-28	WOS:000339808600024
J	Osborne, LC; Monticelli, LA; Nice, TJ; Sutherland, TE; Siracusa, MC; Hepworth, MR; Tomov, VT; Kobuley, D; Tran, SV; Bittinger, K; Bailey, AG; Laughlin, AL; Boucher, JL; Wherry, EJ; Bushman, FD; Allen, JE; Virgin, HW; Artis, D				Osborne, Lisa C.; Monticelli, Laurel A.; Nice, Timothy J.; Sutherland, Tara E.; Siracusa, Mark C.; Hepworth, Matthew R.; Tomov, Vesselin T.; Kobuley, Dmytro; Tran, Sara V.; Bittinger, Kyle; Bailey, Aubrey G.; Laughlin, Alice L.; Boucher, Jean-Luc; Wherry, E. John; Bushman, Frederic D.; Allen, Judith E.; Virgin, Herbert W.; Artis, David			Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation	SCIENCE			English	Article							GUT MICROBIOTA; INFLAMMATION; INFECTIONS; CHITINASE; CELLS; YM1; BACTERIA; IMMUNITY; MICROFLORA; INDUCTION	The mammalian intestine is colonized by beneficial commensal bacteria and is a site of infection by pathogens, including helminth parasites. Helminths induce potent immunomodulatory effects, but whether these effects are mediated by direct regulation of host immunity or indirectly through eliciting changes in the microbiota is unknown. We tested this in the context of virus-helminth coinfection. Helminth coinfection resulted in impaired antiviral immunity and was associated with changes in the microbiota and STAT6-dependent helminth-induced alternative activation of macrophages. Notably, helminth-induced impairment of antiviral immunity was evident in germ-free mice, but neutralization of Ym1, a chitinase-like molecule that is associated with alternatively activated macrophages, could partially restore antiviral immunity. These data indicate that helminth-induced immunomodulation occurs independently of changes in the microbiota but is dependent on Ym1.	[Osborne, Lisa C.; Monticelli, Laurel A.; Siracusa, Mark C.; Hepworth, Matthew R.; Kobuley, Dmytro; Tran, Sara V.; Bittinger, Kyle; Bailey, Aubrey G.; Laughlin, Alice L.; Bushman, Frederic D.; Artis, David] Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Osborne, Lisa C.; Monticelli, Laurel A.; Siracusa, Mark C.; Hepworth, Matthew R.; Kobuley, Dmytro; Tran, Sara V.; Wherry, E. John; Artis, David] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nice, Timothy J.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Sutherland, Tara E.; Allen, Judith E.] Univ Edinburgh, Inst Immunol & Infect Res, Ctr Immun Infect & Evolut, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland; [Hepworth, Matthew R.; Tomov, Vesselin T.] Univ Penn, Dept Med, Perelman Sch Med, Div Gastroenterol, Philadelphia, PA 19104 USA; [Boucher, Jean-Luc] Univ Paris 05, Chim & Biochim Pharmacol & Toxicol Lab, Paris, France; [Artis, David] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Washington University (WUSTL); University of Edinburgh; University of Pennsylvania; Pennsylvania Medicine; UDICE-French Research Universities; Universite Paris Cite; University of Pennsylvania	Artis, D (corresponding author), Univ Penn, Dept Microbiol, Perelman Sch Med, Philadelphia, PA 19104 USA.	dartis@mail.med.upenn.edu	Osborne, Lisa/K-3027-2015; Laughlin, Alice/HIR-4050-2022; Wherry, John/ABI-1280-2020; Bittinger, Kyle/ABG-2342-2020; Nice, Timothy/X-9114-2019; Sutherland, Tara/S-1427-2019; Allen, Judith E/C-9198-2011	Osborne, Lisa/0000-0002-7170-3235; Nice, Timothy/0000-0002-4471-7666; Sutherland, Tara/0000-0001-9334-8206; Allen, Judith E/0000-0002-3829-066X; Bailey, Aubrey/0000-0002-0712-217X; Virgin, Herbert/0000-0001-8580-7628; Hepworth, Matthew/0000-0002-9613-7858; Artis, David/0000-0002-1753-4100	NIH Tetramer Core Facility [HHSN272201300006C]; University of Pennsylvania Matthew J. Ryan Veterinary Hospital Pathology Lab; NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases [P30-DK050306]; Penn Center for AIDS Research [P30-AI045008]; Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory; National Cancer Institute Comprehensive Cancer Center [2-P30 CA016520]; NIH [AI061570, AI074878, AI087990, AI095466, AI095608, AI097333, AI106697, AI102942, T32-AI007532, F32-AI085828, AI083022, AI082630, K08-DK097301, 5T32A100716334]; Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Edmond J. Safra Foundation/Cancer Research Institute Irvington Fellowship; Medical Research Council UK [MR/J001929/1]; Cancer Research Institute; American Cancer Society; Crohn's and Colitis Genetics Initiative grant [274415]; Broad Foundation [IBD-0357];  [R01 AI 084887]; MRC [MR/J001929/1] Funding Source: UKRI; Medical Research Council [MR/J001929/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI087990, R01AI061570, R01AI097333, U19AI083022, P01AI106697, R01AI102942, R01AI095466, R01AI084887, R01AI074878, U19AI082630, F32AI085828, U01AI095608, T32AI007532, P30AI045008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, K08DK097301] Funding Source: NIH RePORTER	NIH Tetramer Core Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pennsylvania Matthew J. Ryan Veterinary Hospital Pathology Lab; NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Penn Center for AIDS Research; Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory; National Cancer Institute Comprehensive Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Edmond J. Safra Foundation/Cancer Research Institute Irvington Fellowship; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research Institute; American Cancer Society(American Cancer Society); Crohn's and Colitis Genetics Initiative grant; Broad Foundation; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the Artis laboratory for discussions and critical reading of the manuscript; F. Finkelman for providing anti-IL-4 clone 1D11.2; the NIH Tetramer Core Facility (contract HHSN272201300006C) for providing MHCII IA<SUP>b</SUP> tetramers; the University of Pennsylvania Matthew J. Ryan Veterinary Hospital Pathology Lab, the NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center for Molecular Studies in Digestive and Liver Diseases (P30-DK050306), and its core facilities (Molecular Pathology and Imaging, Molecular Biology, Cell Culture, and Transgenic and Chimeric Mouse); the Penn Center for AIDS Research (P30-AI045008) for assistance and support; and the Abramson Cancer Center Flow Cytometry and Cell Sorting Resource Laboratory for technical advice and support. The ACC Flow Cytometry and Cell Sorting Shared Resource is partially supported by a National Cancer Institute Comprehensive Cancer Center Support grant (2-P30 CA016520). The data tabulated in this paper are reported in the main paper and in the supplementary materials. Illumina MiSeq data can be found in the National Center for Biotechnology Information Sequence Read Archive with accession number SRP043964. Research in the Artis lab is supported by the NIH (AI061570, AI074878, AI087990, AI095466, AI095608, AI097333, AI106697, and AI102942 to D. A.; T32-AI007532 to L. A. M.; and F32-AI085828 to M. C. S.), the Crohn's and Colitis Foundation of America (D. A. and M. R. H.), the Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (D. A.), and the Edmond J. Safra Foundation/Cancer Research Institute Irvington Fellowship (L.C.O.). E. J. W. and V. T. T. are supported by NIH grants AI083022, AI082630, and K08-DK097301. T. E. S. and J. E. A. were supported by the Medical Research Council UK (MR/J001929/1). T.J.N. was supported by NIH training grant 5T32A100716334 and postdoctoral fellowships from the Cancer Research Institute and American Cancer Society. H. W. V. was supported by grant R01 AI 084887, the Crohn's and Colitis Genetics Initiative grant 274415, and the Broad Foundation grant IBD-0357. Washington University and H. W. V. receive income based on licenses for MNV technology. The authors declare no other potential conflicts of interest.	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Arora M, 2006, P NATL ACAD SCI USA, V103, P7777, DOI 10.1073/pnas.0508492103; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bancroft AJ, 2012, TRENDS PARASITOL, V28, P93, DOI 10.1016/j.pt.2011.12.001; Benson A, 2009, CELL HOST MICROBE, V6, P187, DOI 10.1016/j.chom.2009.06.005; Broadhurst MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003000; Chang NCA, 2001, J BIOL CHEM, V276, P17497, DOI 10.1074/jbc.M010417200; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Ford AQ, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-6; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Leung JM, 2013, INT J PARASITOL, V43, P253, DOI 10.1016/j.ijpara.2012.10.015; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Loke P'ng, 2002, BMC Immunol, V3, P7, DOI 10.1186/1471-2172-3-7; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Metenou S, 2012, CURR OPIN HIV AIDS, V7, P231, DOI 10.1097/COH.0b013e3283522c3d; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nair MG, 2005, INFECT IMMUN, V73, P385, DOI 10.1128/IAI.73.1.385-394.2005; Owhashi M, 2000, J BIOL CHEM, V275, P1279, DOI 10.1074/jbc.275.2.1279; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Potian JA, 2011, J EXP MED, V208, P1863, DOI 10.1084/jem.20091473; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Stelekati E, 2012, CELL HOST MICROBE, V12, P458, DOI 10.1016/j.chom.2012.10.001; Sutherland TE, 2009, CLIN EXP ALLERGY, V39, P943, DOI 10.1111/j.1365-2222.2009.03243.x; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Wolff MJ, 2012, TRENDS PARASITOL, V28, P187, DOI 10.1016/j.pt.2012.02.008; Zhao J, 2013, PARASITOL RES, V112, P2689, DOI 10.1007/s00436-013-3436-x	40	186	191	2	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					578	582		10.1126/science.1256942	http://dx.doi.org/10.1126/science.1256942			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082704	Green Accepted			2022-12-28	WOS:000339651300049
J	Benayoun, BA; Pollina, EA; Ucar, D; Mahmoudi, S; Karra, K; Wong, ED; Devarajan, K; Daugherty, AC; Kundaje, AB; Mancini, E; Hitz, BC; Gupta, R; Rando, TA; Baker, JC; Snyder, MP; Cherry, JM; Brunet, A				Benayoun, Berenice A.; Pollina, Elizabeth A.; Ucar, Duygu; Mahmoudi, Salah; Karra, Kalpana; Wong, Edith D.; Devarajan, Keerthana; Daugherty, Aaron C.; Kundaje, Anshul B.; Mancini, Elena; Hitz, Benjamin C.; Gupta, Rakhi; Rando, Thomas A.; Baker, Julie C.; Snyder, Michael P.; Cherry, J. Michael; Brunet, Anne			H3K4me3 Breadth Is Linked to Cell Identity and Transcriptional Consistency	CELL			English	Article							EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; GENE-EXPRESSION; GENOME-WIDE; HISTONE H3; CHROMATIN-STRUCTURE; ANALYSIS REVEALS; LYSINE 4; COMPLEX; METHYLATION	Trimethylation of histone H3 at lysine 4 (H3K4me3) is a chromatin modification known to mark the transcription start sites of active genes. Here, we show that H3K4me3 domains that spread more broadly over genes in a given cell type preferentially mark genes that are essential for the identity and function of that cell type. Using the broadest H3K4me3 domains as a discovery tool in neural progenitor cells, we identify novel regulators of these cells. Machine learning models reveal that the broadest H3K4me3 domains represent a distinct entity, characterized by increased marks of elongation. The broadest H3K4me3 domains also have more paused polymerase at their promoters, suggesting a unique transcriptional output. Indeed, genes marked by the broadest H3K4me3 domains exhibit enhanced transcriptional consistency rather than increased transcriptional levels, and perturbation of H3K4me3 breadth leads to changes in transcriptional consistency. Thus, H3K4me3 breadth contains information that could ensure transcriptional precision at key cell identity/function genes.	[Benayoun, Berenice A.; Pollina, Elizabeth A.; Ucar, Duygu; Mahmoudi, Salah; Karra, Kalpana; Wong, Edith D.; Devarajan, Keerthana; Daugherty, Aaron C.; Kundaje, Anshul B.; Mancini, Elena; Hitz, Benjamin C.; Gupta, Rakhi; Baker, Julie C.; Snyder, Michael P.; Cherry, J. Michael; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Benayoun, Berenice A.; Rando, Thomas A.; Brunet, Anne] Stanford Univ, Paul F Glenn Labs Biol Aging, Stanford, CA 94305 USA; [Pollina, Elizabeth A.; Brunet, Anne] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA; [Rando, Thomas A.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rando, Thomas A.] VA Palo Alto Hlth Care Syst, RR&D REAP, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Brunet, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	anne.brunet@stanford.edu	Kundaje, Anshul/Y-2598-2019; Benayoun, Bérénice A./K-7048-2012; Wong, Edith/GYU-9347-2022; Kundaje, Anshul/Y-2739-2019	Kundaje, Anshul/0000-0003-3084-2287; Benayoun, Bérénice A./0000-0002-7401-4777; Kundaje, Anshul/0000-0003-3084-2287; Cherry, J. Michael/0000-0001-9163-5180; Rando, Thomas/0000-0001-5843-8564; Snyder, Michael/0000-0003-0784-7987	NIH [DP1 AG044848, P01 GM099130, P01 AG036695, R01 GM103787, F31 AG043232]; Glenn Laboratories for the Biology of Aging; Dean's fellowship at Stanford University; NSF GRFP; Department of Genetics at Stanford University; EMBO; Wenner-Gren Fellowhip; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790, R01GM103787, P01GM099130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG043232, P01AG036695, DP1AG044848] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Laboratories for the Biology of Aging; Dean's fellowship at Stanford University; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Department of Genetics at Stanford University; EMBO(European Molecular Biology Organization (EMBO)); Wenner-Gren Fellowhip; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We especially thank Joanna Wysocka and Michael Bassik for stimulating scientific discussion on this research. We thank Sivan Bercovici, Andreas Beyer, Will Greenleaf, Eric Greer, Courtney Hodges, Jonathan Pritchard, Julien Sage, Dario Valenzano, Anton Valouev, Reiner Veitia, and members of the Brunet lab for critical discussion and feedback on the manuscript. This work was supported by NIH DP1 AG044848 (A.B.), P01 GM099130 (A.B. and M.P.S), P01 AG036695 (A.B. and T.A.R.), R01 GM103787 (J.C.B.), the Glenn Laboratories for the Biology of Aging (A.B. and T.A.R.), the Dean's fellowship at Stanford University (B.A.B.), NSF GRFP and NIH F31 AG043232 graduate fellowship (E.A.P.), the Department of Genetics at Stanford University (D.U.), and EMBO long-term postdoctoral fellowship and the Wenner-Gren Fellowhip (S.M.).	Adli M, 2010, NAT METHODS, V7, P615, DOI [10.1038/NMETH.1478, 10.1038/nmeth.1478]; Agoston Z, 2014, DEVELOPMENT, V141, P28, DOI 10.1242/dev.097295; Aiden AP, 2010, CELL STEM CELL, V6, P591, DOI 10.1016/j.stem.2010.03.016; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Ardehali MB, 2011, EMBO J, V30, P2817, DOI 10.1038/emboj.2011.194; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Boettiger AN, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001136; Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dong D, 2011, NUCLEIC ACIDS RES, V39, P403, DOI 10.1093/nar/gkq844; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Field Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000216; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hansen AS, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.56; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hodl M, 2012, CURR BIOL, V22, P2253, DOI 10.1016/j.cub.2012.10.008; Ingham PW, 1998, INT J DEV BIOL, V42, P423; Jeong M, 2014, NAT GENET, V46, P17, DOI 10.1038/ng.2836; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuo AJ, 2012, NATURE, V484, P115, DOI 10.1038/nature10956; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Lujan E, 2012, P NATL ACAD SCI USA, V109, P2527, DOI 10.1073/pnas.1121003109; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Nehar S, 2009, FEBS LETT, V583, P3247, DOI 10.1016/j.febslet.2009.09.018; Ninkovic J, 2013, CELL STEM CELL, V13, P403, DOI 10.1016/j.stem.2013.07.002; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Perez-Lluch S, 2011, NUCLEIC ACIDS RES, V39, P4628, DOI 10.1093/nar/gkq1322; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Sakurai Y, 2010, DEV BIOL, V347, P392, DOI 10.1016/j.ydbio.2010.08.028; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schmitz SU, 2011, EMBO J, V30, P4586, DOI 10.1038/emboj.2011.383; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Wang YZ, 2011, STEM CELLS, V29, P907, DOI 10.1002/stem.644; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; Webb AE, 2013, CELL REP, V4, P477, DOI 10.1016/j.celrep.2013.06.035; Weinberger L, 2012, MOL CELL, V47, P193, DOI 10.1016/j.molcel.2012.05.008; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	62	280	283	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					673	688		10.1016/j.cell.2014.06.027	http://dx.doi.org/10.1016/j.cell.2014.06.027			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083876	Green Accepted, Bronze			2022-12-28	WOS:000340944300018
J	McHeyzer-Williams, MG				McHeyzer-Williams, Michael G.			B Cell Liaison Confounds HIV-1 Evolution	CELL			English	Editorial Material							ANTIBODIES	B cells expressing potent and broadly neutralizing antibodies to HIV-1 have been found in many infected individuals, suggesting that adaptive immunity has the capacity to defeat viral escape. Gao et al. uncover an intermediate stage in this process when viral escape from one "helper'' B cell lineage selects variants that drive a separate B cell lineage toward broad neutralization.	Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	McHeyzer-Williams, MG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu						Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052	9	0	0	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					475	476		10.1016/j.cell.2014.07.018	http://dx.doi.org/10.1016/j.cell.2014.07.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083862	Bronze			2022-12-28	WOS:000340944300001
J	Forbes, HJ; Bhaskaran, K; Thomas, SL; Smeeth, L; Clayton, T; Langan, SM				Forbes, Harriet J.; Bhaskaran, Krishnan; Thomas, Sara L.; Smeeth, Liam; Clayton, Tim; Langan, Sinead M.			Quantification of risk factors for herpes zoster: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTHERPETIC NEURALGIA; RHEUMATOID-ARTHRITIS; IMMUNE DYSFUNCTION; LONG-TERM; VACCINE; VIRUS; EPIDEMIOLOGY; INFECTION; DISEASES; ASTHMA	Objectives To quantify the effects of possible risk factors for herpes zoster at different ages. Design Case-control study. Setting UK Clinical Practice Research Datalink primary care data. Participants 144 959 adults diagnosed with zoster between 2000 and 2011; 549 336 age, sex, and practice matched controls. Main outcome measures Conditional logistic regression was used to generate adjusted odds ratios to estimate the strength of association of each potential risk factor with zoster and assess effect modification by age. Results The median age of the cases and controls was 62 years. Factors associated with increased risk of zoster included rheumatoid arthritis (3111 (2.1%) v 8029 (1.5%); adjusted odds ratio 1.46, 99% confidence interval 1.38 to 1.55), inflammatory bowel disease (1851 (1.3%) v 5118 (0.9%); 1.36, 1.26 to 1.46), chronic obstructive pulmonary disease (6815 (4.7%) v 20 201 (3.7%); 1.32, 1.27 to 1.37), asthma (10 243 (7.1%) v 31 865 (5.8%); 1.21, 1.17 to 1.25), chronic kidney disease (8724 (6.0%) v 29 437 (5.4%); 1.14, 1.09 to 1.18), and depression (6830 (4.7%) v 22 052 (4.0%); 1.15, 1.10 to 1.20). Type 1, but not type 2, diabetes showed some association with zoster (adjusted odds ratio 1.27, 1.07 to 1.50). The relative effects of many assessed risk factors were larger in younger patients. Patients with severely immunosuppressive conditions were at greatest risk of zoster-for example, patients with lymphoma (adjusted odds ratio 3.90, 3.21 to 4.74) and myeloma (2.16, 1.84 to 2.53), who are not eligible for zoster vaccination. Conclusions A range of conditions were associated with increased risk of zoster. In general, the increased risk was proportionally greater in younger age groups. Current vaccines are contraindicated in people at the greatest risk of zoster, highlighting the need for alternative risk reduction strategies in these groups.	[Forbes, Harriet J.; Bhaskaran, Krishnan; Thomas, Sara L.; Smeeth, Liam; Clayton, Tim; Langan, Sinead M.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Forbes, HJ (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.	harriet.forbes@lshtm.ac.uk	Smeeth, Liam/X-5862-2018	Smeeth, Liam/0000-0002-9168-6022; Forbes, Harriet/0000-0001-6888-2212; Bhaskaran, Krishnan/0000-0001-5364-8757; Langan, Sinead/0000-0002-7022-7441; Clayton, Tim/0000-0002-1266-3288	National Institute for Health Research (NIHR) [NIHR/CS/010/014]; NIHR [PDF-2011-04-007, CDF-2010-03-32]; Wellcome Trust; Medical Research Council [MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [CDF-2010-03-32, NIHR/CS/010/014, PDF-2011-04-007, NF-SI-0510-10090] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research supported by a National Institute for Health Research (NIHR) clinician scientist fellowship (to SML; grant number NIHR/CS/010/014). KB is supported by an NIHR postdoctoral fellowship (PDF-2011-04-007). LS is supported by a Wellcome Trust senior research fellowship in clinical science. SLT is supported by an NIHR career development fellowship (CDF-2010-03-32). All authors carried out this research independently of the funding bodies. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the UK Department of Health.	[Anonymous], 2004, INVESTING GEN PRACTI; [Anonymous], 2011, READ COD; Arana A, 2011, EPIDEMIOLOGY, V22, P876, DOI [10.1097/EDE.0b013e31823198fc, 10.1097/EDE.0b013e3182093a0f]; Blank LJ, 2012, JAIDS-J ACQ IMM DEF, V61, P203, DOI 10.1097/QAI.0b013e318266cd3c; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Campbell J, 2013, PHARMACOEPIDEM DR S, V22, P280; Centers for Disease Control and Prevention, 2008, PREV HERP ZOST REC A; Choo PW, 1997, ARCH INTERN MED, V157, P1217, DOI 10.1001/archinte.157.11.1217; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; CUPPS TR, 1982, IMMUNOL REV, V65, P133, DOI 10.1111/j.1600-065X.1982.tb00431.x; Drolet M, 2010, J PAIN, V11, P1211, DOI 10.1016/j.jpain.2010.02.020; DWORKIN RH, 1992, J ABNORM PSYCHOL, V101, P200, DOI 10.1037/0021-843X.101.1.200; Ernst P, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-59; Gauthier A, 2009, EPIDEMIOL INFECT, V137, P38, DOI 10.1017/S0950268808000678; Gebo KA, 2005, JAIDS-J ACQ IMM DEF, V40, P169, DOI 10.1097/01.qai.0000178408.62675.b0; Geerlings SE, 1999, FEMS IMMUNOL MED MIC, V26, P259, DOI 10.1111/j.1574-695X.1999.tb01397.x; Gnann JW, 2002, NEW ENGL J MED, V347, P340, DOI 10.1056/NEJMcp1302674; Hauser AB, 2008, PERITON DIALYSIS INT, V28, pS183; Heymann AD, 2008, INFECTION, V36, P226, DOI 10.1007/s15010-007-6347-x; Hope-Simpson R E, 1975, J R Coll Gen Pract, V25, P571; HOPESIMPSON RE, 1965, P ROY SOC MED, V58, P9, DOI 10.1177/003591576505800106; Irwin M, 1998, J INFECT DIS, V178, pS104, DOI 10.1086/514272; Irwin MR, 2013, CLIN INFECT DIS, V56, P1085, DOI 10.1093/cid/cis1208; Jih JS, 2009, ACTA DERM-VENEREOL, V89, P612, DOI 10.2340/00015555-0729; Joesoef RM, 2012, MAYO CLIN PROC, V87, P961, DOI 10.1016/j.mayocp.2012.05.021; Kanbayashi Y, 2012, CLIN J PAIN, V28, P712, DOI 10.1097/AJP.0b013e318243ee01; Katz J, 2005, J PAIN, V6, P782, DOI 10.1016/j.jpain.2005.07.006; Kim BS, 2013, J PEDIATR-US, V163, P816, DOI 10.1016/j.jpeds.2013.03.010; Kuo CC, 2012, AM J KIDNEY DIS, V59, P428, DOI 10.1053/j.ajkd.2011.10.049; KUSNECOV AW, 1994, INT ARCH ALLERGY IMM, V105, P107, DOI 10.1159/000236812; Langan SM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001420; Lasserre A, 2012, J CLIN VIROL, V55, P153, DOI 10.1016/j.jcv.2012.06.020; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Long MD, 2013, ALIMENT PHARM THER, V37, P420, DOI 10.1111/apt.12182; Lua PJ, 2009, VACCINE, V27, P882, DOI 10.1016/j.vaccine.2008.11.077; Morgan D, 2001, AIDS, V15, P223, DOI 10.1097/00002030-200101260-00012; NAGASAWA K, 1990, ANN RHEUM DIS, V49, P630, DOI 10.1136/ard.49.8.630; Oldroyd J, 2005, POSTGRAD MED J, V81, P486, DOI 10.1136/pgmj.2004.029124; Opstelten W, 2002, FAM PRACT, V19, P471, DOI 10.1093/fampra/19.5.471; Opstelten W, 2007, ANN FAM MED, V5, P305, DOI 10.1370/afm.707; Oxman MN, 2005, NEW ENGL J MED, V352, P2271, DOI 10.1056/NEJMoa051016; PEARCE N, 1993, INT J EPIDEMIOL, V22, P1189, DOI 10.1093/ije/22.6.1189; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Rubben A, 1997, BRIT J DERMATOL, V137, P259, DOI 10.1046/j.1365-2133.1997.18161913.x; Smitten AL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1431, DOI 10.1002/art.23112; Takabatake N, 2005, RESP MED, V99, P485, DOI 10.1016/j.rmed.2004.09.013; Thomas SL, 2004, LANCET INFECT DIS, V4, P26, DOI 10.1016/S1473-3099(03)00857-0; Tyring SK, 2007, VACCINE, V25, P1877, DOI 10.1016/j.vaccine.2006.10.027; van Hoek AJ, 2009, VACCINE, V27, P1454, DOI 10.1016/j.vaccine.2008.12.024; Veetil BMA, 2013, ARTHRIT CARE RES, V65, P854, DOI 10.1002/acr.21928; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wu MY, 2012, AM J KIDNEY DIS, V60, P548, DOI 10.1053/j.ajkd.2012.03.018; Yang IA, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002991.pub3; Yang YW, 2011, J EUR ACAD DERMATOL, V25, P447, DOI 10.1111/j.1468-3083.2010.03811.x; Yang YW, 2011, CAN MED ASSOC J, V183, pE275, DOI 10.1503/cmaj.101137	55	134	139	3	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2014	348								g2911	10.1136/bmj.g2911	http://dx.doi.org/10.1136/bmj.g2911			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5CN	25134101	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000336146200003
J	Wright, KE; Hjerrild, KA; Bartlett, J; Douglas, AD; Jin, J; Brown, RE; Illingworth, JJ; Ashfield, R; Clemmensen, SB; de Jongh, WA; Draper, SJ; Higgins, MK				Wright, Katherine E.; Hjerrild, Kathryn A.; Bartlett, Jonathan; Douglas, Alexander D.; Jin, Jing; Brown, Rebecca E.; Illingworth, Joseph J.; Ashfield, Rebecca; Clemmensen, Stine B.; de Jongh, Willem A.; Draper, Simon J.; Higgins, Matthew K.			Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; SIZE-DISTRIBUTION ANALYSIS; PLASMODIUM-FALCIPARUM; PFRH5 POLYMORPHISMS; HOMOLOG; ULTRACENTRIFUGATION; CONSTRAINTS; PREDICTION; RECEPTOR; SYSTEM	Invasion of host erythrocytes is essential to the life cycle of Plasmodium parasites and development of the pathology of malaria. The stages of erythrocyte invasion, including initial contact, apical reorientation, junction formation, and active invagination, are directed by coordinated release of specialized apical organelles and their parasite protein contents'. Among these proteins, and central to invasion by all species, are two parasite protein families, the reticulocyte-binding protein homologue (RH) and erythrocyte-binding like proteins, which mediate host-parasite interactions(2). RH5 from Plasmodium falciparum (PfRH5) is the only member of either family demonstrated to be necessary for erythrocyte invasion in all tested strains, through its interaction with the erythrocyte surface protein basigin (also known as CD 147 and EMMPRIN)(3,4). Antibodies targeting PfRH5 or basigin efficiently block parasite invasion in vitro(4-9), making PfRH5 an excellent vaccine candidate. Here we present crystal structures of PfRH5 in complex with basigin and two distinct inhibitory antibodies. PfRH5 adopts a novel fold in which two three-helical bundles come together in a kite-like architecture, presenting binding sites for basigin and inhibitory antibodies at one tip. This provides the first structural insight into erythrocyte binding by the Plasmodium RH protein family and identifies novel inhibitory epitopes to guide design of a new generation of vaccines against the blood-stage parasite.	[Wright, Katherine E.; Bartlett, Jonathan; Higgins, Matthew K.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Hjerrild, Kathryn A.; Douglas, Alexander D.; Jin, Jing; Brown, Rebecca E.; Illingworth, Joseph J.; Ashfield, Rebecca; Draper, Simon J.] Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England; [Clemmensen, Stine B.; de Jongh, Willem A.] ExpreS2 Biotechnol, DK-2970 Horsholm, Denmark	University of Oxford; University of Oxford; Jenner Institute	Higgins, MK (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	simon.draper@ndm.ox.ac.uk; matthew.higgins@bioch.ox.ac.uk	Douglas, Alexander/E-7040-2012; Draper, Simon J/F-1758-2011; Bartlett, Jonathan D/AAF-8293-2020	Douglas, Alexander/0000-0002-5410-7562; Draper, Simon J/0000-0002-9415-1357; Bartlett, Jonathan D/0000-0001-9133-1953; Higgins, Matthew/0000-0002-2870-1955; Wright, Katherine/0000-0003-3968-5468	UK Medical Research Council (MRC) [G1000527]; European Vaccine Initiative(EVI)(InnoMalVac); UK MRC [MR/K025554/1]; European Community [242095 EVIMalaR]; Wellcome Trust [089455/2/09/z]; Medical Research Council [G1000527, MR/K025554/1] Funding Source: researchfish; MRC [MR/K025554/1, G1000527] Funding Source: UKRI	UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Vaccine Initiative(EVI)(InnoMalVac); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	M.K.H. is a Wellcome Trust Investigator (101020/Z/13/Z). K.E.W. is funded by a Wellcome Trust PhD studentship. S.J.D. holds a UK Medical Research Council (MRC) Career Development Fellowship (G1000527), and is a Jenner Investigator and Lister Institute Research Prize Fellow. The project was also funded by the European Vaccine Initiative(EVI)(InnoMalVac); the UK MRC(MR/K025554/1); the European Community's Seventh Framework Programme (FP7/2007-2013, grant agreement number 242095 EVIMalaR); and a Wellcome Trust Training Fellowship (089455/2/09/z to ADD). We thank J. Furze and D. Alanine; D. Staunton and E. Lowe; A. Round (ESRF); and R. Flaig and J. Brandao-Neto (Diamond Light Source).	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Baum J, 2009, INT J PARASITOL, V39, P371, DOI 10.1016/j.ijpara.2008.10.006; Birmanns S, 2011, J STRUCT BIOL, V173, P428, DOI 10.1016/j.jsb.2010.11.002; Bricogne G., 2011, BUSTER VERSION 2 10; Bustamante LY, 2013, VACCINE, V31, P373, DOI 10.1016/j.vaccine.2012.10.106; Chen L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002199; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Crosnier C, 2011, NATURE, V480, P534, DOI 10.1038/nature10606; Douglas AD, 2014, J IMMUNOL, V192, P245, DOI 10.4049/jimmunol.1302045; Douglas AD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1615; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guinier A., 1955, SMALL ANGLE SCATTERI; Hayton K, 2008, CELL HOST MICROBE, V4, P40, DOI 10.1016/j.chom.2008.06.001; Hayton K, 2013, MOL BIOCHEM PARASIT, V187, P103, DOI 10.1016/j.molbiopara.2012.12.005; Higgins MK, 2014, PROTEIN SCI, V23, P354, DOI 10.1002/pro.2428; Hirose S, 2007, BIOINFORMATICS, V23, P2046, DOI 10.1093/bioinformatics/btm302; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miura K, 2009, CLIN VACCINE IMMUNOL, V16, P963, DOI 10.1128/CVI.00042-09; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Porod G., 1982, GEN THEORY SMALL ANG; Reddy KS, 2014, INFECT IMMUN, V82, P152, DOI 10.1128/IAI.00970-13; Rodriguez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003300; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tham WH, 2012, TRENDS PARASITOL, V28, P23, DOI 10.1016/j.pt.2011.10.002; Tham WH, 2010, P NATL ACAD SCI USA, V107, P17327, DOI 10.1073/pnas.1008151107; Tran TM, 2014, J INFECT DIS, V209, P789, DOI 10.1093/infdis/jit553; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wanaguru M, 2013, P NATL ACAD SCI USA, V110, P20735, DOI 10.1073/pnas.1320771110; Williams AR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002991; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	47	129	134	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2014	515	7527					427	+		10.1038/nature13715	http://dx.doi.org/10.1038/nature13715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU7HE	25132548	Green Accepted			2022-12-28	WOS:000345770600049
J	Fonseca-Pereira, D; Arroz-Madeira, S; Rodrigues-Campos, M; Barbosa, IAM; Domingues, RG; Bento, T; Almeida, ARM; Ribeiro, H; Potocnik, AJ; Enomoto, H; Veiga-Fernandes, H				Fonseca-Pereira, Diogo; Arroz-Madeira, Silvia; Rodrigues-Campos, mariana; Barbosa, Ines A. M.; Domingues, Rita G.; Bento, Teresa; Almeida, Afonso R. M.; Ribeiro, Helder; Potocnik, Alexandre J.; Enomoto, Hideki; Veiga-Fernandes, Henrique			The neurotrophic factor receptor RET drives haematopoietic stem cell survival and function	NATURE			English	Article							NERVOUS-SYSTEM; MICE LACKING; FETAL; EXPRESSION; MIGRATION; COMPONENT; KIDNEY; DEATH	Haematopoiesis is a developmental cascade that generates all blood cell lineages in health and disease. This process relies on quiescent haematopoietic stem cells capable of differentiating, self renewing and expanding upon physiological demand(1,2). However, the mechanisms that regulate haematopoietic stem cell homeostasis and function remain largely unknown. Here we show that the neurotrophic factor receptor RET (rearranged during transfection) drives haematopoietic stem cell survival, expansion and function. We find that haematopoietic stem cells express RET and that its neurotrophic factor partners are produced in the haematopoietic stem cell environment. Ablation of Ret leads to impaired survival and reduced numbers of haematopoietic stem cells with normal differentiation potential, but loss of cell-autonomous stress response and reconstitution potential. Strikingly, RET signals provide haematopoietic stem cells with critical Bcl2 and Bcl2l1 surviving cues, downstream of p38 mitogen-activated protein (MAP) kinase and cyclic-AMP-response element binding protein (CREB) activation. Accordingly, enforced expression of RET downstream targets, Bcl2 or Bcl2l1, is sufficient to restore the activity of Ret null progenitors in vivo. Activation of RET results in improved haematopoietic stem cell survival, expansion and in vivo transplantation efficiency. Remarkably, human cord-blood progenitor expansion and transplantation is also improved by neurotrophic factors, opening the way for exploration of RET agonists in human haematopoietic stem cell transplantation. Ourwork shows that neurotrophic factors are novel components of the haematopoietic stem cell microenvironment, revealing that	[Fonseca-Pereira, Diogo; Arroz-Madeira, Silvia; Rodrigues-Campos, mariana; Barbosa, Ines A. M.; Domingues, Rita G.; Bento, Teresa; Almeida, Afonso R. M.; Ribeiro, Helder; Veiga-Fernandes, Henrique] Fac Med Lisbon, Inst Mol Med, P-1649028 Lisbon, Portugal; [Potocnik, Alexandre J.] MRC Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England; [Potocnik, Alexandre J.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3JT, Midlothian, Scotland; [Enomoto, Hideki] RIKEN Ctr Dev Biol, Lab Neuronal Differentiat & Regenerat, Kobe, Hyogo 6500047, Japan; [Enomoto, Hideki] Kobe Univ, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Universidade de Lisboa; MRC National Institute for Medical Research; University of Edinburgh; RIKEN; Kobe University	Veiga-Fernandes, H (corresponding author), Fac Med Lisbon, Inst Mol Med, Ave Prof Egas Moniz,Edif Egas Moniz, P-1649028 Lisbon, Portugal.	jhfernandes@medicina.ulisboa.pt	da Fonseca Pereira, Diogo/O-9894-2019; Fonseca-Pereira, Diogo/U-1275-2018	Fonseca-Pereira, Diogo/0000-0002-7400-9804; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Rodrigues-Campos, Mariana/0000-0002-6116-5613; Ribeiro, Helder/0000-0002-7090-9274; Barbosa, Ines/0000-0001-8977-0930; Potocnik, Alexandre/0000-0002-4730-8593; Almeida, Afonso/0000-0002-4292-8558	Fundacao para a Ciencia e Tecnologia, Portugal; Fundacao para a Ciencia e Tecnologia, Portugal [PTDC/SAU-MII/104931/2008]; European Molecular Biology Organisation [1648]; European Research Council [207057]; National Blood Foundation, USA; Medical Research Council [MC_U117565359] Funding Source: researchfish; MRC [MC_U117565359] Funding Source: UKRI	Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); European Molecular Biology Organisation; European Research Council(European Research Council (ERC)European Commission); National Blood Foundation, USA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank I. Monteiro Grillo and the radiotherapy service at Hospital de Santa Maria; H. Ferreira and the service of obstetrics, gynaecology and reproductive medicine at the Hospital of Santa Maria; the Instituto de Medicina Molecular animal facility, flow cytometry unit, bioimaging unit and histology unit for technical assistance. We also thank all members of H.V.-F. laboratory for discussion. D. F.-P., S. A.-M., R. G. D. and A. R. M. A. were supported by scholarships from Fundacao para a Ciencia e Tecnologia, Portugal. H.V.-F. was supported by Fundacao para a Ciencia e Tecnologia (PTDC/SAU-MII/104931/2008), Portugal, the European Molecular Biology Organisation (Project 1648), European Research Council (Project 207057) and National Blood Foundation, USA.	Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lucas D, 2013, NAT MED, V19, P695, DOI 10.1038/nm.3155; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Almeida ARM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052949; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Nishino J, 1999, NEURON, V23, P725, DOI 10.1016/S0896-6273(01)80031-3; Patel A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002734; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Perianayagam MC, 2006, EUR J CLIN INVEST, V36, P353, DOI 10.1111/j.1365-2362.2006.01637.x; Rossi J, 1999, NEURON, V22, P243, DOI 10.1016/S0896-6273(00)81086-7; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shukla A, 2009, AM J PATHOL, V175, P2197, DOI 10.2353/ajpath.2009.090400; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Uesaka T, 2010, J NEUROSCI, V30, P5211, DOI 10.1523/JNEUROSCI.6244-09.2010; van de Pavert SA, 2014, NATURE, V508, P123, DOI 10.1038/nature13158; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Winkler IG, 2010, BLOOD, V116, P375, DOI 10.1182/blood-2009-07-233437; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053	34	71	73	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					98	+		10.1038/nature13498	http://dx.doi.org/10.1038/nature13498			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25079320				2022-12-28	WOS:000342420800043
J	Sederer, LI; Sharfstein, SS				Sederer, Lloyd I.; Sharfstein, Steven S.			Fixing the Troubled Mental Health System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Sederer, Lloyd I.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Sederer, Lloyd I.] New York State Off Mental Hlth, Albany, NY USA; [Sharfstein, Steven S.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Sharfstein, Steven S.] Sheppard Pratt Hlth Syst, Baltimore, MD 21204 USA	Columbia University; University System of Maryland; University of Maryland Baltimore	Sharfstein, SS (corresponding author), Sheppard Pratt Hlth Syst, 6501 N Charles St, Baltimore, MD 21204 USA.	ssharfstein@sheppardpratt.org						American Foundation for Suicide Prevention, FACTS AND FIGURES; Baird M, 2014, ANN FAM MED, V12, P183, DOI 10.1370/afm.1634; Deegan PE, 2006, PSYCHIAT SERV, V57, P1636, DOI 10.1176/appi.ps.57.11.1636; Lewin Group; Missouri Department of Social Services, 2009, MISSOURI HEALTHNET M; Melek S. P., 2012, MILLIMAN RESEARCH RE; Sederer LI, 2013, WALL STREET JOURNAL; Sederer LI, 2014, JAMA PSYCHIAT, V71, P485, DOI 10.1001/jamapsychiatry.2014.26	7	10	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2014	312	12					1195	1196		10.1001/jama.2014.10369	http://dx.doi.org/10.1001/jama.2014.10369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP3QA	25122559				2022-12-28	WOS:000341990600014
J	Sidibe, M; Dybul, M; Birx, D				Sidibe, Michel; Dybul, Mark; Birx, Deborah			MDG 6 and beyond: from halting and reversing AIDS to ending the epidemic	LANCET			English	Editorial Material							METAANALYSIS; HIV; SEX		[Sidibe, Michel] UNAIDS, CH-1211 Geneva 27, Switzerland; [Dybul, Mark] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Birx, Deborah] US Dept State, Off US Global AIDS Coordinator, Washington, DC 20520 USA	UNAIDS	Sidibe, M (corresponding author), UNAIDS, CH-1211 Geneva 27, Switzerland.	sidibem@unaids.org						Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Mathers BM, 2013, B WORLD HEALTH ORGAN, V91, P102, DOI 10.2471/BLT.12.108282; Murray CJL, 2013, LANCET, V382, P9, DOI 10.1016/S0140-6736(13)60225-1; UNAIDS, 2014, GAP REP 2014	5	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2014	384	9947					935	936		10.1016/S0140-6736(14)61222-8	http://dx.doi.org/10.1016/S0140-6736(14)61222-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO9ML	25073423				2022-12-28	WOS:000341679700006
J	Dannappel, M; Vlantis, K; Kumari, S; Polykratis, A; Kim, C; Wachsmuth, L; Eftychi, C; Lin, J; Corona, T; Hermance, N; Zelic, M; Kirsch, P; Basic, M; Bleich, A; Kelliher, M; Pasparakis, M				Dannappel, Marius; Vlantis, Katerina; Kumari, Snehlata; Polykratis, Apostolos; Kim, Chun; Wachsmuth, Laurens; Eftychi, Christina; Lin, Juan; Corona, Teresa; Hermance, Nicole; Zelic, Matija; Kirsch, Petra; Basic, Marijana; Bleich, Andre; Kelliher, Michelle; Pasparakis, Manolis			RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis	NATURE			English	Article							NECROSIS-FACTOR RECEPTOR; KAPPA-B ACTIVATION; IN-VIVO; CELL; MICE; KINASE; DELETION; KERATINOCYTES; INFLAMMATION; DEFICIENT	Necroptosis has emerged as an important pathway of programmed cell death in embryonic development, tissue homeostasis, immunity and inflammation(1-8). RIPK1 is implicated in inflammatory and cell death signalling(9-13) and its kinase activity is believed to drive RIPK3-mediated necroptosis(14,15). Here we show that kinase-independent scaffolding RIPK1 functions regulate homeostasis and prevent inflammation in barrier tissues by inhibiting epithelial cell apoptosis and necroptosis. Intestinal epithelial cell (IEC)-specific RIPK1 knockout caused IEC apoptosis, villus atrophy, loss of goblet and Paneth cells and premature death in mice. This pathology developed independently of the microbiota and of MyD88 signalling but was partly rescued by TNFR1 (also known as TNFRSF1A) deficiency. Epithelial FADD ablation inhibited IEC apoptosis and prevented the premature death of mice with IEC-specific RIPK1 knockout. However, mice lacking both RIPK1 and FADD in IECs displayed RIPK3-dependent IEC necroptosis, Paneth cell loss and focal erosive inflammatory lesions in the colon. Moreover, a RIPK1 kinase inactive knock-in delayed but did not prevent inflammation caused by FADD deficiency in IECs or keratinocytes, showing that RIPK3-dependent necroptosis of FADD-deficient epithelial cells only partly requires RIPK1 kinase activity. Epidermis-specific RIPK1 knockout triggered keratinocyte apoptosis and necroptosis and caused severe skin inflammation that was prevented by RIPK3 but not FADD deficiency. These findings revealed that RIPK1 inhibits RIPK3-mediated necroptosis in keratinocytes in vivo and identified necroptosis as a more potent trigger of inflammation compared with apoptosis. Therefore, RIPK1 is a master regulator of epithelial cell survival, homeostasis and inflammation in the intestine and the skin.	[Dannappel, Marius; Vlantis, Katerina; Kumari, Snehlata; Polykratis, Apostolos; Kim, Chun; Wachsmuth, Laurens; Eftychi, Christina; Lin, Juan; Corona, Teresa; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50931 Cologne, Germany; [Dannappel, Marius; Vlantis, Katerina; Kumari, Snehlata; Polykratis, Apostolos; Kim, Chun; Wachsmuth, Laurens; Eftychi, Christina; Lin, Juan; Corona, Teresa; Pasparakis, Manolis] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Hermance, Nicole; Zelic, Matija; Kelliher, Michelle] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Kirsch, Petra] Univ Ulm, Tierforschungszentrum, D-89081 Ulm, Germany; [Basic, Marijana; Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, D-30625 Hannover, Germany	University of Cologne; University of Cologne; University of Massachusetts System; University of Massachusetts Worcester; Ulm University; Hannover Medical School	Pasparakis, M (corresponding author), Univ Cologne, Ctr Mol Med CMMC, Inst Genet, D-50931 Cologne, Germany.	pasparakis@uni-koeln.de	Kumari, Snehlata/ABA-5739-2020; Corona, Teresa/AAU-8333-2021; Eftychi, Christina/AAB-1135-2020; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017	Kumari, Snehlata/0000-0002-4971-3162; Corona, Teresa/0000-0002-9324-229X; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Polykratis, Apostolos/0000-0001-6720-3302; Wachsmuth, Laurens/0000-0003-1701-9384; Kim, Chun/0000-0001-9497-708X	European Research Council [2012-ADG_20120314]; German Research Council (DFG) [SFB670, SFB829, SPP1656]; European Commission [223404, 223151]; Deutsche Krebshilfe; Else Kroner-Fresenius-Stiftung; Helmholtz Alliance (PCCC); National Institute of Allergy and Infectious Diseases division of the National Institutes of Health [RO1AI075118]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI095213, R01AI075118] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); German Research Council (DFG)(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Deutsche Krebshilfe(Deutsche Krebshilfe); Else Kroner-Fresenius-Stiftung; Helmholtz Alliance (PCCC); National Institute of Allergy and Infectious Diseases division of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to V. Dixit for Ripk3<SUP>-/-</SUP>, D. Gumucio for Villin-Cre and S. Robine for Villin-CreER<SUP>T2</SUP> mice. We thank C. Uthoff-Hachenberg, J. Buchholz, E. Mahlberg, B. Kuhnel, B. Hulser, P. Jankowski, S. Assenmacher and P. Scholl for technical assistance. M. P. acknowledges funding from the European Research Council (2012-ADG_20120314), the German Research Council (DFG; SFB670, SFB829, SPP1656), the European Commission (grants 223404 (Masterswitch) and 223151 (InflaCare)), the Deutsche Krebshilfe, the Else Kroner-Fresenius-Stiftung and the Helmholtz Alliance (PCCC). Research reported in this publication was also supported by the National Institute of Allergy and Infectious Diseases division of the National Institutes of Health under award RO1AI075118 to M.K.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Gentle IE, 2011, J BIOL CHEM, V286, P13282, DOI 10.1074/jbc.M110.216226; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Kim JY, 2011, J CELL SCI, V124, P647, DOI 10.1242/jcs.075770; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kumari S, 2013, IMMUNITY, V39, P899, DOI 10.1016/j.immuni.2013.10.009; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mc Guire C, 2010, J IMMUNOL, V185, P7646, DOI 10.4049/jimmunol.1000930; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Piao JH, 2011, J BIOL CHEM, V286, P17879, DOI 10.1074/jbc.M111.221853; Polykratis A, 2014, J IMMUNOL; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Snippert HJ, 2011, NAT PROTOC, V6, P1221, DOI 10.1038/nprot.2011.365; Steinbrecher KA, 2008, J IMMUNOL, V180, P2588, DOI 10.4049/jimmunol.180.4.2588; Tscharntke M, 2007, J CELL SCI, V120, P1480, DOI 10.1242/jcs.03426; Ukena SN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001308; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vlantis K, 2011, J CLIN INVEST, V121, P2781, DOI 10.1172/JCI45349; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	47	355	362	4	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					90	+		10.1038/nature13608	http://dx.doi.org/10.1038/nature13608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25132550	Green Accepted			2022-12-28	WOS:000341174800036
J	Jost, TS				Jost, Timothy Stoltzfus			Subsidies and the Survival of the ACA - Divided Decisions on Premium Tax Credits	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							Blumberg LJ, 2014, HALBIG V BURWELL POT	1	1	1	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 4	2014	371	10					890	891		10.1056/NEJMp1408958	http://dx.doi.org/10.1056/NEJMp1408958			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5NB	25075618				2022-12-28	WOS:000341390600005
J	Schuh, S; Freedman, S; Coates, A; Allen, U; Parkin, PC; Stephens, D; Ungar, W; DaSilva, Z; Willan, AR				Schuh, Suzanne; Freedman, Stephen; Coates, Allan; Allen, Upton; Parkin, Patricia C.; Stephens, Derek; Ungar, Wendy; DaSilva, Zelia; Willan, Andrew R.			Effect of Oximetry on Hospitalization in Bronchiolitis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LENGTH-OF-STAY; PULSE OXIMETRY; EMERGENCY-DEPARTMENT; MANAGEMENT; CHILDREN; INFANTS; OXYGEN; DEXAMETHASONE; EPINEPHRINE; DIAGNOSIS	IMPORTANCE Routine use of pulse oximetry has been associated with changes in bronchiolitis management and may have lowered the hospitalization threshold for patients with bronchiolitis. OBJECTIVE To examine if infants with bronchiolitis whose displayed oximetry measurements have been artificially elevated 3 percentage points above true values experience hospitalization rates at least 15% lower compared with infants with true values displayed. DESIGN, SETTING, AND PARTICIPANTS Randomized, double-blind, parallel-group trial conducted from 2008 to 2013 in a tertiary-care pediatric emergency department in Toronto, Ontario, Canada. Participants were 213 otherwise healthy infants aged 4 weeks to 12 months with mild to moderate bronchiolitis and true oxygen saturations of 88% or higher. INTERVENTIONS Pulse oximetry measurements with true saturation values displayed or with altered saturation values displayed that have been increased 3 percentage points above true values. MAIN OUTCOMES AND MEASURES The primary outcome was hospitalization within 72 hours, defined as inpatient admission within this interval or active hospital care for greater than 6 hours. Secondary outcomes included the use of supplemental oxygen in the emergency department, level of physician agreement with discharge from the emergency department, length of emergency department stay, and unscheduled visits for bronchiolitis within 72 hours. RESULTS Forty-four of 108 patients (41%) in the true oximetry group and 26 of 105 (25%) in the altered oximetry group were hospitalized within 72 hours (difference, 16% [95% Cl for the difference, 3.6% to 28.4%]; P = .005). Using the emergency department physician as a random effect, the primary treatment effect remained significant (adjusted odds ratio, 4.0 [95% CI, 1.6 to 10.5]; P = .009). None of the secondary outcomes were significantly different between the groups. There were 23 of 108 (21.3%) subsequent unscheduled medical visits for bronchiolitis in the true oximetry group and 15 of 105 (14.3%) in the altered oximetry group (difference, 7% [95% CI,-0.3% to 0.2%]; P = .18). CONCLUSIONS AND RELEVANCE Among infants presenting to an emergency department with mild to moderate bronchiolitis, those with an artificially elevated pulse oximetry reading were less likely to be hospitalized within 72 hours or to receive active hospital care for more than 6 hours than those with unaltered oximetry readings. This suggests that oxygen saturation should not be the only factor in the decision to admit, and its use may need to be reevaluated.	[Schuh, Suzanne; Allen, Upton; Parkin, Patricia C.; DaSilva, Zelia] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Schuh, Suzanne; Coates, Allan; Allen, Upton; Parkin, Patricia C.; Stephens, Derek; Ungar, Wendy; Willan, Andrew R.] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Freedman, Stephen] Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Alberta Childrens Hospital; University of Calgary	Schuh, S (corresponding author), Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	suzanne.schuh@sickkids.ca		Ungar, Wendy/0000-0002-0762-0101	Thrasher Research Fund; Physicians' Services Incorporated Foundation	Thrasher Research Fund; Physicians' Services Incorporated Foundation	This study was supported by the Thrasher Research Fund and the Physicians' Services Incorporated Foundation. Masimo provided the oximeters used in the study.	Barben J, 2008, THORAX, V63, P1103, DOI 10.1136/thx.2007.094706; Bass JL, 2004, PEDIATRICS, V114, P805, DOI 10.1542/peds.2004-0227; Bergman AB, 2004, ARCH PEDIAT ADOL MED, V158, P594, DOI 10.1001/archpedi.158.6.594; CORNELI HM, 2008, NEW ENGL J MED, V359, P1972; Corneli HM, 2007, NEW ENGL J MED, V357, P331, DOI 10.1056/NEJMoa071255; Corneli HM, 2012, PEDIATR EMERG CARE, V28, P99, DOI 10.1097/PEC.0b013e3182440b9b; Ehrenwerth J, 1993, ANESTHESIA EQUIPMENT; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Fouzas S, 2011, PEDIATRICS, V128, P740, DOI 10.1542/peds.2011-0271; Halstead S, 2012, PEDIATRICS, V129, pE605, DOI 10.1542/peds.2011-0889; Hunt CE, 1999, J PEDIATR-US, V135, P580, DOI 10.1016/S0022-3476(99)70056-9; Langley JM, 2003, J INFECT DIS, V188, P1764, DOI 10.1086/379740; Leader S, 2003, J PEDIATR-US, V143, pS127, DOI 10.1067/S0022-3476(03)00510-9; Lieberthal AS, 2006, PEDIATRICS, V118, P1774, DOI 10.1542/peds.2006-2223; LOWELL DI, 1987, PEDIATRICS, V79, P939; Mallory MD, 2003, PEDIATRICS, V111, DOI 10.1542/peds.111.1.e45; Mower WR, 1997, PEDIATRICS, V99, P681, DOI 10.1542/peds.99.5.681; MOWER WR, 1995, CHEST, V108, P1297, DOI 10.1378/chest.108.5.1297; Plint AC, 2004, ACAD EMERG MED, V11, P353, DOI 10.1197/j.aem.2003.12.003; Plint AC, 2009, NEW ENGL J MED, V360, P2079, DOI 10.1056/NEJMoa0900544; REBUCK AS, 1988, AM REV RESPIR DIS, V137, P962, DOI 10.1164/ajrccm/137.4.962; Schroeder AR, 2004, ARCH PEDIAT ADOL MED, V158, P527, DOI 10.1001/archpedi.158.6.527; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; SIGN, BRONCH CHILDR NAT CL; Smyth RL, 2006, LANCET, V368, P312, DOI 10.1016/S0140-6736(06)69077-6; VISWANATHAN M, 2003, EVID REP TECHNOL ASS, V69, P1; Zorc JJ, 2010, PEDIATRICS, V125, P342, DOI 10.1542/peds.2009-2092	27	65	66	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					712	718		10.1001/jama.2014.8637	http://dx.doi.org/10.1001/jama.2014.8637			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25138332	Bronze			2022-12-28	WOS:000340438700019
J	Vaishnava, P; Eagle, KA				Vaishnava, Prashant; Eagle, Kim A.			ACC/AHA, Adult Treatment Panel III, and ESC guidelines overestimated risk for CVD in older adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Vaishnava, Prashant; Eagle, Kim A.] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Vaishnava, P (corresponding author), Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA.							Montori VM, 2014, JAMA-J AM MED ASSOC, V311, P465, DOI 10.1001/jama.2014.110	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC13	10.7326/0003-4819-161-4-201408190-02013	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133380				2022-12-28	WOS:000342347300012
J	Arena, BJ				Arena, Blaise J.			Outside my comfort zone	SCIENCE			English	Editorial Material																			0	0	0	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					842	842		10.1126/science.345.6198.842	http://dx.doi.org/10.1126/science.345.6198.842			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AN4XM	25124444				2022-12-28	WOS:000340593100050
J	Rilling, JK; Young, LJ				Rilling, James K.; Young, Larry J.			The biology of mammalian parenting and its effect on offspring social development	SCIENCE			English	Review							VOLES MICROTUS-OCHROGASTER; OXYTOCIN RECEPTOR GENE; CEREBROSPINAL-FLUID; MATERNAL-CARE; HUMAN FATHERS; BEHAVIOR; BRAIN; AMYGDALA; SYSTEM; TESTOSTERONE	Parents know the transformative nature of having and caring for a child. Among many mammals, giving birth leads from an aversion to infant stimuli to irresistible attraction. Here, we review the biological mechanisms governing this shift in parental motivation in mammals. Estrogen and progesterone prepare the uterus for embryo implantation and placental development. Prolactin stimulates milk production, whereas oxytocin initiates labor and triggers milk ejection during nursing. These same molecules, interacting with dopamine, also activate specific neural pathways to motivate parents to nurture, bond with, and protect their offspring. Parenting in turn shapes the neural development of the infant social brain. Recent work suggests that many of the principles governing parental behavior and its effect on infant development are conserved from rodent to humans.	[Rilling, James K.; Young, Larry J.] Emory Univ, Yerkes Natl Primate Res Ctr, Dept Psychiat & Behav Sci, Silvio O Conte Ctr Oxytocin & Social Cognit,Ctr T, Atlanta, GA 30329 USA; [Rilling, James K.] Emory Univ, Dept Anthropol, Atlanta, GA 30329 USA	Emory University; Emory University	Young, LJ (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Dept Psychiat & Behav Sci, Silvio O Conte Ctr Oxytocin & Social Cognit,Ctr T, Atlanta, GA 30329 USA.	lyoun03@emory.edu	Young, Larry/HGE-5031-2022		Positive Neuroscience Award from the John Templeton Foundation; National Institute of Mental Health (NIMH) [R01MH096983]; NIMH [1P50MH100023]; NIH [OD P51OD11132]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH100023, R01MH096983] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	Positive Neuroscience Award from the John Templeton Foundation; National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge the support of a Positive Neuroscience Award from the John Templeton Foundation to J.K.R., National Institute of Mental Health (NIMH) R01MH096983 to L.J.Y., and NIMH 1P50MH100023 to J.K.R. and L.J.Y., as well as NIH OD P51OD11132 to the Yerkes National Primate Research Center during the writing of this manuscript.	Ahern TH, 2011, DEV PSYCHOBIOL, V53, P118, DOI 10.1002/dev.20498; Apter-Levi Y, 2014, BRAIN RES, V1580, P124, DOI 10.1016/j.brainres.2013.10.052; Apter-Levy Y, 2013, AM J PSYCHIAT, V170, P1161, DOI 10.1176/appi.ajp.2013.12121597; Barr RG, 2012, P NATL ACAD SCI USA, V109, P17294, DOI 10.1073/pnas.1121267109; Barrett CE, 2014, NEUROPHARMACOLOGY, V85, P357, DOI 10.1016/j.neuropharm.2014.05.041; Bosch OJ, 2012, HORM BEHAV, V61, P293, DOI 10.1016/j.yhbeh.2011.11.002; Bradley B, 2013, EUR J PSYCHOTRAUMATO, V4, DOI 10.3402/ejpt.v4i0.21659; Champagne FA, 2011, HORM BEHAV, V60, P4, DOI 10.1016/j.yhbeh.2011.02.016; Dulac C, 2014, SCIENCE, V345, P765, DOI 10.1126/science.1253291; Feldman R, 2007, J CHILD PSYCHOL PSYC, V48, P329, DOI 10.1111/j.1469-7610.2006.01701.x; Feldman R, 2012, HORM BEHAV, V61, P380, DOI 10.1016/j.yhbeh.2012.01.008; Fries ABW, 2005, P NATL ACAD SCI USA, V102, P17237, DOI 10.1073/pnas.0504767102; Gee DG, 2013, P NATL ACAD SCI USA, V110, P15638, DOI 10.1073/pnas.1307893110; Gettler LT, 2013, HORM BEHAV, V64, P755, DOI 10.1016/j.yhbeh.2013.08.019; Gleason ED, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0824; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; Hanson JL, 2013, CHILD DEV, V84, P1566, DOI 10.1111/cdev.12069; Kryski KR, 2014, PERS INDIV DIFFER, V64, P107, DOI 10.1016/j.paid.2014.02.028; Landi Nicole, 2011, Front Psychiatry, V2, P32, DOI 10.3389/fpsyt.2011.00032; Laurent HK, 2012, INFANT BEHAV DEV, V35, P761, DOI 10.1016/j.infbeh.2012.07.007; Laurent HK, 2012, SOC COGN AFFECT NEUR, V7, P125, DOI 10.1093/scan/nsq091; Mah BL, 2015, DEPRESS ANXIETY, V32, P76, DOI 10.1002/da.22245; Mascaro Jennifer S, 2014, Soc Cogn Affect Neurosci, V9, P1704, DOI 10.1093/scan/nst166; Mascaro JS, 2014, PSYCHONEUROENDOCRINO, V46, P153, DOI 10.1016/j.psyneuen.2014.04.014; Mascaro JS, 2013, P NATL ACAD SCI USA, V110, P15746, DOI 10.1073/pnas.1305579110; McQuaid RJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00128; Michalska Kalina J, 2014, Front Behav Neurosci, V8, P21, DOI 10.3389/fnbeh.2014.00021; Modi ME, 2014, PSYCHONEUROENDOCRINO, V45, P49, DOI 10.1016/j.psyneuen.2014.02.011; Neumann ID, 2013, PSYCHONEUROENDOCRINO, V38, P1985, DOI 10.1016/j.psyneuen.2013.03.003; Pena CJ, 2014, EUR J NEUROSCI, V39, P946, DOI 10.1111/ejn.12479; Riem MME, 2011, BIOL PSYCHIAT, V70, P291, DOI 10.1016/j.biopsych.2011.02.006; Riem MME, 2011, SOC COGN AFFECT NEUR, V6, P294, DOI 10.1093/scan/nsq035; Rilling JK, 2013, NEUROPSYCHOLOGIA, V51, P731, DOI 10.1016/j.neuropsychologia.2012.12.017; Ross HE, 2009, FRONT NEUROENDOCRIN, V30, P534, DOI 10.1016/j.yfrne.2009.05.004; Stolzenberg DS, 2011, NEUROSCI BIOBEHAV R, V35, P826, DOI 10.1016/j.neubiorev.2010.10.003; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; Striepens N, 2013, SCI REP-UK, V3, DOI 10.1038/srep03440; Tottenham N, 2012, DEVELOPMENTAL SCI, V15, P307, DOI 10.1111/j.1467-7687.2011.01128.x; WANG ZX, 1994, P NATL ACAD SCI USA, V91, P400, DOI 10.1073/pnas.91.1.400; Weisman O, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0828; Weisman O, 2014, PROG NEURO-PSYCHOPH, V49, P47, DOI 10.1016/j.pnpbp.2013.11.006; Weisman O, 2012, BIOL PSYCHIAT, V72, P982, DOI 10.1016/j.biopsych.2012.06.011; Yu P, 2013, PSYCHONEUROENDOCRINO, V38, P3128, DOI 10.1016/j.psyneuen.2013.09.012; Ziegler TE, 2009, HORM BEHAV, V56, P436, DOI 10.1016/j.yhbeh.2009.07.012	44	306	309	8	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					771	776		10.1126/science.1252723	http://dx.doi.org/10.1126/science.1252723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124431	Green Accepted			2022-12-28	WOS:000340593100035
J	van Zanten, ARH; Sztark, F; Kaisers, UX; Zielmann, S; Felbinger, TW; Sablotzki, AR; DeWaele, JJ; Timsit, JF; Honing, MLH; Keh, D; Vincent, JL; Zazzo, JF; Fijn, HBM; Petit, L; Preiser, JC; van Horssen, PJ; Hofman, Z				van Zanten, Arthur R. H.; Sztark, Franois; Kaisers, Udo X.; Zielmann, Siegfried; Felbinger, Thomas W.; Sablotzki, Armin R.; DeWaele, Jan J.; Timsit, Jean-Francis; Honing, Marina L. H.; Keh, Didier; Vincent, Jean-Louis; Zazzo, Jean-Fabien; Fijn, Harvey B. M.; Petit, Laurent; Preiser, Jean-Charles; van Horssen, Peter J.; Hofman, Zandrie			High-Protein Enteral Nutrition Enriched With Immune-Modulating Nutrients vs Standard High-Protein Enteral Nutrition and Nosocomial Infections in the ICU A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY-ILL PATIENTS; GAMMA-LINOLENIC ACID; PARENTERAL GLUTAMINE SUPPLEMENTATION; INTENSIVE-CARE PATIENTS; ACUTE LUNG INJURY; EICOSAPENTAENOIC ACID; VENTILATED PATIENTS; IMMUNONUTRITION; ANTIOXIDANTS; PATIENT	IMPORTANCE Enteral administration of immune-modulating nutrients (eg, glutamine, omega-3 fatty acids, selenium, and antioxidants) has been suggested to reduce infections and improve recovery from critical illness. However, controversy exists on the use of immune-modulating enteral nutrition, reflected by lack of consensus in guidelines. OBJECTIVE To determine whether high-protein enteral nutrition enriched with immune-modulating nutrients (IMHP) reduces the incidence of infections compared with standard high-protein enteral nutrition (HP) in mechanically ventilated critically ill patients. DESIGN, SETTING, AND PARTICIPANTS The MetaPlus study, a randomized, double-blind, multicenter trial, was conducted from February 2010 through April 2012 including a 6-month follow-up period in 14 intensive care units (ICUs) in the Netherlands, Germany, France, and Belgium. A total of 301 adult patients who were expected to be ventilated for more than 72 hours and to require enteral nutrition for more than 72 hours were randomized to the IMHP (n = 152) or HP (n = 149) group and included in an intention-to-treat analysis, performed for the total population as well as predefined medical, surgical, and trauma subpopulations. INTERVENTIONS High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition, initiated within 48 hours of ICU admission and continued during the ICU stay for a maximum of 28 days. MAIN OUTCOMES AND MEASURES The primary outcome measure was incidence of new infections according to the Centers for Disease Control and Prevention (CDC) definitions. Secondary end points included mortality, Sequential Organ Failure Assessment (SOFA) scores, mechanical ventilation duration, ICU and hospital lengths of stay, and subtypes of infections according CDC definitions. RESULTS There were no statistically significant differences in incidence of new infections between the groups: 53%(95% CI, 44%-61%) in the IMHP group vs 52%(95% CI, 44%-61%) in the HP group (P = .96). No statistically significant differences were observed in other end points, except for a higher 6-month mortality rate in the medical subgroup: 54%(95% CI, 40%-67%) in the IMHP group vs 35%(95% CI, 22%-49%) in the HP group (P = .04), with a hazard ratio of 1.57 (95% CI, 1.03-2.39; P = .04) for 6-month mortality adjusted for age and Acute Physiology and Chronic Health Evaluation II score comparing the groups. CONCLUSIONS AND RELEVANCE Among adult patients breathing with the aid of mechanical ventilation in the ICU, IMHP compared with HP did not improve infectious complications or other clinical end points and may be harmful as suggested by increased adjusted mortality at 6 months. These findings do not support the use of IMHP nutrients in these patients.	[van Zanten, Arthur R. H.; Fijn, Harvey B. M.] Gelderse Vallei Hosp, NL-6716 RP Ede, Netherlands; [Sztark, Franois; Petit, Laurent] CHU Bordeaux, Grp Hop Pellegrin, Bordeaux, France; [Kaisers, Udo X.] Univ Klinikum Leipzig, Leipzig, Germany; [Zielmann, Siegfried] Heinrich Braun Klinikum, Zwickau, Germany; [Felbinger, Thomas W.] Klinikum Neuperlach, Munich, Germany; [Sablotzki, Armin R.] Klinikum St Georg, Leipzig, Germany; [DeWaele, Jan J.] Ghent Univ Hosp, Ghent, Belgium; [Timsit, Jean-Francis] Hop Univ Albert Michallon, Grenoble, France; [Honing, Marina L. H.] Med Ctr Alkmaar, Alkmaar, Netherlands; [Keh, Didier] Charite Univ Med Berlin, Berlin, Germany; [Vincent, Jean-Louis; Preiser, Jean-Charles] Univ Libre Bruxelles, Erasme Univ Hosp, Brussels, Belgium; [Zazzo, Jean-Fabien] Hop Antoine Beclere, Clamart, France; [van Horssen, Peter J.; Hofman, Zandrie] Nutricia Res, Nutricia Adv Med Nutr, Utrecht, Netherlands	Gelderse Vallei Hospital; CHU Bordeaux; Leipzig University; Munchen Klinik; Ghent University; Ghent University Hospital; CHU Grenoble Alpes; Medical Center Of Alkmaar; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; Danone Nutricia	van Zanten, ARH (corresponding author), Gelderse Vallei Hosp, Dept Intens Care, Willy Brandtlaan 10, NL-6716 RP Ede, Netherlands.	zantena@zgv.nl	van Zanten, Arthur R.H./ABB-1169-2021; De Waele, Jan J/E-2704-2013; Preiser, Jean-Charles/AAL-2355-2021	van Zanten, Arthur R.H./0000-0001-6276-7192; De Waele, Jan J/0000-0003-1017-9748; Preiser, Jean-Charles/0000-0003-3163-0390; Vincent, Jean-Louis/0000-0001-6011-6951; LAURENT, PETIT/0000-0003-1530-5678	Nutricia Advanced Medical Nutrition, Nutricia Research, Utrecht, the Netherlands	Nutricia Advanced Medical Nutrition, Nutricia Research, Utrecht, the Netherlands	Nutricia Advanced Medical Nutrition, Nutricia Research, Utrecht, the Netherlands was the study sponsor.	Allingstrup MJ, 2012, CLIN NUTR, V31, P462, DOI 10.1016/j.clnu.2011.12.006; Andrews PJD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1542; Avenell A, 2006, P NUTR SOC, V65, P236, DOI 10.1079/PNS2006498; Beale RJ, 1999, CRIT CARE MED, V27, P2799, DOI 10.1097/00003246-199912000-00032; Bistrian BR, 2013, NEW ENGL J MED, V369, P482, DOI 10.1056/NEJMc1306658; Blaser AR, 2012, INTENS CARE MED, V38, P384, DOI 10.1007/s00134-011-2459-y; Bollhalder L, 2013, CLIN NUTR, V32, P213, DOI 10.1016/j.clnu.2012.11.003; Calder PC, 2004, LIPIDS, V39, P1147, DOI 10.1007/s11745-004-1342-z; Drover JW, 2010, JPEN-PARENTER ENTER, V34, P644, DOI 10.1177/0148607110372391; Fadda V, 2013, CLIN NUTR, V32, P492, DOI 10.1016/j.clnu.2013.01.017; Gadek JE, 1999, CRIT CARE MED, V27, P1409, DOI 10.1097/00003246-199908000-00001; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Hegazi RA, 2011, CRIT CARE, V15, DOI 10.1186/cc10430; Heyland D, 2013, NEW ENGL J MED, V368, P1853, DOI DOI 10.1056/NEJM0A1212722.ERRATUM; Heyland D, 2013, NEW ENGL J MED, V368, P1489, DOI 10.1056/NEJMoa1212722; Heyland DK, 2005, INTENS CARE MED, V31, P327, DOI 10.1007/s00134-004-2522-z; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; Manzanares W, 2012, CRIT CARE, V16, DOI 10.1186/cc11316; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Montejo JC, 2003, CLIN NUTR, V22, P221, DOI 10.1016/S0261-5614(03)00007-4; Novak F, 2002, CRIT CARE MED, V30, P2022, DOI 10.1097/00003246-200209000-00011; Pasin L, 2013, NEW ENGL J MED, V369, P482, DOI 10.1056/NEJMc1306658; Peterson SJ, 2010, J AM DIET ASSOC, V110, P427, DOI 10.1016/j.jada.2009.11.020; Pontes-Arruda A, 2006, CRIT CARE MED, V34, P2325, DOI 10.1097/01.CCM.0000234033.65657.B6; Rice TW, 2011, JAMA-J AM MED ASSOC, V306, P1574, DOI 10.1001/jama.2011.1435; Singer P, 2006, CRIT CARE MED, V34, P1033, DOI 10.1097/01.CCM.0000206111.23629.0A; Weijs PJM, 2013, CURR OPIN CLIN NUTR, V16, P194, DOI 10.1097/MCO.0b013e32835bdf7e; Weijs PJM, 2012, JPEN-PARENTER ENTER, V36, P60, DOI 10.1177/0148607111415109; Wernerman J, 2011, ACTA ANAESTH SCAND, V55, P812, DOI 10.1111/j.1399-6576.2011.02453.x; Wernerman J, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-25	31	167	174	1	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					514	524		10.1001/jama.2014.7698	http://dx.doi.org/10.1001/jama.2014.7698			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	25096691	Bronze			2022-12-28	WOS:000339808600020
J	Wilson, AH				Wilson, A. H.			The Prostate Gland: A Review of its Anatomy, Pathology, and Treatment (Reprinted from vol 9, pg 449, 1887)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		WILSON AH, 1887, JAMA-J AM MED ASSOC, V9, P449	1	3	3	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					562	562		10.1001/jama.2013.279650	http://dx.doi.org/10.1001/jama.2013.279650			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	25096708				2022-12-28	WOS:000339808600036
J	Orlando, L; Willerslev, E				Orlando, Ludovic; Willerslev, Eske			An epigenetic window into the past?	SCIENCE			English	Editorial Material							GENOME SEQUENCE; METHYLATION; DNA; NEANDERTHAL; PATTERNS		[Orlando, Ludovic; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, DK-1350 Copenhagen K, Denmark	University of Copenhagen	Orlando, L (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Oster Voldgade 5-7, DK-1350 Copenhagen K, Denmark.	lorlando@snm.ku.dk	Willerslev, Eske/A-9619-2011; Orlando, Ludovic/A-8932-2013; Willerslev, Eske/AAA-5686-2019	Willerslev, Eske/0000-0002-7081-6748; Orlando, Ludovic/0000-0003-3936-1850; 				Bell O, 2011, NAT REV GENET, V12, P554, DOI 10.1038/nrg3017; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Gokhman D, 2014, SCIENCE, V344, P523, DOI 10.1126/science.1250368; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Llamas B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030226; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Pedersen JS, 2014, GENOME RES, V24, P454, DOI 10.1101/gr.163592.113; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Shim J, 2013, SCI REP-UK, V3, DOI [10.1038/srep01389, 10.1038/srep02325]; Smith O, 2014, SCI REP-UK, V4, DOI 10.1038/srep05559; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tobi EW, 2009, HUM MOL GENET, V18, P4046, DOI 10.1093/hmg/ddp353	15	25	25	4	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					511	512		10.1126/science.1256515	http://dx.doi.org/10.1126/science.1256515			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM2AU	25082684				2022-12-28	WOS:000339651300022
J	Ghuman, MS; Saggar, K				Ghuman, Mandeep Singh; Saggar, Kavita			Heterotopic Ossification of a Midline Abdominal Incision	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ghuman, Mandeep Singh; Saggar, Kavita] Dayanand Med Coll & Hosp, Ludhiana, Punjab, India	Dayanand Medical College & Hospital	Ghuman, MS (corresponding author), Dayanand Med Coll & Hosp, Ludhiana, Punjab, India.	dr_msghuman@yahoo.co.in		Ghuman, Mandeep S/0000-0001-7755-7200					0	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					464	464		10.1056/NEJMicm1312006	http://dx.doi.org/10.1056/NEJMicm1312006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0SK	25075838				2022-12-28	WOS:000339556900011
J	Gonzalez, A; Vazquez-Baeza, Y; Knight, R				Gonzalez, Antonio; Vazquez-Baeza, Yoshiki; Knight, Rob			SnapShot: The Human Microbiome	CELL			English	Editorial Material							GUT MICROBIOME		[Gonzalez, Antonio; Knight, Rob] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Vazquez-Baeza, Yoshiki] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Gonzalez, A (corresponding author), Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA.		Gonzalez, Antonio/A-6421-2018; Vazquez-Baeza, Yoshiki/HCI-4852-2022; Knight, Rob/D-1299-2010	Vazquez-Baeza, Yoshiki/0000-0001-6014-2009; Knight, Rob/0000-0002-0975-9019	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053	8	15	17	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					690	U250		10.1016/j.cell.2014.07.019	http://dx.doi.org/10.1016/j.cell.2014.07.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083877	Bronze			2022-12-28	WOS:000340944300020
J	Zhang, XR; Zuo, XX; Yang, B; Li, ZR; Xue, YC; Zhou, Y; Huang, J; Zhao, XL; Zhou, J; Yan, Y; Zhang, HQ; Guo, PP; Sun, H; Guo, L; Zhang, Y; Fu, XD				Zhang, Xiaorong; Zuo, Xinxin; Yang, Bo; Li, Zongran; Xue, Yuanchao; Zhou, Yu; Huang, Jie; Zhao, Xiaolu; Zhou, Jie; Yan, Yun; Zhang, Huiqiong; Guo, Peipei; Sun, Hui; Guo, Lin; Zhang, Yi; Fu, Xiang-Dong			MicroRNA Directly Enhances Mitochondrial Translation during Muscle Differentiation	CELL			English	Article							LIVER-MITOCHONDRIA; TRANSCRIPTION MACHINERY; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; UP-REGULATION; RNA; PROTEIN; ARGONAUTE; REPRESSION; GW182	MicroRNAs are well known to mediate translational repression and mRNA degradation in the cytoplasm. Various microRNAs have also been detected in membrane-compartmentalized organelles, but the functional significance has remained elusive. Here, we report that miR-1, a microRNA specifically induced during myogenesis, efficiently enters the mitochondria where it unexpectedly stimulates, rather than represses, the translation of specific mitochondrial genome-encoded transcripts. We show that this positive effect requires specific miR:mRNA base-pairing and Ago2, but not its functional partner GW182, which is excluded from the mitochondria. We provide evidence for the direct action of Ago2 in mitochondrial translation by crosslinking immuno-precipitation coupled with deep sequencing (CLIP-seq), functional rescue with mitochondria-targeted Ago2, and selective inhibition of the microRNA machinery in the cytoplasm. These findings unveil a positive function of microRNA in mitochondrial translation and suggest a highly coordinated myogenic program via miR-1-mediated translational stimulation in the mitochondria and repression in the cytoplasm.	[Zhang, Xiaorong; Zuo, Xinxin; Yang, Bo; Li, Zongran; Xue, Yuanchao; Huang, Jie; Zhao, Xiaolu; Zhou, Jie; Yan, Yun; Zhang, Huiqiong; Guo, Peipei; Sun, Hui; Guo, Lin; Zhang, Yi; Fu, Xiang-Dong] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Xue, Yuanchao; Zhou, Yu; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Fu, Xiang-Dong] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Wuhan University; University of California System; University of California San Diego; University of California System; University of California San Diego	Fu, XD (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	xdfu@ucsd.edu	Yan, Yun/GPC-5871-2022; Zhou, Yu/AAP-9964-2021	Yan, Yun/0000-0002-3701-9608; Zhang, Yi/0000-0003-1035-6134; Huang, Jie/0000-0003-3842-6181; XUE, YUANCHAO/0000-0002-8113-2333; Zhou, Yu/0000-0002-2102-9377; Zhang, Xiaorong/0000-0002-6194-7746	China 973 pro-gram [2011CB811300, 2012CB910800]; Chinese 111 program [B06018]; NIH [GM049369, GM052872]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049369, R01GM052872] Funding Source: NIH RePORTER	China 973 pro-gram(National Basic Research Program of China); Chinese 111 program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Drs. Immo Scheffler, Amy Pasquinelli, Shobha Vasudevan, and David Chan for insightful discussion during the course of this investigation, Dr. Xiaoyan Ding for providing the C2C12 cell line, and Dr. Anna Lombes for the gift of anti-ND1 antibody. This work was supported by the China 973 pro-gram (2011CB811300, 2012CB910800), the Chinese 111 program grant (B06018), and NIH grants (GM049369 and GM052872).	Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bandiera S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020746; Barrey E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020220; Bestwick ML, 2013, TRENDS BIOCHEM SCI, V38, P283, DOI 10.1016/j.tibs.2013.03.006; Bian Z, 2010, CELL RES, V20, P1076, DOI 10.1038/cr.2010.119; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; BOSMANN HB, 1972, J CELL BIOL, V55, P147, DOI 10.1083/jcb.55.1.147; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cavelier L, 2000, EXP CELL RES, V259, P79, DOI 10.1006/excr.2000.4949; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Czech B, 2011, NAT REV GENET, V12, P19, DOI 10.1038/nrg2916; Das S, 2012, CIRC RES, V110, P1596, DOI 10.1161/CIRCRESAHA.112.267732; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Franko A, 2008, MOL CELL BIOL, V28, P2446, DOI 10.1128/MCB.00980-07; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Iwasaki S, 2009, FLY, V3, P204; Jakymiw A, 2007, J CELL SCI, V120, P1317, DOI 10.1242/jcs.03429; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mahata B, 2006, SCIENCE, V314, P471, DOI 10.1126/science.1129754; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Mortensen RD, 2011, P NATL ACAD SCI USA, V108, P8281, DOI 10.1073/pnas.1105401108; Moyes CD, 1997, AM J PHYSIOL-CELL PH, V272, pC1345, DOI 10.1152/ajpcell.1997.272.4.C1345; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; SCHNAITMAN C, 1968, J CELL BIOL, V38, P158, DOI 10.1083/jcb.38.1.158; Sripada L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044873; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Surovtseva YV, 2011, P NATL ACAD SCI USA, V108, P17921, DOI 10.1073/pnas.1108852108; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Temperley RJ, 2010, BBA-BIOENERGETICS, V1797, P1081, DOI 10.1016/j.bbabio.2010.02.036; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2012, WIRES RNA, V3, P311, DOI 10.1002/wrna.121; Wang DM, 2012, GENE DEV, V26, P693, DOI 10.1101/gad.182758.111; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	53	290	306	6	113	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					607	619		10.1016/j.cell.2014.05.047	http://dx.doi.org/10.1016/j.cell.2014.05.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083871	Bronze, Green Accepted			2022-12-28	WOS:000340944300013
J	Weber, SJ; Chantasri, A; Dressel, J; Jordan, AN; Murch, KW; Siddiqi, I				Weber, S. J.; Chantasri, A.; Dressel, J.; Jordan, A. N.; Murch, K. W.; Siddiqi, I.			Mapping the optimal route between two quantum states	NATURE			English	Article							SYMMETRY; QUBIT	A central feature of quantum mechanics is that a measurement result is intrinsically probabilistic. Consequently, continuously monitoring a quantum system will randomly perturb its natural unitary evolution. The ability to control a quantum system in the presence of these fluctuations is of increasing importance in quantum information processing and finds application in fields ranging from nuclear magnetic resonance(1) to chemical synthesis(2). A detailed understanding of this stochastic evolution is essential for the development of optimized control methods. Here we reconstruct the individual quantum trajectories(3-5) of a superconducting circuit that evolves under the competing influences of continuous weak measurement and Rabi drive. By tracking individual trajectories that evolve between any chosen initial and final states, we can deduce the most probable path through quantum state space. These pre- and post-selected quantum trajectories also reveal the optimal detector signal in the form of a smooth, time-continuous function that connects the desired boundary conditions. Our investigation reveals the rich interplay between measurement dynamics, typically associated with wave function collapse, and unitary evolution of the quantum state as described by the Schrodinger equation. These results and the underlying theory(6), based on a principle of least action, reveal the optimal route from initial to final states, and may inform new quantum control methods for state steering and information processing.	[Weber, S. J.; Siddiqi, I.] Univ Calif Berkeley, Dept Phys, Quantum Nanoelect Lab, Berkeley, CA 94720 USA; [Chantasri, A.; Jordan, A. N.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Chantasri, A.; Jordan, A. N.] Univ Rochester, Ctr Coherence & Quantum Opt, Rochester, NY 14627 USA; [Dressel, J.] Univ Calif Riverside, Dept Elect Engn, Riverside, CA 92521 USA; [Jordan, A. N.] Chapman Univ, Inst Quantum Studies, Orange, CA 92866 USA; [Murch, K. W.] Washington Univ, Dept Phys, St Louis, MO 63130 USA	University of California System; University of California Berkeley; University of Rochester; University of Rochester; University of California System; University of California Riverside; Chapman University System; Chapman University; Washington University (WUSTL)	Murch, KW (corresponding author), Washington Univ, Dept Phys, St Louis, MO 63130 USA.	murch@physics.wustl.edu	Siddiqi, Irfan/E-5548-2015; Jordan, Andrew N/E-4558-2011	Jordan, Andrew N/0000-0002-9646-7013	Army Research Office; Office of Naval Research; Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office; NSF [DMR-0844899]	Army Research Office; Office of Naval Research(Office of Naval Research); Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office; NSF(National Science Foundation (NSF))	We thank A. N. Korotkov, S. G. Rajeev, N. Roch and D. Toyli for discussions. This research was supported in part by the Army Research Office, Office of Naval Research and the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), through the Army Research Office. All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA, the ODNI or the US government. A.N.J. acknowledges support from NSF grant no. DMR-0844899 (CAREER).	AHARONOV Y, 1964, PHYS REV B, V134, P1410, DOI 10.1103/PhysRev.134.B1410; AHARONOV Y, 1988, PHYS REV LETT, V60, P1351, DOI 10.1103/PhysRevLett.60.1351; Blok MS, 2014, NAT PHYS, V10, P189, DOI [10.1038/nphys2881, 10.1038/NPHYS2881]; Campagne-Ibarcq P, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.180402; Carmichael H. J., 1994, P INT S COH STAT PRE, P75; Carmichael H.J., 1993, AN OPEN SYSTEMS APPR; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Chantasri A, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.042110; de Lange G, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.080501; Gambetta J, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.012112; Groen JP, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.090506; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Hatridge M, 2013, SCIENCE, V339, P178, DOI 10.1126/science.1226897; Hatridge M, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134501; Jordan AN, 2013, NATURE, V502, P177, DOI 10.1038/502177a; Koch J, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042319; Korotkov A. N., 2011, PREPRINT; Korotkov AN, 1999, PHYS REV B, V60, P5737, DOI 10.1103/PhysRevB.60.5737; Murch KW, 2013, NATURE, V502, P211, DOI 10.1038/nature12539; Paik H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.240501; Riste D, 2013, NATURE, V502, P350, DOI 10.1038/nature12513; Roch N, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.170501; Sayrin C, 2011, NATURE, V477, P73, DOI 10.1038/nature10376; Shapiro M., 2012, QUANTUM CONTROL OF M; Vandersypen LMK, 2004, REV MOD PHYS, V76, P1037, DOI 10.1103/RevModPhys.76.1037; Vijay R, 2012, NATURE, V490, P77, DOI 10.1038/nature11505; Vijay R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.110502; WATANABE S, 1955, REV MOD PHYS, V27, P179, DOI 10.1103/RevModPhys.27.179; Williams NS, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.026804; Wiseman H. M., 2010, QUANTUM MEASUREMENT	30	138	138	2	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					570	+		10.1038/nature13559	http://dx.doi.org/10.1038/nature13559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079554	Green Submitted, Green Published			2022-12-28	WOS:000339566300030
J	Powers, AM				Powers, Ann M.			Chikungunya virus control: is a vaccine on the horizon?	LANCET			English	Editorial Material							LA REUNION ISLAND; DENGUE VACCINES; COST		Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA	Centers for Disease Control & Prevention - USA	Powers, AM (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO 80521 USA.	apowers@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; Andre F E, 2002, Dev Biol (Basel), V110, P25; [Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P513; Chang L-J, 2014, LANCET; Douglas DL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002127; Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681; Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500; Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99; Hoke CH, 2012, VACCINE, V30, P6713, DOI 10.1016/j.vaccine.2012.08.025; Mahoney RT, 2012, VACCINE, V30, P4892, DOI 10.1016/j.vaccine.2012.02.064; Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755; Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189; Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197; US Centers for Disease Control and Prevention, 2003, REP CAS LYM DIS YEAR; Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858; World Health Organization, DENG SEV DENG FACT S	16	14	15	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2008	2009		10.1016/S0140-6736(14)61290-3	http://dx.doi.org/10.1016/S0140-6736(14)61290-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW6BD	25132506	Green Accepted			2022-12-28	WOS:000346353600009
J	Boussemart, L; Malka-Mahieu, H; Girault, I; Allard, D; Hemmingsson, O; Tomasic, G; Thomas, M; Basmadjian, C; Ribeiro, N; Thuaud, F; Mateus, C; Routier, E; Kamsu-Kom, N; Agoussi, S; Eggermont, AM; Desaubry, L; Robert, C; Vagner, S				Boussemart, Lise; Malka-Mahieu, Helene; Girault, Isabelle; Allard, Delphine; Hemmingsson, Oskar; Tomasic, Gorana; Thomas, Marina; Basmadjian, Christine; Ribeiro, Nigel; Thuaud, Frederic; Mateus, Christina; Routier, Emilie; Kamsu-Kom, Nyam; Agoussi, Sandrine; Eggermont, Alexander M.; Desaubry, Laurent; Robert, Caroline; Vagner, Stephan			eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies	NATURE			English	Article							TRANSLATION INITIATION; ACQUIRED-RESISTANCE; FEEDBACK INHIBITION; RAF; SILVESTROL	In BRAF(V600)-mutant tumours, most mechanisms of resistance to drugs that target the BRAF and/or MEK kinases rely on reactivation of the RAS-RAF-MEK-ERK mitogen-activated protein kinase (MAPK) signal transduction pathway, on activation of the alternative, PI(3) K-AKT-mTOR, pathway (which is ERK independent) or on modulation of the caspase-dependent apoptotic cascade(1-3). All three pathways converge to regulate the formation of the eIF4F eukaryotic translation initiation complex, which binds to the 7-methylguanylate cap (m(7)G) at the 59 end of messenger RNA, thereby modulating the translation of specific mRNAs(4,5). Here we show that the persistent formation of the eIF4F complex, comprising the eIF4E cap-binding protein, the eIF4G scaffolding protein and the eIF4A RNA helicase, is associated with resistance to anti-BRAF, anti-MEK and anti-BRAF plus anti-MEK drug combinations in BRAF(V600)-mutant melanoma, colon and thyroid cancer cell lines. Resistance to treatment and maintenance of eIF4F complex formation is associated with one of three mechanisms: reactivation of MAPK signalling, persistent ERK-independent phosphorylation of the inhibitory eIF4E-binding protein 4EBP1 or increased pro-apoptotic BCL-2-modifying factor (BMF)-dependent degradation of eIF4G. The development of an in situ method to detect the eIF4E-eIF4G interactions shows that eIF4F complex formation is decreased in tumours that respond to anti-BRAF therapy and increased in resistant metastases compared to tumours before treatment. Strikingly, inhibiting the eIF4F complex, either by blocking the eIF4E-eIF4G interaction or by targeting eIF4A, synergizes with inhibiting BRAF(V600) to kill the cancer cells. eIF4F not only appears to be an indicator of both innate and acquired resistance but also is a promising therapeutic target. Combinations of drugs targeting BRAF(and/or MEK) and eIF4F may overcome most of the resistance mechanisms arising in BRAF(V600)-mutant cancers.	[Boussemart, Lise; Malka-Mahieu, Helene; Girault, Isabelle; Allard, Delphine; Hemmingsson, Oskar; Kamsu-Kom, Nyam; Agoussi, Sandrine; Robert, Caroline; Vagner, Stephan] Inserm UMR981, F-94805 Villejuif, France; [Boussemart, Lise; Malka-Mahieu, Helene; Eggermont, Alexander M.; Robert, Caroline; Vagner, Stephan] Univ Paris Sud, Univ Paris 11, F-94276 Le Kremlin Bicetre, France; [Boussemart, Lise; Thomas, Marina; Mateus, Christina; Routier, Emilie; Eggermont, Alexander M.; Robert, Caroline; Vagner, Stephan] Gustave Roussy, Dermatooncol, F-94805 Villejuif, France; [Tomasic, Gorana] Gustave Roussy, Dept Pathol, F-94805 Villejuif, France; [Basmadjian, Christine; Ribeiro, Nigel; Thuaud, Frederic; Desaubry, Laurent] Strasbourg Univ, CNRS, UMR7200, F-67400 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Robert, C (corresponding author), Inserm UMR981, F-94805 Villejuif, France.	caroline.robert@gustaveroussy.fr; stephan.vagner@inserm.fr	Vagner, Stephan/G-3664-2013; Robert, Caroline/G-6157-2018; Desaubry, Laurent G/R-5446-2017	Robert, Caroline/0000-0002-9493-0238; Desaubry, Laurent G/0000-0002-1192-2970; ALLARD, Delphine/0000-0001-7534-8982; vagner, stephan/0000-0003-1452-7164; Girault, Isabelle/0000-0002-9587-5197	Institut National du CAncer (INCA); Association pour la Recherche sur le Cancer (ARC); Ligue contre le Cancer via an Integrated Research Action Program Melanoma (PAIR Melanome); Canceropole Ile de France and Ensemble Contre le Melanome; ARC; AAREC Filia Research for fellowships; Wenner-Gren Foundation; Swedish Society of Medicine	Institut National du CAncer (INCA)(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Ligue contre le Cancer via an Integrated Research Action Program Melanoma (PAIR Melanome); Canceropole Ile de France and Ensemble Contre le Melanome; ARC(Australian Research Council); AAREC Filia Research for fellowships; Wenner-Gren Foundation; Swedish Society of Medicine	The authors thank J. Tanaka for providing hippuristanol. We thank the following Gustave Roussy platforms: Imaging and Cytometry Platform IRCIV (S. Salome-Desmoulez), Module de Developpement en Pathologie, SIRIC SOCRATE (J. Adam), Translational Research Laboratory and Biobank (M. Breckler and L. Lacroix), Plateforme d'evaluation Preclinique (P. Gonin and K. Ser-le Roux), Genomic Core Facility (N. Pata-Merci) and Bioinformatic Core Facility (G. Meurice). We also thank V. Camara-Clayette for help with <SUP>35</SUP>S experiments, S. Roy for patient data collection and L. Saint Ange for text editing. C. R. and S.V.'s team was supported by Institut National du CAncer (INCA), Association pour la Recherche sur le Cancer (ARC) and Ligue contre le Cancer via an Integrated Research Action Program Melanoma (PAIR Melanome), Canceropole Ile de France and Ensemble Contre le Melanome. L. D. was supported by the Association pour la Recherche sur le Cancer (ARC). We also thank the ARC and AAREC Filia Research for fellowships to N. R. and C. B. O.H. was supported by the Wenner-Gren Foundation and the Swedish Society of Medicine.	Blagden SP, 2011, NAT REV CLIN ONCOL, V8, P280, DOI 10.1038/nrclinonc.2011.16; Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753; Cencic R, 2012, METHOD ENZYMOL, V511, P437, DOI 10.1016/B978-0-12-396546-2.00020-6; Cencic R, 2010, LEUKEMIA RES, V34, P535, DOI 10.1016/j.leukres.2009.07.043; Gupta SV, 2011, AAPS J, V13, P357, DOI 10.1208/s12248-011-9276-7; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Lito P, 2013, NAT MED, V19, P1401, DOI 10.1038/nm.3392; Liu T, 2012, J MED CHEM, V55, P8859, DOI 10.1021/jm3011542; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Oikonomou E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021632; Packer LM, 2009, PIGM CELL MELANOMA R, V22, P785, DOI 10.1111/j.1755-148X.2009.00618.x; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Pratilas CA, 2009, P NATL ACAD SCI USA, V106, P4519, DOI 10.1073/pnas.0900780106; Sadlish H, 2013, ACS CHEM BIOL, V8, P1519, DOI 10.1021/cb400158t; Shao Y, 2012, CELL DEATH DIFFER, V19, P2029, DOI 10.1038/cdd.2012.94; Shi HB, 2014, CANCER DISCOV, V4, P80, DOI 10.1158/2159-8290.CD-13-0642; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Tentori L, 2013, TRENDS PHARMACOL SCI, V34, P656, DOI 10.1016/j.tips.2013.10.003; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thuaud F, 2009, J MED CHEM, V52, P5176, DOI 10.1021/jm900365v	21	240	247	7	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 4	2014	513	7516					105	+		10.1038/nature13572	http://dx.doi.org/10.1038/nature13572			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2SD	25079330				2022-12-28	WOS:000341174800039
J	Kundu, P; Pettersson, S				Kundu, Parag; Pettersson, Sven			IMMUNOLOGY Mammalian watchdog targets bacteria	NATURE			English	Editorial Material							ARYL-HYDROCARBON RECEPTOR; ACTIVATION; PATHWAY		[Kundu, Parag; Pettersson, Sven] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 637551, Singapore; [Kundu, Parag; Pettersson, Sven] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 637551, Singapore; [Pettersson, Sven] Singapore Gen Hosp, Natl Canc Ctr, Singapore, Singapore; [Pettersson, Sven] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National Cancer Centre Singapore (NCCS); Singapore General Hospital; Karolinska Institutet	Kundu, P (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore 637551, Singapore.	sven.pettersson@ki.se	Pettersson, Sven/F-9511-2015	Kundu, Parag/0000-0002-8684-7530				Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; De Vleesschauwer D, 2006, MOL PLANT MICROBE IN, V19, P1406, DOI 10.1094/MPMI-19-1406; Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828; Inoue H, 2012, J IMMUNOL, V188, P4654, DOI 10.4049/jimmunol.1101575; Jin GB, 2010, TOXICOL SCI, V116, P514, DOI 10.1093/toxsci/kfq153; Mavrodi DV, 2010, APPL ENVIRON MICROB, V76, P866, DOI 10.1128/AEM.02009-09; Moura-Alves P, 2014, NATURE, V512, P387, DOI 10.1038/nature13684; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Pierson LS, 2010, APPL MICROBIOL BIOT, V86, P1659, DOI 10.1007/s00253-010-2509-3; Smith T, 1897, J Exp Med, V2, P543, DOI 10.1084/jem.2.5.543; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Theis KR, 2013, P NATL ACAD SCI USA, V110, P19832, DOI 10.1073/pnas.1306477110; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	13	6	8	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 28	2014	512	7515					377	378		10.1038/nature13741	http://dx.doi.org/10.1038/nature13741			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN8GC	25119031	Green Accepted			2022-12-28	WOS:000340840600019
J	Cavender, MA; Sabatine, MS				Cavender, Matthew A.; Sabatine, Marc S.			Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials	LANCET			English	Article							ELEVATION MYOCARDIAL-INFARCTION; GLYCOPROTEIN IIB/IIIA INHIBITORS; ASSOCIATION TASK-FORCE; UNFRACTIONATED HEPARIN; CLINICAL-TRIALS; PRACTICE GUIDELINES; ACUTE CATHETERIZATION; PRIMARY PCI; CLOPIDOGREL; ABCIXIMAB	Background Bivalirudin is an alternative to heparin in patients undergoing percutaneous coronary intervention (PCI). We aimed to define the effects of a bivalirudin-based anticoagulation regimen compared with a heparin-based anticoagulation regimen on ischaemic and bleeding outcomes. Methods We searched Medline, the Cochrane Library, and relevant meeting abstracts (search done on April 9, 2014) for randomised trials that assessed bivalirudin versus heparin in patients planned for PCI. The primary efficacy endpoint was the incidence of major adverse cardiac events (MACE) up to 30 days. Secondary efficacy endpoints were death, myocardial infarction, ischaemia-driven revascularisation, and stent thrombosis. The primary safety endpoint was major bleeding up to 30 days. We calculated pooled risk ratios and 95% CIs using random-effects models. Findings We included data from 16 trials involving 33 958 patients, of whom 2422 experienced MACE and 1406 had a major bleed. There was an increase in the risk of MACE with bivalirudin-based regimens compared with heparin-based regimens (risk ratio 1.09, 95% CI 1.01-1 17; p=0.0204), which was largely driven by increases in myocardial infarction (1.12, 1.03-1.23) and seemingly also by ischaemia-driven revascularisation (1.16, 0.997-1.34) with bivalirudin compared with heparin, with no effect on mortality (0 99, 0 82-1.18). Bivalirudin increased the risk of stent thrombosis (risk ratio 1.38, 95% CI 1.09-1.74; p=0.0074), which was primarily due to an increase in acute cases in ST-segment elevation myocardial infarction (4.27, 2.28-8 00; p<0 0001). Overall, bivalirudin-based regimens lowered the risk of major bleeding (risk ratio 0.62, 95% CI 0 49-0.78; p<0 0001), but the magnitude of this effect varied greatly (p<0 0001) depending on whether glycoprotein IIb/IIIa inhibitors were used predominantly in the heparin arm only (0.53, 0.47-0 61; p<0 0001), provisionally in both arms (0.78, 0.51-1.19; p=0 25), or planned in both arms (1.07, 0.87-1.31; p=0 53). Interpretation Compared with a heparin-based regimen, a bivalirudin-based regimen increases the risk of myocardial infarction and stent thrombosis, but decreases the risk of bleeding, with the magnitude of the reduction depending on concomitant glycoprotein IIb/IIIa inhibitor use. Physicians should weigh the trade-off between ischaemic and bleeding events when choosing between different anticoagulant regimens.	[Cavender, Matthew A.; Sabatine, Marc S.] Brigham & Womens Hosp, Div Cardiovasc Med, TIMI Study Grp, Boston, MA 02115 USA; [Cavender, Matthew A.; Sabatine, Marc S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sabatine, MS (corresponding author), TIMI Study Grp, Office Level One,350 Longwood Ave, Boston, MA 02115 USA.	msabatine@partners.org	Sabatine, Marc/AAJ-6751-2020	Sabatine, Marc/0000-0002-0691-3359	Brigham and Women's Hospital from Abbott Laboratories; Accumetrics; Amgen; AstraZeneca; Bristol-Myers Squibb; Critical Diagnostics; Daiichi-Sankyo; Eisai; Genzyme; GlaxoSmithKline; Intarcia; Merck; Nanosphere; Roche Diagnostics; Sanofi-Aventis; Takeda	Brigham and Women's Hospital from Abbott Laboratories; Accumetrics; Amgen(Amgen); AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Critical Diagnostics; Daiichi-Sankyo(Daiichi Sankyo Company Limited); Eisai(Eisai Co Ltd); Genzyme(Sanofi-AventisGenzyme Corporation); GlaxoSmithKline(GlaxoSmithKline); Intarcia; Merck(Merck & Company); Nanosphere; Roche Diagnostics; Sanofi-Aventis(Sanofi-Aventis); Takeda(Takeda Pharmaceutical Company Ltd)	MSS has received research grant support through Brigham and Women's Hospital from Abbott Laboratories, Accumetrics, Amgen, AstraZeneca, Bristol-Myers Squibb, Critical Diagnostics, Daiichi-Sankyo, Eisai, Genzyme, GlaxoSmithKline, Intarcia, Merck, Nanosphere, Roche Diagnostics, Sanofi-Aventis, and Takeda; and has done consulting for Aegerion, Amgen, AstraZeneca, Bristol-Myers Squibb, Cubist, GlaxoSmithKline, Intarcia, Merck, MyoKardia, Pfizer, Quest Diagnostics, Sanofi-Aventis, Vertex, and Zeus Scientific. MAC declares no competing interests.	Alexopoulos D, 2012, CIRC-CARDIOVASC INTE, V5, P797, DOI 10.1161/CIRCINTERVENTIONS.112.972323; Anderson JL, 2013, CIRCULATION, V127, pE663, DOI 10.1161/CIR.0b013e31828478ac; Bellemain-Appaix A, 2012, JAMA-J AM MED ASSOC, V308, P2507, DOI 10.1001/jama.2012.50788; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; Briguori C, 2014, SCI SESS AM COLL CAR; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deshpande Niteen V, 2012, Indian Heart J, V64, P444, DOI 10.1016/j.ihj.2012.07.022; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Friedrich JO, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-5; Gibson CM, 2006, J AM COLL CARDIOL, V47, P2364, DOI 10.1016/j.jacc.2005.12.077; Giugliano RP, 2009, NEW ENGL J MED, V360, P2176, DOI 10.1056/NEJMoa0901316; Han Y, 2014, CHIN INT THER CIT 20; Jacobs AK, 2013, NEW ENGL J MED, V369, P393, DOI 10.1056/NEJMc1305978; Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944; Kastrati A, 2011, NEW ENGL J MED, V365, P1980, DOI 10.1056/NEJMoa1109596; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Lincoff AM, 2004, JAMA-J AM MED ASSOC, V292, P696, DOI 10.1001/jama.292.6.696; Lincoff AM, 2004, AM J CARDIOL, V93, P1092, DOI 10.1016/j.amjcard.2004.01.033; Lincoff AM, 2003, JAMA-J AM MED ASSOC, V289, P853, DOI 10.1001/jama.289.7.853; Lincoff AM, 2002, AM HEART J, V143, P847, DOI 10.1067/mhj.2002.122173; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehran R, 2009, LANCET, V374, P1149, DOI 10.1016/S0140-6736(09)61484-7; Moliterno DJ, 2011, CATHETER CARDIO INTE, V77, P1001, DOI 10.1002/ccd.22876; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Patti G, 2012, AM J CARDIOL, V110, P478, DOI 10.1016/j.amjcard.2012.04.017; Pocock SJ, 2010, CIRCULATION, V121, P43, DOI 10.1161/CIRCULATIONAHA.109.878017; Schulz S, 2013, EUROINTERVENTION, V9, P430, DOI 10.4244/EIJV9I4A71; Schulz S, 2010, EUR HEART J, V31, P582, DOI 10.1093/eurheartj/ehq008; Shahzad A, 2014, LANCET; Spencer FA, 2007, CIRCULATION, V116, P2793, DOI 10.1161/CIRCULATIONAHA.107.694273; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Steinberg KK, 1997, AM J EPIDEMIOL, V145, P917; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Stone GW, 2007, LANCET, V369, P907, DOI 10.1016/S0140-6736(07)60450-4; Stone GW, 2007, JAMA-J AM MED ASSOC, V297, P591, DOI 10.1001/jama.297.6.591; Subherwal S, 2013, AM HEART J, V165, P644, DOI 10.1016/j.ahj.2012.11.012; Tarantini G, 2014, AM HEART J, V167, P401, DOI 10.1016/j.ahj.2013.11.013; Tavano D, 2009, AM J CARDIOL, V104, P1222, DOI 10.1016/j.amjcard.2009.06.035; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; White HD, 2008, J AM COLL CARDIOL, V52, P807, DOI 10.1016/j.jacc.2008.05.036; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Zeymer U, 2014, EUR HEART J, V35, P2460, DOI 10.1093/eurheartj/ehu214	42	141	145	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					599	606		10.1016/S0140-6736(14)61216-2	http://dx.doi.org/10.1016/S0140-6736(14)61216-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25131979				2022-12-28	WOS:000340573300032
J	Lane, M; Robker, RL; Robertson, SA				Lane, Michelle; Robker, Rebecca L.; Robertson, Sarah A.			Parenting from before conception	SCIENCE			English	Review							IN-VITRO FERTILIZATION; HIGH-FAT DIET; TRANSGENERATIONAL EPIGENETIC INHERITANCE; FEMALE REPRODUCTIVE-TRACT; DEVELOPMENTAL ORIGINS; GENE-EXPRESSION; TRANSCRIPTIONAL PROFILE; VASCULAR DYSFUNCTION; MATERNAL NUTRITION; PATERNAL OBESITY	At fertilization, the gametes endow the embryo with a genomic blueprint, the integrity of which is affected by the age and environmental exposures of both parents. Recent studies reveal that parental history and experiences also exert effects through epigenomic information not contained in the DNA sequence, including variations in sperm and oocyte cytosine methylation and chromatin patterning, noncoding RNAs, and mitochondria. Transgenerational epigenetic effects interact with conditions at conception to program the developmental trajectory of the embryo and fetus, ultimately affecting the lifetime health of the child. These insights compel us to revise generally held notions to accommodate the prospect that biological parenting commences well before birth, even prior to conception.	[Robertson, Sarah A.] Univ Adelaide, Robinson Res Inst, Sch Med, South Adelaide, SA 5005, Australia; Univ Adelaide, Sch Paediat & Reprod Hlth, Sch Med, South Adelaide, SA 5005, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide	Robertson, SA (corresponding author), Univ Adelaide, Robinson Res Inst, Sch Med, South Adelaide, SA 5005, Australia.	sarah.robertson@adelaide.edu.au	Robertson, Sarah A/C-8182-2009	Robertson, Sarah A/0000-0002-9967-0084; Robker, Rebecca/0000-0002-1538-4604	National Health and Medical Research Council (Australia)	National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	M.L., R. L. R., and S. A. R. are funded by the National Health and Medical Research Council (Australia). We thank L. Wu for the oocyte image in Fig. 2, and R. Richards and J. Thompson for critical comments. M. L. is an employee of Repromed Ltd. (Australia), and S. A. R. receives royalties on a patent describing use of granulocyte-macrophage colony-stimulating factor in IVF, licensed to Origio A/S (Denmark).	Aitken RJ, 2014, ASIAN J ANDROL, V16, P31, DOI 10.4103/1008-682X.122203; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Bermejo-Alvarez P, 2010, P NATL ACAD SCI USA, V107, P3394, DOI 10.1073/pnas.0913843107; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Carone BR, 2010, CELL, V143, P1084, DOI 10.1016/j.cell.2010.12.008; Ceelen M, 2008, J CLIN ENDOCR METAB, V93, P1682, DOI 10.1210/jc.2007-2432; Chen M., 2014, DIABETES; Chong S, 2007, NAT GENET, V39, P574, DOI 10.1038/ng0507-574; Concepcion CP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002797; Daxinger L, 2012, NAT REV GENET, V13, P153, DOI 10.1038/nrg3188; Dias BG, 2014, NAT NEUROSCI, V17, P89, DOI 10.1038/nn.3594; Doherty AS, 2000, BIOL REPROD, V62, P1526, DOI 10.1095/biolreprod62.6.1526; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; Feuer SK, 2014, ENDOCRINOLOGY, V155, P1956, DOI 10.1210/en.2013-2081; Figueroa-Colon R, 2000, AM J CLIN NUTR, V71, P829, DOI 10.1093/ajcn/71.3.829; Fleming TP, 2012, REPROD FERT DEVELOP, V24, P35, DOI 10.1071/RD11905; Fowden AL, 2008, J NEUROENDOCRINOL, V20, P439, DOI 10.1111/j.1365-2826.2008.01663.x; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Fullston T, 2011, REPROD FERT DEVELOP, V23, P691, DOI 10.1071/RD10292; Gannon JR, 2014, ADV EXP MED BIOL, V791, P53, DOI 10.1007/978-1-4614-7783-9_4; Gapp K, 2014, NAT NEUROSCI, V17, P667, DOI 10.1038/nn.3695; Gardner DK, 2010, MOL HUM REPROD, V16, P539, DOI 10.1093/molehr/gaq042; Godfrey KM, 2010, TRENDS ENDOCRIN MET, V21, P199, DOI 10.1016/j.tem.2009.12.008; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Hammoud SS, 2011, HUM REPROD, V26, P2558, DOI 10.1093/humrep/der192; Hochberg Z, 2011, ENDOCR REV, V32, P159, DOI 10.1210/er.2009-0039; Jimenez-Chillaron JC, 2009, DIABETES, V58, P460, DOI 10.2337/db08-0490; Kafka JK, 2012, AIDS, V26, P27, DOI 10.1097/QAD.0b013e32834e57b2; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Lazaraviciute G., 2014, HUM REPROD UPDATE; Lee KM, 2009, LEUKEMIA RES, V33, P250, DOI 10.1016/j.leukres.2008.06.031; Leese HJ, 2008, REPROD FERT DEVELOP, V20, P1, DOI 10.1071/RD07153; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Luzzo KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049217; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; Miao M, 2014, ANDROLOGY-US, V2, P138, DOI 10.1111/j.2047-2927.2013.00166.x; Mitchell M, 2011, FERTIL STERIL, V95, P1349, DOI 10.1016/j.fertnstert.2010.09.038; Mitchell M, 2009, BIOL REPROD, V80, P622, DOI 10.1095/biolreprod.108.072595; Nadeau JH, 2009, HUM MOL GENET, V18, pR202, DOI 10.1093/hmg/ddp366; Nehra D, 2012, AGING CELL, V11, P1046, DOI 10.1111/acel.12006; Ng SF, 2014, FASEB J, V28, P1830, DOI 10.1096/fj.13-244046; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Noblanc A, 2013, FREE RADICAL BIO MED, V65, P719, DOI 10.1016/j.freeradbiomed.2013.07.044; Oliver VF, 2012, FERTIL STERIL, V97, P147, DOI 10.1016/j.fertnstert.2011.10.027; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Palmer NO, 2011, REPROD FERT DEVELOP, V23, P929, DOI 10.1071/RD10326; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Poon HK, 2009, THERIOGENOLOGY, V71, P1367, DOI 10.1016/j.theriogenology.2008.12.016; Radford E. J., 2014, SCIENCE; Rando OJ, 2012, CELL, V151, P702, DOI 10.1016/j.cell.2012.10.020; Rattanatray L, 2010, ENDOCRINOLOGY, V151, P5195, DOI 10.1210/en.2010-0501; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Rexhaj E, 2013, J CLIN INVEST, V123, P5052, DOI 10.1172/JCI68943; Robertson SA, 2005, CELL TISSUE RES, V322, P43, DOI 10.1007/s00441-005-1127-3; Robker RL, 2009, J CLIN ENDOCR METAB, V94, P1533, DOI 10.1210/jc.2008-2648; Scherrer U, 2012, CIRCULATION, V125, P1890, DOI 10.1161/CIRCULATIONAHA.111.071183; Selesniemi K, 2011, P NATL ACAD SCI USA, V108, P12319, DOI 10.1073/pnas.1018793108; Sjoblom C, 2005, ENDOCRINOLOGY, V146, P2142, DOI 10.1210/en.2004-1260; Soubry A, 2014, BIOESSAYS, V36, P359, DOI 10.1002/bies.201300113; Soubry A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-29; Stojanov T, 2001, BIOL REPROD, V64, P696, DOI 10.1095/biolreprod64.2.696; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Sun CS, 2014, DEVELOPMENT, V141, P1140, DOI 10.1242/dev.103952; Tian X, 2013, DEV BIOL, V376, P51, DOI 10.1016/j.ydbio.2013.01.015; Tian X, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113910; van Balkom IDC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045090; Wai T, 2010, BIOL REPROD, V83, P52, DOI 10.1095/biolreprod.109.080887; Ward WS, 2010, MOL HUM REPROD, V16, P30, DOI 10.1093/molehr/gap080; Waterland RA, 2004, NUTRITION, V20, P63, DOI 10.1016/j.nut.2003.09.011; Watkins AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028745; Williams CL, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-49; Wong CL, 2007, THERIOGENOLOGY, V68, P654, DOI 10.1016/j.theriogenology.2007.04.062; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; Yadav RP, 2014, MOL CELL ENDOCRINOL, V382, P498, DOI 10.1016/j.mce.2013.04.015	76	186	192	1	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					756	760		10.1126/science.1254400	http://dx.doi.org/10.1126/science.1254400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124428				2022-12-28	WOS:000340593100032
J	Rubenstein, M; Cornejo, A; Nagpal, R				Rubenstein, Michael; Cornejo, Alejandro; Nagpal, Radhika			Programmable self-assembly in a thousand-robot swarm	SCIENCE			English	Article								Self-assembly enables nature to build complex forms, from multicellular organisms to complex animal structures such as flocks of birds, through the interaction of vast numbers of limited and unreliable individuals. Creating this ability in engineered systems poses challenges in the design of both algorithms and physical systems that can operate at such scales. We report a system that demonstrates programmable self-assembly of complex two-dimensional shapes with a thousand-robot swarm. This was enabled by creating autonomous robots designed to operate in large groups and to cooperate through local interactions and by developing a collective algorithm for shape formation that is highly robust to the variability and error characteristic of large-scale decentralized systems. This work advances the aim of creating artificial swarms with the capabilities of natural ones.	[Rubenstein, Michael] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Harvard University; Harvard University	Rubenstein, M (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.	mrubenst@seas.harvard.edu	Rubenstein, Michael/I-4373-2015		Wyss Institute for Biologically Inspired Engineering; NSF [CCF-0926148, CCF-0643898]	Wyss Institute for Biologically Inspired Engineering; NSF(National Science Foundation (NSF))	Supported by the Wyss Institute for Biologically Inspired Engineering and by NSF grants CCF-0926148 and CCF-0643898.	Anderson C, 2002, INSECT SOC, V49, P99, DOI 10.1007/s00040-002-8286-y; Arbuckle DJ, 2010, AUTON ROBOT, V28, P197, DOI 10.1007/s10514-009-9162-7; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Camazine S., 2003, SELF ORG BIOL SYSTEM; De Rosa M, 2006, IEEE INT CONF ROBOT, P1462, DOI 10.1109/ROBOT.2006.1641915; Goldstein SC, 2005, COMPUTER, V38, P99, DOI 10.1109/MC.2005.198; Gross R, 2006, IEEE T ROBOT, V22, P1115, DOI 10.1109/TRO.2006.882919; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Konolige K, 2006, SPR TRA ADV ROBOT, V21, P131; Lawrence Peter A, 1993, MAKING FLY GENETICS, V6; McLurkin J., 2006, AAAI SPRING S BOLDL, P72; Mlot NJ, 2011, P NATL ACAD SCI USA, V108, P7669, DOI 10.1073/pnas.1016658108; MOORE D, 2004, 2 INT C EMB NETW SEN, P50; Nagpal R, 2003, LECT NOTES COMPUT SC, V2634, P333; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rubenstein M., 2012, P 2012 IEEE INT C RO, P3293; Stoy K, 2006, ROBOT AUTON SYST, V54, P135, DOI 10.1016/j.robot.2005.09.017; Tolley MT, 2011, INT J ROBOT RES, V30, P1566, DOI 10.1177/0278364911398160; Tomita K, 1999, IEEE T ROBOTIC AUTOM, V15, P1035, DOI 10.1109/70.817668; Vartholomeos P, 2006, IEEE INT CONF ROBOT, P649, DOI 10.1109/ROBOT.2006.1641784; Werfel J, 2006, IEEE INT CONF ROBOT, P2787, DOI 10.1109/ROBOT.2006.1642123; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; William E., 2010, P 2010 INT C ROB AUT, P1438; Wood R, 2013, SCI AM, V308, P60, DOI 10.1038/scientificamerican0313-60; Wurman PR, 2008, AI MAG, V29, P9; Yim M, 2007, IEEE ROBOT AUTOM MAG, V14, P43, DOI 10.1109/MRA.2007.339623	26	645	661	27	380	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					795	799		10.1126/science.1254295	http://dx.doi.org/10.1126/science.1254295			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124435				2022-12-28	WOS:000340593100040
J	Coberly, EA; Hammer, RD				Coberly, Emily A.; Hammer, Richard D.			Morphologic Changes in Erythrocytes in Hypertriglyceridemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Coberly, Emily A.; Hammer, Richard D.] Univ Missouri, Sch Med, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Coberly, EA (corresponding author), Univ Missouri, Sch Med, Columbia, MO 65211 USA.	hammerrd@health.missouri.edu	Hammer, Richard D/H-8753-2019	Hammer, Richard D/0000-0002-7173-9414; Coberly, Emily/0000-0002-7199-5821					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					E9	E9		10.1056/NEJMicm1315541	http://dx.doi.org/10.1056/NEJMicm1315541			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZL	25119625				2022-12-28	WOS:000340819600001
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED A trial to extend breast cancer screening may be unethical	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Department of Health, 2011, IMPR OUTC STRAT CANC; ISRCTN Register, 2010, EV AG EXT NHS BREAST; Marmot MG, 2013, BRIT J CANCER, V108, P2205, DOI 10.1038/bjc.2013.177; National Health Service, 2007, CANC REF STRAT; Public Health England NHS Breast Cancer Screening Programme, WHAT DOES NHS BREAST; Richards M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6843; Science and Technology Committee, 2014, 244 HC SCI TECHN COM	7	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2014	349								g5105	10.1136/bmj.g5105	http://dx.doi.org/10.1136/bmj.g5105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RR	25116342	Green Published, Bronze			2022-12-28	WOS:000340506700008
J	Ashley, EA; Dhorda, M; Fairhurst, RM; Amaratunga, C; Lim, P; Suon, S; Sreng, S; Anderson, JM; Mao, S; Sam, B; Sopha, C; Chuor, CM; Nguon, C; Sovannaroth, S; Pukrittayakamee, S; Jittamala, P; Chotivanich, K; Chutasmit, K; Suchatsoonthorn, C; Runcharoen, R; Hien, TT; Thuy-Nhien, NT; Thanh, NV; Phu, NH; Htut, Y; Han, KT; Aye, KH; Mokuolu, OA; Olaosebikan, RR; Folaranmi, OO; Mayxay, M; Khanthavong, M; Hongvanthong, B; Newton, PN; Onyamboko, MA; Fanello, CI; Tshefu, AK; Mishra, N; Valecha, N; Phyo, AP; Nosten, F; Yi, P; Tripura, R; Borrmann, S; Bashraheil, M; Peshu, J; Faiz, MA; Ghose, A; Hossain, MA; Samad, R; Rahman, MR; Hasan, MM; Islam, A; Miotto, O; Amato, R; MacInnis, B; Stalker, J; Kwiatkowski, DP; Bozdech, Z; Jeeyapant, A; Cheah, PY; Sakulthaew, T; Chalk, J; Intharabut, B; Silamut, K; Lee, SJ; Vihokhern, B; Kunasol, C; Imwong, M; Tarning, J; Taylor, WJ; Yeung, S; Woodrow, CJ; Flegg, JA; Das, D; Smith, J; Venkatesan, M; Plowe, CV; Stepniewska, K; Guerin, PJ; Dondorp, AM; Day, NP; White, NJ				Ashley, E. A.; Dhorda, M.; Fairhurst, R. M.; Amaratunga, C.; Lim, P.; Suon, S.; Sreng, S.; Anderson, J. M.; Mao, S.; Sam, B.; Sopha, C.; Chuor, C. M.; Nguon, C.; Sovannaroth, S.; Pukrittayakamee, S.; Jittamala, P.; Chotivanich, K.; Chutasmit, K.; Suchatsoonthorn, C.; Runcharoen, R.; Hien, T. T.; Thuy-Nhien, N. T.; Thanh, N. V.; Phu, N. H.; Htut, Y.; Han, K-T.; Aye, K. H.; Mokuolu, O. A.; Olaosebikan, R. R.; Folaranmi, O. O.; Mayxay, M.; Khanthavong, M.; Hongvanthong, B.; Newton, P. N.; Onyamboko, M. A.; Fanello, C. I.; Tshefu, A. K.; Mishra, N.; Valecha, N.; Phyo, A. P.; Nosten, F.; Yi, P.; Tripura, R.; Borrmann, S.; Bashraheil, M.; Peshu, J.; Faiz, M. A.; Ghose, A.; Hossain, M. A.; Samad, R.; Rahman, M. R.; Hasan, M. M.; Islam, A.; Miotto, O.; Amato, R.; MacInnis, B.; Stalker, J.; Kwiatkowski, D. P.; Bozdech, Z.; Jeeyapant, A.; Cheah, P. Y.; Sakulthaew, T.; Chalk, J.; Intharabut, B.; Silamut, K.; Lee, S. J.; Vihokhern, B.; Kunasol, C.; Imwong, M.; Tarning, J.; Taylor, W. J.; Yeung, S.; Woodrow, C. J.; Flegg, J. A.; Das, D.; Smith, J.; Venkatesan, M.; Plowe, C. V.; Stepniewska, K.; Guerin, P. J.; Dondorp, A. M.; Day, N. P.; White, N. J.			Spread of Artemisinin Resistance in Plasmodium falciparum Malaria	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARASITE CLEARANCE; ARTESUNATE; CAMBODIA; SUSCEPTIBILITY; EFFICACY; PROVINCE; RATES	BACKGROUND Artemisinin resistance in Plasmodium falciparum has emerged in Southeast Asia and now poses a threat to the control and elimination of malaria. Mapping the geographic extent of resistance is essential for planning containment and elimination strategies. METHODS Between May 2011 and April 2013, we enrolled 1241 adults and children with acute, uncomplicated falciparum malaria in an open-label trial at 15 sites in 10 countries (7 in Asia and 3 in Africa). Patients received artesunate, administered orally at a daily dose of either 2 mg per kilogram of body weight per day or 4 mg per kilogram, for 3 days, followed by a standard 3-day course of artemisinin-based combination therapy. Parasite counts in peripheral-blood samples were measured every 6 hours, and the parasite clearance half-lives were determined. RESULTS The median parasite clearance half-lives ranged from 1.9 hours in the Democratic Republic of Congo to 7.0 hours at the Thailand-Cambodia border. Slowly clearing in-fections (parasite clearance half-life >5 hours), strongly associated with single point mutations in the "propeller" region of the P. falciparum kelch protein gene on chromosome 13 (kelch13), were detected throughout mainland Southeast Asia from southern Vietnam to central Myanmar. The incidence of pretreatment and post-treatment gametocytemia was higher among patients with slow parasite clearance, suggesting greater potential for transmission. In western Cambodia, where artemisinin-based combination therapies are failing, the 6-day course of antimalarial therapy was associated with a cure rate of 97.7% (95% confidence interval, 90.9 to 99.4) at 42 days. CONCLUSIONS Artemisinin resistance to P. falciparum, which is now prevalent across mainland Southeast Asia, is associated with mutations in kelch13. Prolonged courses of artemisinin-based combination therapies are currently efficacious in areas where standard 3-day treatments are failing. (Funded by the U. K. Department of International Development and others; ClinicalTrials.gov number, NCT01350856.)	[Ashley, E. A.; Fanello, C. I.; Phyo, A. P.; Nosten, F.; Tripura, R.; Miotto, O.; Jeeyapant, A.; Cheah, P. Y.; Sakulthaew, T.; Intharabut, B.; Silamut, K.; Lee, S. J.; Vihokhern, B.; Kunasol, C.; Tarning, J.; Taylor, W. J.; Woodrow, C. J.; Dondorp, A. M.; Day, N. P.; White, N. J.] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand; [Pukrittayakamee, S.; Jittamala, P.; Chotivanich, K.; Imwong, M.] Mahidol Univ, Fac Trop Med, Bangkok 10400, Thailand; [Chutasmit, K.] Phusing Hosp, Srisaket, Thailand; [Runcharoen, R.] Khunhan Hosp, Srisaket, Thailand; [Suchatsoonthorn, C.] Kraburi Hosp, Ranong, Thailand; [Phyo, A. P.; Nosten, F.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Ashley, E. A.; Dhorda, M.; Hien, T. T.; Mayxay, M.; Newton, P. N.; Onyamboko, M. A.; Fanello, C. I.; Phyo, A. P.; Nosten, F.; Cheah, P. Y.; Chalk, J.; Lee, S. J.; Tarning, J.; Taylor, W. J.; Woodrow, C. J.; Flegg, J. A.; Das, D.; Smith, J.; Venkatesan, M.; Stepniewska, K.; Guerin, P. J.; Dondorp, A. M.; Day, N. P.; White, N. J.] Univ Oxford, Ctr Trop Med, Oxford, England; [Dhorda, M.; Flegg, J. A.; Das, D.; Smith, J.; Venkatesan, M.; Stepniewska, K.; Guerin, P. J.] Univ Oxford, Ctr Trop Med, Worldwide Antimalarial Resistance Network, Oxford, England; [Miotto, O.; Amato, R.; MacInnis, B.; Stalker, J.; Kwiatkowski, D. P.] Univ Oxford, Nuffield Dept Med, Med Res Council Ctr Genom & Global Hlth, Oxford, England; [Amato, R.; Kwiatkowski, D. P.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Miotto, O.; MacInnis, B.; Stalker, J.; Kwiatkowski, D. P.] Wellcome Trust Sanger Inst, Cambridge, England; [Yeung, S.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Global Hlth & Dev, London WC1, England; [Yeung, S.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Policy & Clin Res Dept, London WC1, England; [Dhorda, M.; Smith, J.; Venkatesan, M.; Plowe, C. V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Malaria Grp,Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Fairhurst, R. M.; Amaratunga, C.; Lim, P.; Anderson, J. M.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Lim, P.; Suon, S.; Sreng, S.; Chuor, C. M.; Nguon, C.; Sovannaroth, S.; Yi, P.] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Mao, S.] Sampov Meas Referral Hosp, Pursat, Cambodia; [Sam, B.] Ratanakiri Referral Hosp, Ratanakiri, Cambodia; [Sopha, C.] Makara 16 Referral Hosp, Preah Vihear, Cambodia; [Hien, T. T.; Thuy-Nhien, N. T.; Thanh, N. V.; Phu, N. H.] Oxford Univ Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Htut, Y.; Han, K-T.; Aye, K. H.] Dept Med Res, Lower Myanmar, Yangon, Myanmar; [Mokuolu, O. A.; Olaosebikan, R. R.] Univ Ilorin, Dept Paediat & Child Hlth, Ilorin, Nigeria; [Folaranmi, O. O.] Univ Ilorin, Teaching Hosp, Dept Histopathol, Ilorin, Nigeria; [Mayxay, M.; Newton, P. N.] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Viangchan, Laos; [Mayxay, M.] Univ Hlth Sci, Fac Postgrad Studies, Viangchan, Laos; [Khanthavong, M.; Hongvanthong, B.] Ctr Malariol Parasitol & Entomol, Viangchan, Laos; [Onyamboko, M. A.; Tshefu, A. K.] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Mishra, N.; Valecha, N.] Indian Council Med Res, Natl Inst Malaria Res, Sect 8, New Delhi, India; [Borrmann, S.; Bashraheil, M.; Peshu, J.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Borrmann, S.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Borrmann, S.] German Ctr Infect Res, Tubingen, Germany; [Faiz, M. A.; Ghose, A.; Hossain, M. A.; Samad, R.; Rahman, M. R.] Malaria Res Grp, Dhaka, Bangladesh; [Faiz, M. A.; Ghose, A.; Hossain, M. A.; Samad, R.; Rahman, M. R.] Dev Care Fdn, Dhaka, Bangladesh; [Rahman, M. R.] Shaheed Suhrawardy Med Coll, Dhaka, Bangladesh; [Ghose, A.; Hossain, M. A.; Samad, R.; Hasan, M. M.] Chittagong Med Coll, Chittagong, Bangladesh; [Islam, A.] Ramu Upazila Hlth Complex, Coxs Bazar, Bangladesh; [Bozdech, Z.] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford; University of Oxford; Worldwide Antimalarial Resistance Network (WWARN); University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Center Parasitology, Entomology & Malaria Control; University of Ilorin; University of Ilorin; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Kenya Medical Research Institute; Eberhard Karls University of Tubingen; German Center for Infection Research; Chittagong Medical College; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	White, NJ (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, 420-6 Rajvithi Rd, Bangkok 10400, Thailand.	nickw@tropmedres.ac	Mishra, Dr. Neelima/D-3924-2017; Guerin, Philippe/AAH-8873-2021; White, Nick/AAC-6527-2019; Mokuolu, Olugbenga/G-4334-2016; Rahman, Ridwanur/K-2637-2019; Nosten, Francois/AAC-5509-2019; Fanello, Caterina/AAT-9679-2021; Phyo, Aung Pyae/GYU-6181-2022; Bozdech, Zbynek/A-2205-2011; Imwong, Mallika/ABE-6493-2020; Lim, Pharath/AAF-6699-2020; Phyo, Aung Pyae/K-2413-2019; Miotto, Olivo/AAE-7124-2019; Borrmann, Steffen/G-1838-2013	White, Nick/0000-0002-1897-1978; Mokuolu, Olugbenga/0000-0001-8273-5876; Nosten, Francois/0000-0002-7951-0745; Fanello, Caterina/0000-0003-1932-9562; Phyo, Aung Pyae/0000-0002-0383-9624; Phyo, Aung Pyae/0000-0002-0383-9624; Miotto, Olivo/0000-0001-8060-6771; Ashley, Elizabeth/0000-0002-7620-4822; Kunasol, Chanon/0000-0003-1744-0005; Flegg, Jennifer/0000-0002-8809-726X; Newton, Paul/0000-0002-4608-6431; Cheah, Phaik Yeong/0000-0001-6327-3266; Folaranmi, Olaleke/0000-0002-0237-8934; Mishra, Neelima/0000-0003-1361-6077; Lim, Pharath/0000-0002-1012-2461; Olaosebikan, Rasaq/0000-0002-3244-2212; Chirasatienpon, Tharisara/0000-0003-4320-054X; Borrmann, Steffen/0000-0001-9189-4393; Amato, Roberto/0000-0001-8633-9221; Thuy-Nhien, Nguyen/0000-0002-4101-5706; Guerin, Philippe/0000-0002-6008-2963; Woodrow, Charles/0000-0002-5134-7165; Bozdech, Zbynek/0000-0002-9830-8446; Stepniewska, Kasia/0000-0002-1713-6209; Tarning, Joel/0000-0003-4566-4030; Yeung, Shunmay/0000-0002-0997-0850; Kwiatkowski, Dominic/0000-0002-5023-0176	U.K. Department for International Development; Worldwide Antimalarial Resistance Network; National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Bill and Melinda Gates Foundation; Wellcome Trust of Great Britain; Medical Research Council [G0600718B] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001000, ZIAAI001066] Funding Source: NIH RePORTER	U.K. Department for International Development; Worldwide Antimalarial Resistance Network; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust of Great Britain(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the U.K. Department for International Development, the Worldwide Antimalarial Resistance Network, the Intramural Research Program of the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, and the Bill and Melinda Gates Foundation. The Mahidol-University Oxford Tropical Medicine Research Programme is funded by the Wellcome Trust of Great Britain.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; [Anonymous], 2014, STAT REP ART RES; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Barnes KI, 2008, J INFECT DIS, V197, P1605, DOI 10.1086/587645; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Carrara VI, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001398; Carrara VI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004551; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Chotivanich K, 2014, ANTIMICROB AGENTS CH, V58, P3157, DOI 10.1128/AAC.01924-13; Denis MB, 2006, TROP MED INT HEALTH, V11, P1800, DOI 10.1111/j.1365-3156.2006.01739.x; Dondorp AM, 2009, NEW ENGL J MED, V361, P1714; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kyaw MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057689; Leang R, 2013, CAMBODIA MALAR J, V12, P343; Leang R, 2013, ANTIMICROB AGENTS CH, V57, P818, DOI 10.1128/AAC.00686-12; Lopera-Mesa TM, 2013, J INFECT DIS, V207, P1655, DOI 10.1093/infdis/jit082; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Mok S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-391; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Saralamba S, 2011, P NATL ACAD SCI USA, V108, P397, DOI 10.1073/pnas.1006113108; Snounou G, 1998, PARASITOL TODAY, V14, P462, DOI 10.1016/S0169-4758(98)01340-4; Snow RW, 2001, TRENDS PARASITOL, V17, P593, DOI 10.1016/S1471-4922(01)02031-1; Stepniewska K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-127; Stepniewska K, 2010, J INFECT DIS, V201, P570, DOI 10.1086/650301; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Hien TT, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-355; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-278; Witkowski B, 2013, LANCET INFECT DIS, V13, P1043, DOI 10.1016/S1473-3099(13)70252-4; Witkowski B, 2013, ANTIMICROB AGENTS CH, V57, P914, DOI 10.1128/AAC.01868-12; World Health Organization, 2009, METH SURV ANT DRUG E; World Health Organization, 2012, UPD WHO POL REC SING; Worldwide Antimalarial Resistance Network, PAR CLEAR EST PCE	36	1348	1383	19	567	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					411	423		10.1056/NEJMoa1314981	http://dx.doi.org/10.1056/NEJMoa1314981			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0SK	25075834	Green Accepted, Green Published			2022-12-28	WOS:000339556900006
J	Packard, RM				Packard, Randall M.			The Origins of Antimalarial-Drug Resistance	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Johns Hopkins Sch Med, Dept Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Packard, RM (corresponding author), Johns Hopkins Sch Med, Dept Hist Med, Baltimore, MD 21205 USA.							Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Packard, 2016, HIST GLOBAL HLTH INT; Verdrager Jacques, 1995, Southeast Asian Journal of Tropical Medicine and Public Health, V26, P23; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]	4	58	59	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					397	399		10.1056/NEJMp1403340	http://dx.doi.org/10.1056/NEJMp1403340			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0SK	25075832				2022-12-28	WOS:000339556900003
J	Gane, E				Gane, Ed			Hepatitis C beware-the end is nigh	LANCET			English	Editorial Material							HCV GENOTYPE 1; NULL RESPONDERS; DISEASE BURDEN; VIRUS; RIBAVIRIN; DACLATASVIR; PEGINTERFERON; ASUNAPREVIR; INFECTION; THERAPY		[Gane, Ed] Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland 1142, New Zealand; [Gane, Ed] Univ Auckland, Fac Med, Auckland 1, New Zealand	Auckland City Hospital; University of Auckland	Gane, E (corresponding author), Auckland City Hosp, New Zealand Liver Transplant Unit, Auckland 1142, New Zealand.	edgane@adhb.govt.nz						Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society, 2014, REC TEST MAN TREAT H; Chayama K, 2012, HEPATOLOGY, V55, P742, DOI 10.1002/hep.24724; Chu TW, 2012, GASTROENTEROLOGY, V142, P790, DOI 10.1053/j.gastro.2011.12.057; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; European Association for the Study of the Liver, 2014, EASL REC TREATM HEP; Everson GT, 2014, J HEPATOL, V60, pS46, DOI 10.1016/S0168-8278(14)60113-6; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Forns X, 2014, GASTROENTEROLOGY, V146, P1669, DOI 10.1053/j.gastro.2014.02.051; Foster GR, 2011, GASTROENTEROLOGY, V141, P881, DOI 10.1053/j.gastro.2011.05.046; Guedj J, 2013, P NATL ACAD SCI USA, V110, P3991, DOI 10.1073/pnas.1203110110; Hagan LM, 2014, HEPATOLOGY, V60, P37, DOI 10.1002/hep.27151; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Jacobson IM, 2013, HEPATOLOGY, V58, p1379A; Kohli A, 2013, 64 ANN M AM ASS STUD; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; Lawitz E, 2014, LANCET; Lenz O, 2013, HEPATOLOGY, V58, p743A; Lok AS, 2014, J HEPATOL, V60, P490, DOI 10.1016/j.jhep.2013.10.019; Lok AS, 2012, NEW ENGL J MED, V366, P216, DOI 10.1056/NEJMoa1104430; Manns M, 2014, LANCET; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; North CS, 2013, GEN HOSP PSYCHIAT, V35, P122, DOI 10.1016/j.genhosppsych.2012.11.002; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Sievert W, 2011, LIVER INT, V31, P61, DOI 10.1111/j.1478-3231.2011.02540.x; Vierling JM, 2012, HEPATOLOGY, V56, P1522; Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P60, DOI 10.1111/jvh.12249; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	29	17	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 1	2014	384	9954					1557	1560		10.1016/S0140-6736(14)61225-3	http://dx.doi.org/10.1016/S0140-6736(14)61225-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AR9NK	25078308				2022-12-28	WOS:000343901700008
J	Goubau, D; Schlee, M; Deddouche, S; Pruijssers, AJ; Zillinger, T; Goldeck, M; Schuberth, C; Van der Veen, AG; Fujimura, T; Rehwinkel, J; Iskarpatyoti, JA; Barchet, W; Ludwig, J; Dermody, TS; Hartmann, G; Sousa, CRE				Goubau, Delphine; Schlee, Martin; Deddouche, Safia; Pruijssers, Andrea J.; Zillinger, Thomas; Goldeck, Marion; Schuberth, Christine; Van der Veen, Annemarthe G.; Fujimura, Tsutomu; Rehwinkel, Jan; Iskarpatyoti, Jason A.; Barchet, Winfried; Ludwig, Janos; Dermody, Terence S.; Hartmann, Gunther; Reis e Sousa, Caetano			Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5 '-diphosphates	NATURE			English	Article							DOUBLE-STRANDED-RNA; INDUCIBLE GENE-I; 5'-TRIPHOSPHATE RNA; DENDRITIC CELLS; INNATE IMMUNITY; VIRUS; INFECTION; ACID; GENERATION; INSIGHTS	Mammalian cells possess mechanisms to detect and defend themselves from invading viruses. In the cytosol, the RIG-I-like receptors (RLRs), RIG-I (retinoic acid-inducible gene I; encoded by DDX58) and MDA5 (melanoma differentiation-associated gene 5; encoded by IFIH1) sense atypical RNAs associated with virus infection(1,2). Detection triggers a signalling cascade via the adaptor MAVS that culminates in the production of type I interferons (IFN-alpha and beta; hereafter IFN), which are key antiviral cytokines. RIG-I and MDA5 are activated by distinct viral RNA structures and much evidence indicates that RIG-I responds to RNAs bearing a triphosphate (ppp) moiety in conjunction with a blunt-ended, base-paired region at the 5'-end (reviewed in refs 1-3). Here we show that RIG-I also mediates antiviral responses to RNAs bearing 5'-diphosphates (5'pp). Genomes from mammalian reoviruses with 5'pp termini, 5'pp-RNA isolated from yeast L-A virus, and base-paired 5'pp-RNAs made by in vitro transcription or chemical synthesis, all bind to RIG-I and serve as RIG-I agonists. Furthermore, a RIG-I-dependent response to 5'pp-RNA is essential for controlling reovirus infection in cultured cells and in mice. Thus, the minimal determinant for RIG-I recognition is a base-paired RNA with 5'pp. Such RNAs are found in some viruses but not in uninfected cells, indicating that recognition of 5'pp-RNA, like that of 5'ppp-RNA, acts as a powerful means of self/non-self discrimination by the innate immune system.	[Goubau, Delphine; Deddouche, Safia; Van der Veen, Annemarthe G.; Rehwinkel, Jan; Reis e Sousa, Caetano] Canc Res UK, London Res Inst, Immunobiol Lab, London WC2A 3LY, England; [Schlee, Martin; Zillinger, Thomas; Goldeck, Marion; Schuberth, Christine; Barchet, Winfried; Ludwig, Janos; Hartmann, Gunther] Univ Klinikum Bonn, Inst Klin Chem, D-53127 Bonn, Germany; [Schlee, Martin; Zillinger, Thomas; Goldeck, Marion; Schuberth, Christine; Barchet, Winfried; Ludwig, Janos; Hartmann, Gunther] Univ Klinikum Bonn, Klin Pharmakol, D-53127 Bonn, Germany; [Pruijssers, Andrea J.; Iskarpatyoti, Jason A.; Dermody, Terence S.] Vanderbilt Univ, Dept Pediat, Sch Med, Nashville, TN 37232 USA; [Pruijssers, Andrea J.; Iskarpatyoti, Jason A.; Dermody, Terence S.] Vanderbilt Univ, Sch Med, Elizabeth B Lamb Ctr Pediat Res, Nashville, TN 37232 USA; [Fujimura, Tsutomu] Univ Salamanca, Inst Biol Func & Genom, Consejo Super Invest Cient, Salamanca 37007, Spain; [Dermody, Terence S.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Cancer Research UK; University of Bonn; University of Bonn; Vanderbilt University; Vanderbilt University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Vanderbilt University	Goubau, D (corresponding author), Canc Res UK, London Res Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	delphine.goubau@cancer.org.uk; caetano@cancer.org.uk	Ludwig, Janos/I-3544-2013; Goldeck, Marion/AAX-5599-2020; Schlee, Martin/AAL-1238-2021; Rehwinkel, Jan/CAG-1436-2022; Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021; Hartmann, Gunther/P-7492-2017; Zillinger, Thomas/AAD-7320-2020; Fujimura, Tsutomu/K-5807-2014; Pruijssers, Andrea J/S-5725-2018	Rehwinkel, Jan/0000-0003-3841-835X; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Hartmann, Gunther/0000-0003-1021-2018; Zillinger, Thomas/0000-0002-0866-4835; Fujimura, Tsutomu/0000-0002-9457-6769; Pruijssers, Andrea J/0000-0001-7910-626X; Barchet, Winfried/0000-0002-6745-6606; Schlee, Martin/0000-0003-3671-7639; Goldeck, Marion/0000-0003-1899-4763	Cancer Research UK; European Research Council (ERC Advanced Researcher Grant) [AdG-2010-268670]; Public Health Service award [R37 AI038296]; Elizabeth B. Lamb Center for Pediatric Research; Fundacion Ramon Areces; Deutsche Forschungsgemeinschaft [SFB670, DFG SCHL1930/1-1, SFB704, SFB832, KFO177]; DFG Excellence Cluster ImmunoSensation; German Center of Infectious Disease (DZIF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI038296, R01AI038296, R01AI050800] Funding Source: NIH RePORTER; Cancer Research UK [15689] Funding Source: researchfish; Medical Research Council [MC_UU_12010/8] Funding Source: researchfish; MRC [MC_UU_12010/8] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); European Research Council (ERC Advanced Researcher Grant); Public Health Service award(United States Department of Health & Human ServicesUnited States Public Health Service); Elizabeth B. Lamb Center for Pediatric Research; Fundacion Ramon Areces; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG Excellence Cluster ImmunoSensation(German Research Foundation (DFG)); German Center of Infectious Disease (DZIF); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Akira and J. Tschopp (deceased) for gifts of mice and cells, as well as N. O'Reilly, the LRI Equipment Park (D. Phillips), and the LRI Protein Analysis and Proteomics Facility (R. George and S. Kjaer) for technical assistance. We also thank P. Maillard and K. Snelgrove for reading the manuscript, P. Tortora, G. Deho and M. Freire for their insights on the synthesis of poly(I: C) and all members of the CRUK Immunobiology Laboratory for helpful discussions and comments. C. R. S., D. G., S. D. and A. G. V. V. are funded by Cancer Research UK, a prize from Fondation Bettencourt-Schueller, and a grant from the European Research Council (ERC Advanced Researcher Grant AdG-2010-268670). A. J. P. and T. S. D. are supported by Public Health Service award R37 AI038296 and the Elizabeth B. Lamb Center for Pediatric Research. T. F. is supported by the Fundacion Ramon Areces. G. H., M. S. and W. B. are supported by the Deutsche Forschungsgemeinschaft (http://www.dfg.de; SFB670 to M. S., W. B. and G. H., DFG SCHL1930/1-1 to M. S., SFB704 to G. H. and W. B., SFB832 and KFO177 to G. H.). G. H. and M. S. are supported by the DFG Excellence Cluster ImmunoSensation. G. H. is supported by the German Center of Infectious Disease (DZIF).	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Barton ES, 2001, J BIOL CHEM, V276, P2200, DOI 10.1074/jbc.M004680200; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Boehme KW, 2011, J VIROL, V85, P11781, DOI 10.1128/JVI.02289-10; Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675; Dermody TS, 2013, FIELDS VIROLOGY, P1304; DIAZRUIZ JR, 1978, PREP BIOCHEM, V8, P1, DOI 10.1080/00327487808068215; Diebold SS, 2003, NATURE, V424, P324, DOI 10.1038/nature01783; Fujimura T, 2011, P NATL ACAD SCI USA, V108, P17667, DOI 10.1073/pnas.1111900108; Fujimura T, 2010, J BIOL CHEM, V285, P22909, DOI 10.1074/jbc.M110.138982; Gerlier D, 2011, MICROBIOL MOL BIOL R, V75, P468, DOI 10.1128/MMBR.00007-11; Goldeck M, 2014, ANGEW CHEM INT EDIT, V53, P4694, DOI 10.1002/anie.201400672; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; GRUNBERGMANAGO M, 1955, SCIENCE, V122, P907, DOI 10.1126/science.122.3176.907; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Kohlway A, 2013, EMBO REP, V14, P772, DOI 10.1038/embor.2013.108; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rehwinkel J, 2013, CURR OPIN MICROBIOL, V16, P485, DOI 10.1016/j.mib.2013.04.009; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Schlee M, 2013, IMMUNOBIOLOGY, V218, P1322, DOI 10.1016/j.imbio.2013.06.007; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Vela A, 2012, J BIOL CHEM, V287, P42564, DOI 10.1074/jbc.M112.385146; VIRGIN HW, 1988, J VIROL, V62, P4594, DOI 10.1128/JVI.62.12.4594-4604.1988; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863	34	364	376	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					372	+		10.1038/nature13590	http://dx.doi.org/10.1038/nature13590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25119032	Bronze, Green Accepted			2022-12-28	WOS:000342988600053
J	Marusyk, A; Tabassum, DP; Altrock, PM; Almendro, V; Michor, F; Polyak, K				Marusyk, Andriy; Tabassum, Doris P.; Altrock, Philipp M.; Almendro, Vanessa; Michor, Franziska; Polyak, Kornelia			Non-cell-autonomous driving of tumour growth supports sub-clonal heterogeneity	NATURE			English	Article							IL-6 FAMILY CYTOKINE; CANCER; EVOLUTION; MODEL; TUMORIGENESIS; INFLAMMATION; COMPETITION; MUTATIONS; SELECTION; LEUKEMIA	Cancers arise through a process of somatic evolution that can result in substantial sub-clonal heterogeneity within tumours. The mechanisms responsible for the coexistence of distinct sub-clones and the biological consequences of this coexistence remain poorly understood. Here we used a mouse xenograft model to investigate the impact of sub-clonal heterogeneity on tumour phenotypes and the competitive expansion of individual clones. We found that tumour growth can be driven by a minor cell subpopulation, which enhances the proliferation of all cells within a tumour by overcoming environmental constraints and yet can be outcompeted by faster proliferating competitors, resulting in tumour collapse. We developed a mathematical modelling framework to identify the rules underlying the generation of intra-tumour clonal heterogeneity. We found that non-cell-autonomous driving of tumour growth, together with clonal interference, stabilizes sub-clonal heterogeneity, thereby enabling inter-clonal interactions that can lead to new phenotypic traits.	[Marusyk, Andriy; Tabassum, Doris P.; Almendro, Vanessa; Polyak, Kornelia] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Marusyk, Andriy; Almendro, Vanessa; Polyak, Kornelia] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Marusyk, Andriy; Almendro, Vanessa; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Tabassum, Doris P.; Polyak, Kornelia] Harvard Univ, Sch Med, BBS Program, Boston, MA 02115 USA; [Altrock, Philipp M.; Michor, Franziska] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Altrock, Philipp M.; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Altrock, Philipp M.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Polyak, Kornelia] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Polyak, Kornelia] Broad Inst, Cambridge, MA 02138 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Polyak, K (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	kornelia_polyak@dfci.harvard.edu	Kessenbrock, Kai/B-6936-2011; Altrock, Philipp/X-9063-2018	Altrock, Philipp/0000-0001-7731-3345	Dana-Farber Cancer Institute Physical Sciences-Oncology Center [U54CA143798]; CDRMP Breast Cancer Research Program [W81XWH-09-1-0561]; Cellex Foundation; Deutsche Akademie der Naturforscher Leopoldina [LPDS2012-12]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	Dana-Farber Cancer Institute Physical Sciences-Oncology Center; CDRMP Breast Cancer Research Program; Cellex Foundation; Deutsche Akademie der Naturforscher Leopoldina; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. DeGregori, A. Goldman, A. Rozhok, M. Gonen and members of the Polyak and Michor laboratories for their critical reading of this manuscript and discussions. We thank L. Cameron in the DFCI Confocal Microscopy for her technical support. This work was supported by the Dana-Farber Cancer Institute Physical Sciences-Oncology Center (U54CA143798 to F. M.), CDRMP Breast Cancer Research Program W81XWH-09-1-0561 (A. M.), Cellex Foundation (V. A.), Deutsche Akademie der Naturforscher Leopoldina LPDS2012-12 (P. M. A.) and the Breast Cancer Research Foundation (K.P.).	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; DeGregori J, 2013, ONCOGENE, V32, P1869, DOI 10.1038/onc.2012.281; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ernst M, 2008, J CLIN INVEST, V118, P1727, DOI 10.1172/JCI34944; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gatenby RA, 2008, NAT REV CANCER, V8, P56, DOI 10.1038/nrc2255; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Kreso A, 2013, SCIENCE, V339, P543, DOI 10.1126/science.1227670; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Levayer R, 2013, J CELL BIOL, V200, P689, DOI 10.1083/jcb.201301051; Maley CC, 2004, CANCER EPIDEM BIOMAR, V13, P1375; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Merlo LMF, 2006, NAT REV CANCER, V6, P924, DOI 10.1038/nrc2013; Nagy JD, 2004, B MATH BIOL, V66, P663, DOI 10.1016/j.bulm.2003.10.001; Navin NE, 2010, MOL ONCOL, V4, P267, DOI 10.1016/j.molonc.2010.04.010; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Putoczki T, 2010, J LEUKOCYTE BIOL, V88, P1109, DOI 10.1189/jlb.0410226; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Weinberg RA, 2007, BIOL CANC; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702	29	378	391	3	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					54	+		10.1038/nature13556	http://dx.doi.org/10.1038/nature13556			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25079331	Green Submitted, Green Accepted			2022-12-28	WOS:000342420800033
J	Zid, BM; O'Shea, EK				Zid, Brian M.; O'Shea, Erin K.			Promoter sequences direct cytoplasmic localization and translation of mRNAs during starvation in yeast	NATURE			English	Article							SHOCK TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; HEAT-SHOCK; PROCESSING BODIES; STRESS GRANULES; P-BODIES; IN-VIVO; GENE; STABILITY; EXPRESSION	A universal feature of the response to stress and nutrient limitation is transcriptional upregulation of genes that encode proteins important for survival. Under many such conditions, the overall protein synthesis level is reduced, thereby dampening the stress response at the level of protein expression(1). For example, during glucose starvation in Saccharomyces cerevisiae (yeast), translation is rapidly repressed, yet the transcription of many stress-and glucose-repressed genes is increased(2,3). Here we show, using ribosomal profiling and microscopy, that this transcriptionally upregulated gene set consists of two classes: one class produces messenger RNAs that are translated during glucose starvation and are diffusely localized in the cytoplasm, including many heat-shock protein mRNAs; and the other class produces mRNAs that are not efficiently translated during glucose starvation and are concentrated in foci that co-localize with P bodies and stress granules, a class that isenriched for mRNAs involved in glucose metabolism. Surprisingly, the information specifying the differential localization and protein production of these two classes of mRNA is encoded in the promoter sequence: promoter responsiveness to heat-shock factor 1 (Hsf1) specifies diffuse cytoplasmic localization and higher protein production on glucose starvation. Thus, promoter sequences can influence not only the levels of mRNAs but also the subcellular localization of mRNAs and the efficiency with which they are translated, enabling cells to tailor protein production to the environmental conditions.	[Zid, Brian M.; O'Shea, Erin K.] Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA; [Zid, Brian M.; O'Shea, Erin K.] Harvard Univ, Ctr Syst Biol, Fac Arts & Sci, Cambridge, MA 02138 USA; [O'Shea, Erin K.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [O'Shea, Erin K.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	O'Shea, EK (corresponding author), Harvard Univ, Dept Mol & Cell Biol, Cambridge, MA 02138 USA.	Erin_Oshea@harvard.edu		Zid, Brian/0000-0003-1876-2479	American Cancer Society; New England Division Funding A Cure initiative; Howard Hughes Medical Institute	American Cancer Society(American Cancer Society); New England Division Funding A Cure initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank A. Subramaniam, S. Mukherji, V. Denic, B. Stern and M. Waldram for feedback on the paper, members of the O'Shea, Denic, and Calarco laboratories for discussions, and C. Daly for sequencing assistance. This research was supported by the American Cancer Society and the New England Division Funding A Cure initiative (B.M.Z.) and the Howard Hughes Medical Institute (E.K.O.).	Arribere JA, 2011, MOL CELL, V44, P745, DOI 10.1016/j.molcel.2011.09.019; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Bregman A, 2011, CELL, V147, P1473, DOI 10.1016/j.cell.2011.12.005; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cook KE, 2012, G3-GENES GENOM GENET, V2, P1129, DOI 10.1534/g3.112.003251; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hahn JS, 2004, J BIOL CHEM, V279, P5169, DOI 10.1074/jbc.M311005200; Haim-Vilmovsky L, 2009, NAT PROTOC, V4, P1274, DOI 10.1038/nprot.2009.115; Hansen AS, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.56; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lutfiyya LL, 1998, GENETICS, V150, P1377; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Simpson CE, 2012, BIOCHEM SOC T, V40, P794, DOI 10.1042/BST20120078; Stohr N, 2006, J CELL BIOL, V175, P527, DOI 10.1083/jcb.200608071; SUSEK RE, 1990, MOL CELL BIOL, V10, P6362, DOI 10.1128/MCB.10.12.6362; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Trcek T, 2011, CELL, V147, P1484, DOI 10.1016/j.cell.2011.11.051; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; WIEDERRECHT G, 1988, CELL, V54, P841, DOI 10.1016/S0092-8674(88)91197-X	29	127	129	1	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2014	514	7520					117	+		10.1038/nature13578	http://dx.doi.org/10.1038/nature13578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP9SS	25119046	Green Accepted, Green Submitted			2022-12-28	WOS:000342420800047
J	Campbell, PT				Campbell, Peter T.			Obesity: a certain and avoidable cause of cancer	LANCET			English	Editorial Material							RISK-FACTORS; DISEASE		Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30303 USA	American Cancer Society	Campbell, PT (corresponding author), Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30303 USA.	peter.campbell@cancer.org						Bhaskaran K, 2014, LANCET; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Hastings G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5124; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lindkvist B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-103; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; MORRIS JN, 1966, LANCET, V2, P553, DOI 10.1016/S0140-6736(66)93034-0; Ng M., 2014, LANCET; Park J, 2014, NAT REV ENDOCRINOL, DOI [0.1038/ nrendo. 2014.94, DOI 10.1038/NREND0.2014.94]; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sturm R, 2014, CA-CANCER J CLIN, V64, P337, DOI 10.3322/caac.21237	11	14	19	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 30	2014	384	9945					727	728		10.1016/S0140-6736(14)61172-7	http://dx.doi.org/10.1016/S0140-6736(14)61172-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AO5DD	25129326				2022-12-28	WOS:000341361500011
J	LaBella, C				LaBella, Cynthia			Concussion and Female Middle School Athletes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SPORT-RELATED CONCUSSION; UNITED-STATES; EPIDEMIOLOGY; COLLEGIATE; PLAYERS	JAMA PEDIATRICS Concussion Among Female Middle-School Soccer Players John W. O'Kane, MD: Amy Spieker, MPH; Marni R. Levy, BS; Moni Neradilek, MS: Nayak L. Polissar, PhD: Melissa A. Schiff, MD, MPH IMPORTANCE Despite recent increased awareness about sports concussions, little research has evaluated concussions among middle-school athletes. OBJECTIVES To evaluate the frequency and duration of concussions in female youth soccer players and to determine if concussions result in stopping play and seeking medical care. DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study from March 2008 through May 2012 among 4 soccer clubs from the Puget Sound region of Washington State, involving 351 elite female soccer players, aged 11 to 14 years, from 33 randomly selected youth soccer teams. Of the players contacted, 83.1% participated and 92.4% completed the study. MAIN OUTCOMES AND MEASURES Concussion cumulative incidence, incidence rate, and description of the number, type, and duration of symptoms. We inquired weekly about concussion symptoms and, if present, the symptom type and duration, the event resulting in symptom onset, and whether the player sought medical attention or played while symptomatic. RESULTS Among the 351 soccer players, there were 59 concussions with 43 742 athletic exposure hours. Cumulative concussion incidence was 13.0% per season, and the incidence rate was 1.2 per 1000 athletic exposure hours (95% CI, 0.9-1.6). Symptoms lasted a median of 4.0 days (mean, 9.4 days). Heading the ball accounted for 30.5% of concussions. Players with the following symptoms had a longer recover time than players without these symptoms: light sensitivity (16.0 vs 3.0 days, P = .001), emotional lability (15.0 vs 3.5 days, P = .002), noise sensitivity (12.0 vs 3.0 days, P = .004), memory loss (9.0 vs 4.0 days, P = .04), nausea (9.0 vs 3.0 days, P = .02), and concentration problems (7.0 vs 2.0 days, P = .02). Most players (58.6%) continued to play with symptoms, with almost half (44.1%) seeking medical attention. CONCLUSIONS AND RELEVANCE Concussion rates in young female soccer players are greater than those reported in older age groups, and most of those concussed report playing with symptoms. Heading the ball is a frequent precipitating event. Awareness of recommendations to not play and seek medical attention is lacking for this age group.	Northwestern Univ, Feinberg Sch Med, Dept Pediat, 225 E Chicago Ave,POB 69, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	LaBella, C (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pediat, 225 E Chicago Ave,POB 69, Chicago, IL 60611 USA.	clabella@luriechildrens.org						Buzzini SRR, 2006, CURR OPIN PEDIATR, V18, P376, DOI 10.1097/01.mop.0000236385.26284.ec; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist J., 2007, Morbidity and Mortality Weekly Report, V56, P733; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Scopaz KA, 2013, SPORTS HEALTH, V5, P537, DOI 10.1177/1941738112473059	9	3	3	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 20	2014	312	7					739	+		10.1001/jama.2014.6668	http://dx.doi.org/10.1001/jama.2014.6668			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN2TR	25083908				2022-12-28	WOS:000340438700022
J	Rauch, W; Kleidorfer, M				Rauch, Wolfgang; Kleidorfer, Manfred			WATER TREATMENT Replace contamination, not the pipes	SCIENCE			English	Editorial Material									[Rauch, Wolfgang; Kleidorfer, Manfred] Univ Innsbruck, Inst Infrastruct Engn, A-6020 Innsbruck, Austria	University of Innsbruck	Rauch, W (corresponding author), Univ Innsbruck, Inst Infrastruct Engn, Technikerstr 13, A-6020 Innsbruck, Austria.	wolfgang.rauch@uibk.ac.at	Kleidorfer, Manfred/A-5985-2009; Rauch, Wolfgang/ABC-9481-2020	Kleidorfer, Manfred/0000-0002-4001-1711; Rauch, Wolfgang/0000-0002-6462-2832				Bach PM, 2014, ENVIRON MODELL SOFTW, V54, P88, DOI 10.1016/j.envsoft.2013.12.018; Hvitved-Jacobsen T., 2013, SEWER PROCESSES MICR; Larsen TA, 2013, SOURCE SEPARATION AND DECENTRALIZATION FOR WASTEWATER MANAGEMENT, P1; MAKI AW, 1984, WATER RES, V18, P893, DOI 10.1016/0043-1354(84)90275-6; Olmsted F. H., 1900, ENG NEWS, V44, P19; Pikaar I, 2014, SCIENCE, V345, P812, DOI 10.1126/science.1251418; WHO/UNICEF, 2014, PROGR DRINK WAT SAN; Zhang L, 2008, WATER RES, V42, P1, DOI 10.1016/j.watres.2007.07.013	8	21	23	3	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					734	735		10.1126/science.1257988	http://dx.doi.org/10.1126/science.1257988			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124414				2022-12-28	WOS:000340593100016
J	Garrick-Bethell, I; Perera, V; Nimmo, F; Zuber, MT				Garrick-Bethell, Ian; Perera, Viranga; Nimmo, Francis; Zuber, Maria T.			The tidal-rotational shape of the Moon and evidence for polar wander	NATURE			English	Article							INTERNAL STRUCTURE; GRAVITY-FIELD; LUNAR; ASYMMETRY	The origin of the Moon's large-scale topography is important for understanding lunar geology(1), lunar orbital evolution(2) and the Moon's orientation in the sky(3). Previous hypotheses for its origin have included late accretion events(4), large impacts(5), tidal effects(6) and convection processes(7). However, testing these hypotheses and quantifying the Moon's topography is complicated by the large basins that have formed since the crust crystallized. Here we estimate the large-scale lunar topography and gravity spherical harmonics outside these basins and show that the bulk of the spherical harmonic degree-2 topography is consistent with a crust-building process controlled by early tidal heating throughout the Moon. The remainder of the degree-2 topography is consistent with a frozen tidal-rotational bulge that formed later, at a semi-major axis of about 32 Earth radii. The probability of the degree-2 shape having both tidal-heating and frozen shape characteristics by chance is less than 1%. We also infer that internal density contrasts eventually reoriented the Moon's polar axis by 36 +/- 4 degrees, to the configuration we observe today. Together, these results link the geology of the near and far sides, and resolve long-standing questions about the Moon's large-scale shape, gravity and history of polar wander.	[Garrick-Bethell, Ian; Perera, Viranga; Nimmo, Francis] Univ Calif Santa Cruz, Dept Earth & Planetary Sci, Santa Cruz, CA 95064 USA; [Garrick-Bethell, Ian] Kyung Hee Univ, Sch Space Res, Yongin 446701, Gyeonggi Do, South Korea; [Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	University of California System; University of California Santa Cruz; Kyung Hee University; Massachusetts Institute of Technology (MIT)	Garrick-Bethell, I (corresponding author), Univ Calif Santa Cruz, Dept Earth & Planetary Sci, 1156 High St, Santa Cruz, CA 95064 USA.	igarrick@ucsc.edu	Perera, Viranga/S-6140-2019; Perera, Viranga/A-8537-2018	Perera, Viranga/0000-0002-6061-4915; Perera, Viranga/0000-0002-6061-4915; Garrick-Bethell, Ian/0000-0002-6327-5867	National Research Foundation (NRF) - Ministry of Education of Korea	National Research Foundation (NRF) - Ministry of Education of Korea	This work was supported by the BK21-plus programme through the National Research Foundation (NRF), funded by the Ministry of Education of Korea. Conversations with E. Mazarico are appreciated. We acknowledge the GRAIL and LRO teams for the gravity and topography data used in the analysis.	Borg LE, 2011, NATURE, V477, P70, DOI 10.1038/nature10328; Dwyer CA, 2011, NATURE, V479, P212, DOI 10.1038/nature10564; Garrick-Bethell I, 2006, SCIENCE, V313, P652, DOI 10.1126/science.1128237; Garrick-Bethell I, 2010, SCIENCE, V330, P949, DOI 10.1126/science.1193424; Garrick-Bethell I, 2009, ICARUS, V204, P399, DOI 10.1016/j.icarus.2009.05.032; Jeffreys H., 1937, MONTHLY NOTICES ROYA, V4, P1; Jutzi M, 2011, NATURE, V476, P69, DOI 10.1038/nature10289; LAMBECK K, 1980, PHYS EARTH PLANET IN, V22, P29, DOI 10.1016/0031-9201(80)90097-7; Laneuville M, 2013, J GEOPHYS RES-PLANET, V118, P1435, DOI 10.1002/jgre.20103; Loper DE, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001441; MELOSH HJ, 1975, EARTH PLANET SC LETT, V26, P353, DOI 10.1016/0012-821X(75)90011-4; MELOSH HJ, 1975, EARTH PLANET SC LETT, V25, P322, DOI 10.1016/0012-821X(75)90248-4; Meyer J, 2010, ICARUS, V208, P1, DOI 10.1016/j.icarus.2010.01.029; Namiki N, 2009, SCIENCE, V323, P900, DOI 10.1126/science.1168029; OJAKANGAS GW, 1989, ICARUS, V81, P220, DOI 10.1016/0019-1035(89)90052-3; RUNCORN SK, 1983, NATURE, V304, P589, DOI 10.1038/304589a0; Sedgwick W. F., 1898, MESSENGER MATH, V27, P171; Siegler MA, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003652; Smith DE, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043751; Smith DE, 1997, J GEOPHYS RES-PLANET, V102, P1591, DOI 10.1029/96JE02940; Solomon S. C., 1977, P LUNAR PLANET SCI C, P583; Stevenson D. J., 2001, P LUNAR PLANET SCI C, V32, P1175; UREY HC, 1959, ASTROPHYS J, V129, P842, DOI 10.1086/146679; Wieczorek MA, 2013, SCIENCE, V339, P671, DOI 10.1126/science.1231530; Wilhelms D.E., 1987, USGS PROFESSIONAL PA; Williams JG, 2001, J GEOPHYS RES-PLANET, V106, P27933, DOI 10.1029/2000JE001396; Zhong SJ, 2000, J GEOPHYS RES-PLANET, V105, P4153, DOI 10.1029/1999JE001075; Zhong SJ, 2000, EARTH PLANET SC LETT, V177, P131, DOI 10.1016/S0012-821X(00)00041-8; Zuber MT, 2013, SCIENCE, V339, P668, DOI 10.1126/science.1231507; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839	30	28	28	3	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					181	184		10.1038/nature13639	http://dx.doi.org/10.1038/nature13639			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25079322	Green Submitted			2022-12-28	WOS:000340200700029
J	Jez, JM; Blankenship, RE				Jez, Joseph M.; Blankenship, Robert E.			Lights, X-Rays, Oxygen!	CELL			English	Editorial Material							FREE-ELECTRON LASERS; PHOTOSYSTEM-II; DIFFRACTION; SPECTROSCOPY; WATER	Photosystem II uses metal ions to oxidize water to form O-2. Two recent papers employ the new technique of serial femtosecond crystallography utilizing X-ray free-electron lasers and nanocrystals to obtain initial structures of intermediate states of photosystem II catalysis at the site of oxygen production.	[Jez, Joseph M.; Blankenship, Robert E.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Blankenship, Robert E.] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@wustl.edu						Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; Bogan MJ, 2013, ANAL CHEM, V85, P3464, DOI 10.1021/ac303716r; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Doerr A, 2011, NAT METHODS, V8, P283, DOI 10.1038/nmeth0411-283; Kern J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5371; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kupitz C., 2014, NATURE; Schlichting I, 2012, CURR OPIN STRUC BIOL, V22, P613, DOI 10.1016/j.sbi.2012.07.015; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186	10	0	2	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					701	704		10.1016/j.cell.2014.07.037	http://dx.doi.org/10.1016/j.cell.2014.07.037			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126779	Bronze			2022-12-28	WOS:000340944700004
J	Scheeres, DJ				Scheeres, Daniel J.			SOLAR SYSTEM Sandcastles in space	NATURE			English	Editorial Material							ROTATIONAL BREAKUP; FORCES	Analysis of a kilometre-sized, near-Earth asteroid shows that forces weaker than the weight of a penny can keep it from falling apart. This has implications for understanding the evolution of the Solar System.	Univ Colorado, Dept Aerosp Engn Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Scheeres, DJ (corresponding author), Univ Colorado, Dept Aerosp Engn Sci, Boulder, CO 80309 USA.	scheeres@colorado.edu		SCHEERES, DANIEL/0000-0003-0558-3842				AHRENS TJ, 1992, NATURE, V360, P429, DOI 10.1038/360429a0; Farnocchia D, 2014, ICARUS, V229, P321, DOI 10.1016/j.icarus.2013.09.022; Goldreich P, 2009, ASTROPHYS J, V691, P54, DOI 10.1088/0004-637X/691/1/54; Hirabayashi M, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/1/L12; Jacobson SA, 2011, ICARUS, V214, P161, DOI 10.1016/j.icarus.2011.04.009; Jewitt D, 2014, ASTROPHYS J LETT, V784, DOI 10.1088/2041-8205/784/1/L8; Jewitt D, 2013, ASTROPHYS J LETT, V778, DOI 10.1088/2041-8205/778/1/L21; Rozitis B, 2014, NATURE, V512, P174, DOI 10.1038/nature13632; Sanchez P, 2014, METEORIT PLANET SCI, V49, P788, DOI 10.1111/maps.12293; Scheeres DJ, 2010, ICARUS, V210, P968, DOI 10.1016/j.icarus.2010.07.009; Walsh KJ, 2008, NATURE, V454, P188, DOI 10.1038/nature07078	11	3	4	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					139	140		10.1038/512139a	http://dx.doi.org/10.1038/512139a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25119230				2022-12-28	WOS:000340200700016
J	Kohli, A; Shaffer, A; Sherman, A; Kottilil, S				Kohli, Anita; Shaffer, Ashton; Sherman, Amy; Kottilil, Shyam			Treatment of Hepatitis C A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TREATMENT-NAIVE PATIENTS; SUSTAINED VIROLOGICAL RESPONSE; VIRUS GENOTYPE 1; PEGINTERFERON ALPHA-2A; PEGYLATED INTERFERON; PLUS RIBAVIRIN; COMBINATION THERAPY; DRUG-INTERACTIONS; B-VIRUS; HCV	IMPORTANCE Hepatitis C virus (HCV) infects more than 185 million individuals worldwide. Twenty percent of patients chronically infected with HCV progress to cirrhosis. New, simpler therapeutics using direct-acting antivirals that target various stages of the HCV life cycle are in development to eradicate HCV without concomitant interferon. OBJECTIVES To summarize published evidence on safety, efficacy (measured by a sustained virologic response [SVR], which is the treatment goal of undetectable plasma HCV RNA 12 or 24 weeks after therapy completion), and tolerability of current US Food and Drug Administration-approved interferon-based regimens and oral interferon-free regimens used for treating HCV infection and coinfection with human immunodeficiency virus (HIV) and HCV; to provide treatment recommendations for specialists and generalists based on published evidence. EVIDENCE REVIEW A literature search of Web of Science, Scopus, Embase, Agricola, Cochrane Library, Cinahl Plus, ClinicalTrials.gov, Conference Papers Index, Gideon, PsycINFO, Google Scholar, and Oaister was conducted from January 1, 2009, to May 30, 2014. Publications describing phase 2, 3, and 4 studies evaluating the treatment of HCV were included. Forty-one studies involving 19 063 adult patients were included. Strength of clinical data and subsequent HCV treatment recommendations were graded according to the Oxford Centre for Evidence-Based Medicine. FINDINGS Patients infected with HCV genotype 1 represent 60% to 75% of HCV infections in the United States. Hepatitis C virus genotype 1 is more difficult to cure than genotype 2 or genotype 3. Patients with HCV genotype 1 should receive treatment with sofosbuvir + pegylated interferon + ribavirin because of the shorter duration of therapy and high rates of SVR (89%-90%). Simeprevir + pegylated interferon + ribavirin is an alternative for patients with HCV genotype 1 (SVR, 79%-86%). Patients with HCV genotypes 2 and 3, representing 20% to 29% of US HCV infections, should receive therapy with sofosbuvir + ribavirin alone (SVR for genotype 2, 12 weeks' duration: 82%-93%; SVR for genotype 3, 24 weeks' duration, 80%-95%). Patients with HIV-HCV coinfection and patients with compensated cirrhosis (ie, cirrhosis but preserved synthetic liver function) should receive the same treatment as HCV-monoinfected patients. CONCLUSIONS AND RELEVANCE New, short-duration, simpler therapies result in high SVR rates for HCV-infected patients. In conjunction with increased screening for HCV as suggested by recent Centers for Disease Control and Prevention guidelines, availability of new therapiesmay lead to the treatment of many more people with chronic HCV infection.	[Kohli, Anita] Leidos Biomed Res Inc, Clin Res Directorate, Clin Monitoring Res Program, Frederick Natl Lab Canc Res, Frederick, MD USA; [Kohli, Anita] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA; [Shaffer, Ashton; Sherman, Amy; Kottilil, Shyam] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Kottilil, S (corresponding author), NIAID, Immunopathogenesis Sect, Immunoregulat Lab, 10 Ctr Dr,Bldg 10,Room 11N204, Bethesda, MD 20892 USA.	skottilil@niaid.nih.gov	Shaffer, Ashton/M-8002-2017; Kottilil, Shyam/ABF-7605-2021	Shaffer, Ashton/0000-0003-0150-4043; 	Intramural Research Program of the National Institutes of Health (National Institute of Allergy and Infectious Diseases and the Clinical Research Center); National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000390] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health (National Institute of Allergy and Infectious Diseases and the Clinical Research Center); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the Intramural Research Program of the National Institutes of Health (National Institute of Allergy and Infectious Diseases and the Clinical Research Center). This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E.	Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society, 2014, REC TEST MAN TREAT H; [Anonymous], 2013, OL FULL PRESCR INF Q; [Anonymous], 2013, SOV FULL PRESC INF V; Backus LI, 2005, AIDS, V19, pS13, DOI 10.1097/01.aids.0000192065.09281.01; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Chak E, 2011, LIVER INT, V31, P1090, DOI 10.1111/j.1478-3231.2011.02494.x; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Davis GL, 2010, GASTROENTEROLOGY, V138, P513, DOI 10.1053/j.gastro.2009.09.067; Delwart E, 2012, J INFECT DIS, V205, P875, DOI 10.1093/infdis/jir862; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Flamm SL, 2013, CLIN GASTROENTEROL H, V11, P81, DOI 10.1016/j.cgh.2012.10.006; Flamm SL, 2011, HEPATOLOGY, V54, p838A; Freeman AJ, 2001, HEPATOLOGY, V34, P809, DOI 10.1053/jhep.2001.27831; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Germer JJ, 2011, J CLIN MICROBIOL, V49, P3040, DOI 10.1128/JCM.00457-11; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hayashi N, 2012, J VIRAL HEPATITIS, V19, pE134, DOI 10.1111/j.1365-2893.2011.01528.x; Hayashi N, 2014, J GASTROENTEROL, V49, P138, DOI 10.1007/s00535-013-0875-1; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Kiser JJ, 2013, NAT REV GASTRO HEPAT, V10, P596, DOI 10.1038/nrgastro.2013.106; Kowdley KV, 2013, LANCET, V381, P2100, DOI 10.1016/S0140-6736(13)60247-0; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; Kwo PY, 2010, LANCET, V376, P705, DOI 10.1016/S0140-6736(10)60934-8; Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853; Lawitz E, 2013, LANCET INFECT DIS, V13, P401, DOI 10.1016/S1473-3099(13)70033-1; Manos MM, 2012, J MED VIROL, V84, P1744, DOI 10.1002/jmv.23399; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Muir AJ, 2011, HEPATOLOGY, V54, P1538, DOI 10.1002/hep.24549; Neukam K, 2013, J INFECTION, V67, P59, DOI 10.1016/j.jinf.2013.03.010; Osinusi A, 2013, JAMA-J AM MED ASSOC, V310, P804, DOI 10.1001/jama.2013.109309; Pallier C, 2009, HEPATOLOGY, V49, P50, DOI 10.1002/hep.22634; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Poynard T, 1998, LANCET, V352, P1426, DOI 10.1016/S0140-6736(98)07124-4; Raimondi S, 2009, J HEPATOL, V50, P1142, DOI 10.1016/j.jhep.2009.01.019; Reddy KR, 2011, J HEPATOL, V54, pS190, DOI 10.1016/S0168-8278(11)60468-6; Rodriguez-Torres M, 2009, NEW ENGL J MED, V360, P257, DOI 10.1056/NEJMoa0805062; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; Seden K, 2011, CURR OPIN HIV AIDS, V6, P514, DOI 10.1097/COH.0b013e32834b54dc; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Sulkowski M, 2013, LANCET INFECT DIS, V13, P597, DOI 10.1016/S1473-3099(13)70149-X; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Swain MG, 2010, GASTROENTEROLOGY, V139, P1593, DOI 10.1053/j.gastro.2010.07.009; Vachon MLC, 2011, J HEPATOL, V54, P41, DOI 10.1016/j.jhep.2010.06.025; Wilby KJ, 2012, ANN HEPATOL, V11, P179, DOI 10.1016/S1665-2681(19)31022-1; Zeuzem S, 2014, GASTROENTEROLOGY, V146, pe6; Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	58	327	340	1	78	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					631	640		10.1001/jama.2014.7085	http://dx.doi.org/10.1001/jama.2014.7085			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117132				2022-12-28	WOS:000340136400022
J	Enayat, M; Sun, ZX; Singh, UR; Aluru, R; Schmaus, S; Yaresko, A; Liu, Y; Lin, CT; Tsurkan, V; Loidl, A; Deisenhofer, J; Wahl, P				Enayat, Mostafa; Sun, Zhixiang; Singh, Udai Raj; Aluru, Ramakrishna; Schmaus, Stefan; Yaresko, Alexander; Liu, Yong; Lin, Chengtian; Tsurkan, Vladimir; Loidl, Alois; Deisenhofer, Joachim; Wahl, Peter			Real-space imaging of the atomic-scale magnetic structure of Fe1+yTe	SCIENCE			English	Article							PHASES; STATE	Spin-polarized scanning tunneling microscopy (SP-STM) has been used extensively to study magnetic properties of nanostructures. Using SP-STM to visualize magnetic order in strongly correlated materials on an atomic scale is highly desirable, but challenging. We achieved this goal in iron tellurium (Fe1+yTe), the nonsuperconducting parent compound of the iron chalcogenides, by using a STM tip with a magnetic cluster at its apex. Our images of the magnetic structure reveal that the magnetic order in the monoclinic phase is a unidirectional stripe order; in the orthorhombic phase at higher excess iron concentration (y > 0.12), a transition to a phase with coexisting magnetic orders in both directions is observed. It may be possible to generalize the technique to other high-temperature superconductor families, such as the cuprates.	[Enayat, Mostafa; Sun, Zhixiang; Singh, Udai Raj; Aluru, Ramakrishna; Schmaus, Stefan; Yaresko, Alexander; Liu, Yong; Lin, Chengtian; Wahl, Peter] Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; [Tsurkan, Vladimir; Loidl, Alois; Deisenhofer, Joachim] Univ Augsburg, Ctr Elect Correlat & Magnetism, D-86159 Augsburg, Germany; [Tsurkan, Vladimir] Moldavian Acad Sci, Inst Appl Phys, MD-2028 Kishinev, Moldova; [Wahl, Peter] Univ St Andrews, Sch Phys & Astron, Scottish Univ Phys Alliance, St Andrews KY16 9SS, Fife, Scotland	Max Planck Society; University of Augsburg; Academy of Sciences of Moldova; Institute of Applied Physics - Moldova; University of St Andrews	Wahl, P (corresponding author), Max Planck Inst Festkorperforsch, Heisenbergstr 1, D-70569 Stuttgart, Germany.	gpw2@st-andrews.ac.uk	Deisenhofer, Joachim/G-8937-2011; Yaresko, Alexander/P-7978-2018; Wahl, Peter/F-9337-2014; Loidl, Alois/L-8199-2015	Deisenhofer, Joachim/0000-0002-7645-9390; Wahl, Peter/0000-0002-8635-1519; Loidl, Alois/0000-0002-5579-0746	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [680.50.1119]; Deutsche Forschungsgemeinschaft Transregional Research Center (Augsburg, Munich, Stuttgart) [TRR80]; Engineering and Physical Sciences Research Council; Max Planck Society; Engineering and Physical Sciences Research Council [EP/I031014/1] Funding Source: researchfish; EPSRC [EP/I031014/1] Funding Source: UKRI	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission); Deutsche Forschungsgemeinschaft Transregional Research Center (Augsburg, Munich, Stuttgart); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge discussions with S. Chi, M. Etzkorn, F. Kruger, A.P. Mackenzie, S. Rossler, U. Rossler, and M. Ternes. Z.S. acknowledges financial support from Rubicon grant 680.50.1119 (Nederlandse Organisatie voor Wetenschappelijk Onderzoek). V.T., A.L., and J.D. acknowledge financial support from the Deutsche Forschungsgemeinschaft Transregional Research Center TRR80 (Augsburg, Munich, Stuttgart). P.W. acknowledges funding from the Engineering and Physical Sciences Research Council and Max Planck Society.	Balatsky AV, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.144522; Bao W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.247001; Bode M, 1998, PHYS REV LETT, V81, P4256, DOI 10.1103/PhysRevLett.81.4256; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; Ducatman S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.157206; Fang C, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/67005; FRUCHART D, 1975, MATER RES BULL, V10, P169, DOI 10.1016/0025-5408(75)90151-8; Glasbrenner JK, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.064509; He XB, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.220502; Inosov DS, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.187001; Ishida K, 2009, J PHYS SOC JPN, V78, DOI 10.1143/JPSJ.78.062001; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Koz C, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.094509; Li SL, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.054503; Lumsden MD, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/20/203203; Ma FJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.177003; Machida T, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.214508; Machida T, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.074714; Martinelli A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.094115; Mizuguchi Y, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.102001; Paglione J, 2010, NAT PHYS, V6, P645, DOI 10.1038/NPHYS1759; Rodriguez EE, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.064403; Rossler S, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.174506; Smith A., 2006, J SCANNING PROBE MIC, V1, P3; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Turner AM, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224504; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; WIESENDANGER R, 1990, PHYS REV LETT, V65, P247, DOI 10.1103/PhysRevLett.65.247; Wiesendanger R, 2009, REV MOD PHYS, V81, P1495, DOI 10.1103/RevModPhys.81.1495; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; Zaliznyak IA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.216403	35	65	65	7	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					653	656		10.1126/science.1251682	http://dx.doi.org/10.1126/science.1251682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25081481	Green Submitted			2022-12-28	WOS:000339962800034
J	Lu, XY; Park, JT; Zhang, R; Luo, HQ; Nevidomskyy, AH; Si, QM; Dai, PC				Lu, Xingye; Park, J. T.; Zhang, Rui; Luo, Huiqian; Nevidomskyy, Andriy H.; Si, Qimiao; Dai, Pengcheng			Nematic spin correlations in the tetragonal state of uniaxial-strained BaFe2-xNixAs2	SCIENCE			English	Article							IRON ARSENIDE SUPERCONDUCTOR; TRANSITION; ANISOTROPY; ORDER	Understanding the microscopic origins of electronic phases in high-transition temperature (high-T-c) superconductors is important for elucidating the mechanism of superconductivity. In the paramagnetic tetragonal phase of BaFe2-xTxAs2 (where T is Co or Ni) iron pnictides, an in-plane resistivity anisotropy has been observed. Here, we use inelastic neutron scattering to show that low-energy spin excitations in these materials change from fourfold symmetric to twofold symmetric at temperatures corresponding to the onset of the in-plane resistivity anisotropy. Because resistivity and spin excitation anisotropies both vanish near optimal superconductivity, we conclude that they are likely intimately connected.	[Lu, Xingye; Zhang, Rui; Luo, Huiqian; Dai, Pengcheng] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing 100190, Peoples R China; [Park, J. T.] Tech Univ Munich, Heinz Maier Leibnitz Zentrum MLZ, D-85748 Garching, Germany; [Nevidomskyy, Andriy H.; Si, Qimiao; Dai, Pengcheng] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA	Chinese Academy of Sciences; Institute of Physics, CAS; Technical University of Munich; Rice University	Dai, PC (corresponding author), Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA.	pdai@rice.edu	Zhang, Rui/AAK-3934-2021; Lu, Xingye/Q-4184-2019; Dai, Pengcheng/C-9171-2012; Park, Jitae T/G-1358-2016	Lu, Xingye/0000-0002-0409-1240; Dai, Pengcheng/0000-0002-6088-3170; Park, Jitae T/0000-0001-6565-0192; luo, hui qian/0000-0003-1514-0041; Zhang, Rui/0000-0002-4293-1175; Nevidomskyy, Andriy/0000-0002-8684-7979; Lu, Xingye/0000-0001-7526-3145	Ministry of Science and Technology of China [2012CB821400, 2011CBA00110]; National Natural Science Foundation of China; China Academy of Engineering Physics; U.S. NSF [DMR-1308603, DMR-1362219, DMR-1309531]; Robert A. Welch Foundation [C-1839, C-1818, C-1411]; Alexander von Humboldt Foundation; NSF [PHYS-1066293]; Division Of Materials Research [1362219] Funding Source: National Science Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Academy of Engineering Physics(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); U.S. NSF(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NSF(National Science Foundation (NSF)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The work at the Institute of Physics, Chinese Academy of Sciences is supported by Ministry of Science and Technology of China (973 project: 2012CB821400 and 2011CBA00110), National Natural Science Foundation of China and China Academy of Engineering Physics. The work at Rice is supported by the U.S. NSF-DMR-1308603 and DMR-1362219 (P.D.), by Robert A. Welch Foundation grant no. C-1839 (P.D.), C-1818 (A.H.N.), and no. C-1411 (Q.S.), and by the U.S. NSF-DMR-1309531 and the Alexander von Humboldt Foundation (Q.S.). A.H.N. and Q.S. acknowledge the hospitality of the Aspen Center for Physics, where support was provided by NSF grant PHYS-1066293.	Allan MP, 2013, NAT PHYS, V9, P220, DOI [10.1038/nphys2544, 10.1038/NPHYS2544]; Chen CC, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.100504; Chu JH, 2010, SCIENCE, V329, P824, DOI 10.1126/science.1190482; Dai JH, 2009, P NATL ACAD SCI USA, V106, P4118, DOI 10.1073/pnas.0900886106; Dai PC, 2012, NAT PHYS, V8, P709, DOI 10.1038/NPHYS2438; de la Cruz C, 2008, NATURE, V453, P899, DOI 10.1038/nature07057; Dhital C, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.087001; Fang C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.224509; Fernandes RM, 2014, NAT PHYS, V10, P97, DOI 10.1038/nphys2877; Fernandes RM, 2012, SUPERCOND SCI TECH, V25, DOI 10.1088/0953-2048/25/8/084005; Fisher IR, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124506; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Harriger LW, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054544; Huang Q, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.257003; Ishida S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.207001; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kasahara S, 2012, NATURE, V486, P382, DOI 10.1038/nature11178; Kim MG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.134522; Kreyssig A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.134512; Kuo HH, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.054540; Lee CC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.267001; Lester C, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.144523; Lu XY, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.257001; Luo HQ, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.247002; Lv WC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224506; Nakajima M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.217003; Park JT, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.024437; Song Y, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.184511; Stewart GR, 2011, REV MOD PHYS, V83, P1589, DOI 10.1103/RevModPhys.83.1589; Tanatar MA, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.184508; Wang MY, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.094516; Yi M, 2011, P NATL ACAD SCI USA, V108, P6878, DOI 10.1073/pnas.1015572108; Zhang Y, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.085121	36	150	152	1	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					657	660		10.1126/science.1251853	http://dx.doi.org/10.1126/science.1251853			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25081483	Green Submitted			2022-12-28	WOS:000339962800035
J	Aguzzi, A				Aguzzi, Adriano			Alzheimer's disease under strain	NATURE			English	Editorial Material							PRION STRAINS; KINETICS; SCRAPIE; AGENT; MICE		Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch		Aguzzi, Adriano/0000-0002-0344-6708				Aguzzi A, 2013, CELL, V154, P1182, DOI 10.1016/j.cell.2013.08.049; Aguzzi A, 2009, NATURE, V459, P924, DOI 10.1038/459924a; FRASER H, 1973, J COMP PATHOL, V83, P29, DOI 10.1016/0021-9975(73)90024-8; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Meisl G, 2014, P NATL ACAD SCI USA, V111, P9384, DOI 10.1073/pnas.1401564111; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Sigurdson CJ, 2007, NAT METHODS, V4, P1023, DOI 10.1038/nmeth1131; Sigurdson CJ, 2006, J VIROL, V80, P12303, DOI 10.1128/JVI.01120-06; Stohr J, 2014, P NATL ACAD SCI USA, V111, P10329, DOI 10.1073/pnas.1408968111; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111	15	30	30	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					32	34		10.1038/512032a	http://dx.doi.org/10.1038/512032a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25100477				2022-12-28	WOS:000339908000022
J	Chao, JT; Wong, AKO; Tavassoli, S; Young, BP; Chruscicki, A; Fang, NN; Howe, LJ; Mayor, T; Foster, LJ; Loewen, CJR				Chao, Jesse T.; Wong, Andrew K. O.; Tavassoli, Shabnam; Young, Barry P.; Chruscicki, Adam; Fang, Nancy N.; Howe, Leann J.; Mayor, Thibault; Foster, Leonard J.; Loewen, Christopher J. R.			Polarization of the Endoplasmic Reticulum by ER-Septin Tethering	CELL			English	Article							MESSENGER-RNA TRANSPORT; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; BUDDING YEAST; CORTICAL ER; CELL CORTEX; PROTEIN; COMPARTMENTALIZATION; ORGANIZATION; BINDING	Polarization of the plasma membrane (PM) into domains is an important mechanism to compartmentalize cellular activities and to establish cell polarity. Polarization requires formation of diffusion barriers that prevent mixing of proteins between domains. Recent studies have uncovered that the endoplasmic reticulum (ER) of budding yeast and neurons is polarized by diffusion barriers, which in neurons controls glutamate signaling in dendritic spines. The molecular identity of these barriers is currently unknown. Here, we show that a direct interaction between the ER protein Scs2 and the septin Shs1 creates the ER diffusion barrier in yeast. Barrier formation requires Epo1, a novel ER-associated subunit of the polarisome that interacts with Scs2 and Shs1. ER-septin tethering polarizes the ER into separate mother and bud domains, one function of which is to position the spindle in the mother until M phase by confining the spindle capture protein Num1 to the mother ER.	[Chao, Jesse T.; Wong, Andrew K. O.; Tavassoli, Shabnam; Young, Barry P.; Loewen, Christopher J. R.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Chruscicki, Adam; Fang, Nancy N.; Howe, Leann J.; Mayor, Thibault; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Fang, Nancy N.; Mayor, Thibault; Foster, Leonard J.] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Loewen, CJR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	cloewen@mail.ubc.ca		Chao, Jesse/0000-0002-6995-9581	Canadian Institute of Health Research (CIHR); Michael Smith Foundation for Health Research (MSFHR); Canada Foundation for Innovation (CFI)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This research was supported by grants from the Canadian Institute of Health Research (CIHR), the Michael Smith Foundation for Health Research (MSFHR), and the Canada Foundation for Innovation (CFI). C.J.R.L. and T.M. are CIHR New Investigators and MSFHR Scholars, C.J.R.L. is a Tula Foundation Investigator, and L.J.F. is the Canada Research Chair in Organelle Proteomics.	Caudron F, 2009, DEV CELL, V16, P493, DOI 10.1016/j.devcel.2009.04.003; Chao Jesse Tzu-Cheng, 2009, J Vis Exp, DOI 10.3791/1225; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Cui-Wang TT, 2012, CELL, V148, P309, DOI 10.1016/j.cell.2011.11.056; Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892; Egelhofer TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002022; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; FARKASOVSKY M, 1995, J CELL BIOL, V131, P1003, DOI 10.1083/jcb.131.4.1003; Faty M, 2002, CURR GENET, V41, P123, DOI 10.1007/s00294-002-0304-0; Fischer MA, 2009, TRAFFIC, V10, P1084, DOI 10.1111/j.1600-0854.2009.00926.x; Furuita K, 2010, J BIOL CHEM, V285, P12961, DOI 10.1074/jbc.M109.082602; Garcia G, 2011, J CELL BIOL, V195, P993, DOI 10.1083/jcb.201107123; Heil-Chapdelaine RA, 2000, J CELL BIOL, V151, P1337, DOI 10.1083/jcb.151.6.1337; Iwase M, 2007, GENETICS, V177, P215, DOI 10.1534/genetics.107.073007; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Newman JRS, 2000, P NATL ACAD SCI USA, V97, P13203, DOI 10.1073/pnas.97.24.13203; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; SEPSENWOL S, 1989, J CELL BIOL, V108, P55, DOI 10.1083/jcb.108.1.55; Sharma S, 2013, NATURE, V499, P238, DOI 10.1038/nature12229; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Shepard KA, 2003, P NATL ACAD SCI USA, V100, P11429, DOI 10.1073/pnas.2033246100; Spira F, 2012, NAT CELL BIOL, V14, P640, DOI 10.1038/ncb2487; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tang XY, 2012, J CELL BIOL, V196, P743, DOI 10.1083/jcb.201112017; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Toulmay A, 2012, J CELL SCI, V125, P49, DOI 10.1242/jcs.085118; Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330; Wagner W, 2011, NAT CELL BIOL, V13, P40, DOI 10.1038/ncb2132; YEH E, 1995, J CELL BIOL, V130, P687, DOI 10.1083/jcb.130.3.687	36	73	73	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					620	632		10.1016/j.cell.2014.06.033	http://dx.doi.org/10.1016/j.cell.2014.06.033			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083872	Bronze			2022-12-28	WOS:000340944300014
J	Pai, SY; Logan, BR; Griffith, LM; Buckley, RH; Parrott, RE; Dvorak, CC; Kapoor, N; Hanson, IC; Filipovich, AH; Jyonouchi, S; Sullivan, KE; Small, TN; Burroughs, L; Skoda-Smith, S; Haight, AE; Grizzle, A; Pulsipher, MA; Chan, KW; Fuleihan, RL; Haddad, E; Loechelt, B; Aquino, VM; Gillio, A; Davis, J; Knutsen, A; Smith, AR; Moore, TB; Schroeder, ML; Goldman, FD; Connelly, JA; Porteus, MH; Xiang, Q; Shearer, WT; Fleisher, TA; Kohn, DB; Puck, JM; Notarangelo, LD; Cowan, MJ; O'Reilly, RJ				Pai, Sung-Yun; Logan, Brent R.; Griffith, Linda M.; Buckley, Rebecca H.; Parrott, Roberta E.; Dvorak, Christopher C.; Kapoor, Neena; Hanson, Imelda C.; Filipovich, Alexandra H.; Jyonouchi, Soma; Sullivan, Kathleen E.; Small, Trudy N.; Burroughs, Lauri; Skoda-Smith, Suzanne; Haight, Ann E.; Grizzle, Audrey; Pulsipher, Michael A.; Chan, Ka Wah; Fuleihan, Ramsay L.; Haddad, Elie; Loechelt, Brett; Aquino, Victor M.; Gillio, Alfred; Davis, Jeffrey; Knutsen, Alan; Smith, Angela R.; Moore, Theodore B.; Schroeder, Marlis L.; Goldman, Frederick D.; Connelly, James A.; Porteus, Matthew H.; Xiang, Qun; Shearer, William T.; Fleisher, Thomas A.; Kohn, Donald B.; Puck, Jennifer M.; Notarangelo, Luigi D.; Cowan, Morton J.; O'Reilly, Richard J.			Transplantation Outcomes for Severe Combined Immunodeficiency, 2000-2009	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; SOYBEAN AGGLUTININ; RECONSTITUTION; LYMPHOCYTES; EXPERIENCE; CHILDREN; DISEASES; CHILDHOOD	BACKGROUND The Primary Immune Deficiency Treatment Consortium was formed to analyze the results of hematopoietic-cell transplantation in children with severe combined immunodeficiency (SCID) and other primary immunodeficiencies. Factors associated with a good transplantation outcome need to be identified in order to design safer and more effective curative therapy, particularly for children with SCID diagnosed at birth. METHODS We collected data retrospectively from 240 infants with SCID who had received transplants at 25 centers during a 10-year period (2000 through 2009). RESULTS Survival at 5 years, freedom from immunoglobulin substitution, and CD3+ T-cell and IgA recovery were more likely among recipients of grafts from matched sibling donors than among recipients of grafts from alternative donors. However, the survival rate was high regardless of donor type among infants who received transplants at 3.5 months of age or younger (94%) and among older infants without prior infection (90%) or with infection that had resolved (82%). Among actively infected infants without a matched sibling donor, survival was best among recipients of haploidentical T-cell-depleted transplants in the absence of any pretransplantation conditioning. Among survivors, reduced-intensity or myelo-ablative pretransplantation conditioning was associated with an increased likelihood of a CD3+ T-cell count of more than 1000 per cubic millimeter, freedom from immunoglobulin substitution, and IgA recovery but did not significantly affect CD4+ T-cell recovery or recovery of phytohemagglutinin-induced T-cell proliferation. The genetic subtype of SCID affected the quality of CD3+ T-cell recovery but not survival. CONCLUSIONS Transplants from donors other than matched siblings were associated with excellent survival among infants with SCID identified before the onset of infection. All available graft sources are expected to lead to excellent survival among asymptomatic infants. (Funded by the National Institute of Allergy and Infectious Diseases and others.)	[Pai, Sung-Yun] Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA USA; [Notarangelo, Luigi D.] Harvard Stem Cell Inst, Manton Ctr Orphan Dis Res, Div Immunol, Boston, MA USA; [Pai, Sung-Yun] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Logan, Brent R.; Xiang, Qun] Med Coll Wisconsin, Div Biostat, Milwaukee, WI 53226 USA; [Small, Trudy N.; O'Reilly, Richard J.] Mem Sloan Kettering Canc Ctr, Bone Marrow Transplant Program, New York, NY 10065 USA; [Griffith, Linda M.] NIAID, Div Allergy Immunol & Transplantat, NIH, Bethesda, MD 20892 USA; [Fleisher, Thomas A.] NIAID, Ctr Clin, Dept Lab Med, NIH, Bethesda, MD 20892 USA; [Buckley, Rebecca H.; Parrott, Roberta E.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Buckley, Rebecca H.; Parrott, Roberta E.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Dvorak, Christopher C.; Puck, Jennifer M.; Cowan, Morton J.] Univ Calif San Francisco, Benioff Childrens Hosp, Div Allergy Immunol Blood & Marrow Transplantat, San Francisco, CA 94143 USA; [Kapoor, Neena] Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Hanson, Imelda C.; Shearer, William T.] Texas Childrens Hosp, Sect Pediat Immunol Allergy & Rheumatol, Baylor Coll Med, Houston, TX 77030 USA; [Filipovich, Alexandra H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Jyonouchi, Soma; Sullivan, Kathleen E.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Burroughs, Lauri; Skoda-Smith, Suzanne] Seattle Childrens Hosp, Div Clin Res, Fred Hutchinson Canc Res Ctr, Seattle, WA USA; [Haight, Ann E.; Grizzle, Audrey] Childrens Healthcare Atlanta, Aflac Canc & Blood Disorders Ctr, Atlanta, GA USA; Emory Univ, Sch Med, Atlanta, GA USA; [Pulsipher, Michael A.] Univ Utah, Huntsman Canc Inst, Primary Childrens Hosp, Div Hematol, Salt Lake City, UT USA; [Chan, Ka Wah] Texas Transplant Inst, San Antonio, TX USA; [Chan, Ka Wah] Methodist Childrens Hosp South Texas, San Antonio, TX USA; [Fuleihan, Ramsay L.] Northwestern Univ, Feinberg Sch Med, Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Haddad, Elie] Univ Montreal, Ctr Hosp Univ St Justine, Montreal, PQ, Canada; [Loechelt, Brett] Childrens Natl Med Ctr, Div Blood & Marrow Transplantat & Allergy & Immun, Washington, DC 20010 USA; [Aquino, Victor M.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Gillio, Alfred] Hackensack Univ, Med Ctr, Pediat Blood & Marrow Transplant Program, Hackensack, NJ USA; [Davis, Jeffrey] BC Childrens Hosp, Dept Pediat, Vancouver, BC, Canada; [Schroeder, Marlis L.] Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3T 2N2, Canada; [Knutsen, Alan] St Louis Univ, Cardinal Glennon Childrens Med Ctr, Div Pediat Allergy & Immunol, St Louis, MO 63103 USA; [Smith, Angela R.] Univ Minnesota, Div Pediat Blood & Marrow Transplantat, Minneapolis, MN USA; [Moore, Theodore B.; Kohn, Donald B.] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA USA; [Goldman, Frederick D.] Univ Alabama Birmingham, Childrens Alabama, Dept Pediat, Birmingham, AL USA; [Connelly, James A.] Univ Michigan, Dept Pediat Hematol Oncol, Ann Arbor, MI 48109 USA; [Porteus, Matthew H.] Stanford Univ, Div Hematol Oncol Stem Cell Transplantat, Stanford, CA 94305 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Dana-Farber Cancer Institute; Medical College of Wisconsin; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; Duke University; University of California System; University of California San Francisco; Children's Hospital Los Angeles; Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Fred Hutchinson Cancer Center; Seattle Children's Hospital; Children's Healthcare of Atlanta (CHOA); Emory University; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Children's National Health System; University of Texas System; University of Texas Southwestern Medical Center Dallas; Hackensack University Medical Center; BC Childrens Hospital; University of British Columbia; University of Manitoba; Saint Louis University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles; University of Alabama System; University of Alabama Birmingham; University of Michigan System; University of Michigan; Stanford University	O'Reilly, RJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	oreillyr@mskcc.org	Haddad, Elie/AAQ-4971-2020; Dvorak, Christopher C/AAX-1630-2020; Pai, Sung-Yun/AAH-7762-2019; Notarangelo, Luigi D/F-9718-2016	Dvorak, Christopher C/0000-0002-6146-3952; Pai, Sung-Yun/0000-0002-0158-8147; Notarangelo, Luigi D/0000-0002-8335-0262; Hanson, Imelda/0000-0001-9457-0757; Shearer, William/0000-0002-2483-2130; Haddad, Elie/0000-0003-2446-6879; Davis, Jeffrey/0000-0002-5959-7345	NIAID [1U54AI082973]; NIH Office of Rare Diseases Research, National Center for Advancing Translational Sciences [R13AI094943]; National Cancer Institute [CA23766]; David Center, Texas Children's Hospital; National Heart, Lung, and Blood Institute (NHLBI) [HL085288, HL36444]; NHLBI [2U01HL069254]; St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE [P01CA023766, P30CA014236] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036444, K23HL085288, U01HL069254] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI105776, R13AI094943, U54AI082973] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Office of Rare Diseases Research, National Center for Advancing Translational Sciences; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); David Center, Texas Children's Hospital; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); St. Baldrick's Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the NIAID (1U54AI082973) and the NIH Office of Rare Diseases Research, National Center for Advancing Translational Sciences (R13AI094943), a Translational Investigator Service Award (to Dr. Pai), and grants from the National Cancer Institute (CA23766, to Dr. O'Reilly), the David Center, Texas Children's Hospital (to Dr. Shearer), and the National Heart, Lung, and Blood Institute (NHLBI) (HL085288 and HL36444, to Dr. Burroughs). Activities of the Pediatric Blood and Marrow Transplant Consortium, a core group representing 19 centers participating in this study, were also partially supported by grants from the NHLBI (2U01HL069254) and the St. Baldrick's Foundation.	Al-Herz W, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00054; Antoine C, 2003, LANCET, V361, P553, DOI 10.1016/S0140-6736(03)12513-5; Bhattacharya A, 2005, BONE MARROW TRANSPL, V36, P295, DOI 10.1038/sj.bmt.1705054; Borgmann-Staudt A, 2012, BONE MARROW TRANSPL, V47, P271, DOI 10.1038/bmt.2011.78; Brown L, 2011, BLOOD, V117, P3243, DOI 10.1182/blood-2010-08-300384; Buckley RH, 2013, J CLIN IMMUNOL, V33, P96, DOI 10.1007/s10875-012-9797-6; Buckley RH, 2011, IMMUNOL RES, V49, P25, DOI 10.1007/s12026-010-8191-9; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Cavazzana-Calvo M, 2007, BLOOD, V109, P4575, DOI 10.1182/blood-2006-07-029090; Cavazzana-Calvo M, 2013, BRIT J HAEMATOL, V160, P146, DOI 10.1111/bjh.12119; ComansBitter WM, 1997, J PEDIATR-US, V130, P388, DOI 10.1016/S0022-3476(97)70200-2; Comeau AM, 2010, J INHERIT METAB DIS, V33, pS273, DOI 10.1007/s10545-010-9103-9; COWAN MJ, 1985, J CLIN IMMUNOL, V5, P370, DOI 10.1007/BF00915333; Dvorak CC, 2008, BIOL BLOOD MARROW TR, V14, P1125, DOI 10.1016/j.bbmt.2008.07.008; Dvorak CC, 2013, J CLIN IMMUNOL, V33, P1156, DOI 10.1007/s10875-013-9917-y; Fernandes JF, 2012, BLOOD, V119, P2949, DOI 10.1182/blood-2011-06-363572; GATTI RA, 1968, LANCET, V2, P1366; Gennery AR, 2010, J ALLERGY CLIN IMMUN, V126, P602, DOI 10.1016/j.jaci.2010.06.015; Griffith LM, 2008, J ALLERGY CLIN IMMUN, V122, P1087, DOI 10.1016/j.jaci.2008.09.045; Haddad E, 1998, BLOOD, V91, P3646; Haddad E, 2013, J ALLERGY CLIN IMMUN, V131, P994, DOI 10.1016/j.jaci.2013.01.047; Kwan A, 2013, J ALLERGY CLIN IMMUN, V132, P140, DOI 10.1016/j.jaci.2013.04.024; Muller SM, 2001, BLOOD, V98, P1847, DOI 10.1182/blood.V98.6.1847; Myers LA, 2002, BLOOD, V99, P872, DOI 10.1182/blood.V99.3.872; Neven B, 2009, BLOOD, V113, P4114, DOI 10.1182/blood-2008-09-177923; OREILLY RJ, 1986, VOX SANG, V51, P81, DOI 10.1111/j.1423-0410.1986.tb02013.x; OREILLY RJ, 1977, NEW ENGL J MED, V297, P1311, DOI 10.1056/NEJM197712152972403; Puck JM, 2007, J ALLERGY CLIN IMMUN, V120, P760, DOI 10.1016/j.jaci.2007.08.043; Railey MD, 2009, J PEDIAT, V155; REISNER Y, 1983, BLOOD, V61, P341; Routes JM, 2009, JAMA-J AM MED ASSOC, V302, P2465, DOI 10.1001/jama.2009.1806; Sanders JE, 2004, PEDIATR TRANSPLANT, V8, P39, DOI 10.1111/j.1398-2265.2004.00165.x; Sarzotti-Kelsoe M, 2009, BLOOD, V114, P1445, DOI 10.1182/blood-2009-01-199323; Shearer WT, 2003, J ALLERGY CLIN IMMUN, V112, P973, DOI 10.1016/j.jaci.2003.07.003; Shearer WT, 2013, J ALLERGY CLIN IMMUN, V133, P1092; Titman P, 2008, BLOOD, V112, P3907, DOI 10.1182/blood-2008-04-151332; Tsuji Y, 2006, BONE MARROW TRANSPL, V37, P469, DOI 10.1038/sj.bmt.1705273	37	418	441	2	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					434	446		10.1056/NEJMoa1401177	http://dx.doi.org/10.1056/NEJMoa1401177			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0SK	25075835	Green Accepted			2022-12-28	WOS:000339556900008
J	Prue, G				Prue, Gillian			Vaccinate boys as well as girls against HPV: it works, and it may be cost effective	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HUMAN-PAPILLOMAVIRUS; GENITAL WARTS; MEN		Queens Univ Belfast, Sch Nursing & Midwifery, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast	Prue, G (corresponding author), Queens Univ Belfast, Sch Nursing & Midwifery, Belfast BT9 7BL, Antrim, North Ireland.	g.prue@qub.ac.uk						Baandrup L, 2013, SEX TRANSM DIS, V40, P130, DOI 10.1097/OLQ.0b013e31827bd66b; Baio G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049699; Bowyer HL, 2014, J FAM PLAN REPROD H, V40, P14, DOI 10.1136/jfprhc-2013-100583; Boyce T., 2013, BR J SCH NURS, V8, P71, DOI [10.12968/bjsn.2013.8.2.71, DOI 10.12968/BJSN.2013.8.2.71]; Burger EA, 2009, PLOS ONE, V201420; Desai S, 2011, SEX TRANSM INFECT, V87, P464, DOI 10.1136/sti.2010.048421; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Marty R, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-10; Newman PA, 2013, SEX TRANSM INFECT, V89, P568, DOI 10.1136/sextrans-2012-050980; Public Health England, 2013, ANN HPV VACC COV 201; Public Health England, 2014, HPV VACC PROGR SCHED; Zou HC, 2014, J INFECT DIS, V209, P642, DOI 10.1093/infdis/jit626	12	9	9	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 29	2014	349								g4834	10.1136/bmj.g4834	http://dx.doi.org/10.1136/bmj.g4834			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NG	25073786	Green Published			2022-12-28	WOS:000339906000007
J	Treasure, T; Monson, K; Fiorentino, F; Russell, C				Treasure, Tom; Monson, Kathryn; Fiorentino, Francesca; Russell, Christopher			Operating to remove recurrent colorectal cancer: have we got it right?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARCINOEMBRYONIC ANTIGEN; PULMONARY-METASTASECTOMY; LARGE-BOWEL; FOLLOW-UP; CARCINOMA METASTASES; HEPATIC RESECTION; DETECT RECURRENCE; LIVER METASTASES; NATURAL-HISTORY; CLINICAL-TRIAL		[Treasure, Tom] UCL, Clin Operat Res Unit, London, England; [Monson, Kathryn] Univ Sussex, Brighton & Sussex Med Sch, SHORE C, Falmer, England; [Fiorentino, Francesca] Univ London Imperial Coll Sci Technol & Med, Dept Cardiothorac Surg, London, England	University of London; University College London; University of Brighton; University of Sussex; Imperial College London	Treasure, T (corresponding author), UCL, Clin Operat Res Unit, London, England.	tom.treasure@gmail.com						COCHRANE JPS, 1980, BRIT MED J, V280, P593, DOI 10.1136/bmj.280.6214.593; Doshi P, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2865; ELLIS H, 1975, BRIT J SURG, V62, P830, DOI 10.1002/bjs.1800621020; Fiorentino F, 2011, BRIT J CANCER, V104, P1085, DOI 10.1038/sj.bjc.6606060; Fiorentino F, 2010, J ROY SOC MED, V103, P60, DOI 10.1258/jrsm.2009.090299; GOLDENBERG D M, 1981, British Medical Journal, V282, P373; Grunhagen D, 2013, CRIT REV ONCOL HEMAT, V86, P222, DOI 10.1016/j.critrevonc.2012.10.007; HUGHES ESR, 1982, BRIT J SURG, V69, P410, DOI 10.1002/bjs.1800690718; HUGHES K, 1989, SURG CLIN N AM, V69, P339; HUGHES KS, 1986, SURGERY, V100, P278; HUGHES KS, 1988, SURGERY, V103, P278; Lennon T, 1994, BR J CANC S22, V70, P16; Loder E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3601; MACH JP, 1974, LANCET, V2, P535; MACKAY AM, 1974, BRIT MED J, V4, P382, DOI 10.1136/bmj.4.5941.382; MARTIN EW, 1980, J SURG RES, V28, P389, DOI 10.1016/0022-4804(80)90100-6; MARTIN EW, 1979, AM J SURG, V137, P167, DOI 10.1016/0002-9610(79)90137-5; MCCORMACK PM, 1992, ARCH SURG-CHICAGO, V127, P1403; MEEKER WR, 1978, CANCER, V41, P854, DOI 10.1002/1097-0142(197803)41:3<854::AID-CNCR2820410312>3.0.CO;2-J; NHS, 2012, NAT CANC PAT EXP SUR; NICHOLSON JR, 1978, DIS COLON RECTUM, V21, P163, DOI 10.1007/BF02586559; NORTHOVER J, 1994, JAMA-J AM MED ASSOC, V272, P31, DOI 10.1001/jama.1994.03520010041025; POLK HC, 1971, SURGERY, V69, P9; Poston G, 2011, COLORECTAL CANC DIAG; Primrose JN, 2014, JAMA-J AM MED ASSOC, V311, P263, DOI 10.1001/jama.2013.285718; ROSEN CB, 1992, ANN SURG, V216, P493, DOI 10.1097/00000658-199210000-00012; SCHEELE J, 1990, DIS COLON RECTUM, V33, P745, DOI 10.1007/BF02052319; SCHEELE J, 1990, BRIT J SURG, V77, P1241, DOI 10.1002/bjs.1800771115; SCHEELE J, 1995, WORLD J SURG, V19, P59, DOI 10.1007/BF00316981; SCHEELE J, 1991, SURGERY, V110, P13; Slack W, 1982, PROTOCOL MULTICENTRE, DOI [10.5061/dryad.k8t8b, DOI 10.5061/DRYAD.K8T8B]; STAAB HJ, 1978, J SURG ONCOL, V10, P273, DOI 10.1002/jso.2930100313; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; Treasure T, 2009, EJSO-EUR J SURG ONC, V35, P686, DOI 10.1016/j.ejso.2008.12.005; Treasure T, 2013, BMJ; Treasure T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004385; Treasure T, 2010, J THORAC ONCOL, V5, pS203, DOI 10.1097/JTO.0b013e3181dca239; Treasure T, 2010, J THORAC ONCOL, V5, pS179, DOI 10.1097/JTO.0b013e3181dca251; WANGENSTEEN OH, 1954, SURG GYNECOL OBSTET, V99, P257; WELCH JP, 1978, AM J SURG, V135, P505, DOI 10.1016/0002-9610(78)90028-4	40	15	15	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 13	2014	348								g2085	10.1136/bmj.g2085	http://dx.doi.org/10.1136/bmj.g2085			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5CN	25134098	Green Submitted			2022-12-28	WOS:000336146200001
J	Kuypers, DRJ				Kuypers, Dirk R. J.			Alemtuzumab induction therapy in kidney transplantation	LANCET			English	Editorial Material							RENAL-TRANSPLANTATION; END-POINTS; INHIBITORS; TRIALS		Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, B-3000 Leuven, Belgium	KU Leuven; University Hospital Leuven	Kuypers, DRJ (corresponding author), Univ Hosp Leuven, Dept Nephrol & Renal Transplantat, B-3000 Leuven, Belgium.	dirk.kuypers@uzleuven.be	Kuypers, Dirk RJ/D-4393-2018	Kuypers, Dirk RJ/0000-0001-5546-9680				Budde K, 2011, LANCET, V377, P837, DOI 10.1016/S0140-6736(10)62318-5; Chhabra D, 2013, AM J TRANSPLANT, V13, P2902, DOI 10.1111/ajt.12437; Cibrik D, 2013, TRANSPLANTATION, V95, P933, DOI 10.1097/TP.0b013e3182848e03; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Flechner SM, 2005, AM J TRANSPLANT, V5, P3009, DOI 10.1111/j.1600-6143.2005.01123.x; Haynes R, 2013, TRANSPLANT RES, V2, DOI 10.1186/2047-1440-2-7; Ibrahim A, 2013, AM J TRANSPLANT, V13, P707, DOI 10.1111/ajt.12050; Levitsky J, 2012, HUM IMMUNOL, V73, P141, DOI 10.1016/j.humimm.2011.11.008; Opelz G, 2008, TRANSPLANTATION, V85, P661, DOI 10.1097/TP.0b013e3181661695; Pengel LHM, 2011, TRANSPL INT, V24, P1216, DOI 10.1111/j.1432-2277.2011.01357.x; Schold JD, 2010, AM J TRANSPLANT, V10, P1163, DOI 10.1111/j.1600-6143.2010.03104.x; The Lancet, 2014, LANCET; Vanrenterghem Y, 2011, TRANSPLANTATION, V91, P976, DOI 10.1097/TP.0b013e31820c10eb	13	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 8	2014	384	9955					1649	1651		10.1016/S0140-6736(14)61174-0	http://dx.doi.org/10.1016/S0140-6736(14)61174-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AT7KU	25078307				2022-12-28	WOS:000345116200009
J	Viale, A; Pettazzoni, P; Lyssiotis, CA; Ying, HQ; Sanchez, N; Marchesini, M; Carugo, A; Green, T; Seth, S; Giuliani, V; Kost-Alimova, M; Muller, F; Colla, S; Nezi, L; Genovese, G; Deem, AK; Kapoor, A; Yao, WT; Brunetto, E; Kang, Y; Yuan, M; Asara, JM; Wang, YA; Heffernan, TP; Kimmelman, AC; Wang, HM; Fleming, JB; Cantley, LC; DePinho, RA; Draetta, GF				Viale, Andrea; Pettazzoni, Piergiorgio; Lyssiotis, Costas A.; Ying, Haoqiang; Sanchez, Nora; Marchesini, Matteo; Carugo, Alessandro; Green, Tessa; Seth, Sahil; Giuliani, Virginia; Kost-Alimova, Maria; Muller, Florian; Colla, Simona; Nezi, Luigi; Genovese, Giannicola; Deem, Angela K.; Kapoor, Avnish; Yao, Wantong; Brunetto, Emanuela; Kang, Ya'an; Yuan, Min; Asara, John M.; Wang, Y. Alan; Heffernan, Timothy P.; Kimmelman, Alec C.; Wang, Huamin; Fleming, Jason B.; Cantley, Lewis C.; DePinho, Ronald A.; Draetta, Giulio F.			Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function	NATURE			English	Article							INHIBITION; METABOLISM; AUTOPHAGY; GLUCOSE; IMATINIB; GROWTH; BRAF	Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers in western countries, with a median survival of 6 months and an extremely low percentage of long-term surviving patients. KRAS mutations are known to be a driver event of PDAC(1), but targeting mutant KRAS has proved challenging(2). Targeting oncogene-driven signalling pathways is a clinically validated approach for several devastating diseases(3,4). Still, despite marked tumour shrinkage, the frequency of relapse indicates that a fraction of tumour cells survives shut down of oncogenic signalling(5,6). Here we explore the role of mutant KRAS in PDAC maintenance using a recently developed inducible mouse model of mutated Kras(1) (Kras(G12D), herein KRas) in a p53(LoxP/WT) background. We demonstrate that a subpopulation of dormant tumour cells surviving oncogene ablation (surviving cells) and responsible for tumour relapse has features of cancer stem cells and relies on oxidative phosphorylation for survival. Transcriptomic and metabolic analyses of surviving cells reveal prominent expression of genes governing mitochondrial function, autophagy and lysosome activity, as well as a strong reliance on mitochondrial respiration and a decreased dependence on glycolysis for cellular energetics. Accordingly, surviving cells show high sensitivity to oxidative phosphorylation inhibitors, which can inhibit tumour recurrence. Our integrated analyses illuminate a therapeutic strategy of combined targeting of the KRAS pathway and mitochondrial respiration to manage pancreatic cancer.	[Viale, Andrea; Pettazzoni, Piergiorgio; Ying, Haoqiang; Sanchez, Nora; Marchesini, Matteo; Carugo, Alessandro; Green, Tessa; Muller, Florian; Colla, Simona; Nezi, Luigi; Genovese, Giannicola; Deem, Angela K.; Kapoor, Avnish; Yao, Wantong; Wang, Y. Alan; Draetta, Giulio F.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA; [Viale, Andrea; Pettazzoni, Piergiorgio; Sanchez, Nora; Marchesini, Matteo; Carugo, Alessandro; Green, Tessa; Nezi, Luigi; Yao, Wantong; Draetta, Giulio F.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Lyssiotis, Costas A.; Cantley, Lewis C.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Carugo, Alessandro] European Inst Oncol, Dept Expt Oncol, I-20139 Milan, Italy; [Seth, Sahil; Giuliani, Virginia; Kost-Alimova, Maria; Heffernan, Timothy P.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Brunetto, Emanuela] Ist Sci San Raffaele, Pathol Unit, I-20132 Milan, Italy; [Kang, Ya'an; Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Yuan, Min; Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Dept Med, Boston, MA 02115 USA; [Kimmelman, Alec C.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Cornell University; IRCCS European Institute of Oncology (IEO); University of Texas System; UTMD Anderson Cancer Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Dana-Farber Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Viale, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA.	aviale@mdanderson.org; gdraetta@mdanderson.org	Grieshaber-Bouyer, Ricardo/R-7512-2016; Lyssiotis, Costas A/AAI-1923-2019; Cantley, Lewis C/D-1800-2014; Pettazzoni, Piergiorgio/GRJ-3011-2022; Marchesini, Matteo/AAC-4629-2022; Nezi, Luigi/AAB-1957-2019; Ying, Haoqiang/AAK-4325-2020; Seth, Sahil/I-5809-2019; Brunetto, Emanuela/AAB-2211-2019	Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Lyssiotis, Costas A/0000-0001-9309-6141; Cantley, Lewis C/0000-0002-1298-7653; Nezi, Luigi/0000-0002-4670-7656; Seth, Sahil/0000-0003-4579-3959; Genovese, Giannicola/0000-0003-1392-9954; DePinho, Ronald/0000-0002-5625-577X; Muller, Florian/0000-0001-7568-2948; Pettazzoni, Piergiorgio/0000-0001-9039-2463; Brunetto, Emanuela/0000-0003-4246-5247; Carugo, Alessandro/0000-0001-5182-3320; Marchesini, Matteo/0000-0001-9489-7899; Colla, Simona/0000-0001-6583-8910	Cancer Center Core Grant [CA16672]; National Cancer Institute (NCI) [CA016672]; MDACC Flow Cytometry and Cellular Imaging Core Facility - NCI [P30CA16672]; FACS; Hirshberg Foundation for Pancreatic Cancer Research; Harvard Stem Cell Institute; Sheikh Ahmed Center for Pancreatic Cancer Research; American Italian Cancer Foundation; National Institutes of Health (NIH) [P01CA117969]; NIH/NCI [P01CA120964]; Viragh Family Foundation; NATIONAL CANCER INSTITUTE [P01CA117969, P30CA016672, P50CA127003, P01CA120964] Funding Source: NIH RePORTER	Cancer Center Core Grant; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MDACC Flow Cytometry and Cellular Imaging Core Facility - NCI; FACS; Hirshberg Foundation for Pancreatic Cancer Research; Harvard Stem Cell Institute; Sheikh Ahmed Center for Pancreatic Cancer Research; American Italian Cancer Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Viragh Family Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Divakaruni, J. Dunn, C. Smith, K. McGirr and D. Ferrick for their support with the Seahorse Bioscience XF96 Analyser; T. Tieu for vector cloning and J. Kovacs for support with the YSI analyser; J. D. Lechleiter for the protocol to measure mitochondrial potential in vivo; H. Sandoval, C. Tacchetti, M. E. Di Francesco, J. Marszalek and P. Jones for discussions and suggestions; K. Dunner Jr and the High Resolution Electron Microscopy Facility at the MD Anderson Cancer Center (MDACC) for TEM (Cancer Center Core Grant CA16672); W. N. Hittelman and the Center for Targeted Therapy for confocal microscopy; the Dana-Farber Cancer Institute Microarray Core Facility for Affymetrix expression profiling and the MDACC Sequencing and Microarray Facility (SMF) funded by National Cancer Institute (NCI) grant CA016672 (SMF) for exome sequencing; the MDACC Flow Cytometry and Cellular Imaging Core Facility supported by grant NCI#P30CA16672 for flow cytometers and FACS; D. Jayanta for providing GFP-LC3 constructs; B. Perrazzona, U. Varadarajan and R. Dewan for lab management; and S. Jiang for assistance in maintenance of mouse colonies. A. V. is thankful to A. Fantino, S. Rapi, V. Giuliani and P. Viale for their continuous support. This study was supported by grants from the Hirshberg Foundation for Pancreatic Cancer Research to A. V., Harvard Stem Cell Institute to R. A. D. and A. V., Sheikh Ahmed Center for Pancreatic Cancer Research to G. F. D., T. P. H. and A. V., American Italian Cancer Foundation to G. F. D., National Institutes of Health (NIH) P01CA117969 to R. A. D., NIH/NCI P01CA120964 to J. M. A., The Viragh Family Foundation to J. B. F.; C. A. L. is a Pancreatic Cancer Action Network-AACR Pathway to Leadership Fellow.	Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gaglio D, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.56; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Itoh Y, 2004, J CEREBR BLOOD F MET, V24, P993, DOI 10.1097/01.WCB.0000127661.07591.DE; Jang S, 2013, LANCET ONCOL, V14, pE60, DOI 10.1016/S1470-2045(12)70539-9; Kantarjian H, 2002, NEW ENGL J MED, V346, P645, DOI 10.1056/NEJMoa011573; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kim MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020636; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Lagadinou ED, 2013, CELL STEM CELL, V12, P329, DOI 10.1016/j.stem.2012.12.013; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu YB, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-98; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Quintas-Cardama A, 2009, NAT REV CLIN ONCOL, V6, P535, DOI 10.1038/nrclinonc.2009.112; Samudio I, 2010, J CLIN INVEST, V120, P142, DOI 10.1172/JCI38942; Shi YH, 2012, P NATL ACAD SCI USA, V109, P16510, DOI 10.1073/pnas.1119738109; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zheng W, 2013, J CEREBR BLOOD F MET, V33, P600, DOI 10.1038/jcbfm.2012.214	29	751	765	8	196	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 30	2014	514	7524					628	+		10.1038/nature13611	http://dx.doi.org/10.1038/nature13611			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AR8BW	25119024	Green Accepted			2022-12-28	WOS:000343801500049
J	Chan, M				Chan, Margaret			Ebola Virus Disease in West Africa - No Early End to the Outbreak	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									World Hlth Org, Geneva, Switzerland	World Health Organization	Chan, M (corresponding author), World Hlth Org, Geneva, Switzerland.				World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)			0	139	147	0	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2014	371	13					1183	1185		10.1056/NEJMp1409859	http://dx.doi.org/10.1056/NEJMp1409859			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP4WH	25140856				2022-12-28	WOS:000342079700004
J	Kwon, I; Xiang, SH; Kato, M; Wu, L; Theodoropoulos, P; Wang, T; Kim, J; Yun, J; Xie, Y; McKnight, SL				Kwon, Ilmin; Xiang, Siheng; Kato, Masato; Wu, Leeju; Theodoropoulos, Pano; Wang, Tao; Kim, Jiwoong; Yun, Jonghyun; Xie, Yang; McKnight, Steven L.			Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells	SCIENCE			English	Article							SR SPLICING FACTORS; INTRANUCLEAR DISTRIBUTION; HEXANUCLEOTIDE REPEAT; PROTEIN-KINASES; ALS; DEGENERATION; EXPANSION; GRANULES; SEQUENCE; FOCI	Many RNA regulatory proteins controlling pre-messenger RNA splicing contain serine: arginine (SR) repeats. Here, we found that these SR domains bound hydrogel droplets composed of fibrous polymers of the low-complexity domain of heterogeneous ribonucleoprotein A2 (hnRNPA2). Hydrogel binding was reversed upon phosphorylation of the SR domain by CDC2-like kinases 1 and 2 (CLK1/2). Mutated variants of the SR domains changing serine to glycine (SR-to-GR variants) also bound to hnRNPA2 hydrogels but were not affected by CLK1/2. When expressed in mammalian cells, these variants bound nucleoli. The translation products of the sense and antisense transcripts of the expansion repeats associated with the C9orf72 gene altered in neurodegenerative disease encode GR(n) and PRn repeat polypeptides. Both peptides bound to hnRNPA2 hydrogels independent of CLK1/2 activity. When applied to cultured cells, both peptides entered cells, migrated to the nucleus, bound nucleoli, and poisoned RNA biogenesis, which caused cell death.	[Kwon, Ilmin; Xiang, Siheng; Kato, Masato; Wu, Leeju; Theodoropoulos, Pano; McKnight, Steven L.] UT Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Wang, Tao; Kim, Jiwoong; Yun, Jonghyun; Xie, Yang] UT Southwestern Med Ctr, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), UT Southwestern Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu	Wang, Tao/K-3518-2016; Yun, Jonghyun/Z-2461-2019; Xiang, Siheng/A-5063-2010	Yun, Jonghyun/0000-0002-9599-4356; Xiang, Siheng/0000-0003-4475-5707	NIGMS NIH HHS [U01 GM107623] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM107623] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Aubol BE, 2013, J MOL BIOL, V425, P2894, DOI 10.1016/j.jmb.2013.05.013; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Bubulya PA, 2004, J CELL BIOL, V167, P51, DOI 10.1083/jcb.200404120; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; DINGWALL C, 1988, J CELL BIOL, V107, P841, DOI 10.1083/jcb.107.3.841; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Duncan PI, 1998, EXP CELL RES, V241, P300, DOI 10.1006/excr.1998.4083; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Menegay HJ, 2000, J CELL SCI, V113, P3241; Mizielinska S, 2013, ACTA NEUROPATHOL, V126, P845, DOI 10.1007/s00401-013-1200-z; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; NEUGEBAUER KM, 1995, J CELL BIOL, V129, P899, DOI 10.1083/jcb.129.4.899; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; ROTH MB, 1990, J CELL BIOL, V111, P2217, DOI 10.1083/jcb.111.6.2217; THIRY M, 1995, EUR J CELL BIOL, V68, P14; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	27	395	395	4	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2014	345	6201					1139	1145		10.1126/science.1254917	http://dx.doi.org/10.1126/science.1254917			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AO2TV	25081482	Green Accepted			2022-12-28	WOS:000341179800037
J	Lara-Astiaso, D; Weiner, A; Lorenzo-Vivas, E; Zaretsky, I; Jaitin, DA; David, E; Keren-Shaul, H; Mildner, A; Winter, D; Jung, S; Friedman, N; Amit, I				Lara-Astiaso, David; Weiner, Assaf; Lorenzo-Vivas, Erika; Zaretsky, Irina; Jaitin, Diego Adhemar; David, Eyal; Keren-Shaul, Hadas; Mildner, Alexander; Winter, Deborah; Jung, Steffen; Friedman, Nir; Amit, Ido			Chromatin state dynamics during blood formation	SCIENCE			English	Article							MACROPHAGE; COMMITMENT; LANDSCAPE; ENHANCERS	Chromatin modifications are crucial for development, yet little is known about their dynamics during differentiation. Hematopoiesis provides a well-defined model to study chromatin state dynamics; however, technical limitations impede profiling of homogeneous differentiation intermediates. We developed a high-sensitivity indexing-first chromatin immunoprecipitation approach to profile the dynamics of four chromatin modifications across 16 stages of hematopoietic differentiation. We identify 48,415 enhancer regions and characterize their dynamics. We find that lineage commitment involves de novo establishment of 17,035 lineage-specific enhancers. These enhancer repertoire expansions foreshadow transcriptional programs in differentiated cells. Combining our enhancer catalog with gene expression profiles, we elucidate the transcription factor network controlling chromatin dynamics and lineage specification in hematopoiesis. Together, our results provide a comprehensive model of chromatin dynamics during development.	[Lara-Astiaso, David; Lorenzo-Vivas, Erika; Zaretsky, Irina; Jaitin, Diego Adhemar; David, Eyal; Keren-Shaul, Hadas; Mildner, Alexander; Winter, Deborah; Jung, Steffen; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Weiner, Assaf; Friedman, Nir] Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel; [Weiner, Assaf; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Friedman, N (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, IL-91904 Jerusalem, Israel.	nir@cs.huji.ac.il; ido.amit@weizmann.ac.il	Jung, Steffen/K-1409-2012; mildner, alexander/GQA-3761-2022; Friedman, Nir/H-9692-2012; Winter, Deborah R./AAQ-9253-2020; Mildner, Alexander/ABG-6122-2020; mildner, alexander/AAF-9451-2022; mildner, alexander/AFK-2161-2022	Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; Friedman, Nir/0000-0002-9678-3550; Winter, Deborah R./0000-0003-1806-673X; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427	European Research Council [309788, 340712]; Israeli Science Foundation [1782/11]; Human Frontier Science Program, Career Development Award [CDA00028/2011-c]; European Molecular Biology Organization; National Human Genome Research Institute Center for Excellence in Genome Science [1P50HG006193]; Israeli Centers of Research Excellence (I-CORE); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Israeli Science Foundation(Israel Science Foundation); Human Frontier Science Program, Career Development Award; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); National Human Genome Research Institute Center for Excellence in Genome Science; Israeli Centers of Research Excellence (I-CORE); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Amit and Friedman laboratories for critical discussions. We thank G. Brodsky for artwork. This work was supported by grants from the European Research Council (nos. 309788 and 340712), the Israeli Science Foundation (1782/11), the Human Frontier Science Program, Career Development Award (CDA00028/2011-c) (I. A.), a European Molecular Biology Organization Young Investigator Award (I. A.), the National Human Genome Research Institute Center for Excellence in Genome Science (1P50HG006193), and the Israeli Centers of Research Excellence (I-CORE). RNA-seq, ChIP-seq, and ATAC-seq data are deposited in the Gene Expression Omnibus under accession number GSE60103. The data can be viewed from the following Web site: http://compbio.cs.huji.ac.il/blood-chromatin/index.html. A patent application for iChIP has been filed by Yeda, Weizmann Institute of Science, Israel.	Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cantor AB, 2002, ONCOGENE, V21, P3368, DOI 10.1038/sj.onc.1205326; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Furey TS, 2012, NAT REV GENET, V13, P840, DOI 10.1038/nrg3306; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Ouyang WM, 2011, TRENDS IMMUNOL, V32, P26, DOI 10.1016/j.it.2010.10.005; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Shankaranarayanan P, 2011, NAT METHODS, V8, P565, DOI [10.1038/NMETH.1626, 10.1038/nmeth.1626]; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905	27	507	522	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 22	2014	345	6199					943	949		10.1126/science.1256271	http://dx.doi.org/10.1126/science.1256271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3YL	25103404	Green Accepted			2022-12-28	WOS:000340524700050
J	Frank, DA; Marrazzo, J				Frank, David A.; Marrazzo, Jeanne			Self-collected samples are less accurate for HPV testing than clinician-collected samples	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Frank, David A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Marrazzo, Jeanne] Univ Washington, Seattle, WA 98195 USA	Harvard University; Dana-Farber Cancer Institute; University of Washington; University of Washington Seattle	Frank, DA (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.			Marrazzo, Jeanne/0000-0002-9277-7364				World Health Organization, MORTALITY DATABASE	1	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC11	10.7326/0003-4819-161-4-201408190-02011	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133378				2022-12-28	WOS:000342347300010
J	Kar-Purkayastha, I				Kar-Purkayastha, Ishani			The art of medicine The age of miracles	LANCET			English	Editorial Material												ishanik@doctors.org.uk							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					574	575		10.1016/S0140-6736(14)61355-6	http://dx.doi.org/10.1016/S0140-6736(14)61355-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AN4QR	25136719	Bronze			2022-12-28	WOS:000340573300013
J	DiazGranados, CA; Dunning, AJ; Kimmel, M; Kirby, D; Treanor, J; Collins, A; Pollak, R; Christoff, J; Earl, J; Landolfi, V; Martin, E; Gurunathan, S; Nathan, R; Greenberg, DP; Tornieporth, NG; Decker, MD; Talbot, HK				DiazGranados, Carlos A.; Dunning, Andrew J.; Kimmel, Murray; Kirby, Daniel; Treanor, John; Collins, Avi; Pollak, Richard; Christoff, Janet; Earl, John; Landolfi, Victoria; Martin, Earl; Gurunathan, Sanjay; Nathan, Richard; Greenberg, David P.; Tornieporth, Nadia G.; Decker, Michael D.; Talbot, H. Keipp			Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; SEASONAL INFLUENZA; DOUBLE-BLIND; ELDERLY SUBJECTS; TRIAL; IMMUNOGENICITY; SAFETY; HOSPITALIZATIONS; METAANALYSIS; MORTALITY	BACKGROUND As compared with a standard-dose vaccine, a high-dose, trivalent, inactivated influenza vaccine (IIV3-HD) improves antibody responses to influenza among adults 65 years of age or older. This study evaluated whether IIV3-HD also improves protection against laboratory-confirmed influenza illness. METHODS We conducted a phase IIIb-IV, multicenter, randomized, double-blind, active-controlled trial to compare IIV3-HD (60 mu g of hemagglutinin per strain) with standard-dose trivalent, inactivated influenza vaccine (IIV3-SD [15 mu g of hemagglutinin per strain]) in adults 65 years of age or older. Assessments of relative efficacy, effectiveness, safety (serious adverse events), and immunogenicity (hemagglutination-inhibition [HAI] titers) were performed during the 2011-2012 (year 1) and the 2012-2013 (year 2) northern-hemisphere influenza seasons. RESULTS A total of 31,989 participants were enrolled from 126 research centers in the United States and Canada (15,991 were randomly assigned to receive IIV3-HD, and 15,998 to receive IIV3-SD). In the intention-to-treat analysis, 228 participants in the IIV3-HD group (1.4%) and 301 participants in the IIV3-SD group (1.9%) had laboratory-confirmed influenza caused by any viral type or subtype associated with a protocol-defined influenza-like illness (relative efficacy, 24.2%; 95% confidence interval [CI], 9.7 to 36.5). At least one serious adverse event during the safety surveillance period was reported by 1323 (8.3%) of the participants in the IIV3-HD group, as compared with 1442 (9.0%) of the participants in the IIV3-SD group (relative risk, 0.92; 95% CI, 0.85 to 0.99). After vaccination, HAI titers and seroprotection rates (the percentage of participants with HAI titers >= 1:40) were significantly higher in the IIV3-HD group. CONCLUSIONS Among persons 65 years of age or older, IIV3-HD induced significantly higher antibody responses and provided better protection against laboratory-confirmed influenza illness than did IIV3-SD.	[DiazGranados, Carlos A.; Dunning, Andrew J.; Kirby, Daniel; Christoff, Janet; Landolfi, Victoria; Gurunathan, Sanjay; Greenberg, David P.; Tornieporth, Nadia G.; Decker, Michael D.] Sanofi Pasteur, Swiftwater, PA 18370 USA; [Collins, Avi] ReS Pharmaceut Serv, Ft Washington, PA USA; [Greenberg, David P.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Kimmel, Murray] Accelovance, Melbourne, FL USA; [Treanor, John] Univ Rochester, Rochester, NY USA; [Pollak, Richard] Endeavor Clin Trials, San Antonio, TX USA; [Martin, Earl] Martin Diagnost Clin, Tomball, TX USA; [Earl, John] PMG Res Hickory, Hickory, NC USA; [Nathan, Richard] Idaho Falls Infect Dis & Snake River Res, Idaho Falls, ID USA; [Decker, Michael D.] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA; [Talbot, H. Keipp] Vanderbilt Univ, Med Ctr, Nashville, TN USA	Sanofi-Aventis; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Rochester; Vanderbilt University; Vanderbilt University	DiazGranados, CA (corresponding author), Sanofi Pasteur, 1 Discovery Dr, Swiftwater, PA 18370 USA.	carlos.diazgranados@sanofipasteur.com		Decker, Michael/0000-0003-1008-7472	Sanofi Pasteur	Sanofi Pasteur	Funded by Sanofi Pasteur; ClinicalTrials.gov number, NCT01427309.	[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P473; [Anonymous], 2012, MMWR MORB MORTAL WKL, V61, P414; [Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P997; [Anonymous], 2013, WKLY EPIDEMIOL REC, V88, P101; Atmar RL, 2010, EXPERT REV VACCINES, V9, P1399, DOI [10.1586/erv.10.134, 10.1586/ERV.10.134]; Banzhoff A, 2008, INFLUENZA OTHER RESP, V2, P243, DOI 10.1111/j.1750-2659.2008.00059.x; Couch Robert B., 1997, Journal of Infectious Diseases, V176, pS38, DOI 10.1086/514173; De Villiers PJT, 2009, VACCINE, V28, P228, DOI 10.1016/j.vaccine.2009.09.092; DiazGranados CA, 2013, VACCINE, V31, P861, DOI 10.1016/j.vaccine.2012.12.013; DiazGranados CA, 2012, VACCINE, V31, P49, DOI 10.1016/j.vaccine.2012.10.084; Falsey AR, 2009, J INFECT DIS, V200, P172, DOI 10.1086/599790; Fiore AE, 2010, MMWR RECOMM REP, V59, P1147; Nuorti J. Pekka, 2010, Morbidity and Mortality Weekly Report, V59, P1; Fiore Anthony E., 2010, Morbidity and Mortality Weekly Report, V59, P993; GOVAERT TME, 1994, JAMA-J AM MED ASSOC, V272, P1661, DOI 10.1001/jama.272.21.1661; Govaert TME, 1998, FAM PRACT, V15, P16, DOI 10.1093/fampra/15.1.16; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Kendal AP, 1982, CONCEPTS PROCEDURES, pB19; Makela MJ, 2000, J INFECTION, V40, P42, DOI 10.1053/jinf.1999.0602; Mannino S, 2012, AM J EPIDEMIOL, V176, P527, DOI 10.1093/aje/kws313; McElhaney JE, 2013, LANCET INFECT DIS, V13, P485, DOI 10.1016/S1473-3099(13)70046-X; McElhaney JE, 2005, VACCINE, V23, pS10, DOI 10.1016/j.vaccine.2005.04.019; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Newcombe RG, 1999, STAT MED, V18, P1293, DOI 10.1002/(SICI)1097-0258(19990530)18:10<1293::AID-SIM175>3.0.CO;2-7; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Palache A, 2011, VACCINE, V29, P9459, DOI 10.1016/j.vaccine.2011.10.030; Praditsuwan Rungnirand, 2005, Journal of the Medical Association of Thailand, V88, P256; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Skowronski DM, 2013, AM J EPIDEMIOL, V177, P593, DOI 10.1093/aje/kwt021; Talbot HK, 2010, CLIN INFECT DIS, V50, P747, DOI 10.1086/650486; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tsang P, 2014, VACCINE, V32, P2507, DOI 10.1016/j.vaccine.2013.09.074	33	489	499	2	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					635	645		10.1056/NEJMoa1315727	http://dx.doi.org/10.1056/NEJMoa1315727			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZL	25119609				2022-12-28	WOS:000340819600009
J	Mozaffarian, D; Fahimi, S; Singh, GM; Micha, R; Khatibzadeh, S; Engell, RE; Lim, S; Danaei, G; Ezzati, M; Powles, J				Mozaffarian, Dariush; Fahimi, Saman; Singh, Gitanjali M.; Micha, Renata; Khatibzadeh, Shahab; Engell, Rebecca E.; Lim, Stephen; Danaei, Goodarz; Ezzati, Majid; Powles, John		Global Burden Dis Nutr Chronic Dis	Global Sodium Consumption and Death from Cardiovascular Causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; SALT REDUCTION; RACIAL-DIFFERENCES; RISK-FACTORS; DISEASE; HYPERTENSION; BURDEN; HEALTH; METAANALYSIS; ASSOCIATION	BACKGROUND High sodium intake increases blood pressure, a risk factor for cardiovascular disease, but the effects of sodium intake on global cardiovascular mortality are uncertain. METHODS We collected data from surveys on sodium intake as determined by urinary excretion and diet in persons from 66 countries (accounting for 74.1% of adults throughout the world), and we used these data to quantify the global consumption of sodium according to age, sex, and country. The effects of sodium on blood pressure, according to age, race, and the presence or absence of hypertension, were calculated from data in a new meta-analysis of 107 randomized interventions, and the effects of blood pressure on cardiovascular mortality, according to age, were calculated from a meta-analysis of cohorts. Cause-specific mortality was derived from the Global Burden of Disease Study 2010. Using comparative risk assessment, we estimated the cardiovascular effects of current sodium intake, as compared with a reference intake of 2.0 g of sodium per day, according to age, sex, and country. RESULTS In 2010, the estimated mean level of global sodium consumption was 3.95 g per day, and regional mean levels ranged from 2.18 to 5.51 g per day. Globally, 1.65 million annual deaths from cardiovascular causes (95% uncertainty interval [confidence interval], 1.10 million to 2.22 million) were attributed to sodium intake above the reference level; 61.9% of these deaths occurred in men and 38.1% occurred in women. These deaths accounted for nearly 1 of every 10 deaths from cardiovascular causes (9.5%). Four of every 5 deaths (84.3%) occurred in low-and middle-income countries, and 2 of every 5 deaths (40.4%) were premature (before 70 years of age). The rate of death from cardiovascular causes associated with sodium intake above the reference level was highest in the country of Georgia and lowest in Kenya. CONCLUSIONS In this modeling study, 1.65 million deaths from cardiovascular causes that occurred in 2010 were attributed to sodium consumption above a reference level of 2.0 g per day.	[Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Mozaffarian, Dariush; Fahimi, Saman; Singh, Gitanjali M.; Micha, Renata; Khatibzadeh, Shahab; Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Mozaffarian, Dariush] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Mozaffarian, Dariush] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Fahimi, Saman; Powles, John] Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC PHE Ctr Environm & Hlth, London, England; [Engell, Rebecca E.; Lim, Stephen] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Cambridge; Imperial College London; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Mozaffarian, D (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, 665 Huntington Ave,Bldg 2-319, Boston, MA 02115 USA.	dariush.mozaffarian@tufts.edu	TURRINI, AIDA/P-2413-2019; Tsugane, Shoichiro/A-2424-2015; Bjerregaard, Peter/ABD-8894-2020; Koksal, Eda/AAW-2900-2021; Calleja, Neville/E-3895-2019; Steingrimsdottir, Laufey/L-3150-2015; Castetbon, Katia/F-2686-2017; Turrini, Aida/K-5353-2016; Fisberg, Regina M/C-4069-2012; Forsyth, Simon J/N-9522-2013; Mozaffarian, Dariush/ABC-2822-2020; Danaei, Goodarz/B-6085-2008; Panagiotakos, Demosthenes/C-9776-2013	TURRINI, AIDA/0000-0002-2188-9406; Tsugane, Shoichiro/0000-0003-4105-2774; Bjerregaard, Peter/0000-0001-7153-8447; Koksal, Eda/0000-0002-7930-9910; Calleja, Neville/0000-0003-1800-2103; Turrini, Aida/0000-0002-2188-9406; Fisberg, Regina M/0000-0002-4490-9035; Forsyth, Simon J/0000-0002-3100-3584; Panagiotakos, Demosthenes/0000-0001-8583-153X; Jackson, Maria/0000-0002-7031-7244; Ding, Eric/0000-0002-5881-8097; Neal, Bruce/0000-0002-0490-7465; Elliott, Paul/0000-0002-7511-5684; Chen, Yu/0000-0002-1519-4894; Waskiewicz, Anna/0000-0001-5091-2145	Bill and Melinda Gates Foundation; Medical Research Council [G0801056] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the Bill and Melinda Gates Foundation.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; [Anonymous], 2011, 2010 REP DIET GUID A; [Anonymous], 2003, DIET NUTR PREV CHRON; Asaria P, 2007, LANCET, V370, P2004; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; D'Elia L, 2011, J AM COLL CARDIOL, V57, P1210, DOI 10.1016/j.jacc.2010.09.070; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Department of Agriculture Department of Health and Human Services (US), 2011, DIET GUID AM 2010; Duc AH, 2011, HEALTH POLICY PLANN, V26, P210, DOI 10.1093/heapol/czq045; ELLIOTT P, 1988, BRIT MED J, V297, P319; Food and Nutrition Board Institute of Medicine, 2010, STRAT RED SOD INT US; Frieden TR, 2011, NEW ENGL J MED, V365, DOI [10.1056/NEJMp1110421, 10.1056/NEJMP1110421]; General Assembly of the United Nations, 2011, HIGH LEV M NONC DIS; Graudal NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub3; He F. J., 2013, BMJ, V346; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004937.pub2; Institute of Medicine, 2013, SOD INT POP ASEV; Laatikainen T, 2006, EUR J CLIN NUTR, V60, P965, DOI 10.1038/sj.ejcn.1602406; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CMM, 2003, HYPERTENSION, V42, P69, DOI 10.1161/01.HYP.0000075083.04415.4B; Lewington S, 2003, LANCET, V361, P1060; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Martikainen JA, 2011, EUR J CLIN NUTR, V65, P1148, DOI 10.1038/ejcn.2011.78; Micha R, 2012, EUR J CLIN NUTR, V66, P119, DOI 10.1038/ejcn.2011.147; National Institute for Health and Clinical Excellence, 2010, PREV CARD DIS POP LE, V25; O'Flaherty M, 2012, B WORLD HEALTH ORGAN, V90, P522, DOI 10.2471/BLT.11.092643; PARMER RJ, 1994, HYPERTENSION, V24, P752, DOI 10.1161/01.HYP.24.6.752; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Rubinstein A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-627; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Scientific Advisory Committee on Nutrition, 2003, SALT HLTH; Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174; Textor SC, 2012, AM J KIDNEY DIS, V59, P229, DOI 10.1053/j.ajkd.2011.09.023; Turban S, 2013, AM J KIDNEY DIS, V61, P88, DOI 10.1053/j.ajkd.2012.08.036; van Bommel E, 2012, INT J CLIN PHARM TH, V50, P478, DOI 10.5414/CP201724; Van Vliet BN, 2008, INT J OBESITY, V32, pS35, DOI 10.1038/ijo.2008.205; Whelton PK, 2012, CIRCULATION, V126, P2880, DOI 10.1161/CIR.0b013e318279acbf; Whelton PK, 2013, CIRCULATION, V27, pe263; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; World Health Organization, 2012, WHO GUID SOD INT AD; Wyness LA, 2012, PUBLIC HEALTH NUTR, V15, P254, DOI 10.1017/S1368980011000966	45	726	768	3	100	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					624	634		10.1056/NEJMoa1304127	http://dx.doi.org/10.1056/NEJMoa1304127			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZL	25119608	Green Published			2022-12-28	WOS:000340819600008
J	De Rybel, B; Adibi, M; Breda, AS; Wendrich, JR; Smit, ME; Novak, O; Yamaguchi, N; Yoshida, S; Van Isterdael, G; Palovaara, J; Nijsse, B; Boekschoten, MV; Hooiveld, G; Beeckman, T; Wagner, D; Ljung, K; Fleck, C; Weijers, D				De Rybel, Bert; Adibi, Milad; Breda, Alice S.; Wendrich, Jos R.; Smit, Margot E.; Novak, Ondrej; Yamaguchi, Nobutoshi; Yoshida, Saiko; Van Isterdael, Gert; Palovaara, Joakim; Nijsse, Bart; Boekschoten, Mark V.; Hooiveld, Guido; Beeckman, Tom; Wagner, Doris; Ljung, Karin; Fleck, Christian; Weijers, Dolf			PLANT DEVELOPMENT Integration of growth and patterning during vascular tissue formation in Arabidopsis	SCIENCE			English	Article							DEPENDENT AUXIN GRADIENTS; SOLID-PHASE EXTRACTION; SHOOT APICAL MERISTEM; TRANSCRIPTION FACTOR; ROOT; CYTOKININS; PURIFICATION; EXPRESSION; TRANSPORT; GENES	Coordination of cell division and pattern formation is central to tissue and organ development, particularly in plants where walls prevent cell migration. Auxin and cytokinin are both critical for division and patterning, but it is unknown how these hormones converge upon tissue development. We identify a genetic network that reinforces an early embryonic bias in auxin distribution to create a local, nonresponding cytokinin source within the root vascular tissue. Experimental and theoretical evidence shows that these cells act as a tissue organizer by positioning the domain of oriented cell divisions. We further demonstrate that the auxin-cytokinin interaction acts as a spatial incoherent feed-forward loop, which is essential to generate distinct hormonal response zones, thus establishing a stable pattern within a growing vascular tissue.	[De Rybel, Bert; Breda, Alice S.; Wendrich, Jos R.; Smit, Margot E.; Yoshida, Saiko; Palovaara, Joakim; Weijers, Dolf] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands; [Adibi, Milad] LifeGlimmer GmbH, D-12163 Berlin, Germany; [Adibi, Milad] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Adibi, Milad; Nijsse, Bart; Fleck, Christian] Wageningen Univ, Lab Syst & Synthet Biol, NL-6703 HA Wageningen, Netherlands; [Novak, Ondrej; Ljung, Karin] SLU, Dept Forest Genet & Plant Physiol, Ume Plant Sci Ctr UPSC, SE-90183 Umea, Sweden; [Novak, Ondrej] Palacky Univ, Lab Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, CZ-78371 Olomouc, Czech Republic; [Novak, Ondrej] Inst Expt Bot AS CR, CZ-78371 Olomouc, Czech Republic; [Yamaguchi, Nobutoshi; Wagner, Doris] Univ Penn, Dept Biol, Philadelphia, PA USA; [Van Isterdael, Gert; Beeckman, Tom] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Van Isterdael, Gert; Beeckman, Tom] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Boekschoten, Mark V.; Hooiveld, Guido] Wageningen Univ, Div Human Nutr, NL-6703 HA Wageningen, Netherlands; [Boekschoten, Mark V.] TI Food & Nutr, NL-6703 HA Wageningen, Netherlands	Wageningen University & Research; University of Freiburg; Wageningen University & Research; Swedish University of Agricultural Sciences; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; University of Pennsylvania; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Wageningen University & Research; Top Institute Food & Nutrition	Fleck, C (corresponding author), Wageningen Univ, Lab Syst & Synthet Biol, Dreijenlaan 3, NL-6703 HA Wageningen, Netherlands.	christian.fleck@wur.nl; dolf.weijers@wur.nl	Wendrich, Jos/V-9061-2019; Yoshida, Saiko/AAE-5693-2019; Boekschoten, Mark/AAS-4597-2021; Ljung, Karin/AAE-8691-2019; Weijers, Dolf/A-2076-2010; Wendrich, Jos R/H-3686-2013; NOVAK, Ondrej/F-7031-2014; Beeckman, Tom/ABA-1164-2020; Yamaguchi, Nobutoshi/AAU-6928-2020; Beeckman, Tom/ABI-1703-2020; Hooiveld, Guido JEJ/F-4912-2010; Weijers, Dolf/ABI-1332-2020	Wendrich, Jos/0000-0002-6198-3763; Yoshida, Saiko/0000-0001-6111-9353; Boekschoten, Mark/0000-0002-2139-0795; Ljung, Karin/0000-0003-2901-189X; Weijers, Dolf/0000-0003-4378-141X; Wendrich, Jos R/0000-0002-6198-3763; NOVAK, Ondrej/0000-0003-3452-0154; Yamaguchi, Nobutoshi/0000-0003-3738-6157; Beeckman, Tom/0000-0001-8656-2060; Hooiveld, Guido JEJ/0000-0003-1954-3542; Weijers, Dolf/0000-0003-4378-141X; Van Isterdael, Gert/0000-0001-6626-1316; De Rybel, Bert/0000-0002-9551-042X; Smit, Margot/0000-0001-8285-5130; Fleck, Christian/0000-0002-6371-4495; Breda, Alice Sarah/0000-0002-5593-3620; Wagner, Doris/0000-0003-4656-2490	FEBS Fellowship; Marie Curie Fellowship [IEF-2009-252503]; Netherlands Organization for Scientific Research (NWO) [ALW-VIDI-864.06.012, ALW-820.02.019]; ERA-CAPS project EURO-PEC [849.13.006]; European Research Council (Starting Grant "CELLPATTERN") [281573]; European Union 7th framework project [305564]; Ministry of Education, Youth, and Sports of the Czech Republic [LK21306, LO1204]; grant agency of the Czech Republic [14-34792S]; NSF [IOS 1257111]; Austrian Science Fund (FWF) [I 1476] Funding Source: researchfish	FEBS Fellowship; Marie Curie Fellowship(European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ERA-CAPS project EURO-PEC; European Research Council (Starting Grant "CELLPATTERN"); European Union 7th framework project; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); grant agency of the Czech Republic(Grant Agency of the Czech Republic); NSF(National Science Foundation (NSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We would like to thank H. Sakakibara, Y. Helariutta, T. Laux, and B. Muller for sharing plant materials; J. Jansen for technical assistance with microarray hybridizations; and M. Glosov and H. Martinkova for their help with cytokinin analyses. B. D. R. was supported by long-term FEBS and Marie Curie Fellowships (IEF-2009-252503), and D. Weijers received funding from the Netherlands Organization for Scientific Research (NWO; ALW-VIDI-864.06.012 and ALW-820.02.019 and the ERA-CAPS project EURO-PEC; 849.13.006) and the European Research Council (Starting Grant "CELLPATTERN," contract no. 281573). M. A. was funded by the SysmedIBD project funded under the European Union 7th framework project (contract no. 305564). O.N. acknowledges the Ministry of Education, Youth, and Sports of the Czech Republic (The program "Navrat" for Research, Development, and Innovations, grant LK21306; the National Program for Sustainability I, grant LO1204) and grant funding no. 14-34792S provided by the grant agency of the Czech Republic. K. L. acknowledges the Swedish Governmental Agency for Innovations Systems (VINNOVA) and the Swedish Research Council (V.R.). D. Wagner was supported by NSF grant (IOS 1257111). The transcriptomics data files are available at GEO (accession no. GSE56868).	Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Besnard F, 2014, NATURE, V505, P417, DOI 10.1038/nature12791; Bishopp A, 2011, CURR BIOL, V21, P927, DOI 10.1016/j.cub.2011.04.049; Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Rybel B, 2014, PHYSIOL PLANTARUM, V151, P126, DOI 10.1111/ppl.12091; De Rybel B, 2013, DEV CELL, V24, P426, DOI 10.1016/j.devcel.2012.12.013; De Rybel B, 2011, PLANT PHYSIOL, V156, P1292, DOI 10.1104/pp.111.177337; De Rybel B, 2010, CURR BIOL, V20, P1697, DOI 10.1016/j.cub.2010.09.007; De Smet I, 2004, J MICROSC-OXFORD, V213, P76, DOI 10.1111/j.1365-2818.2004.01269.x; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Help H, 2011, PLANT SIGNAL BEHAV, V6, P1837, DOI 10.4161/psb.6.11.17600; Hoyerova K, 2006, PHYTOCHEMISTRY, V67, P1151, DOI 10.1016/j.phytochem.2006.03.010; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jonsson H, 2006, P NATL ACAD SCI USA, V103, P1633, DOI 10.1073/pnas.0509839103; Kierzkowski D, 2012, SCIENCE, V335, P1096, DOI 10.1126/science.1213100; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Kuroha T, 2009, PLANT CELL, V21, P3152, DOI 10.1105/tpc.109.068676; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Llavata-Peris Cristina, 2013, Methods Mol Biol, V959, P137, DOI 10.1007/978-1-62703-221-6_8; LLOYD CW, 1991, DEVELOPMENT S, V1, P55; Mahonen AP, 2000, GENE DEV, V14, P2938, DOI 10.1101/gad.189200; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Matsumoto-Kitano M, 2008, P NATL ACAD SCI USA, V105, P20027, DOI 10.1073/pnas.0805619105; Merks RMH, 2011, PLANT PHYSIOL, V155, P656, DOI 10.1104/pp.110.167619; Miyashima S, 2013, EMBO J, V32, P178, DOI 10.1038/emboj.2012.301; Muraro D, 2014, P NATL ACAD SCI USA, V111, P857, DOI 10.1073/pnas.1221766111; Ohashi-Ito K, 2007, DEVELOPMENT, V134, P2959, DOI 10.1242/dev.006296; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Rupp HM, 1999, PLANT J, V18, P557, DOI 10.1046/j.1365-313X.1999.00472.x; Saiga S, 2008, DEVELOPMENT, V135, P1751, DOI 10.1242/dev.014993; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Saulsberry A, 2002, DEVELOPMENT, V129, P3403; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Svacinova J, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-17; Tokunaga H, 2012, PLANT J, V69, P355, DOI 10.1111/j.1365-313X.2011.04795.x; Truernit E, 2008, PLANT CELL, V20, P1494, DOI 10.1105/tpc.107.056069; Vieten A, 2005, DEVELOPMENT, V132, P4521, DOI 10.1242/dev.02027; Yamaguchi Nobutoshi, 2014, Arabidopsis Book, V12, pe0170, DOI 10.1199/tab.0170; Yoshida S, 2014, DEV CELL, V29, P75, DOI 10.1016/j.devcel.2014.02.002; Zurcher E, 2013, PLANT PHYSIOL, V161, P1066, DOI 10.1104/pp.112.211763	50	192	195	13	259	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197							1255215	10.1126/science.1255215	http://dx.doi.org/10.1126/science.1255215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104393				2022-12-28	WOS:000339962800001
J	Reboldi, A; Dang, EV; McDonald, JG; Liang, GS; Russell, DW; Cyster, JG				Reboldi, Andrea; Dang, Eric V.; McDonald, Jeffrey G.; Liang, Guosheng; Russell, David W.; Cyster, Jason G.			25-Hydroxycholesterol suppresses interleukin-1-driven inflammation downstream of type I interferon	SCIENCE			English	Article							LIVER-X-RECEPTORS; LIPID-METABOLISM; CELL-MIGRATION; INFLAMMASOMES; MACROPHAGES; ACTIVATION; PATHWAYS; EBI2; MICE	Type I interferon (IFN) protects against viruses, yet it also has a poorly understood suppressive influence on inflammation. Here, we report that activated mouse macrophages lacking the IFN-stimulated gene cholesterol 25-hydroxylase (Ch25h) and that are unable to produce the oxysterol 25-hydroxycholesterol (25-HC) overproduce inflammatory interleukin-1 (IL-1) family cytokines. 25-HC acts by antagonizing sterol response element-binding protein (SREBP) processing to reduce Il1b transcription and to broadly repress IL-1-activating inflammasomes. In accord with these dual actions of 25-HC, Ch25h-deficient mice exhibit increased sensitivity to septic shock, exacerbated experimental autoimmune encephalomyelitis, and a stronger ability to repress bacterial growth. These findings identify an oxysterol, 25-HC, as a critical mediator in the negative-feedback pathway of IFN signaling on IL-1 family cytokine production and inflammasome activity.	[Reboldi, Andrea; Dang, Eric V.; Cyster, Jason G.] Univ Calif San Francisco, Dept Microbiol & Immunol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [McDonald, Jeffrey G.; Liang, Guosheng; Russell, David W.] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cyster, JG (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jason.cyster@ucsf.edu		Dang, Eric/0000-0002-2389-6167; Russell, David/0000-0002-0277-403X	UCSF; Clayton Foundation for Research; American Asthma Foundation; NIH [AI40098, 2P01HL20948]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI040098, R01AI040098] Funding Source: NIH RePORTER	UCSF; Clayton Foundation for Research; American Asthma Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Hellman for help with the sepsis model, J. Bluestone for help with the EAE model, B. Y. Han for help with GEO submission, and Y. Xu and J. An for expert technical assistance. The data presented in the paper are tabulated in the main paper and in the supplementary materials. D.W.R. holds U.S. Patent No. 6,562,609 "Oxidoreductase for use in human therapeutics and diagnostics." A.R. was an Irvington Institute Postdoctoral Fellow at the Cancer Research Institute, E.V.D is supported by the UCSF Medical Scientist Training Program (MSTP) and the Biomedical Sciences (BMS) Graduate program and D.W.R. by the Clayton Foundation for Research. J.G.C. is an Investigator at the Howard Hughes Medical Institute and recipient of an award from the American Asthma Foundation. This work was supported by NIH grants AI40098 and 2P01HL20948. RNAseq data have been deposited in GEO under accession number GSE58993.	Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Bjorkhem I, 2009, J LIPID RES, V50, pS213, DOI 10.1194/jlr.R800025-JLR200; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; Diczfalusy U, 2013, BIOCHIMIE, V95, P455, DOI 10.1016/j.biochi.2012.06.016; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gross O, 2012, IMMUNITY, V36, P388, DOI 10.1016/j.immuni.2012.01.018; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Inoue M, 2013, IMMUNOLOGY, V139, P11, DOI 10.1111/imm.12081; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jeon TI, 2012, TRENDS ENDOCRIN MET, V23, P65, DOI 10.1016/j.tem.2011.10.004; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Ludigs K, 2012, CELL MOL LIFE SCI, V69, P3395, DOI 10.1007/s00018-012-0989-2; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; McDonald JG, 2010, J LEUKOCYTE BIOL, V88, P1071, DOI 10.1189/jlb.0710418; Park K, 2010, J LEUKOCYTE BIOL, V88, P1081, DOI 10.1189/jlb.0610318; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Zou T, 2011, INFECT IMMUN, V79, P1526, DOI 10.1128/IAI.01195-10	33	279	286	5	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					679	684		10.1126/science.1254790	http://dx.doi.org/10.1126/science.1254790			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104388	Green Accepted			2022-12-28	WOS:000339962800041
J	Wilson, AC; Colombe, Y; Brown, KR; Knill, E; Leibfried, D; Wineland, DJ				Wilson, A. C.; Colombe, Y.; Brown, K. R.; Knill, E.; Leibfried, D.; Wineland, D. J.			Tunable spin-spin interactions and entanglement of ions in separate potential wells	NATURE			English	Article							QUANTUM SIMULATION; TRAPPED IONS; COMPUTERS; PHYSICS	Quantum simulation(1,2)-the use of one quantum system to simulate a less controllable one-may provide an understanding of the many quantum systems which cannot be modelled using classical computers. Considerable progress in control and manipulation has been achieved for various quantum systems(3-5), but one of the remaining challenges is the implementation of scalable devices. In this regard, individual ions trapped in separate tunable potential wells are promising(6-8). Here we implement the basic features of this approach and demonstrate deterministic tuning of the Coulomb interaction between two ions, independently controlling their local wells. The scheme is suitable for emulating a range of spin-spin interactions, but to characterize the performance of our set-up we select one that entangles the internal states of the two ions with a fidelity of 0.82(1) (the digit inparentheses shows the standard error of the mean). Extension of this building block to a two-dimensional network, which is possible using ion-trap microfabrication processes(9), may provide a new quantum simulator architecture with broad flexibility in designing and scaling the arrangement of ions and their mutual interactions. To perform useful quantum simulations, including those of condensed-matter phenomena such as the fractional quantum Hall effect, an array of tens of ions might be sufficient(4,10,11).	[Wilson, A. C.; Colombe, Y.; Knill, E.; Leibfried, D.; Wineland, D. J.] NIST, Boulder, CO 80305 USA; [Brown, K. R.] Georgia Tech Res Inst, Atlanta, GA 30332 USA	National Institute of Standards & Technology (NIST) - USA; University System of Georgia; Georgia Institute of Technology	Wilson, AC (corresponding author), NIST, 325 Broadway, Boulder, CO 80305 USA.	andrew.wilson@nist.gov			Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA); ONR; NIST Quantum Information Program	Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA); ONR(Office of Naval Research); NIST Quantum Information Program	We thank K. McCormick, A. Keith and D. Allcock for comments on the manuscript. This research was funded by the Office of the Director of National Intelligence (ODNI), Intelligence Advanced Research Projects Activity (IARPA), ONR, and the NIST Quantum Information Program. All statements of fact, opinion or conclusions contained herein are those of the authors and should not be construed as representing the official views or policies of IARPA or the ODNI. This work, a submission of NIST, is not subject to US copyright.	Bermudez A, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.040302; Britton JW, 2012, NATURE, V484, P489, DOI 10.1038/nature10981; Brown KR, 2011, NATURE, V471, P196, DOI 10.1038/nature09721; Chiaverini J, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022324; Ciaramicoli G, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.017901; Cirac JI, 2012, NAT PHYS, V8, P264, DOI 10.1038/nphys2275; Cirac JI, 2000, NATURE, V404, P579, DOI 10.1038/35007021; Daniilidis N, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/15/154012; Efron B., 1994, MONOGRAPHS STAT APPL; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; Harlander M, 2011, NATURE, V471, P200, DOI 10.1038/nature09800; Hauke P, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/8/082401; Hayes D, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.020503; HEINZEN DJ, 1990, PHYS REV A, V42, P2977, DOI 10.1103/PhysRevA.42.2977; Junemann J, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.230404; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Kim K, 2010, NATURE, V465, P590, DOI 10.1038/nature09071; Knill E, 2010, NATURE, V463, P441, DOI 10.1038/463441a; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Leibfried D, 2003, NATURE, V422, P412, DOI 10.1038/nature01492; Leibfried D, 2010, NATURE, V463, P608, DOI 10.1038/463608b; Li J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2383; Lloyd S, 1996, SCIENCE, V273, P1073, DOI 10.1126/science.273.5278.1073; Nielsen AEB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3864; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Schmied R, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/11/115011; Schmied R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.233002; Seidelin S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.253003; Shi T, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.013606; Tan TR, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.263002; Tseng CH, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.032309	39	61	61	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					57	+		10.1038/nature13565	http://dx.doi.org/10.1038/nature13565			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25100480	Green Submitted			2022-12-28	WOS:000339908000030
J	Goldoni, M; Bonini, S; Urban, ML; Palmisano, A; De Palma, G; Galletti, E; Coggiola, M; Buzio, C; Mutti, A; Vaglio, A				Goldoni, Matteo; Bonini, Silvia; Urban, Maria L.; Palmisano, Alessandra; De Palma, Giuseppe; Galletti, Elisa; Coggiola, Marco; Buzio, Carlo; Mutti, Antonio; Vaglio, Augusto			Asbestos and Smoking as Risk Factors for Idiopathic Retroperitoneal Fibrosis	ANNALS OF INTERNAL MEDICINE			English	Article							LUNG-CANCER; CHRONIC PERIAORTITIS; EXPOSURE; DISEASE; GUIDELINES; MECHANISMS	Background: Idiopathic retroperitoneal fibrosis (RPF) is a rare disease. Asbestos exposure has been proposed as a risk factor for idiopathic RPF. Objective: To investigate the role of asbestos and other occupational agents (such as silica, metals, and organic solvents), as well as environmental agents (such as smoking), and their interactions as potential risk factors for idiopathic RPF. Design: Case-control study. Setting: National referral hospital for idiopathic RPF. Patients: 90 patients with idiopathic RPF and 270 control participants matched for age, sex, and region of residency. Measurements: Occupational history was obtained using structured questionnaires administered by blinded specialists in occupational medicine. Exposure to nonoccupational agents and presence of diseases that were potentially predisposing to idiopathic RPF were assessed through patient interviews and examination of medical records. Results: A history of asbestos exposure was associated with idiopathic RPF (odds ratio [OR], 4.22 [95% CI, 2.14 to 8.33]). Both current smoking (OR, 3.21 [CI, 1.46 to 7.07]) and former smoking (OR, 2.93 [CI, 1.39 to 6.14]) were more prevalent among patients than among those who never smoked. A multiplicative effect was found between tobacco smoke and both occupational asbestos exposure (OR, 12.04 [CI, 4.32 to 38.28]) and extraoccupational asbestos exposure (OR, 8.42 [CI, 2.77 to 30.58]). Limitation: Retrospective, questionnaire-based assessment of occupational exposure. Conclusion: Exposure to asbestos and tobacco smoke resulted in strong risk factors for idiopathic RPF. Coexposure to asbestos and smoke had a multiplicative effect on risk compared with single exposure.	Univ Parma, Italian Workers Compensat Author Res Ctr, I-43100 Parma, Italy; Univ Hosp, Parma, Italy; Univ Brescia, Brescia, Italy	University of Parma; University of Parma; University Hospital of Parma; University of Brescia	Vaglio, A (corresponding author), Azienda Osped Univ Parma, Unita Operat Nefrol, Via Gramsci 14, I-43126 Parma, Italy.	augusto.vaglio@virgilio.it	, De Palma Giuseppe/F-1147-2010; Mutti, Antonio/ABE-3833-2021; Mutti, Antonio/AAB-9037-2020; Vaglio, Augusto/AHE-8117-2022; Mutti, Antonio/C-1095-2011; Goldoni, Matteo/E-9153-2011	, De Palma Giuseppe/0000-0001-9821-3060; Mutti, Antonio/0000-0003-2189-3808; Vaglio, Augusto/0000-0002-3814-9172; Mutti, Antonio/0000-0003-2189-3808; Goldoni, Matteo/0000-0002-1342-3921; Urban, Maria Letizia/0000-0003-1334-9538				Berry G, 2004, ANN OCCUP HYG, V48, P459, DOI 10.1093/annhyg/meh023; BOULARD JC, 1995, LANCET, V345, P1379, DOI 10.1016/S0140-6736(95)92584-8; Bovenzi M, 2004, INT ARCH OCC ENV HEA, V77, P10, DOI 10.1007/s00420-003-0462-5; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Case BW, 2006, OCCUP ENVIRON MED, V63, P507, DOI 10.1136/oem.2006.027631; Cronin CG, 2008, AM J ROENTGENOL, V191, P423, DOI 10.2214/AJR.07.3629; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Gilkeson GS, 1996, RHEUM DIS CLIN N AM, V22, P23, DOI 10.1016/S0889-857X(05)70260-X; Goldberg M, 2009, EUR J CANCER PREV, V18, P489, DOI 10.1097/CEJ.0b013e32832f9bee; Gustavsson P, 2002, AM J EPIDEMIOL, V155, P1016, DOI 10.1093/aje/155.11.1016; Heiat A, 2001, ARCH INTERN MED, V161, P1194, DOI 10.1001/archinte.161.9.1194; Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P57, DOI 10.1097/BOR.0b013e3283418057; MAGUIRE GP, 1991, NEW YORK STATE J MED, V91, P357; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Martorana D, 2006, ARTHRIT RHEUM-ARTHR, V55, P126, DOI 10.1002/art.21698; MITCHINSON MJ, 1984, HISTOPATHOLOGY, V8, P589, DOI 10.1111/j.1365-2559.1984.tb02371.x; Nesti M, 2004, AM J IND MED, V45, P55, DOI 10.1002/ajim.10313; NICHOLSON W J, 1982, American Journal of Industrial Medicine, V3, P259, DOI 10.1002/ajim.4700030305; PARUMS DV, 1990, ARCH PATHOL LAB MED, V114, P383; Pfau JC, 2005, ENVIRON HEALTH PERSP, V113, P25, DOI 10.1289/ehp.7431; Pipitone N, 2012, BEST PRACT RES CL RH, V26, P439, DOI 10.1016/j.berh.2012.07.004; Semple SE, 2004, SCAND J WORK ENV HEA, V30, P241, DOI 10.5271/sjweh.785; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Uibu T, 2004, LANCET, V363, P1422, DOI 10.1016/S0140-6736(04)16100-X; Uibu T, 2009, BMJ CASE REP, V2009; Vaglio A, 2006, LANCET, V367, P241, DOI 10.1016/S0140-6736(06)68035-5; Vaglio A, 2011, LANCET, V378, P338, DOI 10.1016/S0140-6736(11)60934-3; VAINIO H, 1994, SCAND J WORK ENV HEA, V20, P235, DOI 10.5271/sjweh.1402; van Bommel EFH, 2009, MEDICINE, V88, P193, DOI 10.1097/MD.0b013e3181afc420; Wood DM, 2005, TOB CONTROL, V14, P141, DOI 10.1136/tc.2004.009977; Wraith D, 2008, STAT METHODS MED RES, V17, P171, DOI 10.1177/0962280206075525	31	48	53	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 5	2014	161	3					181	U130		10.7326/M13-2648	http://dx.doi.org/10.7326/M13-2648			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3KH	25089862				2022-12-28	WOS:000340486000003
J	Roy, A; Eisenhut, M; Harris, RJ; Rodrigues, LC; Sridhar, S; Habermann, S; Snell, L; Mangtani, P; Adetifa, I; Lalvani, A; Abubakar, I				Roy, A.; Eisenhut, M.; Harris, R. J.; Rodrigues, L. C.; Sridhar, S.; Habermann, S.; Snell, L.; Mangtani, P.; Adetifa, I.; Lalvani, A.; Abubakar, I.			Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GAMMA RELEASE ASSAY; SKIN-TEST; DIAGNOSIS; RISK; PROTECTION; TESTS	Objectives To determine whether BCG vaccination protects against Mycobacterium tuberculosis infection as assessed by interferon. release assays (IGRA) in children. Design Systematic review and meta-analysis. Searches of electronic databases 1950 to November 2013, checking of reference lists, hand searching of journals, and contact with experts. Setting Community congregate settings and households. Inclusion criteria Vaccinated and unvaccinated children aged under 16 with known recent exposure to patients with pulmonary tuberculosis. Children were screened for infection with M tuberculosis with interferon. release assays. Data extraction Study results relating to diagnostic accuracy were extracted and risk estimates were combined with random effects meta-analysis. Results The primary analysis included 14 studies and 3855 participants. The estimated overall risk ratio was 0.81 (95% confidence interval 0.71 to 0.92), indicating a protective efficacy of 19% against infection among vaccinated children after exposure compared with unvaccinated children. The observed protection was similar when estimated with the two types of interferon. release assays (ELISpot or QuantiFERON). Restriction of the analysis to the six studies (n = 1745) with information on progression to active tuberculosis at the time of screening showed protection against infection of 27% (risk ratio 0.73, 0.61 to 0.87) compared with 71% (0.29, 0.15 to 0.58) against active tuberculosis. Among those infected, protection against progression to disease was 58% (0.42, 0.23 to 0.77). Conclusions BCG protects against M tuberculosis infection as well as progression from infection to disease.	[Roy, A.; Harris, R. J.; Abubakar, I.] Publ Hlth England, Ctr Infect Dis Surveillance & Control, London NW9 5EQ, England; [Eisenhut, M.; Habermann, S.; Snell, L.] NHS Fdn Trust, Luton & Dunstable Univ Hosp, Luton, Beds, England; [Rodrigues, L. C.; Mangtani, P.] London Sch Hyg & Trop Med, London WC1, England; [Sridhar, S.; Lalvani, A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, TB Res Ctr, Resp Infect Sect, London, England; [Adetifa, I.] MRC, Fajara, Gambia; [Abubakar, I.] UCL, Ctr Infect Dis Epidemiol, London, England; [Abubakar, I.] UCL, MRC Clin Trials Unit, London, England	Public Health England; Oxford University Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Medical Research Council Clinical Trials Unit; University of London; University College London	Abubakar, I (corresponding author), Publ Hlth England, Ctr Infect Dis Surveillance & Control, London NW9 5EQ, England.	i.abubakar@ucl.ac.uk	RODRIGUES, LAURA CUNHA/AAO-4130-2021; Snell, Luke Blagdon/ABD-7401-2020	Snell, Luke Blagdon/0000-0002-6263-9497; Lalvani, Ajit/0000-0002-2396-246X; Sridhar, Saranya/0000-0002-4267-3102; Rodrigues, Laura Cunha/0000-0001-9008-660X; Mangtani, Punam/0000-0001-7074-2999; Abubakar, Ibrahim/0000-0002-0370-1430	UK National Institute for Health Research; UK MRC; National Institute for Health Research [NF-SI-0508-10179, NF-SI-0513-10155, HPRU-2012-10080] Funding Source: researchfish	UK National Institute for Health Research(National Institute for Health Research (NIHR)); UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. IA is supported by the UK National Institute for Health Research and the UK MRC.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Abubakar I, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17370; Adetifa IMO, 2010, PEDIATR INFECT DIS J, V29, P439, DOI 10.1097/INF.0b013e3181cb45da; Altet-Gomez N, 2011, EUR RESPIR J, V37, P1166, DOI 10.1183/09031936.00022710; Bianchi L, 2009, PEDIATR INFECT DIS J, V28, P510, DOI 10.1097/INF.0b013e31819abf6b; COLDITZ GA, 1994, JAMA-J AM MED ASSOC, V271, P698, DOI 10.1001/jama.271.9.698; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Dosanjh DPS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028754; Eisenhut M, 2009, VACCINE, V27, P6116, DOI 10.1016/j.vaccine.2009.08.031; Eriksen J, 2010, THORAX, V65, P1067, DOI 10.1136/thx.2010.140186; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; FINE PEM, 1988, BRIT MED BULL, V44, P691, DOI 10.1093/oxfordjournals.bmb.a072277; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2004, STAT MED, V23, P1663, DOI 10.1002/sim.1752; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Lalvani A, 2007, CURR OPIN INFECT DIS, V20, P264, DOI 10.1097/QCO.0b013e32813e3fd8; Lalvani A, 2010, THORAX, V65, P1036, DOI 10.1136/thx.2010.140996; Lienhardt C, 2005, LANCET, V366, P1414, DOI 10.1016/S0140-6736(05)67535-6; Mangtani P, 2014, CLIN INFECT DIS, V58, P470, DOI 10.1093/cid/cit790; Neira-Munoz E, 2008, PEDIATR INFECT DIS J, V27, P836, DOI 10.1097/INF.0b013e31816ff7c5; Okada K, 2008, EPIDEMIOL INFECT, V136, P1179, DOI 10.1017/S0950268807009831; Radhakrishna S, 2006, INDIAN J MED RES, V123, P119; Rodrigues LC, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5974; Rutherford ME, 2012, INT J TUBERC LUNG D, V16, P496, DOI 10.5588/ijtld.11.0491; Soysal A, 2005, LANCET, V366, P1443, DOI 10.1016/S0140-6736(05)67534-4; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Tsiouris SJ, 2006, INT J TUBERC LUNG D, V10, P939; Tsolia MN, 2010, PEDIATR INFECT DIS J, V29, P1137, DOI 10.1097/INF.0b013e3181ebfe8a; Wells G., NEWCASTLE OTTAWA SCA; Zodpey Sanjay P, 2007, Indian J Public Health, V51, P205	33	286	293	2	52	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2014	349								g4643	10.1136/bmj.g4643	http://dx.doi.org/10.1136/bmj.g4643			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MP	25097193	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000340206000002
J	Maizels, RM; Gause, WC				Maizels, Rick M.; Gause, William C.			How helminths go viral	SCIENCE			English	Editorial Material							INFECTION; IMMUNITY; MICROBIOTA		[Maizels, Rick M.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland; [Maizels, Rick M.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Gause, William C.] Rutgers State Univ, Ctr Immun & Infammat, Dept Med, New Jersey Med Sch, Newark, NJ 07102 USA	University of Edinburgh; University of Edinburgh; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Maizels, RM (corresponding author), Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh, Midlothian, Scotland.	r.maizels@ed.ac.uk						Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Griffiths EC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2286; Kjetland EF, 2014, INT J STD AIDS, V25, P705, DOI 10.1177/0956462414523743; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Rausch S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074026; Reese TA, 2014, SCIENCE, V345, P573, DOI 10.1126/science.1254517; Salgame P, 2013, NAT IMMUNOL, V14, P1118, DOI 10.1038/ni.2736; Taylor MD, 2012, TRENDS IMMUNOL, V33, P181, DOI 10.1016/j.it.2012.01.001; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Weinstock JV, 2013, INT J PARASITOL, V43, P245, DOI 10.1016/j.ijpara.2012.10.016	12	15	15	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					517	518		10.1126/science.1258443	http://dx.doi.org/10.1126/science.1258443			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082688				2022-12-28	WOS:000339651300026
J	Monem, M; Trompeter, A				Monem, Mohammed; Trompeter, Alex			More than just a simple fracture	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UNICAMERAL BONE-CYST; STEROID INJECTIONS; AUTOLOGOUS MARROW; LESIONS		[Monem, Mohammed] Kingston Hosp, Kingston Upon Thames, Surrey, England; [Trompeter, Alex] St Georges Healthcare NHS Trust, London SW17 0QT, England	St Georges University London	Trompeter, A (corresponding author), St Georges Healthcare NHS Trust, London SW17 0QT, England.	alex_trompeter@hotmail.com	Trompeter, Alex/AAV-8781-2021	Trompeter, Alex/0000-0001-7887-497X				Allen D, 2012, ORTHOBULLETS; Clifford R, 2012, WHEELESSONLINE; Daldrup-Link HE., 2010, ESSENTIALS PEDIAT RA; Donaldson S, 2011, CURR OPIN PEDIATR, V23, P73, DOI 10.1097/MOP.0b013e3283421111; FAHEY JJ, 1973, J BONE JOINT SURG AM, VA 55, P59, DOI 10.2106/00004623-197355010-00004; Greenspan A, 2006, DIFFERENTIAL DIAGNOS; HashemiNejad A, 1997, J BONE JOINT SURG BR, V79B, P727, DOI 10.1302/0301-620X.79B5.7825; Killian JT, 1998, J PEDIATR ORTHOPED, V18, P621, DOI 10.1097/00004694-199809000-00013; KOMIYA S, 1993, CLIN ORTHOP RELAT R, P204; Lokiec F, 1996, J BONE JOINT SURG BR, V78B, P934, DOI 10.1302/0301-620X78B6.6840; Lokiec F, 1998, J PEDIATR ORTHOP B, V7, P262, DOI 10.1097/01202412-199810000-00004; Murphey MD, 2003, RADIOLOGY, V229, P545, DOI 10.1148/radiol.2292021130; Murphey MD, 2001, RADIOGRAPHICS, V21, P1283, DOI 10.1148/radiographics.21.5.g01se251283; NEER CS, 1966, J BONE JOINT SURG AM, VA 48, P731, DOI 10.2106/00004623-196648040-00006; Remotti F, 2012, ARCH PATHOL LAB MED, V136, P772, DOI 10.5858/arpa.2011-0557-RA; SCAGLIETTI O, 1982, CLIN ORTHOP RELAT R, P33; Van Der Woude HJ, 2012, RADIOLOGY ASSISTANT; WIENTROUB S, 1989, J PEDIATR ORTHOPED, V9, P186; Wright JG, 2008, J BONE JOINT SURG AM, V90A, P722, DOI 10.2106/JBJS.G.00620; Yandow SM, 1998, J PEDIATR ORTHOPED, V18, P616, DOI 10.1097/00004694-199809000-00012	20	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2014	349								g4600	10.1136/bmj.g4600	http://dx.doi.org/10.1136/bmj.g4600			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VN	25099710				2022-12-28	WOS:000339565700002
J	Page, L				Page, Leigh			FEATURE AMA data operation makes millions, even monitors non-members	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											Page, L (corresponding author), 2525 North Talman Ave, Chicago, IL USA.	leighpage@comcast.net						AMA, AMA THER INS; AMA, 2007, VOIC UN         0823; AMA, NO CONT NO REL FORMS; AMA, DOCTORFINDER; AMA, 2012, AMA ANN REP; AMA, PHYS DAT RESTR PROGR; [Anonymous], 1997, LANCET, V350, P872; [Anonymous], 2000, ACP INTERNIST    APR; [Anonymous], BUNDESARZTREGISTER; [Anonymous], DOCT LISTS; General Medical Council (United Kingdom), LIST REG MED PRACT; *KAIS FAM FDN, 2002, NAT SURV PHYS 2; Wolfe S., 2012, PUBLIC CITIZEN HLTH	13	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	2014	348								g3119	10.1136/bmj.g3119	http://dx.doi.org/10.1136/bmj.g3119			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH5FQ	25134105				2022-12-28	WOS:000336154300002
J	Campbell, JL; Fletcher, E; Britten, N; Green, C; Holt, TA; Lattimer, V; Richards, DA; Richards, SH; Salisbury, C; Calitri, R; Bowyer, V; Chaplin, K; Kandiyali, R; Murdoch, J; Roscoe, J; Varley, A; Warren, FC; Taylor, RS				Campbell, John L.; Fletcher, Emily; Britten, Nicky; Green, Colin; Holt, Tim A.; Lattimer, Valerie; Richards, David A.; Richards, Suzanne H.; Salisbury, Chris; Calitri, Raff; Bowyer, Vicky; Chaplin, Katherine; Kandiyali, Rebecca; Murdoch, Jamie; Roscoe, Julia; Varley, Anna; Warren, Fiona C.; Taylor, Rod S.			Telephone triage for management of same-day consultation requests in general practice (the ESTEEM trial): a cluster-randomised controlled trial and cost-consequence analysis	LANCET			English	Article							PRIMARY-CARE; DAY APPOINTMENTS; NURSE; WORKLOAD; QUALITY; SAFETY	Background Telephone triage is increasingly used to manage workload in primary care; however, supporting evidence for this approach is scarce. We aimed to assess the effectiveness and cost consequences of general practitioner-(GP)-led and nurse-led telephone triage compared with usual care for patients seeking same-day consultations in primary care. Methods We did a pragmatic, cluster-randomised controlled trial and economic evaluation between March 1, 2011, and March 31, 2013, at 42 practices in four centres in the UK. Practices were randomly assigned (1: 1: 1), via a computer-generated randomisation sequence minimised for geographical location, practice deprivation, and practice list size, to either GP-led triage, nurse-led computer-supported triage, or usual care. We included patients who telephoned the practice seeking a same-day face-to-face consultation with a GP. Allocations were concealed from practices until after they had agreed to participate and a stochastic element was included within the minimisation algorithm to maintain concealment. Patients, clinicians, and researchers were not masked to allocation, but practice assignment was concealed from the trial statistician. The primary outcome was primary care workload (patient contacts, including those attending accident and emergency departments) in the 28 days after the first same-day request. Analyses were by intention to treat and per protocol. This trial was registered with the ISRCTN register, number ISRCTN20687662. Findings We randomly assigned 42 practices to GP triage (n=13), nurse triage (n=15), or usual care (n=14), and 20 990 patients (n=6695 vs 7012 vs 7283) were randomly assigned, of whom 16 211 (77%) patients provided primary outcome data (n=5171 vs 5468 vs 5572). GP triage was associated with a 33% increase in the mean number of contacts per person over 28 days compared with usual care (2.65 [SD 1.74] vs 1.91 [1.43]; rate ratio [RR] 1.33, 95% CI 1.30-1.36), and nurse triage with a 48% increase (2.81 [SD 1.68]; RR 1.48, 95% CI 1.44-1.52). Eight patients died within 7 days of the index request: five in the GP-triage group, two in the nurse-triage group, and one in the usual-care group; however, these deaths were not associated with the trial group or procedures. Although triage interventions were associated with increased contacts, estimated costs over 28 days were similar between all three groups (roughly 75 pound per patient). Interpretation Introduction of telephone triage delivered by a GP or nurse was associated with an increase in the number of primary care contacts in the 28 days after a patient's request for a same-day GP consultation, with similar costs to those of usual care. Telephone triage might be useful in aiding the delivery of primary care. The whole-system implications should be assessed when introduction of such a system is considered.	[Campbell, John L.; Fletcher, Emily; Richards, Suzanne H.; Calitri, Raff; Warren, Fiona C.; Taylor, Rod S.] Univ Exeter, Sch Med, Primary Care Res Grp, Exeter EX1 2LU, Devon, England; [Britten, Nicky; Green, Colin; Richards, David A.; Kandiyali, Rebecca] Univ Exeter, Sch Med, Inst Hlth Serv Res, Exeter EX1 2LU, Devon, England; [Holt, Tim A.] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Lattimer, Valerie; Murdoch, Jamie; Varley, Anna] Univ E Anglia, Fac Med & Hlth Sci, Sch Hlth Sci, Norwich NR4 7TJ, Norfolk, England; [Salisbury, Chris; Chaplin, Katherine] Univ Bristol, Sch Social & Community Med, Ctr Acad Primary Care, Bristol, Avon, England; [Bowyer, Vicky; Roscoe, Julia] Univ Warwick, Warwick Med Sch, Dept Hlth Sci, Coventry CV4 7AL, W Midlands, England	University of Exeter; University of Exeter; University of Oxford; University of East Anglia; University of Bristol; University of Warwick	Campbell, JL (corresponding author), Univ Exeter, Sch Med, Smeall Bldg,St Lukes Campus, Exeter EX1 2LU, Devon, England.	john.campbell@exeter.ac.uk	Campbell, John/A-5792-2011; Murdoch, Jamie/ABE-3382-2020; Taylor, Rod/R-9581-2019; Salisbury, Chris/C-6724-2008; Kandiyali, Rebecca/M-9025-2014; Richards, David/B-4807-2009	Campbell, John/0000-0002-6752-3493; Taylor, Rod/0000-0002-3043-6011; Salisbury, Chris/0000-0002-4378-3960; Warren, Fiona/0000-0002-3833-0182; Richards, Suzanne/0000-0003-1416-0569; Roscoe, Julia/0000-0002-3562-3385; Murdoch, Jamie/0000-0002-9021-3629; Kandiyali, Rebecca/0000-0001-8566-9536; Richards, David/0000-0002-8821-5027; Calitri, Raff/0000-0003-0889-4670	Health Technology Assessment Programme UK National Institute for Health Research; National Institute for Health Research [08/53/15, NF-SI-0611-10203, CL-2010-13-005] Funding Source: researchfish	Health Technology Assessment Programme UK National Institute for Health Research; National Institute for Health Research(National Institute for Health Research (NIHR))	Health Technology Assessment Programme UK National Institute for Health Research.	[Anonymous], 2013, GP PATIENT SURVEY; Bunn F, 2009, COCHRANE DB SYST REV, V4; Campbell JL, HTA IN PRESS; Campbell J, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-57; Campbell JL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-4; Campbell MK, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5661; Craig D., 2007, NHS EC EVALUATION DA; Curtis L., 2012, UNIT COSTS HLTH SOCI; Gallagher M, 1998, BRIT J GEN PRACT, V48, P1141; Jiwa M, 2002, BRIT J GEN PRACT, V52, P390; Kinnersley P, 2000, BRIT MED J, V320, P1043, DOI 10.1136/bmj.320.7241.1043; Lattimer V, 1998, BMJ-BRIT MED J, V317, P1054; McKinstry B, 2010, QUAL SAF HEALTH CARE, V19, P298, DOI 10.1136/qshc.2008.027763; McKinstry B, 2002, BRIT J GEN PRACT, V52, P306; Mohammed MA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-430; NHS Information Centre, 2008, GP WORKL SURV 2007; NHS Institute for Innovation and Improvement, 2008, STOUR ACC SYST NEW W; NICE, 2011, ASS COST IMP METH GU; Plain Healthcare, 2008, OD CLIN DEC SUPP SOF; Richards DA, 2004, J ADV NURS, V47, P551, DOI 10.1111/j.1365-2648.2004.03132.x; Richards DA, 2002, BRIT MED J, V325, P1214, DOI 10.1136/bmj.325.7374.1214; Salisbury C, 2007, BRIT J GEN PRACT, V57, P608; Stoddart H, 2003, FAM PRACT, V20, P41, DOI 10.1093/fampra/20.1.41; UK Government, 2013, IND MULT DEPR 2010; Venning P, 2000, BMJ-BRIT MED J, V320, P1048, DOI 10.1136/bmj.320.7241.1048; Vinogradova Y., 2009, TRENDS CONSULTATION; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Zhou Y, 2015, EMERG MED J, V32, P373, DOI 10.1136/emermed-2013-203451	29	109	113	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 22	2014	384	9957					1859	1868		10.1016/S0140-6736(14)61058-8	http://dx.doi.org/10.1016/S0140-6736(14)61058-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7LA	25098487	Green Accepted, Green Published, Green Submitted, hybrid			2022-12-28	WOS:000345116800026
J	Jackson, RN; Golden, SM; van Erp, PBG; Carter, J; Westra, ER; Brouns, SJJ; van der Oost, J; Terwilliger, TC; Read, RJ; Wiedenheft, B				Jackson, Ryan N.; Golden, Sarah M.; van Erp, Paul B. G.; Carter, Joshua; Westra, Edze R.; Brouns, Stan J. J.; van der Oost, John; Terwilliger, Thomas C.; Read, Randy J.; Wiedenheft, Blake			Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli	SCIENCE			English	Article							BACTERIAL IMMUNE-SYSTEM; PROCESSES PRE-CRRNA; THERMUS-THERMOPHILUS; CAS SYSTEMS; INTERFERENCE COMPLEX; TARGET RECOGNITION; ANTIVIRAL DEFENSE; SEED SEQUENCE; DNA; CASCADE	Clustered regularly interspaced short palindromic repeats (CRISPRs) are essential components of RNA-guided adaptive immune systems that protect bacteria and archaea from viruses and plasmids. In Escherichia coli, short CRISPR-derived RNAs (crRNAs) assemble into a 405-kilodalton multisubunit surveillance complex called Cascade (CRISPR-associated complex for antiviral defense). Here we present the 3.24 angstrom resolution x-ray crystal structure of Cascade. Eleven proteins and a 61-nucleotide crRNA assemble into a seahorse-shaped architecture that binds double-stranded DNA targets complementary to the crRNA-guide sequence. Conserved sequences on the 3' and 5' ends of the crRNA are anchored by proteins at opposite ends of the complex, whereas the guide sequence is displayed along a helical assembly of six interwoven subunits that present five-nucleotide segments of the crRNA in pseudo-A-form configuration. The structure of Cascade suggests a mechanism for assembly and provides insights into the mechanisms of target recognition.	[Jackson, Ryan N.; Golden, Sarah M.; van Erp, Paul B. G.; Carter, Joshua; Wiedenheft, Blake] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Westra, Edze R.; Brouns, Stan J. J.; van der Oost, John] Wageningen Univ, Dept Agrotechnol & Food Sci, Lab Microbiol, NL-6703 HB Wageningen, Netherlands; [Terwilliger, Thomas C.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Read, Randy J.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England	Montana State University System; Montana State University Bozeman; Wageningen University & Research; United States Department of Energy (DOE); Los Alamos National Laboratory; University of Cambridge	Wiedenheft, B (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	bwiedenheft@gmail.com	van+der+Oost, John/Y-2548-2019; Terwilliger, Thomas/AEF-4827-2022; Read, Randy J/L-1418-2013; Jackson, Ryan N/J-2209-2019; Terwilliger, Thomas C/K-4109-2012; Terwilliger, Thomas/AAM-4079-2020	Read, Randy J/0000-0001-8273-0047; Jackson, Ryan N/0000-0001-7403-3794; Terwilliger, Thomas C/0000-0001-6384-0320; Terwilliger, Thomas/0000-0001-6384-0320; Carter, Joshua/0000-0002-9194-7966; Brouns, Stan/0000-0002-9573-1724	European Union under REA grant [327606]; Netherlands Organization of Scientific Research [864.11.005]; Vici grant [865.05.001]; Wellcome Trust [082961/Z/07/Z]; NIH [GM063210, F32 GM108436, P20GM103500, R01GM108888]; Howard Hughes Medical Institute [52006931]; NSF Experimental Program to Stimulate Competitive Research [EPS-110134]; M. J. Murdock Charitable Trust; Montana State University Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P01GM063210, F32GM108436, R01GM108888, P20GM103500] Funding Source: NIH RePORTER	European Union under REA grant; Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Vici grant; Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NSF Experimental Program to Stimulate Competitive Research; M. J. Murdock Charitable Trust; Montana State University Agricultural Experiment Station; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Richardson and D. Richardson for technical suggestions and discussion and A. McCoy for implementing the EM scale factor refinement in Phaser. X-ray diffraction data was collected with assistance from J. Nix at Advanced Light Source (ALS) beamline 4.2.2 (DE-AC02-05CH11231), R. Sanishvili and C. Ogata at Advanced Photon Source (APS) beamline 23-ID (Y1-GM-1104), the Structural Biology Center at APS 19-ID (DE-AC02-06CH11357), and Stanford Synchrotron Radiation Lightsource (DE-AC02-76SF00515 and P41GM103393). E.R.W. received funding from the People Program (Marie Curie Actions) of the European Union's Seventh Framework Program (FP7/2007-2013) under REA grant agreement 327606. S.J.J. B. is supported by a Vidi grant from the Netherlands Organization of Scientific Research (864.11.005) and J.v.d.O. by a Vici grant (865.05.001). R.J.R. is supported by a Principal Research Fellowship from the Wellcome Trust (grant 082961/Z/07/Z). T. C. T. and R.J.R. are supported by a grant (GM063210) from the NIH. J.C. is supported by a grant for undergraduate research from the Howard Hughes Medical Institute (52006931). R.N.J. is supported by a National Research Service Award postdoctoral fellowship (F32 GM108436) from the NIH. Research in the Wiedenheft lab is supported by the NIH (P20GM103500 and R01GM108888), the NSF Experimental Program to Stimulate Competitive Research (EPS-110134), the M. J. Murdock Charitable Trust, and the Montana State University Agricultural Experiment Station. Atomic coordinates have been deposited into the Protein Data Bank with accession code 4TVX.	Bondy-Denomy J, 2014, TRENDS MICROBIOL, V22, P218, DOI 10.1016/j.tim.2014.01.007; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Ebihara A, 2006, PROTEIN SCI, V15, P1494, DOI 10.1110/ps.062131106; Garside EL, 2012, RNA, V18, P2020, DOI 10.1261/rna.033100.112; Gesner EM, 2011, NAT STRUCT MOL BIOL, V18, P688, DOI 10.1038/nsmb.2042; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; Hrle A, 2013, RNA BIOL, V10, P1670, DOI 10.4161/rna.26500; Jackson RN, 2014, CURR OPIN STRUC BIOL, V24, P106, DOI 10.1016/j.sbi.2014.01.001; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Koo Y, 2013, J MOL BIOL, V425, P3799, DOI 10.1016/j.jmb.2013.02.032; Kunne T, 2014, TRENDS MICROBIOL, V22, P74, DOI 10.1016/j.tim.2013.12.003; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Mulepati S, 2012, J BIOL CHEM, V287, P22445, DOI 10.1074/jbc.C112.379503; Nam KH, 2012, FEBS LETT, V586, P3956, DOI 10.1016/j.febslet.2012.09.041; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Sashital DG, 2012, MOL CELL, V46, P606, DOI 10.1016/j.molcel.2012.03.020; Sashital DG, 2011, NAT STRUCT MOL BIOL, V18, P680, DOI 10.1038/nsmb.2043; Schirle NT, 2012, SCIENCE, V336, P1037, DOI 10.1126/science.1221551; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Sheng G, 2014, P NATL ACAD SCI USA, V111, P652, DOI 10.1073/pnas.1321032111; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Terwilliger Thomas C., 2013, Journal of Structural and Functional Genomics, V14, P91, DOI 10.1007/s10969-013-9157-7; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Westra ER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003742; Westra ER, 2012, ANNU REV GENET, V46, P311, DOI 10.1146/annurev-genet-110711-155447; Westra ER, 2012, MOL CELL, V46, P595, DOI 10.1016/j.molcel.2012.03.018; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108	38	175	196	3	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2014	345	6203					1473	1479		10.1126/science.1256328	http://dx.doi.org/10.1126/science.1256328			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP0LM	25103409	Green Accepted			2022-12-28	WOS:000341752900034
J	Sawamiphak, S; Stainier, DYR				Sawamiphak, Suphansa; Stainier, Didier Y. R.			DEVELOPMENTAL BIOLOGY It takes muscle to make blood cells	NATURE			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; AORTIC ENDOTHELIUM; DORSAL AORTA; SMOOTH-MUSCLE; SOMITE		[Sawamiphak, Suphansa; Stainier, Didier Y. R.] Max Planck Inst Heart & Lung Res, Dept Dev Genet, D-61231 Bad Nauheim, Germany	Max Planck Society	Sawamiphak, S (corresponding author), Max Planck Inst Heart & Lung Res, Dept Dev Genet, D-61231 Bad Nauheim, Germany.	suphansa.sawamiphak@mpi-bn.mpg.de; didier.stainier@mpi-bn.mpg.de		Stainier, Didier/0000-0002-0382-0026				Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Clements WK, 2011, NATURE, V474, P220, DOI 10.1038/nature10107; Esner M, 2006, DEVELOPMENT, V133, P737, DOI 10.1242/dev.02226; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kobayashi I, 2014, NATURE, V512, P319, DOI 10.1038/nature13623; Lam EYN, 2010, BLOOD, V116, P909, DOI 10.1182/blood-2010-01-264382; Mayeuf-Louchart A, 2014, P NATL ACAD SCI USA, V111, P8844, DOI 10.1073/pnas.1407606111; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Nguyen PD, 2014, NATURE, V512, P314, DOI 10.1038/nature13678; Pouget C, 2006, DEVELOPMENT, V133, P1013, DOI 10.1242/dev.02269; Sato Y, 2008, DEV CELL, V14, P890, DOI 10.1016/j.devcel.2008.03.024; Svetic V, 2007, DEVELOPMENT, V134, P1011, DOI 10.1242/dev.02789	13	0	0	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					257	258		10.1038/nature13740	http://dx.doi.org/10.1038/nature13740			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119030				2022-12-28	WOS:000340508200020
J	Kos, J; Zwitter, T; Wyse, R; Bienayme, O; Binney, J; Bland-Hawthorn, J; Freeman, K; Gibson, BK; Gilmore, G; Grebel, EK; Helmi, A; Kordopatis, G; Munari, U; Navarro, J; Parker, Q; Reid, WA; Seabroke, G; Sharma, S; Siebert, A; Siviero, A; Steinmetz, M; Watson, FG; Williams, MEK				Kos, Janez; Zwitter, Tomaz; Wyse, Rosemary; Bienayme, Olivier; Binney, James; Bland-Hawthorn, Joss; Freeman, Kenneth; Gibson, Brad K.; Gilmore, Gerry; Grebel, Eva K.; Helmi, Amina; Kordopatis, Georges; Munari, Ulisse; Navarro, Julio; Parker, Quentin; Reid, Warren A.; Seabroke, George; Sharma, Sanjib; Siebert, Arnaud; Siviero, Alessandro; Steinmetz, Matthias; Watson, Fred G.; Williams, Mary E. K.			Pseudo-three-dimensional maps of the diffuse interstellar band at 862 nm	SCIENCE			English	Article							MILKY-WAY; COOL STAR; RAVE; SPECTRA; GALAXY; ANTHRACENE; EMISSION; CARRIER; SEARCH	The diffuse interstellar bands (DIBs) are absorption lines observed in visual and near-infrared spectra of stars. Understanding their origin in the interstellar medium is one of the oldest problems in astronomical spectroscopy, as DIBs have been known since 1922. In a completely new approach to understanding DIBs, we combined information from nearly 500,000 stellar spectra obtained by the massive spectroscopic survey RAVE (Radial Velocity Experiment) to produce the first pseudo-three-dimensional map of the strength of the DIB at 8620 angstroms covering the nearest 3 kiloparsecs from the Sun, and show that it follows our independently constructed spatial distribution of extinction by interstellar dust along the Galactic plane. Despite having a similar distribution in the Galactic plane, the DIB 8620 carrier has a significantly larger vertical scale height than the dust. Even if one DIB may not represent the general DIB population, our observations outline the future direction of DIB research.	[Kos, Janez; Zwitter, Tomaz] Univ Ljubljana, Fac Math & Phys, Ljubljana 1000, Slovenia; [Wyse, Rosemary] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Bienayme, Olivier; Siebert, Arnaud] Univ Strasbourg, Observ Astron Strasbourg, CNRS, F-67000 Strasbourg, France; [Binney, James] Rudolf Peierls Ctr Theoret Phys, Oxford OX1 3NP, England; [Bland-Hawthorn, Joss; Sharma, Sanjib] Univ Sydney, Sch Phys A28, Sydney Inst Astron, Sydney, NSW 2008, Australia; [Freeman, Kenneth] Australian Natl Univ, Res Sch Astron & Astrophys, Canberra, ACT, Australia; [Gibson, Brad K.] Univ Cent Lancashire, Jeremiah Horrocks Inst, Preston PR1 2HE, Lancs, England; [Gilmore, Gerry; Kordopatis, Georges] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Grebel, Eva K.] Heidelberg Univ, Zentrum Astron, Astron Rechen Inst, D-69120 Heidelberg, Germany; [Helmi, Amina] Univ Groningen, Kapteyn Astron Inst, NL-9700 AV Groningen, Netherlands; [Munari, Ulisse] Astron Observ Padova, Inst Nazl Astrofis, I-36012 Asiago, VI, Italy; [Navarro, Julio] Univ Victoria, Victoria, BC V8P 5C2, Canada; [Parker, Quentin; Reid, Warren A.] Macquarie Univ, Dept Phys & Astron, Sydney, NSW 2109, Australia; [Parker, Quentin; Reid, Warren A.] Macquarie Univ, Ctr Astron Astrophys & Astrophoton, Sydney, NSW 2109, Australia; [Parker, Quentin; Watson, Fred G.] Australian Astron Observ, N Ryde, NSW 1670, Australia; [Seabroke, George] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Siviero, Alessandro] Univ Padua, Dept Phys & Astron, I-35122 Padua, Italy; [Siviero, Alessandro; Steinmetz, Matthias; Williams, Mary E. K.] Leibniz Inst Astrophys Potsdam AIP, D-14482 Potsdam, Germany	University of Ljubljana; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Oxford; University of Sydney; Australian National University; University of Central Lancashire; University of Cambridge; Ruprecht Karls University Heidelberg; University of Groningen; University of Padua; University of Victoria; Macquarie University; Macquarie University; University of London; University College London; University of Padua; Leibniz Institut fur Astrophysik Potsdam (AIP)	Kos, J (corresponding author), Univ Ljubljana, Fac Math & Phys, Jadranska 19, Ljubljana 1000, Slovenia.	janez.kos@fmf.uni-lj.si	bland-hawthorn, joss/ABE-7646-2020; Steinmetz, Matthias/Q-7785-2019; Gibson, Brad/M-3592-2015; Grebel, Eva K./H-5140-2012; Parker, Quentin A/F-5330-2010; Munari, Ulisse/C-5311-2018	bland-hawthorn, joss/0000-0001-7516-4016; Steinmetz, Matthias/0000-0001-6516-7459; Gibson, Brad/0000-0003-4446-3130; Grebel, Eva K./0000-0002-1891-3794; Munari, Ulisse/0000-0001-6805-9664; Binney, James/0000-0002-1926-2436; Seabroke, George/0000-0003-4072-9536; Zwitter, Toma\\{z}/0000-0002-2325-8763; Arnaud, Siebert/0000-0001-8059-2840; Parker, Quentin/0000-0002-2062-0173; Freeman, Kenneth/0000-0001-6280-1207; Sharma, Sanjib/0000-0002-0920-809X; Navarro, Julio/0000-0003-3862-5076	Anglo-Australian Observatory; Leibniz-Institut fur Astrophysik Potsdam; Australian National University; Australian Research Council; French National Research Agency; German Research Foundation [SFB 881]; Istituto Nazionale di Astrofisica at Padova; Johns Hopkins University; U.S. National Science Foundation [AST-0908326]; W. M. Keck foundation; Macquarie University; Netherlands Research School for Astronomy; Natural Sciences and Engineering Research Council of Canada; Slovenian Research Agency; Center of Excellence Space. si; Swiss National Science Foundation; Science and Technology Facilities Council of the UK; Opticon; Strasbourg Observatory; European Research Council; University of Groningen, Heidelberg; University of Sydney; Science and Technology Facilities Council [PP/D001528/1, PP/D001242/1, ST/K00106X/1, ST/K000977/1, ST/J00149X/1, ST/G002479/1, ST/J001341/1] Funding Source: researchfish; STFC [ST/K00106X/1, ST/J001341/1, PP/D001528/1, PP/D001242/1, ST/K000977/1, ST/J00149X/1, ST/G002479/1] Funding Source: UKRI	Anglo-Australian Observatory; Leibniz-Institut fur Astrophysik Potsdam; Australian National University(Australian National University); Australian Research Council(Australian Research Council); French National Research Agency(French National Research Agency (ANR)); German Research Foundation(German Research Foundation (DFG)); Istituto Nazionale di Astrofisica at Padova(Istituto Nazionale Astrofisica (INAF)); Johns Hopkins University(Johns Hopkins University); U.S. National Science Foundation(National Science Foundation (NSF)); W. M. Keck foundation(W.M. Keck Foundation); Macquarie University; Netherlands Research School for Astronomy; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Center of Excellence Space. si; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Science and Technology Facilities Council of the UK(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Opticon; Strasbourg Observatory; European Research Council(European Research Council (ERC)European Commission); University of Groningen, Heidelberg; University of Sydney(University of Sydney); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We are grateful to the anonymous referees for valuable advice on the discussion of possible DIB origins. J.K. and T.Z. thank A. F. Kodre for a stimulating discussion of the topic. Funding for RAVE has been provided by the Anglo-Australian Observatory; the Leibniz-Institut fur Astrophysik Potsdam; the Australian National University; the Australian Research Council; the French National Research Agency; the German Research Foundation (SFB 881); the Istituto Nazionale di Astrofisica at Padova; The Johns Hopkins University; the U.S. National Science Foundation (AST-0908326); the W. M. Keck foundation; the Macquarie University; the Netherlands Research School for Astronomy; the Natural Sciences and Engineering Research Council of Canada; the Slovenian Research Agency; Center of Excellence Space. si; the Swiss National Science Foundation; the Science and Technology Facilities Council of the UK; Opticon; Strasbourg Observatory; European Research Council; and the Universities of Groningen, Heidelberg, and Sydney. The RAVE Web site is at www.rave-survey.org.	Binney J, 2014, MON NOT R ASTRON SOC, V437, P351, DOI 10.1093/mnras/stt1896; Chen HC, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220413; de Bruijne JHJ, 2012, ASTROPHYS SPACE SCI, V341, P31, DOI 10.1007/s10509-012-1019-4; Deng LC, 2012, RES ASTRON ASTROPHYS, V12, P735, DOI 10.1088/1674-4527/12/7/003; Eisenstein DJ, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/3/72; Freeman K. C., 2012, ASTRONOMICAL SOC PAC, V458, P393; Friedman SD, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/33; Galazutdinov G, 2011, MON NOT R ASTRON SOC, V412, P1259, DOI 10.1111/j.1365-2966.2010.17985.x; Gilmore G, 2012, MESSENGER, V147, P25; Gontcharov GA, 2010, ASTRON LETT+, V36, P584, DOI 10.1134/S1063773710080074; HERBIG GH, 1995, ANNU REV ASTRON ASTR, V33, P19, DOI 10.1146/annurev.aa.33.090195.000315; Hobbs LM, 2009, ASTROPHYS J, V705, P32, DOI 10.1088/0004-637X/705/1/32; Iglesias-Groth S, 2010, MON NOT R ASTRON SOC, V407, P2157, DOI 10.1111/j.1365-2966.2010.17075.x; Khoperskov S. A., 2014, TRANSPORT CHARGED DU; Kordopatis G, 2013, ASTRON J, V146, DOI 10.1088/0004-6256/146/5/134; Kos J, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/86; Kos J, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/72; Krelowski J, 2010, ASTROPHYS J LETT, V714, pL64, DOI 10.1088/2041-8205/714/1/L64; Maier JP, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/1/41; Milisavljevic D, 2014, ASTROPHYS J LETT, V782, DOI 10.1088/2041-8205/782/1/L5; Munari U, 2008, ASTRON ASTROPHYS, V488, P969, DOI 10.1051/0004-6361:200810232; Peek J. E. G., 2013, ULTRAVIOLET EXTINCTI; Salama F, 1999, ASTROPHYS J, V526, P265, DOI 10.1086/307978; SANDERS DB, 1984, ASTROPHYS J, V276, P182, DOI 10.1086/161602; Sarre PJ, 2006, J MOL SPECTROSC, V238, P1, DOI 10.1016/j.jms.2006.03.009; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; SEMBACH KR, 1994, ASTRON ASTROPHYS, V289, P539; Sharma S, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/1/3; SNOW TP, 1977, ASTRON J, V82, P113, DOI 10.1086/112016; Thorburn JA, 2003, ASTROPHYS J, V584, P339, DOI 10.1086/345665; Tielens AGGM, 2005, PHYSICS AND CHEMISTRY OF THE INTERSTELLAR MEDIUM, P1, DOI 10.1017/CBO9780511819056; van Loon JT, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220210; WOUTERLOOT JGA, 1990, ASTRON ASTROPHYS, V230, P21	34	37	37	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					791	795		10.1126/science.1253171	http://dx.doi.org/10.1126/science.1253171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124434	Green Submitted			2022-12-28	WOS:000340593100039
J	Moy, RH; Cole, BS; Yasunaga, A; Gold, B; Shankarling, G; Varble, A; Molleston, JM; TenOever, BR; Lynch, KW; Cherry, S				Moy, Ryan H.; Cole, Brian S.; Yasunaga, Ari; Gold, Beth; Shankarling, Ganesh; Varble, Andrew; Molleston, Jerome M.; TenOever, Benjamin R.; Lynch, Kristen W.; Cherry, Sara			Stem-Loop Recognition by DDX17 Facilitates miRNA Processing and Antiviral Defense	CELL			English	Article							DEXD/H-BOX HELICASE; RNA INTERFERENCE; IMMUNE-RESPONSE; PROTEIN; REVEALS; VIRUS; P68; MICROPROCESSOR; BIOGENESIS; COMPLEX	DEAD-box helicases play essential roles in RNA metabolism across species, but emerging data suggest that they have additional functions in immunity. Through RNAi screening, we identify an evolutionarily conserved and interferon-independent role for the DEAD-box helicase DDX17 in restricting Rift Valley fever virus (RVFV), a mosquito-transmitted virus in the bunyavirus family that causes severe morbidity and mortality in humans and livestock. Loss of Drosophila DDX17 (Rm62) in cells and flies enhanced RVFV infection. Similarly, depletion of DDX17 but not the related helicase DDX5 increased RVFV replication in human cells. Using crosslinking immunoprecipitation high-throughput sequencing (CLIP-seq), we show that DDX17 binds the stem loops of host pri-miRNA to facilitate their processing and also an essential stem loop in bunyaviral RNA to restrict infection. Thus, DDX17 has dual roles in the recognition of stem loops: in the nucleus for endogenous microRNA (miRNA) biogenesis and in the cytoplasm for surveillance against structured non-self-elements.	[Moy, Ryan H.; Yasunaga, Ari; Gold, Beth; Molleston, Jerome M.; Cherry, Sara] Univ Penn, Perelman Sch Med, Penn Genome Frontiers Inst, Dept Microbiol, Philadelphia, PA 19104 USA; [Cole, Brian S.; Shankarling, Ganesh; Lynch, Kristen W.] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Varble, Andrew; TenOever, Benjamin R.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Icahn School of Medicine at Mount Sinai	Cherry, S (corresponding author), Univ Penn, Perelman Sch Med, Penn Genome Frontiers Inst, Dept Microbiol, Philadelphia, PA 19104 USA.	cherrys@mail.med.upenn.edu		tenOever, Benjamin/0000-0003-0324-3078; Moy, Ryan/0000-0002-0507-8590; Molleston, Jerome/0000-0003-3702-8317; cherry, sara/0000-0003-3956-6610	National Institutes of Health [R01AI074951, U54AI057168, R01AI095500, RO1GM103383, T32AI007324]; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095500, T32AI007324, U54AI057168, R56AI074951, R01AI074951] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103383, R01GM067719] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Spradling for Rm62 mutant flies; A. Bowie for DDX17 siRNA sequences; E. Dardenne for DDX17 plasmid; and M. Tartell for technical help. This work was supported by grants from the National Institutes of Health to S.C. (R01AI074951, U54AI057168, and R01AI095500), K.W.L. (RO1GM103383), and R.H.M. (T32AI007324). S.C. and B.R.T. are recipients of the Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award.	Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003; Boeke J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020761; Bortz E, 2011, MBIO, V2, DOI 10.1128/mBio.00151-11; Boutros M, 2004, SCIENCE, V303, P832, DOI 10.1126/science.1091266; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; Cziko AMJ, 2009, GENETICS, V182, P1051, DOI 10.1534/genetics.109.103234; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; EMERY VC, 1987, VIROLOGY, V156, P1, DOI 10.1016/0042-6822(87)90430-2; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Fullam A, 2013, BBA-GENE REGUL MECH, V1829, P854, DOI 10.1016/j.bbagrm.2013.03.012; Fuller-Pace FV, 2013, BBA-GENE REGUL MECH, V1829, P756, DOI 10.1016/j.bbagrm.2013.03.004; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Goh PY, 2004, J VIROL, V78, P5288, DOI 10.1128/JVI.78.10.5288-5298.2004; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hong SG, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003706; Hopkins KC, 2013, GENE DEV, V27, P1511, DOI 10.1101/gad.215384.113; Ikegami T, 2011, VIRUSES-BASEL, V3, P493, DOI 10.3390/v3050493; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jalal C, 2007, NUCLEIC ACIDS RES, V35, P3590, DOI 10.1093/nar/gkm058; Kim T, 2010, P NATL ACAD SCI USA, V107, P15181, DOI 10.1073/pnas.1006539107; Lei EP, 2006, NAT GENET, V38, P936, DOI 10.1038/ng1850; Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Miyashita M, 2011, MOL CELL BIOL, V31, P3802, DOI 10.1128/MCB.01368-10; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Moy RH, 2014, IMMUNITY, V40, P51, DOI 10.1016/j.immuni.2013.10.020; Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107; Parvatiyar K, 2012, NAT IMMUNOL, V13, P1155, DOI 10.1038/ni.2460; Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458; Samaan S, 2014, NUCLEIC ACIDS RES, V42, P2197, DOI 10.1093/nar/gkt1216; Shankarling G, 2014, MOL CELL BIOL, V34, P71, DOI 10.1128/MCB.00740-13; Shapiro JS, 2014, P NATL ACAD SCI USA, V111, P7108, DOI 10.1073/pnas.1319635111; Shapiro JS, 2010, RNA, V16, P2068, DOI 10.1261/rna.2303610; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Staley JP, 1999, MOL CELL, V3, P55, DOI 10.1016/S1097-2765(00)80174-4; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vourekas A, 2012, NAT STRUCT MOL BIOL, V19, P773, DOI 10.1038/nsmb.2347; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Xue YC, 2009, MOL CELL, V36, P996, DOI 10.1016/j.molcel.2009.12.003; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhang ZQ, 2011, IMMUNITY, V34, P866, DOI 10.1016/j.immuni.2011.03.027; Zhou R, 2008, MOL CELL, V32, P592, DOI 10.1016/j.molcel.2008.10.018; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108; Zonta E, 2013, NUCLEIC ACIDS RES, V41, P554, DOI 10.1093/nar/gks1046	54	76	82	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					764	777		10.1016/j.cell.2014.06.023	http://dx.doi.org/10.1016/j.cell.2014.06.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126784	Green Accepted, Bronze			2022-12-28	WOS:000340944700009
J	Johnson, CD; Besselink, MG; Carter, R				Johnson, C. D.; Besselink, M. G.; Carter, R.			Acute pancreatitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ALCOHOL-ASSOCIATED PANCREATITIS; RANDOMIZED CONTROLLED-TRIAL; EARLY ENTERAL NUTRITION; INFLAMMATORY RESPONSE; ORGAN FAILURE; SEVERITY; CLASSIFICATION; MORTALITY; RISK		[Johnson, C. D.] Southampton Univ Hosp, Southampton SO16 6YD, Hants, England; [Besselink, M. G.] Acad Med Ctr Amsterdam, Dutch Pancreatitis Study Grp, Amsterdam, Netherlands; [Carter, R.] Glasgow Royal Infirm, West Scotland Pancreat Unit, Glasgow G4 0SF, Lanark, Scotland	University of Southampton; University of Amsterdam; Academic Medical Center Amsterdam; University of Glasgow	Johnson, CD (corresponding author), Southampton Univ Hosp, Southampton SO16 6YD, Hants, England.	cdj@soton.ac.uk	Besselink, Marc G/R-4268-2019; Pereira, Stephen P/C-5639-2009	Besselink, Marc G/0000-0003-2650-9350; Pereira, Stephen P/0000-0003-0821-1809				Al-Omran M, 2010, COCHRANE DB SYST REV, V1; Bakker OJ, 2013, UNITED EUROPEAN GAST, V1, pA1; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Besselink M, 2013, PANCREATOLOGY, V13, pE1, DOI 10.1016/j.pan.2013.07.063; Boreham B, 2003, PANCREATOLOGY, V3, P303, DOI 10.1159/000071768; de Vries AC, 2007, PANCREATOLOGY, V7, P531, DOI 10.1159/000108971; Dellinger EP, 2012, ANN SURG, V256, P875, DOI 10.1097/SLA.0b013e318256f778; Du XJ, 2011, PANCREAS, V40, P1220, DOI 10.1097/MPA.0b013e3182217f17; Eatock FC, 2005, AM J GASTROENTEROL, V100, P432, DOI 10.1111/j.1572-0241.2005.40587.x; En-Qiang M, 2009, CHINESE MED J-PEKING, V122, P169, DOI 10.3760/cma.j.issn.0366-6999.2009.02.011; Garcea G, 2008, PANCREAS, V37, pE54, DOI 10.1097/MPA.0b013e3181771451; Gislason H, 2004, Scand J Surg, V93, P29; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Johnson CD, 2004, GUT, V53, P1340, DOI 10.1136/gut.2004.039883; Johnson CD, 2001, GUT, V48, P62, DOI 10.1136/gut.48.1.62; Kumar A, 2006, J CLIN GASTROENTEROL, V40, P431, DOI 10.1097/00004836-200605000-00013; Larvin M, 1997, EUR J GASTROEN HEPAT, V9, P122, DOI 10.1097/00042737-199702000-00004; Liu CL, 2005, ALIMENT PHARM THERAP, V22, P423, DOI 10.1111/j.1365-2036.2005.02580.x; Mao EQ, 2010, CHINESE MED J-PEKING, V123, P1639, DOI 10.3760/cmaj.issn.0366-6999.2010.13.005; Mofidi R, 2006, BRIT J SURG, V93, P738, DOI 10.1002/bjs.5290; Moolla Z, 2013, WORLD J SURG, V37, P156, DOI 10.1007/s00268-012-1801-z; Nikkola J, 2013, ALCOHOL ALCOHOLISM, V48, P483, DOI 10.1093/alcalc/agt019; Nordback I, 2009, GASTROENTEROLOGY, V136, P848, DOI 10.1053/j.gastro.2008.11.044; Petrov MS, 2009, BRIT J SURG, V96, P1243, DOI 10.1002/bjs.6862; Powell JJ, 2000, BRIT J SURG, V87, P1375, DOI 10.1046/j.1365-2168.2000.01558.x; Singh VK, 2009, CLIN GASTROENTEROL H, V7, P1247, DOI 10.1016/j.cgh.2009.08.012; Symersky T, 2006, J PANCREAS, V7, P447; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; van Baal MC, 2011, BRIT J SURG, V98, P18, DOI 10.1002/bjs.7304; van Baal MC, 2012, ANN SURG, V255, P860, DOI 10.1097/SLA.0b013e3182507646; van Santvoort HC, 2010, NEW ENGL J MED, V362, P1491, DOI 10.1056/NEJMoa0908821; Villatoro E, 2010, COCHRANE DB SYST REV, V12; Wang MD, 2013, CHINESE MED J-PEKING, V126, P1987, DOI 10.3760/cma.j.issn.0366-6999.20130194; Wilcox CM, 2006, GASTROINTEST ENDOSC, V63, P1037, DOI 10.1016/j.gie.2006.02.024; Wu BU, 2011, CLIN GASTROENTEROL H, V9, P710, DOI 10.1016/j.cgh.2011.04.026	36	77	85	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2014	349								g4859	10.1136/bmj.g4859	http://dx.doi.org/10.1136/bmj.g4859			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN3RR	25116169	Bronze			2022-12-28	WOS:000340506700004
J	Bizzarro, M				Bizzarro, Martin			PLANETARY SCIENCE Probing the solar system's prenatal history	SCIENCE			English	Editorial Material							MOLECULAR CLOUDS; STARS; SUN		Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark	University of Copenhagen	Bizzarro, M (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr Star & Planet Format, DK-1350 Copenhagen, Denmark.	bizzarro@snm.ku.dk	Bizzarro, Martin/I-8701-2012; Bizzarro, Martin/M-7474-2019	Bizzarro, Martin/0000-0001-9966-2124; Bizzarro, Martin/0000-0001-9966-2124	European Research Council [616027] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Colin P, 2013, MON NOT R ASTRON SOC, V435, P1701, DOI 10.1093/mnras/stt1409; Fressin F, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/81; Holst JC, 2013, P NATL ACAD SCI USA, V110, P8819, DOI 10.1073/pnas.1300383110; Lugaro M, 2014, SCIENCE, V345, P650, DOI 10.1126/science.1253338; Murray N, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/2/133; Onehag A, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015138; Wallerstein G, 1997, REV MOD PHYS, V69, P995, DOI 10.1103/RevModPhys.69.995	11	0	0	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					620	621		10.1126/science.1257083	http://dx.doi.org/10.1126/science.1257083			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104370	Green Accepted			2022-12-28	WOS:000339962800018
J	Hong, CS; Abrams, MK; Ferris, TG				Hong, Clemens S.; Abrams, Melinda K.; Ferris, Timothy G.			Toward Increased Adoption of Complex Care Management	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hong, Clemens S.; Ferris, Timothy G.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ferris, Timothy G.] Partners Hlth Care, Boston, MA USA; [Abrams, Melinda K.] Commonwealth Fund, New York, NY USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System; Commonwealth Fund	Hong, CS (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							Hong C.S., 2014, CARING HIGH NEED HIG; McCall N, 2013, EVALUATION EXTENDED; Melek S., 2008, CHRONIC CONDITIONS C; Toussaint J, 2013, PIONEER ACO DASHBOAR	4	47	47	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					491	493		10.1056/NEJMp1401755	http://dx.doi.org/10.1056/NEJMp1401755			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM5LE	25099573				2022-12-28	WOS:000339899100002
J	Kennicutt, MC; Chown, SL; Cassano, JJ; Liggett, D; Massom, R; Peck, LS; Rintoul, SR; Storey, JWV; Vaughan, DG; Wilson, TJ; Sutherland, WJ				Kennicutt, Mahlon C., II; Chown, Steven L.; Cassano, John J.; Liggett, Daniela; Massom, Rob; Peck, Lloyd S.; Rintoul, Steve R.; Storey, John W. V.; Vaughan, David G.; Wilson, Terry J.; Sutherland, William J.			Polar Research: Six priorities for Antarctic science	NATURE			English	Editorial Material							WEST ANTARCTICA; THWAITES		[Kennicutt, Mahlon C., II] Texas A&M Univ, College Stn, TX 77843 USA; [Kennicutt, Mahlon C., II] Sci Comm Antarctic Res, The Hague, Netherlands; [Chown, Steven L.] Monash Univ, Clayton, Vic 3800, Australia	Texas A&M University System; Texas A&M University College Station; Monash University	Kennicutt, MC (corresponding author), Texas A&M Univ, College Stn, TX 77843 USA.	mckennicutt@gmail.com	Rintoul, Stephen R/A-1471-2012; Siegert, Martin/M-9939-2019; Morozova, Polina A./A-3471-2014; Chown, Steven L/H-3347-2011; Siegert, Martin J/A-3826-2008; Schloss, Irene R./U-5411-2018; Chown, Steven/ABD-7646-2021; Lopez-Martinez, Jeronimo/C-5744-2011; Clark, Melody S/D-7371-2014; Vaughan, David/C-8348-2011	Rintoul, Stephen R/0000-0002-7055-9876; Siegert, Martin/0000-0002-0090-4806; Chown, Steven L/0000-0001-6069-5105; Siegert, Martin J/0000-0002-0090-4806; Schloss, Irene R./0000-0002-5917-8925; Lopez-Martinez, Jeronimo/0000-0002-1750-8287; Clark, Melody S/0000-0002-3442-3824; Massom, Robert/0000-0003-1533-5084; Liggett, Daniela/0000-0003-4184-5205; Sutherland, William/0000-0002-6498-0437; /0000-0002-9621-6660; Vaughan, David/0000-0002-9065-0570; Wilson, Gary/0000-0003-0025-3641	NERC [NE/F016646/1, NE/G00465X/1, NE/G00465X/2] Funding Source: UKRI; Natural Environment Research Council [NE/G00465X/1, NE/F016646/1, NE/G00465X/2] Funding Source: researchfish; Division Of Ocean Sciences [1129101] Funding Source: National Science Foundation	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Brady A.-M., 2014, EMERGING POLITICS AN; Brierley, 2014, TIME CHANGE CLIMATE; Chown SL, 2012, SCIENCE, V337, P158, DOI 10.1126/science.1222821; Chown SL, 2012, P NATL ACAD SCI USA, V109, P4938, DOI 10.1073/pnas.1119787109; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Shaw JD, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001888; Tin T., 2014, ANTARCTIC FUTURES HU	8	136	141	3	109	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					23	25		10.1038/512023a	http://dx.doi.org/10.1038/512023a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM5NX	25100467	Bronze			2022-12-28	WOS:000339908000012
J	Cao, J; Zhang, S				Cao, Jing; Zhang, Song			Multiple Comparison Procedures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Cao, Jing] So Methodist Univ, Dept Stat Sci, Dallas, TX 75275 USA; [Zhang, Song] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA	Southern Methodist University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Cao, J (corresponding author), So Methodist Univ, Dallas, TX 75275 USA.	jcao@smu.edu						Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hsu J., 1996, MULTIPLE COMP THEORY, DOI DOI 10.1007/978-1-4899-7180-7; Saitz R, 2014, JAMA-J AM MED ASSOC, V312, P502, DOI 10.1001/jama.2014.7862; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694	6	96	97	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 6	2014	312	5					543	544		10.1001/jama.2014.9440	http://dx.doi.org/10.1001/jama.2014.9440			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM4FL	25096694				2022-12-28	WOS:000339808600023
J	Fuchs, ERH				Fuchs, Erica R. H.			Global manufacturing and the future of technology	SCIENCE			English	Editorial Material							COMPETITIVENESS; INNOVATION; LOCATION		Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Fuchs, ERH (corresponding author), Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA.	erhf@andrew.cmu.edu						Bernstein S., 2012, 2126 STANF GRAD SCH; Branstetter L., 2001, CHANGING FRONTIER RE; Burger R., 2014, COOPERATIVE RES NEW; Cummings JN, 2009, INFORM SYST RES, V20, P420, DOI 10.1287/isre.1090.0239; Fuchs E, 2010, MANAGE SCI, V56, P2323, DOI 10.1287/mnsc.1100.1227; Fuchs ERH, 2011, INT J PROD ECON, V132, P79, DOI 10.1016/j.ijpe.2011.03.008; Fuchs ERH, 2010, RES POLICY, V39, P1133, DOI 10.1016/j.respol.2010.07.003; Gibson CB, 2006, ADMIN SCI QUART, V51, P451, DOI 10.2189/asqu.51.3.451; Helveston J., 2013, WILL SUBSIDIES DRIVE; International Organization of Motor Vehicle Manufacturers (OICA), 2013, WORLD MOT VEH PROD C; Lecuyer C., 2005, MAKING SILCON VALLEY; Lerner J, 2011, J FINANC, V66, P445, DOI 10.1111/j.1540-6261.2010.01639.x; Macher JT, 2008, INNOVATION GLOBAL IN; Marshall, 1990, PRINCIPLES EC; National Research Council, 1999, FUND REV GOV SUPP CO; Pisano G.P., 2012, PRODUCING PROSPERITY; Ricardo D., 1953, WORKS CORRES D RICAR; Samuelson PA, 2004, J ECON PERSPECT, V18, P135, DOI 10.1257/0895330042162403; Yang C., 2013, GAINS OTHERS LOSSES	19	19	19	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					519	520		10.1126/science.1250193	http://dx.doi.org/10.1126/science.1250193			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM2AU	25082689				2022-12-28	WOS:000339651300027
J	Zhou, HP; Chen, Q; Li, G; Luo, S; Song, TB; Duan, HS; Hong, ZR; You, JB; Liu, YS; Yang, Y				Zhou, Huanping; Chen, Qi; Li, Gang; Luo, Song; Song, Tze-bing; Duan, Hsin-Sheng; Hong, Ziruo; You, Jingbi; Liu, Yongsheng; Yang, Yang			Interface engineering of highly efficient perovskite solar cells	SCIENCE			English	Article							SOLUTION-PROCESSED PEROVSKITE; ELECTRON EXTRACTION; THERMAL-PROPERTIES; LOW-COST; LIGHT; THERMOCHEMISTRY; ENHANCEMENT; THERMOLYSIS	Advancing perovskite solar cell technologies toward their theoretical power conversion efficiency (PCE) requires delicate control over the carrier dynamics throughout the entire device. By controlling the formation of the perovskite layer and careful choices of other materials, we suppressed carrier recombination in the absorber, facilitated carrier injection into the carrier transport layers, and maintained good carrier extraction at the electrodes. When measured via reverse bias scan, cell PCE is typically boosted to 16.6% on average, with the highest efficiency of similar to 19.3% in a planar geometry without antireflective coating. The fabrication of our perovskite solar cells was conducted in air and from solution at low temperatures, which should simplify manufacturing of large-area perovskite devices that are inexpensive and perform at high levels.	[Zhou, Huanping; Chen, Qi; Li, Gang; Luo, Song; Song, Tze-bing; Duan, Hsin-Sheng; Hong, Ziruo; You, Jingbi; Liu, Yongsheng; Yang, Yang] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Zhou, Huanping; Chen, Qi; Luo, Song; Song, Tze-bing; Duan, Hsin-Sheng; Liu, Yongsheng; Yang, Yang] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yang, Y (corresponding author), Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA.	yangy@ucla.edu	Chen, Qi/Z-2897-2019; You, Jingbi/A-2941-2011; yang, yang/GWB-9426-2022; Hong, Ziruo/B-9798-2009; Song, Tze-Bin/G-4590-2013; Liu, Yongsheng/C-9258-2011; Yang, Yang/A-2944-2011; yang, yang/HGT-7999-2022; You, Jingbi/L-5348-2019; Li, Gang/A-5667-2012; Lang, Ming/HIK-0758-2022; yang, yang/GVT-5210-2022	Chen, Qi/0000-0002-9647-5873; You, Jingbi/0000-0002-4651-9081; Hong, Ziruo/0000-0003-2763-003X; Song, Tze-Bin/0000-0002-1645-9831; Liu, Yongsheng/0000-0002-7135-723X; You, Jingbi/0000-0002-4651-9081; Li, Gang/0000-0001-8399-7771; 	NSF [ECCS-1202231]; Air Force Office of Scientific Research [FA9550-12-1-0074]; UCLA; Div Of Electrical, Commun & Cyber Sys [1202231] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); UCLA; Div Of Electrical, Commun & Cyber Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was financially supported by a grant from the NSF (grant no. ECCS-1202231, Program Director P. Werbos), a grant from the Air Force Office of Scientific Research (grant no. FA9550-12-1-0074, Program Manager C. Lee), and UCLA Internal Funds. We thank H. S. Jung and B. Kim of Sungkyunkwan University in Korea for valuable discussion in the starting stage of a perovskite solar cell, S. Lu for synthesizing Co salt, B. Bob and E. Richard for editing, W. Hsu for assistance with UPS measurements and analysis, L. Dou for TiO<INF>2</INF> nanocrystal synthesis, J. D. Huang for inspiring technical discussion, K. Emery (National Renewable Energy Laboratory) for calibrating UCLA's in-house KG5 Si reference cell and valuable discussion on EQE measurement, and M. O'Donnell (Newport Corporation) for helping on spectral mismatch factor calculation.	Abrusci A, 2013, NANO LETT, V13, P3124, DOI 10.1021/nl401044q; BLAZEJOWSKI J, 1986, THERMOCHIM ACTA, V105, P257, DOI 10.1016/0040-6031(86)85244-3; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Chen Q, 2014, J AM CHEM SOC, V136, P622, DOI 10.1021/ja411509g; Christians JA, 2014, J AM CHEM SOC, V136, P758, DOI 10.1021/ja411014k; Conings B, 2014, ADV MATER, V26, P2041, DOI 10.1002/adma.201304803; Docampo P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3761; DOKURNO P, 1990, THERMOCHIM ACTA, V165, P31, DOI 10.1016/0040-6031(90)80204-C; Eperon GE, 2014, ADV FUNCT MATER, V24, P151, DOI 10.1002/adfm.201302090; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI [10.1038/NPHOTON.2013.80, 10.1038/nphoton.2013.80]; Jeng JY, 2013, ADV MATER, V25, P3727, DOI 10.1002/adma.201301327; Jeon NJ, 2013, J AM CHEM SOC, V135, P19087, DOI 10.1021/ja410659k; Karlin KD, 2007, PROG INORG CHEM, V55, P1, DOI 10.1002/9780470144428; Kim HS, 2013, NANO LETT, V13, P2412, DOI 10.1021/nl400286w; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; King RR, 2011, PROG PHOTOVOLTAICS, V19, P797, DOI 10.1002/pip.1044; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Leijtens T, 2013, ADV MATER, V25, P3227, DOI 10.1002/adma.201300947; Liang PW, 2014, ADV MATER, V26, P3748, DOI 10.1002/adma.201400231; Liu DY, 2014, NAT PHOTONICS, V8, P133, DOI 10.1038/nphoton.2013.342; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Lotsch BV, 2014, ANGEW CHEM INT EDIT, V53, P635, DOI 10.1002/anie.201309368; Malinkiewicz O, 2014, NAT PHOTONICS, V8, P128, DOI [10.1038/NPHOTON.2013.141, 10.1038/nphoton.2013.341]; Park NG, 2013, J PHYS CHEM LETT, V4, P2423, DOI 10.1021/jz400892a; Persson I, 2011, INORG CHEM, V50, P1058, DOI 10.1021/ic1017714; Ponseca CS, 2014, J AM CHEM SOC, V136, P5189, DOI 10.1021/ja412583t; Qin P, 2014, NANOSCALE, V6, P1508, DOI 10.1039/c3nr05884k; Snaith HJ, 2006, ADV MATER, V18, P1910, DOI 10.1002/adma.200502256; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Snaith HJ, 2013, J PHYS CHEM LETT, V4, P3623, DOI 10.1021/jz4020162; Son D.-Y., 2014, J PHYS CHEM C; Wojciechowski K, 2014, ENERG ENVIRON SCI, V7, P1142, DOI 10.1039/c3ee43707h; Yella A, 2014, NANO LETT, V14, P2591, DOI 10.1021/nl500399m; You JB, 2014, ACS NANO, V8, P1674, DOI 10.1021/nn406020d; Zhang W, 2013, NANO LETT, V13, P4505, DOI 10.1021/nl4024287; Zhou YH, 2012, SCIENCE, V336, P327, DOI 10.1126/science.1218829; Zhu ZL, 2014, J AM CHEM SOC, V136, P3760, DOI 10.1021/ja4132246	38	5360	5472	171	5591	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					542	546		10.1126/science.1254050	http://dx.doi.org/10.1126/science.1254050			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082698				2022-12-28	WOS:000339651300040
J	Marchi, S; Bottke, WF; Elkins-Tanton, LT; Bierhaus, M; Wuennemann, K; Morbidelli, A; Kring, DA				Marchi, S.; Bottke, W. F.; Elkins-Tanton, L. T.; Bierhaus, M.; Wuennemann, K.; Morbidelli, A.; Kring, D. A.			Widespread mixing and burial of Earth's Hadean crust by asteroid impacts	NATURE			English	Article							HEAVY BOMBARDMENT; DETRITAL ZIRCONS; LUNAR CATACLYSM; ARCHEAN CRUST; BILLION YEARS; U-PB; MOON; CONSTRAINTS; ACCRETION; ORIGIN	The history of the Hadean Earth (similar to 4.0-4.5 billion years ago) is poorly understood because few known rocks are older than similar to 3.8 billion years old(1). The main constraints from this era come from ancient submillimetre zircon grains(2,3). Some of these zircons date back to similar to 4.4 billion years ago when the Moon, and presumably the Earth, was being pummelled by an enormous flux of extraterrestrial bodies(4). The magnitude and exact timing of these early terrestrial impacts, and their effects on crustal growth and evolution, are unknown. Here we provide a new bombardment model of the Hadean Earth that has been calibrated using existing lunar(4) and terrestrial data(5). We find that the surface of the Hadean Earth was widely reprocessed by impacts through mixing and burial by impact-generated melt. This model may explain the age distribution of Hadean zircons and the absence of early terrestrial rocks. Existing oceans would have repeatedly boiled away into steam atmospheres as a result of large collisions as late as about 4 billion years ago.	[Marchi, S.; Bottke, W. F.] SW Res Inst, Boulder, CO 80302 USA; [Elkins-Tanton, L. T.] Carnegie Inst Sci, Washington, DC 20015 USA; [Bierhaus, M.; Wuennemann, K.] Museum Nat Kunde, D-10115 Berlin, Germany; [Morbidelli, A.] Observ Cote Azur, F-06304 Nice, France; [Kring, D. A.] Univ Space Res Assoc, Lunar & Planetary Inst, Houston, TX 77058 USA	Carnegie Institution for Science; Leibniz Institut fur Evolutions und Biodiversitatsforschung; UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Universities Space Research Association (USRA)	Marchi, S (corresponding author), SW Res Inst, Boulder, CO 80302 USA.	marchi@boulder.swri.edu			NASA Solar System Exploration Research Virtual Institute [NNA14AB03A, NNA14AB07A]; Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V. Alliance 'Planetary Evolution and Life'; European Research Council [290568]	NASA Solar System Exploration Research Virtual Institute; Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V. Alliance 'Planetary Evolution and Life'; European Research Council(European Research Council (ERC)European Commission)	We thank H. J. Melosh, S. J. Mojzsis, T. M. Harrison, A. J. Cavosie, A. I. S. Kemp, W. L. Griffin, M. M. Wielicki, R. J. Walker, E. B. Watson, P. Holden, O. Abramov, R. M. Canup, H. F. Levison, D. Nesvorny, O. Nebel, N. H. Sleep and N. Arndt for comments and criticisms that helped to shape the current paper. We gratefully acknowledge the developers of iSALE-2D/3D (www.isale-code.de). S.M., W.F.B. and D.A.K. received support from the NASA Solar System Exploration Research Virtual Institute grant no. NNA14AB03A and NNA14AB07A; K.W. and M.B. were supported by the Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V. Alliance 'Planetary Evolution and Life'. A.M. was supported by the European Research Council Advanced Grant 'ACCRETE' (contract number 290568).	Abramov O, 2013, CHEM ERDE-GEOCHEM, V73, P227, DOI 10.1016/j.chemer.2013.08.004; Abramov O, 2012, ICARUS, V218, P906, DOI 10.1016/j.icarus.2011.12.022; Ahrens T. J., 1977, IMPACT EXPLOSION CRA, P639; Arndt NT, 2012, ANNU REV EARTH PL SC, V40, P521, DOI 10.1146/annurev-earth-042711-105316; Bedard JH, 2006, GEOCHIM COSMOCHIM AC, V70, P1188, DOI 10.1016/j.gca.2005.11.008; Bierhaus M., 2013, LUNAR PLANET SCI, V44, P2420; Bjorkman M. D., 1987, INT J IMPACT ENG, V5, P155; Bottke WF, 2012, NATURE, V485, P78, DOI 10.1038/nature10967; Bottke WF, 2010, SCIENCE, V330, P1527, DOI 10.1126/science.1196874; Canup RM, 2004, ANNU REV ASTRON ASTR, V42, P441, DOI 10.1146/annurev.astro.41.082201.113457; Cavosie A. J., 2007, DEV PRECAMBRIAN GEOL, V15, P111; Cavosie AJ, 2005, EARTH PLANET SC LETT, V235, P663, DOI 10.1016/j.epsl.2005.04.028; Chambers JE, 2004, EARTH PLANET SC LETT, V223, P241, DOI 10.1016/j.epsl.2004.04.031; CHAPMAN CR, 1986, SATELLITES, P492; Collins GS, 2004, METEORIT PLANET SCI, V39, P217, DOI 10.1111/j.1945-5100.2004.tb00337.x; Darling J, 2009, GEOLOGY, V37, P927, DOI 10.1130/G30251A.1; Elbeshausen D, 2009, ICARUS, V204, P716, DOI 10.1016/j.icarus.2009.07.018; Elkins-Tanton LT, 2005, EARTH PLANET SC LETT, V239, P219, DOI 10.1016/j.epsl.2005.07.029; Fassett CI, 2012, J GEOPHYS RES-PLANET, V117, DOI 10.1029/2012JE004154; Grieve R. A., 2006, GEOL SOC AM SPEC PAP, V405; GRIEVE RAF, 1992, METEORITICS, V27, P526, DOI 10.1111/j.1945-5100.1992.tb01074.x; Griffin WL, 2014, LITHOS, V189, P2, DOI 10.1016/j.lithos.2013.08.018; Harrison TM, 2007, EARTH PLANET SC LETT, V261, P9, DOI 10.1016/j.epsl.2007.05.016; Harrison TM, 2009, ANNU REV EARTH PL SC, V37, P479, DOI 10.1146/annurev.earth.031208.100151; Herzberg C, 2010, EARTH PLANET SC LETT, V292, P79, DOI 10.1016/j.epsl.2010.01.022; HOLSAPPLE KA, 1993, ANNU REV EARTH PL SC, V21, P333, DOI 10.1146/annurev.ea.21.050193.002001; Huffman AR, 1996, TECTONOPHYSICS, V256, P165, DOI 10.1016/0040-1951(95)00162-X; Ivanov BA, 2003, GEOLOGY, V31, P869, DOI 10.1130/G19669.1; Ivanov BA, 2002, GEOL SOC AM SPEC PAP, V356, P619; Jones AP, 2005, GEOL SOC AM SPEC PAP, V388, DOI 10.1130/2005.2388(40); Kamber BS, 2005, EARTH PLANET SC LETT, V240, P276, DOI 10.1016/j.epsl.2005.09.037; Kamber BS, 2001, GEOL SOC SPEC PUBL, V190, P177, DOI 10.1144/GSL.SP.2001.190.01.13; Kemp AIS, 2010, EARTH PLANET SC LETT, V296, P45, DOI 10.1016/j.epsl.2010.04.043; Kruijer T. S., 2014, LUNAR PLANET SCI, V45, P2895; Marchi S, 2013, NAT GEOSCI, V6, P303, DOI [10.1038/ngeo1769, 10.1038/NGEO1769]; Marchi S, 2013, NATURE, V499, P59, DOI 10.1038/nature12280; Marchi S, 2012, EARTH PLANET SC LETT, V325, P27, DOI 10.1016/j.epsl.2012.01.021; Marchi S, 2009, ASTRON J, V137, P4936, DOI 10.1088/0004-6256/137/6/4936; McKinnon W.B., 1985, LUNAR PLANET SCI, P544; Melosh HJ, 2007, METEORIT PLANET SCI, V42, P2079, DOI 10.1111/j.1945-5100.2007.tb01009.x; Melosh H. J, 1989, OXFORD MONOGRAPHS GE, V11; MELOSH HJ, 1979, J GEOPHYS RES, V84, P7513, DOI 10.1029/JB084iB13p07513; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; Morbidelli A, 2012, EARTH PLANET SC LETT, V355, P144, DOI 10.1016/j.epsl.2012.07.037; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Norman MD, 2014, EARTH PLANET SC LETT, V388, P387, DOI 10.1016/j.epsl.2013.11.040; Nutman AP, 2006, SCIENCE, V311, DOI 10.1126/science.1120977; OKEEFE JD, 1993, J GEOPHYS RES-PLANET, V98, P17011, DOI 10.1029/93JE01330; Pearce JA, 2014, GEOLOGY, V42, P175, DOI 10.1130/focus022014.1; Pierazzo E, 1997, ICARUS, V127, P408, DOI 10.1006/icar.1997.5713; Pierazzo E, 2000, ICARUS, V145, P252, DOI 10.1006/icar.1999.6332; Potter RWK, 2012, ICARUS, V220, P730, DOI 10.1016/j.icarus.2012.05.032; Raymond SN, 2013, ICARUS, V226, P671, DOI 10.1016/j.icarus.2013.06.019; Reese CC, 2006, ICARUS, V184, P102, DOI 10.1016/j.icarus.2006.04.008; Rogers AD, 2013, J GEOPHYS RES-PLANET, V118, P1094, DOI 10.1002/jgre.20083; Ryder G, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001583; Schlichting HE, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/1/8; Schmitt RT, 2000, METEORIT PLANET SCI, V35, P545, DOI 10.1111/j.1945-5100.2000.tb01435.x; SLEEP NH, 1989, NATURE, V342, P139, DOI 10.1038/342139a0; Sleep NH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002527; Strom RG, 2005, SCIENCE, V309, P1847, DOI 10.1126/science.1113544; Stu┬ffler D., 1972, FORTSCHRITTE MINERAL, V49, P50; Thompson S. L., 1972, SCRR710714 SAND LAB; TONKS WB, 1993, J GEOPHYS RES-PLANET, V98, P5319, DOI 10.1029/92JE02726; TONKS WB, 1992, ICARUS, V100, P326, DOI 10.1016/0019-1035(92)90104-F; Turcotte D.L., 2002, GEODYNAMICS, DOI DOI 10.1002/GJ.987; Walker RJ, 2009, CHEM ERDE-GEOCHEM, V69, P101, DOI 10.1016/j.chemer.2008.10.001; Watson EB, 2005, SCIENCE, V308, P841, DOI 10.1126/science.1110873; Watters WA, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2007JE002964; WICHMAN RW, 1989, J GEOPHYS RES-SOLID, V94, P17333, DOI 10.1029/JB094iB12p17333; Wielicki MM, 2012, EARTH PLANET SC LETT, V321, P20, DOI 10.1016/j.epsl.2012.01.009; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550; Wunnemann K, 2008, EARTH PLANET SC LETT, V269, P529, DOI 10.1016/j.epsl.2008.03.007; Wunnemann K, 2006, ICARUS, V180, P514, DOI 10.1016/j.icarus.2005.10.013; Wunnemann K., 2011, P 11 HYP IMP S FRAUN, P1; Zahnle K, 2007, SPACE SCI REV, V129, P35, DOI 10.1007/s11214-007-9225-z	79	150	154	3	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					578	+		10.1038/nature13539	http://dx.doi.org/10.1038/nature13539			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079556				2022-12-28	WOS:000339566300032
J	Patel, A; Laffan, MA; Waheed, U; Brett, SJ				Patel, Amit; Laffan, Michael A.; Waheed, Umeer; Brett, Stephen J.			Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CRITICALLY-ILL PATIENTS; HYDROXYETHYL STARCH 130/0.4; DIFFERENT VOLUME THERAPIES; RETRACTED ARTICLE. SEE; ACUTE KIDNEY INJURY; FLUID RESUSCITATION; SEPTIC SHOCK; HYPOPROTEINEMIC PATIENTS; HYPOALBUMINEMIC PATIENTS; HYPERONCOTIC COLLOIDS	Objective To assess the efficacy and safety of pooled human albumin solutions as part of fluid volume expansion and resuscitation (with or without improvement of baseline hypoalbuminaemia) in critically unwell adults with sepsis of any severity. Design Systematic review and meta-analysis of randomised clinical trials, with trial sequential analysis, subgroup, and meta-regression analyses. Data sources PubMed, PubMed Central, Web of Science (includes Medline, Conference Proceedings Citation Index, Data Citation Index, Chinese Science Citation Database, CAB abstracts, Derwent Innovations Index), OvidSP (includes Embase, Ovid Medline, HMIC, PsycINFO, Maternity and Infant Care, Transport Database), Cochrane Library, clinicaltrials.gov, controlled-trials.com, online material, relevant conference proceedings, hand searching of reference lists, and contact with authors as necessary. Eligibility criteria Prospective randomised clinical trials of adults with sepsis of any severity (with or without baseline hypoalbuminaemia) in critical or intensive care who received pooled human albumin solutions as part of fluid volume expansion and resuscitation (with or without improvement of hypoalbuminaemia) compared with those who received control fluids (crystalloid or colloid), were included if all-cause mortality outcome data were available. No restriction of language, date, publication status, or primary study endpoint was applied. Data extraction Two reviewers independently assessed articles for inclusion, extracted data to assess risk of bias, trial methods, patients, interventions, comparisons, and outcome. The relative risk of all-cause mortality was calculated using a random effects model accounting for clinical heterogeneity. Primary outcome measure All-cause mortality at final follow-up. Results Eighteen articles reporting on 16 primary clinical trials that included 4190 adults in critical or intensive care with sepsis, severe sepsis, or septic shock. A median of 70.0 g daily of pooled human albumin was received over a median of 3 days by adults with a median age of 60.8 years as part of fluid volume expansion and resuscitation, with or without correction of hypoalbuminaemia. The relative risk of death was similar between albumin groups (that received a median of 175 g in total) and control fluid groups (relative risk 0.94; 95% confidence interval 0.87 to 1.01; P=0.11; I-2=0%). Trial sequential analysis corrected the 95% confidence interval for random error (0.85 to 1.02; D-2=0%). Eighty eight per cent of the required information size (meta-analysis sample size) of 4894 patients was achieved, and the cumulative effect size measure (z score) entered the futility area, supporting the notion of no relative benefit of albumin (GRADE quality of evidence was moderate). Evidence of no difference was also found when albumin was compared with crystalloid fluid (relative risk 0.93; 0.86 to 1.01; P=0.07; I-2=0%) in 3878 patents (GRADE quality of evidence was high; 79.9% of required information size) or colloid fluids in 299 patients (relative risk 1.04; 0.79 to 1.38; P=0.76; I-2=0%) (GRADE quality of evidence was very low; 5.8% of required information size). When studies at high risk of bias were excluded in a predefined subgroup analysis, the finding of no mortality benefit remained, and the cumulative z score was just outside the boundary of futility. Overall, the meta-analysis was robust to sensitivity, subgroup, meta-regression, and trial sequential analyses. Conclusions In this analysis, human albumin solutions as part of fluid volume expansion and resuscitation for critically unwell adults with sepsis of any severity (with or without baseline hypoalbuminaemia) were not robustly effective at reducing all-cause mortality. Albumin seems to be safe in this setting, as a signal towards harm was not detected, but this analysis does not support a recommendation for use.	[Patel, Amit; Waheed, Umeer; Brett, Stephen J.] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Ctr Perioperat Med & Crit Care Res, London W12 0HS, England; [Patel, Amit] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, MRC Clin Sci Ctr, London, England; [Patel, Amit; Laffan, Michael A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Ctr Haematol, London, England	Imperial College London; Imperial College London; Imperial College London	Patel, A (corresponding author), Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, Ctr Perioperat Med & Crit Care Res, London W12 0HS, England.	amit.patel@imperial.ac.uk		Laffan, Michael/0000-0002-8268-3268	Medical Research Council (MRC); National Institute for Health Research (NIHR) Biomedical Research Centre	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR))	This research was not directly funded. AP is funded by the Medical Research Council (MRC) Chain-Florey Fellowship scheme based at the Clinical Sciences Centre, Imperial College London. All authors are supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust and Imperial College London. The views expressed are those of the authors and not necessarily those of the NHS, NIHR, or Department of Health. The research and authors are independent of funders.	Administration UFaD, 2013, FDA SAF COMM BOX WAR; Agency EM, 2013, EMA8094702013 AG EM; Almeida A, 2013, LACTATED RINGER VERS; Annane D, 2013, JAMA-J AM MED ASSOC, V310, P1809, DOI 10.1001/jama.2013.280502; [Anonymous], 2013, 174 NICE CLIN; [Anonymous], 2009, CHEST; [Anonymous], 2013, BRIT NAT FORM BNF; Artero A, 2010, J CRIT CARE, V25, P276, DOI 10.1016/j.jcrc.2009.12.004; Bansal M, 2013, CURR DRUG SAF, V8, P236, DOI 10.2174/15748863113089990046; Bar-Or D, 2005, CRIT CARE MED, V33, P1638, DOI 10.1097/01.CCM.0000169876.14858.91; Boldt J, 1996, INTENS CARE MED, V22, P1075, DOI 10.1007/s001340050216; BOLDT J, 1995, BRIT J ANAESTH, V75, P740, DOI 10.1093/bja/75.6.740; Boldt J, 1996, CRIT CARE MED, V24, P385, DOI 10.1097/00003246-199603000-00005; Boldt J, 2014, BRIT J ANAESTH, V112, P397, DOI 10.1093/bja/aet488; Boldt J, 2014, INTENS CARE MED, V40, P145, DOI 10.1007/s00134-013-3164-9; Boldt J, 1996, ANESTH ANALG, V83, P254, DOI 10.1097/00000539-199608000-00010; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bulanov A Iu, 2004, Anesteziol Reanimatol, P25; Bunn F, 2012, COCHRANE DB SYST REV, V7; Caironi P, 2014, NEW ENGL J MED, V370, P1412, DOI 10.1056/NEJMoa1305727; Charpentier J, 2011, INTENS CARE MED, V37, pS115; Christopher KB, 2012, INTENS CARE MED, V38, P1; COHEN IL, 1993, CRIT CARE MED, V21, P476, DOI 10.1097/00003246-199303000-00032; Cohen J, 2001, CRIT CARE MED, V29, P880, DOI 10.1097/00003246-200104000-00039; COOK DJ, 1993, JAMA-J AM MED ASSOC, V269, P2749, DOI 10.1001/jama.269.21.2749; Cui Jin-ying, 2012, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V24, P18; Dechartres A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2304; Delaney AP, 2011, CRIT CARE MED, V39, P386, DOI 10.1097/CCM.0b013e3181ffe217; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI 10.1007/s00134-004-2210-z; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dolecek M, 2009, HEPATO-GASTROENTEROL, V56, P1622; Dubois MJ, 2006, CRIT CARE MED, V34, P2536, DOI 10.1097/01.CCM.0000239119.57544.0C; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ernest D, 1999, CRIT CARE MED, V27, P46, DOI 10.1097/00003246-199901000-00025; FALK JL, 1988, J CLIN PHARMACOL, V28, P412, DOI 10.1002/j.1552-4604.1988.tb05751.x; Farrugia A, 2014, REV RECENT CLIN TRIA, V9, P21, DOI 10.2174/1574887108666131213120816; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Finfer S, 2004, VOX SANG, V87, P123, DOI 10.1111/j.1741-6892.2004.00468.x; Finfer S, 2006, BRIT MED J, V333, P1044, DOI 10.1136/bmj.38985.398704.7C; Finfer S, 2011, INTENS CARE MED, V37, P86, DOI 10.1007/s00134-010-2039-6; Finfer S, 2010, CRIT CARE, V14, DOI 10.1186/cc9293; FOLEY EF, 1990, ARCH SURG-CHICAGO, V125, P739; Friedman G, 2008, J CLIN ANESTH, V20, P528, DOI 10.1016/j.jclinane.2008.05.022; Gattas DJ, 2013, INTENS CARE MED, V39, P558, DOI 10.1007/s00134-013-2840-0; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; GOLUB R, 1994, CRIT CARE MED, V22, P613, DOI 10.1097/00003246-199404000-00017; Gondos T, 2010, EUR J ANAESTH, V27, P794, DOI 10.1097/EJA.0b013e32833b3504; Guidet B, 2007, J CRIT CARE, V22, P197, DOI 10.1016/j.jcrc.2006.11.005; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haase N, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f839; Hartog CS, 2010, INTENS CARE MED, V36, P553, DOI 10.1007/s00134-009-1736-5; HAUPT MT, 1982, CRIT CARE MED, V10, P159, DOI 10.1097/00003246-198203000-00004; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hondebrink Y, 1997, INTENSIVE CARE ME S1, V23, pS184; Hospital L., 2012, HOSP PRES RES FIN RE; Jacob M, 2008, CRIT CARE, V12, DOI 10.1186/cc6812; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leitch A, 2013, J INTENSIVE CARE SOC, V14, P45, DOI DOI 10.1177/175114371301400110; LeLorier J, 1997, NEW ENGL J MED, V337, P536, DOI 10.1056/NEJM199708213370806; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Martin GS, 2005, CRIT CARE MED, V33, P1681, DOI 10.1097/01.CCM.0000171539.47006.02; Martin GS, 2002, CRIT CARE MED, V30, P2175, DOI 10.1097/00003246-200210000-00001; Matejtschuk P, 2000, BRIT J ANAESTH, V85, P887, DOI 10.1093/bja/85.6.887; Mayr W, 2004, VOX SANG, V87, P142, DOI 10.1111/j.1423-0410.2004.00547.x; McIntyre L, 2012, TRANSFUS MED REV, V26, P333, DOI 10.1016/j.tmrv.2011.11.003; McIntyre LA, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.10.007; METILDI LA, 1984, SURG GYNECOL OBSTET, V158, P207; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Onwuegbuzie A.J., 2004, UNDERSTANDING STAT, V3, P201, DOI DOI 10.1207/S15328031US0304_1; Palumbo D, 2006, MINERVA ANESTESIOL, V72, P655; Panagiotou OA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f707; Patel Amit, 2013, Br J Hosp Med (Lond), V74, P657; Patel A, 2013, INTENS CARE MED, V39, P811, DOI 10.1007/s00134-013-2863-6; Perel P, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000567.pub5; Perner A, 2012, NEW ENGL J MED, V367, P124, DOI 10.1056/NEJMoa1204242; Quinlan GJ, 1998, CLIN SCI, V95, P459, DOI 10.1042/CS19980191; Quinlan GJ, 2004, CRIT CARE MED, V32, P755, DOI 10.1097/01.CCM.0000114574.18641.5D; RACKOW EC, 1983, CRIT CARE MED, V11, P839, DOI 10.1097/00003246-198311000-00001; RACKOW EC, 1989, CRIT CARE MED, V17, P394, DOI 10.1097/00003246-198905000-00003; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Roberts I, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001208.pub3, 10.1002/14651858.CD001208.pub4]; Rubin H, 1997, CRIT CARE MED, V25, P249, DOI 10.1097/00003246-199702000-00009; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Salerno F, 2013, CLIN GASTROENTEROL H, V11, P123, DOI 10.1016/j.cgh.2012.11.007; Schortgen F, 2008, INTENS CARE MED, V34, P2157, DOI 10.1007/s00134-008-1225-2; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Sterne JAC, 2001, BMJ-BRIT MED J, V322, P226, DOI 10.1136/bmj.322.7280.226; STOCKWELL MA, 1992, ANAESTHESIA, V47, P7, DOI 10.1111/j.1365-2044.1992.tb01942.x; STOCKWELL MA, 1992, ANAESTHESIA, V47, P3, DOI 10.1111/j.1365-2044.1992.tb01941.x; Tabor E, 1999, TRANSFUSION, V39, P1160, DOI 10.1046/j.1537-2995.1999.39111160.x; Thomas-Rueddel DO, 2012, INTENS CARE MED, V38, P1134, DOI 10.1007/s00134-012-2560-x; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Thorlund K., 2011, USER MANUAL TRIAL SE; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Timmer B, 1998, NETHERLANDS J MED, V52, pA42; Trof RJ, 2010, INTENS CARE MED, V36, P697, DOI 10.1007/s00134-010-1776-x; van der Heijden M, 2009, CRIT CARE MED, V37, P1275, DOI 10.1097/CCM.0b013e31819cedfd; Veneman TF, 2004, WIEN KLIN WOCHENSCHR, V116, P305, DOI 10.1007/BF03040900; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Vincent JL, 2004, CRIT CARE MED, V32, P2029, DOI 10.1097/01.CCM.0000142574.00425.E9; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156; Vincent JL, 2003, BRIT J ANAESTH, V91, P625, DOI 10.1093/bja/aeg233; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; von Hoegen I, 2001, CRIT CARE MED, V29, P994, DOI 10.1097/00003246-200105000-00021; Wang Y, 2013, CHINESE MED J-PEKING, V126, P3379, DOI 10.3760/cma.j.issn.0366-6999.20130743; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wiedermann CJ, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13747; Wiedermann CJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9308; Wise J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1738; WOJTYSIAK SL, 1992, CRIT CARE MED, V20, P164, DOI 10.1097/00003246-199202000-00005; YIM JM, 1995, ARCH INTERN MED, V155, P2450, DOI 10.1001/archinte.155.22.2450; Zarychanski R, 2013, JAMA-J AM MED ASSOC, V309, P678, DOI 10.1001/jama.2013.430; Zhang ZH, 2013, CRIT CARE, V17, DOI 10.1186/cc11919	124	122	132	1	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 22	2014	349								g4561	10.1136/bmj.g4561	http://dx.doi.org/10.1136/bmj.g4561			28	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM0VN	25099709	Green Published, hybrid			2022-12-28	WOS:000339565700001
J	del Rio, C; Mehta, AK; Lyon, M; Guarner, J				del Rio, Carlos; Mehta, Aneesh K.; Lyon, Marshall, III; Guarner, Jeannette			Ebola Hemorrhagic Fever in 2014: The Tale of an Evolving Epidemic	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VIRUS		Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Anat & Cell Biol, Atlanta, GA 30322 USA	Emory University; Rollins School Public Health; Emory University	del Rio, C (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.	cdelrio@emory.edu	del Rio, Carlos/B-3763-2012; Mehta, Aneesh/B-8054-2012; Guarner, Jeannette/B-8273-2013	del Rio, Carlos/0000-0002-0153-3517; Mehta, Aneesh/0000-0002-6552-9162; Guarner, Jeannette/0000-0001-5610-3541				Baize S., 2014, N ENGL J MED; Centers for Disease Control and Prevention, 2014, CDC URG ALL US RES A; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Geisbert TW, 2003, AM J PATHOL, V163, P2347, DOI 10.1016/S0002-9440(10)63591-2; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Marzi A, 2014, EXPERT REV VACCINES, V13, P521, DOI 10.1586/14760584.2014.885841; Qiu XG, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003876; SMADEL JE, 1953, AM J PUBLIC HLTH NAT, V43, P1327; Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027; Wong G, 2014, TRENDS MICROBIOL, V22, P456, DOI 10.1016/j.tim.2014.04.002	10	28	28	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 18	2014	161	10					746	U200		10.7326/M14-1880	http://dx.doi.org/10.7326/M14-1880			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AX9TT	25133433				2022-12-28	WOS:000347245600034
J	Skowronska-Krawczyk, D; Ma, Q; Schwartz, M; Scully, K; Li, WB; Liu, ZJ; Taylor, H; Tollkuhn, J; Ohgi, KA; Notani, D; Kohwi, Y; Kohwi-Shigematsu, T; Rosenfeld, MG				Skowronska-Krawczyk, Dorota; Ma, Qi; Schwartz, Michal; Scully, Kathleen; Li, Wenbo; Liu, Zhijie; Taylor, Havilah; Tollkuhn, Jessica; Ohgi, Kenneth A.; Notani, Dimple; Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi; Rosenfeld, Michael G.			Required enhancer-matrin-3 network interactions for a homeodomain transcription program	NATURE			English	Article							NUCLEAR-MATRIX; ATTACHMENT REGION; DNA; PROTEIN; DOMAIN; PIT-1; ORGANIZATION; SCAFFOLD; GENOME; SATB1	Homeodomain proteins, described 30 years ago(1,2), exert essential roles in development as regulators of target gene expression(3,4); however, the molecular mechanisms underlying transcriptional activity of homeodomain factors remain poorly understood. Here investigation of a developmentally required POU-homeodomain transcription factor, Pit1 (also known as Pou1f1), has revealed that, unexpectedly, binding of Pit1-occupied enhancers(5) to a nuclear matrin-3-rich network/architecture(6,7) is a key event in effective activation of the Pit1-regulated enhancer/coding gene transcriptional program. Pit1 association with Satb1 (ref. 8) and beta-catenin is required for this tethering event. A naturally occurring, dominant negative, point mutation in human PIT1(R271W), causing combined pituitary hormone deficiency(9), results in loss of Pit1 association with beta-catenin and Satb1 and therefore the matrin-3-rich network, blocking Pit1-dependent enhancer/coding target gene activation. This defective activation can be rescued by artificial tethering of the mutant R271W Pit1 protein to the matrin-3 network, bypassing the pre-requisite association with beta-catenin and Satb1 otherwise required. The matrin-3 network-tethered R271W Pit1 mutant, but not the untethered protein, restores Pit1-dependent activation of the enhancers and recruitment of co-activators, exemplified by p300, causing both enhancer RNA transcription and target gene activation. These studies have thus revealed an unanticipated homeodomain factor/beta-catenin/Satb1-dependent localization of targetgene regulatory enhancer regions to a subnuclear architectural structure that serves as an underlying mechanism by which an enhancer-bound homeodomain factor effectively activates developmental gene transcriptional programs.	[Skowronska-Krawczyk, Dorota; Ma, Qi; Schwartz, Michal; Scully, Kathleen; Li, Wenbo; Liu, Zhijie; Taylor, Havilah; Tollkuhn, Jessica; Ohgi, Kenneth A.; Notani, Dimple; Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, Sch Med, La Jolla, CA 92093 USA; [Schwartz, Michal] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel; [Kohwi, Yoshinori; Kohwi-Shigematsu, Terumi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; Bar Ilan University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, Sch Med, La Jolla, CA 92093 USA.	dkrawczyk@ucsd.edu; mrosenfeld@ucsd.edu	li, wenbo/GZM-8930-2022; Ma, Qi/C-9716-2015	Tollkuhn, Jessica/0000-0001-5991-7620; Schwartz, Michal/0000-0001-5442-0201; Notani, Dimple/0000-0002-9460-8070; Ma, Qi/0000-0002-8705-4460	UCSD Neuroscience Microscopy Shared Facility [P30 NS047101]; NIH [NS034934, DK039949, DK018477, HL065445, CA173903]; EMBO Long Term Fellowship; Swiss National Science Foundation; San Diego Foundation; NATIONAL CANCER INSTITUTE [R01CA173903, P30CA023100, R37CA039681] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018477, R37DK039949, R01DK039949, P01DK074868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934, R01NS048243, P30NS047101] Funding Source: NIH RePORTER	UCSD Neuroscience Microscopy Shared Facility; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO Long Term Fellowship(European Molecular Biology Organization (EMBO)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); San Diego Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Ghassemian for assistance with mass spectrometry; C. Nelson for cell culture assistance; J. Hightower for assistance with figures and manuscript preparation; T. Suter for help with images analysis. We acknowledge J. Santini and the UCSD Neuroscience Microscopy Shared Facility (Grant P30 NS047101) for imaging. These studies were supported by grants NS034934, DK039949, DK018477, HL065445, CA173903 to M.G.R. from NIH. D.S.-K. was supported by EMBO Long Term Fellowship, The Swiss National Science Foundation and The San Diego Foundation. M.G.R. is an Investigator with HHMI.	Affolter M, 1990, CURR OPIN CELL BIOL, V2, P485, DOI 10.1016/0955-0674(90)90132-X; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; Gasser SM, 1998, CHROMATIN PRACTICAL, P111; Gibcus JH, 2013, MOL CELL, V49, P773, DOI 10.1016/j.molcel.2013.02.011; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Mancini MG, 1999, J CELL BIOCHEM, V72, P322, DOI 10.1002/(SICI)1097-4644(19990301)72:3<322::AID-JCB2>3.3.CO;2-0; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MIRKOVITCH J, 1984, CELL, V39, P223, DOI 10.1016/0092-8674(84)90208-3; NAKAYASU H, 1991, P NATL ACAD SCI USA, V88, P10312, DOI 10.1073/pnas.88.22.10312; Nickerson JA, 2001, J CELL SCI, V114, P463; Notani D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000296; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Prince KL, 2011, NAT REV ENDOCRINOL, V7, P727, DOI 10.1038/nrendo.2011.119; RADOVICK S, 1992, SCIENCE, V257, P1115, DOI 10.1126/science.257.5073.1115; Reeves R, 2001, GENE, V277, P63, DOI 10.1016/S0378-1119(01)00689-8; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; S'iakste N I, 2001, Mol Biol (Mosk), V35, P739; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Xu L, 1998, NATURE, V395, P301, DOI 10.1038/26270; Zeitz MJ, 2009, J CELL BIOCHEM, V108, P125, DOI 10.1002/jcb.22234; Zhu XY, 2007, CURR OPIN CELL BIOL, V19, P605, DOI 10.1016/j.ceb.2007.09.011	33	45	46	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					257	+		10.1038/nature13573	http://dx.doi.org/10.1038/nature13573			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119036	Green Accepted, Green Submitted			2022-12-28	WOS:000342663100048
J	Van Nostrand, JL; Brady, CA; Jung, HY; Fuentes, DR; Kozak, MM; Johnson, TM; Lin, CY; Lin, CJ; Swiderski, DL; Vogel, H; Bernstein, JA; Attie-Bitach, T; Chang, CP; Wysocka, J; Martin, DM; Attardi, LD				Van Nostrand, Jeanine L.; Brady, Colleen A.; Jung, Heiyoun; Fuentes, Daniel R.; Kozak, Margaret M.; Johnson, Thomas M.; Lin, Chieh-Yu; Lin, Chien-Jung; Swiderski, Donald L.; Vogel, Hannes; Bernstein, Jonathan A.; Attie-Bitach, Tania; Chang, Ching-Pin; Wysocka, Joanna; Martin, Donna M.; Attardi, Laura D.			Inappropriate p53 activation during development induces features of CHARGE syndrome	NATURE			English	Article							NEURAL CREST; EMBRYONIC LETHALITY; PHENOTYPIC SPECTRUM; TUMOR SUPPRESSION; CHD7 MUTATIONS; MICE; GENE; INHIBITION; EXPRESSION; ANOMALIES	CHARGE syndrome is a multiple anomaly disorder in which patients present with a variety of phenotypes, including ocular coloboma, heart defects, choanal atresia, retarded growth and development, genitourinary hypoplasia and ear abnormalities(1). Despite 70-90% of CHARGE syndrome cases resulting from mutations in the gene CHD7, which encodes an ATP-dependent chromatin remodeller, the pathways underlying the diverse phenotypes remain poorly understood(2). Surprisingly, our studies of a knock-in mutant mouse strain that expresses a stabilized and transcriptionally dead variant of the tumour-suppressor protein p53 (p53(25,26,53,54))(3), along with a wild-type allele ofp53 (also known as Trp53), revealed late-gestational embryonic lethality associated with a host of phenotypes that are characteristic of CHARGE syndrome, including coloboma, inner and outer ear malformations, heart outflow tract defects and craniofacial defects. We found that the p53(25,26,53,54) mutant protein stabilized and hyperactivated wildtype p53, which then inappropriately induced its target genes and triggered cell-cycle arrest or apoptosis during development. Importantly, these phenotypes were only observed with a wild-type p53 allele, as p53(25,26,53,54/-) embryos were fully viable. Furthermore, we found that CHD7 can bind to the p53 promoter, thereby negatively regu-lating p53 expression, and that CHD7 loss in mouse neural crest cells or samples from patients with CHARGE syndrome results in p53 activation. Strikingly, we found that p53 heterozygosity partially rescued the phenotypes in Chd7-null mouse embryos, demonstrating that p53 contributes to the phenotypes that result from CHD7 loss. Thus, inappropriate p53 activation during development can promote CHARGE phenotypes, supporting the idea that p53 has a critical role in developmental syndromes and providing important insight into the mechanisms underlying CHARGE syndrome.	[Van Nostrand, Jeanine L.; Brady, Colleen A.; Jung, Heiyoun; Kozak, Margaret M.; Johnson, Thomas M.; Attardi, Laura D.] Stanford Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Fuentes, Daniel R.; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Lin, Chieh-Yu; Vogel, Hannes] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Lin, Chien-Jung; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Swiderski, Donald L.] Univ Michigan, Sch Med, Dept Otolaryngol, Ann Arbor, MI 48109 USA; [Bernstein, Jonathan A.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Attie-Bitach, Tania] Hop Necker Enfants Malad, APHP, Dept Genet, F-75015 Paris, France; [Attie-Bitach, Tania] Univ Paris Descartes Sorbonne Paris Cite, Inst Imagine, Unite INSERM U1163, F-75015 Paris, France; [Chang, Ching-Pin] Indiana Univ Sch Med, Krannert Inst Cardiol, Indianapolis, IN 46202 USA; [Martin, Donna M.] Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA; [Martin, Donna M.] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA; [Attardi, Laura D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Michigan System; University of Michigan; Stanford University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Indiana University System; Indiana University Bloomington; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Stanford University	Attardi, LD (corresponding author), Stanford Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA.	attardi@stanford.edu	ATTIE-BITACH, Tania/K-1453-2017	ATTIE-BITACH, Tania/0000-0002-1155-3626; Fuentes, Daniel/0000-0002-0412-6933; Vogel, Otto Hannes/0000-0002-0960-3508; Van Nostrand, Jeanine/0000-0003-1363-9527; Kozak, Margaret/0000-0001-9111-1942	NSF; NCI [1F31CA167917-01]; NIH [RO1 GM095555, R01 HL118087, RO1 HL121197, R01 DC009410, RO1 CA140875]; American Heart Association [12EIA8960018]; March of Dimes Foundation [6-FY11-260]; ACS; LLS; NATIONAL CANCER INSTITUTE [R01CA140875, T32CA009302, F31CA167917] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118087, R01HL121197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095555] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009410] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); March of Dimes Foundation(March of Dimes); ACS(American Cancer Society); LLS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank S. Spano-Mello, K. T. Bieging, N. Raj and M. Monje-Deisseroth for reading the manuscript and S. E. Artandi and T. Williams for discussion. We thank H. Chou for immunohistochemistry assistance; E. L. Van Nostrand, P. Lavori, and A. McMillian for statistical analysis; K. Weinberg and D. Min for thymus analysis assistance; M. Shkreli for kidney analysis assistance; B. Liu and J. A. Helms for craniofacial analysis assistance; and M. Bowen for Chd7 mouse experiment assistance. We thank S. E. Artandi for plasmids; S. E. Artandi and P. Khavari for control human fibroblast cell lines; D. Lane and B. Vojtesek for wild-type p53-specific antibody (pAB242); P. Scacheri for wild-type and Chd7-null mouse embryonic stem cells; and T. Denecker and G. Goudefroye for TP53 sequencing in patients. This work was supported by funding from the NSF and NCI (grant number 1F31CA167917-01) to J.L.V.N.; from the NIH (RO1 GM095555) to J.W.; from the American Heart Association (12EIA8960018), March of Dimes Foundation (#6-FY11-260) and NIH (R01 HL118087 and RO1 HL121197) to C.-P.C.; from the NIH (R01 DC009410) to D. M. M.; and from the ACS, LLS and NIH (RO1 CA140875) to L.D.A.	Adams ME, 2007, J COMP NEUROL, V504, P519, DOI 10.1002/cne.21460; ARMSTRONG JF, 1995, CURR BIOL, V5, P931, DOI 10.1016/S0960-9822(95)00183-7; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Balow SA, 2013, DEV BIOL, V382, P57, DOI 10.1016/j.ydbio.2013.07.026; Bosman EA, 2005, HUM MOL GENET, V14, P3463, DOI 10.1093/hmg/ddi375; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Brock KE, 2003, AM J MED GENET A, V123A, P111, DOI 10.1002/ajmg.a.20526; Corsten-Janssen N, 2013, MOL SYNDROMOL, V4, P235, DOI 10.1159/000351127; Corsten-Janssen N, 2013, CIRC-CARDIOVASC GENE, V6, P248, DOI 10.1161/CIRCGENETICS.113.000054; DAVENPORT SLH, 1986, CLIN GENET, V29, P298; Hurd EA, 2007, MAMM GENOME, V18, P94, DOI 10.1007/s00335-006-0107-6; Hurd EA, 2010, DEVELOPMENT, V137, P3139, DOI 10.1242/dev.047894; Inoue H, 2010, EUR J PEDIATR, V169, P839, DOI 10.1007/s00431-009-1126-6; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Lalani SR, 2006, AM J HUM GENET, V78, P303, DOI 10.1086/500273; Lane DP, 1996, ONCOGENE, V12, P2461; Legendre M, 2012, J MED GENET, V49, P698, DOI 10.1136/jmedgenet-2012-100926; Lengner CJ, 2006, J CELL BIOL, V172, P909, DOI 10.1083/jcb.200508130; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Morimoto AK, 2006, AM J NEURORADIOL, V27, P1663; Rada-Iglesias A, 2012, CELL STEM CELL, V11, P633, DOI 10.1016/j.stem.2012.07.006; Ragan DC, 1999, J UROLOGY, V161, P622, DOI 10.1016/S0022-5347(01)61984-0; Rinon A, 2011, DEVELOPMENT, V138, P1827, DOI 10.1242/dev.053645; Sanlaville D, 2006, J MED GENET, V43, P211, DOI 10.1136/jmg.2005.036160; Sato TN, 2000, METH MOL B, V137, P223; Schnetz MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001023; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Zentner GE, 2010, AM J MED GENET A, V152A, P674, DOI 10.1002/ajmg.a.33323	35	98	98	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2014	514	7521					228	+		10.1038/nature13585	http://dx.doi.org/10.1038/nature13585			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3BG	25119037	Green Submitted, Green Accepted			2022-12-28	WOS:000342663100042
J	Asch, DA; Weinstein, DF				Asch, David A.; Weinstein, Debra F.			Innovation in Medical Education	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Asch, David A.] Univ Penn, Perelman Sch Med, Ctr Hlth Care Innovat, Philadelphia, PA 19104 USA; [Asch, David A.] Univ Penn, Wharton Sch, Philadelphia, PA 19104 USA; [Asch, David A.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Weinstein, Debra F.] Massachusetts Gen Hosp, Dept Med, Partners Hlth Care Syst, Boston, MA 02114 USA; [Weinstein, Debra F.] Harvard Univ, Sch Med, Boston, MA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Harvard Medical School	Asch, DA (corresponding author), Univ Penn, Perelman Sch Med, Ctr Hlth Care Innovat, Philadelphia, PA 19104 USA.			Asch, David/0000-0002-7970-286X				Asch DA, 2014, ACAD MED, V89, P24, DOI 10.1097/ACM.0000000000000067; Asch DA, 2009, JAMA-J AM MED ASSOC, V302, P1277, DOI 10.1001/jama.2009.1356; Eden J., 2014, GRADUATE MED ED MEET; NICHOLSON S, 2003, W9649 NBER; Weinstein DF, 2011, ENSURING EFFECTIVE P	5	68	68	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 28	2014	371	9					794	795		10.1056/NEJMp1407463	http://dx.doi.org/10.1056/NEJMp1407463			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AN7ZN	25075620				2022-12-28	WOS:000340819800004
J	Chalmers, J; Chalmers, I				Chalmers, Jan; Chalmers, Iain			Project A tapestry of Palestinian life: remembering Samar Alhallaq	LANCET			English	Editorial Material												pht@btinternet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 23	2014	384	9944					656	657		10.1016/S0140-6736(14)61223-X	http://dx.doi.org/10.1016/S0140-6736(14)61223-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AO5CJ	25110328	Bronze			2022-12-28	WOS:000341359100015
J	Rich, PD; Liaw, HP; Lee, AK				Rich, P. Dylan; Liaw, Hua-Peng; Lee, Albert K.			Large environments reveal the statistical structure governing hippocampal representations	SCIENCE			English	Article							PLACE FIELDS; SPATIAL REPRESENTATION; SINGLE NEURONS; CA1; CELLS; DYNAMICS; MEMORY; BEHAVIOR; RECALL; BRAIN	The rules governing the formation of spatial maps in the hippocampus have not been determined. We investigated the large-scale structure of place field activity by recording hippocampal neurons in rats exploring a previously unencountered 48-meter-long track. Single-cell and population activities were well described by a two-parameter stochastic model. Individual neurons had their own characteristic propensity for forming fields randomly along the track, with some cells expressing many fields andmany exhibiting fewor none. Because of the particular distribution of propensities across cells, the number of neurons with fields scaled logarithmically with track length over a wide, ethological range. These features constrain hippocampal memory mechanisms, may allow efficient encoding of environments and experiences of vastly different extents and durations, and could reflect general principles of population coding.	[Rich, P. Dylan; Liaw, Hua-Peng; Lee, Albert K.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Rich, P. Dylan] Univ Cambridge, Dept Psychol, Cambridge CB2 3EB, England	Howard Hughes Medical Institute; University of Cambridge	Rich, PD (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	richp@janelia.hhmi.org; leea@janelia.hhmi.org			Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank M. Karlsson, J. Osborne, M. Copeland, and J. Cox and the Vivarium staff for technical assistance and S. Druckmann, J. Dudman, A. Hantman, J. Cohen, and D. Lee for valuable comments on the manuscript. All primary electrophysiological and behavioral data are archived at the Janelia Farm Research Campus. This work was supported by the Howard Hughes Medical Institute.	Buzsaki G, 2014, NAT REV NEUROSCI, V15, P264, DOI 10.1038/nrn3687; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; DAVIS DE, 1948, J MAMMAL, V29, P207, DOI 10.2307/1375387; Dragoi G, 2011, NATURE, V469, P397, DOI 10.1038/nature09633; Epsztein J, 2011, NEURON, V70, P109, DOI 10.1016/j.neuron.2011.03.006; Fenton AA, 2008, J NEUROSCI, V28, P11250, DOI 10.1523/JNEUROSCI.2862-08.2008; Gelbard-Sagiv H, 2008, SCIENCE, V322, P96, DOI 10.1126/science.1164685; Greenwood M, 1920, J ROY STATIST SOC  A, V83, P255; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Hollup SA, 2001, J NEUROSCI, V21, P1635, DOI 10.1523/JNEUROSCI.21-05-01635.2001; Jarsky T, 2008, J COMP NEUROL, V506, P535, DOI 10.1002/cne.21564; Karlsson MP, 2008, J NEUROSCI, V28, P14271, DOI 10.1523/JNEUROSCI.4261-08.2008; Kjelstrup KB, 2008, SCIENCE, V321, P140, DOI 10.1126/science.1157086; Lee D, 2012, SCIENCE, V337, P849, DOI 10.1126/science.1221489; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lundberg O., 1940, RANDOM PROCESSES THE; MILNERBR.HS, 1973, J PHYSIOL-LONDON, V230, P359, DOI 10.1113/jphysiol.1973.sp010192; Mizuseki K, 2011, NAT NEUROSCI, V14, P1174, DOI 10.1038/nn.2894; Muniak MA, 2007, J NEUROSCI, V27, P11687, DOI 10.1523/JNEUROSCI.1486-07.2007; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Silva AJ, 2009, SCIENCE, V326, P391, DOI 10.1126/science.1174519; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Tsodyks M, 1995, INT J NEURAL SYS S, V6, P81; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	31	81	81	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					814	817		10.1126/science.1255635	http://dx.doi.org/10.1126/science.1255635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124440				2022-12-28	WOS:000340593100045
J	Markov, IL				Markov, Igor L.			Limits on fundamental limits to computation	NATURE			English	Review							PHYSICAL LIMITS; MOORES LAW; POWER; INFORMATION; ALGORITHMS; CHALLENGES; IMPACT	An indispensable part of our personal and working lives, computing has also become essential to industries and governments. Steady improvements in computer hardware have been supported by periodic doubling of transistor densities in integrated circuits over the past fifty years. Such Moore scaling now requires ever-increasing efforts, stimulating research in alternative hardware and stirring controversy. To help evaluate emerging technologies and increase our understanding of integrated-circuit scaling, here I review fundamental limits to computation in the areas of manufacturing, energy, physical space, design and verification effort, and algorithms. To outline what is achievable in principle and in practice, I recapitulate how some limits were circumvented, and compare loose and tight limits. Engineering difficulties encountered by emerging technologies may indicate yet unknown limits.	[Markov, Igor L.] Univ Michigan, Dept EECS, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Markov, IL (corresponding author), Google Inc, 1600 Amphitheatre Pkwy, Mountain View, CA 94043 USA.	imarkov@eecs.umich.edu			Semiconductor Research Corporation (SRC) - Intel [2264.001]; Semiconductor Research Corporation (SRC) - IBM [2264.001]; US Airforce Research Laboratory [FA8750-11-2-0043]; US National Science Foundation (NSF) [1162087]; Division of Computing and Communication Foundations [1162087] Funding Source: National Science Foundation	Semiconductor Research Corporation (SRC) - Intel; Semiconductor Research Corporation (SRC) - IBM; US Airforce Research Laboratory(United States Department of DefenseUS Air Force Research Laboratory); US National Science Foundation (NSF)(National Science Foundation (NSF)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported in part by the Semiconductor Research Corporation (SRC) Task 2264.001 (funded by Intel and IBM), a US Airforce Research Laboratory award (FA8750-11-2-0043), and a US National Science Foundation (NSF) award (1162087).	Aaronson S, 2004, J ACM, V51, P595, DOI 10.1145/1008731.1008735; Aaronson S., 2009, ACM T COMPLEXITY THE, V1; Aaronson Scott, 2005, ACM SIGACT NEWS, V36, P30; Adya SN, 2006, INTEGRATION, V39, P340, DOI 10.1016/j.vlsi.2005.08.003; AHARONOV Y, 1961, PHYS REV, V122, P1649, DOI 10.1103/PhysRev.122.1649; Almeida VR, 2004, NATURE, V431, P1081, DOI 10.1038/nature02921; Amdahl GM, 2013, COMPUTER, V46, P38, DOI 10.1109/MC.2013.418; Andreesen M., 2011, WALL STREET J; [Anonymous], 2010, P 19 INT S PHYS DES, DOI DOI 10.1145/1735023.1735037; [Anonymous], 2004, LAUR041778; [Anonymous], 2002, APPROXIMATION ALGORI; Asenov A, 1998, IEEE T ELECTRON DEV, V45, P2505, DOI 10.1109/16.735728; Avigad J, 2014, COMMUN ACM, V57, P66, DOI 10.1145/2591012; Bachrach J., 2007, MITCSAILTR2007017; Balasubramonian R., 2011, MULTI CORE CACHE HIE; Barroso L. A., 2013, SYNTHESIS LECT COMPU, V8, P1; BENNETT CH, 1985, SCI AM, V253, P48, DOI 10.1038/scientificamerican0785-48; Berut A, 2012, NATURE, V483, P187, DOI 10.1038/nature10872; Blencowe MP, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.052104; Bohr M., 2007, IEEE SOLID STATE CIR, V12, P11, DOI [DOI 10.1109/N-SSC.2007.4785534, 10.1109/N-SSC.2007.4785534]; Bohr MT, 1995, INTERNATIONAL ELECTRON DEVICES MEETING, 1995 - IEDM TECHNICAL DIGEST, P241, DOI 10.1109/IEDM.1995.499187; Borkar S, 2007, DES AUT CON, P746, DOI 10.1109/DAC.2007.375263; Brewer E, 2012, COMPUTER, V45, P23, DOI 10.1109/MC.2012.37; Cavin RK, 2012, P IEEE, V100, P1720, DOI 10.1109/JPROC.2012.2190155; Chang MCF, 2001, P IEEE, V89, P456, DOI 10.1109/5.920578; Chien AA, 2013, COMPUTER, V46, P48, DOI 10.1109/MC.2013.431; Chinnery D., 2007, CLOSING POWER GAP AS; Chinnery David, 2004, CLOSING GAP ASIC CUS; Cong J, 2011, IEEE DES TEST COMPUT, V28, P6, DOI 10.1109/MDT.2010.141; Davis JA, 2001, P IEEE, V89, P305, DOI 10.1109/5.915376; Dean J, 2013, COMMUN ACM, V56, P74, DOI 10.1145/2408776.2408794; Demmel J, 2013, INT PARALL DISTRIB P, P585, DOI 10.1109/IPDPS.2013.123; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Dreslinski RG, 2010, P IEEE, V98, P253, DOI 10.1109/JPROC.2009.2034764; Dror RO, 2011, IEEE MICRO, V31, P8, DOI 10.1109/MM.2011.38; Esmaeilzadeh H, 2013, COMMUN ACM, V56, P93, DOI 10.1145/2408776.2408797; FISHER DC, 1988, IEEE T COMPUT, V37, P211, DOI 10.1109/12.2150; Fortnow L, 2009, COMMUN ACM, V52, P78, DOI 10.1145/1562164.1562186; Getov V, 2013, COMPUTER, V46, P24, DOI 10.1109/MC.2013.421; Halfill T. R., 2010, MICROPROCESSOR REPOR; Hameed R, 2011, COMMUN ACM, V54, P85, DOI 10.1145/2001269.2001291; Herken R., 2013, UNIVERSAL TURING MAC; Hisamoto D, 2000, IEEE T ELECTRON DEV, V47, P2320, DOI 10.1109/16.887014; Ho R., 1999, 1999 IEEE/ACM International Conference on Computer-Aided Design. Digest of Technical Papers (Cat. No.99CH37051), P425, DOI 10.1109/ICCAD.1999.810688; Jain R, 2010, COMMUN ACM, V53, P102, DOI 10.1145/1859204.1859231; Kim S, 2005, IEEE T COMPUT, V54, P651, DOI 10.1109/TC.2005.91; Krauss L. M., 2004, UNIVERSAL LIMITS COM; LANDAUER R, 1961, IBM J RES DEV, V5, P183, DOI 10.1147/rd.53.0183; Lavagno L., 2006, ELECT DESIGN AUTOMAT; Lee YJ, 2012, ICCAD-IEEE ACM INT, P539; Lloyd S, 2000, NATURE, V406, P1047, DOI 10.1038/35023282; Ma X., 2011, COMPUTATIONAL LITHOG; Mak WK, 2012, IEEE T VLSI SYST, V20, P2346, DOI 10.1109/TVLSI.2011.2176353; Markov I. L, 2003, IEEE T CAD, V22, P716; Markov IL, 2012, ICCAD-IEEE ACM INT, P275; Markov IL., 2013, IEEE DESIGN TEST, V30, P78, DOI 10.1109/MDAT.2012.2237133; Mazzola L, 2003, NAT BIOTECHNOL, V21, P1137, DOI 10.1038/nbt1003-1137; MEINDL JD, 1995, P IEEE, V83, P619, DOI 10.1109/5.371970; Mernik M, 2005, ACM COMPUT SURV, V37, P316, DOI 10.1145/1118890.1118892; Metcalfe B, 2013, COMPUTER, V46, P26, DOI 10.1109/MC.2013.374; Miranda M., 2012, IEEE SPECTRUM; Monroe C, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.022317; Moore G. E., 1965, ELECTRONICS, V38, P1, DOI DOI 10.1109/JPROC.1998.658762; Naeemi A., 2014, P 51 ANN DES AUT C, P1; Nielsen M. A., 2011, QUANTUM COMPUTATION, DOI DOI 10.1017/CBO9780511976667; Oestergaard J, 2001, IEEE T APPL SUPERCON, V11, P2375, DOI 10.1109/77.920339; Olukotun K., 2014, P S PRINC PRACT PAR; Ozdal MM, 2012, IEEE T COMPUT AID D, V31, P1558, DOI 10.1109/TCAD.2012.2196279; Padua D., 2011, ENCY PARALLEL COMPUT, DOI 10.1007/978-0-387-09766-4_2219; Patil D, 2007, P S COMP ARITHM, P16, DOI 10.1109/ARITH.2007.31; PENDRY JB, 1983, J PHYS A-MATH GEN, V16, P2161, DOI 10.1088/0305-4470/16/10/012; Pinckney N, 2013, IEEE MICRO, V33, P30, DOI 10.1109/MM.2013.73; Puri R., 2013, P ACM ISPD NEW YORK, P179; Rabaey J.M., 2003, DIGITAL INTEGRATED C; Ren J, 2011, IEEE T APPL SUPERCON, V21, P780, DOI 10.1109/TASC.2011.2104352; Ronnow T. F., 2014, SCIENCE, V20, P1330; Rosenbaum D, 2012, 8 C THEOR QUANT COMP, P294; Rosenbaum D., OPTIMAL QUANTUM CIRC; Rutenbar R. A., 2006, P IEEE ACM INT C COM, P458; Ryan PS, 2013, COMPUTER, V46, P54, DOI 10.1109/MC.2013.402; Saeedi M, 2013, ACM COMPUT SURV, V45, DOI 10.1145/2431211.2431220; Sangiovanni-Vincentelli A, 2004, DES AUT CON, P409, DOI 10.1145/996566.996684; Saxena P, 2004, IEEE T COMPUT AID D, V23, P451, DOI 10.1109/TCAD.2004.825841; Seabaugh A, 2013, IEEE SPECTRUM; Shaw D. E., 2013, P INT S HIGH PERF DI, P129; Shelar RS, 2013, IEEE T COMPUT AID D, V32, P1623, DOI 10.1109/TCAD.2013.2266404; Sherwin MS, 1999, PHYS REV A, V60, P3508, DOI 10.1103/PhysRevA.60.3508; Shin S. W., 2014, QUANTUM IS D WAVE MA; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Simonite T., 2013, MIT TECHNOL REV 0904; Sipser M, 2013, CENGAGE LEARNING, V3rd; Spielman D., 2001, P S THEOR COMP; Sylvester D, 2000, IEEE T COMPUT AID D, V19, P242, DOI 10.1109/43.828553; Taylor MB, 2012, DES AUT CON, P1131; Wenisch TF, 2012, IEEE MICRO, V32, P6, DOI 10.1109/MM.2012.78; Whitney RS, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.130601; Wolf SA, 2001, SCIENCE, V294, P1488, DOI 10.1126/science.1065389; Yeraswork Z, 2013, EE TIMES; Zhirnov VV, 2003, P IEEE, V91, P1934, DOI 10.1109/JPROC.2003.818324	99	224	226	12	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 14	2014	512	7513					147	154		10.1038/nature13570	http://dx.doi.org/10.1038/nature13570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM9KO	25119233	Green Submitted			2022-12-28	WOS:000340200700022
J	Deutsch, C; Berelson, W; Thunell, R; Weber, T; Tems, C; McManus, J; Crusius, J; Ito, T; Baumgartner, T; Ferreira, V; Mey, J; van Geen, A				Deutsch, Curtis; Berelson, William; Thunell, Robert; Weber, Thomas; Tems, Caitlin; McManus, James; Crusius, John; Ito, Taka; Baumgartner, Timothy; Ferreira, Vicente; Mey, Jacob; van Geen, Alexander			Centennial changes in North Pacific anoxia linked to tropical trade winds	SCIENCE			English	Article							ARABIAN SEA; OCEAN; DENITRIFICATION; VARIABILITY; HYPOXIA; PRESERVATION; CIRCULATION; DIAGENESIS; SEDIMENTS; DRIVEN	Climate warming is expected to reduce oxygen (O-2) supply to the ocean and expand its oxygen minimum zones (OMZs). We reconstructed variations in the extent of North Pacific anoxia since 1850 using a geochemical proxy for denitrification (delta N-15) from multiple sediment cores. Increasing delta N-15 since similar to 1990 records an expansion of anoxia, consistent with observed O-2 trends. However, this was preceded by a longer declining delta N-15 trend that implies that the anoxic zone was shrinking for most of the 20th century. Both periods can be explained by changes in winds over the tropical Pacific that drive upwelling, biological productivity, and O-2 demand within the OMZ. If equatorial Pacific winds resume their predicted weakening trend, the ocean's largest anoxic zone will contract despite a global O-2 decline.	[Deutsch, Curtis; Weber, Thomas] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Berelson, William; Tems, Caitlin] Univ So Calif, Dept Earth Sci, Los Angeles, CA USA; [Thunell, Robert] Univ S Carolina, Dept Earth & Ocean Sci, Columbia, SC 29208 USA; [McManus, James] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Crusius, John] Univ Washington, Sch Oceanog, US Geol Survey, Seattle, WA 98195 USA; [Ito, Taka] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Baumgartner, Timothy; Ferreira, Vicente] Ctr Invest Cient & Educ Super Ensenada, Dept Oceanog Biol, Ensenada, Baja California, Mexico; [Mey, Jacob; van Geen, Alexander] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Mey, Jacob] CUNY, Kingsborough Community Coll, Dept Phys Sci, New York, NY 10021 USA	University of Washington; University of Washington Seattle; University of Southern California; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Oregon State University; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; University System of Georgia; Georgia Institute of Technology; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada; Columbia University; City University of New York (CUNY) System	Deutsch, C (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	cdeutsch@uw.edu	Ito, Takamitsu/F-3856-2010; McManus, James/GSM-7165-2022; Mey, Jacob/D-5957-2014	Ito, Takamitsu/0000-0001-9873-099X; Mey, Jacob/0000-0003-0116-4149	National Science Foundation [OCE-0851483, OCE-1242313, OCE-0727123, OCE-0624777]; Gordon and Betty Moore Foundation [GBMF3775]; U.S. Geological Survey Coastal and Marine Geology Program; Climate Center of Lamont-Doherty Earth Observatory (LDEO); Division Of Ocean Sciences [1232779] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); U.S. Geological Survey Coastal and Marine Geology Program(United States Geological Survey); Climate Center of Lamont-Doherty Earth Observatory (LDEO); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by grants from the National Science Foundation (OCE-0851483 to C.D.; OCE-1242313 to T.I.; OCE-0727123 to W.B.; OCE-0624777 to J.M.), by the Gordon and Betty Moore Foundation through Grant GBMF3775 to C.D., and by the U.S. Geological Survey Coastal and Marine Geology Program (J.C.). A grant from the Climate Center of Lamont-Doherty Earth Observatory (LDEO) contributed to the collection and dating of the Soledad Basin core. This is LDEO contribution number 7812.	Allan R, 2006, J CLIMATE, V19, P5816, DOI 10.1175/JCLI3937.1; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; ALTABET MA, 1989, J GEOPHYS RES-OCEANS, V94, P12771, DOI 10.1029/JC094iC09p12771; Antonov J. I., 2010, NOAA ATLAS NESDROS I, V66; Bopp L, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001445; Bopp L, 2013, BIOGEOSCIENCES, V10, P6225, DOI 10.5194/bg-10-6225-2013; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; Castro CG, 2001, GLOBAL BIOGEOCHEM CY, V15, P819, DOI 10.1029/2000GB001324; Chan F, 2008, SCIENCE, V319, P920, DOI 10.1126/science.1149016; CODISPOTI LA, 1985, MAR CHEM, V16, P277, DOI 10.1016/0304-4203(85)90051-9; Deutsch C, 2011, SCIENCE, V333, P336, DOI 10.1126/science.1202422; DeVries T, 2012, NAT GEOSCI, V5, P547, DOI [10.1038/ngeo1515, 10.1038/NGEO1515]; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; England MH, 2014, NAT CLIM CHANGE, V4, P222, DOI [10.1038/NCLIMATE2106, 10.1038/nclimate2106]; Ganeshram RS, 2000, PALEOCEANOGRAPHY, V15, P361, DOI 10.1029/1999PA000422; Ito T, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041595; Ito T, 2013, GLOBAL BIOGEOCHEM CY, V27, P1119, DOI 10.1002/2013GB004567; Jaccard SL, 2012, NAT GEOSCI, V5, P151, DOI [10.1038/ngeo1352, 10.1038/NGEO1352]; Keeling RF, 2010, ANNU REV MAR SCI, V2, P199, DOI 10.1146/annurev.marine.010908.163855; Kienast SS, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000650; Koslow JA, 2013, NATURE, V502, P163, DOI 10.1038/502163a; Kritee K, 2012, GEOCHIM COSMOCHIM AC, V92, P243, DOI 10.1016/j.gca.2012.05.020; Lehmann MF, 2002, GEOCHIM COSMOCHIM AC, V66, P3573, DOI 10.1016/S0016-7037(02)00968-7; Matear RJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001997; McClatchie S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044497; Merrifield MA, 2011, J CLIMATE, V24, P4126, DOI 10.1175/2011JCLI3932.1; Prokopenko MG, 2006, EARTH PLANET SC LETT, V242, P186, DOI 10.1016/j.epsl.2005.11.044; Sherwood OA, 2014, NATURE, V505, P78, DOI 10.1038/nature12784; Sigman D. M., 2001, ENCY OCEAN SCI, V4, P1884; Sigman DM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035784; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Stramma L, 2008, SCIENCE, V320, P655, DOI 10.1126/science.1153847; Thunell RC, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI [10.1029/2002GB002028, 10.1029/2003GB002185]; Tokinaga H, 2012, NATURE, V491, P439, DOI 10.1038/nature11576; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; van Geen A, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000911; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Vecchi GA, 2006, NATURE, V441, P73, DOI 10.1038/nature04744; Weber T, 2014, P NATL ACAD SCI USA, V111, P8741, DOI 10.1073/pnas.1317193111	39	106	106	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					665	668		10.1126/science.1252332	http://dx.doi.org/10.1126/science.1252332			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104384				2022-12-28	WOS:000339962800037
J	You, Z				You, Zhong			MATERIALS DESIGN Folding structures out of flat materials	SCIENCE			English	Editorial Material							MEMBRANES; ORIGAMI		Univ Oxford, Dept Engn Sci, Oxford OX3 0PL, England	University of Oxford	You, Z (corresponding author), Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX3 0PL, England.	zhong.you@eng.ox.ac.uk						Felton S, 2014, SCIENCE, V345, P644, DOI 10.1126/science.1252610; Gattas, 2013, THESIS OXFORD U UK; Heimbs S., 2013, DYNAMIC FAILURE COMP, P491, DOI [10.1007/978-94-007-5329-7_11, DOI 10.1007/978-94-007-5329-7_11]; Kuribayashi-Shigetomi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051085; Ma JY, 2014, J APPL MECH-T ASME, V81, DOI 10.1115/1.4024405; Nojima T, 2002, JSME INT J C-MECH SY, V45, P364, DOI 10.1299/jsmec.45.364; Pickett GT, 2007, EPL-EUROPHYS LETT, V78, DOI 10.1209/0295-5075/78/48003; Silverberg JL, 2014, SCIENCE, V345, P647, DOI 10.1126/science.1252876; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Yim M., 2009, ENCY COMPLEXITY SYST, P5618, DOI [10.1007/978-0-387-30440-3_334, DOI 10.1007/978-0-387-30440-3_334, 10.1007/978-0-387-30440-3334, DOI 10.1007/978-0-387-30440-3334]	10	40	41	8	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					623	624		10.1126/science.1257841	http://dx.doi.org/10.1126/science.1257841			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104372				2022-12-28	WOS:000339962800020
J	Sanchez-Valencia, JR; Dienel, T; Groning, O; Shorubalko, I; Mueller, A; Jansen, M; Amsharov, K; Ruffieux, P; Fasel, R				Sanchez-Valencia, Juan Ramon; Dienel, Thomas; Groening, Oliver; Shorubalko, Ivan; Mueller, Andreas; Jansen, Martin; Amsharov, Konstantin; Ruffieux, Pascal; Fasel, Roman			Controlled synthesis of single-chirality carbon nanotubes	NATURE			English	Article							SURFACE-CATALYZED CYCLODEHYDROGENATION; CAP PRECURSOR MOLECULES; GROWTH-MECHANISM; AROMATIC PRECURSORS; FULLERENES; SEPARATION; NANORINGS; MODES; METAL	Over the past two decades, single-walled carbon nanotubes (SWCNTs) have received much attention because their extraordinary properties are promising for numerous applications(1,2). Many of these properties depend sensitively on SWCNT structure, which is characterized by the chiral index (n,m) that denotes the length and orientation of the circumferential vector in the hexagonal carbon lattice. Electronic properties are particularly strongly affected, with subtle structural changes switching tubes from metallic to semiconducting with various band-gaps. Monodisperse 'single-chirality' (that is, with a single (n, m) index) SWCNTs are thus needed to fully exploit their technological potential(1,2). Controlled synthesis through catalyst engineering(3-6), end-cap engineering(7) or cloning strategies(8,9), and also tube sorting based on chromatography(10,11), density-gradient centrifugation, electrophoresis and other techniques(12), have delivered SWCNT samples with narrow distributions of tube diameter and a large fraction of a predetermined tube type. But an effective pathway to truly monodisperse SWCNTs remains elusive. The use of template molecules to unambiguously dictate the diameter and chirality of the resulting nanotube(8,13-16) holds great promise in this regard, but has hitherto had only limited practical success(7,17,18). Here we show that this bottom-up strategy can produce targeted nanotubes: we convert molecular precursors into ultrashort singly capped (6,6) 'armchair' nanotube seeds using surface-catalysed cyclodehydrogenation on a platinum (111) surface, and then elongate these during a subsequent growth phase to produce single-chirality and essentially defect-free SWCNTs with lengths up to a few hundred nanometres. We expect that our on-surface synthesis approach will provide a route to nanotube-based materials with highly optimized properties for applications such as light detectors, photovoltaics, field-effect transistors and sensors(2).	[Sanchez-Valencia, Juan Ramon; Dienel, Thomas; Groening, Oliver; Ruffieux, Pascal; Fasel, Roman] Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-8600 Dubendorf, Switzerland; [Shorubalko, Ivan] Empa, Swiss Fed Labs Mat Sci & Technol, Lab Reliabil Sci & Technol, CH-8600 Dubendorf, Switzerland; [Mueller, Andreas; Jansen, Martin; Amsharov, Konstantin] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Fasel, Roman] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Max Planck Society; University of Bern	Fasel, R (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, Nanotech Surfaces Lab, CH-8600 Dubendorf, Switzerland.	konstantin.amsharov@fau.de; roman.fasel@empa.ch	Shorubalko, Ivan/AAT-5887-2021; Ruffieux, Pascal/E-8227-2010; Shorubalko, Ivan/E-1089-2011; Sanchez-Valencia, Juan Ramon/K-3253-2014; Gröning, Oliver/J-9727-2012; Fasel, Roman/B-5396-2011; Fasel, Roman/M-9992-2019; Dienel, Thomas/F-2356-2010	Shorubalko, Ivan/0000-0001-9868-7303; Ruffieux, Pascal/0000-0001-5729-5354; Shorubalko, Ivan/0000-0001-9868-7303; Sanchez-Valencia, Juan Ramon/0000-0003-2493-4433; Fasel, Roman/0000-0002-1553-6487; Fasel, Roman/0000-0002-1553-6487; Dienel, Thomas/0000-0001-8146-8841	Swiss National Science Foundation; State Secretariat for Education, Research and Innovation via the COST Action [MP0901]; Deutsche Forschungsgemeinschaft	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State Secretariat for Education, Research and Innovation via the COST Action; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This research was supported in part by the Swiss National Science Foundation and by the State Secretariat for Education, Research and Innovation via the COST Action MP0901 'NanoTP'. K.A. acknowledges financial support from Deutsche Forschungsgemeinschaft.	Amsharov K, 2010, ANGEW CHEM INT EDIT, V49, P9392, DOI 10.1002/anie.201005000; Bunz UHF, 2012, ANGEW CHEM INT EDIT, V51, P7094, DOI 10.1002/anie.201201494; Chiang WH, 2009, NAT MATER, V8, P882, DOI [10.1038/nmat2531, 10.1038/NMAT2531]; Dresselhaus MS, 2005, PHYS REP, V409, P47, DOI 10.1016/j.physrep.2004.10.006; Gavillet J, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.275504; He MSA, 2011, CHEM COMMUN, V47, P1219, DOI 10.1039/c0cc02751k; Hersam MC, 2008, NAT NANOTECHNOL, V3, P387, DOI 10.1038/nnano.2008.135; Hong G, 2012, CARBON, V50, P2067, DOI 10.1016/j.carbon.2012.01.035; Jariwala D, 2013, CHEM SOC REV, V42, P2824, DOI 10.1039/c2cs35335k; Jorio A, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.115411; Jorio A, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.075207; Jorio A., 2008, CARBON NANOTUBES ADV; Liu HP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1313; Mueller A, 2012, FULLER NANOTUB CAR N, V20, P401, DOI 10.1080/1536383X.2012.655215; Mueller A, 2012, EUR J ORG CHEM, V2012, P6155, DOI 10.1002/ejoc.201200841; Mueller A, 2010, TETRAHEDRON LETT, V51, P3221, DOI 10.1016/j.tetlet.2010.04.055; Omachi H, 2013, NAT CHEM, V5, P572, DOI [10.1038/nchem.1655, 10.1038/NCHEM.1655]; Omachi H, 2012, ACCOUNTS CHEM RES, V45, P1378, DOI 10.1021/ar300055x; Otero G, 2008, NATURE, V454, P865, DOI 10.1038/nature07193; Piscanec S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.035427; Rao AM, 1997, SCIENCE, V275, P187, DOI 10.1126/science.275.5297.187; Rim KT, 2007, ANGEW CHEM INT EDIT, V46, P7891, DOI 10.1002/anie.200701117; Smalley RE, 2006, J AM CHEM SOC, V128, P15824, DOI 10.1021/ja065767r; Soares J. S., 2012, J NANOTECHNOL, P1, DOI DOI 10.1155/2012/512738; Telg H, 2012, ACS NANO, V6, P904, DOI 10.1021/nn2044356; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Wang H, 2010, J AM CHEM SOC, V132, P16747, DOI 10.1021/ja106937y; Xu YQ, 2006, J AM CHEM SOC, V128, P6560, DOI 10.1021/ja060944+; Yao YG, 2009, NANO LETT, V9, P1673, DOI 10.1021/nl900207v; Yu XC, 2010, NANO LETT, V10, P3343, DOI 10.1021/nl1010178	30	401	413	35	891	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					61	+		10.1038/nature13607	http://dx.doi.org/10.1038/nature13607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25100481	Green Submitted			2022-12-28	WOS:000339908000031
J	Schwartz, N; Temkin, P; Jurado, S; Lim, BK; Heifets, BD; Polepalli, JS; Malenka, RC				Schwartz, Neil; Temkin, Paul; Jurado, Sandra; Lim, Byung Kook; Heifets, Boris D.; Polepalli, Jai S.; Malenka, Robert C.			Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens	SCIENCE			English	Article							MEDIUM SPINY NEURONS; NEUROPATHIC PAIN; INDIRECT PATHWAYS; ADENOSINE A(2A); ARCUATE NUCLEUS; MESSENGER-RNAS; BASAL GANGLIA; ANIMAL-MODELS; GALANIN; MECHANISMS	Several symptoms associated with chronic pain, including fatigue and depression, are characterized by reduced motivation to initiate or complete goal-directed tasks. However, it is unknown whether maladaptive modifications in neural circuits that regulate motivation occur during chronic pain. Here, we demonstrate that the decreased motivation elicited in mice by two different models of chronic pain requires a galanin receptor 1-triggered depression of excitatory synaptic transmission in indirect pathway nucleus accumbens medium spiny neurons. These results demonstrate a previously unknown pathological adaption in a key node of motivational neural circuitry that is required for one of the major sequela of chronic pain states and syndromes.	[Schwartz, Neil; Temkin, Paul; Jurado, Sandra; Lim, Byung Kook; Heifets, Boris D.; Polepalli, Jai S.; Malenka, Robert C.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Stanford, CA 94305 USA; [Jurado, Sandra] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Lim, Byung Kook] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	Stanford University; University System of Maryland; University of Maryland Baltimore; University of California System; University of California San Diego	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, 265 Campus Dr, Stanford, CA 94305 USA.	malenka@stanford.edu	Temkin, Paul A/F-9262-2011; Jurado, Sandra/S-9936-2017	Jurado, Sandra/0000-0001-9864-9307; Heifets, Boris/0000-0003-1474-0379; Lim, Byungkook/0000-0002-3766-5415; Polepalli, Jai/0000-0003-2004-2163	Banting postdoctoral fellowship; NIH; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227] Funding Source: NIH RePORTER	Banting postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Malenka lab for helpful feedback and comments during the study. We thank S. Fang and A. Darvishzadeh for help with stereotaxic injections and P. Rothwell for setting up the operant behavior chambers and software. This work was supported by a Banting postdoctoral fellowship (N.S.) and the NIH (R.C.M.). All primary data (behavioral, electrophysiological, and immunohistochemical) are archived in the Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine.	Anderson ME, 2013, BEHAV BRAIN RES, V239, P90, DOI 10.1016/j.bbr.2012.10.045; Baliki MN, 2012, NAT NEUROSCI, V15, P1117, DOI 10.1038/nn.3153; Balleine BW, 2010, NEUROPSYCHOPHARMACOL, V35, P48, DOI 10.1038/npp.2009.131; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Borsook D, 2007, EUR J PAIN, V11, P7, DOI 10.1016/j.ejpain.2005.12.005; Chaudhuri A, 2004, LANCET, V363, P978, DOI 10.1016/S0140-6736(04)15794-2; Cobos EJ, 2012, PAIN, V153, P876, DOI 10.1016/j.pain.2012.01.016; Cui GH, 2013, NATURE, V494, P238, DOI 10.1038/nature11846; Dersh J, 2002, PSYCHOSOM MED, V64, P773, DOI 10.1097/01.PSY.0000024232.11538.54; Dolen G, 2013, NATURE, V501, P179, DOI 10.1038/nature12518; Dong Y, 2006, J NEUROPHYSIOL, V95, P3228, DOI 10.1152/jn.01117.2005; Durieux PF, 2009, NAT NEUROSCI, V12, P393, DOI 10.1038/nn.2286; Einstein EB, 2013, EUR J NEUROSCI, V37, P1541, DOI 10.1111/ejn.12151; Farrar AM, 2010, NEUROSCIENCE, V166, P1056, DOI 10.1016/j.neuroscience.2009.12.056; Gu XL, 2007, BEHAV BRAIN RES, V179, P331, DOI 10.1016/j.bbr.2007.02.033; Imbe H, 2004, NEUROSCI LETT, V368, P102, DOI 10.1016/j.neulet.2004.06.073; Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998; Jonsson T, 2011, ACTA ANAESTH SCAND, V55, P69, DOI 10.1111/j.1399-6576.2010.02329.x; Jurado S, 2010, NAT NEUROSCI, V13, P1053, DOI 10.1038/nn.2613; Kasanetz F, 2010, SCIENCE, V328, P1709, DOI 10.1126/science.1187801; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Lee BR, 2011, NEUROPHARMACOLOGY, V61, P1060, DOI 10.1016/j.neuropharm.2010.12.033; Lemos JC, 2012, NATURE, V490, P402, DOI 10.1038/nature11436; Lim BK, 2012, NATURE, V487, P183, DOI 10.1038/nature11160; Lobo MK, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00041; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; Max MB, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-14; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Nicholson B, 2004, PAIN MED, V5, pS9, DOI 10.1111/j.1526-4637.2004.04019.x; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; Nikolova YS, 2013, GENES BRAIN BEHAV, V12, P516, DOI 10.1111/gbb.12035; Nishii H, 2007, REGUL PEPTIDES, V141, P105, DOI 10.1016/j.regpep.2006.12.022; Norheim KB, 2011, RHEUMATOLOGY, V50, P1009, DOI 10.1093/rheumatology/keq454; O'Brien CP, 2005, PHARMACOL THERAPEUT, V108, P18, DOI 10.1016/j.pharmthera.2005.06.018; Roane HS, 2008, J APPL BEHAV ANAL, V41, P155, DOI 10.1901/jaba.2008.41-155; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Santerre JL, 2012, PHARMACOL BIOCHEM BE, V102, P477, DOI 10.1016/j.pbb.2012.06.009; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Scott DJ, 2006, J NEUROSCI, V26, P10789, DOI 10.1523/JNEUROSCI.2577-06.2006; Sergeyev V, 2001, MOL BRAIN RES, V90, P93, DOI 10.1016/S0169-328X(01)00088-2; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Turk DC, 2010, MAYO CLIN PROC, V85, pS42, DOI 10.4065/mcp.2009.0648; Unschuld PG, 2008, J AFFECT DISORDERS, V105, P177, DOI 10.1016/j.jad.2007.05.006; Urban R, 2011, PAIN, V152, P990, DOI 10.1016/j.pain.2010.12.003; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wray NR, 2012, MOL PSYCHIATR, V17, P36, DOI 10.1038/mp.2010.109; Yalcin I, 2011, BIOL PSYCHIAT, V70, P946, DOI 10.1016/j.biopsych.2011.07.017; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	48	182	186	3	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					535	542		10.1126/science.1253994	http://dx.doi.org/10.1126/science.1253994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082697	Green Accepted			2022-12-28	WOS:000339651300039
J	Masri, S; Rigor, P; Cervantes, M; Ceglia, N; Sebastian, C; Xiao, CY; Roqueta-Rivera, M; Deng, CX; Osborne, TF; Mostoslavsky, R; Baldi, P; Sassone-Corsi, P				Masri, Selma; Rigor, Paul; Cervantes, Marlene; Ceglia, Nicholas; Sebastian, Carlos; Xiao, Cuiying; Roqueta-Rivera, Manuel; Deng, Chuxia; Osborne, Timothy F.; Mostoslavsky, Raul; Baldi, Pierre; Sassone-Corsi, Paolo			Partitioning Circadian Transcription by SIRT6 Leads to Segregated Control of Cellular Metabolism	CELL			English	Article							DEACETYLASE SIRT6; GENE-EXPRESSION; GENOMIC INSTABILITY; CLOCK; PROMOTER; IDENTIFICATION; ACETYLATION; CLOCK-BMAL1; ACTIVATION; REGULATORS	Circadian rhythms are intimately linked to cellular metabolism. Specifically, the NAD(+)-dependent deacetylase SIRT1, the founding member of the sirtuin family, contributes to clock function. Whereas SIRT1 exhibits diversity in deacetylation targets and subcellular localization, SIRT6 is the only constitutively chromatin-associated sirtuin and is prominently present at transcriptionally active genomic loci. Comparison of the hepatic circadian transcriptomes reveals that SIRT6 and SIRT1 separately control transcriptional specificity and therefore define distinctly partitioned classes of circadian genes. SIRT6 interacts with CLOCK:BMAL1 and, differently from SIRT1, governs their chromatin recruitment to circadian gene promoters. Moreover, SIRT6 controls circadian chromatin recruitment of SREBP-1, resulting in the cyclic regulation of genes implicated in fatty acid and cholesterol metabolism. This mechanism parallels a phenotypic disruption in fatty acid metabolism in SIRT6 null mice as revealed by circadian metabolome analyses. Thus, genomic partitioning by two independent sirtuins contributes to differential control of circadian metabolism.	[Masri, Selma; Cervantes, Marlene; Baldi, Pierre; Sassone-Corsi, Paolo] Univ Calif Irvine, Ctr Epigenet & Metab, Irvine, CA 92697 USA; [Masri, Selma; Cervantes, Marlene; Baldi, Pierre; Sassone-Corsi, Paolo] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Rigor, Paul; Ceglia, Nicholas; Baldi, Pierre] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA; [Rigor, Paul; Ceglia, Nicholas; Baldi, Pierre; Sassone-Corsi, Paolo] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Sebastian, Carlos; Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Xiao, Cuiying; Deng, Chuxia] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Roqueta-Rivera, Manuel; Osborne, Timothy F.] Sanford Burnham Med Res Inst, Metabol Dis Program, Orlando, FL 32827 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Sanford Burnham Prebys Medical Discovery Institute	Sassone-Corsi, P (corresponding author), Univ Calif Irvine, Ctr Epigenet & Metab, Irvine, CA 92697 USA.	psc@uci.edu	Sebastian, Carlos/H-8014-2018; Sebastian, Carlos/CAG-6271-2022; deng, chuxia/N-6713-2016	Sebastian, Carlos/0000-0001-6623-8028; Roqueta-Rivera, Manuel/0000-0001-6011-0226; Masri, Selma/0000-0002-8619-8331; Cervantes, Marlene/0000-0003-4619-6144	NIH [GM097899, LM010235, LM07443, AG043745]; NSF [IIS-1321053]; Merieux Research Grant [53923]; Sirtris Pharmaceuticals [SP-48984]; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056011, ZIADK056009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM097899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG043745] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010235, T15LM007443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Merieux Research Grant; Sirtris Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank Katrin Chua for reagents and helpful discussions. We thank all members of the Sassone-Corsi lab and Melanie Oakes, Seung-Ah Chung, Valentina Ciobanu, Yuzo Kanomata, and Andrea Eckhart for helpful discussion and technical assistance. Funding for S.M. was provided by NIH postdoctoral fellowship GM097899. Funding for P.B. was provided by NSF (IIS-1321053) and NIH (LM010235 and LM07443). Financial support for P.S.-C. was provided by NIH (AG043745), Merieux Research Grant (53923), and Sirtris Pharmaceuticals (SP-48984).	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Belden WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002166; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P3333, DOI 10.1073/pnas.1214266110; BENNETT MK, 1995, J BIOL CHEM, V270, P25578, DOI 10.1074/jbc.270.43.25578; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Cretenet G, 2010, CELL METAB, V11, P47, DOI 10.1016/j.cmet.2009.11.002; Daily K, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-495; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Duong HA, 2011, SCIENCE, V332, P1436, DOI 10.1126/science.1196766; Elhanati S, 2013, CELL REP, V4, P905, DOI 10.1016/j.celrep.2013.08.006; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gil R, 2013, NUCLEIC ACIDS RES, V41, P8537, DOI 10.1093/nar/gkt642; Gut P, 2013, NATURE, V502, P489, DOI 10.1038/nature12752; Hall JA, 2013, J CLIN INVEST, V123, P973, DOI 10.1172/JCI64094; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Katada S, 2012, CELL, V148, P24, DOI 10.1016/j.cell.2012.01.001; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kawahara TLA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002153; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kiyohara YB, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn018; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Masri S, 2010, NAT NEUROSCI, V13, P1324, DOI 10.1038/nn.2668; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Michishita E, 2009, CELL CYCLE, V8, P2664, DOI 10.4161/cc.8.16.9367; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Patel VR, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2111; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ram O, 2011, CELL, V147, P1628, DOI 10.1016/j.cell.2011.09.057; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Rozen S, 2000, Methods Mol Biol, V132, P365; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Seo YK, 2009, P NATL ACAD SCI USA, V106, P13765, DOI 10.1073/pnas.0904246106; Tennen RI, 2011, TRENDS BIOCHEM SCI, V36, P39, DOI 10.1016/j.tibs.2010.07.009; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Toiber D, 2013, MOL CELL, V51, P454, DOI 10.1016/j.molcel.2013.06.018; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Xie XH, 2009, BIOINFORMATICS, V25, P167, DOI 10.1093/bioinformatics/btn605; Yang B, 2009, CELL CYCLE, V8, P2662, DOI 10.4161/cc.8.16.9329; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	59	200	204	2	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					659	672		10.1016/j.cell.2014.06.050	http://dx.doi.org/10.1016/j.cell.2014.06.050			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083875	Green Accepted, Bronze			2022-12-28	WOS:000340944300017
J	Scherz-Shouval, R; Santagata, S; Mendillo, ML; Sholl, LM; Ben-Aharon, I; Beck, AH; Dias-Santagata, D; Koeva, M; Stemmer, SM; Whitesell, L; Lindquist, S				Scherz-Shouval, Ruth; Santagata, Sandro; Mendillo, Marc L.; Sholl, Lynette M.; Ben-Aharon, Irit; Beck, Andrew H.; Dias-Santagata, Dora; Koeva, Martina; Stemmer, Salomon M.; Whitesell, Luke; Lindquist, Susan			The Reprogramming of Tumor Stroma by HSF1 Is a Potent Enabler of Malignancy	CELL			English	Article							HEAT-SHOCK FACTOR-1; TRANSCRIPTION FACTOR HSF1; BREAST-CANCER; TGF-BETA; GENE-EXPRESSION; LUNG-CANCER; FIBROBLASTS; MICROENVIRONMENT; PROGRESSION; GROWTH	Stromal cells within the tumor microenvironment are essential for tumor progression and metastasis. Surprisingly little is known about the factors that drive the transcriptional reprogramming of stromal cells within tumors. We report that the transcriptional regulator heat shock factor 1 (HSF1) is frequently activated in cancer-associated fibroblasts (CAFs), where it is a potent enabler of malignancy. HSF1 drives a transcriptional program in CAFs that complements, yet is completely different from, the program it drives in adjacent cancer cells. This CAF program is uniquely structured to support malignancy in a non-cell-autonomous way. Two central stromal signaling molecules-TGF-beta and SDF1-play a critical role. In early-stage breast and lung cancer, high stromal HSF1 activation is strongly associated with poor patient outcome. Thus, tumors co-opt the ancient survival functions of HSF1 to orchestrate malignancy in both cell-autonomous and non-cell-autonomous ways, with far-reaching therapeutic implications.	[Scherz-Shouval, Ruth; Santagata, Sandro; Mendillo, Marc L.; Koeva, Martina; Whitesell, Luke; Lindquist, Susan] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Santagata, Sandro; Sholl, Lynette M.] Harvard Univ, Sch Med, Dept Pathol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Santagata, Sandro] Dana Farber Canc Ctr, Dept Canc Biol, Boston, MA 02215 USA; [Ben-Aharon, Irit; Stemmer, Salomon M.] Rabin Med Ctr, Davidoff Ctr, Inst Oncol, IL-49100 Petah Tiqwa, Israel; [Ben-Aharon, Irit; Stemmer, Salomon M.] Tel Aviv Univ, Sackler Fac Med, IL-69978 Ramat Aviv, Israel; [Beck, Andrew H.] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Dias-Santagata, Dora] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Dias-Santagata, Dora] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Koeva, Martina] MIT, Dept Biol Engn, Cambridge, MA 02142 USA; [Lindquist, Susan] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lindquist, Susan] Howard Hughes Med Inst, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Whitesell, L (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	whitesell@wi.mit.edu; lindquist_admin@wi.mit.edu		scherz-shouval, ruth/0000-0002-4570-121X; Santagata, Sandro/0000-0002-7528-9668; Mendillo, Marc/0000-0001-8128-0128	Human Frontiers Science Program; Fulbright Program; Israel National Postdoctoral Award Program for Women in Science; Jared Branfman Sunflowers for Life Fund; V Foundation; NIH [K08 NS064168]; National Cancer Institute of the NIH [K99CA175293]; Komen Foundation [KG110450]; J&J COSAT focused funding program; Alexander and Margaret Stewart Trust; Koch Institute Frontier Research Program through the Kathy and Curt Marble Cancer Research Fund; NATIONAL CANCER INSTITUTE [K99CA175293, P30CA014051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS064168] Funding Source: NIH RePORTER	Human Frontiers Science Program(Human Frontier Science Program); Fulbright Program; Israel National Postdoctoral Award Program for Women in Science; Jared Branfman Sunflowers for Life Fund; V Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Komen Foundation(Susan G. Komen Breast Cancer Foundation); J&J COSAT focused funding program; Alexander and Margaret Stewart Trust; Koch Institute Frontier Research Program through the Kathy and Curt Marble Cancer Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank I. Barrasa, G. Bell, S. Gupta, and T. DiCesare for bioinformatic analysis and graphical assistance. We thank M. Duquette and A. Topolszky (WIBR), K. Lynch (MGH), and A. Tuvar (Rabin Medical Center) for technical assistance. We thank C. K. Dai for cloning Bi-Tet-Hsf1 and R. Jaenisch and Y. Freyzon for construction of Bi-Tet-Hsf1 transgenic mice. We thank K. Polyak, P. Gupta, D. Pincus, L. Clayton, and members of the S. L. lab for helpful discussions and comments. We thank R. Weinberg for the gift of cell lines and for helpful discussions. R. S.-S. was supported by the Human Frontiers Science Program, the Fulbright Program, and the Israel National Postdoctoral Award Program for Women in Science. S. S. is supported by the Jared Branfman Sunflowers for Life Fund, the V Foundation, and by NIH grant K08 NS064168. M. L. M. was supported by the National Cancer Institute of the NIH under Award Number K99CA175293. L. W. was supported by the Komen Foundation, Grant KG110450, and by the J&J COSAT focused funding program. S. L. is an investigator of the Howard Hughes Medical Institute. Support for this study was also provided by the Alexander and Margaret Stewart Trust and the Koch Institute Frontier Research Program through the Kathy and Curt Marble Cancer Research Fund. D.D.-S. is a consultant for Bioreference Labs, submitted a patent application (pending) for the SNaPshot methods described here, has licensed SNaPshot technology, and receives royalties from Bioreference Labs.	Beck AH, 2008, LAB INVEST, V88, P591, DOI 10.1038/labinvest.2008.31; Bissell MJ, 2011, NAT MED, V17, P320, DOI 10.1038/nm.2328; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Dias-Santagata D, 2010, EMBO MOL MED, V2, P146, DOI 10.1002/emmm.201000070; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Fang F, 2012, CANCER-AM CANCER SOC, V118, P1782, DOI 10.1002/cncr.26482; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Goldstraw Peter, 2007, J Thorac Oncol, V2, P706, DOI 10.1097/JTO.0b013e31812f3c1a; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Henderson B, 2013, CELL STRESS CHAPERON, V18, P685, DOI 10.1007/s12192-013-0444-9; Jin XJ, 2011, CELL METAB, V14, P91, DOI 10.1016/j.cmet.2011.03.025; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kojima Y, 2010, P NATL ACAD SCI USA, V107, P20009, DOI 10.1073/pnas.1013805107; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lujambio A, 2013, CELL, V153, P449, DOI 10.1016/j.cell.2013.03.020; Maity TK, 2011, CYTOKINE, V54, P61, DOI 10.1016/j.cyto.2010.12.017; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Meng L, 2010, ONCOGENE, V29, P5204, DOI 10.1038/onc.2010.277; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Pillai RN, 2014, MOL CANCER THER, V13, P557, DOI 10.1158/1535-7163.MCT-13-0669; Place AE, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2912; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Qiu W, 2008, NAT GENET, V40, P650, DOI 10.1038/ng.117; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Sakurai H, 2010, FEBS J, V277, P4140, DOI 10.1111/j.1742-4658.2010.07829.x; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Santagata S, 2012, ACS CHEM BIOL, V7, P339, DOI 10.1021/cb200353m; Santagata S, 2011, P NATL ACAD SCI USA, V108, P18378, DOI 10.1073/pnas.1115031108; Sasaki H, 2002, J IMMUNOL, V168, P5178, DOI 10.4049/jimmunol.168.10.5178; Saturno Grazia, 2013, Oncotarget, V4, P1185; Scott KL, 2011, CANCER CELL, V20, P92, DOI 10.1016/j.ccr.2011.05.025; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249	44	231	241	1	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					564	578		10.1016/j.cell.2014.05.045	http://dx.doi.org/10.1016/j.cell.2014.05.045			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083868	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000340944300010
J	Maurice, J				Maurice, John			Joep Lange Obituary	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 26	2014	384	9940					302	302		10.1016/S0140-6736(14)61052-7	http://dx.doi.org/10.1016/S0140-6736(14)61052-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM3AE	25072065	Bronze			2022-12-28	WOS:000339722400016
J	Emberson, J; Lees, KR; Lyden, P; Blackwell, L; Albers, G; Bluhmki, E; Brott, T; Cohen, G; Davis, S; Donnan, G; Grotta, J; Howard, G; Kaste, M; Koga, M; von Kummer, R; Lansberg, M; Lindley, RI; Murray, G; Olivot, JM; Parsons, M; Tilley, B; Toni, D; Toyoda, K; Wahlgren, N; Wardlaw, J; Whiteley, W; del Zoppo, GJ; Baigent, C; Sandercock, P; Hacke, W				Emberson, Jonathan; Lees, Kennedy R.; Lyden, Patrick; Blackwell, Lisa; Albers, Gregory; Bluhmki, Erich; Brott, Thomas; Cohen, Geoff; Davis, Stephen; Donnan, Geoffrey; Grotta, James; Howard, George; Kaste, Markku; Koga, Masatoshi; von Kummer, Ruediger; Lansberg, Maarten; Lindley, Richard I.; Murray, Gordon; Olivot, Jean Marc; Parsons, Mark; Tilley, Barbara; Toni, Danilo; Toyoda, Kazunori; Wahlgren, Nils; Wardlaw, Joanna; Whiteley, William; del Zoppo, Gregory J.; Baigent, Colin; Sandercock, Peter; Hacke, Werner		Stroke Thrombolysis Trialists	Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials	LANCET			English	Article							TISSUE-PLASMINOGEN-ACTIVATOR; POOLED ANALYSIS; ATLANTIS; ECASS; EPITHET; NINDS	Background Alteplase is effective for treatment of acute ischaemic stroke but debate continues about its use after longer times since stroke onset, in older patients, and among patients who have had the least or most severe strokes. We assessed the role of these factors in affecting good stroke outcome in patients given alteplase. Methods We did a pre-specified meta-analysis of individual patient data from 6756 patients in nine randomised trials comparing alteplase with placebo or open control. We included all completed randomised phase 3 trials of intravenous alteplase for treatment of acute ischaemic stroke for which data were available. Retrospective checks confirmed that no eligible trials had been omitted. We defined a good stroke outcome as no significant disability at 3-6 months, defined by a modified Rankin Score of 0 or 1. Additional outcomes included symptomatic intracranial haemorrhage (defined by type 2 parenchymal haemorrhage within 7 days and, separately, by the SITS-MOST definition of parenchymal type 2 haemorrhage within 36 h), fatal intracranial haemorrhage within 7 days, and 90-day mortality. Findings Alteplase increased the odds of a good stroke outcome, with earlier treatment associated with bigger proportional benefit. Treatment within 3.0 h resulted in a good outcome for 259 (32.9%) of 787 patients who received alteplase versus 176 (23.1%) of 762 who received control (OR 1.75, 95% CI 1.35-2.27); delay of greater than 3.0 h, up to 4.5 h, resulted in good outcome for 485 (35.3%) of 1375 versus 432 (30.1%) of 1437 (OR 1.26, 95% CI 1.05-1.51); and delay of more than 4.5 h resulted in good outcome for 401 (32.6%) of 1229 versus 357 (30.6%) of 1166 (OR 1.15, 95% CI 0.95-1.40). Proportional treatment benefits were similar irrespective of age or stroke severity. Alteplase significantly increased the odds of symptomatic intracranial haemorrhage (type 2 parenchymal haemorrhage definition 231 [6.8%] of 3391 vs 44 [1.3%] of 3365, OR 5.55, 95% CI 4.01-7.70, p<0.0001; SITS-MOST definition 124 [3.7%] vs 19 [0.6%], OR 6.67, 95% CI 4.11-10.84, p<0.0001) and of fatal intracranial haemorrhage within 7 days (91 [2.7%] vs 13 [0.4%]; OR 7.14, 95% CI 3.98-12.79, p<0.0001). The relative increase in fatal intracranial haemorrhage from alteplase was similar irrespective of treatment delay, age, or stroke severity, but the absolute excess risk attributable to alteplase was bigger among patients who had more severe strokes. There was no excess in other early causes of death and no significant effect on later causes of death. Consequently, mortality at 90 days was 608 (17.9%) in the alteplase group versus 556 (16.5%) in the control group (hazard ratio 1.11, 95% CI 0.99-1.25, p=0.07). Taken together, therefore, despite an average absolute increased risk of early death from intracranial haemorrhage of about 2%, by 3-6 months this risk was off set by an average absolute increase in disability-free survival of about 10% for patients treated within 3.0 h and about 5% for patients treated after 3.0 h, up to 4.5 h. Interpretation Irrespective of age or stroke severity, and despite an increased risk of fatal intracranial haemorrhage during the first few days after treatment, alteplase signifi cantly improves the overall odds of a good stroke outcome when delivered within 4.5 h of stroke onset, with earlier treatment associated with bigger proportional benefits. Copyright (C) Emberson et al. Open Access article distributed under the terms of CC BY.	[Emberson, Jonathan; Blackwell, Lisa; Baigent, Colin] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Emberson, Jonathan; Blackwell, Lisa; Baigent, Colin] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Lees, Kennedy R.] Univ Glasgow, Glasgow, Lanark, Scotland; [Lyden, Patrick] Cedars Sinai, Dept Neurol, Los Angeles, CA USA; [Albers, Gregory; Lansberg, Maarten; Olivot, Jean Marc] Stanford Univ, Stanford, CA 94305 USA; [Bluhmki, Erich] Boehringer Ingelheim KG, Ingelheim, Germany; [Brott, Thomas] Mayo Clin, Jacksonville, FL 32224 USA; [Cohen, Geoff; Murray, Gordon; Wardlaw, Joanna; Whiteley, William; Sandercock, Peter] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Davis, Stephen] Univ Melbourne, Melbourne, Vic, Australia; [Donnan, Geoffrey] Florey Inst Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Grotta, James; Tilley, Barbara] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA; [Howard, George] Univ Alabama Birmingham, Birmingham, AL USA; [Kaste, Markku] Univ Helsinki, Cent Hosp, Helsinki, Finland; [Koga, Masatoshi; Toyoda, Kazunori] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [von Kummer, Ruediger] Tech Univ Dresden, D-01062 Dresden, Germany; [Lindley, Richard I.] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Parsons, Mark] Univ Newcastle, Newcastle, NSW 2300, Australia; [Toni, Danilo] Univ Roma La Sapienza, Rome, Italy; [Wahlgren, Nils] Karolinska Inst, Stockholm, Sweden; [del Zoppo, Gregory J.] Univ Washington, Seattle, WA 98195 USA; [Hacke, Werner] Heidelberg Univ, Heidelberg, Germany	University of Oxford; University of Oxford; University of Glasgow; Cedars Sinai Medical Center; Stanford University; Boehringer Ingelheim; Mayo Clinic; University of Edinburgh; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham; University of Helsinki; Helsinki University Central Hospital; National Cerebral & Cardiovascular Center - Japan; Technische Universitat Dresden; George Institute for Global Health; University of Sydney; University of Newcastle; Sapienza University Rome; Karolinska Institutet; University of Washington; University of Washington Seattle; Ruprecht Karls University Heidelberg	Baigent, C (corresponding author), Univ Oxford, Clin Trial Serv Unit, Nuffield Dept Populat Hlth, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.	colin.baigent@ctsu.ox.ac.uk	Lueck, Christian Joseph/O-4031-2016; Hernandez, María/GYU-3543-2022; Koga, Masatoshi/GWR-2715-2022; von Kummer, Rüdiger/AAA-4478-2019; Hacke, Werner/ABE-8661-2020; Toni, Danilo/K-3151-2016; Toyoda, Kazunori/J-3828-2015; Wardlaw, Joanna M/Y-3456-2019; Lindley, Richard/B-8148-2013; Demchuk, Andrew M/E-1103-2012; Grotta, James/AAH-7423-2021	Lueck, Christian Joseph/0000-0003-1537-7612; Koga, Masatoshi/0000-0002-6758-4026; von Kummer, Rüdiger/0000-0003-0119-4604; Toni, Danilo/0000-0003-2735-8427; Toyoda, Kazunori/0000-0002-8346-9845; Wardlaw, Joanna M/0000-0002-9812-6642; Lindley, Richard/0000-0002-0104-5679; Demchuk, Andrew M/0000-0002-4930-7789; Howard, George/0000-0002-3068-5720; Murray, Gordon/0000-0001-9866-4734; Albers, Gregory/0000-0003-0263-4632; Emberson, Jonathan/0000-0001-7792-9422; Lansberg, Maarten/0000-0002-3545-6927; Kaste, Markku/0000-0001-6557-6412; grotta, james/0000-0002-3667-4248; Donnan, Geoffrey/0000-0001-6324-3403; Whiteley, William/0000-0002-4816-8991	UK Medical Research Council; British Heart Foundation; University of Glasgow; University of Edinburgh; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053716, R01NS038710] Funding Source: NIH RePORTER; MRC [G0800803, G0400069, MC_U137686849, G0902303] Funding Source: UKRI; Medical Research Council [G0400069, MR/K026992/1, MC_U137686849, G0902303, G0800803] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); University of Glasgow; University of Edinburgh; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK Medical Research Council, British Heart Foundation, University of Glasgow, University of Edinburgh.	Australian Government Department of Health Therapeutic goods administration, PROD CONS MED INF AC; Australian Stroke Foundation, CLIN GUID STROK MAN; Brott T, 1997, STROKE, V28, P2119, DOI 10.1161/01.STR.28.11.2119; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; Emberson J, 2013, INT J STROKE, V8, P278, DOI 10.1111/ijs.12040; Ford GA, 2010, STROKE, V41, P2568, DOI 10.1161/STROKEAHA.110.581884; Frank B, 2014, INT J STROKE, DOI 10.1111/ijs.12249; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; HALEY EC, 1993, STROKE, V24, P1000, DOI 10.1161/01.STR.24.7.1000; Hemmen TM, 2010, STROKE, V41, P2265, DOI 10.1161/STROKEAHA.110.592295; Howard G, 2012, ANN NY ACAD SCI, V1268, P14, DOI 10.1111/j.1749-6632.2012.06665.x; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Minematsu K, 2013, J STROKE CEREBROVASC, V22, P571, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.001; Mishra NK, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6046; Mishra NK, 2010, STROKE, V41, P2840, DOI 10.1161/STROKEAHA.110.586206; MORI E, 1992, NEUROLOGY, V42, P976, DOI 10.1212/WNL.42.5.976; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wang Shen-yan, 2003, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V15, P542; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; YAMAGUCHI T, 1993, CEREBROVASC DIS, V3, P269, DOI 10.1159/000108714	29	1439	1492	9	150	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1929	1935		10.1016/S0140-6736(14)60584-5	http://dx.doi.org/10.1016/S0140-6736(14)60584-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25106063	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000345450100028
J	Watanabe, K; Kimura, Y; Obara, T				Watanabe, Kenta; Kimura, Yuki; Obara, Tetsuya			Gas in the retropharyngeal space: descending necrotising mediastinitis	LANCET			English	Editorial Material									[Watanabe, Kenta] Tokyo Metropolitan Tama Med Ctr, Dept Otolaryngol Head & Neck Surg, Fuchu, Tokyo 1838524, Japan; [Obara, Tetsuya] Tokyo Metropolitan Tama Med Ctr, Dept Thorac Surg, Fuchu, Tokyo 1838524, Japan; [Kimura, Yuki] Keiyukai Sapporo Hosp, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido, Japan		Watanabe, K (corresponding author), Tokyo Metropolitan Tama Med Ctr, Dept Otolaryngol Head & Neck Surg, 2-8-29 Musashidai, Fuchu, Tokyo 1838524, Japan.	quentaw@aol.com							0	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1952	1952		10.1016/S0140-6736(14)61138-7	http://dx.doi.org/10.1016/S0140-6736(14)61138-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25132504				2022-12-28	WOS:000345450100031
J	Calo, S; Shertz-Wall, C; Lee, SC; Bastidas, RJ; Nicolas, FE; Granek, JA; Mieczkowski, P; Torres-Martinez, S; Ruiz-Vazquez, RM; Cardenas, ME; Heitman, J				Calo, Silvia; Shertz-Wall, Cecelia; Lee, Soo Chan; Bastidas, Robert J.; Nicolas, Francisco E.; Granek, Joshua A.; Mieczkowski, Piotr; Torres-Martinez, Santiago; Ruiz-Vazquez, Rosa M.; Cardenas, Maria E.; Heitman, Joseph			Antifungal drug resistance evoked via RNAi-dependent epimutations	NATURE			English	Article							FUNGUS MUCOR-CIRCINELLOIDES; GERMLINE EPIMUTATION; GENE; INTERFERENCE; EXPRESSION; TARGET; INITIATION; ASCOBOLUS; RAPAMYCIN; ELEGANS	Microorganisms evolve via a range of mechanisms that may include or involve sexual/parasexual reproduction, mutators, aneuploidy, Hsp90 and even prions. Mechanisms that may seem detrimental can be repurposed to generate diversity. Here we show that the human fungal pathogen Mucor circinelloides develops spontaneous resistance to the antifungal drug FK506 (tacrolimus) via two distinct mechanisms. One involves Mendelian mutations that confer stable drug resistance; the other occurs via an epigenetic RNA interference (RNAi)-mediated pathway resulting in unstable drug resistance. The peptidylprolyl isomerase FKBP12 interacts with FK506 forming a complex that inhibits the protein phosphatase calcineurin(1). Calcineurin inhibition by FK506 blocks M. circinelloides transition to hyphae and enforces yeast growth(2). Mutations in the fkbA gene encoding FKBP12 or the calcineurin cnbR or cnaA genes confer FK506 resistance and restore hyphal growth. In parallel, RNAi is spontaneously triggered to silence the fkbA gene, giving rise to drug-resistant epimutants. FK506-resistant epimutants readily reverted to the drug-sensitive wild-type phenotype when grown without exposure to the drug. The establishment of these epimutants is accompanied by generation of abundant fkbA small RNAs and requires the RNAi pathway as well as other factors that constrain or reverse the epimutant state. Silencing involves the generation of a double-stranded RNA trigger intermediate using the fkbA mature mRNA as a template to produce antisense fkbA RNA. This study uncovers a novel epigenetic RNAi-based epimutation mechanism controlling phenotypic plasticity, with possible implications for antimicrobial drug resistance and RNAi-regulatory mechanisms in fungi and other eukaryotes.	[Calo, Silvia; Shertz-Wall, Cecelia; Lee, Soo Chan; Bastidas, Robert J.; Granek, Joshua A.; Cardenas, Maria E.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Nicolas, Francisco E.] Reg Campus Int Excellence Campus Mare Nostrum, Murcia 30100, Spain; [Nicolas, Francisco E.; Torres-Martinez, Santiago; Ruiz-Vazquez, Rosa M.] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Murcia 30100, Spain; [Granek, Joshua A.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Granek, Joshua A.] Duke Univ, Med Ctr, Duke Ctr Genom Microbial Syst, Durham, NC 27710 USA; [Mieczkowski, Piotr] Univ N Carolina, High Throughput Sequencing Facil, Chapel Hill, NC 27599 USA	Duke University; University of Murcia; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill	Heitman, J (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	heitm001@duke.edu	Ruiz-Vázquez, Rosa María/K-6778-2014; Calo, Silvia/ABG-7530-2020; Heitman, Joseph/ABC-6006-2021; Torres-Martinez, Santiago/K-7660-2014; Paniagua, Enrique/H-3536-2015; Nicolás, Francisco E./D-5717-2014	Ruiz-Vázquez, Rosa María/0000-0002-6675-8506; Calo, Silvia/0000-0003-3014-7372; Torres-Martinez, Santiago/0000-0002-7083-4516; Paniagua, Enrique/0000-0001-5006-6428; Nicolás, Francisco E./0000-0003-3762-5971; Granek, Joshua/0000-0003-3908-5016; Mieczkowski, Piotr/0000-0003-2418-0096	NIH [R37 AI39115-17, R01 AI50438-10, R01 CA154499-04]; Spanish MICINN [BFU2009-07220]; MINECO [BFU2012-32246]; FEDER; NATIONAL CANCER INSTITUTE [R01CA154499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039115, R01AI039115, R01AI050438] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MINECO(Spanish Government); FEDER(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. Skalsky and V. Ponnusamy for technical support and J. Wostemeyer for trisporic acid. We thank B. Cullen, T. Petes, B. Billmyre, M. Feretzaki, J. Kingsbury and V. Ponnusamy for critical reading. This work was supported by NIH grants R37 AI39115-17, R01 AI50438-10, R01 CA154499-04 and the Spanish MICINN BFU2009-07220 and MINECO BFU2012-32246, co-financed by FEDER.	Anders S., 2014, HTSEQ PYTHON FRAMEWO; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bastidas RJ, 2012, EUKARYOT CELL, V11, P270, DOI 10.1128/EC.05284-11; Baulcombe DC, 1996, PLANT MOL BIOL, V32, P79, DOI 10.1007/BF00039378; Calo S, 2012, MOL MICROBIOL, V83, P379, DOI 10.1111/j.1365-2958.2011.07939.x; CARDENAS ME, 1995, EMBO J, V14, P5892, DOI 10.1002/j.1460-2075.1995.tb00277.x; Cervantes M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069283; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colot V, 1996, CELL, V86, P855, DOI 10.1016/S0092-8674(00)80161-0; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cubas P, 1999, NATURE, V401, P157, DOI 10.1038/43657; de Haro JP, 2009, EUKARYOT CELL, V8, P1486, DOI 10.1128/EC.00191-09; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elmayan T, 1996, PLANT J, V9, P787, DOI 10.1046/j.1365-313X.1996.9060787.x; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Gent JI, 2010, MOL CELL, V37, P679, DOI 10.1016/j.molcel.2010.01.012; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; Gutierrez A, 2011, J MICROBIOL METH, V84, P442, DOI 10.1016/j.mimet.2011.01.002; Heger A., 2013, PYSAM PYTHON INTERFA; HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094; Hitchins MP, 2007, NEW ENGL J MED, V356, P697, DOI 10.1056/NEJMoa064522; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; LASKER BA, 1980, J BACTERIOL, V141, P565, DOI 10.1128/JB.141.2.565-569.1980; Lee SC, 2014, MBIO, V5, DOI 10.1128/mBio.01390-14; Lee SC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003625; Li CH, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002086; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Murcia-Flores L, 2007, J BIOL CHEM, V282, P15394, DOI 10.1074/jbc.M610366200; Nicolas FE, 2003, EMBO J, V22, P3983, DOI 10.1093/emboj/cdg384; Nicolas FE, 2007, FUNGAL GENET BIOL, V44, P504, DOI 10.1016/j.fgb.2006.09.003; Nicolas FE, 2010, NUCLEIC ACIDS RES, V38, P5535, DOI 10.1093/nar/gkq301; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; ORLOWSKI M, 1991, MICROBIOL REV, V55, P234, DOI 10.1128/MMBR.55.2.234-258.1991; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reyes-Turcu FE, 2012, CURR OPIN GENET DEV, V22, P156, DOI 10.1016/j.gde.2011.12.004; RHOUNIM L, 1992, EMBO J, V11, P4451, DOI 10.1002/j.1460-2075.1992.tb05546.x; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Timmons L, 2004, BIOESSAYS, V26, P715, DOI 10.1002/bies.20078; Wassenegger M, 1998, PLANT MOL BIOL, V37, P349, DOI 10.1023/A:1005946720438; Wetzel J, 2012, MICROBIOL-SGM, V158, P1016, DOI 10.1099/mic.0.054106-0; Yamanaka S, 2013, NATURE, V493, P557, DOI 10.1038/nature11716	44	90	93	2	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					555	+		10.1038/nature13575	http://dx.doi.org/10.1038/nature13575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25079329	Green Published, Green Accepted			2022-12-28	WOS:000342075800042
J	Stanbrook, MB				Stanbrook, Matthew B.			In COPD, fluticasone or budesonide increases serious pneumonia but not mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Toronto, Univ Hlth Network, Toronto, ON, Canada	University of Toronto; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Univ Hlth Network, Toronto, ON, Canada.							GOLD, 2011, GLOB STRAT DIAGN MAN; Nannini LJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006829.pub2; Suissa S, 2013, THORAX, V68, P1029, DOI 10.1136/thoraxjnl-2012-202872	3	3	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4							JC8	10.7326/0003-4819-161-4-201408190-02008	http://dx.doi.org/10.7326/0003-4819-161-4-201408190-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AP8RU	25133387				2022-12-28	WOS:000342347300007
J	Rader, DJ; Hovingh, GK				Rader, Daniel J.; Hovingh, G. Kees			HDL and cardiovascular disease	LANCET			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; PLASMA LECITHIN; STATIN THERAPY; HIGH-RISK; ATHEROSCLEROSIS; ACYLTRANSFERASE; DEFICIENCY; INHIBITION	The cholesterol contained within HDL is inversely associated with risk of coronary heart disease and is a key component of predicting cardiovascular risk. However, despite its properties consistent with atheroprotection, the causal relation between HDL and atherosclerosis is uncertain. Human genetics and failed clinical trials have created scepticism about the HDL hypothesis. Nevertheless, drugs that raise HDL-C concentrations, cholesteryl ester transfer protein inhibitors, are in late-stage clinical development, and other approaches that promote HDL function, including reverse cholesterol transport, are in early-stage clinical development. The final chapters regarding the effect of HDL-targeted therapeutic interventions on coronary heart disease events remain to be written.	[Rader, Daniel J.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Dept Genet, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Rader, Daniel J.] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Hovingh, G. Kees] Univ Amsterdam, Acad Med Ctr, Dept Med, NL-1105 AZ Amsterdam, Netherlands	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Amsterdam; Academic Medical Center Amsterdam	Rader, DJ (corresponding author), 11-125 Smilow Ctr Translat Res,3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu			AstraZeneca; BristolMyersSquibb; National Institutes of Health; Netherlands Organisation for Scientific Research	AstraZeneca(AstraZeneca); BristolMyersSquibb(Bristol-Myers Squibb); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	DJR reports grants from AstraZeneca, BristolMyersSquibb, and National Institutes of Health, during the conduct of the study. DJR is a founder of VascularStrategies, which performs assays of HDL function as a service, and is an inventor on a patent method for reverse cholesterol transport in human beings that is licensed to VascularStrategies by the University of Pennsylvania. GKH reports grants from the Netherlands Organisation for Scientific Research, outside the submitted work.	BADIMON JJ, 1990, J CLIN INVEST, V85, P1234, DOI 10.1172/JCI114558; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Barth JL, 2001, TRENDS CARDIOVAS MED, V11, P26, DOI 10.1016/S1050-1738(01)00080-9; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Bochem AE, 2013, EUR HEART J, V34, P286, DOI 10.1093/eurheartj/ehs376; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Boekholdt SM, 2013, CIRCULATION, V128, P1504, DOI 10.1161/CIRCULATIONAHA.113.002670; Calabresi L, 2012, ATHEROSCLEROSIS, V222, P299, DOI 10.1016/j.atherosclerosis.2011.11.034; Calabresi L, 2011, J LIPID RES, V52, P1569, DOI 10.1194/jlr.P014977; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; Cannon CP, 2010, NEW ENGL J MED, V363, P2406, DOI 10.1056/NEJMoa1009744; Cuchel M., 2012, ARTERIOSCLER THROMB, V32, pA71; de Grooth GJ, 2004, J LIPID RES, V45, P1967, DOI 10.1194/jlr.R400007-JLR200; De Nardo D, 2014, NAT IMMUNOL, V15, P152, DOI 10.1038/ni.2784; Degoma EM, 2011, NAT REV CARDIOL, V8, P266, DOI 10.1038/nrcardio.2010.200; Di Angelantonio E, 2012, JAMA-J AM MED ASSOC, V307, P2499, DOI 10.1001/jama.2012.6571; Do R, 2013, NAT GENET, V45, P1345, DOI 10.1038/ng.2795; Duivenvoorden R, 2011, J AM COLL CARDIOL, V58, P2481, DOI 10.1016/j.jacc.2010.11.092; Edmondson AC, 2009, J CLIN INVEST, V119, P1042, DOI 10.1172/JCI37176; Ford J, 2014, BRIT J CLIN PHARM; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Funder JW, 2010, HYPERTENSION, V55, P221, DOI 10.1161/HYPERTENSIONAHA.109.146936; Gille A, 2014, ARTERIOSCLER THROMB; GLOMSET JA, 1966, J LIPID RES, V7, P638; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Hoekstra M, 2010, WORLD J GASTROENTERO, V16, P5916, DOI 10.3748/wjg.v16.i47.5916; Holleboom AG, 2013, J LIPID RES, V54, P1964, DOI 10.1194/jlr.P028449; Hovingh GK, 2005, CIRCULATION, V112, P879, DOI 10.1161/CIRCULATIONAHA.105.540427; Hovingh GK, 2005, CURR OPIN LIPIDOL, V16, P139, DOI 10.1097/01.mol.0000162318.47172.ef; Hovingh GK, 2004, J AM COLL CARDIOL, V44, P1429, DOI 10.1016/j.jacc.2004.06.070; Hovingh GK, 2004, J INTERN MED, V255, P299, DOI 10.1046/j.0954-6820.2003.01256.x; Huang Y, 2014, NAT MED, V20, P193, DOI 10.1038/nm.3459; Johannsen TH, 2012, J AM COLL CARDIOL, V60, P2041, DOI 10.1016/j.jacc.2012.07.045; KANNEL WB, 1964, ANN INTERN MED, V61, P888, DOI 10.7326/0003-4819-61-5-888; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; Mackey RH, 2012, J AM COLL CARDIOL, V60, P508, DOI 10.1016/j.jacc.2012.03.060; Mora S, 2013, CIRCULATION, V128, P1189, DOI 10.1161/CIRCULATIONAHA.113.002671; Mora S, 2011, ANN INTERN MED, V155, P742, DOI 10.7326/0003-4819-155-11-201112060-00006; Nicholls SJ, 2012, CARDIOVASC DRUG THER, V26, P181, DOI 10.1007/s10557-012-6373-5; Nicholls SJ, 2011, JAMA-J AM MED ASSOC, V306, P2099, DOI 10.1001/jama.2011.1649; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Oldoni F, 2014, CIRC RES, V114, P124, DOI 10.1161/CIRCRESAHA.113.300634; Olsson AG, 2005, EUR HEART J, V26, P890, DOI 10.1093/eurheartj/ehi186; Parks JS, 2012, CURR OPIN LIPIDOL, V23, P196, DOI 10.1097/MOL.0b013e328352dd1a; Rader DJ, 2014, ANNU REV MED, V65, P385, DOI 10.1146/annurev-med-050311-163305; Rader DJ, 2012, J CLIN ENDOCR METAB, V97, P3399, DOI 10.1210/jc.2012-2185; Rader DJ, 2012, NAT MED, V18, P1344, DOI 10.1038/nm.2937; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Ray KK, 2014, EUR HEART J, V35, P1792, DOI 10.1093/eurheartj/ehu105; Ray KK, 2009, ARTERIOSCL THROM VAS, V29, P424, DOI 10.1161/ATVBAHA.108.181735; Ray KK, 2014, EUR HEART J; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rayner KJ, 2011, J CLIN INVEST, V121, P2921, DOI 10.1172/JCI57275; Ridker PM, 2010, LANCET, V376, P333, DOI 10.1016/S0140-6736(10)60713-1; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; Rousset X, 2011, CURR ATHEROSCLER REP, V13, P249, DOI 10.1007/s11883-011-0171-6; Rousset X, 2009, CURR OPIN ENDOCRINOL, V16, P163, DOI 10.1097/MED.0b013e328329233b; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; Santos RD, 2008, J CLIN LIPIDOL, V2, P237, DOI 10.1016/j.jacl.2008.06.002; SCHAEFER EJ, 1980, ANN INTERN MED, V93, P261, DOI 10.7326/0003-4819-93-2-261; Schaefer EJ, 2014, CURR OPIN LIPIDOL, V25, P194, DOI 10.1097/MOL.0000000000000074; Schaefer EJ, 2010, CURR OPIN LIPIDOL, V21, P289, DOI 10.1097/MOL.0b013e32833c1ef6; Schwartz GG, 2012, NEW ENGL J MED, V367, P2089, DOI 10.1056/NEJMoa1206797; Sirtori CR, 2001, CIRCULATION, V103, P1949; Superko HR, 2012, J CLIN LIPIDOL, V6, P496, DOI 10.1016/j.jacl.2012.03.001; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tardif JC, 2014, EUR HEART J; Tardif JC, 2007, JAMA-J AM MED ASSOC, V297, P1675, DOI 10.1001/jama.297.15.jpc70004; Toth PP, 2013, J CLIN LIPIDOL, V7, P484, DOI 10.1016/j.jacl.2013.08.001; Turner S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001826; van Capelleveen JC, 2014, CIRC RES, V114, P193, DOI 10.1161/CIRCRESAHA.114.301804; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Waksman R, 2010, J AM COLL CARDIOL, V55, P2727, DOI 10.1016/j.jacc.2009.12.067; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Wu BJ, 2013, CIRC RES, V112, P278, DOI 10.1161/CIRCRESAHA.111.300104	78	399	414	8	91	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					618	625		10.1016/S0140-6736(14)61217-4	http://dx.doi.org/10.1016/S0140-6736(14)61217-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25131981				2022-12-28	WOS:000340573300034
J	Cherniak, W; Silverman, M				Cherniak, William; Silverman, Michael			Syphilitic Gumma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cherniak, William; Silverman, Michael] Bridge Hlth Med & Dent, Toronto, ON, Canada		Cherniak, W (corresponding author), Bridge Hlth Med & Dent, Toronto, ON, Canada.	william@bridgetohealth.ca	Silverman, Michael/J-3776-2014	Silverman, Michael/0000-0002-0389-7656; Cherniak, William/0000-0003-3001-2400					0	3	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					667	667		10.1056/NEJMicm1313142	http://dx.doi.org/10.1056/NEJMicm1313142			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZL	25119612				2022-12-28	WOS:000340819600012
J	Mellor, N; Bishopp, A				Mellor, Nathan; Bishopp, Anthony			PLANT SCIENCE The innermost secrets of root development	SCIENCE			English	Editorial Material							POLAR AUXIN TRANSPORT; VASCULAR TISSUE; ARABIDOPSIS		[Mellor, Nathan; Bishopp, Anthony] Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England	University of Nottingham	Mellor, N (corresponding author), Univ Nottingham, Ctr Plant Integrat Biol, Loughborough LE12 5RD, Leics, England.	anthony.bishopp@nottingham.ac.uk		Bishopp, Anthony/0000-0003-2962-9542				Bishopp A, 2011, CURR BIOL, V21, P917, DOI 10.1016/j.cub.2011.04.017; De Rybel B, 2014, SCIENCE, V345, DOI 10.1126/science.1255215; De Rybel B, 2013, DEV CELL, V24, P426, DOI 10.1016/j.devcel.2012.12.013; Galweiler L, 1998, SCIENCE, V282, P2226, DOI 10.1126/science.282.5397.2226; Mahonen AP, 2006, SCIENCE, V311, P94, DOI 10.1126/science.1118875; Muraro D, 2014, P NATL ACAD SCI USA, V111, P857, DOI 10.1073/pnas.1221766111; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; van Berkel K, 2013, DEVELOPMENT, V140, P2253, DOI 10.1242/dev.079111; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001	10	1	1	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					622	623		10.1126/science.1257843	http://dx.doi.org/10.1126/science.1257843			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104371				2022-12-28	WOS:000339962800019
J	Silverberg, JL; Evans, AA; McLeod, L; Hayward, RC; Hull, T; Santangelo, CD; Cohen, I				Silverberg, Jesse L.; Evans, Arthur A.; McLeod, Lauren; Hayward, Ryan C.; Hull, Thomas; Santangelo, Christian D.; Cohen, Itai			Using origami design principles to fold reprogrammable mechanical metamaterials	SCIENCE			English	Article							PROGRAMMABLE MATTER	Although broadly admired for its aesthetic qualities, the art of origami is now being recognized also as a framework for mechanical metamaterial design. Working with the Miura-ori tessellation, we find that each unit cell of this crease pattern is mechanically bistable, and by switching between states, the compressive modulus of the overall structure can be rationally and reversibly tuned. By virtue of their interactions, these mechanically stable lattice defects also lead to emergent crystallographic structures such as vacancies, dislocations, and grain boundaries. Each of these structures comes from an arrangement of reversible folds, highlighting a connection between mechanical metamaterials and programmable matter. Given origami's scale-free geometric character, this framework for metamaterial design can be directly transferred to milli-, micro-, and nanometer-size systems.	[Silverberg, Jesse L.; McLeod, Lauren; Cohen, Itai] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA; [Evans, Arthur A.; Santangelo, Christian D.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Hayward, Ryan C.] Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; [Hull, Thomas] Western New England Univ, Dept Math, Springfield, MA 01119 USA	Cornell University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Western New England University	Silverberg, JL (corresponding author), Cornell Univ, Dept Phys, Ithaca, NY 14853 USA.	JLS533@cornell.edu	Santangelo, Christian D/A-5665-2012; Hayward, Ryan C/P-4745-2016	Hayward, Ryan C/0000-0001-6483-2234; MCLEOD, ROBERT/0000-0001-6354-0168; Silverberg, Jesse/0000-0002-0075-9549; Cohen, Itai/0000-0001-9218-043X; Hull, Thomas/0000-0002-3215-9767	National Science Foundation [EFRI ODISSEI-1240441]; Graduate Research Fellowship Program; Directorate For Engineering [1240441] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Graduate Research Fellowship Program; Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	The authors thank R. J. Lang, B. Johnson, B. Parker, and M. Schneider for artistic inspiration, as well as N. Bende, J. Na, M. Byun, and the Cohen laboratory for useful discussions. We also thank F. Parish for assistance with the laser cutter, as well as X. Cheng, N. Lin, and B. Leahy for their design and construction efforts on the 3D laser scanner hardware. This work was funded by the National Science Foundation through award EFRI ODISSEI-1240441 and the Graduate Research Fellowship Program, which funded J.L.S.	Abbena E, 2006, MODERN DIFFERENTIAL; An B, 2011, ROBOTICA, V29, P87, DOI 10.1017/S0263574710000731; Bassik N, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3212896; Ben Amar M, 2013, P NATL ACAD SCI USA, V110, P10525, DOI 10.1073/pnas.1217391110; Bern M., 1996, P S DISCR ALG, V7, P175; Chaikin P. M., 2000, PRINCIPLES CONDENSED; Dias MA, 2012, EPL-EUROPHYS LETT, V100, DOI 10.1209/0295-5075/100/54005; Dias MA, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.114301; EBBESEN TW, 1995, ADV MATER, V7, P582, DOI 10.1002/adma.19950070618; Felton SM, 2013, IEEE INT CONF ROBOT, P277, DOI 10.1109/ICRA.2013.6630588; Fukushige T, 2005, J MICROELECTROMECH S, V14, P243, DOI 10.1109/JMEMS.2004.839345; Gatzke T.D., 2006, INT J SHAPE MODEL, V12, P1, DOI DOI 10.1142/S0218654306000810; Hawkes E, 2010, P NATL ACAD SCI USA, V107, P12441, DOI 10.1073/pnas.0914069107; Jamal M, 2013, ADV HEALTHC MATER, V2, P1142, DOI 10.1002/adhm.201200458; Kadic M, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/12/126501; Kim J, 2012, SCIENCE, V335, P1201, DOI 10.1126/science.1215309; Kim J, 2012, SOFT MATTER, V8, P2375, DOI 10.1039/c2sm06681e; Lee Jaimy, 2012, Mod Healthc, V42, P24; Lifshitz E. M., 1986, LANDAU LIFSHITZ COUR, V7; Liu AQ, 2012, J OPTICS-UK, V14, DOI 10.1088/2040-8978/14/11/114009; Liu YM, 2011, CHEM SOC REV, V40, P2494, DOI 10.1039/c0cs00184h; Mahadevan L, 2005, SCIENCE, V307, P1740, DOI 10.1126/science.1105169; Miura K, 1985, I SPACE ASTRONAUT SC, V618, P1; Onal C. D., 2011, 2011 IEEE International Conference on Robotics and Automation (ICRA 2011), P4608, DOI 10.1109/ICRA.2011.5980139; Papa A, 2008, J SPACECRAFT ROCKETS, V45, P10, DOI 10.2514/1.18285; Py C, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.156103; Ryu J, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3700719; Schenk M, 2013, P NATL ACAD SCI USA, V110, P3276, DOI 10.1073/pnas.1217998110; Shyer AE, 2013, SCIENCE, V342, P212, DOI 10.1126/science.1238842; Steltz E., 2009, IEEE RSJ INT C INT R, P5672; TOFFOLI T, 1991, PHYSICA D, V47, P263, DOI 10.1016/0167-2789(91)90296-L; Wegener M, 2013, SCIENCE, V342, P939, DOI 10.1126/science.1246545; Wei ZY, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.215501	33	558	577	101	932	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					647	650		10.1126/science.1252876	http://dx.doi.org/10.1126/science.1252876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104381				2022-12-28	WOS:000339962800032
J	Tour, JM				Tour, James M.			Seeds of selective nanotube growth	NATURE			English	Editorial Material							WALLED CARBON NANOTUBES; CATALYSTS		[Tour, James M.] Rice Univ, Dept Chem, Houston, TX 77005 USA; [Tour, James M.] Rice Univ, Dept Mat Sci & NanoEngn, Houston, TX 77005 USA; [Tour, James M.] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA	Rice University; Rice University; Rice University	Tour, JM (corresponding author), Rice Univ, Dept Chem, Houston, TX 77005 USA.	tour@rice.edu		Tour, James/0000-0002-8479-9328				Bachilo SM, 2002, SCIENCE, V298, P2361, DOI 10.1126/science.1078727; Doorn SK, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.016802; Dresselhaus M.S., 1996, SCI FULLERENES CARBO; Fort EH, 2011, J MATER CHEM, V21, P1373, DOI 10.1039/c0jm02517h; Haroz EH, 2013, NANOSCALE, V5, P1411, DOI 10.1039/c2nr32769d; Kitiyanan B, 2000, CHEM PHYS LETT, V317, P497, DOI 10.1016/S0009-2614(99)01379-2; Matsuda Y, 2010, J PHYS CHEM LETT, V1, P2946, DOI 10.1021/jz100889u; Pint CL, 2008, ACS NANO, V2, P1871, DOI 10.1021/nn8003718; Sanchez-Valencia JR, 2014, NATURE, V512, P61, DOI 10.1038/nature13607; Yang F, 2014, NATURE, V510, P522, DOI 10.1038/nature13434	10	12	12	0	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					30	31		10.1038/512030a	http://dx.doi.org/10.1038/512030a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM5NX	25100476				2022-12-28	WOS:000339908000020
J	Benton, MJ				Benton, Michael J.			How birds became birds	SCIENCE			English	Editorial Material							EVOLUTION; DINOSAUR; FEATHERS; COLOR		Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England	University of Bristol	Benton, MJ (corresponding author), Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England.	mike.benton@bristol.ac.uk	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824	NERC [NE/I027630/1] Funding Source: UKRI; Natural Environment Research Council [NE/I027630/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Allen V, 2013, NATURE, V497, P104, DOI 10.1038/nature12059; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Clarke J, 2013, SCIENCE, V340, P690, DOI 10.1126/science.1235463; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Godefroit P, 2014, SCIENCE, V345, P451, DOI 10.1126/science.1253351; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Lee MSY, 2014, SCIENCE, V345, P562, DOI 10.1126/science.1252243; Li QG, 2010, SCIENCE, V327, P1369, DOI 10.1126/science.1186290; Puttick MN, 2014, EVOLUTION, V68, P1497, DOI 10.1111/evo.12363; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Xu X, 2000, NATURE, V408, P705, DOI 10.1038/35047056; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740	13	5	5	5	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					508	509		10.1126/science.1257633	http://dx.doi.org/10.1126/science.1257633			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082682				2022-12-28	WOS:000339651300020
J	Guo, HS; Zhu, P; Yan, LY; Li, R; Hu, BQ; Lian, Y; Yan, J; Ren, XL; Lin, SL; Li, JS; Jin, XH; Shi, XD; Liu, P; Wang, XY; Wang, W; Wei, Y; Li, XL; Guo, F; Wu, XL; Fan, XY; Yong, J; Wen, L; Xie, SX; Tang, FC; Qiao, J				Guo, Hongshan; Zhu, Ping; Yan, Liying; Li, Rong; Hu, Boqiang; Lian, Ying; Yan, Jie; Ren, Xiulian; Lin, Shengli; Li, Junsheng; Jin, Xiaohu; Shi, Xiaodan; Liu, Ping; Wang, Xiaoye; Wang, Wei; Wei, Yuan; Li, Xianlong; Guo, Fan; Wu, Xinglong; Fan, Xiaoying; Yong, Jun; Wen, Lu; Xie, Sunney X.; Tang, Fuchou; Qiao, Jie			The DNA methylation landscape of human early embryos	NATURE			English	Article							STEM-CELLS; PREIMPLANTATION DEVELOPMENT; SINGLE-CELL; CHROMATIN STATE; HUMAN GENOME; PATTERNS; MAINTENANCE; EVOLUTION; DYNAMICS; OOCYTES	DNA methylation is a crucial element in the epigenetic regulation of mammalian embryonic development(1-5). However, its dynamic patterns have not been analysed at the genome scale in human preimplantation embryos due to technical difficulties and the scarcity of required materials. Here we systematically profile the methylome of human early embryos from the zygotic stage through to post-implantation by reduced representation bisulphite sequencing and whole-genome bisulphite sequencing. We show that the major wave of genome-wide demethylation is complete at the 2-cell stage, contrary to previous observations in mice. Moreover, the demethylation of the paternal genome is much faster than that of the maternal genome, and by the end of the zygotic stage the genome-wide methylation level in male pronudei is already lower than that in female pronudei. The inverse correlation between promoter methylation and gene expression gradually strengthens during early embryonic development, reaching its peak at the post-implantation stage. Furthermore, we show that active genes, with the trimethylation of histone H3 at lysine 4 (H3K4me3) mark at the promoter regions in pluripotent human embryonic stem cells, are essentially devoid of DNA methylation in both mature gametes and throughout pre-implantation development. Finally, we also show that long interspersed nuclear elements or short interspersed nuclear elements that are evolutionarily young are demethylated to a milder extent compared to older elements in the same family and have higher abundance of transcripts, indicating that early embryos tend to retain higher residual methylation at the evolutionarily younger and more active transposable elements. Our work provides insights into the critical features of the methylome of human early embryos, as well as its functional relation to the regulation of gene expression and the repression of transposable elements.	[Guo, Hongshan; Zhu, Ping; Yan, Liying; Li, Rong; Hu, Boqiang; Lian, Ying; Yan, Jie; Ren, Xiulian; Lin, Shengli; Li, Junsheng; Jin, Xiaohu; Shi, Xiaodan; Liu, Ping; Li, Xianlong; Guo, Fan; Wu, Xinglong; Fan, Xiaoying; Yong, Jun; Wen, Lu; Xie, Sunney X.; Tang, Fuchou; Qiao, Jie] Peking Univ, Hosp 3, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China; [Guo, Hongshan; Zhu, Ping; Yan, Liying; Li, Rong; Hu, Boqiang; Lian, Ying; Yan, Jie; Ren, Xiulian; Lin, Shengli; Li, Junsheng; Jin, Xiaohu; Shi, Xiaodan; Liu, Ping; Li, Xianlong; Guo, Fan; Wu, Xinglong; Fan, Xiaoying; Yong, Jun; Wen, Lu; Xie, Sunney X.; Tang, Fuchou; Qiao, Jie] Peking Univ, Hosp 3, Coll Life Sci, Ctr Reprod Med, Beijing 100871, Peoples R China; [Zhu, Ping] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Yan, Liying; Li, Rong; Lian, Ying; Yan, Jie; Ren, Xiulian; Lin, Shengli; Li, Junsheng; Jin, Xiaohu; Shi, Xiaodan; Liu, Ping; Qiao, Jie] Minist Educ, Key Lab Assisted Reprod, Beijing 100191, Peoples R China; [Wang, Xiaoye; Wang, Wei; Wei, Yuan] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing 100191, Peoples R China; [Yong, Jun; Xie, Sunney X.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Tang, Fuchou] Minist Educ, Key Lab Cell Proliferat & Differentia, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Peking University; Harvard University	Tang, FC (corresponding author), Peking Univ, Hosp 3, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing 100871, Peoples R China.	tangfuchou@pku.edu.cn; jie.qiao@263.net	Guo, Fan/J-1857-2019; Guo, Fan/AAX-4952-2021; Wu, Xinglong/GQH-0693-2022	Guo, Fan/0000-0002-0165-073X; Wu, Xinglong/0000-0003-4373-2511; Li, Xianlong/0000-0001-7745-2695; Zhu, Ping/0000-0002-4521-7524; Qiao, Jie/0000-0003-2126-1376	National Basic Research Program of China [2012CB966704, 2011CB944504, 2011CB966303, 2011CB944503]; National Natural Science of China [31322037, 31230047, 31271543, 81170538]; Beijing Municipal Science and Technology Commission [Z131100005213006]; National Natural Science Foundation of China [81000275]; National Key Technologies Research and Development Program [2012BAI32B01]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technologies Research and Development Program(National Key Technology R&D Program)	F.T. and J.Q. were supported by grants from the National Basic Research Program of China (2012CB966704, 2011CB944504 and 2011CB966303) and from the National Natural Science of China (31322037, 31230047, 31271543 and 81170538). J.Q. and F.T. were supported by a grant from the Beijing Municipal Science and Technology Commission (Z131100005213006). L.Y. was supported by grants from the National Natural Science Foundation of China (81000275) and National Basic Research Program of China (2011CB944503). R.L. was supported by a grant from National Key Technologies Research and Development Program (2012BAI32B01).	Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo HS, 2013, GENOME RES, V23, P2126, DOI 10.1101/gr.161679.113; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Inoue A, 2011, CELL RES, V21, P1670, DOI 10.1038/cr.2011.189; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li R, 2008, REPROD BIOMED ONLINE, V16, P627, DOI 10.1016/S1472-6483(10)60475-0; Li R, 2013, EUR J OBSTET GYN R B, V167, P146, DOI 10.1016/j.ejogrb.2012.11.018; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Niakan KK, 2012, DEVELOPMENT, V139, P829, DOI 10.1242/dev.060426; O'Leary T, 2012, NAT BIOTECHNOL, V30, P278, DOI 10.1038/nbt.2135; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seisenberger S, 2012, MOL CELL, V48, P849, DOI 10.1016/j.molcel.2012.11.001; Shirane K, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003439; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Van der Heijden GW, 2009, MOL REPROD DEV, V76, P101, DOI 10.1002/mrd.20933; Wu H, 2012, CELL STEM CELL, V10, P487, DOI 10.1016/j.stem.2012.04.012; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Zhu J, 2013, CELL, V152, P642, DOI 10.1016/j.cell.2012.12.033	40	577	608	10	260	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					606	+		10.1038/nature13544	http://dx.doi.org/10.1038/nature13544			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079557				2022-12-28	WOS:000339566300038
J	Thompson, IM; Tangen, CM				Thompson, Ian M.; Tangen, Catherine M.			Prostate cancer screening comes of age	LANCET			English	Editorial Material							TRIAL; RADIOTHERAPY; MORTALITY		[Thompson, Ian M.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Tangen, Catherine M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Fred Hutchinson Cancer Center	Thompson, IM (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA.	thompsoni@uthscsa.edu						Andriole GL, 2012, J NATL CANCER I, V104, P125, DOI 10.1093/jnci/djr500; D'Amico AV, 2008, JAMA-J AM MED ASSOC, V299, P289, DOI 10.1001/jama.299.3.289; Klotz L, 2010, J CLIN ONCOL, V28, P126, DOI 10.1200/JCO.2009.24.2180; Powell IJ, 2010, J UROLOGY, V183, P1792, DOI 10.1016/j.juro.2010.01.015; Roach M, 2008, J CLIN ONCOL, V26, P585, DOI 10.1200/JCO.2007.13.9881; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Schroder FH, 2014, LANCET; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Thompson IM, 2004, NEW ENGL J MED, V350, P2239, DOI 10.1056/NEJMoa031918; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	12	12	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 6	2014	384	9959					2004	2006		10.1016/S0140-6736(14)61008-4	http://dx.doi.org/10.1016/S0140-6736(14)61008-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AW6BD	25108887				2022-12-28	WOS:000346353600007
J	Chiasson, JL; Le Lorier, J				Chiasson, Jean-Louis; Le Lorier, Jacques			Glycaemic control, cardiovascular disease, and mortality in type 2 diabetes	LANCET			English	Editorial Material							GLUCOSE CONTROL; FOLLOW-UP		[Chiasson, Jean-Louis; Le Lorier, Jacques] Univ Montreal, Dept Med, CRCHUM, Montreal, PQ H2X 0A9, Canada	Universite de Montreal	Chiasson, JL (corresponding author), Univ Montreal, Dept Med, CRCHUM, 900 St Denis St,Pavill R, Montreal, PQ H2X 0A9, Canada.	jean.louis.chiasson@umontreal.ca						Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gaborit B, 2013, HORM METAB RES, V45, P991, DOI 10.1055/s-0033-1358669; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gerstein HC, 2014, LANCET; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Jankovic D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050077; Lachin JM, 2010, DIABETES CARE, V33, P2719, DOI 10.2337/dc10-1506; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pop-Busui R, 2010, DIABETES CARE, V33, P1578, DOI 10.2337/dc10-0125; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Winhofer Y, 2012, DIABETES, V61, P1210, DOI 10.2337/db11-1275	16	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 29	2014	384	9958					1906	1907		10.1016/S0140-6736(14)60884-9	http://dx.doi.org/10.1016/S0140-6736(14)60884-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AU2LP	25088436				2022-12-28	WOS:000345450100008
J	Pefanis, E; Wang, JG; Rothschild, G; Lim, J; Chao, J; Rabadan, R; Economides, AN; Basu, U				Pefanis, Evangelos; Wang, Jiguang; Rothschild, Gerson; Lim, Junghyun; Chao, Jaime; Rabadan, Raul; Economides, Aris N.; Basu, Uttiya			Noncoding RNA transcription targets AID to divergently transcribed loci in B cells	NATURE			English	Article							POLYMERASE-II; CHROMOSOMAL REARRANGEMENTS; PROMOTER DIRECTIONALITY; SOMATIC HYPERMUTATION; SEQUENCING REVEALS; EXOSOME; GENOME; DNA; LYMPHOCYTES; TERMINATION	The vast majority of the mammalian genome has the potential to express noncoding RNA (ncRNA). The 11-subunit RNA exosome complex is the main source of cellular 3'-5' exoribonucleolytic activity and potentially regulates the mammalian noncoding transcriptome(1). Here we generated a mouse model in which the essential subunit Exosc3 of the RNA exosome complex can be conditionally deleted. Exosc3-deficient B cells lack the ability to undergo normal levels of class switch recombination and somatic hypermutation, two mutagenic DNA processes used to generate antibody diversity via the B-cell mutator protein activation-induced cytidine deaminase (AID)(2,3). The transcriptome of Exosc3-deficient B cells has revealed the presence of many novel RNA exosome substrate ncRNAs. RNA exosome substrate RNAs include xTSS-RNAs, transcription start site (TSS)-associated antisense transcripts that can exceed 500 base pairs in length and are transcribed divergently from cognate coding gene transcripts. xTSS-RNAs are most strongly expressed at genes that accumulate AID mediated somatic mutations and/or are frequent translocation partners of DNA double-strand breaks generated at Igh in B cells(4,5). Strikingly, translocations near TSSs or within gene bodies occur over regions of RNA exosome substrate ncRNA expression. These RNA exosome-regulated, antisense-transcribed regions of the B-cell genome recruit AID and accumulate single-strand DNA structures containing RNA-DNA hybrids. We propose that RNA exosome regulation of ncRNA recruits AID to single-strand DNA-forming sites of antisense and divergent transcription in the B-cell genome, thereby creating a link between ncRNA transcription and overall maintenance of B-cell genomic integrity.	[Pefanis, Evangelos; Wang, Jiguang; Rothschild, Gerson; Lim, Junghyun; Chao, Jaime; Basu, Uttiya] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Pefanis, Evangelos; Economides, Aris N.] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Wang, Jiguang; Rabadan, Raul] Columbia Univ Coll Phys & Surg, Dept Syst Biol, New York, NY 10032 USA; [Wang, Jiguang; Rabadan, Raul] Columbia Univ Coll Phys & Surg, Dept Biomed Informat, New York, NY 10032 USA	Columbia University; Regeneron; Columbia University; Columbia University	Rabadan, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA.	rr2579@columbia.edu; ub2121@columbia.edu	Lim, Junghyun/AAX-3678-2021; Rabadan, Raul/AAZ-7367-2020; Wang, Jiguang/B-2717-2012	Lim, Junghyun/0000-0002-5292-7487; Rabadan, Raul/0000-0001-7946-9255; Wang, Jiguang/0000-0002-6923-4097; Economides, Aris/0000-0002-6508-8942	National Institutes of Health (NIH) [1DP2OD008651-01]; National Institute of Allergy and Infectious Diseases [1R01AI099195-01A1]; NIH [1R01CA185486-01, 1R01CA179044-01A1, 1U54CA121852-05]; NATIONAL CANCER INSTITUTE [R01CA179044, R01CA185486, U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099195] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008651] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank L. Symington, S. Goff, S. Ghosh, S. Silverstein, C. Lima, F. Chedin, L. Macdonald, C.-S. Lin and O. Couronne for critical input and reagents. This work was supported by grants from the National Institutes of Health (NIH; 1DP2OD008651-01) and the National Institute of Allergy and Infectious Diseases (1R01AI099195-01A1) (to U. B.); NIH (1R01CA185486-01; 1R01CA179044-01A1; 1U54CA121852-05) (to R.R.).	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen PR, 2013, NAT STRUCT MOL BIOL, V20, P1367, DOI 10.1038/nsmb.2703; Andersen PK, 2013, WIRES RNA, V4, P233, DOI 10.1002/wrna.1156; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Basu U, 2011, CELL, V144, P353, DOI 10.1016/j.cell.2011.01.001; Castellano-Pozo M, 2013, MOL CELL, V52, P583, DOI 10.1016/j.molcel.2013.10.006; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Economides AN, 2013, P NATL ACAD SCI USA, V110, pE3179, DOI 10.1073/pnas.1217812110; Flynn RA, 2012, CURR OPIN GENET DEV, V22, P172, DOI 10.1016/j.gde.2011.11.002; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Frendewey D, 2010, METHOD ENZYMOL, V476, P295, DOI 10.1016/S0076-6879(10)76017-1; Ginno PA, 2012, MOL CELL, V45, P814, DOI 10.1016/j.molcel.2012.01.017; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Jolly CJ, 1997, NUCLEIC ACIDS RES, V25, P1913, DOI 10.1093/nar/25.10.1913; Keim C, 2013, GENE DEV, V27, P1, DOI 10.1101/gad.200014.112; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Lohr JG, 2012, P NATL ACAD SCI USA, V109, P3879, DOI 10.1073/pnas.1121343109; Ntini E, 2013, NAT STRUCT MOL BIOL, V20, P923, DOI 10.1038/nsmb.2640; Oliveira TY, 2012, J IMMUNOL METHODS, V375, P176, DOI 10.1016/j.jim.2011.10.007; Pasqualucci L, 2011, NAT GENET, V43, P830, DOI 10.1038/ng.892; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Schneider C, 2013, TRENDS BIOCHEM SCI, V38, P485, DOI 10.1016/j.tibs.2013.06.013; Schulz D, 2013, CELL, V155, P1075, DOI 10.1016/j.cell.2013.10.024; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Storb U, 2014, ADV IMMUNOL, V122, P253, DOI 10.1016/B978-0-12-800267-4.00007-9; Sun JB, 2013, GENE DEV, V27, P1821, DOI 10.1101/gad.210211.112; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	40	116	119	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2014	514	7522					389	+		10.1038/nature13580	http://dx.doi.org/10.1038/nature13580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ7JH	25119026	Green Accepted			2022-12-28	WOS:000342988600057
J	Hwang, YJ; Dixon, SN; Reiss, JP; Wald, R; Parikh, CR; Gandhi, S; Shariff, SZ; Pannu, N; Nash, DM; Rehman, F; Garg, AX				Hwang, Y. Joseph; Dixon, Stephanie N.; Reiss, Jeffrey P.; Wald, Ron; Parikh, Chirag R.; Gandhi, Sonja; Shariff, Salimah Z.; Pannu, Neesh; Nash, Danielle M.; Rehman, Faisal; Garg, Amit X.			Atypical Antipsychotic Drugs and the Risk for Acute Kidney Injury and Other Adverse Outcomes in Older Adults A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							NEUROLEPTIC MALIGNANT SYNDROME; URINARY RETENTION; OLANZAPINE; RISPERIDONE; DEMENTIA; EFFICACY; SAFETY	Background: Several adverse outcomes attributed to atypical anti-psychotic drugs, specifically quetiapine, risperidone, and olanzapine, are known to cause acute kidney injury (AKI). Such outcomes include hypotension, acute urinary retention, and the neuroleptic malignant syndrome or rhabdomyolysis. Objective: To investigate the risk for AKI and other adverse outcomes associated with use of atypical antipsychotic drugs versus nonuse. Design: Population-based cohort study. Setting: Ontario, Canada, from 2003 to 2012. Patients: Adults aged 65 years or older who received a new outpatient prescription for an oral atypical antipsychotic drug (n = 97 777) matched 1:1 with those who did not receive such a prescription. Measurements: The primary outcome was hospitalization with AKI (assessed by using a hospital diagnosis code and, in a subpopulation, serum creatinine levels) within 90 days of prescription for atypical antipsychotic drugs. Results: Atypical antipsychotic drug use versus nonuse was associated with a higher risk for hospitalization with AKI (relative risk [RR], 1.73 [95% CI, 1.55 to 1.92]). This association was consistent when AKI was assessed in a subpopulation for which information on serum creatinine levels was available (5.46% vs. 3.34%; RR, 1.70 [CI, 1.22 to 2.38]; absolute risk increase, 2.12% [CI, 0.80% to 3.43%]). Drug use was also associated with hypotension (RR, 1.91 [CI, 1.60 to 2.28]), acute urinary retention (RR, 1.98 [CI, 1.63 to 2.40]), and all-cause mortality (RR, 2.39 [CI, 2.28 to 2.50]). Limitation: Only older adults were included in the study. Conclusion: Atypical antipsychotic drug use is associated with an increased risk for AKI and other adverse outcomes that may explain the observed association with AKI. The findings support current safety concerns about the use of these drugs in older adults.	[Hwang, Y. Joseph; Dixon, Stephanie N.; Shariff, Salimah Z.; Garg, Amit X.] London Hlth Sci Ctr, London Kidney Clin Res Unit, London, ON N6A 4G5, Canada; [Reiss, Jeffrey P.] London Hlth Sci Ctr, London, ON N6A 5W9, Canada; [Wald, Ron] St Michaels Hosp, Div Nephrol, Toronto, ON M5C 2T2, Canada; [Parikh, Chirag R.] Yale Univ, New Haven, CT 06510 USA; [Parikh, Chirag R.] Vet Affairs Med Ctr, New Haven, CT 06510 USA; [Pannu, Neesh] Univ Alberta, Div Nephrol & Crit Care, Edmonton, AB T6G 2G3, Canada; [Rehman, Faisal] Univ Hosp, London, ON N6A 5A5, Canada	London Health Sciences Centre; London Health Sciences Centre; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; University of Alberta; Western University (University of Western Ontario)	Garg, AX (corresponding author), London Hlth Sci Ctr, London Kidney Clin Res Unit, Room ELL 101,800 Commissioners Rd East, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Rehman, Faisal/GYA-3738-2022	Parikh, Chirag/0000-0001-9051-7385; Shariff, Salimah/0000-0002-1219-6763	Academic Medical Organization of Southwestern Ontario	Academic Medical Organization of Southwestern Ontario	Academic Medical Organization of Southwestern Ontario.	Ahuja N, 2010, J PSYCHOPHARMACOL, V24, P125, DOI 10.1177/0269881108096901; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Cohen Randi, 2007, Am J Geriatr Pharmacother, V5, P241, DOI 10.1016/j.amjopharm.2007.09.003; Duggal HS, 2008, PROG NEURO-PSYCHOPH, V32, P1074, DOI 10.1016/j.pnpbp.2008.01.010; Finkel S, 2004, J AM GERIATR SOC, V52, pS258, DOI 10.1111/j.1532-5415.2004.52602.x; Fleet JL, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-81; Gandhi S, 2013, JAMA-J AM MED ASSOC, V310, P2544, DOI 10.1001/jama.2013.282426; Gandhi S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001921; Health Canada, 2005, INCR MORT ASS US AT; Hilmer SN, 2012, J GERONTOL A-BIOL, V67, P181, DOI 10.1093/gerona/glr066; Hwang YJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001821; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Juurlink D, 2006, CANADIAN I HLTH INFO; Khan I, 2011, CHEST, V140, p113A, DOI [10.1378/chest.1114380, DOI 10.1378/CHEST.1114380]; Kidney Disease: Improving Global Outcomes (KDIGO), 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Knol W, 2008, J AM GERIATR SOC, V56, P661, DOI 10.1111/j.1532-5415.2007.01625.x; Lam NN, 2013, AM J KIDNEY DIS, V61, P723, DOI 10.1053/j.ajkd.2012.12.008; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Pariente A, 2012, ARCH INTERN MED, V172, P648, DOI 10.1001/archinternmed.2012.28; Patel AM, 2013, ANN INTERN MED, V158, P869, DOI 10.7326/0003-4819-158-12-201306180-00004; Rabins PV, 2005, JAMA-J AM MED ASSOC, V294, P1963, DOI 10.1001/jama.294.15.1963; RAITASUO V, 1994, LANCET, V344, P1705, DOI 10.1016/S0140-6736(94)90489-8; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Reid RJ, 2001, MED CARE, V39, P86, DOI 10.1097/00005650-200101000-00010; Ritchie CW, 2006, INT J GERIATR PSYCH, V21, P171, DOI 10.1002/gps.1446; Sajatovic M, 2008, BIPOLAR DISORD, V10, P662, DOI 10.1111/j.1399-5618.2008.00614.x; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Shih AWY, 2012, KIDNEY INT, V82, P903, DOI 10.1038/ki.2012.227; Sokolski KN, 2004, ANN PHARMACOTHER, V38, P899, DOI 10.1345/aph.1D502; Sturmer T, 2011, EPIDEMIOLOGY, V22, P298, DOI 10.1097/EDE.0b013e318212640c; U.S. Food and Drug Administration, 2005, PUBL HLTH ADV DEATHS; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Weir MA, 2011, ARCH INTERN MED, V171, P703, DOI 10.1001/archinternmed.2011.103; Zhao YY, 2012, ANN INTERN MED, V156, P560, DOI [10.7326/0003-4819-156-8-201204170-00401, 10.7326/0003-4819-156-8-201204170-00003]	36	82	85	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 19	2014	161	4					242	+		10.7326/M13-2796	http://dx.doi.org/10.7326/M13-2796			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AP8RU	25133360				2022-12-28	WOS:000342347300014
J	Laurance, J				Laurance, Jeremy			Donald Nixon Ross Obituary	LANCET			English	Biographical-Item																		ROSS DH, PUBLICATION LIST	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 16	2014	384	9943					576	576		10.1016/S0140-6736(14)61356-8	http://dx.doi.org/10.1016/S0140-6736(14)61356-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN4QR	25136720				2022-12-28	WOS:000340573300014
J	Hoadley, KA; Yau, C; Wolf, DM; Cherniack, AD; Tamborero, D; Ng, S; Leiserson, MDM; Niu, BF; McLellan, MD; Uzunangelov, V; Zhang, JS; Kandoth, C; Akbani, R; Shen, H; Omberg, L; Chu, A; Margolin, AA; van't Veer, LJ; Lopez-Bigas, N; Laird, PW; Raphael, BJ; Ding, L; Robertson, AG; Byers, LA; Mills, GB; Weinstein, JN; Van Waes, C; Chen, Z; Collisson, EA; Benz, CC; Perou, CM; Stuart, JM; Abbott, R; Abbott, S; Aksoy, BA; Aldape, K; Ally, A; Amin, S; Anastassiou, D; Auman, JT; Baggerly, KA; Balasundaram, M; Balu, S; Baylin, SB; Benz, SC; Berman, BP; Bernard, B; Bhatt, AS; Birol, I; Black, AD; Bodenheimer, T; Bootwalla, MS; Bowen, J; Bressler, R; Bristow, CA; Brooks, AN; Broom, B; Buda, E; Burton, R; Butterfield, YSN; Carlin, D; Carter, SL; Casasent, TD; Chang, K; Chanock, S; Chin, L; Cho, DY; Cho, J; Chuah, E; Chun, HJE; Cibulskis, K; Ciriello, G; Cleland, J; Cline, M; Craft, B; Creighton, CJ; Danilova, L; Davidsen, T; Davis, C; Dees, ND; Delehaunty, K; Demchok, JA; Dhalla, N; DiCara, D; Dinh, H; Dobson, JR; Dodda, D; Doddapaneni, H; Donehower, L; Dooling, DJ; Dresdner, G; Drummond, J; Eakin, A; Edgerton, M; Eldred, JM; Eley, G; Ellrott, K; Fan, C; Fei, S; Felau, I; Frazer, S; Freeman, SS; Frick, J; Fronick, CC; Fulton, LL; Fulton, R; Gabriel, SB; Gao, JJ; Gastier-Foster, JM; Gehlenborg, N; George, M; Getz, G; Gibbs, R; Goldman, M; Gonzalez-Perez, A; Gross, B; Guin, R; Gunaratne, P; Hadjipanayis, A; Hamilton, MP; Hamilton, SR; Han, L; Han, Y; Harper, HA; Haseley, P; Haussler, D; Hayes, DN; Heiman, DI; Helman, E; Helsel, C; Herbrich, SM; Herman, JG; Hinoue, T; Hirst, C; Hirst, M; Holt, RA; Hoyle, AP; Iype, L; Jacobsen, A; Jeffreys, SR; Jensen, MA; Jones, CD; Jones, SJM; Ju, ZL; Jung, J; Kahles, A; Kahn, A; Kalicki-Veizer, J; Kalra, D; Kanchi, KL; Kane, DW; Kim, H; Kim, J; Knijnenburg, T; Koboldt, DC; Kovar, C; Kramer, R; Kreisberg, R; Kucherlapati, R; Ladanyi, M; Lander, ES; Larson, DE; Lawrence, MS; Lee, D; Lee, E; Lee, S; Lee, W; Lehmann, KV; Leinonen, K; Leraas, KM; Lerner, S; Levine, DA; Lewis, L; Ley, TJ; Li, HI; Li, J; Li, W; Liang, H; Lichtenberg, TM; Lin, J; Lin, L; Lin, P; Liu, WB; Liu, YC; Liu, YX; Lorenzi, PL; Lu, C; Lu, YL; Luquette, LJ; Ma, S; Magrini, VJ; Mahadeshwar, HS; Mardis, ER; Margolin, A; Marra, MA; Mayo, M; McAllister, C; McGuire, SE; McMichael, JF; Melott, J; Meng, SW; Meyerson, M; Mieczkowski, PA; Miller, CA; Miller, ML; Miller, M; Moore, RA; Morgan, M; Morton, D; Mose, LE; Mungall, AJ; Muzny, D; Nguyen, L; Noble, MS; Noushmehr, H; O'Laughlin, M; Ojesina, AI; Yang, TO; Ozenberger, B; Pantazi, A; Parfenov, M; Park, PJ; Parker, JS; Paull, E; Pedamallu, CS; Pihl, T; Pohl, C; Pot, D; Protopopov, A; Przytycka, T; Radenbaugh, A; Ramirez, NC; Ramirez, R; Ratsch, G; Reid, J; Ren, XJ; Reva, B; Reynolds, SM; Rhie, SK; Roach, J; Rovira, H; Ryan, M; Saksena, G; Salama, S; Sander, C; Santoso, N; Schein, JE; Schmidt, H; Schultz, N; Schumacher, SE; Seidman, J; Senbabaoglu, Y; Seth, S; Sharpe, S; Shen, RL; Sheth, M; Shi, Y; Shmulevich, I; Silva, GO; Simons, JV; Sinha, R; Sipahimalani, P; Smith, SM; Sofia, HJ; Sokolov, A; Soloway, MG; Song, XZ; Sougnez, C; Spellman, P; Staudt, L; Stewart, C; Stojanov, P; Su, XP; Sumer, SO; Sun, YC; Swatloski, T; Tabak, B; Tam, A; Tan, DH; Tang, JB; Tarnuzzer, R; Taylor, BS; Thiessen, N; Thorsson, V; Triche, T; Van Den Berg, DJ; Vandin, F; Varhol, RJ; Vaske, CJ; Veluvolu, U; Verhaak, R; Voet, D; Walker, J; Wallis, JW; Waltman, P; Wan, YH; Wang, M; Wang, WY; Wang, ZN; Waring, S; Weinhold, N; Weisenberger, DJ; Wendl, MC; Wheeler, D; Wilkerson, MD; Wilson, RK; Wise, L; Wong, A; Wu, CJ; Wu, CC; Wu, HT; Wu, JY; Wylie, T; Xi, L; Xi, RB; Xia, Z; Xu, AW; Yang, D; Yang, LM; Yang, LX; Yang, Y; Yao, J; Yao, R; Ye, K; Yoshihara, K; Yuan, Y; Yung, AK; Zack, T; Zeng, D; Zenklusen, JC; Zhang, HL; Zhang, JH; Zhang, NX; Zhang, QY; Zhang, W; Zhao, W; Zheng, SY; Zhu, J; Zmuda, E; Zou, LH				Hoadley, Katherine A.; Yau, Christina; Wolf, Denise M.; Cherniack, Andrew D.; Tamborero, David; Ng, Sam; Leiserson, Max D. M.; Niu, Beifang; McLellan, Michael D.; Uzunangelov, Vladislav; Zhang, Jiashan; Kandoth, Cyriac; Akbani, Rehan; Shen, Hui; Omberg, Larsson; Chu, Andy; Margolin, Adam A.; van't Veer, Laura J.; Lopez-Bigas, Nuria; Laird, Peter W.; Raphael, Benjamin J.; Ding, Li; Robertson, A. Gordon; Byers, Lauren A.; Mills, Gordon B.; Weinstein, John N.; Van Waes, Carter; Chen, Zhong; Collisson, Eric A.; Benz, Christopher C.; Perou, Charles M.; Stuart, Joshua M.; Abbott, Rachel; Abbott, Scott; Aksoy, B. Arman; Aldape, Kenneth; Ally, Adrian; Amin, Samirkumar; Anastassiou, Dimitris; Auman, J. Todd; Baggerly, Keith A.; Balasundaram, Miruna; Balu, Saianand; Baylin, Stephen B.; Benz, Stephen C.; Berman, Benjamin P.; Bernard, Brady; Bhatt, Ami S.; Birol, Inanc; Black, Aaron D.; Bodenheimer, Tom; Bootwalla, Moiz S.; Bowen, Jay; Bressler, Ryan; Bristow, Christopher A.; Brooks, Angela N.; Broom, Bradley; Buda, Elizabeth; Burton, Robert; Butterfield, Yaron S. N.; Carlin, Daniel; Carter, Scott L.; Casasent, Tod D.; Chang, Kyle; Chanock, Stephen; Chin, Lynda; Cho, Dong-Yeon; Cho, Juok; Chuah, Eric; Chun, Hye-Jung E.; Cibulskis, Kristian; Ciriello, Giovanni; Cleland, James; Cline, Melisssa; Craft, Brian; Creighton, Chad J.; Danilova, Ludmila; Davidsen, Tanja; Davis, Caleb; Dees, Nathan D.; Delehaunty, Kim; Demchok, John A.; Dhalla, Noreen; DiCara, Daniel; Dinh, Huyen; Dobson, Jason R.; Dodda, Deepti; Doddapaneni, HarshaVardhan; Donehower, Lawrence; Dooling, David J.; Dresdner, Gideon; Drummond, Jennifer; Eakin, Andrea; Edgerton, Mary; Eldred, Jim M.; Eley, Greg; Ellrott, Kyle; Fan, Cheng; Fei, Suzanne; Felau, Ina; Frazer, Scott; Freeman, Samuel S.; Frick, Jessica; Fronick, Catrina C.; Fulton, Lucinda L.; Fulton, Robert; Gabriel, Stacey B.; Gao, Jianjiong; Gastier-Foster, Julie M.; Gehlenborg, Nils; George, Myra; Getz, Gad; Gibbs, Richard; Goldman, Mary; Gonzalez-Perez, Abel; Gross, Benjamin; Guin, Ranabir; Gunaratne, Preethi; Hadjipanayis, Angela; Hamilton, Mark P.; Hamilton, Stanley R.; Han, Leng; Han, Yi; Harper, Hollie A.; Haseley, Psalm; Haussler, David; Hayes, D. Neil; Heiman, David I.; Helman, Elena; Helsel, Carmen; Herbrich, Shelley M.; Herman, James G.; Hinoue, Toshinori; Hirst, Carrie; Hirst, Martin; Holt, Robert A.; Hoyle, Alan P.; Iype, Lisa; Jacobsen, Anders; Jeffreys, Stuart R.; Jensen, Mark A.; Jones, Corbin D.; Jones, Steven J. M.; Ju, Zhenlin; Jung, Joonil; Kahles, Andre; Kahn, Ari; Kalicki-Veizer, Joelle; Kalra, Divya; Kanchi, Krishna-Latha; Kane, David W.; Kim, Hoon; Kim, Jaegil; Knijnenburg, Theo; Koboldt, Daniel C.; Kovar, Christie; Kramer, Roger; Kreisberg, Richard; Kucherlapati, Raju; Ladanyi, Marc; Lander, Eric S.; Larson, David E.; Lawrence, Michael S.; Lee, Darlene; Lee, Eunjung; Lee, Semin; Lee, William; Lehmann, Kjong-Van; Leinonen, Kalle; Leraas, Kristen M.; Lerner, Seth; Levine, Douglas A.; Lewis, Lora; Ley, Timothy J.; Li, Haiyan I.; Li, Jun; Li, Wei; Liang, Han; Lichtenberg, Tara M.; Lin, Jake; Lin, Ling; Lin, Pei; Liu, Wenbin; Liu, Yingchun; Liu, Yuexin; Lorenzi, Philip L.; Lu, Charles; Lu, Yiling; Luquette, Lovelace J.; Ma, Singer; Magrini, Vincent J.; Mahadeshwar, Harshad S.; Mardis, Elaine R.; Margolin, Adam; Marra, Marco A.; Mayo, Michael; McAllister, Cynthia; McGuire, Sean E.; McMichael, Joshua F.; Melott, James; Meng, Shaowu; Meyerson, Matthew; Mieczkowski, Piotr A.; Miller, Christopher A.; Miller, Martin L.; Miller, Michael; Moore, Richard A.; Morgan, Margaret; Morton, Donna; Mose, Lisle E.; Mungall, Andrew J.; Muzny, Donna; Nguyen, Lam; Noble, Michael S.; Noushmehr, Houtan; O'Laughlin, Michelle; Ojesina, Akinyemi I.; Yang, TaiHsien Ou; Ozenberger, Brad; Pantazi, Angeliki; Parfenov, Michael; Park, Peter J.; Parker, Joel S.; Paull, Evan; Pedamallu, Chandra Sekhar; Pihl, Todd; Pohl, Craig; Pot, David; Protopopov, Alexei; Przytycka, Teresa; Radenbaugh, Amie; Ramirez, Nilsa C.; Ramirez, Ricardo; Ratsch, Gunnar; Reid, Jeffrey; Ren, Xiaojia; Reva, Boris; Reynolds, Sheila M.; Rhie, Suhn K.; Roach, Jeffrey; Rovira, Hector; Ryan, Michael; Saksena, Gordon; Salama, Sofie; Sander, Chris; Santoso, Netty; Schein, Jacqueline E.; Schmidt, Heather; Schultz, Nikolaus; Schumacher, Steven E.; Seidman, Jonathan; Senbabaoglu, Yasin; Seth, Sahil; Sharpe, Samantha; Shen, Ronglai; Sheth, Margi; Shi, Yan; Shmulevich, Ilya; Silva, Grace O.; Simons, Janae V.; Sinha, Rileen; Sipahimalani, Payal; Smith, Scott M.; Sofia, Heidi J.; Sokolov, Artem; Soloway, Mathew G.; Song, Xingzhi; Sougnez, Carrie; Spellman, Paul; Staudt, Louis; Stewart, Chip; Stojanov, Petar; Su, Xiaoping; Sumer, S. Onur; Sun, Yichao; Swatloski, Teresa; Tabak, Barbara; Tam, Angela; Tan, Donghui; Tang, Jiabin; Tarnuzzer, Roy; Taylor, Barry S.; Thiessen, Nina; Thorsson, Vesteinn; Triche, Timothy, Jr.; Van Den Berg, David J.; Vandin, Fabio; Varhol, Richard J.; Vaske, Charles J.; Veluvolu, Umadevi; Verhaak, Roeland; Voet, Doug; Walker, Jason; Wallis, John W.; Waltman, Peter; Wan, Yunhu; Wang, Min; Wang, Wenyi; Wang, Zhining; Waring, Scot; Weinhold, Nils; Weisenberger, Daniel J.; Wendl, Michael C.; Wheeler, David; Wilkerson, Matthew D.; Wilson, Richard K.; Wise, Lisa; Wong, Andrew; Wu, Chang-Jiun; Wu, Chia-Chin; Wu, Hsin-Ta; Wu, Junyuan; Wylie, Todd; Xi, Liu; Xi, Ruibin; Xia, Zheng; Xu, Andrew W.; Yang, Da; Yang, Liming; Yang, Lixing; Yang, Yang; Yao, Jun; Yao, Rong; Ye, Kai; Yoshihara, Kosuke; Yuan, Yuan; Yung, Alfred K.; Zack, Travis; Zeng, Dong; Zenklusen, Jean Claude; Zhang, Hailei; Zhang, Jianhua; Zhang, Nianxiang; Zhang, Qunyuan; Zhang, Wei; Zhao, Wei; Zheng, Siyuan; Zhu, Jing; Zmuda, Erik; Zou, Lihua		Canc Genome Atlas Res Network	Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin	CELL			English	Article							CELL LUNG-CANCER; MUTATIONS; CISPLATIN; MIGRATION; MODELS; GENES; HEAD	Recent genomic analyses of pathologically defined tumor types identify "within-a-tissue'' disease subtypes. However, the extent to which genomic signatures are shared across tissues is still unclear. We performed an integrative analysis using five genome-wide platforms and one proteomic platform on 3,527 specimens from 12 cancer types, revealing a unified classification into 11 major subtypes. Five subtypes were nearly identical to their tissue-oforigin counterparts, but several distinct cancer types were found to converge into common subtypes. Lung squamous, head and neck, and a subset of bladder cancers coalesced into one subtype typified by TP53 alterations, TP63 amplifications, and high expression of immune and proliferation pathway genes. Of note, bladder cancers split into three pancancer subtypes. The multiplatform classification, while correlated with tissue-of-origin, provides independent information for predicting clinical outcomes. All data sets are available for data-mining from a unified resource to support further biological discoveries and insights into novel therapeutic strategies.	[Hoadley, Katherine A.; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Yau, Christina; Benz, Christopher C.] Buck Inst Res Aging, Novato, CA 94945 USA; [Wolf, Denise M.; van't Veer, Laura J.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94115 USA; [Cherniack, Andrew D.] Harvard & MIT, Eli & Edythe Broad Inst, Cambridge, MA 02142 USA; [Tamborero, David; Lopez-Bigas, Nuria] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Res Unit Biomed Informat, Barcelona 08003, Spain; [Ng, Sam; Uzunangelov, Vladislav; Stuart, Joshua M.] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Leiserson, Max D. M.; Raphael, Benjamin J.] Brown Univ, Dept Comp Sci, Providence, RI 02912 USA; [Leiserson, Max D. M.; Raphael, Benjamin J.] Brown Univ, Ctr Computat Mol Biol, Providence, RI 02912 USA; [Niu, Beifang; McLellan, Michael D.; Kandoth, Cyriac; Ding, Li] Washington Univ, Genome Inst, St Louis, MO 63108 USA; [Zhang, Jiashan] NCI, NIH, Bethesda, MD 20892 USA; [Akbani, Rehan; Byers, Lauren A.; Mills, Gordon B.; Weinstein, John N.] UT MD Anderson Canc Ctr, Houston, TX 77030 USA; [Shen, Hui; Laird, Peter W.] Univ So Calif, Keck Sch Med, Epigenome Ctr, Los Angeles, CA 90033 USA; [Omberg, Larsson; Margolin, Adam A.] Sage Bionetworks, Seattle, WA 98109 USA; [Chu, Andy; Robertson, A. Gordon] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Lopez-Bigas, Nuria] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain; [Collisson, Eric A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94148 USA; [Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Van Waes, Carter] NIDCD, NIH, Bethesda, MD 20892 USA; [Chen, Zhong] NIDCD, NIH, Head & Neck Surg Branch, Bethesda, MD 20892 USA	University of North Carolina; University of North Carolina Chapel Hill; Buck Institute for Research on Aging; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Pompeu Fabra University; University of California System; University of California Santa Cruz; Brown University; Brown University; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Southern California; British Columbia Cancer Agency; ICREA; University of California System; University of California San Francisco; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Benz, CC (corresponding author), Buck Inst Res Aging, Novato, CA 94945 USA.	cbenz@buckinstitute.org; cperou@med.unc.edu; jstuart@ucsc.edu	Magrini, Vincent/AAT-5830-2020; Zheng, sy/GRS-3136-2022; Akbani, Rehan/AAG-1490-2019; Xia, Zheng/AAC-5360-2022; Kim, Hoon/AAL-9283-2020; Van Den Berg, David J/G-8598-2017; Pedamallu, Chandra Sekhar/AAV-6723-2020; liu, ying/GXF-4294-2022; Mardis, Elaine/W-2202-2019; Li, Jun/AAE-4393-2022; Laird, Peter W/G-8683-2012; Verhaak, Roel/ABE-7058-2020; Shen, Hui/AAO-4387-2020; Cherniack, Andrew/AAC-5310-2019; Kalra, D/H-6661-2019; Ladanyi, Marc/AAG-8585-2019; LIU, YING/GZL-7252-2022; Ye, Kai/GSD-9856-2022; Hirst, Martin/B-7684-2016; Parker, Joel/AAG-1108-2019; Holt, Robert A/C-3303-2009; Yuan, Yuan/H-4007-2013; Rätsch, Gunnar/O-5914-2017; Schultz, Nikolaus/ABE-6347-2020; Wu, Chia-Chin/ABD-5516-2021; Lopez-Bigas, Nuria/F-6193-2011; Li, Jun/O-9911-2014; N, Houtan/C-9692-2013; Kahles, Andre/ABB-8343-2020; Staudt, Louis/AAC-5324-2019; BERMAN, BENJAMIN/AAT-3720-2021; Cherniack, Andrew D./AAY-8132-2020; Marra, Marco A/B-5987-2008; Drummond, Jennifer/AAG-1654-2020; tamborero, david/M-5283-2015; Pedamallu, Chandra Sekhar/AAV-6745-2020; Perou, Charles M/H-9934-2014; Kucherlapati, Raju/ABC-8807-2021; Jones, Steven J/C-3621-2009; Skanderup, Anders Jacobsen/K-1081-2013; Wilson, Richard K./AAF-4139-2019; Cibulskis, Kristian/AAC-7380-2019; Stojanov, Petar/GQI-4462-2022; Gao, JianJiong/B-5673-2016; Han, Leng/HCH-3491-2022; Lawrence, Michael/AAC-8202-2020; Salama, Sofie/K-6412-2019; Reva, Boris/AAB-8932-2022; Mungall, Andrew J./U-7067-2018; Yoshihara, Kosuke/AAU-9874-2020; Seth, Sahil/I-5809-2019; Schein, Jacquie E/G-3674-2015; Birol, Inanc/G-5440-2011; Weisenberger, Daniel/AAA-8314-2020; Gasull, Martina/J-4076-2019; Vaske, Charles/D-6018-2013	Magrini, Vincent/0000-0002-2019-4872; Xia, Zheng/0000-0003-3364-8324; Kim, Hoon/0000-0003-4244-6126; Van Den Berg, David J/0000-0002-5404-5218; Li, Jun/0000-0002-1171-7141; Laird, Peter W/0000-0001-9117-3641; Kalra, D/0000-0001-5254-4067; Ye, Kai/0000-0002-2851-6741; Holt, Robert A/0000-0002-7259-1247; Yuan, Yuan/0000-0003-4706-7897; Rätsch, Gunnar/0000-0001-5486-8532; Wu, Chia-Chin/0000-0002-5208-6016; Lopez-Bigas, Nuria/0000-0003-4925-8988; Li, Jun/0000-0002-1171-7141; N, Houtan/0000-0003-4051-8114; Kahles, Andre/0000-0002-3411-0692; BERMAN, BENJAMIN/0000-0002-2099-9005; Cherniack, Andrew D./0000-0003-0470-0111; Marra, Marco A/0000-0001-7146-7175; Drummond, Jennifer/0000-0002-2612-5958; tamborero, david/0000-0002-7218-2806; Perou, Charles M/0000-0001-9827-2247; Jones, Steven J/0000-0003-3394-2208; Skanderup, Anders Jacobsen/0000-0001-6847-4980; Wilson, Richard K./0000-0002-1992-1358; Stojanov, Petar/0000-0001-7815-776X; Gao, JianJiong/0000-0002-5739-1781; Han, Leng/0000-0002-7380-2640; Mungall, Andrew J./0000-0002-0905-2742; Yoshihara, Kosuke/0000-0002-2254-3378; Seth, Sahil/0000-0003-4579-3959; Birol, Inanc/0000-0003-0950-7839; Weisenberger, Daniel/0000-0001-8303-2603; Przytycka, Teresa/0000-0002-6261-277X; Lehmann, Kjong-Van/0000-0002-1936-298X; Weinstein, John/0000-0001-9401-6908; Sinha, Rileen/0000-0001-5497-5055; Xi, Ruibin/0000-0001-7545-7361; Gonzalez-Perez, Abel/0000-0002-8582-4660; Park, Peter/0000-0001-9378-960X; Omberg, Larsson/0000-0002-4719-9120; Heiman, David/0000-0001-7895-4259; Shen, Hui/0000-0001-9767-4084; Pot, David/0000-0002-1480-9826; Benz, Stephen/0000-0002-4067-0602; Jensen, Mark/0000-0001-5215-101X; Chang, Kyle/0000-0001-5295-9676; Dobson, Jason/0000-0002-2306-2250; Vaske, Charles/0000-0001-8151-6612; Bowen, Jay/0000-0001-6861-9043; Cho, Dongyeon/0000-0002-4421-9982; Stuart, Joshua/0000-0002-2171-565X; Auman, James/0000-0002-9328-8829; Li, Wei/0000-0001-9931-5990; Ou Yang, Tai-Hsien/0000-0001-9650-1253; Kandoth, Cyriac/0000-0002-1345-3573; MCLELLAN, MICHAEL/0000-0002-2703-8784; doddapaneni, harshavardhan/0000-0002-2433-633X; Salama, Sofie/0000-0001-6999-7193; Ciriello, Giovanni/0000-0003-2021-8683; Freeman, Samuel/0000-0001-8285-0057; Hoadley, Katherine/0000-0002-1216-477X; Fei, Suzanne/0000-0002-9688-2890; Rhie, Suhn/0000-0002-5522-5296; Triche, Tim/0000-0001-5665-946X; Levine, Douglas/0000-0003-1038-8232; Davis, Caleb/0000-0002-5125-0494; Cibulskis, Kristian/0000-0003-1343-1582	Chapman Foundation; Dell Foundation; MD Anderson Physician Scientist Award; Burroughs Welcome Career Award at the Scientific Interface; United States National Institutes of Health [K08 CA137153, K08 CA176561, P50 CA083639, R01 CA071468, R01 HG005690, R01 HG007069, R01CA180006, R21 CA155679, U01 CA168394, U24 CA143867-05, U24 CA143883, U24 CA143848, U24 CA143858];  [U54 CA112970];  [U24 CA143799];  [U24 CA143835];  [U24 CA143840];  [U24 CA143843];  [U24 CA143845];  [U24 CA143866];  [U24 CA143867];  [U24 CA143882];  [U24 CA144025];  [U54 HG003273];  [U54 HG003067];  [U54 HG003079];  [ZIA-DC-000073];  [ZIA-DC-000074];  [P30 CA016672]; NATIONAL CANCER INSTITUTE [U24CA143866, U24CA143867, P01CA101937, U24CA180951, U24CA143835, U01CA168394, U24CA143799, R01CA071468, U24CA143845, P30CA016672, R21CA176561, K08CA137153, P50CA083639, P30CA016056, R01CA180006, U24CA143883, P50CA100632, U24CA144025, P50CA098258, P01CA099031, R21CA155679, U24CA143858, U24CA143840, U24CA143843, U24CA143848, P30CA016086, R01CA180778, U54CA112970, U24CA143882] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003273, U54HG003079, R01HG007069, R01HG005690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000074, ZIADC000073] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Chapman Foundation; Dell Foundation; MD Anderson Physician Scientist Award; Burroughs Welcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); ICREA(ICREA)	We thank the thousands of patients and their loved ones who contributed materially, emotionally, and intellectually to this study. We thank D. A. Wheeler and M. L. Meyerson for scientific review of the work and M. P. Schroeder for help setting up Gitools. We thank K. R. Shaw, B. A. Ozenberger, H.J. Sofia, C. M. Hutter, and J.C. Zenklusen for administrative support. This work was supported by grants from the Chapman Foundation and Dell Foundation to J.N.W., a MD Anderson Physician Scientist Award to L. A. B., a Burroughs Welcome Career Award at the Scientific Interface to B. J. R., and support from the following grants from the United States National Institutes of Health: K08 CA137153, K08 CA176561, P50 CA083639, R01 CA071468, R01 HG005690, R01 HG007069, R01CA180006, R21 CA155679, U01 CA168394, U24 CA143858, U24 CA143867-05, U24 CA143883, U24 CA143848, U24 CA143858, U24 CA143866, U54 CA112970, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, U54 HG003273, U54 HG003067, U54 HG003079, ZIA-DC-000073, ZIA-DC-000074, and P30 CA016672 for the MD Anderson CCSG Functional Proteomics Core.	Akbani R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4887; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bhattacharya A, 2011, CLIN CANCER RES, V17, P7024, DOI 10.1158/1078-0432.CCR-11-1944; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chung CH, 2002, NAT GENET, V32, P533, DOI 10.1038/ng1038; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Crum CP, 2010, ANNU REV PATHOL-MECH, V5, P349, DOI 10.1146/annurev-pathol-121808-102117; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Grilley-Olson JE, 2013, ARCH PATHOL LAB MED, V137, P32, DOI 10.5858/arpa.2012-0033-OA; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Herzog A, 2013, CLIN CANCER RES, V19, P3808, DOI 10.1158/1078-0432.CCR-12-2716; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Leong CO, 2007, J CLIN INVEST, V117, P1370, DOI 10.1172/JCI30866; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Lu H, 2011, CANCER RES, V71, P6867, DOI 10.1158/0008-5472.CAN-11-2460; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maier S, 2011, HUM PATHOL, V42, P1078, DOI 10.1016/j.humpath.2010.11.010; Martinez E, 2014, ONCOGENE; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Ng S, 2012, BIOINFORMATICS, V28, pI640, DOI 10.1093/bioinformatics/bts402; Nielsen TO, 2010, CLIN CANCER RES, V16, P5222, DOI 10.1158/1078-0432.CCR-10-1282; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tamborero D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02650; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Troester MA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-276; Vandin F, 2012, BIOCOMPUT-PAC SYM, P55; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Walter V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056823; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Willis DL, 2013, CURR OPIN UROL, V23, P435, DOI 10.1097/MOU.0b013e328363e415; Yang XP, 2011, CANCER RES, V71, P3688, DOI 10.1158/0008-5472.CAN-10-3445	39	905	931	6	163	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					929	944		10.1016/j.cell.2014.06.049	http://dx.doi.org/10.1016/j.cell.2014.06.049			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25109877	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000340944700021
J	Lisewski, AM; Quiros, JP; Ng, CL; Adikesavan, AK; Miura, K; Putluri, N; Eastman, RT; Scanfeld, D; Regenbogen, SJ; Altenhofen, L; Llinas, M; Sreekumar, A; Long, C; Fidock, DA; Lichtarge, O				Lisewski, Andreas Martin; Quiros, Joel P.; Ng, Caroline L.; Adikesavan, Anbu Karani; Miura, Kazutoyo; Putluri, Nagireddy; Eastman, Richard T.; Scanfeld, Daniel; Regenbogen, Sam J.; Altenhofen, Lindsey; Llinas, Manuel; Sreekumar, Arun; Long, Carole; Fidock, David A.; Lichtarge, Olivier			Supergenomic Network Compression and the Discovery of EXP1 as a Glutathione Transferase Inhibited by Artesunate	CELL			English	Article							PLASMODIUM-FALCIPARUM; PROTEIN FUNCTION; OXIDATIVE STRESS; BLOOD STAGES; ARTEMISININ; SEQUENCE; PREDICTION; MECHANISM; ASSOCIATION; SENSITIVITY	A central problem in biology is to identify gene function. One approach is to infer function in large supergenomic networks of interactions and ancestral relationships among genes; however, their analysis can be computationally prohibitive. We show here that these biological networks are compressible. They can be shrunk dramatically by eliminating redundant evolutionary relationships, and this process is efficient because in these networks the number of compressible elements rises linearly rather than exponentially as in other complex networks. Compression enables global network analysis to computationally harness hundreds of interconnected genomes and to produce functional predictions. As a demonstration, we show that the essential, but functionally uncharacterized Plasmodium falciparum antigen EXP1 is a membrane glutathione S-transferase. EXP1 efficiently degrades cytotoxic hematin, is potently inhibited by artesunate, and is associated with artesunate metabolism and susceptibility in drug-pressured malaria parasites. These data implicate EXP1 in the mode of action of a frontline antimalarial drug.	[Lisewski, Andreas Martin; Adikesavan, Anbu Karani; Lichtarge, Olivier] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lisewski, Andreas Martin; Lichtarge, Olivier] Baylor Coll Med, Computat & Integrat Biomed Res Ctr, Houston, TX 77030 USA; [Quiros, Joel P.] Baylor Coll Med, Integrat Mol & Biomed Sci Grad Program, Houston, TX 77030 USA; [Adikesavan, Anbu Karani; Putluri, Nagireddy; Sreekumar, Arun] Baylor Coll Med, Dept Cell & Mol Biol, Houston, TX 77030 USA; [Putluri, Nagireddy; Sreekumar, Arun; Lichtarge, Olivier] Baylor Coll Med, Verna & Marrs McLean Dept Biochem, Houston, TX 77030 USA; [Putluri, Nagireddy; Sreekumar, Arun; Lichtarge, Olivier] Baylor Coll Med, Alkek Ctr Mol Discovery, Houston, TX 77030 USA; [Sreekumar, Arun] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Regenbogen, Sam J.; Lichtarge, Olivier] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Ng, Caroline L.; Eastman, Richard T.; Scanfeld, Daniel; Fidock, David A.] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Fidock, David A.] Columbia Univ, Med Ctr, Dept Med, Div Infect Dis, New York, NY 10032 USA; [Miura, Kazutoyo; Eastman, Richard T.; Long, Carole] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA; [Altenhofen, Lindsey; Llinas, Manuel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Altenhofen, Lindsey; Llinas, Manuel] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Altenhofen, Lindsey; Llinas, Manuel] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16802 USA; [Altenhofen, Lindsey; Llinas, Manuel] Penn State Univ, Ctr Infect Dis Dynam, State Coll, PA 16802 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Princeton University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Lisewski, AM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	lisewski@bcm.edu; lichtarge@bcm.edu	Miura, Kazutoyo/AAY-9751-2020; Regenbogen, Sam/AAP-7690-2020	Miura, Kazutoyo/0000-0003-4455-2432; Putluri, Nagireddy/0000-0003-4488-7400; Regenbogen, Sam/0000-0002-8588-4911; Fidock, David/0000-0001-6753-8938	NIH [GM066099, GM079656, AI50234, AI109023]; NSF [CCF-0905536, DBI-1062455]; Alkek CMD Grants; Divisions of Intramural Research at the National Institute of Allergy and Infectious Diseases, National Institutes of Health; Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Disease Grant; NIH Director's New Innovators award [1DP2OD001315-01]; Centre for Quantitative Biology [P50 GM071508]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI109023, R01AI050234, ZIAAI001020, R37AI050234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079656, P50GM071508, R01GM066099] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001315] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [1356569] Funding Source: National Science Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Alkek CMD Grants; Divisions of Intramural Research at the National Institute of Allergy and Infectious Diseases, National Institutes of Health; Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Disease Grant; NIH Director's New Innovators award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre for Quantitative Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support came from NIH GM066099 and GM079656 and NSF CCF-0905536, DBI-1062455 (to O.L.) and from NIH AI50234 and AI109023 (to D. A. F.). N.P. and A.S. were supported by Alkek CMD Grants. K.M., R.E., and C.L. were supported by the Divisions of Intramural Research at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. M.L. is funded through a Burroughs Wellcome Fund Investigators in Pathogenesis of Infectious Disease Grant and an NIH Director's New Innovators award (1DP2OD001315-01) with generous support from the Centre for Quantitative Biology (P50 GM071508). The authors gratefully acknowledge comments and help from Dr. Theodore Wensel, Dr. Christophe Herman, Dr. Timothy Palzkill, Dr. Santha Kumar, and Dr. David Marciano.	Abu Bakar N, 2010, J CELL SCI, V123, P441, DOI 10.1242/jcs.061499; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Cardi D, 2010, J BIOL CHEM, V285, P26406, DOI 10.1074/jbc.M109.090340; CASPERS P, 1991, MOL BIOCHEM PARASIT, V47, P143, DOI 10.1016/0166-6851(91)90173-4; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Chugh M, 2013, P NATL ACAD SCI USA, V110, P5392, DOI 10.1073/pnas.1218412110; Deponte M, 2005, METHOD ENZYMOL, V401, P241, DOI 10.1016/S0076-6879(05)01015-3; FRY M, 1992, BIOCHEM PHARMACOL, V43, P1545, DOI 10.1016/0006-2952(92)90213-3; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Gruring C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1169; Habig M, 2009, J BIOMOL SCREEN, V14, P679, DOI 10.1177/1087057109336586; Holm PJ, 2006, J MOL BIOL, V360, P934, DOI 10.1016/j.jmb.2006.05.056; HOPE IA, 1984, NATURE, V308, P191, DOI 10.1038/308191a0; HOPE IA, 1985, NUCLEIC ACIDS RES, V13, P369, DOI 10.1093/nar/13.2.369; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Klonis N, 2013, CURR OPIN MICROBIOL, V16, P722, DOI 10.1016/j.mib.2013.07.005; Klonis N, 2013, P NATL ACAD SCI USA, V110, P5157, DOI 10.1073/pnas.1217452110; Klonis N, 2011, P NATL ACAD SCI USA, V108, P11405, DOI 10.1073/pnas.1104063108; Lam BK, 1997, J BIOL CHEM, V272, P13923, DOI 10.1074/jbc.272.21.13923; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Melvin I, 2009, BIOINFORMATICS, V25, P121, DOI 10.1093/bioinformatics/btn567; Meraldi V, 2004, PARASITE IMMUNOL, V26, P265, DOI 10.1111/j.0141-9838.2004.00705.x; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Morgenstern R, 2011, DRUG METAB REV, V43, P300, DOI 10.3109/03602532.2011.558511; Mukanganyama S, 2001, FREE RADICAL RES, V35, P427, DOI 10.1080/10715760100300941; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Ochoa A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-90; OEXLE K, 1995, PHYS REV E, V51, P2651, DOI 10.1103/PhysRevE.51.2651; Park DJ, 2012, P NATL ACAD SCI USA, V109, P13052, DOI 10.1073/pnas.1210585109; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; SIMMONS D, 1987, EMBO J, V6, P485, DOI 10.1002/j.1460-2075.1987.tb04779.x; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, P816, DOI 10.1093/nar/gki233; Spielmann T, 2006, MOL MICROBIOL, V59, P779, DOI 10.1111/j.1365-2958.2005.04983.x; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Teuscher F, 2012, ANTIMICROB AGENTS CH, V56, P428, DOI 10.1128/AAC.05456-11; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Venner E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014286; von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825; Wang B, 2009, J CENT SOUTH UNIV T, V16, P474, DOI 10.1007/s11771-009-0079-2; Witkowski B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032620; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09; World Health Organization, 2011, GUID TREATM MAL; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	55	81	88	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					916	928		10.1016/j.cell.2014.07.011	http://dx.doi.org/10.1016/j.cell.2014.07.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126794	Bronze, Green Accepted			2022-12-28	WOS:000340944700020
J	Macilwain, C				Macilwain, Colin			Europe needs a research leader who will lead	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	0	0	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 7	2014	512	7512					7	7		10.1038/512007a	http://dx.doi.org/10.1038/512007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM5NX	25100449	Bronze			2022-12-28	WOS:000339908000004
J	Atature, M; Morton, JJL				Atatuere, Mete; Morton, John J. L.			A gem of a quantum teleporter	SCIENCE			English	Editorial Material							PODOLSKY-ROSEN CHANNELS; STATE; ENTANGLEMENT; QUBITS		[Atatuere, Mete] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Morton, John J. L.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England	University of Cambridge; University of London; University College London	Atature, M (corresponding author), Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England.	ma424@cam.ac.uk; jjl.morton@ucl.ac.uk	Atature, Mete/ABD-9297-2020; Morton, John/I-3515-2013	Atature, Mete/0000-0003-3852-0944	Engineering and Physical Sciences Research Council [EP/K025945/1, EP/I035536/1, EP/I035536/2] Funding Source: researchfish; EPSRC [EP/I035536/1, EP/I035536/2, EP/K025945/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		BENNETT CH, 1993, PHYS REV LETT, V70, P1895, DOI 10.1103/PhysRevLett.70.1895; Bernien H, 2013, NATURE, V497, P86, DOI 10.1038/nature12016; Boschi D, 1998, PHYS REV LETT, V80, P1121, DOI 10.1103/PhysRevLett.80.1121; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; de Lange G, 2010, SCIENCE, V330, P60, DOI 10.1126/science.1192739; Einstein A, 1935, PHYS REV, V47, P0777, DOI 10.1103/PhysRev.47.777; Furusawa A, 1998, SCIENCE, V282, P706, DOI 10.1126/science.282.5389.706; Ma XS, 2012, NATURE, V489, P269, DOI 10.1038/nature11472; Nolleke C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.140403; Olmschenk S, 2009, SCIENCE, V323, P486, DOI 10.1126/science.1167209; Simon C, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.110405	12	1	1	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					510	511		10.1126/science.1256698	http://dx.doi.org/10.1126/science.1256698			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082683				2022-12-28	WOS:000339651300021
J	Stahler, S; Palla, F				Stahler, Steven; Palla, Francesco			The beat of young stars	SCIENCE			English	Editorial Material							SPREAD		[Stahler, Steven] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Palla, Francesco] Arcetri Observ, I-50125 Florence, Italy	University of California System; University of California Berkeley; Istituto Nazionale Astrofisica (INAF)	Stahler, S (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	stahler@berkeley.edu		palla, francesco/0000-0002-3321-0456				Aerts C., 2010, ASTRON ASTROPHYS LIB; Baraffe I, 2009, ASTROPHYS J LETT, V702, pL27, DOI 10.1088/0004-637X/702/1/L27; Jeffries RD, 2011, MON NOT R ASTRON SOC, V418, P1948, DOI 10.1111/j.1365-2966.2011.19613.x; Marconi M, 1998, ASTROPHYS J, V507, pL141, DOI 10.1086/311704; Stahler S., 2004, FORMATION STARS; Zwintz K, 2006, ASTRON ASTROPHYS, V457, P237, DOI 10.1051/0004-6361:20065449; Zwintz K, 2014, SCIENCE, V345, P550, DOI [10.1126/science.1253645, 10.1126/science.1253057]	7	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 1	2014	345	6196					514	515		10.1126/science.1257301	http://dx.doi.org/10.1126/science.1257301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM2AU	25082686				2022-12-28	WOS:000339651300024
J	Eleftheriadou, I; Tentolouris, N; Jude, EB				Eleftheriadou, Ioanna; Tentolouris, Nicholas; Jude, Edward B.			CASE REPORT A patient with type 2 diabetes and a burning sensation in his feet	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERIPHERAL NEUROPATHIC PAIN; MANAGEMENT		[Eleftheriadou, Ioanna; Tentolouris, Nicholas] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Jude, Edward B.] Tameside Hosp NHS Fdn Trust, Ashton Under Lyne OL6 9RW, Lancs, England; [Jude, Edward B.] Univ Manchester, Ashton Under Lyne OL6 9RW, Lancs, England	Athens Medical School; National & Kapodistrian University of Athens; University of Manchester	Jude, EB (corresponding author), Tameside Hosp NHS Fdn Trust, Ashton Under Lyne OL6 9RW, Lancs, England.	Edward.jude@tgh.nhs.uk	TENTOLOURIS, NIKOLAOS/AAH-6231-2019	TENTOLOURIS, NIKOLAOS/0000-0003-0615-2534; Eleftheriadou, Ioanna/0000-0003-2763-2481				Attal N, 2010, EUR J NEUROL, V17, P1113, DOI 10.1111/j.1468-1331.2010.02999.x; Bril V, 2011, MUSCLE NERVE, V43, P910, DOI 10.1002/mus.22092; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Iyer S, 2013, EXPERT OPIN PHARMACO, V14, P1765, DOI 10.1517/14656566.2013.811490; National Institute for Health and Care Excellence, 2010, NEUR PAIN PHARM MAN; Tentolouris NK, 2011, NAT REV ENDOCRINOL, V7, P381, DOI 10.1038/nrendo.2011.93; Tesfaye S, 2011, DIABETES METAB RES R; Tesfaye S, 2013, PAIN, V154, P2616, DOI 10.1016/j.pain.2013.05.043; Tesfaye S, 2013, DIABETES CARE, V36, P2456, DOI 10.2337/dc12-1964; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303	10	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2014	349								g4658	10.1136/bmj.g4658	http://dx.doi.org/10.1136/bmj.g4658			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5NW	25081249				2022-12-28	WOS:000339907800001
J	Perakslis, ED				Perakslis, Eric D.			Cybersecurity in Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Perakslis, Eric D.] Harvard Univ, Sch Med, Countway Lib Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Perakslis, Eric D.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Perakslis, ED (corresponding author), Harvard Univ, Sch Med, Countway Lib Med, Ctr Biomed Informat, Boston, MA 02115 USA.			Perakslis, Eric/0000-0003-2395-810X				[Anonymous], 2013, SCI AM; Filkins B., 2014, NORSE            FEB; Krebs on Security, 2013, WASH HOSP HIT 1 03 M; *NAT RES COUNC, 1997, REC PROT EL HLTH INF; Ponemon Institute, 2013, 2013 COST DAT BREACH	5	33	32	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 31	2014	371	5					395	397		10.1056/NEJMp1404358	http://dx.doi.org/10.1056/NEJMp1404358			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AM0SK	25075831				2022-12-28	WOS:000339556900002
J	Sovacool, BK				Sovacool, Benjamin K.			Energy studies need social science	NATURE			English	Editorial Material							US		[Sovacool, Benjamin K.] Aarhus Univ, DK-8000 Aarhus C, Denmark; [Sovacool, Benjamin K.] Aarhus Univ, Ctr Energy Technol, DK-8000 Aarhus C, Denmark; [Sovacool, Benjamin K.] Vermont Law Sch, South Royalton, VT USA	Aarhus University; Aarhus University	Sovacool, BK (corresponding author), Aarhus Univ, DK-8000 Aarhus C, Denmark.	sovacool@vt.edu	Sovacool, Benjamin/Y-2392-2019	Sovacool, Benjamin/0000-0002-4794-9403				Allcott H, 2010, SCIENCE, V327, P1204, DOI 10.1126/science.1180775; D'Agostino AL, 2011, ENERGY, V36, P508, DOI 10.1016/j.energy.2010.10.013; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Gaffigan M.E., 2008, ADV ENERGY TECHNOLOG; Goldblatt D. L., 2012, TACKLING LONG TERM G; Lutzenhiser L, 1999, ENERG POLICY, V27, P217, DOI 10.1016/S0301-4215(99)00012-9; STERN PC, 1993, SCIENCE, V260, P1897, DOI 10.1126/science.260.5116.1897; US Department of Energy, 2011, REP 1 QUADR TECHN RE, P125	9	187	187	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					529	530		10.1038/511529a	http://dx.doi.org/10.1038/511529a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AM0VT	25079540	Bronze			2022-12-28	WOS:000339566300013
J	Hewitt, PE; Ijaz, S; Brailsford, SR; Brett, R; Dicks, S; Haywood, B; Kennedy, ITR; Kitchen, A; Patel, P; Poh, J; Russell, K; Tettmar, KI; Tossell, J; Ushiro-Lumb, I; Tedder, RS				Hewitt, Patricia E.; Ijaz, Samreen; Brailsford, Su R.; Brett, Rachel; Dicks, Steven; Haywood, Becky; Kennedy, Iain T. R.; Kitchen, Alan; Patel, Poorvi; Poh, John; Russell, Katherine; Tettmar, Kate I.; Tossell, Joanne; Ushiro-Lumb, Ines; Tedder, Richard S.			Hepatitis E virus in blood components: a prevalence and transmission study in southeast England	LANCET			English	Article							NON-B HEPATITIS; NON-A; INFECTION; DONORS; WALES; RNA; RECIPIENTS; THERAPY; HIV	Background The prevalence of hepatitis E virus (HEV) genotype 3 infections in the English population (including blood donors) is unknown, but is probably widespread, and the virus has been detected in pooled plasma products. HEV-infected donors have been retrospectively identified through investigation of reported cases of possible transfusion-transmitted hepatitis E. The frequency of HEV transmission by transfusion and its outcome remains unknown. We report the prevalence of HEV RNA in blood donations, the transmission of the virus through a range of blood components, and describe the resulting morbidity in the recipients. Methods From Oct 8, 2012, to Sept 30, 2013, 225 000 blood donations that were collected in southeast England were screened retrospectively for HEV RNA. Donations containing HEV were characterised by use of serology and genomic phylogeny. Recipients, who received any blood components from these donations, were identified and the outcome of exposure was ascertained. Findings 79 donors were viraemic with genotype 3 HEV, giving an RNA prevalence of one in 2848. Most viraemic donors were seronegative at the time of donation. The 79 donations had been used to prepare 129 blood components, 62 of which had been transfused before identification of the infected donation. Follow-up of 43 recipients showed 18 (42%) had evidence of infection. Absence of detectable antibody and high viral load in the donation rendered infection more likely. Recipient immunosuppression delayed or prevented seroconversion and extended the duration of viraemia. Three recipients cleared longstanding infection after intervention with ribavirin or alteration in immunosuppressive therapy. Ten recipients developed prolonged or persistent infection. Transaminitis was common, but short-term morbidity was rare; only one recipient developed apparent but clinically mild post-transfusion hepatitis. Interpretation Our findings suggest that HEV genotype 3 infections are widespread in the English population and in blood donors. Transfusion-transmitted infections rarely caused acute morbidity, but in some immunosuppressed patients became persistent. Although at present blood donations are not screened, an agreed policy is needed for the identification of patients with persistent HEV infection, irrespective of origin, so that they can be offered antiviral therapy.	[Hewitt, Patricia E.; Brailsford, Su R.; Brett, Rachel; Dicks, Steven; Kitchen, Alan; Patel, Poorvi; Tettmar, Kate I.; Tossell, Joanne; Ushiro-Lumb, Ines; Tedder, Richard S.] Natl Hlth Serv Blood & Transplant, London, England; [Ijaz, Samreen; Dicks, Steven; Haywood, Becky; Patel, Poorvi; Tettmar, Kate I.; Ushiro-Lumb, Ines; Tedder, Richard S.] Publ Hlth England, Virus Reference Dept, Microbiol Serv, Blood Borne Virus Unit, London NW9 5EQ, England; [Brailsford, Su R.; Kennedy, Iain T. R.; Russell, Katherine] Publ Hlth England, Infect Dis Surveillance Ctr, London NW9 5EQ, England; [Tedder, Richard S.] UCL, London, England	NHS Blood & Transplant (NHSBT); Public Health England; Public Health England; University of London; University College London	Tedder, RS (corresponding author), Publ Hlth England, Virus Reference Dept, Microbiol Serv, Blood Borne Virus Unit, London NW9 5EQ, England.	richard.tedder@phe.gov.uk	Ushiro-Lumb, Ines/GXM-3502-2022	Ushiro-Lumb, Ines/0000-0003-0989-8091; Ijaz, Samreen/0000-0001-6658-3542; Tedder, Richard/0000-0002-9672-5721; Haywood, Becky/0000-0002-1461-9619; Kennedy, Iain/0000-0003-0395-1269	Public Health England; National Health Service Blood and Transplant	Public Health England; National Health Service Blood and Transplant	Public Health England and National Health Service Blood and Transplant.	Andersson MI, 2013, AIDS, V27, P487, DOI 10.1097/QAD.0b013e32835b1074; BALAYAN MS, 1983, INTERVIROLOGY, V20, P23, DOI 10.1159/000149370; BALAYAN MS, 1990, J MED VIROL, V32, P58, DOI 10.1002/jmv.1890320110; Baylis SA, 2012, VOX SANG, V103, P89, DOI 10.1111/j.1423-0410.2011.01583.x; Beale MA, 2011, VOX SANG, V100, P340, DOI 10.1111/j.1423-0410.2010.01412.x; Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x; Casas M, 2009, VET MICROBIOL, V138, P78, DOI 10.1016/j.vetmic.2009.03.008; Cleland A, 2013, VOX SANG, V105, P283, DOI 10.1111/vox.12056; Coilly A, 2013, TRANSPLANTATION, V96, pE4, DOI 10.1097/TP.0b013e318296c9f7; Colson P, 2010, J INFECT DIS, V202, P825, DOI 10.1086/655898; Corman VM, 2013, VOX SANG, V104, P179, DOI 10.1111/j.1423-0410.2012.01638.x; Dalton HR, 2009, NEW ENGL J MED, V361, P1025, DOI 10.1056/NEJMc0903778; Feray C, 2014, LANCET, V383, P218, DOI 10.1016/S0140-6736(14)60072-6; Garson JA, 2012, J VIROL METHODS, V186, P157, DOI 10.1016/j.jviromet.2012.07.027; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; Ijaz S, 2005, J INFECT DIS, V192, P1166, DOI 10.1086/444396; Ijaz S, 2012, VOX SANG, V102, P272, DOI 10.1111/j.1423-0410.2011.01554.x; Ijaz S, 2014, J INFECT DIS, V209, P1212, DOI 10.1093/infdis/jit652; Ijaz S, 2009, J CLIN VIROL, V44, P272, DOI 10.1016/j.jcv.2009.01.005; Juhl D, 2014, TRANSFUSION, V54, P49, DOI 10.1111/trf.12121; Kamar N, 2008, NEW ENGL J MED, V358, P811, DOI 10.1056/NEJMoa0706992; Kamar N, 2013, SEMIN LIVER DIS, V33, P62, DOI 10.1055/s-0033-1338115; KHUROO MS, 1980, AM J MED, V68, P818, DOI 10.1016/0002-9343(80)90200-4; Lewis HC, 2008, EMERG INFECT DIS, V14, P165, DOI 10.3201/eid1401.070307; Masuda JI, 2005, HEPATOL RES, V31, P178, DOI 10.1016/j.hepres.2005.01.008; REYES GR, 1990, SCIENCE, V247, P1335, DOI 10.1126/science.2107574; Said B, 2014, EPIDEMIOL INFECT, V142, P1467, DOI 10.1017/S0950268813002318; Singh GKJ, 2013, J INFECTION, V66, P103, DOI 10.1016/j.jinf.2011.11.027; Tei S, 2003, LANCET, V362, P371, DOI 10.1016/S0140-6736(03)14025-1; Versluis J, 2013, BLOOD, V122, P1079, DOI 10.1182/blood-2013-03-492363	30	352	360	0	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2014	384	9956					1766	1773		10.1016/S0140-6736(14)61034-5	http://dx.doi.org/10.1016/S0140-6736(14)61034-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AT7KX	25078306	Green Submitted			2022-12-28	WOS:000345116400027
J	Anders, C; Niewoehner, O; Duerst, A; Jinek, M				Anders, Carolin; Niewoehner, Ole; Duerst, Alessia; Jinek, Martin			Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease	NATURE			English	Article							RNA; CRISPR; SPECIFICITY; SYSTEM; REFINEMENT; DROSOPHILA	The CRISPR-associated protein Cas9 is anRNA-guided endonuclease that cleaves double-stranded DNA bearing sequences complementary to a 20-nucleotide segment in the guideRNA(1,2). Cas9 hase merged as a versatile molecular tool for genome editing and gene expression control(3). RNA-guided DNA recognition and cleavage strictly require the presence of a protospacer adjacent motif (PAM) in the target DNA(1,4-6). Here we report a crystal structure of Streptococcus pyogenes Cas9 in complex with a single-molecule guide RNA and a target DNA containing a canonical 5'-NGG-3' PAM. The structure reveals that the PAM motif resides in a base-paired DNA duplex. The non-complementary strand GG dinucleotide is read out via major-groove interactions with conserved arginine residues from the carboxyterminal domain of Cas9. Interactions with the minor groove of the PAM duplex and the phosphodiester group at the +1 position in the target DNA strand contribute to local strand separation immediately upstream of the PAM. These observations suggest a mechanism for PAM-dependent target DNA melting and RNA-DNA hybrid formation. Furthermore, this study establishes a framework for the rational engineering of Cas9 enzymes with novel PAM specificities.	[Anders, Carolin; Niewoehner, Ole; Duerst, Alessia; Jinek, Martin] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland	University of Zurich	Jinek, M (corresponding author), Univ Zurich, Inst Biochem, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jinek@bioc.uzh.ch	Jinek, Martin/E-6621-2011	Jinek, Martin/0000-0002-7601-210X	European Research Council [337284 ANTIVIRNA]; University of Zurich	European Research Council(European Research Council (ERC)European Commission); University of Zurich	We are grateful to J. Doudna for agreement on research directions, helpful discussions and encouragement throughout the project. We thank B. Blattmann and C. Stutz-Ducommun for crystallization screening, N. Ban and M. Leibundgut for the gift of iridium hexamine, and R. Dutzler for sharing synchrotron beam time and crystallographic advice. We thank E. Charpentier, I. Fonfara, S. Sternberg, P. Sledz, A. May and S. Kassube for critical reading of the manuscript. Part of this work was performed at the Swiss Light Source at the Paul Scherrer Institute, Villigen, Switzerland. We thank T. Tomizaki, V. Olieric and M. Wang for assistance with X-ray data collection. This work was supported by the European Research Council Starting Grant no. 337284 ANTIVIRNA and by start-up funds from the University of Zurich.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Bassett AR, 2013, CELL REP, V4, P220, DOI 10.1016/j.celrep.2013.06.020; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Briner AE, 2014, APPL ENVIRON MICROB, V80, P994, DOI 10.1128/AEM.03015-13; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gratz SJ, 2013, GENETICS, V194, P1029, DOI 10.1534/genetics.113.152710; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, NAT BIOTECHNOL, V31, P833, DOI 10.1038/nbt.2675; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Sapranauskas R, 2011, NUCLEIC ACIDS RES, V39, P9275, DOI 10.1093/nar/gkr606; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025	36	737	833	11	360	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2014	513	7519					569	+		10.1038/nature13579	http://dx.doi.org/10.1038/nature13579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AP4VB	25079318	Green Accepted			2022-12-28	WOS:000342075800045
J	Busrgmann, R				Buesrgmann, Roland			EARTH SCIENCE Warning signs of the Iquique earthquake	NATURE			English	Editorial Material							CHILE; FORESHOCKS		Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Busrgmann, R (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	burgmann@seismo.berkeley.edu	Burgmann, Roland/AAE-5138-2022	Burgmann, Roland/0000-0002-3560-044X				Bejar-Pizarro M, 2013, NAT GEOSCI, V6, P462, DOI [10.1038/ngeo1802, 10.1038/NGEO1802]; Bouchon M, 2013, NAT GEOSCI, V6, P299, DOI [10.1038/ngeo1770, 10.1038/NGEO1770]; Brodsky EE, 2014, SCIENCE, V344, P700, DOI 10.1126/science.1255202; Burgmann R, 2014, ANNU REV EARTH PL SC, V42, P509, DOI 10.1146/annurev-earth-060313-054953; Hayes GP, 2014, NATURE, V512, P295, DOI 10.1038/nature13677; Jordan TH, 2010, SEISMOL RES LETT, V81, P571, DOI 10.1785/gssrl.81.4.571; Kato A, 2014, GEOPHYS RES LETT; Metois M, 2013, GEOPHYS J INT, V194, P1283, DOI 10.1093/gji/ggt183; Ruiz S, 2014, SCIENCE, V345, P1165, DOI 10.1126/science.1256074; Schurr B, 2014, NATURE, V512, P299, DOI 10.1038/nature13681; Shirzaei M, 2013, EARTH PLANET SC LETT, V371, P59, DOI 10.1016/j.epsl.2013.04.024	11	15	16	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 21	2014	512	7514					258	259		10.1038/nature13655	http://dx.doi.org/10.1038/nature13655			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN3SF	25119029				2022-12-28	WOS:000340508200021
J	Royle, NJ; Russell, AF; Wilson, AJ				Royle, Nick J.; Russell, Andrew F.; Wilson, Alastair J.			The evolution of flexible parenting	SCIENCE			English	Review							PHENOTYPIC PLASTICITY; OFFSPRING CONFLICT; SELECTION; CARE; ECOLOGY; BIRD; COADAPTATION; POPULATIONS	Parenting behaviors, such as the provisioning of food by parents to offspring, are known to be highly responsive to changes in environment. However, we currently know little about how such flexibility affects the ways in which parenting is adapted and evolves in response to environmental variation. This is because few studies quantify how individuals vary in their response to changing environments, especially social environments created by other individuals with which parents interact. Social environmental factors differ from nonsocial factors, such as food availability, because parents and offspring both contribute and respond to the social environment they experience. This interdependence leads to the coevolution of flexible behaviors involved in parenting, which could, paradoxically, constrain the ability of individuals to rapidly adapt to changes in their nonsocial environment.	[Royle, Nick J.; Russell, Andrew F.; Wilson, Alastair J.] Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Penryn TR10 9EZ, Cornwall, England	University of Exeter	Royle, NJ (corresponding author), Univ Exeter, Coll Life & Environm Sci, Ctr Ecol & Conservat, Cornwall Campus, Penryn TR10 9EZ, Cornwall, England.	n.j.royle@exeter.ac.uk	Royle, Nick J/H-2802-2015	Royle, Nick J/0000-0002-1617-3884; Wilson, Alastair/0000-0002-5045-2051	Natural Environment Research Council (NERC) [NE/C002199/1]; NERC [NE/K005766/1]; Biotechnology and Biological Sciences Research Council David Phillips Fellowship [BB/G022976/1]; Biotechnology and Biological Sciences Research Council [BB/G022976/1, BB/G022976/2] Funding Source: researchfish; Natural Environment Research Council [NE/D000394/1, NE/K005766/1, NE/I025468/1] Funding Source: researchfish; BBSRC [BB/G022976/2, BB/G022976/1] Funding Source: UKRI; NERC [NE/I025468/1] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank C. Hinde, M. Kolliker, H. Klug, A. Moore, and two anonymous reviewers for comments on a previous version of the manuscript. We also thank H. Fitzjohn for collecting the data presented in Box 1, which have been deposited in the Open Research Exeter (ORE) data repository and are freely available at http://hdl.handle.net/10871/15217. N.J.R. was funded by Natural Environment Research Council (NERC) grant NE/C002199/1, A. F. R. by NERC grant NE/K005766/1, and A.J.W. by a Biotechnology and Biological Sciences Research Council David Phillips Fellowship (BB/G022976/1).	Agrawal AF, 2001, SCIENCE, V292, P1710, DOI 10.1126/science.1059910; Balshine S, 2012, EVOLUTION OF PARENTAL CARE, P62; Berenos C, 2014, MOL ECOL, V23, P3434, DOI 10.1111/mec.12827; Brommer JE, 2008, EVOLUTION, V62, P2326, DOI 10.1111/j.1558-5646.2008.00451.x; Costa J., 2006, OTHER INSECT SOC; DeWitt T.J., 2004, PHENOTYPIC PLASTICIT; Dingemanse NJ, 2013, ANIM BEHAV, V85, P1031, DOI 10.1016/j.anbehav.2012.12.032; Dobler R, 2009, ANIM BEHAV, V77, P1427, DOI 10.1016/j.anbehav.2009.02.013; Foster SA, 2013, ANIM BEHAV, V85, P1061, DOI 10.1016/j.anbehav.2013.02.008; Ghalambor CK, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0154; Gomez-Mestre I, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1869; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Head ML, 2014, ECOL LETT, V17, P803, DOI 10.1111/ele.12284; Head ML, 2012, EVOLUTION, V66, P3570, DOI 10.1111/j.1558-5646.2012.01699.x; Johnstone RA, 2014, BEHAV ECOL, V25, P216, DOI 10.1093/beheco/art109; Kilner RM, 2012, EVOLUTION OF PARENTAL CARE, P119; Kolliker M, 2012, EVOLUTION OF PARENTAL CARE, P285; Kolliker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008606; Kolliker M, 2000, P ROY SOC B-BIOL SCI, V267, P2127, DOI 10.1098/rspb.2000.1259; Lock JE, 2004, AM NAT, V164, P13, DOI 10.1086/421444; Maestripieri D, 2004, BEHAV ECOL SOCIOBIOL, V55, P381, DOI 10.1007/s00265-003-0720-2; Martin JGA, 2011, METHODS ECOL EVOL, V2, P362, DOI 10.1111/j.2041-210X.2010.00084.x; McAdam AG, 2014, QUANTITATIVE GENETICS IN THE WILD, P84; Moore AJ, 1997, EVOLUTION, V51, P1352, DOI 10.1111/j.1558-5646.1997.tb01458.x; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Piersma T, 2003, TRENDS ECOL EVOL, V18, P228, DOI 10.1016/S0169-5347(03)00036-3; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Renn SCP, 2013, ANIM BEHAV, V85, P1012, DOI 10.1016/j.anbehav.2013.02.012; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; West-Eberhard Mary Jane, 2003, pi; Westneat DF, 2011, AM NAT, V178, P652, DOI 10.1086/662173; Wilson AJ, 2006, PLOS BIOL, V4, P1270, DOI 10.1371/journal.pbio.0040216; Wilson AJ, 2014, HEREDITY, V112, P70, DOI 10.1038/hdy.2013.7; Wilson AJ, 2006, AM NAT, V167, pE23, DOI 10.1086/498138; Wolf JB, 2003, P NATL ACAD SCI USA, V100, P4655, DOI 10.1073/pnas.0635741100; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105	40	87	87	3	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 15	2014	345	6198					776	781		10.1126/science.1253294	http://dx.doi.org/10.1126/science.1253294			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN4XM	25124432	Green Submitted			2022-12-28	WOS:000340593100036
J	Borde, V; Lichten, M				Borde, Valerie; Lichten, Michael			A Timeless but Timely Connection between Replication and Recombination	CELL			English	Editorial Material							DOUBLE-STRAND BREAKS; DNA; MEIOSIS	Initiation of meiotic recombination by DNA double-strand break formation is temporally coordinated with replication. Murakami and Keeney show that this coordination requires recruitment of the Dbf4-dependent kinase to the replication fork by the conserved TIM-TIPIN complex. The same mechanism may regulate other important replication-associated processes.	[Borde, Valerie] Inst Curie, CNRS, Ctr Rech, UMR3664, F-75248 Paris, France; [Lichten, Michael] NCI, Ctr Canc Res, Biochem & Mol Biol Lab, Bethesda, MD 20892 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Borde, V (corresponding author), Inst Curie, CNRS, Ctr Rech, UMR3664, F-75248 Paris, France.	valerie.borde@curie.fr; mlichten@helix.nih.gov	Lichten, Michael/C-5795-2013	Lichten, Michael/0000-0001-9707-2956	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC005268] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Borde V, 2013, CURR OPIN GENET DEV, V23, P147, DOI 10.1016/j.gde.2012.12.002; Gerard A, 2006, EMBO REP, V7, P817, DOI 10.1038/sj.embor.7400750; Higgins JD, 2012, PLANT CELL, V24, P4096, DOI 10.1105/tpc.112.102483; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; Murakami H, 2008, GENE DEV, V22, P286, DOI 10.1101/gad.1642308; Murakami H, 2014, CELL, V158, P861, DOI 10.1016/j.cell.2014.06.028; Tanaka S, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010371; Wu PYJ, 2014, MOL CELL, V53, P655, DOI 10.1016/j.molcel.2014.01.022	9	9	9	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 14	2014	158	4					697	698		10.1016/j.cell.2014.07.029	http://dx.doi.org/10.1016/j.cell.2014.07.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RF	25126777	Bronze			2022-12-28	WOS:000340944700002
J	Mente, A; O'Donnell, MJ; Rangarajan, S; McQueen, MJ; Poirier, P; Wielgosz, A; Morrison, H; Li, W; Wang, XY; Di, C; Mony, P; Devanath, A; Rosengren, A; Oguz, A; Zatonska, K; Yusufali, AH; Lopez-Jaramillo, P; Avezum, A; Ismail, N; Lanas, F; Puoane, T; Diaz, R; Kelishadi, R; Iqbal, R; Yusuf, R; Chifamba, J; Khatib, R; Teo, K; Yusuf, S				Mente, Andrew; O'Donnell, Martin J.; Rangarajan, Sumathy; McQueen, Matthew J.; Poirier, Paul; Wielgosz, Andreas; Morrison, Howard; Li, Wei; Wang, Xingyu; Di, Chen; Mony, Prem; Devanath, Anitha; Rosengren, Annika; Oguz, Aytekin; Zatonska, Katarzyna; Yusufali, Afzal Hussein; Lopez-Jaramillo, Patricio; Avezum, Alvaro; Ismail, Noorhassim; Lanas, Fernando; Puoane, Thandi; Diaz, Rafael; Kelishadi, Roya; Iqbal, Romaina; Yusuf, Rita; Chifamba, Jephat; Khatib, Rasha; Teo, Koon; Yusuf, Salim		PURE Investigators	Association of Urinary Sodium and Potassium Excretion with Blood Pressure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RISK-FACTORS; COUNTRIES; HYPERTENSION; COMMUNITY	Background Higher levels of sodium intake are reported to be associated with higher blood pressure. Whether this relationship varies according to levels of sodium or potassium intake and in different populations is unknown. Methods We studied 102,216 adults from 18 countries. Estimates of 24-hour sodium and potassium excretion were made from a single fasting morning urine specimen and were used as surrogates for intake. We assessed the relationship between electrolyte excretion and blood pressure, as measured with an automated device. Results Regression analyses showed increments of 2.11 mm Hg in systolic blood pressure and 0.78 mm Hg in diastolic blood pressure for each 1-g increment in estimated sodium excretion. The slope of this association was steeper with higher sodium intake (an increment of 2.58 mm Hg in systolic blood pressure per gram for sodium excretion >5 g per day, 1.74 mm Hg per gram for 3 to 5 g per day, and 0.74 mm Hg per gram for <3 g per day; P<0.001 for interaction). The slope of association was steeper for persons with hypertension (2.49 mm Hg per gram) than for those without hypertension (1.30 mm Hg per gram, P<0.001 for interaction) and was steeper with increased age (2.97 mm Hg per gram at >55 years of age, 2.43 mm Hg per gram at 45 to 55 years of age, and 1.96 mm Hg per gram at <45 years of age; P<0.001 for interaction). Potassium excretion was inversely associated with systolic blood pressure, with a steeper slope of association for persons with hypertension than for those without it (P<0.001) and a steeper slope with increased age (P<0.001). Conclusions In this study, the association of estimated intake of sodium and potassium, as determined from measurements of excretion of these cations, with blood pressure was nonlinear and was most pronounced in persons consuming high-sodium diets, persons with hypertension, and older persons.	[Mente, Andrew; O'Donnell, Martin J.; Rangarajan, Sumathy; McQueen, Matthew J.; Khatib, Rasha; Teo, Koon; Yusuf, Salim] McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Mente, Andrew; Khatib, Rasha; Teo, Koon; Yusuf, Salim] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8L 2X2, Canada; [O'Donnell, Martin J.; Teo, Koon; Yusuf, Salim] McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; [McQueen, Matthew J.] McMaster Univ, Dept Lab Med, Hamilton, ON L8L 2X2, Canada; [Poirier, Paul] Univ Laval, Heart & Lung Inst, Quebec City, PQ, Canada; [Wielgosz, Andreas] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Morrison, Howard] Publ Hlth Agcy Canada, Ctr Chron Dis Prevent & Control, Ottawa, ON, Canada; [O'Donnell, Martin J.] Natl Univ Ireland, Hlth Res Board, Clin Res Facil, Galway, Ireland; [Li, Wei] Chinese Acad Med Sci, Cardiovasc Inst, Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Li, Wei] Chinese Acad Med Sci, Fuwai Hosp, Beijing 100730, Peoples R China; [Wang, Xingyu] Beijing Hypertens League Inst, Beijing, Peoples R China; [Di, Chen] Beijing Jishuitan Hosp, Beijing, Peoples R China; [Mony, Prem] St Johns Res Inst, Div Epidemiol & Populat Hlth, Bangalore, Karnataka, India; [Devanath, Anitha] St Johns Res Inst, Clin Biochem Sect, Div Infect Dis, Bangalore, Karnataka, India; [Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Oguz, Aytekin] Istanbul Medeniyet Univ, Fac Med, Dept Internal Med, Istanbul, Turkey; [Zatonska, Katarzyna] Wroclaw Med Univ, Dept Social Med, Wroclaw, Poland; [Yusufali, Afzal Hussein] Dubai Hlth Author, Hatta Hosp, Dubai, U Arab Emirates; [Lopez-Jaramillo, Patricio] Univ Santander, Fdn Oftalmol Santander Med Sch, Floridablanca, Colombia; [Avezum, Alvaro] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil; [Ismail, Noorhassim] Univ Kebangsaan Malaysia, Med Ctr, Dept Community Hlth, Bangi, Malaysia; [Lanas, Fernando] Univ La Frontera, Temuco, Chile; [Puoane, Thandi] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Santa Fe, Argentina; [Kelishadi, Roya] Isfahan Univ Med Sci, Isfahan Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran; [Iqbal, Romaina] Aga Khan Univ, Dept Community Hlth Sci, Karachi, Pakistan; [Iqbal, Romaina] Aga Khan Univ, Dept Med, Karachi, Pakistan; [Yusuf, Rita] Independent Univ, Sch Life Sci, Dhaka, Bangladesh; [Yusuf, Rita] Independent Univ, Ctr Hlth Populat & Dev, Dhaka, Bangladesh; [Chifamba, Jephat] Univ Zimbabwe, Coll Hlth Sci, Dept Physiol, Harare, Zimbabwe; [Khatib, Rasha] Birzeit Univ, Inst Community & Publ Hlth, Birzeit, Israel	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University; Laval University; Quebec Heart & Lung Institute; University of Ottawa; Public Health Agency of Canada; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Hypertension League; St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Research Institute; University of Gothenburg; Istanbul Medeniyet University; Wroclaw Medical University; Universidad Industrial de Santander; Instituto Dante Pazzanese de Cardiologia; Universiti Kebangsaan Malaysia; Universidad de La Frontera; University of the Western Cape; Isfahan University Medical Science; Aga Khan University; Aga Khan University; Independent University Bangladesh (IUB); Independent University Bangladesh (IUB); University of Zimbabwe; Birzeit University	Mente, A (corresponding author), McMaster Univ, Hamilton Hlth Sci, Populat Hlth Res Inst, 2nd Fl,Rm C2-104,237 Barton St E, Hamilton, ON L8L 2X2, Canada.	andrew.mente@phri.ca	Mony, Prem K./GRF-4752-2022; Lanas, Fernando/AAE-8842-2022; Igumbor, Ehimario U/B-2652-2012; O'Donnell, Martin/ABE-7459-2020; Oguz, Aytekin/AAJ-2732-2021; Zatońska, Katarzyna/ABD-4236-2021; Avezum, Alvaro AA/K-6137-2016; Khatib, Rasha/GXV-8883-2022; Husseini, Abdullatif/E-8377-2015; Avezum, Alvaro/AAP-7687-2020; Kelishadi, Roya/E-6154-2012; Chifamba, Jephat/AHE-4535-2022; Qorbani, Mostafa/M-8171-2017; Gomez-Arbelaez, Diego/K-1883-2013	Mony, Prem K./0000-0002-1399-0520; Igumbor, Ehimario U/0000-0002-6313-6031; O'Donnell, Martin/0000-0002-7347-7761; Oguz, Aytekin/0000-0002-2595-5167; Avezum, Alvaro AA/0000-0002-3073-6890; Husseini, Abdullatif/0000-0001-8767-5956; Kelishadi, Roya/0000-0001-7455-1495; Chifamba, Jephat/0000-0001-8166-1182; Yusuf, Rita/0000-0002-0151-9571; Gomez-Arbelaez, Diego/0000-0001-6150-0066; Lanas, Fernando/0000-0003-3595-9759; Yusuf, Salim/0000-0003-4776-5601; Camacho, Paul Anthony/0000-0002-6233-9582; Gulec, Sadi/0000-0002-2685-2522; Zatonska, Katarzyna/0000-0002-3772-5588; Ismail, Noor Hassim/0000-0003-1547-7904; Rosengren, Annika/0000-0002-5409-6605; Yusufali, Afzalhussein/0000-0003-3378-2646; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Teo, Koon/0000-0002-3731-0956; Iqbal, Romaina/0000-0002-5364-4366; Jerling, Johann/0000-0003-2600-3536	Heart and Stroke Foundation of Ontario	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	Funded by the Heart and Stroke Foundation of Ontario and others.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Chien KL, 2008, J HYPERTENS, V26, P1750, DOI 10.1097/HJH.0b013e328306a0a7; Eckel RH, 2014, CIRCULATION, V129, pS76, DOI 10.1161/01.cir.0000437740.48606.d1; ELLIOTT P, 1988, BRIT MED J, V297, P319; Havas S, 2004, AM J PUBLIC HEALTH, V94, P19, DOI 10.2105/AJPH.94.1.19; He FJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1325; HOLBROOK JT, 1984, AM J CLIN NUTR, V40, P786, DOI 10.1093/ajcn/40.4.786; Kawamura M, 2006, HYPERTENS RES, V29, P397, DOI 10.1291/hypres.29.397; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; MCCARRON DA, 1984, SCIENCE, V224, P1392, DOI 10.1126/science.6729459; Mente A, 2014, J HYPERTENS, V32, P1005, DOI 10.1097/HJH.0000000000000122; Mente A, 2009, J NUTR, V139, P743, DOI 10.3945/jn.108.098319; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Prospective Studies Collaboration, 2008, LANCET, V372, P292; Ritz E, 2009, J RENAL NUTR, V19, P61, DOI 10.1053/j.jrn.2008.10.007; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; SMITH WCS, 1988, BRIT MED J, V297, P329, DOI 10.1136/bmj.297.6644.329; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; Townsend MS, 2005, AM J HYPERTENS, V18, P261, DOI 10.1016/j.amjhyper.2004.09.017; Weinberger MH, 1997, AM J HYPERTENS, V10, pS46; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	24	529	549	3	86	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 14	2014	371	7					601	611		10.1056/NEJMoa1311989	http://dx.doi.org/10.1056/NEJMoa1311989			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7ZL	25119606	Bronze			2022-12-28	WOS:000340819600006
J	Ge, PS; Runyon, BA				Ge, Phillip S.; Runyon, Bruce A.			Serum Ammonia Level for the Evaluation of Hepatic Encephalopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE LIVER-FAILURE; ARTERIAL AMMONIA; DIAGNOSIS; SEVERITY		[Ge, Phillip S.; Runyon, Bruce A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Runyon, BA (corresponding author), Santa Monica UCLA Med Ctr, Div Digest Dis, 1223 16th St,Ste 3100, Santa Monica, CA 90404 USA.	barunyon@mednet.ucla.edu						Bernal W, 2007, HEPATOLOGY, V46, P1844, DOI 10.1002/hep.21838; Bhatia V, 2006, GUT, V55, P98, DOI 10.1136/gut.2004.061754; Elgouhari HM, 2009, CLEV CLIN J MED, V76, P252, DOI 10.3949/ccjm.76a.08072; Ferenci P., 2014, UPTODATE; Goldbecker A, 2013, GUT, V62, P1497, DOI 10.1136/gutjnl-2012-303262; Kundra A, 2005, CLIN BIOCHEM, V38, P696, DOI 10.1016/j.clinbiochem.2005.04.013; Nicolao F, 2003, J HEPATOL, V38, P441, DOI 10.1016/S0168-8278(02)00436-1; Ong JP, 2003, AM J MED, V114, P188, DOI 10.1016/S0002-9343(02)01477-8; Riggio O, 2011, CLIN GASTROENTEROL H, V9, pe1; Riggio O, 2011, CLIN GASTROENTEROL H, V9, P613, DOI 10.1016/j.cgh.2011.03.017; Weissenborn K, 1998, J HEPATOL, V28, P646, DOI 10.1016/S0168-8278(98)80289-4	11	31	32	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 13	2014	312	6					643	644		10.1001/jama.2014.2398	http://dx.doi.org/10.1001/jama.2014.2398			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM8OU	25117134				2022-12-28	WOS:000340136400024
J	Kraft, B; Tegetmeyer, HE; Sharma, R; Klotz, MG; Ferdelman, TG; Hettich, RL; Geelhoed, JS; Strous, M				Kraft, Beate; Tegetmeyer, Halina E.; Sharma, Ritin; Klotz, Martin G.; Ferdelman, Timothy G.; Hettich, Robert L.; Geelhoed, Jeanine S.; Strous, Marc			The environmental controls that govern the end product of bacterial nitrate respiration	SCIENCE			English	Article							REDUCTION; DENITRIFICATION; SEDIMENTS; ANAMMOX	In the biogeochemical nitrogen cycle, microbial respiration processes compete for nitrate as an electron acceptor. Denitrification converts nitrate into nitrogenous gas and thus removes fixed nitrogen from the biosphere, whereas ammonification converts nitrate into ammonium, which is directly reusable by primary producers. We combined multiple parallel long-term incubations of marine microbial nitrate-respiring communities with isotope labeling and metagenomics to unravel how specific environmental conditions select for either process. Microbial generation time, supply of nitrite relative to nitrate, and the carbon/nitrogen ratio were identified as key environmental controls that determine whether nitrite will be reduced to nitrogenous gas or ammonium. Our results define the microbial ecophysiology of a biogeochemical feedback loop that is key to global change, eutrophication, and wastewater treatment.	[Kraft, Beate; Tegetmeyer, Halina E.; Ferdelman, Timothy G.; Geelhoed, Jeanine S.; Strous, Marc] Max Planck Inst Marine Mikrobiol, D-28359 Bremen, Germany; [Tegetmeyer, Halina E.; Strous, Marc] Univ Bielefeld, Ctr Biotechnol, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany; [Sharma, Ritin; Hettich, Robert L.] Univ Tennessee, UT ORNL Grad Sch Genome Sci & Technol, Knoxville, TN 37996 USA; [Sharma, Ritin; Hettich, Robert L.] Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37830 USA; [Klotz, Martin G.] Univ N Carolina, Dept Biol Sci, Charlotte, NC 28223 USA; [Klotz, Martin G.] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Peoples R China; [Geelhoed, Jeanine S.] NIOZ Royal Netherlands Inst Sea Res, NL-4401 NT Yerseke, Netherlands; [Strous, Marc] Univ Calgary, Dept Geosci, Calgary, AB T2N 1N4, Canada	Max Planck Society; University of Bielefeld; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of North Carolina; University of North Carolina Charlotte; Xiamen University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Calgary	Strous, M (corresponding author), Max Planck Inst Marine Mikrobiol, D-28359 Bremen, Germany.	mstrous@ucalgary.ca	Strous, Marc/B-4064-2017; Ferdelman, Timothy G/A-3758-2013; Klotz, Martin G/AAC-3880-2020; Sharma, Ritin/AAB-4693-2021; Hettich, Robert L/N-1458-2016; Klotz, Martin G/D-2091-2009; Kraft, Beate/AAK-7157-2021	Strous, Marc/0000-0001-9600-3828; Ferdelman, Timothy G/0000-0002-9701-3793; Klotz, Martin G/0000-0002-1783-375X; Sharma, Ritin/0000-0001-8365-9916; Hettich, Robert L/0000-0001-7708-786X; Klotz, Martin G/0000-0002-1783-375X; Tegetmeyer, Halina E./0000-0003-1970-4457; Kraft, Beate/0000-0003-0310-5206	European Research Council (ERC) [MASEM 242635]; ERC [StG 306933]; University of North Carolina at Charlotte; NSF [EF-0541797]; State Key Laboratory of Marine Environmental Science at Xiamen University, China; German Federal State Nordrhein-Westfalen; Max Planck Society; Direct For Biological Sciences [1202648] Funding Source: National Science Foundation	European Research Council (ERC)(European Research Council (ERC)European Commission); ERC(European Research Council (ERC)European Commission); University of North Carolina at Charlotte; NSF(National Science Foundation (NSF)); State Key Laboratory of Marine Environmental Science at Xiamen University, China; German Federal State Nordrhein-Westfalen; Max Planck Society(Max Planck SocietyFoundation CELLEX); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by European Research Council (ERC) starting grant MASEM 242635 (M.S.); ERC grant StG 306933 (J.S.G.); research incentive funds from the University of North Carolina at Charlotte, NSF grant EF-0541797, and a distinguished fellowship at the State Key Laboratory of Marine Environmental Science at Xiamen University, China (M.G.K.); the German Federal State Nordrhein-Westfalen; and the Max Planck Society. We thank I. Kattelmann and R. Vahrenhorst for their support in metagenomic sequencing and analysis, and T. Hargesheimer for CARD-FISH analysis. Raw sequencing data are publicly available under accession numbers SAMN02566827-30, SAMN02592751, SAMN02584197-8 (http://trace.ncbi.nlm.nih.gov/Traces/sra), JDSF00000000, JDSG00000000, and JDSH00000000 (www.ncbi.nlm.nih.gov/bioproject/231836).	AKUNNA JC, 1993, WATER RES, V27, P1303, DOI 10.1016/0043-1354(93)90217-6; Behrendt A, 2013, BIOGEOSCIENCES, V10, P7509, DOI 10.5194/bg-10-7509-2013; Bru D, 2011, ISME J, V5, P532, DOI 10.1038/ismej.2010.130; Brunet RC, 1996, FEMS MICROBIOL ECOL, V21, P131, DOI 10.1016/0168-6496(96)00051-7; Dong LF, 2011, LIMNOL OCEANOGR, V56, P279, DOI 10.4319/lo.2011.56.1.0279; Dong LF, 2009, APPL ENVIRON MICROB, V75, P3171, DOI 10.1128/AEM.02511-08; Fowler D, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0164; Gao H, 2012, LIMNOL OCEANOGR, V57, P185, DOI 10.4319/lo.2012.57.1.0185; Hanke A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00231; JOYE SB, 1995, SCIENCE, V270, P623, DOI 10.1126/science.270.5236.623; Mazeas L, 2008, RAPID COMMUN MASS SP, V22, P1746, DOI 10.1002/rcm.3524; Ogilvie BG, 1997, FEMS MICROBIOL ECOL, V23, P11, DOI 10.1016/S0168-6496(97)00004-4; Schmidt CS, 2011, SOIL BIOL BIOCHEM, V43, P1607, DOI 10.1016/j.soilbio.2011.02.015; Strohm TO, 2007, APPL ENVIRON MICROB, V73, P1420, DOI 10.1128/AEM.02508-06; Tiedje J.M., 1983, ANTON LEEUW INT J G, V48, P569, DOI DOI 10.1007/BF00399542; Tugtas AE, 2007, BIOTECHNOL BIOENG, V98, P756, DOI 10.1002/bit.21487; Vieira-Silva S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000808	17	276	290	57	681	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 8	2014	345	6197					676	679		10.1126/science.1254070	http://dx.doi.org/10.1126/science.1254070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6GW	25104387	Green Submitted			2022-12-28	WOS:000339962800040
J	Nair, KPS; Marsden, J				Nair, Krishnan Padmakumari Sivaraman; Marsden, Jonathan			The management of spasticity in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SPINAL-CORD-INJURY; QUALITY-OF-LIFE; TOXIN TYPE-A; INTRATHECAL BACLOFEN; MULTIPLE-SCLEROSIS; STRETCHING DEVICE; AMERICAN-ACADEMY; LIMB SPASTICITY; MUSCLE; STROKE		[Nair, Krishnan Padmakumari Sivaraman] Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Neurol, Sheffield, S Yorkshire, England; [Marsden, Jonathan] Univ Plymouth, Fac Hlth & Human Sci, Sch Hlth Profess, Plymouth PL4 8AA, Devon, England	University of Sheffield; University of Plymouth	Nair, KPS (corresponding author), Sheffield Teaching Hosp NHS Fdn Trust, Royal Hallamshire Hosp, Dept Neurol, Sheffield, S Yorkshire, England.	siva.nair@sth.nhs.uk	Nair, Krishnan/AAE-3474-2020	Nair, Krishnan/0000-0002-4004-2315	GW Pharmaceuticals, United Kingdom	GW Pharmaceuticals, United Kingdom	We have read and understood the BMJ Group policy on declaration of interests and declare the following interest: in 2009 KPSN was a site investigator for a clinical trial of Sativex for spasticity funded by GW Pharmaceuticals, United Kingdom.	Ada L, 2006, AUST J PHYSIOTHER, V52, P241, DOI 10.1016/S0004-9514(06)70003-4; Amatya B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009974.pub2; Baker K, 2007, INT J THER REHABIL, V14, P104, DOI 10.12968/ijtr.2007.14.3.23523; Ben Smail D, 2006, MULT SCLER, V12, P101, DOI 10.1191/1352458506ms1232sr; Chou R, 2004, J PAIN SYMPTOM MANAG, V28, P140, DOI 10.1016/j.jpainsymman.2004.05.002; Daniels J, 2009, J NEUROPSYCH CLIN N, V21, P371, DOI 10.1176/appi.neuropsych.21.4.371; Denno MS, 2013, ARCH PHYS MED REHAB, V94, P1731, DOI 10.1016/j.apmr.2013.03.014; Doucet BM, 2013, J HAND THER, V26, P139, DOI 10.1016/j.jht.2012.10.001; Ghidini A, 2008, ACTA OBSTET GYN SCAN, V87, P1006, DOI 10.1080/00016340802356909; Gracies JM, 2000, ARCH PHYS MED REHAB, V81, P1547, DOI 10.1053/apmr.2000.16346; Halpern R, 2013, PM&R, V5, P747, DOI 10.1016/j.pmrj.2013.04.022; Ibuki A, 2010, PROSTHET ORTHOT INT, V34, P46, DOI 10.3109/03093640903476802; Jo HM, 2013, NEUROREHABILITATION, V32, P369, DOI 10.3233/NRE-130857; Kagawa S, 2013, J STROKE CEREBROVASC, V22, P364, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.021; Katalinic OM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007455.pub2; Kheder Ammar, 2012, Pract Neurol, V12, P289, DOI 10.1136/practneurol-2011-000155; Kim EH, 2013, ANN REHABIL MED-ARM, V37, P235, DOI 10.5535/arm.2013.37.2.235; Kocabas H, 2010, EUR J PHYS REHAB MED, V46, P5; Koppel BS, 2014, NEUROLOGY, V82, P1556, DOI 10.1212/WNL.0000000000000363; Lakhan SE, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-59; Lee SJ, 2011, ANN REHABIL MED-ARM, V35, P344, DOI 10.5535/arm.2011.35.3.344; Manella KJ, 2013, RESTOR NEUROL NEUROS, V31, P633, DOI 10.3233/RNN-120255; Martin A, 2014, NEUROPSYCH DIS TREAT, V10, P111, DOI 10.2147/NDT.S53913; McCrory P, 2009, J REHABIL MED, V41, P536, DOI 10.2340/16501977-0366; McIntyre A, 2014, J SPINAL CORD MED, V37, P11, DOI 10.1179/2045772313Y.0000000102; Montane E, 2004, NEUROLOGY, V63, P1357; Moran LR, 2004, PEDIATRICS, V114, P267; Morley A, 2013, DISABIL REHABIL, V35, P1284, DOI 10.3109/09638288.2012.726691; National Institute for Health and Care Excellence, 2012, SPAST CHILDR YOUNG P; Nielsen JB, 2007, ACTA PHYSIOL, V189, P171, DOI 10.1111/j.1748-1716.2006.01652.x; ODwyer NJ, 1996, BRAIN, V119, P1737, DOI 10.1093/brain/119.5.1737; Pandyan AD, 2005, DISABIL REHABIL, V27, P2, DOI 10.1080/09638280400014576; Phadke CP, 2013, AM J PHYS MED REHAB, V92, P357, DOI 10.1097/PHM.0b013e31827d68a4; Pinder C, 2008, DISABIL REHABIL, V30, P381, DOI 10.1080/09638280701353442; Ross JC, 2011, NEUROCRIT CARE, V14, P103, DOI 10.1007/s12028-010-9422-6; Royal College of Physicians, 2009, SPAST AD MAN US BOT; Schiess MC, 2011, NEUROMODULATION, V14, P38, DOI 10.1111/j.1525-1403.2010.00308.x; Shaw L, 2010, HLTH TECHNOL ASSESS, V14; Simon O, 2010, EUR J PHYS REHAB MED, V46, P401; Simpson DM, 2008, NEUROLOGY, V70, P1691, DOI 10.1212/01.wnl.0000311391.00944.c4; Stetkarova I, 2010, NEUROREHAB NEURAL RE, V24, P609, DOI 10.1177/1545968310363585; Taricco M, 2006, Eura Medicophys, V42, P5; The National Collaborating Centre for Chronic Conditions, 2004, MULT SCLER NAT CLIN; Tyry T, 2013, J NEUROL SCI, V333, P376, DOI DOI 10.1016/j.jns.2013.07.1371; Wade DT, 2010, MULT SCLER J, V16, P707, DOI 10.1177/1352458510367462; Wissel J, 2009, J REHABIL MED, V41, P13, DOI 10.2340/16501977-0303; Yasar E, 2010, SPINAL CORD, V48, P828, DOI 10.1038/sc.2010.34; Yelnik AP, 2010, J REHABIL MED, V42, P801, DOI 10.2340/16501977-0613; Zahavi A, 2004, J NEUROL NEUROSUR PS, V75, P1553, DOI 10.1136/jnnp.2003.014282	49	54	56	0	25	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2014	349								g4737	10.1136/bmj.g4737	http://dx.doi.org/10.1136/bmj.g4737			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM9MP	25096594				2022-12-28	WOS:000340206000003
J	Trimarchi, T; Bilal, E; Ntziachristos, P; Fabbri, G; Dalla-Favera, R; Tsirigos, A; Aifantis, I				Trimarchi, Thomas; Bilal, Erhan; Ntziachristos, Panagiotis; Fabbri, Giulia; Dalla-Favera, Riccardo; Tsirigos, Aristotelis; Aifantis, Iannis			Genome-wide Mapping and Characterization of Notch-Regulated Long Noncoding RNAs in Acute Leukemia	CELL			English	Article							INITIATING CELL-ACTIVITY; DIVERGENT TRANSCRIPTION; PROSTATE-CANCER; CHROMATIN; REVEALS; ACTIVATION; ANNOTATION; REPRESSION; SUPPRESSOR; EXPRESSION	Notch signaling is a key developmental pathway that is subject to frequent genetic and epigenetic perturbations in many different human tumors. Here we investigate whether long noncoding RNA (lncRNA) genes, in addition to mRNAs, are key downstream targets of oncogenic Notch1 in human T cell acute lymphoblastic leukemia (T-ALL). By integrating transcriptome profiles with chromatin state maps, we have uncovered many previously unreported T-ALL-specific IncRNA genes, a fraction of which are directly controlled by the Notch1/Rpbjk activator complex. Finally we have shown that one specific Notch-regulated lncRNA, LUNAR1, is required for efficient T-ALL growth in vitro and in vivo due to its ability to enhance IGF1R mRNA expression and sustain IGF1 signaling. These results confirm that IncRNAs are important downstream targets of the Notch signaling pathway, and additionally they are key regulators of the oncogenic state in T-ALL.	[Trimarchi, Thomas; Ntziachristos, Panagiotis; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, Laura & Isaac Perlmutter Canc Ctr, New York, NY 10016 USA; [Trimarchi, Thomas; Ntziachristos, Panagiotis; Aifantis, Iannis] NYU, Sch Med, Helen L & Martin S Kimmel Ctr Stem Cell Biol, New York, NY 10016 USA; [Trimarchi, Thomas; Ntziachristos, Panagiotis; Tsirigos, Aristotelis; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Bilal, Erhan] IBM Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA; [Fabbri, Giulia; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Fabbri, Giulia; Dalla-Favera, Riccardo] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Tsirigos, Aristotelis] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; International Business Machines (IBM); Columbia University; Columbia University; New York University	Tsirigos, A (corresponding author), NYU, Sch Med, Dept Pathol, 550 First Ave, New York, NY 10016 USA.	aristotelis.tsirigos@nyumc.org; iannis.aifantis@nyumc.org	Ntziachristos, Panagiotis/CAG-2071-2022	Tsirigos, Aristotelis/0000-0002-7512-8477	NIH/NCI [P30 CA016087-30]; Chair's Grant [U10 CA98543]; National Cancer Institute, National Institutes of Health (Bethesda, MD, USA) [U24 CA114766]; National Institutes of Health [1RO1CA133379, 1RO1CA105129, 1RO1CA149655, 5RO1CA173636, 5RO1CA169784, 1RO1GM088847, 5T32CA009161-37, 5T32GM0072-38]; William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society [6340-11, 6373-13]; Chemotherapy Foundation; Irma T. Hirschl Trust; V Foundation for Cancer Research; St. Baldrick's Foundation; American Society of Hematology fellowship; NATIONAL CANCER INSTITUTE [R01CA173636, K99CA188293, R01CA105129, P30CA016087, R01CA149655, T32CA009161, R01CA133379, U10CA098543, R01CA169784, U24CA114766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088847] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chair's Grant; National Cancer Institute, National Institutes of Health (Bethesda, MD, USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William Lawrence and Blanche Hughes Foundation; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Chemotherapy Foundation; Irma T. Hirschl Trust; V Foundation for Cancer Research; St. Baldrick's Foundation; American Society of Hematology fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank the members of the I.A. laboratory for helpful discussions throughout the duration of the project. We thank Drs. Danny Reinberg, Roberto Bonasio, Howard Chang, and Adam Schmidtt for valuable discussions, technical advice, and reagents. We thank Drs. Sergei Koralov and Jane Skok for their continued support and helpful insight. We are grateful to Dr. Mignon Loh and the Children's Oncology Group for providing patient samples and to Dr. A. Heguy and the NYU Genome Technology Center (supported in part by NIH/NCI P30 CA016087-30 grant) for assistance with sequencing experiments. Research is supported by the Chair's Grant U10 CA98543 and Human Specimen Banking Grant U24 CA114766 of the Children's Oncology Group from the National Cancer Institute, National Institutes of Health (Bethesda, MD, USA). I.A. was supported by the National Institutes of Health (1RO1CA133379, 1RO1CA105129, 1RO1CA149655, 5RO1CA173636, 5RO1CA169784, and 1RO1GM088847). I.A. was also supported by the William Lawrence and Blanche Hughes Foundation, The Leukemia & Lymphoma Society (TRP#6340-11, LLS#6373-13), The Chemotherapy Foundation, The Irma T. Hirschl Trust, The V Foundation for Cancer Research, and the St. Baldrick's Foundation. T.T. is supported by NIH training grants 5T32CA009161-37 and 5T32GM0072-38. I.A. is a Howard Hughes Medical Institute Early Career Scientist. A.T. carried out a portion of this work while at the Computational Biology Center, IBM Research (Yorktown Heights, NY, USA). P.N. is supported by an American Society of Hematology fellowship.	Almada AE, 2013, NATURE, V499, P360, DOI 10.1038/nature12349; Boumil RM, 2001, HUM MOL GENET, V10, P2225; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Clark MB, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000625; De Keersmaecker K, 2013, NAT GENET, V45, P186, DOI 10.1038/ng.2508; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Du Z, 2013, NAT STRUCT MOL BIOL, V20, P908, DOI 10.1038/nsmb.2591; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Garding A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003373; Gomez JA, 2013, CELL, V152, P743, DOI 10.1016/j.cell.2013.01.015; Grote P, 2013, DEV CELL, V24, P206, DOI 10.1016/j.devcel.2012.12.012; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; King B, 2013, CELL, V153, P1552, DOI 10.1016/j.cell.2013.05.041; Klattenhoff CA, 2013, CELL, V152, P570, DOI 10.1016/j.cell.2013.01.003; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Kretz M, 2013, NATURE, V493, P231, DOI 10.1038/nature11661; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Lee CS, 2012, BLOOD, V120, P3288, DOI 10.1182/blood-2012-04-423061; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Li XY, 2011, J EXP MED, V208, P663, DOI 10.1084/jem.20102384; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Look A Thomas, 2004, Clin Adv Hematol Oncol, V2, P779; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Ntziachristos P, 2012, NAT MED, V18, P298, DOI 10.1038/nm.2651; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Prensner JR, 2013, NAT GENET, V45, P1392, DOI 10.1038/ng.2771; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yang LQ, 2013, NATURE, V500, P598, DOI 10.1038/nature12451; Yang LQ, 2011, CELL, V147, P773, DOI 10.1016/j.cell.2011.08.054; Yildirim E, 2013, CELL, V152, P727, DOI 10.1016/j.cell.2013.01.034; Yu L, 2011, LEUKEMIA, V25, P1042, DOI 10.1038/leu.2011.33; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	67	326	348	0	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 31	2014	158	3					593	606		10.1016/j.cell.2014.05.049	http://dx.doi.org/10.1016/j.cell.2014.05.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AN9RB	25083870	Bronze, Green Accepted			2022-12-28	WOS:000340944300012
J	Smith, ZD; Chan, MM; Humm, KC; Karnik, R; Mekhoubad, S; Regev, A; Eggan, K; Meissner, A				Smith, Zachary D.; Chan, Michelle M.; Humm, Kathryn C.; Karnik, Rahul; Mekhoubad, Shila; Regev, Aviv; Eggan, Kevin; Meissner, Alexander			DNA methylation dynamics of the human preimplantation embryo	NATURE			English	Article							STEM-CELLS; EPIGENETIC INHERITANCE; NONCODING RNA; MOUSE; RETROTRANSPOSONS; PLURIPOTENT; MAINTENANCE; LANDSCAPE; MECHANISM; EVOLUTION	In mammals, cytosine methylation is predominantly restricted to CpG dinudeotides and stably distributed across the genome, with local, cell-type-specific regulation directed by DNA binding factors(1-3). This comparatively static landscape is in marked contrast with the events of fertilization, during which the paternal genome is globally reprogrammed. Paternal genome demethylation includes the majority of CpGs, although methylation remains detectable at several notable features(4-7). These dynamics have been extensively characterized in the mouse, with only limited observations available in other mammals, and direct measurements are required to understand the extent to which early embryonic landscapes are conserved(8-10). We present genome-scale DNA methylation maps of human preimplantation development and embryonic stem cell derivation, confirming a transient state of global hypomethylation that includes most CpGs, while sites of residual maintenance are primarily restricted to gene bodies. Although most features share similar dynamics to those in mouse, maternally contributed methylation is divergently targeted to species-specific sets of CpG island promoters that extend beyond known imprint control regions. Retrotransposon regulation is also highly diverse, and transitions from maternally to embryonically expressed elements. Together, our data confirm that paternal genome demethylation is a general attribute of early mammalian development that is characterized by distinct modes of epigenetic regulation.	[Smith, Zachary D.; Chan, Michelle M.; Karnik, Rahul; Regev, Aviv; Eggan, Kevin; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Smith, Zachary D.; Karnik, Rahul; Eggan, Kevin; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Smith, Zachary D.; Humm, Kathryn C.; Karnik, Rahul; Mekhoubad, Shila; Eggan, Kevin; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Smith, Zachary D.; Mekhoubad, Shila; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Chan, Michelle M.] MIT, Computat & Syst Biol Program, Cambridge, MA 02142 USA; [Humm, Kathryn C.] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Boston, MA 02215 USA; [Humm, Kathryn C.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Humm, Kathryn C.] Boston IVF, Waltham, MA 02451 USA; [Humm, Kathryn C.; Regev, Aviv] MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Regev, Aviv] MIT, Cambridge, MA 02142 USA; [Eggan, Kevin] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Howard Hughes Medical Institute	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	keggan@scrb.harvard.edu; alexander_meissner@harvard.edu	Eggan, Kevin/P-7119-2018	Karnik, Rahul/0000-0002-0400-635X	Harvard Stem Cell Institute; NIH Pioneer Award [5DP10D003958]; Burroughs Wellcome Career Award at the Scientific Interface; HHMI; Center for Excellence in Genome Science from the NHGRI [1P50HG006193-01]; New York Stem Cell Foundation;  [P01GM099117]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); HHMI(Howard Hughes Medical Institute); Center for Excellence in Genome Science from the NHGRI; New York Stem Cell Foundation; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank all members of the Meissner, Regev and Eggan laboratories, in particular M. Ziller for critical reading of the text and K. Koszka for supervising human embryo thawing. We also thank D. Sakkas and R. Holmes of Boston IVF for clinical assessment of embryo morphology and viability, as well as S. Levine, M. Gravina and K. Thai from the MIT BioMicro Center. Finally, we thank T. S. Mikkelsen, H. Gu, and A. Gnirke from the Broad Institute for their guidance and expertise. A.R. is an investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute. This work was supported by the Harvard Stem Cell Institute (K.E.), and NIH Pioneer Award (5DP10D003958), the Burroughs Wellcome Career Award at the Scientific Interface and HHMI (to A.R. and K.E.), P01GM099117 (to A.M. and K. E.) and a Center for Excellence in Genome Science from the NHGRI (1P50HG006193-01, to A.R. and A.M.). A.M. is a New York Stem Cell Foundation Robertson Investigator. This research was supported by The New York Stem Cell Foundation.	Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chenoweth JG, 2010, METHODS MOL BIOL, V636, P25, DOI 10.1007/978-1-60761-691-7_2; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Fuchs NV, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-115; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Hackett JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0328; Hancks DC, 2012, CURR OPIN GENET DEV, V22, P191, DOI 10.1016/j.gde.2012.02.006; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kelsey G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0336; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kobayashi H, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002440; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lepikhov K, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-8; Lu XY, 2014, NAT STRUCT MOL BIOL, V21, P423, DOI 10.1038/nsmb.2799; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mertineit C, 1998, DEVELOPMENT, V125, P889; Molaro A, 2011, CELL, V146, P1028, DOI 10.1016/j.cell.2011.08.016; Santos F, 2010, HUM REPROD, V25, P2387, DOI 10.1093/humrep/deq151; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; Smits G, 2008, NAT GENET, V40, P971, DOI 10.1038/ng.168; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Woodfine K, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-1; Wu GM, 2013, NAT CELL BIOL, V15, P1089, DOI 10.1038/ncb2816; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	31	378	398	4	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 30	2014	511	7511					611	+		10.1038/nature13581	http://dx.doi.org/10.1038/nature13581			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM0VT	25079558	Green Submitted, Green Accepted			2022-12-28	WOS:000339566300039
J	Gammon, K				Gammon, Katharine			DRUG DISCOVERY Leaving no stone unturned	NATURE			English	Editorial Material																		Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Hancock REW, 2012, NAT REV MICROBIOL, V10, P243, DOI 10.1038/nrmicro2745; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/nnano.2013.254, 10.1038/NNANO.2013.254]; Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]; Lee RE, 2014, NAT MED, V20, P152, DOI 10.1038/nm.3458; Scholl D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033637; Tan CM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003592; Wilson MC, 2014, NATURE, V506, P58, DOI 10.1038/nature12959; Zlitni S, 2013, NAT CHEM BIOL, V9, P796, DOI [10.1038/nchembio.1361, 10.1038/NCHEMBIO.1361]	9	15	15	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					S10	S12		10.1038/509S10a	http://dx.doi.org/10.1038/509S10a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24784422	Bronze			2022-12-28	WOS:000335199100006
J	Antoniou, AC; Casadei, S; Heikkinen, T; Barrowdale, D; Pylkas, K; Roberts, J; Lee, A; Subramanian, D; De Leeneer, K; Fostira, F; Tomiak, E; Neuhausen, SL; Teo, ZL; Khan, S; Aittomaki, K; Moilanen, JS; Turnbull, C; Seal, S; Mannermaa, A; Kallioniemi, A; Lindeman, GJ; Buys, SS; Andrulis, IL; Radice, P; Tondini, C; Manoukian, S; Toland, AE; Miron, P; Weitzel, JN; Domchek, SM; Poppe, B; Claes, KBM; Yannoukakos, D; Concannon, P; Bernstein, JL; James, PA; Easton, DF; Goldgar, DE; Hopper, JL; Rahman, N; Peterlongo, P; Nevanlinna, H; King, MC; Couch, FJ; Southey, MC; Winqvist, R; Foulkes, WD; Tischkowitz, M				Antoniou, A. C.; Casadei, S.; Heikkinen, T.; Barrowdale, D.; Pylkaes, K.; Roberts, J.; Lee, A.; Subramanian, D.; De Leeneer, K.; Fostira, F.; Tomiak, E.; Neuhausen, S. L.; Teo, Z. L.; Khan, S.; Aittomaeki, K.; Moilanen, J. S.; Turnbull, C.; Seal, S.; Mannermaa, A.; Kallioniemi, A.; Lindeman, G. J.; Buys, S. S.; Andrulis, I. L.; Radice, P.; Tondini, C.; Manoukian, S.; Toland, A. E.; Miron, P.; Weitzel, J. N.; Domchek, S. M.; Poppe, B.; Claes, K. B. M.; Yannoukakos, D.; Concannon, P.; Bernstein, J. L.; James, P. A.; Easton, D. F.; Goldgar, D. E.; Hopper, J. L.; Rahman, N.; Peterlongo, P.; Nevanlinna, H.; King, M. -C.; Couch, F. J.; Southey, M. C.; Winqvist, R.; Foulkes, W. D.; Tischkowitz, M.			Breast-Cancer Risk in Families with Mutations in PALB2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; ASCERTAINMENT SAMPLING PROBLEM; BRCA2-INTERACTING PROTEIN; ATAXIA-TELANGIECTASIA; SUSCEPTIBILITY GENE; PANCREATIC-CANCER; BRCA2; PENETRANCE; CARRIERS; WOMEN	BACKGROUND Germline loss-of-function mutations in PALB2 are known to confer a predisposition to breast cancer. However, the lifetime risk of breast cancer that is conferred by such mutations remains unknown. METHODS We analyzed the risk of breast cancer among 362 members of 154 families who had deleterious truncating, splice, or deletion mutations in PALB2. The age-specific breast-cancer risk for mutation carriers was estimated with the use of a modified segregation-analysis approach that allowed for the effects of PALB2 genotype and residual familial aggregation. RESULTS The risk of breast cancer for female PALB2 mutation carriers, as compared with the general population, was eight to nine times as high among those younger than 40 years of age, six to eight times as high among those 40 to 60 years of age, and five times as high among those older than 60 years of age. The estimated cumulative risk of breast cancer among female mutation carriers was 14% (95% confidence interval [CI], 9 to 20) by 50 years of age and 35% (95% CI, 26 to 46) by 70 years of age. Breast-cancer risk was also significantly influenced by birth cohort (P < 0.001) and by other familial factors (P = 0.04). The absolute breast-cancer risk for PALB2 female mutation carriers by 70 years of age ranged from 33% (95% CI, 25 to 44) for those with no family history of breast cancer to 58% (95% CI, 50 to 66) for those with two or more first-degree relatives with breast cancer at 50 years of age. CONCLUSIONS Loss-of-function mutations in PALB2 are an important cause of hereditary breast cancer, with respect both to the frequency of cancer-predisposing mutations and to the risk associated with them. Our data suggest the breast-cancer risk for PALB2 mutation carriers may overlap with that for BRCA2 mutation carriers.	[Antoniou, A. C.; Barrowdale, D.; Lee, A.; Easton, D. F.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Easton, D. F.] Univ Cambridge, Dept Oncol, Cambridge, England; [Easton, D. F.] Univ Cambridge, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Tischkowitz, M.] Univ Cambridge, Dept Med Genet, Cambridge, England; [Tischkowitz, M.] Univ Cambridge, Natl Inst Hlth Res Cambridge Biomed Res Ctr, Cambridge, England; [Roberts, J.; Subramanian, D.; Tischkowitz, M.] Addenbrookes Hosp, East Anglian Reg Genet Serv, Dept Clin Genet, Cambridge CB2 0QQ, England; [Seal, S.; Tondini, C.; Rahman, N.] Inst Canc Res, Oncogenet Team, London SW3 6JB, England; [Seal, S.; Tondini, C.; Rahman, N.] Royal Marsden Natl Hlth Serv Fdn Trust, London, England; [Casadei, S.; King, M. -C.] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Heikkinen, T.; Khan, S.; Nevanlinna, H.] Univ Helsinki, Dept Obstet & Gynecol, Helsinki, Finland; [Heikkinen, T.; Khan, S.; Nevanlinna, H.] Helsinki Univ Cent Hosp, Helsinki, Finland; [Aittomaeki, K.] Helsinki Univ Cent Hosp, Dept Clin Genet, Helsinki, Finland; [Pylkaes, K.; Winqvist, R.] Univ Oulu, Dept Clin Chem, Lab Canc Genet & Tumor Biol, Oulu, Finland; [Pylkaes, K.; Winqvist, R.] Univ Oulu, Bioctr, Oulu, Finland; [Pylkaes, K.; Winqvist, R.] Oulu Univ Hosp, Lab Canc Genet & Tumor Biol, Northern Finland Lab Ctr NordLab, Oulu, Finland; [Moilanen, J. S.] Univ Oulu, Dept Clin Genet, Oulu, Finland; [Moilanen, J. S.] Oulu Univ Hosp, Oulu, Finland; [Mannermaa, A.] Univ Eastern Finland, Bioctr Kuopio, Kuopio, Finland; [Mannermaa, A.] Univ Eastern Finland, Canc Ctr Eastern Finland, Kuopio, Finland; [Kallioniemi, A.] Univ Tampere, Inst Biomed Technol Canc Genom, FIN-33101 Tampere, Finland; [De Leeneer, K.; Poppe, B.; Claes, K. B. M.] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium; [Fostira, F.; Yannoukakos, D.] Natl Ctr Sci Res Demokritos, Inst Nucl & Radiol Sci & Technol Energy & Safety, Mol Diagnost Lab, Athens, Greece; [Tomiak, E.] Childrens Hosp Eastern Ontario, Dept Genet, Eastern Ontario Reg Genet Program, Ottawa, ON K1H 8L1, Canada; [Andrulis, I. L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Foulkes, W. D.] McGill Univ, Program Canc Genet, Dept Human Genet, Lady Davis Inst,Hlth Ctr, Montreal, PQ, Canada; [Foulkes, W. D.] McGill Univ, Program Canc Genet, Dept Oncol, Lady Davis Inst,Hlth Ctr, Montreal, PQ, Canada; [Foulkes, W. D.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Neuhausen, S. L.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Duarte, CA 91010 USA; [Weitzel, J. N.] City Hope Natl Med Ctr, Div Clin Canc Genet, Duarte, CA USA; [Teo, Z. L.; Southey, M. C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Lindeman, G. J.] Royal Melbourne Hosp, Familial Canc Ctr, Parkville, Vic 3050, Australia; [Lindeman, G. J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Stem Cells & Canc Div, Parkville, Vic 3050, Australia; [James, P. A.] Univ Melbourne, Peter MacCallum Canc Ctr, Familial Canc Ctr, Melbourne, Vic, Australia; [Hopper, J. L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic, Australia; [Buys, S. S.; Goldgar, D. E.] Univ Utah, Sch Med, Huntsman Canc Inst, Salt Lake City, UT USA; [Radice, P.] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, Dept Prevent & Predict Med, Unit Mol Bases Genet Risk & Genet Testing, I-20133 Milan, Italy; [Manoukian, S.] Ist Nazl Tumori, Fdn Ist Ricovero & Cura Carattere Sci, Dept Prevent & Predict Med, Unit Med Genet, I-20133 Milan, Italy; [Peterlongo, P.] Fdn Italiana Ric Canc, Ist Oncol Mol, Milan, Italy; [Turnbull, C.] Azienda Osped Papa Giovanni XXIII, Med Oncol Unit, Bergamo, Italy; [Toland, A. E.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Miron, P.] Case Western Reserve Univ, Sch Med, Dept Genet & Genome Sci, Cleveland, OH USA; [Domchek, S. M.] Univ Penn, Abramson Canc Ctr, Basser Res Ctr, Philadelphia, PA 19104 USA; [Concannon, P.] Univ Florida, Genet Inst, Gainesville, FL USA; [Concannon, P.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA; [Bernstein, J. L.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Couch, F. J.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Couch, F. J.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of Washington; University of Washington Seattle; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Eastern Finland; University of Eastern Finland; Tampere University; Ghent University; Ghent University Hospital; National Centre of Scientific Research "Demokritos"; University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Lady Davis Institute; McGill University; Lady Davis Institute; McGill University; McGill University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; University of Melbourne; Royal Melbourne Hospital; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; ASST Papa Giovanni XXIII; University System of Ohio; Ohio State University; Case Western Reserve University; University of Pennsylvania; Pennsylvania Medicine; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Memorial Sloan Kettering Cancer Center; Mayo Clinic; Mayo Clinic	Tischkowitz, M (corresponding author), Addenbrookes Hosp, Addenbrookes Treatment Ctr, Dept Med Genet, Box 134,Level 6,Hills Rd, Cambridge CB2 0QQ, England.	mdt33@cam.ac.uk	Radice, Paolo/O-3119-2013; De Leeneer, Kim/AFS-1595-2022; manoukian, siranoush/E-7132-2017; Peterlongo, Paolo/Q-4717-2018; Tischkowitz, Marc/O-4452-2018; Moilanen, Jukka S/G-2604-2012; Fostira, Florentia/Z-5730-2019; Andrulis, Irene L./E-7267-2013; Foulkes, William D./AAR-9586-2021; Claes, Kathleen/AFR-6830-2022; Turnbull, Clare/AAA-6596-2019; TONDINI, CARLO ALBERTO/AAB-7786-2019; Rahman, Nazneen/D-2802-2013	Radice, Paolo/0000-0001-6298-4111; De Leeneer, Kim/0000-0002-9319-411X; manoukian, siranoush/0000-0002-6034-7562; Peterlongo, Paolo/0000-0001-6951-6855; Tischkowitz, Marc/0000-0002-7880-0628; Moilanen, Jukka S/0000-0002-8041-3205; Foulkes, William D./0000-0001-7427-4651; Claes, Kathleen/0000-0003-0841-7372; TONDINI, CARLO ALBERTO/0000-0003-0635-8954; James, Paul/0000-0002-4361-4657; Khan, Sofia/0000-0003-4185-8882; Winqvist, Robert/0000-0003-0932-9104; Nevanlinna, Heli/0000-0002-0916-2976; King, Mary-Claire/0000-0001-9426-1743; Heikkinen, Tuomas/0000-0003-1154-6204; Turnbull, Clare/0000-0002-1734-5772; Rahman, Nazneen/0000-0003-4376-0440; Southey, Melissa/0000-0002-6313-9005; Thorne, Heather/0000-0003-3610-2511; Lindeman, Geoffrey/0000-0001-9386-2416; Kallioniemi, Anne/0000-0003-3552-8158; Barrowdale, Daniel/0000-0003-1661-3939; Concannon, Patrick/0000-0002-5801-1859; Yannoukakos, Drakoulis/0000-0001-7509-3510; Pylkas, Katri/0000-0002-2449-0521; Roberts, Jonathan/0000-0003-3153-1077	European Union Seventh Framework Program, European Research Council [310018]; Cancer Research UK [C12292/A11174]; National Institutes of Health [R01CA175716, CA128978, CA116167, CA116201, UM1 CA164920, RFA CA-06-503, U01 CA69467, U01 CA69417, U01 CA69398, U01 CA69631, U01 CA69446, U01 CA69638]; Academy of Finland [122715, 250083, 251314, 266528]; Finnish Cancer Foundation; Sigrid Juselius Foundation; University of Oulu; University of Oulu Support Foundation; Biocenter Oulu; special Finnish Government EVO funds; Helsinki University Central Hospital Research Fund; Nordic Cancer Union; Fund for Scientific Research Flanders [G.A044.10]; Ghent University [BOF10/GOA/019]; European Union European Social Fund; National Strategic Reference Framework Research Funding Program, General Secretariat for Research and Technology; Ohio State Comprehensive Cancer Center; Stefanie Spielman Fund for Breast Cancer Research; National Cancer Institute [RC4A153828, CA083178, CA097397, CA114236, CA129639]; Associazione Italiana per la Ricerca sul Cancro [IG 4017]; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori; National Health and Medical Research Council Australia [APP1029974]; Victorian Cancer Agency [CTTS07, EOI09_50]; Victorian Breast Cancer Research Consortium; Cancer Research UK [16563, 10118, 15106, 11174, 11022] Funding Source: researchfish; Cancer Foundation Finland sr [110135] Funding Source: researchfish; National Breast Cancer Foundation [IF-12-06] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U01CA069638, R01CA129639, R01CA157744, R01CA097397, R01CA116167, U01CA069446, U01CA083178, R01CA128978, P30CA016520, U01CA069467, R35CA197458, U01CA069631, P50CA116201, U01CA069417, RC4CA153828, R01CA114236, U01CA116167, R01CA175716, UM1CA164920, U01CA069398] Funding Source: NIH RePORTER	European Union Seventh Framework Program, European Research Council(European Research Council (ERC)); Cancer Research UK(Cancer Research UK); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Oulu; University of Oulu Support Foundation; Biocenter Oulu; special Finnish Government EVO funds; Helsinki University Central Hospital Research Fund; Nordic Cancer Union; Fund for Scientific Research Flanders(FWO); Ghent University(Ghent University); European Union European Social Fund(European Social Fund (ESF)European Commission); National Strategic Reference Framework Research Funding Program, General Secretariat for Research and Technology; Ohio State Comprehensive Cancer Center; Stefanie Spielman Fund for Breast Cancer Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori; National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cancer Agency; Victorian Breast Cancer Research Consortium; Cancer Research UK(Cancer Research UK); Cancer Foundation Finland sr; National Breast Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the European Union Seventh Framework Program (2007-2013)/European Research Council (310018, to Dr. Tischkowitz); Cancer Research UK (C12292/A11174, to Dr. Antoniou); the National Institutes of Health (R01CA175716, to Drs. Casadei and King; CA128978, CA116167, and CA116201, to Dr. Couch; and RFA CA-06-503, UM1 CA164920, RFA CA-06-503, U01 CA69467, U01 CA69417, U01 CA69398, U01 CA69631, U01 CA69446, and U01 CA69638, to Drs. Teo, Southey, Andrulis, Goldgar, and Hopper); the Academy of Finland (122715, to Dr. Winqvist; 250083, to Dr. Pylkas; Center of Excellence 251314, to Dr. Winqvist; and 266528, to Dr. Nevanlinna); the Finnish Cancer Foundation (to Dr. Winqvist and to Dr. Nevanlinna); the Sigrid Juselius Foundation (to Dr. Winqvist and to Dr. Nevanlinna); the University of Oulu, the University of Oulu Support Foundation and Biocenter Oulu, and the special Finnish Government EVO funds for Oulu University Hospital-based research activities (to Dr. Winqvist); the Helsinki University Central Hospital Research Fund and the Nordic Cancer Union (to Dr. Nevanlinna); the Fund for Scientific Research Flanders (G.A044.10, to Dr. Claes); Ghent University (BOF10/GOA/019, to Dr. De Leeneer); the European Union European Social Fund and Greek national funds through the operational program "Education and Lifelong Learning" of the National Strategic Reference Framework Research Funding Program, General Secretariat for Research and Technology (to Dr. Yannoukakos); Ohio State Comprehensive Cancer Center and the Stefanie Spielman Fund for Breast Cancer Research (to Dr. Toland); the National Cancer Institute (RC4A153828, to Dr. Weitzel; and CA083178, CA097397, CA114236, and CA129639, to Drs. Concannon and Bernstein); Susan G. Komen (to Drs. Domchek and Foulkes); Associazione Italiana per la Ricerca sul Cancro (IG 4017, to Drs. Manoukian and Peterlongo); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori (to Dr. Peterlongo); and National Health and Medical Research Council Australia (APP1029974), the Victorian Cancer Agency (CTTS07, EOI09_50), and the Victorian Breast Cancer Research Consortium (to Dr. Southey).	Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Antoniou AC, 2008, BRIT J CANCER, V98, P1457, DOI 10.1038/sj.bjc.6604305; Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Barnes DR, 2013, BRIT J CANCER, V108, P2610, DOI 10.1038/bjc.2013.277; Begg CB, 2002, J NATL CANCER I, V94, P1221; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Blanco A, 2012, BREAST CANCER RES TR, V132, P307, DOI 10.1007/s10549-011-1842-2; Byrnes GB, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2099; CANNINGS C, 1977, CLIN GENET, V12, P208; Casadei S, 2011, CANCER RES, V71, P2222, DOI 10.1158/0008-5472.CAN-10-3958; Ding YC, 2011, BREAST CANCER RES TR, V126, P771, DOI 10.1007/s10549-010-1195-2; Erkko H, 2008, CLIN CANCER RES, V14, P4667, DOI 10.1158/1078-0432.CCR-08-0210; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Evans DG, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3829; EWENS WJ, 1986, THEOR POPUL BIOL, V30, P388, DOI 10.1016/0040-5809(86)90042-0; Foulkes WD, 2002, J MED GENET, V39, P407, DOI 10.1136/jmg.39.6.407; Foulkes WD, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1828; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Heikkinen T, 2009, CLIN CANCER RES, V15, P3214, DOI 10.1158/1078-0432.CCR-08-3128; Honrado E, 2006, CRIT REV ONCOL HEMAT, V59, P27, DOI 10.1016/j.critrevonc.2006.01.006; Jones S, 2009, SCIENCE, V324, P217, DOI 10.1126/science.1171202; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; LANGE K, 1988, GENET EPIDEMIOL, V5, P471, DOI 10.1002/gepi.1370050611; Levy-Lahad E, 2001, P NATL ACAD SCI USA, V98, P3232, DOI 10.1073/pnas.051624098; Murphy CD, 2008, CANCER, V113, P3116, DOI 10.1002/cncr.23913; Olsen JH, 2005, BRIT J CANCER, V93, P260, DOI 10.1038/sj.bjc.6602658; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; SHUTE NCE, 1988, AM J HUM GENET, V43, P387; Sy SMH, 2009, J BIOL CHEM, V284, P18302, DOI 10.1074/jbc.M109.016717; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Tischkowitz M, 2010, CANCER RES, V70, P7353, DOI 10.1158/0008-5472.CAN-10-1012; Tischkowitz MD, 2009, GASTROENTEROLOGY, V137, P1183, DOI 10.1053/j.gastro.2009.06.055; Weischer M, 2008, J CLIN ONCOL, V26, P542, DOI 10.1200/JCO.2007.12.5922; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Zhang F, 2009, CURR BIOL, V19, P524, DOI 10.1016/j.cub.2009.02.018	38	543	553	1	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 7	2014	371	6					497	506		10.1056/NEJMoa1400382	http://dx.doi.org/10.1056/NEJMoa1400382			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AM5LE	25337756	Green Published, Green Accepted			2022-12-28	WOS:000339899100004
